Citrus Sinensis ID: 036815

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010---
Protein Sequence
MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ
Secondary Structure (PSIPRED)
cccEEEcccccccccccccccccccccEEEccccccccccccccccccccccEEEcccccccccccHHHHcccccccEEEccccccEEEcccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccHHHHHccccccEEEccccccEEcccccccccccccEEcccccccccccccccccccccccEEEcccccccccccHHHHccccccEEEccccccEEcccccHHcccccccEEEccccccEEcccHHHHccccccEEEccccEEEEccccccccccccccEEccccccEEcccccccccccccEEEcccccccccccccccccccccEEEccccEEEEcccHHcccccccccEEccccEEEEcccccccccccccEEEcccccccccccHHHHHcccccccccccccccccccccccccccccccccccEEcccHHHcccccccccccccccccccHHHHHcccccccccccccccccccHHHHHccccccEEEcccccccccccHHHHccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHccccccccccEEEEEEEcccEEEEEcccccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEcccccccccccccccEEEcccccccccccccccEEEccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHcccccEEEccccccccccccccHHHHHHHHHHHHHHHHccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEcccccccccccHHHccccccEEEEcccccccccccHHHHHcccccEEEEEccccccccccHHHHHccccccEEEEccccccccccccHcccccccccEEEEcccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHHHHHHcccEEEcccccccccccHHHcccccccEEEcccccccccccHHHHHHcccccEEEcccccccccHHHHHccccccEEEEEccccccccccHHHHcccccccEEEcccccccccccHHHccccccEEEEEcEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccccEEEccHHHHcccccEEEEcccccccccccHHHHcccccEEEEccccccccccccccccccEEEcccccccccccHHHcccccccEEEccccccccccHHHccccccEEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHccccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEcccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHccccccccccccccccccccccccccccHHHcccccccccHHHHHHHHccccHccEEEcccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHcHcHcHHHHHHEEcccccEEEEEEccccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEcccccHHHHHHcHHHEEcccccccEEEEEccccccccccHcEEEEEcccccHEHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccHHHccHHHcccccccccccccHHHHHHHHHHHHHHHHcccccccccccc
Coil and Loop (DISEMBL)
MLSVLKLssnlftlnstsllqlpfgLKQLelssaglvglvpdnlfsklpnlVYLNASYnnltgflpetllsnsdklelLDLSynnltgsisgfslnenscnsllhldlsqnhimdvipsslsnctkLKILNLSFNLLageiprtfgqlsslqrldlsnnhitgwipselgNACDSLLElklphnnitgsfpvtlsscsWLQLldlsnnnisgpfpdsvlenlgsleslilsnnmisgsfpdsisscktlrivdfssnrvsgiippdicpgvssleelrlpdnlitgvipgqlsectqlKVIDLSLNylngsipqelgKLEHLEQFIAWFNglegkippelgkcknlkdlilnnnklsgeipaelfscsnlewisltgneltgqippefsRLTRLAVLQLGnnrfkgeipgelgncsslvwldlnsnnltgdipprlgrqlgakplggflssnTLVFVRNVGnsckgvggllefagirperllqiptlkscdfarmysgpvlslftQYQTLEYLDLSYnqfrgkipdEIGDMIALQVLELAHNqlsgeipsslgrlrnlgvfdashnrlqgqipesfsNLSFLVQIdlsnneltgpipqrgqlstlpasqyannpglcgvplpecrngnnqpalnpsvdaarHGHRVAAAAWANSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATtwkidkekeplsinVATFQRQLRKLKFSQLIeatngfsaesligcggfGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGkikhrnlvpllgyckigeeRLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCflhhnciphiihrdmkssnvlldhemearVSDFGMARLISALDTHLsvstlagtpgyvppeyyqsfrctakgdvYSFGVVLLELltgkrptdkddfgdtnlvGWVKMKVregkqmevidpelllvtkgtdesEAEEVKEMVRYLEITLQcvddfpskrpnmlq
Flexible Loop (DISEMBL)
MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSsnrvsgiippdiCPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLnslqashaattwkidkekepLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMEtlgkikhrnlvPLLGYCKIGEERLLVYEFMKFGSLEEVlhgrakardqrilTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLtgkrptdkddfgdtnlvgWVKMKvregkqmevidpelllvtkgtdesEAEEVKEMVRYLEITlqcvddfpskrpnmlq
Low Complexity Region (SEG)
MLSVlklssnlftlnstsllqlPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGkcknlkdlilnnnklSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDaarhghrvaaaawaNSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDarkkiargaakgLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ
Disordered region (IsUnstruct)
******LSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSN*************************GLCGVPL*******************RHGHRVAAAAWANSIVMGVLISIASICILIVWAIAMRARR********L**LQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK*********VKEMVRYLEITLQCVDD**********
Disordered Region (DISOPRED)
MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPEC***************************ANSIVMGVLISIASICILIVWAIAMRARR*******************************INVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC*GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML*
Disordered Region (DISEMBL)
MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ
Disordered Region (DISPRO)
MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNG****************HRVAAAAWANSIVMGVLISIASICILIVWAIAMRARR****************************PLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFP********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1013	2.2.26 [Sep-21-2011]
Q9ZPS9	1143	Serine/threonine-protein	yes	no	0.995	0.881	0.749	0.0
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.973	0.845	0.504	0.0
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.967	0.811	0.501	0.0
Q9LJF3	1164	Receptor-like protein kin	no	no	0.953	0.829	0.514	0.0
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.967	0.811	0.500	0.0
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.940	0.796	0.497	0.0
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.949	0.807	0.378	1e-168
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.930	0.755	0.349	1e-144
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.926	0.75	0.343	1e-140
C0LGJ1	1106	Probable LRR receptor-lik	no	no	0.885	0.811	0.343	1e-137

>sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1

 Score = 1529 bits (3959), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 765/1021 (74%), Positives = 878/1021 (85%), Gaps = 13/1021 (1%)

Query: 2    LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
            LSVLKLS N F LNSTSLL LP  L  LELSS+GL+G +P+N FSK  NL+ +  SYNN 
Sbjct: 105  LSVLKLSENFFVLNSTSLLLLPLTLTHLELSSSGLIGTLPENFFSKYSNLISITLSYNNF 164

Query: 62   TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
            TG LP  L  +S KL+ LDLSYNN+TG ISG ++  +SC S+ +LD S N I   I  SL
Sbjct: 165  TGKLPNDLFLSSKKLQTLDLSYNNITGPISGLTIPLSSCVSMTYLDFSGNSISGYISDSL 224

Query: 122  SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
             NCT LK LNLS+N   G+IP++FG+L  LQ LDLS+N +TGWIP E+G+ C SL  L+L
Sbjct: 225  INCTNLKSLNLSYNNFDGQIPKSFGELKLLQSLDLSHNRLTGWIPPEIGDTCRSLQNLRL 284

Query: 182  PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
             +NN TG  P +LSSCSWLQ LDLSNNNISGPFP+++L + GSL+ L+LSNN+ISG FP 
Sbjct: 285  SYNNFTGVIPESLSSCSWLQSLDLSNNNISGPFPNTILRSFGSLQILLLSNNLISGDFPT 344

Query: 242  SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
            SIS+CK+LRI DFSSNR SG+IPPD+CPG +SLEELRLPDNL+TG IP  +S+C++L+ I
Sbjct: 345  SISACKSLRIADFSSNRFSGVIPPDLCPGAASLEELRLPDNLVTGEIPPAISQCSELRTI 404

Query: 302  DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
            DLSLNYLNG+IP E+G L+ LEQFIAW+N + G+IPPE+GK +NLKDLILNNN+L+GEIP
Sbjct: 405  DLSLNYLNGTIPPEIGNLQKLEQFIAWYNNIAGEIPPEIGKLQNLKDLILNNNQLTGEIP 464

Query: 362  AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL 421
             E F+CSN+EW+S T N LTG++P +F  L+RLAVLQLGNN F GEIP ELG C++LVWL
Sbjct: 465  PEFFNCSNIEWVSFTSNRLTGEVPKDFGILSRLAVLQLGNNNFTGEIPPELGKCTTLVWL 524

Query: 422  DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL 481
            DLN+N+LTG+IPPRLGRQ G+K L G LS NT+ FVRNVGNSCKGVGGL+EF+GIRPERL
Sbjct: 525  DLNTNHLTGEIPPRLGRQPGSKALSGLLSGNTMAFVRNVGNSCKGVGGLVEFSGIRPERL 584

Query: 482  LQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH 541
            LQIP+LKSCDF RMYSGP+LSLFT+YQT+EYLDLSYNQ RGKIPDEIG+MIALQVLEL+H
Sbjct: 585  LQIPSLKSCDFTRMYSGPILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSH 644

Query: 542  NQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ 601
            NQLSGEIP ++G+L+NLGVFDAS NRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ
Sbjct: 645  NQLSGEIPFTIGQLKNLGVFDASDNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ 704

Query: 602  LSTLPASQYANNPGLCGVPLPECRNGNNQ-PALNPSVDAARHGHRVAAAAWANSIVMGVL 660
            LSTLPA+QYANNPGLCGVPLPEC+NGNNQ PA       A+HG R  AA+WANSIV+GVL
Sbjct: 705  LSTLPATQYANNPGLCGVPLPECKNGNNQLPAGTEEGKRAKHGTR--AASWANSIVLGVL 762

Query: 661  ISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 720
            IS AS+CILIVWAIA+RARR++A++ KML+SLQA ++ATTWKI+KEKEPLSINVATFQRQ
Sbjct: 763  ISAASVCILIVWAIAVRARRRDADDAKMLHSLQAVNSATTWKIEKEKEPLSINVATFQRQ 822

Query: 721  LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 780
            LRKLKFSQLIEATNGFSA S+IG GGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE
Sbjct: 823  LRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 882

Query: 781  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
            METLGKIKHRNLVPLLGYCKIGEERLLVYEFM++GSLEEVLHG      +RIL W+ RKK
Sbjct: 883  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKK 942

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
            IA+GAAKGLCFLHHNCIPHIIHRDMKSSNVLLD +MEARVSDFGMARLISALDTHLSVST
Sbjct: 943  IAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVST 1002

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
            LAGTPGYVPPEYYQSFRCTAKGDVYS GVV+LE+L+GKRPTDK++FGDTNLVGW KMK R
Sbjct: 1003 LAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPTDKEEFGDTNLVGWSKMKAR 1062

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEE--------VKEMVRYLEITLQCVDDFPSKRPNML 1012
            EGK MEVID +LL   +G+ ES  E+        VKEM+RYLEI L+CVDDFPSKRPNML
Sbjct: 1063 EGKHMEVIDEDLL--KEGSSESLNEKEGFEGGVIVKEMLRYLEIALRCVDDFPSKRPNML 1120

Query: 1013 Q 1013
            Q
Sbjct: 1121 Q 1121

Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  960 bits (2482), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 519/1029 (50%), Positives = 685/1029 (66%), Gaps = 43/1029 (4%)

Query: 2    LSVLKLSSNLFTLNSTSLLQLPFG----LKQLELSSAGLVG---LVPDNLFSKLPNLVYL 54
            L VL LSSN  +++  S++   F     L  + +S+  LVG     P    S L +L  +
Sbjct: 127  LQVLDLSSN--SISDYSMVDYVFSKCSNLVSVNISNNKLVGKLGFAP----SSLQSLTTV 180

Query: 55   NASYNNLTGFLPETLLSN-SDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHI 113
            + SYN L+  +PE+ +S+    L+ LDL++NNL+G  S  S     C +L    LSQN++
Sbjct: 181  DLSYNILSDKIPESFISDFPASLKYLDLTHNNLSGDFSDLSFG--ICGNLTFFSLSQNNL 238

Query: 114  M-DVIPSSLSNCTKLKILNLSFNLLAGEIP--RTFGQLSSLQRLDLSNNHITGWIPSELG 170
              D  P +L NC  L+ LN+S N LAG+IP    +G   +L++L L++N ++G IP EL 
Sbjct: 239  SGDKFPITLPNCKFLETLNISRNNLAGKIPNGEYWGSFQNLKQLSLAHNRLSGEIPPELS 298

Query: 171  NACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLIL 230
              C +L+ L L  N  +G  P   ++C WLQ L+L NN +SG F ++V+  +  +  L +
Sbjct: 299  LLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNNYLSGDFLNTVVSKITGITYLYV 358

Query: 231  SNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSS--LEELRLPDNLITGVI 288
            + N ISGS P S+++C  LR++D SSN  +G +P   C   SS  LE++ + +N ++G +
Sbjct: 359  AYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSGTV 418

Query: 289  PGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELG-KCKNLK 347
            P +L +C  LK IDLS N L G IP+E+  L +L   + W N L G IP  +  K  NL+
Sbjct: 419  PMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLE 478

Query: 348  DLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGE 407
             LILNNN L+G IP  +  C+N+ WISL+ N LTG+IP     L++LA+LQLGNN   G 
Sbjct: 479  TLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGN 538

Query: 408  IPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS-CKG 466
            +P +LGNC SL+WLDLNSNNLTGD+P  L  Q G   + G +S     FVRN G + C+G
Sbjct: 539  VPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAGLV-MPGSVSGKQFAFVRNEGGTDCRG 597

Query: 467  VGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPD 526
             GGL+EF GIR ERL ++P + SC   R+YSG  +  F+   ++ Y D+SYN   G IP 
Sbjct: 598  AGGLVEFEGIRAERLERLPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPP 657

Query: 527  EIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQID 586
              G+M  LQVL L HN+++G IP S G L+ +GV D SHN LQG +P S  +LSFL  +D
Sbjct: 658  GYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLD 717

Query: 587  LSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRV 646
            +SNN LTGPIP  GQL+T P S+YANN GLCGVPL  C +   +P     + +  H  + 
Sbjct: 718  VSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRP-----ITSRIHAKKQ 772

Query: 647  AAAAWANSIVMGVLISIASICILIVWAIAMR-ARRKEAEEVKMLNSLQASHAATTWKIDK 705
              A    +++ G+  S     +L++    +R  ++KE +  K + SL  S  + +WK+  
Sbjct: 773  TVAT---AVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTS-GSCSWKLSS 828

Query: 706  EKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKK 765
              EPLSINVATF++ LRKL F+ L+EATNGFSAE+++G GGFGEV+KA L+DGS VAIKK
Sbjct: 829  VPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKK 888

Query: 766  LIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA 825
            LIR++ QGDREFMAEMET+GKIKHRNLVPLLGYCK+GEERLLVYE+MK+GSLE VLH ++
Sbjct: 889  LIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKS 948

Query: 826  KARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM 885
              +    L W ARKKIA GAA+GL FLHH+CIPHIIHRDMKSSNVLLD + EARVSDFGM
Sbjct: 949  SKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGM 1008

Query: 886  ARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
            ARL+SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYS+GV+LLELL+GK+P D  +
Sbjct: 1009 ARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGE 1068

Query: 946  FG-DTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDF 1004
            FG D NLVGW K   RE +  E++DPEL+     TD+S      E+  YL+I  QC+DD 
Sbjct: 1069 FGEDNNLVGWAKQLYREKRGAEILDPELV-----TDKSGD---VELFHYLKIASQCLDDR 1120

Query: 1005 PSKRPNMLQ 1013
            P KRP M+Q
Sbjct: 1121 PFKRPTMIQ 1129

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  937 bits (2421), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 519/1035 (50%), Positives = 668/1035 (64%), Gaps = 55/1035 (5%)

Query: 2    LSVLKLSSNLFTLN-STSLLQLP---------FGLKQLELSSAGLVGLVPDNLFSKLPNL 51
            +S   + SNL +LN S + L  P         F L+ L+LS   + G    NLF  + ++
Sbjct: 153  ISSFGVCSNLKSLNLSKNFLDPPGKEMLKGATFSLQVLDLSYNNISGF---NLFPWVSSM 209

Query: 52   VYLNASY-----NNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHL 106
             ++   +     N L G +PE    N   L  LDLS NN +     F      C++L HL
Sbjct: 210  GFVELEFFSIKGNKLAGSIPELDFKN---LSYLDLSANNFSTVFPSFK----DCSNLQHL 262

Query: 107  DLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIP 166
            DLS N     I SSLS+C KL  LNL+ N   G +P+   +  SLQ L L  N   G  P
Sbjct: 263  DLSSNKFYGDIGSSLSSCGKLSFLNLTNNQFVGLVPKLPSE--SLQYLYLRGNDFQGVYP 320

Query: 167  SELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLE 226
            ++L + C +++EL L +NN +G  P +L  CS L+L+D+SNNN SG  P   L  L +++
Sbjct: 321  NQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDISNNNFSGKLPVDTLLKLSNIK 380

Query: 227  SLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPG-VSSLEELRLPDNLIT 285
            +++LS N   G  PDS S+   L  +D SSN ++GIIP  IC   +++L+ L L +NL  
Sbjct: 381  TMVLSFNKFVGGLPDSFSNLPKLETLDMSSNNLTGIIPSGICKDPMNNLKVLYLQNNLFK 440

Query: 286  GVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKN 345
            G IP  LS C+QL  +DLS NYL GSIP  LG L  L+  I W N L G+IP EL   + 
Sbjct: 441  GPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILWLNQLSGEIPQELMYLQA 500

Query: 346  LKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK 405
            L++LIL+ N L+G IPA L +C+ L WISL+ N+L+G+IP    RL+ LA+L+LGNN   
Sbjct: 501  LENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSIS 560

Query: 406  GEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS-C 464
            G IP ELGNC SL+WLDLN+N L G IPP L +Q G   +   L+    V+++N G+  C
Sbjct: 561  GNIPAELGNCQSLIWLDLNTNFLNGSIPPPLFKQSGNIAVA-LLTGKRYVYIKNDGSKEC 619

Query: 465  KGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKI 524
             G G LLEF GIR E+L +I T   C+F R+Y G     F    ++ +LDLSYN+  G I
Sbjct: 620  HGAGNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSI 679

Query: 525  PDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQ 584
            P E+G M  L +L L HN LSG IP  LG L+N+ + D S+NR  G IP S ++L+ L +
Sbjct: 680  PKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGE 739

Query: 585  IDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLP-ECRNGNNQPALNPSVDAARH- 642
            IDLSNN L+G IP+     T P  ++ANN  LCG PLP  C +G       P  DA +H 
Sbjct: 740  IDLSNNNLSGMIPESAPFDTFPDYRFANN-SLCGYPLPLPCSSG-------PKSDANQHQ 791

Query: 643  -GHRVAAAAWANSIVMGVLISIASICILIVWAIAMRARRKEAE---EVKMLNSLQASHAA 698
              HR   A+ A S+ MG+L S+  I  LI+ AI  + RR++ E   E  M     ++ A 
Sbjct: 792  KSHR-RQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATAN 850

Query: 699  TTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDG 758
            + WK    +E LSIN+A F++ LRKL F+ L+EATNGF  +SL+G GGFG+V+KA LKDG
Sbjct: 851  SAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDG 910

Query: 759  SSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLE 818
            S VAIKKLI +S QGDREF AEMET+GKIKHRNLVPLLGYCK+GEERLLVYE+MK+GSLE
Sbjct: 911  SVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLE 970

Query: 819  EVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA 878
            +VLH R K   +  L W AR+KIA GAA+GL FLHHNCIPHIIHRDMKSSNVLLD  +EA
Sbjct: 971  DVLHDRKKTGIK--LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEA 1028

Query: 879  RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            RVSDFGMARL+SA+DTHLSVSTLAGTPGYVPPEYYQSFRC+ KGDVYS+GVVLLELLTGK
Sbjct: 1029 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1088

Query: 939  RPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITL 998
            +PTD  DFGD NLVGWVK+  + GK  +V D ELL       E  + E+ E++++L++  
Sbjct: 1089 QPTDSADFGDNNLVGWVKLHAK-GKITDVFDRELL------KEDASIEI-ELLQHLKVAC 1140

Query: 999  QCVDDFPSKRPNMLQ 1013
             C+DD   KRP M+Q
Sbjct: 1141 ACLDDRHWKRPTMIQ 1155

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  934 bits (2415), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 527/1024 (51%), Positives = 668/1024 (65%), Gaps = 58/1024 (5%)

Query: 26   LKQLELSSAGLV-GLVPDNLFSKLPNLVYLNASYNNLTGFL------------------- 65
            L+ L+LSS  L    + D +FS   NLV +N S+N L G L                   
Sbjct: 126  LEVLDLSSNSLTDSSIVDYVFSTCLNLVSVNFSHNKLAGKLKSSPSASNKRITTVDLSNN 185

Query: 66   ------PETLLSN-SDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIM-DVI 117
                  PET +++  + L+ LDLS NN+TG  S  S     C +L    LSQN I  D  
Sbjct: 186  RFSDEIPETFIADFPNSLKHLDLSGNNVTGDFSRLSFGL--CENLTVFSLSQNSISGDRF 243

Query: 118  PSSLSNCTKLKILNLSFNLLAGEIP--RTFGQLSSLQRLDLSNNHITGWIPSELGNACDS 175
            P SLSNC  L+ LNLS N L G+IP    +G   +L++L L++N  +G IP EL   C +
Sbjct: 244  PVSLSNCKLLETLNLSRNSLIGKIPGDDYWGNFQNLRQLSLAHNLYSGEIPPELSLLCRT 303

Query: 176  LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI 235
            L  L L  N++TG  P + +SC  LQ L+L NN +SG F  +V+  L  + +L L  N I
Sbjct: 304  LEVLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNI 363

Query: 236  SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSS--LEELRLPDNLITGVIPGQLS 293
            SGS P S+++C  LR++D SSN  +G +P   C   SS  LE+L + +N ++G +P +L 
Sbjct: 364  SGSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELG 423

Query: 294  ECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELG-KCKNLKDLILN 352
            +C  LK IDLS N L G IP+E+  L  L   + W N L G IP  +     NL+ LILN
Sbjct: 424  KCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILN 483

Query: 353  NNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
            NN L+G +P  +  C+N+ WISL+ N LTG+IP    +L +LA+LQLGNN   G IP EL
Sbjct: 484  NNLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSEL 543

Query: 413  GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS-CKGVGGLL 471
            GNC +L+WLDLNSNNLTG++P  L  Q G   + G +S     FVRN G + C+G GGL+
Sbjct: 544  GNCKNLIWLDLNSNNLTGNLPGELASQAGLV-MPGSVSGKQFAFVRNEGGTDCRGAGGLV 602

Query: 472  EFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDM 531
            EF GIR ERL   P + SC   R+YSG  + +F+   ++ YLDLSYN   G IP   G M
Sbjct: 603  EFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAM 662

Query: 532  IALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNE 591
              LQVL L HN L+G IP S G L+ +GV D SHN LQG +P S   LSFL  +D+SNN 
Sbjct: 663  GYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNN 722

Query: 592  LTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAW 651
            LTGPIP  GQL+T P ++YANN GLCGVPLP C +G        S     H H     + 
Sbjct: 723  LTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSG--------SRPTRSHAHP-KKQSI 773

Query: 652  ANSIVMGVLISIASICILIVWAI-AMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPL 710
            A  +  G++ S   I +LI+    A + ++KE +  K + SL  +  +++WK+    EPL
Sbjct: 774  ATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESL-PTSGSSSWKLSSVHEPL 832

Query: 711  SINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLS 770
            SINVATF++ LRKL F+ L+EATNGFSA+S+IG GGFG+V+KA L DGS VAIKKLI+++
Sbjct: 833  SINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVT 892

Query: 771  CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ 830
             QGDREFMAEMET+GKIKHRNLVPLLGYCKIGEERLLVYE+MK+GSLE VLH + K +  
Sbjct: 893  GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTK-KGG 951

Query: 831  RILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
              L W ARKKIA GAA+GL FLHH+CIPHIIHRDMKSSNVLLD +  ARVSDFGMARL+S
Sbjct: 952  IFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVS 1011

Query: 891  ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG-DT 949
            ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYS+GV+LLELL+GK+P D ++FG D 
Sbjct: 1012 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDN 1071

Query: 950  NLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
            NLVGW K   RE +  E++DPEL+     TD+S      E++ YL+I  QC+DD P KRP
Sbjct: 1072 NLVGWAKQLYREKRGAEILDPELV-----TDKSGD---VELLHYLKIASQCLDDRPFKRP 1123

Query: 1010 NMLQ 1013
             M+Q
Sbjct: 1124 TMIQ 1127

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  933 bits (2412), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 514/1026 (50%), Positives = 662/1026 (64%), Gaps = 46/1026 (4%)

Query: 2    LSVLKLSSNLFTLNSTSLLQLP-FGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASY-- 58
            L  L LS N        +L+   F L+ L+LS   + G    NLF  + ++ ++   +  
Sbjct: 162  LKSLNLSKNFLDPPGKEMLKAATFSLQVLDLSYNNISGF---NLFPWVSSMGFVELEFFS 218

Query: 59   ---NNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMD 115
               N L G +PE    N   L  LDLS NN +     F      C++L HLDLS N    
Sbjct: 219  LKGNKLAGSIPELDFKN---LSYLDLSANNFSTVFPSFK----DCSNLQHLDLSSNKFYG 271

Query: 116  VIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDS 175
             I SSLS+C KL  LNL+ N   G +P+   +  SLQ L L  N   G  P++L + C +
Sbjct: 272  DIGSSLSSCGKLSFLNLTNNQFVGLVPKLPSE--SLQYLYLRGNDFQGVYPNQLADLCKT 329

Query: 176  LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI 235
            ++EL L +NN +G  P +L  CS L+L+D+S NN SG  P   L  L ++++++LS N  
Sbjct: 330  VVELDLSYNNFSGMVPESLGECSSLELVDISYNNFSGKLPVDTLSKLSNIKTMVLSFNKF 389

Query: 236  SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPG-VSSLEELRLPDNLITGVIPGQLSE 294
             G  PDS S+   L  +D SSN ++G+IP  IC   +++L+ L L +NL  G IP  LS 
Sbjct: 390  VGGLPDSFSNLLKLETLDMSSNNLTGVIPSGICKDPMNNLKVLYLQNNLFKGPIPDSLSN 449

Query: 295  CTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNN 354
            C+QL  +DLS NYL GSIP  LG L  L+  I W N L G+IP EL   + L++LIL+ N
Sbjct: 450  CSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILWLNQLSGEIPQELMYLQALENLILDFN 509

Query: 355  KLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGN 414
             L+G IPA L +C+ L WISL+ N+L+G+IP    RL+ LA+L+LGNN   G IP ELGN
Sbjct: 510  DLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGN 569

Query: 415  CSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS-CKGVGGLLEF 473
            C SL+WLDLN+N L G IPP L +Q G   +   L+    V+++N G+  C G G LLEF
Sbjct: 570  CQSLIWLDLNTNFLNGSIPPPLFKQSGNIAVA-LLTGKRYVYIKNDGSKECHGAGNLLEF 628

Query: 474  AGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA 533
             GIR E+L +I T   C+F R+Y G     F    ++ +LDLSYN+  G IP E+G M  
Sbjct: 629  GGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYY 688

Query: 534  LQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
            L +L L HN LSG IP  LG L+N+ + D S+NR  G IP S ++L+ L +IDLSNN L+
Sbjct: 689  LSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLS 748

Query: 594  GPIPQRGQLSTLPASQYANNPGLCGVPLP-ECRNGNNQPALNPSVDAARH--GHRVAAAA 650
            G IP+     T P  ++ANN  LCG PLP  C +G       P  DA +H   HR   A+
Sbjct: 749  GMIPESAPFDTFPDYRFANN-SLCGYPLPIPCSSG-------PKSDANQHQKSHR-RQAS 799

Query: 651  WANSIVMGVLISIASICILIVWAIAMRARRKEAE---EVKMLNSLQASHAATTWKIDKEK 707
             A S+ MG+L S+  I  LI+ AI  + RR++ E   E  M     ++ A + WK    +
Sbjct: 800  LAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAR 859

Query: 708  EPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI 767
            E LSIN+A F++ LRKL F+ L+EATNGF  +SL+G GGFG+V+KA LKDGS VAIKKLI
Sbjct: 860  EALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLI 919

Query: 768  RLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA 827
             +S QGDREF AEMET+GKIKHRNLVPLLGYCK+GEERLLVYE+MK+GSLE+VLH R K 
Sbjct: 920  HVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKI 979

Query: 828  RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
              +  L W AR+KIA GAA+GL FLHHNCIPHIIHRDMKSSNVLLD  +EARVSDFGMAR
Sbjct: 980  GIK--LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMAR 1037

Query: 888  LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG 947
            L+SA+DTHLSVSTLAGTPGYVPPEYYQSFRC+ KGDVYS+GVVLLELLTGK+PTD  DFG
Sbjct: 1038 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFG 1097

Query: 948  DTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSK 1007
            D NLVGWVK+  + GK  +V D ELL       E  + E+ E++++L++   C+DD   K
Sbjct: 1098 DNNLVGWVKLHAK-GKITDVFDRELL------KEDASIEI-ELLQHLKVACACLDDRHWK 1149

Query: 1008 RPNMLQ 1013
            RP M+Q
Sbjct: 1150 RPTMIQ 1155

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  872 bits (2254), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 496/996 (49%), Positives = 637/996 (63%), Gaps = 43/996 (4%)

Query: 31   LSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSI 90
            +S A +VG V   L      L +L  S N ++G   +  +S    LE LD+S NN +  I
Sbjct: 185  ISGANVVGWV---LSDGCGELKHLAISGNKISG---DVDVSRCVNLEFLDVSSNNFSTGI 238

Query: 91   SGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSS 150
                     C++L HLD+S N +      ++S CT+LK+LN+S N   G IP     L S
Sbjct: 239  PFLG----DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKS 292

Query: 151  LQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNI 210
            LQ L L+ N  TG IP  L  ACD+L  L L  N+  G+ P    SCS L+ L LS+NN 
Sbjct: 293  LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 352

Query: 211  SGPFPDSVLENLGSLESLILSNNMISGSFPDSISS-CKTLRIVDFSSNRVSGIIPPDICP 269
            SG  P   L  +  L+ L LS N  SG  P+S+++   +L  +D SSN  SG I P++C 
Sbjct: 353  SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 412

Query: 270  G-VSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAW 328
               ++L+EL L +N  TG IP  LS C++L  + LS NYL+G+IP  LG L  L     W
Sbjct: 413  NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 472

Query: 329  FNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEF 388
             N LEG+IP EL   K L+ LIL+ N L+GEIP+ L +C+NL WISL+ N LTG+IP   
Sbjct: 473  LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 532

Query: 389  SRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGF 448
             RL  LA+L+L NN F G IP ELG+C SL+WLDLN+N   G IP  + +Q G K    F
Sbjct: 533  GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG-KIAANF 591

Query: 449  LSSNTLVFVRNVG--NSCKGVGGLLEFAGIRPERLLQIPTLKSCDF-ARMYSGPVLSLFT 505
            ++    V+++N G    C G G LLEF GIR E+L ++ T   C+  +R+Y G     F 
Sbjct: 592  IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 651

Query: 506  QYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASH 565
               ++ +LD+SYN   G IP EIG M  L +L L HN +SG IP  +G LR L + D S 
Sbjct: 652  NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 711

Query: 566  NRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECR 625
            N+L G+IP++ S L+ L +IDLSNN L+GPIP+ GQ  T P +++ NNPGLCG PLP C 
Sbjct: 712  NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCD 771

Query: 626  NGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLISIASICILIVWAIAMRARRKEAEE 685
              N   A   +     HG R   A+ A S+ MG+L S   +CI  +  +    R++  ++
Sbjct: 772  PSN---ADGYAHHQRSHGRR--PASLAGSVAMGLLFSF--VCIFGLILVGREMRKRRRKK 824

Query: 686  VKMLNSLQASHAA--------TTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFS 737
               L      H          T WK+   KE LSIN+A F++ LRKL F+ L++ATNGF 
Sbjct: 825  EAELEMYAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFH 884

Query: 738  AESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
             +SLIG GGFG+V+KA LKDGS+VAIKKLI +S QGDREFMAEMET+GKIKHRNLVPLLG
Sbjct: 885  NDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLG 944

Query: 798  YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
            YCK+G+ERLLVYEFMK+GSLE+VLH   KA  +  L W  R+KIA G+A+GL FLHHNC 
Sbjct: 945  YCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVK--LNWSTRRKIAIGSARGLAFLHHNCS 1002

Query: 858  PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
            PHIIHRDMKSSNVLLD  +EARVSDFGMARL+SA+DTHLSVSTLAGTPGYVPPEYYQSFR
Sbjct: 1003 PHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1062

Query: 918  CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK 977
            C+ KGDVYS+GVVLLELLTGKRPTD  DFGD NLVGWVK   +  +  +V DPEL+    
Sbjct: 1063 CSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKL-RISDVFDPELM---- 1117

Query: 978  GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
               E  A E+ E++++L++ + C+DD   +RP M+Q
Sbjct: 1118 --KEDPALEI-ELLQHLKVAVACLDDRAWRRPTMVQ 1150

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  592 bits (1527), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 414/1094 (37%), Positives = 587/1094 (53%), Gaps = 132/1094 (12%)

Query: 26   LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
            L+ L+LS   L GL+P  L S+LP L+YL+ S N+ +G LP +   +   L  LD+S N+
Sbjct: 115  LQTLDLSGNSLTGLLP-RLLSELPQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNS 173

Query: 86   LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLK----------------- 128
            L+G I          ++L +L +  N     IPS + N + LK                 
Sbjct: 174  LSGEIPP---EIGKLSNLSNLYMGLNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEI 230

Query: 129  -------ILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
                    L+LS+N L   IP++FG+L +L  L+L +  + G IP ELGN C SL  L L
Sbjct: 231  SKLKHLAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAELIGLIPPELGN-CKSLKSLML 289

Query: 182  PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
              N+++G  P+ LS    L       N +SG  P S +     L+SL+L+NN  SG  P 
Sbjct: 290  SFNSLSGPLPLELSEIPLLTF-SAERNQLSGSLP-SWMGKWKVLDSLLLANNRFSGEIPH 347

Query: 242  SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
             I  C  L+ +  +SN +SG IP ++C G  SLE + L  NL++G I      C+ L  +
Sbjct: 348  EIEDCPMLKHLSLASNLLSGSIPRELC-GSGSLEAIDLSGNLLSGTIEEVFDGCSSLGEL 406

Query: 302  DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
             L+ N +NGSIP++L KL  L       N   G+IP  L K  NL +   + N+L G +P
Sbjct: 407  LLTNNQINGSIPEDLWKLP-LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLP 465

Query: 362  AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL 421
            AE+ + ++L+ + L+ N+LTG+IP E  +LT L+VL L  N F+G+IP ELG+C+SL  L
Sbjct: 466  AEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTL 525

Query: 422  DLNSNNLTGDIPPR----------------LGRQLGAKPLGGF--LSSNTLVFVRNVGNS 463
            DL SNNL G IP +                L   + +KP   F  +    L F+++ G  
Sbjct: 526  DLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIF 585

Query: 464  CKGVGGLLEFAGIRPERLLQIPTLKSCDFARMY-SGPVLSLFTQYQTLEYLDLSYNQFRG 522
                  L   +G  PE L +   L     +  + SG + +  ++   L  LDLS N   G
Sbjct: 586  DLSYNRL---SGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTG 642

Query: 523  KIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFL 582
             IP E+G+ + LQ L LA+NQL+G IP S G L +L   + + N+L G +P S  NL  L
Sbjct: 643  SIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKEL 702

Query: 583  VQIDLS------------------------NNELTGPIPQR-GQLSTLPASQYANN---- 613
              +DLS                         N+ TG IP   G L+ L     + N    
Sbjct: 703  THMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSG 762

Query: 614  ---PGLCGVPLPECRN--GNNQPALNPS------------------------VDAARHGH 644
                 +CG+P  E  N   NN     PS                         D    G 
Sbjct: 763  EIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGT 822

Query: 645  RVAAAAWANSIVMG-VLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKI 703
            ++ +A     +++G  +I    +  L  WA+  R ++++  E    + L+       + +
Sbjct: 823  KLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFL 882

Query: 704  D--KEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSV 761
               + +EPLSIN+A F++ L K++   ++EAT+ FS +++IG GGFG V+KA L    +V
Sbjct: 883  SGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTV 942

Query: 762  AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVL 821
            A+KKL     QG+REFMAEMETLGK+KH NLV LLGYC   EE+LLVYE+M  GSL+  L
Sbjct: 943  AVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWL 1002

Query: 822  HGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVS 881
              R +     +L W  R KIA GAA+GL FLHH  IPHIIHRD+K+SN+LLD + E +V+
Sbjct: 1003 --RNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVA 1060

Query: 882  DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPT 941
            DFG+ARLISA ++H+S + +AGT GY+PPEY QS R T KGDVYSFGV+LLEL+TGK PT
Sbjct: 1061 DFGLARLISACESHVS-TVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPT 1119

Query: 942  DKDDFGDT---NLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITL 998
               DF ++   NLVGW   K+ +GK ++VIDP  LLV+     S+       +R L+I +
Sbjct: 1120 GP-DFKESEGGNLVGWAIQKINQGKAVDVIDP--LLVSVALKNSQ-------LRLLQIAM 1169

Query: 999  QCVDDFPSKRPNML 1012
             C+ + P+KRPNML
Sbjct: 1170 LCLAETPAKRPNML 1183

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  514 bits (1324), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 362/1035 (34%), Positives = 561/1035 (54%), Gaps = 92/1035 (8%)

Query: 26   LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
            L+ L L++  L G +P  L  ++  L YL+   N L G +P++L ++   L+ LDLS NN
Sbjct: 241  LEILNLANNSLTGEIPSQL-GEMSQLQYLSLMANQLQGLIPKSL-ADLGNLQTLDLSANN 298

Query: 86   LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL-SNCTKLKILNLSFNLLAGEIPRT 144
            LTG I     N    + LL L L+ NH+   +P S+ SN T L+ L LS   L+GEIP  
Sbjct: 299  LTGEIPEEFWN---MSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVE 355

Query: 145  FGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLD 204
              +  SL++LDLSNN + G IP  L    + L +L L +N + G+   ++S+ + LQ L 
Sbjct: 356  LSKCQSLKQLDLSNNSLAGSIPEALFELVE-LTDLYLHNNTLEGTLSPSISNLTNLQWLV 414

Query: 205  LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP 264
            L +NN+ G  P  +   L  LE L L  N  SG  P  I +C +L+++D   N   G IP
Sbjct: 415  LYHNNLEGKLPKEI-SALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIP 473

Query: 265  PDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQ 324
            P I   +  L  L L  N + G +P  L  C QL ++DL+ N L+GSIP   G L+ LEQ
Sbjct: 474  PSIGR-LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQ 532

Query: 325  FIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG-----------------------EIP 361
             + + N L+G +P  L   +NL  + L++N+L+G                       EIP
Sbjct: 533  LMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIP 592

Query: 362  AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL 421
             EL +  NL+ + L  N+LTG+IP    ++  L++L + +N   G IP +L  C  L  +
Sbjct: 593  LELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHI 652

Query: 422  DLNSNNLTGDIPPRLGR--QLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFA----- 474
            DLN+N L+G IPP LG+  QLG   L    SSN   FV ++         LL  +     
Sbjct: 653  DLNNNFLSGPIPPWLGKLSQLGELKL----SSNQ--FVESLPTELFNCTKLLVLSLDGNS 706

Query: 475  --GIRPERLLQIPTLKSCDFAR-MYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDM 531
              G  P+ +  +  L   +  +  +SG +     +   L  L LS N   G+IP EIG +
Sbjct: 707  LNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQL 766

Query: 532  IALQ-VLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
              LQ  L+L++N  +G+IPS++G L  L   D SHN+L G++P S  ++  L  +++S N
Sbjct: 767  QDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFN 826

Query: 591  ELTGPIPQRGQLSTLPASQYANNPGLCGVPLPEC---RNGNNQPALNPSVDAARHGHRVA 647
             L G +  + Q S  PA  +  N GLCG PL  C   R+ N Q  L+             
Sbjct: 827  NLGGKL--KKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLS------------- 871

Query: 648  AAAWANSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEK 707
                A S+V+   IS  +   L++  IA+  +++  +  K +     ++ +++       
Sbjct: 872  ----ARSVVIISAISALTAIGLMILVIALFFKQRH-DFFKKVGHGSTAYTSSSSSSQATH 926

Query: 708  EPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI 767
            +PL  N A+       +++  ++EAT+  S E +IG GG G+V+KA L++G +VA+KK++
Sbjct: 927  KPLFRNGASKS----DIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKIL 982

Query: 768  -RLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE--RLLVYEFMKFGSLEEVLHGR 824
             +     ++ F  E++TLG+I+HR+LV L+GYC    E   LL+YE+MK GS+ + LH  
Sbjct: 983  WKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHED 1042

Query: 825  AKA--RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD 882
                 + +++L W+AR +IA G A+G+ +LHH+C+P I+HRD+KSSNVLLD  MEA + D
Sbjct: 1043 KPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGD 1102

Query: 883  FGMARLISA-LDTHLSVST-LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            FG+A++++   DT+   +T  A + GY+ PEY  S + T K DVYS G+VL+E++TGK P
Sbjct: 1103 FGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMP 1162

Query: 941  TDKDDFGDTNLVGWVK--MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITL 998
            TD     + ++V WV+  ++V    + ++IDP+L  +    +++  +        LEI L
Sbjct: 1163 TDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQ-------VLEIAL 1215

Query: 999  QCVDDFPSKRPNMLQ 1013
            QC    P +RP+  Q
Sbjct: 1216 QCTKTSPQERPSSRQ 1230

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  501 bits (1289), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 356/1035 (34%), Positives = 549/1035 (53%), Gaps = 96/1035 (9%)

Query: 26   LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
            L+ L L      G +P  L   L ++ YLN   N L G +P+ L   ++ L+ LDLS NN
Sbjct: 242  LQTLNLGDNSFSGEIPSQL-GDLVSIQYLNLIGNQLQGLIPKRLTELAN-LQTLDLSSNN 299

Query: 86   LTGSISGFSLNEN--SCNSLLHLDLSQNHIMDVIPSSL-SNCTKLKILNLSFNLLAGEIP 142
            LTG I     +E     N L  L L++N +   +P ++ SN T LK L LS   L+GEIP
Sbjct: 300  LTGVI-----HEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIP 354

Query: 143  RTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQL 202
                   SL+ LDLSNN +TG IP  L    + L  L L +N++ G+   ++S+ + LQ 
Sbjct: 355  AEISNCQSLKLLDLSNNTLTGQIPDSLFQLVE-LTNLYLNNNSLEGTLSSSISNLTNLQE 413

Query: 203  LDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGI 262
              L +NN+ G  P  +   LG LE + L  N  SG  P  I +C  L+ +D+  NR+SG 
Sbjct: 414  FTLYHNNLEGKVPKEI-GFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGE 472

Query: 263  IPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHL 322
            IP  I   +  L  L L +N + G IP  L  C Q+ VIDL+ N L+GSIP   G L  L
Sbjct: 473  IPSSIGR-LKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTAL 531

Query: 323  EQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG-----------------------E 359
            E F+ + N L+G +P  L   KNL  +  ++NK +G                       +
Sbjct: 532  ELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGD 591

Query: 360  IPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV 419
            IP EL   +NL+ + L  N+ TG+IP  F +++ L++L +  N   G IP ELG C  L 
Sbjct: 592  IPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLT 651

Query: 420  WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLL-------E 472
             +DLN+N L+G IP  LG+     PL G L  ++  FV ++      +  +L        
Sbjct: 652  HIDLNNNYLSGVIPTWLGKL----PLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNS 707

Query: 473  FAGIRPERLLQIPTLKSCDFAR-MYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDM 531
              G  P+ +  +  L + +      SGP+ S   +   L  L LS N   G+IP EIG +
Sbjct: 708  LNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQL 767

Query: 532  IALQ-VLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
              LQ  L+L++N  +G IPS++  L  L   D SHN+L G++P    ++  L  ++LS N
Sbjct: 768  QDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYN 827

Query: 591  ELTGPIPQRGQLSTLPASQYANNPGLCGVPLPEC-RNGN-NQPALNPSVDAARHGHRVAA 648
             L G +  + Q S   A  +  N GLCG PL  C R G+ NQ +L+P             
Sbjct: 828  NLEGKL--KKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKT----------- 874

Query: 649  AAWANSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKE 708
                  +++  + S+A+I ++++  I    +  +     +   ++  ++A +      + 
Sbjct: 875  -----VVIISAISSLAAIALMVLVIILFFKQNHD-----LFKKVRGGNSAFSSNSSSSQA 924

Query: 709  PLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI- 767
            PL  N          +K+  ++EAT+  + E +IG GG G+V+KA LK+G ++A+KK++ 
Sbjct: 925  PLFSNGGAKS----DIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILW 980

Query: 768  RLSCQGDREFMAEMETLGKIKHRNLVPLLGYC--KIGEERLLVYEFMKFGSLEEVLHGRA 825
            +     ++ F  E++TLG I+HR+LV L+GYC  K     LL+YE+M  GS+ + LH   
Sbjct: 981  KDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANE 1040

Query: 826  KARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM 885
              + + +L W+ R KIA G A+G+ +LH++C+P I+HRD+KSSNVLLD  +EA + DFG+
Sbjct: 1041 NTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGL 1100

Query: 886  ARLISA-LDTHLSVSTL-AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK 943
            A++++   DT+   +T+ AG+ GY+ PEY  S + T K DVYS G+VL+E++TGK PT+ 
Sbjct: 1101 AKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEA 1160

Query: 944  DDFGDTNLVGWVKMKV-----REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITL 998
                +T++V WV+  +      E ++ ++ID EL  +    +E+         + LEI L
Sbjct: 1161 MFDEETDMVRWVETVLDTPPGSEARE-KLIDSELKSLLPCEEEA-------AYQVLEIAL 1212

Query: 999  QCVDDFPSKRPNMLQ 1013
            QC   +P +RP+  Q
Sbjct: 1213 QCTKSYPQERPSSRQ 1227

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGJ1|Y1743_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g74360 OS=Arabidopsis thaliana GN=At1g74360 PE=1 SV=1

 Score =  490 bits (1262), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 349/1016 (34%), Positives = 512/1016 (50%), Gaps = 119/1016 (11%)

Query: 85   NLTGS-ISG-FSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIP 142
            NLT S ISG    N ++   L +LDLS+N I   IP  LS C  LK LNLS N+L GE+ 
Sbjct: 93   NLTDSTISGPLFKNFSALTELTYLDLSRNTIEGEIPDDLSRCHNLKHLNLSHNILEGEL- 151

Query: 143  RTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQL 202
             +   LS+L+ LDLS N ITG I S     C+SL+   L  NN TG      + C  L+ 
Sbjct: 152  -SLPGLSNLEVLDLSLNRITGDIQSSFPLFCNSLVVANLSTNNFTGRIDDIFNGCRNLKY 210

Query: 203  LDLS---------------------NNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
            +D S                     +N++SG    S+     +L+ L LS N   G FP 
Sbjct: 211  VDFSSNRFSGEVWTGFGRLVEFSVADNHLSGNISASMFRGNCTLQMLDLSGNAFGGEFPG 270

Query: 242  SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
             +S+C+ L +++   N+ +G IP +I   +SSL+ L L +N  +  IP  L   T L  +
Sbjct: 271  QVSNCQNLNVLNLWGNKFTGNIPAEIGS-ISSLKGLYLGNNTFSRDIPETLLNLTNLVFL 329

Query: 302  DLSLNYLNGSIPQELG-------------------------KLEHLEQFIAWFNGLEGKI 336
            DLS N   G I +  G                         KL +L +    +N   G++
Sbjct: 330  DLSRNKFGGDIQEIFGRFTQVKYLVLHANSYVGGINSSNILKLPNLSRLDLGYNNFSGQL 389

Query: 337  PPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAV 396
            P E+ + ++LK LIL  N  SG+IP E  +   L+ + L+ N+LTG IP  F +LT L  
Sbjct: 390  PTEISQIQSLKFLILAYNNFSGDIPQEYGNMPGLQALDLSFNKLTGSIPASFGKLTSLLW 449

Query: 397  LQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSN---- 452
            L L NN   GEIP E+GNC+SL+W ++ +N L+G   P L R +G+ P   F  +     
Sbjct: 450  LMLANNSLSGEIPREIGNCTSLLWFNVANNQLSGRFHPELTR-MGSNPSPTFEVNRQNKD 508

Query: 453  -----------------------TLVFVRNVGNSCKGV-GGLLEFAGIRP--ERLLQIPT 486
                                     V+      SC+ +   +L+  G+ P       + T
Sbjct: 509  KIIAGSGECLAMKRWIPAEFPPFNFVYAILTKKSCRSLWDHVLKGYGLFPVCSAGSTVRT 568

Query: 487  LKSCDFARM----YSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHN 542
            LK   + ++    +SG + +  +Q   L  L L +N+F GK+P EIG +  L  L L  N
Sbjct: 569  LKISAYLQLSGNKFSGEIPASISQMDRLSTLHLGFNEFEGKLPPEIGQL-PLAFLNLTRN 627

Query: 543  QLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNE-LTGPIPQRGQ 601
              SGEIP  +G L+ L   D S N   G  P S ++L+ L + ++S N  ++G IP  GQ
Sbjct: 628  NFSGEIPQEIGNLKCLQNLDLSFNNFSGNFPTSLNDLNELSKFNISYNPFISGAIPTTGQ 687

Query: 602  LSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLI 661
            ++T     +  NP L   P    ++GNN   ++  V   R   R     W     + + +
Sbjct: 688  VATFDKDSFLGNP-LLRFPSFFNQSGNNTRKISNQVLGNR--PRTLLLIW-----ISLAL 739

Query: 662  SIASICILIVWAIAMRARRKEAE-EVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 720
            ++A I  L+V  I +   +   E E+ +L+  +  H  T+         LS  +   +  
Sbjct: 740  ALAFIACLVVSGIVLMVVKASREAEIDLLDGSKTRHDMTS-SSGGSSPWLSGKIKVIRLD 798

Query: 721  LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 780
                 ++ +++AT+ FS E ++G GG+G V++  L DG  VA+KKL R   + ++EF AE
Sbjct: 799  KSTFTYADILKATSNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQREGTEAEKEFRAE 858

Query: 781  METL-----GKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
            ME L     G   H NLV L G+C  G E++LV+E+M  GSLEE++  + K      L W
Sbjct: 859  MEVLSANAFGDWAHPNLVRLYGWCLDGSEKILVHEYMGGGSLEELITDKTK------LQW 912

Query: 836  DARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
              R  IA   A+GL FLHH C P I+HRD+K+SNVLLD    ARV+DFG+ARL++  D+H
Sbjct: 913  KKRIDIATDVARGLVFLHHECYPSIVHRDVKASNVLLDKHGNARVTDFGLARLLNVGDSH 972

Query: 896  LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWV 955
            +S + +AGT GYV PEY Q+++ T +GDVYS+GV+ +EL TG+R  D    G+  LV W 
Sbjct: 973  VS-TVIAGTIGYVAPEYGQTWQATTRGDVYSYGVLTMELATGRRAVDG---GEECLVEWA 1028

Query: 956  KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
            + +V  G       P  L  TK  + +E     +M   L+I ++C  D P  RPNM
Sbjct: 1029 R-RVMTGNMTAKGSPITLSGTKPGNGAE-----QMTELLKIGVKCTADHPQARPNM 1078

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1013
224101951	1134	predicted protein [Populus trichocarpa]	0.998	0.891	0.826	0.0
224108193	1135	predicted protein [Populus trichocarpa]	0.988	0.881	0.824	0.0
225424494	1134	PREDICTED: serine/threonine-protein kina	0.999	0.892	0.819	0.0
255561787	1140	serine/threonine-protein kinase bri1, pu	0.989	0.878	0.817	0.0
356528178	1196	PREDICTED: serine/threonine-protein kina	0.997	0.844	0.793	0.0
351721933	1173	ATP binding/protein serine/threonine kin	0.997	0.861	0.792	0.0
223452280	1086	ATP-binding/protein serine/threonine kin	0.997	0.930	0.792	0.0
449464870	1157	PREDICTED: serine/threonine-protein kina	0.999	0.874	0.795	0.0
312190384	1141	leucine-rich receptor kinase [Eutrema pa	0.998	0.886	0.754	0.0
229914865	1143	brassinosteroid receptor-like protein [E	0.997	0.883	0.754	0.0

>gi|224101951|ref|XP_002312487.1| predicted protein [Populus trichocarpa] gi|222852307|gb|EEE89854.1| predicted protein [Populus trichocarpa]

 Score = 1709 bits (4427), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 837/1013 (82%), Positives = 914/1013 (90%), Gaps = 2/1013 (0%)

Query: 1    MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            MLS L LSSN FT+NSTSLL LP+ L+QL+LSS GL G VP+  FSK PNLVY+N S+NN
Sbjct: 104  MLSALNLSSNPFTVNSTSLLHLPYALQQLQLSSTGLEGPVPEKFFSKNPNLVYVNLSHNN 163

Query: 61   LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
            L+    + LL NSDK++ LDLSYNN TGSISG  + ENSCNSL  LDLS N +MD IP S
Sbjct: 164  LSSLP-DDLLLNSDKVQALDLSYNNFTGSISGLRV-ENSCNSLSQLDLSGNFLMDSIPPS 221

Query: 121  LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
            LSNCT LK LNLSFN++ GEIPR+ G+L SLQRLDLS+NHI+GWIPSELGNAC+SLLELK
Sbjct: 222  LSNCTNLKTLNLSFNMITGEIPRSLGELGSLQRLDLSHNHISGWIPSELGNACNSLLELK 281

Query: 181  LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
            L +NNI+G  PV+ S CSWLQ LDLSNNNISGPFPDS+L+NLGSLE L++S N+ISG FP
Sbjct: 282  LSYNNISGPIPVSFSPCSWLQTLDLSNNNISGPFPDSILQNLGSLERLLISYNLISGLFP 341

Query: 241  DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
             S+SSCK+L+++D SSNR SG IPPDICPG +SLEELRLPDNLI G IP QLS+C++LK 
Sbjct: 342  ASVSSCKSLKVLDLSSNRFSGTIPPDICPGAASLEELRLPDNLIEGEIPAQLSQCSKLKT 401

Query: 301  IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
            +DLS+N+LNGSIP ELG LE+LEQ IAW+NGLEGKIPPELGKCKNLKDLILNNN LSG I
Sbjct: 402  LDLSINFLNGSIPAELGNLENLEQLIAWYNGLEGKIPPELGKCKNLKDLILNNNNLSGII 461

Query: 361  PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
            P ELFSCSNLEWISLT N+ TG+IP EF  L+RLAVLQL NN   GEIP ELGNCSSLVW
Sbjct: 462  PVELFSCSNLEWISLTSNQFTGKIPREFGLLSRLAVLQLANNSLSGEIPTELGNCSSLVW 521

Query: 421  LDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
            LDLNSN LTG+IPPRLGRQLGAK L G LS NTLVFVRNVGNSCKGVGGLLEFAGI+ ER
Sbjct: 522  LDLNSNKLTGEIPPRLGRQLGAKALSGILSGNTLVFVRNVGNSCKGVGGLLEFAGIKAER 581

Query: 481  LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA 540
            LLQ+PTLK+CDF R+YSG VLSLFTQYQTLEYLDLSYN+ RGKIPDEIG+M+ALQVLELA
Sbjct: 582  LLQVPTLKTCDFTRLYSGAVLSLFTQYQTLEYLDLSYNELRGKIPDEIGEMMALQVLELA 641

Query: 541  HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRG 600
            HNQLSGEIP+SLG+L+NLGVFDASHNRLQGQIP+SFSNLSFLVQIDLSNNELTG IPQRG
Sbjct: 642  HNQLSGEIPASLGQLKNLGVFDASHNRLQGQIPDSFSNLSFLVQIDLSNNELTGEIPQRG 701

Query: 601  QLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVL 660
            QLSTLPA+QYANNPGLCGVPL  C +GN+  A NP+ D  R G + +A +WANSIV+G+L
Sbjct: 702  QLSTLPATQYANNPGLCGVPLNPCGSGNSHAASNPAPDGGRGGRKSSATSWANSIVLGIL 761

Query: 661  ISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 720
            ISIAS+CIL+VWA+AMR R KEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ
Sbjct: 762  ISIASLCILVVWAVAMRVRHKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 821

Query: 721  LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 780
            LRKLKFSQLIEATNGFSA SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE
Sbjct: 822  LRKLKFSQLIEATNGFSAASLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 881

Query: 781  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
            METLGKIKHRNLVPLLGYCKIGEERLLVYEFM+FGSLEE+LHGR +ARD+ ILTWD RKK
Sbjct: 882  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMEFGSLEEMLHGRGRARDRPILTWDERKK 941

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
            IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST
Sbjct: 942  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 1001

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
            LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK+DFGDTNLVGWVKMKVR
Sbjct: 1002 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKEDFGDTNLVGWVKMKVR 1061

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            EGKQMEVIDPE L VTKGTDE+EAEEVKEMVRYLEI+LQCVDDFPSKRP+MLQ
Sbjct: 1062 EGKQMEVIDPEFLSVTKGTDEAEAEEVKEMVRYLEISLQCVDDFPSKRPSMLQ 1114

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108193|ref|XP_002314754.1| predicted protein [Populus trichocarpa] gi|222863794|gb|EEF00925.1| predicted protein [Populus trichocarpa]

 Score = 1696 bits (4392), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 826/1002 (82%), Positives = 900/1002 (89%), Gaps = 1/1002 (0%)

Query: 12   FTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLS 71
            FT++STSLL LP+ L+QL+L   GL G VP+N FSK PNLVY N S+NNL+  LP+ LL 
Sbjct: 115  FTVSSTSLLHLPYALQQLQLCYTGLEGPVPENFFSKNPNLVYANLSHNNLSELLPDDLLL 174

Query: 72   NSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILN 131
            NSDK++ LDLSYNN TGS SG  + ENSCNSL  LDLS NH+MD IP +LSNCT LK LN
Sbjct: 175  NSDKVQTLDLSYNNFTGSFSGLKI-ENSCNSLSQLDLSGNHLMDSIPPTLSNCTNLKNLN 233

Query: 132  LSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFP 191
            LSFN+L GEIPR+FG+LSSLQRLDLS+NHITGWIPSELGNAC+SLLELK+ +NNI+G  P
Sbjct: 234  LSFNMLTGEIPRSFGKLSSLQRLDLSHNHITGWIPSELGNACNSLLELKISYNNISGPVP 293

Query: 192  VTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRI 251
            V+LS CS LQ LDLSNNNISGPFPDS+L+NL SLE L+LS N+ISGSFP SIS CK+L+I
Sbjct: 294  VSLSPCSLLQTLDLSNNNISGPFPDSILQNLASLERLLLSYNLISGSFPASISYCKSLKI 353

Query: 252  VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS 311
            VD SSNR SG IPPDICPG +SLEELRLPDNLI G IP QLS+C++LK +D S+N+LNGS
Sbjct: 354  VDLSSNRFSGTIPPDICPGAASLEELRLPDNLIIGEIPAQLSQCSKLKTLDFSINFLNGS 413

Query: 312  IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLE 371
            IP ELGKLE+LEQ IAW+N LEGKIPPELGKC+NLKDLILNNN LSG IP ELF C+NLE
Sbjct: 414  IPAELGKLENLEQLIAWYNSLEGKIPPELGKCRNLKDLILNNNNLSGIIPVELFRCTNLE 473

Query: 372  WISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGD 431
            WISLT N+ TG+IP EF  L+RLAVLQL NN   GEIP ELGNCSSLVWLDLNSN LTG+
Sbjct: 474  WISLTSNQFTGEIPREFGLLSRLAVLQLANNSLSGEIPTELGNCSSLVWLDLNSNKLTGE 533

Query: 432  IPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCD 491
            IPPRLGRQLGAK L G LS NTLVFVRNVGNSCKGVGGLLEFAGI+ ERLLQ+PT K+CD
Sbjct: 534  IPPRLGRQLGAKALSGILSGNTLVFVRNVGNSCKGVGGLLEFAGIKAERLLQVPTFKTCD 593

Query: 492  FARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSS 551
            F  MYSG VLS FTQYQTLEYLDLSYN+ RGKIPDEIGDM+ALQVLEL+HNQLSGEIP+S
Sbjct: 594  FTIMYSGAVLSRFTQYQTLEYLDLSYNELRGKIPDEIGDMMALQVLELSHNQLSGEIPAS 653

Query: 552  LGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYA 611
            LG+L+NLGVFDASHNRLQGQIP+SFSNLSFLVQIDLS+NELTG IPQRGQLSTLPA+QYA
Sbjct: 654  LGQLKNLGVFDASHNRLQGQIPDSFSNLSFLVQIDLSSNELTGEIPQRGQLSTLPATQYA 713

Query: 612  NNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLISIASICILIV 671
            NNPGLCGVPL  C +GN+  A NP  D  R G + AAA+WANSIV+G+LISIAS+CILIV
Sbjct: 714  NNPGLCGVPLTPCGSGNSHTASNPPSDGGRGGRKTAAASWANSIVLGILISIASLCILIV 773

Query: 672  WAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIE 731
            WAIA+R R KEAEEVKML SLQAS+AATTWKIDKEKEPLSINVATFQR LRKLKFSQLIE
Sbjct: 774  WAIAVRVRHKEAEEVKMLKSLQASYAATTWKIDKEKEPLSINVATFQRHLRKLKFSQLIE 833

Query: 732  ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN 791
            ATNGFSA SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN
Sbjct: 834  ATNGFSAASLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN 893

Query: 792  LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            LVPLLGYCKIGEERLLVYEFM+FGSL+E+LHGR +ARD+RILTWD RKKIARGAAKGLCF
Sbjct: 894  LVPLLGYCKIGEERLLVYEFMEFGSLDEMLHGRGRARDRRILTWDERKKIARGAAKGLCF 953

Query: 852  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            LHHNCIPHIIHRDMKSSNVLLD+EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE
Sbjct: 954  LHHNCIPHIIHRDMKSSNVLLDNEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 1013

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE 971
            YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE
Sbjct: 1014 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE 1073

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            LL VTKGTDE+EAEEVKEM RYLEI+LQCVDDFPSKR +MLQ
Sbjct: 1074 LLSVTKGTDEAEAEEVKEMTRYLEISLQCVDDFPSKRASMLQ 1115

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225424494|ref|XP_002281730.1| PREDICTED: serine/threonine-protein kinase BRI1-like 2 [Vitis vinifera]

 Score = 1684 bits (4360), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 830/1013 (81%), Positives = 912/1013 (90%), Gaps = 1/1013 (0%)

Query: 1    MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            MLSVL LS NLF +NST LLQLP GL QL+LSSAGLVGLVP+NLFSKLPNLV    + NN
Sbjct: 104  MLSVLSLSGNLFYVNSTGLLQLPVGLTQLDLSSAGLVGLVPENLFSKLPNLVSATLALNN 163

Query: 61   LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
            LTG LP+ LL NSDKL++LDLSYNNLTGSISG  + ENSC SL+ LDLS N++MD +PSS
Sbjct: 164  LTGSLPDDLLLNSDKLQVLDLSYNNLTGSISGLKI-ENSCTSLVVLDLSGNNLMDSLPSS 222

Query: 121  LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
            +SNCT L  LNLS+N L GEIP +FG L +LQRLDLS N +TGW+PSELGN C SL E+ 
Sbjct: 223  ISNCTSLNTLNLSYNNLTGEIPPSFGGLKNLQRLDLSRNRLTGWMPSELGNTCGSLQEID 282

Query: 181  LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
            L +NNITG  P + SSCSWL+LL+L+NNNISGPFPDS+L++L SLE+L+LS N ISG+FP
Sbjct: 283  LSNNNITGLIPASFSSCSWLRLLNLANNNISGPFPDSILQSLASLETLLLSYNNISGAFP 342

Query: 241  DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
             SISSC+ L++VDFSSN++SG IPPDICPG +SLEELR+PDNLI+G IP +LS+C++LK 
Sbjct: 343  ASISSCQNLKVVDFSSNKLSGFIPPDICPGAASLEELRIPDNLISGEIPAELSQCSRLKT 402

Query: 301  IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
            ID SLNYL G IP ++G+LE+LEQ IAWFN L+G+IPPELGKC+NLKDLILNNN L G+I
Sbjct: 403  IDFSLNYLKGPIPPQIGRLENLEQLIAWFNALDGEIPPELGKCRNLKDLILNNNNLGGKI 462

Query: 361  PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
            P+ELF+C NLEWISLT N LTGQIPPEF  L+RLAVLQLGNN   G+IP EL NCSSLVW
Sbjct: 463  PSELFNCGNLEWISLTSNGLTGQIPPEFGLLSRLAVLQLGNNSLSGQIPRELANCSSLVW 522

Query: 421  LDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
            LDLNSN LTG+IPPRLGRQLGAK L G LS NTL FVRN+GNSCKGVGGLLEFAGIRPER
Sbjct: 523  LDLNSNRLTGEIPPRLGRQLGAKSLSGILSGNTLAFVRNLGNSCKGVGGLLEFAGIRPER 582

Query: 481  LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA 540
            LLQIPTLK+CDF RMYSG VLSLFT+YQTLEYLDLSYN+ RGKIPDEIG M+ALQVLEL+
Sbjct: 583  LLQIPTLKTCDFTRMYSGAVLSLFTKYQTLEYLDLSYNELRGKIPDEIGGMVALQVLELS 642

Query: 541  HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRG 600
            HNQLSGEIPSSLG+LRNLGVFDASHNRLQG IP+SFSNLSFLVQIDLS NELTG IP RG
Sbjct: 643  HNQLSGEIPSSLGQLRNLGVFDASHNRLQGHIPDSFSNLSFLVQIDLSYNELTGQIPTRG 702

Query: 601  QLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVL 660
            QLSTLPASQYANNPGLCGVPLPEC+N +NQP       A + G R A A+WANSIV+GVL
Sbjct: 703  QLSTLPASQYANNPGLCGVPLPECQNDDNQPVTVIDNTAGKGGKRPATASWANSIVLGVL 762

Query: 661  ISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 720
            ISIASICILIVWAIAMRARRKEAEEVKMLNSLQA HAATTWKIDKEKEPLSINVATFQRQ
Sbjct: 763  ISIASICILIVWAIAMRARRKEAEEVKMLNSLQACHAATTWKIDKEKEPLSINVATFQRQ 822

Query: 721  LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 780
            LRKL+FSQLIEATNGFSA SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE
Sbjct: 823  LRKLRFSQLIEATNGFSAASLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 882

Query: 781  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
            METLGKIKHRNLVPLLGYCK+GEERLLVYEFM++GSLEE+LHG+AKARD+RILTW+ RKK
Sbjct: 883  METLGKIKHRNLVPLLGYCKVGEERLLVYEFMEYGSLEEMLHGKAKARDRRILTWEERKK 942

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
            IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST
Sbjct: 943  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 1002

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
            LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK+DFGDTNLVGWVKMKV+
Sbjct: 1003 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKEDFGDTNLVGWVKMKVK 1062

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            EGK MEVIDPELL VTKGTDE+EAEEV EMVRYL+IT+QCV+DFPSKRPNMLQ
Sbjct: 1063 EGKGMEVIDPELLSVTKGTDEAEAEEVNEMVRYLDITMQCVEDFPSKRPNMLQ 1115

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255561787|ref|XP_002521903.1| serine/threonine-protein kinase bri1, putative [Ricinus communis] gi|223538941|gb|EEF40539.1| serine/threonine-protein kinase bri1, putative [Ricinus communis]

 Score = 1676 bits (4341), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 819/1002 (81%), Positives = 903/1002 (90%)

Query: 12   FTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLS 71
            FT+NSTSLLQLP+ L+ LELSSA L+G+VP+N FSK PN VY+N S+NNLTG LP+ LLS
Sbjct: 119  FTVNSTSLLQLPYALQHLELSSAVLLGVVPENFFSKYPNFVYVNLSHNNLTGSLPDDLLS 178

Query: 72   NSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILN 131
             SDKL++LDLSYNN TGSISGF ++++SCNSL  LDLS NH+   IP SLSNCT LK LN
Sbjct: 179  YSDKLQVLDLSYNNFTGSISGFKIDQSSCNSLWQLDLSGNHLEYFIPPSLSNCTNLKSLN 238

Query: 132  LSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFP 191
            LS N+L GEIPR+FG+LSSLQRLDLS+NH+TGWIPSELGNAC SLLE+KL  NNI+GS P
Sbjct: 239  LSSNMLTGEIPRSFGELSSLQRLDLSHNHLTGWIPSELGNACSSLLEVKLSFNNISGSIP 298

Query: 192  VTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRI 251
            ++ S+CSWLQ+LDLSNNNI+GPFPDS+L+NL SLE L+LS N+ISGSFP SIS CK LR+
Sbjct: 299  ISFSTCSWLQVLDLSNNNITGPFPDSILQNLSSLERLLLSYNLISGSFPVSISYCKNLRV 358

Query: 252  VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS 311
            VD SSN+ SGIIPP+ICPG +SLEELR+PDNLI G IP QLS+C++LK +D S+NYLNGS
Sbjct: 359  VDLSSNKFSGIIPPEICPGAASLEELRMPDNLIVGEIPAQLSQCSKLKSLDFSINYLNGS 418

Query: 312  IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLE 371
            IP ELGKL +LEQ IAW+NGLEGKIP ELGKC+NLKDLILNNN L+GEIP ELF CSNLE
Sbjct: 419  IPAELGKLGNLEQLIAWYNGLEGKIPAELGKCRNLKDLILNNNHLTGEIPVELFDCSNLE 478

Query: 372  WISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGD 431
            WISLT N+++G+IP EF  L+RLAVLQLGNN   GEIP ELGNCSSLVWLDL SN LTG+
Sbjct: 479  WISLTSNQISGKIPSEFGLLSRLAVLQLGNNSLSGEIPRELGNCSSLVWLDLGSNRLTGE 538

Query: 432  IPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCD 491
            IPPRLGRQLGAK LGG  S NTLVFVRNVGNSC+GVGGLLEFAGIR ERLLQ PTLK+CD
Sbjct: 539  IPPRLGRQLGAKALGGIPSGNTLVFVRNVGNSCQGVGGLLEFAGIRSERLLQFPTLKTCD 598

Query: 492  FARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSS 551
            F R+Y+GPVLSLFTQYQTLEYLDLS NQ RGKIPDE+G+M+ALQVL L++NQLSGEIP S
Sbjct: 599  FTRLYTGPVLSLFTQYQTLEYLDLSNNQLRGKIPDEMGEMMALQVLVLSYNQLSGEIPPS 658

Query: 552  LGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYA 611
            LG+L+NLGVFDASHNRLQG+IP+SFSNLSFLVQIDLS NELTG IPQRGQLSTLPA+QYA
Sbjct: 659  LGQLKNLGVFDASHNRLQGEIPDSFSNLSFLVQIDLSYNELTGEIPQRGQLSTLPATQYA 718

Query: 612  NNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLISIASICILIV 671
            +NPGLCGVPL +C   N Q   +P       G + AA++WANSIV+G+LIS+AS+CILIV
Sbjct: 719  HNPGLCGVPLSDCHGKNGQGTTSPIAYGGEGGRKSAASSWANSIVLGILISVASLCILIV 778

Query: 672  WAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIE 731
            WAIAMR R KEAE+VKML+SLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIE
Sbjct: 779  WAIAMRVRHKEAEDVKMLSSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIE 838

Query: 732  ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN 791
            ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN
Sbjct: 839  ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN 898

Query: 792  LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            LVPLLGYCKIGEERLLVYEFM+FGSL+E+LHGR +  D+RILTWD RKKIARGAAKGLCF
Sbjct: 899  LVPLLGYCKIGEERLLVYEFMEFGSLDEMLHGRVRTIDRRILTWDERKKIARGAAKGLCF 958

Query: 852  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE
Sbjct: 959  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 1018

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE 971
            YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID E
Sbjct: 1019 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDQE 1078

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            LL VTK TDE+E EEVKEMVRYLEITLQCVDDFPSKRPNMLQ
Sbjct: 1079 LLSVTKKTDEAEVEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1120

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356528178|ref|XP_003532682.1| PREDICTED: serine/threonine-protein kinase BRI1-like 2-like [Glycine max]

 Score = 1667 bits (4317), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 805/1015 (79%), Positives = 900/1015 (88%), Gaps = 5/1015 (0%)

Query: 1    MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            MLSVLKLS N F++NSTSL+ LP+ L QL+LS  G+ G VP+NLFSK PNLV +N SYNN
Sbjct: 165  MLSVLKLSLNSFSVNSTSLVNLPYSLTQLDLSFGGVTGPVPENLFSKCPNLVVVNLSYNN 224

Query: 61   LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
            LTG +PE    NSDKL++LDLS NNL+G I G  +    C SLL LDLS N + D IP S
Sbjct: 225  LTGPIPENFFQNSDKLQVLDLSSNNLSGPIFGLKM---ECISLLQLDLSGNRLSDSIPLS 281

Query: 121  LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
            LSNCT LK LNL+ N+++G+IP+ FGQL+ LQ LDLS+N + GWIPSE GNAC SLLELK
Sbjct: 282  LSNCTSLKNLNLANNMISGDIPKAFGQLNKLQTLDLSHNQLIGWIPSEFGNACASLLELK 341

Query: 181  LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
            L  NNI+GS P   SSC+WLQLLD+SNNN+SG  PDS+ +NLGSL+ L L NN I+G FP
Sbjct: 342  LSFNNISGSIPSGFSSCTWLQLLDISNNNMSGQLPDSIFQNLGSLQELRLGNNAITGQFP 401

Query: 241  DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
             S+SSCK L+IVDFSSN+  G +P D+CPG +SLEELR+PDNLITG IP +LS+C+QLK 
Sbjct: 402  SSLSSCKKLKIVDFSSNKFYGSLPRDLCPGAASLEELRMPDNLITGKIPAELSKCSQLKT 461

Query: 301  IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
            +D SLNYLNG+IP ELG+LE+LEQ IAWFNGLEG+IPP+LG+CKNLKDLILNNN L+G I
Sbjct: 462  LDFSLNYLNGTIPDELGELENLEQLIAWFNGLEGRIPPKLGQCKNLKDLILNNNHLTGGI 521

Query: 361  PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
            P ELF+CSNLEWISLT NEL+G+IP EF  LTRLAVLQLGNN   GEIP EL NCSSLVW
Sbjct: 522  PIELFNCSNLEWISLTSNELSGEIPREFGLLTRLAVLQLGNNSLSGEIPSELANCSSLVW 581

Query: 421  LDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
            LDLNSN LTG+IPPRLGRQ GAK L G LS NTLVFVRNVGNSCKGVGGLLEF+GIRPER
Sbjct: 582  LDLNSNKLTGEIPPRLGRQQGAKSLFGILSGNTLVFVRNVGNSCKGVGGLLEFSGIRPER 641

Query: 481  LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA 540
            LLQ+PTL++CDF R+YSGPVLSLFT+YQTLEYLDLSYN+ RGKIPDE GDM+ALQVLEL+
Sbjct: 642  LLQVPTLRTCDFTRLYSGPVLSLFTKYQTLEYLDLSYNELRGKIPDEFGDMVALQVLELS 701

Query: 541  HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRG 600
            HNQLSGEIPSSLG+L+NLGVFDASHNRLQG IP+SFSNLSFLVQIDLSNNELTG IP RG
Sbjct: 702  HNQLSGEIPSSLGQLKNLGVFDASHNRLQGHIPDSFSNLSFLVQIDLSNNELTGQIPSRG 761

Query: 601  QLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVL 660
            QLSTLPASQYANNPGLCGVPLP+C+N N+QP  NPS D ++ GH+ A A WANSIVMG+L
Sbjct: 762  QLSTLPASQYANNPGLCGVPLPDCKNDNSQPTTNPSDDISKGGHKSATATWANSIVMGIL 821

Query: 661  ISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 720
            IS+AS+CILIVWAIAMRARRKEAEEVK+LNSLQA HAATTWKIDKEKEPLSINVATFQRQ
Sbjct: 822  ISVASVCILIVWAIAMRARRKEAEEVKILNSLQACHAATTWKIDKEKEPLSINVATFQRQ 881

Query: 721  LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 780
            LRKLKFSQLIEATNGFSA SLIGCGGFGEVF+ATLKDGSSVAIKKLIRLSCQGDREFMAE
Sbjct: 882  LRKLKFSQLIEATNGFSAASLIGCGGFGEVFRATLKDGSSVAIKKLIRLSCQGDREFMAE 941

Query: 781  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
            METLGKIKHRNLVPLLGYCK+GEERLLVYE+M++GSLEE+LHGR K RD+RILTW+ RKK
Sbjct: 942  METLGKIKHRNLVPLLGYCKVGEERLLVYEYMEYGSLEEMLHGRIKTRDRRILTWEERKK 1001

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
            IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME+RVSDFGMARLISALDTHLSVST
Sbjct: 1002 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMESRVSDFGMARLISALDTHLSVST 1061

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
            LAGTPGYVPPEYYQSFRCTAKGDVYSFGVV+LELL+GKRPTDK+DFGDTNLVGW K+K+ 
Sbjct: 1062 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVMLELLSGKRPTDKEDFGDTNLVGWAKIKIC 1121

Query: 961  EGKQMEVIDPELLLVTKGTDESEAE--EVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            EGKQMEVID +LLL T+GTDE+EAE  EVKEM+RYLEIT+QCVDD PS+RPNMLQ
Sbjct: 1122 EGKQMEVIDNDLLLATQGTDEAEAEAKEVKEMIRYLEITMQCVDDLPSRRPNMLQ 1176

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351721933|ref|NP_001237994.1| ATP binding/protein serine/threonine kinase [Glycine max] gi|212717135|gb|ACJ37409.1| ATP binding/protein serine/threonine kinase [Glycine max]

 Score = 1663 bits (4307), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 803/1013 (79%), Positives = 897/1013 (88%), Gaps = 3/1013 (0%)

Query: 1    MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            MLSVLK+S N F++NSTSLL LP+ L QL+LS  G+ G VP+NLFSK PNLV +N SYNN
Sbjct: 144  MLSVLKMSLNSFSVNSTSLLNLPYSLTQLDLSFGGVTGPVPENLFSKCPNLVVVNLSYNN 203

Query: 61   LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
            LTG +PE    NSDKL++LDLSYNNL+G I G  +    C SLL LDLS N + D IP S
Sbjct: 204  LTGPIPENFFQNSDKLQVLDLSYNNLSGPIFGLKM---ECISLLQLDLSGNRLSDSIPLS 260

Query: 121  LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
            LSNCT LKILNL+ N+++G+IP+ FGQL+ LQ LDLS+N + GWIPSE GNAC SLLELK
Sbjct: 261  LSNCTSLKILNLANNMVSGDIPKAFGQLNKLQTLDLSHNQLNGWIPSEFGNACASLLELK 320

Query: 181  LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
            L  NNI+GS P + SSCSWLQLLD+SNNN+SG  PD++ +NLGSL+ L L NN I+G FP
Sbjct: 321  LSFNNISGSIPPSFSSCSWLQLLDISNNNMSGQLPDAIFQNLGSLQELRLGNNAITGQFP 380

Query: 241  DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
             S+SSCK L+IVDFSSN++ G IP D+CPG  SLEELR+PDNLITG IP +LS+C++LK 
Sbjct: 381  SSLSSCKKLKIVDFSSNKIYGSIPRDLCPGAVSLEELRMPDNLITGEIPAELSKCSKLKT 440

Query: 301  IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
            +D SLNYLNG+IP ELG+LE+LEQ IAWFN LEG IPP+LG+CKNLKDLILNNN L+G I
Sbjct: 441  LDFSLNYLNGTIPDELGELENLEQLIAWFNSLEGSIPPKLGQCKNLKDLILNNNHLTGGI 500

Query: 361  PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
            P ELF+CSNLEWISLT NEL+ +IP +F  LTRLAVLQLGNN   GEIP EL NC SLVW
Sbjct: 501  PIELFNCSNLEWISLTSNELSWEIPRKFGLLTRLAVLQLGNNSLTGEIPSELANCRSLVW 560

Query: 421  LDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
            LDLNSN LTG+IPPRLGRQLGAK L G LS NTLVFVRNVGNSCKGVGGLLEF+GIRPER
Sbjct: 561  LDLNSNKLTGEIPPRLGRQLGAKSLFGILSGNTLVFVRNVGNSCKGVGGLLEFSGIRPER 620

Query: 481  LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA 540
            LLQ+PTL++CDFAR+YSGPVLS FT+YQTLEYLDLSYN+ RGKIPDE GDM+ALQVLEL+
Sbjct: 621  LLQVPTLRTCDFARLYSGPVLSQFTKYQTLEYLDLSYNELRGKIPDEFGDMVALQVLELS 680

Query: 541  HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRG 600
            HNQLSGEIPSSLG+L+NLGVFDASHNRLQG IP+SFSNLSFLVQIDLSNNELTG IP RG
Sbjct: 681  HNQLSGEIPSSLGQLKNLGVFDASHNRLQGHIPDSFSNLSFLVQIDLSNNELTGQIPSRG 740

Query: 601  QLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVL 660
            QLSTLPASQYANNPGLCGVPLP+C+N N+Q   NPS D ++   + A A WANSIVMG+L
Sbjct: 741  QLSTLPASQYANNPGLCGVPLPDCKNDNSQTTTNPSDDVSKGDRKSATATWANSIVMGIL 800

Query: 661  ISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 720
            IS+AS+CILIVWAIAMRARRKEAEEVKMLNSLQA HAATTWKIDKEKEPLSINVATFQRQ
Sbjct: 801  ISVASVCILIVWAIAMRARRKEAEEVKMLNSLQACHAATTWKIDKEKEPLSINVATFQRQ 860

Query: 721  LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 780
            LRKLKFSQLIEATNGFSA SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE
Sbjct: 861  LRKLKFSQLIEATNGFSAASLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 920

Query: 781  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
            METLGKIKHRNLVPLLGYCK+GEERLLVYE+M++GSLEE+LHGR K RD+RILTW+ RKK
Sbjct: 921  METLGKIKHRNLVPLLGYCKVGEERLLVYEYMEYGSLEEMLHGRIKTRDRRILTWEERKK 980

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
            IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD+EME+RVSDFGMARLISALDTHLSVST
Sbjct: 981  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDNEMESRVSDFGMARLISALDTHLSVST 1040

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
            LAGTPGYVPPEYYQSFRCT KGDVYSFGVV+LELL+GKRPTDK+DFGDTNLVGW K+KVR
Sbjct: 1041 LAGTPGYVPPEYYQSFRCTVKGDVYSFGVVMLELLSGKRPTDKEDFGDTNLVGWAKIKVR 1100

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            EGKQMEVID +LLL T+GTDE+EA+EVKEM+RYLEITLQCVDD PS+RPNMLQ
Sbjct: 1101 EGKQMEVIDNDLLLATQGTDEAEAKEVKEMIRYLEITLQCVDDLPSRRPNMLQ 1153

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|223452280|gb|ACM89468.1| ATP-binding/protein serine/threonine kinase [Glycine max]

 Score = 1661 bits (4302), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 803/1013 (79%), Positives = 897/1013 (88%), Gaps = 3/1013 (0%)

Query: 1    MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            MLSVLK+S N F++NSTSLL LP+ L QL+LS  G+ G VP+NLFSK PNLV +N SYNN
Sbjct: 57   MLSVLKMSLNSFSVNSTSLLNLPYSLTQLDLSFGGVTGPVPENLFSKCPNLVVVNLSYNN 116

Query: 61   LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
            LTG +PE    NSDKL++LDLSYNNL+G I G  +    C SLL LDLS N + D IP S
Sbjct: 117  LTGPIPENFFQNSDKLQVLDLSYNNLSGPIFGLKM---ECISLLQLDLSGNRLSDSIPLS 173

Query: 121  LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
            LSNCT LKILNL+ N+++G+IP+ FGQL+ LQ LDLS+N + GWIPSE GNAC SLLELK
Sbjct: 174  LSNCTSLKILNLANNMVSGDIPKAFGQLNKLQTLDLSHNQLNGWIPSEFGNACASLLELK 233

Query: 181  LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
            L  NNI+GS P + SSCSWLQLLD+SNNN+SG  PD++ +NLGSL+ L L NN I+G FP
Sbjct: 234  LSFNNISGSIPPSFSSCSWLQLLDISNNNMSGQLPDAIFQNLGSLQELRLGNNAITGQFP 293

Query: 241  DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
             S+SSCK L+IVDFSSN++ G IP D+CPG  SLEELR+PDNLITG IP +LS+C++LK 
Sbjct: 294  SSLSSCKKLKIVDFSSNKIYGSIPRDLCPGAVSLEELRMPDNLITGEIPAELSKCSKLKT 353

Query: 301  IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
            +D SLNYLNG+IP ELG+LE+LEQ IAWFN LEG IPP+LG+CKNLKDLILNNN L+G I
Sbjct: 354  LDFSLNYLNGTIPDELGELENLEQLIAWFNSLEGSIPPKLGQCKNLKDLILNNNHLTGGI 413

Query: 361  PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
            P ELF+CSNLEWISLT NEL+ +IP +F  LTRLAVLQLGNN   GEIP EL NC SLVW
Sbjct: 414  PIELFNCSNLEWISLTSNELSWEIPRKFGLLTRLAVLQLGNNSLTGEIPSELANCRSLVW 473

Query: 421  LDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
            LDLNSN LTG+IPPRLGRQLGAK L G LS NTLVFVRNVGNSCKGVGGLLEF+GIRPER
Sbjct: 474  LDLNSNKLTGEIPPRLGRQLGAKSLFGILSGNTLVFVRNVGNSCKGVGGLLEFSGIRPER 533

Query: 481  LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA 540
            LLQ+PTL++CDFAR+YSGPVLS FT+YQTLEYLDLSYN+ RGKIPDE GDM+ALQVLEL+
Sbjct: 534  LLQVPTLRTCDFARLYSGPVLSQFTKYQTLEYLDLSYNELRGKIPDEFGDMVALQVLELS 593

Query: 541  HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRG 600
            HNQLSGEIPSSLG+L+NLGVFDASHNRLQG IP+SFSNLSFLVQIDLSNNELTG IP RG
Sbjct: 594  HNQLSGEIPSSLGQLKNLGVFDASHNRLQGHIPDSFSNLSFLVQIDLSNNELTGQIPSRG 653

Query: 601  QLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVL 660
            QLSTLPASQYANNPGLCGVPLP+C+N N+Q   NPS D ++   + A A WANSIVMG+L
Sbjct: 654  QLSTLPASQYANNPGLCGVPLPDCKNDNSQTTTNPSDDVSKGDRKSATATWANSIVMGIL 713

Query: 661  ISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 720
            IS+AS+CILIVWAIAMRARRKEAEEVKMLNSLQA HAATTWKIDKEKEPLSINVATFQRQ
Sbjct: 714  ISVASVCILIVWAIAMRARRKEAEEVKMLNSLQACHAATTWKIDKEKEPLSINVATFQRQ 773

Query: 721  LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 780
            LRKLKFSQLIEATNGFSA SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE
Sbjct: 774  LRKLKFSQLIEATNGFSAASLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 833

Query: 781  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
            METLGKIKHRNLVPLLGYCK+GEERLLVYE+M++GSLEE+LHGR K RD+RILTW+ RKK
Sbjct: 834  METLGKIKHRNLVPLLGYCKVGEERLLVYEYMEYGSLEEMLHGRIKTRDRRILTWEERKK 893

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
            IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD+EME+RVSDFGMARLISALDTHLSVST
Sbjct: 894  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDNEMESRVSDFGMARLISALDTHLSVST 953

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
            LAGTPGYVPPEYYQSFRCT KGDVYSFGVV+LELL+GKRPTDK+DFGDTNLVGW K+KVR
Sbjct: 954  LAGTPGYVPPEYYQSFRCTVKGDVYSFGVVMLELLSGKRPTDKEDFGDTNLVGWAKIKVR 1013

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            EGKQMEVID +LLL T+GTDE+EA+EVKEM+RYLEITLQCVDD PS+RPNMLQ
Sbjct: 1014 EGKQMEVIDNDLLLATQGTDEAEAKEVKEMIRYLEITLQCVDDLPSRRPNMLQ 1066

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449464870|ref|XP_004150152.1| PREDICTED: serine/threonine-protein kinase BRI1-like 2-like [Cucumis sativus] gi|449520831|ref|XP_004167436.1| PREDICTED: serine/threonine-protein kinase BRI1-like 2-like [Cucumis sativus]

 Score = 1623 bits (4202), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 806/1013 (79%), Positives = 907/1013 (89%), Gaps = 1/1013 (0%)

Query: 1    MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            ML  L LS+N FT+NST+LLQLP+ L+QLELS A +VG VP+NLFSK PNLV+++ S+NN
Sbjct: 126  MLLALNLSTNSFTINSTTLLQLPYNLQQLELSLAKVVGSVPENLFSKCPNLVFVDLSFNN 185

Query: 61   LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
            LT +LPE LL N++KL+ LD+SYNNLTG ISG  ++ENSCNSLL +DLS N I+  IPSS
Sbjct: 186  LTSYLPENLLLNANKLQDLDISYNNLTGLISGLRIDENSCNSLLRVDLSANRIIGSIPSS 245

Query: 121  LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
            +SNCT L+ L L+ NLL+GEIPR+ G+LSSLQR+D+S+N +TGW+PS+  NAC+SL ELK
Sbjct: 246  ISNCTNLQTLGLADNLLSGEIPRSLGELSSLQRVDISHNQLTGWLPSDWRNACNSLQELK 305

Query: 181  LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
            L +NNI+G  P + S+CSWLQ++DLSNNNISGP PDS+ +NL SL+SL+LSNN+ISG  P
Sbjct: 306  LCYNNISGVIPASFSACSWLQIMDLSNNNISGPLPDSIFKNLISLQSLLLSNNIISGPLP 365

Query: 241  DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
             SIS CK L++VD SSNR+SG++PP ICPG  SL+EL++PDNLI G IP +LS C+QLK 
Sbjct: 366  SSISHCKKLQLVDLSSNRISGLVPPGICPGAESLQELKMPDNLIIGGIPPELSLCSQLKT 425

Query: 301  IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
            ID SLNYLNGSIP ELG+L++LEQ IAWFN LEGKIPPELGKC++LKD+ILNNN+LSGEI
Sbjct: 426  IDFSLNYLNGSIPAELGRLQNLEQLIAWFNSLEGKIPPELGKCRSLKDVILNNNRLSGEI 485

Query: 361  PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
            P ELF+CSNLEWISLT NELTG++P EF  L+RLAVLQLGNN   G+IPGEL NCS+LVW
Sbjct: 486  PTELFNCSNLEWISLTSNELTGEVPKEFGLLSRLAVLQLGNNSLSGQIPGELANCSTLVW 545

Query: 421  LDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
            LDLNSN LTG+IPPRLGRQLGAK L G LS NTLVFVRNVGNSCKGVGGLLEFAGIRPER
Sbjct: 546  LDLNSNKLTGEIPPRLGRQLGAKSLNGILSGNTLVFVRNVGNSCKGVGGLLEFAGIRPER 605

Query: 481  LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA 540
            L Q PTLK+CDF R+YSGPVLSLFT+YQTLEYLDLSYN+ RG+IP+E GDM+ALQVLEL+
Sbjct: 606  LQQEPTLKTCDFTRLYSGPVLSLFTKYQTLEYLDLSYNELRGRIPEEFGDMVALQVLELS 665

Query: 541  HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRG 600
            HNQLSGEIP S GRL+NLGVFDASHNRLQG IP+SFSNLSFLVQIDLS NELTG IP RG
Sbjct: 666  HNQLSGEIPESFGRLKNLGVFDASHNRLQGHIPDSFSNLSFLVQIDLSYNELTGRIPSRG 725

Query: 601  QLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVL 660
            QLSTLPASQYANNPGLCGVPLPEC + ++Q   +P+ DA++   +    +W NSIV+GVL
Sbjct: 726  QLSTLPASQYANNPGLCGVPLPECPS-DDQQQTSPNGDASKGRTKPEVGSWVNSIVLGVL 784

Query: 661  ISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 720
            ISIA +CILIVWAIAMRARRKEAEEVKMLNSLQA HA TTWKIDKEKEPLSINVATFQRQ
Sbjct: 785  ISIACVCILIVWAIAMRARRKEAEEVKMLNSLQAIHAPTTWKIDKEKEPLSINVATFQRQ 844

Query: 721  LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 780
            LRKLKFSQLIEATNGFSAESLIG GGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE
Sbjct: 845  LRKLKFSQLIEATNGFSAESLIGSGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 904

Query: 781  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
            METLGKIKH NLVPLLGYCKIGEERLLVYEFM+FGSLEE+LHGRAK +D+RILTWD RKK
Sbjct: 905  METLGKIKHGNLVPLLGYCKIGEERLLVYEFMEFGSLEEMLHGRAKMQDRRILTWDERKK 964

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
            IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH++EARVSDFGMARLISALDTHLSVST
Sbjct: 965  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHDLEARVSDFGMARLISALDTHLSVST 1024

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
            LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK+DFGDTNLVGWVKMKV 
Sbjct: 1025 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKEDFGDTNLVGWVKMKVN 1084

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            +GKQMEVIDPELL VTK +DESEAEEVKEMVRYLEITL+CV++FPSKRPNMLQ
Sbjct: 1085 DGKQMEVIDPELLSVTKTSDESEAEEVKEMVRYLEITLRCVEEFPSKRPNMLQ 1137

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|312190384|gb|ADQ43184.1| leucine-rich receptor kinase [Eutrema parvulum]

 Score = 1567 bits (4058), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 768/1018 (75%), Positives = 881/1018 (86%), Gaps = 7/1018 (0%)

Query: 2    LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
            LSVLKLS N F LNSTSLL LP  L  LELSS+GL+G++P+N FSK  NL+ +  SYNN 
Sbjct: 107  LSVLKLSENFFVLNSTSLLLLPLSLTHLELSSSGLIGILPENFFSKYSNLISITLSYNNF 166

Query: 62   TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
            TG LPE +   S KL+ LDLSYNN+TGSISG ++  +SC SL  LD S N I   IP SL
Sbjct: 167  TGKLPEDVFLGSKKLQTLDLSYNNITGSISGLTIPLSSCVSLSFLDFSGNSISGYIPDSL 226

Query: 122  SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
             NCT LK LNLS+N   G+IP++FG+L SLQ LDLS+N +TGWIP  +G+AC +L  L++
Sbjct: 227  INCTNLKSLNLSYNNFDGQIPKSFGELKSLQSLDLSHNQLTGWIPPAIGDACGTLQNLRI 286

Query: 182  PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
             +NN+TG  P +LSSCSWLQ+LDLSNNNISGPFP+ +L + GSL+ L+LSNN ISG FP 
Sbjct: 287  SYNNVTGVIPDSLSSCSWLQILDLSNNNISGPFPNRILRSFGSLQILLLSNNFISGEFPP 346

Query: 242  SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
            +IS+CKTLRIVDFSSNR SG+IPPD+CPG +SLEELR+PDNL+TG IP  +S+C++L+ I
Sbjct: 347  TISACKTLRIVDFSSNRFSGVIPPDLCPGAASLEELRIPDNLVTGDIPPAISQCSELRTI 406

Query: 302  DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
            DLSLNYLNG+IP E+GKL+ LEQFIAW+N + G IPPE+GK +NLKDLILNNN+L+GEIP
Sbjct: 407  DLSLNYLNGTIPPEIGKLQKLEQFIAWYNNISGNIPPEIGKLQNLKDLILNNNQLTGEIP 466

Query: 362  AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL 421
             E F+CSN+EWIS T N LTG++P +F  L+RLAVLQLGNN F GEIP ELG C++LVWL
Sbjct: 467  PEFFNCSNIEWISFTSNRLTGEVPRDFGNLSRLAVLQLGNNNFTGEIPSELGKCTTLVWL 526

Query: 422  DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL 481
            DLN+N+LTG+IPPRLGRQ G+K L G LS NT+ FVRNVGNSCKGVGGL+EF+GIRPERL
Sbjct: 527  DLNTNHLTGEIPPRLGRQPGSKALSGLLSGNTMAFVRNVGNSCKGVGGLVEFSGIRPERL 586

Query: 482  LQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH 541
            LQIP+LKSCDF RMYSGP+LSLFT+YQT+EYLDLSYNQ RGKI DEIG+MIALQVLEL+H
Sbjct: 587  LQIPSLKSCDFTRMYSGPILSLFTRYQTIEYLDLSYNQLRGKISDEIGEMIALQVLELSH 646

Query: 542  NQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ 601
            NQLSGEIPS++G+L+NLGVFDAS NRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ
Sbjct: 647  NQLSGEIPSTIGQLKNLGVFDASDNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ 706

Query: 602  LSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLI 661
            LSTLPASQYANNPGLCGVPLPEC+NGNNQ    P  +  R  H   AA+WANSIV+GVLI
Sbjct: 707  LSTLPASQYANNPGLCGVPLPECKNGNNQLPPGPE-EGKRPKHGTTAASWANSIVLGVLI 765

Query: 662  SIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQL 721
            S AS+CILIVWAIA+RAR+++AE+ KML+SLQA ++ATTWKI+KEKEPLSINVATFQRQL
Sbjct: 766  SAASVCILIVWAIAVRARKRDAEDAKMLHSLQAVNSATTWKIEKEKEPLSINVATFQRQL 825

Query: 722  RKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEM 781
            RKLKFSQLIEATNGFSA S+IG GGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEM
Sbjct: 826  RKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEM 885

Query: 782  ETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKI 841
            ETLGKIKHRNLVPLLGYCKIGEERLLVYEFM++GSLEEVLHG      +RIL W+ RKKI
Sbjct: 886  ETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRILNWEERKKI 945

Query: 842  ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
            A+GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL
Sbjct: 946  AKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 1005

Query: 902  AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE 961
            AGTPGYVPPEYYQSFRCT+KGDVYS GVV+LE+L+GKRPTDKD+FGDTNLVGW KMK RE
Sbjct: 1006 AGTPGYVPPEYYQSFRCTSKGDVYSVGVVMLEILSGKRPTDKDEFGDTNLVGWSKMKARE 1065

Query: 962  GKQMEVIDPELLLVTKGTDE-SEAEE-----VKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            GK M+VID +LL + +G++  SE E      VKEM+RYLEI L+CVDDFPSKRPNMLQ
Sbjct: 1066 GKHMDVIDEDLLSIREGSESLSEKESFGRVNVKEMLRYLEIALRCVDDFPSKRPNMLQ 1123

Source: Eutrema parvulum

Species: Eutrema parvulum

Genus: Eutrema

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|229914865|gb|ACQ90590.1| brassinosteroid receptor-like protein [Eutrema halophilum]

 Score = 1556 bits (4030), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 769/1019 (75%), Positives = 882/1019 (86%), Gaps = 9/1019 (0%)

Query: 2    LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
            LSVLKLS N F LNSTSLL LP  L  LELSS+GL+G++P+  F K  NL+ +  SYNN 
Sbjct: 107  LSVLKLSENFFVLNSTSLLLLPLSLTHLELSSSGLIGILPEIFFPKYSNLISITLSYNNF 166

Query: 62   TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
            TG LP+ +     KL+ LDLSYNN+TGSISG ++  +SC SL  LD S N I   IP SL
Sbjct: 167  TGNLPKDVFLGGKKLQTLDLSYNNITGSISGLTIPLSSCLSLSFLDFSGNSISGYIPDSL 226

Query: 122  SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
             NCT LK LNLS+N   G+IP++FG+L SLQ LDLS+N +TGWIP E+G+AC SL  L++
Sbjct: 227  INCTNLKSLNLSYNNFDGQIPKSFGELKSLQSLDLSHNRLTGWIPPEIGDACGSLQNLRV 286

Query: 182  PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
             +NNITG  P +LSSCSWLQ+LDLSNNNISGPFPD +L + GSL+ L+LSNN+ISG FP 
Sbjct: 287  SYNNITGVIPDSLSSCSWLQILDLSNNNISGPFPDKILRSFGSLQILLLSNNLISGEFPS 346

Query: 242  SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
            S+S+CK+LRI DFSSNR SG+IPPD+CPG +SLEELR+PDNL+TG IP ++S+C++L+ I
Sbjct: 347  SLSACKSLRIADFSSNRFSGVIPPDLCPGAASLEELRIPDNLVTGQIPPEISQCSELRTI 406

Query: 302  DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
            DLSLNYLNG+IP E+G L+ LEQFIAW+N + GKIPPE+GK +NLKDLILNNN+L+GEIP
Sbjct: 407  DLSLNYLNGTIPPEIGNLQKLEQFIAWYNNISGKIPPEIGKLQNLKDLILNNNQLTGEIP 466

Query: 362  AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL 421
             E F+CSN+EWIS T N LTG++P EF  L+RLAVLQLGNN F GEIP ELG C++LVWL
Sbjct: 467  PEFFNCSNIEWISFTSNRLTGEVPREFGILSRLAVLQLGNNNFTGEIPSELGKCTTLVWL 526

Query: 422  DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL 481
            DLN+N+LTG+IPPRLGRQ G+K L G LS NT+ FVRNVGNSCKGVGGL+EFAGIRPERL
Sbjct: 527  DLNTNHLTGEIPPRLGRQPGSKALSGLLSGNTMAFVRNVGNSCKGVGGLVEFAGIRPERL 586

Query: 482  LQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH 541
            LQIP+LKSCDF RMYSGP+LSLFT+YQT+EYLDLSYNQ RGKIPDEIG+MIALQVLEL+H
Sbjct: 587  LQIPSLKSCDFTRMYSGPILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSH 646

Query: 542  NQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ 601
            NQLSGEIP ++G+L+NLGVFDAS NRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ
Sbjct: 647  NQLSGEIPFTIGQLKNLGVFDASDNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ 706

Query: 602  LSTLPASQYANNPGLCGVPLPECRNGNNQ-PALNPSVDAARHGHRVAAAAWANSIVMGVL 660
            LSTLPASQYA+NPGLCGVPLPEC+NGNNQ PA    V  A+HG R  AA+WANSIV+GVL
Sbjct: 707  LSTLPASQYADNPGLCGVPLPECKNGNNQLPAGTEEVKRAKHGTR--AASWANSIVLGVL 764

Query: 661  ISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQ 720
            IS ASICILIVWAIA+RAR+++AE+ KML+SLQA ++ATTWKI+KEKEPLSINVATFQRQ
Sbjct: 765  ISAASICILIVWAIAVRARKRDAEDAKMLHSLQAVNSATTWKIEKEKEPLSINVATFQRQ 824

Query: 721  LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 780
            LRKLKFSQLIEATNGFSA S+IG GGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE
Sbjct: 825  LRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE 884

Query: 781  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
            METLGKIKHRNLVPLLGYCKIGEERLLVYEFM++GSLEEVLHG      +R+L+W+ RKK
Sbjct: 885  METLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRVLSWEERKK 944

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
            IA+GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST
Sbjct: 945  IAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 1004

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
            LAGTPGYVPPEYYQSFRCT+KGDVYS GVV+LE+L+GKRPTDKD+FGDTNLVGW KMK R
Sbjct: 1005 LAGTPGYVPPEYYQSFRCTSKGDVYSIGVVMLEILSGKRPTDKDEFGDTNLVGWSKMKAR 1064

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEE------VKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            EGK M+VID +LL   +G++     E      VKEM+RYLEI L+CVDDFPSKRPNMLQ
Sbjct: 1065 EGKHMDVIDEDLLSEKEGSESLSEREGFGGVMVKEMLRYLEIALRCVDDFPSKRPNMLQ 1123

Source: Eutrema halophilum

Species: Eutrema halophilum

Genus: Eutrema

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1013
TAIR|locus:2041150	1143	BRL2 "BRI1-like 2" [Arabidopsi	0.976	0.865	0.718	0.0
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.942	0.819	0.491	1.6e-244
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.929	0.809	0.495	7.1e-235
TAIR|locus:2005498	1196	BRI1 "BRASSINOSTEROID INSENSIT	0.942	0.798	0.487	2.2e-231
UNIPROTKB|Q942F3	1121	P0480C01.18-1 "cDNA clone:J033	0.872	0.788	0.498	2.4e-218
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.935	0.795	0.363	5.9e-144
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.935	0.759	0.336	1.2e-131
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.588	0.476	0.331	3.6e-128
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.623	0.553	0.327	2.9e-124
UNIPROTKB|Q8RZV7	1294	P0413C03.22 "Putative extra sp	0.923	0.723	0.345	3.5e-123

TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 3747 (1324.1 bits), Expect = 0., P = 0.
 Identities = 717/998 (71%), Positives = 827/998 (82%)

Query:    23 PFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS 82
             P  L  LELSS+GL+G +P+N FSK  NL+ +  SYNN TG LP  L  +S KL+ LDLS
Sbjct:   126 PLTLTHLELSSSGLIGTLPENFFSKYSNLISITLSYNNFTGKLPNDLFLSSKKLQTLDLS 185

Query:    83 YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIP 142
             YNN+TG ISG ++  +SC S+ +LD S N I   I  SL NCT LK LNLS+N   G+IP
Sbjct:   186 YNNITGPISGLTIPLSSCVSMTYLDFSGNSISGYISDSLINCTNLKSLNLSYNNFDGQIP 245

Query:   143 RTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQL 202
             ++FG+L  LQ LDLS+N +TGWIP E+G+ C SL  L+L +NN TG  P +LSSCSWLQ 
Sbjct:   246 KSFGELKLLQSLDLSHNRLTGWIPPEIGDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQS 305

Query:   203 LDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGI 262
             LDLSNNNISGPFP+++L + GSL+ L+LSNN+ISG FP SIS+CK+LRI DFSSNR SG+
Sbjct:   306 LDLSNNNISGPFPNTILRSFGSLQILLLSNNLISGDFPTSISACKSLRIADFSSNRFSGV 365

Query:   263 IPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHL 322
             IPPD+CPG +SLEELRLPDNL+TG IP  +S+C++L+ IDLSLNYLNG+IP E+G L+ L
Sbjct:   366 IPPDLCPGAASLEELRLPDNLVTGEIPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKL 425

Query:   323 EQFIAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELTG 382
             EQFIAW+N + G+IPPE+G               +GEIP E F+CSN+EW+S T N LTG
Sbjct:   426 EQFIAWYNNIAGEIPPEIGKLQNLKDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTG 485

Query:   383 QIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA 442
             ++P +F  L+RLAVLQLGNN F GEIP ELG C++LVWLDLN+N+LTG+IPPRLGRQ G+
Sbjct:   486 EVPKDFGILSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPGS 545

Query:   443 KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLS 502
             K L G LS NT+ FVRNVGNSCKGVGGL+EF+GIRPERLLQIP+LKSCDF RMYSGP+LS
Sbjct:   546 KALSGLLSGNTMAFVRNVGNSCKGVGGLVEFSGIRPERLLQIPSLKSCDFTRMYSGPILS 605

Query:   503 LFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFD 562
             LFT+YQT+EYLDLSYNQ RGKIPDEIG+MIALQVLEL+HNQLSGEIP ++G+L+NLGVFD
Sbjct:   606 LFTRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSHNQLSGEIPFTIGQLKNLGVFD 665

Query:   563 ASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLP 622
             AS NRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPA+QYANNPGLCGVPLP
Sbjct:   666 ASDNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGVPLP 725

Query:   623 ECRNGNNQ-PALNPSVDXXXXXXXXXXXXXXNSIVMGVLISIASICILIVWAIAMRARRK 681
             EC+NGNNQ PA   + +              NSIV+GVLIS AS+CILIVWAIA+RARR+
Sbjct:   726 ECKNGNNQLPA--GTEEGKRAKHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARRR 783

Query:   682 EAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESL 741
             +A++ KML+SLQA ++ATTWKI+KEKEPLSINVATFQRQLRKLKFSQLIEATNGFSA S+
Sbjct:   784 DADDAKMLHSLQAVNSATTWKIEKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASM 843

Query:   742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
             IG GGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI
Sbjct:   844 IGHGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 903

Query:   802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             GEERLLVYEFM++GSLEEVLHG      +RIL W+            LCFLHHNCIPHII
Sbjct:   904 GEERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHII 963

Query:   862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAK 921
             HRDMKSSNVLLD +MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAK
Sbjct:   964 HRDMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAK 1023

Query:   922 GDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV--TKGT 979
             GDVYS GVV+LE+L+GKRPTDK++FGDTNLVGW KMK REGK MEVID +LL    ++  
Sbjct:  1024 GDVYSIGVVMLEILSGKRPTDKEEFGDTNLVGWSKMKAREGKHMEVIDEDLLKEGSSESL 1083

Query:   980 DESEAEE----VKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
             +E E  E    VKEM+RYLEI L+CVDDFPSKRPNMLQ
Sbjct:  1084 NEKEGFEGGVIVKEMLRYLEIALRCVDDFPSKRPNMLQ 1121

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0010233 "phloem transport" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009734 "auxin mediated signaling pathway" evidence=RCA;IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 2356 (834.4 bits), Expect = 1.6e-244, P = 1.6e-244
 Identities = 486/989 (49%), Positives = 642/989 (64%)

Query:    35 GLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSD-KLELLDLSYNNLTGSISGF 93
             G +G  P    S L +L  ++ SYN L+  +PE+ +S+    L+ LDL++NNL+G  S  
Sbjct:   165 GKLGFAP----SSLQSLTTVDLSYNILSDKIPESFISDFPASLKYLDLTHNNLSGDFSDL 220

Query:    94 SLNENSCNSLLHLDLSQNHIM-DVIPSSLSNCTKLKILNLSFNLLAGEIPRT--FGQLSS 150
             S     C +L    LSQN++  D  P +L NC  L+ LN+S N LAG+IP    +G   +
Sbjct:   221 SFG--ICGNLTFFSLSQNNLSGDKFPITLPNCKFLETLNISRNNLAGKIPNGEYWGSFQN 278

Query:   151 LQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNI 210
             L++L L++N ++G IP EL   C +L+ L L  N  +G  P   ++C WLQ L+L NN +
Sbjct:   279 LKQLSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNNYL 338

Query:   211 SGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPG 270
             SG F ++V+  +  +  L ++ N ISGS P S+++C  LR++D SSN  +G +P   C  
Sbjct:   339 SGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFCSL 398

Query:   271 VSS--LEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAW 328
              SS  LE++ + +N ++G +P +L +C  LK IDLS N L G IP+E+  L +L   + W
Sbjct:   399 QSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMW 458

Query:   329 FNGLEGKIPPELGXXXXXXXXXXXXXXX-SGEIPAELFSCSNLEWISLTGNELTGQIPPE 387
              N L G IP  +                 +G IP  +  C+N+ WISL+ N LTG+IP  
Sbjct:   459 ANNLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSG 518

Query:   388 FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGG 447
                L++LA+LQLGNN   G +P +LGNC SL+WLDLNSNNLTGD+P  L  Q G   + G
Sbjct:   519 IGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAGLV-MPG 577

Query:   448 FLSSNTLVFVRNVGNS-CKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQ 506
              +S     FVRN G + C+G GGL+EF GIR ERL ++P + SC   R+YSG  +  F+ 
Sbjct:   578 SVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSGMTMYTFSA 637

Query:   507 YQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHN 566
               ++ Y D+SYN   G IP   G+M  LQVL L HN+++G IP S G L+ +GV D SHN
Sbjct:   638 NGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHN 697

Query:   567 RLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRN 626
              LQG +P S  +LSFL  +D+SNN LTGPIP  GQL+T P S+YANN GLCGVPL  C +
Sbjct:   698 NLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGS 757

Query:   627 GNNQPALNPSVDXXXXXXXXXXXXXXNSIVMGVLISIASICILIVWAIAMR-ARRKEAEE 685
                +P  +                   +++ G+  S     +L++    +R  ++KE + 
Sbjct:   758 APRRPITS--------RIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKR 809

Query:   686 VKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCG 745
              K + SL  S  + +WK+    EPLSINVATF++ LRKL F+ L+EATNGFSAE+++G G
Sbjct:   810 EKYIESLPTS-GSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSG 868

Query:   746 GFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER 805
             GFGEV+KA L+DGS VAIKKLIR++ QGDREFMAEMET+GKIKHRNLVPLLGYCK+GEER
Sbjct:   869 GFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEER 928

Query:   806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDM 865
             LLVYE+MK+GSLE VLH ++  +    L W             L FLHH+CIPHIIHRDM
Sbjct:   929 LLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDM 988

Query:   866 KSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVY 925
             KSSNVLLD + EARVSDFGMARL+SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVY
Sbjct:   989 KSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVY 1048

Query:   926 SFGVVLLELLTGKRPTDKDDFG-DTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEA 984
             S+GV+LLELL+GK+P D  +FG D NLVGW K   RE +  E++DPEL+     TD+S  
Sbjct:  1049 SYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELV-----TDKSG- 1102

Query:   985 EEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
              +V E+  YL+I  QC+DD P KRP M+Q
Sbjct:  1103 -DV-ELFHYLKIASQCLDDRPFKRPTMIQ 1129

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 2265 (802.4 bits), Expect = 7.1e-235, P = 7.1e-235
 Identities = 479/966 (49%), Positives = 615/966 (63%)

Query:    26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSN-SDKLELLDLSYN 84
             L  +  S   L G +  +  +    +  ++ S N  +  +PET +++  + L+ LDLS N
Sbjct:   152 LVSVNFSHNKLAGKLKSSPSASNKRITTVDLSNNRFSDEIPETFIADFPNSLKHLDLSGN 211

Query:    85 NLTGSISGFSLNENSCNSLLHLDLSQNHIM-DVIPSSLSNCTKLKILNLSFNLLAGEIPR 143
             N+TG  S  S     C +L    LSQN I  D  P SLSNC  L+ LNLS N L G+IP 
Sbjct:   212 NVTGDFSRLSFG--LCENLTVFSLSQNSISGDRFPVSLSNCKLLETLNLSRNSLIGKIPG 269

Query:   144 T--FGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQ 201
                +G   +L++L L++N  +G IP EL   C +L  L L  N++TG  P + +SC  LQ
Sbjct:   270 DDYWGNFQNLRQLSLAHNLYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSCGSLQ 329

Query:   202 LLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSG 261
              L+L NN +SG F  +V+  L  + +L L  N ISGS P S+++C  LR++D SSN  +G
Sbjct:   330 SLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTG 389

Query:   262 IIPPDICPGVSS--LEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKL 319
              +P   C   SS  LE+L + +N ++G +P +L +C  LK IDLS N L G IP+E+  L
Sbjct:   390 EVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKEIWTL 449

Query:   320 EHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXXXXXX-SGEIPAELFSCSNLEWISLTGN 378
               L   + W N L G IP  +                 +G +P  +  C+N+ WISL+ N
Sbjct:   450 PKLSDLVMWANNLTGGIPESICVDGGNLETLILNNNLLTGSLPESISKCTNMLWISLSSN 509

Query:   379 ELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGR 438
              LTG+IP    +L +LA+LQLGNN   G IP ELGNC +L+WLDLNSNNLTG++P  L  
Sbjct:   510 LLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPGELAS 569

Query:   439 QLGAKPLGGFLSSNTLVFVRNVGNS-CKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYS 497
             Q G   + G +S     FVRN G + C+G GGL+EF GIR ERL   P + SC   R+YS
Sbjct:   570 QAGLV-MPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYS 628

Query:   498 GPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRN 557
             G  + +F+   ++ YLDLSYN   G IP   G M  LQVL L HN L+G IP S G L+ 
Sbjct:   629 GMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKA 688

Query:   558 LGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLC 617
             +GV D SHN LQG +P S   LSFL  +D+SNN LTGPIP  GQL+T P ++YANN GLC
Sbjct:   689 IGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLC 748

Query:   618 GVPLPECRNGNNQPALNPSVDXXXXXXXXXXXXXXNSIVMGVLISIASICILIVWAI-AM 676
             GVPLP C +G+      P+                  +  G++ S   I +LI+    A 
Sbjct:   749 GVPLPPCSSGSR-----PT----RSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRAR 799

Query:   677 RARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGF 736
             + ++KE +  K + SL  S  +++WK+    EPLSINVATF++ LRKL F+ L+EATNGF
Sbjct:   800 KVQKKEKQREKYIESLPTS-GSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGF 858

Query:   737 SAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
             SA+S+IG GGFG+V+KA L DGS VAIKKLI+++ QGDREFMAEMET+GKIKHRNLVPLL
Sbjct:   859 SADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLL 918

Query:   797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
             GYCKIGEERLLVYE+MK+GSLE VLH + K +    L W             L FLHH+C
Sbjct:   919 GYCKIGEERLLVYEYMKYGSLETVLHEKTK-KGGIFLDWSARKKIAIGAARGLAFLHHSC 977

Query:   857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
             IPHIIHRDMKSSNVLLD +  ARVSDFGMARL+SALDTHLSVSTLAGTPGYVPPEYYQSF
Sbjct:   978 IPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSF 1037

Query:   917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFG-DTNLVGWVKMKVREGKQMEVIDPELLLV 975
             RCTAKGDVYS+GV+LLELL+GK+P D ++FG D NLVGW K   RE +  E++DPEL+  
Sbjct:  1038 RCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTD 1097

Query:   976 TKGTDE 981
               G  E
Sbjct:  1098 KSGDVE 1103

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2232 (790.8 bits), Expect = 2.2e-231, P = 2.2e-231
 Identities = 485/994 (48%), Positives = 620/994 (62%)

Query:    31 LSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSI 90
             +S A +VG V   L      L +L  S N ++G   +  +S    LE LD+S NN +  I
Sbjct:   185 ISGANVVGWV---LSDGCGELKHLAISGNKISG---DVDVSRCVNLEFLDVSSNNFSTGI 238

Query:    91 SGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSS 150
               F L +  C++L HLD+S N +      ++S CT+LK+LN+S N   G IP     L S
Sbjct:   239 P-F-LGD--CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKS 292

Query:   151 LQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNI 210
             LQ L L+ N  TG IP  L  ACD+L  L L  N+  G+ P    SCS L+ L LS+NN 
Sbjct:   293 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 352

Query:   211 SGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCK-TLRIVDFSSNRVSGIIPPDICP 269
             SG  P   L  +  L+ L LS N  SG  P+S+++   +L  +D SSN  SG I P++C 
Sbjct:   353 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 412

Query:   270 GV-SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAW 328
                ++L+EL L +N  TG IP  LS C++L  + LS NYL+G+IP  LG L  L     W
Sbjct:   413 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 472

Query:   329 FNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEF 388
              N LEG+IP EL                +GEIP+ L +C+NL WISL+ N LTG+IP   
Sbjct:   473 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 532

Query:   389 SRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGF 448
              RL  LA+L+L NN F G IP ELG+C SL+WLDLN+N   G IP  + +Q G K    F
Sbjct:   533 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG-KIAANF 591

Query:   449 LSSNTLVFVRNVG--NSCKGVGGLLEFAGIRPERLLQIPTLKSCDF-ARMYSGPVLSLFT 505
             ++    V+++N G    C G G LLEF GIR E+L ++ T   C+  +R+Y G     F 
Sbjct:   592 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 651

Query:   506 QYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASH 565
                ++ +LD+SYN   G IP EIG M  L +L L HN +SG IP  +G LR L + D S 
Sbjct:   652 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 711

Query:   566 NRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECR 625
             N+L G+IP++ S L+ L +IDLSNN L+GPIP+ GQ  T P +++ NNPGLCG PLP C 
Sbjct:   712 NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC- 770

Query:   626 NGNNQPALNPSVDXXXXXXXXXXXXXXNSIVMGVLISIASICILIVWAIAMRARRKEAE- 684
                  P+                     S+ MG+L S   I  LI+    MR RR++ E 
Sbjct:   771 ----DPSNADGYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEA 826

Query:   685 EVKML-----NSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAE 739
             E++M      NS   +   T WK+   KE LSIN+A F++ LRKL F+ L++ATNGF  +
Sbjct:   827 ELEMYAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHND 886

Query:   740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
             SLIG GGFG+V+KA LKDGS+VAIKKLI +S QGDREFMAEMET+GKIKHRNLVPLLGYC
Sbjct:   887 SLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYC 946

Query:   800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
             K+G+ERLLVYEFMK+GSLE+VLH   KA  +  L W             L FLHHNC PH
Sbjct:   947 KVGDERLLVYEFMKYGSLEDVLHDPKKAGVK--LNWSTRRKIAIGSARGLAFLHHNCSPH 1004

Query:   860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
             IIHRDMKSSNVLLD  +EARVSDFGMARL+SA+DTHLSVSTLAGTPGYVPPEYYQSFRC+
Sbjct:  1005 IIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1064

Query:   920 AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGT 979
              KGDVYS+GVVLLELLTGKRPTD  DFGD NLVGWVK   +  +  +V DPEL+      
Sbjct:  1065 TKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKL-RISDVFDPELM------ 1117

Query:   980 DESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
              E  A E+ E++++L++ + C+DD   +RP M+Q
Sbjct:  1118 KEDPALEI-ELLQHLKVAVACLDDRAWRRPTMVQ 1150

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

GO:0010224 "response to UV-B" evidence=IGI

GO:0005768 "endosome" evidence=IDA

GO:0046982 "protein heterodimerization activity" evidence=IPI

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0010268 "brassinosteroid homeostasis" evidence=IEP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0043234 "protein complex" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0009911 "positive regulation of flower development" evidence=IGI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IEP;IMP

GO:0010584 "pollen exine formation" evidence=IMP

GO:0048657 "tapetal cell differentiation" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0005496 "steroid binding" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 2109 (747.5 bits), Expect = 2.4e-218, P = 2.4e-218
 Identities = 461/924 (49%), Positives = 577/924 (62%)

Query:   106 LDLSQNHIMDVIPSSL-----SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNH 160
             LDLS N I D   S L     +    ++ L+L+ N ++G +P  F   S LQ LDLS N 
Sbjct:   176 LDLSNNKITD--DSDLRWMVDAGVGAVRWLDLALNRISG-VPE-FTNCSGLQYLDLSGNL 231

Query:   161 ITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLE 220
             I G +P    + C  L  L L  N++ G FP  ++  + L  L+LSNNN SG  P     
Sbjct:   232 IVGEVPGGALSDCRGLKVLNLSFNHLAGVFPPDIAGLTSLNALNLSNNNFSGELPGEAFA 291

Query:   221 NLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSS-LEELRL 279
              L  L +L LS N  +GS PD+++S   L+ +D SSN  SG IP  +C   +S L  L L
Sbjct:   292 KLQQLTALSLSFNHFNGSIPDTVASLPELQQLDLSSNTFSGTIPSSLCQDPNSKLHLLYL 351

Query:   280 PDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE 339
              +N +TG IP  +S CT L  +DLSLNY+NGSIP  LG L +L+  I W N LEG+IP  
Sbjct:   352 QNNYLTGGIPDAVSNCTSLVSLDLSLNYINGSIPASLGDLGNLQDLILWQNELEGEIPAS 411

Query:   340 LGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQL 399
             L                +G IP EL  C+ L WISL  N L+G IP    +L+ LA+L+L
Sbjct:   412 LSRIQGLEHLILDYNGLTGSIPPELAKCTKLNWISLASNRLSGPIPSWLGKLSYLAILKL 471

Query:   400 GNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRN 459
              NN F G IP ELG+C SLVWLDLNSN L G IP  L +Q G   +G  +     V++RN
Sbjct:   472 SNNSFSGPIPPELGDCQSLVWLDLNSNQLNGSIPKELAKQSGKMNVG-LIVGRPYVYLRN 530

Query:   460 --VGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSY 517
               + + C+G G LLEF  IRP+ L ++P+ K C+F RMY G     F +  ++ +LDLSY
Sbjct:   531 DELSSECRGKGSLLEFTSIRPDDLSRMPSKKLCNFTRMYVGSTEYTFNKNGSMIFLDLSY 590

Query:   518 NQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFS 577
             NQ    IP E+GDM  L ++ L HN LSG IPS L   + L V D S+N+L+G IP SFS
Sbjct:   591 NQLDSAIPGELGDMFYLMIMNLGHNLLSGTIPSRLAEAKKLAVLDLSYNQLEGPIPNSFS 650

Query:   578 NLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSV 637
              LS L +I+LSNN+L G IP+ G L+T P SQY NN GLCG PLP C   ++ P    S 
Sbjct:   651 ALS-LSEINLSNNQLNGTIPELGSLATFPKSQYENNTGLCGFPLPPC--DHSSP--RSSN 705

Query:   638 DXXXXXXXXXXXXXXNSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLNSL---QA 694
             D              +SI MG+L S+  I ++I+ AI  + RR + EE      +     
Sbjct:   706 DHQSHRRQASMA---SSIAMGLLFSLFCIIVIII-AIGSKRRRLKNEEASTSRDIYIDSR 761

Query:   695 SHAATT---WKIDKE-KEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEV 750
             SH+AT    W+ +      LSIN+A F++ L+ L  + L+EATNGF     IG GGFG+V
Sbjct:   762 SHSATMNSDWRQNLSGTNLLSINLAAFEKPLQNLTLADLVEATNGFHIACQIGSGGFGDV 821

Query:   751 FKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE 810
             +KA LKDG  VAIKKLI +S QGDREF AEMET+GKIKHRNLVPLLGYCK GEERLLVY+
Sbjct:   822 YKAQLKDGKVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKAGEERLLVYD 881

Query:   811 FMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNV 870
             +MKFGSLE+VLH R K   +  L W+            L FLHHNCIPHIIHRDMKSSNV
Sbjct:   882 YMKFGSLEDVLHDRKKIGKK--LNWEARRKIAVGAARGLAFLHHNCIPHIIHRDMKSSNV 939

Query:   871 LLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVV 930
             L+D ++EARVSDFGMARL+S +DTHLSVSTLAGTPGYVPPEYYQSFRCT KGDVYS+GVV
Sbjct:   940 LIDEQLEARVSDFGMARLMSVVDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVV 999

Query:   931 LLELLTGKRPTDKDDFG-DTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKE 989
             LLELLTGK PTD  DFG D NLVGWVK   +  K  +V DPELL       E  + E+ E
Sbjct:  1000 LLELLTGKPPTDSADFGEDNNLVGWVKQHTKL-KITDVFDPELL------KEDPSVEL-E 1051

Query:   990 MVRYLEITLQCVDDFPSKRPNMLQ 1013
             ++ +L+I   C+DD PS+RP ML+
Sbjct:  1052 LLEHLKIACACLDDRPSRRPTMLK 1075

GO:0001578 "microtubule bundle formation" evidence=IMP

GO:0009647 "skotomorphogenesis" evidence=IMP

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1407 (500.3 bits), Expect = 5.9e-144, P = 5.9e-144
 Identities = 367/1011 (36%), Positives = 523/1011 (51%)

Query:    26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
             LK     S    G +P  + SKL +L  L+ SYN L   +P++       L +L+L    
Sbjct:   212 LKNFAAPSCFFNGPLPKEI-SKLKHLAKLDLSYNPLKCSIPKSF-GELHNLSILNLVSAE 269

Query:    86 LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
             L G I        +C SL  L LS N +   +P  LS    L   +   N L+G +P   
Sbjct:   270 LIGLIPP---ELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLTF-SAERNQLSGSLPSWM 325

Query:   146 GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL 205
             G+   L  L L+NN  +G IP E+ + C  L  L L  N ++GS P  L     L+ +DL
Sbjct:   326 GKWKVLDSLLLANNRFSGEIPHEIED-CPMLKHLSLASNLLSGSIPRELCGSGSLEAIDL 384

Query:   206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPP 265
             S N +SG   + V +   SL  L+L+NN I+GS P+ +     L  +D  SN  +G IP 
Sbjct:   385 SGNLLSGTI-EEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSNNFTGEIPK 442

Query:   266 DICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF 325
              +    ++L E     N + G +P ++     LK + LS N L G IP+E+GKL  L   
Sbjct:   443 SLWKS-TNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVL 501

Query:   326 IAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELTGQIP 385
                 N  +GKIP ELG                G+IP ++ + + L+ + L+ N L+G IP
Sbjct:   502 NLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIP 561

Query:   386 ------------PEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIP 433
                         P+ S L    +  L  NR  G IP ELG C  LV + L++N+L+G+IP
Sbjct:   562 SKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIP 621

Query:   434 PRLGRQLGAKPLGGFLSSNTLV--FVRNVGNSCKGVGGLL---EFAGIRPERLLQIPTLK 488
               L R      L   LS N L     + +GNS K  G  L   +  G  PE    + +L 
Sbjct:   622 ASLSRLTNLTILD--LSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLV 679

Query:   489 SCDFAR-MYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE 547
               +  +    GPV +     + L ++DLS+N   G++  E+  M  L  L +  N+ +GE
Sbjct:   680 KLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGE 739

Query:   548 IPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPA 607
             IPS LG L  L   D S N L G+IP     L  L  ++L+ N L G +P  G       
Sbjct:   740 IPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSK 799

Query:   608 SQYANNPGLCG-VPLPECRNGNNQPALNPSVDXXXXXXXXXXXXXXNSIVMGVLISIASI 666
             +  + N  LCG V   +C+           ++                  + V + + S 
Sbjct:   800 ALLSGNKELCGRVVGSDCK-----------IEGTKLRSAWGIAGLMLGFTIIVFVFVFS- 847

Query:   667 CILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKID--KEKEPLSINVATFQRQLRKL 724
               L  WA+  R ++++  E    + L+       + +   + +EPLSIN+A F++ L K+
Sbjct:   848 --LRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKV 905

Query:   725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETL 784
             +   ++EAT+ FS +++IG GGFG V+KA L    +VA+KKL     QG+REFMAEMETL
Sbjct:   906 RLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETL 965

Query:   785 GKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXX 844
             GK+KH NLV LLGYC   EE+LLVYE+M  GSL+  L  +    +  +L W         
Sbjct:   966 GKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLE--VLDWSKRLKIAVG 1023

Query:   845 XXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
                 L FLHH  IPHIIHRD+K+SN+LLD + E +V+DFG+ARLISA ++H+S + +AGT
Sbjct:  1024 AARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVS-TVIAGT 1082

Query:   905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT---NLVGWVKMKVRE 961
              GY+PPEY QS R T KGDVYSFGV+LLEL+TGK PT  D F ++   NLVGW   K+ +
Sbjct:  1083 FGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPD-FKESEGGNLVGWAIQKINQ 1141

Query:   962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012
             GK ++VIDP  LLV+     S+       +R L+I + C+ + P+KRPNML
Sbjct:  1142 GKAVDVIDP--LLVSVALKNSQ-------LRLLQIAMLCLAETPAKRPNML 1183

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1291 (459.5 bits), Expect = 1.2e-131, P = 1.2e-131
 Identities = 347/1030 (33%), Positives = 541/1030 (52%)

Query:    26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
             L+ L L++  L G +P  L  ++  L YL+   N L G +P++L ++   L+ LDLS NN
Sbjct:   241 LEILNLANNSLTGEIPSQL-GEMSQLQYLSLMANQLQGLIPKSL-ADLGNLQTLDLSANN 298

Query:    86 LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL-SNCTKLKILNLSFNLLAGEIPRT 144
             LTG I     N    + LL L L+ NH+   +P S+ SN T L+ L LS   L+GEIP  
Sbjct:   299 LTGEIPEEFWN---MSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVE 355

Query:   145 FGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLD 204
               +  SL++LDLSNN + G IP  L    + L +L L +N + G+   ++S+ + LQ L 
Sbjct:   356 LSKCQSLKQLDLSNNSLAGSIPEALFELVE-LTDLYLHNNTLEGTLSPSISNLTNLQWLV 414

Query:   205 LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP 264
             L +NN+ G  P  +   L  LE L L  N  SG  P  I +C +L+++D   N   G IP
Sbjct:   415 LYHNNLEGKLPKEI-SALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIP 473

Query:   265 PDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQ 324
             P I   +  L  L L  N + G +P  L  C QL ++DL+ N L+GSIP   G L+ LEQ
Sbjct:   474 PSI-GRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQ 532

Query:   325 FIAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSG-----------------------EIP 361
              + + N L+G +P  L                +G                       EIP
Sbjct:   533 LMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIP 592

Query:   362 AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL 421
              EL +  NL+ + L  N+LTG+IP    ++  L++L + +N   G IP +L  C  L  +
Sbjct:   593 LELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHI 652

Query:   422 DLNSNNLTGDIPPRLGR--QLGAKPLGGFLSSNTLV--FVRNVGNSCKGVGGLLE---FA 474
             DLN+N L+G IPP LG+  QLG   L    SSN  V      + N  K +   L+     
Sbjct:   653 DLNNNFLSGPIPPWLGKLSQLGELKL----SSNQFVESLPTELFNCTKLLVLSLDGNSLN 708

Query:   475 GIRPERLLQIPTLKSCDFAR-MYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA 533
             G  P+ +  +  L   +  +  +SG +     +   L  L LS N   G+IP EIG +  
Sbjct:   709 GSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQD 768

Query:   534 LQ-VLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
             LQ  L+L++N  +G+IPS++G L  L   D SHN+L G++P S  ++  L  +++S N L
Sbjct:   769 LQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNL 828

Query:   593 TGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDXXXXXXXXXXXXXX 652
              G + +  Q S  PA  +  N GLCG PL  C    N+   N                  
Sbjct:   829 GGKLKK--QFSRWPADSFLGNTGLCGSPLSRC----NRVRSNNKQQGLSARSV------- 875

Query:   653 NSIVMGVLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSI 712
               +++  + ++ +I ++I+  IA+  +++  +  K +     ++ +++       +PL  
Sbjct:   876 --VIISAISALTAIGLMIL-VIALFFKQRH-DFFKKVGHGSTAYTSSSSSSQATHKPLFR 931

Query:   713 NVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI-RLSC 771
             N A+       +++  ++EAT+  S E +IG GG G+V+KA L++G +VA+KK++ +   
Sbjct:   932 NGASKS----DIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDL 987

Query:   772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE--RLLVYEFMKFGSLEEVLHGRAKA-- 827
               ++ F  E++TLG+I+HR+LV L+GYC    E   LL+YE+MK GS+ + LH       
Sbjct:   988 MSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLE 1047

Query:   828 RDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
             + +++L W+            + +LHH+C+P I+HRD+KSSNVLLD  MEA + DFG+A+
Sbjct:  1048 KKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAK 1107

Query:   888 LISA-LDTHLSVST-LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
             +++   DT+   +T  A + GY+ PEY  S + T K DVYS G+VL+E++TGK PTD   
Sbjct:  1108 VLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVF 1167

Query:   946 FGDTNLVGWVK--MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDD 1003
               + ++V WV+  ++V    + ++IDP+L  +    +E  A +V      LEI LQC   
Sbjct:  1168 GAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLP-FEEDAACQV------LEIALQCTKT 1220

Query:  1004 FPSKRPNMLQ 1013
              P +RP+  Q
Sbjct:  1221 SPQERPSSRQ 1230

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 745 (267.3 bits), Expect = 3.6e-128, Sum P(2) = 3.6e-128
 Identities = 206/621 (33%), Positives = 307/621 (49%)

Query:    26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
             ++ L L    L GL+P  L ++L NL  L+ S NNLTG + E      ++LE L L+ N 
Sbjct:   266 IQYLNLIGNQLQGLIPKRL-TELANLQTLDLSSNNLTGVIHEEFW-RMNQLEFLVLAKNR 323

Query:    86 LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
             L+GS+     + N+  SL  L LS+  +   IP+ +SNC  LK+L+LS N L G+IP + 
Sbjct:   324 LSGSLPKTICSNNT--SLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSL 381

Query:   146 GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL 205
              QL  L  L L+NN + G + S + N  + L E  L HNN+ G  P  +     L+++ L
Sbjct:   382 FQLVELTNLYLNNNSLEGTLSSSISNLTN-LQEFTLYHNNLEGKVPKEIGFLGKLEIMYL 440

Query:   206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPP 265
               N  SG  P  +  N   L+ +    N +SG  P SI   K L  +    N + G IP 
Sbjct:   441 YENRFSGEMPVEI-GNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPA 499

Query:   266 DICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF 325
              +      +  + L DN ++G IP      T L++  +  N L G++P  L  L++L + 
Sbjct:   500 SL-GNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRI 558

Query:   326 IAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELTGQIP 385
                 N   G I P  G                G+IP EL   +NL+ + L  N+ TG+IP
Sbjct:   559 NFSSNKFNGSISPLCGSSSYLSFDVTENGF-EGDIPLELGKSTNLDRLRLGKNQFTGRIP 617

Query:   386 PEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPL 445
               F +++ L++L +  N   G IP ELG C  L  +DLN+N L+G IP  LG+     PL
Sbjct:   618 RTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKL----PL 673

Query:   446 GGFLSSNTLVFVRNVGNSCKGVGGLL-------EFAGIRPERLLQIPTLKSCDFAR-MYS 497
              G L  ++  FV ++      +  +L          G  P+ +  +  L + +      S
Sbjct:   674 LGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLS 733

Query:   498 GPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQ-VLELAHNQLSGEIPSSLGRLR 556
             GP+ S   +   L  L LS N   G+IP EIG +  LQ  L+L++N  +G IPS++  L 
Sbjct:   734 GPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLP 793

Query:   557 NLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGL 616
              L   D SHN+L G++P    ++  L  ++LS N L G + +  Q S   A  +  N GL
Sbjct:   794 KLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGL 851

Query:   617 CGVPLPEC-RNGN-NQPALNP 635
             CG PL  C R G+ NQ +L+P
Sbjct:   852 CGSPLSHCNRAGSKNQRSLSP 872

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 782 (280.3 bits), Expect = 2.9e-124, Sum P(2) = 2.9e-124
 Identities = 219/668 (32%), Positives = 334/668 (50%)

Query:    26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
             L++L +S A L G +P++L   L  L  L+ S N L G +P +L S    LE L L+ N 
Sbjct:   107 LQKLTISGANLTGTLPESLGDCL-GLKVLDLSSNGLVGDIPWSL-SKLRNLETLILNSNQ 164

Query:    86 LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNL-LAGEIPRT 144
             LTG I     + + C+ L  L L  N +   IP+ L   + L+++ +  N  ++G+IP  
Sbjct:   165 LTGKIPP---DISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSE 221

Query:   145 FGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLD 204
              G  S+L  L L+   ++G +PS LG     L  L +    I+G  P  L +CS L  L 
Sbjct:   222 IGDCSNLTVLGLAETSVSGNLPSSLGKL-KKLETLSIYTTMISGEIPSDLGNCSELVDLF 280

Query:   205 LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP 264
             L  N++SG  P  + + L  LE L L  N + G  P+ I +C  L+++D S N +SG IP
Sbjct:   281 LYENSLSGSIPREIGQ-LTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIP 339

Query:   265 PDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQ 324
               I   +S LEE  + DN  +G IP  +S C+ L  + L  N ++G IP ELG L  L  
Sbjct:   340 SSI-GRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTL 398

Query:   325 FIAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELTGQI 384
             F AW N LEG IPP L                +G IP+ LF   NL  + L  N L+G I
Sbjct:   399 FFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFI 458

Query:   385 PPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKP 444
             P E    + L  L+LG NR  GEIP  +G+   + +LD +SN L G +P  +G     + 
Sbjct:   459 PQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQM 518

Query:   445 LGGFLSSNTLV-FVRNVGNSCKGVGGL----LEFAGIRPERLLQIPTLKSCDFAR-MYSG 498
             +   LS+N+L   + N  +S  G+  L     +F+G  P  L ++ +L     ++ ++SG
Sbjct:   519 ID--LSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSG 576

Query:   499 PVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQV-LELAHNQLSGEIPSSLGRLRN 557
              + +       L+ LDL  N+  G+IP E+GD+  L++ L L+ N+L+G+IPS +  L  
Sbjct:   577 SIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNK 636

Query:   558 LGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLC 617
             L + D SHN L+G +    +N+  LV +++S N  +G +P       L       N  LC
Sbjct:   637 LSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLC 695

Query:   618 GVPLPEC----RNGNNQPALNPSVDXXXXXXXXXXXXXXNSIVMGVLISIASICILIVWA 673
                   C    R GN    L    D                + + +LI++ ++ ++I+ A
Sbjct:   696 SSTQDSCFLTYRKGNG---LGDDGDASRTRKLR--------LTLALLITL-TVVLMILGA 743

Query:   674 IAM-RARR 680
             +A+ RARR
Sbjct:   744 VAVIRARR 751

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
 Identities = 351/1016 (34%), Positives = 498/1016 (49%)

Query:    26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
             L +L++S       +P ++  +L NL  L A    L+G +P+ L  N  KL +++LS+N 
Sbjct:   307 LTELDISDNNFDAELPSSM-GELGNLTQLIAKNAGLSGNMPKEL-GNCKKLTVINLSFNA 364

Query:    86 LTGSI-SGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRT 144
             L G I   F+       +++   +  N +   +P  +      + + L  N  +G +P  
Sbjct:   365 LIGPIPEEFA----DLEAIVSFFVEGNKLSGRVPDWIQKWKNARSIRLGQNKFSGPLPVL 420

Query:   145 FGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLD 204
                L  L      +N ++G IPS +  A +SL  L L HNN+TG+       C+ L  L+
Sbjct:   421 --PLQHLLSFAAESNLLSGSIPSHICQA-NSLHSLLLHHNNLTGTIDEAFKGCTNLTELN 477

Query:   205 LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP 264
             L +N+I G  P  + E    L +L LS N  +G  P  +   KTL  +  S+N ++G IP
Sbjct:   478 LLDNHIHGEVPGYLAEL--PLVTLELSQNKFAGMLPAELWESKTLLEISLSNNEITGPIP 535

Query:   265 PDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQ 324
               I   +S L+ L + +NL+ G IP  + +   L  + L  N L+G IP  L     L  
Sbjct:   536 ESIGK-LSVLQRLHIDNNLLEGPIPQSVGDLRNLTNLSLRGNRLSGIIPLALFNCRKLAT 594

Query:   325 FIAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELTGQI 384
                 +N L G IP  +                SG IPAE+  C   E      NE     
Sbjct:   595 LDLSYNNLTGNIPSAISHLTLLDSLILSSNQLSGSIPAEI--CVGFE------NEAH--- 643

Query:   385 PPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKP 444
              P+   L    +L L  N+  G+IP  + NC+ ++ L+L  N L G IP  LG       
Sbjct:   644 -PDSEFLQHHGLLDLSYNQLTGQIPTSIKNCAMVMVLNLQGNLLNGTIPVELGELTN--- 699

Query:   445 LGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIR----------PERLLQI-PTLKSCDFA 493
                 L+S  L F   VG      G L++  G+           P ++ QI P +   D +
Sbjct:   700 ----LTSINLSFNEFVGPMLPWSGPLVQLQGLILSNNHLDGSIPAKIGQILPKIAVLDLS 755

Query:   494 -RMYSG--PVLSLFTQYQTLEYLDLSYNQFRGKI----PDEIGDMIALQVLELAHNQLSG 546
                 +G  P   L   Y  L +LD+S N   G I    PD       L     + N  SG
Sbjct:   756 SNALTGTLPQSLLCNNY--LNHLDVSNNHLSGHIQFSCPDGKEYSSTLLFFNSSSNHFSG 813

Query:   547 EIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLP 606
              +  S+     L   D  +N L G++P + S+LS L  +DLS+N L G IP  G  +   
Sbjct:   814 SLDESISNFTQLSTLDIHNNSLTGRLPSALSDLSSLNYLDLSSNNLYGAIPC-GICNIFG 872

Query:   607 ASQYANNPG--LCGVPLPECRNGNNQPALNPSVDXXXXXXXXXXXXXXNSIVMGVLISIA 664
              S +AN  G  +    L +C  G        S +               +I +    +  
Sbjct:   873 LS-FANFSGNYIDMYSLADCAAGGIC-----STNGTDHKALHPYHRVRRAITI-CAFTFV 925

Query:   665 SICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKID-----KEKEPLSINVATFQR 719
              I +L++ A+ +R +   +  +   ++ +A         D     K +EPLSIN+ATF+ 
Sbjct:   926 IIIVLVLLAVYLRRKLVRSRPLAFESASKAKATVEPTSTDELLGKKSREPLSINLATFEH 985

Query:   720 QLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIR-LSCQGDREFM 778
              L ++    +++AT  FS   +IG GGFG V+KA L +G  VAIK+L      QGDREF+
Sbjct:   986 ALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFL 1045

Query:   779 AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
             AEMET+GK+KH NLVPLLGYC  G+ER L+YE+M+ GSLE  L  RA A +   L W   
Sbjct:  1046 AEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEA--LGWPDR 1103

Query:   839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
                       L FLHH  +PHIIHRDMKSSN+LLD   E RVSDFG+AR+ISA +TH+S 
Sbjct:  1104 LKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVST 1163

Query:   899 STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDF-GDTNLVGWVKM 957
               +AGT GY+PPEY  + + T KGDVYSFGVV+LELLTG+ PT +++  G  NLVGWV+ 
Sbjct:  1164 D-IAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVGWVRW 1222

Query:   958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
              +  GKQ E+ DP  L V+    E       +M R L I   C  D P KRP ML+
Sbjct:  1223 MIARGKQNELFDP-CLPVSSVWRE-------QMARVLAIARDCTADEPFKRPTMLE 1270

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0009554 "megasporogenesis" evidence=IMP

GO:0009556 "microsporogenesis" evidence=IMP

GO:0048658 "tapetal layer development" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8GUQ5	BRI1_SOLLC	2, ., 7, ., 1, 1, ., 1	0.5009	0.9674	0.8119	N/A	no
Q8L899	BRI1_SOLPE	2, ., 7, ., 1, 1, ., 1	0.5014	0.9674	0.8119	N/A	no
Q9ZPS9	BRL2_ARATH	2, ., 7, ., 1, 1, ., 1	0.7492	0.9950	0.8818	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: grail3.0010068301 hypothetical protein (1134 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1013
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-121
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-76
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-43
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-27
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-18
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-14
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-04
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	2e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.003
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  392 bits (1009), Expect = e-121
 Identities = 299/998 (29%), Positives = 472/998 (47%), Gaps = 143/998 (14%)

Query: 26   LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
            +  ++LS   + G +   +F +LP +  +N S N L+G +P+ + + S  L  L+LS NN
Sbjct: 71   VVSIDLSGKNISGKISSAIF-RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129

Query: 86   LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
             TGSI   S+      +L  LDLS N +   IP+ + + + LK+L+L  N+L G+IP + 
Sbjct: 130  FTGSIPRGSI-----PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 146  GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL 205
              L+SL+ L L++N + G IP ELG    SL  + L +NN++G  P  +   + L  LDL
Sbjct: 185  TNLTSLEFLTLASNQLVGQIPRELGQM-KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243

Query: 206  SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPP 265
              NN++GP P S L NL +L+ L L  N +SG  P SI S + L  +D S N +SG I P
Sbjct: 244  VYNNLTGPIPSS-LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI-P 301

Query: 266  DICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF 325
            ++   + +LE L L  N  TG IP  L+   +L+V+ L  N  +G IP+ LGK  +L   
Sbjct: 302  ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361

Query: 326  IAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIP 385
                N L G+IP  L    NL  LIL +N L GEIP  L +C +L  + L  N  +G++P
Sbjct: 362  DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421

Query: 386  PEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPL 445
             EF++L  +  L + NN  +G I     +  SL  L L  N   G +P   G        
Sbjct: 422  SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-------- 473

Query: 446  GGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFAR-MYSGPVLSLF 504
                S                                    L++ D +R  +SG V    
Sbjct: 474  ----SKR----------------------------------LENLDLSRNQFSGAVPRKL 495

Query: 505  TQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDAS 564
                 L  L LS N+  G+IPDE+     L  L+L+HNQLSG+IP+S   +  L   D S
Sbjct: 496  GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555

Query: 565  HNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCG----VP 620
             N+L G+IP++  N+  LVQ+++S+N L G +P  G    + AS  A N  LCG      
Sbjct: 556  QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG 615

Query: 621  LPECRNGNNQPALNPSVDAARHGHRVAAAAW---ANSIVMGVLISIASICILIVWAIAMR 677
            LP C+     P+                  W     ++   +++++ +   + +      
Sbjct: 616  LPPCKRVRKTPSW-----------------WFYITCTLGAFLVLALVAFGFVFI------ 652

Query: 678  ARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFS 737
             R +   E+K              +++ E         T++ Q    K S+ I   +  S
Sbjct: 653  -RGRNNLELK--------------RVENED-------GTWELQFFDSKVSKSITINDILS 690

Query: 738  A---ESLIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMAEMET--LGKIKHRN 791
            +   E++I  G  G  +K  ++K+G    +K++       D   +   E   +GK++H N
Sbjct: 691  SLKEENVISRGKKGASYKGKSIKNGMQFVVKEI------NDVNSIPSSEIADMGKLQHPN 744

Query: 792  LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            +V L+G C+  +   L++E+++  +L EVL           L+W+ R+KIA G AK L F
Sbjct: 745  IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRF 795

Query: 852  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            LH  C P ++  ++    +++D + E  +    +  L+   DT   +S+      YV PE
Sbjct: 796  LHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL-CTDTKCFISS-----AYVAPE 848

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE 971
              ++   T K D+Y FG++L+ELLTGK P D +     ++V W +    +      IDP 
Sbjct: 849  TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
            +       D S  +   E+V  + + L C    P+ RP
Sbjct: 909  I-----RGDVSVNQ--NEIVEVMNLALHCTATDPTARP 939

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  270 bits (691), Expect = 3e-76
 Identities = 174/486 (35%), Positives = 262/486 (53%), Gaps = 45/486 (9%)

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
           +N +++  ++LS   ++G+I     +L  +Q ++LSNN ++G IP ++     SL  L L
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
            +NN TGS P        L+ LDLSNN +SG  P+ +  +  SL+ L L  N++ G  P+
Sbjct: 126 SNNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPNDI-GSFSSLKVLDLGGNVLVGKIPN 182

Query: 242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
           S+++  +L  +  +SN++ G IP ++   + SL+ + L  N ++G IP ++   T L  +
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQ-MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
           DL  N L G IP  LG L++L+    + N L G IPP +   + L  L L++N LSGEIP
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Query: 362 AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL 421
             +    NLE + L  N  TG+IP   + L RL VLQL +N+F GEIP  LG  ++L  L
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361

Query: 422 DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL 481
           DL++NNLTG+IP             G  SS  L  +    NS +G               
Sbjct: 362 DLSTNNLTGEIPE------------GLCSSGNLFKLILFSNSLEG--------------- 394

Query: 482 LQIP-TLKSCDFARM-------YSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA 533
            +IP +L +C   R        +SG + S FT+   + +LD+S N  +G+I     DM +
Sbjct: 395 -EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453

Query: 534 LQVLELAHNQLSGEIPSSLG--RLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNE 591
           LQ+L LA N+  G +P S G  RL NL   D S N+  G +P    +LS L+Q+ LS N+
Sbjct: 454 LQMLSLARNKFFGGLPDSFGSKRLENL---DLSRNQFSGAVPRKLGSLSELMQLKLSENK 510

Query: 592 LTGPIP 597
           L+G IP
Sbjct: 511 LSGEIP 516

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  163 bits (416), Expect = 7e-46
 Identities = 67/197 (34%), Positives = 105/197 (53%), Gaps = 14/197 (7%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYC 799
           +G GGFG V+ A   K G  VAIK + +       E  + E+E L K+ H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
           +      LV E+ + GSL+++L       ++  L+ D   +I     +GL +LH N    
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK-----ENEGKLSEDEILRILLQILEGLEYLHSN---G 112

Query: 860 IIHRDMKSSNVLLDH-EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FR 917
           IIHRD+K  N+LLD    + +++DFG+++L++       + T+ GTP Y+ PE       
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGY 170

Query: 918 CTAKGDVYSFGVVLLEL 934
            + K D++S GV+L EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  161 bits (410), Expect = 2e-44
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 59/292 (20%)

Query: 739  ESLIGCGGFGEVFKATLKDGSS-----VAIKKLIRLSCQGD--REFMAEMETLGKIKHRN 791
               +G G FGEV+K TLK         VA+K L +         EF+ E   + K+ H N
Sbjct: 4    GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPN 62

Query: 792  LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            +V LLG C   E  ++V E+M  G L + L    +    + L+       A   A+G+ +
Sbjct: 63   IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL----RKNRPKELSLSDLLSFALQIARGMEY 118

Query: 852  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-- 909
            L      + IHRD+ + N L+   +  ++SDFG++R +   D +          G +P  
Sbjct: 119  LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV------KGGKLPIR 169

Query: 910  ---PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP----TDKDDFGDTNLVGWVKMKVRE 961
               PE  +  + T+K DV+SFGV+L E+ T G+ P    ++ +          V   +++
Sbjct: 170  WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE----------VLEYLKK 219

Query: 962  GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            G ++                       E+ +   + LQC  + P  RP   +
Sbjct: 220  GYRL---------------PKPPNCPPELYK---LMLQCWAEDPEDRPTFSE 253

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  159 bits (404), Expect = 9e-44
 Identities = 70/202 (34%), Positives = 107/202 (52%), Gaps = 14/202 (6%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGY 798
            +G G FG+V+ A  K  G  VAIK + +   + DRE  + E++ L K+KH N+V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
            +  ++  LV E+ + G L ++L      + +  L+ D  +   R     L +LH     
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLL------KKRGRLSEDEARFYLRQILSALEYLHSK--- 116

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
            I+HRD+K  N+LLD +   +++DFG+AR    LD    ++T  GTP Y+ PE       
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
               D++S GV+L ELLTGK P
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  158 bits (403), Expect = 1e-43
 Identities = 73/292 (25%), Positives = 119/292 (40%), Gaps = 60/292 (20%)

Query: 739  ESLIGCGGFGEVFKATLKDGSS-----VAIKKLIRLSCQGD--REFMAEMETLGKIKHRN 791
               +G G FGEV+K  LK         VA+K L +         EF+ E   + K+ H N
Sbjct: 4    GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPN 62

Query: 792  LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            +V LLG C   E   +V E+M+ G L   L           L+       A   A+G+ +
Sbjct: 63   VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIARGMEY 117

Query: 852  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-- 909
            L      + IHRD+ + N L+   +  ++SDFG++R +                G +P  
Sbjct: 118  LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY------DDDYYRKRGGKLPIR 168

Query: 910  ---PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP----TDKDDFGDTNLVGWVKMKVRE 961
               PE  +  + T+K DV+SFGV+L E+ T G++P    ++++          V   ++ 
Sbjct: 169  WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----------VLEYLKN 218

Query: 962  GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            G ++                       E+     + LQC  + P  RP   +
Sbjct: 219  GYRL---------------PQPPNCPPELYD---LMLQCWAEDPEDRPTFSE 252

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  158 bits (402), Expect = 2e-43
 Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 54/290 (18%)

Query: 742  IGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPLL 796
            +G G FGEV+K  LK        VA+K L   + + +R +F+ E   + K+ H N+V LL
Sbjct: 3    LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 797  GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ---RILTWDARKKIARGAAKGLCFLH 853
            G C   E   LV E+M+ G L + L              L+       A   AKG+ +L 
Sbjct: 63   GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 854  HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP---- 909
                   +HRD+ + N L+  ++  ++SDFG++R +   D +        T G +P    
Sbjct: 123  SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK-----KTGGKLPIRWM 174

Query: 910  -PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP----TDKDDFGDTNLVGWVKMKVREGK 963
             PE  +    T+K DV+SFGV+L E+ T G  P    ++++          V   +R+G 
Sbjct: 175  APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----------VLEYLRKGY 224

Query: 964  QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            ++    PE             +E+ E++      L C    P  RP   +
Sbjct: 225  RLP--KPEYCP----------DELYELM------LSCWQLDPEDRPTFSE 256

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  157 bits (400), Expect = 3e-43
 Identities = 70/211 (33%), Positives = 105/211 (49%), Gaps = 25/211 (11%)

Query: 742 IGCGGFGEVFKATLKDGSS-----VAIKKL-IRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FGEV+K TLK         VA+K L    S +   EF+ E   + K+ H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
           LG C  GE   +V E+M  G L + L      +    LT     ++A   AKG+ +L   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLR-----KHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----P 910
              + +HRD+ + N L+   +  ++SDFG++R I   D            G +P     P
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-----YRKRGGGKLPIKWMAP 173

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E  +  + T+K DV+SFGV+L E+ T G++P
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  154 bits (391), Expect = 5e-42
 Identities = 89/281 (31%), Positives = 130/281 (46%), Gaps = 43/281 (15%)

Query: 742  IGCGGFGEVFKATLK-DGSSVAIKKLI--RLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
            +G G FG V+KA  K  G  VA+K L       + D+    E+  L ++ H N+V L+  
Sbjct: 7    LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 799  CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
             +  +   LV E+ + G L + L           L+ D  KKIA    +GL +LH N   
Sbjct: 67   FEDKDHLYLVMEYCEGGDLFDYL------SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117

Query: 859  HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE------Y 912
             IIHRD+K  N+LLD     +++DFG+A+ +    + L  +T  GTP Y+ PE       
Sbjct: 118  GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNG 175

Query: 913  YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL 972
            Y       K DV+S GV+L ELLTGK P     F   N++      +R      +   E 
Sbjct: 176  Y-----GPKVDVWSLGVILYELLTGKPP-----FSGENILD-QLQLIRRILGPPLEFDEP 224

Query: 973  LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                     S +EE K++++     L   D  PSKRP   +
Sbjct: 225  ------KWSSGSEEAKDLIKKC---L-NKD--PSKRPTAEE 253

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  141 bits (358), Expect = 1e-37
 Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 18/209 (8%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           F     IG GGFGEV+KA   + G  VAIK +   S +   + + E++ L K KH N+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 795 LLG--YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
             G    K  +E  +V EF   GSL+++L         + LT      + +   KGL +L
Sbjct: 62  YYGSYLKK--DELWIVMEFCSGGSLKDLLKST-----NQTLTESQIAYVCKELLKGLEYL 114

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPE 911
           H N    IIHRD+K++N+LL  + E ++ DFG++ +L      +    T+ GTP ++ PE
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN----TMVGTPYWMAPE 167

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                    K D++S G+  +EL  GK P
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (325), Expect = 3e-33
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)

Query: 741  LIGCGGFGEVFKATLKD-GSSVAIKK--LIRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
            L+G G FG V+ A  KD G  +A+K   L   S +       E+  L  ++H N+V   G
Sbjct: 7    LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 798  YCKIGEERLLVY---EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
              +  EE+  +    E++  GSL  +L    K  +  I      +K  R   +GL +LH 
Sbjct: 67   -SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI------RKYTRQILEGLAYLHS 119

Query: 855  NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
            N    I+HRD+K +N+L+D +   +++DFG A+ +  ++T     ++ GTP ++ PE  +
Sbjct: 120  N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 915  SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL 974
                    D++S G  ++E+ TGK P     + +         K+    +   I PE L 
Sbjct: 177  GEEYGRAADIWSLGCTVIEMATGKPP-----WSELGNPMAALYKIGSSGEPPEI-PEHL- 229

Query: 975  VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010
                     +EE K+ +R      +C+   P KRP 
Sbjct: 230  ---------SEEAKDFLR------KCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  119 bits (301), Expect = 6e-30
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 14/204 (6%)

Query: 740 SLIGCGGFGEVFKATLK-DGSSVAIKKL-IRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
            ++G G  G V+K   K  G   A+KK+ +    +  ++ + E++TL   +   +V   G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 798 -YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            + K GE  + V E+M  GSL ++L  +     + +L       IAR   KGL +LH   
Sbjct: 67  AFYKEGEISI-VLEYMDGGSLADLL-KKVGKIPEPVL-----AYIARQILKGLDYLHTK- 118

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
             HIIHRD+K SN+L++ + E +++DFG+++++   +T    +T  GT  Y+ PE  Q  
Sbjct: 119 -RHIIHRDIKPSNLLINSKGEVKIADFGISKVLE--NTLDQCNTFVGTVTYMSPERIQGE 175

Query: 917 RCTAKGDVYSFGVVLLELLTGKRP 940
             +   D++S G+ LLE   GK P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 1e-29
 Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 49/280 (17%)

Query: 740  SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
            + IG G FG+V     + G  VA+K L   S      F+AE   +  ++H NLV LLG  
Sbjct: 12   ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVV 69

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
              G    +V E+M  GSL + L  R +A    ++T   +   A    +G+ +L      +
Sbjct: 70   LQGNPLYIVTEYMAKGSLVDYLRSRGRA----VITLAQQLGFALDVCEGMEYLEEK---N 122

Query: 860  IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----PEYYQ 914
             +HRD+ + NVL+  ++ A+VSDFG+A+           ++     G +P     PE  +
Sbjct: 123  FVHRDLAARNVLVSEDLVAKVSDFGLAK----------EASQGQDSGKLPVKWTAPEALR 172

Query: 915  SFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL 973
              + + K DV+SFG++L E+ + G+ P  +    D      V   V +G +ME       
Sbjct: 173  EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPHVEKGYRME------- 219

Query: 974  LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                   E    EV ++++       C +  P+KRP   Q
Sbjct: 220  -----APEGCPPEVYKVMK------DCWELDPAKRPTFKQ 248

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  117 bits (295), Expect = 7e-29
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 14/201 (6%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           IG G  GEV+KAT    G  VAIKK +RL  Q     + E+  +   KH N+V       
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKK-MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 801 IGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
           +G+E  +V E+M  GSL +++     +  + +I        + R   +GL +LH     +
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY------VCREVLQGLEYLHSQ---N 136

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS N+LL  +   +++DFG A  ++        +++ GTP ++ PE  +     
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--KSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E+  G+ P
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  116 bits (292), Expect = 7e-29
 Identities = 66/235 (28%), Positives = 112/235 (47%), Gaps = 34/235 (14%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLL 796
            IG G FG+V+      DG    +K+ I LS   ++E    + E++ L K+ H N++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKE-IDLSNMSEKEREDALNEVKILKKLNHPNII--- 62

Query: 797 GYCKIGEERLLVYEFMKF---GSLEEVLHGRAKARD----QRILTWDARKKIARGAAKGL 849
            Y +  EE+  +   M++   G L + +  + K       ++IL W  +          L
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLAL 116

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV-STLAGTPGYV 908
            +LH      I+HRD+K  N+ L      ++ DFG++++   L + + +  T+ GTP Y+
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV---LSSTVDLAKTVVGTPYYL 170

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
            PE  Q+     K D++S G VL EL T K P     F   NL+    +K+ +G+
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHP-----FEGENLLELA-LKILKGQ 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 4e-28
 Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 30/211 (14%)

Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKK--LIRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
           LIG G FG V+K   L+ G  VAIK+  L ++  +  +  M E++ L  +KH N+V  +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 798 YCKIGEERLLVYEFMKFGSLEEVL--HGR------AKARDQRILTWDARKKIARGAAKGL 849
             +  +   ++ E+ + GSL +++   G       A    Q +L             +GL
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-VL-------------QGL 112

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH      +IHRD+K++N+L   +   +++DFG+A  ++  D     +++ GTP ++ 
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMA 167

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +    +   D++S G  ++ELLTG  P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 8e-28
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 28/214 (13%)

Query: 742 IGCGGFGEVFKATLK-DGSS----VAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG V+K     +G      VAIK L   +  + ++E + E   +  + H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           LG C +  +  L+ + M  G L + +   +     Q +L W          AKG+ +L  
Sbjct: 75  LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEE 127

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP----- 909
                ++HRD+ + NVL+      +++DFG+A+L+   +            G VP     
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG-----GKVPIKWMA 179

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
            E       T K DV+S+GV + EL+T G +P +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 54/281 (19%)

Query: 741  LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD------REFMAEMETLGKIKHRNLVP 794
             IG G FG+V+K  LK  + VA+K     +C+        R+F+ E E L +  H N+V 
Sbjct: 2    KIGKGNFGDVYKGVLKGNTEVAVK-----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56

Query: 795  LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH- 853
            L+G C   +   +V E +  GSL   L  +      + L      +++  AA G+ +L  
Sbjct: 57   LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL-----QMSLDAAAGMEYLES 111

Query: 854  HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP---- 909
             NC    IHRD+ + N L+      ++SDFGM+R     +    + T++     +P    
Sbjct: 112  KNC----IHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWT 162

Query: 910  -PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI 968
             PE     R T++ DV+S+G++L E  +          GDT   G    + RE       
Sbjct: 163  APEALNYGRYTSESDVWSYGILLWETFS---------LGDTPYPGMSNQQTRE------- 206

Query: 969  DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
                  +  G      +   E +    + LQC    P  RP
Sbjct: 207  -----RIESGYRMPAPQLCPEEIY--RLMLQCWAYDPENRP 240

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (288), Expect = 2e-27
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 20/223 (8%)

Query: 735 GFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIR---LSCQGDREFMAEMETLGKIKH-R 790
            +     +G G FGEV+ A  +D   VA+K L +      +    F+ E++ L  + H  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           N+V L  + +      LV E++  GSLE++L    K   +  L+      I       L 
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK---KIGRKGPLSESEALFILAQILSALE 115

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSV----STLAGTP 905
           +LH      IIHRD+K  N+LLD +    ++ DFG+A+L+    +  S+    ST  GTP
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 906 GYVPPEYYQSFRC---TAKGDVYSFGVVLLELLTGKRPTDKDD 945
           GY+ PE          ++  D++S G+ L ELLTG  P + + 
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  111 bits (279), Expect = 6e-27
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 37/224 (16%)

Query: 742 IGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVP 794
           +G G FG+VF           D   VA+K L   +    R+ F  E E L   +H N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK----------KIARG 844
             G C  G+  ++V+E+M+ G L + L  R+   D   L                +IA  
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFL--RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 845 AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD-------THLS 897
            A G+ +L      H +HRD+ + N L+ +++  ++ DFGM+R +   D       T L 
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           +        ++PPE     + T + DV+SFGVVL E+ T GK+P
Sbjct: 188 IR-------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  110 bits (276), Expect = 8e-27
 Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 20/211 (9%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           F+ E  +G G FGEV++   K+   VAIK L        ++F  E++ L +++H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
              C +GE   ++ E M+ GSL   L    ++ + ++L   +   +A   A+G+ +L   
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFL----RSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI-----SALDTHLSVSTLAGTPGYVPP 910
              + IHRD+ + N+L+  ++  +V+DFG+ARLI      + D  +     A       P
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA-------P 173

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E       + K DV+SFG++L E+ T G+ P
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (266), Expect = 2e-25
 Identities = 71/210 (33%), Positives = 108/210 (51%), Gaps = 23/210 (10%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIK--KLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G FG+V+ A  L  G  +A+K  ++     +  +E   EM+ L  +KH NLV    Y
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV---KY 64

Query: 799 CKIGEERLLVYEFMKF---GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
             +   R  VY FM++   G+LEE+L    +  D+ ++     +       +GL +LH +
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVI-----RVYTLQLLEGLAYLHSH 118

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT--HLSVSTLAGTPGYVPPEYY 913
               I+HRD+K +N+ LDH    ++ DFG A  +    T     V +LAGTP Y+ PE  
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 914 QSFRCTAKG---DVYSFGVVLLELLTGKRP 940
              +    G   D++S G V+LE+ TGKRP
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 6e-25
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 12/201 (5%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV++    + + VA+K L   +     +F+AE + + K++H  L+ L   C +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
            E   +V E MK+GSL E L G A     R L       +A   A G+ +L      + I
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLEAQ---NYI 125

Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCTA 920
           HRD+ + NVL+      +V+DFG+AR+I   +        A  P  +  PE     R + 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIK--EDIYEAREGAKFPIKWTAPEAALYNRFSI 183

Query: 921 KGDVYSFGVVLLELLT-GKRP 940
           K DV+SFG++L E++T G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 8e-25
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 28/215 (13%)

Query: 739 ESLIGCGGFGEVFKATLKDGS----SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLV 793
           E +IG G FGEV +  LK        VAIK L   S    R +F+ E   +G+  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            L G        +++ E+M+ GSL++ L    +  D +  T      + RG A G+ +L 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL----RENDGK-FTVGQLVGMLRGIASGMKYLS 123

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP---- 909
                  +HRD+ + N+L++  +  +VSDFG++R +   +   +  T  G  G +P    
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTKG--GKIPIRWT 175

Query: 910 -PEY--YQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            PE   Y+ F  T+  DV+SFG+V+ E+++ G+RP
Sbjct: 176 APEAIAYRKF--TSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 6e-24
 Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 29/212 (13%)

Query: 742 IGCGGFGEVFKAT--LKDGSS--VAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V K    +K G    VA+K L +     G +EF+ E   + ++ H  +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
           G CK GE  +LV E    G L + L  R +     +         A   A G+ +L    
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK- 114

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----PE 911
             H +HRD+ + NVLL +  +A++SDFGM+R + A   +      A T G  P     PE
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR----ATTAGRWPLKWYAPE 168

Query: 912 --YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
              Y  F  ++K DV+S+GV L E  + G +P
Sbjct: 169 CINYGKF--SSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (253), Expect = 8e-24
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 14/210 (6%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR---EFMAEMETLGKIKHRNLVPLLGY 798
           IG G FG VFK   K    V   K I LS    R   E + E   L K+    ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE- 66

Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             + + +L +V E+ + G L    H   K +  R L  D   +       GL  LH    
Sbjct: 67  SFLDKGKLNIVMEYAENGDL----HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-- 120

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             I+HRD+KS N+ LD     ++ D G+A+L+S  D     +T+ GTP Y+ PE  +   
Sbjct: 121 -KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCEDKP 177

Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDDFG 947
              K DV++ GVVL E  TGK P D ++ G
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQG 207

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  101 bits (254), Expect = 9e-24
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 15/212 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYC 799
           +G G  G V K   +    +   K IRL       ++ + E++ L K     +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
               +  +  E+M  GSL+++L        +RIL      KIA    KGL +LH      
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERIL-----GKIAVAVLKGLTYLHEKH--K 121

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
           IIHRD+K SN+L++   + ++ DFG++ +L+++L       T  GT  Y+ PE  Q    
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----AKTFVGTSSYMAPERIQGNDY 176

Query: 919 TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           + K D++S G+ L+EL TG+ P   ++     
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  101 bits (254), Expect = 1e-23
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 25/218 (11%)

Query: 742 IGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+VF A        +D   VA+K L   S    ++F  E E L  ++H+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRI-----------LTWDARKKIARG 844
            G C  G   L+V+E+M+ G L   L  R+   D +I           LT      IA  
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 845 AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
            A G+ +L      H +HRD+ + N L+   +  ++ DFGM+R I + D +  V      
Sbjct: 131 IASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTML 186

Query: 905 P-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           P  ++PPE     + T + D++SFGVVL E+ T GK+P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  100 bits (251), Expect = 2e-23
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 15/204 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+     +   VAIK  IR     + +F+ E + + K+ H  LV L G C  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKT-IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQR-ILTWDARKKIARGAAKGLCFLHHNCIPHI 860
                LV+EFM+ G L + L      R QR   + +    +     +G+ +L  +    +
Sbjct: 71  RSPICLVFEFMEHGCLSDYL------RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD+ + N L+      +VSDFGM R +  LD   + ST    P  +  PE +   + +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179

Query: 920 AKGDVYSFGVVLLELLT-GKRPTD 942
           +K DV+SFGV++ E+ + GK P +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+  T    + VA+K L   +   +  F+ E + + K++H  LV L   C  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 802 GEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
            E   +V E+M  GSL + L    G+     Q +   D   +IA G A    +L      
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV---DMAAQIAEGMA----YLESR--- 122

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFR 917
           + IHRD+ + N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE     R
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAREGAKFPIKWTAPEAANYGR 180

Query: 918 CTAKGDVYSFGVVLLELLT-GKRP 940
            T K DV+SFG++L E++T G+ P
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 15/207 (7%)

Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHRNLV 793
           F     +G G +G V+KA  K+ G  VAIK +     + D +E + E+  L +     +V
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
              G      +  +V E+   GS+ +++    K    + LT +    I     KGL +LH
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIM----KIT-NKTLTEEEIAAILYQTLKGLEYLH 116

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
            N     IHRD+K+ N+LL+ E +A+++DFG++  ++  DT    +T+ GTP ++ PE  
Sbjct: 117 SN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWMAPEVI 171

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           Q      K D++S G+  +E+  GK P
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 742 IGCGGFGEVFKATL-----KDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVP 794
           +G G FG+V            G  VA+K L   S +     +F  E+E L  + H N+V 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 795 LLGYC--KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
             G C    G    L+ E++  GSL + L       + + L        +    KG+ +L
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL-----LFSSQICKGMDYL 125

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG-YVPPE 911
                   IHRD+ + N+L++ E   ++SDFG+A+++     +  V     +P  +  PE
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPT 941
             ++ + ++  DV+SFGV L EL T   P+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 98.5 bits (245), Expect = 2e-22
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 26/219 (11%)

Query: 742 IGCGGFGEVFKAT------LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+VF A        KD   VA+K L   +    ++F  E E L  ++H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGA---------- 845
            G C  G+  ++V+E+MK G L + L  RA   D  IL  D + + A+G           
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFL--RAHGPDAMILV-DGQPRQAKGELGLSQMLHIA 129

Query: 846 ---AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA 902
              A G+ +L      H +HRD+ + N L+   +  ++ DFGM+R + + D +       
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 903 GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               ++PPE     + T + DV+SFGV+L E+ T GK+P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.0 bits (245), Expect = 2e-22
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 30/210 (14%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHRNLVPLL 796
           IG G +G+V+KA   K G  VA+KK IR+       F    + E++ L K++H N+V L 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKK-IRME-NEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 797 GYC--KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
                K      +V+E+M    L  +L        +   T    K   +   +GL +LH 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLD-----SPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG-----YVP 909
           N    I+HRD+K SN+L++++   +++DFG+AR  +        ++   T       Y P
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYT------KRNSADYTNRVITLWYRP 169

Query: 910 PE-YYQSFRCTAKGDVYSFGVVLLELLTGK 938
           PE    + R   + D++S G +L EL  GK
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.8 bits (243), Expect = 3e-22
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 17/213 (7%)

Query: 742 IGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+VF A        +D   VA+K L   S    ++F  E E L  ++H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVL--HG-----RAKARDQRILTWDARKKIARGAAKG 848
            G C  G+  ++V+E+MK G L + L  HG      A+      LT      IA+  A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L      H +HRD+ + N L+   +  ++ DFGM+R + + D +           ++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           PPE     + T + DV+S GVVL E+ T GK+P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 13/203 (6%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK +IR     + +F+ E + + K+ H NLV L G C  
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
                +V E+M  G L   L  R K +       D    +     + + +L  N     I
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVC----EAMEYLESNGF---I 122

Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCTA 920
           HRD+ + N L+  +   +VSDFG+AR +  LD   + S     P  + PPE +   R ++
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 921 KGDVYSFGVVLLELLT-GKRPTD 942
           K DV+SFGV++ E+ + GK P +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 96.8 bits (241), Expect = 6e-22
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 26/218 (11%)

Query: 742 IGCGGFGEVFKATL------KDGSSVAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLVP 794
           IG G FG VF+A        +  + VA+K L    S     +F  E   + +  H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVL------------HGRAKAR----DQRILTWDAR 838
           LLG C +G+   L++E+M +G L E L            H  + AR    +   L+   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 839 KKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
             IA+  A G+ +L        +HRD+ + N L+   M  +++DFG++R I + D + + 
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 899 STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
              A    ++PPE     R T + DV+++GVVL E+ +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 7e-22
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   K        + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDARKKIARGA---AKGLC 850
           LLG    G+  L+V E M  G L+  L   R +A +   L     +K  + A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L        +HRD+ + N ++  ++  ++ DFGM R I   D +       G  G +P 
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 185

Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T K DV+SFGVVL E+ T
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)

Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKK-LIRLSCQGDREFMAEMET----LGKIKHRNLVP 794
           L+G G FG V++   L DG   A+K+  +    Q  +E + ++E     L K++H N+V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 795 LLGYCKIGEERLLVY-EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            LG  +  E+ L ++ E +  GSL ++L       +  I      +   R    GL +LH
Sbjct: 67  YLGTER-EEDNLYIFLELVPGGSLAKLLKKYGSFPEPVI------RLYTRQILLGLEYLH 119

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                + +HRD+K +N+L+D     +++DFGMA+ +       S     G+P ++ PE  
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK---GSPYWMAPEVI 173

Query: 914 -QSFRCTAKGDVYSFGVVLLELLTGKRP 940
            Q        D++S G  +LE+ TGK P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 13/204 (6%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK  I      + +F+ E + + K+ H  LV L G C  
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKA-INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
            +   +V EFM+ G L   L  R     Q  L+ D    + +   +G+ +L  N     I
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQR-----QGKLSKDMLLSMCQDVCEGMEYLERN---SFI 122

Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCTA 920
           HRD+ + N L+      +VSDFGM R +  LD   + S+ A  P  + PPE +   + ++
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180

Query: 921 KGDVYSFGVVLLELLT-GKRPTDK 943
           K DV+SFGV++ E+ T GK P +K
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEK 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 14/200 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LVPL  Y  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAVV 70

Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
            EE + +V EFM  GSL + L    K  D + L       +A   A G+ ++      + 
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFL----KEGDGKYLKLPQLVDMAAQIADGMAYIERM---NY 123

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE     R T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L EL+T  R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 69/225 (30%), Positives = 111/225 (49%), Gaps = 21/225 (9%)

Query: 729 LIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI 787
           L + T  F    +IG G +G+V+KA   K G  VAIK +  +  + + E   E   L K 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59

Query: 788 -KHRNLVPLLG-YCK----IGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
             H N+    G + K      +++L LV E    GS+ +++ G  + + +R L  +    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG-LRKKGKR-LKEEWIAY 117

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
           I R   +GL +LH N    +IHRD+K  N+LL    E ++ DFG++  + +  T    +T
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS--TLGRRNT 172

Query: 901 LAGTPGYVPPEYY---QSFRCT--AKGDVYSFGVVLLELLTGKRP 940
             GTP ++ PE     +    +  A+ DV+S G+  +EL  GK P
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 62/232 (26%), Positives = 106/232 (45%), Gaps = 18/232 (7%)

Query: 735 GFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKL-IRLSCQGDRE-FMAEMETLGKIKHRN 791
            F     +G G +G V+K   L D    A+K++ +    Q +RE  + E+  L  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           ++        G +  +V E+  FG L + +  R K R  +++      +I     +GL  
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR--KLIPEQEIWRIFIQLLRGLQA 118

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           LH      I+HRD+KS+N+LL      ++ D G+++++          T  GTP Y+ PE
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPE 171

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
            ++    + K D++S G +L E+ T   P +     D         KV+ GK
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY------KVQRGK 217

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.9 bits (233), Expect = 5e-21
 Identities = 64/218 (29%), Positives = 117/218 (53%), Gaps = 23/218 (10%)

Query: 734 NGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLSCQGDR-EFMAEMETLGKIK 788
           +  + + +IG G FGEVF+  LK       +VAIK L     +  R +F++E   +G+  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
           H N++ L G     +  +++ E+M+ G+L++ L    +  D    ++     + RG A G
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSSYQLVGML-RGIAAG 119

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L      + +HRD+ + N+L++  +E +VSDFG++R++   D      T +G  G +
Sbjct: 120 MKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE--DDPEGTYTTSG--GKI 172

Query: 909 P-----PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           P     PE     + T+  DV+SFG+V+ E+++ G+RP
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.8 bits (230), Expect = 1e-20
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 14/203 (6%)

Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 11  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 67

Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L       +A   A G+ ++     
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 121

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 122 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 178

Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 38/278 (13%)

Query: 742  IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
            IG G    V+ A  L +   VAIK++    CQ   + +  E++ + +  H N+V      
Sbjct: 9    IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
             +G+E  LV  ++  GSL +++        +  L       + +   KGL +LH N    
Sbjct: 69   VVGDELWLVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---G 122

Query: 860  IIHRDMKSSNVLLDHEMEARVSDFGMARLI--SALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             IHRD+K+ N+LL  +   +++DFG++  +      T     T  GTP ++ PE  +   
Sbjct: 123  QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 918  -CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
                K D++SFG+  +EL TG  P  K          +  MKV             L++T
Sbjct: 183  GYDFKADIWSFGITAIELATGAAPYSK----------YPPMKV-------------LMLT 219

Query: 977  KGTDESEAEEVKEMVRY----LEITLQCVDDFPSKRPN 1010
               D    E   +  +Y     ++   C+   PSKRP 
Sbjct: 220  LQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 65/208 (31%), Positives = 110/208 (52%), Gaps = 22/208 (10%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL-GYC 799
           +G G FG+V+KA  K+    A  K+I++  + + E FM E++ L + KH N+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY- 71

Query: 800 KIGEERLLVY-EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
              E +L +  EF   G+L+ ++        +R LT    + + R   + L FLH +   
Sbjct: 72  -FYENKLWILIEFCDGGALDSIM-----LELERGLTEPQIRYVCRQMLEALNFLHSH--- 122

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGM-ARLISALDTHLSVSTLAGTPGYVPPEYY--QS 915
            +IHRD+K+ N+LL  + + +++DFG+ A+  S L       T  GTP ++ PE    ++
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACET 179

Query: 916 FRCTA---KGDVYSFGVVLLELLTGKRP 940
           F+      K D++S G+ L+EL   + P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 1e-20
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 742 IGCGGFGEVFKATLKDGSSV-AIKKL----IRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG+V     KD   + A+K L    I    + +   + E   L +I H  +V L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH-TLTERNILSRINHPFIVKLH 59

Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK---GLCFL 852
            Y    EE+L LV E+   G L   L    +  ++R   +         AA+    L +L
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY---------AAEIVLALEYL 109

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           H      II+RD+K  N+LLD +   +++DFG+A+ +S        +T  GTP Y+ PE 
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELS--SEGSRTNTFCGTPEYLAPEV 164

Query: 913 YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                     D +S GV+L E+LTGK P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 24/214 (11%)

Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKK--LIRLSCQGDREFM--------AEMETLGKIKH 789
           LIG G +G V+ A  +  G  +A+K+  L                    +E+ETL  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 790 RNLVPLLGYCKIGEERLLVY-EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
            N+V  LG+    EE L ++ E++  GS+   L    +  +Q +      +       +G
Sbjct: 68  LNIVQYLGFET-TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV------RFFTEQVLEG 120

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           L +LH      I+HRD+K+ N+L+D +   ++SDFG+++    +  +    ++ G+  ++
Sbjct: 121 LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 909 PPEYYQSFRC--TAKGDVYSFGVVLLELLTGKRP 940
            PE   S+    +AK D++S G V+LE+  G+RP
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.5 bits (231), Expect = 2e-20
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 37/212 (17%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHRNLVPLL 796
           +G G +G V+KA   K G  VA+KK IRL    +       + E+  L ++KH N+V LL
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKK-IRL-DNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
                 E +L LV+E+     L++ L  R       ++     K I     +GL + H +
Sbjct: 65  DVI-HTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLI-----KSIMYQLLRGLAYCHSH 117

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS---ALDTHLSVSTLAGTPGYVPPE- 911
               I+HRD+K  N+L++ +   +++DFG+AR         TH  V     T  Y  PE 
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYRAPEI 169

Query: 912 -----YYQSFRCTAKGDVYSFGVVLLELLTGK 938
                +Y     +   D++S G +  E++TGK
Sbjct: 170 LLGSKHY-----STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 38/231 (16%)

Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIK-----KLIRLSCQGDREFMAEMETLGKIK- 788
           F    +IG G F  V  A  K      AIK     +LI+           E E L ++  
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY--VKIEKEVLTRLNG 60

Query: 789 HRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK 847
           H  ++ L  Y    EE L  V E+   G L + +  +  + D++   +      A     
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRF-----YAAEILL 113

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV--------- 898
            L +LH      IIHRD+K  N+LLD +M  +++DFG A+++    +  S          
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 899 ---------STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                    ++  GT  YV PE           D+++ G ++ ++LTGK P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)

Query: 742 IGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLV 793
           +G G FG+V+K  L         +SVAIK L + + +    +EF  E E +  ++H N+V
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD----------QRILTWDARKKIAR 843
            LLG C   +   +++E++  G L E L   +   D          +  L       IA 
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 844 GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG 903
             A G+ +L  +   H +HRD+ + N L+   +  ++SDFG++R I + D +   S    
Sbjct: 132 QIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
              ++PPE     + T + D++SFGVVL E+ + G +P
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.5 bits (227), Expect = 3e-20
 Identities = 63/227 (27%), Positives = 110/227 (48%), Gaps = 17/227 (7%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K    +VA+K L +       EF+ E   + +IKH NLV LLG C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +  +++ +       +A   +  + +L      + 
Sbjct: 73  REPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 921 KGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME 966
           K DV++FGV+L E+ T G  P    D         V   + +G +ME
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKGYRME 225

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.8 bits (225), Expect = 4e-20
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 14/200 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+  T    + VA+K L +        F+ E + + K++H  LV L  Y  +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVV 70

Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
            EE + +V E+M  GSL + L    K  + R L       +A   A G+ ++      + 
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL----KDGEGRALKLPNLVDMAAQVAAGMAYIERM---NY 123

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++S+N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE     R T
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L EL+T  R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 65/200 (32%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKK--LIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G  G VFKA   + G +VA+KK  L RL      + + E++ L   +H  +V LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
              G   +LV E+M    L EVL        +R L     K   R   KG+ ++H N   
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDE-----ERPLPEAQVKSYMRMLLKGVAYMHAN--- 118

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE-YYQSFR 917
            I+HRD+K +N+L+  +   +++DFG+ARL S  +     S    T  Y  PE  Y + +
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSE-EEPRLYSHQVATRWYRAPELLYGARK 177

Query: 918 CTAKGDVYSFGVVLLELLTG 937
                D+++ G +  ELL G
Sbjct: 178 YDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 24/204 (11%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           L+G G FGEVFK TLKD + VA+K     +C+ D       +F++E   L +  H N+V 
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVK-----TCKEDLPQELKIKFLSEARILKQYDHPNIVK 56

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH- 853
           L+G C    +R  +Y  M+     + L    K +D+  L      K A  AA G+ +L  
Sbjct: 57  LIGVCT---QRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLES 111

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEY 912
            NC    IHRD+ + N L+      ++SDFGM+R     D   S S L   P  +  PE 
Sbjct: 112 KNC----IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEA 165

Query: 913 YQSFRCTAKGDVYSFGVVLLELLT 936
               R +++ DV+S+G++L E  +
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 67/222 (30%), Positives = 114/222 (51%), Gaps = 24/222 (10%)

Query: 730 IEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMAEMETL 784
           I+A+     E +IG G FGEV    LK        VAIK L    + +  R+F++E   +
Sbjct: 1   IDASC-IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59

Query: 785 GKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARG 844
           G+  H N++ L G     +  ++V E+M+ GSL+  L    +  D +  T      + RG
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQ-FTVIQLVGMLRG 114

Query: 845 AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
            A G+ +L        +HRD+ + N+L++  +  +VSDFG++R++   D   +  T  G 
Sbjct: 115 IASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEAAYTTRG- 168

Query: 905 PGYVP-----PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            G +P     PE     + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 169 -GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 15/205 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK +I+     + EF+ E + + K+ H  LV L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 802 GEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
                +V E+M  G L   L     + +  ++L      ++ +   +G+ +L        
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL------EMCKDVCEGMAYLESK---QF 121

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD+ + N L+D +   +VSDFG++R +  LD   + S  +  P  + PPE     + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179

Query: 920 AKGDVYSFGVVLLELLT-GKRPTDK 943
           +K DV++FGV++ E+ + GK P ++
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G +G+V+KA  +  G  VAIK +I+L    D E +  E+  L + +H N+V   G  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
              ++  +V E+   GSL+++         +  L+      + R   KGL +LH      
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQ-----VTRGPLSELQIAYVCRETLKGLAYLHET---G 121

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS---TLAGTPGYVPPEYYQ-- 914
            IHRD+K +N+LL  + + +++DFG++  ++A     +++   +  GTP ++ PE     
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTA-----TIAKRKSFIGTPYWMAPEVAAVE 176

Query: 915 -SFRCTAKGDVYSFGVVLLELLTGKRP 940
                  K D+++ G+  +EL   + P
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 32/222 (14%)

Query: 741 LIGCGGFGEVFKATLKD-------GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNL 792
            +G G FGEV++ T  D          VA+K L + +  Q  +EF+ E   +    H N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR-ILTWDARKKIARGAAKGLCF 851
           V LLG C + E + ++ E M+ G L   L      R    +LT      I    AKG  +
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 852 LHHNCIPHIIHRDMKSSNVLL-----DHEMEARVSDFGMARLISALDTH-------LSVS 899
           L      H IHRD+ + N L+     D +   ++ DFG+AR I   D +       L V 
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 900 TLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            +A       PE     + T + DV+SFGV++ E+LT G++P
Sbjct: 179 WMA-------PESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 16/203 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSV-AIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLG 797
           IG G FG+V     +D   + A+K + +  C      R  + E   L ++ H  LV L  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             +  E   LV + +  G L   L  + K  ++++  W             L +LH    
Sbjct: 68  SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE------IVLALEYLHSK-- 119

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             IIHRD+K  N+LLD +    ++DF +A  ++     L+ ST +GTPGY+ PE      
Sbjct: 120 -GIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTST-SGTPGYMAPEVLCRQG 175

Query: 918 CTAKGDVYSFGVVLLELLTGKRP 940
            +   D +S GV   E L GKRP
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 87.5 bits (217), Expect = 7e-19
 Identities = 69/207 (33%), Positives = 99/207 (47%), Gaps = 16/207 (7%)

Query: 742 IGCGGFGEVFKATL--KDGSS----VAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVP 794
           +G G FGEV++     +DG +    VA+K L     + D   F+ E   + K  H+N+V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           L+G       R ++ E M  G L+  L   R +      LT       AR  AKG  +L 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARV---SDFGMARLISALDTHLSVSTLAGTP-GYVP 909
            N   H IHRD+ + N LL  +   RV   +DFGMAR I     +      A  P  ++P
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS-YYRKGGRAMLPIKWMP 189

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLT 936
           PE +     T+K DV+SFGV+L E+ +
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 87.5 bits (217), Expect = 1e-18
 Identities = 84/303 (27%), Positives = 131/303 (43%), Gaps = 68/303 (22%)

Query: 741  LIGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRNL 792
             +G G FG+V KA           S+VA+K L   + + D  + ++EME +  I KH+N+
Sbjct: 19   PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 793  VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR------AKARDQRI----LTWDARKKIA 842
            + LLG C       +V E+   G+L + L  R      A   D R     LT       A
Sbjct: 79   INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 843  RGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD-------TH 895
               A+G+ FL        IHRD+ + NVL+  +   +++DFG+AR I  +D         
Sbjct: 139  YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 896  LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWV 955
            L V  +A       PE       T + DV+SFGV+L E+ T          G +   G +
Sbjct: 196  LPVKWMA-------PEALFDRVYTHQSDVWSFGVLLWEIFT---------LGGSPYPG-I 238

Query: 956  KMK-----VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010
             ++     ++EG +ME   P+             +E+  ++R       C  + PS+RP 
Sbjct: 239  PVEELFKLLKEGYRME--KPQNC----------TQELYHLMR------DCWHEVPSQRPT 280

Query: 1011 MLQ 1013
              Q
Sbjct: 281  FKQ 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 23/207 (11%)

Query: 742 IGCGGFGEVFKATL----KDGSS--VAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT     K  +   VA+K L   +   +RE  M+E++ +  +  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL- 852
            LLG C IG   L++ E+  +G L   L  + ++     LT +     +   AKG+ FL 
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRES----FLTLEDLLSFSYQVAKGMAFLA 158

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
             NCI    HRD+ + NVLL H    ++ DFG+AR I   D++  V   A  P  ++ PE
Sbjct: 159 SKNCI----HRDLAARNVLLTHGKIVKICDFGLARDIMN-DSNYVVKGNARLPVKWMAPE 213

Query: 912 YYQSFRC--TAKGDVYSFGVVLLELLT 936
               F C  T + DV+S+G++L E+ +
Sbjct: 214 --SIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.9 bits (215), Expect = 2e-18
 Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V+ A  +  G  VAIK+ + L  Q  +E +  E+  + + KH N+V  L   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQ-MNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
            +G+E  +V E++  GSL +V+       D+  +       + R   + L FLH N    
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIA-----AVCRECLQALEFLHSN---Q 135

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS N+LL  +   +++DFG    I+   +    ST+ GTP ++ PE        
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYG 193

Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E++ G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 72/234 (30%), Positives = 119/234 (50%), Gaps = 31/234 (13%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG+V     + G+ VA+K  I+      + F+AE   + +++H NLV LLG   I
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVK-CIKNDATA-QAFLAEASVMTQLRHSNLVQLLGV--I 68

Query: 802 GEER---LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
            EE+    +V E+M  GSL + L  R ++    +L  D   K +    + + +L  N   
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEAN--- 121

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL-DT-HLSVSTLAGTPGYVPPEYYQSF 916
           + +HRD+ + NVL+  +  A+VSDFG+ +  S+  DT  L V        +  PE  +  
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREK 174

Query: 917 RCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
           + + K DV+SFG++L E+ + G+ P  +    D      V  +V +G +M+  D
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD 222

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 23/214 (10%)

Query: 739 ESLIGCGGFGEVFKATLK----DGSSVAIKKL-IRLSCQGDREFMAEMETLGKIKHRNLV 793
           E +IG G FGEV +  LK        VAIK L    + +  R+F++E   +G+  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            L G        +++ EFM+ G+L+  L    +  D +  T      + RG A G+ +L 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFL----RQNDGQ-FTVIQLVGMLRGIAAGMKYLS 123

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG------Y 907
                + +HRD+ + N+L++  +  +VSDFG++R    L+   S  T   + G      +
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPIRW 177

Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             PE     + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G VF A  +  G  VAIK+ I L  Q  +E +  E+  + ++K+ N+V  L   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQ-INLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
            +G+E  +V E++  GSL +V+        Q          + R   + L FLH N    
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTETCMDEAQI-------AAVCRECLQALEFLHAN---Q 135

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS NVLL  +   +++DFG    I+   +    ST+ GTP ++ PE        
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYG 193

Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E++ G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 42/279 (15%)

Query: 741  LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA---EMETLGKIKHRNLVPLLG 797
            ++G G FG V     K    + I K I +      E +A   E + L  + H N++    
Sbjct: 7    VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 798  YCKIGEERLLVYEFMKFGSLEEVLHGRAKA--RDQRILTWDARKKIARGAAKGLCFLHHN 855
                 +  ++V E+   G+L E +  R  +   +  IL +  +  +A         LHH 
Sbjct: 67   NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA---------LHHV 117

Query: 856  CIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                I+HRD+K+ N+LLD H+M  ++ DFG+++++S   +     T+ GTP Y+ PE  +
Sbjct: 118  HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCE 174

Query: 915  SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL 974
                  K D+++ G VL EL + KR      F   NL   V +K+  G    + D     
Sbjct: 175  GKPYNQKSDIWALGCVLYELASLKRA-----FEAANLPALV-LKIMSGTFAPISD----- 223

Query: 975  VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                            +R L +++  +D  PSKRP + Q
Sbjct: 224  -----------RYSPDLRQLILSMLNLD--PSKRPQLSQ 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKL--IRLSCQGDREFMA---EMETLGKIKHRNLVP 794
           L+G G FG V+     D G  +A+K++     S +  +E  A   E++ L  ++H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDARKKIARGAAKGLCFL 852
             G  +  E   +  E+M  GS+++ L  +G         LT    +K  R   +G+ +L
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--------ALTETVTRKYTRQILEGVEYL 120

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS-VSTLAGTPGYVPPE 911
           H N    I+HRD+K +N+L D     ++ DFG ++ +  + +  + + ++ GTP ++ PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                    K DV+S G  ++E+LT K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 29/270 (10%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
            +G G FGEV+     + + VA+K L +      + F+ E   +  ++H  LV L      
Sbjct: 14   LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 802  GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
             E   ++ E+M  GSL + L      +       D   +IA G A    ++      + I
Sbjct: 73   EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA----YIERK---NYI 125

Query: 862  HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEY--YQSFRC 918
            HRD++++NVL+   +  +++DFG+AR+I   D   +    A  P  +  PE   + SF  
Sbjct: 126  HRDLRAANVLVSESLMCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGSF-- 181

Query: 919  TAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQM---EVIDPELLL 974
            T K DV+SFG++L E++T GK P      G +N    V   ++ G +M   E    EL  
Sbjct: 182  TIKSDVWSFGILLYEIVTYGKIPYP----GMSN--SDVMSALQRGYRMPRMENCPDELYD 235

Query: 975  VTKGTDESEAEEVKEMVRYLEITLQCVDDF 1004
            + K   + +AEE +    YL+  L   DDF
Sbjct: 236  IMKTCWKEKAEE-RPTFDYLQSVL---DDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 19/212 (8%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA---EMETLGKIKHRNLVPLLGY 798
           IG G FG+++ A  K  S   + K I L+    +E  A   E+  L K+KH N+V     
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 799 CKIGEERLLVYEFMKFGSLEEVL---HGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
            +      +V E+   G L + +    G   + DQ IL+W  +       + GL  +H  
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSWFVQ------ISLGLKHIHDR 120

Query: 856 CIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
               I+HRD+KS N+ L    M A++ DFG+AR ++  D+     T  GTP Y+ PE  Q
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQ 175

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDF 946
           +     K D++S G VL EL T K P + ++ 
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 4e-18
 Identities = 80/297 (26%), Positives = 124/297 (41%), Gaps = 49/297 (16%)

Query: 734  NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRN 791
                  S +G G  G V K  LK+   +   K I      D  ++ + E+E     K   
Sbjct: 1    EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 792  LVPLLGY------CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK---KIA 842
            +V   G         IG    +  E+ + GSL+ +   + K R  RI      K   KIA
Sbjct: 61   IVKYYGAFLDESSSSIG----IAMEYCEGGSLDSIY-KKVKKRGGRI----GEKVLGKIA 111

Query: 843  RGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTL 901
                KGL +LH      IIHRD+K SN+LL  + + ++ DFG++  L+++L       T 
Sbjct: 112  ESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-----GTF 163

Query: 902  AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE 961
             GT  Y+ PE  Q    +   DV+S G+ LLE+   + P   +       +  +   V  
Sbjct: 164  TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN- 222

Query: 962  GKQMEVIDPELLLVTKGTDESEAEEV--KEMVRYLEITLQCVDDFPSKRPN---MLQ 1013
               M    PEL       DE        +E   +++   QC++  P++RP    ML+
Sbjct: 223  ---MPN--PEL------KDEPGNGIKWSEEFKDFIK---QCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 18/202 (8%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VAIK L + S   +  F+AE   + +++H  LV L  Y  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRL--YAVV 70

Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L    K  +   LT +    +A   A+G+ F+      + 
Sbjct: 71  TQEPIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIERK---NY 123

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEY--YQSFR 917
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE   Y +F 
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTF- 180

Query: 918 CTAKGDVYSFGVVLLELLTGKR 939
            T K DV+SFG++L E++T  R
Sbjct: 181 -TIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 85.6 bits (212), Expect = 6e-18
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 18/211 (8%)

Query: 741 LIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEMETLG-KIKHRNLVPL 795
           ++G G FG+V  A LK  +      A+KK + L        M E   L    +H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKAR-DQRILTWDARKKIARGAAKGLCFLHH 854
               +  E    V E++  G L  + H ++  R D+    + A + I      GL FLH 
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIIC-----GLQFLHK 114

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                II+RD+K  NVLLD +   +++DFGM +     +     ST  GTP Y+ PE  +
Sbjct: 115 K---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILK 169

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
             +     D +SFGV+L E+L G+ P   +D
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 88.3 bits (219), Expect = 8e-18
 Identities = 45/117 (38%), Positives = 63/117 (53%), Gaps = 7/117 (5%)

Query: 513 LDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQI 572
           L L     RG IP++I  +  LQ + L+ N + G IP SLG + +L V D S+N   G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 573 PESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLP---AS-QYANNPGLCGVP-LPEC 624
           PES   L+ L  ++L+ N L+G +P    L       AS  + +N GLCG+P L  C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP--AALGGRLLHRASFNFTDNAGLCGIPGLRAC 537

Length = 623

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 15/211 (7%)

Query: 741 LIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQG-DREFMAEMETLGKIKHRNLV 793
            +G G FGEVF A  K        + V +K L +   +    EF  E++   K+ H+N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRI---LTWDARKKIARGAAKGLC 850
            LLG C+  E   ++ E+   G L++ L       ++     L+   +  +    A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            L +      +HRD+ + N L+  + E +VS   +++ +   + +   + L     ++ P
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR-WLAP 187

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E  Q    + K DV+SFGV++ E+ T G+ P
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 84.3 bits (208), Expect = 1e-17
 Identities = 88/306 (28%), Positives = 137/306 (44%), Gaps = 76/306 (24%)

Query: 739  ESLIGCGGFGEVFKATLK-DGS--SVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRNLV 793
            E +IG G FG+V +A +K DG   + AIK L   + + D R+F  E+E L K+  H N++
Sbjct: 7    EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 794  PLLGYCKIGEERLLVY---EFMKFGSLEEVL---------------HGRAKARDQRILTW 835
             LLG C   E R  +Y   E+  +G+L + L               HG A     + L  
Sbjct: 67   NLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL- 122

Query: 836  DARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR----LISA 891
                + A   A G+ +L        IHRD+ + NVL+   + ++++DFG++R     +  
Sbjct: 123  ----QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 892  LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
                L V  +A     +    Y  +  T K DV+SFGV+L E+++          G T  
Sbjct: 176  TMGRLPVRWMA-----IESLNYSVY--TTKSDVWSFGVLLWEIVS---------LGGTPY 219

Query: 952  VGW----VKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSK 1007
             G     +  K+ +G +ME   P      +  D    +EV E++R      QC  D P +
Sbjct: 220  CGMTCAELYEKLPQGYRME--KP------RNCD----DEVYELMR------QCWRDRPYE 261

Query: 1008 RPNMLQ 1013
            RP   Q
Sbjct: 262  RPPFAQ 267

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 44/275 (16%)

Query: 742  IGCGGFGEVFKATL----KDGSSVAIKK--LIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
            +G G FGE   ATL    +D S V  K+  L RLS +  R+ + E+  L  ++H N++  
Sbjct: 8    LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 796  LGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
              +       L+  E+   G+L ++++  + +  ++ ++ W             + ++H 
Sbjct: 65   YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHK 119

Query: 855  NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                 I+HRD+K+ N+ L      ++ DFG+++++     +    T+ GTP Y+ PE  Q
Sbjct: 120  A---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMAETVVGTPYYMSPELCQ 174

Query: 915  SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL 974
              +   K D+++ G VL ELLT KR      F  TN +  V +K+ +G    V+      
Sbjct: 175  GVKYNFKSDIWALGCVLYELLTLKRT-----FDATNPLNLV-VKIVQGNYTPVVSV---- 224

Query: 975  VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
                     + E+  +V         +   P KRP
Sbjct: 225  --------YSSELISLVH------SLLQQDPEKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G FG V K   K DG  +  K++    ++ +  ++ ++E+  L ++KH N+V    Y
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64

Query: 799 CK--IGEERLLVYEFMKF---GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
               I      +Y  M++   G L +++  + K   + I      + I R   + L  L+
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQ-KCKKERKYI----EEEFIWRILTQLLLALY 119

Query: 854 --HNCIPH---IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
             HN       ++HRD+K +N+ LD     ++ DFG+A+++          T  GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG--HDSSFAKTYVGTPYYM 177

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            PE         K D++S G ++ EL     P
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 83.2 bits (205), Expect = 3e-17
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 16/208 (7%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLV 793
           F+    IG G FGEVFK        V   K+I L    D   +   E+  L +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDARKKIARGAAKGLCFL 852
              G    G +  ++ E++  GS  ++L  RA   D+ +I T      + +   KGL +L
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIAT------MLKEILKGLDYL 117

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           H       IHRD+K++NVLL  + + +++DFG+A  ++  DT +  +T  GTP ++ PE 
Sbjct: 118 HSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEV 172

Query: 913 YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            Q     +K D++S G+  +EL  G+ P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 740 SLIGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
             +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V 
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 795 LLGYC-KIGEERL-LVYEFMKFGSLEEVLH-GRAKARDQRILTWDARKKIARGAAKGLCF 851
             G C   G   L LV E++ +GSL + L   R +   +++L +      A    KG+ +
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY------ASQICKGMEY 123

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-- 909
           L        +HRD+ + N+L++ E   ++ DFG+ +++     +  V      PG  P  
Sbjct: 124 LG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR----EPGESPIF 176

Query: 910 ---PEYYQSFRCTAKGDVYSFGVVLLELLT 936
              PE     + +   DV+SFGVVL EL T
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 82.3 bits (203), Expect = 4e-17
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLI-----RLSCQGD-REFMAEMETLGKIKHRNLVP 794
           ++G G +G V+      G  +A+K++       L+ + +  +   E++ L  +KH N+V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
            LG C       +  EF+  GS+  +L+ R     + +       K  +    G+ +LH+
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVF-----CKYTKQILDGVAYLHN 120

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS----TLAGTPGYVPP 910
           NC+   +HRD+K +NV+L      ++ DFG AR ++ +  H + S    ++ GTP ++ P
Sbjct: 121 NCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E         K D++S G  + E+ TGK P
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 82.6 bits (205), Expect = 5e-17
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)

Query: 739 ESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-------FMA--EMETLGKIK 788
              +G G +  V+KA   + G  VAIKK I+L   G+R+       F A  E++ L ++K
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKK-IKL---GERKEAKDGINFTALREIKLLQELK 60

Query: 789 HRNLVPLLG-YCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK-IARGA 845
           H N++ LL  +    +  + LV+EFM    LE+V+      +D+ I+   A  K      
Sbjct: 61  HPNIIGLLDVFGH--KSNINLVFEFM-ETDLEKVI------KDKSIVLTPADIKSYMLMT 111

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP 905
            +GL +LH N    I+HRD+K +N+L+  +   +++DFG+AR   + +  +  +    T 
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM--THQVVTR 166

Query: 906 GYVPPEYYQSFRCTAKG---DVYSFGVVLLELLTGK 938
            Y  PE    F     G   D++S G +  ELL   
Sbjct: 167 WYRAPELL--FGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.4 bits (203), Expect = 5e-17
 Identities = 78/241 (32%), Positives = 119/241 (49%), Gaps = 30/241 (12%)

Query: 717 FQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDR 775
           F      L    L + T+ +     IG G +G+V+K T  KDGS  A+K L  +S   D 
Sbjct: 5   FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDE 63

Query: 776 EFMAEMETLGKI-KHRNLVPLLG-YCK----IGEERLLVYEFMKFGSLEEVLHG---RAK 826
           E  AE   L  +  H N+V   G + K    +G +  LV E    GS+ E++ G     +
Sbjct: 64  EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 827 ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA 886
             D+ ++++     I  GA  GL  LH+N    IIHRD+K +N+LL  E   ++ DFG++
Sbjct: 124 RLDEAMISY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Query: 887 RLISALDTHLSVSTLAGTPGYVPPE-------YYQSFRCTAKGDVYSFGVVLLELLTGKR 939
             +++  T L  +T  GTP ++ PE       Y  S+   A+ DV+S G+  +EL  G  
Sbjct: 176 AQLTS--TRLRRNTSVGTPFWMAPEVIACEQQYDYSY--DARCDVWSLGITAIELGDGDP 231

Query: 940 P 940
           P
Sbjct: 232 P 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 6e-17
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 27/207 (13%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGY 798
           IG G +G V+KA     G  VAIKK+            A  E++ L ++ H N++ LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
            +   +  LV+EFM    L +++  R     QR L     K       +GL F H +   
Sbjct: 67  FRHKGDLYLVFEFMD-TDLYKLIKDR-----QRGLPESLIKSYLYQLLQGLAFCHSH--- 117

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS--- 915
            I+HRD+K  N+L++ E   +++DFG+AR                T  YV   +Y++   
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARS-------FGSPVRPYTH-YVVTRWYRAPEL 169

Query: 916 -FRCTAKG---DVYSFGVVLLELLTGK 938
                      D++S G +  ELL+ +
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 82.3 bits (203), Expect = 6e-17
 Identities = 74/294 (25%), Positives = 125/294 (42%), Gaps = 53/294 (18%)

Query: 742  IGCGGFGEVFKAT------LKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVP 794
            +G G FG+V KAT          ++VA+K L   +   + R+ ++E   L ++ H +++ 
Sbjct: 8    LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 795  LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAK------------------ARDQRILTWD 836
            L G C      LL+ E+ K+GSL   L    K                    D+R LT  
Sbjct: 68   LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 837  ARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                 A   ++G+ +L       ++HRD+ + NVL+    + ++SDFG++R +   D+++
Sbjct: 128  DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 897  SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWV 955
              S       ++  E       T + DV+SFGV+L E++T G  P          L   +
Sbjct: 185  KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIAPERLFNLL 242

Query: 956  KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
            K     G +ME              E+ +EE+  ++        C    P KRP
Sbjct: 243  KT----GYRME------------RPENCSEEMYNLML------TCWKQEPDKRP 274

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.9 bits (202), Expect = 7e-17
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 19/204 (9%)

Query: 742 IGCGGFGEVF-----KATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPL 795
           +G G FG+V       A    G  VA+K L R   Q +   +  E+  L  + H N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 796 LGYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            G C     +   L+ E++  GSL + L        Q +L        A+   +G+ +LH
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-------FAQQICEGMAYLH 124

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VPPEY 912
                H IHRD+ + NVLLD++   ++ DFG+A+ +     +  V     +P +    E 
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181

Query: 913 YQSFRCTAKGDVYSFGVVLLELLT 936
            +  + +   DV+SFGV L ELLT
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 81.2 bits (200), Expect = 8e-17
 Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 29/229 (12%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCK 800
           IG G FG V +     G  VA+K +    C    + F+ E   + K+ H+NLV LLG   
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNI---KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI- 68

Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
           +     +V E M  G+L   L  R +A    +++     + +   A+G+ +L       +
Sbjct: 69  LHNGLYIVMELMSKGNLVNFLRTRGRA----LVSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLIS-ALD-THLSVSTLAGTPGYVPPEYYQSFRC 918
           +HRD+ + N+L+  +  A+VSDFG+AR+ S  +D + L V        +  PE  +  + 
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKF 174

Query: 919 TAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME 966
           ++K DV+S+GV+L E+ + G+ P  K    +      VK  V +G +ME
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKGYRME 217

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.1 bits (201), Expect = 9e-17
 Identities = 65/219 (29%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLG 797
           +G GGFG V    +K    + A+K + +       +     +E E L +  H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 798 YCKIGEERLLVY---EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
             K   ++  +Y   E+   G L  +L  R    +     + AR  IA        +LH+
Sbjct: 61  TFK---DKKYIYMLMEYCLGGELWTILRDRGLFDE-----YTARFYIA-CVVLAFEYLHN 111

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI-SALDTHLSVSTLAGTPGYVPPEYY 913
                II+RD+K  N+LLD     ++ DFG A+ + S   T     T  GTP YV PE  
Sbjct: 112 R---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFCGTPEYVAPEII 164

Query: 914 QSFRCTAKG-----DVYSFGVVLLELLTGKRP--TDKDD 945
            +     KG     D +S G++L ELLTG+ P   D +D
Sbjct: 165 LN-----KGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 81.3 bits (200), Expect = 1e-16
 Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 70/301 (23%)

Query: 741  LIGCGGFGEVFKATLK-DG--SSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLVPL 795
            +IG G FG+V KA +K DG     AIK++   + + D R+F  E+E L K+ H  N++ L
Sbjct: 2    VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 796  LGYCKIGEERLLVYEFMKFGSLEEVL---------------HGRAKARDQRILTWDARKK 840
            LG C+      L  E+   G+L + L               +  A     + L       
Sbjct: 62   LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL-----H 116

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR----LISALDTHL 896
             A   A+G+ +L        IHRD+ + N+L+     A+++DFG++R     +      L
Sbjct: 117  FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 897  SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGW-- 954
             V  +A     +    Y  +  T   DV+S+GV+L E+++          G T   G   
Sbjct: 174  PVRWMA-----IESLNYSVY--TTNSDVWSYGVLLWEIVS---------LGGTPYCGMTC 217

Query: 955  --VKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012
              +  K+ +G ++E   P         D    +EV +++R      QC  + P +RP+  
Sbjct: 218  AELYEKLPQGYRLE--KP------LNCD----DEVYDLMR------QCWREKPYERPSFA 259

Query: 1013 Q 1013
            Q
Sbjct: 260  Q 260

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 68/279 (24%), Positives = 108/279 (38%), Gaps = 44/279 (15%)

Query: 741  LIGCGGFGEVFKATLKDGSS----VAIKKL--IRLS-CQGDREFMAEMETLGKIKHRNLV 793
             +G G FG V +            VA+K L   +LS    D  F+ E   +  + H NL+
Sbjct: 2    KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENLI 59

Query: 794  PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
             L G   +    ++V E    GSL + L   A          D   +IA     G+ +L 
Sbjct: 60   RLYGVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLE 114

Query: 854  HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEY 912
                   IHRD+ + N+LL  + + ++ DFG+ R +   + H  +      P  +  PE 
Sbjct: 115  SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171

Query: 913  YQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQ-MEVIDP 970
             ++   +   DV+ FGV L E+ T G+ P             W       G Q ++ ID 
Sbjct: 172  LRTRTFSHASDVWMFGVTLWEMFTYGEEP-------------WAG---LSGSQILKKIDK 215

Query: 971  ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
            E   + +     +            + LQC    P+ RP
Sbjct: 216  EGERLERPEACPQ--------DIYNVMLQCWAHNPADRP 246

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT K  G  VA+KK+  L  Q  RE +  E+  +   +H N+V +    
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 800 KIGEERLLVYEFMKFGSLEE-VLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
            +G+E  +V EF++ G+L + V H R        +  +    +     K L FLH     
Sbjct: 86  LVGDELWVVMEFLEGGALTDIVTHTR--------MNEEQIATVCLAVLKALSFLHAQ--- 134

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
            +IHRD+KS ++LL  +   ++SDFG    +S  +     S L GTP ++ PE       
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKS-LVGTPYWMAPEVISRLPY 192

Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
             + D++S G++++E++ G+ P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLI-----RLSCQGDREFMAEMETLGKIKHRNLVP 794
           L+G G FG V K   + +G S+ I   I     R   Q  +E    M  +G + H  +V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 795 LLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           LLG C  G    LV +    GSL + V   R     QR+L W  +       AKG+ +L 
Sbjct: 74  LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
            + +   +HR++ + N+LL  +   +++DFG+A L+   D     S       ++  E  
Sbjct: 127 EHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
              R T + DV+S+GV + E+++ G  P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 81.1 bits (200), Expect = 2e-16
 Identities = 73/216 (33%), Positives = 102/216 (47%), Gaps = 28/216 (12%)

Query: 741 LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV-----P 794
           ++G G FG+V  A LK  G   A+K L +     D +    M     ++ R L      P
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTM-----VEKRVLALAWENP 56

Query: 795 LLG--YC--KIGEERLLVYEFMKFGSLEEVLHGRAKAR-DQRILTWDARKKIARGAAKGL 849
            L   YC  +  E    V EF+  G L  + H + K R D    T+ A + +      GL
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVC-----GL 109

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            FLH      II+RD+K  NV+LD +   +++DFGM +     D     ST  GTP Y+ 
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIA 164

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PE  Q  + T   D +SFGV+L E+L G+ P   DD
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 43/132 (32%), Positives = 72/132 (54%), Gaps = 14/132 (10%)

Query: 810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSN 869
           EFM  GSL+ +       +    +  +   KIA    +GL +L++  +  I+HRD+K SN
Sbjct: 83  EFMDCGSLDRIY------KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSN 134

Query: 870 VLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFG 928
           +L++   + ++ DFG++  LI+++       T  GT  Y+ PE  Q  + T K DV+S G
Sbjct: 135 ILVNSRGQIKLCDFGVSGELINSI-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189

Query: 929 VVLLELLTGKRP 940
           + ++EL  GK P
Sbjct: 190 ISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 17/206 (8%)

Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+ AT    + VA+K + +        F+AE   +  ++H  LV L   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
               E   ++ EFM  GSL + L     ++       D   +IA G A    F+      
Sbjct: 70  VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA----FIEQR--- 121

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEY--YQS 915
           + IHRD++++N+L+   +  +++DFG+AR+I   D   +    A  P  +  PE   + S
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
           F  T K DV+SFG++L+E++T G+ P
Sbjct: 180 F--TIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 18/205 (8%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKL--IRLSC-QGDREFMAEMETLGKIKHRNLVPLLG 797
           +G GGFGEV    +K  G   A KKL   RL   +G++  + E + L K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 798 YCKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
             +  ++  LV   M  G L+  +   G     + R + +         AA+ +C L H 
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFY---------AAQIICGLEHL 111

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
               I++RD+K  NVLLD     R+SD G+A  +        +   AGTPGY+ PE  Q 
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQG 168

Query: 916 FRCTAKGDVYSFGVVLLELLTGKRP 940
                  D ++ G  L E++ G+ P
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 29/218 (13%)

Query: 740 SLIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDRE---------FMAEMETLGKIKH 789
           +LIG G FG V+       G  +A+K++   S     +            E+  L +++H
Sbjct: 6   ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 790 RNLVPLLGYCKIGEERLLVY-EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
            N+V  LG   +  + L ++ E++  GS+  +L+      +  +      +   R   KG
Sbjct: 66  ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV------RNFVRQILKG 118

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR------LISALDTHLSVSTLA 902
           L +LH+     IIHRD+K +N+L+D++   ++SDFG+++      L +  +      +L 
Sbjct: 119 LNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR--PSLQ 173

Query: 903 GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           G+  ++ PE  +    T K D++S G +++E+LTGK P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 79.7 bits (196), Expect = 5e-16
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 18/210 (8%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRL-----SCQGDREFMAEMETLGKIKHRNLVP 794
           ++G G FG V+K   + +G +V I   I++       + + EFM E   +  + H +LV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           LLG C +     LV + M  G L + +H  +     Q +L W  +       AKG+ +L 
Sbjct: 74  LLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                 ++HRD+ + NVL+      +++DFG+ARL+   +   +         ++  E  
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
              + T + DV+S+GV + EL+T G +P D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 39/217 (17%)

Query: 740 SLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHRNLVP 794
            ++G G +G V K   K  G  VAIKK      + D +     + E++ L +++H N+V 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L    +      LV+E+++   LE +            L  DA +       + + + H 
Sbjct: 65  LKEAFRRKGRLYLVFEYVERTLLELL------EASPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHLS--VST--------LAG 903
           +   +IIHRD+K  N+L+      ++ DFG AR + A   + L+  V+T        L G
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175

Query: 904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
              Y  P            DV++ G ++ ELL G  P
Sbjct: 176 DTNYGKPV-----------DVWAIGCIMAELLDG-EP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 57/208 (27%), Positives = 106/208 (50%), Gaps = 15/208 (7%)

Query: 742 IGCGGFGEVFKATLKDGS---SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPLLG 797
           +G G FG V K   K       VAIK L   + +  R E M E E + ++ +  +V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
            C+  E  +LV E    G L + L G+   +D+  +T     ++    + G+ +L     
Sbjct: 63  VCE-AEALMLVMEMASGGPLNKFLSGK---KDE--ITVSNVVELMHQVSMGMKYLEGK-- 114

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD+ + NVLL ++  A++SDFG+++ + A D++    +    P  +  PE     
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 917 RCTAKGDVYSFGVVLLELLT-GKRPTDK 943
           + +++ DV+S+G+ + E  + G++P  K
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKK 201

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 78.7 bits (194), Expect = 5e-16
 Identities = 75/224 (33%), Positives = 110/224 (49%), Gaps = 26/224 (11%)

Query: 741 LIGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL D        A+K L R++   + E F+ E   +    H N++ L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARG--AAKGLCFL 852
           LG C   E   L+V  +MK G L   +  R++  +  +     +  I  G   AKG+ +L
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTV-----KDLIGFGLQVAKGMEYL 114

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT-HLSV--STLAGTP-GYV 908
                   +HRD+ + N +LD     +V+DFG+AR I   D  + SV   T A  P  ++
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI--YDKEYYSVHNHTGAKLPVKWM 169

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP-TDKDDFGDTN 950
             E  Q+ + T K DV+SFGV+L EL+T G  P  D D F  T 
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV 213

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 47/216 (21%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKK--------LIRLSCQGDREFMAEMETLGKIKHRNL 792
           IG G +G VFK   ++ G  VAIKK        +I+      +  + E+  L ++KH NL
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK------KIALREIRMLKQLKHPNL 62

Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
           V L+   +   +  LV+E+     L E+       ++ R +     KKI     + + F 
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNEL------EKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 853 H-HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS--VST--------L 901
           H HNCI    HRD+K  N+L+  + + ++ DFG AR+++      +  V+T        L
Sbjct: 117 HKHNCI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172

Query: 902 AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
            G   Y PP            DV++ G V  ELLTG
Sbjct: 173 VGDTQYGPPV-----------DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (193), Expect = 7e-16
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 18/209 (8%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKL-IRLSCQ-GDREFMA---EMETLGKIKHRNLVP 794
           L+G G FGEV+     D G  +A+K++      Q   +E  A   E++ L  ++H  +V 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 795 LLGYCKIGEERLL--VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
             G  +  EE+ L    E+M  GS+++ L           LT +  ++  R   +G+ +L
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA------LTENVTRRYTRQILQGVSYL 122

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL-DTHLSVSTLAGTPGYVPPE 911
           H N I   +HRD+K +N+L D     ++ DFG ++ I  +  +   + ++ GTP ++ PE
Sbjct: 123 HSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                    K DV+S    ++E+LT K P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 81.5 bits (201), Expect = 7e-16
 Identities = 49/148 (33%), Positives = 75/148 (50%), Gaps = 17/148 (11%)

Query: 807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL------HHNCIPHI 860
           LV ++   G L + +  RAK             +  R    GL F+      HH    H+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKT-----------NRTFREHEAGLLFIQVLLAVHHVHSKHM 164

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+KS+N+LL      ++ DFG +++ +A  +     T  GTP YV PE ++    + 
Sbjct: 165 IHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK 224

Query: 921 KGDVYSFGVVLLELLTGKRPTDKDDFGD 948
           K D++S GV+L ELLT KRP D ++  +
Sbjct: 225 KADMFSLGVLLYELLTLKRPFDGENMEE 252

Length = 496

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 78.9 bits (194), Expect = 9e-16
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT+K  G  VA+KK+  L  Q  RE +  E+  +   +H N+V +    
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
            +G+E  +V EF++ G+L +++    +  +++I        +     K L  LH      
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAA------VCLAVLKALSVLHAQ---G 136

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS ++LL H+   ++SDFG    +S         +L GTP ++ PE        
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYG 194

Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            + D++S G++++E++ G+ P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 78.6 bits (193), Expect = 1e-15
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V+ A  +  G  VAIK++  L  Q  +E +  E+  + + K+ N+V  L   
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
            +G+E  +V E++  GSL +V+        Q          + R   + L FLH N    
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AAVCRECLQALDFLHSN---Q 135

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS N+LL  +   +++DFG    I+   +    ST+ GTP ++ PE        
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYG 193

Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E++ G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 30/206 (14%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FG+V+KA  K+   +A  K+I    + + E +M E++ L    H N+V LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
                 ++ EF   G+++ V+        +R LT    + + +   + L +LH N    I
Sbjct: 73  YENNLWILIEFCAGGAVDAVM-----LELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMA----RLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           IHRD+K+ N+L   + + +++DFG++    R I   D+ +      GTP ++ PE     
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVM-- 176

Query: 917 RCTA--------KGDVYSFGVVLLEL 934
            C          K DV+S G+ L+E+
Sbjct: 177 -CETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 18/215 (8%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRL-----SCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDARKKIARGAAKG 848
            ++  LLG C +     L+ + M FG L + V   +     Q +L W  +       AKG
Sbjct: 69  PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLV 793
           F+    IG G FGEV+K        V   K+I L    D   +   E+  L +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
              G    G +  ++ E++  GS  ++L       +  I T      I R   KGL +LH
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIAT------ILREILKGLDYLH 118

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                  IHRD+K++NVLL  + + +++DFG+A  ++  DT +  +T  GTP ++ PE  
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +      K D++S G+  +EL  G+ P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.2 bits (191), Expect = 3e-15
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 22/205 (10%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG V     K  G   A+K     K+++L  Q +   + E   L  I+H  LV L
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK-QVE-HVLNEKRILQSIRHPFLVNL 66

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
            G  +      LV E++  G L   L      +  R     AR   A+     L +LH  
Sbjct: 67  YGSFQDDSNLYLVMEYVPGGELFSHLR-----KSGRFPEPVARFYAAQVVL-ALEYLHSL 120

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
               I++RD+K  N+LLD +   +++DFG A+ +    T+    TL GTP Y+ PE   S
Sbjct: 121 ---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-RTY----TLCGTPEYLAPEIILS 172

Query: 916 FRCTAKGDVYSFGVVLLELLTGKRP 940
                  D ++ G+++ E+L G  P
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           ++G G FG        +       K IRL  S     +   E   L K+KH N+V     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 799 CKIGEERLLVYEFMKFGSL-EEVLHGRAKA-RDQRILTWDARKKIARGAAKGLCF-LHHN 855
            +      +V E+   G L +++   R K   +  IL W  +          +C  + H 
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ----------MCLGVQHI 116

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
               ++HRD+KS N+ L    + ++ DFG ARL+++   +    T  GTP YVPPE +++
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWEN 174

Query: 916 FRCTAKGDVYSFGVVLLELLTGKRP 940
                K D++S G +L EL T K P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 16/199 (8%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FG+V+KA  K+  ++A  K+I    + + E +M E+E L    H  +V LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
              +  ++ EF   G+++ ++         R LT    + I R   + L +LH      I
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIM-----LELDRGLTEPQIQVICRQMLEALQYLHSM---KI 131

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY--QSFRC 918
           IHRD+K+ NVLL  + + +++DFG++     + T     +  GTP ++ PE    ++ + 
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 919 TA---KGDVYSFGVVLLEL 934
           T    K D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 20/212 (9%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKH---RNLVP 794
           LIG G +G V++   +  G  VA+K +I L    D   +   E+  L +++     N+  
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
             G    G    ++ E+ + GS+  ++  +A    ++ ++      I R     L ++H 
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYIS-----VIIREVLVALKYIHK 119

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                +IHRD+K++N+L+ +    ++ DFG+A L++        ST  GTP ++ PE   
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAPEVIT 174

Query: 915 SFRC-TAKGDVYSFGVVLLELLTGKRPTDKDD 945
             +    K D++S G+ + E+ TG  P    D
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 76.5 bits (188), Expect = 4e-15
 Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 36/280 (12%)

Query: 742  IGCGGFGEVFKATLKDGSSVA--IKKLIRLSCQGDRE--FMAEMETLGKIKHRNLVPLLG 797
            IG G FG+V       G S A  + K +R S   D +  F+ E++   ++ H N++  LG
Sbjct: 3    IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 798  YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             C      LLV EF   G L+  L        Q     D  +++A   A GL +LH    
Sbjct: 63   QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLHQA-- 119

Query: 858  PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF- 916
               IH D+   N  L  ++  ++ D+G+A      D +++    A    ++ PE  +   
Sbjct: 120  -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 917  ------RCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
                    T K +++S GV + EL T   +P    D  D  ++  V   VRE + +++  
Sbjct: 179  QDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQVLKQV---VRE-QDIKLPK 232

Query: 970  PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
            P+L             ++K   R+ E+   C  D P  RP
Sbjct: 233  PQL-------------DLKYSDRWYEVMQFCWLD-PETRP 258

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 76.3 bits (187), Expect = 4e-15
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRL---SCQGDREFMA---EMETLGKIKHRNLVP 794
           L+G G FG V+     D       K ++    S +  +E  A   E++ L  ++H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 795 LLGYCKIGEERLLV--YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
             G  +   E+ L    E+M  GS+++ L           LT    +K  R   +G+ +L
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA------LTESVTRKYTRQILEGMSYL 122

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPE 911
           H N I   +HRD+K +N+L D     ++ DFG + RL +   +   + ++ GTP ++ PE
Sbjct: 123 HSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                    K DV+S G  ++E+LT K P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 77.2 bits (190), Expect = 5e-15
 Identities = 67/206 (32%), Positives = 95/206 (46%), Gaps = 18/206 (8%)

Query: 741 LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREF---MAEMETLGKIKHRNLVPLL 796
           ++G G FG+V  A LK  G   A+K L +     D +    M E   L   ++   +  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 797 GYCKIGEERLL-VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKI-ARGAAKGLCFLHH 854
             C    +RL  V EF+  G L  + H +   R       +AR +  A      L FLH 
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD-----EARARFYAAEITSALMFLHD 114

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                II+RD+K  NVLLDHE   +++DFGM +    +    + ST  GTP Y+ PE  Q
Sbjct: 115 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQ 169

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRP 940
                   D ++ GV+L E+L G  P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)

Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLV 793
           F+    IG G FGEV+KA  K     VAIK +     + + E +  E++ L + +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 794 PLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
              G   +   +L ++ E+   GS  ++L    K  +  I        I R    GL +L
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAF------ILREVLLGLEYL 114

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           H       IHRD+K++N+LL  E + +++DFG++  ++   T    +T  GTP ++ PE 
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWMAPEV 169

Query: 913 YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            +      K D++S G+  +EL  G+ P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 7e-15
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 29/208 (13%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMA--EMETLGKIK-HRNLVPLLG 797
           +G G FG V+ A  K+ G  VAIKK+ +     + E M   E+++L K+  H N+V L  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             +  +E   V+E+M     E  L+   K R  +  +    + I     +GL  +H +  
Sbjct: 66  VFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH-- 118

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS-VSTLAGTPGYVPPE----- 911
               HRD+K  N+L+      +++DFG+AR I +   +   VS    T  Y  PE     
Sbjct: 119 -GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS----TRWYRAPEILLRS 173

Query: 912 -YYQSFRCTAKGDVYSFGVVLLELLTGK 938
             Y S       D+++ G ++ EL T +
Sbjct: 174 TSYSS-----PVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 42/224 (18%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMA-----EMETLGKIKHRNLVPL 795
           +G G FGEV+KA  +K G  VA+KK++  +   +++        E++ L K+KH N+VPL
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILKKLKHPNVVPL 72

Query: 796 LGYC-----KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRI-LTWDARKKIARGAAK 847
           +        K   +R  VY    +    L  +L       +  + LT    K       +
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE------NPSVKLTESQIKCYMLQLLE 126

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG- 906
           G+ +LH N   HI+HRD+K++N+L+D++   +++DFG+AR     D         G  G 
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY---DGPPPNPKGGGGGGT 180

Query: 907 -----------YVPPEY-YQSFRCTAKGDVYSFGVVLLELLTGK 938
                      Y PPE      R T   D++  G V  E+ T +
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 73/282 (25%), Positives = 127/282 (45%), Gaps = 36/282 (12%)

Query: 736  FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKHRN 791
            F  E  IG G F EV++AT L DG  VA+KK+     +  +   + + E++ L ++ H N
Sbjct: 4    FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 792  LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            ++          E  +V E    G L  ++    K +  R++     K + +   +    
Sbjct: 64   VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK--RLI---PEKTVWKYFVQLCSA 118

Query: 852  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            L H     ++HRD+K +NV +      ++ D G+ R  S+  T  +  +L GTP Y+ PE
Sbjct: 119  LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPE 176

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEVID- 969
                     K D++S G +L E+   + P     +GD       KM +    K++E  D 
Sbjct: 177  RIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGD-------KMNLYSLCKKIEQCDY 225

Query: 970  PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
            P L        +  +EE++++V        C++  P KRP++
Sbjct: 226  PPL------PSDHYSEELRQLVN------MCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 76.6 bits (188), Expect = 8e-15
 Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 16/220 (7%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRNLV 793
           F   S +G G  G VFK + K    +  +KLI L  +     + + E++ L +     +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
              G      E  +  E M  GSL++VL    +  +Q +       K++    KGL +L 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTYLR 120

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPEY 912
                 I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ PE 
Sbjct: 121 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 173

Query: 913 YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLV 952
            Q    + + D++S G+ L+E+  G+ P    D  +  L+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 75.8 bits (186), Expect = 9e-15
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 15/201 (7%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYC 799
           IG G  G V  A  K  G  VA+K ++ L  Q  RE +  E+  +   +H+N+V +    
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
            +GEE  ++ EF++ G+L +++  + +  +++I T      +     + LC+LH      
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV-SQTRLNEEQIAT------VCESVLQALCYLHSQ---G 137

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS ++LL  +   ++SDFG    IS  D     S L GTP ++ PE        
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKS-LVGTPYWMAPEVISRTPYG 195

Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            + D++S G++++E++ G+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 75.7 bits (186), Expect = 9e-15
 Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 19/207 (9%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKL--IRLSC-QGDREFMAEMETLGKIKHRNLVPLLG 797
           +G GGFGEV    ++  G   A KKL   RL   +G    M E   L K+  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 798 YCKIGEERLLVYEFMKFGSLE----EVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
             +   +  LV   M  G L      V        + R   + A+         GL  LH
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISGLEHLH 114

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                 II+RD+K  NVLLD++   R+SD G+A  +   D        AGTPG++ PE  
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELL 169

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           Q        D ++ GV L E++  + P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V+ A  +  G  VAI+++  L  Q  +E +  E+  + + K+ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
            +G+E  +V E++  GSL +V+        Q          + R   + L FLH N    
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AAVCRECLQALEFLHSN---Q 136

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS N+LL  +   +++DFG    I+   +    ST+ GTP ++ PE        
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYG 194

Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E++ G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRL-----SCQGDREFMAEMETLGKIKHRNLVP 794
           ++G G FG V+K   + DG +V I   I++     S + ++E + E   +  +    +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 795 LLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           LLG C +     LV + M +G L + V   + +   Q +L W  +       AKG+ +L 
Sbjct: 74  LLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                 ++HRD+ + NVL+      +++DFG+ARL+   +T            ++  E  
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
              R T + DV+S+GV + EL+T G +P D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLV 793
           F+    IG G FGEVFK        V   K+I L    D   +   E+  L +     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
              G      +  ++ E++  GS  ++L       + +I T      I R   KGL +LH
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIAT------ILREILKGLDYLH 118

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                  IHRD+K++NVLL    E +++DFG+A  ++  DT +  +T  GTP ++ PE  
Sbjct: 119 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +     +K D++S G+  +EL  G+ P
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 22/200 (11%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG------DREFMAEMETLGKIKHRNLVP 794
           IG G FGEVF   L+ D + VA+K     SC+         +F+ E   L +  H N+V 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVK-----SCRETLPPDLKAKFLQEARILKQYSHPNIVR 57

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L+G C   +   +V E ++ G     L         + L      ++   AA G+ +L  
Sbjct: 58  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELI-----QMVENAAAGMEYLES 112

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYY 913
               H IHRD+ + N L+  +   ++SDFGM+R       + S   +   P  +  PE  
Sbjct: 113 K---HCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEAL 168

Query: 914 QSFRCTAKGDVYSFGVVLLE 933
              R +++ DV+SFG++L E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT K  G  VA+KK+  L  Q  RE +  E+  +    H N+V +    
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
            +G+E  +V EF++ G+L +++    +  +++I T      +     + L +LH+     
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAT------VCLSVLRALSYLHNQ---G 138

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS ++LL  +   ++SDFG    +S         +L GTP ++ PE        
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS--KEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            + D++S G++++E++ G+ P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 24/211 (11%)

Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDARKKIARGA---AKGLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +    + KK+ + A   A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 185

Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.6 bits (191), Expect = 2e-14
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 25/196 (12%)

Query: 758 GSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLGYCKIGEERLL-VYEFMK 813
           G  VAIK L   + + + +   F  E     ++ H N+V LL   +     L  V+E++ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 814 FGSLEEVL--HGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVL 871
             +L EVL   G   A +   L       +A    +G           I+HRD+K  N++
Sbjct: 63  GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG-----------IVHRDLKPQNIM 111

Query: 872 L---DHEMEARVSDFGMARLIS----ALDTHLSVST-LAGTPGYVPPEYYQSFRCTAKGD 923
           +        A+V DFG+  L+     A    L+ +T + GTP Y  PE  +    T   D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 924 VYSFGVVLLELLTGKR 939
           +Y++G++ LE LTG+R
Sbjct: 172 LYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 41/228 (17%)

Query: 734 NGFSAESLIGCGGFGEVFKATL-KDG--SSVAIKKLIRLSCQGD-REFMAEMETLGKI-K 788
           N    + +IG G FG+V KA + KDG     AIK++   + + D R+F  E+E L K+  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA-- 846
           H N++ LLG C+      L  E+   G+L + L      R  R+L  D    IA   A  
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL------RKSRVLETDPAFAIANSTAST 120

Query: 847 --------------KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR----L 888
                         +G+ +L        IHRD+ + N+L+     A+++DFG++R     
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177

Query: 889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
           +      L V  +A     +    Y  +  T   DV+S+GV+L E+++
Sbjct: 178 VKKTMGRLPVRWMA-----IESLNYSVY--TTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
           IG G FG V+ A  ++    VAIKK+    + S +  ++ + E+  L +++H N +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 798 YCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            C + E    LV E+   GS  ++L    K      L       I  GA +GL +LH + 
Sbjct: 83  -CYLREHTAWLVMEYC-LGSASDILEVHKKP-----LQEVEIAAICHGALQGLAYLHSHE 135

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
               IHRD+K+ N+LL      +++DFG A L+S        ++  GTP ++ PE   + 
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVS------PANSFVGTPYWMAPEVILAM 186

Query: 917 ---RCTAKGDVYSFGVVLLELLTGKRP 940
              +   K DV+S G+  +EL   K P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.7 bits (184), Expect = 3e-14
 Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 18/211 (8%)

Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKI-KHRNLVPL 795
           ++G G FG+V  A LK    + A+K L +     D +    M E   L    KH  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
              C   ++RL  V E++  G L   +    +  + R   + A          GL FLH 
Sbjct: 62  HS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE------IVLGLQFLHE 114

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                II+RD+K  NVLLD E   +++DFGM +    +   ++ ST  GTP Y+ PE   
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILS 169

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                   D ++ GV+L E+L G+ P + DD
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 18/214 (8%)

Query: 741 LIGCGGFGEVFKATLK--DGSS--VAIK--KLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           ++G G FG V +  L   DGS   VA+K  KL   +     EF++E   +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 795 LLGYCKIGEER------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
           L+G C            +++  FMK G L   L           L      K     A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GY 907
           + +L +    + IHRD+ + N +L  +M   V+DFG+++ I + D +     +A  P  +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ-GRIAKMPVKW 181

Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           +  E       T+K DV++FGV + E+ T G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 75.0 bits (184), Expect = 3e-14
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 20/217 (9%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHRN 791
           F+   ++G G FG+V  A  K    + AIK L +     D +    M E   L       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 792 LVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            +  L  C    +RL  V E++  G L   +    K ++ + + + A   +      GL 
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLF 115

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           FLH      II+RD+K  NV+LD E   +++DFGM +    +   ++  T  GTP Y+ P
Sbjct: 116 FLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAP 170

Query: 911 EY--YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           E   YQ +  +   D +++GV+L E+L G+ P D +D
Sbjct: 171 EIIAYQPYGKSV--DWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLI--RLSCQGDREFMA---EMETLGKIKHRNLVP 794
           L+G G FG V+     D G  +A+K++     S +  +E  A   E++ L  + H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 795 LLGYCKIGEERLL--VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
             G  +   ER L    E M  GS+++ L           LT +  +K  R   +G+ +L
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA------LTENVTRKYTRQILEGVSYL 122

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPE 911
           H N I   +HRD+K +N+L D     ++ DFG + RL +   +   + ++ GTP ++ PE
Sbjct: 123 HSNMI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                    K D++S G  ++E+LT K P
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.9 bits (185), Expect = 3e-14
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 25/209 (11%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKL---IRLSCQGDREFMAEM--ETLGKIKHRNLVPL 795
           +G G +G V+KA  +     VA+KK+    R +    R F   M  + LG   H N+V L
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD--HPNIVKL 72

Query: 796 LGYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           L   K   ++   LV+E+M     E  LH   +A    IL    ++ I     K L ++H
Sbjct: 73  LNVIKAENDKDIYLVFEYM-----ETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH 124

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA---GTPGYVPP 910
                ++IHRD+K SN+LL+ +   +++DFG+AR +S L+ +     L     T  Y  P
Sbjct: 125 SG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181

Query: 911 EYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           E         KG D++S G +L E+L GK
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 27/217 (12%)

Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDARKK 840
           ++ LLG C       ++ E+   G+L E L  R           A+  D++ +T+     
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ-MTFKDLVS 141

Query: 841 IARGAAKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                A+G+ +L    CI    HRD+ + NVL+      +++DFG+AR ++ +D +   +
Sbjct: 142 CTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 900 TLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                  ++ PE       T + DV+SFGV++ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 69/226 (30%), Positives = 108/226 (47%), Gaps = 49/226 (21%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHRNLVPL 795
           L+G G +G V K   K+ G  VAIKK   L  + D+      M E+  L +++H NLV L
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 796 LGYCKIGEERLLVYEFMK---FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
           +   +  +   LV+EF+       LE+  +G  ++R ++ L +    +I RG      F 
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-F----QILRGIE----FC 116

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG-----Y 907
           H +   +IIHRD+K  N+L+      ++ DFG AR            TLA  PG     Y
Sbjct: 117 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR------------TLAA-PGEVYTDY 160

Query: 908 VPPEYYQSFRC----TAKG---DVYSFGVVLLELLTGKR--PTDKD 944
           V   +Y++       T  G   D+++ G ++ E+LTG+   P D D
Sbjct: 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 25/212 (11%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREF---MAEMETLGKIKHRNLVPLLG 797
           I  G +G VF A  K  G   AIK + +       +    + E + L + +   +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 798 YCKIGEERL-LVYEFMKFGSLEEVLH--GRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           Y   G++ L LV E++  G L  +L   G   + D+ +    AR  IA      L +LH 
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDV----ARIYIAE-IVLALEYLHS 111

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFG------MARLISALDTHLSVSTLAGTPGYV 908
           N    IIHRD+K  N+L+D     +++DFG      + R I+  D       + GTP Y+
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            PE       +   D +S G +L E L G  P
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 74.1 bits (182), Expect = 4e-14
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)

Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLG-KIKHRNLVPL 795
           ++G G FG+V  A LK    V AIK L +     D +    M E   L    KH  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
               +  +    V E++  G L   +    K  + R   + A   +A      L FLH +
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA------LMFLHRH 115

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
               +I+RD+K  N+LLD E   +++DFGM +    +   ++ +T  GTP Y+ PE  Q 
Sbjct: 116 ---GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 916 FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
                  D ++ GV++ E++ G+ P + D+  D
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)

Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
           ++G G +G V+ A  L     +AIK++     +  +    E+     +KHRN+V  LG  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
                  +  E +  GSL  +L    G  K  +Q I+ +   K+I     +GL +LH N 
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT--KQI----LEGLKYLHDN- 127

Query: 857 IPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY-Q 914
              I+HRD+K  NVL++ +    ++SDFG ++ ++ ++      T  GT  Y+ PE   +
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDK 183

Query: 915 SFR-CTAKGDVYSFGVVLLELLTGKRP 940
             R   A  D++S G  ++E+ TGK P
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 29/279 (10%)

Query: 736  FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLV 793
            F     +G G  G V K   +    +  +KLI L  +     + + E++ L +     +V
Sbjct: 3    FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 794  PLLG-YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
               G +   GE  + + E M  GSL++VL  +A    + IL      KI+    +GL +L
Sbjct: 63   GFYGAFYSDGEISICM-EHMDGGSLDQVLK-KAGRIPENILG-----KISIAVLRGLTYL 115

Query: 853  HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPE 911
                   I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ PE
Sbjct: 116  REK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPE 168

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE 971
              Q    T + D++S G+ L+E+  G+ P    D           M  R   + E  +  
Sbjct: 169  RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-----AKELEAMFGRPVSEGEAKESH 223

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010
              +     D      + E++ Y+      V++ P K P+
Sbjct: 224  RPVSGHPPDSPRPMAIFELLDYI------VNEPPPKLPS 256

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.9 bits (181), Expect = 5e-14
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 742 IGCGGFGEV-FKATLKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLG 797
           IG G FG V F   +++   VAIKK+     Q +   ++ + E+  L K++H N +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 798 YCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH-HN 855
            C + E    LV E+   GS  ++L    K   +  +       +  GA +GL +LH HN
Sbjct: 83  -CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLAYLHSHN 135

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
               +IHRD+K+ N+LL      ++ DFG A +++        +   GTP ++ PE   +
Sbjct: 136 ----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILA 185

Query: 916 F---RCTAKGDVYSFGVVLLELLTGKRP 940
               +   K DV+S G+  +EL   K P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.0 bits (181), Expect = 5e-14
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 26/214 (12%)

Query: 736 FSAESLIGCGGFGEV-FKATLKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKHRN 791
           F+    IG G FG V F   ++    VAIKK+    + S +  ++ + E++ L +IKH N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 792 LVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            +   G C + E    LV E+   GS  ++L    K   +  +       I  GA +GL 
Sbjct: 87  SIEYKG-CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-----AITHGALQGLA 139

Query: 851 FLH-HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           +LH HN    +IHRD+K+ N+LL    + +++DFG A + S        ++  GTP ++ 
Sbjct: 140 YLHSHN----MIHRDIKAGNILLTEPGQVKLADFGSASIAS------PANSFVGTPYWMA 189

Query: 910 PEYYQSF---RCTAKGDVYSFGVVLLELLTGKRP 940
           PE   +    +   K DV+S G+  +EL   K P
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 73.7 bits (182), Expect = 6e-14
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 54/230 (23%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-----EMETLGKIKH 789
           +     IG G +G V  A   + G  VAIKK+  +    D    A     E++ L  ++H
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRH 58

Query: 790 RNLVPLLG-------------YCKIGEERLLVYEFMKFGS-LEEVLHGRAKARDQRILTW 835
            N++ LL              Y        +V E M   + L +V+       D  I   
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVY--------IVTELM--ETDLHKVIKSPQPLTDDHI--- 105

Query: 836 DARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
              +       +GL +LH     ++IHRD+K SN+L++   + ++ DFG+AR +   +  
Sbjct: 106 ---QYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159

Query: 896 LSVSTLAGTPGYVPPEYY-------QSFRCTAKGDVYSFGVVLLELLTGK 938
               T      YV   +Y        S R T   D++S G +  ELLT K
Sbjct: 160 KGFLT-----EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 742 IGCGGFGEVFKATLKDGSS-VAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLG 797
           IG G FG V+ AT    +  VA+KK+     Q +   ++ + E++ L ++KH N +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 798 YCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            C + E    LV E+   GS  ++L    K   +  +       I  GA +GL +LH + 
Sbjct: 89  -CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHSHN 141

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           +   IHRD+K+ N+LL    + +++DFG A   S        ++  GTP ++ PE   + 
Sbjct: 142 M---IHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAM 192

Query: 917 ---RCTAKGDVYSFGVVLLELLTGKRP 940
              +   K DV+S G+  +EL   K P
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 15/209 (7%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMA---EMETLGKIKHRNLVPLLG 797
           +G G +GEV     + DG    IKKL  L     RE  A   E + L ++KH N+V    
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             + GE+ LL Y  M F    ++ H + K +  ++L  +   +     A  L +LH    
Sbjct: 67  SWE-GEDGLL-YIVMGFCEGGDLYH-KLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-- 121

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV-STLAGTPGYVPPEYYQSF 916
            HI+HRD+K+ NV L      +V D G+AR+   L+    + STL GTP Y+ PE + + 
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARV---LENQCDMASTLIGTPYYMSPELFSNK 177

Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
               K DV++ G  + E+ T K   +  D
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKD 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 74.2 bits (182), Expect = 8e-14
 Identities = 79/253 (31%), Positives = 120/253 (47%), Gaps = 15/253 (5%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
           L N   L  LDL+ N L  +I    L E +  +L  LDL  N+I D+ P      + LK 
Sbjct: 89  LLNLLPLPSLDLNLNRLRSNI--SELLELT--NLTSLDLDNNNITDIPPLIGLLKSNLKE 144

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           L+LS N +   +P     L +L+ LDLS N ++  +P  L N   +L  L L  N I+  
Sbjct: 145 LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNL-SNLNNLDLSGNKIS-D 200

Query: 190 FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTL 249
            P  +   S L+ LDLSNN+I      S L NL +L  L LSNN +    P+SI +   L
Sbjct: 201 LPPEIELLSALEELDLSNNSII-ELLSS-LSNLKNLSGLELSNNKLE-DLPESIGNLSNL 257

Query: 250 RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN 309
             +D S+N++S I        +++L EL L  N ++      ++    L  + L+L    
Sbjct: 258 ETLDLSNNQISSI---SSLGSLTNLRELDLSGNSLSN-ALPLIALLLLLLELLLNLLLTL 313

Query: 310 GSIPQELGKLEHL 322
            ++  +L  +   
Sbjct: 314 KALELKLNSILLN 326

Length = 394

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 742 IGCGGFGEVFKA---TLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V K      K   +VA+K L   +       E + E   + ++ +  +V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
           G C+  E  +LV E  + G L + L       ++ I       ++    + G+ +L    
Sbjct: 63  GICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNIT------ELVHQVSMGMKYLEET- 114

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQS 915
             + +HRD+ + NVLL  +  A++SDFG+++ + A + +    T    P  +  PE    
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++ ++K DV+SFGV++ E  + G++P
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 25/213 (11%)

Query: 739 ESLIGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGD--REFMAEMETLGKIKHRNL 792
           E ++G G FGE+ +  LK  S     VAI  L R  C     R F+AE  TLG+  H N+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
           V L G    G   ++V E+M  G+L+  L      + +  L       +  G A G+ +L
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLR-----KHEGQLVAGQLMGMLPGLASGMKYL 123

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL----ISALDTHLSVSTLAGTPGYV 908
                   +H+ + +  VL++ ++  ++S F   RL      A+ T +S  +      + 
Sbjct: 124 SEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV---LWA 175

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            PE  Q    ++  DV+SFG+V+ E+++ G+RP
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 70/225 (31%), Positives = 111/225 (49%), Gaps = 37/225 (16%)

Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE-----FMAEMETLGKIKH 789
           F     IG G +G+V+KA  KD G  VA+KK +RL    ++E      + E++ L ++ H
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKK-VRL--DNEKEGFPITAIREIKILRQLNH 65

Query: 790 RNLVPL----------LGYCKIGEERLLVYEFMK---FGSLEEVLHGRAKARDQRILTWD 836
           RN+V L          L + K      LV+E+M     G LE    G     +  I    
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHI---- 118

Query: 837 ARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
             K   +   +GL + H     + +HRD+K SN+LL+++ + +++DFG+ARL ++ ++  
Sbjct: 119 --KSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 897 SVSTLAGTPGYVPPE-YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
             + +  T  Y PPE      R     DV+S G +L EL T K+P
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 27/283 (9%)

Query: 736  FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRNLV 793
            F   S +G G  G V K   K    +  +KLI L  +     + + E++ L +     +V
Sbjct: 7    FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 794  PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
               G      E  +  E M  GSL++VL   AK   + IL      K++    +GL +L 
Sbjct: 67   GFYGAFYSDGEISICMEHMDGGSLDQVLK-EAKRIPEEIL-----GKVSIAVLRGLAYLR 120

Query: 854  HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPEY 912
                  I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ PE 
Sbjct: 121  EK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPER 173

Query: 913  YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE- 971
             Q    + + D++S G+ L+EL  G+ P    D  +   +    +   E  +   I P  
Sbjct: 174  LQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233

Query: 972  ----LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010
                  +   G D   A  + E++ Y+      V++ P K PN
Sbjct: 234  RPPGRPVSGHGMDSRPAMAIFELLDYI------VNEPPPKLPN 270

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 18/211 (8%)

Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRN 791
           F    ++G GGFGEV    ++  G   A KKL +   +   G+   + E + L K+  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLE-EVLH-GRAKARDQRILTWDARKKIARGAAKGL 849
           +V L    +  +   LV   M  G L+  + H G A   + R + +         AA+  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY---------AAEIC 112

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           C L       I++RD+K  N+LLD     R+SD G+A  +    T   +    GT GY+ 
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMA 169

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  ++ R T   D ++ G +L E++ G+ P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.5 bits (183), Expect = 2e-13
 Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 4/99 (4%)

Query: 349 LILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEI 408
           L L+N  L G IP ++    +L+ I+L+GN + G IPP    +T L VL L  N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 409 PGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGG 447
           P  LG  +SL  L+LN N+L+G +P      LG + L  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA----ALGGRLLHR 517

Length = 623

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 31/239 (12%)

Query: 719 RQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREF 777
           R L  +  S L +    F    ++G G +G+V+K   +K G   AIK ++ ++   + E 
Sbjct: 1   RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEI 59

Query: 778 MAEMETLGKIKH-RNLVPLLG-YCKIG-----EERLLVYEFMKFGSLEEVLHGRAKARDQ 830
             E+  L K  H RN+    G + K       ++  LV EF   GS+ +++    K    
Sbjct: 60  KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV----KNTKG 115

Query: 831 RILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
             L  D    I R   +GL  LH      +IHRD+K  NVLL    E ++ DFG++   +
Sbjct: 116 NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVS---A 169

Query: 891 ALDTHLS-VSTLAGTPGYVPPEYYQSFRCTA--------KGDVYSFGVVLLELLTGKRP 940
            LD  +   +T  GTP ++ PE      C          + D++S G+  +E+  G  P
Sbjct: 170 QLDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGD-------REFMAEMETLGKIKHRNLV 793
           IG G +G V++A     G  VA+KK +R+  + D       RE       L  ++H N+V
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKK-VRMDNERDGIPISSLREITL----LLNLRHPNIV 69

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            L    ++   + L   F+     E+ L            +    K +     +GL +LH
Sbjct: 70  ELK---EVVVGKHLDSIFLVMEYCEQDL-ASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS--VSTLAGTPGYVPPE 911
            N I   IHRD+K SN+LL  +   +++DFG+AR        ++  V TL     Y  PE
Sbjct: 126 ENFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL----WYRAPE 178

Query: 912 YYQSFRC---TAKGDVYSFGVVLLELLTGK 938
                 C   T   D+++ G +L ELL  K
Sbjct: 179 LL--LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 18/211 (8%)

Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRN 791
           F    ++G GGFGEV    ++  G   A K+L +   +   G+   + E + L K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDARKKIARGAAKGL 849
           +V L    +  +   LV   M  G L+  ++  G     ++R L +         AA+ L
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY---------AAEIL 112

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           C L      + ++RD+K  N+LLD     R+SD G+A  I   +   S+    GT GY+ 
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMA 169

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE   + R T   D +  G ++ E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 72/239 (30%), Positives = 113/239 (47%), Gaps = 26/239 (10%)

Query: 717 FQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDR 775
           F    + + F    + ++ +     IG G +G+VFK    K+GS  A+K L  +    D 
Sbjct: 1   FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDE 59

Query: 776 EFMAEMETLGKIK-HRNLVPLLGY-----CKIGEERLLVYEFMKFGSLEEVLHG---RAK 826
           E  AE   L  +  H N+V   G       K G++  LV E    GS+ +++ G   R +
Sbjct: 60  EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119

Query: 827 ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA 886
             ++ I+ +     I   A  GL  LH N     IHRD+K +N+LL  E   ++ DFG++
Sbjct: 120 RMEEPIIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171

Query: 887 RLISALDTHLSVSTLAGTPGYVPPEYY---QSFRCT--AKGDVYSFGVVLLELLTGKRP 940
             +++  T L  +T  GTP ++ PE     Q    T  A+ DV+S G+  +EL  G  P
Sbjct: 172 AQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 30/209 (14%)

Query: 742 IGCGGFGEVFKATL----KDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G FG   KA L    +DG    IK++   ++S +   E   E+  L  +KH N+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63

Query: 796 LGYCKIGEERLLVYEFMKF---GSLEEVLHGRAKA--RDQRILTWDARKKIARGAAKGLC 850
             Y +  EE   +Y  M +   G L + ++ +      + +IL W  +          +C
Sbjct: 64  --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ----------IC 111

Query: 851 F-LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
             L H     I+HRD+KS N+ L  +   ++ DFG+AR++++  T     T  GTP Y+ 
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGTPYYLS 169

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           PE  ++     K D+++ G VL E+ T K
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 11/209 (5%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKHRN 791
           F  E  IG G F EV++AT L D   VA+KK+     +  +  ++ + E++ L ++ H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           ++  L       E  +V E    G L +++    K +  R++     + + +   +    
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK--RLI---PERTVWKYFVQLCSA 118

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           + H     ++HRD+K +NV +      ++ D G+ R  S+  T  +  +L GTP Y+ PE
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPE 176

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                    K D++S G +L E+   + P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.9 bits (177), Expect = 3e-13
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 38/215 (17%)

Query: 740 SLIGCGGFGEVFKATLKD-GSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLL 796
           S +G G +G+V  A     G  VAIKKL R   S    +    E+  L  + H N++ LL
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 797 GYCKIGEER------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
                           LV   M    L  ++      + Q+ L+ D  + +     +GL 
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMG-ADLNNIV------KCQK-LSDDHIQFLVYQILRGLK 132

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           ++H      IIHRD+K SN+ ++ + E ++ DFG+AR      T           GYV  
Sbjct: 133 YIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-----------GYVAT 178

Query: 911 EYYQS-------FRCTAKGDVYSFGVVLLELLTGK 938
            +Y++              D++S G ++ ELLTGK
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.8 bits (176), Expect = 3e-13
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 30/210 (14%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           IG G  G V+K   +    +   K+I  + +    R+   E+E L  + H N+V      
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
               E  ++ EFM  GSLE    G   A +Q +        +AR    G+ +LH     H
Sbjct: 142 DHNGEIQVLLEFMDGGSLE----GTHIADEQFL------ADVARQILSGIAYLHRR---H 188

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE-------- 911
           I+HRD+K SN+L++     +++DFG++R+++   T    ++  GT  Y+ PE        
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPERINTDLNH 246

Query: 912 -YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
             Y  +     GD++S GV +LE   G+ P
Sbjct: 247 GAYDGY----AGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 71.6 bits (175), Expect = 4e-13
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 25/216 (11%)

Query: 742 IGCGGFGEVFKATL----KD----GSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD      +VA+K L   +   D  + ++EME +  I KH+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR----------AKARDQRILTWDARKKI 841
           ++ LLG C       ++ E+   G+L E L  R               +  LT+      
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 842 ARGAAKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
           A   A+G+ +L    CI    HRD+ + NVL+  +   +++DFG+AR +  +D +   + 
Sbjct: 140 AYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.8 bits (173), Expect = 6e-13
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)

Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V +A              +VA+K L   +   D  + ++EME +  I KH+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR----------AKARDQRILTWDARKKI 841
           ++ LLG C       ++ E+   G+L E L  R               +  L++      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 842 ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
           A   A+G+ +L        IHRD+ + NVL+  +   +++DFG+AR +  +D +   S  
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 902 AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                ++ PE       T + DV+SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.0 bits (174), Expect = 6e-13
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 20/217 (9%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHRN 791
           F+   ++G G FG+V  A  K    + AIK L +     D +    M E   L       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 792 LVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            +  L  C    +RL  V E++  G L   +    K ++   + + A        A GL 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE------IAIGLF 115

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           FLH      II+RD+K  NV+LD E   +++DFGM +    +    +  T  GTP Y+ P
Sbjct: 116 FLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAP 170

Query: 911 EY--YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           E   YQ +      D ++FGV+L E+L G+ P D +D
Sbjct: 171 EIIAYQPY--GKSVDWWAFGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 43/281 (15%)

Query: 741  LIGCGGFGEVFKAT-LKDGSSVAIKKL----IRLSCQGD--REFMAEMETLGKIKHRNLV 793
             +G G F   ++A  +K G+ +A+K++       S Q +       E+  + ++ H +++
Sbjct: 7    QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 794  PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
             +LG         L  E+M  GS+  +L  +  A  + ++             +GL +LH
Sbjct: 67   RMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVII-----NYTEQLLRGLSYLH 120

Query: 854  HNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMA-RLISALD-THLSVSTLAGTPGYVPP 910
             N    IIHRD+K +N+L+D      R++DFG A RL +           L GT  ++ P
Sbjct: 121  EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 911  EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP 970
            E  +  +     DV+S G V++E+ T K P + +                          
Sbjct: 178  EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK----------------------HSN 215

Query: 971  ELLLVTKGTDESEAEEVKEMVR--YLEITLQCVDDFPSKRP 1009
             L L+ K    + A  + E +     ++TL+C++  P  RP
Sbjct: 216  HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.4 bits (172), Expect = 6e-13
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 18/206 (8%)

Query: 741 LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREF---MAEMETLG-KIKHRNLVPL 795
           ++G G FG+VF A LK      AIK L +     D +    M E   L    +H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKAR-DQRILTWDARKKIARGAAKGLCFLHH 854
               +  E    V E++  G L  + H ++  + D    T+ A + I      GL FLH 
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIIC-----GLQFLHS 114

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                I++RD+K  N+LLD +   +++DFGM +    +       T  GTP Y+ PE   
Sbjct: 115 K---GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILL 169

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRP 940
             +     D +SFGV+L E+L G+ P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 69.6 bits (170), Expect = 7e-13
 Identities = 68/247 (27%), Positives = 111/247 (44%), Gaps = 26/247 (10%)

Query: 742 IGCGGFGEVFKATLKDG---SSVAIKKL-IRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
           IG G FG+V    +  G   + V +K+L +  S Q   +F+ E +    ++H NL+  LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDAR--KKIARGAAKGLCFLHHN 855
            C      LLV EF   G L+  L    KA     +T D    +++A   A GL  LH N
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAEL---MTPDPTTLQRMACEIALGLLHLHKN 119

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
              + IH D+   N LL  ++  ++ D+G++      D +++   L     ++ PE    
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 916 FRC-------TAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEV 967
                     T + +V+S GV + EL   G +P       D  ++ +    VRE +Q+++
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH--LSDEQVLTYT---VRE-QQLKL 230

Query: 968 IDPELLL 974
             P L L
Sbjct: 231 PKPRLKL 237

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.4 bits (172), Expect = 7e-13
 Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 16/212 (7%)

Query: 741 LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDRE---FMAEMETLGK-IKHRNLVPL 795
           +IG G FG+V  A  K DGS  A+K L + +    +E    MAE   L K +KH  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
               +  E+   V +++  G L    H +   R++  L   AR   A   A  + +LH  
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGEL--FFHLQ---RERCFLEPRARFYAAE-VASAIGYLHSL 115

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
              +II+RD+K  N+LLD +    ++DFG+ +    ++   + ST  GTP Y+ PE  + 
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRK 170

Query: 916 FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG 947
                  D +  G VL E+L G  P    D  
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 15/203 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR----EFMAEMETLGKIKHRNLVPLLG 797
           IG G FG+V +   +D   +   K IR +    R      +AE   L ++    +VPL  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             +  E+  LV  F+  G L   L      R+ R     AR   A    + LC L +   
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQ-----REGRFDLSRARFYTA----ELLCALENLHK 111

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
            ++I+RD+K  N+LLD++    + DFG+ +L    D     +T  GTP Y+ PE      
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHG 169

Query: 918 CTAKGDVYSFGVVLLELLTGKRP 940
            T   D ++ GV+L E+LTG  P
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 69.6 bits (170), Expect = 9e-13
 Identities = 68/285 (23%), Positives = 123/285 (43%), Gaps = 43/285 (15%)

Query: 742  IGCGGFGEVFKATL-----KDGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPL 795
            +G   FG+++K  L          VAIK L  ++  Q   EF  E   + ++ H N+V L
Sbjct: 13   LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 796  LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD-----------QRILTWDARKKIARG 844
            LG     +   +++E++  G L E L  R+   D           +  L       IA  
Sbjct: 73   LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 845  AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
             A G+ +L  +     +H+D+ + N+L+  ++  ++SD G++R I + D +         
Sbjct: 133  IAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 905  PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ 964
              ++PPE     + ++  D++SFGVVL E+ +         FG     G+   +V     
Sbjct: 190  IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS---------FGLQPYYGFSNQEV----- 235

Query: 965  MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
            +E++    LL         +E+     R   +  +C  + PS+RP
Sbjct: 236  IEMVRKRQLLPC-------SEDCPP--RMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 1e-12
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 26/208 (12%)

Query: 740 SLIGCGGFGEVFKAT-LKDGSSVAIKKL-IRLSCQGD-----REFMAEMETLGKIKHRNL 792
           + IG G +G V+KA  L  G  VA+KK+ + LS +G      RE +A ++ L   +H N+
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE-IALLKQLESFEHPNI 63

Query: 793 VPLLGYCKIGE-ER----LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK 847
           V LL  C     +R     LV+E +     ++ L        +  L  +  K + R   +
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
           G+ FLH + I   +HRD+K  N+L+  + + +++DFG+AR+       ++++++  T  Y
Sbjct: 119 GVDFLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTLWY 172

Query: 908 VPPE-YYQSFRCTAKGDVYSFGVVLLEL 934
             PE   QS   T   D++S G +  EL
Sbjct: 173 RAPEVLLQSSYATPV-DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 17/215 (7%)

Query: 733 TNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKK--LIRLSCQGDRE-FMAEMETLGKIK 788
              F  E  IG G F  V+KA  L DG  VA+KK  +  +     R+  + E++ L ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVL-HGRAKAR--DQRILTWDARKKIARGA 845
           H N++  L       E  +V E    G L  ++ H + + R   +R + W    ++    
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCSA- 118

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP 905
                 L H     I+HRD+K +NV +      ++ D G+ R  S+  T  +  +L GTP
Sbjct: 119 ------LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTP 170

Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            Y+ PE         K D++S G +L E+   + P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 23/215 (10%)

Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      K+     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR----------AKARDQRILTWDARKKI 841
           ++ LLG C       ++ E+   G+L E L  R               +  L++      
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 842 ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
           A   A+G+ +L        IHRD+ + NVL+  +   +++DFG+AR I  +D +   +  
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 902 AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                ++ PE       T + DV+SFGV+L E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 69.6 bits (170), Expect = 1e-12
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 20/217 (9%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHRN 791
           F+   ++G G FG+V  A  K    + AIK L +     D +    M E   L       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 792 LVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            +  L  C    +RL  V E++  G L   +    + ++   + + A   I      GL 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLF 115

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           FLH      II+RD+K  NV+LD E   +++DFGM +    +   ++  T  GTP Y+ P
Sbjct: 116 FLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAP 170

Query: 911 EY--YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           E   YQ +  +   D ++FGV+L E+L G+ P + +D
Sbjct: 171 EIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 18/211 (8%)

Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDR-EFMA--EMETLGKIKHRN 791
           F    ++G GGFGEV    ++  G   A KKL +   +  + E MA  E + L K+  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDARKKIARGAAKGL 849
           +V L    +  +   LV   M  G L+  ++  G     ++R + +         AA+  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY---------AAEIT 112

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           C L       I++RD+K  N+LLD     R+SD G+A  I   +T   +    GT GY+ 
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMA 169

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  ++ R T   D +  G ++ E++ GK P
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 46/174 (26%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGY 798
           IG G FGEVFKA   K    VA+KK++  + +      A  E++ L  +KH N+V L+  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 799 C---KIGEER-----LLVYEF-------------MKFGSLEEVLHGRAKARDQRILTWDA 837
           C        R      LV+EF             +KF +L E+                 
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF-TLSEI----------------- 121

Query: 838 RKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA 891
            KK+ +    GL ++H N    I+HRDMK++N+L+  +   +++DFG+AR  S 
Sbjct: 122 -KKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 42/227 (18%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKL----IRLSCQGDREFMA----------EMETLGK 786
           +G G +G+V KA     G  VAIKK+    I      DR+ +           E++ + +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 787 IKHRNLVPLLG-YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK-IARG 844
           IKH N++ L+  Y + G+   LV + M    L++V+       D++I   +++ K I   
Sbjct: 77  IKHENIMGLVDVYVE-GDFINLVMDIMA-SDLKKVV-------DRKIRLTESQVKCILLQ 127

Query: 845 AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR-------LISALDTHLS 897
              GL  LH     + +HRD+  +N+ ++ +   +++DFG+AR         +       
Sbjct: 128 ILNGLNVLH-KW--YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 898 VSTLAGTPG-----YVPPE-YYQSFRCTAKGDVYSFGVVLLELLTGK 938
                 T       Y  PE    + +     D++S G +  ELLTGK
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 41/227 (18%)

Query: 735 GFSAESLIGCGGFGEVFKATLKDGSS---VAIKKLIRLSCQGDREFMA---EMETLGKIK 788
            +  E  IG G +G V+KA  K+G      AIKK      Q      +   E+  L ++K
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 789 HRNLVPLLGYCKIGEERL--LVYEFMKFGSLEEVLHGRAKARDQ------RILTWDARKK 840
           H N+V L+       ++   L++++ +    + +   R   R        + L W     
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI--- 117

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL--DHEMEARV--SDFGMARLI-SALDTH 895
                  G+ +LH N    ++HRD+K +N+L+  +      V   D G+ARL  + L   
Sbjct: 118 -----LNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 896 LSVSTLAGTPGYVPPE------YYQSFRCTAKGDVYSFGVVLLELLT 936
             +  +  T  Y  PE      +Y     T   D+++ G +  ELLT
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.9 bits (168), Expect = 3e-12
 Identities = 68/206 (33%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 741 LIGCGGFGEVFKATLK-DGSSVAIK---KLIRLSCQGDREFMAEMETLGK-IKHRNLVPL 795
           +IG G FG+V  A  K DG   A+K   K I L+ +  +  MAE   L K +KH  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
               +  E+   V +F+  G L   L       + R     AR   A   A  L +LH  
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR-----ARFYAAE-IASALGYLHS- 114

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYYQ 914
              +I++RD+K  N+LLD +    ++DFG+ +  I+  DT    +T  GTP Y+ PE  +
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---TTTFCGTPEYLAPEVIR 169

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRP 940
                   D +  G VL E+L G  P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.9 bits (169), Expect = 3e-12
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 21/215 (9%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNL 792
           +     IG G +G V  A   + G  VAIKK+          +  + E++ L   KH N+
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66

Query: 793 VPLLGYCK----IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
           + +    +      ++  +V + M+   L  ++H      ++ I  +    ++ RG    
Sbjct: 67  IAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYF--LYQLLRG---- 119

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI-SALDTHLSVST-LAGTPG 906
           L ++H   +   IHRD+K SN+L++ + E R+ DFGMAR + S+   H    T    T  
Sbjct: 120 LKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 907 YVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRP 940
           Y  PE   S    T   D++S G +  E+L G+R 
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 31/222 (13%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH-RNLV 793
           F    L+G G +G+V+K   +K G   AIK ++ ++   + E   E+  L K  H RN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 794 PLLG-YCK-----IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK 847
              G + K     + ++  LV EF   GS+ +++    K      L  +    I R   +
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAYICREILR 122

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS-VSTLAGTPG 906
           GL  LH +    +IHRD+K  NVLL    E ++ DFG++   + LD  +   +T  GTP 
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNTFIGTPY 176

Query: 907 YVPPEYYQSFRCTA--------KGDVYSFGVVLLELLTGKRP 940
           ++ PE      C          K D++S G+  +E+  G  P
Sbjct: 177 WMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 4e-12
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 11/92 (11%)

Query: 90  ISGFSLNE--------NSCNSLLHL---DLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
           I G  L+         N  + L HL   +LS N I   IP SL + T L++L+LS+N   
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 139 GEIPRTFGQLSSLQRLDLSNNHITGWIPSELG 170
           G IP + GQL+SL+ L+L+ N ++G +P+ LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYCK 800
           IG G +G+V+KA   +   +A  K+I+L    D   +  E+  +   KH N+V   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
             ++  +  EF   GSL+++ H      + +I        ++R   +GL +LH       
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGPLSESQI------AYVSRETLQGLYYLHSK---GK 127

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           +HRD+K +N+LL      +++DFG++  I+A  T     +  GTP ++ PE     R   
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVER--- 182

Query: 921 KG------DVYSFGVVLLELLTGKRP 940
           KG      D+++ G+  +EL   + P
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 18/207 (8%)

Query: 741 LIGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPL 795
            IG G FG+V++       +    VA+K     +    RE F+ E   + +  H ++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH- 854
           +G         +V E    G L   L     + D   L        +   +  L +L   
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLI-----LYSYQLSTALAYLESK 126

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
             +    HRD+ + NVL+      ++ DFG++R +   +++   S       ++ PE   
Sbjct: 127 RFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPESIN 181

Query: 915 SFRCTAKGDVYSFGVVLLELLT-GKRP 940
             R T+  DV+ FGV + E+L  G +P
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 66.9 bits (163), Expect = 7e-12
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   +D       + VA+K +   +   +R EF+ E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDARKKIARGAAK---GLC 850
           LLG    G+  L+V E M  G L+  L   R +A +         +++ + AA+   G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+       +HRD+ + N ++ H+   ++ DFGM R I   D +       G  G +P 
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 185

Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   D++SFGVVL E+ +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.5 bits (165), Expect = 7e-12
 Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 20/209 (9%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-----KHRNLVPL 795
           +IG G + +V    LK    +   K+I+     D E +  ++T   +      H  LV L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
              C   E RL  V EF+  G L  + H     + QR L  +  +  +   +  L FLH 
Sbjct: 62  HS-CFQTESRLFFVIEFVSGGDL--MFH----MQRQRKLPEEHARFYSAEISLALNFLHE 114

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYY 913
                II+RD+K  NVLLD E   +++D+GM +  I   DT    ST  GTP Y+ PE  
Sbjct: 115 R---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFCGTPNYIAPEIL 168

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRPTD 942
           +        D ++ GV++ E++ G+ P D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 17/198 (8%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKHRNLVPLLGYC 799
           +G G +G+V+KA       +A  K+I+L   GD   + + E   + + KH N+V   G  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
              E+  +  E+   GSL+++ H      + +I        + R   +GL +LH      
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQI------AYVCRETLQGLAYLHSKGK-- 127

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
            +HRD+K +N+LL    + +++DFG+A  I+A  T     +  GTP ++ PE     +  
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNG 184

Query: 920 AKG---DVYSFGVVLLEL 934
                 D+++ G+  +EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.4 bits (164), Expect = 8e-12
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE----FMAEMETLGKIKHRNLVPLL 796
           +IG G + +V    LK    +   K+++     D E       E     +      +  L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
             C     RL LV E++  G L  + H     + QR L  +  +  A      L FLH  
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDL--MFH----MQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
               II+RD+K  NVLLD +   +++D+GM +    L    + ST  GTP Y+ PE  + 
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 916 FRCTAKGDVYSFGVVLLELLTGKRPTD 942
                  D ++ GV++ E++ G+ P D
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 1e-11
 Identities = 31/83 (37%), Positives = 46/83 (55%)

Query: 331 GLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSR 390
           GL G IP ++ K ++L+ + L+ N + G IP  L S ++LE + L+ N   G IP    +
Sbjct: 429 GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488

Query: 391 LTRLAVLQLGNNRFKGEIPGELG 413
           LT L +L L  N   G +P  LG
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 42/237 (17%)

Query: 740 SLIGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
             +G G FG V     +          +AI ++IRL  + ++    E   L ++ H  ++
Sbjct: 7   KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL--KQEQHVHNEKRVLKEVSHPFII 64

Query: 794 PLLGYCKIGEERLL--VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            L  +    ++R L  + E++  G L   L    +  +   L +         A++ +C 
Sbjct: 65  RL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY---------ASEIVCA 113

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           L +     I++RD+K  N+LLD E   +++DFG A+            TL GTP Y+ PE
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE 168

Query: 912 YYQSFRCTAKG-----DVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
             QS     KG     D ++ G+++ E+L G  P     F D N  G +  K+  GK
Sbjct: 169 VIQS-----KGHNKAVDWWALGILIYEMLVGYPP-----FFDDNPFG-IYEKILAGK 214

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 16/204 (7%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDRE---FMAEMETLGK-IKHRNLVPLL 796
           IG G FG+V  A  K DG   A+K L + +    +E    MAE   L K +KH  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
              +  ++   V +++  G L   L      R++      AR   A   A  L +LH   
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQ-----RERSFPEPRARFYAAE-IASALGYLHSL- 115

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
             +II+RD+K  N+LLD +    ++DFG+ +    ++   + ST  GTP Y+ PE  +  
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 917 RCTAKGDVYSFGVVLLELLTGKRP 940
                 D +  G VL E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.1 bits (164), Expect = 2e-11
 Identities = 41/124 (33%), Positives = 55/124 (44%), Gaps = 25/124 (20%)

Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
           DS      +  +   +  + G IP DI   +  L+ + L  N I G IP  L   T L+V
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEV 470

Query: 301 IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
           +DLS N  NGSIP+ LG+L                         +L+ L LN N LSG +
Sbjct: 471 LDLSYNSFNGSIPESLGQL------------------------TSLRILNLNGNSLSGRV 506

Query: 361 PAEL 364
           PA L
Sbjct: 507 PAAL 510

Length = 623

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 37/216 (17%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL--G 797
           +IG GGFGEV+     D G   A+K L +      R  M + ETL  +  R ++ L+  G
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETLA-LNERIMLSLVSTG 54

Query: 798 YCKI----------GEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDARKKIARGA 845
            C             ++   + + M  G L   L  HG    ++ R             A
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----------A 103

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP 905
            + +  L H     +++RD+K +N+LLD     R+SD G+A   S    H SV    GT 
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTH 159

Query: 906 GYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRP 940
           GY+ PE  Q      +  D +S G +L +LL G  P
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.8 bits (160), Expect = 3e-11
 Identities = 68/236 (28%), Positives = 102/236 (43%), Gaps = 31/236 (13%)

Query: 720 QLRKLKFSQLIEATN--------GFSAESLIGCGGFGEVFKATLKDGS--SVAIK----- 764
           QL K K S   +            F+    +G G FG V  AT K+     VAIK     
Sbjct: 8   QLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS 67

Query: 765 KLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR 824
           K+I+   Q D  F +E + L  I H   V L G  K      LV EF+  G     L  R
Sbjct: 68  KIIKQK-QVDHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-R 124

Query: 825 AKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG 884
            K     +  + A + +       L F +   + +I++RD+K  N+LLD +   +++DFG
Sbjct: 125 NKRFPNDVGCFYAAQIV-------LIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFG 176

Query: 885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            A+++          TL GTP Y+ PE   +       D ++ G+ + E+L G  P
Sbjct: 177 FAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.5 bits (159), Expect = 3e-11
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 18/208 (8%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-----KHRNLVPL 795
           +IG G + +V    LK    +   K+++     D E +  ++T   +      H  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 796 LGYCKIGEERLL-VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
              C   E RL  V E++  G L   +  + K  ++    + A   +A      L +LH 
Sbjct: 62  HS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHE 114

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                II+RD+K  NVLLD E   +++D+GM +    L    + ST  GTP Y+ PE  +
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTD 942
                   D ++ GV++ E++ G+ P D
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 26/177 (14%)

Query: 807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMK 866
           LV E++  G    ++       +     W A++ IA     G+  LH      IIHRD+K
Sbjct: 74  LVMEYLNGGDCASLIKTLGGLPED----W-AKQYIAE-VVLGVEDLHQR---GIIHRDIK 124

Query: 867 SSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYS 926
             N+L+D     +++DFG++R        L      GTP Y+ PE           D +S
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWS 178

Query: 927 FGVVLLELLTGKRP----TDKDDFGD--TNLVGWVKMKVREGKQMEVIDPELLLVTK 977
            G V+ E L G  P    T    F +  +  + W + +V+E    E +D    L+ +
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE-EVKEFCSPEAVD----LINR 230

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 18/214 (8%)

Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDR-EFMA--EMETLGKIKHRN 791
           F    ++G GGFGEV    ++  G   A KKL +   +  + E MA  E   L K+  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDARKKIARGAAKGL 849
           +V L    +  +   LV   M  G L+  ++  G     +QR + +         AA+  
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY---------AAELC 112

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           C L       I++RD+K  N+LLD     R+SD G+A  I   +T   V    GT GY+ 
Sbjct: 113 CGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMA 169

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK 943
           PE   + + T   D +  G ++ E++ G+ P  K
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 14/184 (7%)

Query: 758 GSSVAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLVPLLGYCKIGEER--LLVYEFMK 813
           G  VA+K L +    G+   +   E+E L  + H N+V   G C         L+ EF+ 
Sbjct: 33  GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91

Query: 814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD 873
            GSL+E L      R++  +    + K A    KG+ +L        +HRD+ + NVL++
Sbjct: 92  SGSLKEYL-----PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE 143

Query: 874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VPPEYYQSFRCTAKGDVYSFGVVLL 932
            E + ++ DFG+ + I     + +V     +P +   PE     +     DV+SFGV L 
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 933 ELLT 936
           ELLT
Sbjct: 204 ELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 38/108 (35%), Positives = 55/108 (50%), Gaps = 11/108 (10%)

Query: 840 KIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHLSV 898
           KIA    K L +LH      +IHRD+K SNVL++   + ++ DFG    IS  L   ++ 
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG----ISGYLVDSVAK 160

Query: 899 STLAGTPGYVPPEYYQSFRCTA----KGDVYSFGVVLLELLTGKRPTD 942
           +  AG   Y+ PE             K DV+S G+ ++EL TG+ P D
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 17/212 (8%)

Query: 742 IGCGGFGEVFKATLKDGSS---VAIKKL-IRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           +G G FG V +  L    S   VA+K + I +  + + E F++E   + +  H N++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 797 GYCKIGEER------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           G C    E       +++  FMK G L   L         + L      K     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVP 909
           +L        IHRD+ + N +L+  M   V+DFG+++ I   D +     +A  P  ++ 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ-GRIAKMPVKWIA 182

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            E       T K DV+SFGV + E+ T G+ P
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +GCG  G VF A   D    VA+KK++    Q  +  + E++ + ++ H N+V +     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 801 IGEERL--------------LVYEFMKFGSLEEVL-HGRAKARDQRILTWDARKKIARGA 845
                L              +V E+M+   L  VL  G       R+  +          
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQ--------L 123

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLS----VST 900
            +GL ++H     +++HRD+K +NV ++ E +  ++ DFG+AR+   +D H S    +S 
Sbjct: 124 LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARI---VDPHYSHKGYLSE 177

Query: 901 LAGTPGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
              T  Y  P    S     K  D+++ G +  E+LTGK
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 25/230 (10%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKL--IRLSCQ-GDREFMAEMETLGKIKHRNLVPLLG 797
           +G GGFGEV    +K+ G   A KKL   RL  + G++  + E E L K+    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 798 YCKIGEERLLVYEFMKFGSLE-EVLH-GRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
             +      LV   M  G L+  + + G      +R++ + A+         G+  LH  
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLHS- 113

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
               I++RDMK  NVLLD +   R+SD G+A     L    +++  AGT GY+ PE  + 
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPEILKE 168

Query: 916 FRCTAKGDVYSFGVVLLELLTGKRP-------TDKDDFGDTNLVGWVKMK 958
              +   D ++ G  + E++ G+ P         K++     L   VK +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE 218

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 68/280 (24%), Positives = 118/280 (42%), Gaps = 43/280 (15%)

Query: 747  FGEVFKATL------KDGSSVAIKKLI-RLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
            FG+V+K  L      +   +VAIK L  +       EF  E     +++H N+V LLG  
Sbjct: 18   FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK----------IARGAAKGL 849
               +   +++ +     L E L  R+   D      D   K          I    A G+
Sbjct: 78   TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137

Query: 850  CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
             FL  +   H++H+D+ + NVL+  ++  ++SD G+ R + A D +  +        ++ 
Sbjct: 138  EFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMS 194

Query: 910  PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
            PE     + +   D++S+GVVL E+ +         +G     G+    V     +E+I 
Sbjct: 195  PEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGLQPYCGYSNQDV-----IEMIR 240

Query: 970  PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
               +L     D+  A     M       L+C ++FPS+RP
Sbjct: 241  NRQVLPCP--DDCPAWVYTLM-------LECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 75/275 (27%), Positives = 121/275 (44%), Gaps = 40/275 (14%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDRE---FMAE---METLGKIK 788
           F   +++G G FG+V  A  K    + AIK L +       E    M E    ET    +
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 789 HRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKI-ARGAA 846
           H  LV L   C   E+ +  V E+   G L  ++H       +       R    A    
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEP------RAVFYAACVV 111

Query: 847 KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTP 905
            GL +LH N    I++RD+K  N+LLD E   +++DFG+ +  +   D     ST  GTP
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTP 165

Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP---TDKDDFGDTNLVGWVKMKVREG 962
            ++ PE       T   D +  GV++ E+L G+ P    D+++  D+     V  +VR  
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS----IVNDEVRYP 221

Query: 963 KQMEVIDPELL--LVTK------GTDESEAEEVKE 989
           + +      ++  L+ +      G+ E +AE+VK+
Sbjct: 222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 35/209 (16%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
           +G G  G V+KA       +   K+I L  + +  ++ M+E+E L K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 800 KIGEERLLVYEFMKFGSL-------EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
            +     +  EFM  GSL       E VL GR                IA    KGL +L
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVL-GR----------------IAVAVVKGLTYL 111

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR-LISALDTHLSVSTLAGTPGYVPPE 911
                  I+HRD+K SN+L++   + ++ DFG++  L++++       T  GT  Y+ PE
Sbjct: 112 WS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK-----TYVGTNAYMAPE 163

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                +     DV+S G+  +EL  G+ P
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.2 bits (156), Expect = 7e-11
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGD-------REFMAEMETLGKIKHRNLV 793
           IG G +G V+KA     G  VA+K  +R+    D       RE +A ++ L    H N+V
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKS-VRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIV 65

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            L+  C            + F  +++ L           L  +  K + R   +GL FLH
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
            NCI   +HRD+K  N+L+    + +++DFG+AR+ S     ++++ +  T  Y  PE  
Sbjct: 126 ANCI---VHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEVL 179

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGK 938
                    D++S G +  E+   K
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 65/226 (28%), Positives = 96/226 (42%), Gaps = 37/226 (16%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL--G 797
           +IG GGFGEV+     D G   A+K L +      R  M + ETL  +  R ++ L+  G
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETLA-LNERIMLSLVSTG 54

Query: 798 YC----------KIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDARKKIARGA 845
            C             ++   + + M  G L   L  HG     + R             A
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----------A 103

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP 905
           A+ +  L H     +++RD+K +N+LLD     R+SD G+A   S    H SV    GT 
Sbjct: 104 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTH 159

Query: 906 GYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           GY+ PE  Q      +  D +S G +L +LL G  P  +    D +
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 64.5 bits (157), Expect = 7e-11
 Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 47/231 (20%)

Query: 726 FSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR------LSCQGDREFM 778
           F  + E TN +     +G G FG V  A     G +VAIKK+++      L+ +  RE  
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-- 59

Query: 779 AEMETLGKIKHRNLVPLLGYCKI----GEERLLVYEFMKFGSLEEVLHGRAKARDQRILT 834
             ++ L  ++H N++ L     I     E+   V E +    L  +L  R     Q I  
Sbjct: 60  --LKLLKHLRHENIISL---SDIFISPLEDIYFVTELLG-TDLHRLLTSR-PLEKQFI-- 110

Query: 835 WDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT 894
               +       +GL ++H      ++HRD+K SN+L++   + ++ DFG+AR+    D 
Sbjct: 111 ----QYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDP 160

Query: 895 HLSVSTLAGTPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLTGK 938
            ++        GYV   YY++        +   + D++S G +  E+L GK
Sbjct: 161 QMT--------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 63.7 bits (155), Expect = 8e-11
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 23/210 (10%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +G V+K   +        K IRL        + + E++ L K     +V   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL--HHNCI 857
            I     +  E+M  GSL+++  G         +  D  ++I     KGL FL   HN  
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAG---GVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
             IIHRD+K +NVL++   + ++ DFG++  L+++L       T  G   Y+ PE  +S 
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-----AKTNIGCQSYMAPERIKSG 176

Query: 917 RCTAKG------DVYSFGVVLLELLTGKRP 940
                       DV+S G+ +LE+  G+ P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.1 bits (156), Expect = 8e-11
 Identities = 70/246 (28%), Positives = 102/246 (41%), Gaps = 34/246 (13%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIR---LSCQGDREFMAEMETLGKIKHRNLVPLL- 796
           +G G FG V  A  K  G   AIK L +   L  +  +    E   L ++ H  +V ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH-H 854
            +    E R+  + EF+  G L    H R   R       D  K     A   L F + H
Sbjct: 86  SF--QDENRVYFLLEFVVGGEL--FTHLRKAGR----FPNDVAKFYH--AELVLAFEYLH 135

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
           +    II+RD+K  N+LLD++   +V+DFG A+ +          TL GTP Y+ PE  Q
Sbjct: 136 SK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVIQ 188

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRP-TDKDDF--------GDTNLVGWVKMKVRE-GKQ 964
           S       D ++ GV+L E + G  P  D   F        G      W   + R+  K 
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248

Query: 965 MEVIDP 970
           +   D 
Sbjct: 249 LLQTDH 254

Length = 329

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 63.9 bits (155), Expect = 2e-10
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 30/197 (15%)

Query: 757 DGSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG 815
           D     + K + L+ +    +  +E+  L    H  +V      K  ++ LL+ E+   G
Sbjct: 91  DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150

Query: 816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF---------LHHNCIPHIIHRDMK 866
            L + +  R K      L +   +        GL F         +H   +   +HRD+K
Sbjct: 151 DLNKQIKQRLKEH----LPFQEYEV-------GLLFYQIVLALDEVHSRKM---MHRDLK 196

Query: 867 SSNVLLDHEMEARVSDFGMARLIS---ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGD 923
           S+N+ L      ++ DFG ++  S   +LD     S+  GTP Y+ PE ++  R + K D
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDV---ASSFCGTPYYLAPELWERKRYSKKAD 253

Query: 924 VYSFGVVLLELLTGKRP 940
           ++S GV+L ELLT  RP
Sbjct: 254 MWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 63.1 bits (153), Expect = 3e-10
 Identities = 82/342 (23%), Positives = 135/342 (39%), Gaps = 84/342 (24%)

Query: 116 VIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDS 175
           ++PSSLS    L +L+ S    + +       L  L  LDL+ N +              
Sbjct: 61  LLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLR------------- 106

Query: 176 LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI 235
                   +NI+    +T      L  LDL NNNI+   P  +     +L+ L LS+N I
Sbjct: 107 --------SNISELLELTN-----LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI 152

Query: 236 SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSEC 295
             S P  + +   L+ +D S N +S +  P +   +S+L  L L  N I+          
Sbjct: 153 E-SLPSPLRNLPNLKNLDLSFNDLSDL--PKLLSNLSNLNNLDLSGNKIS---------- 199

Query: 296 TQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNK 355
                           +P E+  L  LE+     N +  ++   L   KNL  L L+NNK
Sbjct: 200 ---------------DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243

Query: 356 LSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNC 415
           L  ++P  + + SNLE + L+ N+++  I                           LG+ 
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNNQIS-SISS-------------------------LGSL 276

Query: 416 SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFV 457
           ++L  LDL+ N+L+  +P      L  + L   L +   + +
Sbjct: 277 TNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL 318

Length = 394

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 3e-10
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 26/215 (12%)

Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLI----RLSCQGDREFMAEMETLGKIKHR 790
           +   S IG G +G V  AT K  G  VAIKK+     +  CQ     + E++ L + KH 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ---RTLREIKILRRFKHE 63

Query: 791 NLVPLLGYCKIG-----EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGA 845
           N++ +L   +        +  +V E M     E  L+   K +    L+ D  +      
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQH---LSNDHIQYFLYQI 115

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
            +GL ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 116 LRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 29/221 (13%)

Query: 741 LIGCGGFGEVF---KATLKD-GSSVAIKKLIRLSCQ-GDR-EFMAEMETLGKIKHRNLVP 794
           ++G G FG+VF   K T  D G   A+K L + + +  DR     E + L ++ H  +V 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 795 LLGYCKIGEERL-LVYEFMKFGSL-----EEVLHGRAKARDQRILTWDARKKIARGAAKG 848
           L  Y    E +L L+ +F++ G L     +EV+            T +  K      A  
Sbjct: 63  L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----------FTEEDVKFYLAELALA 110

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           L  LH      II+RD+K  N+LLD E   +++DFG+++   ++D      +  GT  Y+
Sbjct: 111 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYM 165

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
            PE       T   D +SFGV++ E+LTG  P    D  +T
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 34/227 (14%)

Query: 736 FSAESL-----IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGK-- 786
           F+AE L     IG G FG V K   K   ++   K IR +      +  + +++ + +  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 787 -----IKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKAR-DQRILTWDARKK 840
                +K    +   G C I  E L+     KF      ++   K+   + IL      K
Sbjct: 61  DCPYIVKFYGALFREGDCWICME-LMDISLDKFYKY---VYEVLKSVIPEEILG-----K 111

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHLSVS 899
           IA    K L +L       IIHRD+K SN+LLD     ++ DFG    IS  L   ++ +
Sbjct: 112 IAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFG----ISGQLVDSIAKT 165

Query: 900 TLAGTPGYVPPEYYQSFRCTA---KGDVYSFGVVLLELLTGKRPTDK 943
             AG   Y+ PE            + DV+S G+ L E+ TGK P  K
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 40/225 (17%)

Query: 742 IGCGGFGEVF------------KATLKDGSS-----VAIKKLIRLSCQGDR-EFMAEMET 783
           +G G FGEV             KA  ++ ++     VA+K L   +    R +F+ E++ 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----AKARDQRILTWDAR 838
           L ++   N+  LLG C +     ++ E+M+ G L + L          A + + L++   
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 839 KKIARGAAKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS 897
             +A   A G+ +L   N     +HRD+ + N L+      +++DFGM+R + + D    
Sbjct: 133 LYMATQIASGMRYLESLN----FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD---- 184

Query: 898 VSTLAGTPGYVPPEYYQSFRC------TAKGDVYSFGVVLLELLT 936
              + G      P  + ++        T K DV++FGV L E+LT
Sbjct: 185 YYRVQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.9 bits (153), Expect = 6e-10
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 1/93 (1%)

Query: 225 LESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLI 284
           ++ L L N  + G  P+ IS  + L+ ++ S N + G IPP +   ++SLE L L  N  
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL-GSITSLEVLDLSYNSF 478

Query: 285 TGVIPGQLSECTQLKVIDLSLNYLNGSIPQELG 317
            G IP  L + T L++++L+ N L+G +P  LG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.9 bits (153), Expect = 6e-10
 Identities = 41/118 (34%), Positives = 59/118 (50%), Gaps = 29/118 (24%)

Query: 29  LELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTG 88
           L L + GL G +P+++ SKL +L  +N S N++ G +P +L  +   LE+LDLSYN+  G
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSL-GSITSLEVLDLSYNSFNG 480

Query: 89  SISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFG 146
           S                           IP SL   T L+ILNL+ N L+G +P   G
Sbjct: 481 S---------------------------IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 16/218 (7%)

Query: 736 FSAESLIGCGGFGEVFKATLK--DGS--SVAIKKL-IRLSCQGD-REFMAEMETLGKIKH 789
           F+   ++G G FG V +A LK  DGS   VA+K L   +    D  EF+ E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 790 RNLVPLLGYC--KIGEERL----LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIAR 843
            N++ L+G       + RL    ++  FMK G L   L       +   L      +   
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 844 GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG 903
             A G+ +L      + IHRD+ + N +L+  M   V+DFG+++ I + D +        
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
              ++  E       T   DV++FGV + E++T G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.5 bits (152), Expect = 7e-10
 Identities = 33/86 (38%), Positives = 50/86 (58%), Gaps = 1/86 (1%)

Query: 179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGS 238
           L L +  + G  P  +S    LQ ++LS N+I G  P S L ++ SLE L LS N  +GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGS 481

Query: 239 FPDSISSCKTLRIVDFSSNRVSGIIP 264
            P+S+    +LRI++ + N +SG +P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 7e-10
 Identities = 65/247 (26%), Positives = 93/247 (37%), Gaps = 58/247 (23%)

Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKL----IRLSCQGDREFMAEMETLGKIK 788
           + F    +IG G FGEV+    KD   V A+K L    +    Q      AE + L    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59

Query: 789 HRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARK-----KIA 842
              +V L  Y    EE L LV E+M  G L               +    RK     + A
Sbjct: 60  SPWIVKLY-YSFQDEEHLYLVMEYMPGGDL---------------MNLLIRKDVFPEETA 103

Query: 843 RG-AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA--------------R 887
           R   A+ +  L        IHRD+K  N+L+D +   +++DFG+                
Sbjct: 104 RFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 888 LISALDT--------------HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLE 933
             + L                  + ST  GTP Y+ PE  +      + D +S GV+L E
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANST-VGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Query: 934 LLTGKRP 940
           +L G  P
Sbjct: 223 MLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.2 bits (148), Expect = 9e-10
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 15/209 (7%)

Query: 741 LIGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           L+G G FG+V     KA+ K  +   +KK + ++       + E   L   +H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
              +  +    V E++  G L    H       +R+ + D  +         L +LH   
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL--FFH----LSRERVFSEDRTRFYGAEIVSALDYLHSG- 114

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I++RD+K  N++LD +   +++DFG+ +    +    ++ T  GTP Y+ PE  +  
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDN 170

Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                 D +  GVV+ E++ G+ P    D
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 1e-09
 Identities = 41/115 (35%), Positives = 58/115 (50%), Gaps = 4/115 (3%)

Query: 300 VID-LSLNY--LNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKL 356
            ID L L+   L G IP ++ KL HL+      N + G IPP LG   +L+ L L+ N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 357 SGEIPAELFSCSNLEWISLTGNELTGQIPPEF-SRLTRLAVLQLGNNRFKGEIPG 410
           +G IP  L   ++L  ++L GN L+G++P     RL   A     +N     IPG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533

Length = 623

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.0 bits (148), Expect = 1e-09
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 13/210 (6%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNL 792
           +  + +IG G +G V  A     G  VAIKK+  +          + E++ L  ++H ++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
           V +         R     ++ F  +E  LH   KA D   LT +  +       + L ++
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYI 119

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV--STLAGTPGYVPP 910
           H     ++ HRD+K  N+L + + + ++ DFG+AR ++  DT  ++  +    T  Y  P
Sbjct: 120 HTA---NVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAP 175

Query: 911 EYYQSF--RCTAKGDVYSFGVVLLELLTGK 938
           E   SF  + T   D++S G +  E+LTGK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 40/214 (18%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLG 797
           +G G +G V  A   + G+ VAIKKL R   Q +   +    E+  L  +KH N++ LL 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLLD 81

Query: 798 YCKIGE------ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
                       +  LV  FM  G+    L    K  + RI      + +     KGL +
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRI------QFLVYQMLKGLKY 133

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           +H      IIHRD+K  N+ ++ + E ++ DFG+AR     D+ ++        GYV   
Sbjct: 134 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMT--------GYVVTR 179

Query: 912 YYQS-------FRCTAKGDVYSFGVVLLELLTGK 938
           +Y++          T   D++S G ++ E+LTGK
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 48/218 (22%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLG 797
           IG G +G V+KA     G  VA+KK IRL  + +      + E+  L ++ H N+V LL 
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 798 YCKIGEERLLVYEF--------MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
                 +  LV+EF        M    L  +     K+   ++L             +GL
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL-------------QGL 113

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTPG 906
            F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V TL     
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-EVVTL----W 165

Query: 907 YVPPE------YYQSFRCTAKGDVYSFGVVLLELLTGK 938
           Y  PE      YY     +   D++S G +  E++T +
Sbjct: 166 YRAPEILLGCKYY-----STAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 41/212 (19%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIR----LSCQGD-REFMAEMETLGKIKHRNLVPL 795
           IG G F EV KA + K G   AIK + +    L    + RE  A +  L    H N++ L
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA-LRRLSP--HPNILRL 63

Query: 796 LGYCKIGEERL-----LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
               ++  +R      LV+E M   +L E++ GR     +R L     K       K L 
Sbjct: 64  ---IEVLFDRKTGRLALVFELMD-MNLYELIKGR-----KRPLPEKRVKSYMYQLLKSLD 114

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            +H N    I HRD+K  N+L+  +   +++DFG  R I    +    +    T  Y  P
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGI---YSKPPYTEYISTRWYRAP 167

Query: 911 E------YYQSFRCTAKGDVYSFGVVLLELLT 936
           E      YY       K D+++ G V  E+L+
Sbjct: 168 ECLLTDGYY-----GPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 27/201 (13%)

Query: 749 EVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC-KIGEERLL 807
           EVF  T+KD +S      I+++       + E   L  + H+N++P+L  C + GE   +
Sbjct: 37  EVFVKTVKDHAS-----EIQVTL-----LLQESCLLYGLSHQNILPILHVCIEDGEPPFV 86

Query: 808 VYEFMKFGSLEEVLH-GR-AKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDM 865
           +Y +M +G+L+  L   R  +A + + L+      +A   A G+ +LH      +IH+D+
Sbjct: 87  LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDI 143

Query: 866 KSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----PEYYQSFRCTA 920
            + N ++D E++ +++D  ++R +  +D H       G     P      E   +   ++
Sbjct: 144 AARNCVIDEELQVKITDNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSS 198

Query: 921 KGDVYSFGVVLLELLT-GKRP 940
             DV+SFGV+L EL+T G+ P
Sbjct: 199 ASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 35/226 (15%)

Query: 742 IGCGGFGEVFKA-TLKDGSS-VAIKKLIRLSCQGDREFM--------AEMETLGKIKHRN 791
           IG G +G+VFKA  LK+G   VA+K   R+  Q   E M        A +  L   +H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 792 LVPLLGYCKIG----EERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA 846
           +V L   C +     E +L LV+E +     +++     K  +  + T +  K +     
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPT-ETIKDMMFQLL 120

Query: 847 KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
           +GL FLH +    ++HRD+K  N+L+    + +++DFG+AR+ S     ++++++  T  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLW 174

Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP-----TDKDDFG 947
           Y  PE           D++S G +  E+   ++P     +D D  G
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 16/205 (7%)

Query: 741 LIGCGGFGEVFKATLK-DGSSVAIKKLIR---LSCQGDREFMAEMETLGK-IKHRNLVPL 795
           +IG G FG+V  A  K +    A+K L +   L  + ++  M+E   L K +KH  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
               +  ++   V +++  G L   L      R++  L   AR   A   A  L +LH  
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAE-IASALGYLHS- 114

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
              +I++RD+K  N+LLD +    ++DFG+ +    ++ + + ST  GTP Y+ PE    
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHK 170

Query: 916 FRCTAKGDVYSFGVVLLELLTGKRP 940
                  D +  G VL E+L G  P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 46/231 (19%)

Query: 742 IGCGGFGEV---------------FKATLKDGSS--VAIKKLIRLSCQGDR-EFMAEMET 783
           +G G FGEV               F   ++ G    VA+K L   + +  R +F+ E++ 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-------------AKARDQ 830
           L ++K  N++ LLG C   +   ++ E+M+ G L + L                  A   
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 831 RILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
             +++ +   +A   A G+ +L      + +HRD+ + N L+   +  +++DFGM+R + 
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 891 ALDTHLSVSTLAGTPGYVPPEYYQSFRC------TAKGDVYSFGVVLLELL 935
           A D +  +   A     V P  + ++ C      T   DV++FGV L E+L
Sbjct: 190 AGD-YYRIQGRA-----VLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 47/184 (25%), Positives = 91/184 (49%), Gaps = 12/184 (6%)

Query: 761 VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEE 819
           VA+K L     +  R +F+ E++ + ++K+ N++ LLG C   +   ++ E+M+ G L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 820 VLHGR------AKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD 873
            L  R        A +   ++      +A   A G+ +L      + +HRD+ + N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVG 163

Query: 874 HEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLL 932
           +    +++DFGM+R + + D +  +   A  P  ++  E     + T   DV++FGV L 
Sbjct: 164 NHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 933 ELLT 936
           E+ T
Sbjct: 223 EMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 28/210 (13%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLG 797
           IG G +G V+K    K G  VA+KK IRL  + +      + E+  L +++H N+V L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKK-IRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 798 YCKIGEERL-LVYEFMKFGSLEEVLH--GRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
              + E RL L++EF+    L++ L    + +  D  ++     K       +G+ F H 
Sbjct: 67  VL-MQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELV-----KSYLYQILQGILFCHS 119

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTPGYVPPE 911
                ++HRD+K  N+L+D++   +++DFG+AR       + TH  V TL     Y  PE
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-EVVTL----WYRAPE 171

Query: 912 -YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
               S R +   D++S G +  E+ T K+P
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT-KKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 21/154 (13%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDRE-----FMAEMETLGKIKHRNLVPL 795
           IG G +G V+KA     G  VA+KK IRL  + + E      + E+  L ++ H N+V L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKK-IRL--ETEDEGVPSTAIREISLLKELNHPNIVRL 63

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAK-ARDQRILTWDARKKIARGAAKGLCFLH 853
           L      E +L LV+EF+    L++ +        D  ++     K       +G+ + H
Sbjct: 64  LDVV-HSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLI-----KSYLYQLLQGIAYCH 116

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
            +    ++HRD+K  N+L+D E   +++DFG+AR
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 22/223 (9%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKL-IRLSCQGD--REFMAEMETLGKIKHRNLVPLLG 797
           +G GG+G+VF A  KD G  VA+K++   L  + +  R  + E + L   K   LV LL 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWD-ARKKIARGAAKGLCFLHHNC 856
             +  E   L  E++  G        R    +  +L+ D AR  +A      +  LH   
Sbjct: 69  AFQDDEYLYLAMEYVPGGDF------RTLLNNLGVLSEDHARFYMAEMFE-AVDALHE-- 119

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
               IHRD+K  N L+D     +++DFG+++ I         +++ G+P Y+ PE  +  
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGK 173

Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT--NLVGWVKM 957
                 D +S G +L E L G  P       +T  NL  W + 
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 25/229 (10%)

Query: 734 NGFSAESLIGCGGFGEVF----KATLKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKI 787
             F  +SL+G G FGEV     KAT   G   A+K + +  L  Q    F  E   +  I
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 788 KHRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA 846
            +   +P L Y    ++ L LV E+   G L  +L+      D+ +    A+  +A    
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVL 113

Query: 847 KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
                +H       +HRD+K  NVL+D     +++DFG A  ++A +  ++     GTP 
Sbjct: 114 A----IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPD 168

Query: 907 YVPPEYYQSFRCTAKG------DVYSFGVVLLELLTGKRPTDKDDFGDT 949
           Y+ PE   +     KG      D +S GV+  E++ G+ P  +     T
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT 217

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 39/114 (34%), Positives = 52/114 (45%), Gaps = 26/114 (22%)

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           L L    L G IP    +L  LQ ++LS N I G IP  LG+              IT  
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS--------------ITS- 467

Query: 190 FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSI 243
                     L++LDLS N+ +G  P+S L  L SL  L L+ N +SG  P ++
Sbjct: 468 ----------LEVLDLSYNSFNGSIPES-LGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 25/215 (11%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGYC 799
           +G G +  V+K   +    +   K I L  +      A  E+  + ++KH N+V L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 800 KIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
               + +LV+E+M    L++ +  HG      +  L  +  K       KG+ F H N  
Sbjct: 68  HTENKLMLVFEYMD-KDLKKYMDTHG-----VRGALDPNTVKSFTYQLLKGIAFCHEN-- 119

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG---TPGYVPPEYYQ 914
             ++HRD+K  N+L++   E +++DFG+AR        + V+T +    T  Y  P+   
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFG-----IPVNTFSNEVVTLWYRAPDVLL 173

Query: 915 SFRC-TAKGDVYSFGVVLLELLTGK---RPTDKDD 945
             R  +   D++S G ++ E++TG+     T+ +D
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 50/212 (23%), Positives = 96/212 (45%), Gaps = 34/212 (16%)

Query: 742 IGCGGFGEVFKATLK-------DGSSVAIKKLIRLSCQGDREFMAEMET---LGKIKHRN 791
           +G G F  ++K  L+        G    +  ++++     R+ +A  ET   + ++ H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           LV L G C + +E ++V E++KFG L+  LH   + ++   L W  +  +A+  A  L +
Sbjct: 63  LVKLYGVC-VRDENIMVEEYVKFGPLDVFLH---REKNNVSLHW--KLDVAKQLASALHY 116

Query: 852 LHHNCIPHIIHRDMKSSNVLL-DHEME------ARVSDFGMARLISALDTHLSVSTLAGT 904
           L       ++H ++   N+L+  + +        ++SD G+        T LS       
Sbjct: 117 LEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVER 167

Query: 905 PGYVPPEYYQ--SFRCTAKGDVYSFGVVLLEL 934
             ++ PE  +      T   D +SFG  LLE+
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.0 bits (143), Expect = 5e-09
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 26/209 (12%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G FG V+  T  +DG  VA+KK+       +SC+  R F  E++ L   KH N++  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK--RVFR-ELKMLCFFKHDNVLSA 64

Query: 796 LGYCKIG-----EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           L   +       EE  +V E M+   L +++        Q  L+ D  K       +GL 
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQ-SDLHKII-----VSPQP-LSSDHVKVFLYQILRGLK 117

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           +LH      I+HRD+K  N+L++     ++ DFG+AR+    D    ++    T  Y  P
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAP 173

Query: 911 EYYQ-SFRCTAKGDVYSFGVVLLELLTGK 938
           E    S   T+  D++S G +  ELL  +
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 6e-09
 Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 31/234 (13%)

Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 2   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 57

Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 58  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 111

Query: 832 I----LTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D  + +     +GL ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 112 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 168

Query: 888 LISALDTHLSVSTLAGTPGYVPPEY---YQSFRCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE    +  +  T   D++S G ++ ELLTG+
Sbjct: 169 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 8e-09
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 38/223 (17%)

Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           +G G +G V  A   +    VA+KKL R   S    R    E+  L  +KH N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 799 CKIG------EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
                      E  LV   M    L  ++  +        L+ +  + +     +GL ++
Sbjct: 83  FTPATSIENFNEVYLVTNLMG-ADLNNIVKCQK-------LSDEHVQFLIYQLLRGLKYI 134

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE- 911
           H      IIHRD+K SNV ++ + E R+ DFG+AR          ++    T  Y  PE 
Sbjct: 135 HS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEI 186

Query: 912 ------YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
                 Y Q+       D++S G ++ ELL GK     +D+ D
Sbjct: 187 MLNWMHYNQTV------DIWSVGCIMAELLKGKALFPGNDYID 223

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 8e-09
 Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 45/232 (19%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-----EMETLGKIKH 789
           +++   +G G +G V  A   + G  VAIKKL R       E  A     E+  L  ++H
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR---PFQSEIFAKRAYRELTLLKHMQH 73

Query: 790 RNLVPLLGY---CKIGEER---LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIAR 843
            N++ LL        G+E     LV  +M    L++++           L+ D  + +  
Sbjct: 74  ENVIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHP--------LSEDKVQYLVY 124

Query: 844 GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG 903
               GL ++H      IIHRD+K  N+ ++ + E ++ DFG+AR   A  T         
Sbjct: 125 QMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT--------- 172

Query: 904 TPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
             GYV   +Y++              D++S G ++ E+LTGK      D+ D
Sbjct: 173 --GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.2 bits (139), Expect = 1e-08
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 28/147 (19%)

Query: 806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDM 865
           +L+ +++K G L ++L        +  L+    KKI R   + L  LH +   +IIH D+
Sbjct: 85  VLIMDYIKDGDLFDLLK------KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDI 135

Query: 866 KSSNVLLDHEME-ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE------YYQSFRC 918
           K  NVL D   +   + D+G+ ++I       + S   GT  Y  PE      Y  SF  
Sbjct: 136 KLENVLYDRAKDRIYLCDYGLCKIIG------TPSCYDGTLDYFSPEKIKGHNYDVSF-- 187

Query: 919 TAKGDVYSFGVVLLELLTGKRPTDKDD 945
               D ++ GV+  ELLTGK P  +D+
Sbjct: 188 ----DWWAVGVLTYELLTGKHPFKEDE 210

Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 42/226 (18%)

Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDRE----FMAEMETLGKIK 788
           N       IG G  G+V+K   K    V A+K++ R    G++E     + +++ + K  
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRR---TGNKEENKRILMDLDVVLK-S 70

Query: 789 HR--NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA 846
           H    +V   GY     +  +  E M    L+++L        + IL      K+     
Sbjct: 71  HDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDIL-----GKMTVAIV 124

Query: 847 KGLCFL--HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAG 903
           K L +L   H     +IHRD+K SN+LLD     ++ DFG++ RL+ +     + +  AG
Sbjct: 125 KALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS----KAKTRSAG 176

Query: 904 TPGYVPPEYYQSFRCTAK---------GDVYSFGVVLLELLTGKRP 940
              Y+ PE     R              DV+S G+ L+EL TG+ P
Sbjct: 177 CAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 57.2 bits (139), Expect = 1e-08
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 39/211 (18%)

Query: 745 GGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE---F----MAEMETLGKIKHRNLVPL- 795
           G +G V++A  K  G  VA+KKL       ++E   F    + E+  L K++H N+V + 
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKM-----EKEKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 796 ---LGYCKIGEERLLVYEFMK--FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
              +G     ++  +V E+++    SL E +                 K +      G+ 
Sbjct: 71  EVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQP--------FLQSEVKCLMLQLLSGVA 120

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS--VSTLAGTPGYV 908
            LH N    I+HRD+K+SN+LL++    ++ DFG+AR   +     +  V TL     Y 
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL----WYR 173

Query: 909 PPEYYQSFRC-TAKGDVYSFGVVLLELLTGK 938
            PE     +  +   D++S G +  ELLT K
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 64/285 (22%), Positives = 106/285 (37%), Gaps = 39/285 (13%)

Query: 76  LELLDLSYNNLT-GSISGFSLNENSCNSLLHLDLSQNH------IMDVIPSSLSNCTKLK 128
           L++L L  N L   +    +       SL  L LS N        +  +   L+    L+
Sbjct: 25  LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQ 84

Query: 129 ILNLSFNLLAGEIPRTFG---QLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLP--- 182
            L+LS N L  +         + SSLQ L L+NN +       L      L +L      
Sbjct: 85  ELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG---DRGLRLLAKGLKDLPPALEK 141

Query: 183 ----HNNIT--GSFPV--TLSSCSWLQLLDLSNNNISGPFPDSVLENLGS---LESLILS 231
                N +       +   L +   L+ L+L+NN I      ++ E L +   LE L L+
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201

Query: 232 NNMI----SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGV----SSLEELRLPDNL 283
           NN +    + +  ++++S K+L +++   N ++      +   +     SL  L L  N 
Sbjct: 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261

Query: 284 ITGVIPGQLSEC----TQLKVIDLSLNYLNGSIPQELGKLEHLEQ 324
           IT      L+E       L  +DL  N       Q L +      
Sbjct: 262 ITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPG 306

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 57.9 bits (140), Expect = 2e-08
 Identities = 27/58 (46%), Positives = 39/58 (67%), Gaps = 1/58 (1%)

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLG-RLRNLGVFDASHN 566
           LE LDLSYN F G IP+ +G + +L++L L  N LSG +P++LG RL +   F+ + N
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 55/194 (28%), Positives = 78/194 (40%), Gaps = 23/194 (11%)

Query: 64  FLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH-LDLSQNHIMD----VIP 118
            L + L      LE L L  N L G+           N  L  L+L+ N I D     + 
Sbjct: 127 LLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA 186

Query: 119 SSLSNCTKLKILNLSFNLL----AGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNA-- 172
             L     L++L+L+ N L    A  +  T   L SL+ L+L +N++T    + L +A  
Sbjct: 187 EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALL 246

Query: 173 --CDSLLELKLPHNNITGSFPVTLS-----SCSWLQLLDLSNNNISGPFPD----SVLEN 221
               SLL L L  N+IT      L+       S L  LDL  N            S+LE 
Sbjct: 247 SPNISLLTLSLSCNDITDDGAKDLAEVLAEKES-LLELDLRGNKFGEEGAQLLAESLLEP 305

Query: 222 LGSLESLILSNNMI 235
              LESL + ++  
Sbjct: 306 GNELESLWVKDDSF 319

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.2 bits (141), Expect = 2e-08
 Identities = 59/234 (25%), Positives = 93/234 (39%), Gaps = 34/234 (14%)

Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGD----REFMAEMETLGKIKHRNLVPL 795
           LIG GG GEV+ A        VA+KK IR     +    + F+ E +    + H  +VP+
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKK-IREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
              C  G+    VY  M +     +         +  L+ +  +K + GA   L   H  
Sbjct: 68  YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF--LSIFHKI 122

Query: 856 CIP----H---IIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHLSVST------- 900
           C      H   ++HRD+K  N+LL    E  + D+G A       +  L +         
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 901 --------LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDF 946
                   + GTP Y+ PE       +   D+Y+ GV+L ++LT   P  +   
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236

Length = 932

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)

Query: 741 LIGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           L+G G FG+V     KAT +  +   +KK + ++       + E   L   +H  L  L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
              +  +    V E+   G L    H    +R+ R+ + D  +         L +LH   
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFH---LSRE-RVFSEDRARFYGAEIVSALDYLHSE- 114

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
             ++++RD+K  N++LD +   +++DFG+ +    +    ++ T  GTP Y+ PE  +  
Sbjct: 115 -KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDN 171

Query: 917 RCTAKGDVYSFGVVLLELLTGKRP 940
                 D +  GVV+ E++ G+ P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 15/204 (7%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           L+G G FG+V     K        K++R      ++ +A   T  ++      P L   K
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 801 IG---EERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
                 +RL  V E+   G L    H       +R+ T +  +         L +LH   
Sbjct: 62  YAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAEIVSALEYLHSR- 114

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +++RD+K  N++LD +   +++DFG+ +    +    ++ T  GTP Y+ PE  +  
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 917 RCTAKGDVYSFGVVLLELLTGKRP 940
                 D +  GVV+ E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 61/219 (27%), Positives = 91/219 (41%), Gaps = 28/219 (12%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNL--- 792
           F    +IG G FGEV    +K    +   K++        E +   ET    + RN+   
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKIL-----NKWEMLKRAETACFREERNVLVN 57

Query: 793 -----VPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA 846
                +  L Y    E  L LV ++   G L  +L   +K  D+  L  D  +       
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDR--LPEDMARFYIAEMV 112

Query: 847 KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
             +  +H     H +HRD+K  NVLLD     R++DFG   L    D  +  S   GTP 
Sbjct: 113 LAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPD 168

Query: 907 YVPPEYYQSF-----RCTAKGDVYSFGVVLLELLTGKRP 940
           Y+ PE  Q+      +   + D +S GV + E+L G+ P
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 8/88 (9%)

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPEYYQSF- 916
           H +HRD+K  N+L+D     R++DFG   +L+   D  +  S   GTP Y+ PE  Q+  
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSSVAVGTPDYISPEILQAME 179

Query: 917 ----RCTAKGDVYSFGVVLLELLTGKRP 940
               +   + D +S GV + E+L G+ P
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 50.2 bits (121), Expect = 4e-08
 Identities = 23/60 (38%), Positives = 32/60 (53%)

Query: 102 SLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHI 161
           +L  LDLS N +  +   +      LK+L+LS N L    P  F  L SL+ LDLS N++
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 20/203 (9%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGY 798
           +G G +  V+K   + +G  VA+K +I +  +    F A  E   L  +KH N+V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 799 CKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
               E    V+E+M     + ++   G     + R+  +           +GL ++H   
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ--------LLRGLAYIHGQ- 122

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-S 915
             HI+HRD+K  N+L+ +  E +++DFG+AR  S      S   +  T  Y PP+    +
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGA 178

Query: 916 FRCTAKGDVYSFGVVLLELLTGK 938
              ++  D++  G + +E+L G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.1 bits (135), Expect = 5e-08
 Identities = 38/100 (38%), Positives = 56/100 (56%), Gaps = 12/100 (12%)

Query: 846 AKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
           AKG+ FL   NCI    HRD+ + N+LL H    ++ DFG+AR I   D++  V   A  
Sbjct: 224 AKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIRN-DSNYVVKGNARL 278

Query: 905 P-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT-GKRP 940
           P  ++ PE    F C  T + DV+S+G++L E+ + G  P
Sbjct: 279 PVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.6 bits (134), Expect = 6e-08
 Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 10/97 (10%)

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+K  N+LLD     +++DFG    + A +  +   T  GTP Y+ PE  +S     
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 921 ----KGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVG 953
               + D +S GV L E+L G  P     F   +LVG
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP-----FYADSLVG 254

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.3 bits (133), Expect = 6e-08
 Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 38/224 (16%)

Query: 742 IGCGGFGEV-----------------FKATLKDGSSVAIKKLIRLSCQGDR-EFMAEMET 783
           +G G FGEV                    +      VA+K L   + +  R +F+ E++ 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVL-----HGRAKARDQRILTWDAR 838
           + ++K  N++ LL  C   +   ++ E+M+ G L + L        A+  D   +++   
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 839 KKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
             +A   A G+ +L      + +HRD+ + N L+      +++DFGM+R + + D +   
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY--- 186

Query: 899 STLAGTPGYVPPEYYQSF------RCTAKGDVYSFGVVLLELLT 936
             + G    V P  + S+      + T   DV++FGV L E+LT
Sbjct: 187 -RIQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 55/230 (23%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE-----FMAEMETLGKIKHRNLVPL 795
           IG G +G VFKA  ++    VA+K   R+    D E      + E+  L ++KH+N+V L
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 796 LGYCKIGEERLLVYEF----MK--FGSLE-EVLHGRAKARDQRILTWDARKKIARGAAKG 848
                  ++  LV+E+    +K  F S   ++     K+   ++L             KG
Sbjct: 65  YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLL-------------KG 111

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL--ISALDTHLSVSTLAGTPG 906
           L F H +   +++HRD+K  N+L++   E +++DFG+AR   I        V TL     
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL----W 164

Query: 907 YVPPE-------YYQSFRCTAKGDVYSFGVVLLELLTGKRP----TDKDD 945
           Y PP+       Y  S       D++S G +  EL    RP     D DD
Sbjct: 165 YRPPDVLFGAKLYSTSI------DMWSAGCIFAELANAGRPLFPGNDVDD 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 7e-08
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 31/213 (14%)

Query: 742 IGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREFMAEMETLGKIKHRNLV------- 793
           IG G FG+V++   KD   + A+K L +      +E +A+ E    I  RN++       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 794 -PLLGYCKIG----EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
            P +   K       +  LV ++M  G L   L    +  + R     A+  IA      
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR-----AKFYIAE-LVLA 108

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           L  LH      I++RD+K  N+LLD      + DFG+++  + L  + + +T  GT  Y+
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 909 PPEYYQSFRCTAKG-DVYSFGVVLLELLTGKRP 940
            PE     +   K  D +S GV++ E+  G  P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 8e-08
 Identities = 39/100 (39%), Positives = 57/100 (57%), Gaps = 12/100 (12%)

Query: 846 AKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
           A+G+ FL   NCI    HRD+ + NVLL     A++ DFG+AR I   D++  V   A  
Sbjct: 222 AQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMN-DSNYVVKGNARL 276

Query: 905 P-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT-GKRP 940
           P  ++ PE    F C  T + DV+S+G++L E+ + GK P
Sbjct: 277 PVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 55.3 bits (133), Expect = 8e-08
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 6/95 (6%)

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
           I +   +GL +LH      IIHRD+K+ N+ ++   +  + D G A+        L    
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--- 215

Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELL 935
           LAGT     PE     +  +K D++S G+VL E+L
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 54.4 bits (131), Expect = 9e-08
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 27/218 (12%)

Query: 742 IGCGGFGEVF---KATLKD-GSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHRNLV 793
           +G G +G+VF   K    D G   A+K L + +     +       E + L  ++    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 794 PLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
             L Y    + +L L+ +++  G L   L+ R    +  +  + A   +A      L  L
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA------LDHL 121

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           H      II+RD+K  N+LLD E    ++DFG+++   A +   + S   GT  Y+ PE 
Sbjct: 122 HQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEV 177

Query: 913 YQSFRCTAKG-----DVYSFGVVLLELLTGKRPTDKDD 945
               R  + G     D +S GV+  ELLTG  P   D 
Sbjct: 178 ---IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.0 bits (132), Expect = 9e-08
 Identities = 68/283 (24%), Positives = 110/283 (38%), Gaps = 54/283 (19%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE----FMAEMETLGKIKHRN 791
           F +  +IG G FGEV     KD   +   K++R +   ++E      AE + L +     
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           +V +    +      L+ EF+  G +  +L  +    ++    + A   +A  A   L F
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD--------TH-------- 895
                    IHRD+K  N+LLD +   ++SDFG+   +            TH        
Sbjct: 123 ---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 896 ------------------LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
                             L+ ST+ GTP Y+ PE +         D +S GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Query: 938 KRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTD 980
             P   +   +T        KV   K+  V  PE+ +  K  D
Sbjct: 233 YPPFCSETPQET------YRKVMNWKETLVFPPEVPISEKAKD 269

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.0 bits (132), Expect = 1e-07
 Identities = 65/246 (26%), Positives = 98/246 (39%), Gaps = 38/246 (15%)

Query: 719 RQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDR 775
           R++RKL+          +    +IG G FGEV     K    V   KL+    +  + D 
Sbjct: 33  RKIRKLQMK-----AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87

Query: 776 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLL--VYEFMKFGSLEEVLHGRAKARDQRIL 833
            F  E   +    +   V  L +C   +++ L  V E+M  G L  ++            
Sbjct: 88  AFFWEERDIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLVNLMS----------- 135

Query: 834 TWDARKKIARGAAKGLCFLHHNCIPH--IIHRDMKSSNVLLDHEMEARVSDFGMARLISA 891
            +D  +K A+     +  L  + I    +IHRD+K  N+LLD     +++DFG    +  
Sbjct: 136 NYDVPEKWAKFYTAEVV-LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194

Query: 892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVY--------SFGVVLLELLTGKRPTDK 943
               +   T  GTP Y+ PE  +S      GD Y        S GV L E+L G  P   
Sbjct: 195 TGM-VRCDTAVGTPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249

Query: 944 DDFGDT 949
           D    T
Sbjct: 250 DSLVGT 255

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)

Query: 741 LIGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           L+G G FG+V     KAT K  +   +KK + ++       + E   L   +H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60

Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
            Y     +RL  V E+   G L    H       +R+ + D  +         L +LH  
Sbjct: 61  KYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFYGAEIVSALGYLHSC 114

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYYQ 914
               +++RD+K  N++LD +   +++DFG+ +  IS   T   + T  GTP Y+ PE  +
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLE 168

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRP 940
                   D +  GVV+ E++ G+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 14/199 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGYC 799
           +G G +  V+K   K    +   K+IRL  +    F A  E   L  +KH N+V L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
              E   LV+E++    L + +           L  +  K       +GL ++H     +
Sbjct: 73  HTKETLTLVFEYVH-TDLCQYMDKHPGG-----LHPENVKLFLFQLLRGLSYIHQR---Y 123

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE-YYQSFRC 918
           I+HRD+K  N+L+    E +++DFG+AR  S + +H + S    T  Y PP+    S   
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKS-VPSH-TYSNEVVTLWYRPPDVLLGSTEY 181

Query: 919 TAKGDVYSFGVVLLELLTG 937
           +   D++  G + +E++ G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 27/213 (12%)

Query: 740 SLIGCGGFGEVFKATLKDGSSV-------AIKKLIRLSCQGDREFM-AEMETLGKIKHRN 791
            ++G GG+G+VF+     G+          +KK   +  Q D     AE   L  +KH  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           +V L+   + G +  L+ E++  G L   L        + I   D         +  L  
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHL------EREGIFMEDTACFYLSEISLALEH 115

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR--LISALDTHLSVSTLAGTPGYVP 909
           LH      II+RD+K  N+LLD +   +++DFG+ +  +     TH    T  GT  Y+ 
Sbjct: 116 LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH----TFCGTIEYMA 168

Query: 910 PEYYQSFRCTAKGDV--YSFGVVLLELLTGKRP 940
           PE     R      V  +S G ++ ++LTG  P
Sbjct: 169 PEILM--RSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.3 bits (130), Expect = 2e-07
 Identities = 67/283 (23%), Positives = 111/283 (39%), Gaps = 54/283 (19%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE----FMAEMETLGKIKHRN 791
           F +  +IG G FGEV     KD   V   K++R +   ++E      AE + L +     
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           +V +    +      L+ EF+  G +  +L  +    ++    + A   +A  +   L F
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-------------RLISALDT---- 894
                    IHRD+K  N+LLD +   ++SDFG+               L  +L +    
Sbjct: 123 ---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173

Query: 895 -----------------HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
                             L+ ST+ GTP Y+ PE +         D +S GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Query: 938 KRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTD 980
             P   +   +T        KV   K+  +  PE+ +  K  D
Sbjct: 233 YPPFCSETPQET------YKKVMNWKETLIFPPEVPISEKAKD 269

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 69/299 (23%)

Query: 741  LIGCGGFGEVFKATLKDGSS--VAIK----------KLIRLSCQGDREFMAEMETLGK-I 787
             +G G FG V+K   K+     +A+K          K  R   +   + ++E+  + + +
Sbjct: 7    HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 788  KHRNLVPLLGYCKIGEERLLVYEFMK----------FGSLEEVLHGRAKARDQRILTWDA 837
            +H N+V    Y K   E   +Y  M           F SL+E    R    ++RI  W  
Sbjct: 67   RHPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFT--EERI--W-- 116

Query: 838  RKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS 897
               I       L +LH      I+HRD+  +N++L  + +  ++DFG+A+         S
Sbjct: 117  --NIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172

Query: 898  VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
            V    GT  Y  PE  ++     K DV++FG +L ++ T + P     F  TN+      
Sbjct: 173  V---VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP-----FYSTNM------ 218

Query: 958  KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITL---QCVDDFPSKRPNMLQ 1013
                          L L TK   E+  E + E +   ++T     C+      RP+++Q
Sbjct: 219  --------------LSLATKIV-EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQ 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 6/87 (6%)

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-- 916
             +HRD+K  NVLLD     R++DFG    + A D  +  +   GTP Y+ PE  Q+   
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-DGTVQSNVAVGTPDYISPEILQAMED 180

Query: 917 ---RCTAKGDVYSFGVVLLELLTGKRP 940
              R   + D +S GV + E+L G+ P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 28/214 (13%)

Query: 739 ESLIGCGGFGEVFKAT---LKDG-----SSVAIKKLIRLSCQGDREFMAEMETLGKIKHR 790
           ESL G G F ++FK     + D      + V +K L +        F      + ++ H+
Sbjct: 1   ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59

Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           +LV   G C  G+E ++V E++KFGSL+  L    K ++   ++W  + ++A+  A  L 
Sbjct: 60  HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK---KNKNLINISW--KLEVAKQLAWALH 114

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG------T 904
           FL    +    H ++ + NVLL  E E R +  G    I   D  +S++ L         
Sbjct: 115 FLEDKGLT---HGNVCAKNVLLIRE-EDRKT--GNPPFIKLSDPGISITVLPKEILLERI 168

Query: 905 PGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTG 937
           P +VPPE  ++ +  +   D +SFG  L E+ +G
Sbjct: 169 P-WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 67/261 (25%), Positives = 107/261 (40%), Gaps = 71/261 (27%)

Query: 742 IGCGGFGEVFKAT---LKDGSS---VAIKKLIRLSCQGD-REFMAEMETLGKI-KHRNLV 793
           +G G FG+V +A+   ++  +S   VA+K L   +   + +  M E++ L  I  H N+V
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 794 PLLGYC-KIGEERLLVYEFMKFGSL--------EEVLHGRAKA-----------RDQRIL 833
            LLG C K G   +++ E+ KFG+L        E     R K+           + QR+ 
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 834 TWDARKKIARGA------------------------------------AKGLCFL-HHNC 856
           +  + +  A                                       A+G+ FL    C
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC 194

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQS 915
           I    HRD+ + N+LL      ++ DFG+AR I   D        A  P  ++ PE    
Sbjct: 195 I----HRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARLPLKWMAPESIFD 249

Query: 916 FRCTAKGDVYSFGVVLLELLT 936
              T + DV+SFGV+L E+ +
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 72/300 (24%), Positives = 129/300 (43%), Gaps = 45/300 (15%)

Query: 736  FSAESLIGCGGFGEVF---KATLKD-GSSVAIKKL----IRLSCQGDREFMAEMETLGKI 787
            F    ++G G +G+VF   K +  D G   A+K L    I    +       E + L  I
Sbjct: 2    FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 788  KHRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA 846
            +    +  L Y    + +L L+ +++  G L   L  R + ++Q +  +     +A    
Sbjct: 62   RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA---- 117

Query: 847  KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
                 L H     II+RD+K  N+LLD      ++DFG+++     +   + S   GT  
Sbjct: 118  -----LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIE 171

Query: 907  YVPPEYYQSFRCTAKG-----DVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE 961
            Y+ P+     R    G     D +S GV++ ELLTG  P   D  G+ N    +  ++ +
Sbjct: 172  YMAPDI---VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD--GEKNSQAEISRRILK 226

Query: 962  G-----KQMEVIDPELL--LVTK------GTDESEAEEVKEMVRYLEITLQCVDDFPSKR 1008
                  ++M  +  +++  L+ K      G   S+A+E+K+   + +I     DD  +K+
Sbjct: 227  SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW---DDLAAKK 283

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 60/213 (28%), Positives = 87/213 (40%), Gaps = 29/213 (13%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
           +IG G FGEV     K    V   KL+    +  + D  F  E   +    +   V  L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 798 YCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIAR-GAAKGLCFLHHN 855
           Y    +  L +V E+M  G L  ++             +D  +K AR   A+ +  L   
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAEVVLALDAI 158

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                IHRD+K  N+LLD     +++DFG    ++  +  +   T  GTP Y+ PE  +S
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKS 217

Query: 916 FRCTAKGDVY--------SFGVVLLELLTGKRP 940
                 GD Y        S GV L E+L G  P
Sbjct: 218 ----QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.4 bits (125), Expect = 5e-07
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG-DREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +G V+KA  KDG       L ++   G       E+  L ++KH N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 801 IGEER--LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK--------GLC 850
              +R   L++++ +      +   RA   +++ +      ++ RG  K        G+ 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPV------QLPRGMVKSLLYQILDGIH 122

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEAR----VSDFGMARLI-SALDTHLSVSTLAGTP 905
           +LH N    ++HRD+K +N+L+  E   R    ++D G ARL  S L     +  +  T 
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 906 GYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
            Y  PE     R   K  D+++ G +  ELLT +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 27/209 (12%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGY 798
           +G G +  V+K   K  G  VA+K+ IRL  +    F A  E   L  +KH N+V L   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKE-IRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRA-KARDQRILTWDARKKIARGAAKGLCFLHHN 855
               +   LV+E++    L++ +   G      + R+  +    ++ RG    L + H  
Sbjct: 72  IHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLF----QLLRG----LAYCHQR 122

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS--VSTLAGTPGYVPPEYY 913
               ++HRD+K  N+L+    E +++DFG+AR  S      S  V TL     Y PP+  
Sbjct: 123 ---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL----WYRPPDVL 175

Query: 914 QSFRC-TAKGDVYSFGVVLLELLTGKRPT 941
                 +   D++  G +  E+ TG RP 
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATG-RPL 203

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 23/206 (11%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLS------CQGDREFMAEMETLGKIKHRNLVPL 795
           +G G +  VFK   K   ++   K IRL       C   RE    +  L  +KH N+V L
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE----VSLLKNLKHANIVTL 68

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
                      LV+E++    L++ L          +++    K       +GL + H  
Sbjct: 69  HDIIHTERCLTLVFEYLD-SDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE-YYQ 914
               I+HRD+K  N+L++ + E +++DFG+AR  S      S   +  T  Y PP+    
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRP 940
           S   +   D++  G +L E+ TG RP
Sbjct: 178 STEYSTPIDMWGVGCILYEMATG-RP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.1 bits (125), Expect = 6e-07
 Identities = 45/155 (29%), Positives = 82/155 (52%), Gaps = 22/155 (14%)

Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHRNLVPL- 795
           IG G +G V+KA  +    ++A+KK IRL  Q D       + E+  L +++H N+V L 
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKK-IRLE-QEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 796 -LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            + +    E+RL LV+E++     + +      A++ R++     K       +G+ + H
Sbjct: 68  DVVHS---EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI-----KTYLYQILRGIAYCH 119

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMAR 887
            +    ++HRD+K  N+L+D    A +++DFG+AR
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.4 bits (126), Expect = 6e-07
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIR-LSCQGD-REFMAEMETLGKIKHRNLVPLLGY 798
           IG G +G V  A   +    VAIKK+      + D +  + E++ L  + H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 799 CKIGEER-----LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
                        +VYE M    L +++      R  + L+ D  +       +GL ++H
Sbjct: 73  MPPPHREAFNDVYIVYELMD-TDLHQII------RSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                +++HRD+K SN+LL+   + ++ DFG+AR  +  +    ++    T  Y  PE  
Sbjct: 126 S---ANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELL 180

Query: 914 QSFRC---TAKGDVYSFGVVLLELLTGK 938
            +  C   T   DV+S G +  ELL  K
Sbjct: 181 LN--CSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.3 bits (125), Expect = 6e-07
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 30/211 (14%)

Query: 735 GFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRN 791
           G  A+ ++ C  F  V       G +VA+KKL R         R +  E+  L  + H+N
Sbjct: 30  GSGAQGIV-CAAFDTVL------GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKN 81

Query: 792 LVPLLGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDARKKIARGAA 846
           ++ LL      K  EE   VY  M+    +L +V+H          L +           
Sbjct: 82  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM--------- 132

Query: 847 KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
             LC + H     IIHRD+K SN+++  +   ++ DFG+AR      T+  ++    T  
Sbjct: 133 --LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRY 187

Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
           Y  PE           D++S G ++ EL+ G
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG-DREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +G V+KA  KDG       L ++   G       E+  L ++KH N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 801 IGEER--LLVYEFMKFGSLEEVLHGRAKARDQRI--LTWDARKKIARGAAKGLCFLHHNC 856
              +R   L++++ +      +   RA   +++   L     K +      G+ +LH N 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 857 IPHIIHRDMKSSNVLLDHEMEAR----VSDFGMARLI-SALDTHLSVSTLAGTPGYVPPE 911
              ++HRD+K +N+L+  E   R    ++D G ARL  S L     +  +  T  Y  PE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 912 YYQSFRCTAKG-DVYSFGVVLLELLTGK 938
                R   K  D+++ G +  ELLT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 20/215 (9%)

Query: 736 FSAESLIGCGGFGEVF---KATLKDGSSVAIKKLIRLSCQGDREFMAE-----METLGKI 787
           F    ++G G +G+VF   K T  D   +   K+++ +    +    E        L  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 788 KHRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA 846
           +    +  L Y    E +L L+ +++  G +   L+ R    +  +  +     +A    
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA---- 117

Query: 847 KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
                L H     I++RD+K  N+LLD E    ++DFG+++   + +   + S   GT  
Sbjct: 118 -----LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIE 171

Query: 907 YVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGKRP 940
           Y+ PE  +      K  D +S G+++ ELLTG  P
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 55/244 (22%), Positives = 107/244 (43%), Gaps = 25/244 (10%)

Query: 742 IGCGGFGEVFKATLKDGSSVA---IKKL-IRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
           IG G FG+V  + +   + VA   +K+L    S +   EF+ + +    ++H N++  LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRA-KARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            C      LLV+E+ + G L+  L       R+ ++L     +++A   A G+  +H + 
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMACEIAAGVTHMHKH- 118

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
             + +H D+   N  L  ++  +V D+G+       D   +         ++ PE    F
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 917 R-------CTAKGDVYSFGVVLLELL-TGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI 968
                    T   +V++ GV L EL     +P       D  ++  V   +++ +Q+++ 
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPY--SHLSDREVLNHV---IKD-QQVKLF 230

Query: 969 DPEL 972
            P+L
Sbjct: 231 KPQL 234

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 51.1 bits (122), Expect = 2e-06
 Identities = 52/199 (26%), Positives = 77/199 (38%), Gaps = 25/199 (12%)

Query: 407 EIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKG 466
           +    L N   L  LDLN N L  +I   L                +L    N       
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRSNISELLELTN----------LTSLDLDNNNITD--- 130

Query: 467 VGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPD 526
                    I P   L    LK  D +      + S       L+ LDLS+N     +P 
Sbjct: 131 ---------IPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPK 180

Query: 527 EIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQID 586
            + ++  L  L+L+ N++S ++P  +  L  L   D S+N +  ++  S SNL  L  ++
Sbjct: 181 LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE 238

Query: 587 LSNNELTGPIPQRGQLSTL 605
           LSNN+L       G LS L
Sbjct: 239 LSNNKLEDLPESIGNLSNL 257

Length = 394

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 28/88 (31%), Positives = 51/88 (57%), Gaps = 8/88 (9%)

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR-LISALDTHLSVSTLAGTPG 906
           G+ ++H      I+HRD+K+ N+ L + +  ++ DFG++R L+ + D     +T  GTP 
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATTFTGTPY 170

Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLEL 934
           Y+ PE  +     +K D++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)

Query: 740 SLIGCGGFGEVFKATLKDGSS-VAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           ++IG G FG V++A   D S  VAIKK+++     +RE +     +  + H N++ L  Y
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127

Query: 799 -----CKIGEERLLVYEFMKFGSLEEVLHGRAK--ARDQRILTWDARKKIARGAAKGLCF 851
                 K  E+ + +   M+F  + + +H   K  AR+   L     K  +    + L +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEF--IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           +H      I HRD+K  N+L+D      ++ DFG A+  + L    SVS +       P 
Sbjct: 186 IHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRFYRAPE 240

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
               +   T   D++S G ++ E++ G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 17/210 (8%)

Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSS-VAIKKLIRLSCQGDREF----MAEMETLGKIK 788
           N F    ++G G +G V K   K+    VAIKK      + + E     + E++ L  +K
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58

Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
             N+V L    +   +  LV+E+++   LE +         +++ ++  +        K 
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQ------LIKA 112

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + + H N    I+HRD+K  N+L+ H    ++ DFG AR +S   ++ + +    T  Y 
Sbjct: 113 IHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYR 168

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            PE           D++S G +L EL  G+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 52/196 (26%), Positives = 78/196 (39%), Gaps = 12/196 (6%)

Query: 745 GGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE 804
           G  GEVF  T         KK+I  +  G +    E++ L  I HR ++ L+   +    
Sbjct: 103 GSEGEVFVCTKHGDEQR--KKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKST 160

Query: 805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRD 864
             +V    K   L   +        ++ +T      I R   + L +LH      IIHRD
Sbjct: 161 VCMVMPKYKC-DLFTYVDRSGPLPLEQAIT------IQRRLLEALAYLHGR---GIIHRD 210

Query: 865 MKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDV 924
           +K+ N+ LD    A + DFG A  + A          +GT     PE        AK D+
Sbjct: 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDI 270

Query: 925 YSFGVVLLELLTGKRP 940
           +S G+VL E+      
Sbjct: 271 WSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 14/200 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGYC 799
           +G G +  VFK   K   ++   K IRL  +      A  E+  L  +KH N+V L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
              +   LV+E++    L++ +          I++    K       +GL + H      
Sbjct: 74  HTDKSLTLVFEYLD-KDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE-YYQSFRC 918
           ++HRD+K  N+L++   E +++DFG+AR  S      S   +  T  Y PP+    S   
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEY 182

Query: 919 TAKGDVYSFGVVLLELLTGK 938
           + + D++  G +  E+ +G+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.1 bits (120), Expect = 3e-06
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 10/96 (10%)

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA----LDTHLSVSTLAG 903
           GL ++H     +++HRD+K  N+L++ + E ++ DFG+AR  S         +  +    
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM--TEYVA 171

Query: 904 TPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGK 938
           T  Y  PE   SF+  T   DV+S G +L ELL  K
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.0 bits (119), Expect = 4e-06
 Identities = 69/266 (25%), Positives = 108/266 (40%), Gaps = 53/266 (19%)

Query: 329 FNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEF 388
            +     +P  L +  +L DL+  +   S +    L +   L  + L  N L   I    
Sbjct: 55  SSNTLLLLPSSLSRLLSL-DLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL 113

Query: 389 SRLTRLAVLQLGNNRFKGEIPGELGN-CSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGG 447
             LT L  L L NN    +IP  +G   S+L  LDL+ N +                   
Sbjct: 114 -ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE------------------ 153

Query: 448 FLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQY 507
                                     + +R    L+   L   D +      +  L +  
Sbjct: 154 -----------------------SLPSPLRNLPNLKNLDLSFNDLSD-----LPKLLSNL 185

Query: 508 QTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNR 567
             L  LDLS N+    +P EI  + AL+ L+L++N +  E+ SSL  L+NL   + S+N+
Sbjct: 186 SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243

Query: 568 LQGQIPESFSNLSFLVQIDLSNNELT 593
           L+  +PES  NLS L  +DLSNN+++
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNNQIS 268

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.5 bits (106), Expect = 4e-06
 Identities = 25/61 (40%), Positives = 32/61 (52%), Gaps = 1/61 (1%)

Query: 150 SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNN 209
           +L+ LDLSNN +T  IP        +L  L L  NN+T   P   S    L+ LDLS NN
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 210 I 210
           +
Sbjct: 60  L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 6e-06
 Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 1/61 (1%)

Query: 126 KLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNN 185
            LK L+LS N L       F  L +L+ LDLS N++T  I  E  +   SL  L L  NN
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNN 59

Query: 186 I 186
           +
Sbjct: 60  L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 7e-06
 Identities = 23/63 (36%), Positives = 32/63 (50%), Gaps = 3/63 (4%)

Query: 75  KLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSF 134
            L+ LDLS N LT  I   +       +L  LDLS N++  + P + S    L+ L+LS 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFK--GLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 135 NLL 137
           N L
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 8e-06
 Identities = 72/298 (24%), Positives = 113/298 (37%), Gaps = 77/298 (25%)

Query: 734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRN 791
           + F +  +IG G FGEV     KD G   A+KKL        +  M E E +  ++  R+
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERD 53

Query: 792 L---------VPLLGYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQRILTWD-ARK 839
           +         V L  Y    +E    L+ E++  G +  +L      +D    T +  R 
Sbjct: 54  ILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL----MKKD--TFTEEETRF 105

Query: 840 KIARGAAKGLCFLH-HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA------------ 886
            IA      +  +H        IHRD+K  N+LLD +   ++SDFG+             
Sbjct: 106 YIAE-TILAIDSIHKLG----YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160

Query: 887 -RLISALDTHLSVST-------------------LA----GTPGYVPPEYYQSFRCTAKG 922
             L  AL ++                        LA    GTP Y+ PE +       + 
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220

Query: 923 DVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTD 980
           D +S GV++ E+L G  P   D+  +T        K+   K+      E+ L  +  D
Sbjct: 221 DWWSLGVIMYEMLVGYPPFCSDNPQETYR------KIINWKETLQFPDEVPLSPEAKD 272

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.7 bits (104), Expect = 1e-05
 Identities = 24/59 (40%), Positives = 33/59 (55%)

Query: 534 LQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
           L+ L+L++N+L+     +   L NL V D S N L    PE+FS L  L  +DLS N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.7 bits (104), Expect = 1e-05
 Identities = 20/61 (32%), Positives = 28/61 (45%), Gaps = 1/61 (1%)

Query: 175 SLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNM 234
           +L  L L +N +T            L++LDLS NN++          L SL SL LS N 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNN 59

Query: 235 I 235
           +
Sbjct: 60  L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 1e-05
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 1/59 (1%)

Query: 200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNR 258
           L+ LDLSNN ++   PD   + L +L+ L LS N ++   P++ S   +LR +D S N 
Sbjct: 2   LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Length = 60

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)

Query: 846 AKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
           A+G+ FL   NC+    HRD+ + NVLL      ++ DFG+AR I     ++S  +    
Sbjct: 247 ARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
             ++ PE       T   DV+S+G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.5 bits (101), Expect = 2e-05
 Identities = 27/64 (42%), Positives = 36/64 (56%), Gaps = 4/64 (6%)

Query: 50  NLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLS 109
           NL  L+ S N LT  +P+        L++LDLS NNLT SIS  +   +   SL  LDLS
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAF--SGLPSLRSLDLS 56

Query: 110 QNHI 113
            N++
Sbjct: 57  GNNL 60

Length = 60

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 2e-05
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 4/98 (4%)

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
           I R   + + +LH N    IIHRD+K+ N+ ++H  +  + DFG A     ++ +     
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYG 242

Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            AGT     PE           D++S G+VL E+ T  
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 14/200 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGYC 799
           +G G +  V+K   K   ++   K IRL  +      A  E+  L  +KH N+V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
              +   LV+E++    L++ L           +     K       +GL + H      
Sbjct: 74  HTEKSLTLVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---K 124

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE-YYQSFRC 918
           ++HRD+K  N+L++   E +++DFG+AR  S      S   +  T  Y PP+    S   
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDY 182

Query: 919 TAKGDVYSFGVVLLELLTGK 938
           + + D++  G +  E+ TG+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 48.6 bits (115), Expect = 2e-05
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 33/230 (14%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLG- 797
           IG G FGEVF    K        K I      +RE    + E+  + ++KH+N+V  +  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 798 -YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-N 855
              K  ++  ++ EF   G L   +    K   +  +   A   I R     L + H+  
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK--IEEHAIVDITRQLLHALAYCHNLK 138

Query: 856 CIPH---IIHRDMKSSNVLLDHEME-----------------ARVSDFGMARLISALDTH 895
             P+   ++HRD+K  N+ L   +                  A++ DFG+++ I      
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IE 195

Query: 896 LSVSTLAGTPGYVPPEY--YQSFRCTAKGDVYSFGVVLLELLTGKRPTDK 943
               +  GTP Y  PE   +++     K D+++ G ++ EL +GK P  K
Sbjct: 196 SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Length = 1021

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.5 bits (101), Expect = 3e-05
 Identities = 26/61 (42%), Positives = 32/61 (52%), Gaps = 2/61 (3%)

Query: 345 NLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNR 403
           NLK L L+NN+L+  IP   F    NL+ + L+GN LT   P  FS L  L  L L  N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 404 F 404
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.3 bits (112), Expect = 3e-05
 Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 5/109 (4%)

Query: 829 DQRILTWDARKKIARGAAKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +   L++      +   A G+ FL   NC+    HRD+ + NVL+      ++ DFG+AR
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLAR 287

Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
            I     ++S  +      ++ PE   +   T   DV+SFG++L E+ T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 24/208 (11%)

Query: 740 SLIGCGGFGEVFKA-TLKDGSSVAIKKLIR---LSCQGDREFMAEMETLGKIKHRNLVPL 795
             IG G  G V  A     G +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGL 80

Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           L      K  EE   VY  M+    +L +V+           +  D  ++++    + LC
Sbjct: 81  LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ----------MDLD-HERMSYLLYQMLC 129

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 186

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++ G 
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.9 bits (111), Expect = 4e-05
 Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 3/109 (2%)

Query: 509 TLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRL 568
            L+ LDLS N+    +P  + ++  L+ L+L+ N LS ++P  L  L NL   D S N++
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198

Query: 569 QGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLC 617
              +P     LS L ++DLSNN +   +     L  L   + +NN    
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 4e-05
 Identities = 24/61 (39%), Positives = 28/61 (45%), Gaps = 2/61 (3%)

Query: 369 NLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNN 427
           NL+ + L+ N LT  IP   F  L  L VL L  N      P       SL  LDL+ NN
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 428 L 428
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 7e-05
 Identities = 28/62 (45%), Positives = 33/62 (53%), Gaps = 2/62 (3%)

Query: 25 GLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYN 84
           LK L+LS+  L  + PD  F  LPNL  L+ S NNLT  +     S    L  LDLS N
Sbjct: 1  NLKSLDLSNNRLTVI-PDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGN 58

Query: 85 NL 86
          NL
Sbjct: 59 NL 60

Length = 60

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 37/148 (25%), Positives = 58/148 (39%), Gaps = 14/148 (9%)

Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           N+V L  Y    +   LV +  + G L   +       ++ +  W A   +A  A     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            LH      I+ RD+  +N+LLD     +++ F     +       +V  +     Y  P
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E       T   D +S G +L ELLTGK
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 28/208 (13%)

Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88

Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 137

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++ G 
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 42/189 (22%), Positives = 82/189 (43%), Gaps = 36/189 (19%)

Query: 763 IKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY--------CKIGEERLLVYEFMKF 814
            K LI +          E++ L +I   N++ + G+         ++     L+ E+   
Sbjct: 58  HKVLIDI-------TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL----SLILEYCTR 106

Query: 815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH-HNCIPHIIHRDMKSSNVLLD 873
           G L EVL        ++ L++  +  +A    KGL  L+ +   P+   +++ S + L+ 
Sbjct: 107 GYLREVL------DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KNLTSVSFLVT 157

Query: 874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF--RCTAKGDVYSFGVVL 931
              + ++   G+ +++S+     +V+ +     Y   +         T K D+YS GVVL
Sbjct: 158 ENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 932 LELLTGKRP 940
            E+ TGK P
Sbjct: 213 WEIFTGKIP 221

Length = 283

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 45.1 bits (106), Expect = 2e-04
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 32/211 (15%)

Query: 8   SSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPE 67
           S+ L ++ +T    LP  ++++ELS   +  L P+ L S L +L      +N ++  LPE
Sbjct: 229 SNQLTSIPAT----LPDTIQEMELSINRITEL-PERLPSALQSLD---LFHNKISC-LPE 279

Query: 68  TLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKL 127
            L    ++L  L +  N++       +L  +  + + HL++ Q++ +  +P +L     L
Sbjct: 280 NL---PEELRYLSVYDNSIR------TLPAHLPSGITHLNV-QSNSLTALPETLP--PGL 327

Query: 128 KILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNIT 187
           K L    N L   +P +      LQ LD+S N IT  +P  L     ++  L +  N +T
Sbjct: 328 KTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP---PTITTLDVSRNALT 380

Query: 188 GSFPVTLSSCSWLQLLDLSNNNISGPFPDSV 218
            + P  L +   LQ++  S NN+    P+S+
Sbjct: 381 -NLPENLPAA--LQIMQASRNNLV-RLPESL 407

Length = 754

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 2e-04
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)

Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 130

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 187

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 17/103 (16%)

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDT-----HLSVST-------LAGTPG 906
           I+HRD+K  N+L+      +++DFG++++ + +L T     H+   T       + GTP 
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           Y+ PE           D ++ G++L E L G  P     FGDT
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF----FGDT 220

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 6/97 (6%)

Query: 846 AKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
           AKG+ FL    CI    HRD+ + N+LL      ++ DFG+AR I     ++        
Sbjct: 189 AKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             ++ PE       T + DV+SFGV+L E+ + G  P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 6/97 (6%)

Query: 846 AKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
           A+G+ FL    CI    HRD+ + N+LL      ++ DFG+AR I     ++   +    
Sbjct: 184 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             ++ PE       T + DV+SFGV+L E+ + G  P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 8/84 (9%)

Query: 742 IGCGGFGEVFKAT----LKDGS--SVAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT     K  +  +VA+K L   +   +RE  M+E++ L  +  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102

Query: 794 PLLGYCKIGEERLLVYEFMKFGSL 817
            LLG C +G   L++ E+  +G L
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDL 126

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 23/208 (11%)

Query: 745 GGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFM---AEMETLGKIKHRNLVPLLGYCKI 801
                + K      + VA+KK I L      +      E+ T  +++H N++P +    +
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70

Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
             E  +V   M +GS E++L    K      L   A   I +     L ++H       I
Sbjct: 71  DSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALDYIHSK---GFI 123

Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-------VPPE-YY 913
           HR +K+S++LL  + +  +S  G+   +S +        +   P         + PE   
Sbjct: 124 HRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181

Query: 914 QSFR-CTAKGDVYSFGVVLLELLTGKRP 940
           Q+ +    K D+YS G+   EL  G  P
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.1 bits (104), Expect = 4e-04
 Identities = 44/173 (25%), Positives = 83/173 (47%), Gaps = 15/173 (8%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR----EFMAEMETLGKIKHRNLVPLLG 797
           I  G FG+V+    K+ S +   K+++ +   ++    +  AE + L   K   +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             +      LV E++  G ++ +LH      ++      A K I+   A  L +LH +  
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM-----AVKYISE-VALALDYLHRH-- 123

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             IIHRD+K  N+L+ +E   +++DFG++++   L+  L++  +  TP    P
Sbjct: 124 -GIIHRDLKPDNMLISNEGHIKLTDFGLSKV--TLNRELNMMDILTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 24/188 (12%)

Query: 758 GSSVAIKKLIRLSCQGDRE----FMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK 813
                IK ++++     R+    F      + ++ H+++V L G C    E ++V EF++
Sbjct: 28  SYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVE 87

Query: 814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL- 872
           FG L+  +H     R   +LT   + K+A+  A  L +L       ++H ++ + N+LL 
Sbjct: 88  FGPLDLFMH-----RKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLA 139

Query: 873 ----DHEMEA--RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYS 926
               D E     ++SD G+   I+ L     V  +   P   P     S   +   D +S
Sbjct: 140 REGIDGECGPFIKLSDPGIP--ITVLSRQECVERI---PWIAPECVEDSKNLSIAADKWS 194

Query: 927 FGVVLLEL 934
           FG  L E+
Sbjct: 195 FGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 7e-04
 Identities = 19/60 (31%), Positives = 26/60 (43%)

Query: 273 SLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGL 332
           +L+ L L +N +T +  G       LKV+DLS N L    P+    L  L       N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 8e-04
 Identities = 34/132 (25%), Positives = 50/132 (37%), Gaps = 41/132 (31%)

Query: 861 IHRDMKSSNVLLDHEMEARVSDFGM------------------AR--------LISALD- 893
           IHRD+K  N+L+D +   +++DFG+                   R          S +D 
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 894 --------------THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKR 939
                               +L GTP Y+ PE       T   D +S GV+L E+L G+ 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 940 PTDKDDFGDTNL 951
           P   D   +T L
Sbjct: 243 PFLADTPAETQL 254

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 0.001
 Identities = 19/59 (32%), Positives = 28/59 (47%)

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRL 568
           L+ LDLS N+           +  L+VL+L+ N L+   P +   L +L   D S N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)

Query: 742 IGCGGFGEVFKATL----KDGSS--VAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT     K+ +   VA+K L   +   +RE  M+E++ L  + +H+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA 827
            LLG C  G   L++ E+  +G L   L  +A+ 
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 21/60 (35%), Positives = 33/60 (55%), Gaps = 1/60 (1%)

Query: 249 LRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL 308
           L+ +D S+NR++ I P     G+ +L+ L L  N +T + P   S    L+ +DLS N L
Sbjct: 2   LKSLDLSNNRLTVI-PDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 9/92 (9%)

Query: 742 IGCGGFGEVFKAT------LKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGR 824
            LLG C K G   +++ EF KFG+L   L  +
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSK 106

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.3 bits (92), Expect = 0.003
 Identities = 34/152 (22%), Positives = 60/152 (39%), Gaps = 20/152 (13%)

Query: 740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG-DREFMAEMETLGKI-KHRNLVP-LL 796
            L+  G    V+    KD   V   K+     +G DRE   E+  L  + +    VP +L
Sbjct: 4   KLLKGGLTNRVYLLGTKDEDYVL--KINPSREKGADRE--REVAILQLLARKGLPVPKVL 59

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
              +      L+ E+++  +L+EV               + ++ IA   A+ L  LH   
Sbjct: 60  ASGESDGWSYLLMEWIEGETLDEVSE-------------EEKEDIAEQLAELLAKLHQLP 106

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARL 888
           +  + H D+   N+L+D      + D+  A  
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.4 bits (94), Expect = 0.004
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 8/89 (8%)

Query: 742 IGCGGFGEVFKATLKDGS------SVAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG V +AT    S       VA+K L   +   +++  M+E++ +  +  H N+V
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLH 822
            LLG C  G    ++ E+ ++G L + LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1013
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
PLN00181	793	protein SPA1-RELATED; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
PRK10345	210	hypothetical protein; Provisional	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.71
smart00090	237	RIO RIO-like kinase.	99.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PLN03150	623	hypothetical protein; Provisional	99.64
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.55
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.54
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.53
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.51
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.37
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.36
PLN03150	623	hypothetical protein; Provisional	99.34
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.33
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
KOG1243	690	consensus Protein kinase [General function predict	99.28
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.27
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.25
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.21
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.21
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.16
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.15
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.12
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.04
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.02
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.0
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.0
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.91
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.9
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.88
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.79
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.78
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.78
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.77
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.76
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.73
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.72
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.68
COG4248	637	Uncharacterized protein with protein kinase and he	98.63
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.58
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.54
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.51
KOG4341	483	consensus F-box protein containing LRR [General fu	98.51
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.51
PRK09902	216	hypothetical protein; Provisional	98.49
KOG4341	483	consensus F-box protein containing LRR [General fu	98.48

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-103  Score=1003.24  Aligned_cols=868  Identities=33%  Similarity=0.547  Sum_probs=711.4

Q ss_pred             CCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcc
Q 036815           24 FGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSL  103 (1013)
Q Consensus        24 ~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L  103 (1013)
                      ..++.|+|++|++.+.++ ..|..+++|+.|+|++|.+++.+|..++..+++|++|+|++|++++..+.     ..+++|
T Consensus        69 ~~v~~L~L~~~~i~~~~~-~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~-----~~l~~L  142 (968)
T PLN00113         69 SRVVSIDLSGKNISGKIS-SAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR-----GSIPNL  142 (968)
T ss_pred             CcEEEEEecCCCccccCC-hHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc-----cccCCC
Confidence            469999999999988665 46899999999999999999889998888999999999999999854332     357899


Q ss_pred             cEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCC
Q 036815          104 LHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPH  183 (1013)
Q Consensus       104 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~  183 (1013)
                      ++|+|++|.+++..|..+.++++|++|+|++|.+.+..|..|+++++|++|++++|.+++.+|..+.. +++|++|+|++
T Consensus       143 ~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~~  221 (968)
T PLN00113        143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ-MKSLKWIYLGY  221 (968)
T ss_pred             CEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcC-cCCccEEECcC
Confidence            99999999999889999999999999999999999899999999999999999999999888877655 68999999999


Q ss_pred             CCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccC
Q 036815          184 NNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGII  263 (1013)
Q Consensus       184 n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  263 (1013)
                      |++++..|..+.++++|++|++++|.+++.+|.. +.++++|++|++++|++++..|..+.++++|+.|++++|.+.+.+
T Consensus       222 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  300 (968)
T PLN00113        222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS-LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI  300 (968)
T ss_pred             CccCCcCChhHhcCCCCCEEECcCceeccccChh-HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC
Confidence            9999999999999999999999999998878765 688999999999999999889999999999999999999998776


Q ss_pred             CCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCC
Q 036815          264 PPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKC  343 (1013)
Q Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l  343 (1013)
                      |.. +..+++|+.|++++|.+++..|..++.+++|+.|++++|.+++.+|..++.+++|+.|++++|.+.+.+|..+..+
T Consensus       301 p~~-~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~  379 (968)
T PLN00113        301 PEL-VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS  379 (968)
T ss_pred             Chh-HcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCc
Confidence            654 4678999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEc
Q 036815          344 KNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL  423 (1013)
Q Consensus       344 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  423 (1013)
                      ++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..|..++.|+.|++++|++++.+|..+..+++|++|++
T Consensus       380 ~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  459 (968)
T PLN00113        380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL  459 (968)
T ss_pred             CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEEC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccc-cCcccc
Q 036815          424 NSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMY-SGPVLS  502 (1013)
Q Consensus       424 ~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~  502 (1013)
                      ++|+++|.+|..++.                                              +.|+.++++.+. .+..|.
T Consensus       460 ~~n~~~~~~p~~~~~----------------------------------------------~~L~~L~ls~n~l~~~~~~  493 (968)
T PLN00113        460 ARNKFFGGLPDSFGS----------------------------------------------KRLENLDLSRNQFSGAVPR  493 (968)
T ss_pred             cCceeeeecCccccc----------------------------------------------ccceEEECcCCccCCccCh
Confidence            999999888865421                                              123333444332 345677


Q ss_pred             cccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcc
Q 036815          503 LFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFL  582 (1013)
Q Consensus       503 ~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l  582 (1013)
                      .+..+++|++|+|++|+++|.+|..++.+++|++|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..++.|
T Consensus       494 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  573 (968)
T PLN00113        494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL  573 (968)
T ss_pred             hhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCccc
Confidence            78888999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEEECcCCCCCCcCCCCCCCCCCCcccccCCCCCCCCCC----CCCCCCCCCCCCCCCccccccccchhhhhhhhhHHHH
Q 036815          583 VQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPL----PECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMG  658 (1013)
Q Consensus       583 ~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~~  658 (1013)
                      +.+++++|+++|.+|..+++.++...++.||+++||.+.    ++|...             ... .    .+.. ++++
T Consensus       574 ~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-------------~~~-~----~~~~-~~~~  634 (968)
T PLN00113        574 VQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-------------RKT-P----SWWF-YITC  634 (968)
T ss_pred             CEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-------------ccc-c----eeee-ehhH
Confidence            999999999999999999999999999999999998653    234210             000 0    0111 1111


Q ss_pred             HHHHHHHHHHHHHHHHHHHhhhhhHHHHHHhhhhhcccccccccccccCCccchhhhHHhh-hccccCHHHHHHHhcCCC
Q 036815          659 VLISIASICILIVWAIAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQR-QLRKLKFSQLIEATNGFS  737 (1013)
Q Consensus       659 ~~~~~~~i~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~y~  737 (1013)
                      +++++++++++++.++++|+|++.  +.+..+     .....|....           +.. ..+.++++++   ...|.
T Consensus       635 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~-----------~~~~~~~~~~~~~~---~~~~~  693 (968)
T PLN00113        635 TLGAFLVLALVAFGFVFIRGRNNL--ELKRVE-----NEDGTWELQF-----------FDSKVSKSITINDI---LSSLK  693 (968)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhcc--cccccc-----cccccccccc-----------cccccchhhhHHHH---HhhCC
Confidence            111111111111111122222111  110000     0001121110           000 0112333333   34577


Q ss_pred             CCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCC
Q 036815          738 AESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGS  816 (1013)
Q Consensus       738 ~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  816 (1013)
                      ..++||+|+||.||+|++. +++.||||++......    ...|++++++++||||++++++|.+++..|+||||+++|+
T Consensus       694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~  769 (968)
T PLN00113        694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN  769 (968)
T ss_pred             cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence            8899999999999999984 7899999987543222    2356889999999999999999999999999999999999


Q ss_pred             HHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcce
Q 036815          817 LEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL  896 (1013)
Q Consensus       817 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  896 (1013)
                      |.++++.         ++|.++.+++.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||.+.....     
T Consensus       770 L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        770 LSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             HHHHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            9999952         7899999999999999999996656699999999999999999888875 665543221     


Q ss_pred             eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhccc
Q 036815          897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT  976 (1013)
Q Consensus       897 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  976 (1013)
                       .....+++.|+|||++.+..++.++|||||||++|||+||+.||+..........+|++...........+|+.+... 
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  912 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD-  912 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC-
Confidence             112367899999999999999999999999999999999999997654445567778776554444444455544210 


Q ss_pred             CCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          977 KGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       977 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        .    ....+++.++.+++.+||+.||++||||+|
T Consensus       913 --~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e  943 (968)
T PLN00113        913 --V----SVNQNEIVEVMNLALHCTATDPTARPCAND  943 (968)
T ss_pred             --C----CccHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence              0    111234556789999999999999999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.4e-60  Score=602.14  Aligned_cols=518  Identities=37%  Similarity=0.566  Sum_probs=464.8

Q ss_pred             CCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccC-CCCcCCCCCCcccEEECCCCCCCCCCCccccCCCC
Q 036815           48 LPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSIS-GFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTK  126 (1013)
Q Consensus        48 l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~  126 (1013)
                      ..+++.|+|++|.+++.++. .+..+++|+.|+|++|++++..+ .++   ..+++|++|+|++|.+++.+|.  ..+++
T Consensus        68 ~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n~~~~~ip~~~~---~~l~~L~~L~Ls~n~l~~~~p~--~~l~~  141 (968)
T PLN00113         68 SSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQLSGPIPDDIF---TTSSSLRYLNLSNNNFTGSIPR--GSIPN  141 (968)
T ss_pred             CCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCCccCCcCChHHh---ccCCCCCEEECcCCccccccCc--cccCC
Confidence            45799999999999977765 46889999999999999975332 222   3578999999999999887774  56899


Q ss_pred             CCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEcc
Q 036815          127 LKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLS  206 (1013)
Q Consensus       127 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~  206 (1013)
                      |++|+|++|.+++..|..++.+++|++|++++|.+.+.+|..+.. +++|++|+|++|++.+..|..+..+++|++|+|+
T Consensus       142 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~  220 (968)
T PLN00113        142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN-LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG  220 (968)
T ss_pred             CCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhh-CcCCCeeeccCCCCcCcCChHHcCcCCccEEECc
Confidence            999999999999899999999999999999999998888887755 6999999999999999999999999999999999


Q ss_pred             CCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccc
Q 036815          207 NNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITG  286 (1013)
Q Consensus       207 ~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  286 (1013)
                      +|++.+.+|.. +..+++|++|++++|.+++..|..++++++|+.|++++|.+++.+|..+ ..+++|+.|++++|.+.+
T Consensus       221 ~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~n~l~~  298 (968)
T PLN00113        221 YNNLSGEIPYE-IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI-FSLQKLISLDLSDNSLSG  298 (968)
T ss_pred             CCccCCcCChh-HhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhH-hhccCcCEEECcCCeecc
Confidence            99999888876 5889999999999999999999999999999999999999997776655 568999999999999999


Q ss_pred             cCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcC
Q 036815          287 VIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS  366 (1013)
Q Consensus       287 ~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  366 (1013)
                      .+|..+.++++|+.|++++|.+.+.+|..++.+++|+.|++++|.+.+.+|..++.+++|+.|++++|++++.+|..+..
T Consensus       299 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~  378 (968)
T PLN00113        299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS  378 (968)
T ss_pred             CCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCC
Q 036815          367 CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLG  446 (1013)
Q Consensus       367 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~  446 (1013)
                      +++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+.++++|+.|++++|+++|.+|..+...       
T Consensus       379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-------  451 (968)
T PLN00113        379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM-------  451 (968)
T ss_pred             cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccC-------
Confidence            9999999999999999999999999999999999999999999999999999999999999999887654332       


Q ss_pred             CcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccc-cCcccccccCCCccCEEEccCCcccccCC
Q 036815          447 GFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMY-SGPVLSLFTQYQTLEYLDLSYNQFRGKIP  525 (1013)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~L~~L~ls~N~l~g~iP  525 (1013)
                                                            +.|+.++++++. .+.+|..+ ..++|+.||+++|+++|.+|
T Consensus       452 --------------------------------------~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~  492 (968)
T PLN00113        452 --------------------------------------PSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVP  492 (968)
T ss_pred             --------------------------------------CCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccC
Confidence                                                  223333333322 23344433 45789999999999999999


Q ss_pred             hhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCC-CCCCCC
Q 036815          526 DEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQ-RGQLST  604 (1013)
Q Consensus       526 ~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~-~~~~~~  604 (1013)
                      ..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|..+..++.|+.|+|++|+++|.+|. ...+..
T Consensus       493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  572 (968)
T PLN00113        493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES  572 (968)
T ss_pred             hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999996 456777


Q ss_pred             CCcccccCCCCCCCCC
Q 036815          605 LPASQYANNPGLCGVP  620 (1013)
Q Consensus       605 ~~~~~~~~n~~lc~~~  620 (1013)
                      +....+.+|+..+..|
T Consensus       573 L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        573 LVQVNISHNHLHGSLP  588 (968)
T ss_pred             cCEEeccCCcceeeCC
Confidence            8888888998665444

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=425.26  Aligned_cols=281  Identities=51%  Similarity=0.844  Sum_probs=242.1

Q ss_pred             hccccCHHHHHHHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEE
Q 036815          720 QLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC  799 (1013)
Q Consensus       720 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  799 (1013)
                      ..+.+++.++..||++|...++||+|+||.||+|...+++.||||++........++|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999987554433156699999999999999999999999


Q ss_pred             EeCC-EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          800 KIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       800 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      .+.+ +.++|||||++|+|.++++.....    +++|.+|.+||.++|+||+|||+.+.+.||||||||+|||+|+++++
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9988 599999999999999999865432    58999999999999999999999988899999999999999999999


Q ss_pred             EEeecccceeccccCcceeeeee-ccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC-CCCccHHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTL-AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD-FGDTNLVGWVK  956 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~-~~~~~~~~~~~  956 (1013)
                      ||+|||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+... ..+..+.+|+.
T Consensus       217 KlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~  294 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK  294 (361)
T ss_pred             EccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence            99999999765431  1111222 89999999999999999999999999999999999999988644 33456899999


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..+...+++|+.+..   +...    ...++.++..++.+|++.+|++||+|.|
T Consensus       295 ~~~~~~~~~eiiD~~l~~---~~~~----~~~~~~~~~~~a~~C~~~~~~~RP~m~~  344 (361)
T KOG1187|consen  295 PLLEEGKLREIVDPRLKE---GEYP----DEKEVKKLAELALRCLRPDPKERPTMSQ  344 (361)
T ss_pred             HHHHCcchhheeCCCccC---CCCC----hHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence            999999999999998742   1111    0156667889999999999999999975

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=377.69  Aligned_cols=247  Identities=28%  Similarity=0.437  Sum_probs=200.7

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeec-cCccchHHHHHHHHHHhccCCcceeeeccEEEeCC-EEEEEEEcc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE-ERLLVYEFM  812 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  812 (1013)
                      .+..+.||+|..|+||+++++ +++.+|+|++.. .+....+++.+|++++++.+||+||++||+|...+ ..+++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            445689999999999999997 677889998843 34445678999999999999999999999999988 599999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      ++|+|++++...+      .+++....+|+.+|++||.|||+ +   +||||||||+|||++..|++||||||.++.+..
T Consensus       161 DgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  161 DGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             CCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            9999999997543      38999999999999999999996 6   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      .    ......||..|||||.+.+..|+.++||||||++++|+++|+.||...........+.+...+.+ .     +|.
T Consensus       232 S----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-p-----pP~  301 (364)
T KOG0581|consen  232 S----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-P-----PPR  301 (364)
T ss_pred             h----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-C-----CCC
Confidence            2    34678899999999999999999999999999999999999999987522222222222222211 1     111


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +..  ..++          .++.+|+..||+.||.+|||++|
T Consensus       302 lP~--~~fS----------~ef~~FV~~CL~Kdp~~R~s~~q  331 (364)
T KOG0581|consen  302 LPE--GEFS----------PEFRSFVSCCLRKDPSERPSAKQ  331 (364)
T ss_pred             CCc--ccCC----------HHHHHHHHHHhcCCcccCCCHHH
Confidence            100  0011          13668999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=371.30  Aligned_cols=201  Identities=33%  Similarity=0.537  Sum_probs=180.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .++|...+.||+|+||+||+|+++ ++..||||.+.+.  .....+-+..|+++++.++|||||++++++..++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            367899999999999999999987 5789999998765  4444566889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC------CcEEEeec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE------MEARVSDF  883 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~Df  883 (1013)
                      |||.||+|.+|++.++.      +++.+++.++.|+|.||++||++   +||||||||+|||++..      -.+||+||
T Consensus        89 EyC~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             EeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            99999999999987653      89999999999999999999999   99999999999999865      45899999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |+|+.+..   .....+.+|++-|||||+++..+|+.|+|+||+|+|+|||++|+.||+...
T Consensus       160 GfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  160 GFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             chhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            99998763   233456789999999999999999999999999999999999999998543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-43  Score=384.20  Aligned_cols=243  Identities=27%  Similarity=0.437  Sum_probs=204.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-cCCCEEEEEEeecc---CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATL-KDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .+|...+.||+|+|++||++++ ..|+.||+|++.+.   .....+.+.+|+++.++++|||||+++++|++....|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4699999999999999999998 68999999998653   3344577899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |+|+.++|.++++.+      +++++.+++.+++||+.||.|||++   +|+|||||..|++++++.++||+|||+|..+
T Consensus        98 ELC~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQL  168 (592)
T ss_pred             EecCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeee
Confidence            999999999999733      3499999999999999999999999   9999999999999999999999999999988


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH-HHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM-KVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~  968 (1013)
                      ...  .....+.+|||.|.|||++....++..+||||+|||+|-|++|++||+....     .+.... +..+-.....+
T Consensus       169 e~~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-----kety~~Ik~~~Y~~P~~l  241 (592)
T KOG0575|consen  169 EYD--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-----KETYNKIKLNEYSMPSHL  241 (592)
T ss_pred             cCc--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----HHHHHHHHhcCccccccc
Confidence            643  2345678999999999999999999999999999999999999999986432     111111 11111111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+                     ...++|.++|++||.+|||++|
T Consensus       242 s~---------------------~A~dLI~~lL~~~P~~Rpsl~~  265 (592)
T KOG0575|consen  242 SA---------------------EAKDLIRKLLRPNPSERPSLDE  265 (592)
T ss_pred             CH---------------------HHHHHHHHHhcCCcccCCCHHH
Confidence            11                     1358999999999999999864

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-44  Score=371.67  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=198.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc-------chHHHHHHHHHHhccCCcceeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ-------GDREFMAEMETLGKIKHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  804 (1013)
                      .+.|.+.+.+|+|+||.|-+|..+ +|+.||||.+.+....       ....+++|+++|++++|||||+++++|...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            456889999999999999999876 7999999988653221       22346899999999999999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC---CcEEEe
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE---MEARVS  881 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~  881 (1013)
                      .|+||||++||+|.+.+-....      +.+..-+.+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence            9999999999999999976544      66777789999999999999999   99999999999999766   679999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCC--C-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHH
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR--C-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK  958 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  958 (1013)
                      |||+|+..+.   ...+.+.+|||.|.|||++.+..  + ..++|+||+||++|-+++|.+||...... ..+    ...
T Consensus       322 DFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-~sl----~eQ  393 (475)
T KOG0615|consen  322 DFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-PSL----KEQ  393 (475)
T ss_pred             ccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-ccH----HHH
Confidence            9999998753   33456789999999999997553  2 34889999999999999999999864322 212    222


Q ss_pred             HhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       959 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +..+++...             +  ..+.+--.+..++|.+||..||++|||++|
T Consensus       394 I~~G~y~f~-------------p--~~w~~Iseea~dlI~~mL~VdP~~R~s~~e  433 (475)
T KOG0615|consen  394 ILKGRYAFG-------------P--LQWDRISEEALDLINWMLVVDPENRPSADE  433 (475)
T ss_pred             HhcCccccc-------------C--hhhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence            222322111             0  111112234569999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=384.03  Aligned_cols=245  Identities=32%  Similarity=0.496  Sum_probs=196.1

Q ss_pred             CCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccc--hHHHHHHHHHHhccCCcceeeeccEEEeCC-EEEEEEEccc
Q 036815          737 SAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRNLVPLLGYCKIGE-ERLLVYEFMK  813 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  813 (1013)
                      .+.+.+|+|+||+||+|.+.....||||++.......  .++|.+|+.++.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3445699999999999999844449999886543222  458999999999999999999999999887 7999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCcccEEeCCCC-cEEEeecccceeccc
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH-IIHRDMKSSNVLLDHEM-EARVSDFGMARLISA  891 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~  891 (1013)
                      +|+|.++++..    ....+++..+.+++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++....
T Consensus       124 ~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  124 GGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             CCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            99999999864    234599999999999999999999999   7 99999999999999997 999999999987543


Q ss_pred             cCcceeeeeeccCCCccCccccc--CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQ--SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ..  .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....  ......+.............+
T Consensus       197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~Rp~~p~~~~  272 (362)
T KOG0192|consen  197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGLRPPIPKECP  272 (362)
T ss_pred             cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCCCCCCccCC
Confidence            21  2334478999999999999  56999999999999999999999999987543  111111111111111111111


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                           ..+..++.+||+.||++||++.|
T Consensus       273 ---------------------~~l~~l~~~CW~~dp~~RP~f~e  295 (362)
T KOG0192|consen  273 ---------------------PHLSSLMERCWLVDPSRRPSFLE  295 (362)
T ss_pred             ---------------------HHHHHHHHHhCCCCCCcCCCHHH
Confidence                                 12568889999999999999754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-44  Score=352.39  Aligned_cols=249  Identities=26%  Similarity=0.431  Sum_probs=202.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeec--cCccchHHHHHHHHHHhccCCcceeeecc-EEEeCCE-EEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLG-YCKIGEE-RLLVY  809 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~  809 (1013)
                      +|++.++||+|+||+||++... +|..||.|++.-  .+....+....|+.+|++++|||||++++ -+.++.. .++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            4788899999999999999864 899999998852  23334567889999999999999999999 4444444 89999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCcccEEeCCCCcEEEeecccce
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH--IIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |+++.|+|..++...+.  ..+.+++.++++++.|++.||.++|+..+ +  |+||||||.||+++.+|.+||+|||+++
T Consensus       100 E~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HhhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHh
Confidence            99999999999976543  34669999999999999999999999422 4  9999999999999999999999999999


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      .+.....  .....+|||.||+||.+.+..|+.||||||+||++|||+.-++||.++.     +.. ...++..+.....
T Consensus       177 ~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~-L~~KI~qgd~~~~  248 (375)
T KOG0591|consen  177 FLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLS-LCKKIEQGDYPPL  248 (375)
T ss_pred             HhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHH-HHHHHHcCCCCCC
Confidence            8865332  2446789999999999999999999999999999999999999998762     222 2334444443322


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .+.-.                 ...+..+|..|+.+||+.||+.
T Consensus       249 p~~~Y-----------------S~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  249 PDEHY-----------------STDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             cHHHh-----------------hhHHHHHHHHHccCCcccCCCc
Confidence            21111                 1235588899999999999973

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.5e-43  Score=343.45  Aligned_cols=263  Identities=25%  Similarity=0.325  Sum_probs=199.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|+...++|+|+||+||+++++ +|+.||||++.....  ...+-..+|++++++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45888899999999999999987 589999999865332  223557899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      ||+. ++.+-+....     ..++.+.+.++++|++.|+.|+|++   ++|||||||+||+++..|.+||||||+|+.+.
T Consensus        82 ~~dh-TvL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP-----NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             ecch-HHHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            9995 4444444322     2388899999999999999999999   99999999999999999999999999999886


Q ss_pred             ccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc--------
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE--------  961 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------  961 (1013)
                      .  +...++..+.|..|+|||.+.+ .+|++.+||||+||++.||++|.+.|.+.+.-+.  ...+...+..        
T Consensus       153 ~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ--Ly~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  153 A--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ--LYLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             C--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH--HHHHHHHHcccCHHHHHH
Confidence            4  2333456788999999999887 7899999999999999999999999987653222  2222222211        


Q ss_pred             ---Ccccc-ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 ---GKQME-VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ---~~~~~-~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         ...+. +.-|+..    ...+.+.....-..-+++++..|++.||.+|++.+|
T Consensus       229 F~~N~~F~Gv~lP~~~----~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~q  280 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPE----HPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQ  280 (396)
T ss_pred             hccCCceeeeecCCCC----CccchhhhcccchHHHHHHHHHHhcCCccccccHHH
Confidence               11111 1111110    000000000001113679999999999999998654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-42  Score=352.09  Aligned_cols=241  Identities=27%  Similarity=0.374  Sum_probs=200.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.++||+|+||+||.++.+ +++.+|+|++.+....   ..+...+|..++.+++||+||+++..|.+.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            356999999999999999999976 5788999988764433   345688999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      +||+.||.|..+|.....      +++..++-++.+|+.||.|||++   +|||||+||+|||+|.+|+++|+|||+++.
T Consensus       104 ld~~~GGeLf~hL~~eg~------F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR------FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EeccCCccHHHHHHhcCC------cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            999999999999975443      89999999999999999999999   999999999999999999999999999985


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-cc-cc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-KQ-ME  966 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~-~~  966 (1013)
                      ...  ......+.+||+.|||||++.+..|+.++|.||+||++|||++|.+||...+     ...+.+...... .. ..
T Consensus       175 ~~~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k~~~~p~  247 (357)
T KOG0598|consen  175 DLK--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGKLPLPPG  247 (357)
T ss_pred             ccc--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCcCCCCCc
Confidence            432  2223445799999999999999999999999999999999999999998644     233333333322 11 11


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      .+++                     ...+++.+.+..||++|..
T Consensus       248 ~ls~---------------------~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  248 YLSE---------------------EARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             cCCH---------------------HHHHHHHHHhccCHHHhcC
Confidence            1111                     1348899999999999963

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=372.04  Aligned_cols=243  Identities=28%  Similarity=0.460  Sum_probs=198.3

Q ss_pred             CCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCC
Q 036815          737 SAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGS  816 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  816 (1013)
                      +..+.||+|-||.||.|.+.....||+|.+... .-..++|.+|+++|++++|++||+++++|..++..|||||||+.|+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            445789999999999999987779999988654 3445788999999999999999999999999899999999999999


Q ss_pred             HHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcce
Q 036815          817 LEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL  896 (1013)
Q Consensus       817 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  896 (1013)
                      |.+++...    ....+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+.... +...
T Consensus       288 Ll~yLr~~----~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~  359 (468)
T KOG0197|consen  288 LLDYLRTR----EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYT  359 (468)
T ss_pred             HHHHhhhc----CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC-Ccee
Confidence            99999762    234488899999999999999999999   999999999999999999999999999995433 3333


Q ss_pred             eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcc
Q 036815          897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV  975 (1013)
Q Consensus       897 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  975 (1013)
                      ......-+..|.|||.+....++.|||||||||++|||+| |+.||.+....  ...+    .+..+..+...+  .   
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--ev~~----~le~GyRlp~P~--~---  428 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--EVLE----LLERGYRLPRPE--G---  428 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--HHHH----HHhccCcCCCCC--C---
Confidence            3333445679999999999999999999999999999999 99998764421  2222    222232222111  0   


Q ss_pred             cCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          976 TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       976 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                         ++          ..+.+++..||+.+|++|||++
T Consensus       429 ---CP----------~~vY~lM~~CW~~~P~~RPtF~  452 (468)
T KOG0197|consen  429 ---CP----------DEVYELMKSCWHEDPEDRPTFE  452 (468)
T ss_pred             ---CC----------HHHHHHHHHHhhCCcccCCCHH
Confidence               11          1256899999999999999975

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=359.21  Aligned_cols=247  Identities=25%  Similarity=0.366  Sum_probs=202.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ..+|.+++.||+|+|++||+|+.. .++.||||++.+.-   ....+-+.+|-++|.++ .||.|++++..|.++...|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            467999999999999999999976 68999999875422   12224467899999999 89999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |+||+++|+|.++|+..+.      +++...+.++.+|+.||+|||++   |||||||||+|||+|++|++||+|||.|+
T Consensus       152 vLe~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999987654      89999999999999999999999   99999999999999999999999999999


Q ss_pred             eccccCcc-----------eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 036815          888 LISALDTH-----------LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       888 ~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~  956 (1013)
                      .+......           .....++||..|.+||++.....++.+|+|+||||+|+|+.|++||.+..    .+.-+.+
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyliFqk  298 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYLIFQK  298 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHHHHHH
Confidence            87542211           11245889999999999999999999999999999999999999998633    1222222


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....+-...+.+++.                     +.+|+.+.|..||.+|+|++|
T Consensus       299 I~~l~y~fp~~fp~~---------------------a~dLv~KLLv~dp~~Rlt~~q  334 (604)
T KOG0592|consen  299 IQALDYEFPEGFPED---------------------ARDLIKKLLVRDPSDRLTSQQ  334 (604)
T ss_pred             HHHhcccCCCCCCHH---------------------HHHHHHHHHccCccccccHHH
Confidence            222222222222221                     358999999999999999864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.3e-41  Score=381.64  Aligned_cols=253  Identities=30%  Similarity=0.495  Sum_probs=209.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      .+....+.||+|+||+||+|+..      +...||||.+++.... ...+|++|++++..++|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34566789999999999999853      3567999999876665 6788999999999999999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCC--------CccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARD--------QRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      +|+|||..|+|.++|..+.....        ..+++..+.+.||.|||.||+||-++   .+|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence            99999999999999975543221        22388999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ||+|||++|.+...+.+.......-+.+|||||.+..++||++||||||||++||+++ |+.||.+....+      +-.
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------VIe  716 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------VIE  716 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------HHH
Confidence            9999999998876666544444555779999999999999999999999999999999 999998754322      223


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .++.++..+..+        ..+          .++++|+.+||+..|++||+++|
T Consensus       717 ~i~~g~lL~~Pe--------~CP----------~~vY~LM~~CW~~~P~~RPsF~e  754 (774)
T KOG1026|consen  717 CIRAGQLLSCPE--------NCP----------TEVYSLMLECWNENPKRRPSFKE  754 (774)
T ss_pred             HHHcCCcccCCC--------CCC----------HHHHHHHHHHhhcCcccCCCHHH
Confidence            344444432211        111          23679999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=353.35  Aligned_cols=250  Identities=27%  Similarity=0.421  Sum_probs=196.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCC--EEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE--ERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  810 (1013)
                      .+|...+.||+|+||+||++...+ |+..|||.+........+.+.+|+.+|++++|||||+++|......  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            357788999999999999999874 8999999886543333566899999999999999999999754444  6899999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-CCcEEEeecccceec
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-EMEARVSDFGMARLI  889 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~  889 (1013)
                      |+++|+|.+++.....     .+++..++.+++||++||+|||++   |||||||||+|||++. ++.+||+|||.++..
T Consensus        97 y~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             ccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            9999999999976542     389999999999999999999999   9999999999999999 799999999999876


Q ss_pred             cc-cCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          890 SA-LDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       890 ~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      .. ...........||+.|||||++.++ ...+++||||+||++.||+||++||...    .....++-......... .
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~~P-~  243 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDSLP-E  243 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCCCC-C
Confidence            53 1122223457899999999999853 3445999999999999999999999763    11122222222222111 1


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ++..+.                 ....+++.+|++.||++||||+|
T Consensus       244 ip~~ls-----------------~~a~~Fl~~C~~~~p~~Rpta~e  272 (313)
T KOG0198|consen  244 IPDSLS-----------------DEAKDFLRKCFKRDPEKRPTAEE  272 (313)
T ss_pred             CCcccC-----------------HHHHHHHHHHhhcCcccCcCHHH
Confidence            221110                 11348999999999999999874

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=354.38  Aligned_cols=267  Identities=22%  Similarity=0.289  Sum_probs=203.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc-hHHHHHHHHHHhccC-CcceeeeccEEEeCC-EEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG-DREFMAEMETLGKIK-HRNLVPLLGYCKIGE-ERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  808 (1013)
                      -++|.+.++||.|.||.||+|+.. +++.||||++++.-... +-.-.+|+..++++. ||||+++.+++.+.+ ..|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            357999999999999999999976 68899999986543333 233478999999998 999999999999988 99999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      ||||+ .+|++.+..+     .+++++..++.|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+||.
T Consensus        89 fE~Md-~NLYqLmK~R-----~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDR-----NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             HHhhh-hhHHHHHhhc-----CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence            99998 6999999765     35699999999999999999999999   999999999999999888999999999998


Q ss_pred             ccccCcceeeeeeccCCCccCcccc-cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYY-QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      +.....   .+..+.|..|+|||++ +.+.|+.+.||||+|||++|+.+-++.|.+...-++.  -.+...++.....+.
T Consensus       160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi--~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI--YKICEVLGTPDKDSW  234 (538)
T ss_pred             cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH--HHHHHHhCCCccccc
Confidence            765443   4567889999999986 5678999999999999999999999999876533221  111122222111111


Q ss_pred             cC-hhhhcc----cCCCChhhHHH--HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 ID-PELLLV----TKGTDESEAEE--VKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d-~~~~~~----~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. ..+...    ...........  -....++++++.+|+++||.+||||+|
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~  287 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ  287 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence            00 000000    00000000000  012234679999999999999999975

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=5.8e-45  Score=371.53  Aligned_cols=514  Identities=29%  Similarity=0.425  Sum_probs=392.0

Q ss_pred             eecccCCcccccccccccCC------------CCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhh
Q 036815            4 VLKLSSNLFTLNSTSLLQLP------------FGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLS   71 (1013)
Q Consensus         4 ~L~l~~n~~~~~~~~~~~~~------------~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~   71 (1013)
                      .|.+|.+.++++|....+..            ..+..|.+++|.+....++  ..++..|..|++++|+++ .+|+++ .
T Consensus        13 ~lnlsnr~l~~vp~~vyq~~~t~~e~e~wW~qv~l~~lils~N~l~~l~~d--l~nL~~l~vl~~~~n~l~-~lp~ai-g   88 (565)
T KOG0472|consen   13 SLNLSNRSLKDVPTEVYQINLTTGEGENWWEQVDLQKLILSHNDLEVLRED--LKNLACLTVLNVHDNKLS-QLPAAI-G   88 (565)
T ss_pred             ccccccchhhhccHHHHHHHhhccchhhhhhhcchhhhhhccCchhhccHh--hhcccceeEEEeccchhh-hCCHHH-H
Confidence            46788888888877655322            2377888888887553332  577888889999999887 666554 5


Q ss_pred             CCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCC
Q 036815           72 NSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSL  151 (1013)
Q Consensus        72 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  151 (1013)
                      .+..++.|+.|+|++...++..    ....+++.|+.++|.+.. .++.++.+-.|+.|+..+|+++ ..|+.+..+.+|
T Consensus        89 ~l~~l~~l~vs~n~ls~lp~~i----~s~~~l~~l~~s~n~~~e-l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l  162 (565)
T KOG0472|consen   89 ELEALKSLNVSHNKLSELPEQI----GSLISLVKLDCSSNELKE-LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKL  162 (565)
T ss_pred             HHHHHHHhhcccchHhhccHHH----hhhhhhhhhhccccceee-cCchHHHHhhhhhhhccccccc-cCchHHHHHHHH
Confidence            6678888999999888655443    356788889999998876 5667888888899999999988 667788888889


Q ss_pred             CEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcc
Q 036815          152 QRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS  231 (1013)
Q Consensus       152 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~  231 (1013)
                      ..|++.+|+++ ..|+..-+ ++.|++|++.+|-++ .+|..++.+.+|.-|+|..|+|. .+|.  |.++..|++|+++
T Consensus       163 ~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lPe--f~gcs~L~Elh~g  236 (565)
T KOG0472|consen  163 SKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLPE--FPGCSLLKELHVG  236 (565)
T ss_pred             HHhhccccchh-hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCCC--CCccHHHHHHHhc
Confidence            99999999988 66665555 688999999988888 66778888999999999999988 7774  7888889999999


Q ss_pred             cccCCCcCCcCCC-CCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCC
Q 036815          232 NNMISGSFPDSIS-SCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG  310 (1013)
Q Consensus       232 ~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~  310 (1013)
                      .|+|. .+|.... .++++.+||+.+|+++ ..|..+| -+++|+.|++++|.|+ ..|..++++ .|+.|-+.+|++. 
T Consensus       237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c-lLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-  310 (565)
T KOG0472|consen  237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC-LLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-  310 (565)
T ss_pred             ccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH-HhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-
Confidence            99888 5665554 7889999999999998 6777776 3788999999999998 557788888 8999999999887 


Q ss_pred             CCCcccccCc---chHHHHh--hhcccc---C----------CCCcCcCCCCCCceEECccccccccCchhhcCCCC---
Q 036815          311 SIPQELGKLE---HLEQFIA--WFNGLE---G----------KIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSN---  369 (1013)
Q Consensus       311 ~~p~~l~~l~---~L~~L~l--~~n~l~---~----------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~---  369 (1013)
                      .+...+-+..   -|++|.-  ...+++   |          ...+....+.+.+.|++++-+++ .+|.+.+....   
T Consensus       311 TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~  389 (565)
T KOG0472|consen  311 TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEI  389 (565)
T ss_pred             HHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcc
Confidence            3433332211   1333321  011111   0          11123345677889999999998 77877766555   


Q ss_pred             CCeEEecCCccCCCCChhhhccCCCc-eEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCc
Q 036815          370 LEWISLTGNELTGQIPPEFSRLTRLA-VLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGF  448 (1013)
Q Consensus       370 L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~  448 (1013)
                      .+..+++.|++. ++|..+..+..+. .+.+++|.++ .+|..++.+++|..|+|++|-+- ++|..+            
T Consensus       390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~------------  454 (565)
T KOG0472|consen  390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEM------------  454 (565)
T ss_pred             eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhh------------
Confidence            788899999998 8888888887764 4566666665 88888899999999999988664 555443            


Q ss_pred             ccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhh
Q 036815          449 LSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI  528 (1013)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i  528 (1013)
                                                                              +++..|+.||+|.|+|. .+|..+
T Consensus       455 --------------------------------------------------------~~lv~Lq~LnlS~NrFr-~lP~~~  477 (565)
T KOG0472|consen  455 --------------------------------------------------------GSLVRLQTLNLSFNRFR-MLPECL  477 (565)
T ss_pred             --------------------------------------------------------hhhhhhheecccccccc-cchHHH
Confidence                                                                    34456999999999999 999999


Q ss_pred             hCCCCCcEEecCCCccCCCCccc-ccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCCCCCCCCCCc
Q 036815          529 GDMIALQVLELAHNQLSGEIPSS-LGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPA  607 (1013)
Q Consensus       529 ~~l~~L~~L~L~~n~l~g~ip~~-~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~~~~~~  607 (1013)
                      -.+..|..+-.++|++. .+|++ +.+|.+|..|||.+|.+. +||+.++++++|++|++++|+|.-+..+.---++...
T Consensus       478 y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~Pr~~iLmkgT~ai  555 (565)
T KOG0472|consen  478 YELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQPRHQILMKGTAAI  555 (565)
T ss_pred             hhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCCCHHHHhccChHHH
Confidence            99999988888889998 67766 999999999999999998 9999999999999999999999932222222245555


Q ss_pred             ccccCCC
Q 036815          608 SQYANNP  614 (1013)
Q Consensus       608 ~~~~~n~  614 (1013)
                      ++|.+++
T Consensus       556 L~ylrdr  562 (565)
T KOG0472|consen  556 LSYLRDR  562 (565)
T ss_pred             HHHhccc
Confidence            6666554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-40  Score=351.09  Aligned_cols=268  Identities=24%  Similarity=0.296  Sum_probs=200.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC--CEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  808 (1013)
                      +.|+..++||+|.||.||+|++. +|+.||+|++....  ........+|+.+|++++||||+++.+...+.  +..|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            45777789999999999999975 78999999996543  33346678999999999999999999988775  789999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      +|||+. +|.-++...     ...+++.+++.+++|++.||+|+|++   ||+|||||.+|||||.+|.+||+|||+|++
T Consensus       197 FeYMdh-DL~GLl~~p-----~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP-----GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             Eecccc-hhhhhhcCC-----CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence            999994 888877542     23499999999999999999999999   999999999999999999999999999998


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC--ccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG--KQM  965 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~  965 (1013)
                      +.... ....+..+.|..|+|||.+.|. .|+.++|+||+|||+.||++|++.|.+...  ....+.+-......  ..+
T Consensus       268 y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--veQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  268 YTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--VEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             ccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--HHHHHHHHHHhCCCChhcc
Confidence            76533 3335567789999999998765 799999999999999999999999987542  11122222222211  111


Q ss_pred             cccC-h--hhhcccCCCChhhHHHHHH-HHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVID-P--ELLLVTKGTDESEAEEVKE-MVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d-~--~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+ |  ........+.....+.... ....++++..+|..||.+|.||.+
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~  396 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS  396 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence            1110 0  0000000001100111100 123678999999999999999863

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.8e-40  Score=320.98  Aligned_cols=266  Identities=23%  Similarity=0.309  Sum_probs=202.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|...+++|+|.||.||+|++. +|+.||||++......  -.....+|++.++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999975 7899999998654333  24567899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      ||+ -+|+..++...     ..++-..++.++.++++|++|+|++   .|+||||||.|+|++++|.+||+|||+|+.+.
T Consensus        82 fm~-tdLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             ecc-ccHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccC
Confidence            998 59999997543     4588899999999999999999999   99999999999999999999999999999987


Q ss_pred             ccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ..+.....  .+.|..|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.++..  .+....+-.....+......+
T Consensus       153 ~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  153 SPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             CCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHHcCCCCcccCcc
Confidence            65544332  3678899999998765 689999999999999999999888776432  111222222222221111100


Q ss_pred             ----hhhhcccCCCChhhH--HHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 ----PELLLVTKGTDESEA--EEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ----~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          |+..... .......  --.......++++.+|+..||.+|+|++|
T Consensus       229 ~~~lpdY~~~~-~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q  277 (318)
T KOG0659|consen  229 MTSLPDYVKIQ-QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ  277 (318)
T ss_pred             ccccccHHHHh-cCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence                1110000 0000000  00011123579999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=356.76  Aligned_cols=248  Identities=27%  Similarity=0.411  Sum_probs=204.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ....|....+||+|+.|.||.|+.. +++.||||++........+-+.+|+.+|+..+|+|||++++.|..++..|.|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            3456888899999999999999865 688999999977666666778999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      ||+||+|.+.+....       +++.++..|++++++||+|||.+   +|+|||||.+||+++.+|.+||+|||++..+.
T Consensus       351 ym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             ecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            999999999996433       89999999999999999999999   99999999999999999999999999998775


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ....  .....+|||.|||||++....|++|+||||||++++||+.|.+||-.+.   .....|...  ..+.. +.-.+
T Consensus       421 ~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---PlrAlyLIa--~ng~P-~lk~~  492 (550)
T KOG0578|consen  421 EEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIA--TNGTP-KLKNP  492 (550)
T ss_pred             cccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---hHHHHHHHh--hcCCC-CcCCc
Confidence            4332  3456789999999999999999999999999999999999999997522   111112111  11111 11111


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +..                -..+.+|+.+||+.||++||+|+|
T Consensus       493 ~kl----------------S~~~kdFL~~cL~~dv~~RasA~e  519 (550)
T KOG0578|consen  493 EKL----------------SPELKDFLDRCLVVDVEQRASAKE  519 (550)
T ss_pred             ccc----------------CHHHHHHHHHHhhcchhcCCCHHH
Confidence            110                012568999999999999999975

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=338.18  Aligned_cols=258  Identities=27%  Similarity=0.406  Sum_probs=204.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccch-HHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +.|+....||.|..++||+|+.. .++.||||++.-..+... +.+.+|+..|+.++||||++++..|..+...|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            56999999999999999999965 679999999876666655 7899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      |.+|++.+.+.......    +++..+..|++++++||.|||.+   |.||||||+.||||+.+|.+||+|||.+-.+..
T Consensus       106 Ma~GS~ldIik~~~~~G----l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDG----LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hcCCcHHHHHHHHcccc----ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            99999999998665433    89999999999999999999999   999999999999999999999999998765533


Q ss_pred             cCcce-ee-eeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          892 LDTHL-SV-STLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       892 ~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      ..... .. ....||+.|||||+++.  ..|+.|+||||||++..|+++|..||.....     .+.....+........
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----mkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----MKVLLLTLQNDPPTLL  253 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----HHHHHHHhcCCCCCcc
Confidence            22211 11 45689999999999543  4688999999999999999999999986432     1222222222211110


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .        ...+  .......-..+.+++..||+.||++||||++
T Consensus       254 t--------~~~~--~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk  289 (516)
T KOG0582|consen  254 T--------SGLD--KDEDKKFSKSFREMIALCLVKDPSKRPTASK  289 (516)
T ss_pred             c--------ccCC--hHHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence            0        0000  0111111224678899999999999999864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.6e-40  Score=350.96  Aligned_cols=242  Identities=26%  Similarity=0.399  Sum_probs=201.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....  +-+.+.+|++++++++||||+.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46888899999999999999987 5788999977553322  23568999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+.| +|..++....      .++++.+..|++|++.||.|||+.   +|+|||+||.||+++..|.+|+||||+|+.+.
T Consensus        82 ~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             hhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc
Confidence            9996 9999997544      399999999999999999999999   99999999999999999999999999999876


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      .  .....+.+.|||.|||||++.+.+|+..+|+||+||++||+++|++||....     ..+.++....++..+..   
T Consensus       152 ~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~d~v~~p~---  221 (808)
T KOG0597|consen  152 T--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKSILKDPVKPPS---  221 (808)
T ss_pred             c--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhcCCCCCcc---
Confidence            4  3444567899999999999999999999999999999999999999997532     33334433333221111   


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      .                 ....+..++...|..||.+|.|-.
T Consensus       222 ~-----------------~S~~f~nfl~gLL~kdP~~RltW~  246 (808)
T KOG0597|consen  222 T-----------------ASSSFVNFLQGLLIKDPAQRLTWT  246 (808)
T ss_pred             c-----------------ccHHHHHHHHHHhhcChhhcccHH
Confidence            0                 011266899999999999998743

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=319.77  Aligned_cols=236  Identities=27%  Similarity=0.348  Sum_probs=197.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|+..+.||.|+||+|.+++.+ +|..+|+|++.+.....   .+...+|..+++.+.||+++++++.|.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46889999999999999999987 68899999886543322   345678999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||.|..+++..++      +++..++-+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||+|+..
T Consensus       124 eyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             eccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            99999999999976543      89999999999999999999999   9999999999999999999999999999987


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ...     ..+.+|||.|+|||++....+..++|.|||||++|||+.|.+||.....    ...+-+.....-.....+.
T Consensus       195 ~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~~fs  265 (355)
T KOG0616|consen  195 SGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPSYFS  265 (355)
T ss_pred             cCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCcccC
Confidence            532     4578999999999999999999999999999999999999999986543    2222222222223333333


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKR 1008 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1008 (1013)
                      ++                     +.+++...++.|-.+|
T Consensus       266 ~~---------------------~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  266 SD---------------------AKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HH---------------------HHHHHHHHHhhhhHhh
Confidence            33                     3478888888888877

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-39  Score=351.58  Aligned_cols=244  Identities=27%  Similarity=0.452  Sum_probs=199.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc----Cc-cchHHHHHHHHHHhccC-CcceeeeccEEEeCCE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL----SC-QGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  804 (1013)
                      ..++|.+.+.||+|+||+|+.|.+. +++.||+|.+.+.    .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3568999999999999999999875 6899999965442    12 23456778999999998 9999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeec
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDF  883 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Df  883 (1013)
                      .|+||||+.||+|.+++....+      +.+..++.+++|++.|++|+|++   ||+||||||+||+++.+ +++||+||
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~------l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGR------LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCC------CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecc
Confidence            9999999999999999976332      78899999999999999999999   99999999999999999 99999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCC-CC-ccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR-CT-AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      |++....  ..........||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+...     ....... +..
T Consensus       166 G~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~~l~~k-i~~  237 (370)
T KOG0583|consen  166 GLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VPNLYRK-IRK  237 (370)
T ss_pred             ccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HHHHHHH-Hhc
Confidence            9998764  1223355778999999999999877 75 78999999999999999999998632     1111111 221


Q ss_pred             C--cccccc-ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 G--KQMEVI-DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~--~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +  .....+ .+                     .+..++.+|+.+||.+|+|+.|
T Consensus       238 ~~~~~p~~~~S~---------------------~~~~Li~~mL~~~P~~R~t~~~  271 (370)
T KOG0583|consen  238 GEFKIPSYLLSP---------------------EARSLIEKMLVPDPSTRITLLE  271 (370)
T ss_pred             CCccCCCCcCCH---------------------HHHHHHHHHcCCCcccCCCHHH
Confidence            1  111111 11                     2458999999999999999764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=349.55  Aligned_cols=248  Identities=26%  Similarity=0.409  Sum_probs=195.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccc--hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +.+.+...||+|+||+||+|+|.  ..||||++.......  -+.|+.|+.++++-+|.||+-+.|||..++. .||+.+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            44667889999999999999996  469999886544433  4679999999999999999999999988777 999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      |+|.+|+.+++-..     ..++..+.+.|++||++||.|||.+   +|||||+|..||++.+++.|||+|||++..-..
T Consensus       469 CeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             ccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            99999999998543     3489999999999999999999999   999999999999999999999999999975433


Q ss_pred             cCcceeeeeeccCCCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS---FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      -..........|...|||||+++.   .+|++.+||||||||+|||++|..||.. ...+..+     ..+..|..+   
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIi-----fmVGrG~l~---  611 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQII-----FMVGRGYLM---  611 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheE-----EEecccccC---
Confidence            233333445678889999999863   4789999999999999999999999983 3222211     112222111   


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                       ++......          ..-.++.+|+..||..+|++||.+.
T Consensus       612 -pd~s~~~s----------~~pk~mk~Ll~~C~~~~~~eRP~F~  644 (678)
T KOG0193|consen  612 -PDLSKIRS----------NCPKAMKRLLSDCWKFDREERPLFP  644 (678)
T ss_pred             -ccchhhhc----------cCHHHHHHHHHHHHhcCcccCccHH
Confidence             11110000          1112356888999999999999875

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=347.42  Aligned_cols=398  Identities=27%  Similarity=0.284  Sum_probs=287.8

Q ss_pred             CCcEEecCCCCcccccCcccccC-C-CCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCc
Q 036815           25 GLKQLELSSAGLVGLVPDNLFSK-L-PNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNS  102 (1013)
Q Consensus        25 ~l~~L~L~~~~i~~~~~~~~~~~-l-~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~  102 (1013)
                      ....|+++.+++.. +....+.+ + +.-+.||+++|.+. .+....|.++++|+++++.+|.++.++.. .   ....+
T Consensus        53 ~~~lldcs~~~lea-~~~~~l~g~lp~~t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt~IP~f-~---~~sgh  126 (873)
T KOG4194|consen   53 NTRLLDCSDRELEA-IDKSRLKGFLPSQTQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELTRIPRF-G---HESGH  126 (873)
T ss_pred             CceeeecCcccccc-ccccccCCcCccceeeeeccccccc-cCcHHHHhcCCcceeeeeccchhhhcccc-c---ccccc
Confidence            34455666665532 21111211 1 22345667766666 34444566666777777776666643332 1   12345


Q ss_pred             ccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECC
Q 036815          103 LLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLP  182 (1013)
Q Consensus       103 L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~  182 (1013)
                      |+.|+|.+|.|+.+..+.++.++.|+.|||+.|.|+.+.-..|..-.++++|+|++|+|+ .+...-|..+.+|.+|.|+
T Consensus       127 l~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLs  205 (873)
T KOG4194|consen  127 LEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLS  205 (873)
T ss_pred             eeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecc
Confidence            677777777777666666777777777777777776655556666666777777777776 5555556666677777777


Q ss_pred             CCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeeccc
Q 036815          183 HNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGI  262 (1013)
Q Consensus       183 ~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  262 (1013)
                      +|+|+...+..|.++++|+.|+|..|+|. .+....|.++++|+.|.|..|.|.......|..+.+++.|+|+.|+++ .
T Consensus       206 rNrittLp~r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~-~  283 (873)
T KOG4194|consen  206 RNRITTLPQRSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ-A  283 (873)
T ss_pred             cCcccccCHHHhhhcchhhhhhcccccee-eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh-h
Confidence            77777666666777777777777777765 444455677777777777777777655666777777777777777777 3


Q ss_pred             CCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCC
Q 036815          263 IPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK  342 (1013)
Q Consensus       263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~  342 (1013)
                      +.....-++++|+.|+|++|.|..+-++++..+++|++|+|++|+|+...+..|..|..|++|.|+.|.+...--..|..
T Consensus       284 vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~  363 (873)
T KOG4194|consen  284 VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVG  363 (873)
T ss_pred             hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHH
Confidence            34444446788888888888888888888888899999999999999777888999999999999999998777778889


Q ss_pred             CCCCceEECccccccccCch---hhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCc
Q 036815          343 CKNLKDLILNNNKLSGEIPA---ELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV  419 (1013)
Q Consensus       343 l~~L~~L~L~~N~l~~~~p~---~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  419 (1013)
                      +++|+.|||++|.+++.+.+   .+..+++|+.|++.+|++..+.-.+|..+..|++|+|.+|.|..+-|.+|..+ .|+
T Consensus       364 lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk  442 (873)
T KOG4194|consen  364 LSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELK  442 (873)
T ss_pred             hhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhh
Confidence            99999999999999876544   46679999999999999995555689999999999999999998999999999 999


Q ss_pred             EEEccCCcCCcCC
Q 036815          420 WLDLNSNNLTGDI  432 (1013)
Q Consensus       420 ~L~l~~N~l~~~~  432 (1013)
                      .|-+..-.+-++.
T Consensus       443 ~Lv~nSssflCDC  455 (873)
T KOG4194|consen  443 ELVMNSSSFLCDC  455 (873)
T ss_pred             hhhhcccceEEec
Confidence            9999877776554

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-38  Score=339.03  Aligned_cols=206  Identities=26%  Similarity=0.349  Sum_probs=178.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ..++|+..+.||+|+||.||+|+-+ +|..+|+|++.+..-.   ..+.+..|-.+|...++|+||+++-.|.+.+..||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999976 5889999998764332   33567889999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||++||++..+|....      .+++..++.++.+++-|+..+|+.   |+|||||||+|+|||..|++||+|||++.
T Consensus       219 iMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             EEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence            999999999999997543      389999999999999999999999   99999999999999999999999999985


Q ss_pred             ecccc--------------------Cccee-------------------------eeeeccCCCccCcccccCCCCCccc
Q 036815          888 LISAL--------------------DTHLS-------------------------VSTLAGTPGYVPPEYYQSFRCTAKG  922 (1013)
Q Consensus       888 ~~~~~--------------------~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~  922 (1013)
                      -+...                    .....                         ....+|||.|+|||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            43210                    00000                         0135699999999999999999999


Q ss_pred             hhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          923 DVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       923 DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      |.||+|||+|||+.|.+||..+..
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp  393 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETP  393 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999987653

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=351.40  Aligned_cols=390  Identities=28%  Similarity=0.291  Sum_probs=343.3

Q ss_pred             ceecccCCccccccccccc--CCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEe
Q 036815            3 SVLKLSSNLFTLNSTSLLQ--LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLD   80 (1013)
Q Consensus         3 ~~L~l~~n~~~~~~~~~~~--~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~   80 (1013)
                      ..||++++++..++.+.+.  .|+..+.|++++|++.. +....|.++++|+++++.+|.++ .+|.. -....+|+.|+
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~-id~~~f~nl~nLq~v~l~~N~Lt-~IP~f-~~~sghl~~L~  131 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSH-IDFEFFYNLPNLQEVNLNKNELT-RIPRF-GHESGHLEKLD  131 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeecccccccc-CcHHHHhcCCcceeeeeccchhh-hcccc-cccccceeEEe
Confidence            4689999999988655433  44556779999999966 55566899999999999999998 78862 34456799999


Q ss_pred             CCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCc
Q 036815           81 LSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNH  160 (1013)
Q Consensus        81 Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  160 (1013)
                      |.+|.|+.+...   .+..++.|+.||||.|.|+.+.-.+|..-.++++|+|++|.|+.+..+.|..+.+|..|.|++|+
T Consensus       132 L~~N~I~sv~se---~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNr  208 (873)
T KOG4194|consen  132 LRHNLISSVTSE---ELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNR  208 (873)
T ss_pred             eeccccccccHH---HHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCc
Confidence            999999854332   23467899999999999999988899988999999999999999999999999999999999999


Q ss_pred             ccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCC
Q 036815          161 ITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP  240 (1013)
Q Consensus       161 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  240 (1013)
                      |+ .+|...|+.+++|+.|+|..|+|.-.....|.++++|+.|.|..|+|. .+.+.+|-.+.++++|+|..|+++....
T Consensus       209 it-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~  286 (873)
T KOG4194|consen  209 IT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNE  286 (873)
T ss_pred             cc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhhhc
Confidence            99 999999998999999999999999666778999999999999999998 7778889999999999999999998888


Q ss_pred             cCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCc
Q 036815          241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLE  320 (1013)
Q Consensus       241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~  320 (1013)
                      .++.++++|+.|++++|.|. .+..+..+-.++|++|+|++|+|+...+++|..+.+|++|.|++|.+...-...|..++
T Consensus       287 g~lfgLt~L~~L~lS~NaI~-rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ls  365 (873)
T KOG4194|consen  287 GWLFGLTSLEQLDLSYNAIQ-RIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLS  365 (873)
T ss_pred             ccccccchhhhhccchhhhh-eeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhh
Confidence            89999999999999999998 45555556678999999999999999999999999999999999999966667899999


Q ss_pred             chHHHHhhhccccCCCC---cCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceE
Q 036815          321 HLEQFIAWFNGLEGKIP---PELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVL  397 (1013)
Q Consensus       321 ~L~~L~l~~n~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  397 (1013)
                      +|+.|+|..|.+...+-   ..|..|++|+.|.|.+|++....-..|..+.+|+.|||.+|.|..+-|.+|..+ +|+.|
T Consensus       366 sL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~L  444 (873)
T KOG4194|consen  366 SLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKEL  444 (873)
T ss_pred             hhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhh
Confidence            99999999999986554   467889999999999999995555688999999999999999998999999999 89998


Q ss_pred             EccCC
Q 036815          398 QLGNN  402 (1013)
Q Consensus       398 ~L~~N  402 (1013)
                      .+..-
T Consensus       445 v~nSs  449 (873)
T KOG4194|consen  445 VMNSS  449 (873)
T ss_pred             hhccc
Confidence            77543

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=314.32  Aligned_cols=246  Identities=24%  Similarity=0.346  Sum_probs=198.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEee--ccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLI--RLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +.|++.+.||+|.|+.||++... +|+.+|+|.+.  +.+..+.+++.+|+++-+.++||||+++.+.+.+.+..|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            46888889999999999999765 68899988763  3344567889999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC---CcEEEeecccce
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE---MEARVSDFGMAR  887 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~  887 (1013)
                      +|.|++|..-+-.+      ..+++..+-..++||++||.|+|.+   +|||||+||.|+++.+.   .-+|++|||+|.
T Consensus        91 ~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             cccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999998776543      3478888999999999999999999   99999999999999543   458999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-cCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-EGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~  966 (1013)
                      .+.   ........+|||+|||||+++..+|+..+|||+.|||+|-++.|.+||.+.+... .+.+.++.... .++.++
T Consensus       162 ~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~I~~g~yd~~~~~w~  237 (355)
T KOG0033|consen  162 EVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQIKAGAYDYPSPEWD  237 (355)
T ss_pred             EeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhccccCCCCcccC
Confidence            876   3334567789999999999999999999999999999999999999998744221 11111111111 011122


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      -+.++                     ..+++++||..||++|.|+.|
T Consensus       238 ~is~~---------------------Ak~LvrrML~~dP~kRIta~E  263 (355)
T KOG0033|consen  238 TVTPE---------------------AKSLIRRMLTVNPKKRITADE  263 (355)
T ss_pred             cCCHH---------------------HHHHHHHHhccChhhhccHHH
Confidence            11111                     348999999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-38  Score=342.52  Aligned_cols=241  Identities=29%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +-|..++.||.|+.|.|-.|++. +|+.+|||.+.+..   ......+.+|+-+|+.+.||||+++|+++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45788899999999999999975 79999999886542   223456889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||.|.+++..++.      +++.++++++.||+.|+.|+|..   +|+|||+||+|+++|..+++||+|||+|..-
T Consensus        92 Eyv~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EecCCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc
Confidence            99999999999976554      88999999999999999999999   9999999999999999999999999999764


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc--ccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK--QME  966 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  966 (1013)
                      ..   ..-..+.+|+|.|.|||+++|.+| +.++||||+|||+|.++||+.||+++.     +.. .-.++..|.  ...
T Consensus       163 ~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~-LLlKV~~G~f~MPs  233 (786)
T KOG0588|consen  163 VP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRV-LLLKVQRGVFEMPS  233 (786)
T ss_pred             cC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHH-HHHHHHcCcccCCC
Confidence            32   222346789999999999999987 578999999999999999999998533     111 122233232  223


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+.++                     +.+++.+|+.+||++|.|++|
T Consensus       234 ~Is~e---------------------aQdLLr~ml~VDp~~RiT~~e  259 (786)
T KOG0588|consen  234 NISSE---------------------AQDLLRRMLDVDPSTRITTEE  259 (786)
T ss_pred             cCCHH---------------------HHHHHHHHhccCccccccHHH
Confidence            33332                     358999999999999999864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=335.72  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=208.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccch-HHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +.....++++||+|.||.|.++....+..||||+++..+.... .+|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            4566788999999999999999998789999999987655544 789999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      ||++|+|.+++..+....    +.-....+|+.||+.||+||.+.   ++||||+.++|+|++.++++||+|||+++.+.
T Consensus       616 YmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            999999999997654321    34455677999999999999999   99999999999999999999999999999877


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc--CCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT--GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ..+.+.......-+.+|||||.+.-+++++++|||+||+++||+++  ...||....  +.+..+-.......+....++
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhcCCCCcceec
Confidence            7676666666667889999999999999999999999999999876  788887533  223333333323222221111


Q ss_pred             -ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 -DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 -d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .|..       .         ...+++++.+||+.|-++|||++|
T Consensus       767 ~~P~~-------c---------p~~lyelml~Cw~~es~~RPsFe~  796 (807)
T KOG1094|consen  767 SRPPA-------C---------PQGLYELMLRCWRRESEQRPSFEQ  796 (807)
T ss_pred             cCCCc-------C---------cHHHHHHHHHHhchhhhcCCCHHH
Confidence             1111       1         113679999999999999999864

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=334.02  Aligned_cols=245  Identities=27%  Similarity=0.398  Sum_probs=198.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc-hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG-DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ..|+..+.||+|+||.||+|.+. .++.||+|++.-....+ .+++++|+.++.+++++||.++|+.+..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35777899999999999999976 67889999885443333 46789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      |.||++.+.+....      .+++..+..|+++++.|+.|||.+   +.+|||||+.||++..+|.+|++|||.+..+..
T Consensus        93 ~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             hcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999996433      247777888999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ...  ...+.+||+.|||||++.+..|+.|+||||+|++.+||++|.+|+........-      ..+     .+..+|.
T Consensus       164 ~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------flI-----pk~~PP~  230 (467)
T KOG0201|consen  164 TVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------FLI-----PKSAPPR  230 (467)
T ss_pred             hhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------Eec-----cCCCCCc
Confidence            322  236789999999999999889999999999999999999999998764321100      000     0111121


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.   ..++          ..+.+|+..||+.||+.||||.+
T Consensus       231 L~---~~~S----------~~~kEFV~~CL~k~P~~RpsA~~  259 (467)
T KOG0201|consen  231 LD---GDFS----------PPFKEFVEACLDKNPEFRPSAKE  259 (467)
T ss_pred             cc---cccC----------HHHHHHHHHHhhcCcccCcCHHH
Confidence            11   0111          12568999999999999999974

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.7e-38  Score=315.43  Aligned_cols=267  Identities=22%  Similarity=0.243  Sum_probs=198.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc--hHHHHHHHHHHhccCCcceeeeccEEEe--CCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRNLVPLLGYCKI--GEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  808 (1013)
                      +.|+..+.|++|+||.||+|+++ +++.||+|++.......  .-.-.+|+.++.+.+|||||.+-.+..-  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45888999999999999999987 67889999986543221  2346899999999999999999988754  3578999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      ||||+ -+|...++...     +++...+++.++.|+++|++|||.+   .|+|||+||+|+|++..|.+||+|||+||.
T Consensus       156 Me~~E-hDLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             HHHHH-hhHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence            99999 59999997644     3488999999999999999999999   999999999999999999999999999998


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh--cCccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR--EGKQM  965 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~  965 (1013)
                      ++..-  ...+..+.|..|+|||.+.+. .|+++.|+||+|||+.||+++++.|.+...-++  ...+.....  ....+
T Consensus       227 ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~llGtPte~iw  302 (419)
T KOG0663|consen  227 YGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFKLLGTPSEAIW  302 (419)
T ss_pred             hcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHHHhCCCccccC
Confidence            87542  234556789999999998765 689999999999999999999999987653322  111211121  11112


Q ss_pred             cccCh-hh---hcccCCCChhhHHHHHHH---HHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDP-EL---LLVTKGTDESEAEEVKEM---VRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~-~~---~~~~~~~~~~~~~~~~~~---~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..++. ..   ....+.....-.......   ..-.+++..++..||++|.||+|
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~  357 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED  357 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence            11110 00   000000000000000000   22458999999999999999975

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-37  Score=337.21  Aligned_cols=245  Identities=26%  Similarity=0.326  Sum_probs=193.9

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      |+..+.||+|+||.||+|.+. +++.||+|++.....   .....+.+|++++++++|++|+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            777899999999999999975 689999998754322   2234578899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++|+|.+++....    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          82 MNGGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             cCCCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            99999998885432    12488999999999999999999999   999999999999999999999999999987543


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ..   ......|+..|+|||++.+..++.++||||+||++|||++|+.||........  .+-+.........  .....
T Consensus       155 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~--~~~~~  227 (285)
T cd05631         155 GE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKEDQE--EYSEK  227 (285)
T ss_pred             CC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhcccc--cCCcc
Confidence            21   12345689999999999999999999999999999999999999986543211  1111111111100  00000


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                             .+          ..+.+++.+||+.||++||++
T Consensus       228 -------~s----------~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05631         228 -------FS----------EDAKSICRMLLTKNPKERLGC  250 (285)
T ss_pred             -------CC----------HHHHHHHHHHhhcCHHHhcCC
Confidence                   11          125689999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-38  Score=304.09  Aligned_cols=245  Identities=25%  Similarity=0.359  Sum_probs=201.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++++.||+|.||.||.|+.+ ++..||+|++.+..   ...++++.+|+++-+.++||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            357999999999999999999976 56789999987643   33457899999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      +||.+.|.+...+......    .+++.....+++|+|.|+.|+|.+   +||||||||+|+|++.++..|++|||-+..
T Consensus       101 lEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             EEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            9999999999999854432    377888889999999999999999   999999999999999999999999999875


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      -+    .....+.+||..|.|||+..+..++.++|+|++|++.||++.|.+||.... .+..+.+..+...   .....+
T Consensus       174 ~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~---~~p~~i  245 (281)
T KOG0580|consen  174 AP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDL---KFPSTI  245 (281)
T ss_pred             cC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccc---cCCccc
Confidence            43    233456789999999999999999999999999999999999999998754 2222222211111   111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..                     ...++|.+|+..+|.+|.+..|
T Consensus       246 s~---------------------~a~dlI~~ll~~~p~~r~~l~~  269 (281)
T KOG0580|consen  246 SG---------------------GAADLISRLLVKNPIERLALTE  269 (281)
T ss_pred             Ch---------------------hHHHHHHHHhccCccccccHHH
Confidence            11                     1458999999999999987643

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=323.10  Aligned_cols=205  Identities=30%  Similarity=0.458  Sum_probs=175.9

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeec--cCccchHHHHHHHHHHhccCCcceeeeccEEEe-----C
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI-----G  802 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  802 (1013)
                      +...+|...+.||+|+||.|+.|.++ +|+.||||++..  ......++..+|+.+++.++|+||+.+.+++..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34556777899999999999999986 689999999863  233445678899999999999999999998865     3


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      ...|+|+|+|+ -+|...++...      .++.+.+..+++|+++||+|+|+.   +|+|||+||+|++++.+..+||+|
T Consensus        99 ~DvYiV~elMe-tDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen   99 NDVYLVFELME-TDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             ceeEEehhHHh-hHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecc
Confidence            46799999996 68999996433      388999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ||+|+...........+....|..|+|||++. ...|+.+.||||+|||+.||++|++-|.+.+
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d  232 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD  232 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence            99999876543333446678899999999864 5689999999999999999999999998765

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-38  Score=321.85  Aligned_cols=242  Identities=23%  Similarity=0.398  Sum_probs=204.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-cCCCEEEEEEeeccCccchH---HHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATL-KDGSSVAIKKLIRLSCQGDR---EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .+|++.+.||+|.||.|-+|.. ..|+.||||.+.+....+.+   .+.+|+++|..++||||+.+|++|+..+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4688889999999999999986 57999999998776555554   4788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||..+|.|++|+..+..      +++.+++.+++||..|+.|+|.+   ++||||+|.+|||+|.++++||+|||++-.+
T Consensus       133 EYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  133 EYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence            99999999999986554      89999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....   ...+++|++-|.+||++.|.+| ++.+|-||+||++|-++.|..||++.+..     . .-..+..+.+.+.-
T Consensus       204 ~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----~-lvrQIs~GaYrEP~  274 (668)
T KOG0611|consen  204 ADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----R-LVRQISRGAYREPE  274 (668)
T ss_pred             cccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----H-HHHHhhcccccCCC
Confidence            5322   2456789999999999999887 57899999999999999999999986532     1 22233344443322


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .|.-                    ...+|++||..+|++|.|+++
T Consensus       275 ~PSd--------------------A~gLIRwmLmVNP~RRATieD  299 (668)
T KOG0611|consen  275 TPSD--------------------ASGLIRWMLMVNPERRATIED  299 (668)
T ss_pred             CCch--------------------HHHHHHHHHhcCcccchhHHH
Confidence            2211                    347899999999999999754

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1e-41  Score=347.78  Aligned_cols=473  Identities=28%  Similarity=0.443  Sum_probs=382.8

Q ss_pred             CCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCE
Q 036815           74 DKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQR  153 (1013)
Q Consensus        74 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  153 (1013)
                      ..|+.|.+++|.++.....    ...+..|..|++++|++.. .|.+++.+..++.|+.++|++. .+|+.+..+.+|+.
T Consensus        45 v~l~~lils~N~l~~l~~d----l~nL~~l~vl~~~~n~l~~-lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~  118 (565)
T KOG0472|consen   45 VDLQKLILSHNDLEVLRED----LKNLACLTVLNVHDNKLSQ-LPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVK  118 (565)
T ss_pred             cchhhhhhccCchhhccHh----hhcccceeEEEeccchhhh-CCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhh
Confidence            4688999999999854333    3466789999999999986 6778999999999999999998 78999999999999


Q ss_pred             eeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccc
Q 036815          154 LDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN  233 (1013)
Q Consensus       154 L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n  233 (1013)
                      |++++|.+. .+|++++. +..|+.++..+|+++ ..|..+..+.+|..|++.+|+++ ..|..... ++.|++|+...|
T Consensus       119 l~~s~n~~~-el~~~i~~-~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N  193 (565)
T KOG0472|consen  119 LDCSSNELK-ELPDSIGR-LLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSN  193 (565)
T ss_pred             hhcccccee-ecCchHHH-Hhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHH-HHHHHhcccchh
Confidence            999999999 88888887 478999999999999 66778899999999999999998 66666545 889999999999


Q ss_pred             cCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCC
Q 036815          234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP  313 (1013)
Q Consensus       234 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  313 (1013)
                      .+. .+|..++.+.+|..|++.+|+|. .+|  .|+++..|.+|+++.|+|.....+...+++++.+||+..|+++ +.|
T Consensus       194 ~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~P  268 (565)
T KOG0472|consen  194 LLE-TLPPELGGLESLELLYLRRNKIR-FLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVP  268 (565)
T ss_pred             hhh-cCChhhcchhhhHHHHhhhcccc-cCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCc
Confidence            998 79999999999999999999998 666  5678999999999999999444444569999999999999999 899


Q ss_pred             cccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCC---CCeEE-------ecCCcc---
Q 036815          314 QELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSN---LEWIS-------LTGNEL---  380 (1013)
Q Consensus       314 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~-------L~~N~l---  380 (1013)
                      ..++.+++|+.|++++|.++ .+|.+++++ .|+.|-+.+|.+. .+-.++-+...   |++|.       ++.-.-   
T Consensus       269 de~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e  345 (565)
T KOG0472|consen  269 DEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE  345 (565)
T ss_pred             hHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence            99999999999999999999 789999999 9999999999986 33333322211   22221       111100   


Q ss_pred             -CCCCC----hhhhccCCCceEEccCCeeeeecCCCCcCCCC---CcEEEccCCcCCcCCCchhhhccCCCCCCCcccCC
Q 036815          381 -TGQIP----PEFSRLTRLAVLQLGNNRFKGEIPGELGNCSS---LVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSN  452 (1013)
Q Consensus       381 -~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~  452 (1013)
                       .+..|    .....+.+.+.|+++.-+++ .+|.+...--.   .+..+++.|++. ++|..+......          
T Consensus       346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkel----------  413 (565)
T KOG0472|consen  346 TAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKEL----------  413 (565)
T ss_pred             ccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHH----------
Confidence             01111    12234556778888888887 66765433332   567888888876 566655432110          


Q ss_pred             ceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCC
Q 036815          453 TLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI  532 (1013)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~  532 (1013)
                                                        ...+..+.+..+.+|..+.++++|+.|+|++|-+. .+|.+++.+.
T Consensus       414 ----------------------------------vT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv  458 (565)
T KOG0472|consen  414 ----------------------------------VTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLV  458 (565)
T ss_pred             ----------------------------------HHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhh
Confidence                                              01122333445566777788899999999999999 8999999999


Q ss_pred             CCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcc-cccCCCcceEEECcCCCCCCcCCCCCCCCCCCccccc
Q 036815          533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE-SFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYA  611 (1013)
Q Consensus       533 ~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~l~~l~l~~n~l~~~~p~~~~~~~~~~~~~~  611 (1013)
                      .||.||+|+|+|. .+|+++..+..|+.+-.++|++. .+|. .+.++.+|..|||.+|.+...+|..|...++..+...
T Consensus       459 ~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~  536 (565)
T KOG0472|consen  459 RLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELD  536 (565)
T ss_pred             hhheecccccccc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEec
Confidence            9999999999999 89999999999999999999997 5555 4999999999999999999999999999999999999


Q ss_pred             CCC
Q 036815          612 NNP  614 (1013)
Q Consensus       612 ~n~  614 (1013)
                      |||
T Consensus       537 gNp  539 (565)
T KOG0472|consen  537 GNP  539 (565)
T ss_pred             CCc
Confidence            998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-37  Score=348.64  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=194.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeC-C
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIG-E  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  803 (1013)
                      .++|++.+.||+|+||.||+|.+.      +++.||+|++..... ...+.+.+|+++++++ +||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467999999999999999999742      356799998764322 2345688999999999 899999999988764 4


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCC-------------------------------------------------------
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKAR-------------------------------------------------------  828 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------------  828 (1013)
                      ..++||||+++|+|.+++.......                                                       
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6789999999999999997532100                                                       


Q ss_pred             -CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCc
Q 036815          829 -DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY  907 (1013)
Q Consensus       829 -~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  907 (1013)
                       ...++++.++..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence             023478889999999999999999999   9999999999999999999999999999865432222222334566789


Q ss_pred             cCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHH
Q 036815          908 VPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEE  986 (1013)
Q Consensus       908 ~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~  986 (1013)
                      +|||++.+..++.++|||||||++|||++ |..||......+    .+ ......+.....  +      ...       
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~-~~~~~~~~~~~~--~------~~~-------  302 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EF-CQRLKDGTRMRA--P------ENA-------  302 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HH-HHHHhcCCCCCC--C------CCC-------
Confidence            99999999899999999999999999997 999997643211    11 111111111110  0      000       


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          987 VKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       987 ~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         ...+.+++.+||+.||++|||+.|
T Consensus       303 ---~~~l~~li~~cl~~dp~~RPs~~e  326 (338)
T cd05102         303 ---TPEIYRIMLACWQGDPKERPTFSA  326 (338)
T ss_pred             ---CHHHHHHHHHHccCChhhCcCHHH
Confidence               112568999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=336.84  Aligned_cols=232  Identities=31%  Similarity=0.493  Sum_probs=188.3

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCHH
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLE  818 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  818 (1013)
                      .+-+|.|+.|.||.|+.+ ++.||||++....       ..+++-|++++||||+.+.|+|.....+|||||||..|.|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            467999999999999997 7899999884322       34678899999999999999999999999999999999999


Q ss_pred             HHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceee
Q 036815          819 EVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV  898 (1013)
Q Consensus       819 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  898 (1013)
                      ++++..      ++++-.....+..+||.||.|||.+   .|||||||.-||||+.+..+||+|||.++.....   .+.
T Consensus       201 ~VLka~------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STk  268 (904)
T KOG4721|consen  201 EVLKAG------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STK  268 (904)
T ss_pred             HHHhcc------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---hhh
Confidence            999754      3477788899999999999999999   9999999999999999999999999999876543   233


Q ss_pred             eeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCC
Q 036815          899 STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKG  978 (1013)
Q Consensus       899 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  978 (1013)
                      ..++||..|||||+++..+.+.|+||||||||+|||+||..||..-+....      .+-+......-.++...      
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwGVGsNsL~LpvPstc------  336 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWGVGSNSLHLPVPSTC------  336 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EEeccCCcccccCcccC------
Confidence            457899999999999999999999999999999999999999875332110      00111111111111111      


Q ss_pred             CChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          979 TDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       979 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                 ..-|.-++++||+-.|..||++.|
T Consensus       337 -----------P~GfklL~Kqcw~sKpRNRPSFrq  360 (904)
T KOG4721|consen  337 -----------PDGFKLLLKQCWNSKPRNRPSFRQ  360 (904)
T ss_pred             -----------chHHHHHHHHHHhcCCCCCccHHH
Confidence                       012456889999999999999864

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=350.36  Aligned_cols=247  Identities=26%  Similarity=0.436  Sum_probs=198.6

Q ss_pred             CCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ...+.++||.|.||.|++|+++    ....||||.++.... ....+|..|+.||.+++||||+++.|+.......+||+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3557789999999999999986    235799999875433 34567999999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |||++|+|+.+|+.+..     .+++.+..-++++||.||+||.++   ++|||||..+||||+.+-.+|++|||++|.+
T Consensus       710 EyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             hhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence            99999999999976542     289999999999999999999999   9999999999999999999999999999987


Q ss_pred             cccC-cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          890 SALD-THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       890 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      +++. .........-+.+|.|||.+...+++.+||||||||+|||.++ |.+||.....  ++...-+..-.+-+..++ 
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--QdVIkaIe~gyRLPpPmD-  858 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAIEQGYRLPPPMD-  858 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--HHHHHHHHhccCCCCCCC-
Confidence            6533 1111222223569999999999999999999999999999988 9999876432  222211222111111111 


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                           ....+.+|+..||+.|-.+||+++|
T Consensus       859 ---------------------CP~aL~qLMldCWqkdR~~RP~F~q  883 (996)
T KOG0196|consen  859 ---------------------CPAALYQLMLDCWQKDRNRRPKFAQ  883 (996)
T ss_pred             ---------------------CcHHHHHHHHHHHHHHhhcCCCHHH
Confidence                                 1224779999999999999999865

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-38  Score=326.20  Aligned_cols=261  Identities=26%  Similarity=0.336  Sum_probs=192.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCC-----EEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE-----ERLLV  808 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  808 (1013)
                      .|...+++|.|+||.||+|... +++.||||++......    -.+|+++|++++|||||++.-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4677899999999999999976 4689999998543322    236999999999999999999886532     23589


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeecccce
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMAR  887 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~  887 (1013)
                      ||||+ .+|.++++....  ....++...++-+..||.+||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus       101 leymP-~tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHhch-HHHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            99999 599999975322  223477788889999999999999998   99999999999999987 899999999999


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-----
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-----  961 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----  961 (1013)
                      .+......   .....|..|+|||.+.|. .|+.+.||||.|||+.||+-|++-|.+++. ..++.+.++.....     
T Consensus       175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence            88765544   345678899999998765 699999999999999999999999998543 23344444332111     


Q ss_pred             ----CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 ----GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ----~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ....+.-.|.+..   ..... ......-...++++.++++.+|.+|.++.|
T Consensus       251 ~~mn~~y~~~~~p~ik~---~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~  302 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKA---HPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALE  302 (364)
T ss_pred             hhcCcccccccCccccc---cccee-ecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence                0111111111110   00000 000011123579999999999999998753

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=323.86  Aligned_cols=264  Identities=28%  Similarity=0.388  Sum_probs=191.3

Q ss_pred             CCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhc--cCCcceeeeccEEEeCC----EEEEEE
Q 036815          736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGK--IKHRNLVPLLGYCKIGE----ERLLVY  809 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~  809 (1013)
                      .+..++||+|+||.||+|... ++.||||++.   .+..+.|+.|-++++.  ++|+||++++++-..+.    +++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            344567999999999999997 6999999874   3456678888888765  48999999999876655    889999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC------IPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ||.+.|+|.+|+..+       .++|....+|+..+++||+|||+..      ++.|+|||||++||||..|+++.|+||
T Consensus       288 ~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             eeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            999999999999754       3999999999999999999999753      478999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCC------CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC------TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      |+|..+............+||.+|||||++.+..-      -.+.||||+|.|+|||+++...++.....+-.+.  ...
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp--fe~  438 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP--FEA  438 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc--hhH
Confidence            99999876554444445789999999999976531      2368999999999999997765542111110000  001


Q ss_pred             HHhcCccccccCh-hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDP-ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       958 ~~~~~~~~~~~d~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      .++..+..+.+-. -.....+...++....-..+.-+.+.+..||+.||+.|.||.
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            1111111110000 000000001111111123445577999999999999999974

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=323.50  Aligned_cols=249  Identities=26%  Similarity=0.332  Sum_probs=191.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--------------chHHHHHHHHHHhccCCcceeeec
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--------------GDREFMAEMETLGKIKHRNLVPLL  796 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l~  796 (1013)
                      ..+.|++.+.||+|.||.|-+|++. +++.||||++.+....              .-+.+.+|+.+|++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4578999999999999999999986 6899999988543211              124789999999999999999999


Q ss_pred             cEEEe--CCEEEEEEEcccCCCHHHHhcccccCCCCcc-ccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          797 GYCKI--GEERLLVYEFMKFGSLEEVLHGRAKARDQRI-LTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       797 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ++..+  .+..|+|+|||..|.+...=       ...+ +++.++++++++++.||+|||.+   |||||||||+|+|++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p-------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP-------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS  244 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC-------CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence            99876  46889999999988765432       2333 89999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccC---cceeeeeeccCCCccCcccccCC----CCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          874 HEMEARVSDFGMARLISALD---THLSVSTLAGTPGYVPPEYYQSF----RCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      ++|++||+|||.+..+....   .........|||.|+|||...++    ..+.+.||||+||++|.|+.|+.||.++..
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            99999999999998763321   11223347899999999998663    235689999999999999999999976321


Q ss_pred             CCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          947 GDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       947 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           .+.. .++......-...++                 ....+.++|.+||+.||++|.+..+
T Consensus       325 -----~~l~-~KIvn~pL~fP~~pe-----------------~~e~~kDli~~lL~KdP~~Ri~l~~  368 (576)
T KOG0585|consen  325 -----LELF-DKIVNDPLEFPENPE-----------------INEDLKDLIKRLLEKDPEQRITLPD  368 (576)
T ss_pred             -----HHHH-HHHhcCcccCCCccc-----------------ccHHHHHHHHHHhhcChhheeehhh
Confidence                 1111 112211111100011                 1123559999999999999998753

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=336.65  Aligned_cols=237  Identities=22%  Similarity=0.296  Sum_probs=193.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.....   ...+.+.+|++++++++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46899999999999999999986 688999998854321   23456889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          81 EYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence            9999999999996433      378899999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-cccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-KQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  968 (1013)
                      ...     .....|++.|+|||++.+..++.++||||+||++|||++|+.||.....     .+......... ......
T Consensus       152 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~  221 (291)
T cd05612         152 RDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILAGKLEFPRHL  221 (291)
T ss_pred             cCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCcCCCccC
Confidence            321     1234689999999999998999999999999999999999999976431     11111111110 000111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      +                     ..+.+++.+||+.||.+||+
T Consensus       222 ~---------------------~~~~~li~~~l~~dp~~R~~  242 (291)
T cd05612         222 D---------------------LYAKDLIKKLLVVDRTRRLG  242 (291)
T ss_pred             C---------------------HHHHHHHHHHcCCCHHHccC
Confidence            1                     12458999999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-37  Score=318.55  Aligned_cols=268  Identities=24%  Similarity=0.288  Sum_probs=199.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcc-eeeeccEEEeCC------E
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRN-LVPLLGYCKIGE------E  804 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~  804 (1013)
                      .|...++||+|+||+||+|+.+ +|+.||+|++.-...  .......+|+.++++++|+| |+++++++....      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            4666778999999999999986 688999999865433  24566789999999999999 999999998876      7


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .++|+||++ -+|..++.......  ..++...++.+++|+++|++|||++   +|+||||||.||+|+++|.+||+|||
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence            899999998 69999998655321  3367788999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-  962 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  962 (1013)
                      +|+.+.-..  .......+|..|+|||++.+. .|++..||||+|||++||+++++-|.+....+  ....+......+ 
T Consensus       166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~  241 (323)
T KOG0594|consen  166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPN  241 (323)
T ss_pred             hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCC
Confidence            999664222  224556788999999999877 78999999999999999999999998765321  111122222221 


Q ss_pred             -ccccccC--hhhh-cccCCC-ChhhHHHHHH-HHHHHHHHHhcccCCCCCCCCCC
Q 036815          963 -KQMEVID--PELL-LVTKGT-DESEAEEVKE-MVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       963 -~~~~~~d--~~~~-~~~~~~-~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                       ..+..+.  ++.. ...+.. .......++. .....+++.+|++.+|++|.||+
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~  297 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK  297 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence             1111110  0000 000000 0000111111 12467899999999999999985

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6e-37  Score=337.81  Aligned_cols=259  Identities=23%  Similarity=0.353  Sum_probs=196.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-----------------CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeee
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-----------------GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPL  795 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  795 (1013)
                      ++|++.+.||+|+||.||+|.+.+                 +..||+|.+..... ....++.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578999999999999999998642                 23699998764322 234568999999999999999999


Q ss_pred             ccEEEeCCEEEEEEEcccCCCHHHHhcccccC-------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 036815          796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA-------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIH  862 (1013)
Q Consensus       796 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  862 (1013)
                      ++++.+.+..++||||+++|+|.+++......             .....+++..+.+++.|++.||+|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            99999999999999999999999998643211             1123478899999999999999999999   9999


Q ss_pred             cCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc--CCCC
Q 036815          863 RDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT--GKRP  940 (1013)
Q Consensus       863 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p  940 (1013)
                      |||||+||+++.++.+||+|||+++.....+.........++..|+|||++.+..++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999987644333222233455788999999988899999999999999999987  5567


Q ss_pred             CCCCCCCCccHHHHHHHHHhcCcc-ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          941 TDKDDFGDTNLVGWVKMKVREGKQ-MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       941 f~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      |....  ......++......... .....+.      ..          ...+.+++.+||+.||++|||++|
T Consensus       242 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~------~~----------~~~~~~li~~cl~~~p~~RPs~~~  297 (304)
T cd05096         242 YGELT--DEQVIENAGEFFRDQGRQVYLFRPP------PC----------PQGLYELMLQCWSRDCRERPSFSD  297 (304)
T ss_pred             CCcCC--HHHHHHHHHHHhhhccccccccCCC------CC----------CHHHHHHHHHHccCCchhCcCHHH
Confidence            66432  22222222222211110 0000000      00          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.1e-37  Score=340.72  Aligned_cols=239  Identities=27%  Similarity=0.334  Sum_probs=194.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+++ +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46889999999999999999986 57899999886432   123356889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        98 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             cCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            9999999999996432      378889999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ....     ....|++.|+|||++.+..++.++|||||||++|||++|+.||.....     .+... .+..+...  ++
T Consensus       169 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~-~i~~~~~~--~p  235 (329)
T PTZ00263        169 PDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYE-KILAGRLK--FP  235 (329)
T ss_pred             CCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHH-HHhcCCcC--CC
Confidence            4321     235689999999999999999999999999999999999999975321     11111 11111110  00


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .       ..+          .++.+++.+||+.||++||++
T Consensus       236 ~-------~~~----------~~~~~li~~~L~~dP~~R~~~  260 (329)
T PTZ00263        236 N-------WFD----------GRARDLVKGLLQTDHTKRLGT  260 (329)
T ss_pred             C-------CCC----------HHHHHHHHHHhhcCHHHcCCC
Confidence            0       000          124589999999999999984

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=335.53  Aligned_cols=242  Identities=29%  Similarity=0.402  Sum_probs=196.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|...++||+|+||+|++|..+ +++.+|||.+++...-   +.+..+.|.+++... +||.++.++..|...++.|.|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            56999999999999999999987 5789999998775433   335577888888777 599999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+.||++..+.+       ...+++..++-++..|+.||+|||++   +|||||||.+|||+|.+|++||+|||+++.
T Consensus       448 mey~~Ggdm~~~~~-------~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  448 MEYVAGGDLMHHIH-------TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEecCCCcEEEEEe-------cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence            99999999443332       23389999999999999999999999   999999999999999999999999999985


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      --  ......+++.|||.|||||++.+..|+.++|.|||||++|||+.|..||.+++..+      +...+...   +..
T Consensus       518 ~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d---~~~  586 (694)
T KOG0694|consen  518 GM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVND---EVR  586 (694)
T ss_pred             cC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcC---CCC
Confidence            32  23335678899999999999999999999999999999999999999999865322      11111111   110


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      -|..      .+          .+.+.+++++|..+|++|.-+.
T Consensus       587 yP~~------ls----------~ea~~il~~ll~k~p~kRLG~~  614 (694)
T KOG0694|consen  587 YPRF------LS----------KEAIAIMRRLLRKNPEKRLGSG  614 (694)
T ss_pred             CCCc------cc----------HHHHHHHHHHhccCcccccCCC
Confidence            0100      01          1256899999999999998763

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=334.67  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=203.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCE-EEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE-RLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  809 (1013)
                      ++|.+++.+|+|+||.++.++++ ++..+++|++.-..  ....+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57899999999999999999887 67889999886433  2334467899999999999999999999998888 89999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      +|++||++.+.+...+    +..++++.+..++.|++.|+.|||+.   +|+|||||+.||+++.++.+||+|||+|+..
T Consensus        84 ~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             eecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence            9999999999997654    34589999999999999999999998   9999999999999999999999999999988


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ...+  .......||+.||.||++.+.+|..|+||||+||++|||++-+++|...+...     -+..... +.. ..++
T Consensus       157 ~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----Li~ki~~-~~~-~Plp  227 (426)
T KOG0589|consen  157 NPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----LILKINR-GLY-SPLP  227 (426)
T ss_pred             CCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----HHHHHhh-ccC-CCCC
Confidence            7543  23456789999999999999999999999999999999999999998755332     1111111 110 1111


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..       .          ...+..++..|++.+|+.||+|.|
T Consensus       228 ~~-------y----------s~el~~lv~~~l~~~P~~RPsa~~  254 (426)
T KOG0589|consen  228 SM-------Y----------SSELRSLVKSMLRKNPEHRPSALE  254 (426)
T ss_pred             cc-------c----------cHHHHHHHHHHhhcCCccCCCHHH
Confidence            00       0          112558889999999999999864

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.9e-37  Score=332.93  Aligned_cols=201  Identities=25%  Similarity=0.378  Sum_probs=171.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56999999999999999999986 67899999875432 22345678999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++ +|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~~-~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          85 LDS-DLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             CCc-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            985 8998886432     2378899999999999999999999   999999999999999999999999999976532


Q ss_pred             cCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ...  ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         156 PTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             CCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            221  2234467899999998865 568899999999999999999999997643

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-36  Score=338.29  Aligned_cols=234  Identities=22%  Similarity=0.313  Sum_probs=187.6

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      +.||+|+||.||+|+.+ +++.||+|++.+..   ......+.+|++++++++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 68899999886432   122345778999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      +|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  .
T Consensus        81 ~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~  149 (323)
T cd05571          81 ELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--G  149 (323)
T ss_pred             cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--C
Confidence            9999986432      388999999999999999999999   9999999999999999999999999998753221  1


Q ss_pred             eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-CccccccChhhhc
Q 036815          896 LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEVIDPELLL  974 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~~~~  974 (1013)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.     .......... ......++     
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~~~~p~~~~-----  219 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEIRFPRTLS-----  219 (323)
T ss_pred             CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCCCCCCCCCC-----
Confidence            223345799999999999999999999999999999999999999975321     1111111111 00101011     


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                                      ..+.+++.+||+.||++||+
T Consensus       220 ----------------~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05571         220 ----------------PEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             ----------------HHHHHHHHHHccCCHHHcCC
Confidence                            12558999999999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=302.88  Aligned_cols=257  Identities=21%  Similarity=0.277  Sum_probs=199.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE-cCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeC-----CEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATL-KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG-----EERL  806 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  806 (1013)
                      .++|++.+.+|+|||+.||.++. .+++.+|+|++.-.+.++.+...+|++..++++||||++++++...+     ...|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            46899999999999999999984 47889999999776667778899999999999999999999987443     3589


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      ++++|+..|+|.+.+.....  .+..+++.++.+|+.++++||++||+. .+.++||||||.||++++++.+++.|||.+
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~--kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKI--KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEeehhccccHHHHHHHHhh--cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            99999999999999976554  345699999999999999999999998 234999999999999999999999999998


Q ss_pred             eeccccCc-------ceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 036815          887 RLISALDT-------HLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       887 ~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~  956 (1013)
                      +...-.-.       .+.......|..|+|||.+.   +...+.++|||||||++|+|+.|..||+..-.....+     
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl-----  251 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL-----  251 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-----
Confidence            76432111       01112345789999999985   5567899999999999999999999997522111000     


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             ...+..+.+.......         ....+.+++..|+++||.+||++.|
T Consensus       252 -------aLAv~n~q~s~P~~~~---------yse~l~~lik~mlqvdP~qRP~i~~  292 (302)
T KOG2345|consen  252 -------ALAVQNAQISIPNSSR---------YSEALHQLIKSMLQVDPNQRPTIPE  292 (302)
T ss_pred             -------EEeeeccccccCCCCC---------ccHHHHHHHHHHhcCCcccCCCHHH
Confidence                   0111111111111111         1123679999999999999999753

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=360.87  Aligned_cols=253  Identities=31%  Similarity=0.472  Sum_probs=202.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC--CC----EEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD--GS----SVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      ....+..+.||+|+||.||.|...+  +.    .||+|++.+.. .+...+|.+|..+|+.++|||||+++|+|.+.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3456677899999999999998753  33    48999887654 34457899999999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCC-CccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARD-QRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      ++++|||+||+|..+|++.+.... ...++......++.|||+|+.||+++   ++|||||..+|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999986643322 34589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      +|+.+...+.........-..+|||||.+..+.++.|+|||||||++||++| |..||...+..+     ........++
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-----v~~~~~~ggR  922 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-----VLLDVLEGGR  922 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-----HHHHHHhCCc
Confidence            9996655444433333344579999999999999999999999999999999 999987643211     1121222221


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      . +  .|..      .          ..++++++.+||+.+|++||++.
T Consensus       923 L-~--~P~~------C----------P~~ly~lM~~CW~~~pe~RP~F~  952 (1025)
T KOG1095|consen  923 L-D--PPSY------C----------PEKLYQLMLQCWKHDPEDRPSFR  952 (1025)
T ss_pred             c-C--CCCC------C----------ChHHHHHHHHHccCChhhCccHH
Confidence            1 1  1110      0          11367999999999999999974

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-36  Score=337.82  Aligned_cols=200  Identities=27%  Similarity=0.397  Sum_probs=173.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|++. ++..||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367999999999999999999987 57788888775432 2234578999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.+++....      .+++..+..++.|++.||+|||+..  +|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          84 HMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             cCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            999999999996432      3788999999999999999999851  69999999999999999999999999997653


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ...    .....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             ccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            221    23456899999999999999999999999999999999999999753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=339.11  Aligned_cols=245  Identities=31%  Similarity=0.444  Sum_probs=192.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC--C---CEEEEEEeec---cCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD--G---SSVAIKKLIR---LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      +....++||+|+||.||+|+.+.  +   ..||||....   .......+|.+|+++|++++|||||++||++......+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            34456899999999999999763  2   2389998764   22344577999999999999999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +|||+|.||+|.+++.....     .++..++..++.++|.||+|||++   ++|||||..+|+|++.++.+||+|||++
T Consensus       238 ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999986543     389999999999999999999999   9999999999999999999999999998


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHH-hcCcc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKV-REGKQ  964 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~  964 (1013)
                      +.-..  .........-+.+|+|||.+....|+.++|||||||++||+++ |..||.+....  .    ++..+ ..+..
T Consensus       310 ~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~----v~~kI~~~~~r  381 (474)
T KOG0194|consen  310 RAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--E----VKAKIVKNGYR  381 (474)
T ss_pred             cCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--H----HHHHHHhcCcc
Confidence            75431  1111112235679999999999999999999999999999999 88898864422  1    22222 22222


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....+ .           .      ...+..++.+|+..||++||||.+
T Consensus       382 ~~~~~-~-----------~------p~~~~~~~~~c~~~~p~~R~tm~~  412 (474)
T KOG0194|consen  382 MPIPS-K-----------T------PKELAKVMKQCWKKDPEDRPTMST  412 (474)
T ss_pred             CCCCC-C-----------C------HHHHHHHHHHhccCChhhccCHHH
Confidence            11111 0           0      112447778999999999999863

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.2e-36  Score=329.34  Aligned_cols=202  Identities=26%  Similarity=0.348  Sum_probs=172.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46999999999999999999987 57889999886432  2234568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |++++.+..+....      ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          81 YVEKNMLELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             cCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            99987776554321      2388899999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      .... .......|++.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         152 EGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             cccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence            3221 12234568999999999998889999999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-36  Score=332.92  Aligned_cols=233  Identities=25%  Similarity=0.339  Sum_probs=187.9

Q ss_pred             ecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      ||+|+||.||+|++. +++.||+|++.+..   ......+.+|++++++++||||+++++++.+++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999986 57889999886432   22335678899999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCccee
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS  897 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  897 (1013)
                      .+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  149 (312)
T cd05585          81 FHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DK  149 (312)
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cc
Confidence            99996432      388999999999999999999999   99999999999999999999999999997543221  12


Q ss_pred             eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-ccccccChhhhccc
Q 036815          898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-KQMEVIDPELLLVT  976 (1013)
Q Consensus       898 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~  976 (1013)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+......... .....++       
T Consensus       150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~-------  217 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEPLRFPDGFD-------  217 (312)
T ss_pred             cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCCCCCCcCC-------
Confidence            234578999999999999999999999999999999999999997532     122222222111 0011111       


Q ss_pred             CCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          977 KGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       977 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                                    ..+.+++.+||+.||++||++
T Consensus       218 --------------~~~~~li~~~L~~dp~~R~~~  238 (312)
T cd05585         218 --------------RDAKDLLIGLLSRDPTRRLGY  238 (312)
T ss_pred             --------------HHHHHHHHHHcCCCHHHcCCC
Confidence                          124588999999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-36  Score=337.93  Aligned_cols=197  Identities=28%  Similarity=0.391  Sum_probs=172.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC--CCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD--GSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|.++.  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            469999999999999999998653  3689999885432   22345678899999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       110 ~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999996433      388999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ....     .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  231 (340)
T PTZ00426        181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN  231 (340)
T ss_pred             cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence            5431     12457899999999999888999999999999999999999999753

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=341.33  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=196.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|++++.+++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999987 58899999886432   123356788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          81 EYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            9999999999996432      378899999999999999999999   9999999999999999999999999999765


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ..     ......|++.|+|||++.+..++.++||||+||++|||++|+.||......+  ....+.............+
T Consensus       152 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~  224 (333)
T cd05600         152 VT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLKYWKETLQRPVYDD  224 (333)
T ss_pred             cc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHHhccccccCCCCCc
Confidence            33     2234578999999999999899999999999999999999999997643211  1110100000000000000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.               ......+.+++.+||+.+|++|||++|
T Consensus       225 ~~---------------~~~s~~~~~li~~~l~~~~~rr~s~~~  253 (333)
T cd05600         225 PR---------------FNLSDEAWDLITKLINDPSRRFGSLED  253 (333)
T ss_pred             cc---------------cccCHHHHHHHHHHhhChhhhcCCHHH
Confidence            00               000113568999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.2e-36  Score=327.23  Aligned_cols=238  Identities=20%  Similarity=0.292  Sum_probs=187.5

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEe----CCEEEEEEEc
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKI----GEERLLVYEF  811 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  811 (1013)
                      ...||+|++|.||+|.+ +|+.||||++.......   .+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36899999999999998 58999999886543332   3567899999999999999999999876    3467899999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++|+|.+++....      .+++.....++.|++.|++|||+..  +++||||||+||+++.++.+||+|||+++....
T Consensus       104 ~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        104 CTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            99999999997532      3789999999999999999999731  788999999999999999999999999986543


Q ss_pred             cCcceeeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ..     ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.....     .++............ .+
T Consensus       176 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~-~~  244 (283)
T PHA02988        176 PP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINKNNSLK-LP  244 (283)
T ss_pred             cc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCCCCC-CC
Confidence            21     23457889999999876  6789999999999999999999999975431     122222111111111 11


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..       .          ...+.+++.+||+.||++|||++|
T Consensus       245 ~~-------~----------~~~l~~li~~cl~~dp~~Rps~~e  271 (283)
T PHA02988        245 LD-------C----------PLEIKCIVEACTSHDSIKRPNIKE  271 (283)
T ss_pred             Cc-------C----------cHHHHHHHHHHhcCCcccCcCHHH
Confidence            00       0          112568999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-36  Score=343.36  Aligned_cols=255  Identities=29%  Similarity=0.474  Sum_probs=195.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE------cCCCEEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATL------KDGSSVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  804 (1013)
                      .++|++.+.||+|+||.||+|++      .++..||||++.... ....+.+.+|+++++.+ +||||++++++|.+++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45799999999999999999974      235689999875432 22345688999999999 89999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccC---------------------------------------------------------
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKA---------------------------------------------------------  827 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------------  827 (1013)
                      .++||||+++|+|.+++......                                                         
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            99999999999999999643210                                                         


Q ss_pred             ------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          828 ------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       828 ------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                                  .....+++..+..++.||++||+|||++   +|+||||||+||+++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                        0123478899999999999999999999   9999999999999999999999999999876433222


Q ss_pred             eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          896 LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||...... .....++    ..+....  .+..  
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~----~~~~~~~--~~~~--  341 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMI----KEGYRML--SPEC--  341 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHH----HhCccCC--CCCC--
Confidence            22222345678999999999999999999999999999998 88898754321 1111111    1111000  0000  


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           .         ...+.+++.+||+.||++|||++|
T Consensus       342 -----~---------~~~l~~li~~cl~~dP~~RPs~~e  366 (375)
T cd05104         342 -----A---------PSEMYDIMKSCWDADPLKRPTFKQ  366 (375)
T ss_pred             -----C---------CHHHHHHHHHHccCChhHCcCHHH
Confidence                 0         013568999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.5e-36  Score=332.52  Aligned_cols=201  Identities=24%  Similarity=0.353  Sum_probs=170.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|++++++++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999987 688999998864332 223467889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |++ +++.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          84 YVH-TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CCC-cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            997 68888775432     2378889999999999999999999   99999999999999999999999999997543


Q ss_pred             ccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ...  .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         155 VPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            221  12234567899999999865 45788999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-36  Score=335.32  Aligned_cols=246  Identities=22%  Similarity=0.280  Sum_probs=191.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccC----ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLS----CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  805 (1013)
                      +|++.+.||+|+||.||+|+..    +++.||+|++.+..    ....+.+..|+++++++ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4888999999999999999863    57899999886432    12234578899999999 599999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~  151 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGL  151 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcC
Confidence            99999999999999986432      388999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-c
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-K  963 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~  963 (1013)
                      ++.+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ............ .
T Consensus       152 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~  229 (332)
T cd05614         152 SKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKCDPP  229 (332)
T ss_pred             CccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcCCCC
Confidence            9865332221 12345689999999998765 478899999999999999999999975432221 111111111110 0


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ....++                     ..+.+++.+||+.||++||++.
T Consensus       230 ~~~~~~---------------------~~~~~li~~~l~~dp~~R~~~~  257 (332)
T cd05614         230 FPSFIG---------------------PEAQDLLHKLLRKDPKKRLGAG  257 (332)
T ss_pred             CCCCCC---------------------HHHHHHHHHHcCCCHHHcCCCC
Confidence            011111                     1245889999999999999653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-36  Score=341.35  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=194.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCcc-chHHHHHHHHHHhcc-CCcceeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKI-KHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  804 (1013)
                      .++|++.+.||+|+||.||+|++.      ++..||+|++...... ....+.+|+++++.+ +|+||++++++|..++.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357999999999999999999853      2357999988543322 235688999999999 89999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccC---------------------------------------------------------
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKA---------------------------------------------------------  827 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------------  827 (1013)
                      .++||||+++|+|.+++......                                                         
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            99999999999999998643210                                                         


Q ss_pred             -------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeee
Q 036815          828 -------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST  900 (1013)
Q Consensus       828 -------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  900 (1013)
                             .....+++..+++++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                   1123478899999999999999999999   999999999999999999999999999986543222222223


Q ss_pred             eccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCC
Q 036815          901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGT  979 (1013)
Q Consensus       901 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  979 (1013)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||....... ...   . ....+....  .+..      .
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~---~-~~~~~~~~~--~~~~------~  340 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFY---K-MVKRGYQMS--RPDF------A  340 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHH---H-HHHcccCcc--CCCC------C
Confidence            345678999999998899999999999999999997 999997543211 111   1 111110000  0000      0


Q ss_pred             ChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          980 DESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       980 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                ...+.+++.+||+.||++|||++|
T Consensus       341 ----------~~~l~~li~~cl~~dp~~RPs~~~  364 (374)
T cd05106         341 ----------PPEIYSIMKMCWNLEPTERPTFSQ  364 (374)
T ss_pred             ----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence                      012568999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=311.68  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=196.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhcc--CCcceeeeccEEEeCC----EE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYCKIGE----ER  805 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~  805 (1013)
                      ..+..++.+.||+|.||.||+|+++ |+.||||++..   .+++.+.+|.++++.+  +|+||+.+++.-..+.    +.
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            3456778899999999999999998 99999998853   4567788899988775  9999999998765433    67


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCcccEEeCCCCcEEE
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN-----CIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                      ++|++|.+.|+|.||+...       .++.+...+++..+|.||++||..     .+|.|.|||||+.||+|.+++.+.|
T Consensus       285 wLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            9999999999999999642       388999999999999999999963     3578999999999999999999999


Q ss_pred             eecccceeccccCcc--eeeeeeccCCCccCcccccCCC------CCccchhHhHHHHHHHHHcC----------CCCCC
Q 036815          881 SDFGMARLISALDTH--LSVSTLAGTPGYVPPEYYQSFR------CTAKGDVYSFGVVLLELLTG----------KRPTD  942 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg----------~~pf~  942 (1013)
                      +|+|+|.........  ......+||.+|||||++....      .-..+||||||.|+||++.+          +.||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            999999887654322  2234578999999999986431      12358999999999999764          35666


Q ss_pred             CCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          943 KDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       943 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      +--..+....++.+... ..+....++            ......+.+..+.++++.||..+|..|-||
T Consensus       438 d~Vp~DPs~eeMrkVVC-v~~~RP~ip------------nrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVVC-VQKLRPNIP------------NRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             cCCCCCCCHHHHhccee-ecccCCCCC------------cccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence            55555554444332211 111111111            111223455667899999999999999886

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4e-36  Score=333.24  Aligned_cols=234  Identities=22%  Similarity=0.312  Sum_probs=187.1

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999976 68999999886532   222345778999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      +|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....  .
T Consensus        81 ~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~  149 (323)
T cd05595          81 ELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G  149 (323)
T ss_pred             cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC--C
Confidence            9998886432      388999999999999999999999   9999999999999999999999999998753221  1


Q ss_pred             eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-cCccccccChhhhc
Q 036815          896 LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-EGKQMEVIDPELLL  974 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~  974 (1013)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..     ........ .......++     
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~~~~p~~~~-----  219 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEEIRFPRTLS-----  219 (323)
T ss_pred             CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCCCCCCCCC-----
Confidence            1223456899999999999999999999999999999999999999754321     11111111 111111111     


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                                      ..+.+++.+||+.||++||+
T Consensus       220 ----------------~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05595         220 ----------------PEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             ----------------HHHHHHHHHHccCCHHHhCC
Confidence                            12458999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8e-36  Score=324.32  Aligned_cols=243  Identities=25%  Similarity=0.307  Sum_probs=189.2

Q ss_pred             ecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      ||+|+||+||+|.+. +++.||+|++......   ..+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999976 6889999988643222   224567899999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCccee
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS  897 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  897 (1013)
                      .+++.....  ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||.++.......  .
T Consensus        81 ~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~  153 (280)
T cd05608          81 RYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--K  153 (280)
T ss_pred             HHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--c
Confidence            988854322  233489999999999999999999999   999999999999999999999999999986543222  1


Q ss_pred             eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccC
Q 036815          898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK  977 (1013)
Q Consensus       898 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  977 (1013)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||........ ....... ......  .+++.      
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~-~~~~~~--~~~~~------  223 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQR-ILNDSV--TYPDK------  223 (280)
T ss_pred             ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHh-hcccCC--CCccc------
Confidence            2345689999999999999999999999999999999999999976432211 1111111 110000  00000      


Q ss_pred             CCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          978 GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       978 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                       .          ...+.+++.+||+.||++||+++
T Consensus       224 -~----------~~~~~~li~~~l~~~P~~R~~~~  247 (280)
T cd05608         224 -F----------SPASKSFCEALLAKDPEKRLGFR  247 (280)
T ss_pred             -C----------CHHHHHHHHHHhcCCHHHhcCCC
Confidence             0          11256899999999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.5e-36  Score=338.36  Aligned_cols=243  Identities=27%  Similarity=0.409  Sum_probs=186.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      +|+..+.||+|+||.||+|++. +++.||+|++..... .....+.+|++++++++|+||+++++++.+++..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4667789999999999999976 689999998854322 23466889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|....          ..++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       155 ~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        155 DGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             CCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999986532          146677889999999999999999   9999999999999999999999999999876432


Q ss_pred             CcceeeeeeccCCCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQS-----FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      ..  ......|+..|+|||++..     ...+.++|||||||++|||++|+.||......+  .......... ..... 
T Consensus       222 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~-~~~~~-  295 (353)
T PLN00034        222 MD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICM-SQPPE-  295 (353)
T ss_pred             cc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhc-cCCCC-
Confidence            11  1234578999999998743     334568999999999999999999997432211  1111111100 00000 


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...       ..          ...+.+++.+||+.||++|||++|
T Consensus       296 ~~~-------~~----------~~~l~~li~~~l~~~P~~Rpt~~e  324 (353)
T PLN00034        296 APA-------TA----------SREFRHFISCCLQREPAKRWSAMQ  324 (353)
T ss_pred             CCC-------cc----------CHHHHHHHHHHccCChhhCcCHHH
Confidence            000       00          113568999999999999999864

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.1e-36  Score=348.88  Aligned_cols=250  Identities=24%  Similarity=0.280  Sum_probs=197.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-C-CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-D-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .|.+.+.||+|+||.||+|... + ++.||+|++..........+.+|+++++.++||||+++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999875 3 5778888765444444456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++.....  ...++++..+..++.|++.||+|+|++   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus       148 ~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        148 SGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999998864321  223488999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+....... +.... ...  
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~-~~~~~-~~~--  293 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLY-GKYDP-FPC--  293 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-CCCCC-CCc--
Confidence            222223345689999999999999999999999999999999999999975321     112221111 11100 000  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..+          ..+.+++.+||+.||++|||++|
T Consensus       294 -----~~s----------~~~~~li~~~L~~dP~~Rps~~~  319 (478)
T PTZ00267        294 -----PVS----------SGMKALLDPLLSKNPALRPTTQQ  319 (478)
T ss_pred             -----cCC----------HHHHHHHHHHhccChhhCcCHHH
Confidence                 000          12568999999999999999764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.7e-36  Score=333.30  Aligned_cols=200  Identities=27%  Similarity=0.410  Sum_probs=172.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ......+.+|++++++++||||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999987 57788888765432 2234568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.+++....      .+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          84 HMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             cCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            999999999996432      3788899999999999999999741  79999999999999999999999999987653


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ...    .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            211    22346889999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-35  Score=328.50  Aligned_cols=237  Identities=27%  Similarity=0.351  Sum_probs=185.7

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|++. +++.||+|.+....   ....+.+..|..++... +||||+++++++..++..|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986 57889999886432   12234456677777654 899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-  150 (316)
T cd05592          81 GDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-  150 (316)
T ss_pred             CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence            99999986432      388899999999999999999999   99999999999999999999999999997643222 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.     .+.... +.....  .++..   
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~-i~~~~~--~~~~~---  218 (316)
T cd05592         151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDS-ILNDRP--HFPRW---  218 (316)
T ss_pred             -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHH-HHcCCC--CCCCC---
Confidence             223345789999999999998999999999999999999999999976432     111111 111100  00100   


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                          .+          ..+.+++.+||+.||++||++.
T Consensus       219 ----~~----------~~~~~ll~~~l~~~P~~R~~~~  242 (316)
T cd05592         219 ----IS----------KEAKDCLSKLFERDPTKRLGVD  242 (316)
T ss_pred             ----CC----------HHHHHHHHHHccCCHHHcCCCh
Confidence                00          1245889999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.5e-36  Score=332.09  Aligned_cols=235  Identities=23%  Similarity=0.316  Sum_probs=187.5

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      +.||+|+||.||+|+.. +++.||+|++.+..   ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 68899999886532   223356788999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      +|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....  .
T Consensus        81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~  149 (328)
T cd05593          81 ELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--A  149 (328)
T ss_pred             CHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc--c
Confidence            9998886432      388999999999999999999999   9999999999999999999999999998753221  1


Q ss_pred             eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcc
Q 036815          896 LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV  975 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  975 (1013)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.     .+........ ..  .++..    
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~-~~--~~p~~----  217 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILME-DI--KFPRT----  217 (328)
T ss_pred             cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccC-Cc--cCCCC----
Confidence            122345789999999999998999999999999999999999999975331     1111111110 00  00110    


Q ss_pred             cCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          976 TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       976 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                         .+          ..+.+++.+||+.||++||+
T Consensus       218 ---~~----------~~~~~li~~~L~~dP~~R~~  239 (328)
T cd05593         218 ---LS----------ADAKSLLSGLLIKDPNKRLG  239 (328)
T ss_pred             ---CC----------HHHHHHHHHHcCCCHHHcCC
Confidence               11          12458999999999999983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1e-35  Score=330.58  Aligned_cols=239  Identities=26%  Similarity=0.367  Sum_probs=188.6

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHH---hccCCcceeeeccEEEeCCEEEEE
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETL---GKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      |++.+.||+|+||.||+|.+. +++.||+|++.+..   ....+.+.+|++++   ++++||||+++++++.+++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999976 68899999886432   12234566676654   566899999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|..++..       ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          81 MEYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             EcCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            999999999988853       2389999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-ccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-KQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  967 (1013)
                      ....  ........|++.|+|||++.+..++.++|||||||++|||++|+.||.....     .+......... .....
T Consensus       151 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~~~~~p~~  223 (324)
T cd05589         151 GMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDSIVNDEVRYPRF  223 (324)
T ss_pred             CCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCCC
Confidence            3221  1122346789999999999999999999999999999999999999975432     11111111110 00011


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ++                     ..+.+++.+||+.||++||+++
T Consensus       224 ~~---------------------~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         224 LS---------------------REAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             CC---------------------HHHHHHHHHHhhcCHhHcCCCC
Confidence            11                     1245899999999999999754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-37  Score=330.61  Aligned_cols=243  Identities=26%  Similarity=0.390  Sum_probs=195.3

Q ss_pred             eecccCCcEEEEEEEcC-CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCHHH
Q 036815          741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEE  819 (1013)
Q Consensus       741 ~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  819 (1013)
                      ++|+|.||+||.|++.+ ...+|||.+........+-+..|+..-++++|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999874 45789998866655666678899999999999999999999999999999999999999999


Q ss_pred             HhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC-CCCcEEEeecccceeccccCcceee
Q 036815          820 VLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSV  898 (1013)
Q Consensus       820 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~  898 (1013)
                      .+......-.   -.+.++-.+.+||++||.|||+.   .|||||||.+||+|+ -.|.+||+|||.++.+....+  ..
T Consensus       662 LLrskWGPlK---DNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~T  733 (1226)
T KOG4279|consen  662 LLRSKWGPLK---DNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CT  733 (1226)
T ss_pred             HHHhccCCCc---cchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc--cc
Confidence            9987654311   26778888999999999999999   999999999999996 568999999999988754332  23


Q ss_pred             eeeccCCCccCcccccCC--CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhccc
Q 036815          899 STLAGTPGYVPPEYYQSF--RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT  976 (1013)
Q Consensus       899 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  976 (1013)
                      .++.||..|||||++..+  .|+.++|||||||++.||.||++||......+..     ..+++.-+....++.++    
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-----MFkVGmyKvHP~iPeel----  804 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-----MFKVGMYKVHPPIPEEL----  804 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----hhhhcceecCCCCcHHH----
Confidence            467899999999999765  4889999999999999999999999865433321     11222222222222222    


Q ss_pred             CCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          977 KGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       977 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                 .  .+...+|.+|+.+||.+||+|.+
T Consensus       805 -----------s--aeak~FilrcFepd~~~R~sA~~  828 (1226)
T KOG4279|consen  805 -----------S--AEAKNFILRCFEPDPCDRPSAKD  828 (1226)
T ss_pred             -----------H--HHHHHHHHHHcCCCcccCccHHH
Confidence                       1  12458899999999999999974

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-35  Score=328.30  Aligned_cols=241  Identities=27%  Similarity=0.318  Sum_probs=190.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCC-cceeeeccEEEeCCEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKH-RNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +|++.+.||+|+||.||+|++. +++.||+|++.+..   ....+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4888999999999999999987 46789999886432   2234567889999999876 56888999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          81 EYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            9999999999986432      278899999999999999999999   9999999999999999999999999998753


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......     +.... +.....  .++
T Consensus       152 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~-i~~~~~--~~~  221 (324)
T cd05587         152 IFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQS-IMEHNV--SYP  221 (324)
T ss_pred             CCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHH-HHcCCC--CCC
Confidence            2211  1233457899999999999999999999999999999999999999754311     11111 111110  000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .       ..+          ..+.+++.+||+.||++||++
T Consensus       222 ~-------~~~----------~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 K-------SLS----------KEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             C-------CCC----------HHHHHHHHHHhhcCHHHcCCC
Confidence            0       011          124689999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.3e-36  Score=340.94  Aligned_cols=202  Identities=24%  Similarity=0.318  Sum_probs=172.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .|++.+.||+|+||+||+|++. +++.||+|++.....   .....+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999876 578999998865322   223568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++++||+|||+++.+.
T Consensus        82 ~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~  152 (381)
T cd05626          82 YIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR  152 (381)
T ss_pred             cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence            999999999986432      378889999999999999999999   99999999999999999999999999976431


Q ss_pred             ccCcc---------------------------------------------eeeeeeccCCCccCcccccCCCCCccchhH
Q 036815          891 ALDTH---------------------------------------------LSVSTLAGTPGYVPPEYYQSFRCTAKGDVY  925 (1013)
Q Consensus       891 ~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  925 (1013)
                      .....                                             .......||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (381)
T cd05626         153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW  232 (381)
T ss_pred             cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence            10000                                             001234699999999999988899999999


Q ss_pred             hHHHHHHHHHcCCCCCCCCC
Q 036815          926 SFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       926 slG~il~elltg~~pf~~~~  945 (1013)
                      |+||++|||++|+.||....
T Consensus       233 SlG~il~elltG~~Pf~~~~  252 (381)
T cd05626         233 SVGVILFEMLVGQPPFLAPT  252 (381)
T ss_pred             ehhhHHHHHHhCCCCCcCCC
Confidence            99999999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-36  Score=336.83  Aligned_cols=194  Identities=25%  Similarity=0.291  Sum_probs=168.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|+..      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999986 67899999642      24567899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +. ++|..++....      .+++..++.++.|++.||+|||++   +||||||||+||+++.++.+||+|||+|+....
T Consensus       165 ~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        165 YK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             CC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            96 68888885432      378999999999999999999999   999999999999999999999999999975432


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      .. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       235 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        235 IN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            11 1122345799999999999998999999999999999999999988754

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-35  Score=328.18  Aligned_cols=236  Identities=28%  Similarity=0.365  Sum_probs=187.5

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|+++ +++.||+|++.+..   ....+.+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986 57899999886432   22335567888888876 699999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-  150 (320)
T cd05590          81 GDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-  150 (320)
T ss_pred             chHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-
Confidence            99999886432      388999999999999999999999   99999999999999999999999999987542211 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+....... ...   ..+.   
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~-~~~---~~~~---  217 (320)
T cd05590         151 -KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILN-DEV---VYPT---  217 (320)
T ss_pred             -CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhc-CCC---CCCC---
Confidence             122345789999999999998999999999999999999999999975431     111211111 110   0000   


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                         ..+          ..+.+++.+||+.||++||++
T Consensus       218 ---~~~----------~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         218 ---WLS----------QDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ---CCC----------HHHHHHHHHHcccCHHHCCCC
Confidence               000          124689999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-35  Score=329.78  Aligned_cols=235  Identities=26%  Similarity=0.360  Sum_probs=186.7

Q ss_pred             CeecccCCcEEEEEEEc----CCCEEEEEEeeccC----ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          740 SLIGCGGFGEVFKATLK----DGSSVAIKKLIRLS----CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +.||+|+||.||+|+..    +++.||+|.+....    ......+.+|++++++++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999863    57889999886432    12234578899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          82 LSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             CCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            99999999986432      377888899999999999999999   999999999999999999999999999875432


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ..  .......|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ........ .+..  .+++.
T Consensus       153 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~-~~~~--~~~~~  222 (323)
T cd05584         153 EG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKIL-KGKL--NLPPY  222 (323)
T ss_pred             CC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHH-cCCC--CCCCC
Confidence            11  112345689999999999988899999999999999999999999975431     11111111 1110  01111


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      +       .          ..+.+++.+||+.||++||+
T Consensus       223 ~-------~----------~~~~~li~~~l~~~p~~R~~  244 (323)
T cd05584         223 L-------T----------PEARDLLKKLLKRNPSSRLG  244 (323)
T ss_pred             C-------C----------HHHHHHHHHHcccCHhHcCC
Confidence            1       0          12568999999999999994

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-35  Score=326.83  Aligned_cols=237  Identities=29%  Similarity=0.382  Sum_probs=186.6

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|+++ +++.||+|.+.+..   ......+..|..++... +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999987 57899999886432   22334567788887754 899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  150 (316)
T cd05620          81 GDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-  150 (316)
T ss_pred             CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence            99999986432      378899999999999999999999   99999999999999999999999999987532211 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.     .+.... +.....  .++.    
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~-~~~~~~--~~~~----  217 (316)
T cd05620         151 -NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFES-IRVDTP--HYPR----  217 (316)
T ss_pred             -CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH-HHhCCC--CCCC----
Confidence             123346789999999999999999999999999999999999999975431     111111 111100  0000    


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                         ..+          ..+.+++.+||+.||++||++.
T Consensus       218 ---~~~----------~~~~~li~~~l~~dP~~R~~~~  242 (316)
T cd05620         218 ---WIT----------KESKDILEKLFERDPTRRLGVV  242 (316)
T ss_pred             ---CCC----------HHHHHHHHHHccCCHHHcCCCh
Confidence               000          1245899999999999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=323.83  Aligned_cols=245  Identities=27%  Similarity=0.334  Sum_probs=192.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .|++.++||+|+||.||+|.+. +++.||+|++.....   .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999976 688999998854322   223457789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++|+|.+++....    ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||+++...
T Consensus        81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          81 LMNGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             ccCCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999998886432    13489999999999999999999999   99999999999999999999999999998754


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...   ......|++.|+|||++.+..++.++||||+||++|||++|+.||.......  ..+.+...+.....  ...+
T Consensus       154 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~--~~~~  226 (285)
T cd05605         154 EGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRVKEDQE--EYSE  226 (285)
T ss_pred             CCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHhhhccc--ccCc
Confidence            322   1223468899999999998899999999999999999999999998643211  11111111111100  0000


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      ..                 ...+.+++.+|++.||++||+
T Consensus       227 ~~-----------------~~~~~~li~~~l~~~P~~R~~  249 (285)
T cd05605         227 KF-----------------SEAARSICRQLLTKDPGFRLG  249 (285)
T ss_pred             cc-----------------CHHHHHHHHHHccCCHHHhcC
Confidence            00                 112568999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=308.82  Aligned_cols=243  Identities=26%  Similarity=0.414  Sum_probs=198.6

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      |.++++||+|+||.||+|.++ .|+.+|+|++..  ..+-+++..|+.++++++.|++|++||.+......|+|||||.-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            667889999999999999987 689999998743  34567899999999999999999999999899999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+..+.++.+.     +++++.++..+++..++||+|||..   .-||||||..|||++.+|.+|++|||.|-.+..  .
T Consensus       113 GSiSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--T  182 (502)
T KOG0574|consen  113 GSISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--T  182 (502)
T ss_pred             CcHHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh--h
Confidence            99999997544     4599999999999999999999999   899999999999999999999999999976542  2


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                      -....+..|||.|||||++..-.|..++||||+|++..||..|++||..-..-...      ..+........-.|+.  
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------FMIPT~PPPTF~KPE~--  254 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------FMIPTKPPPTFKKPEE--  254 (502)
T ss_pred             HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------EeccCCCCCCCCChHh--
Confidence            23345678999999999999989999999999999999999999998753321110      0111111111111111  


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                                 +-   ..+-+++++||-..|++|-||.
T Consensus       255 -----------WS---~~F~DFi~~CLiK~PE~R~TA~  278 (502)
T KOG0574|consen  255 -----------WS---SEFNDFIRSCLIKKPEERKTAL  278 (502)
T ss_pred             -----------hh---hHHHHHHHHHhcCCHHHHHHHH
Confidence                       11   1366899999999999998874

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.8e-35  Score=328.64  Aligned_cols=242  Identities=24%  Similarity=0.324  Sum_probs=189.2

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|+++ +++.||+|.+.+..   ......+..|+.++.++ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999986 57889999886532   22234577888888776 899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|..++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-  150 (329)
T cd05618          81 GDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  150 (329)
T ss_pred             CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence            99998885432      388999999999999999999999   99999999999999999999999999987532211 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC---CccHHHHHHHHHhcCccccccChh
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG---DTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ......+.......... . ++..
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-~p~~  227 (329)
T cd05618         151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-IPRS  227 (329)
T ss_pred             -CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-CCCC
Confidence             1223457899999999999999999999999999999999999999642221   11222233222221111 0 1110


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .                 ...+.+++.+||+.||++|||+
T Consensus       228 ~-----------------~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         228 L-----------------SVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             C-----------------CHHHHHHHHHHhcCCHHHcCCC
Confidence            0                 1125689999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=343.89  Aligned_cols=248  Identities=25%  Similarity=0.335  Sum_probs=195.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCC-CEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEE-e------CCE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDG-SSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCK-I------GEE  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-~------~~~  804 (1013)
                      .+++|.++|.+|||+.||.|.+..+ .+||+|++...+...-+.+.+|+++|++++ |+|||.+++... .      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4577889999999999999998766 999999998777777788999999999996 999999999321 1      136


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      ++|.||||+||.|-+++..+...    .+++.++++|+.|+++|+++||.. .++|||||||-+|||++.+++.||||||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence            78999999999999999865543    299999999999999999999996 6679999999999999999999999999


Q ss_pred             cceeccccC-cceee------eeeccCCCccCcccc---cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHH
Q 036815          885 MARLISALD-THLSV------STLAGTPGYVPPEYY---QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGW  954 (1013)
Q Consensus       885 ~a~~~~~~~-~~~~~------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~  954 (1013)
                      .|.-.-... .....      -....|+.|+|||++   .+..+++|+||||+||++|-|+....||+....-.      
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------  265 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------  265 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------
Confidence            986432111 11000      123468999999986   47789999999999999999999999998642111      


Q ss_pred             HHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          955 VKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       955 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          +..+.+.-...+                 +...++.+||+.||++||.+||++.|
T Consensus       266 ----Ilng~Y~~P~~p-----------------~ys~~l~~LI~~mL~~nP~~RPnI~Q  303 (738)
T KOG1989|consen  266 ----ILNGNYSFPPFP-----------------NYSDRLKDLIRTMLQPNPDERPNIYQ  303 (738)
T ss_pred             ----EEeccccCCCCc-----------------cHHHHHHHHHHHHhccCcccCCCHHH
Confidence                111111100000                 12234779999999999999999753

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.6e-36  Score=326.12  Aligned_cols=201  Identities=25%  Similarity=0.412  Sum_probs=166.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc--CCCEEEEEEeeccCcc--chHHHHHHHHHHhcc---CCcceeeeccEEEe-----
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK--DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKI---KHRNLVPLLGYCKI-----  801 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  801 (1013)
                      ++|++.+.||+|+||.||+|++.  +++.||+|++......  ....+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36999999999999999999874  4678999987543222  234566787777665   69999999998853     


Q ss_pred             CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEe
Q 036815          802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVS  881 (1013)
Q Consensus       802 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  881 (1013)
                      ....++||||++ ++|.+++.....    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence            456899999997 689998864322    2378999999999999999999999   99999999999999999999999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |||+++.....   .......|++.|+|||++.+..++.++||||+||++|||++|++||....
T Consensus       153 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         153 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             cccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            99999865432   12234568999999999988899999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-35  Score=324.06  Aligned_cols=253  Identities=27%  Similarity=0.458  Sum_probs=198.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|.+.+.||+|+||.||+|...+      ++.||+|.+...... ..+.+.+|++++++++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468889999999999999998743      478999987654433 3467999999999999999999999999999999


Q ss_pred             EEEEcccCCCHHHHhccccc--------CCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          807 LVYEFMKFGSLEEVLHGRAK--------ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~--------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      +||||+++++|.+++.....        ......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            99999999999999975432        12234588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ||+|||.++...............+++.|+|||++.+..++.++||||+||++|||++ |..||......  .....+  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~--  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECI--  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH--
Confidence            9999999986543222222223345788999999999999999999999999999998 99998753321  111111  


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        ..+..... +..       .          ...+.+++.+||+.||++|||++|
T Consensus       238 --~~~~~~~~-~~~-------~----------~~~~~~li~~~l~~~p~~Rp~~~e  273 (280)
T cd05049         238 --TQGRLLQR-PRT-------C----------PSEVYDIMLGCWKRDPQQRINIKD  273 (280)
T ss_pred             --HcCCcCCC-CCC-------C----------CHHHHHHHHHHcCCCcccCCCHHH
Confidence              11111110 000       0          112568999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.6e-35  Score=324.30  Aligned_cols=237  Identities=27%  Similarity=0.360  Sum_probs=186.6

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|++. +++.||+|.+....   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999986 47889999886532   22234566788888764 899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          81 GDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence            99999986432      378899999999999999999999   999999999999999999999999999875322111


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+.... +.....  .++..   
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~-i~~~~~--~~~~~---  218 (316)
T cd05619         152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQS-IRMDNP--CYPRW---  218 (316)
T ss_pred             --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHH-HHhCCC--CCCcc---
Confidence              22345789999999999998999999999999999999999999975431     111111 111100  00100   


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                          .+          ..+.+++.+||+.||++||++.
T Consensus       219 ----~~----------~~~~~li~~~l~~~P~~R~~~~  242 (316)
T cd05619         219 ----LT----------REAKDILVKLFVREPERRLGVK  242 (316)
T ss_pred             ----CC----------HHHHHHHHHHhccCHhhcCCCh
Confidence                00          1245889999999999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=339.87  Aligned_cols=203  Identities=27%  Similarity=0.402  Sum_probs=177.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....   ......+.+|++++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46899999999999999999987 68999999886432   133456889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++...      ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          81 EYMPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             cCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            999999999999754      2388999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccC---------------------------cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          890 SALD---------------------------THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       890 ~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      ....                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence            4322                           0011234568999999999999999999999999999999999999997


Q ss_pred             CCC
Q 036815          943 KDD  945 (1013)
Q Consensus       943 ~~~  945 (1013)
                      ...
T Consensus       232 ~~~  234 (350)
T cd05573         232 SDT  234 (350)
T ss_pred             CCC
Confidence            643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-36  Score=330.65  Aligned_cols=238  Identities=25%  Similarity=0.320  Sum_probs=189.4

Q ss_pred             CeecccCCcEEEEEEEc----CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          740 SLIGCGGFGEVFKATLK----DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      +.||+|+||.||+++..    +++.||+|++.....  .....+.+|++++++++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            67999999999999762    578999998865322  223457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|+|.+++...      ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          82 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            99999998643      2389999999999999999999999   99999999999999999999999999997653321


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                        .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....     .+....... ...  .+++.  
T Consensus       153 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~-~~~--~~p~~--  220 (318)
T cd05582         153 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILK-AKL--GMPQF--  220 (318)
T ss_pred             --CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHc-CCC--CCCCC--
Confidence              122345789999999999988899999999999999999999999975321     111111111 110  00100  


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           .+          ..+.+++.+||+.||++|||+.+
T Consensus       221 -----~~----------~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 -----LS----------PEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -----CC----------HHHHHHHHHHhhcCHhHcCCCCC
Confidence                 00          12458999999999999999754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-35  Score=316.72  Aligned_cols=246  Identities=29%  Similarity=0.474  Sum_probs=195.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||.||+|.++++..+|+|.+... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            358888999999999999999988889999986533 3345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|+|.+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.++......
T Consensus        83 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          83 NGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             CCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            999999986432     1378999999999999999999999   99999999999999999999999999987653222


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      . .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....     .+..... ..+...  ..+..
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i-~~~~~~--~~~~~  225 (256)
T cd05114         155 Y-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMI-SRGFRL--YRPKL  225 (256)
T ss_pred             e-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH-HCCCCC--CCCCC
Confidence            1 11122335568999999998889999999999999999999 8999865331     1111111 111110  01111


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            .          ...+.+++.+||+.+|++|||++|
T Consensus       226 ------~----------~~~~~~li~~c~~~~p~~Rps~~~  250 (256)
T cd05114         226 ------A----------SMTVYEVMYSCWHEKPEGRPTFAE  250 (256)
T ss_pred             ------C----------CHHHHHHHHHHccCCcccCcCHHH
Confidence                  0          113569999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=340.41  Aligned_cols=203  Identities=26%  Similarity=0.371  Sum_probs=174.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||||++....   ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46899999999999999999986 58899999886432   222355788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.+
T Consensus        81 E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          81 EYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             CCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999986432      389999999999999999999999   9999999999999999999999999998764


Q ss_pred             cccCcce------------------------------------eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHH
Q 036815          890 SALDTHL------------------------------------SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLE  933 (1013)
Q Consensus       890 ~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e  933 (1013)
                      .......                                    ......||+.|+|||++.+..++.++|||||||++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence            3211000                                    0012358999999999999899999999999999999


Q ss_pred             HHcCCCCCCCCC
Q 036815          934 LLTGKRPTDKDD  945 (1013)
Q Consensus       934 lltg~~pf~~~~  945 (1013)
                      |++|..||....
T Consensus       232 l~~G~~Pf~~~~  243 (364)
T cd05599         232 MLVGYPPFCSDN  243 (364)
T ss_pred             hhcCCCCCCCCC
Confidence            999999997543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3e-35  Score=326.67  Aligned_cols=241  Identities=27%  Similarity=0.325  Sum_probs=190.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +|++.+.||+|+||.||+|++. +++.||+|.+.+...   ...+.+..|..++..+ +|++|+++++++.+.+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4888999999999999999987 567999998865322   2234466788888777 5899999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          81 EYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            9999999999986432      378899999999999999999999   9999999999999999999999999999754


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ........ ....  .++
T Consensus       152 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~~i~-~~~~--~~p  221 (323)
T cd05616         152 MWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIM-EHNV--AYP  221 (323)
T ss_pred             CCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHHHHH-hCCC--CCC
Confidence            3211  122345789999999999999999999999999999999999999975431     11111111 1110  000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      ..       .+          ..+.+++.+|++.||++|+++
T Consensus       222 ~~-------~s----------~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 KS-------MS----------KEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             Cc-------CC----------HHHHHHHHHHcccCHHhcCCC
Confidence            00       01          124689999999999999986

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-35  Score=332.92  Aligned_cols=201  Identities=25%  Similarity=0.407  Sum_probs=168.2

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC-----CEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG-----EERL  806 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  806 (1013)
                      +|++.+.||+|+||.||+|++. +++.||+|++....  ......+.+|++++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999976 68999999875422  22345688999999999999999999988543     2579


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||++ ++|.+++....      .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence            9999996 68998886432      388999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCc-ceeeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          887 RLISALDT-HLSVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       887 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +....... ........|++.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~  212 (338)
T cd07859         151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN  212 (338)
T ss_pred             cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            86432221 112234568999999999875  678999999999999999999999997643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.7e-35  Score=327.52  Aligned_cols=242  Identities=25%  Similarity=0.333  Sum_probs=190.2

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      ++||+|+||.||+|++. +++.||+|.+.+...   ...+.+..|..++.++ +||||+++++++.+....|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999986 578999998865322   2234578899999888 799999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++...      ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....  
T Consensus        81 g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  149 (329)
T cd05588          81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--  149 (329)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC--
Confidence            9999888543      2389999999999999999999999   9999999999999999999999999998743211  


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC---ccHHHHHHHHHhcCccccccChh
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD---TNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+   ....++...........  ++..
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~  227 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPRS  227 (329)
T ss_pred             CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--CCCC
Confidence            112234578999999999999999999999999999999999999997432221   12223332222221110  1110


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                             .+          ..+.+++.+||+.||++|||+
T Consensus       228 -------~~----------~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         228 -------LS----------VKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             -------CC----------HHHHHHHHHHhccCHHHcCCC
Confidence                   00          125689999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.7e-35  Score=317.11  Aligned_cols=242  Identities=25%  Similarity=0.317  Sum_probs=188.3

Q ss_pred             ecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      ||+|+||.||+++.+ +|+.||+|++.....   .....+..|++++++++||||+++++++..+...++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999976 589999998854221   1234456799999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCccee
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS  897 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  897 (1013)
                      .+++....    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++.......   .
T Consensus        81 ~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~  150 (277)
T cd05607          81 KYHIYNVG----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---T  150 (277)
T ss_pred             HHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---e
Confidence            98885432    23378999999999999999999999   99999999999999999999999999998664321   2


Q ss_pred             eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccC
Q 036815          898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK  977 (1013)
Q Consensus       898 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  977 (1013)
                      .....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ........... ...    ..    ...
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~----~~----~~~  220 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLE-DEV----KF----EHQ  220 (277)
T ss_pred             eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhc-ccc----cc----ccc
Confidence            234568999999999998889999999999999999999999997532211 11111111111 000    00    000


Q ss_pred             CCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          978 GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       978 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+          ..+.+++.+||+.||++||+++|
T Consensus       221 ~~~----------~~~~~li~~~L~~~P~~R~~~~~  246 (277)
T cd05607         221 NFT----------EESKDICRLFLAKKPEDRLGSRE  246 (277)
T ss_pred             cCC----------HHHHHHHHHHhccCHhhCCCCcc
Confidence            001          12468999999999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=345.36  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=199.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCC-----
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE-----  803 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  803 (1013)
                      ..++|++.+.||+|+||+||+|++. +++.||||.+....  ......+.+|+.++..++|+|++++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            4578999999999999999999875 68999999885432  223456788999999999999999988765432     


Q ss_pred             ---EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEE
Q 036815          804 ---ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       804 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                         ..++||||+++|+|.+++.....  ....+++..+..++.|++.||.|+|+.   +|+||||||+||+++.++.+||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence               36899999999999999975432  234589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR  960 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  960 (1013)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+.+.....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~~  259 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTLA  259 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhc
Confidence            99999987654322223345679999999999999999999999999999999999999997543     2222222111


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       +... .+++..       .          ..+.+++.+||+.||++|||+.|
T Consensus       260 -~~~~-~~~~~~-------~----------~~l~~li~~~L~~dP~~RPs~~e  293 (496)
T PTZ00283        260 -GRYD-PLPPSI-------S----------PEMQEIVTALLSSDPKRRPSSSK  293 (496)
T ss_pred             -CCCC-CCCCCC-------C----------HHHHHHHHHHcccChhhCcCHHH
Confidence             1111 011111       0          12568999999999999999854

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=325.30  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=203.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccc---hHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQG---DREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  807 (1013)
                      ...|++.+.||+|.||.||+++.+. |+.+|+|.+.+.....   ...+.+|+.+|+++. |||||.++++|++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4578899999999999999999874 9999999987655443   358999999999998 9999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC----CcEEEeec
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE----MEARVSDF  883 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~Df  883 (1013)
                      |||++.||.|.+.+...       .+++..+..++.|++.|++|||+.   ||+|||+||+|+++...    +.+|++||
T Consensus       114 vmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            99999999999999754       289999999999999999999999   99999999999999643    47999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      |+|.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||..........      .+..+.
T Consensus       184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~  254 (382)
T KOG0032|consen  184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGD  254 (382)
T ss_pred             CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCC
Confidence            99998764   344667899999999999999999999999999999999999999998755322111      122221


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . +..++.            ...+  ...+.++++.|+..||.+|+||.|
T Consensus       255 ~-~f~~~~------------w~~i--s~~akd~i~~ll~~dp~~R~ta~~  289 (382)
T KOG0032|consen  255 F-DFTSEP------------WDDI--SESAKDFIRKLLEFDPRKRLTAAQ  289 (382)
T ss_pred             C-CCCCCC------------cccc--CHHHHHHHHHhcccCcccCCCHHH
Confidence            1 111110            0111  112458999999999999999864

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-35  Score=326.33  Aligned_cols=236  Identities=26%  Similarity=0.366  Sum_probs=186.5

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      ++||+|+||.||+|+++ +++.||+|++.+..   ....+.+..|.+++..+ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999986 57899999886532   22234567888888866 799999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|..++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-  150 (321)
T cd05591          81 GDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-  150 (321)
T ss_pred             CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence            99999886432      378899999999999999999999   99999999999999999999999999987543211 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                       .......|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ........... .   ..+..  
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~i~~~~-~---~~p~~--  218 (321)
T cd05591         151 -VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFESILHDD-V---LYPVW--  218 (321)
T ss_pred             -ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC-C---CCCCC--
Confidence             122345689999999999998999999999999999999999999975431     11111111111 0   00000  


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                          .+          ..+.+++.+||+.||++||++
T Consensus       219 ----~~----------~~~~~ll~~~L~~dp~~R~~~  241 (321)
T cd05591         219 ----LS----------KEAVSILKAFMTKNPNKRLGC  241 (321)
T ss_pred             ----CC----------HHHHHHHHHHhccCHHHcCCC
Confidence                00          125689999999999999954

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.7e-36  Score=330.87  Aligned_cols=234  Identities=22%  Similarity=0.312  Sum_probs=186.4

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      +.||+|+||.||+|++. +++.||+|.+....   ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999975 68899999886432   122355678999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      +|.+++....      .+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-  150 (325)
T cd05594          81 ELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-  150 (325)
T ss_pred             cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-
Confidence            9999886432      38899999999999999999997 6   99999999999999999999999999987543211 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-cCccccccChhhh
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-EGKQMEVIDPELL  973 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~  973 (1013)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......... .......++    
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~~~~p~~~~----  220 (325)
T cd05594         151 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEIRFPRTLS----  220 (325)
T ss_pred             -cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCCCCCCCCCC----
Confidence             122345689999999999999999999999999999999999999975331     111111111 111111111    


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                                       ..+.+++.+||+.||++|++
T Consensus       221 -----------------~~~~~li~~~L~~dP~~R~~  240 (325)
T cd05594         221 -----------------PEAKSLLSGLLKKDPKQRLG  240 (325)
T ss_pred             -----------------HHHHHHHHHHhhcCHHHhCC
Confidence                             12458999999999999973

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=339.76  Aligned_cols=202  Identities=25%  Similarity=0.353  Sum_probs=172.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46899999999999999999876 68899999886432   122356788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+
T Consensus        81 E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999986432      378899999999999999999999   9999999999999999999999999999643


Q ss_pred             cccCcc------------e---------------------------------eeeeeccCCCccCcccccCCCCCccchh
Q 036815          890 SALDTH------------L---------------------------------SVSTLAGTPGYVPPEYYQSFRCTAKGDV  924 (1013)
Q Consensus       890 ~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  924 (1013)
                      ......            .                                 ......||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence            211000            0                                 0012468999999999999899999999


Q ss_pred             HhHHHHHHHHHcCCCCCCCC
Q 036815          925 YSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       925 wslG~il~elltg~~pf~~~  944 (1013)
                      ||+||++|||++|..||...
T Consensus       232 wSlGvil~elltG~~Pf~~~  251 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             EecchhhhhhhcCCCCCCCC
Confidence            99999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.5e-35  Score=350.81  Aligned_cols=208  Identities=24%  Similarity=0.375  Sum_probs=175.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.++||+|+||.||+|++. +++.||+|++.....   ...+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999986 588999998864322   22456889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccC-----CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          810 EFMKFGSLEEVLHGRAKA-----RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      ||++||+|.+++......     ......++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998643211     1123366788899999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcc----------------eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          885 MARLISALDTH----------------LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       885 ~a~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +++........                .......||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            99876211100                0112246899999999999999999999999999999999999999763

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.9e-36  Score=338.26  Aligned_cols=249  Identities=23%  Similarity=0.304  Sum_probs=193.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            457999999999999999999986 57899999885422   22334578899999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|+|.+++...       .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       122 ~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         122 MEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            9999999999998642       277888899999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCC----CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSF----RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      ..... ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||......     ............
T Consensus       192 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~~~  265 (370)
T cd05596         192 MDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMDHKNS  265 (370)
T ss_pred             ccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCCc
Confidence            54321 1122345799999999998653    4788999999999999999999999864321     111111111100


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCC--CCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSK--RPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~e 1013 (1013)
                      .. ++...     ..          ...+.+++.+||+.+|++  |||++|
T Consensus       266 ~~-~~~~~-----~~----------s~~~~~li~~~L~~~p~r~~R~s~~e  300 (370)
T cd05596         266 LT-FPDDI-----EI----------SKQAKDLICAFLTDREVRLGRNGVDE  300 (370)
T ss_pred             CC-CCCcC-----CC----------CHHHHHHHHHHccChhhccCCCCHHH
Confidence            00 01000     00          012558999999999988  998864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.3e-35  Score=321.15  Aligned_cols=253  Identities=28%  Similarity=0.445  Sum_probs=197.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46889999999999999999852      245688888765554455678999999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccC-------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEE
Q 036815          808 VYEFMKFGSLEEVLHGRAKA-------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                      ||||+++++|.+++......       .....+++..++.++.|++.||+|||++   +++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            99999999999999754321       1123489999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHH
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKV  959 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  959 (1013)
                      +|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||......     +. ...+
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-----~~-~~~i  235 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-----EV-IECI  235 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HH-HHHH
Confidence            99999986543322222223345778999999998899999999999999999998 89998653311     11 1112


Q ss_pred             hcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..... +       ...+          ..+.+++.+||+.||.+|||++|
T Consensus       236 ~~~~~~~~-~-------~~~~----------~~l~~li~~~l~~~p~~Rpt~~~  271 (288)
T cd05093         236 TQGRVLQR-P-------RTCP----------KEVYDLMLGCWQREPHMRLNIKE  271 (288)
T ss_pred             HcCCcCCC-C-------CCCC----------HHHHHHHHHHccCChhhCCCHHH
Confidence            22211110 0       0000          12568999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-35  Score=334.97  Aligned_cols=202  Identities=26%  Similarity=0.357  Sum_probs=174.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ......+.+|+.++.+++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46899999999999999999876 57899999886432   122356788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          81 EFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             cCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9999999999996432      388999999999999999999999   9999999999999999999999999999764


Q ss_pred             cccCcc---------------------------------eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc
Q 036815          890 SALDTH---------------------------------LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT  936 (1013)
Q Consensus       890 ~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  936 (1013)
                      ......                                 .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence            321100                                 00123469999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 036815          937 GKRPTDKD  944 (1013)
Q Consensus       937 g~~pf~~~  944 (1013)
                      |+.||...
T Consensus       232 G~~Pf~~~  239 (363)
T cd05628         232 GYPPFCSE  239 (363)
T ss_pred             CCCCCCCC
Confidence            99999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.3e-36  Score=340.28  Aligned_cols=202  Identities=25%  Similarity=0.347  Sum_probs=172.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+.+..   ......+.+|++++++++||||+++++.+.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6899999999999999999976 58899999875432   1223567899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|..+.
T Consensus        82 ~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~  152 (376)
T cd05598          82 YIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (376)
T ss_pred             CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence            999999999996432      378888999999999999999999   99999999999999999999999999985331


Q ss_pred             ccCc-----------------------------------------ceeeeeeccCCCccCcccccCCCCCccchhHhHHH
Q 036815          891 ALDT-----------------------------------------HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGV  929 (1013)
Q Consensus       891 ~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  929 (1013)
                      ....                                         ........||+.|+|||++.+..++.++||||+||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  232 (376)
T cd05598         153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence            0000                                         00011346899999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCCCC
Q 036815          930 VLLELLTGKRPTDKDD  945 (1013)
Q Consensus       930 il~elltg~~pf~~~~  945 (1013)
                      ++|||++|+.||....
T Consensus       233 ilyell~G~~Pf~~~~  248 (376)
T cd05598         233 ILYEMLVGQPPFLADT  248 (376)
T ss_pred             eeeehhhCCCCCCCCC
Confidence            9999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5e-35  Score=325.09  Aligned_cols=243  Identities=24%  Similarity=0.306  Sum_probs=190.0

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|+.. +++.||+|++.+...   ...+.+.+|+.++.++ +||+|+++++++.+....|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999986 578899998865322   2234578899999888 699999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|..++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-  150 (327)
T cd05617          81 GDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-  150 (327)
T ss_pred             CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-
Confidence            99998886432      389999999999999999999999   99999999999999999999999999987532211 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC-CccHHHHHHHHHhcCccccccChhhh
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG-DTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....++...........  ++..  
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~--  225 (327)
T cd05617         151 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--IPRF--  225 (327)
T ss_pred             -CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--CCCC--
Confidence             1223457899999999999999999999999999999999999999753322 112222222222211110  0100  


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                           .+          ..+.+++.+||+.||++||++.
T Consensus       226 -----~~----------~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         226 -----LS----------VKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             -----CC----------HHHHHHHHHHhccCHHHcCCCC
Confidence                 00          1245899999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.1e-35  Score=317.98  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=198.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999976 68999999875422   222356889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++.....  ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++++|||.+...
T Consensus        82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          82 ELADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EecCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            99999999998864322  223478899999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .....  ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||......   ...+... ...........
T Consensus       157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~-~~~~~~~~~~~  230 (267)
T cd08228         157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQK-IEQCDYPPLPT  230 (267)
T ss_pred             cchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHH-HhcCCCCCCCh
Confidence            43221  122346788999999998888999999999999999999999998654322   1222221 11111111000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                     ..  ....+.+++.+||+.+|++|||+.|
T Consensus       231 ---------------~~--~~~~~~~li~~cl~~~p~~Rp~~~~  257 (267)
T cd08228         231 ---------------EH--YSEKLRELVSMCIYPDPDQRPDIGY  257 (267)
T ss_pred             ---------------hh--cCHHHHHHHHHHCCCCcccCcCHHH
Confidence                           00  0123568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.4e-35  Score=326.22  Aligned_cols=237  Identities=27%  Similarity=0.343  Sum_probs=185.8

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHH-HHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEME-TLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||+||+|++. +++.||+|++.+...   .....+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999986 689999998864321   12234455554 46788999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++..+..++.||++||+|||++   +|+||||||+||+++.++.+||+|||+++.....  
T Consensus        81 g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--  149 (323)
T cd05575          81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--  149 (323)
T ss_pred             CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--
Confidence            99999986432      378899999999999999999999   9999999999999999999999999998753221  


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.     .+........ ..  .+.+.   
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~-~~--~~~~~---  218 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNK-PL--RLKPN---  218 (323)
T ss_pred             CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcC-CC--CCCCC---
Confidence            1122345689999999999999999999999999999999999999975431     1222211111 00  00111   


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                          .          ...+.+++.+||+.||++||++.
T Consensus       219 ----~----------~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 ----I----------SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----C----------CHHHHHHHHHHhhcCHHhCCCCC
Confidence                0          01256899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.4e-36  Score=339.63  Aligned_cols=201  Identities=25%  Similarity=0.338  Sum_probs=171.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +|++.++||+|+||.||+|+.. +++.||+|++.+...   ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999986 578899998864321   223568889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++|+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        82 ~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~  152 (382)
T cd05625          82 YIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (382)
T ss_pred             CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence            999999999986432      378889999999999999999999   99999999999999999999999999975331


Q ss_pred             ccCc---------------------------------------------ceeeeeeccCCCccCcccccCCCCCccchhH
Q 036815          891 ALDT---------------------------------------------HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVY  925 (1013)
Q Consensus       891 ~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  925 (1013)
                      ....                                             ........||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (382)
T cd05625         153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  232 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence            1000                                             0001124689999999999999999999999


Q ss_pred             hHHHHHHHHHcCCCCCCCC
Q 036815          926 SFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       926 slG~il~elltg~~pf~~~  944 (1013)
                      |+||++|||++|+.||...
T Consensus       233 SlGvil~elltG~~Pf~~~  251 (382)
T cd05625         233 SVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             echHHHHHHHhCCCCCCCC
Confidence            9999999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.1e-36  Score=320.08  Aligned_cols=244  Identities=34%  Similarity=0.540  Sum_probs=186.1

Q ss_pred             CCeecccCCcEEEEEEEc-----CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          739 ESLIGCGGFGEVFKATLK-----DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .+.||.|+||.||+|.+.     .+..|+||.+..... ...+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999987     256799998854322 23578999999999999999999999999888899999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++....    ...+++..+..|+.|+++||+|||++   +++|+||+++||+++.++.+||+|||+++.....
T Consensus        84 ~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   84 PGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             ccccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999998652    23389999999999999999999999   9999999999999999999999999999876333


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ..............|+|||.+.+..++.++||||||+++||+++ |+.||....     ..++... +..+..... +..
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----~~~~~~~-~~~~~~~~~-~~~  229 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----NEEIIEK-LKQGQRLPI-PDN  229 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----HHHHHHH-HHTTEETTS-BTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccc-cccccccee-ccc
Confidence            33323333456778999999998889999999999999999999 778876431     1222222 222222111 110


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .                 ...+.+++.+||+.||++|||++|
T Consensus       230 ~-----------------~~~~~~li~~C~~~~p~~RPs~~~  254 (259)
T PF07714_consen  230 C-----------------PKDIYSLIQQCWSHDPEKRPSFQE  254 (259)
T ss_dssp             S-----------------BHHHHHHHHHHT-SSGGGS--HHH
T ss_pred             h-----------------hHHHHHHHHHHcCCChhhCcCHHH
Confidence            0                 012568999999999999999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.3e-36  Score=334.88  Aligned_cols=249  Identities=21%  Similarity=0.256  Sum_probs=195.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46899999999999999999986 688999998865322   23456888999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             CCCCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            9999999999996542     2388999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCccccc------CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQ------SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      ...... ......||+.|+|||++.      +..++.++|||||||++|||++|+.||.....     ............
T Consensus       153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~  226 (330)
T cd05601         153 TANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNFQR  226 (330)
T ss_pred             CCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcCCC
Confidence            432221 223457899999999986      45678899999999999999999999975432     111111111111


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .... +...     ..          ...+.+++.+|++ +|++|||++|
T Consensus       227 ~~~~-~~~~-----~~----------~~~~~~li~~ll~-~p~~R~t~~~  259 (330)
T cd05601         227 FLKF-PEDP-----KV----------SSDFLDLIQSLLC-GQKERLGYEG  259 (330)
T ss_pred             ccCC-CCCC-----CC----------CHHHHHHHHHHcc-ChhhCCCHHH
Confidence            1100 0000     00          1125688889998 9999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.1e-35  Score=325.89  Aligned_cols=238  Identities=24%  Similarity=0.320  Sum_probs=184.9

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHH-HHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEM-ETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||+||+|++. +++.||+|.+.+...   .....+..|. .+++.++||||+++++++.+++..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999987 567899998764321   2223344444 356778999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-  150 (325)
T cd05602          81 GELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  150 (325)
T ss_pred             CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-
Confidence            99999986432      277888889999999999999999   99999999999999999999999999997542211 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+......... .  ..++.+  
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~-~--~~~~~~--  219 (325)
T cd05602         151 -GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKP-L--QLKPNI--  219 (325)
T ss_pred             -CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCC-c--CCCCCC--
Confidence             123345789999999999999999999999999999999999999975331     11222111110 0  011111  


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           +          ..+.+++.+|++.||.+||++.+
T Consensus       220 -----~----------~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         220 -----T----------NSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             -----C----------HHHHHHHHHHcccCHHHCCCCCC
Confidence                 0          12458999999999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.5e-36  Score=329.39  Aligned_cols=198  Identities=30%  Similarity=0.398  Sum_probs=171.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-C-----cceeeeccEEEeCCEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-H-----RNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  807 (1013)
                      +|.+.++||+|+||.|.+|.+. +++.||||+++.. ..-..+...|+.+|..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7999999999999999999986 6899999987543 233455678999999996 4     389999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC--CcEEEeeccc
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE--MEARVSDFGM  885 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~  885 (1013)
                      |+|.+. -+|+++++....    ..++...++.|+.||+.||.+||+.   +|||+||||+|||+...  ..+||+|||.
T Consensus       266 VfELL~-~NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eehhhh-hhHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            999987 699999986554    3389999999999999999999999   99999999999999754  3699999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      |......     ......+..|+|||++.|.+|+.+.||||||||++||++|.+.|.++..
T Consensus       338 Sc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  338 SCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             ccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            9875431     2256778899999999999999999999999999999999888887653

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.1e-35  Score=324.40  Aligned_cols=242  Identities=26%  Similarity=0.310  Sum_probs=190.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +|+..+.||+|+||.||+|.+. +++.||+|++.+..   ....+.+..|.++++.+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3778899999999999999976 68899999886432   222345778888888885 578888999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          81 EYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecccccccc
Confidence            9999999999986432      388999999999999999999999   9999999999999999999999999998754


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ...  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......... ... . .+
T Consensus       152 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i~~-~~~-~-~p  221 (323)
T cd05615         152 MVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQSIME-HNV-S-YP  221 (323)
T ss_pred             CCC--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-CCC-C-CC
Confidence            321  1122345689999999999998999999999999999999999999976431     111111111 110 0 00


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      .       ..+          ..+.+++.+||+.||++|+++.
T Consensus       222 ~-------~~~----------~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         222 K-------SLS----------KEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             c-------cCC----------HHHHHHHHHHcccCHhhCCCCC
Confidence            0       001          1246899999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-35  Score=333.77  Aligned_cols=256  Identities=26%  Similarity=0.411  Sum_probs=196.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCcc-chHHHHHHHHHHhccC-CcceeeeccEEEeCC
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQ-GDREFMAEMETLGKIK-HRNLVPLLGYCKIGE  803 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  803 (1013)
                      ..++|++.+.||+|+||.||+|++..      +..||||++...... ..+.+.+|+++++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            35689999999999999999998631      346999988643322 2456899999999996 999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccC--------------------------------------------------------
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKA--------------------------------------------------------  827 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------  827 (1013)
                      ..|+||||+++|+|.+++......                                                        
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            999999999999999998653210                                                        


Q ss_pred             ----------------------------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          828 ----------------------------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       828 ----------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                                                        .....+++..+..++.|+++|++|||+.   +|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence                                              0112478889999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLV  952 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~  952 (1013)
                      .++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... .. 
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~~-  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TF-  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-HH-
Confidence            999999999999987643322222233456788999999998899999999999999999997 999987532111 11 


Q ss_pred             HHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          953 GWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       953 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         ......+.... .+..       .          ...+.+++.+||+.||++|||+.+
T Consensus       350 ---~~~~~~~~~~~-~~~~-------~----------~~~l~~li~~cl~~dP~~RPt~~~  389 (400)
T cd05105         350 ---YNKIKSGYRMA-KPDH-------A----------TQEVYDIMVKCWNSEPEKRPSFLH  389 (400)
T ss_pred             ---HHHHhcCCCCC-CCcc-------C----------CHHHHHHHHHHCccCHhHCcCHHH
Confidence               11111111110 0000       0          113568999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.9e-36  Score=335.52  Aligned_cols=202  Identities=26%  Similarity=0.359  Sum_probs=173.8

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ..++|++.+.||+|+||.||+|++. +++.||+|.+.+..   ....+.+.+|+.+++.++||||+++++++.++...|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4578999999999999999999987 57889999875422   2234557889999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++...       .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus       121 v~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence            99999999999998532       278889999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCC----CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSF----RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ...... ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||...
T Consensus       191 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         191 KMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             ecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            764322 1222356799999999998754    3788999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-35  Score=319.18  Aligned_cols=247  Identities=25%  Similarity=0.389  Sum_probs=192.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.+..... .....+.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46889999999999999999864    356899998765322 2345688999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|+|.+++....     ..+++..++.++.|++.|++|||++   +++||||||+||+++.++.++++|||.+..
T Consensus        85 ~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            99999999999986432     2388999999999999999999999   999999999999999999999999998765


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      ..... ........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....     .+.... ...+.... 
T Consensus       157 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~~-~~~~~~~~-  228 (266)
T cd05064         157 DKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIKA-VEDGFRLP-  228 (266)
T ss_pred             ccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHH-HHCCCCCC-
Confidence            32211 111112335678999999999999999999999999999875 9999975431     111111 11111110 


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+.       .          ...+.+++.+||+.+|++|||++|
T Consensus       229 ~~~~-------~----------~~~~~~li~~c~~~~p~~RP~~~~  257 (266)
T cd05064         229 APRN-------C----------PNLLHQLMLDCWQKERGERPRFSQ  257 (266)
T ss_pred             CCCC-------C----------CHHHHHHHHHHcCCCchhCCCHHH
Confidence            0000       0          112568999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.3e-35  Score=323.71  Aligned_cols=236  Identities=28%  Similarity=0.342  Sum_probs=187.4

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||+||+|+++ +++.||+|.+.+..   ......+.+|.++++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986 57899999886532   22334567888898887 799999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  150 (318)
T cd05570          81 GDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-  150 (318)
T ss_pred             CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence            99999886432      389999999999999999999999   99999999999999999999999999987532211 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                       .......|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ...... +.....  .++.    
T Consensus       151 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~-i~~~~~--~~~~----  217 (318)
T cd05570         151 -VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQS-ILEDEV--RYPR----  217 (318)
T ss_pred             -CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHH-HHcCCC--CCCC----
Confidence             112345689999999999999999999999999999999999999975431     111111 111110  0000    


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                         ..+          ..+.+++.+||+.||++|||+
T Consensus       218 ---~~~----------~~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         218 ---WLS----------KEAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             ---cCC----------HHHHHHHHHHccCCHHHcCCC
Confidence               000          125689999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=352.86  Aligned_cols=482  Identities=28%  Similarity=0.400  Sum_probs=396.7

Q ss_pred             eecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCC
Q 036815            4 VLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSY   83 (1013)
Q Consensus         4 ~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~   83 (1013)
                      .+|++..+++.||...+..-. +..|+++.|-+.. .|-....+.-+|+.||+++|++. ..|.. ...+++|+.|++++
T Consensus         2 ~vd~s~~~l~~ip~~i~~~~~-~~~ln~~~N~~l~-~pl~~~~~~v~L~~l~lsnn~~~-~fp~~-it~l~~L~~ln~s~   77 (1081)
T KOG0618|consen    2 HVDASDEQLELIPEQILNNEA-LQILNLRRNSLLS-RPLEFVEKRVKLKSLDLSNNQIS-SFPIQ-ITLLSHLRQLNLSR   77 (1081)
T ss_pred             CcccccccCcccchhhccHHH-HHhhhcccccccc-CchHHhhheeeeEEeeccccccc-cCCch-hhhHHHHhhcccch
Confidence            478999999999998877666 8999999997644 24444455666999999999997 55543 46678999999999


Q ss_pred             CcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccC
Q 036815           84 NNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITG  163 (1013)
Q Consensus        84 n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  163 (1013)
                      |-|...+...    ...++|++|.|.+|.+.. .|..+..+.+|+.|++++|++. ..|..+..++.++.+..++|....
T Consensus        78 n~i~~vp~s~----~~~~~l~~lnL~~n~l~~-lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~  151 (1081)
T KOG0618|consen   78 NYIRSVPSSC----SNMRNLQYLNLKNNRLQS-LPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ  151 (1081)
T ss_pred             hhHhhCchhh----hhhhcchhheeccchhhc-CchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh
Confidence            9998665332    367889999999999875 7889999999999999999998 778889999999999999993221


Q ss_pred             cCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCC
Q 036815          164 WIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSI  243 (1013)
Q Consensus       164 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  243 (1013)
                      .++.      ..++.++|..|.+.+.++..+..++.  .|+|.+|.+. .+   .+.++.+|+.|....|++...    .
T Consensus       152 ~lg~------~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~---dls~~~~l~~l~c~rn~ls~l----~  215 (1081)
T KOG0618|consen  152 RLGQ------TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VL---DLSNLANLEVLHCERNQLSEL----E  215 (1081)
T ss_pred             hhcc------ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-hh---hhhhccchhhhhhhhcccceE----E
Confidence            2222      23888999999998888888877777  7999999997 32   257789999999999998732    2


Q ss_pred             CCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchH
Q 036815          244 SSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLE  323 (1013)
Q Consensus       244 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~  323 (1013)
                      -..++|+.|+.++|.++.. .  ....-.+|++++++.|+++. +|++++.+.+|+.++.++|+++ .+|..+...++|+
T Consensus       216 ~~g~~l~~L~a~~n~l~~~-~--~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~  290 (1081)
T KOG0618|consen  216 ISGPSLTALYADHNPLTTL-D--VHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLV  290 (1081)
T ss_pred             ecCcchheeeeccCcceee-c--cccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHH
Confidence            3457899999999999832 2  22234679999999999995 5699999999999999999997 8999999999999


Q ss_pred             HHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCC-C-CCCeEEecCCccCCCCCh-hhhccCCCceEEcc
Q 036815          324 QFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSC-S-NLEWISLTGNELTGQIPP-EFSRLTRLAVLQLG  400 (1013)
Q Consensus       324 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~  400 (1013)
                      .|.+..|.+. .+|+....++.|++|+|..|++. .+|+.+... . +|..|+.+.|++. ..|. .=..++.|+.|.+.
T Consensus       291 ~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~Lyla  367 (1081)
T KOG0618|consen  291 SLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLA  367 (1081)
T ss_pred             HHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHh
Confidence            9999999999 68889999999999999999998 677655443 3 3889999999998 4442 22356789999999


Q ss_pred             CCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCccc
Q 036815          401 NNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER  480 (1013)
Q Consensus       401 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  480 (1013)
                      +|.++...-+.+.+..+|+.|+|++|.|. .+|+..                                            
T Consensus       368 nN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~--------------------------------------------  402 (1081)
T KOG0618|consen  368 NNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASK--------------------------------------------  402 (1081)
T ss_pred             cCcccccchhhhccccceeeeeecccccc-cCCHHH--------------------------------------------
Confidence            99999887778899999999999999986 555432                                            


Q ss_pred             ccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcce
Q 036815          481 LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGV  560 (1013)
Q Consensus       481 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~  560 (1013)
                                             +..+..|+.|+||+|+++ .||.++..+..|++|...+|++. ..| .+.++++|+.
T Consensus       403 -----------------------~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~  456 (1081)
T KOG0618|consen  403 -----------------------LRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKV  456 (1081)
T ss_pred             -----------------------HhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceE
Confidence                                   223456899999999999 89999999999999999999999 899 8999999999


Q ss_pred             EecCCccccC-CCcccccCCCcceEEECcCCC
Q 036815          561 FDASHNRLQG-QIPESFSNLSFLVQIDLSNNE  591 (1013)
Q Consensus       561 L~ls~N~l~g-~~p~~~~~l~~l~~l~l~~n~  591 (1013)
                      +|+|.|+|+- .+|...-. ++|++|||++|.
T Consensus       457 lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  457 LDLSCNNLSEVTLPEALPS-PNLKYLDLSGNT  487 (1081)
T ss_pred             EecccchhhhhhhhhhCCC-cccceeeccCCc
Confidence            9999999984 34444333 899999999996

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-35  Score=317.19  Aligned_cols=247  Identities=24%  Similarity=0.383  Sum_probs=195.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++.+++..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            568999999999999999999888889999986543 2335678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++....    ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++......
T Consensus        85 ~~~L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          85 KGSLLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             CCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999996532    22378889999999999999999999   99999999999999999999999999998764322


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      . .......++..|+|||++.+..++.++|||||||++|+|++ |+.||......  ....+    ......... ..  
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~----~~~~~~~~~-~~--  227 (261)
T cd05072         158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSA----LQRGYRMPR-ME--  227 (261)
T ss_pred             e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHH----HHcCCCCCC-CC--
Confidence            1 11122345678999999998889999999999999999998 99998753211  11111    111111000 00  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..          ...+.+++.+|++.+|++|||++|
T Consensus       228 -----~~----------~~~~~~li~~~l~~~p~~Rp~~~~  253 (261)
T cd05072         228 -----NC----------PDELYDIMKTCWKEKAEERPTFDY  253 (261)
T ss_pred             -----CC----------CHHHHHHHHHHccCCcccCcCHHH
Confidence                 00          012568999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.5e-35  Score=318.05  Aligned_cols=246  Identities=26%  Similarity=0.325  Sum_probs=193.1

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      |+..+.||+|+||+||+|.+. +++.||+|.+.....   .....+.+|++++++++|++|+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677789999999999999986 688999998754322   2234577899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          82 MNGGDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             ccCccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            99999998886432    12489999999999999999999999   999999999999999999999999999976543


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ..   ......|+..|+|||++.+..++.++||||+||++|||++|..||....... .... +........  ..+.+.
T Consensus       155 ~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~-~~~~~~~~~--~~~~~~  227 (285)
T cd05632         155 GE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE-VDRRVLETE--EVYSAK  227 (285)
T ss_pred             CC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhhccc--cccCcc
Confidence            21   1234468999999999998899999999999999999999999997532111 1111 111111111  001110


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                             ..          ..+.+++.+|++.||++|||+.
T Consensus       228 -------~~----------~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         228 -------FS----------EEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             -------CC----------HHHHHHHHHHccCCHhHcCCCc
Confidence                   00          1245899999999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.9e-35  Score=321.58  Aligned_cols=246  Identities=26%  Similarity=0.415  Sum_probs=197.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .+|++.+.||+|+||.||+|.+. +++.||+|.+..........+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57999999999999999999975 68899999887655555677889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++...       .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.++.....
T Consensus       100 ~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654         100 AGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             CCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            999999998532       278889999999999999999999   9999999999999999999999999998765332


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ..  ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......    .+.. ....... ....+. 
T Consensus       170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~-~~~~~~~-~~~~~~-  240 (296)
T cd06654         170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYL-IATNGTP-ELQNPE-  240 (296)
T ss_pred             cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHH-HhcCCCC-CCCCcc-
Confidence            21  1223468889999999998889999999999999999999999997543211    1111 1111100 000000 


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                   .+  ...+.+++.+||..||++|||++|
T Consensus       241 -------------~~--~~~l~~li~~~l~~~p~~Rpt~~e  266 (296)
T cd06654         241 -------------KL--SAIFRDFLNRCLDMDVEKRGSAKE  266 (296)
T ss_pred             -------------cc--CHHHHHHHHHHCcCCcccCcCHHH
Confidence                         00  012568999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.1e-35  Score=319.91  Aligned_cols=253  Identities=28%  Similarity=0.470  Sum_probs=197.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|....      ...||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            358889999999999999998753      25789998754322 23456899999999999999999999999989999


Q ss_pred             EEEEcccCCCHHHHhcccccCCC----------CccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARD----------QRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                      ++|||+++++|.+++........          ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            99999999999999975432111          14588999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHH
Q 036815          877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWV  955 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  955 (1013)
                      .++|+|||+++.....+.........+++.|+|||++.+..++.++|||||||++|||++ |..||......  ....  
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~--  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE--  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH--
Confidence            999999999986543332222334456788999999988899999999999999999998 99998754321  1111  


Q ss_pred             HHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          956 KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       956 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        .+..+..... ..       ..          ...+.+++.+||+.||++|||++|
T Consensus       238 --~i~~~~~~~~-~~-------~~----------~~~~~~l~~~c~~~~p~~Rp~~~~  275 (283)
T cd05048         238 --MIRSRQLLPC-PE-------DC----------PARVYALMIECWNEIPARRPRFKD  275 (283)
T ss_pred             --HHHcCCcCCC-cc-------cC----------CHHHHHHHHHHccCChhhCcCHHH
Confidence              1221111110 00       00          123668999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-36  Score=293.31  Aligned_cols=247  Identities=25%  Similarity=0.388  Sum_probs=195.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc----ch----HHHHHHHHHHhcc-CCcceeeeccEEEeCC
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ----GD----REFMAEMETLGKI-KHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  803 (1013)
                      ..|...+.+|.|..++|.++..+ +|+++|+|++......    ..    +.-.+|+.+++++ .||+|+++.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            45777889999999999998876 6889999988543221    11    3346799999998 6999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..++|+|.|+.|.|.+++...      ..++++..++|++|+.+|++|||.+   +|||||+||+|||++++.++||+||
T Consensus        97 F~FlVFdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            999999999999999999743      3489999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCccccc------CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQ------SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      |+|+.+..+.   .....+|||+|.|||.+.      ...|+..+|+||+|||+|.++.|.+||.-..    ++  .+-.
T Consensus       168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----Qm--lMLR  238 (411)
T KOG0599|consen  168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----QM--LMLR  238 (411)
T ss_pred             ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----HH--HHHH
Confidence            9999876533   345678999999999874      3357889999999999999999999986421    11  1111


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+.+++.. .-.|+              +.+......++|.+||+.||.+|.|++|
T Consensus       239 ~ImeGkyq-F~spe--------------Wadis~~~KdLIsrlLqVdp~~Ritake  279 (411)
T KOG0599|consen  239 MIMEGKYQ-FRSPE--------------WADISATVKDLISRLLQVDPTKRITAKE  279 (411)
T ss_pred             HHHhcccc-cCCcc--------------hhhccccHHHHHHHHHeeCchhcccHHH
Confidence            22222221 11111              1111223458999999999999999875

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.6e-35  Score=317.61  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=196.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  804 (1013)
                      .+++|++.+.||+|+||.||+|.+.      .+..||+|++..... ....++.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999864      246799998754322 234568899999999999999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCC----CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEE
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKAR----DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                      .++||||+++++|.+++.......    ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            999999999999999996533211    123467889999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHH
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKV  959 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  959 (1013)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....     .+..+...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~~~~~~  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRFVM  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH
Confidence            99999976543322222222345678999999998899999999999999999999 7888865321     12222111


Q ss_pred             hcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ...... ..       ..          ...+.+++.+|++.||++|||+.|
T Consensus       236 ~-~~~~~~-~~-------~~----------~~~~~~li~~~l~~~p~~Rps~~e  270 (277)
T cd05062         236 E-GGLLDK-PD-------NC----------PDMLFELMRMCWQYNPKMRPSFLE  270 (277)
T ss_pred             c-CCcCCC-CC-------CC----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence            1 111100 00       00          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=322.42  Aligned_cols=244  Identities=25%  Similarity=0.457  Sum_probs=200.1

Q ss_pred             CCCCeecccCCcEEEEEEEc-CCC----EEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          737 SAESLIGCGGFGEVFKATLK-DGS----SVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ...++||+|+||+||+|.+- +|+    +||+|++.... .+...++..|+.+|.+++|||+++++++|..+. ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            44689999999999999873 343    68888776543 344678999999999999999999999998765 789999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      ||++|+|.++++.++.     .+..+..+.|..|||+||.|||.+   ++|||||..+||||.+-..+|+.|||+|+...
T Consensus       778 ~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             hcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            9999999999986543     377788899999999999999999   99999999999999999999999999999988


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .++.........-.+.|||-|.+....|+.++|||||||++||++| |..||++....+      +...++.+.....  
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------I~dlle~geRLsq--  921 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------IPDLLEKGERLSQ--  921 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------hhHHHhccccCCC--
Confidence            7776666666667889999999999999999999999999999999 999998755322      3333333322111  


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      |.+      .          -..++.++.+||..|+..||+++|
T Consensus       922 Ppi------C----------tiDVy~~mvkCwmid~~~rp~fke  949 (1177)
T KOG1025|consen  922 PPI------C----------TIDVYMVMVKCWMIDADSRPTFKE  949 (1177)
T ss_pred             CCC------c----------cHHHHHHHHHHhccCcccCccHHH
Confidence            111      1          123568889999999999999864

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.4e-35  Score=323.27  Aligned_cols=247  Identities=24%  Similarity=0.408  Sum_probs=191.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCC----EEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGS----SVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .+|++.+.||+|+||.||+|++. +++    .||+|.+.... ....+++.+|+.+++.++||||+++++++..+ ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46999999999999999999864 333    38999875432 23346788999999999999999999998764 5679


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |+||+++|+|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        86 v~e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence            999999999999997532     2378889999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...............++..|+|||++.+..++.++|||||||++|||++ |+.||.....     .++.. ....+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----~~~~~-~~~~~~~~~  231 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISS-ILEKGERLP  231 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH-HHhCCCCCC
Confidence            7654333222223344678999999999999999999999999999998 9999875321     11111 111111110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ++.       .          ...+.+++.+||+.||++|||+.|
T Consensus       232 ~-~~~-------~----------~~~~~~li~~cl~~~p~~Rps~~~  260 (316)
T cd05108         232 Q-PPI-------C----------TIDVYMIMVKCWMIDADSRPKFRE  260 (316)
T ss_pred             C-CCC-------C----------CHHHHHHHHHHccCChhhCcCHHH
Confidence            0 000       0          112568999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.1e-35  Score=316.74  Aligned_cols=245  Identities=26%  Similarity=0.325  Sum_probs=191.9

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      |+..+.||+|+||.||+|.+. +++.||+|.+......   ....+.+|+.++++++|++|+++++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999986 6889999987543222   234577899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++.....    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          82 MNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             cCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            999999998854322    2388999999999999999999999   999999999999999999999999999876532


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ..   ......|+..|+|||++.+..++.++||||+||++|+|++|+.||........ ... .........  ....  
T Consensus       155 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~-~~~~~~~~~--~~~~--  225 (285)
T cd05630         155 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REE-VERLVKEVQ--EEYS--  225 (285)
T ss_pred             Cc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHH-HHhhhhhhh--hhcC--
Confidence            21   12234689999999999999999999999999999999999999976432110 011 111100000  0000  


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                           ....          ..+.+++.+||+.||++|||+
T Consensus       226 -----~~~~----------~~~~~li~~~l~~~p~~R~s~  250 (285)
T cd05630         226 -----EKFS----------PDARSLCKMLLCKDPKERLGC  250 (285)
T ss_pred             -----ccCC----------HHHHHHHHHHhhcCHHHccCC
Confidence                 0011          124589999999999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8e-35  Score=312.22  Aligned_cols=246  Identities=26%  Similarity=0.427  Sum_probs=194.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||.||+|.+.++..||+|.+... ......+.+|+.++++++||||+++++++.+....++||||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            358889999999999999999887778999987543 3345678999999999999999999999998888999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|+|.+++....     ..+++..++.++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.++......
T Consensus        83 ~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          83 NGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            999999986432     1388999999999999999999999   99999999999999999999999999988654322


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                       ........++..|+|||++.+..++.++|||||||++|||++ |..||.....  ......    ...+.....  +..
T Consensus       155 -~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~~~--~~~  225 (256)
T cd05113         155 -YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEK----VSQGLRLYR--PHL  225 (256)
T ss_pred             -eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHH----HhcCCCCCC--CCC
Confidence             111122345678999999988889999999999999999999 9999864321  111111    111111000  000


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                      ....+.+++.+||+.||++|||+.|
T Consensus       226 ----------------~~~~~~~li~~cl~~~p~~Rp~~~~  250 (256)
T cd05113         226 ----------------ASEKVYAIMYSCWHEKAEERPTFQQ  250 (256)
T ss_pred             ----------------CCHHHHHHHHHHcCCCcccCCCHHH
Confidence                            0123678999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6e-35  Score=324.51  Aligned_cols=237  Identities=27%  Similarity=0.352  Sum_probs=185.8

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHH-HHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEME-TLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|+.. +|+.||+|++.+..   ......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999976 68899999886432   122344555554 46778999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|..++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  150 (325)
T cd05604          81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-  150 (325)
T ss_pred             CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-
Confidence            99998886432      388999999999999999999999   99999999999999999999999999987532211 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                       .......|++.|+|||++.+..++.++||||+||++|||++|+.||...+.     .+....... ...  ...+.   
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~-~~~--~~~~~---  218 (325)
T cd05604         151 -DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILH-KPL--VLRPG---  218 (325)
T ss_pred             -CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHc-CCc--cCCCC---
Confidence             122345689999999999999999999999999999999999999975431     111111111 100  01111   


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                          .+          ..+.+++.+|++.||++||++.
T Consensus       219 ----~~----------~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         219 ----AS----------LTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             ----CC----------HHHHHHHHHHhccCHHhcCCCC
Confidence                01          1245889999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.5e-35  Score=338.92  Aligned_cols=200  Identities=24%  Similarity=0.356  Sum_probs=164.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeC--------C
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG--------E  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  803 (1013)
                      .++|++.++||+|+||.||+|... +++.||||++...    .....+|+.++++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999986 5789999987532    23345799999999999999999887432        2


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-cEEEee
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSD  882 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D  882 (1013)
                      ..++||||++ +++.+++.....  ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++ .+||+|
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence            4679999998 477777653221  234489999999999999999999999   999999999999999665 699999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ||+|+.+.....   .....||+.|+|||++.+ ..++.++||||+||++|||++|.+||.+..
T Consensus       215 FGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  275 (440)
T PTZ00036        215 FGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS  275 (440)
T ss_pred             cccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999986643222   223568999999999865 468999999999999999999999997643

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.2e-35  Score=319.05  Aligned_cols=253  Identities=28%  Similarity=0.446  Sum_probs=197.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35888899999999999999753      345688888755444445678999999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc
Q 036815          808 VYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME  877 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  877 (1013)
                      ||||+++++|.+++......          .....+++..++.++.|++.|++|||++   +|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            99999999999999754321          1123488999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHH
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~  956 (1013)
                      ++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......     +...
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~~~~  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-----EVIE  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence            99999999976543322222233456788999999999899999999999999999999 99998653321     1111


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ....+......+        .          ....+.+++.+||+.||++|||++|
T Consensus       237 -~~~~~~~~~~~~--------~----------~~~~~~~li~~~l~~~P~~Rpt~~~  274 (291)
T cd05094         237 -CITQGRVLERPR--------V----------CPKEVYDIMLGCWQREPQQRLNIKE  274 (291)
T ss_pred             -HHhCCCCCCCCc--------c----------CCHHHHHHHHHHcccChhhCcCHHH
Confidence             111111111000        0          0123569999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3e-35  Score=316.87  Aligned_cols=249  Identities=28%  Similarity=0.472  Sum_probs=199.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +..+|++.+.||.|+||.||+|.+.+++.+|+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568899999999999999999988899999988665554567789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        84 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          84 MEKGSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             cccCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999997532    23478999999999999999999999   999999999999999999999999999976543


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ..  .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.....  ........   . +.... ...
T Consensus       157 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~---~-~~~~~-~~~  227 (261)
T cd05148         157 DV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQIT---A-GYRMP-CPA  227 (261)
T ss_pred             cc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHH---h-CCcCC-CCC
Confidence            21  11123345678999999988899999999999999999998 8999875431  11111111   1 10000 000


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       .          ...+.+++.+|++.||++|||++|
T Consensus       228 ~-------~----------~~~~~~~i~~~l~~~p~~Rpt~~~  253 (261)
T cd05148         228 K-------C----------PQEIYKIMLECWAAEPEDRPSFKA  253 (261)
T ss_pred             C-------C----------CHHHHHHHHHHcCCCchhCcCHHH
Confidence            0       0          112568999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=312.72  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=194.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc-----chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ-----GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|.+.+.||+|++|.||+|... +++.||+|.+......     ..+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56899999999999999999875 5889999987543211     12468889999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |+||+++++|.+++....      .+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||.++
T Consensus        82 v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             EEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            999999999999986432      378889999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCccee-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      .......... .....++..|+|||++.+..++.++||||+|+++|||++|+.||.....    ...... ..... ...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~-~~~~~-~~~  226 (263)
T cd06625         153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFK-IATQP-TNP  226 (263)
T ss_pred             eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHH-HhccC-CCC
Confidence            6543221111 1234577899999999998899999999999999999999999865321    111111 11110 000


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .++...                 ...+.+++.+||+.+|++|||+.|
T Consensus       227 ~~~~~~-----------------~~~~~~li~~~l~~~p~~Rpt~~~  256 (263)
T cd06625         227 QLPSHV-----------------SPDARNFLRRTFVENAKKRPSAEE  256 (263)
T ss_pred             CCCccC-----------------CHHHHHHHHHHhhcCcccCCCHHH
Confidence            011000                 012568999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-34  Score=314.51  Aligned_cols=245  Identities=23%  Similarity=0.341  Sum_probs=192.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.++||+|+||.||+|++. +++.||+|.+.... ....+++.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36888999999999999999875 67889999875432 23345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|..+..          +++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          81 MDGGSLDVYRK----------IPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             CCCCChHHhhc----------CCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            99999976531          67888899999999999999999   999999999999999999999999999976543


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCcc--HHHHHHHHHhcCccccccC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN--LVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ..    .....++..|+|||++.+..++.++|||||||++|+|++|+.||.........  ..++...... ........
T Consensus       148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  222 (279)
T cd06619         148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-EDPPVLPV  222 (279)
T ss_pred             cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cCCCCCCC
Confidence            21    23356889999999999889999999999999999999999999753322111  1111111110 00000000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       ..          ...+.+++.+|++.||++||+++|
T Consensus       223 ~-------~~----------~~~~~~li~~~l~~~P~~Rp~~~e  249 (279)
T cd06619         223 G-------QF----------SEKFVHFITQCMRKQPKERPAPEN  249 (279)
T ss_pred             C-------cC----------CHHHHHHHHHHhhCChhhCCCHHH
Confidence            0       00          012568999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-35  Score=303.17  Aligned_cols=247  Identities=23%  Similarity=0.303  Sum_probs=196.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|.-|+||+++.++ +..+|+|++.+..-..   ..+.+.|.+||+.++||.++.+|..|+.+...|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            346677899999999999999874 5889999987644332   345778999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |||+||+|....+.+.    .+.+++..++.++.+++.||+|||..   |||+|||||+||||.++|++.|+||.++...
T Consensus       157 eyCpGGdL~~LrqkQp----~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQP----GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ecCCCccHHHHHhhCC----CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999987544    45599999999999999999999999   9999999999999999999999999987543


Q ss_pred             ccc---------------------------------Ccc---------------------eeeeeeccCCCccCcccccC
Q 036815          890 SAL---------------------------------DTH---------------------LSVSTLAGTPGYVPPEYYQS  915 (1013)
Q Consensus       890 ~~~---------------------------------~~~---------------------~~~~~~~gt~~y~aPE~~~~  915 (1013)
                      ...                                 ...                     ......+||-.|.|||++.|
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            110                                 000                     01123568999999999999


Q ss_pred             CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHH
Q 036815          916 FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLE  995 (1013)
Q Consensus       916 ~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~  995 (1013)
                      ...+.++|.|+|||++|||+.|..||.+....+. +...+.   ......+.  +                 .-...+.+
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~NIv~---~~l~Fp~~--~-----------------~vs~~akD  366 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-LRNIVG---QPLKFPEE--P-----------------EVSSAAKD  366 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-HHHHhc---CCCcCCCC--C-----------------cchhHHHH
Confidence            9999999999999999999999999998654322 111111   11111110  0                 01123569


Q ss_pred             HHHhcccCCCCCCCC
Q 036815          996 ITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       996 li~~cl~~dP~~RPt 1010 (1013)
                      +|++.|..||++|..
T Consensus       367 LIr~LLvKdP~kRlg  381 (459)
T KOG0610|consen  367 LIRKLLVKDPSKRLG  381 (459)
T ss_pred             HHHHHhccChhhhhc
Confidence            999999999999976

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.7e-35  Score=317.62  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=194.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-----cCCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATL-----KDGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||.||+|..     .++..|++|.+..... .....+.+|++++++++||||+++++++..+...|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3578889999999999999985     2457899998864332 223568899999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccC-----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC
Q 036815          808 VYEFMKFGSLEEVLHGRAKA-----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                      ||||+++++|.+++......           .....+++.++..++.|++.||+|||++   +++||||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            99999999999998533210           1123478899999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHH
Q 036815          877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWV  955 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  955 (1013)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....  ....+  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~--  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIE--  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH--
Confidence            999999999986543322222233445678999999988889999999999999999998 9999865321  11111  


Q ss_pred             HHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          956 KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       956 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        ......... .+.       ..+          .++.+++.+|++.||++||+++|
T Consensus       238 --~~~~~~~~~-~~~-------~~~----------~~~~~li~~cl~~~p~~Rp~~~~  275 (283)
T cd05090         238 --MVRKRQLLP-CSE-------DCP----------PRMYSLMTECWQEGPSRRPRFKD  275 (283)
T ss_pred             --HHHcCCcCC-CCC-------CCC----------HHHHHHHHHHcccCcccCcCHHH
Confidence              111111110 000       000          12568999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-34  Score=321.97  Aligned_cols=237  Identities=27%  Similarity=0.340  Sum_probs=184.9

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHH-HHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEME-TLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      ++||+|+||.||+|++. +++.||+|.+.+...   .....+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986 578999998864321   22334555554 57888999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      ++|..++...      ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  149 (321)
T cd05603          81 GELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--  149 (321)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--
Confidence            9999888643      2378888999999999999999999   9999999999999999999999999998753221  


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                      ........|++.|+|||++.+..++.++||||+||++|||++|+.||...+.     ......... ...  .+++.   
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~-~~~--~~~~~---  218 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILH-KPL--QLPGG---  218 (321)
T ss_pred             CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhc-CCC--CCCCC---
Confidence            1122345689999999999998999999999999999999999999976431     111111111 110  00100   


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                          .          ...+.+++.+||+.||++||++.
T Consensus       219 ----~----------~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 ----K----------TVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----C----------CHHHHHHHHHHccCCHhhcCCCC
Confidence                0          11256899999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-35  Score=313.56  Aligned_cols=248  Identities=30%  Similarity=0.484  Sum_probs=195.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.+.||+|+||.||+|.+.+++.||+|.+.... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35689999999999999999998878889999875433 34567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....    ...+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          84 KYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             cCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999996533    23489999999999999999999999   9999999999999999999999999999876532


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ... .......+..|+|||++.+..++.++|||||||++|||++ |+.||.....  ....    .......... ....
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~----~~~~~~~~~~-~~~~  228 (261)
T cd05068         157 IYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVL----QQVDQGYRMP-CPPG  228 (261)
T ss_pred             ccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHHcCCCCC-CCCc
Confidence            111 1111223457999999998899999999999999999999 9999865321  1111    1111111000 0000


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                       ....+.+++.+|++.+|++||++++
T Consensus       229 -----------------~~~~~~~li~~~l~~~P~~Rp~~~~  253 (261)
T cd05068         229 -----------------CPKELYDIMLDCWKEDPDDRPTFET  253 (261)
T ss_pred             -----------------CCHHHHHHHHHHhhcCcccCCCHHH
Confidence                             0123668999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-35  Score=332.21  Aligned_cols=198  Identities=27%  Similarity=0.368  Sum_probs=167.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCC------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE------  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  803 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...  .......+.+|+.+++.++||||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999986 5889999988543  2233456789999999999999999999886543      


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..|+||||+++ ++.+.+..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence            57999999985 56666532        277888999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |+++.....   .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||...+
T Consensus       168 g~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         168 GLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             CCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            999754321   11234568899999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.6e-35  Score=315.98  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=197.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+.....   ....++.+|+++++.++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888999999999999999975 789999998754322   22356889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++.....  ....+++..++.++.|+++|++|||++   +++|+||||+||+++.++.++++|||++...
T Consensus        82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          82 ELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            99999999999864322  223489999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .....  ......++..|+|||++.+..++.++||||||+++|+|++|..||......   ...+.+... ....... .
T Consensus       157 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~-~~~~~~~-~  229 (267)
T cd08229         157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIE-QCDYPPL-P  229 (267)
T ss_pred             ccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhh-cCCCCCC-C
Confidence            43221  122346888999999998888999999999999999999999999754322   111111111 1100000 0


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      +.                .....+.+++.+|++.||++|||++
T Consensus       230 ~~----------------~~~~~~~~li~~~l~~~p~~Rpt~~  256 (267)
T cd08229         230 SD----------------HYSEELRQLVNMCINPDPEKRPDIT  256 (267)
T ss_pred             cc----------------cccHHHHHHHHHhcCCCcccCCCHH
Confidence            00                0011356899999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6e-35  Score=315.71  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=194.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357999999999999999999975 6788999987654444456688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....      .+++..+..++.|++.|++|||+.   +|+|||+||+||+++.++.++|+|||+++....
T Consensus        88 ~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          88 CGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999986432      378999999999999999999999   999999999999999999999999999986642


Q ss_pred             cCcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ...  ......++..|+|||.+.   ...++.++||||+||++|||++|+.||......+. ...+     ....   ..
T Consensus       159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~-----~~~~---~~  227 (267)
T cd06646         159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLM-----SKSN---FQ  227 (267)
T ss_pred             ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heee-----ecCC---CC
Confidence            211  122346788999999874   34578899999999999999999999864321110 0000     0000   00


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+...    ...       .....+.+++.+||+.||++|||++|
T Consensus       228 ~~~~~----~~~-------~~~~~~~~li~~~l~~~P~~Rp~~~~  261 (267)
T cd06646         228 PPKLK----DKT-------KWSSTFHNFVKISLTKNPKKRPTAER  261 (267)
T ss_pred             CCCCc----ccc-------ccCHHHHHHHHHHhhCChhhCcCHHH
Confidence            00000    000       00123568999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-35  Score=315.53  Aligned_cols=251  Identities=23%  Similarity=0.362  Sum_probs=193.3

Q ss_pred             CCCCCeecccCCcEEEEEEEcC----CCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCE-----
Q 036815          736 FSAESLIGCGGFGEVFKATLKD----GSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE-----  804 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  804 (1013)
                      |.+.+.||+|+||.||+|....    +..||+|++.....  .....+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998752    36799998764322  223568899999999999999999998866544     


Q ss_pred             -EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          805 -RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       805 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                       .++|+||+++|+|..++...........+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             789999999999999986554333344589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      |.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....  .   +...... .+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~---~~~~~~~-~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--H---EIYDYLR-HG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--H---HHHHHHH-cC
Confidence            99987654332222222345678999999988899999999999999999999 8888865321  1   1111111 11


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..... .       ..          ....+.+++.+|++.||++|||+.|
T Consensus       232 ~~~~~-~-------~~----------~~~~~~~li~~~l~~~p~~Rp~~~e  264 (273)
T cd05035         232 NRLKQ-P-------ED----------CLDELYDLMYSCWRADPKDRPTFTK  264 (273)
T ss_pred             CCCCC-C-------cC----------CCHHHHHHHHHHcCCChhhCcCHHH
Confidence            11110 0       00          0123678999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.4e-35  Score=322.90  Aligned_cols=201  Identities=23%  Similarity=0.385  Sum_probs=170.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56899999999999999999986 578899998864332 2334678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++ ++.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          86 LDK-DLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             CCC-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            985 8888875432     2378889999999999999999999   999999999999999999999999999976433


Q ss_pred             cCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ...  ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus       157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  209 (309)
T cd07872         157 PTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST  209 (309)
T ss_pred             Ccc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            221  1223467889999998865 468899999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.4e-35  Score=332.45  Aligned_cols=207  Identities=26%  Similarity=0.336  Sum_probs=175.3

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCC
Q 036815          728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       728 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  803 (1013)
                      ++....++|++.+.||+|+||.||+|+++ +++.||+|.+.+..   ....+.+.+|+.+++.++||||+++++++.++.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            33445578999999999999999999987 57889999875422   222345788999999999999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..|+||||+++|+|.+++...       .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999998642       278888899999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCC----CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSF----RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |+++...... ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||....
T Consensus       187 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  251 (371)
T cd05622         187 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (371)
T ss_pred             CceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence            9998764321 1122345799999999998654    37889999999999999999999997643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-34  Score=312.64  Aligned_cols=252  Identities=25%  Similarity=0.410  Sum_probs=199.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++|++++++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999987 78999999875322   223457889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++.....  ....+++.++..++.|++.|++|||+.   +|+||||+|+||+++.++.++++|||.++..
T Consensus        82 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          82 ELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             ecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            99999999999864322  234488999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .....  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||......   ..+.... ...+.......
T Consensus       157 ~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-~~~~~~~~~~~  230 (267)
T cd08224         157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK-IEKCDYPPLPA  230 (267)
T ss_pred             cCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhh-hhcCCCCCCCh
Confidence            43221  122346788999999999888999999999999999999999998754321   1122111 11111111000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +                 .....+.+++.+|++.+|++|||+.|
T Consensus       231 ~-----------------~~~~~~~~~i~~cl~~~p~~Rp~~~~  257 (267)
T cd08224         231 D-----------------HYSEELRDLVSRCINPDPEKRPDISY  257 (267)
T ss_pred             h-----------------hcCHHHHHHHHHHcCCCcccCCCHHH
Confidence            0                 00113568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-34  Score=328.87  Aligned_cols=200  Identities=27%  Similarity=0.403  Sum_probs=168.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCC-----EEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE-----ERL  806 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  806 (1013)
                      +|++.+.||+|+||.||+|++. +++.||+|++....  ....+++.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999975 68999999875431  223456889999999999999999999998766     789


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||+. ++|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEeeccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence            9999997 5788877532      2388999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +....... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus       151 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         151 RVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             eecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            86543221 122334678899999998764 57899999999999999999999997643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.6e-34  Score=310.44  Aligned_cols=246  Identities=28%  Similarity=0.404  Sum_probs=197.2

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|++|.||+|..+ +++.|++|.+...  .......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999986 6889999987532  233456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....    ...+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||+++....
T Consensus        81 ~~~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          81 AENGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             CCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            99999999997532    23488999999999999999999999   999999999999999999999999999987653


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ...  ......+++.|+|||+..+..++.++|||||||++|||++|+.||.....     .... .....+.... +...
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~-~~~~~~~~~~-~~~~  224 (256)
T cd08529         154 NTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALI-LKIIRGVFPP-VSQM  224 (256)
T ss_pred             ccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHH-HHHHcCCCCC-Cccc
Confidence            222  12334678899999999998999999999999999999999999975431     1111 1111111111 0000


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                       ....+.+++.+|++.+|++||++.|
T Consensus       225 -----------------~~~~~~~~i~~~l~~~p~~Rp~~~~  249 (256)
T cd08529         225 -----------------YSQQLAQLIDQCLTKDYRQRPDTFQ  249 (256)
T ss_pred             -----------------cCHHHHHHHHHHccCCcccCcCHHH
Confidence                             0123568999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-34  Score=314.23  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=189.7

Q ss_pred             CCCCCeecccCCcEEEEEEEcCCC---EEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeC------CE
Q 036815          736 FSAESLIGCGGFGEVFKATLKDGS---SVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG------EE  804 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  804 (1013)
                      |.+.+.||+|+||.||+|.+.+..   .||+|.+...  .....+.+.+|++++++++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            456789999999999999986432   5888876543  223346688999999999999999999987432      24


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .++||||+++|+|.+++...........+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999885433222334589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      +++...............+++.|+|||+..+..++.++|||||||++|||++ |+.||.....     .+.. .....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~-~~~~~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIY-DYLRQGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH-HHHHcCC
Confidence            9987644322212223345678999999999899999999999999999999 8889865321     1111 1122211


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .... .+..                 ...+.+++.+||+.||++|||++|
T Consensus       232 ~~~~-~~~~-----------------~~~~~~li~~~l~~~p~~Rps~~~  263 (272)
T cd05075         232 RLKQ-PPDC-----------------LDGLYSLMSSCWLLNPKDRPSFET  263 (272)
T ss_pred             CCCC-CCCC-----------------CHHHHHHHHHHcCCCcccCcCHHH
Confidence            1110 0000                 112568999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=312.47  Aligned_cols=248  Identities=27%  Similarity=0.456  Sum_probs=194.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC----CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD----GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|.++.    ...||+|.+..... ....++.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568999999999999999999752    35789997754332 2345688999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....     ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.++++|||+++.
T Consensus        84 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          84 TEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEcCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            99999999999996532     2488999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |..||.....  .....    ..........
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~----~~~~~~~~~~  229 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIK----AVEDGYRLPP  229 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHH----HHHcCCCCCC
Confidence            753222222223345678999999998899999999999999999998 9999864321  11111    1111111000


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        +      ...          ...+.+++.+|++.+|++||+++|
T Consensus       230 --~------~~~----------~~~l~~li~~cl~~~p~~Rp~~~e  257 (266)
T cd05033         230 --P------MDC----------PSALYQLMLDCWQKDRNERPTFSQ  257 (266)
T ss_pred             --C------CCC----------CHHHHHHHHHHcCCCcccCcCHHH
Confidence              0      000          113569999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.5e-35  Score=323.97  Aligned_cols=255  Identities=27%  Similarity=0.432  Sum_probs=193.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEe-CC
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKI-GE  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  803 (1013)
                      .++|++.+.||+|+||.||+|...      +++.||+|++..... ...+.+.+|++++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999743      247899998754322 2235678899999999 89999999998865 45


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCC-------------------------------------------------------
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKAR-------------------------------------------------------  828 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------------  828 (1013)
                      ..+++|||+++++|.+++.......                                                       
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6789999999999999986432100                                                       


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCcc
Q 036815          829 DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV  908 (1013)
Q Consensus       829 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  908 (1013)
                      ....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            012589999999999999999999999   99999999999999999999999999998764333222233345677899


Q ss_pred             CcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHH
Q 036815          909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEV  987 (1013)
Q Consensus       909 aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~  987 (1013)
                      |||++.+..++.++|||||||++|||++ |..||......+ .    .......+..... +.       ..        
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~----~~~~~~~~~~~~~-~~-------~~--------  301 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-E----FCRRLKEGTRMRA-PE-------YA--------  301 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-H----HHHHHhccCCCCC-Cc-------cC--------
Confidence            9999999999999999999999999998 999987532211 1    1111111111100 00       00        


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          988 KEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       988 ~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        ...+.+++.+||+.+|++||+++|
T Consensus       302 --~~~~~~l~~~cl~~~p~~RPs~~e  325 (337)
T cd05054         302 --TPEIYSIMLDCWHNNPEDRPTFSE  325 (337)
T ss_pred             --CHHHHHHHHHHccCChhhCcCHHH
Confidence              123568999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-34  Score=314.89  Aligned_cols=253  Identities=28%  Similarity=0.435  Sum_probs=195.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||.||+|...      ++..+|+|.+..........+.+|++++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46788999999999999999742      356788888765555556789999999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccC---------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          808 VYEFMKFGSLEEVLHGRAKA---------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      ||||+++++|.+++......         .....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            99999999999999754321         1113478999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......     +....
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-----EAIEC  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-----HHHHH
Confidence            9999999976543222222223345678999999998899999999999999999998 89998643211     11111


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ...+..... +.       ..+          ..+.+++.+||+.||++||+++|
T Consensus       237 -~~~~~~~~~-~~-------~~~----------~~~~~li~~cl~~~P~~Rp~~~~  273 (280)
T cd05092         237 -ITQGRELER-PR-------TCP----------PEVYAIMQGCWQREPQQRMVIKD  273 (280)
T ss_pred             -HHcCccCCC-CC-------CCC----------HHHHHHHHHHccCChhhCCCHHH
Confidence             111111100 00       000          12558999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-34  Score=313.78  Aligned_cols=247  Identities=25%  Similarity=0.403  Sum_probs=189.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCC----EEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGS----SVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||.||+|.+. +++    .|++|.+..... ....++..|+.++++++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46888999999999999999975 344    467776643222 22356778888999999999999999875 456789


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ++||+++|+|.+++....     ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||.++
T Consensus        86 i~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence            999999999999996432     2388999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...............++..|+|||++.+..++.++|||||||++||+++ |+.||.+...  ....++    ...+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~~  231 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDL----LEKGERLA  231 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHCCCcCC
Confidence            7644333222334557778999999998899999999999999999998 9999875421  111111    12111111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        .+..      .          ...+.+++.+|+..||++|||+.|
T Consensus       232 --~~~~------~----------~~~~~~li~~c~~~~p~~Rps~~e  260 (279)
T cd05111         232 --QPQI------C----------TIDVYMVMVKCWMIDENVRPTFKE  260 (279)
T ss_pred             --CCCC------C----------CHHHHHHHHHHcCCCcccCcCHHH
Confidence              1111      0          012457889999999999999864

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.2e-35  Score=330.58  Aligned_cols=202  Identities=26%  Similarity=0.368  Sum_probs=173.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....   ......+.+|+.++.+++||+|+++++++.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999986 58899999886432   223356788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          81 EFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             eCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999986432      388999999999999999999999   9999999999999999999999999998754


Q ss_pred             cccCcc---------------------------------eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc
Q 036815          890 SALDTH---------------------------------LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT  936 (1013)
Q Consensus       890 ~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  936 (1013)
                      ......                                 .......||+.|+|||++.+..++.++||||+||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            321100                                 00113468999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 036815          937 GKRPTDKD  944 (1013)
Q Consensus       937 g~~pf~~~  944 (1013)
                      |+.||...
T Consensus       232 G~~Pf~~~  239 (360)
T cd05627         232 GYPPFCSE  239 (360)
T ss_pred             CCCCCCCC
Confidence            99999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.1e-34  Score=316.39  Aligned_cols=199  Identities=26%  Similarity=0.389  Sum_probs=170.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999976 56778888764332 22235688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++...      ..+++..+..++.|+++||+|||+.+  +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          81 MDGGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            9999999999643      23788999999999999999999731  899999999999999999999999999875432


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ..    .....++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       153 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         153 SM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             cc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence            11    22356889999999998888999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-34  Score=329.94  Aligned_cols=199  Identities=26%  Similarity=0.296  Sum_probs=171.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc---CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK---DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ..+|.+.+.||+|+||.||+|...   .+..||+|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999764   3567899976432     34568999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |++. ++|.+++...      ..+++..++.++.|++.||+|||++   +||||||||+||+++.++.++|+|||+++..
T Consensus       166 e~~~-~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        166 PKYK-CDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             hhcC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9997 6888888422      2389999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      .............||+.|+|||++.+..++.++||||+||++|||++|+.||.+...
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~  292 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV  292 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence            543333333456799999999999999999999999999999999999999976543

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-34  Score=320.66  Aligned_cols=201  Identities=23%  Similarity=0.353  Sum_probs=162.4

Q ss_pred             CCeecccCCcEEEEEEEc---CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEEEEEEccc
Q 036815          739 ESLIGCGGFGEVFKATLK---DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERLLVYEFMK  813 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  813 (1013)
                      .++||+|+||+||+|+.+   +++.||+|++...  .....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999875   4578999987543  223557889999999999999999998854  456889999987


Q ss_pred             CCCHHHHhcccccC---CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe----CCCCcEEEeecccc
Q 036815          814 FGSLEEVLHGRAKA---RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL----DHEMEARVSDFGMA  886 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~a  886 (1013)
                       ++|.+++......   .....+++..++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5888877533211   1223488999999999999999999999   99999999999999    45678999999999


Q ss_pred             eeccccCc-ceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          887 RLISALDT-HLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       887 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +....... ........+|+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            87643221 112234578999999999876 458899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3e-34  Score=308.76  Aligned_cols=246  Identities=29%  Similarity=0.445  Sum_probs=193.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|++++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            4689999999999999999998888889999875433 34567899999999999999999999875 456789999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++....    ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.+.......
T Consensus        84 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          84 KGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999996432    23478999999999999999999999   99999999999999999999999999998764322


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      .. ......++..|+|||++.+..++.++||||||+++|||++ |..||.....     .+.... ......... +   
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~-~~~~~~~~~-~---  225 (260)
T cd05070         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVLEQ-VERGYRMPC-P---  225 (260)
T ss_pred             cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH-HHcCCCCCC-C---
Confidence            11 1122335568999999988889999999999999999999 8899865321     111111 111100000 0   


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ...          ...+.+++.+|++.+|++|||+++
T Consensus       226 ----~~~----------~~~~~~li~~~l~~~p~~Rpt~~~  252 (260)
T cd05070         226 ----QDC----------PISLHELMLQCWKKDPEERPTFEY  252 (260)
T ss_pred             ----CcC----------CHHHHHHHHHHcccCcccCcCHHH
Confidence                000          113668999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.1e-34  Score=313.03  Aligned_cols=254  Identities=28%  Similarity=0.405  Sum_probs=194.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      +++|.+.+.||+|+||.||+|.+.+      +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4679999999999999999999863      4678888765332 22345688999999999999999999999988899


Q ss_pred             EEEEEcccCCCHHHHhcccccC-CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC---cEEEe
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKA-RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM---EARVS  881 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~  881 (1013)
                      ++||||+++++|.+++...... .....+++..+.+++.||+.|++|||++   +++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            9999999999999999755321 1223589999999999999999999999   999999999999998754   59999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHh
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVR  960 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  960 (1013)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......     +.......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~~~~~~  236 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVMEFVTG  236 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHc
Confidence            9999987633222111122233568999999998899999999999999999997 99998754321     11211111


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ... .. .+..       .          ...+.+++.+|++.+|++|||+.|
T Consensus       237 ~~~-~~-~~~~-------~----------~~~~~~~i~~cl~~~p~~Rps~~~  270 (277)
T cd05036         237 GGR-LD-PPKG-------C----------PGPVYRIMTDCWQHTPEDRPNFAT  270 (277)
T ss_pred             CCc-CC-CCCC-------C----------CHHHHHHHHHHcCCCcccCcCHHH
Confidence            111 00 0000       0          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-34  Score=315.31  Aligned_cols=259  Identities=24%  Similarity=0.341  Sum_probs=189.1

Q ss_pred             CCCCCeecccCCcEEEEEEE-----cCCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeC--CEEEE
Q 036815          736 FSAESLIGCGGFGEVFKATL-----KDGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EERLL  807 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  807 (1013)
                      |++.+.||+|+||+||++..     .+++.||+|.+..... .....+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38899999999999988753     2577899998754322 2346788999999999999999999988653  46789


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++++|.+++...       .+++..++.++.|++.|++|||++   +|+||||||+||+++.++.++|+|||+++
T Consensus        86 v~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence            99999999999998642       289999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCccee-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      .......... .....++..|+|||.+.+..++.++|||||||++|||++|..||............+...........+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            7643222111 112335667999999988889999999999999999999999986532211111000000000000000


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+....   ......      ....+.+++.+|+++||++|||+++
T Consensus       236 ~~~~~~~---~~~~~~------~~~~~~~li~~cl~~~p~~Rps~~~  273 (283)
T cd05080         236 LLERGMR---LPCPKN------CPQEVYILMKNCWETEAKFRPTFRS  273 (283)
T ss_pred             hhhcCCC---CCCCCC------CCHHHHHHHHHHhccChhhCCCHHH
Confidence            0000000   000000      0123678999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=308.69  Aligned_cols=245  Identities=27%  Similarity=0.436  Sum_probs=192.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          735 GFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +|++.+.||+|+||.||+|.++++..+|+|.+... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            48889999999999999999887778999987532 23445788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      ++|.+++.....     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.......
T Consensus        84 ~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          84 GCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            999999864321     388999999999999999999999   999999999999999999999999999976542211


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhh
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                       .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......  ....    .........  .+.  
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~----~~~~~~~~~--~~~--  224 (256)
T cd05059         156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVE----SVSAGYRLY--RPK--  224 (256)
T ss_pred             -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHH----HHHcCCcCC--CCC--
Confidence             11112223457999999998899999999999999999999 89998753321  1111    111110000  000  


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          .          ...++.+++.+|++.+|++|||+.|
T Consensus       225 ----~----------~~~~~~~li~~cl~~~p~~Rpt~~~  250 (256)
T cd05059         225 ----L----------APTEVYTIMYSCWHEKPEDRPAFKK  250 (256)
T ss_pred             ----C----------CCHHHHHHHHHHhcCChhhCcCHHH
Confidence                0          0113668999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-35  Score=311.11  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=197.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeecc--CccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRL--SCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ...|++.+.||+||.+.||++...+.+.||+|++...  +.+.-.-|.+|+..|.++ .|.+||++++|-..++..|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            4568999999999999999999988899999987542  333346699999999999 4999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||=+ .+|..++..+....    ..| .++.+.+|++.|+.++|.+   ||||.||||.|+++-. |.+||+|||.|..+
T Consensus       440 E~Gd-~DL~kiL~k~~~~~----~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  440 ECGD-IDLNKILKKKKSID----PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI  509 (677)
T ss_pred             eccc-ccHHHHHHhccCCC----chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence            9754 79999998665432    234 7788999999999999999   9999999999999864 58999999999998


Q ss_pred             cccCcceeeeeeccCCCccCcccccCC-----------CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHH
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSF-----------RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK  958 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  958 (1013)
                      ...........-+||+.||+||.+...           ..++++||||+|||+|+|+.|+.||..-      ...|.+..
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~aKl~  583 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIAKLH  583 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHHHHH
Confidence            877777777778999999999988522           3668999999999999999999998641      12344433


Q ss_pred             HhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       959 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .-.....++-=|++               .+...++++++.||++||.+|||+.|
T Consensus       584 aI~~P~~~Iefp~~---------------~~~~~li~~mK~CL~rdPkkR~si~e  623 (677)
T KOG0596|consen  584 AITDPNHEIEFPDI---------------PENDELIDVMKCCLARDPKKRWSIPE  623 (677)
T ss_pred             hhcCCCccccccCC---------------CCchHHHHHHHHHHhcCcccCCCcHH
Confidence            32222111111111               11122679999999999999999864

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=315.24  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=196.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|.++.      +..||+|.+..... .....+.+|+.+++.++||||+++++++..+...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            578899999999999999998752      36799998754322 23456889999999999999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCC----CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          807 LVYEFMKFGSLEEVLHGRAKAR----DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      +||||+++|+|.+++.......    ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence            9999999999999997543221    123478899999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      ||+++.....+.........++..|+|||.+.+..++.++|||||||++||+++ |..||.....  .....+.    ..
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~----~~  236 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFV----ID  236 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHH----hc
Confidence            999986543322222233456788999999988889999999999999999998 9999865321  1111111    11


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +......+ .       .          ...+.+++.+||+.+|++|||+.|
T Consensus       237 ~~~~~~~~-~-------~----------~~~~~~li~~~l~~~p~~Rpt~~~  270 (277)
T cd05032         237 GGHLDLPE-N-------C----------PDKLLELMRMCWQYNPKMRPTFLE  270 (277)
T ss_pred             CCCCCCCC-C-------C----------CHHHHHHHHHHcCCChhhCCCHHH
Confidence            11111100 0       0          123668999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-34  Score=317.10  Aligned_cols=247  Identities=26%  Similarity=0.409  Sum_probs=197.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            367999999999999999999975 6899999988655555556788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++...       .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||.+.....
T Consensus        98 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          98 LAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             cCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999998532       278889999999999999999999   999999999999999999999999999876543


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ...  ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......     ....+ ......+.
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~-~~~~~~~~  239 (297)
T cd06656         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG-TPELQNPE  239 (297)
T ss_pred             Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC-CCCCCCcc
Confidence            221  12234678899999999988899999999999999999999999975432111100     00000 00000000


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                    ..  ...+.+++.+||+.+|++|||++|
T Consensus       240 --------------~~--~~~~~~li~~~l~~~p~~Rps~~~  265 (297)
T cd06656         240 --------------RL--SAVFRDFLNRCLEMDVDRRGSAKE  265 (297)
T ss_pred             --------------cc--CHHHHHHHHHHccCChhhCcCHHH
Confidence                          00  012458899999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.5e-35  Score=330.05  Aligned_cols=199  Identities=26%  Similarity=0.332  Sum_probs=168.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC------
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG------  802 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  802 (1013)
                      ..++|++.+.||+|+||.||+|.+. .++.||+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999875 58899999886432  22335678899999999999999999988643      


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      ...|+||||+++ ++.+.+..        .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEee
Confidence            356999999985 67666632        278888999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ||+++.....   .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+
T Consensus       163 fg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         163 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             CcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999865322   12234568999999999999899999999999999999999999997643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.7e-34  Score=309.25  Aligned_cols=242  Identities=25%  Similarity=0.380  Sum_probs=186.5

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      +.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999986 68889999765432 22346689999999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCccee
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS  897 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  897 (1013)
                      .+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|++|||.++..........
T Consensus        81 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          81 LTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99986432     2378999999999999999999999   999999999999999999999999999875432111111


Q ss_pred             eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhccc
Q 036815          898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT  976 (1013)
Q Consensus       898 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  976 (1013)
                      ......+..|+|||.+.+..++.++||||+||++|||++ |..||......  .    ............ .+.      
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~----~~~~~~~~~~~~-~~~------  219 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--Q----TREAIEQGVRLP-CPE------  219 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--H----HHHHHHcCCCCC-Ccc------
Confidence            111223457999999998889999999999999999998 88888643211  1    111111110000 000      


Q ss_pred             CCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          977 KGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       977 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ..          ...+.+++.+|++.+|++|||++|
T Consensus       220 -~~----------~~~~~~li~~~l~~~p~~Rps~~~  245 (252)
T cd05084         220 -LC----------PDAVYRLMERCWEYDPGQRPSFST  245 (252)
T ss_pred             -cC----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence             00          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.9e-34  Score=309.39  Aligned_cols=246  Identities=24%  Similarity=0.387  Sum_probs=196.2

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      +|++.+.||+|+||.||++.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788999999999999999986 68899999875432 333467888999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....    ...+++..+..++.|++.||.|||++   +|+|+||||+||++++++.++++|||.++.....
T Consensus        81 ~~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          81 DGGDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             CCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            9999999886432    23478899999999999999999999   9999999999999999999999999999766432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ..  ......+++.|+|||++.+..++.++||||||+++|+|++|..||.....     ...... ...+.... ++...
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~-~~~~~~~~-~~~~~  224 (255)
T cd08219         154 GA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILK-VCQGSYKP-LPSHY  224 (255)
T ss_pred             cc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHH-HhcCCCCC-CCccc
Confidence            21  12345688899999999988899999999999999999999999975331     111111 11111111 11000


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                       ...+.+++.+||+.||++|||+.|
T Consensus       225 -----------------~~~~~~li~~~l~~~P~~Rp~~~~  248 (255)
T cd08219         225 -----------------SYELRSLIKQMFKRNPRSRPSATT  248 (255)
T ss_pred             -----------------CHHHHHHHHHHHhCCcccCCCHHH
Confidence                             012558999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-34  Score=316.42  Aligned_cols=252  Identities=29%  Similarity=0.453  Sum_probs=193.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      +|++.+.||+|+||.||+|+...      ...+++|.+..... ...+++.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47889999999999999998641      24678887654332 224568899999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccC------------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCccc
Q 036815          808 VYEFMKFGSLEEVLHGRAKA------------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSN  869 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  869 (1013)
                      |+||+.+++|.+++......                  .....+++.+++.++.|++.|++|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            99999999999998643211                  1223588999999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCC
Q 036815          870 VLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGD  948 (1013)
Q Consensus       870 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~  948 (1013)
                      |++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999999986543322222223345678999999988889999999999999999998 9999865321  


Q ss_pred             ccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          949 TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .....+    .........  +      ...          ...+.+++.+|++++|++||+++|
T Consensus       236 ~~~~~~----~~~~~~~~~--~------~~~----------~~~~~~~i~~cl~~~P~~Rp~~~~  278 (290)
T cd05045         236 ERLFNL----LKTGYRMER--P------ENC----------SEEMYNLMLTCWKQEPDKRPTFAD  278 (290)
T ss_pred             HHHHHH----HhCCCCCCC--C------CCC----------CHHHHHHHHHHccCCcccCCCHHH
Confidence            111111    111110000  0      000          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.8e-34  Score=309.53  Aligned_cols=246  Identities=27%  Similarity=0.440  Sum_probs=193.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      +|++.+.||+|+||.||+|.++ .++.||+|.+.. ......++.+|++++++++||||+++++++..++..++||||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            4788899999999999999976 478899997653 33345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++....    ...+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||.++......
T Consensus        86 ~~~L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          86 YGNLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             CCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999986432    23488999999999999999999999   99999999999999999999999999998754322


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      .. ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....     .+.... ........ .+   
T Consensus       159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~-~~~~~~~~-~~---  227 (263)
T cd05052         159 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL-LEKGYRME-RP---  227 (263)
T ss_pred             ee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH-HHCCCCCC-CC---
Confidence            11 1112234568999999998899999999999999999998 9999875331     111111 11110000 00   


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ...          ...+.+++.+|++.||++|||+.|
T Consensus       228 ----~~~----------~~~~~~li~~cl~~~p~~Rp~~~~  254 (263)
T cd05052         228 ----EGC----------PPKVYELMRACWQWNPSDRPSFAE  254 (263)
T ss_pred             ----CCC----------CHHHHHHHHHHccCCcccCCCHHH
Confidence                000          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.2e-35  Score=329.43  Aligned_cols=198  Identities=25%  Similarity=0.325  Sum_probs=168.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC------C
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG------E  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  803 (1013)
                      .++|++.+.||+|+||.||+|.+. .++.||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999976 57889999886432  22345678899999999999999999987543      3


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..|+||||+++ ++.+.+..        .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence            57999999985 77777642        277888999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |+++......   ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       171 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         171 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             CCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            9998653321   1234568999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.3e-34  Score=315.95  Aligned_cols=260  Identities=22%  Similarity=0.334  Sum_probs=193.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-----------------CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeee
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-----------------DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPL  795 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  795 (1013)
                      ++|++.+.||+|+||.||+|...                 +...||+|++.... .....++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56999999999999999998643                 23468888875432 2234678999999999999999999


Q ss_pred             ccEEEeCCEEEEEEEcccCCCHHHHhcccccC-----CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccE
Q 036815          796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA-----RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNV  870 (1013)
Q Consensus       796 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  870 (1013)
                      ++++..++..++||||+++++|.+++......     .....+++.++..++.|++.|++|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999999754321     1123478899999999999999999999   999999999999


Q ss_pred             EeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc--CCCCCCCCCCCC
Q 036815          871 LLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT--GKRPTDKDDFGD  948 (1013)
Q Consensus       871 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~  948 (1013)
                      +++.++.++|+|||+++.+.............++..|+|||+..+..++.++|||||||++|||++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence            999999999999999986543222211222334678999999888889999999999999999998  77887643221 


Q ss_pred             ccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          949 TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ................... +..    ..          ....+.+++.+||+.||++|||++|
T Consensus       241 -~~~~~~~~~~~~~~~~~~~-~~~----~~----------~~~~~~~li~~cl~~~p~~Rp~~~~  289 (296)
T cd05095         241 -QVIENTGEFFRDQGRQVYL-PKP----AL----------CPDSLYKLMLSCWRRNAKERPSFQE  289 (296)
T ss_pred             -HHHHHHHHHHhhccccccC-CCC----CC----------CCHHHHHHHHHHcCCCcccCCCHHH
Confidence             1111111111110000000 000    00          0123668999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-34  Score=314.80  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=194.1

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      +|++.+.||+|+||.||+|.+.+      ++.||+|++...... ..+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46778899999999999998642      468999987643322 23568899999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhccccc----------CCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc
Q 036815          808 VYEFMKFGSLEEVLHGRAK----------ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME  877 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  877 (1013)
                      ++||+++++|.+++.....          ......+++..+..++.|++.||+|+|++   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            9999999999999853221          11123478899999999999999999999   9999999999999999999


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHH
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~  956 (1013)
                      +||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||.....     .++..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVIE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence            99999999886543332222233456789999999988889999999999999999998 8888865321     12222


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . +........ +.       ...          ..+.+++.+|++.+|++||+++|
T Consensus       238 ~-i~~~~~~~~-~~-------~~~----------~~~~~li~~cl~~~p~~RP~~~~  275 (283)
T cd05091         238 M-IRNRQVLPC-PD-------DCP----------AWVYTLMLECWNEFPSRRPRFKD  275 (283)
T ss_pred             H-HHcCCcCCC-CC-------CCC----------HHHHHHHHHHhCCCcccCCCHHH
Confidence            2 111111110 00       000          12568999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.6e-34  Score=316.61  Aligned_cols=246  Identities=27%  Similarity=0.420  Sum_probs=196.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .+|++.+.||.|+||.||+|.+. +++.|++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46899999999999999999875 68899999886554445667889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++...       .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        99 ~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          99 AGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             CCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            999999988532       378999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ..  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..     .......... ......+. 
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----~~~~~~~~~~-~~~~~~~~-  239 (296)
T cd06655         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNG-TPELQNPE-  239 (296)
T ss_pred             cc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcC-CcccCCcc-
Confidence            21  122346788999999999888999999999999999999999999764321     1111111110 00000000 


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ...          ..+.+++.+||+.||++|||+.|
T Consensus       240 -----~~~----------~~~~~li~~~l~~dp~~Rpt~~~  265 (296)
T cd06655         240 -----KLS----------PIFRDFLNRCLEMDVEKRGSAKE  265 (296)
T ss_pred             -----cCC----------HHHHHHHHHHhhcChhhCCCHHH
Confidence                 000          12558899999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.4e-34  Score=308.50  Aligned_cols=246  Identities=29%  Similarity=0.437  Sum_probs=192.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.++||+|+||.||+|++.++..||+|++... ....+.+.+|++++++++||||+++++++. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            569999999999999999999887778999987542 234567899999999999999999999874 456789999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|+|.+++....    ...+++..+..++.|+++||+|+|+.   +++||||||+||+++.++.++|+|||.++......
T Consensus        84 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          84 KGSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999996432    23478999999999999999999999   99999999999999999999999999998764322


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      .. ......++..|+|||+..+..++.++|||||||++|||++ |..||......     +... ......... ..+. 
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~-~~~~~~~~~-~~~~-  227 (262)
T cd05071         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD-QVERGYRMP-CPPE-  227 (262)
T ss_pred             cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHH-HHhcCCCCC-Cccc-
Confidence            21 1223346678999999988899999999999999999999 88888653211     1111 111110000 0000 


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                      ....+.+++.+|++.||++|||++|
T Consensus       228 ----------------~~~~l~~li~~~l~~~p~~Rp~~~~  252 (262)
T cd05071         228 ----------------CPESLHDLMCQCWRKEPEERPTFEY  252 (262)
T ss_pred             ----------------cCHHHHHHHHHHccCCcccCCCHHH
Confidence                            1123568999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3e-34  Score=314.41  Aligned_cols=249  Identities=25%  Similarity=0.377  Sum_probs=194.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .+.|++.+.||+|+||.||+|++. +++.|++|.+........+.+.+|+++++.++||||+++++++..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            357999999999999999999986 4788999987655545556788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|..++....     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+.....
T Consensus        91 ~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          91 CPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             CCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999998875322     2388999999999999999999999   999999999999999999999999999875432


Q ss_pred             cCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      .  ........+++.|+|||++.     ...++.++|||||||++|||++|..||.....     ......... .....
T Consensus       163 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~~~  234 (292)
T cd06644         163 T--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAK-SEPPT  234 (292)
T ss_pred             c--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHhc-CCCcc
Confidence            1  11223456888999999984     34567899999999999999999999865321     111111111 11100


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+.      ..          ...+.+++.+||+.||++||+++|
T Consensus       235 ~~~~~------~~----------~~~~~~li~~~l~~~p~~Rp~~~~  265 (292)
T cd06644         235 LSQPS------KW----------SMEFRDFLKTALDKHPETRPSAAQ  265 (292)
T ss_pred             CCCCc------cc----------CHHHHHHHHHHhcCCcccCcCHHH
Confidence            00000      00          112568999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.4e-34  Score=314.70  Aligned_cols=199  Identities=27%  Similarity=0.411  Sum_probs=165.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhcc---CCcceeeeccEEEe-----CC
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKI---KHRNLVPLLGYCKI-----GE  803 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  803 (1013)
                      +|++.+.||+|+||+||+|++. +++.||+|.+......  ....+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999987 5889999987543222  234566777777665   69999999998864     34


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..++||||++ ++|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            5789999998 488888864322    2389999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |+++......   ......++..|+|||++.+..++.++||||+||++|||++|++||...
T Consensus       153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         153 GLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             CccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            9998654321   122346788999999999889999999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-36  Score=319.00  Aligned_cols=247  Identities=25%  Similarity=0.410  Sum_probs=195.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEcCCCEE-EEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          735 GFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      .|.++..||.|+||.||+|..++.... |.|++...+...-+++.-|++||..++||+||++++.|+..+..++..|||+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            466778899999999999998855444 5566555555566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      ||-++.++-.-     ++++++.++..+++|++.||.|||+.   +|||||+|..|||++-+|.++|+|||.+....  .
T Consensus       113 GGAVDaimlEL-----~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~  182 (1187)
T KOG0579|consen  113 GGAVDAIMLEL-----GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--S  182 (1187)
T ss_pred             CchHhHHHHHh-----ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch--h
Confidence            99999988643     35599999999999999999999999   99999999999999999999999999875432  2


Q ss_pred             cceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          894 THLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      .......+.|||.|||||++.     ..+|+.++||||||+++.||..+.+|...     .+..+.+- ++........+
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-----lnpMRVll-KiaKSePPTLl  256 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-----LNPMRVLL-KIAKSEPPTLL  256 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-----cchHHHHH-HHhhcCCCccc
Confidence            233345688999999999874     56899999999999999999999999543     22222111 12111111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      -|.-             +.   ..|.+++.+||..||..||+++|
T Consensus       257 qPS~-------------Ws---~~F~DfLk~cL~Knp~~Rp~aaq  285 (1187)
T KOG0579|consen  257 QPSH-------------WS---RSFSDFLKRCLVKNPRNRPPAAQ  285 (1187)
T ss_pred             Ccch-------------hh---hHHHHHHHHHHhcCCccCCCHHH
Confidence            1111             11   12568999999999999999865

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-34  Score=326.05  Aligned_cols=195  Identities=25%  Similarity=0.280  Sum_probs=167.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ..+|.+.+.||+|+||.||+|.+. .++.||||...      ...+.+|++++++++|+||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999987 47889999532      23457899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +. ++|.+++....     ..+++..++.++.|+++||+|||++   +||||||||+||+++.++.+||+|||+++....
T Consensus       242 ~~-~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        242 YR-SDLYTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             cC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            96 68888885432     2489999999999999999999999   999999999999999999999999999987643


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            222222234569999999999999999999999999999999999887654

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.3e-34  Score=308.63  Aligned_cols=248  Identities=25%  Similarity=0.404  Sum_probs=194.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc------cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC------QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      +|++.+.||+|+||.||+|...+++.+|+|.+.....      .....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4888999999999999999988899999998753221      1124588899999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      +||+++++|.+++....      .+++..+..++.|++.|++|||+.   +|+|+||+|+||++++++.++|+|||.++.
T Consensus        81 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  151 (265)
T cd06631          81 MEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARR  151 (265)
T ss_pred             EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence            99999999999996432      378899999999999999999999   999999999999999999999999999876


Q ss_pred             ccccCc----ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          889 ISALDT----HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       889 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      ......    ........++..|+|||++.+..++.++||||+||++|||++|+.||...+..    ............ 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-  226 (265)
T cd06631         152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMFYIGAHRGL-  226 (265)
T ss_pred             hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHHHhhhccCC-
Confidence            532111    11122346888999999999888999999999999999999999999753211    111111000000 


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...++.       ..          ...+.+++.+||+.+|++|||+.|
T Consensus       227 ~~~~~~-------~~----------~~~~~~~i~~~l~~~p~~Rp~~~~  258 (265)
T cd06631         227 MPRLPD-------SF----------SAAAIDFVTSCLTRDQHERPSALQ  258 (265)
T ss_pred             CCCCCC-------CC----------CHHHHHHHHHHhcCCcccCCCHHH
Confidence            000110       00          112568999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.8e-34  Score=315.60  Aligned_cols=250  Identities=30%  Similarity=0.481  Sum_probs=194.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  805 (1013)
                      ++|.+.+.||+|+||.||+|...      .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            56999999999999999999752      24579999875432 22345688999999999 799999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||+++|+|.+++.....    ..+++.++..++.|++.|++|||++   +|+|+||||+||+++.++.++++|||+
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999964322    2379999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      ++...............++..|+|||++.+..++.++||||+||++|||++ |..||......+ ....    ....+..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~  262 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYK----LIKEGYR  262 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHH----HHHcCCc
Confidence            986543322222223345778999999998899999999999999999998 999987543211 1111    1111111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...  +      ...          ...+.+++.+|++.+|++|||+.|
T Consensus       263 ~~~--~------~~~----------~~~~~~li~~cl~~~p~~Rpt~~e  293 (302)
T cd05055         263 MAQ--P------EHA----------PAEIYDIMKTCWDADPLKRPTFKQ  293 (302)
T ss_pred             CCC--C------CCC----------CHHHHHHHHHHcCCCchhCcCHHH
Confidence            000  0      000          113668999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.6e-34  Score=316.02  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=194.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc--------CCCEEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCC
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK--------DGSSVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  803 (1013)
                      ++|.+.+.||+|+||.||+|++.        +...+|+|.+.... .....++.+|+++++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56999999999999999999863        23469999876432 23345688899999999 7999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ..|+||||+++|+|.+++......          .....+++.++..++.|++.||+|||++   +++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            999999999999999999754321          1223588999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLV  952 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~  952 (1013)
                      .++.+||+|||.++...............+++.|+|||++.+..++.++||||+||++|||++ |..||....     ..
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----~~  249 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VE  249 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----HH
Confidence            999999999999976543221111122234568999999998889999999999999999998 888886432     11


Q ss_pred             HHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          953 GWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       953 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +... ........+. +..       .          ...+.+++.+|++.+|++|||++|
T Consensus       250 ~~~~-~~~~~~~~~~-~~~-------~----------~~~~~~li~~~l~~~p~~Rps~~e  291 (307)
T cd05098         250 ELFK-LLKEGHRMDK-PSN-------C----------TNELYMMMRDCWHAVPSQRPTFKQ  291 (307)
T ss_pred             HHHH-HHHcCCCCCC-CCc-------C----------CHHHHHHHHHHcccChhhCcCHHH
Confidence            2221 1221111110 000       0          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-34  Score=317.68  Aligned_cols=254  Identities=29%  Similarity=0.439  Sum_probs=196.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  804 (1013)
                      .++|++.+.||+|+||.||+|....      ...+|+|.+.... .....++.+|+++++++ +|+||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            4578899999999999999998752      3578999775432 22335688999999999 89999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhccccc----------CCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAK----------ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH  874 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  874 (1013)
                      .++||||+++|+|.+++.....          ......+++..++.++.|++.|++|||+.   +|+||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence            9999999999999999965321          02234589999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHH
Q 036815          875 EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVG  953 (1013)
Q Consensus       875 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~  953 (1013)
                      ++.+||+|||.++...............++..|+|||++.+..++.++|||||||++||+++ |..||......     +
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~  242 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----E  242 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----H
Confidence            99999999999987654322222222345678999999988899999999999999999998 99998653211     1


Q ss_pred             HHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          954 WVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       954 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. .....+..... +..                 ....+.+++.+|++.||++||||+|
T Consensus       243 ~~-~~~~~~~~~~~-~~~-----------------~~~~~~~li~~~l~~~p~~Rps~~e  283 (293)
T cd05053         243 LF-KLLKEGYRMEK-PQN-----------------CTQELYHLMRDCWHEVPSQRPTFKQ  283 (293)
T ss_pred             HH-HHHHcCCcCCC-CCC-----------------CCHHHHHHHHHHcccCcccCcCHHH
Confidence            11 11111111110 000                 0113668999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.4e-35  Score=313.75  Aligned_cols=249  Identities=28%  Similarity=0.487  Sum_probs=194.0

Q ss_pred             CCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccchH--HHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      |++++.||+|+||+||+|+... ++.||+|.+.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678899999999999999874 568999988665433332  2456999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++...      ..+++..+..++.|+++||+|||+.   +|+|+||||+||+++.++.++|+|||.+....  
T Consensus        81 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--  149 (260)
T PF00069_consen   81 PGGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--  149 (260)
T ss_dssp             TTEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST--
T ss_pred             cccccccccccc------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--
Confidence            999999999722      2389999999999999999999999   99999999999999999999999999997642  


Q ss_pred             CcceeeeeeccCCCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ..........++..|+|||++. +..++.++||||+|+++|+|++|..||....  .............. ....    .
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~-~~~~----~  222 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKR-PLPS----S  222 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHT-HHHH----H
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhcccc-cccc----c
Confidence            2222344567889999999998 8889999999999999999999999988641  01111111111110 0000    0


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..    ...       .....+.+++.+||+.||++|||++|
T Consensus       223 ~~----~~~-------~~~~~l~~li~~~l~~~p~~R~~~~~  253 (260)
T PF00069_consen  223 SQ----QSR-------EKSEELRDLIKKMLSKDPEQRPSAEE  253 (260)
T ss_dssp             TT----SHT-------TSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred             cc----ccc-------hhHHHHHHHHHHHccCChhHCcCHHH
Confidence            00    000       00134679999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=321.24  Aligned_cols=202  Identities=28%  Similarity=0.361  Sum_probs=172.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999976 58899999886422   223355888999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....     ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        81 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          81 DYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             ecCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            9999999999996422     2378899999999999999999999   9999999999999999999999999999765


Q ss_pred             cccCcceeeeeeccCCCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ..... .......||+.|+|||++.+     ..++.++||||+||++|||++|+.||...
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         153 LADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            43221 11223468999999999863     45788999999999999999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-34  Score=315.18  Aligned_cols=259  Identities=22%  Similarity=0.335  Sum_probs=192.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC---------------CCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeecc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD---------------GSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLG  797 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  797 (1013)
                      ++|++.+.||+|+||.||+|+...               ...||+|++.... ......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            579999999999999999997642               1248899875432 223456889999999999999999999


Q ss_pred             EEEeCCEEEEEEEcccCCCHHHHhcccccC------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEE
Q 036815          798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKA------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVL  871 (1013)
Q Consensus       798 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  871 (1013)
                      ++......++||||+++++|.+++......      .....+++..+..++.|++.|++|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            999999999999999999999998643210      1112368899999999999999999999   9999999999999


Q ss_pred             eCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc--CCCCCCCCCCCCc
Q 036815          872 LDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT--GKRPTDKDDFGDT  949 (1013)
Q Consensus       872 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~~  949 (1013)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++  +..||.....  .
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--~  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--E  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--H
Confidence            99999999999999976543222222223345678999999988889999999999999999998  5667764321  1


Q ss_pred             cHHHHHHHHHhc-CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          950 NLVGWVKMKVRE-GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       950 ~~~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ............ ........+..      .          ...+.+++.+|++.||++|||++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~------~----------~~~l~~li~~~l~~~p~~RPs~~~  288 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYLSQTPL------C----------PSPVFKLMMRCWSRDIKDRPTFNK  288 (295)
T ss_pred             HHHHHHHHhhhhccccccCCCCCC------C----------CHHHHHHHHHHcCCCchhCcCHHH
Confidence            111111111111 00000000000      0          013679999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.8e-34  Score=311.97  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=193.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46788889999999999999876 57889999876544444456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....      .+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        89 ~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          89 GGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999986432      388999999999999999999999   9999999999999999999999999998765422


Q ss_pred             CcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .  .......|+..|+|||++.   ...++.++||||+||++|+|++|..||........     ...... ....   .
T Consensus       160 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-----~~~~~~-~~~~---~  228 (267)
T cd06645         160 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----LFLMTK-SNFQ---P  228 (267)
T ss_pred             c--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-----HHhhhc-cCCC---C
Confidence            1  1223456889999999874   45688899999999999999999999865331110     000000 0000   0


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.... ....+          ..+.+++.+|++.+|++|||++|
T Consensus       229 ~~~~~-~~~~~----------~~~~~li~~~l~~~P~~R~~~~~  261 (267)
T cd06645         229 PKLKD-KMKWS----------NSFHHFVKMALTKNPKKRPTAEK  261 (267)
T ss_pred             Ccccc-cCCCC----------HHHHHHHHHHccCCchhCcCHHH
Confidence            00000 00000          12558999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=313.99  Aligned_cols=246  Identities=28%  Similarity=0.446  Sum_probs=199.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      +.++.++||-|-||.||.|.|+. .-.||||.++.. .-..++|..|+.+|+.++|||+|+++|+|..+...|||+|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            46778999999999999999974 567999987543 3445789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|+|.+|+....+.    .++--..++++.||+.||+||..+   ++||||+..+|+||.++..+|++|||+++++.. +
T Consensus       347 yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-D  418 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-D  418 (1157)
T ss_pred             CccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC-C
Confidence            99999999866543    266777889999999999999999   999999999999999999999999999998754 2


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      .+.......-...|.|||-+....++.|+|||+|||++||+.| |..||.+-+..+      +-..+..+..++.     
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq------VY~LLEkgyRM~~-----  487 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYGLLEKGYRMDG-----  487 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH------HHHHHhccccccC-----
Confidence            2222223334678999999999999999999999999999999 999988754221      2222233322221     


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         ..++.          .+++++++.||++.|.+||+++|
T Consensus       488 ---PeGCP----------pkVYeLMraCW~WsPsDRPsFae  515 (1157)
T KOG4278|consen  488 ---PEGCP----------PKVYELMRACWNWSPSDRPSFAE  515 (1157)
T ss_pred             ---CCCCC----------HHHHHHHHHHhcCCcccCccHHH
Confidence               01111          13679999999999999999864

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.8e-34  Score=312.80  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=194.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  804 (1013)
                      ..++|++.+.||+|+||.||+|..++      +..||+|.+..... .....+.+|+.++++++||||+++++++.++..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            35689999999999999999997542      45799997653322 223467889999999999999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccC----CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEE
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKA----RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                      .++||||+++|+|.+++......    ......++..+..++.|++.||+|||++   +|+||||||+||+++.++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            99999999999999999753221    1123357788899999999999999999   9999999999999999999999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHH
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKV  959 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  959 (1013)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....     .++.....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVM  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence            99999986543222222222345678999999998899999999999999999998 7888865321     12222111


Q ss_pred             hcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . +..... +       ...          ...+.+++.+|++.||++|||+.|
T Consensus       236 ~-~~~~~~-~-------~~~----------~~~~~~li~~~l~~~p~~Rps~~~  270 (288)
T cd05061         236 D-GGYLDQ-P-------DNC----------PERVTDLMRMCWQFNPKMRPTFLE  270 (288)
T ss_pred             c-CCCCCC-C-------CCC----------CHHHHHHHHHHcCCChhHCcCHHH
Confidence            1 111100 0       000          123668999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=342.77  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=191.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERL  806 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  806 (1013)
                      ..++|++.+.||+|+||+||+|++. .++.||+|.+...  .......+..|+.++++++||||++++++|.+  ....|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999987 4667888876532  22234668899999999999999999998854  45689


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCcccEEeCCC-------
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI----PHIIHRDMKSSNVLLDHE-------  875 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlkp~Nill~~~-------  875 (1013)
                      +||||+++|+|.+++.....  ....+++..++.|+.||+.||+|||+...    .+||||||||+|||++.+       
T Consensus        91 IVMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            99999999999999975322  12348999999999999999999998521    259999999999999642       


Q ss_pred             ----------CcEEEeecccceeccccCcceeeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          876 ----------MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       876 ----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                                +.+||+|||+++......   ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      348999999998654321   1234568999999999854  4588999999999999999999999975


Q ss_pred             CCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          944 DDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       944 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...    ....+.. +........         ...          ...+.++|..||+.+|.+|||+.|
T Consensus       246 ~~~----~~qli~~-lk~~p~lpi---------~~~----------S~eL~dLI~~~L~~dPeeRPSa~Q  291 (1021)
T PTZ00266        246 ANN----FSQLISE-LKRGPDLPI---------KGK----------SKELNILIKNLLNLSAKERPSALQ  291 (1021)
T ss_pred             CCc----HHHHHHH-HhcCCCCCc---------CCC----------CHHHHHHHHHHhcCChhHCcCHHH
Confidence            321    1222221 111110000         000          112568999999999999999864

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.9e-34  Score=307.94  Aligned_cols=247  Identities=27%  Similarity=0.416  Sum_probs=194.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.++||+|+||.||+|..++++.||+|.+.... ....++.+|++++++++|+||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35789999999999999999999889999999876433 34567899999999999999999999864 45689999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....    ...+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+......
T Consensus        83 ~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          83 ENGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             CCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999986432    23488999999999999999999999   9999999999999999999999999999776422


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      .. .......++..|+|||++.+..++.++|||||||++||+++ |+.||.....  .......    ........ .. 
T Consensus       156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~~~~~~~~-~~-  226 (260)
T cd05067         156 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNL----ERGYRMPR-PD-  226 (260)
T ss_pred             Cc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHH----HcCCCCCC-CC-
Confidence            21 11123345678999999998889999999999999999999 9999975331  1111111    11110000 00 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..          ..++.+++.+|++.+|++|||+++
T Consensus       227 ------~~----------~~~~~~li~~~l~~~p~~Rp~~~~  252 (260)
T cd05067         227 ------NC----------PEELYELMRLCWKEKPEERPTFEY  252 (260)
T ss_pred             ------CC----------CHHHHHHHHHHccCChhhCCCHHH
Confidence                  00          013668999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.8e-34  Score=313.03  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=191.3

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      |++.+.||+|+||.||+|.+. ++..+++|.+........+.+.+|+++++.++||||+++++++..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            677889999999999999987 4667788877554444456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      ++|..++....     ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+|++|||++....... 
T Consensus        87 ~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-  157 (282)
T cd06643          87 GAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  157 (282)
T ss_pred             CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-
Confidence            99999876422     3489999999999999999999999   99999999999999999999999999987653211 


Q ss_pred             ceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          895 HLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                       .......+++.|+|||++.     +..++.++||||+||++|||++|+.||.....     .+.+....... ......
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~-~~~~~~  230 (282)
T cd06643         158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSE-PPTLAQ  230 (282)
T ss_pred             -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----HHHHHHHhhcC-CCCCCC
Confidence             1223456889999999974     44577899999999999999999999875321     11111111110 000000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.      ..          ...+.+++.+||+.||.+|||++|
T Consensus       231 ~~------~~----------~~~~~~li~~~l~~~p~~Rp~~~~  258 (282)
T cd06643         231 PS------RW----------SSEFKDFLKKCLEKNVDARWTTTQ  258 (282)
T ss_pred             cc------cc----------CHHHHHHHHHHccCChhhCcCHHH
Confidence            00      00          012568999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.2e-34  Score=314.21  Aligned_cols=260  Identities=23%  Similarity=0.358  Sum_probs=196.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-----------------CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeee
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-----------------GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPL  795 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  795 (1013)
                      ++|++.+.||+|+||.||+|.+.+                 +..||+|.+..... ...+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            579999999999999999998653                 24578888754332 234678899999999999999999


Q ss_pred             ccEEEeCCEEEEEEEcccCCCHHHHhcccccC-----CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccE
Q 036815          796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA-----RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNV  870 (1013)
Q Consensus       796 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  870 (1013)
                      ++++..++..++||||+++++|.+++......     .....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            99999999999999999999999999754321     1123589999999999999999999999   999999999999


Q ss_pred             EeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc--CCCCCCCCCCCC
Q 036815          871 LLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT--GKRPTDKDDFGD  948 (1013)
Q Consensus       871 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~  948 (1013)
                      +++.++.++|+|||.++...............++..|+|||++.+..++.++|||||||++|||++  +..||....  .
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--~  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--D  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--h
Confidence            999999999999999986543332222334456778999999988889999999999999999998  677775432  1


Q ss_pred             ccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          949 TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....................+. .    ..          ....+.+++.+|++.||++|||+.|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~-~----~~----------~~~~l~~li~~cl~~~p~~Rpt~~e  289 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPR-P----PN----------CPKDIYELMLECWRRDEEDRPTFRE  289 (296)
T ss_pred             HHHHHHHHhccccccccccCCC-c----cC----------CCHHHHHHHHHHhccChhcCCCHHH
Confidence            1111111111111000000000 0    00          0123678999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.4e-34  Score=308.33  Aligned_cols=254  Identities=24%  Similarity=0.309  Sum_probs=194.5

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          730 IEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       730 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      +.+++.+.....||+|+||.||+|++. +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566777789999999999999976 5778999987665555567899999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-CCcEEEeecccce
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-EMEARVSDFGMAR  887 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~  887 (1013)
                      +||+++++|.+++......   ...++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++|+|||.+.
T Consensus        84 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EecCCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999999743211   1127788889999999999999999   9999999999999976 6789999999987


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCC--CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFR--CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      .......  ......+++.|+|||++.+..  ++.++||||+|+++|+|++|+.||.......  ...+.......   .
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~~~~---~  230 (268)
T cd06624         158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMFKI---H  230 (268)
T ss_pred             ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhhhcc---C
Confidence            6543221  122345788999999986543  7889999999999999999999986532211  11111110000   0


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..++...                 ...+.+++.+||+.+|++|||++|
T Consensus       231 ~~~~~~~-----------------~~~~~~li~~~l~~~p~~Rpt~~~  261 (268)
T cd06624         231 PEIPESL-----------------SAEAKNFILRCFEPDPDKRASAHD  261 (268)
T ss_pred             CCCCccc-----------------CHHHHHHHHHHcCCCchhCCCHHH
Confidence            0011000                 112558899999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-35  Score=312.28  Aligned_cols=246  Identities=24%  Similarity=0.425  Sum_probs=196.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC---CC--EEEEEEeec-cCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD---GS--SVAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      +..+..++||+|-||.||+|...+   |+  .||||..+. ......+.|..|+.+|+.++||||++++|+|.+ ...|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            345567899999999999998643   33  478887655 333446779999999999999999999999975 56789


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |||.++.|.|..|+.....     .++..+...++.||..||+|||+.   ++|||||..+|||+.+..-+|++|||+++
T Consensus       468 vmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             EEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence            9999999999999986543     388889999999999999999999   99999999999999999999999999999


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      .++..+.. ..+...-+..|||||.+.-.+++.++|||.|||.+||++. |..||.+-...+..      ..+..|....
T Consensus       540 ~~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------~~iEnGeRlP  612 (974)
T KOG4257|consen  540 YLEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------GHIENGERLP  612 (974)
T ss_pred             hccccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------EEecCCCCCC
Confidence            88764433 3334555779999999999999999999999999999988 99999875444321      1122222211


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. +       .+.          .+++.++.+||+.||.+||+++|
T Consensus       613 ~P-~-------nCP----------p~LYslmskcWayeP~kRPrfte  641 (974)
T KOG4257|consen  613 CP-P-------NCP----------PALYSLMSKCWAYEPSKRPRFTE  641 (974)
T ss_pred             CC-C-------CCC----------hHHHHHHHHHhccCcccCCcHHH
Confidence            10 0       111          13678999999999999999864

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.9e-34  Score=315.95  Aligned_cols=201  Identities=23%  Similarity=0.361  Sum_probs=169.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|+++ +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56999999999999999999986 57899999875432 22345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      ++ ++|.+++....     ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        86 ~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          86 LD-KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             cc-cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            98 58988886432     2378899999999999999999999   999999999999999999999999999976432


Q ss_pred             cCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ..  .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus       157 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         157 PT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             CC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            21  11223456889999998765 457889999999999999999999997643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.8e-34  Score=323.44  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=194.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCcc-chHHHHHHHHHHhccC-CcceeeeccEEEeCCEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIK-HRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  805 (1013)
                      ++|.+.+.||+|+||.||+|++.      .++.||+|++...... ..+.+.+|++++.++. ||||+++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46888999999999999999864      2467999998653322 2346889999999997 99999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccC----------------------------------------------------------
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKA----------------------------------------------------------  827 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------------  827 (1013)
                      ++||||+++|+|.++++.....                                                          
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            9999999999999999753210                                                          


Q ss_pred             ----------------------------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          828 ----------------------------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       828 ----------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                                                        .....+++..+..++.|++.||+|||+.   +++||||||+||+++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence                                              0113467888999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLV  952 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~  952 (1013)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+    
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~----  349 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE----  349 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence            999999999999986543222222223456788999999998889999999999999999998 889986533211    


Q ss_pred             HHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          953 GWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       953 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .....+..+....  .+.      ..          ...+.+++.+||+.+|++||+++|
T Consensus       350 -~~~~~~~~~~~~~--~p~------~~----------~~~l~~li~~cl~~~P~~RPs~~e  391 (401)
T cd05107         350 -QFYNAIKRGYRMA--KPA------HA----------SDEIYEIMQKCWEEKFEIRPDFSQ  391 (401)
T ss_pred             -HHHHHHHcCCCCC--CCC------CC----------CHHHHHHHHHHcCCChhHCcCHHH
Confidence             1111111111110  000      00          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.9e-37  Score=330.19  Aligned_cols=293  Identities=25%  Similarity=0.388  Sum_probs=201.1

Q ss_pred             ccEEECCCCCCC-CCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEEC
Q 036815          103 LLHLDLSQNHIM-DVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL  181 (1013)
Q Consensus       103 L~~L~Ls~n~i~-~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L  181 (1013)
                      ++-.|+++|.+. +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .                 
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~-----------------   69 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-S-----------------   69 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-h-----------------
Confidence            445555555554 344555555555555555555554 44555555555555555555544 2                 


Q ss_pred             CCCCCCCcCCccccCCCCCCEEEccCCCCCCC-CChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeec
Q 036815          182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGP-FPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVS  260 (1013)
Q Consensus       182 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  260 (1013)
                              +-..+..++.|+.+++.+|++... +|..+| .+..|+.|+||.|+++ ..|..+..-+++-.|+|++|+|.
T Consensus        70 --------vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie  139 (1255)
T KOG0444|consen   70 --------VHGELSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE  139 (1255)
T ss_pred             --------hhhhhccchhhHHHhhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc
Confidence                    223345555566666666655422 444443 3666666677777666 56666666677777777777776


Q ss_pred             ccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccc-cCCCCcC
Q 036815          261 GIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGL-EGKIPPE  339 (1013)
Q Consensus       261 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l-~~~~p~~  339 (1013)
                       .+|..+|.++..|-.|+|++|++. .+|..+..+..|++|+|++|++...--..+..++.|+.|++++.+- ...+|.+
T Consensus       140 -tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Pts  217 (1255)
T KOG0444|consen  140 -TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTS  217 (1255)
T ss_pred             -cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCc
Confidence             677777778888888888888887 5666788888899999999988754444555666777777776543 2367888


Q ss_pred             cCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCc
Q 036815          340 LGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV  419 (1013)
Q Consensus       340 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  419 (1013)
                      +..|.+|..+|||.|++. .+|+.+.++.+|+.|+||+|+|+ .+....+...+|+.|+|+.|+++ .+|..+++|+.|+
T Consensus       218 ld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~  294 (1255)
T KOG0444|consen  218 LDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLT  294 (1255)
T ss_pred             hhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHH
Confidence            888888888888888887 78888888888888888888887 66667777778888888888887 7888888888888


Q ss_pred             EEEccCCcCC
Q 036815          420 WLDLNSNNLT  429 (1013)
Q Consensus       420 ~L~l~~N~l~  429 (1013)
                      .|++.+|+|+
T Consensus       295 kLy~n~NkL~  304 (1255)
T KOG0444|consen  295 KLYANNNKLT  304 (1255)
T ss_pred             HHHhccCccc
Confidence            8888877765

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.5e-34  Score=309.08  Aligned_cols=250  Identities=27%  Similarity=0.413  Sum_probs=184.6

Q ss_pred             CeecccCCcEEEEEEEcC---CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          740 SLIGCGGFGEVFKATLKD---GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      +.||+|+||.||+|...+   +..+|+|++..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   35789998754332 23356888999999999999999999999988999999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      +|.+++...... .....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++........
T Consensus        81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          81 DLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             cHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999754321 223467788889999999999999999   9999999999999999999999999999754332222


Q ss_pred             eeeeeeccCCCccCcccccCC-------CCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          896 LSVSTLAGTPGYVPPEYYQSF-------RCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      .......++..|+|||++.+.       .++.++|||||||++|||++ |+.||......+  ...+   ... ......
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~---~~~-~~~~~~  230 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY---TVR-EQQLKL  230 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH---Hhh-cccCCC
Confidence            222234567889999998642       35789999999999999996 999996532211  1111   111 111111


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .++...   ...          ...+.+++.+|+ .+|++|||++|
T Consensus       231 ~~~~~~---~~~----------~~~~~~l~~~c~-~~P~~Rpt~~~  262 (269)
T cd05087         231 PKPRLK---LPL----------SDRWYEVMQFCW-LQPEQRPSAEE  262 (269)
T ss_pred             CCCccC---CCC----------ChHHHHHHHHHh-cCcccCCCHHH
Confidence            111110   000          012457888998 58999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.3e-34  Score=308.33  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=193.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---------hHHHHHHHHHHhccCCcceeeeccEEEeCCE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---------DREFMAEMETLGKIKHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  804 (1013)
                      +|.+.+.||+|+||.||+|.+. +++.||+|.+.......         .+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788899999999999999875 57899999875433221         1457889999999999999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .++||||+++++|.+++....      .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccC
Confidence            999999999999999996432      378889999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcc----eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh
Q 036815          885 MARLISALDTH----LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR  960 (1013)
Q Consensus       885 ~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  960 (1013)
                      .++........    .......++..|+|||.+.+..++.++||||+||++|+|++|+.||.....    ... +. ...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~-~~-~~~  225 (267)
T cd06628         152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQA-IF-KIG  225 (267)
T ss_pred             CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHH-HH-HHh
Confidence            99876421111    111234578899999999988899999999999999999999999975321    111 11 111


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .... ..++...                 ...+.+++.+||+.||.+||+++|
T Consensus       226 ~~~~-~~~~~~~-----------------~~~~~~li~~~l~~~p~~Rp~~~~  260 (267)
T cd06628         226 ENAS-PEIPSNI-----------------SSEAIDFLEKTFEIDHNKRPTAAE  260 (267)
T ss_pred             ccCC-CcCCccc-----------------CHHHHHHHHHHccCCchhCcCHHH
Confidence            1100 0011000                 112568899999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.5e-34  Score=313.60  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=196.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc--------CCCEEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeC
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK--------DGSSVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIG  802 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  802 (1013)
                      .++|++.+.||+|+||.||+|+..        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            356889999999999999999742        24578999775432 23346788999999999 899999999999999


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL  872 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  872 (1013)
                      ...++||||+++|+|.+++......          .....+++.++..++.|+++||+|||++   +++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            9999999999999999999754321          1123578899999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccH
Q 036815          873 DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNL  951 (1013)
Q Consensus       873 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~  951 (1013)
                      +.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||....     .
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H
Confidence            9999999999999987654332222223345678999999998889999999999999999998 788876432     2


Q ss_pred             HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          952 VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       952 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .++... ...+..... +.       .          ....+.+++.+||+.+|++|||+.|
T Consensus       246 ~~~~~~-~~~~~~~~~-~~-------~----------~~~~~~~li~~cl~~~p~~Rps~~e  288 (304)
T cd05101         246 EELFKL-LKEGHRMDK-PA-------N----------CTNELYMMMRDCWHAIPSHRPTFKQ  288 (304)
T ss_pred             HHHHHH-HHcCCcCCC-CC-------C----------CCHHHHHHHHHHcccChhhCCCHHH
Confidence            222221 221111110 00       0          0123568999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-34  Score=307.17  Aligned_cols=248  Identities=28%  Similarity=0.433  Sum_probs=196.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.+.||+|+||.||+|..++++.||+|.+... ....+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            4679999999999999999999888889999987543 334567999999999999999999999999888999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....    ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||.++.....
T Consensus        84 ~~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          84 SKGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             CCCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            9999999996532    23489999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      .. ........+..|+|||.+.+..++.++||||+||++||+++ |+.||.....     .............  ..+. 
T Consensus       157 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~~~~~--~~~~-  227 (261)
T cd05034         157 EY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----REVLEQVERGYRM--PRPP-  227 (261)
T ss_pred             hh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCC--CCCC-
Confidence            11 11112234568999999998889999999999999999998 9999865321     1111111110000  0000 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..          ...+.+++.+|++.+|++||+++|
T Consensus       228 ------~~----------~~~~~~~i~~~l~~~p~~Rp~~~~  253 (261)
T cd05034         228 ------NC----------PEELYDLMLQCWDKDPEERPTFEY  253 (261)
T ss_pred             ------CC----------CHHHHHHHHHHcccCcccCCCHHH
Confidence                  00          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.6e-34  Score=309.84  Aligned_cols=254  Identities=23%  Similarity=0.388  Sum_probs=196.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC-----CCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEe-CCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD-----GSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKI-GEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  805 (1013)
                      .++|++.+.||+|+||.||+|.+.+     +..|++|++.... ....+.+.+|+.++++++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4679999999999999999999875     6788898875432 2234568899999999999999999998766 5678


Q ss_pred             EEEEEcccCCCHHHHhcccccCC--CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKAR--DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ++++||+++++|.+++.......  ....+++.+++.++.|++.||+|||+.   +++||||||+||++++++.+|++||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            99999999999999986543211  124589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      |+++.+...+.........++..|+|||++.+..++.++|||||||++||+++ |+.||.....     .++... ...+
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~-~~~~  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FEMAAY-LKDG  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----HHHHHH-HHcC
Confidence            99986643332222223345678999999998889999999999999999999 9999875321     112211 1111


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..... ...       .          ...+.+++.+|++.||++|||+.|
T Consensus       236 ~~~~~-~~~-------~----------~~~~~~li~~~l~~~p~~Rps~~~  268 (280)
T cd05043         236 YRLAQ-PIN-------C----------PDELFAVMACCWALDPEERPSFSQ  268 (280)
T ss_pred             CCCCC-CCc-------C----------CHHHHHHHHHHcCCChhhCCCHHH
Confidence            10000 000       0          013568999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.1e-34  Score=311.41  Aligned_cols=254  Identities=28%  Similarity=0.479  Sum_probs=196.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      .++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ....+++.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999864      46789999875432 22346688999999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccC----------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKA----------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSN  869 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  869 (1013)
                      ++||||+++|+|.+++......                .....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            9999999999999999743211                1123478899999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCC
Q 036815          870 VLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGD  948 (1013)
Q Consensus       870 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~  948 (1013)
                      |+++.++.++|+|||.++................+..|+|||.+.+..++.++|||||||++|||++ |..||.....  
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999876543222111222345678999999998899999999999999999997 8888864321  


Q ss_pred             ccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          949 TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         .++... ...+..... +.       ..          ...+.+++.+|++.||++|||++|
T Consensus       239 ---~~~~~~-~~~~~~~~~-~~-------~~----------~~~l~~li~~~l~~~p~~Rpt~~e  281 (288)
T cd05050         239 ---EEVIYY-VRDGNVLSC-PD-------NC----------PLELYNLMRLCWSKLPSDRPSFAS  281 (288)
T ss_pred             ---HHHHHH-HhcCCCCCC-CC-------CC----------CHHHHHHHHHHcccCcccCCCHHH
Confidence               122221 111211110 00       00          123668999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=314.57  Aligned_cols=239  Identities=28%  Similarity=0.436  Sum_probs=189.3

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      |.-.+.||.|+||.||.|++. +.+.||||++.-...+.   ..++..|+..+++++|||++.+.|+|-.+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            444567999999999999986 67889999985433322   35688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      |- |+-.+++.-..     +++-+.++..|..+.+.||+|||+.   +.||||||..|||+++.|.|||+|||.|....+
T Consensus       108 Cl-GSAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  108 CL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             Hh-ccHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            98 57777775433     3488899999999999999999999   999999999999999999999999999987643


Q ss_pred             cCcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                            ...++|||.|||||++.   .+.|+-|+||||+|++..|+...++|+.....    +...+.....+.      
T Consensus       179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALYHIAQNes------  242 (948)
T KOG0577|consen  179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNES------  242 (948)
T ss_pred             ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHHHHHhcCC------
Confidence                  34678999999999974   57899999999999999999999999764221    111111111111      


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                       |.+.          ..++.  ..|..|+..||+.-|.+|||.+
T Consensus       243 -PtLq----------s~eWS--~~F~~Fvd~CLqKipqeRptse  273 (948)
T KOG0577|consen  243 -PTLQ----------SNEWS--DYFRNFVDSCLQKIPQERPTSE  273 (948)
T ss_pred             -CCCC----------CchhH--HHHHHHHHHHHhhCcccCCcHH
Confidence             1110          01111  1256889999999999999975

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=313.14  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=196.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|++++++++||||+++++++..+...|+||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            457899999999999999999985 5788999987655444556788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....     ..+++..++.++.|++.|+.|||+.   +|+|+||||+||+++.++.++|+|||.+.....
T Consensus        84 ~~~~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          84 CDGGALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             cCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            99999999986432     2489999999999999999999999   999999999999999999999999999876432


Q ss_pred             cCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ..  .......+++.|+|||++.     +..++.++||||+||++|||++|+.||...+..     +.... ........
T Consensus       156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~~  227 (280)
T cd06611         156 TL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLK-ILKSEPPT  227 (280)
T ss_pred             cc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHH-HhcCCCCC
Confidence            21  1223456889999999874     345778999999999999999999998753211     11111 11111100


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+.      ..+          ..+.+++.+||+.+|++|||++|
T Consensus       228 ~~~~~------~~~----------~~~~~li~~~l~~~p~~Rps~~~  258 (280)
T cd06611         228 LDQPS------KWS----------SSFNDFLKSCLVKDPDDRPTAAE  258 (280)
T ss_pred             cCCcc------cCC----------HHHHHHHHHHhccChhhCcCHHH
Confidence            00000      000          12568999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.2e-34  Score=314.09  Aligned_cols=253  Identities=27%  Similarity=0.433  Sum_probs=193.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc--------CCCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeCC
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK--------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  803 (1013)
                      ++|.+.+.||+|+||.||+|+..        ....||+|.+..... .....+.+|+++++++ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            56889999999999999999752        235688887754322 2345688999999999 6999999999999989


Q ss_pred             EEEEEEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ..++||||+++|+|.+++......          .....+++.++..++.|++.||+|||++   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            999999999999999999754321          1123589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLV  952 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~  952 (1013)
                      .++.+||+|||.++.....+.........++..|+|||++.+..++.++|||||||++|||++ |..||.....     .
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~  243 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-----E  243 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----H
Confidence            999999999999986543222211222234567999999998899999999999999999999 8889865321     1


Q ss_pred             HHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          953 GWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       953 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +... ....+...+. ...       .          ...+.+++.+|++.||++|||+.|
T Consensus       244 ~~~~-~~~~~~~~~~-~~~-------~----------~~~l~~li~~cl~~~p~~Rps~~~  285 (314)
T cd05099         244 ELFK-LLREGHRMDK-PSN-------C----------THELYMLMRECWHAVPTQRPTFKQ  285 (314)
T ss_pred             HHHH-HHHcCCCCCC-CCC-------C----------CHHHHHHHHHHcCCCcccCcCHHH
Confidence            1111 1111111111 000       0          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.6e-34  Score=309.55  Aligned_cols=247  Identities=25%  Similarity=0.403  Sum_probs=190.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCC----EEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGS----SVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.++||+|+||+||+|++. +++    .||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56889999999999999999864 444    47899875432 2234678899999999999999999999865 45679


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ++||+++|+|.+++....     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        86 ~~~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            999999999999986432     2388999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...............++..|+|||...+..++.++|||||||++|||++ |..||.....  .....++    ..+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~----~~~~~~~  231 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLL----EKGERLP  231 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----HCCCcCC
Confidence            7653322222222345678999999998899999999999999999998 8999864321  1122221    1111111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ++       ..          ...+.+++.+||+.||++|||+.|
T Consensus       232 ~-~~-------~~----------~~~~~~li~~~l~~dp~~Rp~~~~  260 (279)
T cd05109         232 Q-PP-------IC----------TIDVYMIMVKCWMIDSECRPRFRE  260 (279)
T ss_pred             C-Cc-------cC----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence            0 00       00          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.1e-34  Score=313.17  Aligned_cols=250  Identities=29%  Similarity=0.454  Sum_probs=190.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CC--EEEEEEeecc-CccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GS--SVAIKKLIRL-SCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|..++ +.  .+++|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478999999999999999998763 32  4688876532 223346788999999999 799999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          809 YEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      +||+++++|.+++......          .....+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            9999999999999653311          1123488999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ||+|||++.....   .........+..|+|||++.+..++.++|||||||++|||++ |..||.....     ......
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~~~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----AELYEK  230 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence            9999999864321   111112223557999999988889999999999999999997 9999975432     111111


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ...+.... ...       ..+          ..+.+++.+|++.+|.+|||++|
T Consensus       231 -~~~~~~~~-~~~-------~~~----------~~~~~li~~~l~~~p~~Rp~~~~  267 (297)
T cd05089         231 -LPQGYRME-KPR-------NCD----------DEVYELMRQCWRDRPYERPPFAQ  267 (297)
T ss_pred             -HhcCCCCC-CCC-------CCC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence             11111000 000       000          12568999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-33  Score=308.52  Aligned_cols=202  Identities=28%  Similarity=0.436  Sum_probs=168.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-----CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-----DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  806 (1013)
                      .+|++.+.||+|+||.||+|..+     +++.||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            47889999999999999999742     578999998865554445678999999999999999999998754  34678


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||+++++|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence            9999999999999996432     2378999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcceee-eeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          887 RLISALDTHLSV-STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       887 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      +........... ....++..|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  213 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS  213 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence            876443222111 112234569999999988999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6e-34  Score=311.37  Aligned_cols=201  Identities=29%  Similarity=0.425  Sum_probs=172.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++.....  ...+.+.+|++++++++|||++++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46899999999999999999987 588999998754322  233567899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |++++.+..+....      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07847          81 YCDHTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILT  151 (286)
T ss_pred             ccCccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecC
Confidence            99998888876432      2389999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ....  ......++..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       152 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         152 GPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             CCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            4321  1223457889999999876 557889999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.5e-34  Score=309.83  Aligned_cols=250  Identities=25%  Similarity=0.379  Sum_probs=193.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeC------
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIG------  802 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  802 (1013)
                      .+++.|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.+++++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678999999999999999999976 5788999987543 34456788999999998 799999999998753      


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      ...|+||||+++++|.+++....    ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence            46899999999999999987532    23488999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ||+++......  .......|+..|+|||++.     +..++.++||||+||++|||++|+.||......    ..+.. 
T Consensus       155 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~-  227 (272)
T cd06637         155 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFL-  227 (272)
T ss_pred             CCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHH-
Confidence            99998654321  1223456889999999986     345788999999999999999999998643211    11111 


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ..........+..       .          ...+.+++.+||..||.+|||++|
T Consensus       228 -~~~~~~~~~~~~~-------~----------~~~~~~li~~~l~~~p~~Rpt~~~  265 (272)
T cd06637         228 -IPRNPAPRLKSKK-------W----------SKKFQSFIESCLVKNHSQRPTTEQ  265 (272)
T ss_pred             -HhcCCCCCCCCCC-------c----------CHHHHHHHHHHcCCChhhCCCHHH
Confidence             1111000000000       0          013568999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-34  Score=307.48  Aligned_cols=245  Identities=24%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||.|+||.||+|++. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999986 57899999875433 23345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++...       .+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||.++....
T Consensus        81 ~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          81 CGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             eCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            9999999998643       489999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ...  ......+++.|+|||++.+..++.++|||||||++|+|++|+.||......     .... ............. 
T Consensus       151 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~-~~~~~~~~~~~~~-  221 (274)
T cd06609         151 TMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLF-LIPKNNPPSLEGN-  221 (274)
T ss_pred             ccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHH-HhhhcCCCCCccc-
Confidence            321  123456788999999999888999999999999999999999999754311     1111 1111111000000 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..          ...+.+++.+||..||++|||++|
T Consensus       222 ------~~----------~~~~~~~l~~~l~~~p~~Rpt~~~  247 (274)
T cd06609         222 ------KF----------SKPFKDFVSLCLNKDPKERPSAKE  247 (274)
T ss_pred             ------cc----------CHHHHHHHHHHhhCChhhCcCHHH
Confidence                  00          012568999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.9e-34  Score=306.59  Aligned_cols=246  Identities=27%  Similarity=0.429  Sum_probs=196.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||.||+|...+ ++.|++|.+.....  .+++.+|++++++++||||+++++++.++...|+++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            579999999999999999999874 78999998754322  678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....     ..+++..+..++.|+++|++|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          81 GAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             CCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999986432     3489999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ..  ......++..|+|||++.+..++.++|||||||++|+|++|+.||........    ...  ......     +..
T Consensus       153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~~~--~~~~~~-----~~~  219 (256)
T cd06612         153 MA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----IFM--IPNKPP-----PTL  219 (256)
T ss_pred             cc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----hhh--hccCCC-----CCC
Confidence            21  22334578899999999988999999999999999999999999875332110    000  000000     000


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .         ....  ....+.+++.+|++.||++|||++|
T Consensus       220 ~---------~~~~--~~~~~~~~i~~~l~~~P~~Rps~~~  249 (256)
T cd06612         220 S---------DPEK--WSPEFNDFVKKCLVKDPEERPSAIQ  249 (256)
T ss_pred             C---------chhh--cCHHHHHHHHHHHhcChhhCcCHHH
Confidence            0         0000  0123568999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-33  Score=303.81  Aligned_cols=246  Identities=28%  Similarity=0.405  Sum_probs=192.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|.+.+.||+|+||.||+|.+..+..+|+|.+... ....+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            468899999999999999999887778999976543 234567889999999999999999999875 456789999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++....    ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.++......
T Consensus        84 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          84 KGSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999996532    23378999999999999999999999   99999999999999999999999999998764322


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      .. ......++..|+|||+..+..++.++|||||||++|||++ |..||.....  .....+.   ...... . .+.. 
T Consensus       157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~---~~~~~~-~-~~~~-  227 (260)
T cd05069         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQV---ERGYRM-P-CPQG-  227 (260)
T ss_pred             cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---HcCCCC-C-CCcc-
Confidence            11 1122345678999999988899999999999999999999 8999875321  1111111   111000 0 0000 


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            .          ...+.+++.+||+.||++||++++
T Consensus       228 ------~----------~~~~~~li~~~l~~~p~~Rp~~~~  252 (260)
T cd05069         228 ------C----------PESLHELMKLCWKKDPDERPTFEY  252 (260)
T ss_pred             ------c----------CHHHHHHHHHHccCCcccCcCHHH
Confidence                  0          123568999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.8e-34  Score=318.23  Aligned_cols=255  Identities=29%  Similarity=0.464  Sum_probs=192.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE------cCCCEEEEEEeeccCcc-chHHHHHHHHHHhcc-CCcceeeeccEEEe-CC
Q 036815          733 TNGFSAESLIGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQ-GDREFMAEMETLGKI-KHRNLVPLLGYCKI-GE  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  803 (1013)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++...... ....+.+|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35799999999999999999974      24678999988643322 235688999999999 68999999998865 45


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCC-------------------------------------------------------
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKAR-------------------------------------------------------  828 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------------  828 (1013)
                      ..++||||+++|+|.+++.......                                                       
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986432100                                                       


Q ss_pred             ------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeec
Q 036815          829 ------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA  902 (1013)
Q Consensus       829 ------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  902 (1013)
                            ....+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  012478889999999999999999999   99999999999999999999999999998653322222222334


Q ss_pred             cCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCCh
Q 036815          903 GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDE  981 (1013)
Q Consensus       903 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  981 (1013)
                      ++..|+|||++.+..++.++|||||||++|||++ |..||.......    . .......+.....  +..      .. 
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~-~~~~~~~~~~~~~--~~~------~~-  308 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----E-FCRRLKEGTRMRA--PDY------TT-  308 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----H-HHHHHhccCCCCC--CCC------CC-
Confidence            5678999999988899999999999999999997 999986532211    1 1111111111100  000      00 


Q ss_pred             hhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          982 SEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       982 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                               ..+.+++.+||+.||++|||+.|
T Consensus       309 ---------~~~~~~~~~cl~~~p~~Rps~~e  331 (343)
T cd05103         309 ---------PEMYQTMLDCWHGEPSQRPTFSE  331 (343)
T ss_pred             ---------HHHHHHHHHHccCChhhCcCHHH
Confidence                     12568899999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=304.57  Aligned_cols=244  Identities=22%  Similarity=0.326  Sum_probs=198.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +-|...+.||+|.|+.|-+|++- +|..||||++.+..  ......+.+|++.|+.++|||||++|++...+...|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            44788899999999999999875 79999999986543  3345678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe-CCCCcEEEeecccceec
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL-DHEMEARVSDFGMARLI  889 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~a~~~  889 (1013)
                      .-++|+|.+|+..+..     .+.++-+.+++.||+.|+.|+|+.   .+||||+||+||.+ .+-|-+||+|||++-.+
T Consensus        98 LGD~GDl~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             ecCCchHHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999999975543     388999999999999999999999   99999999999976 55689999999999776


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCC-ccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCT-AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      .+   .....+.+|+..|-|||++.|..|+ +++||||+|||+|.+++|++||......+. +...+..+..       +
T Consensus       170 ~P---G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-LTmImDCKYt-------v  238 (864)
T KOG4717|consen  170 QP---GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-LTMIMDCKYT-------V  238 (864)
T ss_pred             CC---cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-hhhhhccccc-------C
Confidence            54   3345667899999999999998876 579999999999999999999986543321 1111111000       0


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +..+                 ..++.++|..||..||.+|.|.+|
T Consensus       239 Pshv-----------------S~eCrdLI~sMLvRdPkkRAslEe  266 (864)
T KOG4717|consen  239 PSHV-----------------SKECRDLIQSMLVRDPKKRASLEE  266 (864)
T ss_pred             chhh-----------------hHHHHHHHHHHHhcCchhhccHHH
Confidence            1000                 123568999999999999998654

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.6e-34  Score=317.92  Aligned_cols=200  Identities=24%  Similarity=0.309  Sum_probs=164.4

Q ss_pred             CCCeeccc--CCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          738 AESLIGCG--GFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       738 ~~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      +.++||+|  +|++||+++.+ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  67899999876 689999998854322  22356788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.++++||+.+......
T Consensus        82 ~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          82 AYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             CCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            99999999864322    2378999999999999999999999   9999999999999999999999999865433211


Q ss_pred             Ccce-----eeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          893 DTHL-----SVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       893 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ....     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            1100     0112346678999999876  46889999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-34  Score=319.20  Aligned_cols=236  Identities=23%  Similarity=0.267  Sum_probs=180.9

Q ss_pred             ecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhcc---CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKI---KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      ||+|+||+||+|++. +++.||+|++.+....   ....+..|..++.+.   +||||+++++++.++...|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999986 5889999988543221   123345566676655   699999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-  150 (330)
T cd05586          81 GELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-  150 (330)
T ss_pred             ChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence            99999886432      388999999999999999999999   99999999999999999999999999987543221 


Q ss_pred             ceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhh
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                       .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....     .+..+. +..+.. . ++..  
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~-i~~~~~-~-~~~~--  219 (330)
T cd05586         151 -KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRN-IAFGKV-R-FPKN--  219 (330)
T ss_pred             -CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHH-HHcCCC-C-CCCc--
Confidence             122345689999999998754 478999999999999999999999975331     111111 111111 0 0000  


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                          ..+          ..+.+++.+||+.||++||++.
T Consensus       220 ----~~~----------~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         220 ----VLS----------DEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             ----cCC----------HHHHHHHHHHcCCCHHHCCCCC
Confidence                000          1245889999999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.5e-34  Score=309.64  Aligned_cols=250  Identities=24%  Similarity=0.433  Sum_probs=192.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc-CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL-SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36889999999999999999986 6899999987543 222345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|..++....   ....+++..+..++.|++.|+.|||+.+  +|+||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          81 MDAGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             cCCCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            99999999986432   1234899999999999999999999631  899999999999999999999999999876532


Q ss_pred             cCcceeeeeeccCCCccCcccccCC------CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSF------RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      ..    .....+++.|+|||.+.+.      .++.++||||+||++|+|++|+.||.......  ....... .......
T Consensus       156 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~-~~~~~~~  228 (286)
T cd06622         156 SL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSA-IVDGDPP  228 (286)
T ss_pred             Cc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHH-HhhcCCC
Confidence            21    1234578899999998544      35789999999999999999999997532211  1111111 1111111


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . +++..                 ...+.+++.+|++.+|++||+++|
T Consensus       229 ~-~~~~~-----------------~~~~~~li~~~l~~~p~~Rp~~~~  258 (286)
T cd06622         229 T-LPSGY-----------------SDDAQDFVAKCLNKIPNRRPTYAQ  258 (286)
T ss_pred             C-CCccc-----------------CHHHHHHHHHHcccCcccCCCHHH
Confidence            1 11100                 112458999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-34  Score=306.73  Aligned_cols=250  Identities=25%  Similarity=0.375  Sum_probs=197.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+++..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57899999999999999999986 57889999886554445678899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....     ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.+......
T Consensus        83 ~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          83 GGGSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             CCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            9999999986431     2388999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CcceeeeeeccCCCccCcccccCC---CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSF---RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .  .......++..|+|||.+.+.   .++.++|||||||++|||++|+.||........     ... ......   ..
T Consensus       155 ~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-----~~~-~~~~~~---~~  223 (262)
T cd06613         155 I--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-----LFL-ISKSNF---PP  223 (262)
T ss_pred             h--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHH-HHhccC---CC
Confidence            1  112345678899999998776   888999999999999999999999875331110     000 000000   00


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +...         ...  .....+.+++.+|++.+|.+|||++|
T Consensus       224 ~~~~---------~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~  256 (262)
T cd06613         224 PKLK---------DKE--KWSPVFHDFIKKCLTKDPKKRPTATK  256 (262)
T ss_pred             cccc---------chh--hhhHHHHHHHHHHcCCChhhCCCHHH
Confidence            0000         000  11123668999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-33  Score=307.97  Aligned_cols=201  Identities=26%  Similarity=0.367  Sum_probs=169.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|++|.||+|+.. +++.||+|++....  ......+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788999999999999999986 68899999875432  22246688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      ++ ++|.+++.....   ...+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          81 LS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             CC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            98 689888864322   23489999999999999999999999   999999999999999999999999999976543


Q ss_pred             cCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ..  .......+++.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         154 PV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             Cc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            21  112234568899999988654 5788999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.3e-34  Score=314.43  Aligned_cols=250  Identities=27%  Similarity=0.439  Sum_probs=190.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCC--EEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGS--SVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|.++ ++.  .+|+|.+.... ....+.+.+|++++.++ +||||+++++++.+++..|+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46889999999999999999975 344  45777654322 22345788999999999 899999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          809 YEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      |||+++++|.+++......          .....+++.+++.++.|++.|++|||++   +++||||||+||+++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            9999999999999754321          1123588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ||+|||+++.....   .......++..|+|||++.+..++.++|||||||++|||+| |..||......     +....
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~  235 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK  235 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHHH
Confidence            99999998643211   11112234567999999988889999999999999999998 99998653321     11111


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ...+..... .       ...          ...+.+++.+|++.+|++||+++|
T Consensus       236 -~~~~~~~~~-~-------~~~----------~~~~~~li~~~l~~~p~~Rp~~~~  272 (303)
T cd05088         236 -LPQGYRLEK-P-------LNC----------DDEVYDLMRQCWREKPYERPSFAQ  272 (303)
T ss_pred             -HhcCCcCCC-C-------CCC----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence             111100000 0       000          112568999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-33  Score=317.39  Aligned_cols=197  Identities=28%  Similarity=0.408  Sum_probs=167.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeC------
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIG------  802 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  802 (1013)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+.+.+|++++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3578999999999999999999975 678999998754321  2235677899999999999999999987543      


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      ...|+++|++ +++|.+++..       ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence            3568999988 6799888753       2388999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ||+++.....     .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus       162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  219 (343)
T cd07878         162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN  219 (343)
T ss_pred             CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            9999865431     223468999999999876 56889999999999999999999999754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-33  Score=301.88  Aligned_cols=242  Identities=30%  Similarity=0.499  Sum_probs=194.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||.||+|... ++.||+|++..... ..+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            56889999999999999999876 88999998865433 45678999999999999999999999998899999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++.....    ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||.++......
T Consensus        84 ~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          84 KGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             CCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999965432    2489999999999999999999999   99999999999999999999999999998653211


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                           .....+..|+|||++.+..++.++||||||+++||+++ |..||......  .    ............. +.  
T Consensus       157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~----~~~~~~~~~~~~~-~~--  222 (256)
T cd05039         157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D----VVPHVEKGYRMEA-PE--  222 (256)
T ss_pred             -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--H----HHHHHhcCCCCCC-cc--
Confidence                 12234567999999988889999999999999999997 99998653211  1    1111111111110 00  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..          ...+.+++.+|++.+|++|||++|
T Consensus       223 -----~~----------~~~~~~li~~~l~~~p~~Rp~~~~  248 (256)
T cd05039         223 -----GC----------PPEVYKVMKDCWELDPAKRPTFKQ  248 (256)
T ss_pred             -----CC----------CHHHHHHHHHHhccChhhCcCHHH
Confidence                 00          123568999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-33  Score=303.35  Aligned_cols=244  Identities=26%  Similarity=0.419  Sum_probs=193.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-----cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-----QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      +|+..+.||+|+||.||+|... +++.|++|.+.....     ...+.+.+|++++++++|+||+++++++.++...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4788899999999999999987 789999998754332     2345688999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      +||+++++|.+++....      .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+..
T Consensus        81 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~  151 (258)
T cd06632          81 LELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQ  151 (258)
T ss_pred             EEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcccee
Confidence            99999999999986432      378899999999999999999999   999999999999999999999999999886


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      .....   ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||.....     ............. ..
T Consensus       152 ~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~-~~  222 (258)
T cd06632         152 VVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGRSKEL-PP  222 (258)
T ss_pred             ccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHHhcccC-CC
Confidence            54322   223456888999999987766 88999999999999999999999875331     1111111110111 01


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +++..                 ...+.+++.+|++.+|++|||+.|
T Consensus       223 ~~~~~-----------------~~~~~~li~~~l~~~p~~Rp~~~~  251 (258)
T cd06632         223 IPDHL-----------------SDEAKDFILKCLQRDPSLRPTAAE  251 (258)
T ss_pred             cCCCc-----------------CHHHHHHHHHHhhcCcccCcCHHH
Confidence            11100                 012458899999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-34  Score=319.85  Aligned_cols=193  Identities=26%  Similarity=0.346  Sum_probs=164.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|....      .....|+.++++++||||+++++++.++...++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            4468999999999999999999986 467888886422      223569999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      ++. ++|.+++....     ..+++..+..++.||+.||+|||++   +||||||||+||+++.++.+||+|||.++...
T Consensus       138 ~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        138 HYS-SDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             ccC-CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            996 68888885432     3489999999999999999999999   99999999999999999999999999997532


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      ..   .......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       209 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        209 VA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             cC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            21   11234568999999999999999999999999999999998655543

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=304.74  Aligned_cols=247  Identities=30%  Similarity=0.456  Sum_probs=194.8

Q ss_pred             CeecccCCcEEEEEEEcC----CCEEEEEEeeccCccc-hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQG-DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|....    +..|++|.+....... .+.+.+|++++++++|+||+++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999999864    7889999876543332 56789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccC---CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          815 GSLEEVLHGRAKA---RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       815 g~L~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      ++|.+++......   .....+++..++.++.|++.|++|||++   +++||||||+||+++.++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999754211   0124489999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...........++..|+|||.+.+..++.++||||+||++|||++ |..||.....     ..... ....+....  .+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~-~~~~~~~~~--~~  229 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLE-YLRKGYRLP--KP  229 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH-HHHcCCCCC--CC
Confidence            332222334567889999999988889999999999999999999 6999876421     11111 111111110  00


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .      ..          ...+.+++.+|++.+|++|||++|
T Consensus       230 ~------~~----------~~~~~~li~~~l~~~p~~Rps~~~  256 (262)
T cd00192         230 E------YC----------PDELYELMLSCWQLDPEDRPTFSE  256 (262)
T ss_pred             c------cC----------ChHHHHHHHHHccCCcccCcCHHH
Confidence            0      00          123668999999999999999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.7e-34  Score=304.38  Aligned_cols=243  Identities=27%  Similarity=0.411  Sum_probs=190.5

Q ss_pred             CeecccCCcEEEEEEEcC--C--CEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLKD--G--SSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  2  3689998866554 445678999999999999999999999988 889999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      ++|.+++.....    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.+.....
T Consensus        80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999975432    3489999999999999999999999   999999999999999999999999999987654322


Q ss_pred             cee-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          895 HLS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       895 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....     .+.............  .+. 
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~~~--~~~-  224 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----SQILKKIDKEGERLE--RPE-  224 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcCCcCC--CCc-
Confidence            211 123456788999999998899999999999999999998 9999864321     111111111111100  000 


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..          ...+.+++.+|++.+|++|||++|
T Consensus       225 -----~~----------~~~~~~li~~~l~~~p~~Rps~~~  250 (257)
T cd05040         225 -----AC----------PQDIYNVMLQCWAHNPADRPTFAA  250 (257)
T ss_pred             -----cC----------CHHHHHHHHHHCCCCcccCCCHHH
Confidence                 00          123568999999999999999864

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.7e-33  Score=299.59  Aligned_cols=241  Identities=29%  Similarity=0.410  Sum_probs=188.4

Q ss_pred             CeecccCCcEEEEEEEcCCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCHH
Q 036815          740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLE  818 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  818 (1013)
                      ++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            468999999999999888899999987543322 2346889999999999999999999999999999999999999999


Q ss_pred             HHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceee
Q 036815          819 EVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV  898 (1013)
Q Consensus       819 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  898 (1013)
                      +++....     ..+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+|++|||++........ ...
T Consensus        81 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~  151 (250)
T cd05085          81 SFLRKKK-----DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSS  151 (250)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccC
Confidence            9986432     2378999999999999999999999   999999999999999999999999999875432111 111


Q ss_pred             eeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccC
Q 036815          899 STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK  977 (1013)
Q Consensus       899 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  977 (1013)
                      ....++..|+|||++.+..++.++|||||||++||+++ |..||......  .    .......+..... ...      
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~----~~~~~~~~~~~~~-~~~------  218 (250)
T cd05085         152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--Q----AREQVEKGYRMSC-PQK------  218 (250)
T ss_pred             CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--H----HHHHHHcCCCCCC-CCC------
Confidence            12234567999999998889999999999999999998 99998753211  1    1111111111110 000      


Q ss_pred             CCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          978 GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       978 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .          ...+.+++.+|++.+|++|||+.|
T Consensus       219 -~----------~~~~~~li~~~l~~~p~~Rp~~~~  243 (250)
T cd05085         219 -C----------PDDVYKVMQRCWDYKPENRPKFSE  243 (250)
T ss_pred             -C----------CHHHHHHHHHHcccCcccCCCHHH
Confidence             0          123668999999999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4e-34  Score=318.39  Aligned_cols=202  Identities=27%  Similarity=0.345  Sum_probs=172.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+++ +++.||+|.+.+..   ......+.+|..++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999986 57889999875422   222345788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||+|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 Ey~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             eCCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            9999999999996432     2378899999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ..... .......|++.|+|||++.+     ..++.++||||+||++|||++|+.||...
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         153 NQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             cCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            43222 12234568999999999875     46788999999999999999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.8e-33  Score=302.11  Aligned_cols=238  Identities=24%  Similarity=0.426  Sum_probs=184.2

Q ss_pred             eecccCCcEEEEEEEc---CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          741 LIGCGGFGEVFKATLK---DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       741 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      .||+|+||.||+|.++   ++..+|+|++.....  ...+++.+|+.++++++||||+++++++. ++..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   567899997753322  23457889999999999999999999875 45678999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      +|.+++....      .+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||.++........
T Consensus        81 ~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          81 PLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            9999986432      388999999999999999999999   9999999999999999999999999999876443322


Q ss_pred             ee-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhh
Q 036815          896 LS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       896 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                      .. .....++..|+|||.+....++.++|||||||++|||++ |+.||.....     .++... +..+..... ++   
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~-i~~~~~~~~-~~---  221 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVTQM-IESGERMEC-PQ---  221 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-HHCCCCCCC-CC---
Confidence            11 112234578999999988889999999999999999998 9999875321     112221 222111110 00   


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                          ..+          ..+.+++.+|++.||++||+++
T Consensus       222 ----~~~----------~~l~~li~~~~~~~p~~Rp~~~  246 (257)
T cd05116         222 ----RCP----------PEMYDLMKLCWTYGVDERPGFA  246 (257)
T ss_pred             ----CCC----------HHHHHHHHHHhccCchhCcCHH
Confidence                011          1256899999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-33  Score=302.75  Aligned_cols=234  Identities=23%  Similarity=0.401  Sum_probs=179.8

Q ss_pred             CeecccCCcEEEEEEEcC-------------CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          740 SLIGCGGFGEVFKATLKD-------------GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      +.||+|+||.||+|+..+             ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2257888765444344457888999999999999999999999988999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc-------EE
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME-------AR  879 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~k  879 (1013)
                      +||||+++++|..++....     ..+++..++.++.|+++|++|||++   +|+||||||+||+++.++.       ++
T Consensus        81 lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999886432     2378999999999999999999999   9999999999999987654       89


Q ss_pred             EeecccceeccccCcceeeeeeccCCCccCccccc-CCCCCccchhHhHHHHHHHHH-cCCCCCCCCCCCCccHHHHHHH
Q 036815          880 VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELL-TGKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       880 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ++|||.+......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+     ... 
T Consensus       153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~-  220 (262)
T cd05077         153 LSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KER-  220 (262)
T ss_pred             eCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HHH-
Confidence            9999998754321      2345788899999886 567889999999999999998 5888876432111     111 


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ...... ....+           .       ...+.+++.+||+.||++||++.|
T Consensus       221 -~~~~~~-~~~~~-----------~-------~~~~~~li~~cl~~dp~~Rp~~~~  256 (262)
T cd05077         221 -FYEGQC-MLVTP-----------S-------CKELADLMTHCMNYDPNQRPFFRA  256 (262)
T ss_pred             -HHhcCc-cCCCC-----------C-------hHHHHHHHHHHcCCChhhCcCHHH
Confidence             001100 00000           0       113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=344.66  Aligned_cols=483  Identities=29%  Similarity=0.389  Sum_probs=383.1

Q ss_pred             EecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEEC
Q 036815           29 LELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDL  108 (1013)
Q Consensus        29 L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~L  108 (1013)
                      ++.+.+.+ ..||..++.+-. ++.|+++.|-+- ..|-.+....-+|+.||+|+|++..    ++........|+.|++
T Consensus         3 vd~s~~~l-~~ip~~i~~~~~-~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~~----fp~~it~l~~L~~ln~   75 (1081)
T KOG0618|consen    3 VDASDEQL-ELIPEQILNNEA-LQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQISS----FPIQITLLSHLRQLNL   75 (1081)
T ss_pred             cccccccC-cccchhhccHHH-HHhhhccccccc-cCchHHhhheeeeEEeecccccccc----CCchhhhHHHHhhccc
Confidence            56677777 458888876555 999999999776 4445556667779999999999973    3445566789999999


Q ss_pred             CCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCC
Q 036815          109 SQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITG  188 (1013)
Q Consensus       109 s~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  188 (1013)
                      +.|.|.. .|.+..++.+|++|+|.+|++. ..|..+..+++|++|+++.|++. .+|..+.. +..++++..++|....
T Consensus        76 s~n~i~~-vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~-lt~~~~~~~s~N~~~~  151 (1081)
T KOG0618|consen   76 SRNYIRS-VPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEV-LTAEEELAASNNEKIQ  151 (1081)
T ss_pred             chhhHhh-Cchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHh-hhHHHHHhhhcchhhh
Confidence            9999987 5688899999999999999998 78999999999999999999998 78877754 5889999999992222


Q ss_pred             cCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCC
Q 036815          189 SFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDIC  268 (1013)
Q Consensus       189 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  268 (1013)
                      ..+    ... ++.++|..|.+.+.++.++ .++.+  .|+|++|.+.   --.+..+.+|+.|....|+++...     
T Consensus       152 ~lg----~~~-ik~~~l~~n~l~~~~~~~i-~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~-----  215 (1081)
T KOG0618|consen  152 RLG----QTS-IKKLDLRLNVLGGSFLIDI-YNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE-----  215 (1081)
T ss_pred             hhc----ccc-chhhhhhhhhcccchhcch-hhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE-----
Confidence            222    222 8889999998887776653 44444  5999999986   235778889999999999887321     


Q ss_pred             CCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCce
Q 036815          269 PGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD  348 (1013)
Q Consensus       269 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  348 (1013)
                      -..++|+.|+.++|.++...+.  ..-.+|+++|+++|+++ .+|++++.+.+|+.+....|.++ .+|..+..+++|+.
T Consensus       216 ~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~  291 (1081)
T KOG0618|consen  216 ISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVS  291 (1081)
T ss_pred             ecCcchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHH
Confidence            2357899999999998843322  22357899999999999 67788888888888888888885 78888888888888


Q ss_pred             EECccccccccCchhhcCCCCCCeEEecCCccCCCCChhh-hccCC-CceEEccCCeeeeecCCCC--cCCCCCcEEEcc
Q 036815          349 LILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEF-SRLTR-LAVLQLGNNRFKGEIPGEL--GNCSSLVWLDLN  424 (1013)
Q Consensus       349 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~-L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~l~  424 (1013)
                      |....|.++ .+|.....++.|++|+|..|+|. .+|+.+ .-+.. |+.|+.+.|++. ..| .+  ..++.|+.|++.
T Consensus       292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp-~~~e~~~~~Lq~Lyla  367 (1081)
T KOG0618|consen  292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLP-SYEENNHAALQELYLA  367 (1081)
T ss_pred             HHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccc-cccchhhHHHHHHHHh
Confidence            888888888 67778888888888888888888 566544 33333 677777888877 444 22  245677888888


Q ss_pred             CCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccc
Q 036815          425 SNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLF  504 (1013)
Q Consensus       425 ~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  504 (1013)
                      +|.|+...=                                                                    ..+
T Consensus       368 nN~Ltd~c~--------------------------------------------------------------------p~l  379 (1081)
T KOG0618|consen  368 NNHLTDSCF--------------------------------------------------------------------PVL  379 (1081)
T ss_pred             cCcccccch--------------------------------------------------------------------hhh
Confidence            887764321                                                                    123


Q ss_pred             cCCCccCEEEccCCcccccCChh-hhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcce
Q 036815          505 TQYQTLEYLDLSYNQFRGKIPDE-IGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLV  583 (1013)
Q Consensus       505 ~~~~~L~~L~ls~N~l~g~iP~~-i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~  583 (1013)
                      ....+|+.|+||+|++. ++|+. +.++..|+.|+||+|+|+ .+|.++.++..|++|...+|++. ..| ++.+++.|+
T Consensus       380 ~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~  455 (1081)
T KOG0618|consen  380 VNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK  455 (1081)
T ss_pred             ccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence            34578999999999999 78865 689999999999999999 89999999999999999999998 888 899999999


Q ss_pred             EEECcCCCCC-CcCCCCCCCCCCCcccccCCCCCCC
Q 036815          584 QIDLSNNELT-GPIPQRGQLSTLPASQYANNPGLCG  618 (1013)
Q Consensus       584 ~l~l~~n~l~-~~~p~~~~~~~~~~~~~~~n~~lc~  618 (1013)
                      .+|+|.|+|+ +.+|..-+..++..+.+.||+++-.
T Consensus       456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~  491 (1081)
T KOG0618|consen  456 VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVF  491 (1081)
T ss_pred             EEecccchhhhhhhhhhCCCcccceeeccCCccccc
Confidence            9999999998 4577766667889999999996543

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-33  Score=314.28  Aligned_cols=201  Identities=23%  Similarity=0.356  Sum_probs=161.5

Q ss_pred             CCeecccCCcEEEEEEEc---CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEEEEEEccc
Q 036815          739 ESLIGCGGFGEVFKATLK---DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERLLVYEFMK  813 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  813 (1013)
                      ..+||+|+||.||+|+.+   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999975   34789999875432  23467899999999999999999998854  567899999987


Q ss_pred             CCCHHHHhcccccC---CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe----CCCCcEEEeecccc
Q 036815          814 FGSLEEVLHGRAKA---RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL----DHEMEARVSDFGMA  886 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~a  886 (1013)
                       ++|.+++......   .....+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             4787777532211   1223488999999999999999999999   99999999999999    55678999999999


Q ss_pred             eeccccCcc-eeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          887 RLISALDTH-LSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       887 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +........ .......+|+.|+|||++.+ ..++.++||||+||++|||+||++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            876432211 12234568899999999876 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-33  Score=313.87  Aligned_cols=253  Identities=28%  Similarity=0.426  Sum_probs=194.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC--------CCEEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCC
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD--------GSSVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  803 (1013)
                      .+|++.+.||+|+||.||+|++..        +..||+|.+.... ....+++.+|+++++++ +||||+++++++..++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468999999999999999997531        2368899765322 22346788999999999 7999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ..++||||+++|+|.+++......          .....+++.++..++.|++.||+|||++   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            999999999999999999754321          1233588999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLV  952 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~  952 (1013)
                      .++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....     ..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence            999999999999987643222222222334567999999999899999999999999999998 888886532     22


Q ss_pred             HHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          953 GWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       953 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ++.... ........ +..       .          ...+.+++.+|++.+|++|||+.|
T Consensus       244 ~~~~~~-~~~~~~~~-~~~-------~----------~~~l~~li~~cl~~~p~~Rps~~e  285 (334)
T cd05100         244 ELFKLL-KEGHRMDK-PAN-------C----------THELYMIMRECWHAVPSQRPTFKQ  285 (334)
T ss_pred             HHHHHH-HcCCCCCC-CCC-------C----------CHHHHHHHHHHcccChhhCcCHHH
Confidence            222221 11111110 000       0          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-33  Score=305.19  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=198.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|.++ +++.||+|.+.... ....+++.+|++++++++||||+++++++..+...++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999987 58889999876543 23446788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      +++++|.+++....     ..+++..+..++.|++.|++|||+ .   +++|+||||+||+++.++.++|+|||.+....
T Consensus        81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          81 MDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             cCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            99999999997532     348889999999999999999999 8   99999999999999999999999999987653


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      .....    ...++..|+|||.+.+..++.++||||+||++|+|++|+.||..............+...... .... ..
T Consensus       153 ~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~  226 (265)
T cd06605         153 NSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRL-PS  226 (265)
T ss_pred             HHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCCC-Ch
Confidence            22111    256888999999999989999999999999999999999999764332222233322222111 1000 00


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .              .  ....+.+++.+|+..||++|||+.|
T Consensus       227 ~--------------~--~~~~~~~li~~~l~~~p~~Rpt~~~  253 (265)
T cd06605         227 G--------------K--FSPDFQDFVNLCLIKDPRERPSYKE  253 (265)
T ss_pred             h--------------h--cCHHHHHHHHHHcCCCchhCcCHHH
Confidence            0              0  0112568999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.7e-33  Score=300.92  Aligned_cols=246  Identities=27%  Similarity=0.379  Sum_probs=193.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEe-CCEEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKI-GEERLLVYE  810 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  810 (1013)
                      +|++.+.||+|++|.||+|.++ +++.||+|++....  ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999976 57889999885432  2234568899999999999999999998764 446799999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.+++....    ...+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          81 FCEGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             ccCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            999999999996432    23489999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ....  ......+++.|+|||+..+..++.++||||+||++|+|++|+.||...+.     ..+... ...+.... ...
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~-~~~~~~~~-~~~  224 (257)
T cd08223         154 NQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYR-IIEGKLPP-MPK  224 (257)
T ss_pred             ccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH-HHhcCCCC-Ccc
Confidence            3221  22345678899999999999999999999999999999999999875331     122111 11111111 000


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .                 ....+.+++.+|++.||++|||+.|
T Consensus       225 ~-----------------~~~~~~~li~~~l~~~p~~Rp~~~~  250 (257)
T cd08223         225 D-----------------YSPELGELIATMLSKRPEKRPSVKS  250 (257)
T ss_pred             c-----------------cCHHHHHHHHHHhccCcccCCCHHH
Confidence            0                 0113568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.2e-33  Score=303.19  Aligned_cols=202  Identities=26%  Similarity=0.440  Sum_probs=170.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-----cchHHHHHHHHHHhccCCcceeeeccEEEe--CCEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-----QGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  805 (1013)
                      .+|++.+.||+|+||.||+|.+. +++.||+|++.....     .....+.+|+.++++++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46899999999999999999975 588999998754321     122457889999999999999999998875  3577


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++++||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~  152 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA  152 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCC
Confidence            89999999999999996432      278888999999999999999998   999999999999999999999999999


Q ss_pred             ceeccccCc-ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          886 ARLISALDT-HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       886 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ++....... ........++..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            976532211 11122345788999999999888999999999999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.9e-33  Score=300.45  Aligned_cols=246  Identities=23%  Similarity=0.349  Sum_probs=197.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||.|+||.||.++.. +++.+++|++....  ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5889999999999999999875 58889999875432  33446788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....    ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.++....
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          81 ANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             cCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            99999999997542    23478999999999999999999999   999999999999999999999999999987643


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ...  ......+++.|+|||+..+..++.++||||+|+++|||++|..||.....     .+...... .+..... .+ 
T Consensus       154 ~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~-~~~~~~~-~~-  223 (256)
T cd08221         154 EYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIV-QGNYTPV-VS-  223 (256)
T ss_pred             ccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHH-cCCCCCC-cc-
Confidence            221  22345688999999999888889999999999999999999999875321     12222111 1111111 00 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..          ...+.+++.+|++.+|++|||++|
T Consensus       224 ------~~----------~~~~~~~i~~~l~~~p~~R~s~~~  249 (256)
T cd08221         224 ------VY----------SSELISLVHSLLQQDPEKRPTADE  249 (256)
T ss_pred             ------cc----------CHHHHHHHHHHcccCcccCCCHHH
Confidence                  00          112568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-33  Score=302.89  Aligned_cols=248  Identities=27%  Similarity=0.456  Sum_probs=192.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCC---EEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGS---SVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|+..+.||+|+||.||+|+.+ +++   .+|+|++.... ....+.+..|++++++++|||++++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46888899999999999999976 233   68888775432 23346688999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++..
T Consensus        85 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          85 TEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence            99999999999986432     2378999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcceee-eeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          889 ISALDTHLSV-STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       889 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      .......... .....+..|+|||++.+..++.++|||||||++|||++ |+.||.....     .++..... ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~-~~~~~~  230 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAIN-DGFRLP  230 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHh-cCCCCC
Confidence            6432221111 11223457999999988889999999999999999997 9999865321     12222211 111000


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .  +.      .          ....+.+++.+|++.+|++||+++|
T Consensus       231 ~--~~------~----------~~~~~~~li~~c~~~~p~~Rp~~~~  259 (268)
T cd05063         231 A--PM------D----------CPSAVYQLMLQCWQQDRARRPRFVD  259 (268)
T ss_pred             C--CC------C----------CCHHHHHHHHHHcCCCcccCcCHHH
Confidence            0  00      0          0123569999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-33  Score=313.99  Aligned_cols=202  Identities=26%  Similarity=0.346  Sum_probs=171.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.++||+|+||.||+++.+ +++.||+|.+.+..   ......+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46899999999999999999987 46789999875422   122345788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....     ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ey~~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             eccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            9999999999996432     2378899999999999999999999   9999999999999999999999999999765


Q ss_pred             cccCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .... ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         153 MEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             ccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            3322 12223457899999999986     346788999999999999999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.2e-33  Score=307.16  Aligned_cols=238  Identities=26%  Similarity=0.347  Sum_probs=192.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999986 57899999875432   123456889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||+++..
T Consensus        81 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  151 (290)
T cd05580          81 EYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV  151 (290)
T ss_pred             ecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence            9999999999986542      388999999999999999999999   9999999999999999999999999999875


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ...     .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.     .. .......+..  .++
T Consensus       152 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~-~~~~~~~~~~--~~~  218 (290)
T cd05580         152 KGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQ-IYEKILEGKV--RFP  218 (290)
T ss_pred             CCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HH-HHHHHhcCCc--cCC
Confidence            432     2344688999999999888889999999999999999999999975431     11 1111111111  001


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      +.       .          ...+.+++.+||+.||.+||+
T Consensus       219 ~~-------~----------~~~l~~li~~~l~~~p~~R~~  242 (290)
T cd05580         219 SF-------F----------SPDAKDLIRNLLQVDLTKRLG  242 (290)
T ss_pred             cc-------C----------CHHHHHHHHHHccCCHHHccC
Confidence            00       0          012568999999999999993

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.5e-33  Score=300.74  Aligned_cols=240  Identities=26%  Similarity=0.405  Sum_probs=183.8

Q ss_pred             eecccCCcEEEEEEEc---CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCC
Q 036815          741 LIGCGGFGEVFKATLK---DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGS  816 (1013)
Q Consensus       741 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  816 (1013)
                      .||+|+||.||+|.+.   .+..||+|.+..... ...+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   345689998754432 22456899999999999999999999875 457799999999999


Q ss_pred             HHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcce
Q 036815          817 LEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL  896 (1013)
Q Consensus       817 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  896 (1013)
                      |.+++....     ..+++..+.+++.|++.|++|||++   +++||||||+||+++.++.+||+|||+++.........
T Consensus        81 L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          81 LNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            999986432     2389999999999999999999999   99999999999999999999999999998654332211


Q ss_pred             e-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          897 S-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       897 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                      . .....++..|+|||.+.+..++.++|||||||++||+++ |..||.....     ..+.. .+..+.... .++.   
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~-~~~~~~~~~-~~~~---  222 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----PEVMS-FIEQGKRLD-CPAE---  222 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHH-HHHCCCCCC-CCCC---
Confidence            1 112233578999999988889999999999999999996 9999875321     11111 111111111 1110   


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          .          ...+.+++.+||..||++||++++
T Consensus       223 ----~----------~~~l~~li~~c~~~~~~~Rp~~~~  247 (257)
T cd05115         223 ----C----------PPEMYALMKDCWIYKWEDRPNFAK  247 (257)
T ss_pred             ----C----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence                0          123568999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-33  Score=302.85  Aligned_cols=247  Identities=26%  Similarity=0.414  Sum_probs=193.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.+.||+|+||.||+|.+.++..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3679999999999999999999877888999977543 2234678899999999999999999999877 7789999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+......
T Consensus        83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          83 AKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             CCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999996532    23478889999999999999999999   9999999999999999999999999999765432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      .. .......++..|+|||++.+..++.++|||||||++|++++ |+.||...+.  .....+.    ..+...... ..
T Consensus       156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~----~~~~~~~~~-~~  227 (260)
T cd05073         156 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRAL----ERGYRMPRP-EN  227 (260)
T ss_pred             Cc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----hCCCCCCCc-cc
Confidence            21 11122345677999999998889999999999999999999 9999875431  1111111    111111000 00


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                       ....+.+++.+|++.+|++||++++
T Consensus       228 -----------------~~~~~~~~i~~~l~~~p~~Rp~~~~  252 (260)
T cd05073         228 -----------------CPEELYNIMMRCWKNRPEERPTFEY  252 (260)
T ss_pred             -----------------CCHHHHHHHHHHcccCcccCcCHHH
Confidence                             0123668999999999999999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1e-33  Score=329.88  Aligned_cols=200  Identities=23%  Similarity=0.307  Sum_probs=163.8

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCC------cceeeeccEEEeC
Q 036815          730 IEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH------RNLVPLLGYCKIG  802 (1013)
Q Consensus       730 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~  802 (1013)
                      ...+++|++.++||+|+||+||+|.+. .++.||||++.... ...+.+..|+++++.++|      .+++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            345688999999999999999999976 57889999875422 223456677777777754      4588899888764


Q ss_pred             -CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCC----
Q 036815          803 -EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEM----  876 (1013)
Q Consensus       803 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~----  876 (1013)
                       .+.|+|||++ +++|.+++....      .+++..+..|+.||+.||+|||+ .   +||||||||+||+++.++    
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence             5788999988 578888886432      38899999999999999999997 5   999999999999998765    


Q ss_pred             ------------cEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          877 ------------EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       877 ------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                                  .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                        49999999875422     1223467899999999999999999999999999999999999999764


Q ss_pred             C
Q 036815          945 D  945 (1013)
Q Consensus       945 ~  945 (1013)
                      .
T Consensus       349 ~  349 (467)
T PTZ00284        349 D  349 (467)
T ss_pred             C
Confidence            3

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.6e-34  Score=310.52  Aligned_cols=244  Identities=24%  Similarity=0.376  Sum_probs=191.8

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      |.....||+|+||.||+|... ++..||+|++........+.+.+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444567999999999999975 5889999987654444556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      ++|.+++...       .+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||++........
T Consensus       104 ~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         104 GALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999988532       278899999999999999999999   999999999999999999999999999875532221


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                        ......++..|+|||.+.+..++.++|||||||++|||++|+.||......     ..... ....     .++... 
T Consensus       174 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~-~~~~-----~~~~~~-  239 (292)
T cd06658         174 --KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----QAMRR-IRDN-----LPPRVK-  239 (292)
T ss_pred             --cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HHhc-----CCCccc-
Confidence              123356889999999998888999999999999999999999998753211     10111 1100     011000 


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         ...     .  ....+.+++.+|++.||++|||++|
T Consensus       240 ---~~~-----~--~~~~~~~li~~~l~~~P~~Rpt~~~  268 (292)
T cd06658         240 ---DSH-----K--VSSVLRGFLDLMLVREPSQRATAQE  268 (292)
T ss_pred             ---ccc-----c--cCHHHHHHHHHHccCChhHCcCHHH
Confidence               000     0  0112458889999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1e-33  Score=306.28  Aligned_cols=247  Identities=26%  Similarity=0.449  Sum_probs=190.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC-C---CEEEEEEeecc-CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD-G---SSVAIKKLIRL-SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +|++.+.||+|+||.||+|.+.. +   ..||+|.+... ......++..|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            47889999999999999999763 3   36999987543 2233467899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++....     ..+++.+++.++.|++.|++|||++   +++||||||+||+++.++.+|++|||.++..
T Consensus        85 e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          85 EFMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             ecCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence            9999999999986432     2378999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccCcceeeee-e--ccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          890 SALDTHLSVST-L--AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       890 ~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      ........... .  ..+..|+|||++.+..++.++||||+||++||+++ |..||.....  .....++    ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i----~~~~~~  230 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAI----EQDYRL  230 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHH----HcCCcC
Confidence            43222111111 1  12457999999998899999999999999999886 9999875331  1112222    111000


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. .+.       .          ...+.+++.+|++.+|.+||++++
T Consensus       231 ~~-~~~-------~----------~~~~~~li~~~l~~~p~~Rp~~~~  260 (269)
T cd05065         231 PP-PMD-------C----------PTALHQLMLDCWQKDRNARPKFGQ  260 (269)
T ss_pred             CC-ccc-------C----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence            00 000       0          012568999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.8e-33  Score=308.61  Aligned_cols=248  Identities=20%  Similarity=0.279  Sum_probs=192.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|.+. .++.|++|.+.....   .....+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36889999999999999999986 578899998765332   22346788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++|++|.+++....      .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++..
T Consensus        81 e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~  151 (305)
T cd05609          81 EYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIG  151 (305)
T ss_pred             ecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence            9999999999996432      378899999999999999999999   9999999999999999999999999998642


Q ss_pred             cccCc-------------ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 036815          890 SALDT-------------HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       890 ~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~  956 (1013)
                      .....             ........++..|+|||.+.+..++.++|||||||++|||++|..||.+...     .++..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~  226 (305)
T cd05609         152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFG  226 (305)
T ss_pred             CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence            11000             0011123578899999999888899999999999999999999999975321     12222


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ............++.       .          ...+.+++.+|++.||++||++.
T Consensus       227 ~~~~~~~~~~~~~~~-------~----------~~~~~~li~~~l~~~P~~R~~~~  265 (305)
T cd05609         227 QVISDDIEWPEGDEA-------L----------PADAQDLISRLLRQNPLERLGTG  265 (305)
T ss_pred             HHHhcccCCCCcccc-------C----------CHHHHHHHHHHhccChhhccCcc
Confidence            211111000000000       0          01246899999999999999953

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=314.05  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=195.7

Q ss_pred             CCCCCeecccCCcEEEEEEEc--CC--CEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          736 FSAESLIGCGGFGEVFKATLK--DG--SSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ....++||+|+||.||+|.|+  .|  -.||||.+...... .-.+|.+|+.+|.+++|||++++||+..+ ....+|||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            344578999999999999986  34  36899988765444 45789999999999999999999999876 67789999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      .++.|+|.+.++..    ....+.......++.|||.||.||.++   ++||||+..+|+++-....+||+|||+.+.+.
T Consensus       191 LaplGSLldrLrka----~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKA----KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hcccchHHHHHhhc----cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence            99999999999862    234588899999999999999999999   99999999999999999999999999999987


Q ss_pred             ccCcceeeee-eccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          891 ALDTHLSVST-LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       891 ~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ..+..+.+.. ..-...|+|||.++...++.++|||+|||++|||+| |..||.+....  .+.+.    +..+....  
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--qIL~~----iD~~erLp--  335 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--QILKN----IDAGERLP--  335 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--HHHHh----ccccccCC--
Confidence            7665554332 334568999999999999999999999999999999 89998764321  11111    11111000  


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      .|      +.          ...++++++.+||...|++|||+.
T Consensus       336 RP------k~----------csedIY~imk~cWah~paDRptFs  363 (1039)
T KOG0199|consen  336 RP------KY----------CSEDIYQIMKNCWAHNPADRPTFS  363 (1039)
T ss_pred             CC------CC----------ChHHHHHHHHHhccCCccccccHH
Confidence            01      11          112478999999999999999974

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-33  Score=308.48  Aligned_cols=198  Identities=26%  Similarity=0.368  Sum_probs=166.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|+||.||+|++. +|+.||+|++.....  .....+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4888899999999999999986 688999998754322  2235678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      ++ ++|.+++....     ..+++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          81 CD-QDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             CC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            98 57888775322     2389999999999999999999999   999999999999999999999999999986543


Q ss_pred             cCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      ...  ......++..|+|||++.+. .++.++||||+||++|||++|..||..
T Consensus       152 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         152 PVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            221  12234578899999998764 468999999999999999999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.5e-33  Score=300.85  Aligned_cols=241  Identities=29%  Similarity=0.460  Sum_probs=189.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEE-eCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK-IGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||.||+|... +..||+|.+...  ...+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            36889999999999999999876 788999987432  23457889999999999999999999764 456789999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++.....    ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+|++|||+++.....
T Consensus        83 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          83 AKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999865332    2378999999999999999999999   9999999999999999999999999998764322


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      .     ....++..|+|||++.+..++.++|||||||++|||++ |+.||....     ..+.... ...+..... .+ 
T Consensus       156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~-~~~~~~~~~-~~-  222 (256)
T cd05082         156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPR-VEKGYKMDA-PD-  222 (256)
T ss_pred             C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH-HhcCCCCCC-CC-
Confidence            1     12234567999999998889999999999999999997 999986432     1222211 111111110 00 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..          ...+.+++.+|++.+|++|||++|
T Consensus       223 ------~~----------~~~~~~li~~~l~~~p~~Rpt~~~  248 (256)
T cd05082         223 ------GC----------PPVVYDVMKQCWHLDAATRPSFLQ  248 (256)
T ss_pred             ------CC----------CHHHHHHHHHHhcCChhhCcCHHH
Confidence                  00          112568999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-33  Score=310.01  Aligned_cols=244  Identities=25%  Similarity=0.367  Sum_probs=192.3

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      |.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999976 6889999988654445556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      ++|.+++..       ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus       103 ~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-  171 (297)
T cd06659         103 GALTDIVSQ-------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-  171 (297)
T ss_pred             CCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-
Confidence            999998743       2278999999999999999999999   99999999999999999999999999987553321 


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                       .......++..|+|||++.+..++.++|||||||++|||++|+.||......     ..... ........     .. 
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~-~~~~~~~~-----~~-  238 (297)
T cd06659         172 -PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-----QAMKR-LRDSPPPK-----LK-  238 (297)
T ss_pred             -ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HhccCCCC-----cc-
Confidence             1123456889999999999888999999999999999999999999753211     11111 11100000     00 


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .....          ...+.+++.+|++.+|++||+++|
T Consensus       239 ~~~~~----------~~~l~~~i~~~l~~~P~~Rps~~~  267 (297)
T cd06659         239 NAHKI----------SPVLRDFLERMLTREPQERATAQE  267 (297)
T ss_pred             ccCCC----------CHHHHHHHHHHhcCCcccCcCHHH
Confidence            00000          112568999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-34  Score=315.48  Aligned_cols=237  Identities=27%  Similarity=0.450  Sum_probs=188.0

Q ss_pred             CCeecccCCcEEEEEEEc-CCCEEEEEE--eecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCE--EEEEEEc
Q 036815          739 ESLIGCGGFGEVFKATLK-DGSSVAIKK--LIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE--RLLVYEF  811 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~-~~~~vavK~--~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~  811 (1013)
                      ..+||+|+|-+||+|.+. +|-+||--.  +.+.  +....++|..|+++|+.++||||+++|+++.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            468999999999999986 466776322  2222  22334789999999999999999999999877554  6799999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeecccceecc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLIS  890 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~~  890 (1013)
                      |..|+|..|+...+.      ++...++.|++||++||.|||++ .|+|||||||.+||+|+.. |.|||+|.|+|....
T Consensus       125 ~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999987654      77889999999999999999998 5689999999999999865 899999999998765


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh---cCccccc
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR---EGKQMEV  967 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~  967 (1013)
                      ...    .....|||.|||||++. ..|...+||||||+.++||+|+..||..-.    +....++....   ......+
T Consensus       198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----n~AQIYKKV~SGiKP~sl~kV  268 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----NPAQIYKKVTSGIKPAALSKV  268 (632)
T ss_pred             ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----CHHHHHHHHHcCCCHHHhhcc
Confidence            322    23478999999999987 689999999999999999999999997532    22222222221   1112222


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      -||+                     +.+||.+|+.. .++|||+.|
T Consensus       269 ~dPe---------------------vr~fIekCl~~-~~~R~sa~e  292 (632)
T KOG0584|consen  269 KDPE---------------------VREFIEKCLAT-KSERLSAKE  292 (632)
T ss_pred             CCHH---------------------HHHHHHHHhcC-chhccCHHH
Confidence            2333                     35899999999 999999864

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.5e-33  Score=299.88  Aligned_cols=246  Identities=26%  Similarity=0.469  Sum_probs=194.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|.+... ......+.+|++++++++||+++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            358888999999999999999877889999987533 3345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++....     ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++......
T Consensus        83 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          83 HGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             CCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            999999986432     2378899999999999999999999   99999999999999999999999999987653321


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      . .......++.+|+|||++.+..++.++||||+||++|||++ |+.||.....     .+.... ...+.  ....+..
T Consensus       155 ~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~-~~~~~--~~~~~~~  225 (256)
T cd05112         155 Y-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVET-INAGF--RLYKPRL  225 (256)
T ss_pred             c-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHH-HhCCC--CCCCCCC
Confidence            1 11112234678999999998889999999999999999998 9999875321     112211 11110  0011111


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            .          ...+.+++.+||+.+|++|||++|
T Consensus       226 ------~----------~~~~~~l~~~~l~~~p~~Rp~~~~  250 (256)
T cd05112         226 ------A----------SQSVYELMQHCWKERPEDRPSFSL  250 (256)
T ss_pred             ------C----------CHHHHHHHHHHcccChhhCCCHHH
Confidence                  0          123678999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-33  Score=306.07  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=195.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46888899999999999999976 57889999775432 23356789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....      .+++..+..++.+++.|+.|||+.  .+++||||||+||+++.++.++|+|||++.....
T Consensus        85 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          85 MDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             CCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            99999999886432      378999999999999999999973  1899999999999999999999999999865432


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCc------cHHHHHHHHHhcCccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT------NLVGWVKMKVREGKQM  965 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~------~~~~~~~~~~~~~~~~  965 (1013)
                      ..    .....|+..|+|||++.+..++.++|||||||++|++++|+.||........      ...++........   
T Consensus       157 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  229 (284)
T cd06620         157 SI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---  229 (284)
T ss_pred             hc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence            11    1234688999999999888899999999999999999999999985432210      1111222111110   


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         .+.+.       ..   .  ....+.+++.+|++.||++|||++|
T Consensus       230 ---~~~~~-------~~---~--~~~~~~~li~~~l~~dp~~Rpt~~e  262 (284)
T cd06620         230 ---PPRLP-------SS---D--FPEDLRDFVDACLLKDPTERPTPQQ  262 (284)
T ss_pred             ---CCCCC-------ch---h--cCHHHHHHHHHHhcCCcccCcCHHH
Confidence               00000       00   0  0123568999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-33  Score=299.83  Aligned_cols=242  Identities=29%  Similarity=0.416  Sum_probs=189.0

Q ss_pred             CeecccCCcEEEEEEEcCCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCHH
Q 036815          740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLE  818 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  818 (1013)
                      ++||+|+||.||+|.+.+++.||+|++...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999987654333 3467899999999999999999999999999999999999999999


Q ss_pred             HHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceee
Q 036815          819 EVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV  898 (1013)
Q Consensus       819 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  898 (1013)
                      +++....     ..+++..+..++.+++.|++|||++   +++||||||+||+++.++.+||+|||.++...........
T Consensus        81 ~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          81 TFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9986432     2378889999999999999999999   9999999999999999999999999999765421111111


Q ss_pred             eeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccC
Q 036815          899 STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK  977 (1013)
Q Consensus       899 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  977 (1013)
                      .....+..|+|||++.+..++.++||||+||++|||++ |..||......  .....    ........  .+..     
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~----~~~~~~~~--~~~~-----  219 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRER----IESGYRMP--APQL-----  219 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHH----HhcCCCCC--CCcc-----
Confidence            12233567999999998899999999999999999999 88888654311  11111    11110000  0000     


Q ss_pred             CCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          978 GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       978 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .          ...+.+++.+|++.+|++|||++|
T Consensus       220 -~----------~~~~~~li~~~l~~~p~~Rp~~~e  244 (251)
T cd05041         220 -C----------PEEIYRLMLQCWAYDPENRPSFSE  244 (251)
T ss_pred             -C----------CHHHHHHHHHHhccChhhCcCHHH
Confidence             0          113668999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-33  Score=304.78  Aligned_cols=200  Identities=29%  Similarity=0.399  Sum_probs=167.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-----CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeC--CEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-----DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EERL  806 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  806 (1013)
                      -|++.+.||+|+||.||+|+..     ++..||+|.+.... ......+.+|++++++++|||++++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            4788999999999999999742     47889999875432 22346789999999999999999999998775  5678


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||+++++|.+++....     ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++
T Consensus        85 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            9999999999999985432     2379999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcce-eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          887 RLISALDTHL-SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       887 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      +......... ......++..|+|||++.+..++.++|||||||++|||++++.|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~  213 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES  213 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence            8764332211 1123456778999999988889999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.2e-33  Score=303.82  Aligned_cols=200  Identities=26%  Similarity=0.417  Sum_probs=160.5

Q ss_pred             CeecccCCcEEEEEEEcC---CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          740 SLIGCGGFGEVFKATLKD---GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      +.||+|+||.||+|...+   ...+|+|.+..... .....+.+|+++++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997643   34678886643322 22356789999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      +|.+++....... ....++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          81 DLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             cHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            9999997644221 22356788899999999999999999   9999999999999999999999999998754332221


Q ss_pred             eeeeeeccCCCccCccccc-------CCCCCccchhHhHHHHHHHHHc-CCCCCCC
Q 036815          896 LSVSTLAGTPGYVPPEYYQ-------SFRCTAKGDVYSFGVVLLELLT-GKRPTDK  943 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ellt-g~~pf~~  943 (1013)
                      .......++..|+|||++.       ...++.++||||+||++|||++ |..||..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD  212 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence            1222334567899999874       3456789999999999999999 7888764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3e-33  Score=301.95  Aligned_cols=249  Identities=31%  Similarity=0.444  Sum_probs=195.2

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|+||.||+|... +++.|++|.+......  ..+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999875 6889999987654332  456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....      .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          81 CSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             CCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            99999999986432      378889999999999999999999   999999999999999999999999999987644


Q ss_pred             cCccee--eeeeccCCCccCcccccCCC---CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          892 LDTHLS--VSTLAGTPGYVPPEYYQSFR---CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       892 ~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ......  .....+++.|+|||++.+..   ++.++||||||+++||+++|+.||...+...    ..... ....... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~-~~~~~~~-  225 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFH-VGAGHKP-  225 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHH-HhcCCCC-
Confidence            322111  12346788999999998766   8899999999999999999999997533111    11111 1111100 


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .++...     .          ....+.+++.+|++.+|++|||+.|
T Consensus       226 ~~~~~~-----~----------~~~~~~~li~~~l~~~p~~R~~~~~  257 (264)
T cd06626         226 PIPDSL-----Q----------LSPEGKDFLDRCLESDPKKRPTASE  257 (264)
T ss_pred             CCCccc-----c----------cCHHHHHHHHHHccCCcccCCCHHH
Confidence            011000     0          0112458999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-33  Score=301.74  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=194.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc------chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ------GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      +|+..+.||+|+||.||+|... +++.||+|++......      ..+.+.+|++++++++|+||+++++++.+++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999874 6889999987543211      23568899999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-cEEEeecccc
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMA  886 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a  886 (1013)
                      ||||+++++|.+++....      .+++..+..++.|++.||+|||++   +++|+||+|+||+++.++ .++|+|||.+
T Consensus        81 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~  151 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA  151 (268)
T ss_pred             EEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence            999999999999986432      378899999999999999999999   999999999999998776 5999999999


Q ss_pred             eeccccCcc--eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          887 RLISALDTH--LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       887 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      .........  .......++..|+|||++.+..++.++||||+||++|+|++|..||........  ........... .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~-~  228 (268)
T cd06630         152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIASAT-T  228 (268)
T ss_pred             cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhccC-C
Confidence            776432111  111234678899999999888899999999999999999999999975432211  11111111100 0


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....++..                 ...+.+++.+|++.+|++|||+.|
T Consensus       229 ~~~~~~~~-----------------~~~~~~~i~~~l~~~p~~R~~~~~  260 (268)
T cd06630         229 APSIPEHL-----------------SPGLRDVTLRCLELQPEDRPPSRE  260 (268)
T ss_pred             CCCCchhh-----------------CHHHHHHHHHHcCCCcccCcCHHH
Confidence            01011000                 112568999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-33  Score=309.15  Aligned_cols=259  Identities=29%  Similarity=0.406  Sum_probs=197.1

Q ss_pred             CHHHHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEE--
Q 036815          725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCK--  800 (1013)
Q Consensus       725 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--  800 (1013)
                      .++.+..+.++|++.+.||+|+||.||+|.+. +++.+|+|.+... ......+.+|+.+++++ +||||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34555667889999999999999999999886 5788999976432 23346688899999999 6999999999874  


Q ss_pred             ---eCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc
Q 036815          801 ---IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME  877 (1013)
Q Consensus       801 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  877 (1013)
                         .++..++||||+++++|.+++.....  ....+++..+..++.|+++|+.|||+.   +++||||||+||+++.++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence               34578999999999999998864321  223478999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHH
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLV  952 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~  952 (1013)
                      +|++|||+++......  .......|++.|+|||++..     ..++.++||||+||++|||++|+.||......    .
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~  236 (286)
T cd06638         163 VKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----R  236 (286)
T ss_pred             EEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----H
Confidence            9999999998654321  12234468899999998753     45788999999999999999999998754321    1


Q ss_pred             HHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          953 GWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       953 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+..  ..........++..      .          ...+.+++.+||+.||++|||+.|
T Consensus       237 ~~~~--~~~~~~~~~~~~~~------~----------~~~~~~li~~~l~~~p~~Rps~~e  279 (286)
T cd06638         237 ALFK--IPRNPPPTLHQPEL------W----------SNEFNDFIRKCLTKDYEKRPTVSD  279 (286)
T ss_pred             HHhh--ccccCCCcccCCCC------c----------CHHHHHHHHHHccCCcccCCCHHH
Confidence            1110  00010011111110      0          013568999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-33  Score=303.38  Aligned_cols=248  Identities=27%  Similarity=0.425  Sum_probs=192.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-C---CCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-D---GSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .+|++.+.||+|+||.||+|.+. +   +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46889999999999999999874 2   3368998875432 22345789999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....     ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++.
T Consensus        84 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            99999999999996432     2378899999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCccee-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          889 ISALDTHLS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       889 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ......... .....++..|+|||++.+..++.++|||||||++||+++ |..||......  .....+    ..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~----~~~~~~~  229 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAI----EEGYRLP  229 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHH----hCCCcCC
Confidence            654222111 112223568999999998889999999999999999887 99998754321  111111    1111000


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ..    ...          ...+.+++.+|++.+|++|||+.|
T Consensus       230 ----~~----~~~----------~~~~~~li~~~l~~~p~~Rp~~~~  258 (267)
T cd05066         230 ----AP----MDC----------PAALHQLMLDCWQKDRNERPKFEQ  258 (267)
T ss_pred             ----CC----CCC----------CHHHHHHHHHHcccCchhCCCHHH
Confidence                00    000          112568999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.4e-34  Score=283.67  Aligned_cols=207  Identities=25%  Similarity=0.364  Sum_probs=174.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-----CCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEe-CCEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-----GSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKI-GEER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  805 (1013)
                      ..|+....||+|.||.||+|..++     ...+|+|++.....  ......-+|+..++.++||||+.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            458999999999999999996542     23789998854322  223567899999999999999999999877 7889


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC----CcEEEe
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE----MEARVS  881 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~  881 (1013)
                      ++++||.+ -+|...++-++.... +.++...++.|+.||+.|+.|||++   -|+|||+||.||++..+    |.+||+
T Consensus       104 ~l~fdYAE-hDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  104 WLLFDYAE-HDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEehhhh-hhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence            99999998 589998876655443 6799999999999999999999999   99999999999999887    899999


Q ss_pred             ecccceeccccCcce-eeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          882 DFGMARLISALDTHL-SVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |||+|+.+...-... .....+.|..|+|||.+.|. .||++.||||.|||+.||+|-.+.|.+++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            999999886533222 34456778999999998775 68999999999999999999999998654

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-33  Score=309.30  Aligned_cols=202  Identities=25%  Similarity=0.355  Sum_probs=168.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+++++.++|+||+++++++..++..|+||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999875 688999998754332 22346788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+. +++.+++....     ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             eccc-CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            9996 67777764322     2267788889999999999999999   9999999999999999999999999999764


Q ss_pred             cccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .....  ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         154 SIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             CCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            33211  12234568899999998754 5788999999999999999999999754

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-33  Score=307.20  Aligned_cols=246  Identities=26%  Similarity=0.420  Sum_probs=195.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++..++..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67999999999999999999875 67889999875444444567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++...       .+++..+..++.|++.|++|||++   +++||||||+||+++.++.++|+|||++......
T Consensus        99 ~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          99 AGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             CCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            999999998642       278889999999999999999999   9999999999999999999999999998765432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ..  ......+++.|+|||.+.+..++.++|||||||++|++++|+.||..........     .....+. .....+  
T Consensus       169 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~~-~~~~~~--  238 (293)
T cd06647         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT-PELQNP--  238 (293)
T ss_pred             cc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCCC-CCCCCc--
Confidence            22  2233468889999999988889999999999999999999999997543211100     0000000 000000  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                  ..+  ...+.+++.+||+.+|++||+++|
T Consensus       239 ------------~~~--~~~l~~li~~~l~~~p~~Rp~~~~  265 (293)
T cd06647         239 ------------EKL--SAIFRDFLNRCLEMDVEKRGSAKE  265 (293)
T ss_pred             ------------ccc--CHHHHHHHHHHccCChhhCcCHHH
Confidence                        000  112558999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-33  Score=306.39  Aligned_cols=200  Identities=31%  Similarity=0.427  Sum_probs=171.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|+||.||+|++. +++.||+|++....  ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4888999999999999999986 68899999886543  22346789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      + +++|.+++....     ..+++.+++.++.|+++||+|||+.   +++|+||||+||+++.++.++++|||.+.....
T Consensus        81 ~-~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          81 M-PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             c-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            9 999999986433     3489999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ... .......++..|+|||++.+. .++.++||||+||++|||++|.+||...
T Consensus       152 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         152 EEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             CCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            321 122345688899999998654 4688999999999999999998887653

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.2e-33  Score=304.95  Aligned_cols=243  Identities=26%  Similarity=0.384  Sum_probs=193.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            5778899999999999999986 57889999875432 233467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++...       .+++..+..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        85 ~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          85 GGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             CCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999998532       278888999999999999999999   9999999999999999999999999999776432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ..  ......++..|+|||++.+..++.++|||||||++|||++|..||.......     .... .....     .+..
T Consensus       155 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~-~~~~~-----~~~~  221 (277)
T cd06640         155 QI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLFL-IPKNN-----PPTL  221 (277)
T ss_pred             cc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhhh-hhcCC-----CCCC
Confidence            21  1223457889999999988889999999999999999999999987533111     0100 11000     0000


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             .    .  .....+.+++.+||+.+|++||+++|
T Consensus       222 -------~----~--~~~~~~~~li~~~l~~~p~~Rp~~~~  249 (277)
T cd06640         222 -------T----G--EFSKPFKEFIDACLNKDPSFRPTAKE  249 (277)
T ss_pred             -------c----h--hhhHHHHHHHHHHcccCcccCcCHHH
Confidence                   0    0  01123568999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-33  Score=302.95  Aligned_cols=247  Identities=23%  Similarity=0.413  Sum_probs=191.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CC----EEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GS----SVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||.||+|.+++ ++    .||+|....... ....++.+|++++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            468899999999999999998753 33    588887654433 234578899999999999999999999876 78899


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++....     ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||.++
T Consensus        86 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence            999999999999996432     2388999999999999999999998   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...............++..|+|||.+....++.++|||||||++||+++ |+.||.....     .++.. ....+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~-~~~~~~~~~  231 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPD-LLEKGERLP  231 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH-HHhCCCCCC
Confidence            7654332222222334568999999988889999999999999999998 9999875431     12221 111111110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .  +..      .          ...+.+++.+||..||.+|||+.+
T Consensus       232 ~--~~~------~----------~~~~~~~~~~~l~~~p~~Rp~~~~  260 (279)
T cd05057         232 Q--PPI------C----------TIDVYMVLVKCWMIDAESRPTFKE  260 (279)
T ss_pred             C--CCC------C----------CHHHHHHHHHHcCCChhhCCCHHH
Confidence            0  000      0          012568899999999999999853

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2e-33  Score=305.20  Aligned_cols=253  Identities=25%  Similarity=0.424  Sum_probs=193.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|+.+      +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46889999999999999999964      2457888876543332 2467899999999999999999999999988999


Q ss_pred             EEEEcccCCCHHHHhcccccCC---CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          807 LVYEFMKFGSLEEVLHGRAKAR---DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      +||||+++|+|.+++.......   ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997543211   112489999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      |+++...... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||....  .......    ...+
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--~~~~~~~----~~~~  234 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--DEEVLNR----LQAG  234 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--hHHHHHH----HHcC
Confidence            9987543211 112223355678999999988888999999999999999999 788886432  1111111    1111


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ........       ..          ...+.+++.+||+.+|++|||+.|
T Consensus       235 ~~~~~~~~-------~~----------~~~l~~~i~~~l~~~p~~Rp~~~~  268 (275)
T cd05046         235 KLELPVPE-------GC----------PSRLYKLMTRCWAVNPKDRPSFSE  268 (275)
T ss_pred             CcCCCCCC-------CC----------CHHHHHHHHHHcCCCcccCCCHHH
Confidence            11000000       00          013668999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.9e-33  Score=297.97  Aligned_cols=243  Identities=23%  Similarity=0.282  Sum_probs=185.9

Q ss_pred             HHHHHhcCCCCCCee--cccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCC
Q 036815          728 QLIEATNGFSAESLI--GCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       728 ~~~~~~~~y~~~~~l--G~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  803 (1013)
                      +.....++|++.+.+  |+|+||.||++..+ +++.+|+|.+.......     .|+.....+ +||||+++++++..++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334445677777777  99999999999976 57788888764322111     122222222 7999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-cEEEee
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSD  882 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D  882 (1013)
                      ..++||||+++++|.+++....      .+++..+..++.|+++|++|||+.   +++||||||+||+++.++ .++++|
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence            9999999999999999996432      489999999999999999999999   999999999999999998 999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      ||.++.....      ....++..|+|||++.+..++.++||||+||++|||++|+.||............+........
T Consensus       154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (267)
T PHA03390        154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL  227 (267)
T ss_pred             CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC
Confidence            9998765422      1235788999999999989999999999999999999999999854332222233322211110


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      ......+                     ..+.+++.+||++||.+||+.
T Consensus       228 ~~~~~~~---------------------~~~~~li~~~l~~~p~~R~~~  255 (267)
T PHA03390        228 PFIKNVS---------------------KNANDFVQSMLKYNINYRLTN  255 (267)
T ss_pred             CcccccC---------------------HHHHHHHHHHhccChhhCCch
Confidence            1111111                     125689999999999999974

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-33  Score=300.09  Aligned_cols=240  Identities=29%  Similarity=0.486  Sum_probs=185.7

Q ss_pred             CeecccCCcEEEEEEEcC----CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLKD----GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      ++||+|+||.||+|++..    +..||+|.+..... ...+++.+|++++++++||||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998642    26899998764433 24567889999999999999999999875 5567999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      ++|.+++....      .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++.......
T Consensus        80 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          80 GPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            99999997543      378999999999999999999999   999999999999999999999999999987644332


Q ss_pred             cee-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          895 HLS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       895 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....  .....++    ........ ..  
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~~~~~~~-~~--  221 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ESGERLPR-PE--  221 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCcCCC-CC--
Confidence            211 111223467999999998899999999999999999998 9999875321  1122221    11111110 00  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..          ...+.+++.+|++.+|++|||+.|
T Consensus       222 -----~~----------~~~l~~li~~cl~~~p~~Rp~~~~  247 (257)
T cd05060         222 -----EC----------PQEIYSIMLSCWKYRPEDRPTFSE  247 (257)
T ss_pred             -----CC----------CHHHHHHHHHHhcCChhhCcCHHH
Confidence                 00          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=307.25  Aligned_cols=201  Identities=23%  Similarity=0.366  Sum_probs=169.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57999999999999999999986 678999998754322 2234567899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++ +|.+++....     ..+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||.++....
T Consensus        85 ~~~-~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          85 LDT-DLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             CCC-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            984 9999886432     2478999999999999999999999   999999999999999999999999999875432


Q ss_pred             cCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ..  .......++..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       156 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         156 PS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             CC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            11  11122346788999999865 457889999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-33  Score=303.12  Aligned_cols=251  Identities=25%  Similarity=0.410  Sum_probs=192.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc----------chHHHHHHHHHHhccCCcceeeeccEEEeCC
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ----------GDREFMAEMETLGKIKHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  803 (1013)
                      +|.+.+.||+|+||.||+|... +++.||+|.+......          ..+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4788899999999999999875 6889999987432111          1235788999999999999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..++||||+++++|.+++...      ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~  152 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDF  152 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeec
Confidence            999999999999999999654      2378899999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCC--CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR--CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      |+++...............++..|+|||++....  ++.++||||+|+++||+++|..||.....    ...+.. ....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~-~~~~  227 (272)
T cd06629         153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFK-LGNK  227 (272)
T ss_pred             cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHH-hhcc
Confidence            9997654322222223346788999999987654  78999999999999999999999864221    111111 1111


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ....+++...   ..          -...+.+++.+|+++||++|||++|
T Consensus       228 ~-~~~~~~~~~~---~~----------~~~~~~~li~~~l~~~p~~Rps~~~  265 (272)
T cd06629         228 R-SAPPIPPDVS---MN----------LSPVALDFLNACFTINPDNRPTARE  265 (272)
T ss_pred             c-cCCcCCcccc---cc----------CCHHHHHHHHHHhcCChhhCCCHHH
Confidence            0 0111111110   00          0123568999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-33  Score=309.12  Aligned_cols=200  Identities=28%  Similarity=0.428  Sum_probs=170.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++......  ..+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999986 5889999987543222  24568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |++++++.++....      ..+++..+..++.|+++|++|||+.   +++||||+|+||++++++.++|+|||++....
T Consensus        81 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          81 FVDHTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             cCCccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            99999998876432      2278999999999999999999999   99999999999999999999999999998654


Q ss_pred             ccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ...  .......++..|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus       152 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~  204 (286)
T cd07846         152 APG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD  204 (286)
T ss_pred             CCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence            322  12233457889999999875 45788999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.1e-33  Score=306.28  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=195.5

Q ss_pred             CHHHHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEe-
Q 036815          725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKI-  801 (1013)
Q Consensus       725 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  801 (1013)
                      +..++..+.+.|++.+.||+|+||.||+|++. +++.||+|.+... .....++..|+.+++++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555667789999999999999999999985 5788999976443 23345688899999998 79999999998853 


Q ss_pred             -----CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC
Q 036815          802 -----GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       802 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                           ....|+||||+++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence                 4578999999999999999865332    2378888999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceeccccCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccH
Q 036815          877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL  951 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~  951 (1013)
                      .++|+|||++........  ......|++.|+|||++.     +..++.++|||||||++|||++|+.||........  
T Consensus       159 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--  234 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--  234 (282)
T ss_pred             CEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--
Confidence            999999999876532111  123456889999999875     34678899999999999999999999965321110  


Q ss_pred             HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          952 VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       952 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        . .. ......     +...  ....          ...+.+++.+||+.||.+|||+.|
T Consensus       235 --~-~~-~~~~~~-----~~~~--~~~~----------~~~~~~li~~cl~~~p~~Rp~~~e  275 (282)
T cd06636         235 --L-FL-IPRNPP-----PKLK--SKKW----------SKKFIDFIEGCLVKNYLSRPSTEQ  275 (282)
T ss_pred             --h-hh-HhhCCC-----CCCc--cccc----------CHHHHHHHHHHhCCChhhCcCHHH
Confidence              0 00 000000     0000  0000          113668999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-33  Score=303.90  Aligned_cols=233  Identities=20%  Similarity=0.313  Sum_probs=178.3

Q ss_pred             eecccCCcEEEEEEEcC-------------------------CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeee
Q 036815          741 LIGCGGFGEVFKATLKD-------------------------GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL  795 (1013)
Q Consensus       741 ~lG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  795 (1013)
                      .||+|+||.||+|....                         ...|++|.+..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13478887754433334578889999999999999999


Q ss_pred             ccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC
Q 036815          796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE  875 (1013)
Q Consensus       796 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  875 (1013)
                      ++++.++...++||||+++|+|..++....     ..+++..+..++.|+++||+|||++   +|+||||||+||+++..
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            999999999999999999999999986422     2378899999999999999999999   99999999999999764


Q ss_pred             C-------cEEEeecccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHH-cCCCCCCCCCC
Q 036815          876 M-------EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELL-TGKRPTDKDDF  946 (1013)
Q Consensus       876 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~pf~~~~~  946 (1013)
                      +       .+|++|||.+......      ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.....
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            3       3799999988643221      12356788999998865 56889999999999999995 69999875432


Q ss_pred             CCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          947 GDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       947 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+  ...+...   .......           .          ...+.+++.+||+.+|++|||++|
T Consensus       228 ~~--~~~~~~~---~~~~~~~-----------~----------~~~~~~li~~cl~~~p~~Rps~~~  268 (274)
T cd05076         228 SE--KERFYEK---KHRLPEP-----------S----------CKELATLISQCLTYEPTQRPSFRT  268 (274)
T ss_pred             HH--HHHHHHh---ccCCCCC-----------C----------ChHHHHHHHHHcccChhhCcCHHH
Confidence            11  1111110   0000000           0          013568999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.2e-33  Score=303.81  Aligned_cols=247  Identities=29%  Similarity=0.471  Sum_probs=189.1

Q ss_pred             CeecccCCcEEEEEEEcC-------CCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          740 SLIGCGGFGEVFKATLKD-------GSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +.||+|+||.||+|+..+       ++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998753       2578888775432 23356788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCC-CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-----cEEEeeccc
Q 036815          812 MKFGSLEEVLHGRAKAR-DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-----EARVSDFGM  885 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfg~  885 (1013)
                      +++++|.+++....... ....+++.++..++.|++.|++|||+.   +++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997543222 233478999999999999999999999   999999999999999877     899999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      ++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.....  .....+    ...+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~----~~~~~~  231 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQH----VTAGGR  231 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHH----HhcCCc
Confidence            976543222222223345678999999999999999999999999999998 9999864321  111111    111110


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ... ..       .        .  ...+.+++.+||+.+|++||+++|
T Consensus       232 ~~~-~~-------~--------~--~~~~~~li~~~l~~~p~~Rp~~~~  262 (269)
T cd05044         232 LQK-PE-------N--------C--PDKIYQLMTNCWAQDPSERPTFDR  262 (269)
T ss_pred             cCC-cc-------c--------c--hHHHHHHHHHHcCCCcccCCCHHH
Confidence            000 00       0        0  113568999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.5e-33  Score=302.04  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=197.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..+...++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999975 57889999875432 22456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++.....   ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          81 LSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             cCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            999999999975322   13488999999999999999999999   999999999999999999999999999877654


Q ss_pred             cCcce--eeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTHL--SVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      .....  ......++..|+|||++... .++.++|||||||++|||++|+.||....... .....    .....  ...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~----~~~~~--~~~  227 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLT----LQNDP--PSL  227 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHH----hcCCC--CCc
Confidence            33221  12334688899999998776 78899999999999999999999997543211 11111    11100  000


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....    .        ...-...+.+++.+|++.||++|||++|
T Consensus       228 ~~~~----~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (267)
T cd06610         228 ETGA----D--------YKKYSKSFRKMISLCLQKDPSKRPTAEE  260 (267)
T ss_pred             CCcc----c--------cccccHHHHHHHHHHcCCChhhCcCHHH
Confidence            0000    0        0000123568999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.8e-33  Score=300.92  Aligned_cols=243  Identities=25%  Similarity=0.337  Sum_probs=196.6

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +|++.+.||.|+||.||+|++. +++.||+|.+.+...   ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4888999999999999999986 588999998865332   234678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+.+++|.+++...      ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||.+....
T Consensus        81 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          81 LLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             CCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            99999999999643      2388999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...   ......++..|+|||++.+..++.++||||+|+++|+|++|..||......   ...+.......  .....++
T Consensus       152 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~~~~~  223 (258)
T cd05578         152 PDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET--ADVLYPA  223 (258)
T ss_pred             CCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc--ccccCcc
Confidence            322   223456788999999998888999999999999999999999999865432   12222211111  0011111


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      ..                 ...+.+++.+||+.||.+||++
T Consensus       224 ~~-----------------~~~~~~~i~~~l~~~p~~R~~~  247 (258)
T cd05578         224 TW-----------------STEAIDAINKLLERDPQKRLGD  247 (258)
T ss_pred             cC-----------------cHHHHHHHHHHccCChhHcCCc
Confidence            10                 0235689999999999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.2e-33  Score=299.21  Aligned_cols=246  Identities=24%  Similarity=0.354  Sum_probs=196.2

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|+||.||+++.. +++.||+|.+...  .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999976 6789999987543  223345789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++.....    ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        81 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          81 CEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             CCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            999999999864322    2378899999999999999999999   999999999999999999999999999986543


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ...  ......+++.|+|||+..+..++.++|||||||++|+|++|+.||....     ..+.+..... +..... ...
T Consensus       154 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~-~~~~~~-~~~  224 (256)
T cd08218         154 TVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIR-GSYPPV-SSH  224 (256)
T ss_pred             chh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhc-CCCCCC-ccc
Confidence            221  1223457889999999998889999999999999999999999987532     1222222111 111100 000


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             .          ...+.+++.+|++.+|++||++.|
T Consensus       225 -------~----------~~~~~~li~~~l~~~p~~Rp~~~~  249 (256)
T cd08218         225 -------Y----------SYDLRNLVSQLFKRNPRDRPSVNS  249 (256)
T ss_pred             -------C----------CHHHHHHHHHHhhCChhhCcCHHH
Confidence                   0          112568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-33  Score=301.59  Aligned_cols=244  Identities=27%  Similarity=0.435  Sum_probs=185.1

Q ss_pred             CeecccCCcEEEEEEEcC-CC--EEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLKD-GS--SVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|++++ +.  .+++|.+.... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999864 33  46778765322 23345788999999999 899999999999999999999999999


Q ss_pred             CCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          815 GSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       815 g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      |+|.+++......          .....+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            9999999754321          1123478999999999999999999998   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      +++.....   ........+..|+|||++.+..++.++|||||||++|||++ |..||.....     .+.... ...+.
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~-~~~~~  228 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK-LPQGY  228 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHH-HhCCC
Confidence            98632211   11112234567999999988889999999999999999997 9999865321     111111 11111


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..        ...          ...+.+++.+|++.||.+|||++|
T Consensus       229 ~~~~~--------~~~----------~~~~~~li~~~l~~~p~~Rps~~~  260 (270)
T cd05047         229 RLEKP--------LNC----------DDEVYDLMRQCWREKPYERPSFAQ  260 (270)
T ss_pred             CCCCC--------CcC----------CHHHHHHHHHHcccChhhCCCHHH
Confidence            10000        000          113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.1e-33  Score=302.80  Aligned_cols=246  Identities=23%  Similarity=0.384  Sum_probs=190.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCC----CEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDG----SSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|.+.+.    ..||+|...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4688899999999999999987532    468888775443 2334678999999999999999999998875 457899


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++.
T Consensus        85 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          85 MELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEcCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            99999999999996432     2378999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      ...... .......++..|+|||.+....++.++|||||||++||+++ |..||......  ....+    ...+.....
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~----~~~~~~~~~  229 (270)
T cd05056         157 LEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGR----IENGERLPM  229 (270)
T ss_pred             cccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH----HHcCCcCCC
Confidence            643221 11222334568999999988889999999999999999986 99999754321  11111    111111110


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .+.       .          ...+.+++.+|+.++|++|||+.|
T Consensus       230 -~~~-------~----------~~~~~~li~~~l~~~P~~Rpt~~~  257 (270)
T cd05056         230 -PPN-------C----------PPTLYSLMTKCWAYDPSKRPRFTE  257 (270)
T ss_pred             -CCC-------C----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence             000       0          013568999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.2e-33  Score=307.54  Aligned_cols=260  Identities=30%  Similarity=0.394  Sum_probs=197.7

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEe
Q 036815          724 LKFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKI  801 (1013)
Q Consensus       724 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  801 (1013)
                      +.+.++..++++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344555667889999999999999999999985 57889999775432 2346678899999998 89999999999875


Q ss_pred             C-----CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC
Q 036815          802 G-----EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       802 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                      .     +..++||||+++++|.++++....  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~  165 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence            3     358999999999999998864321  223488999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceeccccCcceeeeeeccCCCccCcccccCC-----CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccH
Q 036815          877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-----RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL  951 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~  951 (1013)
                      .+||+|||.++.......  ......++..|+|||++...     .++.++||||+||++|||++|+.||...... ...
T Consensus       166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~  242 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTL  242 (291)
T ss_pred             CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHH
Confidence            999999999886543221  12234678899999997543     3688999999999999999999998753211 111


Q ss_pred             HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          952 VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       952 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..     ..........++.-                ....+.+++.+|++.+|++||++.|
T Consensus       243 ~~-----~~~~~~~~~~~~~~----------------~~~~l~~li~~~l~~~p~~Rps~~~  283 (291)
T cd06639         243 FK-----IPRNPPPTLLHPEK----------------WCRSFNHFISQCLIKDFEARPSVTH  283 (291)
T ss_pred             HH-----HhcCCCCCCCcccc----------------cCHHHHHHHHHHhhcChhhCcCHHH
Confidence            11     11111111111100                0113568999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.8e-33  Score=301.13  Aligned_cols=241  Identities=26%  Similarity=0.311  Sum_probs=187.2

Q ss_pred             ecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      ||+|+||+||+|... +++.||+|.+....   ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999876 68899999875432   12234567899999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCccee
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS  897 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  897 (1013)
                      .+++.....    ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+.....   ...
T Consensus        81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~  150 (277)
T cd05577          81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKK  150 (277)
T ss_pred             HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCc
Confidence            999865432    2489999999999999999999999   999999999999999999999999999876543   111


Q ss_pred             eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccC
Q 036815          898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK  977 (1013)
Q Consensus       898 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  977 (1013)
                      .....++..|+|||++.+..++.++||||+||++|+|++|+.||........ ....... .....  ....       .
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-~~~~~--~~~~-------~  219 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRR-TLEMA--VEYP-------D  219 (277)
T ss_pred             cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhc-ccccc--ccCC-------c
Confidence            2334678899999999888899999999999999999999999976432111 1111110 00000  0000       0


Q ss_pred             CCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          978 GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       978 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..          ...+.+++.+||+.||++||++.|
T Consensus       220 ~~----------~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         220 KF----------SPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             cC----------CHHHHHHHHHHccCChhHccCCCc
Confidence            00          112568999999999999996543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-33  Score=302.23  Aligned_cols=258  Identities=26%  Similarity=0.336  Sum_probs=195.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  809 (1013)
                      ++|+..+.||.|++|.||+|.+. +++.+|+|.+..... ....++.+|++++++++||||++++++|.+  ....++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788899999999999999986 578899998764322 334678999999999999999999998865  34689999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++.....  ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            99999999998754322  233478899999999999999999999   9999999999999999999999999998754


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .....    ....++..|+|||.+.+..++.++||||+||++|+|++|+.||...........+....... ..... ++
T Consensus       156 ~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~-~~  229 (287)
T cd06621         156 VNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPE-LK  229 (287)
T ss_pred             ccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchh-hc
Confidence            32111    23457788999999998899999999999999999999999998653321222222221111 01000 00


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...    ....       .-...+.+++.+|++.+|++|||+.|
T Consensus       230 ~~~----~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~e  262 (287)
T cd06621         230 DEP----GNGI-------KWSEEFKDFIKQCLEKDPTRRPTPWD  262 (287)
T ss_pred             cCC----CCCC-------chHHHHHHHHHHHcCCCcccCCCHHH
Confidence            000    0000       00123569999999999999999864

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.7e-33  Score=305.89  Aligned_cols=243  Identities=26%  Similarity=0.388  Sum_probs=191.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566678999999999999876 57789999775332 223456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++..       ..+++..+..++.|+++|+.|||++   +++|+||+|+||+++.++.++++|||++......
T Consensus        85 ~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          85 GGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             CCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            99999998853       2378899999999999999999999   9999999999999999999999999999765432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ..  ......++..|+|||++.+..++.++|||||||++|||++|+.||.......     +.. ......     .+..
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~-~~~~~~-----~~~~  221 (277)
T cd06642         155 QI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VLF-LIPKNS-----PPTL  221 (277)
T ss_pred             ch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HHh-hhhcCC-----CCCC
Confidence            21  1223457889999999998889999999999999999999999986432111     111 011110     0100


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ..         .....+.+++.+|++.+|++|||+.|
T Consensus       222 ----~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~  249 (277)
T cd06642         222 ----EG---------QYSKPFKEFVEACLNKDPRFRPTAKE  249 (277)
T ss_pred             ----Cc---------ccCHHHHHHHHHHccCCcccCcCHHH
Confidence                00         00123568999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.7e-33  Score=299.80  Aligned_cols=201  Identities=26%  Similarity=0.436  Sum_probs=169.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--c---cchHHHHHHHHHHhccCCcceeeeccEEEeC--CEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--C---QGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  805 (1013)
                      .+|++.+.||+|+||.||+|.+. +++.||+|.+....  .   ...+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46889999999999999999986 58899999875321  1   1224678899999999999999999988763  467


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~  152 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGA  152 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcc
Confidence            89999999999999986432      267888899999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcc-eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          886 ARLISALDTH-LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       886 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      ++........ .......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            9865322111 112234578899999999888899999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6e-33  Score=300.42  Aligned_cols=248  Identities=20%  Similarity=0.337  Sum_probs=191.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC--CCEEEEEEeeccC----------ccchHHHHHHHHHHhc-cCCcceeeeccEEEe
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD--GSSVAIKKLIRLS----------CQGDREFMAEMETLGK-IKHRNLVPLLGYCKI  801 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  801 (1013)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999875  6789999874321          1122456778888765 799999999999999


Q ss_pred             CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEE
Q 036815          802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       802 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                      ++..++||||+++++|.+++.....  ....+++..++.++.|++.|+.|||+ .   +++|+||+|+||+++.++.+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKE--KKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEE
Confidence            9999999999999999998854221  12348899999999999999999996 5   8999999999999999999999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR  960 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  960 (1013)
                      +|||.+.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||....     ........ .
T Consensus       156 ~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~-~  226 (269)
T cd08528         156 TDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLATKI-V  226 (269)
T ss_pred             ecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHHHH-h
Confidence            9999998754322   2334568889999999998889999999999999999999999986432     11111111 1


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....... ..      ...          ...+.+++.+|++.||++||++.|
T Consensus       227 ~~~~~~~-~~------~~~----------~~~l~~li~~cl~~~p~~Rp~~~e  262 (269)
T cd08528         227 EAVYEPL-PE------GMY----------SEDVTDVITSCLTPDAEARPDIIQ  262 (269)
T ss_pred             hccCCcC-Cc------ccC----------CHHHHHHHHHHCCCCCccCCCHHH
Confidence            1111100 00      000          113568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7e-33  Score=299.09  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=199.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|++|.||+|++. +++.|++|++..... ...+.+.+|++++++++|+|++++++++..+...++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36889999999999999999987 489999998765433 3456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      +++++|.+++...      ..+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          81 MDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             cCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999653      338899999999999999999999 8   99999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      .....  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......  ...+........ ... ..+.
T Consensus       152 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~-~~~-~~~~  225 (264)
T cd06623         152 NTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDG-PPP-SLPA  225 (264)
T ss_pred             cCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcC-CCC-CCCc
Confidence            32222  12446788999999999889999999999999999999999999764321  111111111111 000 0110


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..      .          ...+.+++.+|++++|++|||+.|
T Consensus       226 ~~------~----------~~~l~~li~~~l~~~p~~R~~~~~  252 (264)
T cd06623         226 EE------F----------SPEFRDFISACLQKDPKKRPSAAE  252 (264)
T ss_pred             cc------C----------CHHHHHHHHHHccCChhhCCCHHH
Confidence            00      0          113568999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.5e-33  Score=303.44  Aligned_cols=253  Identities=24%  Similarity=0.397  Sum_probs=194.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-----CCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEe--CCEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-----DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKI--GEER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  805 (1013)
                      +.|++.+.||+|+||.||+|++.     ++..||+|.+...... ..+.+.+|++++++++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45788899999999999999864     3678999988654432 35679999999999999999999999877  5578


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||+++++|.+++.....     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  155 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL  155 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence            999999999999999965432     389999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCccee-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCcc----------HHHH
Q 036815          886 ARLISALDTHLS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN----------LVGW  954 (1013)
Q Consensus       886 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~----------~~~~  954 (1013)
                      +........... .....++..|+|||...+..++.++|||||||++|||++|+.|+.........          ...+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            987653222111 11234456799999998889999999999999999999999998653322110          1111


Q ss_pred             HHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          955 VKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       955 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. ..........  +.                ....++.+++.+|++.+|++||||.|
T Consensus       236 ~~-~~~~~~~~~~--~~----------------~~~~~~~~li~~cl~~~p~~Rpt~~e  275 (284)
T cd05038         236 LE-LLKEGERLPR--PP----------------SCPDEVYDLMKLCWEAEPQDRPSFAD  275 (284)
T ss_pred             HH-HHHcCCcCCC--Cc----------------cCCHHHHHHHHHHhccChhhCCCHHH
Confidence            11 1111100000  00                00124678999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.5e-33  Score=304.49  Aligned_cols=199  Identities=29%  Similarity=0.390  Sum_probs=169.6

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc-----chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ-----GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      +|++.+.||+|+||.||+|.+. +++.||+|++......     ....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999976 6889999998654322     234577899999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+ +++|.+++....     ..+++..++.++.|+++||+|||++   +|+||||||+||+++.++.++|+|||+++.
T Consensus        81 ~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             Eccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeee
Confidence            9999 899999996432     2489999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ......  ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~  206 (298)
T cd07841         152 FGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD  206 (298)
T ss_pred             ccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence            654322  1223356788999998854 46788999999999999999998887653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-33  Score=307.37  Aligned_cols=207  Identities=25%  Similarity=0.367  Sum_probs=170.6

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC---CCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeC--CEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD---GSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EERL  806 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  806 (1013)
                      +|++.+.||+|+||.||+|....   ++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999999864   7899999886532   23345678899999999999999999999887  7899


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC----CCcEEEee
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH----EMEARVSD  882 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~D  882 (1013)
                      +||||+++ ++.+.+...... ....+++..++.++.|++.|++|||+.   +|+||||||+||+++.    ++.+||+|
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            99999985 677766533321 123588999999999999999999999   9999999999999999    89999999


Q ss_pred             cccceeccccCc-ceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          883 FGMARLISALDT-HLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       883 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      ||+++....... ........++..|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            999987643222 1122344678899999988664 578999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-33  Score=307.72  Aligned_cols=247  Identities=23%  Similarity=0.294  Sum_probs=194.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|... +++.||+|.+......   ..+.+..|++++++++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36889999999999999999987 4899999988654332   3356889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+.+++|.+++....    ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          81 DYCPGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EecCCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            9999999999986432    23489999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccCcce---------------------------eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          890 SALDTHL---------------------------SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       890 ~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      .......                           ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            3221100                           1112357889999999998889999999999999999999999997


Q ss_pred             CCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          943 KDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       943 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      ..+..    ..+.............           ..        ....+.+++.+|++.||++|||
T Consensus       234 ~~~~~----~~~~~~~~~~~~~~~~-----------~~--------~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         234 GSNRD----ETFSNILKKEVTFPGS-----------PP--------VSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             CCchH----HHHHHHhcCCccCCCc-----------cc--------cCHHHHHHHHHHccCCHhHCCC
Confidence            54321    1111111000000000           00        1123568999999999999999

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-32  Score=295.95  Aligned_cols=245  Identities=26%  Similarity=0.393  Sum_probs=194.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|+..+.||+|+||.||+|... +++.+|+|.+....  ....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999975 67889999875432  23346788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeecccceecc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLIS  890 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~~  890 (1013)
                      +++++|.+++....    ...+++..+..++.|+++|++|||++   +++||||+|+||+++.+ +.+|++|||.+....
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          81 APGGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             CCCCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            99999999997533    23478999999999999999999999   99999999999999865 457999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ....   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..     ..+..... ...... ..
T Consensus       154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~-~~  223 (256)
T cd08220         154 SKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMS-GTFAPI-SD  223 (256)
T ss_pred             CCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHh-cCCCCC-CC
Confidence            3221   22346788999999999888999999999999999999999998754321     11111111 111110 00


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       .          ...+.+++.+||+.+|++|||+.|
T Consensus       224 ~-------~----------~~~l~~li~~~l~~~p~~Rpt~~~  249 (256)
T cd08220         224 R-------Y----------SPDLRQLILSMLNLDPSKRPQLSQ  249 (256)
T ss_pred             C-------c----------CHHHHHHHHHHccCChhhCCCHHH
Confidence            0       0          112568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.3e-33  Score=300.05  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=190.1

Q ss_pred             CCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCC------
Q 036815          736 FSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE------  803 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  803 (1013)
                      |.+.+.||+|+||.||+|.+.    .++.||+|.+....  ....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            667889999999999999864    36789999875432  223456889999999999999999999886532      


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..++++||+.+|+|.+++...........+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999998875433222233478899999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      |.++...............+++.|++||.+.+..++.++|||||||++|||++ |+.||.....  .....+..    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~----~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLI----KG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHH----cC
Confidence            99987643322222223345678999999998889999999999999999999 8888865321  11111111    11


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..... ++.                 ....+.+++.+|++.+|++|||+.|
T Consensus       232 ~~~~~-~~~-----------------~~~~~~~l~~~~l~~~p~~Rps~~~  264 (273)
T cd05074         232 NRLKQ-PPD-----------------CLEDVYELMCQCWSPEPKCRPSFQH  264 (273)
T ss_pred             CcCCC-CCC-----------------CCHHHHHHHHHHcCCChhhCcCHHH
Confidence            11000 000                 0123668999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9.8e-33  Score=296.85  Aligned_cols=246  Identities=29%  Similarity=0.453  Sum_probs=193.5

Q ss_pred             CCCCCeecccCCcEEEEEEEcC-----CCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          736 FSAESLIGCGGFGEVFKATLKD-----GSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +++.+.||.|+||.||+|.+.+     +..||+|++...... ..+.+..|++++++++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4577899999999999999864     378999988554333 4567899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++.....    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++..
T Consensus        81 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             eccCCCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence            99999999999965332    1179999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ........ ....+++.|+|||.+.+..++.++||||+||++|+|++ |..||.....     ...... ......... 
T Consensus       154 ~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~-~~~~~~~~~-  225 (258)
T smart00219      154 YDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EEVLEY-LKKGYRLPK-  225 (258)
T ss_pred             cccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-HhcCCCCCC-
Confidence            54322211 12336789999999988889999999999999999998 7888765221     111111 111111100 


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..       .          ...++.+++.+|++.||++|||+.|
T Consensus       226 ~~-------~----------~~~~~~~~i~~~l~~~p~~Rpt~~~  253 (258)
T smart00219      226 PE-------N----------CPPEIYKLMLQCWAEDPEDRPTFSE  253 (258)
T ss_pred             CC-------c----------CCHHHHHHHHHHCcCChhhCcCHHH
Confidence            00       0          0123668999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-33  Score=301.33  Aligned_cols=234  Identities=25%  Similarity=0.418  Sum_probs=179.7

Q ss_pred             CeecccCCcEEEEEEEcC--------CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          740 SLIGCGGFGEVFKATLKD--------GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +.||+|+||.||+|....        ..+||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999998742        234778876544334446788899999999999999999999998999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc--------EEEeec
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME--------ARVSDF  883 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~Df  883 (1013)
                      +++|+|.+++.....     .+++..+..++.|++.|++|||++   +|+||||||+||+++.++.        ++++||
T Consensus        81 ~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          81 VKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             CCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999975432     378899999999999999999999   9999999999999987765        699999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCC-CCCCCCCCCCccHHHHHHHHHhc
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGK-RPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      |.+.....      .....++..|+|||++.+ ..++.++|||||||++|||++|. .||...+.     ..........
T Consensus       153 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~  221 (258)
T cd05078         153 GISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----QKKLQFYEDR  221 (258)
T ss_pred             ccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----HHHHHHHHcc
Confidence            98865432      123457889999999876 45789999999999999999985 55443211     1111111000


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..    +++..                 ..++.+++.+||+.||++|||++|
T Consensus       222 ~~----~~~~~-----------------~~~~~~li~~~l~~~p~~Rps~~~  252 (258)
T cd05078         222 HQ----LPAPK-----------------WTELANLINQCMDYEPDFRPSFRA  252 (258)
T ss_pred             cc----CCCCC-----------------cHHHHHHHHHHhccChhhCCCHHH
Confidence            00    00000                 113568999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-34  Score=295.70  Aligned_cols=202  Identities=29%  Similarity=0.402  Sum_probs=178.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .+.|+.-++||+|+||.||-+..+ +|+.+|.|++.+.   ....+.....|-.++.++..+.||.+--+|+..+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356888899999999999999866 6889999987543   233445678899999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      +..|.||+|.-+|.+...    ..+++..++.++.+|+.||++||..   +||+||+||+|||+|+.|+++|+|.|+|..
T Consensus       264 LtlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             EEeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence            999999999999976654    3399999999999999999999999   999999999999999999999999999998


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +.....   ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||...
T Consensus       337 i~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~  389 (591)
T KOG0986|consen  337 IPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR  389 (591)
T ss_pred             cCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence            765433   34458999999999999999999999999999999999999999864

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5e-33  Score=306.14  Aligned_cols=247  Identities=26%  Similarity=0.428  Sum_probs=188.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCC----EEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGS----SVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|+..+.||+|+||.||+|.+. +++    .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46888899999999999999874 344    468887654322 2234688999999999999999999998654 4679


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |+||+++|+|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        86 v~e~~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eehhcCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            999999999999986432     2378899999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...............++..|+|||++.+..++.++|||||||++|||++ |+.||.....  .....++    ..+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~----~~~~~~~  231 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLL----EKGERLP  231 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HCCCCCC
Confidence            7643322222223345678999999998899999999999999999997 8999865321  1112221    1111110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .  +.      ..          ...+.+++.+|+..+|++||+++|
T Consensus       232 ~--~~------~~----------~~~~~~li~~c~~~~p~~Rp~~~~  260 (303)
T cd05110         232 Q--PP------IC----------TIDVYMVMVKCWMIDADSRPKFKE  260 (303)
T ss_pred             C--CC------CC----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence            0  00      00          113568899999999999999864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-33  Score=304.58  Aligned_cols=201  Identities=27%  Similarity=0.390  Sum_probs=171.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999987 57899999875432  2234678999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |++++.+..+....      ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||.+....
T Consensus        81 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          81 YVERTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             cCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            99987776655322      2378999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...
T Consensus       152 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         152 ARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             CCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            4332 122345678899999999887 8899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-33  Score=298.87  Aligned_cols=232  Identities=24%  Similarity=0.409  Sum_probs=181.2

Q ss_pred             CeecccCCcEEEEEEEcCCC-----------EEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          740 SLIGCGGFGEVFKATLKDGS-----------SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999987433           4677765433322 6778999999999999999999999987 778999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-------cEEEe
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-------EARVS  881 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~  881 (1013)
                      |||+++|+|.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++       .+|++
T Consensus        79 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999975432     478999999999999999999999   999999999999999887       79999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCC--CCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHH
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF--RCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMK  958 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  958 (1013)
                      |||+++....      .....++..|+|||++.+.  .++.++|||||||++|||++ |..||.....  .....+..  
T Consensus       151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~--  220 (259)
T cd05037         151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ--  220 (259)
T ss_pred             CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh--
Confidence            9999986543      1233467789999998876  78999999999999999999 5777765331  11111111  


Q ss_pred             HhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       959 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        ......  .+.                  ...+.+++.+|++.+|.+|||+.|
T Consensus       221 --~~~~~~--~~~------------------~~~~~~li~~~l~~~p~~Rpt~~~  253 (259)
T cd05037         221 --DQHRLP--MPD------------------CAELANLINQCWTYDPTKRPSFRA  253 (259)
T ss_pred             --cCCCCC--CCC------------------chHHHHHHHHHhccChhhCCCHHH
Confidence              000000  000                  024678999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.6e-33  Score=302.72  Aligned_cols=201  Identities=26%  Similarity=0.405  Sum_probs=169.1

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|+..+.||.|++|.||+|++. +++.||+|++....  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999986 68899999875432  22235688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +. ++|.+++....    ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.++....
T Consensus        81 ~~-~~l~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          81 LH-QDLKKFMDASP----LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             cc-cCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            96 68988886432    23488999999999999999999999   999999999999999999999999999876543


Q ss_pred             cCcceeeeeeccCCCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ...  ......++..|+|||++.+.. ++.++|||||||++|||+||+.||....
T Consensus       153 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  205 (284)
T cd07860         153 PVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  205 (284)
T ss_pred             Ccc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            221  122335678899999887644 5889999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=280.24  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=194.5

Q ss_pred             hcCCCCC-CeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEe----CCEE
Q 036815          733 TNGFSAE-SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKI----GEER  805 (1013)
Q Consensus       733 ~~~y~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  805 (1013)
                      +++|++. ++||-|-.|.|..+..+ +++.+|+|++.+     .....+|++.--.. .|||||.++++|+.    ....
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4566663 57999999999999876 688999997743     34556788875444 69999999998864    3456


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCcEEEee
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EMEARVSD  882 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~D  882 (1013)
                      .+|||+|+||.|...+..++.    ..+++.++..|++||..|+.|||+.   +|.||||||+|+|...   +..+||+|
T Consensus       135 LiVmE~meGGeLfsriq~~g~----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGD----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             EeeeecccchHHHHHHHHccc----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            799999999999999986553    4599999999999999999999999   9999999999999965   45689999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      ||+|+.-..   .....+...||.|.|||++...+|+..+|+||+||++|-|++|.+||.....  ..+.--++..+..+
T Consensus       208 fGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~g  282 (400)
T KOG0604|consen  208 FGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTG  282 (400)
T ss_pred             cccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhcc
Confidence            999986432   3345567889999999999999999999999999999999999999986442  11111122333332


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+             .+...+...+.+..+  ++|+.+|+.+|.+|.|++|
T Consensus       283 qy-------------~FP~pEWs~VSe~aK--dlIR~LLkt~PteRlTI~~  318 (400)
T KOG0604|consen  283 QY-------------EFPEPEWSCVSEAAK--DLIRKLLKTEPTERLTIEE  318 (400)
T ss_pred             Cc-------------cCCChhHhHHHHHHH--HHHHHHhcCCchhheeHHH
Confidence            22             222333444555544  9999999999999999864

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.1e-33  Score=302.84  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=188.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHH-HhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMET-LGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++.... .....++..|+.+ ++..+||||+++++++..++..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999986 68999999876432 2233456667665 566689999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |++ |+|.+++.....  ....+++..++.++.|++.||+|||+++  +++||||||+||+++.++.+||+|||.++...
T Consensus        81 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            997 688888764332  2245899999999999999999999852  89999999999999999999999999998653


Q ss_pred             ccCcceeeeeeccCCCccCcccccC----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS----FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...   ......++..|+|||++.+    ..++.++||||+||++|||++|+.||......   ... ...... .....
T Consensus       156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~-~~~~~~-~~~~~  227 (283)
T cd06617         156 DSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQ-LKQVVE-EPSPQ  227 (283)
T ss_pred             ccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHH-HHHHHh-cCCCC
Confidence            211   1223467889999998864    45688999999999999999999998642211   111 111111 10000


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .....       .          ...+.+++.+||..+|++|||++|
T Consensus       228 ~~~~~-------~----------~~~l~~li~~~l~~~p~~Rp~~~~  257 (283)
T cd06617         228 LPAEK-------F----------SPEFQDFVNKCLKKNYKERPNYPE  257 (283)
T ss_pred             CCccc-------c----------CHHHHHHHHHHccCChhhCcCHHH
Confidence            00000       0          012568999999999999999864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-32  Score=299.00  Aligned_cols=245  Identities=24%  Similarity=0.344  Sum_probs=194.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      .|...+.||+|++|.||+|... +++.|++|++........+.+.+|+.++++++||||+++++++..++..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999975 688999998765444445668899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++...       .+++..+..++.|++.|++|||++   +++||||+|+||+++.++.++++|||.+.......
T Consensus       100 ~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648         100 GGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             CCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            99999998641       278899999999999999999999   99999999999999999999999999887554321


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                      .  ......|++.|+|||...+..++.++|||||||++|||++|+.||.....     ......... ........+   
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~-~~~~~~~~~---  238 (285)
T cd06648         170 P--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRD-NLPPKLKNL---  238 (285)
T ss_pred             c--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHh-cCCCCCccc---
Confidence            1  12334688999999999888899999999999999999999999875321     112221111 110000000   


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         ..          ....+.+++.+||+.+|++|||+.|
T Consensus       239 ---~~----------~~~~l~~li~~~l~~~p~~Rpt~~~  265 (285)
T cd06648         239 ---HK----------VSPRLRSFLDRMLVRDPAQRATAAE  265 (285)
T ss_pred             ---cc----------CCHHHHHHHHHHcccChhhCcCHHH
Confidence               00          0113668999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-34  Score=275.90  Aligned_cols=243  Identities=23%  Similarity=0.398  Sum_probs=186.1

Q ss_pred             CCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc-chHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEccc
Q 036815          737 SAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      +....||.|+.|.||+++.+ .|..+|||.+.+.... .-+++...++++..- ++|+||+.+|||..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            44577999999999999987 5788999998765433 345677778776655 48999999999999999999999986


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                       -..+..+..-     ..++++..+-++...++.||.||.+++  +|+|||+||+|||+|+.|++|+||||.+-++-...
T Consensus       175 -~C~ekLlkri-----k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  175 -TCAEKLLKRI-----KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             -HHHHHHHHHh-----cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence             3455555322     234889888999999999999999875  99999999999999999999999999997664322


Q ss_pred             cceeeeeeccCCCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQS---FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      .   .+..+|.+.|||||.+..   ..|+.++||||||+.++|++||+.||.+....-..+.    ....+..  ..+++
T Consensus       247 A---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt----kvln~eP--P~L~~  317 (391)
T KOG0983|consen  247 A---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT----KVLNEEP--PLLPG  317 (391)
T ss_pred             c---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH----HHHhcCC--CCCCc
Confidence            2   244579999999999864   4688899999999999999999999987543322221    1111111  12222


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .     .++++          .+.+++..||+.|+.+||.-
T Consensus       318 ~-----~gFSp----------~F~~fv~~CL~kd~r~RP~Y  343 (391)
T KOG0983|consen  318 H-----MGFSP----------DFQSFVKDCLTKDHRKRPKY  343 (391)
T ss_pred             c-----cCcCH----------HHHHHHHHHhhcCcccCcch
Confidence            1     12222          26789999999999999964

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=309.59  Aligned_cols=204  Identities=30%  Similarity=0.436  Sum_probs=173.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCC------EEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGE------ERL  806 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  806 (1013)
                      -|...+.||+|+||.||+|+++ .|+.||||.+..... ...+..-+|++++++++|+|||+++++-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3556788999999999999965 799999998876443 33466789999999999999999999765433      558


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe--CCCCc--EEEee
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL--DHEME--ARVSD  882 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill--~~~~~--~kl~D  882 (1013)
                      +|||||.||+|+..+.....   ...+++.+.+.++.+++.||.|||++   +||||||||.||++  ..+|+  .||+|
T Consensus        94 lvmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             EEEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence            99999999999999975433   34499999999999999999999999   99999999999998  33343  69999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG  947 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~  947 (1013)
                      ||.|+..+...   .....+||..|.+||++. .+.|+..+|.|||||++|+++||..||......
T Consensus       168 fG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  168 FGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99999876433   566789999999999998 488899999999999999999999999865433

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-32  Score=297.63  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=195.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERLLVY  809 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  809 (1013)
                      +|++.+.||.|+||.||+|.+. +++.||+|.+....  ....+.+..|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4888899999999999999875 67889999875432  2334568889999999999999999998754  45679999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH-----HNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      ||+++++|.+++.....  ....+++..++.++.|+++|++|||     +.   +++|+||||+||+++.++.+|++|||
T Consensus        81 e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             hhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence            99999999999965422  2345899999999999999999999     76   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      ++........  ......+++.|+|||++.+..++.++||||||+++|+|++|+.||....     ...+.. ....+..
T Consensus       156 ~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~-~~~~~~~  227 (265)
T cd08217         156 LAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLAS-KIKEGKF  227 (265)
T ss_pred             ccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHH-HHhcCCC
Confidence            9987654322  1233468899999999998889999999999999999999999997643     111111 1221111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . .+++.                 ....+.+++.+|++.+|++|||++|
T Consensus       228 ~-~~~~~-----------------~~~~~~~l~~~~l~~~p~~Rp~~~~  258 (265)
T cd08217         228 R-RIPYR-----------------YSSELNEVIKSMLNVDPDKRPSTEE  258 (265)
T ss_pred             C-CCccc-----------------cCHHHHHHHHHHccCCcccCCCHHH
Confidence            1 11110                 0123568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.6e-33  Score=298.64  Aligned_cols=249  Identities=22%  Similarity=0.365  Sum_probs=180.6

Q ss_pred             CeecccCCcEEEEEEEcCCC---EEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          740 SLIGCGGFGEVFKATLKDGS---SVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      +.||+|+||.||+|...++.   .+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....|+||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36899999999999865433   45566554322 233567899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      +|.+++......  ....++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++.........
T Consensus        81 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          81 DLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             cHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            999999754321  22367778889999999999999999   9999999999999999999999999998643221111


Q ss_pred             eeeeeeccCCCccCcccccC-------CCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          896 LSVSTLAGTPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      .......++..|+|||++..       ..++.++|||||||++|||++ |..||.....     .+........ .....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~-~~~~~  229 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKD-QQVKL  229 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhh-ccccc
Confidence            12234467889999998753       245789999999999999997 5667754221     1222221211 11122


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .++.+..   ...          .++.+++..|+ .+|++|||++|
T Consensus       230 ~~~~~~~---~~~----------~~~~~l~~~c~-~~P~~Rp~~~~  261 (268)
T cd05086         230 FKPQLEL---PYS----------ERWYEVLQFCW-LSPEKRATAEE  261 (268)
T ss_pred             CCCccCC---CCc----------HHHHHHHHHHh-hCcccCCCHHH
Confidence            2222210   001          12557888999 67999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-33  Score=300.26  Aligned_cols=244  Identities=23%  Similarity=0.381  Sum_probs=192.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc-CccchHHHHHHHHHHhccC---CcceeeeccEEEeCCEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL-SCQGDREFMAEMETLGKIK---HRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .|++.+.||+|+||.||+|.+. +++.||+|.+... ......++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4778899999999999999975 6889999987543 2233456889999999996   999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++...       .+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++++|||.+...
T Consensus        82 e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          82 EYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             ecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            999999999998532       388999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      .....  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......     .+... ....     .
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~-~~~~-----~  218 (277)
T cd06917         152 NQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML-IPKS-----K  218 (277)
T ss_pred             CCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc-cccC-----C
Confidence            54331  2234468889999998865 45688999999999999999999999754321     11110 0000     0


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+.+.   ...         ....+.+++.+|++.||++|||+.|
T Consensus       219 ~~~~~---~~~---------~~~~~~~~i~~~l~~~p~~R~~~~~  251 (277)
T cd06917         219 PPRLE---DNG---------YSKLLREFVAACLDEEPKERLSAEE  251 (277)
T ss_pred             CCCCC---ccc---------CCHHHHHHHHHHcCCCcccCcCHHH
Confidence            01110   000         0123568999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-33  Score=276.47  Aligned_cols=250  Identities=21%  Similarity=0.322  Sum_probs=193.8

Q ss_pred             CeecccCCcEEEEEEE-cCCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          740 SLIGCGGFGEVFKATL-KDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      +.||+|+|+.|--+.. .+|.++|||++.+.......++.+|++++.+. .|+||++++++|+++...|+|||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            6899999999998874 58999999999887777788899999999998 599999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc---EEEeecccceecccc--
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISAL--  892 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~--  892 (1013)
                      ..+++.+..      +++.++.++.++|+.||.|||.+   ||.|||+||+|||-.....   +|||||.++.-+...  
T Consensus       164 LshI~~~~~------F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  164 LSHIQKRKH------FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             HHHHHHhhh------ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            999986543      89999999999999999999999   9999999999999976544   799999987643211  


Q ss_pred             ---CcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC-----ccH----HHHH
Q 036815          893 ---DTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD-----TNL----VGWV  955 (1013)
Q Consensus       893 ---~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~-----~~~----~~~~  955 (1013)
                         .......+..|+..|||||+..     ...|+.++|.||+|||+|-|+.|.+||.+....+     ...    ....
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L  314 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL  314 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence               1122234577888999999864     3368889999999999999999999998754321     011    1111


Q ss_pred             HHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          956 KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       956 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+.++++             .+...+...+.+.  ..+++...+..||..|-+|.+
T Consensus       315 FesIQEGkY-------------eFPdkdWahIS~e--akdlisnLlvrda~~rlsa~~  357 (463)
T KOG0607|consen  315 FESIQEGKY-------------EFPDKDWAHISSE--AKDLISNLLVRDAKQRLSAAQ  357 (463)
T ss_pred             HHHHhccCC-------------cCChhhhHHhhHH--HHHHHHHHHhccHHhhhhhhh
Confidence            122222221             1111222223332  348888889999999988753

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-32  Score=297.78  Aligned_cols=242  Identities=26%  Similarity=0.393  Sum_probs=192.3

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      |++.+.||+|+||.||+|.+. +++.||+|....... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            778899999999999999875 678999997653322 223568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++...       .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.......
T Consensus        86 ~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          86 GGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999998532       378999999999999999999999   99999999999999999999999999987654322


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                      .  ......++..|+|||.+.+..++.++||||+||++|+|++|..||.....     ..+... ...... ..++... 
T Consensus       156 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~~~-~~~~~~~-  225 (277)
T cd06641         156 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFL-IPKNNP-PTLEGNY-  225 (277)
T ss_pred             h--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHH-HhcCCC-CCCCccc-
Confidence            1  12234678899999999888889999999999999999999999864321     111111 111110 0011000 


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                      ...+.+++.+|++.+|.+||+++|
T Consensus       226 ----------------~~~~~~~i~~~l~~~p~~Rp~~~~  249 (277)
T cd06641         226 ----------------SKPLKEFVEACLNKEPSFRPTAKE  249 (277)
T ss_pred             ----------------CHHHHHHHHHHccCChhhCcCHHH
Confidence                            112558899999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-33  Score=301.24  Aligned_cols=252  Identities=28%  Similarity=0.412  Sum_probs=193.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCC------
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGE------  803 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------  803 (1013)
                      ++++|++.+.||+|+||.||+|.++ +++.+++|.+.... ...+.+.+|+++++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            5688999999999999999999986 57889999765433 3456789999999999 7999999999997644      


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..++||||+++++|.+++.....  ....+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+||
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence            48999999999999999864331  123488999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHH
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK  958 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  958 (1013)
                      |.+.......  .......++..|+|||++..     ..++.++||||+||++|+|++|+.||......    ... .. 
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~-  229 (275)
T cd06608         158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----RAL-FK-  229 (275)
T ss_pred             ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----HHH-HH-
Confidence            9997654322  12234568889999998753     34678999999999999999999999643211    111 11 


Q ss_pred             HhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       959 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...........+              .  .....+.+++.+||+.||++|||++|
T Consensus       230 ~~~~~~~~~~~~--------------~--~~~~~~~~li~~~l~~dp~~Rpt~~~  268 (275)
T cd06608         230 IPRNPPPTLKSP--------------E--NWSKKFNDFISECLIKNYEQRPFMEE  268 (275)
T ss_pred             hhccCCCCCCch--------------h--hcCHHHHHHHHHHhhcChhhCcCHHH
Confidence            111100000000              0  00123568999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-33  Score=325.81  Aligned_cols=205  Identities=18%  Similarity=0.265  Sum_probs=160.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcC--CCEEEEEE--------------ee---ccCccchHHHHHHHHHHhccCCcce
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKD--GSSVAIKK--------------LI---RLSCQGDREFMAEMETLGKIKHRNL  792 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni  792 (1013)
                      ..++|++.+.||+|+||+||+|..+.  +..++.|.              +.   .........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34689999999999999999987642  22222220              10   1111223567899999999999999


Q ss_pred             eeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe
Q 036815          793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL  872 (1013)
Q Consensus       793 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  872 (1013)
                      +++++++...+..|+|+|++. +++.+++........ .......+..++.|++.||+|||++   +||||||||+||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            999999999999999999986 577777654322111 1234566788999999999999999   99999999999999


Q ss_pred             CCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          873 DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       873 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      +.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..++.
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            99999999999999876532221 1224578999999999999999999999999999999999876543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=281.07  Aligned_cols=201  Identities=27%  Similarity=0.399  Sum_probs=176.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHH---HHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|...++||+|.||.|.+++.+ .++.+|+|++++.-.....+   -..|-++++..+||.+..+--.|...+..|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            45888999999999999999976 68899999886644433333   356889999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||..||.|.-++..      .+.++++..+.+...|+.||.|||++   +||+||+|.+|.++|.+|++||+|||+++.-
T Consensus       248 eyanGGeLf~HLsr------er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  248 EYANGGELFFHLSR------ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEccCceEeeehhh------hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999988864      34488888899999999999999999   9999999999999999999999999999742


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                        ........+.+|||.|.|||++....|+.++|.|.+||++|||++|+.||...+
T Consensus       319 --I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d  372 (516)
T KOG0690|consen  319 --IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD  372 (516)
T ss_pred             --ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence              233445678899999999999999999999999999999999999999998654

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-32  Score=295.89  Aligned_cols=242  Identities=29%  Similarity=0.440  Sum_probs=180.4

Q ss_pred             CeecccCCcEEEEEEEcC----CCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEE-eCCEEEEEEEccc
Q 036815          740 SLIGCGGFGEVFKATLKD----GSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCK-IGEERLLVYEFMK  813 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  813 (1013)
                      +.||+|+||.||+|.+.+    ...||+|++.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998642    3578999874322 233457888999999999999999999775 4556789999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|+|.+++.....     ..++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          81 HGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            9999999964321     256778889999999999999999   99999999999999999999999999997653211


Q ss_pred             cc--eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcC-CCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          894 TH--LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG-KRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       894 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ..  .......++..|+|||.+.+..++.++|||||||++|||++| .+||....     ......... .+.....  +
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~--~  224 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYLL-QGRRLLQ--P  224 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHh-cCCCCCC--C
Confidence            10  111233456789999999888999999999999999999995 55554321     111221111 1111000  0


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .      ..          ...+.+++.+||+.+|++||++.|
T Consensus       225 ~------~~----------~~~~~~li~~cl~~~p~~Rp~~~~  251 (262)
T cd05058         225 E------YC----------PDPLYEVMLSCWHPKPEMRPTFSE  251 (262)
T ss_pred             C------cC----------CHHHHHHHHHHcCCChhhCCCHHH
Confidence            0      00          013568999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-32  Score=299.89  Aligned_cols=202  Identities=24%  Similarity=0.403  Sum_probs=170.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      +|++.+.||.|++|.||+|++. +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4888999999999999999986 588999998865432 23456778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++ +|.+++.....   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++|||.++.....
T Consensus        81 ~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          81 DK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             Cc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            85 88888864332   23489999999999999999999999   9999999999999999999999999999765332


Q ss_pred             CcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ..  ......++..|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus       154 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         154 VN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             cc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            11  12234568899999988654 56889999999999999999999997654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-32  Score=296.28  Aligned_cols=237  Identities=25%  Similarity=0.336  Sum_probs=188.9

Q ss_pred             ecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      ||.|+||.||+|++. +++.||+|.+.....   ...+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999986 488999998864332   2346789999999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCccee
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS  897 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  897 (1013)
                      .+++....      .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.++......   .
T Consensus        81 ~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~  148 (262)
T cd05572          81 WTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---K  148 (262)
T ss_pred             HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---c
Confidence            99996532      278899999999999999999998   99999999999999999999999999998764322   1


Q ss_pred             eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccC
Q 036815          898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK  977 (1013)
Q Consensus       898 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  977 (1013)
                      .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......   ..+............ ..+..      
T Consensus       149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~~------  218 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYNDILKGNGKL-EFPNY------  218 (262)
T ss_pred             cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHHHHhccCCCC-CCCcc------
Confidence            22346788999999998888999999999999999999999999765421   122222111100000 00000      


Q ss_pred             CCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          978 GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       978 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                       .          ...+.+++.+||+.+|++|||+
T Consensus       219 -~----------~~~~~~~i~~~l~~~p~~R~~~  241 (262)
T cd05572         219 -I----------DKAAKDLIKQLLRRNPEERLGN  241 (262)
T ss_pred             -c----------CHHHHHHHHHHccCChhhCcCC
Confidence             0          1135689999999999999993

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-32  Score=295.77  Aligned_cols=240  Identities=28%  Similarity=0.469  Sum_probs=188.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||.||+|.. .++.||+|++...  .....+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4589999999999999999975 5788999987432  2346788999999999999999999998654 4789999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++.....    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++..... 
T Consensus        82 ~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          82 KGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             CCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999999965432    2478999999999999999999999   9999999999999999999999999998764321 


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                          ......+..|+|||.+.+..++.++|||||||++|||++ |+.||.....     .++... ...+..... .   
T Consensus       154 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~-~~~~~~~~~-~---  219 (254)
T cd05083         154 ----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKEC-VEKGYRMEP-P---  219 (254)
T ss_pred             ----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHH-HhCCCCCCC-C---
Confidence                112234567999999988899999999999999999998 9999875432     111111 111111110 0   


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ...          ...+.+++.+|++.+|++||++++
T Consensus       220 ----~~~----------~~~~~~li~~~l~~~p~~Rp~~~~  246 (254)
T cd05083         220 ----EGC----------PADVYVLMTSCWETEPKKRPSFHK  246 (254)
T ss_pred             ----CcC----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence                000          123568999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-32  Score=293.77  Aligned_cols=246  Identities=32%  Similarity=0.459  Sum_probs=198.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      +|++.+.||+|++|.||+|.+. +++.+++|++..........+.+|++++++++|++++++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999986 688999998866544456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++....     ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          81 GGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             CCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            999999986532     3489999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                      .   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..     ........ ........+.. 
T Consensus       153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~~~~~~-  222 (253)
T cd05122         153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIAT-NGPPGLRNPEK-  222 (253)
T ss_pred             c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHh-cCCCCcCcccc-
Confidence            1   23456888999999998888999999999999999999999998754311     11111111 11111100000 


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                     -...+.+++.+|++.||++|||++|
T Consensus       223 ---------------~~~~~~~~i~~~l~~~p~~R~t~~~  247 (253)
T cd05122         223 ---------------WSDEFKDFLKKCLQKNPEKRPTAEQ  247 (253)
T ss_pred             ---------------cCHHHHHHHHHHccCChhhCCCHHH
Confidence                           0113568999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-32  Score=300.92  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=198.6

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ..++.|++.+.||+|+||.||+|.++ +++.|++|++..... ..+.+.+|++++++++|+|++++++++..+...++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34667889999999999999999987 688999998865433 4567889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++....     ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        95 e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          95 EYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             eccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            9999999999997543     2489999999999999999999998   9999999999999999999999999998755


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .....  ......++..|+|||++.+..++.++|||||||++|+|++|+.||......     ........ .......+
T Consensus       167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~~~  238 (286)
T cd06614         167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFLITT-KGIPPLKN  238 (286)
T ss_pred             ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-cCCCCCcc
Confidence            43211  122345788999999998888999999999999999999999998643211     11111111 11101000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.      ..          ...+.+++.+|++.+|.+|||+.|
T Consensus       239 ~~------~~----------~~~l~~li~~~l~~~p~~Rpt~~~  266 (286)
T cd06614         239 PE------KW----------SPEFKDFLNKCLVKDPEKRPSAEE  266 (286)
T ss_pred             hh------hC----------CHHHHHHHHHHhccChhhCcCHHH
Confidence            00      00          012568999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-35  Score=337.26  Aligned_cols=248  Identities=29%  Similarity=0.421  Sum_probs=195.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeec--cCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +-+|+....||.|.||.||-|... +|+-.|+|.+.-  ........+.+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            457888899999999999999975 578888987642  22233456789999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |||++|+|.+.+...+      ..++.....+..|++.|++|||++   |||||||||.||+++.+|.+|.+|||.|..+
T Consensus      1314 EyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999996433      367777788899999999999999   9999999999999999999999999999987


Q ss_pred             cccCcc--eeeeeeccCCCccCcccccCC---CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH-HHhcCc
Q 036815          890 SALDTH--LSVSTLAGTPGYVPPEYYQSF---RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM-KVREGK  963 (1013)
Q Consensus       890 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~  963 (1013)
                      ......  .......||+.|||||++.+.   ....++||||+|||+.||+||++||..-+.      +|..+ ++..+.
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYHVAAGH 1458 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhHHhccC
Confidence            653211  123357899999999999754   345689999999999999999999986442      23322 222222


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .... +..+               ...  -.+++.+||+.||++|.++.|
T Consensus      1459 ~Pq~-P~~l---------------s~~--g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1459 KPQI-PERL---------------SSE--GRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred             CCCC-chhh---------------hHh--HHHHHHHHHhcCchhhhHHHH
Confidence            2211 1111               111  238999999999999998743

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-32  Score=292.26  Aligned_cols=244  Identities=25%  Similarity=0.437  Sum_probs=196.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|++|.||+|+.. +++.|++|.+.....  .....+.+|++++++++|||++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788999999999999999876 578999998865543  3346789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++...      ..+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          81 AENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             CCCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            9999999998643      2389999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ....  .....++..|+|||...+..++.++||||+|+++|+|++|+.||....   .....|...   .... ..+++.
T Consensus       152 ~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---~~~~~~~~~---~~~~-~~~~~~  222 (254)
T cd06627         152 VSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN---PMAALFRIV---QDDH-PPLPEG  222 (254)
T ss_pred             Cccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHh---ccCC-CCCCCC
Confidence            3321  233567889999999988888999999999999999999999987532   111111111   0100 011110


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .                 ...+.+++.+||+.+|++|||+.|
T Consensus       223 ~-----------------~~~~~~~i~~~l~~~p~~R~~~~~  247 (254)
T cd06627         223 I-----------------SPELKDFLMQCFQKDPNLRPTAKQ  247 (254)
T ss_pred             C-----------------CHHHHHHHHHHHhCChhhCcCHHH
Confidence            0                 112568999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.3e-32  Score=294.12  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=198.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeC--CEEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EERLLVY  809 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  809 (1013)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999987 688999998755432  3356789999999999999999999999888  8899999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++....      .+++..++.++.|+++|++|||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          81 EYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             EecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            9999999999997543      489999999999999999999998   9999999999999999999999999999877


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .............++..|+|||.+.+..++.++||||+|+++|+|++|..||.....    ....... .........+.
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~~~  226 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYK-IGSSGEPPEIP  226 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHh-ccccCCCcCCC
Confidence            543321112345688899999999888899999999999999999999999976541    1111111 11101111111


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...                 ...+.+++.+|++.||++||++.|
T Consensus       227 ~~~-----------------~~~l~~~i~~~l~~~p~~Rp~~~~  253 (260)
T cd06606         227 EHL-----------------SEEAKDFLRKCLRRDPKKRPTADE  253 (260)
T ss_pred             ccc-----------------CHHHHHHHHHhCcCChhhCCCHHH
Confidence            100                 123668999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.5e-33  Score=305.12  Aligned_cols=201  Identities=28%  Similarity=0.354  Sum_probs=167.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeC--CEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIG--EERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  807 (1013)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++......  ....+.+|++++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357999999999999999999986 5899999987543222  123467899999999999999999998754  56899


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||++ ++|.+++....     ..+++..+..++.|+++|++|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus        86 v~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             EEecCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceee
Confidence            999997 48888886432     3489999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .......  ......++..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         157 TYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             ecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            7654321  1222345788999999865 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.8e-33  Score=312.47  Aligned_cols=199  Identities=26%  Similarity=0.368  Sum_probs=168.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeC------
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG------  802 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  802 (1013)
                      ..++|++.+.||+|+||.||+|++. +++.||+|.+...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3578999999999999999999976 6889999987532  222335677899999999999999999988643      


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      ...|+||||+. ++|.+.+...        +++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            35699999997 5888877421        78888999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ||+++......   ......++..|+|||++.+..++.++||||+||++|+|++|+.||...+
T Consensus       162 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         162 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             CccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            99998654321   1223457889999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=297.06  Aligned_cols=199  Identities=26%  Similarity=0.379  Sum_probs=168.4

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      |++.+.||.|++|.||+|.+. +|+.||+|++....  ....+.+.+|++++++++|||++++++++.+++..|+||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677899999999999999976 68999999875432  222356888999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      + ++|.+++.....    ..+++..+..++.|+++||+|||++   +++||||+|+||+++.++.++|+|||.++.....
T Consensus        81 ~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  152 (283)
T cd07835          81 D-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP  152 (283)
T ss_pred             C-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence            6 689999865432    3489999999999999999999999   9999999999999999999999999999765322


Q ss_pred             CcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ..  ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus       153 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         153 VR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             cc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11  12233568899999987654 5788999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-32  Score=301.47  Aligned_cols=201  Identities=26%  Similarity=0.346  Sum_probs=169.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeC--CEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIG--EERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++......  ....+.+|++++++++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46889999999999999999987 5788999988543222  234567899999999999999999998877  889999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||++ ++|.+++....     ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.++.
T Consensus        85 ~e~~~-~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~  155 (293)
T cd07843          85 MEYVE-HDLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLARE  155 (293)
T ss_pred             ehhcC-cCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceee
Confidence            99998 59998886432     2489999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ......  ......+++.|+|||.+.+. .++.++||||+||++|||++|..||....
T Consensus       156 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         156 YGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             ccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            654321  12334578899999998754 46889999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.9e-32  Score=298.37  Aligned_cols=250  Identities=19%  Similarity=0.251  Sum_probs=176.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCC----CEEEEEEeeccCccc--h---------HHHHHHHHHHhccCCcceeeecc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDG----SSVAIKKLIRLSCQG--D---------REFMAEMETLGKIKHRNLVPLLG  797 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l~~  797 (1013)
                      .++|.+.+.||+|+||+||+|.+.++    ..+|+|.........  +         .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36799999999999999999997644    345555432111110  0         11223334456678999999999


Q ss_pred             EEEeCC----EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          798 YCKIGE----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       798 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ++....    ..++++|++. .++.+.+....      ..++..+..++.|+++||+|||+.   +|+||||||+||+++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            765543    3478888775 46666654321      146778899999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcc-----eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC
Q 036815          874 HEMEARVSDFGMARLISALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD  948 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~  948 (1013)
                      .++.++|+|||+|+.+......     .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999876432211     11223469999999999999999999999999999999999999998653222


Q ss_pred             ccH----HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          949 TNL----VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       949 ~~~----~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...    .++... ...+...      .    ...          ...+.+++..|++.+|++||+++|
T Consensus       241 ~~~~~~~~~~~~~-~~~~~~~------~----~~~----------~~~~~~~~~~~~~~~~~~rp~~~~  288 (294)
T PHA02882        241 NLIHAAKCDFIKR-LHEGKIK------I----KNA----------NKFIYDFIECVTKLSYEEKPDYDA  288 (294)
T ss_pred             HHHHHhHHHHHHH-hhhhhhc------c----CCC----------CHHHHHHHHHHHhCCCCCCCCHHH
Confidence            111    111111 1111000      0    000          123668999999999999999864

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.6e-32  Score=301.23  Aligned_cols=242  Identities=27%  Similarity=0.401  Sum_probs=189.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .+|+..+.||+|+||.||+|... +++.||+|++......   ..+++.+|+++++.++||||+++++++.+++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            46889999999999999999976 6889999987543322   2356889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++ |++.+++....     ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++...
T Consensus        95 e~~~-g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          95 EYCL-GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             HhhC-CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence            9998 57777765322     2388999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccCcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...      ....++..|+|||++.   ...++.++||||||+++|||++|+.||.....     ...... ........
T Consensus       166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----~~~~~~-~~~~~~~~  233 (307)
T cd06607         166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYH-IAQNDSPT  233 (307)
T ss_pred             CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----HHHHHH-HhcCCCCC
Confidence            321      2345788999999874   45688899999999999999999999865321     111111 11110000


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . .+.              .  ....+.+++.+||+.||++||++.|
T Consensus       234 ~-~~~--------------~--~~~~~~~li~~~l~~~p~~Rp~~~~  263 (307)
T cd06607         234 L-SSN--------------D--WSDYFRNFVDSCLQKIPQDRPSSEE  263 (307)
T ss_pred             C-Cch--------------h--hCHHHHHHHHHHhcCChhhCcCHHH
Confidence            0 000              0  0123668999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.3e-35  Score=315.66  Aligned_cols=365  Identities=27%  Similarity=0.380  Sum_probs=242.1

Q ss_pred             CCCCCCEeeCcCCccc-CcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCC
Q 036815          147 QLSSLQRLDLSNNHIT-GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL  225 (1013)
Q Consensus       147 ~l~~L~~L~Ls~n~l~-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  225 (1013)
                      -++-.+-.|+++|.++ +..|...- .+++++.|.|.+.++. .+|..++.+.+|+.|.+++|++. .+..+ +..++.|
T Consensus         5 VLpFVrGvDfsgNDFsg~~FP~~v~-qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGE-Ls~Lp~L   80 (1255)
T KOG0444|consen    5 VLPFVRGVDFSGNDFSGDRFPHDVE-QMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGE-LSDLPRL   80 (1255)
T ss_pred             ccceeecccccCCcCCCCcCchhHH-HhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhh-hccchhh
Confidence            3455667788888887 45565553 4578888888888887 67788888888888888888876 33333 4667888


Q ss_pred             cEEEcccccCCC-cCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEee
Q 036815          226 ESLILSNNMISG-SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLS  304 (1013)
Q Consensus       226 ~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls  304 (1013)
                      +.+.+..|++.. -+|..+..+..|+.|||++|+++ ..|..+ ..-+++-.|+|++|+|..+.-..|-+++.|-+||||
T Consensus        81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~L-E~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS  158 (1255)
T KOG0444|consen   81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNL-EYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLS  158 (1255)
T ss_pred             HHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhh-hhhcCcEEEEcccCccccCCchHHHhhHhHhhhccc
Confidence            888888887754 36777778888888888888887 555443 445667778888888775544556677778888888


Q ss_pred             CCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccc-ccCchhhcCCCCCCeEEecCCccCCC
Q 036815          305 LNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS-GEIPAELFSCSNLEWISLTGNELTGQ  383 (1013)
Q Consensus       305 ~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~  383 (1013)
                      +|++. .+|..+.+|..|+.|.+++|.+...--..+..|++|+.|.+++.+=+ ..+|.++..+.+|..+|+|.|.+. .
T Consensus       159 ~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~  236 (1255)
T KOG0444|consen  159 NNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-I  236 (1255)
T ss_pred             cchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-c
Confidence            88877 66667777777777777777665544445556666666666665532 246666666666666666666666 6


Q ss_pred             CChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCC
Q 036815          384 IPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS  463 (1013)
Q Consensus       384 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (1013)
                      +|+.+-++++|+.|+|++|+++ .+....+...+|++|+||+|+|+ .+|..+.                          
T Consensus       237 vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avc--------------------------  288 (1255)
T KOG0444|consen  237 VPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVC--------------------------  288 (1255)
T ss_pred             chHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHh--------------------------
Confidence            6666666666666666666666 45555555566666666666665 3333322                          


Q ss_pred             ccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCccc-ccCChhhhCCCCCcEEecCCC
Q 036815          464 CKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFR-GKIPDEIGDMIALQVLELAHN  542 (1013)
Q Consensus       464 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~-g~iP~~i~~l~~L~~L~L~~n  542 (1013)
                                                                .+++|+.|++.+|+++ .-||+.||.|.+|.++..++|
T Consensus       289 ------------------------------------------KL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN  326 (1255)
T KOG0444|consen  289 ------------------------------------------KLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANN  326 (1255)
T ss_pred             ------------------------------------------hhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcc
Confidence                                                      2334555666666543 126666666666666666666


Q ss_pred             ccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCC
Q 036815          543 QLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNE  591 (1013)
Q Consensus       543 ~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~  591 (1013)
                      .|. -+|+.++.+..|+.|.|++|+|. ++|+.+.-|+.|..|||..|.
T Consensus       327 ~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  327 KLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             ccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence            666 56666666666666666666665 566666666666666666664

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.9e-32  Score=299.37  Aligned_cols=240  Identities=25%  Similarity=0.388  Sum_probs=189.6

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCHH
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLE  818 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  818 (1013)
                      .+||+|+||.||+|..+ +++.||+|++..........+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999885 68899999875544445567889999999999999999999999999999999999999999


Q ss_pred             HHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceee
Q 036815          819 EVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV  898 (1013)
Q Consensus       819 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  898 (1013)
                      +++...       .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+........  ..
T Consensus       106 ~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~  173 (292)
T cd06657         106 DIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR  173 (292)
T ss_pred             HHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cc
Confidence            987432       278899999999999999999999   999999999999999999999999999876543221  12


Q ss_pred             eeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCC
Q 036815          899 STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKG  978 (1013)
Q Consensus       899 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  978 (1013)
                      ....+++.|+|||++.+..++.++||||+||++|+|++|..||.....     ..........      .++..... ..
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~~~~~~~~~~------~~~~~~~~-~~  241 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRDN------LPPKLKNL-HK  241 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhh------CCcccCCc-cc
Confidence            335678899999999888889999999999999999999999875321     1111111100      00000000 00


Q ss_pred             CChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          979 TDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       979 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .          ...+.+++.+||+.||.+||++.|
T Consensus       242 ~----------~~~l~~li~~~l~~~P~~R~~~~~  266 (292)
T cd06657         242 V----------SPSLKGFLDRLLVRDPAQRATAAE  266 (292)
T ss_pred             C----------CHHHHHHHHHHHhCCcccCcCHHH
Confidence            0          112458899999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.1e-32  Score=292.77  Aligned_cols=246  Identities=27%  Similarity=0.378  Sum_probs=194.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|+||.||+|..+ ++..||+|.+....  ....+.+.+|++++++++|+||+++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999986 57889999875432  23345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc-EEEeecccceecc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME-ARVSDFGMARLIS  890 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~a~~~~  890 (1013)
                      +++++|.+++.....    ..+++..+..++.|+++|++|||+.   +++|+||||+||++++++. +|++|||.+....
T Consensus        81 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          81 CDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             CCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            999999999864322    2378999999999999999999999   9999999999999998854 6999999997664


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ....  ......|++.|+|||+..+..++.++|||||||++|||++|..||....     ..+++...... ... ...+
T Consensus       154 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~-~~~-~~~~  224 (257)
T cd08225         154 DSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQG-YFA-PISP  224 (257)
T ss_pred             CCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcc-cCC-CCCC
Confidence            3221  1223468889999999988889999999999999999999999986432     22233222211 110 0111


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..       +          ..+.+++.+|++.+|++|||++|
T Consensus       225 ~~-------~----------~~~~~~i~~~l~~~p~~Rpt~~~  250 (257)
T cd08225         225 NF-------S----------RDLRSLISQLFKVSPRDRPSITS  250 (257)
T ss_pred             CC-------C----------HHHHHHHHHHhccChhhCcCHHH
Confidence            00       0          12568899999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.5e-32  Score=295.69  Aligned_cols=246  Identities=23%  Similarity=0.287  Sum_probs=190.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccCc----cchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLSC----QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  805 (1013)
                      +|++.+.||+|+||.||+|+..    +|+.||+|.+.....    ...+.+.+|+.+++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788999999999999999873    688999998754321    2235678899999999 599999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      |+||||+++++|.+++....      .+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.+||+|||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  151 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  151 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcc
Confidence            99999999999999986432      378889999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCC--CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSF--RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      ++....... .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...... ....++.........
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~  229 (290)
T cd05613         152 SKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSEP  229 (290)
T ss_pred             ceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccCC
Confidence            986543221 112235688899999998753  4678999999999999999999999743221 122222222111111


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .   .++..                 ...+.+++.+|++.||++||+.
T Consensus       230 ~---~~~~~-----------------~~~~~~ll~~~l~~~p~~R~~~  257 (290)
T cd05613         230 P---YPQEM-----------------SALAKDIIQRLLMKDPKKRLGC  257 (290)
T ss_pred             C---CCccC-----------------CHHHHHHHHHHhcCCHHHhcCC
Confidence            0   00000                 0124589999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.6e-32  Score=295.32  Aligned_cols=235  Identities=24%  Similarity=0.320  Sum_probs=178.4

Q ss_pred             eecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhc---cCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          741 LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGK---IKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       741 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      .||+|+||.||+|.+. +++.||+|.+.+....   ....+.+|..+++.   .+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999986 5789999987543221   12334455444443   479999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||++.......
T Consensus        81 ~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          81 GGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            999999986432      389999999999999999999999   99999999999999999999999999987553321


Q ss_pred             cceeeeeeccCCCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                          .....|+..|+|||.+. +..++.++||||+||++|||++|..||........  ..........   ...+++..
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~---~~~~~~~~  222 (279)
T cd05633         152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTV---NVELPDSF  222 (279)
T ss_pred             ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhcC---CcCCcccc
Confidence                12346899999999986 45688999999999999999999999976432221  1111111100   00011100


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                                       ...+.+++.+||+.||++||+
T Consensus       223 -----------------~~~~~~li~~~l~~~p~~R~~  243 (279)
T cd05633         223 -----------------SPELKSLLEGLLQRDVSKRLG  243 (279)
T ss_pred             -----------------CHHHHHHHHHHhcCCHHHhcC
Confidence                             113568899999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-32  Score=292.74  Aligned_cols=236  Identities=23%  Similarity=0.260  Sum_probs=181.7

Q ss_pred             CeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---hHHHHHHHHHH-hccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---DREFMAEMETL-GKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|... +++.||+|.+.+.....   ...+..|..++ ...+|+|++++++++..++..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999985 57899999875432211   22344555544 445899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      ++|.+++....      .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+++....   
T Consensus        82 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---  149 (260)
T cd05611          82 GDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---  149 (260)
T ss_pred             CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence            99999986432      378899999999999999999999   999999999999999999999999999875432   


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-cCccccccChhhh
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-EGKQMEVIDPELL  973 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~  973 (1013)
                         .....++..|+|||.+.+..++.++||||+|+++|||++|..||.....     ......... .........+   
T Consensus       150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~---  218 (260)
T cd05611         150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRINWPEEVKE---  218 (260)
T ss_pred             ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcccCCCCcccc---
Confidence               1234578899999999888889999999999999999999999975332     111111111 1000000000   


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                          ..          ...+.+++.+||+.+|++|||+.
T Consensus       219 ----~~----------~~~~~~~i~~~l~~~p~~R~~~~  243 (260)
T cd05611         219 ----FC----------SPEAVDLINRLLCMDPAKRLGAN  243 (260)
T ss_pred             ----cC----------CHHHHHHHHHHccCCHHHccCCC
Confidence                00          11256899999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5e-32  Score=297.52  Aligned_cols=204  Identities=25%  Similarity=0.335  Sum_probs=167.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccC-CcceeeeccEEEeCCE-----
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEE-----  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  804 (1013)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....  .....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999986 688999998754322  22356888999999995 6999999999877655     


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-CCcEEEeec
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-EMEARVSDF  883 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df  883 (1013)
                      .|+||||+++ ++.+++...... ....+++..++.++.||+.||+|||++   +|+||||||+||+++. ++.+||+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence            7999999995 898888654322 134589999999999999999999999   9999999999999998 889999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |.++.+.....  ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus       156 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         156 GLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             ccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99986533211  1123356788999998765 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-32  Score=291.28  Aligned_cols=247  Identities=23%  Similarity=0.368  Sum_probs=190.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-----ccchHHHHHHHHHHhccCCcceeeeccEEEeC--CEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-----CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  805 (1013)
                      .+|++.+.||+|+||.||+|.+. +++.||+|.+....     ......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46899999999999999999976 58899999874321     12235688999999999999999999998764  467


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++|+||+++++|.+++....      .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~  152 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA  152 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccc
Confidence            89999999999999986432      278888999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCc-ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          886 ARLISALDT-HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       886 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      ++....... ........++..|+|||++.+..++.++|||||||++|++++|+.||.....    ... +...... ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~-~~~~~~~-~~  226 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAA-IFKIATQ-PT  226 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHH-HHHHHcC-CC
Confidence            986532111 1112234688899999999988899999999999999999999999875321    111 1111111 11


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+++.+                 ...+.+++.+|++ +|.+|||+.+
T Consensus       227 ~~~~p~~~-----------------~~~~~~~i~~~l~-~~~~r~~~~~  257 (264)
T cd06653         227 KPMLPDGV-----------------SDACRDFLKQIFV-EEKRRPTAEF  257 (264)
T ss_pred             CCCCCccc-----------------CHHHHHHHHHHhc-CcccCccHHH
Confidence            11111111                 0125689999999 5799999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=307.39  Aligned_cols=201  Identities=27%  Similarity=0.429  Sum_probs=167.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeC-----CEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG-----EER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  805 (1013)
                      +++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999875 68899999875432 22345678899999999999999999987654     357


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      |+|+||++ +++.+++..       ..+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          84 YIVQELME-TDLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             EEEehhcc-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            99999997 488887753       2388999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcce-eeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          886 ARLISALDTHL-SVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       886 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ++......... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            98754322211 1123467889999998654 56889999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6e-32  Score=295.62  Aligned_cols=246  Identities=23%  Similarity=0.292  Sum_probs=190.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccC----ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLS----CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  805 (1013)
                      +|++.+.||+|+||.||+|+..    +++.||+|.+.+..    ....+.+.+|++++.++ +||+|+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999853    56789999876432    12235678899999999 599999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||+++++|.+++...      ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++++|||+
T Consensus        81 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~  151 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGL  151 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcc
Confidence            9999999999999998642      2378899999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCCC--CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSFR--CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-  962 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  962 (1013)
                      ++........ ......++..|+|||.+.+..  .+.++||||||+++|||++|..||...... ....++.+...... 
T Consensus       152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~  229 (288)
T cd05583         152 SKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKP  229 (288)
T ss_pred             cccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHccCC
Confidence            8765432221 122345788999999987655  788999999999999999999998643211 11122222211110 


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      .....++                     ..+.+++.+||+.||++|||+.
T Consensus       230 ~~~~~~~---------------------~~l~~li~~~l~~~p~~R~t~~  258 (288)
T cd05583         230 PFPKTMS---------------------AEARDFIQKLLEKDPKKRLGAN  258 (288)
T ss_pred             CCCcccC---------------------HHHHHHHHHHhcCCHhhccCcc
Confidence            0000011                     1245889999999999999975

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.4e-32  Score=301.25  Aligned_cols=203  Identities=29%  Similarity=0.430  Sum_probs=166.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCC------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGE------  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  803 (1013)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....  .....+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999986 688999998754322  22345678999999999999999999886643      


Q ss_pred             --EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEe
Q 036815          804 --ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVS  881 (1013)
Q Consensus       804 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  881 (1013)
                        ..++||||++ +++.+++....     ..+++.+++.++.|++.||+|||++   +++|+||||+||+++.++.+||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence              4599999997 48888875432     2389999999999999999999999   99999999999999999999999


Q ss_pred             ecccceeccccCcc--eeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          882 DFGMARLISALDTH--LSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |||.+.........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            99999866432211  112234577889999988664 4688999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-32  Score=296.48  Aligned_cols=200  Identities=30%  Similarity=0.422  Sum_probs=169.1

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC--CEEEEEEE
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EERLLVYE  810 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  810 (1013)
                      |++.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677899999999999999987 47899999886543  23345688999999999999999999999887  88999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++ +|.+++....     ..+++..++.++.|+++|++|||+.   +++|+||+|+||++++++.+|++|||.+....
T Consensus        81 ~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~  151 (287)
T cd07840          81 YMDH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT  151 (287)
T ss_pred             cccc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence            9984 8888886432     3489999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      .... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       152 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         152 KRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             CCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            4321 11223456788999998764 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.2e-32  Score=297.83  Aligned_cols=201  Identities=22%  Similarity=0.348  Sum_probs=166.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|++|.||+|+++ +++.||+|++.....  ...+.+.+|++++++++||||+++++++.++...|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46899999999999999999986 688999998754322  223568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-CCcEEEeecccceec
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-EMEARVSDFGMARLI  889 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~  889 (1013)
                      |++ +++.+++.....    ..+++..+..++.||+.||+|||++   +++||||+|+||+++. ++.+||+|||++...
T Consensus        82 ~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             ccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            997 588887754322    2357888889999999999999999   9999999999999985 567999999999765


Q ss_pred             cccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .....  ......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...
T Consensus       154 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        154 GIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             CCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            43211  1223456789999998866 45788999999999999999999999754

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.8e-32  Score=289.37  Aligned_cols=248  Identities=24%  Similarity=0.384  Sum_probs=199.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|+||.||+|.+. +++.|++|++.....  .....+.+|++++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888899999999999999986 588999998865433  3456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++.....  ....+++..+..++.+++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          81 ADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             cCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            999999999976432  124589999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ..  .......+++.|+|||...+..++.++||||+|+++|+|++|+.||...+.     ......... ... ..+...
T Consensus       156 ~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~-~~~~~~  226 (258)
T cd08215         156 TV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILK-GQY-PPIPSQ  226 (258)
T ss_pred             Cc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhc-CCC-CCCCCC
Confidence            32  122345688899999999888899999999999999999999999875431     112221111 111 111100


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             .          ...+.+++.+||..+|++|||+.|
T Consensus       227 -------~----------~~~~~~~i~~~l~~~p~~Rp~~~~  251 (258)
T cd08215         227 -------Y----------SSELRNLVSSLLQKDPEERPSIAQ  251 (258)
T ss_pred             -------C----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence                   0          113568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.4e-32  Score=298.86  Aligned_cols=244  Identities=26%  Similarity=0.396  Sum_probs=198.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc--hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ...|.+.+.||+|.|+.|..|++. ++..||+|.+.+..-..  .+.+.+|+++|..++|||||+++.+.......|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            456899999999999999999976 68999999876543322  345889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+.+|.+.+++.....      ..+..+..++.|+..|++|+|++   .|||||||++||+++.+.++||+|||++..+
T Consensus       135 eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence            99999999999987654      44577888999999999999999   9999999999999999999999999999887


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ..   ........|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++........      ....++..  +
T Consensus       206 ~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------rvl~gk~r--I  274 (596)
T KOG0586|consen  206 DY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------RVLRGKYR--I  274 (596)
T ss_pred             cc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------hheeeeec--c
Confidence            63   333456789999999999998776 578999999999999999999999765432110      00000000  0


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.       ..+          ..+-+++++++-.+|.+|++++|
T Consensus       275 p~-------~ms----------~dce~lLrk~lvl~Pskr~~~dq  302 (596)
T KOG0586|consen  275 PF-------YMS----------CDCEDLLRKFLVLNPSKRGPCDQ  302 (596)
T ss_pred             cc-------eee----------chhHHHHHHhhccCccccCCHHH
Confidence            00       000          01448899999999999999875

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=6.5e-32  Score=294.60  Aligned_cols=197  Identities=27%  Similarity=0.349  Sum_probs=163.6

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccC-CcceeeeccEEEeC--CEEEEEEE
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIK-HRNLVPLLGYCKIG--EERLLVYE  810 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  810 (1013)
                      |++.+.||+|+||.||+|... +++.||+|++.... ........+|+.++.++. |+|++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            677889999999999999976 68899999875432 222334557888898885 99999999999887  88999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |++ +++.+.+....     ..+++..+..++.|++.||+|||+.   +++||||||+||+++. +.+||+|||.++...
T Consensus        81 ~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          81 LMD-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             cCC-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            998 58888876432     2489999999999999999999999   9999999999999999 999999999998664


Q ss_pred             ccCcceeeeeeccCCCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ....   .....++..|+|||++. +..++.++||||+||++|||++|..||...+
T Consensus       151 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         151 SKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             cCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence            3222   12345788999999764 4567889999999999999999999997643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=5.7e-32  Score=294.80  Aligned_cols=243  Identities=24%  Similarity=0.332  Sum_probs=195.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999986 68899999875422   223456889999999998 99999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++..
T Consensus        81 ~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~  151 (280)
T cd05581          81 LEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKV  151 (280)
T ss_pred             EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccc
Confidence            99999999999996532      489999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcc------------------eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCcc
Q 036815          889 ISALDTH------------------LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN  950 (1013)
Q Consensus       889 ~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~  950 (1013)
                      .......                  .......++..|+|||+..+..++.++||||+|+++|++++|+.||.....    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----  227 (280)
T cd05581         152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----  227 (280)
T ss_pred             cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----
Confidence            6432211                  122334578899999999888899999999999999999999999975431    


Q ss_pred             HHHHHHHHHh-cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          951 LVGWVKMKVR-EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       951 ~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      . ........ .......+                     ...+.+++.+||+.+|++|||+
T Consensus       228 ~-~~~~~~~~~~~~~~~~~---------------------~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         228 Y-LTFQKILKLEYSFPPNF---------------------PPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             H-HHHHHHHhcCCCCCCcc---------------------CHHHHHHHHHHhcCCHhhCCCc
Confidence            1 11111111 00111111                     1125689999999999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=250.23  Aligned_cols=201  Identities=26%  Similarity=0.373  Sum_probs=169.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|...++||+|.||+||+|+.+ +++.||+|++.-.  +........+|+.+++.++|+|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566688999999999999976 4788999988543  233356788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      |. .+|..+......     .++.+.++.++.|+++|+.+.|++   ++.|||+||.|.+|+.+|+.|++|||+|+.++-
T Consensus        83 cd-qdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             hh-HHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            98 588888764432     278889999999999999999999   999999999999999999999999999998764


Q ss_pred             cCcceeeeeeccCCCccCcccccCCC-CCccchhHhHHHHHHHHHc-CCCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLT-GKRPTDKDDF  946 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt-g~~pf~~~~~  946 (1013)
                      .-  ...+....|..|++|.++.+.. |++..|+||.||++.|+.. |++.|.+.+.
T Consensus       154 pv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv  208 (292)
T KOG0662|consen  154 PV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV  208 (292)
T ss_pred             ce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence            22  2234456789999999988764 7889999999999999998 6666766543

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=1.8e-32  Score=299.81  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=186.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|+..+.||+|+||.||++.+. +++.||+|++..... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4566788999999999999986 578999998764332 33456889999999996 99999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +. +++.++...... .....+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~-~~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MD-ISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cc-CCHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            87 455554321100 1123489999999999999999999973  2899999999999999999999999999976543


Q ss_pred             cCcceeeeeeccCCCccCcccccCC---CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSF---RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ...   .....++..|+|||++.+.   .++.++||||+||++|||++|+.||....    ...+....... +.     
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~-~~-----  227 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVK-GD-----  227 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcC-CC-----
Confidence            221   1233578899999998766   68899999999999999999999987532    11111111111 00     


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+.+.   ....      ......+.+++.+|++.||++|||++|
T Consensus       228 ~~~~~---~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~  263 (288)
T cd06616         228 PPILS---NSEE------REFSPSFVNFINLCLIKDESKRPKYKE  263 (288)
T ss_pred             CCcCC---CcCC------CccCHHHHHHHHHHccCChhhCcCHHH
Confidence            01110   0000      001123668999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=8e-32  Score=297.01  Aligned_cols=204  Identities=30%  Similarity=0.414  Sum_probs=168.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCC----
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE----  803 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  803 (1013)
                      ...++|++.+.||+|+||.||+|.++ +++.||+|++....  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999986 57899999885432  223356788999999999999999999987654    


Q ss_pred             ------EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc
Q 036815          804 ------ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME  877 (1013)
Q Consensus       804 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  877 (1013)
                            ..++|+||+++ ++...+...     ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~  154 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence                  78999999986 777776543     12489999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +||+|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|++||...
T Consensus       155 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         155 IKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             EEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999987644322 11222345778999998864 45788999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=5.7e-32  Score=296.90  Aligned_cols=247  Identities=24%  Similarity=0.409  Sum_probs=186.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||.||+|.+.+ ++.||||.+..... .....+..|+.++.+. .||||+++++++.++...|+|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568899999999999999999874 88999998864332 2234566777776666 59999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |++ +++.+++....     ..+++..+..++.|++.|++|||+ .   +|+||||+|+||+++.++.+||+|||++..+
T Consensus        95 ~~~-~~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          95 LMS-TCLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             ccC-cCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            986 47777764322     248899999999999999999997 5   8999999999999999999999999998765


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCC----CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFR----CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      .....   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......    .+......... ..
T Consensus       166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~-~~  237 (296)
T cd06618         166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVLTKILQEE-PP  237 (296)
T ss_pred             cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHHHHHhcCC-CC
Confidence            43221   12335778999999987554    788999999999999999999998642211    11111111111 00


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. ...     ..          ....+.+++.+||+.||++|||++|
T Consensus       238 ~~-~~~-----~~----------~~~~l~~li~~~l~~~p~~Rp~~~~  269 (296)
T cd06618         238 SL-PPN-----EG----------FSPDFCSFVDLCLTKDHRKRPKYRE  269 (296)
T ss_pred             CC-CCC-----CC----------CCHHHHHHHHHHccCChhhCCCHHH
Confidence            00 000     00          0113568999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.98  E-value=1.4e-31  Score=296.51  Aligned_cols=240  Identities=28%  Similarity=0.406  Sum_probs=186.5

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      |...+.||+|+||.||+|++. ++..||+|++......   ....+.+|++++++++|||++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            677889999999999999975 5789999987543222   234688899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      ++ |++.+.+....     ..+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++.....
T Consensus       107 ~~-g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         107 CL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            97 57877775322     3388999999999999999999999   999999999999999999999999999875432


Q ss_pred             cCcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      .      ....++..|+|||++.   +..++.++|||||||++|||++|+.||.....     ............. ...
T Consensus       178 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~~-~~~  245 (317)
T cd06635         178 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNESP-TLQ  245 (317)
T ss_pred             c------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHhccCC-CCC
Confidence            1      2345788999999973   45688999999999999999999999865321     1111111111100 000


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...                 ....+.+++.+|++.+|++||++.|
T Consensus       246 ~~~-----------------~~~~l~~li~~~l~~~p~~Rpt~~~  273 (317)
T cd06635         246 SNE-----------------WSDYFRNFVDSCLQKIPQDRPTSEE  273 (317)
T ss_pred             Ccc-----------------ccHHHHHHHHHHccCCcccCcCHHH
Confidence            000                 0112568999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=1.1e-31  Score=289.82  Aligned_cols=238  Identities=25%  Similarity=0.348  Sum_probs=188.3

Q ss_pred             ecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      ||+|+||.||+|++. +++.|++|.+.....   ...+.+.+|++++++++||||+++++.+..+...|+|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 489999998754333   2345688999999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc---
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT---  894 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~---  894 (1013)
                      .+++....      .+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++........   
T Consensus        81 ~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          81 ASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            99996432      389999999999999999999999   999999999999999999999999999876433211   


Q ss_pred             ---ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          895 ---HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       895 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                         ........++..|+|||...+..++.++||||||+++|++++|..||.....     .+....... +....   +.
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~~~---~~  222 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNILN-GKIEW---PE  222 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhc-CCcCC---Cc
Confidence               1122345678899999999888889999999999999999999999975431     111111111 11000   00


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .      ..        ....+.+++.+|++.+|++|||+
T Consensus       223 ~------~~--------~~~~~~~~i~~~l~~~p~~Rpt~  248 (265)
T cd05579         223 D------VE--------VSDEAIDLISKLLVPDPEKRLGA  248 (265)
T ss_pred             c------cc--------CCHHHHHHHHHHhcCCHhhcCCC
Confidence            0      00        01235689999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.98  E-value=6.5e-32  Score=301.59  Aligned_cols=203  Identities=27%  Similarity=0.418  Sum_probs=169.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEe----CCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKI----GEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  805 (1013)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999976 689999998865322  234567789999999999999999998753    3568


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||+. ++|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             EEEEehhh-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence            99999996 6898888533      2389999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcc--eeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          886 ARLISALDTH--LSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       886 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ++........  .......++..|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~  216 (334)
T cd07855         154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN  216 (334)
T ss_pred             ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence            9765432211  11123468889999998765 468899999999999999999999997643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=7.6e-32  Score=298.82  Aligned_cols=199  Identities=22%  Similarity=0.246  Sum_probs=160.8

Q ss_pred             CCCeecccCCcEEEEEEEcCCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          738 AESLIGCGGFGEVFKATLKDGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       738 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      +.+.+|.|+++.||++.. +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            334445555555555444 5899999988653  2334467899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc-
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT-  894 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-  894 (1013)
                      ++.+++.....    ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+|++|||.+........ 
T Consensus        85 ~l~~~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          85 SCEDLLKTHFP----EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            99999975432    2378889999999999999999999   999999999999999999999999998875532211 


Q ss_pred             ----ceeeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          895 ----HLSVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       895 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                          ........++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence                111123456778999999875  35788999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=5.5e-32  Score=295.38  Aligned_cols=199  Identities=29%  Similarity=0.399  Sum_probs=170.2

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      |++.+.||+|++|.||+|... +++.+++|++......  ....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            677889999999999999986 6888999987543322  3467888999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++ ++.+++....     ..+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||.+......
T Consensus        81 ~~-~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          81 DT-DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             CC-CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            85 8888886432     2489999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      .  .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+
T Consensus       152 ~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         152 V--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             c--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2  122234577889999998776 78899999999999999999999997543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=5.2e-33  Score=321.36  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=184.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc-CccchHHHHHHHHHHhccCCcceeeeccEEEe-------
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL-SCQGDREFMAEMETLGKIKHRNLVPLLGYCKI-------  801 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  801 (1013)
                      +...+|+..+.||+||||.||+++.+ ||+.||||++... +......+.+|+..+++++|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888899999999999999998 8999999998543 23334668899999999999999998721100       


Q ss_pred             -----------------------------------------------------------------------C--------
Q 036815          802 -----------------------------------------------------------------------G--------  802 (1013)
Q Consensus       802 -----------------------------------------------------------------------~--------  802 (1013)
                                                                                             +        
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                   0        


Q ss_pred             ---------------------------------CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHH
Q 036815          803 ---------------------------------EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL  849 (1013)
Q Consensus       803 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L  849 (1013)
                                                       ...||-||||+...++++++.....     -.....++++++|++||
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGL  710 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHH
Confidence                                             1247889999987777777643321     04677899999999999


Q ss_pred             HHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc----c------------cCcceeeeeeccCCCccCcccc
Q 036815          850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS----A------------LDTHLSVSTLAGTPGYVPPEYY  913 (1013)
Q Consensus       850 ~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~  913 (1013)
                      +|+|++   |||||||||.||+++++..|||+|||+|....    .            .......+..+||.-|+|||++
T Consensus       711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            999999   99999999999999999999999999998721    0            0111123456899999999998


Q ss_pred             cCC---CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHH
Q 036815          914 QSF---RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEM  990 (1013)
Q Consensus       914 ~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~  990 (1013)
                      .+.   .|+.|+|+||+|||++||+.   ||.-. ++.    ..+-..++.+.....  +.+             ..+++
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-MER----a~iL~~LR~g~iP~~--~~f-------------~~~~~  844 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-MER----ASILTNLRKGSIPEP--ADF-------------FDPEH  844 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCch-HHH----HHHHHhcccCCCCCC--ccc-------------ccccc
Confidence            765   49999999999999999996   45421 110    111122333333322  111             01112


Q ss_pred             HHHHHHHHhcccCCCCCCCCCCC
Q 036815          991 VRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       991 ~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..-..+|++|++.||.+||||.|
T Consensus       845 ~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  845 PEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             hHHHHHHHHHhcCCCccCCCHHH
Confidence            22348899999999999999975

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=1.6e-31  Score=298.91  Aligned_cols=203  Identities=27%  Similarity=0.369  Sum_probs=167.2

Q ss_pred             hcCCCC-CCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc--------------hHHHHHHHHHHhccCCcceeeec
Q 036815          733 TNGFSA-ESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG--------------DREFMAEMETLGKIKHRNLVPLL  796 (1013)
Q Consensus       733 ~~~y~~-~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  796 (1013)
                      .++|.. .+.||+|+||+||+|.+. +++.||+|++.......              ...+.+|++++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            346654 577999999999999976 68899999875432221              12477899999999999999999


Q ss_pred             cEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC
Q 036815          797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       797 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                      +++..++..++||||++ |+|.+++....      .+++.....++.|++.||+|||+.   +|+||||+|+||+++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKG  156 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCC
Confidence            99999999999999997 68999886432      378899999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceeccccC------------cceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          877 EARVSDFGMARLISALD------------THLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      .++++|||.++......            .........++..|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999998654111            01111223467889999998764 468899999999999999999999976


Q ss_pred             CC
Q 036815          944 DD  945 (1013)
Q Consensus       944 ~~  945 (1013)
                      .+
T Consensus       237 ~~  238 (335)
T PTZ00024        237 EN  238 (335)
T ss_pred             CC
Confidence            43

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=7.9e-32  Score=289.41  Aligned_cols=246  Identities=25%  Similarity=0.402  Sum_probs=196.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|++.+.||+|+||.||+|+.. +++.+|+|++....  ......+.+|++++++++|+||+++++++.++...++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788999999999999999876 67899999876432  22345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++.....  ....+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||+++....
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          81 APFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             cCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            999999999865332  224488999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      .    ......+++.|+|||...+..++.++|+||+|+++|||++|+.||...+..     +. ............ .. 
T Consensus       156 ~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~-~~~~~~~~~~~~-~~-  223 (256)
T cd08530         156 N----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DL-RYKVQRGKYPPI-PP-  223 (256)
T ss_pred             C----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH-HHHHhcCCCCCC-ch-
Confidence            3    122345788999999999989999999999999999999999999754321     11 111111111110 00 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                      .....+.+++.+|++.+|++|||+.|
T Consensus       224 ----------------~~~~~~~~li~~~l~~~p~~Rp~~~~  249 (256)
T cd08530         224 ----------------IYSQDLQNFIRSMLQVKPKLRPNCDK  249 (256)
T ss_pred             ----------------hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence                            01123668999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=3.5e-32  Score=304.28  Aligned_cols=201  Identities=30%  Similarity=0.469  Sum_probs=168.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhcc-CCcceeeeccEEEeC--CEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIG--EERL  806 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~  806 (1013)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++++ +||||+++++++...  ...|
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467899999999999999999986 5788999987542  222335577899999999 999999999998653  3689


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||++ ++|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        86 lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             EEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            9999998 5999888542       378889999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcc---eeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          887 RLISALDTH---LSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       887 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +........   .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~  216 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT  216 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence            876433221   12234568889999998754 46788999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=4.1e-32  Score=303.47  Aligned_cols=200  Identities=26%  Similarity=0.399  Sum_probs=167.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeC-----CE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG-----EE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  804 (1013)
                      .++|.+.+.||+|+||+||+|++. +++.||+|++...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999975 6889999987542  222345677899999999999999999988654     34


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+|+||+. ++|.+++...      ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            799999997 6898888543      2388999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +++......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus       154 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         154 LARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             cccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            998664322  11233457889999998764 46889999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=9.9e-32  Score=299.30  Aligned_cols=198  Identities=22%  Similarity=0.303  Sum_probs=160.8

Q ss_pred             Ceeccc--CCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCG--GFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      ..||+|  +||+||+|++. +++.||+|.+......  ..+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999985 6899999987543222  235688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      +++.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+........
T Consensus        84 ~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          84 GSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             CCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            999999875432    2388999999999999999999999   999999999999999999999999986543321111


Q ss_pred             cee-----eeeeccCCCccCcccccCC--CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          895 HLS-----VSTLAGTPGYVPPEYYQSF--RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       895 ~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ...     .....++..|+|||++.+.  .++.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            100     0112345679999998763  4788999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=2.5e-31  Score=288.65  Aligned_cols=234  Identities=24%  Similarity=0.305  Sum_probs=177.8

Q ss_pred             eecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHH---HhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          741 LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMET---LGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       741 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      .||+|+||.||+|... +++.||+|.+.+....   ....+..|..+   ++...||+|+++++++.+.+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 5789999988653221   12223444433   444579999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      |++|.+++...      ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence            99999988543      2389999999999999999999999   99999999999999999999999999987653321


Q ss_pred             cceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                          .....|+..|+|||++.+. .++.++||||+||++|||++|+.||...........   .......      ++.+
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~------~~~~  218 (278)
T cd05606         152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTM------AVEL  218 (278)
T ss_pred             ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhhcc------CCCC
Confidence                1234689999999998754 688999999999999999999999976432221111   1111000      0000


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1009 (1013)
                      .   ...          ...+.+++.+|+..+|++||
T Consensus       219 ~---~~~----------s~~~~~li~~~l~~~p~~R~  242 (278)
T cd05606         219 P---DSF----------SPELRSLLEGLLQRDVNRRL  242 (278)
T ss_pred             C---CcC----------CHHHHHHHHHHhhcCHHhcc
Confidence            0   000          11356899999999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=5.4e-32  Score=302.94  Aligned_cols=201  Identities=25%  Similarity=0.407  Sum_probs=166.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeC---------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG---------  802 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  802 (1013)
                      ..+|++.+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999986 5889999988665555567788999999999999999999876543         


Q ss_pred             -----CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-CC
Q 036815          803 -----EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-EM  876 (1013)
Q Consensus       803 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~  876 (1013)
                           ...|+||||++ ++|.+++...       .+++..++.++.|+++||+|||+.   +|+||||||+||+++. ++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                 35789999998 5888887432       378999999999999999999999   9999999999999975 55


Q ss_pred             cEEEeecccceeccccCcce-eeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          877 EARVSDFGMARLISALDTHL-SVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .+|++|||.++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            78999999998654321111 1122357889999998654 56788999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-31  Score=291.12  Aligned_cols=266  Identities=24%  Similarity=0.282  Sum_probs=190.3

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhcc---CCcceeeeccEEEeCCE-----
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKI---KHRNLVPLLGYCKIGEE-----  804 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  804 (1013)
                      |++.+.||+|+||.||+|+++ +++.||+|++......  ....+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            667889999999999999987 4899999988543222  234566788777666   59999999999988776     


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .+++|||+. ++|.+++.....    ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence            899999998 489888864322    2389999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      .+........   .....++..|+|||++.+..++.++|||||||++|||++|++||...... .....+..........
T Consensus       153 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  228 (287)
T cd07838         153 LARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEE  228 (287)
T ss_pred             cceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChH
Confidence            9987643221   12334788999999999989999999999999999999999998753321 1111111111000000


Q ss_pred             ccccChh--hhcccCCCChhhHHHH-HHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPE--LLLVTKGTDESEAEEV-KEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~--~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .......  ................ .-...+.+++.+||+.||++||+++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  280 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE  280 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHH
Confidence            0000000  0000000001011111 11234668999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=8.1e-32  Score=298.41  Aligned_cols=203  Identities=30%  Similarity=0.441  Sum_probs=166.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeC-------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIG-------  802 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  802 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++......  ....+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999976 5889999988543322  234678899999999999999999987543       


Q ss_pred             -CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEe
Q 036815          803 -EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVS  881 (1013)
Q Consensus       803 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  881 (1013)
                       ...++|+||+++ ++...+....     ..+++..+..++.|+++||+|||++   +|+||||||+||++++++.++|+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence             346999999974 6777765322     2489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceeccccCcc---------eeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          882 DFGMARLISALDTH---------LSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |||+++........         .......+++.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~  230 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK  230 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence            99999765432211         11123456788999998765 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-33  Score=317.29  Aligned_cols=207  Identities=29%  Similarity=0.333  Sum_probs=182.2

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeec---cCccchHHHHHHHHHHhccCCcceeeeccEEEeCCE
Q 036815          729 LIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR---LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       729 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  804 (1013)
                      +.-..++|.+.++||+|+||.|..++.+ +++.||+|++.+   .......-|..|-.+|.--+.+.|+.++-.|.+..+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3344578999999999999999999987 577889998866   233445678999999999999999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+|||||+||+|-..+....      .++++.++.++..|+.||.-+|+.   |+|||||||+|||+|..|++||+|||
T Consensus       150 LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence            999999999999999997544      389999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCccccc----C-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQ----S-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      .+-.+.. +........+|||.|.+||++.    + +.|++.+|.||+||++|||+.|..||..+.
T Consensus       221 sClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  221 SCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             hHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence            9877754 3445556789999999999985    3 679999999999999999999999998643

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-31  Score=291.58  Aligned_cols=199  Identities=27%  Similarity=0.417  Sum_probs=167.5

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEEEcc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      |++.+.||+|+||.||+|+.. +++.|++|++..... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            677899999999999999986 478899998754322 22334567999999998 999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                       +|++.+++....    ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.++.....
T Consensus        81 -~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          81 -EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             -CCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence             789999886543    23489999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CcceeeeeeccCCCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ..   .....++..|+|||++. +..++.++||||||+++|||++|+.||....
T Consensus       153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~  203 (283)
T cd07830         153 PP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS  203 (283)
T ss_pred             CC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence            21   22345788999999875 4557899999999999999999999987543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.8e-31  Score=294.43  Aligned_cols=242  Identities=26%  Similarity=0.367  Sum_probs=186.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +.|+..+.||+|+||.||+|++. +++.||+|.+.....   ....++.+|+++++.++|+|++++++++..+...++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777789999999999999986 578899998753221   22346788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+. |++.+.+....     ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++...
T Consensus        95 e~~~-~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          95 EYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EccC-CCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            9997 58877775322     2378899999999999999999999   9999999999999999999999999998765


Q ss_pred             cccCcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...      ....++..|+|||++.   ...++.++|||||||++|||++|+.||......     ........ .....
T Consensus       166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~-~~~~~  233 (308)
T cd06634         166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQ-NESPA  233 (308)
T ss_pred             cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HHHHHHhh-cCCCC
Confidence            421      2345788999999974   356788999999999999999999998653211     11111111 11000


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....       .          ....+.+++.+||+.+|++||+++|
T Consensus       234 ~~~~-------~----------~~~~~~~li~~cl~~~P~~Rp~~~~  263 (308)
T cd06634         234 LQSG-------H----------WSEYFRNFVDSCLQKIPQDRPTSEV  263 (308)
T ss_pred             cCcc-------c----------ccHHHHHHHHHHhhCCcccCCCHHH
Confidence            0000       0          0112568999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=296.09  Aligned_cols=236  Identities=23%  Similarity=0.275  Sum_probs=189.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++.|.....+|.|+|+.|-.+.+. +++..+||.+.+.    ..+-.+|+.++.+. .||||+++.+.+.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567888888999999999999876 6788999987554    22344677666665 79999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe-CCCCcEEEeecccceec
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL-DHEMEARVSDFGMARLI  889 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~a~~~  889 (1013)
                      .+.|+-+.+.+....       .....+..|+.+|+.|+.|||++   ||||||+||+|||+ +..++++|+|||.++..
T Consensus       397 ~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             hccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            999998887775432       22267778999999999999999   99999999999999 68999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ...     ....+-|..|.|||+.....|++++|+||+|+++|+|++|+.||......     .-+...+..++..+.+.
T Consensus       467 ~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~~~~s~~vS  536 (612)
T KOG0603|consen  467 ERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQMPKFSECVS  536 (612)
T ss_pred             chh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcCCccccccC
Confidence            542     33456688999999999999999999999999999999999999864433     11222333333332222


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .                     ...+++.+||+.||.+||+|+|
T Consensus       537 ~---------------------~AKdLl~~LL~~dP~~Rl~~~~  559 (612)
T KOG0603|consen  537 D---------------------EAKDLLQQLLQVDPALRLGADE  559 (612)
T ss_pred             H---------------------HHHHHHHHhccCChhhCcChhh
Confidence            1                     1348999999999999999975

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.8e-33  Score=270.31  Aligned_cols=269  Identities=26%  Similarity=0.373  Sum_probs=193.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEe--------C
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKI--------G  802 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  802 (1013)
                      ..|....+||+|.||.||+|+.+ +++.||+|++...  .+.-.....+|++++..++|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666788999999999999976 5778899876432  12223557899999999999999999998853        2


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      ...|+||.+|+ -+|.-.+.+..     ..++..++.++++++..||.|+|..   .|+|||+||.|++|+.+|.+||+|
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence            35799999998 48888886432     2388899999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcc--eeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHH
Q 036815          883 FGMARLISALDTH--LSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKV  959 (1013)
Q Consensus       883 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  959 (1013)
                      ||+|+.+...+..  ......+.|..|++||.+.| ..|+++.|||+.|||+.||+||.+-+.+....  .....+....
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql~~Is~Lc  245 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQLHLISQLC  245 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHHHHHHHHh
Confidence            9999877544332  22345567899999998875 46899999999999999999999988765422  1222222222


Q ss_pred             hcC--ccccccC-hhhhc------ccCCCChhhHHHHH---HHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REG--KQMEVID-PELLL------VTKGTDESEAEEVK---EMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~--~~~~~~d-~~~~~------~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...  ..+..+| -.++.      ..++..........   .-...++++.+++..||.+||+++|
T Consensus       246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~  311 (376)
T KOG0669|consen  246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ  311 (376)
T ss_pred             ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence            211  1111111 01110      00110000000000   0013578999999999999999875

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.5e-31  Score=297.10  Aligned_cols=200  Identities=27%  Similarity=0.421  Sum_probs=168.7

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEe-CCE
Q 036815          729 LIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKI-GEE  804 (1013)
Q Consensus       729 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  804 (1013)
                      +...+++|++.+.||+|+||.||+|.+. +++.||+|++.+..  ....+.+.+|++++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456789999999999999999999876 78899999875422  2234668899999999999999999998865 567


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .++|+||+. ++|.+++...       .+++..+..++.|+++||+|||+.   +|+||||+|+||+++.++.++|+|||
T Consensus        85 ~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          85 IYFVTELLG-TDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             EEEEeehhc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccc
Confidence            899999985 6898887532       277888889999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .+......     .....++..|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus       154 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         154 LARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             cccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            98754321     123356788999998765 56889999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1e-31  Score=300.78  Aligned_cols=195  Identities=28%  Similarity=0.434  Sum_probs=163.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC------C
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG------E  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  803 (1013)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++....  ......+.+|++++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999975 68999999875432  22235678999999999999999999998654      3


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..++|+||+. .++..+..        ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        94 ~~~lv~e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             eEEEEecccc-cCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence            5689999997 47776652        1278899999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |+++.....     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       162 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         162 GLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             CCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            998764321     123456788999999876 46889999999999999999999999764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2e-31  Score=297.62  Aligned_cols=201  Identities=30%  Similarity=0.437  Sum_probs=172.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCC-----EEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE-----ERL  806 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  806 (1013)
                      +|++.+.||.|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5889999999999999999986 48899999886543  333467899999999999999999999988765     789


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||++ ++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||.+
T Consensus        81 lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            9999998 58888886432      489999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcc-eeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          887 RLISALDTH-LSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       887 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ......... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            876543210 112334678899999999887 78999999999999999999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=5.2e-31  Score=291.22  Aligned_cols=240  Identities=28%  Similarity=0.401  Sum_probs=186.1

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      |...+.||+|+||+||+|++. +++.|++|++......   ..+.+.+|++++++++|||++++++++.++...|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999975 5788999987543222   224678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +. |++.+++....     ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.+.....
T Consensus       103 ~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633         103 CL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             CC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence            97 57777775322     3488999999999999999999999   999999999999999999999999998864321


Q ss_pred             cCcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                            .....++..|+|||++.   +..++.++|||||||++|||++|..||.....     ........... .....
T Consensus       174 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~-~~~~~  241 (313)
T cd06633         174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQND-SPTLQ  241 (313)
T ss_pred             ------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC-CCCCC
Confidence                  12346788999999974   45688899999999999999999999875431     11111111111 00000


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+.       .          ...+.+++.+||+.+|++||++.|
T Consensus       242 ~~~-------~----------~~~l~~li~~~l~~~P~~Rp~~~~  269 (313)
T cd06633         242 SNE-------W----------TDSFRGFVDYCLQKIPQERPASAE  269 (313)
T ss_pred             ccc-------c----------CHHHHHHHHHHccCChhhCcCHHH
Confidence            000       0          012558999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.2e-31  Score=298.18  Aligned_cols=203  Identities=28%  Similarity=0.417  Sum_probs=169.2

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC
Q 036815          726 FSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG  802 (1013)
Q Consensus       726 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  802 (1013)
                      ..++...+++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3455667899999999999999999999875 68899999885432  22245678899999999999999999988643


Q ss_pred             ------CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC
Q 036815          803 ------EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       803 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                            ...+++++++ +++|.+++...       .+++..+..++.|+++|++|||+.   +|+||||||+||+++.++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence                  3467888876 68998887532       278999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .+||+|||+++....     ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus       158 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         158 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             CEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999875432     1223467889999999866 56788999999999999999999999653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-33  Score=272.88  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=185.9

Q ss_pred             CCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhc-cCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          739 ESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGK-IKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      ...||.|+||+|++-.++ .|+..|||++..... ..++++..|.+...+ -+.||||++||.+..++..|+.||.|+ -
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            467999999999999886 689999999975444 456778889887554 479999999999999999999999997 4


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      +++.+...-. ......+++...-.|....+.||.||.+..  .|||||+||+|||++..|.+||||||.+-.+.   ..
T Consensus       148 SlDklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~S  221 (361)
T KOG1006|consen  148 SLDKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---DS  221 (361)
T ss_pred             hHHHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH---HH
Confidence            6655442111 111234888888899999999999998773  89999999999999999999999999986543   22


Q ss_pred             eeeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc-cChhh
Q 036815          896 LSVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV-IDPEL  972 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~d~~~  972 (1013)
                      ...+..+|...|||||.+..  ..|+.+|||||+|+++||++||+.||.+.+.    ..+.+...+. +..... .+.+ 
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~-gdpp~l~~~~~-  295 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVI-GDPPILLFDKE-  295 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHc-CCCCeecCccc-
Confidence            33445678999999999863  3488999999999999999999999876432    2222222222 111111 1111 


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                                   .+.-...+..++.-|+..|-.+||..+
T Consensus       296 -------------~~~~s~~~~~fintCl~Kd~~~Rpky~  322 (361)
T KOG1006|consen  296 -------------CVHYSFSMVRFINTCLIKDRSDRPKYD  322 (361)
T ss_pred             -------------ccccCHHHHHHHHHHhhcccccCcchh
Confidence                         011122367899999999999999864

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.9e-31  Score=295.93  Aligned_cols=197  Identities=29%  Similarity=0.415  Sum_probs=166.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCC-----
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE-----  803 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  803 (1013)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4578999999999999999999875 68899999875422  122356789999999999999999999886543     


Q ss_pred             -EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          804 -ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       804 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                       ..++||||+ +++|.+++..       ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++++|
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence             458999998 6799888753       2388999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ||+++.....     .....+++.|+|||++.+ ..++.++||||+||++|++++|+.||...
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999765321     123457889999999875 45788999999999999999999999754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-30  Score=279.62  Aligned_cols=234  Identities=27%  Similarity=0.344  Sum_probs=188.8

Q ss_pred             ecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      ||+|+||.||++... +++.||+|.+......   ....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999986 5889999987654322   335688999999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCccee
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS  897 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  897 (1013)
                      .+++....      .+++..+..++.|+++|+.|+|+.   +++|+||+|+||+++.++.++++|||.+.......  ..
T Consensus        81 ~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~  149 (250)
T cd05123          81 FSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SR  149 (250)
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cc
Confidence            99996432      388999999999999999999998   99999999999999999999999999998754322  12


Q ss_pred             eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-CccccccChhhhccc
Q 036815          898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEVIDPELLLVT  976 (1013)
Q Consensus       898 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~~~~~~  976 (1013)
                      .....++..|+|||...+...+.++|+||||+++|++++|..||...+.     .......... .......        
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~--------  216 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDPLRFPEFL--------  216 (250)
T ss_pred             ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCCCCCCCCC--------
Confidence            2345678899999999888889999999999999999999999975432     1111111110 0011111        


Q ss_pred             CCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          977 KGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       977 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                                   ...+.+++.+||..||++|||++
T Consensus       217 -------------~~~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         217 -------------SPEARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             -------------CHHHHHHHHHHhcCCHhhCCCcc
Confidence                         11256899999999999999983

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-32  Score=275.73  Aligned_cols=262  Identities=21%  Similarity=0.304  Sum_probs=205.2

Q ss_pred             CHHHHHHHhcCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeecc
Q 036815          725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLG  797 (1013)
Q Consensus       725 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~  797 (1013)
                      +..++.....+++...++.+|.||.||.|.+.+      .+.|.+|.+.....+ .-..+..|.-.+....|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            455666667889999999999999999997653      345777776543322 2356788998999999999999999


Q ss_pred             EEEe-CCEEEEEEEcccCCCHHHHhcccc--cCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC
Q 036815          798 YCKI-GEERLLVYEFMKFGSLEEVLHGRA--KARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH  874 (1013)
Q Consensus       798 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  874 (1013)
                      ++.+ ....+.++.++..|+|..++...+  .....+.++..+...++.|++.|++|||++   +|||.||..+|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            8865 456789999999999999997332  223345678888999999999999999999   9999999999999999


Q ss_pred             CCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHH
Q 036815          875 EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVG  953 (1013)
Q Consensus       875 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~  953 (1013)
                      .-++||+|=.++|.+-+.+.+.-......+..||+||.+....|+.++|||||||++|||+| |+.||..-+..  ....
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--Em~~  509 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--EMEH  509 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--HHHH
Confidence            99999999999998877676655556667889999999999999999999999999999999 99998754321  1222


Q ss_pred             HHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          954 WVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       954 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.+...+-.+....                      ..++..++.-||+.+|++||+++|
T Consensus       510 ylkdGyRlaQP~NC----------------------PDeLf~vMacCWallpeeRPsf~Q  547 (563)
T KOG1024|consen  510 YLKDGYRLAQPFNC----------------------PDELFTVMACCWALLPEERPSFSQ  547 (563)
T ss_pred             HHhccceecCCCCC----------------------cHHHHHHHHHHHhcCcccCCCHHH
Confidence            22221111111111                      113668899999999999999875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=6.5e-31  Score=282.89  Aligned_cols=247  Identities=21%  Similarity=0.320  Sum_probs=188.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeecc-----CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRL-----SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      +|.+.+.||+|+||.||+|++.. +..+++|.+...     ......++.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58889999999999999998763 344555554321     122334567899999999999999999999998999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++.....  ....+++..++.++.|+++|+.|||+.   +++|+||+|+||+++. +.++++|||.++.
T Consensus        81 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          81 TEYCEGRDLDCKLEELKH--TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             EEeCCCCCHHHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceee
Confidence            999999999998864322  223489999999999999999999999   9999999999999975 5699999999876


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ......  ......+++.|+|||.+.+..++.++||||+|+++|+|++|..||....     ......... .+.... .
T Consensus       155 ~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~-~~~~~~-~  225 (260)
T cd08222         155 LMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIV-EGPTPS-L  225 (260)
T ss_pred             cCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHH-cCCCCC-C
Confidence            543221  1223457889999999988888999999999999999999999986422     111111111 111110 0


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.       ..          ...+.+++.+|++.+|++||++.|
T Consensus       226 ~~-------~~----------~~~~~~li~~~l~~~p~~Rp~~~~  253 (260)
T cd08222         226 PE-------TY----------SRQLNSIMQSMLNKDPSLRPSAAE  253 (260)
T ss_pred             cc-------hh----------cHHHHHHHHHHhcCChhhCcCHHH
Confidence            00       00          113568999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-32  Score=285.09  Aligned_cols=196  Identities=28%  Similarity=0.465  Sum_probs=169.1

Q ss_pred             CCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          739 ESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      .++||+|-||+||-|+++ +|+.||||++.+.  ....+.++.+|+.|+++++||.||.+.-.|+..+..+.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999875 7999999998653  3344577999999999999999999999999999999999999864


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC---CcEEEeecccceecccc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE---MEARVSDFGMARLISAL  892 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~  892 (1013)
                      -|+-.+....     ..+++.....++.||+.||.|||.+   +|||+|+||+|||+.+.   .++||||||+|+.++..
T Consensus       649 MLEMILSsEk-----gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  649 MLEMILSSEK-----GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             HHHHHHHhhc-----ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            4554443322     2388888889999999999999999   99999999999999654   57999999999998753


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      .   ......|||.|.|||+++...|...-|+||+|||+|--+.|..||..+.
T Consensus       721 s---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE  770 (888)
T KOG4236|consen  721 S---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE  770 (888)
T ss_pred             h---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence            3   2346789999999999999999999999999999999999999998643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.1e-30  Score=314.32  Aligned_cols=145  Identities=26%  Similarity=0.368  Sum_probs=129.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.++||+|+||.||+|.+. +++.||+|++......   ....+..|+.+++.++||||+++++++......|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999987 6889999988653322   2356888999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||+.+++|.+++....      .+++..++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999986432      378889999999999999999999   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.8e-31  Score=298.87  Aligned_cols=197  Identities=29%  Similarity=0.434  Sum_probs=167.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCE----
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE----  804 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  804 (1013)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++...  .....+.+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999986 5789999987542  12233567789999999999999999998866554    


Q ss_pred             --EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          805 --RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       805 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                        .++|+||+ +++|.+++..       ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++|+|
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence              89999998 4699998863       2389999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ||.+......     .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~  219 (343)
T cd07851         162 FGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS  219 (343)
T ss_pred             cccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999765322     223467888999999865 46788999999999999999999999754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=3.6e-31  Score=288.77  Aligned_cols=199  Identities=28%  Similarity=0.408  Sum_probs=170.0

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      |+..+.||+|+||.||+|+.. +++.||+|.+....  ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567789999999999999987 48999999886543  233466788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      + ++|.+++....     ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||.++.....
T Consensus        81 ~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          81 D-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             C-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            8 59999997542     2389999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ..  ......++..|+|||.+.+. .++.++||||+||++||+++|+.||....
T Consensus       152 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         152 LR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             cc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence            21  12233457789999998766 78999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=9e-31  Score=292.11  Aligned_cols=201  Identities=27%  Similarity=0.350  Sum_probs=164.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-C--CCEEEEEEeeccC--ccchHHHHHHHHHHhcc-CCcceeeeccEEEeC----CE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-D--GSSVAIKKLIRLS--CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIG----EE  804 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  804 (1013)
                      +|++.+.||+|+||.||+|+.. .  +..||+|++....  ....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999986 3  6789999875422  12245678899999999 599999999875432    45


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .++++||++ ++|.+++...      ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg  150 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFG  150 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCC
Confidence            688999887 6899888543      2388999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcc--eeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          885 MARLISALDTH--LSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       885 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      .++........  .......|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...+
T Consensus       151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            99866432211  11223468899999998765 468899999999999999999999997643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.9e-32  Score=275.53  Aligned_cols=264  Identities=21%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-C-c----ceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-H-R----NLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~  805 (1013)
                      +++|.+...+|+|.||.|-++.+. .+..||+|+++... .-.+...-|+++++++. + |    -+|.+.+||.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999999876 46889999765433 22345677999999993 2 2    478888999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-----------
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-----------  874 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----------  874 (1013)
                      |+|+|.+. -++.+++....    -.+++...++.|++|++++++|||+.   +++|.|+||+||++.+           
T Consensus       167 CivfellG-~S~~dFlk~N~----y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  167 CIVFELLG-LSTFDFLKENN----YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             EEEEeccC-hhHHHHhccCC----ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence            99999884 69999997544    34589999999999999999999999   9999999999999932           


Q ss_pred             ---------CCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          875 ---------EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       875 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                               ...++++|||.|+.....     ....+.|..|+|||++.+-.++.++||||+|||++|+.||...|..-+
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                     245899999999864322     246678999999999999999999999999999999999999987643


Q ss_pred             CCCccHHHHHHHHHhcCccccccChh---------------------hhcccCCCCh---hhHHHHHHHHHHHHHHHhcc
Q 036815          946 FGDTNLVGWVKMKVREGKQMEVIDPE---------------------LLLVTKGTDE---SEAEEVKEMVRYLEITLQCV 1001 (1013)
Q Consensus       946 ~~~~~~~~~~~~~~~~~~~~~~~d~~---------------------~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl 1001 (1013)
                        +.....++....+..+ ...+...                     ...+.+...+   .....-.+...+.+++++||
T Consensus       314 --n~EHLaMMerIlGp~P-~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  314 --NLEHLAMMERILGPIP-SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             --cHHHHHHHHHhhCCCc-HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence              1111122222222110 0000000                     0000000000   00111234556899999999


Q ss_pred             cCCCCCCCCCCC
Q 036815         1002 DDFPSKRPNMLQ 1013 (1013)
Q Consensus      1002 ~~dP~~RPt~~e 1013 (1013)
                      ..||.+|+|+.|
T Consensus       391 ~fDP~~RiTl~E  402 (415)
T KOG0671|consen  391 EFDPARRITLRE  402 (415)
T ss_pred             ccCccccccHHH
Confidence            999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=272.99  Aligned_cols=201  Identities=32%  Similarity=0.415  Sum_probs=171.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchH---HHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDR---EFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .+|....+||+|+||.|.+|..+ +.+.+|||++.+.-...+.   --..|-++|..- +-|.++++..+|..-+..|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            35889999999999999999877 4567999987654322222   224566677665 578999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+.||+|--.++...+      +.+..+..+|.+||-||-+||++   |||+||+|.+||+++.+|++||+|||+++.
T Consensus       429 MEyvnGGDLMyhiQQ~Gk------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             EEEecCchhhhHHHHhcc------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence            999999999999986654      56677788999999999999999   999999999999999999999999999974


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      -  .-...+..+..|||.|+|||++...+|+..+|.|||||++|||+.|++||++++
T Consensus       500 n--i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD  554 (683)
T KOG0696|consen  500 N--IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  554 (683)
T ss_pred             c--ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            2  223445567899999999999999999999999999999999999999999865

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-31  Score=310.94  Aligned_cols=253  Identities=28%  Similarity=0.415  Sum_probs=197.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc----C----CCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeCC
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK----D----GSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  803 (1013)
                      ++..+.+.+|+|+||.||+|...    .    ...||||....... ...+.+..|+++|+.+ +|+||+.++|+|...+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            34456679999999999999853    1    45799998765433 3456799999999999 6999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccc---------cCCCC-ccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRA---------KARDQ-RILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ..++|+||+..|+|.++++..+         ..... ..++......++.|||.||+||++.   ++||||+..+||+++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence            9999999999999999998766         11111 2489999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeec--cCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCcc
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLA--GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTN  950 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~  950 (1013)
                      .+..+||+|||+|+.....+..... ...  -+..|||||.+....|+.|+|||||||++||++| |..||.+-.. ...
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~~  530 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TEE  530 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HHH
Confidence            9999999999999976544433222 122  2456999999999999999999999999999999 8999875211 111


Q ss_pred             HHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          951 LVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       951 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.+    .++.|..++...-        .          ..+++++++.||+.+|++||++.|
T Consensus       531 l~~----~l~~G~r~~~P~~--------c----------~~eiY~iM~~CW~~~p~~RP~F~~  571 (609)
T KOG0200|consen  531 LLE----FLKEGNRMEQPEH--------C----------SDEIYDLMKSCWNADPEDRPTFSE  571 (609)
T ss_pred             HHH----HHhcCCCCCCCCC--------C----------CHHHHHHHHHHhCCCcccCCCHHH
Confidence            222    3444443332111        0          113568999999999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.5e-30  Score=275.38  Aligned_cols=220  Identities=22%  Similarity=0.186  Sum_probs=173.1

Q ss_pred             cCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCHHHHhcc
Q 036815          745 GGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHG  823 (1013)
Q Consensus       745 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  823 (1013)
                      |.||.||+|++. +++.||+|++....     .+.+|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999986 67899999885432     233455555556799999999999999999999999999999999864


Q ss_pred             cccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeecc
Q 036815          824 RAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG  903 (1013)
Q Consensus       824 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  903 (1013)
                      ..      .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++++|||.+......     .....+
T Consensus        79 ~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~  144 (237)
T cd05576          79 FL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAV  144 (237)
T ss_pred             hc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCc
Confidence            32      288999999999999999999999   9999999999999999999999999988655331     122345


Q ss_pred             CCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhh
Q 036815          904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESE  983 (1013)
Q Consensus       904 t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  983 (1013)
                      +..|+|||...+..++.++||||+||++|||++|+.|+.......           ......+ +++       ..    
T Consensus       145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~-~~~-------~~----  201 (237)
T cd05576         145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHTTLN-IPE-------WV----  201 (237)
T ss_pred             CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccccccC-Ccc-------cC----
Confidence            678999999988888999999999999999999998875321100           0000000 000       00    


Q ss_pred             HHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          984 AEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       984 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                            ...+.+++.+|++.||++|||+.
T Consensus       202 ------~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         202 ------SEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             ------CHHHHHHHHHHccCCHHHhcCCC
Confidence                  01256899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-31  Score=293.41  Aligned_cols=258  Identities=26%  Similarity=0.385  Sum_probs=203.4

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEe
Q 036815          724 LKFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKI  801 (1013)
Q Consensus       724 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  801 (1013)
                      +.++.+...++.|++.+.||.|.+|.||+++.. +++.+|||+... ....++++..|+++++.. .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            344555566788999999999999999999975 678888886543 444567788999999888 69999999999864


Q ss_pred             -----CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC
Q 036815          802 -----GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       802 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                           ++..|+|||||.||+..|++.+..    +..+.|+.+..|++.++.|+.+||..   .++|||||-.||+++.++
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENA  160 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccC
Confidence                 678999999999999999998655    34589999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceeccccCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccH
Q 036815          877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL  951 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~  951 (1013)
                      .+|++|||.+..+..  +.....+..|||.|||||++.     ...|+.++|+||+|++..||..|.+|+-....     
T Consensus       161 ~VKLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----  233 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----  233 (953)
T ss_pred             cEEEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----
Confidence            999999999887653  233345678999999999985     33577889999999999999999999764321     


Q ss_pred             HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          952 VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       952 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .   +....   .....+|.+..        ..   .-..++.++|..||..|-++||++.+
T Consensus       234 m---raLF~---IpRNPPPkLkr--------p~---kWs~~FndFIs~cL~Kd~e~RP~~~~  278 (953)
T KOG0587|consen  234 M---RALFL---IPRNPPPKLKR--------PK---KWSKKFNDFISTCLVKDYEQRPSTEE  278 (953)
T ss_pred             h---hhhcc---CCCCCCccccc--------hh---hHHHHHHHHHHHHHhhccccCcchhh
Confidence            1   00010   11111222211        01   11234779999999999999999764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-32  Score=277.21  Aligned_cols=208  Identities=26%  Similarity=0.377  Sum_probs=170.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc-c------hHHHHHHHHHHhccCCcceeeeccEEEe-C
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ-G------DREFMAEMETLGKIKHRNLVPLLGYCKI-G  802 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~------~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  802 (1013)
                      ..++|-..++||+|+|+.||+|.+- ..+.||||+-.-.... +      .+...+|.+|-+.++||.||++|+||.. .
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3467888999999999999999875 4677888853221111 1      1346789999999999999999999975 4


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCcEE
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EMEAR  879 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~k  879 (1013)
                      +..|-|+|||+|.+|+-|+.....      +++.+++.|+.||+.||.||.+. .++|||-|+||.|||+..   -|.+|
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhkl------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKL------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhh------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence            577899999999999999975543      89999999999999999999987 578999999999999954   47899


Q ss_pred             EeecccceeccccCcc-----eeeeeeccCCCccCcccccC----CCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          880 VSDFGMARLISALDTH-----LSVSTLAGTPGYVPPEYYQS----FRCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       880 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      |+|||+++.++.....     .-....+||..|.+||.+.-    ...+.|+||||+|||+|+++.|+.||.....
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            9999999988654332     12345789999999998742    3578899999999999999999999986543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=259.57  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=195.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .++|...++||+|+|++|..++++ +.+.+|+|++++.-.   ++..-++.|-.+..+. +||.+|-+..+|..+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357999999999999999999986 567899998765322   2233456777777666 79999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |.||++||+|--++...      +.++++.++.+...|.-||.|||++   |||+||+|.+||++|.+|++|++|+|+++
T Consensus       329 vieyv~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             EEEEecCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence            99999999997766533      4499999999999999999999999   99999999999999999999999999997


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC--CCCccHHHHHHHHHhcCccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD--FGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      .-  .......++..|||.|.|||++++..|+..+|.|++||+++||+.|+.||+--.  ..+.+..++....+.+....
T Consensus       400 e~--l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir  477 (593)
T KOG0695|consen  400 EG--LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR  477 (593)
T ss_pred             cC--CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence            42  223334567899999999999999999999999999999999999999998433  33444444443333221110


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                        ++..+                 .++...+++.-|..||.+|..
T Consensus       478 --iprsl-----------------svkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  478 --IPRSL-----------------SVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --cccee-----------------ehhhHHHHHHhhcCCcHHhcC
Confidence              00000                 112346777889999998854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=5e-31  Score=246.60  Aligned_cols=207  Identities=22%  Similarity=0.366  Sum_probs=169.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc-CccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL-SCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .+.......||+|+||.|-+.++. +|...|+|.+... ..+..++..+|+.+..+. .+|.+|.+||.....+..++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            344555678999999999988875 7899999988543 334456788899886554 7999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |.|+ -+|+.+-..--  ..+..+++..+-+|+..+.+||.|||++  ..+||||+||+|||++.+|++|+||||.+-.+
T Consensus       125 E~M~-tSldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  125 ELMD-TSLDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             HHhh-hhHHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            9998 47776654322  2345589999999999999999999998  48999999999999999999999999998765


Q ss_pred             cccCcceeeeeeccCCCccCcccccC----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQS----FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG  947 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~~  947 (1013)
                      .+   ....+...|...|||||.+..    ..|+.|+||||+|+.+.||.+++.||+....+
T Consensus       200 ~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  200 VD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             hh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            42   222334578899999998753    47899999999999999999999999875543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=278.23  Aligned_cols=209  Identities=25%  Similarity=0.368  Sum_probs=179.3

Q ss_pred             hhhccccCHHHHHHHhcCCCCCCeecccCCcEEEEEEEcCCC-EEEEEEeeccC---ccchHHHHHHHHHHhccCCccee
Q 036815          718 QRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS-SVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLV  793 (1013)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv  793 (1013)
                      .+.....++++       +.++..||-|+||.|-++..+... .+|+|.+.+..   ....+.+..|-.+|...+.|.||
T Consensus       411 ~~e~a~v~l~d-------l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIv  483 (732)
T KOG0614|consen  411 AEEFAQVKLSD-------LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIV  483 (732)
T ss_pred             Hhhhcccchhh-------hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHH
Confidence            33444455554       455678999999999999876433 37777665533   33345678899999999999999


Q ss_pred             eeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       794 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ++|..|.++...|+.||-|-||.+...+..+..      ++..+.+.++..+++|++|||++   +||+||+||+|.+++
T Consensus       484 rLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd  554 (732)
T KOG0614|consen  484 RLYRTFRDSKYVYMLMEACLGGELWTILRDRGS------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLD  554 (732)
T ss_pred             HHHHHhccchhhhhhHHhhcCchhhhhhhhcCC------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeec
Confidence            999999999999999999999999999976654      78888899999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      .+|-+||.|||+|+.+....   ...+++|||.|.|||++.+...+.++|.||+|+++||+++|.+||.+.+
T Consensus       555 ~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d  623 (732)
T KOG0614|consen  555 NRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD  623 (732)
T ss_pred             cCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence            99999999999999886533   3467899999999999999999999999999999999999999998744

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7.5e-30  Score=274.25  Aligned_cols=207  Identities=27%  Similarity=0.371  Sum_probs=174.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .-|...+.||-|+||.|.+++..| ...+|.|.+.+.+.-.   ...++.|-.||..-+.+.||++|-.|.+.+..|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            458889999999999999998554 5568889886644322   345788999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      +|++||++-.+|....      .+++.-++.++.++..|+++.|..   |+|||||||+|||||.+|++||+|||++.-+
T Consensus       709 dYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             eccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence            9999999999886543      388888899999999999999999   9999999999999999999999999998643


Q ss_pred             cc---------cCcc-------------------------------eeeeeeccCCCccCcccccCCCCCccchhHhHHH
Q 036815          890 SA---------LDTH-------------------------------LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGV  929 (1013)
Q Consensus       890 ~~---------~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  929 (1013)
                      ..         .+..                               ......+||+.|+|||++....++..+|.||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            11         1000                               0012356999999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCc
Q 036815          930 VLLELLTGKRPTDKDDFGDT  949 (1013)
Q Consensus       930 il~elltg~~pf~~~~~~~~  949 (1013)
                      |+|||+.|++||..+...+.
T Consensus       860 il~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcc
Confidence            99999999999987765554

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=291.67  Aligned_cols=244  Identities=24%  Similarity=0.387  Sum_probs=183.8

Q ss_pred             CCCCCeecccCCcE-EEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEccc
Q 036815          736 FSAESLIGCGGFGE-VFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       736 y~~~~~lG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      |.-.+++|.|+-|+ ||+|... |+.||||++..   .-....++|+..++.- +|||||++++.-.++...|++.|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            33446789999885 7999986 89999998743   2234567999999888 69999999999888999999999998


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---C--CcEEEeeccccee
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---E--MEARVSDFGMARL  888 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~Dfg~a~~  888 (1013)
                       .+|.+++.....  +.........+.+..|++.|+++||+.   +||||||||.||||+.   +  .+++|+|||+++.
T Consensus       587 -~sL~dlie~~~~--d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  587 -CSLQDLIESSGL--DVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             -hhHHHHHhcccc--chhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence             799999986411  111111134567899999999999998   9999999999999976   3  5689999999998


Q ss_pred             ccccCcce-eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcC-CCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          889 ISALDTHL-SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG-KRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       889 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +....... ......||.+|+|||++....-+.++||||+||++|+.++| .+||...-..+.+..      -.......
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl------~~~~~L~~  734 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL------TGNYTLVH  734 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh------cCccceee
Confidence            86544322 24567899999999999998888899999999999999995 999976432221111      01100110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       +.+..            +   .  ...++|.+|+++||..||+|.+
T Consensus       735 -L~~~~------------d---~--eA~dLI~~ml~~dP~~RPsa~~  763 (903)
T KOG1027|consen  735 -LEPLP------------D---C--EAKDLISRMLNPDPQLRPSATD  763 (903)
T ss_pred             -eccCc------------h---H--HHHHHHHHhcCCCcccCCCHHH
Confidence             11100            0   0  2458999999999999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.4e-30  Score=267.69  Aligned_cols=132  Identities=28%  Similarity=0.424  Sum_probs=111.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-----C---cceeeeccEEEe--
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-----H---RNLVPLLGYCKI--  801 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--  801 (1013)
                      ..+|.+.++||.|.|++||+|.+. +.+.||+|+++.. ..-.+....|+++|++++     |   .+||++++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            468999999999999999999986 5678999976543 333456788999999983     2   479999999976  


Q ss_pred             --CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe
Q 036815          802 --GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL  872 (1013)
Q Consensus       802 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  872 (1013)
                        +.+.|+|+|++. .+|..+|.....    +-++...+++|++||+.||.|||..|  ||||.||||+|||+
T Consensus       156 pNG~HVCMVfEvLG-dnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVLG-DNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhhh-hHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              458899999985 688888865433    33899999999999999999999998  99999999999999

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.3e-29  Score=294.63  Aligned_cols=203  Identities=21%  Similarity=0.283  Sum_probs=142.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-C----CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccE------EE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-D----GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY------CK  800 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  800 (1013)
                      ..++|++.+.||+|+||.||+|++. +    +..||+|++.....  .+....|  .++...+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3578999999999999999999986 4    68999998753221  1111111  1122222233322221      23


Q ss_pred             eCCEEEEEEEcccCCCHHHHhcccccCC--------------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 036815          801 IGEERLLVYEFMKFGSLEEVLHGRAKAR--------------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMK  866 (1013)
Q Consensus       801 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  866 (1013)
                      .+...++||||+++++|.+++.......              .........+..++.|++.||+|||++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            4667899999999999999986432100              001122345678999999999999999   99999999


Q ss_pred             cccEEeCC-CCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCC----------------------CCCccch
Q 036815          867 SSNVLLDH-EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF----------------------RCTAKGD  923 (1013)
Q Consensus       867 p~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  923 (1013)
                      |+|||++. ++.+||+|||+|+.+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986543222 122346789999999965322                      2344679


Q ss_pred             hHhHHHHHHHHHcCCCCCC
Q 036815          924 VYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       924 vwslG~il~elltg~~pf~  942 (1013)
                      |||+||++|||+++..|++
T Consensus       362 VwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc
Confidence            9999999999999776643

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=5.1e-29  Score=283.34  Aligned_cols=208  Identities=25%  Similarity=0.331  Sum_probs=155.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEE-----------------cCCCEEEEEEeeccCccchH--------------HHHHH
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATL-----------------KDGSSVAIKKLIRLSCQGDR--------------EFMAE  780 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E  780 (1013)
                      ..++|++.++||+|+||+||+|..                 .+++.||||++........+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 23567999998543322222              23447


Q ss_pred             HHHHhccCCcce-----eeeccEEEe--------CCEEEEEEEcccCCCHHHHhcccccC------------------CC
Q 036815          781 METLGKIKHRNL-----VPLLGYCKI--------GEERLLVYEFMKFGSLEEVLHGRAKA------------------RD  829 (1013)
Q Consensus       781 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~  829 (1013)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++.....                  ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677787753        35679999999999999999753211                  01


Q ss_pred             CccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccC
Q 036815          830 QRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP  909 (1013)
Q Consensus       830 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  909 (1013)
                      ...+++..++.++.|++.||.|+|+.   +|+||||||+||+++.++.+||+|||+++....... .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            12357788999999999999999999   999999999999999999999999999976543211 11122345789999


Q ss_pred             cccccCCC--------------------C--CccchhHhHHHHHHHHHcCCC-CCCC
Q 036815          910 PEYYQSFR--------------------C--TAKGDVYSFGVVLLELLTGKR-PTDK  943 (1013)
Q Consensus       910 PE~~~~~~--------------------~--~~~~DvwslG~il~elltg~~-pf~~  943 (1013)
                      ||.+....                    +  ..+.||||+||++|||++|.. ||..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            99875322                    1  124799999999999999875 6653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=8.8e-29  Score=263.30  Aligned_cols=235  Identities=32%  Similarity=0.437  Sum_probs=186.9

Q ss_pred             CCcEEEEEEEc-CCCEEEEEEeeccCccc-hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCHHHHhcc
Q 036815          746 GFGEVFKATLK-DGSSVAIKKLIRLSCQG-DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHG  823 (1013)
Q Consensus       746 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  823 (1013)
                      +||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999886554444 57899999999999999999999999999999999999999999999864


Q ss_pred             cccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeecc
Q 036815          824 RAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG  903 (1013)
Q Consensus       824 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  903 (1013)
                      ...      +++..+..++.+++.+++|||+.   +++|+||+|+||+++.++.++++|||.+.......   ......+
T Consensus        81 ~~~------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~  148 (244)
T smart00220       81 RGR------LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG  148 (244)
T ss_pred             ccC------CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence            332      78899999999999999999999   99999999999999999999999999998765432   2234567


Q ss_pred             CCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhh
Q 036815          904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESE  983 (1013)
Q Consensus       904 t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  983 (1013)
                      +..|+|||...+..++.++||||+|+++|++++|..||.....    ....... .............      .     
T Consensus       149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~~~~-~~~~~~~~~~~~~------~-----  212 (244)
T smart00220      149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLELFKK-IGKPKPPFPPPEW------K-----  212 (244)
T ss_pred             CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHH-HhccCCCCccccc------c-----
Confidence            8899999999888889999999999999999999999875311    1111111 1111110000000      0     


Q ss_pred             HHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          984 AEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       984 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ....+.+++.+|+..+|++||++.|
T Consensus       213 -----~~~~~~~~i~~~l~~~p~~Rp~~~~  237 (244)
T smart00220      213 -----ISPEAKDLIRKLLVKDPEKRLTAEE  237 (244)
T ss_pred             -----CCHHHHHHHHHHccCCchhccCHHH
Confidence                 0123668999999999999999864

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6e-31  Score=255.56  Aligned_cols=199  Identities=28%  Similarity=0.447  Sum_probs=164.6

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCC-----EEEE
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE-----ERLL  807 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  807 (1013)
                      .+-.+.||.|+||.||.+++. +|+.||.|++...  .-...+.+.+|++++..++|.|++..++......     +.|.
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            445688999999999999986 7999999988432  2233567889999999999999999998765432     4578


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ++|.|. .+|...+-.      ...++-+.++.+.+||++||+|||+.   +|.||||||.|.+++++...||||||+|+
T Consensus       135 ~TELmQ-SDLHKIIVS------PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVS------PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHHHH-hhhhheecc------CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence            888886 577777643      34588888999999999999999999   99999999999999999999999999999


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ..+.. ....++....|..|+|||+++|. .|+.+.||||+|||+.|++.++..|....
T Consensus       205 vee~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~  262 (449)
T KOG0664|consen  205 TWDQR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG  262 (449)
T ss_pred             ccchh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence            76543 33334456678899999999875 68999999999999999999998887543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.3e-29  Score=240.46  Aligned_cols=263  Identities=19%  Similarity=0.247  Sum_probs=195.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE-cCCCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEeC--CEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATL-KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIG--EERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  808 (1013)
                      .++|++.+++|+|.|+.||.|.. .+.++++||.+++   ...+.+.+|+.+++.+. ||||++++++..++  ....+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46799999999999999999985 4678899998754   33567899999999996 99999999998774  456799


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeecccce
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMAR  887 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~  887 (1013)
                      +||+.+.+......         .++...++..+.++++||.|+|++   ||+|||+||.|++||.. -..+++|+|+|.
T Consensus       114 FE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence            99999887776653         267778889999999999999999   99999999999999875 458999999999


Q ss_pred             eccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-----
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-----  961 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----  961 (1013)
                      ++-....   ......+..|.-||.+-. ..|+..-|+|||||++..|+..+.||........+++..++....+     
T Consensus       182 FYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y  258 (338)
T KOG0668|consen  182 FYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY  258 (338)
T ss_pred             hcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence            8754332   344566778899998764 4577889999999999999999999986555544454443321100     


Q ss_pred             -CccccccChhhhcccCCCChhhHHHH-------HHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 -GKQMEVIDPELLLVTKGTDESEAEEV-------KEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 -~~~~~~~d~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .+..-.+||+........+.......       -...+.++++.+.|..|-.+||||+|
T Consensus       259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE  318 (338)
T KOG0668|consen  259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE  318 (338)
T ss_pred             HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence             11111244443221111111110000       00123578999999999999999975

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=263.83  Aligned_cols=196  Identities=23%  Similarity=0.366  Sum_probs=168.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCcc-----ch---HHHHHHHHHHhccC---CcceeeeccEEEe
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQ-----GD---REFMAEMETLGKIK---HRNLVPLLGYCKI  801 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-----~~---~~~~~E~~~l~~l~---h~niv~l~~~~~~  801 (1013)
                      .+|+..+.+|+|+||.|+.|.++. ...|++|.+.+...-     .+   ..+-.|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            458999999999999999999874 567888877553211     11   23567999999997   9999999999999


Q ss_pred             CCEEEEEEEccc-CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEE
Q 036815          802 GEERLLVYEFMK-FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       802 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                      ++.+|++||-.. |-+|.+++..+..      +++.++..|++||+.|+++||+.   +|||||||-+||.++.+|-+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence            999999999764 5689999975543      89999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCC
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      +|||.|.....    .+...++||..|.|||++.|..| +..-||||+|+++|.++....||.
T Consensus       712 idfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999976543    23457789999999999999877 566899999999999999999975

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-28  Score=236.54  Aligned_cols=211  Identities=21%  Similarity=0.399  Sum_probs=169.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccE-EEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGY-CKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e  810 (1013)
                      +.|.+.+.+|+|.||.+-+++++. .+.+++|.+. ......++|.+|...--.+ .|.||+.-|++ |...+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            458999999999999999999874 5677888653 3445568899998764444 69999998874 566778889999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC--CCCcEEEeeccccee
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD--HEMEARVSDFGMARL  888 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~a~~  888 (1013)
                      |++.|+|..-+...+       +-+....+++.|++.|+.|||++   ++||||||.+||||-  +..++|+||||..+.
T Consensus       103 ~aP~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             cCccchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence            999999999886432       77788899999999999999999   999999999999993  345899999999876


Q ss_pred             ccccCcceeeeeeccCCCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR  960 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  960 (1013)
                      .+..     ......+..|.|||....     ....+.+|||.||+++|.++||+.||..+...+..+.+|.+...+
T Consensus       173 ~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  173 VGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR  244 (378)
T ss_pred             cCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence            5432     222344667999997642     245678999999999999999999999877777778777766444

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=266.03  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=196.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|.....+|.|.||.||+|+++ .++..|+|.++-....+..-+++|+-+++..+||||+.++|.+...+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467999999999999999999986 6888999988766666667788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      |.||+|.+.-+...      ++++.++..+.+..++|++|||+.   +-+|||||-.||++++.|.+|++|||.+-.+..
T Consensus        94 cgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999876543      489999999999999999999999   999999999999999999999999999866543


Q ss_pred             cCcceeeeeeccCCCccCcccc---cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYY---QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                        .-.....+.||+.|||||+.   +.+.|..++|||++|+...|+..-++|-.....     .+-....-..+  .  -
T Consensus       165 --ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----mr~l~LmTkS~--~--q  233 (829)
T KOG0576|consen  165 --TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----MRALFLMTKSG--F--Q  233 (829)
T ss_pred             --hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----HHHHHHhhccC--C--C
Confidence              22223457899999999986   356788999999999999999998888432111     11111111111  0  0


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      +|.+..   ...        -...+-+|++.|+..+|++|||++
T Consensus       234 pp~lkD---k~k--------ws~~fh~fvK~altknpKkRptae  266 (829)
T KOG0576|consen  234 PPTLKD---KTK--------WSEFFHNFVKGALTKNPKKRPTAE  266 (829)
T ss_pred             CCcccC---Ccc--------chHHHHHHHHHHhcCCCccCCChh
Confidence            111110   000        011256899999999999999986

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=4.9e-28  Score=242.21  Aligned_cols=195  Identities=27%  Similarity=0.370  Sum_probs=164.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCC------E
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE------E  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  804 (1013)
                      .+|.-.+.+|.|+- .|..|.+. .+++||+|++...  .....++..+|...+..+.|+||++++.+|....      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777888999988 66666654 6899999988543  1223466789999999999999999999986543      5


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+|||+|. .+|...+...        ++-.++..|..|++.|++|||+.   +|+|||+||+||++..+..+||.|||
T Consensus        96 ~y~v~e~m~-~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVILME--------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHHhhh-hHHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            699999998 6999888622        67788899999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +|+....   ....+....+..|.|||++.+..+.+.+||||+||++.||++|+..|.+.
T Consensus       164 ~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  164 LARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             hhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence            9986432   23455667888999999999888999999999999999999999999854

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-29  Score=258.13  Aligned_cols=436  Identities=26%  Similarity=0.278  Sum_probs=303.5

Q ss_pred             EEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCc
Q 036815           78 LLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLS  157 (1013)
Q Consensus        78 ~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  157 (1013)
                      ..+.++-.++.++..++      +....++|..|+|+.+++.+|..+++|+.|||++|.|+.+.|++|.++++|..|-+-
T Consensus        50 ~VdCr~~GL~eVP~~LP------~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvly  123 (498)
T KOG4237|consen   50 IVDCRGKGLTEVPANLP------PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLY  123 (498)
T ss_pred             eEEccCCCcccCcccCC------CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhh
Confidence            45666666765555443      577899999999999999999999999999999999999999999999998888766


Q ss_pred             C-CcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCC
Q 036815          158 N-NHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS  236 (1013)
Q Consensus       158 ~-n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~  236 (1013)
                      + |+|+ .+|...|..+..|+.|.+.-|++.-+...+|..+++|..|.+.+|.+. .++...|..+..++++.+..|.+-
T Consensus       124 g~NkI~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~i  201 (498)
T KOG4237|consen  124 GNNKIT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFI  201 (498)
T ss_pred             cCCchh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccc
Confidence            6 8999 899999999999999999999999888888999999999999999887 777777888888999998888754


Q ss_pred             CcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCcccccc-CcccEEEeeCCccCCCCCcc
Q 036815          237 GSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSEC-TQLKVIDLSLNYLNGSIPQE  315 (1013)
Q Consensus       237 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~p~~  315 (1013)
                           ...+++.+.. ++.-|.+.       +++..-..-..+.++++..+.+..|... ..+..--.+           
T Consensus       202 -----cdCnL~wla~-~~a~~~ie-------tsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~-----------  257 (498)
T KOG4237|consen  202 -----CDCNLPWLAD-DLAMNPIE-------TSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSS-----------  257 (498)
T ss_pred             -----cccccchhhh-HHhhchhh-------cccceecchHHHHHHHhcccchhhhhhhHHhHHHhhcc-----------
Confidence                 1233333322 22222222       2233334444555556654444443321 111111111           


Q ss_pred             cccCcchHHHHhhhccccCCCC-cCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCC
Q 036815          316 LGKLEHLEQFIAWFNGLEGKIP-PELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRL  394 (1013)
Q Consensus       316 l~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  394 (1013)
                                   .+...+..| ..|.+|++|+.|+|++|++++.-+.+|.++..+++|.|..|+|...-...|.++..|
T Consensus       258 -------------~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L  324 (498)
T KOG4237|consen  258 -------------EDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGL  324 (498)
T ss_pred             -------------ccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccc
Confidence                         111222223 258899999999999999998889999999999999999999986666789999999


Q ss_pred             ceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCC-chhhhccCCCCCC--------CcccCCceEEEeccCCCcc
Q 036815          395 AVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIP-PRLGRQLGAKPLG--------GFLSSNTLVFVRNVGNSCK  465 (1013)
Q Consensus       395 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~  465 (1013)
                      +.|+|.+|+|+..-|..|..+.+|.+|.|-.|.+-+..- .|++.++..+...        ++.....+.-+......|.
T Consensus       325 ~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~  404 (498)
T KOG4237|consen  325 KTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCG  404 (498)
T ss_pred             eeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccC
Confidence            999999999999999999999999999999999876643 4444432221100        0000000000000011111


Q ss_pred             CCCcccccccCCcccccccCccccccccccccCcccccccCCCcc-CEEEccCCcccccCChhhhCCCCCcEEecCCCcc
Q 036815          466 GVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTL-EYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQL  544 (1013)
Q Consensus       466 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L-~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l  544 (1013)
                                 .++.....           ....-|..-   +-+ ++...|++.++ .+|+.|-  ..-..|++.+|.+
T Consensus       405 -----------~~ee~~~~-----------~s~~cP~~c---~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~  456 (498)
T KOG4237|consen  405 -----------GPEELGCL-----------TSSPCPPPC---TCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAI  456 (498)
T ss_pred             -----------CccccCCC-----------CCCCCCCCc---chhhhhHhhcccchh-hcCCCCC--chhHHHhcccchh
Confidence                       01110000           000111111   111 33456666666 6776553  3456789999999


Q ss_pred             CCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCC
Q 036815          545 SGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN  590 (1013)
Q Consensus       545 ~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n  590 (1013)
                      + .+|.+  .+.+| .+|+|+|+++-.--..|+++++|.+|-||+|
T Consensus       457 ~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  457 T-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             c-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            9 89988  78888 9999999998555667999999999999987

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=9e-28  Score=253.30  Aligned_cols=268  Identities=22%  Similarity=0.239  Sum_probs=200.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC------CcceeeeccEEEeCCE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK------HRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~  804 (1013)
                      ...+|.+....|+|-|++|..|.+. .|+.||||++... ..-.+.=..|+++|+++.      --|+++++..|....+
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            4578999999999999999999986 4789999987542 223445578999999995      2489999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeec
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDF  883 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Df  883 (1013)
                      .|+|+|-+. -+|.+++...+..   ..+....+..+++|+.-||..|...   +|+|.||||+||||++. ..+|||||
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence            999999886 6999999866542   2377788999999999999999998   99999999999999876 45799999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH------
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM------  957 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------  957 (1013)
                      |.|.......    .+.+..+..|.|||++.|.+|+...|+||+||++||+.||+..|.+....+  +..+...      
T Consensus       582 GSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~--MLrl~me~KGk~p  655 (752)
T KOG0670|consen  582 GSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ--MLRLFMELKGKFP  655 (752)
T ss_pred             cccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH--HHHHHHHhcCCCc
Confidence            9998764322    223345668999999999999999999999999999999999998765322  2111111      


Q ss_pred             --HHhcCcccc-ccCh----------------------------hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCC
Q 036815          958 --KVREGKQME-VIDP----------------------------ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPS 1006 (1013)
Q Consensus       958 --~~~~~~~~~-~~d~----------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 1006 (1013)
                        .++.+.+.+ -+|.                            .+.....+......++...+.++.+|+..|+..||+
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence              111111100 0111                            111111122223344555667788999999999999


Q ss_pred             CCCCCCC
Q 036815         1007 KRPNMLQ 1013 (1013)
Q Consensus      1007 ~RPt~~e 1013 (1013)
                      +|.|..|
T Consensus       736 KRit~nq  742 (752)
T KOG0670|consen  736 KRITVNQ  742 (752)
T ss_pred             hcCCHHH
Confidence            9998754

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=4.1e-27  Score=245.26  Aligned_cols=209  Identities=29%  Similarity=0.433  Sum_probs=171.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEE
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  805 (1013)
                      ...+.|..+++||+|.|++||+|++.    ..+.||+|.+...+  ....+..|++++..+ .+.||+++.+++..++..
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            34567999999999999999999864    36789999886543  345688999999999 599999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeecc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFG  884 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg  884 (1013)
                      .+|+||++.....++...         ++...+...++.++.||+++|..   |||||||||+|++.+.. ++-.|+|||
T Consensus       111 ~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             EEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            999999999888888853         67888999999999999999999   99999999999999864 678999999


Q ss_pred             cceeccccC--------------c----------------------------ceeeeeeccCCCccCcccccCC-CCCcc
Q 036815          885 MARLISALD--------------T----------------------------HLSVSTLAGTPGYVPPEYYQSF-RCTAK  921 (1013)
Q Consensus       885 ~a~~~~~~~--------------~----------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~  921 (1013)
                      +|...+...              .                            .......+||++|+|||++... ..+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            997321100              0                            0001235699999999998654 56889


Q ss_pred             chhHhHHHHHHHHHcCCCCCCCCCCCCccHHH
Q 036815          922 GDVYSFGVVLLELLTGKRPTDKDDFGDTNLVG  953 (1013)
Q Consensus       922 ~DvwslG~il~elltg~~pf~~~~~~~~~~~~  953 (1013)
                      +||||.|||+.-+++++.||......-..+.+
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~e  290 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAE  290 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHH
Confidence            99999999999999999999876555444433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.3e-25  Score=233.29  Aligned_cols=206  Identities=34%  Similarity=0.559  Sum_probs=176.7

Q ss_pred             ecccCCcEEEEEEEcC-CCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCHHH
Q 036815          742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEE  819 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  819 (1013)
                      ||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 889999987544322 24678999999999999999999999999899999999999999999


Q ss_pred             HhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-CCcEEEeecccceeccccCcceee
Q 036815          820 VLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-EMEARVSDFGMARLISALDTHLSV  898 (1013)
Q Consensus       820 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~  898 (1013)
                      ++....     ..+++..+..++.+++++++|||+.   +++|+||+|.||+++. ++.++++|||.+........  ..
T Consensus        81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~  150 (215)
T cd00180          81 LLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL  150 (215)
T ss_pred             HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence            986432     2378999999999999999999999   9999999999999999 89999999999987643221  12


Q ss_pred             eeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccC
Q 036815          899 STLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK  977 (1013)
Q Consensus       899 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  977 (1013)
                      ....+...|++||..... .++.++|+|++|++++++                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            334578899999999877 788999999999999999                                           


Q ss_pred             CCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          978 GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       978 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                   ..+.+++.+|++.+|++||+++|
T Consensus       188 -------------~~~~~~l~~~l~~~p~~R~~~~~  210 (215)
T cd00180         188 -------------PELKDLIRKMLQKDPEKRPSAKE  210 (215)
T ss_pred             -------------HHHHHHHHHHhhCCcccCcCHHH
Confidence                         12568999999999999999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.5e-25  Score=235.33  Aligned_cols=199  Identities=33%  Similarity=0.493  Sum_probs=172.1

Q ss_pred             CCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      |.+.+.||+|++|.||+|...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999999875 789999988654443 56788999999999999999999999998899999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++......     +++..+..++.+++.++.|||+.   +++|+|++|+||+++.++.++++|||.+.......
T Consensus        81 ~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       81 GGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             CCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            99999999753321     68889999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeeeeeccCCCccCcccc-cCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          894 THLSVSTLAGTPGYVPPEYY-QSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      .. ......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       153 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 AA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            11 22345677889999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=7.1e-28  Score=246.91  Aligned_cols=399  Identities=24%  Similarity=0.270  Sum_probs=291.8

Q ss_pred             eecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCC
Q 036815            4 VLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSY   83 (1013)
Q Consensus         4 ~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~   83 (1013)
                      +.|.++-.++++|++   +|++.+.|.|..|+|.. +|+++|+.+++|+.||||+|+|+ .|.+.+|.+++.|.+|.+-+
T Consensus        50 ~VdCr~~GL~eVP~~---LP~~tveirLdqN~I~~-iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg  124 (498)
T KOG4237|consen   50 IVDCRGKGLTEVPAN---LPPETVEIRLDQNQISS-IPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYG  124 (498)
T ss_pred             eEEccCCCcccCccc---CCCcceEEEeccCCccc-CChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhc
Confidence            457778889999997   99999999999999965 89999999999999999999998 66667789999998887666


Q ss_pred             -CcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCccc
Q 036815           84 -NNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT  162 (1013)
Q Consensus        84 -n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  162 (1013)
                       |+|+.+....+   ..+.+|+.|.+.-|++.-+..+.|..+++|..|.+.+|.+..+--..|..+..++.+.+..|.+.
T Consensus       125 ~NkI~~l~k~~F---~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i  201 (498)
T KOG4237|consen  125 NNKITDLPKGAF---GGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI  201 (498)
T ss_pred             CCchhhhhhhHh---hhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc
Confidence             99998777655   56778999999999999988999999999999999999998555558999999999999998732


Q ss_pred             C------------cCCccchhccCCCcEEECCCCCCCCcCCccccCC-CCCCEEEccCCCCCCCCChhhhhcCCCCcEEE
Q 036815          163 G------------WIPSELGNACDSLLELKLPHNNITGSFPVTLSSC-SWLQLLDLSNNNISGPFPDSVLENLGSLESLI  229 (1013)
Q Consensus       163 ~------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  229 (1013)
                      .            ..|.. +....-..-..+.++++..+.+..|... ..+.+--.+.+.+.+..|...|..+++|++|+
T Consensus       202 cdCnL~wla~~~a~~~ie-tsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ln  280 (498)
T KOG4237|consen  202 CDCNLPWLADDLAMNPIE-TSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLN  280 (498)
T ss_pred             cccccchhhhHHhhchhh-cccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEec
Confidence            1            11111 1111223334455555655555444322 23332233444555678888899999999999


Q ss_pred             cccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccC
Q 036815          230 LSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN  309 (1013)
Q Consensus       230 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~  309 (1013)
                      |++|+|+.+-+.+|.....++.|.|..|+|. .+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|.|-.|++.
T Consensus       281 lsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  281 LSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             cCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            9999999988999999999999999999998 777888999999999999999999999999999999999999999876


Q ss_pred             CCCCcccccCcchHHH--HhhhccccCCCCcCcCCCCCCceEECccccccc---cCchhhcC------------------
Q 036815          310 GSIPQELGKLEHLEQF--IAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG---EIPAELFS------------------  366 (1013)
Q Consensus       310 ~~~p~~l~~l~~L~~L--~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~---~~p~~l~~------------------  366 (1013)
                      -.        -+|..|  ++..+.-.|..| . ++-..++.+.++.+.+..   ..|++.+.                  
T Consensus       360 Cn--------C~l~wl~~Wlr~~~~~~~~~-C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvR  429 (498)
T KOG4237|consen  360 CN--------CRLAWLGEWLRKKSVVGNPR-C-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVR  429 (498)
T ss_pred             Cc--------cchHHHHHHHhhCCCCCCCC-C-CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHh
Confidence            21        112222  222333222111 1 111234444444443321   12222111                  


Q ss_pred             C-------------CCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCC
Q 036815          367 C-------------SNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN  426 (1013)
Q Consensus       367 l-------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  426 (1013)
                      +             ..-.+|++.+|.++ .+|..  .+.+| .+++++|+++-.-...|.+++.|.+|-|+.|
T Consensus       430 cSnk~lk~lp~~iP~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  430 CSNKLLKLLPRGIPVDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hcccchhhcCCCCCchhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            0             12345777888877 67766  56667 7888888887544556777777877777765

>PLN03210 Resistant to P

Probab=99.92  E-value=8e-24  Score=269.51  Aligned_cols=341  Identities=23%  Similarity=0.299  Sum_probs=244.7

Q ss_pred             CCCccccCCCCCCEEecCCCcc------cccCcccccCC-CCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCC
Q 036815          116 VIPSSLSNCTKLKILNLSFNLL------AGEIPRTFGQL-SSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITG  188 (1013)
Q Consensus       116 ~~~~~l~~l~~L~~L~L~~n~l------~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  188 (1013)
                      +.+.+|.++++|+.|.+..+..      ....|..|..+ .+|+.|++.++.++ .+|..+.  +.+|++|+|.+|++. 
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~--~~~L~~L~L~~s~l~-  624 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFR--PENLVKLQMQGSKLE-  624 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCC--ccCCcEEECcCcccc-
Confidence            4556788889999998866532      22456666665 46899999988887 7787763  478999999998887 


Q ss_pred             cCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCC
Q 036815          189 SFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDIC  268 (1013)
Q Consensus       189 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  268 (1013)
                      .++..+..+++|+.|+|++|.....+|.  +..+++|++|+|++|.....+|..+.++++|+.|++++|.....+|..+ 
T Consensus       625 ~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-  701 (1153)
T PLN03210        625 KLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-  701 (1153)
T ss_pred             ccccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-
Confidence            4566778888999999988754446664  5678889999998886555788888888889999988875444566544 


Q ss_pred             CCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCce
Q 036815          269 PGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD  348 (1013)
Q Consensus       269 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  348 (1013)
                       ++++|+.|++++|......|..   .++|+.|++++|.+. .+|..+ .+                        ++|++
T Consensus       702 -~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l------------------------~~L~~  751 (1153)
T PLN03210        702 -NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RL------------------------ENLDE  751 (1153)
T ss_pred             -CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cc------------------------ccccc
Confidence             5778888888887654444432   356777777777765 444432 23                        34444


Q ss_pred             EECccccc-------cccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEE
Q 036815          349 LILNNNKL-------SGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL  421 (1013)
Q Consensus       349 L~L~~N~l-------~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  421 (1013)
                      |++.++..       ....+......++|+.|+|++|...+.+|.+++++++|+.|++++|...+.+|..+ ++++|+.|
T Consensus       752 L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L  830 (1153)
T PLN03210        752 LILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESL  830 (1153)
T ss_pred             ccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEE
Confidence            44443221       11112223335688889999888777888889999999999998886555788776 78899999


Q ss_pred             EccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCccc
Q 036815          422 DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVL  501 (1013)
Q Consensus       422 ~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  501 (1013)
                      ++++|.....+|.                                                                   
T Consensus       831 ~Ls~c~~L~~~p~-------------------------------------------------------------------  843 (1153)
T PLN03210        831 DLSGCSRLRTFPD-------------------------------------------------------------------  843 (1153)
T ss_pred             ECCCCCccccccc-------------------------------------------------------------------
Confidence            9988754322221                                                                   


Q ss_pred             ccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCC-CccCCCCcccccCCCCcceEecCCcc
Q 036815          502 SLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH-NQLSGEIPSSLGRLRNLGVFDASHNR  567 (1013)
Q Consensus       502 ~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~-n~l~g~ip~~~~~l~~L~~L~ls~N~  567 (1013)
                          ..++|++|+|++|.++ .+|.+++.+++|++|+|++ |+|+ .+|..+..+++|+.|+++++.
T Consensus       844 ----~~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        844 ----ISTNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             ----cccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence                0146788999999998 7898999999999999988 5666 688888888888888888763

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.90  E-value=5e-23  Score=262.25  Aligned_cols=305  Identities=22%  Similarity=0.266  Sum_probs=145.9

Q ss_pred             CCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEc
Q 036815          200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL  279 (1013)
Q Consensus       200 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  279 (1013)
                      |+.|++.++.++ .+|..+  .+.+|++|++.+|++. .++..+..+++|+.|+|++|.....+|.  +..+++|+.|+|
T Consensus       591 Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L  664 (1153)
T PLN03210        591 LRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKL  664 (1153)
T ss_pred             cEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEe
Confidence            444444444443 333321  2344444444444444 3344444444444444444432223321  223444445555


Q ss_pred             CCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccccc
Q 036815          280 PDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE  359 (1013)
Q Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  359 (1013)
                      ++|.....+|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|..   ..+|+.|+|++|.+. .
T Consensus       665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~  739 (1153)
T PLN03210        665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-E  739 (1153)
T ss_pred             cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-c
Confidence            4444333444444555555555555443322344333 3444444444444333333321   234555555555554 3


Q ss_pred             CchhhcCCCCCCeEEecCCccC-------CCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCC
Q 036815          360 IPAELFSCSNLEWISLTGNELT-------GQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDI  432 (1013)
Q Consensus       360 ~p~~l~~l~~L~~L~L~~N~l~-------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  432 (1013)
                      +|..+ .+++|++|++.++...       ...|..+...++|+.|+|++|...+.+|.+++++++|+.|+|++|...+.+
T Consensus       740 lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~L  818 (1153)
T PLN03210        740 FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETL  818 (1153)
T ss_pred             ccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCee
Confidence            44433 3445555555442211       111111222344555555555444455555555555555555554322222


Q ss_pred             CchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCE
Q 036815          433 PPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEY  512 (1013)
Q Consensus       433 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~  512 (1013)
                      |..                                                                    . .+++|++
T Consensus       819 P~~--------------------------------------------------------------------~-~L~sL~~  829 (1153)
T PLN03210        819 PTG--------------------------------------------------------------------I-NLESLES  829 (1153)
T ss_pred             CCC--------------------------------------------------------------------C-CccccCE
Confidence            211                                                                    1 2345667


Q ss_pred             EEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCC-ccccCCCcccccCCCcceEEECcCC
Q 036815          513 LDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASH-NRLQGQIPESFSNLSFLVQIDLSNN  590 (1013)
Q Consensus       513 L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~l~~l~l~~n  590 (1013)
                      |++++|..-..+|..   ..+|+.|+|++|.++ .+|.+++.+++|+.|+|++ |+|+ .+|..+..++.|+.++++++
T Consensus       830 L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        830 LDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             EECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            777765444355543   245667777777776 5777777777777777766 4454 46666666777777777665

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=1.7e-23  Score=245.93  Aligned_cols=80  Identities=28%  Similarity=0.330  Sum_probs=39.7

Q ss_pred             cCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcC
Q 036815          510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSN  589 (1013)
Q Consensus       510 L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~  589 (1013)
                      |+.|++++|+|+ .+|...   .+|+.|++++|+|+ .+|...   .+|+.|++++|+|+ .+|..+.+++.|..|+|++
T Consensus       384 L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~  454 (788)
T PRK15387        384 LKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  454 (788)
T ss_pred             cceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence            444555555555 344322   34555555555555 344322   23445555555554 4555555555555555555


Q ss_pred             CCCCCcCCC
Q 036815          590 NELTGPIPQ  598 (1013)
Q Consensus       590 n~l~~~~p~  598 (1013)
                      |+|+|.+|.
T Consensus       455 N~Ls~~~~~  463 (788)
T PRK15387        455 NPLSERTLQ  463 (788)
T ss_pred             CCCCchHHH
Confidence            555555443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=6.1e-23  Score=241.22  Aligned_cols=266  Identities=27%  Similarity=0.331  Sum_probs=157.2

Q ss_pred             CcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEec
Q 036815          176 LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS  255 (1013)
Q Consensus       176 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  255 (1013)
                      -..|+|+.|.++ .+|..+.  ++|+.|++++|+++ .+|.    .+++|++|++++|+++ .+|..   .++|+.|+++
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls  270 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIF  270 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence            334444444444 2233332  24555555555554 3332    1345555555555555 23322   2455566666


Q ss_pred             CCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCC
Q 036815          256 SNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGK  335 (1013)
Q Consensus       256 ~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~  335 (1013)
                      +|.++ .+|. .   ..+|+.|++++|+++. +|.   ..++|+.|++++|++++ +|..                    
T Consensus       271 ~N~L~-~Lp~-l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~l--------------------  320 (788)
T PRK15387        271 SNPLT-HLPA-L---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPAL--------------------  320 (788)
T ss_pred             CCchh-hhhh-c---hhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCC--------------------
Confidence            66555 2222 1   2345666666666663 232   23567777777777762 3321                    


Q ss_pred             CCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCC
Q 036815          336 IPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNC  415 (1013)
Q Consensus       336 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  415 (1013)
                       |      .+|+.|++++|+++ .+|..   ..+|+.|+|++|+|+ .+|...   .+|+.|++++|+++ .+|..   .
T Consensus       321 -p------~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l---~  381 (788)
T PRK15387        321 -P------SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPAL---P  381 (788)
T ss_pred             -c------ccccccccccCccc-ccccc---ccccceEecCCCccC-CCCCCC---cccceehhhccccc-cCccc---c
Confidence             1      13445556666665 34431   135667777777776 445432   35666777777777 46653   3


Q ss_pred             CCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCcccccccccc
Q 036815          416 SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARM  495 (1013)
Q Consensus       416 ~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  495 (1013)
                      ++|+.|++++|++++ +|..                                                            
T Consensus       382 ~~L~~LdLs~N~Lt~-LP~l------------------------------------------------------------  400 (788)
T PRK15387        382 SGLKELIVSGNRLTS-LPVL------------------------------------------------------------  400 (788)
T ss_pred             cccceEEecCCcccC-CCCc------------------------------------------------------------
Confidence            567888888887763 3321                                                            


Q ss_pred             ccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCccc
Q 036815          496 YSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPES  575 (1013)
Q Consensus       496 ~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~  575 (1013)
                                 .++|+.||+|+|+|+ .+|...   .+|+.|+|++|+|+ .||.+++++++|+.|+|++|+|+|.+|..
T Consensus       401 -----------~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~  464 (788)
T PRK15387        401 -----------PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA  464 (788)
T ss_pred             -----------ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHH
Confidence                       134778888888888 577643   46778888888888 78888888888999999999998888877


Q ss_pred             ccCC
Q 036815          576 FSNL  579 (1013)
Q Consensus       576 ~~~l  579 (1013)
                      +..+
T Consensus       465 L~~l  468 (788)
T PRK15387        465 LREI  468 (788)
T ss_pred             HHHH
Confidence            6443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=3.2e-23  Score=208.35  Aligned_cols=161  Identities=24%  Similarity=0.283  Sum_probs=118.3

Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++..+.     ..+++.+++.++.|++.||+|||++   +      ||+||+++.++.+|+  ||.++.....  
T Consensus         1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~--   62 (176)
T smart00750        1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE--   62 (176)
T ss_pred             CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc--
Confidence            68899986432     3489999999999999999999998   5      999999999999999  9999865431  


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhc
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL  974 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  974 (1013)
                           ...|++.|+|||++.+..++.++|||||||++|||++|+.||............+...... .      ++..  
T Consensus        63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~------~~~~--  128 (176)
T smart00750       63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-D------DPRD--  128 (176)
T ss_pred             -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-C------Cccc--
Confidence                 1257899999999999999999999999999999999999986533212112221111100 0      0000  


Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          975 VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       975 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           . .......+...+.+++.+||+.||++|||+.|
T Consensus       129 -----~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~  161 (176)
T smart00750      129 -----R-SNLESVSAARSFADFMRVCASRLPQRREAANH  161 (176)
T ss_pred             -----c-ccHHHHHhhhhHHHHHHHHHhcccccccCHHH
Confidence                 0 00111122234779999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.89  E-value=6.8e-24  Score=262.62  Aligned_cols=193  Identities=19%  Similarity=0.230  Sum_probs=134.0

Q ss_pred             ccCC-cceeeeccEE-------EeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCC
Q 036815          786 KIKH-RNLVPLLGYC-------KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI  857 (1013)
Q Consensus       786 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  857 (1013)
                      .++| +||++++++|       ...+..+.++||++ ++|.+++...     ...+++.+++.+++||++||+|||++  
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~--   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHSQ--   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHhC--
Confidence            3455 5888888877       22345678889875 6999999632     23489999999999999999999999  


Q ss_pred             CCeEecCCCcccEEeCCC-------------------CcEEEeecccceeccccCc--------------ceeeeeeccC
Q 036815          858 PHIIHRDMKSSNVLLDHE-------------------MEARVSDFGMARLISALDT--------------HLSVSTLAGT  904 (1013)
Q Consensus       858 ~~ivH~Dlkp~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt  904 (1013)
                       +||||||||+|||++..                   +.+|++|||+++.......              ........||
T Consensus       100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence             99999999999999654                   4456666666654211000              0001123578


Q ss_pred             CCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhH
Q 036815          905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEA  984 (1013)
Q Consensus       905 ~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  984 (1013)
                      +.|||||++.+..++.++|||||||++|||++|..|+....       ..... ....    ..++..            
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~~-~~~~----~~~~~~------------  234 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMSS-LRHR----VLPPQI------------  234 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHHH-HHHh----hcChhh------------
Confidence            88999999999999999999999999999999988865311       01110 0000    011110            


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          985 EEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       985 ~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        .........++.+||++||.+||||.|
T Consensus       235 --~~~~~~~~~~~~~~L~~~P~~Rps~~e  261 (793)
T PLN00181        235 --LLNWPKEASFCLWLLHPEPSCRPSMSE  261 (793)
T ss_pred             --hhcCHHHHHHHHHhCCCChhhCcChHH
Confidence              001122457788999999999999875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.2e-22  Score=221.65  Aligned_cols=164  Identities=20%  Similarity=0.229  Sum_probs=128.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc--CCCEEEEEEeeccC-----ccchHHHHHHHHHHhccCCcceee-eccEEEeCC
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK--DGSSVAIKKLIRLS-----CQGDREFMAEMETLGKIKHRNLVP-LLGYCKIGE  803 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~  803 (1013)
                      ..++|++.+.||+|+||+||+|.++  +++.||||++....     ....+.+.+|++++++++|+|+++ +++    .+
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence            4578999999999999999999875  46778999865321     122456899999999999999985 433    24


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CcccEEeCCCCcEEEee
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDM-KSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~D  882 (1013)
                      ..|+||||++|++|... .   .      ..   ...++.|+++||+|||++   ||+|||| ||+||+++.++.+||+|
T Consensus        92 ~~~LVmE~~~G~~L~~~-~---~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-R---P------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             CcEEEEEccCCCCHHHh-C---c------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence            67999999999999632 1   0      00   135788999999999999   9999999 99999999999999999


Q ss_pred             cccceeccccCccee------eeeeccCCCccCcccccC
Q 036815          883 FGMARLISALDTHLS------VSTLAGTPGYVPPEYYQS  915 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  915 (1013)
                      ||+|+.+........      .....+++.|+|||++..
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999997754332111      135668889999999864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.3e-22  Score=197.69  Aligned_cols=240  Identities=25%  Similarity=0.400  Sum_probs=176.8

Q ss_pred             CCCeecccCCcEEEEEEEcCCCEEEEEEeec--cCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          738 AESLIGCGGFGEVFKATLKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       738 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      ...+|.+...|..|+|+++ |..+++|++..  ......++|..|.-.++-+.||||..++|.|.......++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            4457888999999999998 56666676533  33334578999999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      +|+..++...    ...++-.++.+++.++|+|++|||+.. +-|.---+.+..|++|++.+++|. .+-+++.      
T Consensus       273 slynvlhe~t----~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfs------  340 (448)
T KOG0195|consen  273 SLYNVLHEQT----SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFS------  340 (448)
T ss_pred             HHHHHHhcCc----cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceee------
Confidence            9999998654    345788899999999999999999973 223444689999999999888774 1212211      


Q ss_pred             eeeeeeccCCCccCcccccCCCCC---ccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          896 LSVSTLAGTPGYVPPEYYQSFRCT---AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      .+.......|.||+||.++..+-+   .++|+|||++++||+.|...||.....-+      ..+++.-.-..--++|.+
T Consensus       341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme------cgmkialeglrv~ippgi  414 (448)
T KOG0195|consen  341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------CGMKIALEGLRVHIPPGI  414 (448)
T ss_pred             eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh------hhhhhhhccccccCCCCc
Confidence            111223457899999999866543   47999999999999999999998644222      111111111111222222


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             +          ..+.+++.-|+..||.+||.+++
T Consensus       415 -------s----------~hm~klm~icmnedpgkrpkfdm  438 (448)
T KOG0195|consen  415 -------S----------RHMNKLMNICMNEDPGKRPKFDM  438 (448)
T ss_pred             -------c----------HHHHHHHHHHhcCCCCcCCCcce
Confidence                   1          12557888999999999998763

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=4e-21  Score=211.78  Aligned_cols=203  Identities=23%  Similarity=0.272  Sum_probs=165.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEcCC--CEEEEEEeeccCccchHHHHHHHHHHhccCC----cceeeeccEE-EeCCEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKDG--SSVAIKKLIRLSCQGDREFMAEMETLGKIKH----RNLVPLLGYC-KIGEERLL  807 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  807 (1013)
                      +|.+.+.||+|+||.||.|.+...  ..+|+|............+..|..++..+..    +++.++++.. ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999998754  4677776554333333378889999988863    6899999888 47778899


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-----CcEEEee
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-----MEARVSD  882 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~D  882 (1013)
                      ||+.+ |.+|.++.....    .+.++..++.+|+.|++.+|+++|+.   |++||||||+|+.+...     ..+++.|
T Consensus        99 VM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             EEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            99976 589999875443    34489999999999999999999999   99999999999999865     3589999


Q ss_pred             cccceecc--ccCcc--e---e-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          883 FGMARLIS--ALDTH--L---S-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       883 fg~a~~~~--~~~~~--~---~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ||+|+.+.  .....  .   . .....||.+|+++....+...+.+.|+||+++++.|+..|..||....
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            99999332  21111  1   1 234569999999999999999999999999999999999999997644

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=8.7e-22  Score=197.97  Aligned_cols=202  Identities=22%  Similarity=0.291  Sum_probs=170.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      -.|+++++||+|+||.++.|+.- ++++||||.-  .......++..|++.++.+ ..+.|..+|-+..++-+-.+|+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE--PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE--PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEec--cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            36999999999999999999854 7899999942  2233345688899999988 578999998887888888999998


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-----cEEEeecccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-----EARVSDFGMA  886 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfg~a  886 (1013)
                      + |-+|+|...-..     +.++.+++..||.|++.-++|+|++   .+|.|||||+|+||...+     .+.++|||+|
T Consensus       106 L-GPSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             h-CcCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            7 479999886443     3499999999999999999999999   999999999999997543     4899999999


Q ss_pred             eeccccCcc-----eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          887 RLISALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       887 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      +.+....+.     .......||.+||+-....|...+.+.|+-|+|-|+.+.+-|..||.+...
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            987654432     123356799999999999999999999999999999999999999987543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=7.5e-22  Score=189.59  Aligned_cols=203  Identities=22%  Similarity=0.297  Sum_probs=168.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE-cCCCEEEEEEeeccCccchHHHHHHHHHHhccCC-cceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATL-KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH-RNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|.++++||.|+||.+|.|.. .+|.+||||.-..  .....++..|..+++.+++ ..|..+..|..+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            46899999999999999999985 5799999996432  2334567889999999864 677777778888888899999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC---CcEEEeecccce
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE---MEARVSDFGMAR  887 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~  887 (1013)
                      .+ |.+|++...-..     +.++..++..++-|++.-++|+|.+   ++|||||||+|+++.-+   ..+.++|||+|+
T Consensus        92 LL-GPsLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             cc-CccHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            87 479999875433     3389999999999999999999999   99999999999999754   458999999999


Q ss_pred             eccccCcc-----eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          888 LISALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       888 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      .+.+..+.     .......||.+|.+-....+...+.+.|+-|+|.++.++--|..||.+...
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            87543321     223456799999999888888888999999999999999999999987543

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=1.9e-21  Score=230.61  Aligned_cols=56  Identities=27%  Similarity=0.427  Sum_probs=24.7

Q ss_pred             cCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccc----cCCCCcceEecCCcccc
Q 036815          510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSL----GRLRNLGVFDASHNRLQ  569 (1013)
Q Consensus       510 L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~----~~l~~L~~L~ls~N~l~  569 (1013)
                      |++|+|++|+|+ .+|..+.  ..|+.|++++|+|+ .+|.++    +.++++..|+|.+|.++
T Consensus       369 L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        369 ITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             cCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            444444444444 3444433  13444444444444 333322    22344455555555554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=1.9e-22  Score=234.96  Aligned_cols=250  Identities=19%  Similarity=0.236  Sum_probs=181.8

Q ss_pred             CCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--Cccch----HHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          738 AESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGD----REFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       738 ~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ...++|.|++|.|+.+... ....++.|.+...  .....    ..+..|+.+-..++|||++..+..+.+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4678999999988877654 2333444433210  11111    226678888888999999998888877766666699


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++ +|...+....      .+...++..+++|+..|++|+|+.   ||.|||+|++|++++..|.+||+|||.+..+.
T Consensus       402 ~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             cccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeec
Confidence            9998 9999987542      277888899999999999999999   99999999999999999999999999998775


Q ss_pred             ccCcc--eeeeeeccCCCccCcccccCCCCCc-cchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          891 ALDTH--LSVSTLAGTPGYVPPEYYQSFRCTA-KGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       891 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      .....  .......|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||......+....    ...........
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----~~~~~~~~~~~  547 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----TNNYSDQRNIF  547 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----hhccccccccc
Confidence            54443  4456788999999999999998876 48999999999999999999987654443220    00000000000


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+            ......-..+...++.+||++||.+|.|++|
T Consensus       548 ~~~------------~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~  581 (601)
T KOG0590|consen  548 EGP------------NRLLSLLPRETRIIIYRMLQLDPTKRITIEQ  581 (601)
T ss_pred             cCh------------HHHHHhchhhHHHHHHHHccCChhheecHHH
Confidence            000            0001111122458899999999999999864

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2.9e-21  Score=229.06  Aligned_cols=162  Identities=28%  Similarity=0.468  Sum_probs=112.0

Q ss_pred             CCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEcc
Q 036815          345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLN  424 (1013)
Q Consensus       345 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  424 (1013)
                      +|+.|++++|+++ .+|..+.  ++|+.|+|++|+++ .+|..+.  +.|+.|++++|+++ .+|..+.  ++|+.|+++
T Consensus       263 ~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls  333 (754)
T PRK15370        263 ALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAG  333 (754)
T ss_pred             CCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceecccc
Confidence            4666666666666 4555443  36777777777776 4554432  35777777888777 4565442  578888888


Q ss_pred             CCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccc
Q 036815          425 SNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLF  504 (1013)
Q Consensus       425 ~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  504 (1013)
                      +|.+++ +|..+                                                                    
T Consensus       334 ~N~Lt~-LP~~l--------------------------------------------------------------------  344 (754)
T PRK15370        334 ENALTS-LPASL--------------------------------------------------------------------  344 (754)
T ss_pred             CCcccc-CChhh--------------------------------------------------------------------
Confidence            887764 44211                                                                    


Q ss_pred             cCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccc----cCCC
Q 036815          505 TQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESF----SNLS  580 (1013)
Q Consensus       505 ~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~----~~l~  580 (1013)
                        .++|+.|++++|+|+ .+|..+.  .+|+.|+|++|+|+ .+|..+.  .+|+.|++++|+|+ .+|..+    +.++
T Consensus       345 --~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~  415 (754)
T PRK15370        345 --PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGP  415 (754)
T ss_pred             --cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCC
Confidence              135788888888888 6787664  57888888888888 6887765  36888888888887 566543    4457


Q ss_pred             cceEEECcCCCCC
Q 036815          581 FLVQIDLSNNELT  593 (1013)
Q Consensus       581 ~l~~l~l~~n~l~  593 (1013)
                      .+..++|.+|+++
T Consensus       416 ~l~~L~L~~Npls  428 (754)
T PRK15370        416 QPTRIIVEYNPFS  428 (754)
T ss_pred             CccEEEeeCCCcc
Confidence            7888888888887

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1.2e-19  Score=203.92  Aligned_cols=202  Identities=32%  Similarity=0.505  Sum_probs=170.6

Q ss_pred             CCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCc-ceeeeccEEEeCCEEEEEEEc
Q 036815          736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHR-NLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      |.+.+.||.|+||.||++.+.  ..+++|.+......   ....+.+|+.+++.+.|+ +++++++++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999987  78899987654333   356789999999999988 799999999777778999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-cEEEeecccceecc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMARLIS  890 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~  890 (1013)
                      +.++++.+++......   ..++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++...
T Consensus        80 ~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          80 VDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             CCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            9999999777543311   2488899999999999999999999   999999999999999988 79999999998654


Q ss_pred             ccCcce----eeeeeccCCCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          891 ALDTHL----SVSTLAGTPGYVPPEYYQS---FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       891 ~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ......    ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||....
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            433221    2356789999999999987   578889999999999999999999976543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=8.5e-21  Score=191.57  Aligned_cols=172  Identities=11%  Similarity=0.127  Sum_probs=133.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHH---------HHHHHHHHhccCCcceeeeccEEEeC
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE---------FMAEMETLGKIKHRNLVPLLGYCKIG  802 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~  802 (1013)
                      ..++|++.+++|.|+||.||.+.. +++.+|+|.+.+.....++.         +.+|+..+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468999999999999999999766 57789999886543333322         67899999999999999999886543


Q ss_pred             --------CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC
Q 036815          803 --------EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH  874 (1013)
Q Consensus       803 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  874 (1013)
                              +..++||||++|.+|.++..          ++.    ....+++.++..+|+.   |++|||+||+||+++.
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence                    35789999999999988742          222    2456899999999999   9999999999999999


Q ss_pred             CCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc
Q 036815          875 EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT  936 (1013)
Q Consensus       875 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  936 (1013)
                      ++ ++++|||..+.......              ...++....+..++|+|++||.+.....
T Consensus       171 ~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             CC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence            88 99999998865421110              0113344456679999999999876543

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.82  E-value=2.7e-22  Score=182.50  Aligned_cols=169  Identities=33%  Similarity=0.550  Sum_probs=150.7

Q ss_pred             CcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCC
Q 036815          339 ELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSL  418 (1013)
Q Consensus       339 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  418 (1013)
                      .+..+...+.|.||+|+++ .+|..+..+.+|+.|++++|+++ .+|..++.+++|+.|+++-|++. .+|..|+.++.|
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            3455677889999999999 88889999999999999999999 89999999999999999999998 899999999999


Q ss_pred             cEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccC
Q 036815          419 VWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSG  498 (1013)
Q Consensus       419 ~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  498 (1013)
                      +.|||..|++...                                                                   
T Consensus       105 evldltynnl~e~-------------------------------------------------------------------  117 (264)
T KOG0617|consen  105 EVLDLTYNNLNEN-------------------------------------------------------------------  117 (264)
T ss_pred             hhhhccccccccc-------------------------------------------------------------------
Confidence            9999999988632                                                                   


Q ss_pred             cccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccC
Q 036815          499 PVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSN  578 (1013)
Q Consensus       499 ~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~  578 (1013)
                      .+|..|..++.|+.|+|+.|.|. .+|.++|++++||.|.+..|.+- ++|.+++.|++|+.|.+++|+++ .+|.++++
T Consensus       118 ~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~  194 (264)
T KOG0617|consen  118 SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN  194 (264)
T ss_pred             cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence            12344566788999999999999 89999999999999999999999 89999999999999999999998 78888776


Q ss_pred             CC
Q 036815          579 LS  580 (1013)
Q Consensus       579 l~  580 (1013)
                      +.
T Consensus       195 l~  196 (264)
T KOG0617|consen  195 LD  196 (264)
T ss_pred             hh
Confidence            53

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=7e-20  Score=184.07  Aligned_cols=139  Identities=17%  Similarity=0.137  Sum_probs=107.7

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCcc--c-------h-----------------HHHHHHHHHHhccCCcce
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ--G-------D-----------------REFMAEMETLGKIKHRNL  792 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni  792 (1013)
                      ...||+|+||.||+|...+|+.||||++......  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999988643211  1       0                 122359999999988776


Q ss_pred             eeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCcccEE
Q 036815          793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL-HHNCIPHIIHRDMKSSNVL  871 (1013)
Q Consensus       793 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~Nil  871 (1013)
                      .....+..  ...++||||++|+++.......      ..++...+..++.|++.+|.|+ |+.   +|+||||||+||+
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl  150 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL  150 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence            44333222  2338999999988776543211      2378899999999999999999 688   9999999999999


Q ss_pred             eCCCCcEEEeecccceec
Q 036815          872 LDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       872 l~~~~~~kl~Dfg~a~~~  889 (1013)
                      ++ ++.++|+|||+|...
T Consensus       151 i~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         151 YH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EE-CCcEEEEEccccccC
Confidence            98 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=3.5e-21  Score=221.22  Aligned_cols=244  Identities=25%  Similarity=0.296  Sum_probs=175.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCcc-chHHHHHHHHH--HhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          735 GFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ-GDREFMAEMET--LGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +|...+.+|.+.|=+|.+|++++|. |+||++.+.... .-+.+.++++-  ...++|||++++.-+-..+...|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5777899999999999999998776 999988665432 23444443333  4455899999999887777778899999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc-
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS-  890 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~-  890 (1013)
                      .. -+|+|.+..+.-      +...+.+.|+.|++.|+..+|..   ||+|||||.+||||+.-.-+.|+||..-+... 
T Consensus       103 vk-hnLyDRlSTRPF------L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen  103 VK-HNLYDRLSTRPF------LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYL  172 (1431)
T ss_pred             Hh-hhhhhhhccchH------HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccC
Confidence            87 589998875432      77888899999999999999999   99999999999999999899999998765421 


Q ss_pred             ccCcceee----eeeccCCCccCcccccC----------CC-CCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHH
Q 036815          891 ALDTHLSV----STLAGTPGYVPPEYYQS----------FR-CTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGW  954 (1013)
Q Consensus       891 ~~~~~~~~----~~~~gt~~y~aPE~~~~----------~~-~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~  954 (1013)
                      +.++....    .+...-..|.|||.+..          .. .+++.||||+||+++|+++ |++||.-.     ++..+
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aY  247 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAY  247 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhH
Confidence            11222222    22334458999998743          12 5788999999999999998 78888631     12222


Q ss_pred             HHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          955 VKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       955 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...     .   ..+++...          +.++ -..+..++..|++.||++|-+|++
T Consensus       248 r~~-----~---~~~~e~~L----------e~Ie-d~~~Rnlil~Mi~rdPs~RlSAed  287 (1431)
T KOG1240|consen  248 RSG-----N---ADDPEQLL----------EKIE-DVSLRNLILSMIQRDPSKRLSAED  287 (1431)
T ss_pred             hcc-----C---ccCHHHHH----------HhCc-CccHHHHHHHHHccCchhccCHHH
Confidence            111     0   11111110          0000 012458899999999999999864

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=3.5e-19  Score=175.32  Aligned_cols=190  Identities=15%  Similarity=0.100  Sum_probs=141.3

Q ss_pred             CCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccc----hHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEEE
Q 036815          736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG----DREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +.++..|++|+||+||.+.. .+.+++.+.+.......    ...+.+|+++|+++. |+++++++++    ...+++||
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            34678999999999998776 57788877664333211    125789999999995 5889999886    34689999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CcccEEeCCCCcEEEeecccceec
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDM-KSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |+.|.+|.+....            . ...++.|++++++++|+.   ||+|||| ||+||+++.++.++|+|||+|...
T Consensus        79 yI~G~~L~~~~~~------------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         79 YLAGAAMYQRPPR------------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             eecCccHHhhhhh------------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            9999998754310            1 134678999999999999   9999999 799999999999999999999865


Q ss_pred             cccCcc----e-------eeeeeccCCCccCcccccCC-CCC-ccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          890 SALDTH----L-------SVSTLAGTPGYVPPEYYQSF-RCT-AKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       890 ~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      ......    .       .......++.|++|+...-- ..+ ...+.++-|+-+|.++|+..|+..+..
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            432210    0       01123367788888864321 223 567899999999999999998766543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=8.9e-19  Score=177.21  Aligned_cols=139  Identities=17%  Similarity=0.148  Sum_probs=109.8

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccc--------------------------hHHHHHHHHHHhccCCcce
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--------------------------DREFMAEMETLGKIKHRNL  792 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni  792 (1013)
                      .+.||+|+||.||+|++.+|+.||||.+.......                          ...+.+|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            57899999999999998889999999886532110                          1123578999999999987


Q ss_pred             eeeccEEEeCCEEEEEEEcccCCCHHHH-hcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccE
Q 036815          793 VPLLGYCKIGEERLLVYEFMKFGSLEEV-LHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNV  870 (1013)
Q Consensus       793 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Ni  870 (1013)
                      .....+...  ..++||||++|+++... +..       ..++......++.|++.++.++|+ .   ||+||||||+||
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NI  149 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNI  149 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhE
Confidence            544443332  24899999998865433 321       126778889999999999999999 8   999999999999


Q ss_pred             EeCCCCcEEEeecccceecc
Q 036815          871 LLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       871 ll~~~~~~kl~Dfg~a~~~~  890 (1013)
                      +++ ++.++|+|||+|+...
T Consensus       150 ll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         150 LYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EEE-CCCEEEEEcccceecC
Confidence            999 8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=4e-19  Score=184.97  Aligned_cols=235  Identities=20%  Similarity=0.292  Sum_probs=148.1

Q ss_pred             CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccC----------CcceeeeccEEE-
Q 036815          736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIK----------HRNLVPLLGYCK-  800 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------h~niv~l~~~~~-  800 (1013)
                      +...+.||.|+++.||.+++. +++++|+|++......   ..+++++|.-....+.          |-.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999997 4899999988544322   2355666665555432          222222222221 


Q ss_pred             --------eCC--------EEEEEEEcccCCCHHHHhcccccC-CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 036815          801 --------IGE--------ERLLVYEFMKFGSLEEVLHGRAKA-RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHR  863 (1013)
Q Consensus       801 --------~~~--------~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  863 (1013)
                              ...        ..+++|+-+. ++|.+++..-... .....+....+..+..|+++.+++||+.   |+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                    111        2367888776 6888886421111 1123456667778889999999999999   99999


Q ss_pred             CCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccC--------CCCCccchhHhHHHHHHHHH
Q 036815          864 DMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS--------FRCTAKGDVYSFGVVLLELL  935 (1013)
Q Consensus       864 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell  935 (1013)
                      ||+|+|++++.+|.++|+||+.....+..     ......+..|.+||....        ..++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999988764421     111344578999997643        25788999999999999999


Q ss_pred             cCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCC
Q 036815          936 TGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKR 1008 (1013)
Q Consensus       936 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1008 (1013)
                      ++..||.........  .|                .+.    .+.     .+++.  +..+|..+|+++|++|
T Consensus       245 C~~lPf~~~~~~~~~--~~----------------~f~----~C~-----~~Pe~--v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADP--EW----------------DFS----RCR-----DMPEP--VQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTS--GG----------------GGT----TSS--------HH--HHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccc--cc----------------cch----hcC-----CcCHH--HHHHHHHHccCCcccC
Confidence            999999864322110  00                111    111     12222  4489999999999998

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=7.4e-19  Score=180.86  Aligned_cols=191  Identities=21%  Similarity=0.245  Sum_probs=133.3

Q ss_pred             CCcceeeeccEEEe---------------------------CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHH
Q 036815          788 KHRNLVPLLGYCKI---------------------------GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK  840 (1013)
Q Consensus       788 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~  840 (1013)
                      +|||||++.++|.+                           +...|+||..++ .+|.+++..+.       .+......
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-------~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-------RSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-------CchHHHHH
Confidence            59999999987743                           235689999887 69999997543       56667788


Q ss_pred             HHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC--CCC--cEEEeecccceeccccC----cceeeeeeccCCCccCccc
Q 036815          841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD--HEM--EARVSDFGMARLISALD----THLSVSTLAGTPGYVPPEY  912 (1013)
Q Consensus       841 i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~  912 (1013)
                      |+.|+++|+.|||.+   ||.|||+|++||++.  +|+  ...++|||++-.-+...    .........|.-.-||||+
T Consensus       346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            999999999999999   999999999999994  333  46889999875422211    0111122456778999999


Q ss_pred             ccCCC------CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHH
Q 036815          913 YQSFR------CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEE  986 (1013)
Q Consensus       913 ~~~~~------~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~  986 (1013)
                      ....+      --.|+|.|+.|.+.||+++...||.+..........+.+..  -....+.++|.               
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q--LPalp~~vpp~---------------  485 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ--LPALPSRVPPV---------------  485 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh--CCCCcccCChH---------------
Confidence            76432      12489999999999999999999987443222211111111  11112222222               


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          987 VKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       987 ~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                            +.+++...|+.||++||++.
T Consensus       486 ------~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  486 ------ARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             ------HHHHHHHHhcCCccccCCcc
Confidence                  34788899999999999863

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=1.1e-17  Score=169.18  Aligned_cols=136  Identities=20%  Similarity=0.224  Sum_probs=105.7

Q ss_pred             CCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhcc-----CCcceeeeccEEEeCC---EEE-E
Q 036815          737 SAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-----KHRNLVPLLGYCKIGE---ERL-L  807 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l  807 (1013)
                      .-.+.||+|+||.||.  ++.....+||++........+.+.+|+.+++.+     .||||++++|++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999995  543333479987654444567899999999999     5799999999998863   333 7


Q ss_pred             EEEc--ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCcccEEeCC----CCcEEE
Q 036815          808 VYEF--MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL-CFLHHNCIPHIIHRDMKSSNVLLDH----EMEARV  880 (1013)
Q Consensus       808 v~e~--~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl  880 (1013)
                      |+||  +.+++|.+++....       +++.  ..++.+++.++ +|||++   +||||||||+||+++.    +++++|
T Consensus        83 I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence            8999  55799999995421       4444  35577888777 999999   9999999999999974    347999


Q ss_pred             eecccc
Q 036815          881 SDFGMA  886 (1013)
Q Consensus       881 ~Dfg~a  886 (1013)
                      +||+-+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=3e-18  Score=189.74  Aligned_cols=208  Identities=27%  Similarity=0.464  Sum_probs=154.3

Q ss_pred             HhccCCcceeeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCe-Ee
Q 036815          784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI-IH  862 (1013)
Q Consensus       784 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH  862 (1013)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+...     ...+++.....++++++.||+|+|+.   .| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-----~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-----DIKLDYFFILSFIRDISKGLAYLHNS---PIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-----ccCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence            35678999999999999999999999999999999999752     33489999999999999999999998   44 99


Q ss_pred             cCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCC-------CCCccchhHhHHHHHHHHH
Q 036815          863 RDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-------RCTAKGDVYSFGVVLLELL  935 (1013)
Q Consensus       863 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ell  935 (1013)
                      +.+++.|++++....+|++|||+....................-|.|||.+++.       ..+.++||||||++++|++
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            999999999999999999999998876431111111222345579999998763       1467899999999999999


Q ss_pred             cCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          936 TGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       936 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.+.||+........ .+.+.. +.. .....+.|.+...         .+.  ...+..++.+||..+|++||++++
T Consensus       153 ~r~~~~~~~~~~~~~-~eii~~-~~~-~~~~~~rP~i~~~---------~e~--~~~l~~l~~~cw~e~P~~rPs~~~  216 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDP-DEIILR-VKK-GGSNPFRPSIELL---------NEL--PPELLLLVARCWEEIPEKRPSIEQ  216 (484)
T ss_pred             hccCccccccccCCh-HHHHHH-HHh-cCCCCcCcchhhh---------hhc--chHHHHHHHHhcccChhhCccHHH
Confidence            999999875443332 111111 111 1111222222100         011  114678999999999999999864

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=3.6e-20  Score=205.79  Aligned_cols=85  Identities=20%  Similarity=0.291  Sum_probs=40.1

Q ss_pred             CCccCEEEccCCcccccCChhhhC-----CCCCcEEecCCCccC----CCCcccccCCCCcceEecCCccccCC----Cc
Q 036815          507 YQTLEYLDLSYNQFRGKIPDEIGD-----MIALQVLELAHNQLS----GEIPSSLGRLRNLGVFDASHNRLQGQ----IP  573 (1013)
Q Consensus       507 ~~~L~~L~ls~N~l~g~iP~~i~~-----l~~L~~L~L~~n~l~----g~ip~~~~~l~~L~~L~ls~N~l~g~----~p  573 (1013)
                      +++|++||+++|.+++..+..+..     ...|+.|++++|.++    +.++..+..+++|+.+++++|.++..    +.
T Consensus       220 ~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~  299 (319)
T cd00116         220 LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLA  299 (319)
T ss_pred             cCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHH
Confidence            344555555555555422222221     245555555555554    12334444445555555555555532    33


Q ss_pred             ccccCC-CcceEEECcCCC
Q 036815          574 ESFSNL-SFLVQIDLSNNE  591 (1013)
Q Consensus       574 ~~~~~l-~~l~~l~l~~n~  591 (1013)
                      ..+... +.|+.+++.+|.
T Consensus       300 ~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         300 ESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHhhcCCchhhcccCCCC
Confidence            333333 445555555543

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=3.2e-18  Score=202.42  Aligned_cols=200  Identities=20%  Similarity=0.228  Sum_probs=161.4

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccC---CcceeeeccEEEeCCEE
Q 036815          729 LIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK---HRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       729 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~  805 (1013)
                      .....+.|.|.+.||+|+||+||+|...+|+.||+|+-.+.....   |.-=.+++.|++   -+.|+.+..++.-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            344567899999999999999999999889999999765544432   222223444444   23455555555567778


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-------CCcE
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-------EMEA  878 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~~  878 (1013)
                      ++|+||.+.|+|.+++..      .+.++|.-++.++.|+++.+++||..   +||||||||+|+++..       ..-+
T Consensus       770 ~lv~ey~~~Gtlld~~N~------~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINT------NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             eeeeeccccccHHHhhcc------CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence            899999999999999973      34489999999999999999999999   9999999999999943       2458


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP  940 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  940 (1013)
                      +|+|||.+-.+.-..........++|..+-.+|+..|.+++..+|.|.++.+++-|+.|+.-
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99999998765443444566778899999999999999999999999999999999999754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.74  E-value=3.8e-19  Score=195.73  Aligned_cols=186  Identities=27%  Similarity=0.314  Sum_probs=153.9

Q ss_pred             eecccCCcEEEEEEE----cCCCEEEEEEeeccCccc--hHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEEEccc
Q 036815          741 LIGCGGFGEVFKATL----KDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       741 ~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      .+|+|+||.|+.++-    ..+.-+|.|...+.....  ......|..++...+ ||.++++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            369999999998753    236677888765533221  124556788888886 9999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      ||.+...+....      .+++.........++-+++++|+.   +|+|||+|++||+++.+|++++.|||+++..-...
T Consensus        81 gg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhccccCC------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            999988876433      367777788888999999999999   99999999999999999999999999998653221


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      .      .+||..|||||++.  ....++|.||||++++||+||..||..
T Consensus       152 ~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  152 I------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             h------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            1      17899999999998  456789999999999999999999976

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=1.3e-19  Score=165.03  Aligned_cols=180  Identities=27%  Similarity=0.493  Sum_probs=148.7

Q ss_pred             CCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchH
Q 036815          244 SSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLE  323 (1013)
Q Consensus       244 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~  323 (1013)
                      ..+..++.|.+++|+++ .+|+.+ ..+.+|+.|++.+|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppni-a~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNI-AELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcH-HHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            34456666777777776 566665 34777888888888887 66788899999999999999998 8899999999999


Q ss_pred             HHHhhhcccc-CCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCC
Q 036815          324 QFIAWFNGLE-GKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNN  402 (1013)
Q Consensus       324 ~L~l~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  402 (1013)
                      .|++.+|++. ..+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.+++|+.|++.+|
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            9999888875 467889999999999999999998 89999999999999999999998 89999999999999999999


Q ss_pred             eeeeecCCCCcCCCC---CcEEEccCCcCCc
Q 036815          403 RFKGEIPGELGNCSS---LVWLDLNSNNLTG  430 (1013)
Q Consensus       403 ~l~~~~p~~~~~l~~---L~~L~l~~N~l~~  430 (1013)
                      +++ .+|++++++.-   =+.+.+.+|.+..
T Consensus       184 rl~-vlppel~~l~l~~~k~v~r~E~NPwv~  213 (264)
T KOG0617|consen  184 RLT-VLPPELANLDLVGNKQVMRMEENPWVN  213 (264)
T ss_pred             eee-ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence            998 88888876542   2445566666543

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.71  E-value=3.2e-19  Score=198.21  Aligned_cols=259  Identities=26%  Similarity=0.234  Sum_probs=129.9

Q ss_pred             EEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCC---chhhhhCCCCccEEeCCCCcccCccCCCC---cCCCCCC
Q 036815           28 QLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFL---PETLLSNSDKLELLDLSYNNLTGSISGFS---LNENSCN  101 (1013)
Q Consensus        28 ~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~---~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~---~~~~~~~  101 (1013)
                      .|+|+++.+.+.--...|..+.+|++|++++|.+++..   ....+...+.|++|+++++.+......+.   .....++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            45666666542222234566667777777777775321   11224455667777777766652111100   0111234


Q ss_pred             cccEEECCCCCCCCCCCccccCCCC---CCEEecCCCcccc----cCcccccCCCCCCEeeCcCCcccCcCCccchhccC
Q 036815          102 SLLHLDLSQNHIMDVIPSSLSNCTK---LKILNLSFNLLAG----EIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACD  174 (1013)
Q Consensus       102 ~L~~L~Ls~n~i~~~~~~~l~~l~~---L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~  174 (1013)
                      +|++|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+                        .+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~------------------------~~  137 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL------------------------PP  137 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhC------------------------CC
Confidence            5555555555544333333332222   4444444444431    111122233                        14


Q ss_pred             CCcEEECCCCCCCCc----CCccccCCCCCCEEEccCCCCCCCCChhh---hhcCCCCcEEEcccccCCCc----CCcCC
Q 036815          175 SLLELKLPHNNITGS----FPVTLSSCSWLQLLDLSNNNISGPFPDSV---LENLGSLESLILSNNMISGS----FPDSI  243 (1013)
Q Consensus       175 ~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~---~~~l~~L~~L~L~~n~l~~~----~~~~~  243 (1013)
                      +|++|++++|.+++.    .+..+..+++|++|++++|.+++.....+   +..+++|++|++++|.+++.    +...+
T Consensus       138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~  217 (319)
T cd00116         138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETL  217 (319)
T ss_pred             CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHh
Confidence            455555555555421    22234455566666666666653221111   22334666666666666532    22344


Q ss_pred             CCCCCcCEEEecCCeecccCCCCCCC----CCCCCceEEcCCCcccc----cCCccccccCcccEEEeeCCccCC
Q 036815          244 SSCKTLRIVDFSSNRVSGIIPPDICP----GVSSLEELRLPDNLITG----VIPGQLSECTQLKVIDLSLNYLNG  310 (1013)
Q Consensus       244 ~~l~~L~~L~L~~N~l~~~~~~~~~~----~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~ls~N~l~~  310 (1013)
                      ..+++|+.|++++|.+++.....++.    ..+.|+.|++++|.+++    .+...+..+++|+.+++++|.++.
T Consensus       218 ~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~  292 (319)
T cd00116         218 ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE  292 (319)
T ss_pred             cccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence            55666777777777665422222222    23567777777777752    223345556788888888888874

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=5.6e-17  Score=168.76  Aligned_cols=142  Identities=14%  Similarity=0.107  Sum_probs=110.0

Q ss_pred             cCCCCCCeecccCCcEEEEEE--EcCCCEEEEEEeeccCcc------------------------chHHHHHHHHHHhcc
Q 036815          734 NGFSAESLIGCGGFGEVFKAT--LKDGSSVAIKKLIRLSCQ------------------------GDREFMAEMETLGKI  787 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  787 (1013)
                      ..|.+.+.||+|+||.||+|+  ..+|+.||+|++......                        ....+.+|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358889999999999999998  457999999988643210                        012356899999999


Q ss_pred             CCc--ceeeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC-eEecC
Q 036815          788 KHR--NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH-IIHRD  864 (1013)
Q Consensus       788 ~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~D  864 (1013)
                      .+.  .+.+++++    ...++||||++|+++........      .....+...++.|++.++++||+.   + |+|||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~D  174 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---GELVHGD  174 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCC
Confidence            753  33444432    23589999999988876542211      245566788999999999999999   9 99999


Q ss_pred             CCcccEEeCCCCcEEEeecccceec
Q 036815          865 MKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       865 lkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |||+||+++ ++.++++|||.|...
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999 889999999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=3e-17  Score=189.48  Aligned_cols=167  Identities=25%  Similarity=0.390  Sum_probs=122.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ..+|..++.|-.|+||.||.++++. .+.+|.| +.+..     .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence            3679999999999999999999874 5677774 43211     11111  22222334333                  


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                         |+-...+..-+      +++.+        ++.+++|+|+.   +|||||+||+|.+|+.-|++|++|||+++....
T Consensus       136 ---gDc~tllk~~g------~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG------PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             ---chhhhhcccCC------CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence               34344443221      13322        27899999999   999999999999999999999999999876421


Q ss_pred             cC-------------cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          892 LD-------------THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       892 ~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ..             ........+||+.|.|||++..+.|+..+|.|++|+|+||.+.|+.||.++.
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt  262 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT  262 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence            11             0111234689999999999999999999999999999999999999999864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=5.1e-16  Score=160.90  Aligned_cols=134  Identities=21%  Similarity=0.295  Sum_probs=112.8

Q ss_pred             CeecccCCcEEEEEEEcCCCEEEEEEeeccCccc--------hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--------DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      +.||+|++|.||+|.+ .+..|++|+........        ...+.+|++++..+.|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 57889999764322211        23577899999999999988777777777888999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      ++|++|.+++...         .. .+..++.+++.++.++|+.   +++|||++|+||+++ ++.++++|||.++.
T Consensus        81 ~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998532         11 7788999999999999999   999999999999999 78899999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=4.9e-16  Score=158.76  Aligned_cols=142  Identities=18%  Similarity=0.151  Sum_probs=110.5

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCcc----------------------chHHHHHHHHHHhcc
Q 036815          730 IEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ----------------------GDREFMAEMETLGKI  787 (1013)
Q Consensus       730 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l  787 (1013)
                      .....-|.+.+.||+|+||.||+|..++|+.||||++......                      .......|+.++..+
T Consensus        11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   90 (198)
T cd05144          11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL   90 (198)
T ss_pred             HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence            3333448888999999999999999888999999986432100                      112357788889888


Q ss_pred             CCcc--eeeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 036815          788 KHRN--LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDM  865 (1013)
Q Consensus       788 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  865 (1013)
                      .|++  +.+.++    ....++||||++|++|......            .....++.+++.++.++|+.   +|+||||
T Consensus        91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            7774  444443    2455899999999998765420            23457889999999999998   9999999


Q ss_pred             CcccEEeCCCCcEEEeecccceecc
Q 036815          866 KSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       866 kp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      ||+||++++++.++|+|||.+....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=6.3e-16  Score=158.56  Aligned_cols=130  Identities=19%  Similarity=0.305  Sum_probs=105.9

Q ss_pred             eecccCCcEEEEEEEcCCCEEEEEEeeccCcc--------chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ--------GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       741 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .||+|+||.||+|.+ ++..|++|+.......        ...++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            479999999999985 4788999986432211        1245778999999999887665555556667778999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      +|++|.+.+....       .      .++.+++++|.++|+.   +++|||++|+||+++ ++.++++|||.++.
T Consensus        80 ~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998874311       0      7899999999999999   999999999999999 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PLN03150 hypothetical protein; Provisional

Probab=99.64  E-value=3.5e-16  Score=186.02  Aligned_cols=117  Identities=37%  Similarity=0.683  Sum_probs=106.3

Q ss_pred             ccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECc
Q 036815          509 TLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLS  588 (1013)
Q Consensus       509 ~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~  588 (1013)
                      .++.|+|++|.++|.+|.+|+.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|+.++++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcCCCC--CCCCCCCcccccCCCCCCCCCC-CCCC
Q 036815          589 NNELTGPIPQR--GQLSTLPASQYANNPGLCGVPL-PECR  625 (1013)
Q Consensus       589 ~n~l~~~~p~~--~~~~~~~~~~~~~n~~lc~~~~-~~~~  625 (1013)
                      +|+|+|.+|..  ..+..+....+.+|+++||.|. +.|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence            99999999974  2223455678999999999864 5674

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=4.9e-17  Score=175.79  Aligned_cols=173  Identities=23%  Similarity=0.383  Sum_probs=129.6

Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..|+.|++|.-.+|.+++..+..   ....++.....++.|++.|++|   +   +.+|+|+||.||+...+..+||.||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhh
Confidence            56899999999999999975443   2336788889999999999999   6   9999999999999999999999999


Q ss_pred             ccceeccccC----cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHH
Q 036815          884 GMARLISALD----THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMK  958 (1013)
Q Consensus       884 g~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  958 (1013)
                      |+........    .........||..||+||.+.+..|+.|+||||+|++++|++. =..+|+...         ....
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---------t~~d  471 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---------TLTD  471 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---------hhhh
Confidence            9987765433    2223456789999999999999999999999999999999998 222222100         1111


Q ss_pred             HhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       959 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ++.+    .++|+..              .+...-+.++.+++.+.|.+||++.
T Consensus       472 ~r~g----~ip~~~~--------------~d~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  472 IRDG----IIPPEFL--------------QDYPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hhcC----CCChHHh--------------hcCcHHHHHHHHhcCCCcccCchHH
Confidence            2222    2222221              0111124788999999999999753

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1.1e-15  Score=180.33  Aligned_cols=137  Identities=21%  Similarity=0.298  Sum_probs=112.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccC-c-------cchHHHHHHHHHHhccCCcceeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLS-C-------QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  804 (1013)
                      ...|...+.||+|+||+||+|.+... .+++|+..... .       ...+.+.+|++++++++|++++....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            44567789999999999999988643 44444432211 1       112457899999999999999988877777778


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .++||||++|++|.+++.              ....++.++++++.|||+.   +++|||+||+||++ .++.++|+|||
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence            899999999999999874              2457899999999999999   99999999999999 67799999999


Q ss_pred             ccee
Q 036815          885 MARL  888 (1013)
Q Consensus       885 ~a~~  888 (1013)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9975

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=2.3e-16  Score=184.25  Aligned_cols=251  Identities=25%  Similarity=0.323  Sum_probs=190.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC--CCEEEEEEeeccC--ccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD--GSSVAIKKLIRLS--CQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ..|.+.+.||+|+|+.|-.+....  ...+|+|.+....  .........|..+-..+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            457788889999999998887653  3445666553332  222344555777777776 99999999999999999999


Q ss_pred             EEcccCCCHHHHh-cccccCCCCccccHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCcccEEeCCCC-cEEEeeccc
Q 036815          809 YEFMKFGSLEEVL-HGRAKARDQRILTWDARKKIARGAAKGLCFLH-HNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGM  885 (1013)
Q Consensus       809 ~e~~~~g~L~~~l-~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~  885 (1013)
                      ++|..|+++.+.+ +...     ...+.........|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+
T Consensus       100 ~~~s~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             cCcccccccccccccCCc-----cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchh
Confidence            9999999998888 3221     12455566778999999999999 77   999999999999999999 999999999


Q ss_pred             ceeccc-cCcceeeeeecc-CCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-c
Q 036815          886 ARLISA-LDTHLSVSTLAG-TPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-E  961 (1013)
Q Consensus       886 a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~  961 (1013)
                      |..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......+..+..|...... .
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  251 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT  251 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc
Confidence            998876 444555556678 9999999998874 55678999999999999999999998776666555555544311 1


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+..+..                     ...+++.+++..+|..|.+.++
T Consensus       252 ~~~~~~~~~---------------------~~~~~l~k~l~~~~~~r~s~~~  282 (601)
T KOG0590|consen  252 QLPWNSISD---------------------QAHDLLHKILKENPSNRLSIEE  282 (601)
T ss_pred             cCccccCCh---------------------hhhhcccccccCCchhcccccc
Confidence            111111111                     1347778899899999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.55  E-value=2e-14  Score=145.75  Aligned_cols=135  Identities=20%  Similarity=0.229  Sum_probs=96.6

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccc--hHH----------------------HHHHHHHHhccCCcc--e
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DRE----------------------FMAEMETLGKIKHRN--L  792 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i  792 (1013)
                      .+.||+|+||+||+|.+.+++.||||++.......  ...                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            57899999999999998889999999875432111  111                      134555565554332  3


Q ss_pred             eeeccEEEeCCEEEEEEEcccCCCHHHH-hcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccE
Q 036815          793 VPLLGYCKIGEERLLVYEFMKFGSLEEV-LHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNV  870 (1013)
Q Consensus       793 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Ni  870 (1013)
                      .+.+++    ...++||||++++.+... +....       .. .....++.+++.++.++|. .   +|+||||||+||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Ni  146 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNI  146 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhE
Confidence            344332    245899999998543211 11100       11 5567899999999999999 7   999999999999


Q ss_pred             EeCCCCcEEEeecccceec
Q 036815          871 LLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       871 ll~~~~~~kl~Dfg~a~~~  889 (1013)
                      +++ ++.++++|||.|...
T Consensus       147 li~-~~~~~liDfg~a~~~  164 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             EEE-CCcEEEEECcccccc
Confidence            999 889999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.54  E-value=2.9e-16  Score=169.36  Aligned_cols=181  Identities=30%  Similarity=0.466  Sum_probs=156.3

Q ss_pred             CCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEE
Q 036815          342 KCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL  421 (1013)
Q Consensus       342 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  421 (1013)
                      .+..-...+|+.|++. ++|..++.+..|+.+.|..|.+. .+|..+.++..|+.|+|+.|+++ .+|..++.|+ |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence            4455667888999998 88999888889999999999998 88999999999999999999998 8888888876 8899


Q ss_pred             EccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCccc
Q 036815          422 DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVL  501 (1013)
Q Consensus       422 ~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  501 (1013)
                      -+++|+++ .+|..++                                                                
T Consensus       149 i~sNNkl~-~lp~~ig----------------------------------------------------------------  163 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIG----------------------------------------------------------------  163 (722)
T ss_pred             EEecCccc-cCCcccc----------------------------------------------------------------
Confidence            99999887 4554433                                                                


Q ss_pred             ccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCc
Q 036815          502 SLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSF  581 (1013)
Q Consensus       502 ~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~  581 (1013)
                          ...+|..||.|.|.+. ++|..++++.+|+.|++..|++. .+|++++.|+ |..||+|+|+++ .||-.|.++..
T Consensus       164 ----~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~  235 (722)
T KOG0532|consen  164 ----LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRH  235 (722)
T ss_pred             ----cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhh
Confidence                2346788999999999 89999999999999999999999 8999999665 889999999998 89999999999


Q ss_pred             ceEEECcCCCCCCcCCCC
Q 036815          582 LVQIDLSNNELTGPIPQR  599 (1013)
Q Consensus       582 l~~l~l~~n~l~~~~p~~  599 (1013)
                      |++|-|.+|.|+.++-+.
T Consensus       236 Lq~l~LenNPLqSPPAqI  253 (722)
T KOG0532|consen  236 LQVLQLENNPLQSPPAQI  253 (722)
T ss_pred             heeeeeccCCCCCChHHH
Confidence            999999999999876553

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.53  E-value=4.6e-14  Score=137.98  Aligned_cols=135  Identities=20%  Similarity=0.198  Sum_probs=112.5

Q ss_pred             CCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCC--cceeeeccEEEeCCEEEEEEEcccCC
Q 036815          738 AESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH--RNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       738 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  .+++++++++..++..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999864 7899997644332  4678899999999976  58999998888778899999999987


Q ss_pred             CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          816 SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       816 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      .+..+             +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++.
T Consensus        79 ~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            66543             3455677899999999999986434799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=9.1e-14  Score=145.10  Aligned_cols=135  Identities=17%  Similarity=0.218  Sum_probs=104.8

Q ss_pred             CCeec-ccCCcEEEEEEEcCCCEEEEEEeeccC-------------ccchHHHHHHHHHHhccCCcce--eeeccEEEeC
Q 036815          739 ESLIG-CGGFGEVFKATLKDGSSVAIKKLIRLS-------------CQGDREFMAEMETLGKIKHRNL--VPLLGYCKIG  802 (1013)
Q Consensus       739 ~~~lG-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  802 (1013)
                      ...|| .|+.|+||.+... +..+++|.+....             ......+.+|++++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45788 8999999999875 7789998774311             1223567889999999988774  6777664432


Q ss_pred             -C---EEEEEEEcccC-CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc
Q 036815          803 -E---ERLLVYEFMKF-GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME  877 (1013)
Q Consensus       803 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  877 (1013)
                       .   ..++|||+++| .+|.+++...       .++..    .+.+++.++.+||+.   ||+||||||+||+++.++.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGK  180 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCC
Confidence             2   23599999997 6899887532       13433    357899999999999   9999999999999999999


Q ss_pred             EEEeeccccee
Q 036815          878 ARVSDFGMARL  888 (1013)
Q Consensus       878 ~kl~Dfg~a~~  888 (1013)
                      ++|+|||.++.
T Consensus       181 v~LIDfg~~~~  191 (239)
T PRK01723        181 FWLIDFDRGEL  191 (239)
T ss_pred             EEEEECCCccc
Confidence            99999998864

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.51  E-value=1.4e-15  Score=164.23  Aligned_cols=195  Identities=30%  Similarity=0.453  Sum_probs=155.6

Q ss_pred             ccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeE
Q 036815          294 ECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWI  373 (1013)
Q Consensus       294 ~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  373 (1013)
                      .+..-...|++.|++. .+|..++.+..|+.+.++.|.+. .+|..++++..|++|+|+.|+++ .+|..++.|+ |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence            4556678899999999 89999999999999999999998 78889999999999999999998 7888888775 8888


Q ss_pred             EecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCc
Q 036815          374 SLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNT  453 (1013)
Q Consensus       374 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~  453 (1013)
                      -+++|+++ .+|+.++.+..|..|+.+.|.+. .+|..++.+.+|+.|.+..|++. .+|+.+..               
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~---------------  210 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS---------------  210 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC---------------
Confidence            88888888 88888888888888888888887 78888888888888888888776 34443321               


Q ss_pred             eEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCC
Q 036815          454 LVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA  533 (1013)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~  533 (1013)
                                                    +                        .|..||+|.|+++ .||-+|.+|..
T Consensus       211 ------------------------------L------------------------pLi~lDfScNkis-~iPv~fr~m~~  235 (722)
T KOG0532|consen  211 ------------------------------L------------------------PLIRLDFSCNKIS-YLPVDFRKMRH  235 (722)
T ss_pred             ------------------------------C------------------------ceeeeecccCcee-ecchhhhhhhh
Confidence                                          1                        2677888888888 78888888888


Q ss_pred             CcEEecCCCccCCCCcccccCCCC---cceEecCCc
Q 036815          534 LQVLELAHNQLSGEIPSSLGRLRN---LGVFDASHN  566 (1013)
Q Consensus       534 L~~L~L~~n~l~g~ip~~~~~l~~---L~~L~ls~N  566 (1013)
                      |++|-|.+|-|. +-|..|+-.-.   -++|+..-.
T Consensus       236 Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  236 LQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             heeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence            888888888888 67776654333   334444444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.37  E-value=3.9e-13  Score=153.63  Aligned_cols=184  Identities=34%  Similarity=0.546  Sum_probs=128.2

Q ss_pred             cCCCCCCceEECccccccccCchhhcCCC-CCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCC
Q 036815          340 LGKCKNLKDLILNNNKLSGEIPAELFSCS-NLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSL  418 (1013)
Q Consensus       340 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  418 (1013)
                      +..++.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..+..++.|+.|++++|+++ .+|...+.+++|
T Consensus       112 ~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L  188 (394)
T COG4886         112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL  188 (394)
T ss_pred             hhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhh
Confidence            333466777777777777 6666666664 7777777777777 66667777777777777777777 666666677777


Q ss_pred             cEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccC
Q 036815          419 VWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSG  498 (1013)
Q Consensus       419 ~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  498 (1013)
                      +.|++++|+++ .+|...                                                              
T Consensus       189 ~~L~ls~N~i~-~l~~~~--------------------------------------------------------------  205 (394)
T COG4886         189 NNLDLSGNKIS-DLPPEI--------------------------------------------------------------  205 (394)
T ss_pred             hheeccCCccc-cCchhh--------------------------------------------------------------
Confidence            77777777766 333321                                                              


Q ss_pred             cccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccC
Q 036815          499 PVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSN  578 (1013)
Q Consensus       499 ~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~  578 (1013)
                            .....|++|++++|.+. .+|..+..+..+..|.+++|++. .+|..++.+++++.|++++|+++ .++. ++.
T Consensus       206 ------~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~  275 (394)
T COG4886         206 ------ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGS  275 (394)
T ss_pred             ------hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccc
Confidence                  11234667777777554 56677777777777777777777 55777777777777777777776 5555 777


Q ss_pred             CCcceEEECcCCCCCCcCCCC
Q 036815          579 LSFLVQIDLSNNELTGPIPQR  599 (1013)
Q Consensus       579 l~~l~~l~l~~n~l~~~~p~~  599 (1013)
                      +.+++.|++++|.++..+|..
T Consensus       276 ~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         276 LTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             cCccCEEeccCccccccchhh
Confidence            777777777777777766654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.36  E-value=2.7e-12  Score=145.96  Aligned_cols=142  Identities=21%  Similarity=0.240  Sum_probs=100.5

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccc--------------------------h--------------HHHH
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--------------------------D--------------REFM  778 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~--------------~~~~  778 (1013)
                      .+.||.|++|.||+|+.++|+.||||+..+.....                          .              -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999875421100                          0              0244


Q ss_pred             HHHHHHhccC----CcceeeeccEEE-eCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHH-HHHHH
Q 036815          779 AEMETLGKIK----HRNLVPLLGYCK-IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK-GLCFL  852 (1013)
Q Consensus       779 ~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~-~L~~L  852 (1013)
                      +|++.+.+++    |.+-+.+-.++. ..+..++||||++|+++.++.......     .+   ...++.+++. .+..+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-----~~---~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-----LD---RKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-----CC---HHHHHHHHHHHHHHHH
Confidence            5666555552    333333333332 245678999999999998876432110     11   3456666666 47788


Q ss_pred             HhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       853 H~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      |..   |++|+|+||.||+++.+++++++|||++..+..
T Consensus       274 ~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 LRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            988   999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.34  E-value=3.1e-12  Score=152.39  Aligned_cols=95  Identities=31%  Similarity=0.587  Sum_probs=85.4

Q ss_pred             ccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCC-Ccc
Q 036815          504 FTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL-SFL  582 (1013)
Q Consensus       504 ~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~~l  582 (1013)
                      +..+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+++|.+|..+..+ ..+
T Consensus       438 i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~  517 (623)
T PLN03150        438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR  517 (623)
T ss_pred             HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccC
Confidence            3445789999999999999999999999999999999999999999999999999999999999999999998874 467


Q ss_pred             eEEECcCCCCCCcCCC
Q 036815          583 VQIDLSNNELTGPIPQ  598 (1013)
Q Consensus       583 ~~l~l~~n~l~~~~p~  598 (1013)
                      ..+++++|...+.+|.
T Consensus       518 ~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        518 ASFNFTDNAGLCGIPG  533 (623)
T ss_pred             ceEEecCCccccCCCC
Confidence            8899999986554553

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.33  E-value=1.5e-12  Score=148.82  Aligned_cols=62  Identities=42%  Similarity=0.671  Sum_probs=32.5

Q ss_pred             cCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcc
Q 036815          510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE  574 (1013)
Q Consensus       510 L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~  574 (1013)
                      +..+.+++|++. .+|..++.+..|+.|++++|+++ .++. ++.+.+|+.|++++|.+...+|.
T Consensus       234 l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         234 LSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             ccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence            334444455544 33555555555555555555555 4444 55555555555555555544443

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=2.4e-12  Score=130.49  Aligned_cols=157  Identities=24%  Similarity=0.377  Sum_probs=117.5

Q ss_pred             HHHHhccCCcceeeeccEEEeC-----CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhc
Q 036815          781 METLGKIKHRNLVPLLGYCKIG-----EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN  855 (1013)
Q Consensus       781 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  855 (1013)
                      ..-+-++.|.||++++.|+.+.     ....++.|||..|++..+++..+.  .+..+......+++-||..||.|||+.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            3445556799999999988653     346789999999999999976554  334577788889999999999999995


Q ss_pred             CCCCeEecCCCcccEEeCCCCcEEEeecccceecccc--CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHH
Q 036815          856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL--DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLE  933 (1013)
Q Consensus       856 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e  933 (1013)
                       .|.|+|+++..+-|++..+|-+|+.--.-.......  ..........+-++|.|||.=..-..+.++|||+||....|
T Consensus       196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence             678999999999999999988887422111110000  00111223456789999998766677789999999999999


Q ss_pred             HHcCCCC
Q 036815          934 LLTGKRP  940 (1013)
Q Consensus       934 lltg~~p  940 (1013)
                      |..+..-
T Consensus       275 mailEiq  281 (458)
T KOG1266|consen  275 MAILEIQ  281 (458)
T ss_pred             HHHheec
Confidence            9887654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=2.7e-12  Score=142.58  Aligned_cols=199  Identities=24%  Similarity=0.277  Sum_probs=156.4

Q ss_pred             CCCCCCeecc--cCCcEEEEEEE--c-CCCEEEEEEeeccCc--cchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEE
Q 036815          735 GFSAESLIGC--GGFGEVFKATL--K-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       735 ~y~~~~~lG~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  806 (1013)
                      .|.+.+.+|.  |.+|.||.+..  . ++..+|+|+-...-.  .....=.+|+...+++ .|++.++.+..+..++..|
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4677889999  99999999987  3 678899987432222  2233335677776666 4999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEe
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK----GLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVS  881 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~  881 (1013)
                      +-+|++. .++.++.+.....     ++....+.+..+..+    |+.++|+.   +++|-|+||.||+...+ ...+++
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~-----~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNF-----LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             eeecccc-chhHHhhhccccc-----CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence            9999886 6888887754432     566667777888888    99999999   99999999999999999 889999


Q ss_pred             ecccceeccccCcceee---eeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          882 DFGMARLISALDTHLSV---STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      |||+...+....-....   ....|...|++||...+ .++.++|+|++|.++.+..++..++..
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence            99999887654422111   12357788999999865 568899999999999999998777553

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=7.1e-12  Score=143.57  Aligned_cols=147  Identities=19%  Similarity=0.255  Sum_probs=96.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCcc--------------------------c--------hH---
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQ--------------------------G--------DR---  775 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~~---  775 (1013)
                      ..|+. +.||+|++|.||+|+.++ |+.||||+..+....                          .        .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 789999999999999987 999999988643100                          0        01   


Q ss_pred             ---HHHHHHHHHhccC----CcceeeeccEEEe-CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHH
Q 036815          776 ---EFMAEMETLGKIK----HRNLVPLLGYCKI-GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK  847 (1013)
Q Consensus       776 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~  847 (1013)
                         ++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.++-.-.....+...+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               1344444444442    3333443333332 45678999999999998753211111111123333333444444  


Q ss_pred             HHHHHHhcCCCCeEecCCCcccEEeCCCC----cEEEeecccceeccc
Q 036815          848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEM----EARVSDFGMARLISA  891 (1013)
Q Consensus       848 ~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~a~~~~~  891 (1013)
                           ...   |++|+|+||.||+++.++    +++++|||++..++.
T Consensus       277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 345   999999999999999988    999999999987654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.28  E-value=3.5e-11  Score=134.55  Aligned_cols=166  Identities=19%  Similarity=0.268  Sum_probs=128.4

Q ss_pred             EcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCcccc
Q 036815          755 LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT  834 (1013)
Q Consensus       755 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~  834 (1013)
                      ..++.+|.|...............+-++.++.++||||+++++.++..+..|+|+|.+.  .|..++..         +.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l~  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------LG  102 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------hH
Confidence            34688888887654443334456777888999999999999999999999999999985  78888864         33


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCccccc
Q 036815          835 WDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ  914 (1013)
Q Consensus       835 ~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  914 (1013)
                      ...+...+.||+.||.|||+.|  +++|++|.-+.|+|+..|+.||++|.++........  ......--..|..|+.+.
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence            5666778999999999999775  999999999999999999999999998865543221  111222233567777654


Q ss_pred             CCCCCccchhHhHHHHHHHHHcC
Q 036815          915 SFRCTAKGDVYSFGVVLLELLTG  937 (1013)
Q Consensus       915 ~~~~~~~~DvwslG~il~elltg  937 (1013)
                      ...  -..|.|-|||+++|++.|
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCc
Confidence            322  346999999999999999

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.27  E-value=9.5e-13  Score=138.54  Aligned_cols=164  Identities=23%  Similarity=0.179  Sum_probs=92.5

Q ss_pred             CCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCC-CchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCC
Q 036815           23 PFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGF-LPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCN  101 (1013)
Q Consensus        23 ~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~  101 (1013)
                      ...|+++.|.++.+...........|++++.||||.|-+..- ....+...+++|+.|+||.|++..-....  ....++
T Consensus       120 ~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~--~~~~l~  197 (505)
T KOG3207|consen  120 LKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSN--TTLLLS  197 (505)
T ss_pred             HHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcccc--chhhhh
Confidence            345778888888774322124566788888888888877622 22355677888888888888876322211  112455


Q ss_pred             cccEEECCCCCCCCC-CCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEE
Q 036815          102 SLLHLDLSQNHIMDV-IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK  180 (1013)
Q Consensus       102 ~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  180 (1013)
                      .|+.|.|+.|.++.. +...+..+|+|+.|+|..|..-.+......-+..|++|||++|.+.+.-.......++.|..|+
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence            667777777766532 1222345666666666666422232233344556666666666655222112223345555555


Q ss_pred             CCCCCCCC
Q 036815          181 LPHNNITG  188 (1013)
Q Consensus       181 L~~n~l~~  188 (1013)
                      ++.|.|++
T Consensus       278 ls~tgi~s  285 (505)
T KOG3207|consen  278 LSSTGIAS  285 (505)
T ss_pred             ccccCcch
Confidence            55555554

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.25  E-value=7.9e-13  Score=139.13  Aligned_cols=188  Identities=27%  Similarity=0.171  Sum_probs=104.8

Q ss_pred             hCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCC--CCccccCCCCCCEEecCCCcccccCcc-cccC
Q 036815           71 SNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV--IPSSLSNCTKLKILNLSFNLLAGEIPR-TFGQ  147 (1013)
Q Consensus        71 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~--~~~~l~~l~~L~~L~L~~n~l~~~~~~-~~~~  147 (1013)
                      +++.+|++..|.++.+..+...  .....|++++.||||.|-+...  +......+++|+.|+|+.|++..-... .-..
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~--~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~  195 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIE--EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL  195 (505)
T ss_pred             hhHHhhhheeecCccccccchh--hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence            3455666666666665532211  1224566666666666655432  222345667777777777766521111 1124


Q ss_pred             CCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcE
Q 036815          148 LSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLES  227 (1013)
Q Consensus       148 l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~  227 (1013)
                      +++|+.|.|+.|.++..--..+...+|+|+.|+|..|....+.......+..|++|||++|++.+.-.......++.|+.
T Consensus       196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence            56677777777777633333444556777777777775333444444556677777777777653322233456777777


Q ss_pred             EEcccccCCCcC-CcC-----CCCCCCcCEEEecCCeec
Q 036815          228 LILSNNMISGSF-PDS-----ISSCKTLRIVDFSSNRVS  260 (1013)
Q Consensus       228 L~L~~n~l~~~~-~~~-----~~~l~~L~~L~L~~N~l~  260 (1013)
                      |+++.|.+...- |+.     ...+++|++|++..|+|.
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            777777766421 211     233455555555555554

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.21  E-value=3.7e-13  Score=137.96  Aligned_cols=252  Identities=24%  Similarity=0.196  Sum_probs=136.3

Q ss_pred             ccCCCCCcEEeCCCCccCCCC---chhhhhCCCCccEEeCCCCcccC----ccC---CCCcCCCCCCcccEEECCCCCCC
Q 036815           45 FSKLPNLVYLNASYNNLTGFL---PETLLSNSDKLELLDLSYNNLTG----SIS---GFSLNENSCNSLLHLDLSQNHIM  114 (1013)
Q Consensus        45 ~~~l~~L~~L~L~~n~i~~~~---~~~~~~~l~~L~~L~Ls~n~l~~----~~~---~~~~~~~~~~~L~~L~Ls~n~i~  114 (1013)
                      ...+..+++|+||+|.+....   -...+...+.|++.++|+--.+-    ++.   .+...+..++.|++||||+|-+.
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            456777889999999876221   12335666788888887743321    111   11223344556666666666654


Q ss_pred             CCCCccc----cCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcC
Q 036815          115 DVIPSSL----SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSF  190 (1013)
Q Consensus       115 ~~~~~~l----~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  190 (1013)
                      ...+..|    +.+..|++|+|.+|.+.......++.  .|..|.  .|+.   +     ..-++|+++...+|++....
T Consensus       106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk---~-----~~~~~Lrv~i~~rNrlen~g  173 (382)
T KOG1909|consen  106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK---A-----ASKPKLRVFICGRNRLENGG  173 (382)
T ss_pred             ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc---c-----CCCcceEEEEeecccccccc
Confidence            4333332    44566666666666654222211111  011111  0000   0     01145666666666655432


Q ss_pred             ----CccccCCCCCCEEEccCCCCCCCCC---hhhhhcCCCCcEEEcccccCCCc----CCcCCCCCCCcCEEEecCCee
Q 036815          191 ----PVTLSSCSWLQLLDLSNNNISGPFP---DSVLENLGSLESLILSNNMISGS----FPDSISSCKTLRIVDFSSNRV  259 (1013)
Q Consensus       191 ----~~~l~~l~~L~~L~L~~N~l~~~~~---~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l  259 (1013)
                          +..|...+.|+.+.++.|.|.....   ...+..+++|+.|+|.+|.++..    +...++.+++|+.|++++|.+
T Consensus       174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll  253 (382)
T KOG1909|consen  174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLL  253 (382)
T ss_pred             HHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccc
Confidence                2344555667777777776642211   22356677777777777766532    344556667777777777777


Q ss_pred             cccCCCCCC----CCCCCCceEEcCCCccccc----CCccccccCcccEEEeeCCcc
Q 036815          260 SGIIPPDIC----PGVSSLEELRLPDNLITGV----IPGQLSECTQLKVIDLSLNYL  308 (1013)
Q Consensus       260 ~~~~~~~~~----~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~ls~N~l  308 (1013)
                      .......++    ...++|+.|.+.+|.|+..    +..++...+.|+.|+|++|++
T Consensus       254 ~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  254 ENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            654433222    2345677777777776632    223344567777777777777

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.21  E-value=1.5e-12  Score=133.49  Aligned_cols=189  Identities=25%  Similarity=0.271  Sum_probs=96.0

Q ss_pred             hCCCCccEEeCCCCcccC-ccCCCCcCCCCCCcccEEECCCCCCCCCCCcc-------------ccCCCCCCEEecCCCc
Q 036815           71 SNSDKLELLDLSYNNLTG-SISGFSLNENSCNSLLHLDLSQNHIMDVIPSS-------------LSNCTKLKILNLSFNL  136 (1013)
Q Consensus        71 ~~l~~L~~L~Ls~n~l~~-~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~-------------l~~l~~L~~L~L~~n~  136 (1013)
                      ..+++|+.||||+|-++. .+..+.....+|.+|++|.|.+|.+.......             ...-+.|+++....|+
T Consensus        89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNr  168 (382)
T KOG1909|consen   89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNR  168 (382)
T ss_pred             hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccc
Confidence            344455555555555542 12222222234455555555555543221111             1223456666666665


Q ss_pred             cccc----CcccccCCCCCCEeeCcCCcccCcC---CccchhccCCCcEEECCCCCCCCc----CCccccCCCCCCEEEc
Q 036815          137 LAGE----IPRTFGQLSSLQRLDLSNNHITGWI---PSELGNACDSLLELKLPHNNITGS----FPVTLSSCSWLQLLDL  205 (1013)
Q Consensus       137 l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~~---~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L  205 (1013)
                      +.+-    +...|...+.|+.+.++.|.|....   -...+..|++|+.|||.+|-++..    ....+..+++|++|++
T Consensus       169 len~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l  248 (382)
T KOG1909|consen  169 LENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNL  248 (382)
T ss_pred             cccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecc
Confidence            5432    2233444556666666666554111   112233456666666666655532    3345556666777777


Q ss_pred             cCCCCCCCCChhhh----hcCCCCcEEEcccccCCC----cCCcCCCCCCCcCEEEecCCee
Q 036815          206 SNNNISGPFPDSVL----ENLGSLESLILSNNMISG----SFPDSISSCKTLRIVDFSSNRV  259 (1013)
Q Consensus       206 ~~N~l~~~~~~~~~----~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l  259 (1013)
                      ++|.+.......++    ...|+|+.|.+.+|.|+.    .+...+...+.|..|+|++|.+
T Consensus       249 ~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  249 GDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             cccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            77766644333322    335667777777777652    1223344467777777777777

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.20  E-value=4.7e-11  Score=118.96  Aligned_cols=130  Identities=18%  Similarity=0.075  Sum_probs=95.1

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCccee-eeccEEEeCCEEEEEEEcccCCCH
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV-PLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      .+.++.|.++.||+++.. ++.|++|...... .....+..|+++++.+.+..++ +++.+.  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT-ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCc-ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356889999999999876 7889999754322 1233567899999988655544 444433  3345799999999877


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC--IPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      .+.-           .   ....++.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~-----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED-----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc-----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            5430           0   11245678999999999982  12359999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=2.8e-10  Score=112.91  Aligned_cols=136  Identities=16%  Similarity=0.144  Sum_probs=97.7

Q ss_pred             CCeecccCCcEEEEEEEcC-------CCEEEEEEeecc-------------C---------ccchHHH----HHHHHHHh
Q 036815          739 ESLIGCGGFGEVFKATLKD-------GSSVAIKKLIRL-------------S---------CQGDREF----MAEMETLG  785 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~  785 (1013)
                      ...||.|.-+.||.|...+       +..+|||.....             +         ....+.+    ++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998653       479999976321             0         0001223    37999999


Q ss_pred             ccCC--cceeeeccEEEeCCEEEEEEEcccCCCHHH-HhcccccCCCCccccHHHHHHHHHHHHHHHHHH-HhcCCCCeE
Q 036815          786 KIKH--RNLVPLLGYCKIGEERLLVYEFMKFGSLEE-VLHGRAKARDQRILTWDARKKIARGAAKGLCFL-HHNCIPHII  861 (1013)
Q Consensus       786 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iv  861 (1013)
                      ++..  -++.+.+++    ...++||||+++..+.. .+..       ..++..+...+..+++.+|.++ |..   ++|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~~---glV  147 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKEC---NLV  147 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            8853  456666654    45679999998654321 2211       1144456677889999999999 787   999


Q ss_pred             ecCCCcccEEeCCCCcEEEeecccceec
Q 036815          862 HRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       862 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |||+++.||+++ ++.++++|||.|...
T Consensus       148 HGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         148 HADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             cCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999999997 468999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.16  E-value=3.7e-11  Score=116.72  Aligned_cols=124  Identities=33%  Similarity=0.342  Sum_probs=36.4

Q ss_pred             cccEEECCCCCCCCCCCcccc-CCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEE
Q 036815          102 SLLHLDLSQNHIMDVIPSSLS-NCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK  180 (1013)
Q Consensus       102 ~L~~L~Ls~n~i~~~~~~~l~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  180 (1013)
                      ++++|+|++|.|+.+  +.++ .+.+|+.|+|++|.|+.+  +.+..++.|++|++++|+|+ .+...+...+++|++|+
T Consensus        20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY   94 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred             ccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence            445555555555543  2333 345555666666655533  23555566666666666665 34333333455666666


Q ss_pred             CCCCCCCCcC-CccccCCCCCCEEEccCCCCCCCC--ChhhhhcCCCCcEEEc
Q 036815          181 LPHNNITGSF-PVTLSSCSWLQLLDLSNNNISGPF--PDSVLENLGSLESLIL  230 (1013)
Q Consensus       181 L~~n~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~--~~~~~~~l~~L~~L~L  230 (1013)
                      |++|+|.+.. -..+..+++|+.|+|.+|.++..-  ...++..+|+|+.||-
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            6666655432 134455666666666666665221  1134555666666654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.15  E-value=2.2e-11  Score=118.20  Aligned_cols=105  Identities=30%  Similarity=0.258  Sum_probs=35.6

Q ss_pred             CCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEE
Q 036815          100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL  179 (1013)
Q Consensus       100 ~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  179 (1013)
                      +.+|+.|||++|.|+.+  +.+..++.|++|++++|+|+.+.......+++|++|++++|+|.+.-.-.....+++|+.|
T Consensus        41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             -TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            34455555555555543  2355556666666666666543221112455666666666665532222233345666666


Q ss_pred             ECCCCCCCCcC---CccccCCCCCCEEEcc
Q 036815          180 KLPHNNITGSF---PVTLSSCSWLQLLDLS  206 (1013)
Q Consensus       180 ~L~~n~l~~~~---~~~l~~l~~L~~L~L~  206 (1013)
                      +|.+|.++...   ...+..+++|+.||-.
T Consensus       119 ~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen  119 SLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             E-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred             eccCCcccchhhHHHHHHHHcChhheeCCE
Confidence            66666665331   1235677888887754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=5.6e-10  Score=105.86  Aligned_cols=131  Identities=21%  Similarity=0.308  Sum_probs=99.0

Q ss_pred             CeecccCCcEEEEEEEcCCCEEEEEEeeccCccc--------hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--------DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ..+++|+-+.+|.+.+. |.++++|.-.+.....        ..+-.+|+.++.+++--.|.-.+=+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999775 5556676543322211        13457799999988755554444455667778899999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      ++|..|.+.+...             ...++..+-.-+.-||..   +|||+|+.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888643             134667777788889999   999999999999998775 99999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=2e-09  Score=101.35  Aligned_cols=143  Identities=20%  Similarity=0.238  Sum_probs=104.6

Q ss_pred             CCCeecccCCcEEEEEEEcCCCEEEEEEeeccCcc--------chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          738 AESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ--------GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       738 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ....+-+|+-+.|+++.+. |+...||.-......        ..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678889999999999986 888788754322111        1245788999999886444444344455666667999


Q ss_pred             EcccC-CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC---cEEEeeccc
Q 036815          810 EFMKF-GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM---EARVSDFGM  885 (1013)
Q Consensus       810 e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~  885 (1013)
                      ||++| .++.+++.......    ........+++.|-+.+.-||..   +|||||+..+||++..++   .+.++|||+
T Consensus        90 E~~~g~~~vk~~i~~~~~~~----~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE----SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             EeccchhHHHHHHHHHccCc----ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecc
Confidence            99986 47888886544322    22222367888899999999999   999999999999997654   358999999


Q ss_pred             cee
Q 036815          886 ARL  888 (1013)
Q Consensus       886 a~~  888 (1013)
                      +..
T Consensus       163 s~~  165 (229)
T KOG3087|consen  163 SSV  165 (229)
T ss_pred             hhc
Confidence            854

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.04  E-value=1e-10  Score=130.25  Aligned_cols=196  Identities=20%  Similarity=0.238  Sum_probs=149.1

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc--CCCEEEEEEeeccCccchHH--HHHHHHHHhcc-CCcceeeeccEEEeCCEE
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK--DGSSVAIKKLIRLSCQGDRE--FMAEMETLGKI-KHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  805 (1013)
                      ....+|..+..||.|.|+.|+....+  ++..|++|.+.........+  -..|+.+...+ -|.++++.+..+..-+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567899999999999999998744  57789999776544333322  24566666665 588888888877777788


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeecc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFG  884 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg  884 (1013)
                      |+--||+++++.......      ...+++..++++..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||
T Consensus       342 ~ip~e~~~~~s~~l~~~~------~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT------SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             cCchhhhcCcchhhhhHH------HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence            899999999988776621      22367788899999999999999998   99999999999999886 778999999


Q ss_pred             cceeccccCcceeeeeeccCCCcc--CcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYV--PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP  940 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~p  940 (1013)
                      .+..+...     .....+..+++  +|+......+..+.|+||||.-+.+.+++..-
T Consensus       413 ~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  413 CWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             ccccccee-----cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence            98643211     11122333444  55666677888999999999999999998654

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.02  E-value=5.6e-11  Score=118.78  Aligned_cols=129  Identities=25%  Similarity=0.296  Sum_probs=88.5

Q ss_pred             cccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEec
Q 036815          297 QLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLT  376 (1013)
Q Consensus       297 ~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  376 (1013)
                      .|+++|||+|.|+ .+.++..-++.++.|++++|.+. . -..++.+++|+.||||+|.++ .+..+-.++-|.++|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~-v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-T-VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEecccccee-e-ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            3444444444444 33333333444444444444443 1 123677888999999999988 566677788899999999


Q ss_pred             CCccCCCCChhhhccCCCceEEccCCeeeeec-CCCCcCCCCCcEEEccCCcCCcC
Q 036815          377 GNELTGQIPPEFSRLTRLAVLQLGNNRFKGEI-PGELGNCSSLVWLDLNSNNLTGD  431 (1013)
Q Consensus       377 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~  431 (1013)
                      +|.|.  --..++.|.+|..||+++|+|...- -..|++++-|+.+.|.+|.+.+.
T Consensus       361 ~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  361 QNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            99986  2256788889999999999987321 24689999999999999998864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.00  E-value=1.8e-09  Score=112.83  Aligned_cols=142  Identities=20%  Similarity=0.241  Sum_probs=107.5

Q ss_pred             CeecccCCcEEEEEEEcCCCEEEEEEeeccCc-cchHHHHHHHHHHhccCC--cceeeeccEEEeC---CEEEEEEEccc
Q 036815          740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKH--RNLVPLLGYCKIG---EERLLVYEFMK  813 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  813 (1013)
                      +.++.|.++.||+++..+|+.+++|....... .....+.+|+++++.+++  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778999997644322 134568899999999965  3456677766553   25689999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC-------------------------------------  856 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  856 (1013)
                      |.++.+.+..       ..++......++.++++++.+||+..                                     
T Consensus        84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9888765521       12566677778888888888888421                                     


Q ss_pred             ----------------CCCeEecCCCcccEEeCC--CCcEEEeeccccee
Q 036815          857 ----------------IPHIIHRDMKSSNVLLDH--EMEARVSDFGMARL  888 (1013)
Q Consensus       857 ----------------~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~  888 (1013)
                                      ...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            246899999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.00  E-value=9e-11  Score=117.35  Aligned_cols=127  Identities=25%  Similarity=0.285  Sum_probs=61.0

Q ss_pred             CcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEec
Q 036815          176 LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS  255 (1013)
Q Consensus       176 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  255 (1013)
                      |+++||++|.|+ .+.....-.++++.|++|+|.|+ .+..  +..+++|++|||++|.++ .+..+-.++-++++|.|+
T Consensus       286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhccccccchh-hhhhhhhhccceeEEecccccee-eehh--hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            444444444444 22233333444455555555444 2211  334445555555555444 222233334445555555


Q ss_pred             CCeecccCCCCCCCCCCCCceEEcCCCccccc-CCccccccCcccEEEeeCCccCC
Q 036815          256 SNRVSGIIPPDICPGVSSLEELRLPDNLITGV-IPGQLSECTQLKVIDLSLNYLNG  310 (1013)
Q Consensus       256 ~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~ls~N~l~~  310 (1013)
                      +|.|.+.   .-...+-+|+.|++++|+|... -...++++|.|+.+.|.+|++.+
T Consensus       361 ~N~iE~L---SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  361 QNKIETL---SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hhhHhhh---hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            5544321   1112344555555555555432 12456777777777788887773

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.00  E-value=5.2e-11  Score=136.06  Aligned_cols=267  Identities=34%  Similarity=0.306  Sum_probs=165.1

Q ss_pred             CCCCcEEecCCCCcccccCcccc-cCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCC
Q 036815           23 PFGLKQLELSSAGLVGLVPDNLF-SKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCN  101 (1013)
Q Consensus        23 ~~~l~~L~L~~~~i~~~~~~~~~-~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~  101 (1013)
                      ++.++.++...+.+...   ..+ ..+..++.++++.|.|+...  .-+..+.+|+.|++.+|+|.++...    ...++
T Consensus        48 ~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~l~l~~n~i~~~~--~~l~~~~~l~~l~l~~n~i~~i~~~----l~~~~  118 (414)
T KOG0531|consen   48 PSDLEEIDLIFNLDGSD---EDLVESLTSLKELNLRQNLIAKIL--NHLSKLKSLEALDLYDNKIEKIENL----LSSLV  118 (414)
T ss_pred             cchhhhhcchhccccch---hhhHHHhHhHHhhccchhhhhhhh--cccccccceeeeeccccchhhcccc----hhhhh
Confidence            33445555555444221   112 45667777788888776311  1145677888888888888754332    24577


Q ss_pred             cccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEEC
Q 036815          102 SLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL  181 (1013)
Q Consensus       102 ~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L  181 (1013)
                      +|++|+|++|.|+++  ..+..++.|+.|++++|.|+.+  ..+..++.|+.+++++|++. .+.......+.+++.+.+
T Consensus       119 ~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l  193 (414)
T KOG0531|consen  119 NLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDL  193 (414)
T ss_pred             cchheeccccccccc--cchhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhc
Confidence            888888888888876  3467777788888888888744  45666788888888888877 444310244577888888


Q ss_pred             CCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCC--CCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCee
Q 036815          182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLG--SLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRV  259 (1013)
Q Consensus       182 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  259 (1013)
                      ..|.+..+  ..+..+..+..+++..|.++.. ..  ...+.  +|+.+++++|++. ..+..+..+..+..|++..|++
T Consensus       194 ~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~-~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~  267 (414)
T KOG0531|consen  194 GGNSIREI--EGLDLLKKLVLLSLLDNKISKL-EG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRI  267 (414)
T ss_pred             cCCchhcc--cchHHHHHHHHhhcccccceec-cC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccc
Confidence            88877643  2344455555567777777622 11  11222  2777888888776 3336667777777888887777


Q ss_pred             cccCCCCCCCCCCCCceEEcCCCccccc---CCcc-ccccCcccEEEeeCCccCCCC
Q 036815          260 SGIIPPDICPGVSSLEELRLPDNLITGV---IPGQ-LSECTQLKVIDLSLNYLNGSI  312 (1013)
Q Consensus       260 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~---~~~~-~~~l~~L~~L~ls~N~l~~~~  312 (1013)
                      ...   ........+..+....|.+...   .... ....+.++.+.+..|.+....
T Consensus       268 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
T KOG0531|consen  268 SNL---EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS  321 (414)
T ss_pred             ccc---ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence            633   2223445566666777665522   1111 445566777777777766433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.91  E-value=3e-10  Score=132.52  Aligned_cols=205  Identities=21%  Similarity=0.272  Sum_probs=146.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ..+.+.+.+-+-+|+++.++.+.-. .|...++|.....   ...+.+....+-.+.-..+||.+++..--+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3466778888899999999988644 2333344322111   11112222333333333456777766655555678899


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |++|..++++...++....      .+.+..+..+..+..+.+|||+.   .++|+|++|.|+++..+++.+++|||..+
T Consensus       882 ~~~~~~~~~~~Skl~~~~~------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence            9999999999999986542      33334455566788899999998   79999999999999999999999998544


Q ss_pred             eccccC-----------------------------cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCC
Q 036815          888 LISALD-----------------------------THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK  938 (1013)
Q Consensus       888 ~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~  938 (1013)
                      ...-..                             .........+|+.|.+||...+......+|.|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            331110                             001123456899999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 036815          939 RPTDKDD  945 (1013)
Q Consensus       939 ~pf~~~~  945 (1013)
                      +||....
T Consensus      1033 pp~na~t 1039 (1205)
T KOG0606|consen 1033 PPFNAET 1039 (1205)
T ss_pred             CCCCCcc
Confidence            9998644

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.90  E-value=7.1e-09  Score=104.53  Aligned_cols=135  Identities=19%  Similarity=0.188  Sum_probs=97.3

Q ss_pred             CCCCCeecccCCcEEEEEEEcCCCEEEEEEeecc--------------------C--ccchHHHHHHHHHHhccCCc--c
Q 036815          736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRL--------------------S--CQGDREFMAEMETLGKIKHR--N  791 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~h~--n  791 (1013)
                      +.++..||.|.-+.||.|..+.|.++|||.=...                    +  .......++|.++|+++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4567899999999999999999999999932110                    0  00112467899999998654  6


Q ss_pred             eeeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEE
Q 036815          792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVL  871 (1013)
Q Consensus       792 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  871 (1013)
                      |.+.+++    +...+||||++|-.|...-           ++......++..|++-+.-.-..   ||||+|+++-||+
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIl  234 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNIL  234 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEE
Confidence            7777754    5567999999986665432           11222334455555555444456   9999999999999


Q ss_pred             eCCCCcEEEeeccccee
Q 036815          872 LDHEMEARVSDFGMARL  888 (1013)
Q Consensus       872 l~~~~~~kl~Dfg~a~~  888 (1013)
                      ++++|.+.++||-.+..
T Consensus       235 V~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         235 VTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             EecCCCEEEEeCccccc
Confidence            99999999999976643

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.88  E-value=3.7e-10  Score=129.04  Aligned_cols=267  Identities=31%  Similarity=0.331  Sum_probs=127.5

Q ss_pred             CCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEc
Q 036815          126 KLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL  205 (1013)
Q Consensus       126 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L  205 (1013)
                      .++.++...+.+...... ...+..++.+.+..|.+. .+-..+ ..+++|+.|++.+|+|..+.. .+..+++|++|++
T Consensus        50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l-~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~l  125 (414)
T KOG0531|consen   50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHL-SKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDL  125 (414)
T ss_pred             hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhccc-ccccceeeeeccccchhhccc-chhhhhcchheec
Confidence            444555555444322111 134455555666666665 211111 223556666666666653322 1445555666666


Q ss_pred             cCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCccc
Q 036815          206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLIT  285 (1013)
Q Consensus       206 ~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~  285 (1013)
                      ++|.|+..-+   +..++.|+.|++++|.|+.  ...+..+..|+.+++++|++...-+.                    
T Consensus       126 s~N~I~~i~~---l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~--------------------  180 (414)
T KOG0531|consen  126 SFNKITKLEG---LSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIEND--------------------  180 (414)
T ss_pred             cccccccccc---hhhccchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhh--------------------
Confidence            6665552211   2344445555555555542  22333345555555555555422110                    


Q ss_pred             ccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCC--CCceEECccccccccCchh
Q 036815          286 GVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCK--NLKDLILNNNKLSGEIPAE  363 (1013)
Q Consensus       286 ~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~  363 (1013)
                          . ...+..++.+++.+|.+.  ....+..+..+..+.+..|.++..-  .+..+.  .|+.+++++|.+. ..+..
T Consensus       181 ----~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~  250 (414)
T KOG0531|consen  181 ----E-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRIS-RSPEG  250 (414)
T ss_pred             ----h-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcccCccc-ccccc
Confidence                1 234444444444444443  1222333333333344444443111  111222  2566666666665 33355


Q ss_pred             hcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeee---cCCC-CcCCCCCcEEEccCCcCCcCCC
Q 036815          364 LFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGE---IPGE-LGNCSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       364 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~L~l~~N~l~~~~p  433 (1013)
                      +..+.++..|++.+|++...  ..+...+.+..+.+..|.+...   .... ......++.+++..|......+
T Consensus       251 ~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  251 LENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            55666677777777766522  2244455566666666665421   1121 4556677777777776654443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.79  E-value=1.1e-07  Score=100.30  Aligned_cols=141  Identities=15%  Similarity=0.092  Sum_probs=100.2

Q ss_pred             CeecccCCcEEEEEEEcCCCEEEEEEeeccCc-----------cchHHHHHHHHHHhccCCc--ceeeeccEEEe-----
Q 036815          740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC-----------QGDREFMAEMETLGKIKHR--NLVPLLGYCKI-----  801 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~-----  801 (1013)
                      +.+-......|+++.. +|+.|+||+......           .....+.+|...+.++...  ..++.+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4555555556777766 478899997643221           1112478899998888433  33344555543     


Q ss_pred             CCEEEEEEEcccCC-CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC------
Q 036815          802 GEERLLVYEFMKFG-SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH------  874 (1013)
Q Consensus       802 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~------  874 (1013)
                      ....++|+|++++. +|.+++.....    ...+......++.++++.+.-||..   ||+|+|++++||+++.      
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~  179 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGRE  179 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCC
Confidence            23568999999986 79998853211    1245567778999999999999999   9999999999999975      


Q ss_pred             -CCcEEEeeccccee
Q 036815          875 -EMEARVSDFGMARL  888 (1013)
Q Consensus       875 -~~~~kl~Dfg~a~~  888 (1013)
                       ++.+.++||+.++.
T Consensus       180 ~~~~~~LIDl~r~~~  194 (268)
T PRK15123        180 EDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCceEEEEECCcccc
Confidence             46799999998753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.78  E-value=8.1e-08  Score=104.37  Aligned_cols=172  Identities=20%  Similarity=0.266  Sum_probs=130.7

Q ss_pred             CcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe----CCEEEEEEEcccC-CCHHHH
Q 036815          747 FGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI----GEERLLVYEFMKF-GSLEEV  820 (1013)
Q Consensus       747 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~  820 (1013)
                      -.+.|++... ||..|+.|++.............-+++++++.|+|||++.+++..    +...++||+|+++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999865 899999999844333333344556889999999999999998863    4577999999986 467776


Q ss_pred             hcccccCC---------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          821 LHGRAKAR---------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       821 l~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      -.......         .....++..+|.++.|+..||.++|+.   |+.-+-+.|.+|+++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            64333222         234578899999999999999999999   999999999999999999999988887655433


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP  940 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  940 (1013)
                      ...                |.+.+   -.+-|.=.||.+++.+.||..-
T Consensus       446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            210                11111   2367999999999999999654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=3.2e-08  Score=98.12  Aligned_cols=125  Identities=21%  Similarity=0.270  Sum_probs=82.0

Q ss_pred             EEEEEEEcCCCEEEEEEeeccC-------------c--------cc-----hHHHHHHHHHHhccCCc--ceeeeccEEE
Q 036815          749 EVFKATLKDGSSVAIKKLIRLS-------------C--------QG-----DREFMAEMETLGKIKHR--NLVPLLGYCK  800 (1013)
Q Consensus       749 ~V~~~~~~~~~~vavK~~~~~~-------------~--------~~-----~~~~~~E~~~l~~l~h~--niv~l~~~~~  800 (1013)
                      .||.|...+|..+|+|......             .        ..     ....++|++.|.++...  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899999889999999763210             0        00     12367899999999755  566666442 


Q ss_pred             eCCEEEEEEEccc--CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCcccEEeCCCCc
Q 036815          801 IGEERLLVYEFMK--FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL-HHNCIPHIIHRDMKSSNVLLDHEME  877 (1013)
Q Consensus       801 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~Nill~~~~~  877 (1013)
                         ..++||||++  |..+..+....        ++......++.+++..+..+ |..   ||||||+.+.||+++++ .
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence               3469999999  65665544321        11233456777888866664 677   99999999999999988 9


Q ss_pred             EEEeecccceec
Q 036815          878 ARVSDFGMARLI  889 (1013)
Q Consensus       878 ~kl~Dfg~a~~~  889 (1013)
                      +.++|||.|...
T Consensus       145 ~~iIDf~qav~~  156 (188)
T PF01163_consen  145 VYIIDFGQAVDS  156 (188)
T ss_dssp             EEE--GTTEEET
T ss_pred             EEEEecCcceec
Confidence            999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.77  E-value=9.5e-10  Score=110.26  Aligned_cols=229  Identities=19%  Similarity=0.184  Sum_probs=144.6

Q ss_pred             CccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCC--CCCccccCCCCCCEEecCCCcccccCcccccCCCCCC
Q 036815           75 KLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMD--VIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQ  152 (1013)
Q Consensus        75 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~--~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  152 (1013)
                      .++.|.+.++.|..+... ......++.++.|||.+|.|++  .+...+.++|.|+.|+|+.|++...+...-..+.+|+
T Consensus        46 a~ellvln~~~id~~gd~-~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~  124 (418)
T KOG2982|consen   46 ALELLVLNGSIIDNEGDV-MLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLR  124 (418)
T ss_pred             chhhheecCCCCCcchhH-HHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceE
Confidence            444555656655432221 1122356677788888887764  2344567889999999999988754433225678899


Q ss_pred             EeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCc--CCcccc-CCCCCCEEEccCCCCCCCCC-hhhhhcCCCCcEE
Q 036815          153 RLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS--FPVTLS-SCSWLQLLDLSNNNISGPFP-DSVLENLGSLESL  228 (1013)
Q Consensus       153 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~l~-~l~~L~~L~L~~N~l~~~~~-~~~~~~l~~L~~L  228 (1013)
                      .|.|.+..+...-...+...++.+++|.++.|.+...  ...... .-+.+++|+...|...-... ..+..-+|++..+
T Consensus       125 ~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv  204 (418)
T KOG2982|consen  125 VLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSV  204 (418)
T ss_pred             EEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchhe
Confidence            9999988887444445556678888888888854321  111111 22356666665554321100 1123456788888


Q ss_pred             EcccccCCCc-CCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCc------cccccCcccEE
Q 036815          229 ILSNNMISGS-FPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPG------QLSECTQLKVI  301 (1013)
Q Consensus       229 ~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L  301 (1013)
                      .+..|.+... ..+....++.+-.|+|+.|+|.+.-.-+...++++|..|.+++|.+.+....      -++++++++.|
T Consensus       205 ~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vL  284 (418)
T KOG2982|consen  205 FVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVL  284 (418)
T ss_pred             eeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEe
Confidence            8888877643 3456666778888888888888766667777788888888888887654322      13566777766


Q ss_pred             Eee
Q 036815          302 DLS  304 (1013)
Q Consensus       302 ~ls  304 (1013)
                      +=+
T Consensus       285 NGs  287 (418)
T KOG2982|consen  285 NGS  287 (418)
T ss_pred             cCc
Confidence            544

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.76  E-value=1.2e-08  Score=124.08  Aligned_cols=278  Identities=22%  Similarity=0.242  Sum_probs=134.6

Q ss_pred             CCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCC--CCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCC
Q 036815           74 DKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNH--IMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSL  151 (1013)
Q Consensus        74 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~--i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  151 (1013)
                      ...+.+.+-+|.+......     ..+++|+.|-+.+|.  +..+..+.|..++.|++|||++|.--+.+|..++.+-+|
T Consensus       523 ~~~rr~s~~~~~~~~~~~~-----~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIEHIAGS-----SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             hheeEEEEeccchhhccCC-----CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            4555666666655432221     234456666666664  444444456666777777777665555666666667777


Q ss_pred             CEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCC-CCChhhhhcCCCCcEEEc
Q 036815          152 QRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISG-PFPDSVLENLGSLESLIL  230 (1013)
Q Consensus       152 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~~l~~L~~L~L  230 (1013)
                      ++|+++++.+. .+|..+.+ +.+|.+|++..+.-....+.....+++|++|.+..-.... ..-..-..++.+|+.+..
T Consensus       598 ryL~L~~t~I~-~LP~~l~~-Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~  675 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGN-LKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI  675 (889)
T ss_pred             hcccccCCCcc-ccchHHHH-HHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence            77777776666 66666654 3566666666655443445555556666666665443110 000011122223333322


Q ss_pred             ccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCC
Q 036815          231 SNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG  310 (1013)
Q Consensus       231 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~  310 (1013)
                      .....  .+...+..++.|..                     ..+.+.+.++... ..+..+..+.+|+.|.+.++.+..
T Consensus       676 ~~~s~--~~~e~l~~~~~L~~---------------------~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e  731 (889)
T KOG4658|consen  676 TISSV--LLLEDLLGMTRLRS---------------------LLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE  731 (889)
T ss_pred             ecchh--HhHhhhhhhHHHHH---------------------HhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence            11111  00011111111110                     0111222222221 233455666777777777776653


Q ss_pred             CCCcccccC------cchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCC
Q 036815          311 SIPQELGKL------EHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQ  383 (1013)
Q Consensus       311 ~~p~~l~~l------~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  383 (1013)
                      .........      +++..+....+... ..+....-.++|+.|++..+.....+......+..+..+-+..+.+.+.
T Consensus       732 ~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l  809 (889)
T KOG4658|consen  732 IVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL  809 (889)
T ss_pred             hhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence            322222221      12222222222211 2222333446777777777776655555555566666656666665543

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.73  E-value=1.2e-08  Score=124.11  Aligned_cols=297  Identities=23%  Similarity=0.235  Sum_probs=171.3

Q ss_pred             CCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCe--ecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCccc
Q 036815          222 LGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNR--VSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLK  299 (1013)
Q Consensus       222 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  299 (1013)
                      ....+...+-+|.+. .++... .++.|++|-+..|.  +. .++..+|..++.|+.|+|++|.=-+.+|..++.+-+|+
T Consensus       522 ~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr  598 (889)
T KOG4658|consen  522 WNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR  598 (889)
T ss_pred             hhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence            345666666666664 222222 23367777777775  33 55666667777777777777765557777888888888


Q ss_pred             EEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccc--ccCchhhcCCCCCCeEEecC
Q 036815          300 VIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS--GEIPAELFSCSNLEWISLTG  377 (1013)
Q Consensus       300 ~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~  377 (1013)
                      +|++++..++ .+|..+.+|+.|.+|++..+.-...+|.....|++|++|.+..-...  ...-..+..+.+|+.+....
T Consensus       599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~  677 (889)
T KOG4658|consen  599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITI  677 (889)
T ss_pred             cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeec
Confidence            8888888877 77888888888888887777665555666666788888777665422  22333445555555555543


Q ss_pred             CccCCCCChhhhccCCCc----eEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCc
Q 036815          378 NELTGQIPPEFSRLTRLA----VLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNT  453 (1013)
Q Consensus       378 N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~  453 (1013)
                      ...  .+-..+..+++|.    .+.+.++... ..+..++.+.+|+.|.+.++..+...-.+......            
T Consensus       678 ~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~------------  742 (889)
T KOG4658|consen  678 SSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIV------------  742 (889)
T ss_pred             chh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccch------------
Confidence            332  1112223333333    3343344444 55667788888888888887765222111100000            


Q ss_pred             eEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCC
Q 036815          454 LVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA  533 (1013)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~  533 (1013)
                                       ..          ..+.+.+..+.+.+...-+......++|+.|++........+.+....+..
T Consensus       743 -----------------~~----------~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~  795 (889)
T KOG4658|consen  743 -----------------LL----------CFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLE  795 (889)
T ss_pred             -----------------hh----------hHHHHHHHHhhccccccccchhhccCcccEEEEecccccccCCCHHHHhhh
Confidence                             00          011111212222222222222234478888998877766566666777777


Q ss_pred             CcEEecCCCccCCC-CcccccCCCCcceEecC
Q 036815          534 LQVLELAHNQLSGE-IPSSLGRLRNLGVFDAS  564 (1013)
Q Consensus       534 L~~L~L~~n~l~g~-ip~~~~~l~~L~~L~ls  564 (1013)
                      +..+.+..+.+.|- .-.+.+.++++..+.++
T Consensus       796 l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~  827 (889)
T KOG4658|consen  796 LKELILPFNKLEGLRMLCSLGGLPQLYWLPLS  827 (889)
T ss_pred             cccEEecccccccceeeecCCCCceeEecccC
Confidence            77777888888764 33445555555544443

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.72  E-value=7.3e-09  Score=82.65  Aligned_cols=61  Identities=43%  Similarity=0.602  Sum_probs=45.6

Q ss_pred             CcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcc
Q 036815          101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHI  161 (1013)
Q Consensus       101 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  161 (1013)
                      ++|++|++++|+|+.+.+..|.++++|++|++++|+++.+.+.+|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3567777777777777667777777777777777777777777777777777777777764

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.68  E-value=1.7e-08  Score=80.47  Aligned_cols=61  Identities=41%  Similarity=0.597  Sum_probs=47.6

Q ss_pred             CCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcC
Q 036815          368 SNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNL  428 (1013)
Q Consensus       368 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  428 (1013)
                      ++|++|++++|+++...+..|..+++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4677888888888755556778888888888888888877777888888888888888864

...

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.63  E-value=5.1e-07  Score=95.64  Aligned_cols=197  Identities=15%  Similarity=0.209  Sum_probs=133.3

Q ss_pred             CCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEE------Ee-CCEEEEE
Q 036815          737 SAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYC------KI-GEERLLV  808 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~-~~~~~lv  808 (1013)
                      ...+.||+|+.+.+|-.-.-  +..+.|++.........+   .++.|... .||-+-.-+.+=      .. +....+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            35678999999999965321  223556554433332222   23334443 565443312111      11 2235688


Q ss_pred             EEcccCC-CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          809 YEFMKFG-SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       809 ~e~~~~g-~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |+.+.|. ....+.....+...-....|....++++.++.+.+.||+.   |.+-||+.++|+++++++.+.+.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            8888764 3444443222223334478999999999999999999999   99999999999999999999998855433


Q ss_pred             eccccCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcC-CCCCCCC
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTG-KRPTDKD  944 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~pf~~~  944 (1013)
                      ..   ..........|...|.+||.-.     +...+...|-|.+|+++++++.| ++||.+-
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            32   2333445677899999999754     44556789999999999999886 9999864

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.58  E-value=1.4e-08  Score=114.52  Aligned_cols=99  Identities=20%  Similarity=0.387  Sum_probs=77.0

Q ss_pred             HHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCccee--e-----eeeccCCCccCcccccC
Q 036815          843 RGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS--V-----STLAGTPGYVPPEYYQS  915 (1013)
Q Consensus       843 ~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~-----~~~~gt~~y~aPE~~~~  915 (1013)
                      .+++.|+.|+|..  +++||++|.|++|.+++.+.+|++.|+.+...........  +     ........|.|||++.+
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            4455899999998  6999999999999999999999999998865543111100  0     01223458999999999


Q ss_pred             CCCCccchhHhHHHHHHHHH-cCCCCCCC
Q 036815          916 FRCTAKGDVYSFGVVLLELL-TGKRPTDK  943 (1013)
Q Consensus       916 ~~~~~~~DvwslG~il~ell-tg~~pf~~  943 (1013)
                      ...+.++|+||+||.+|.+. .|+.-+..
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a  212 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA  212 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhc
Confidence            88899999999999999998 45555543

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.54  E-value=1.2e-09  Score=109.61  Aligned_cols=157  Identities=27%  Similarity=0.264  Sum_probs=101.9

Q ss_pred             cccEEECCCCCCCC-CCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCC-cccCcCCccchhccCCCcEE
Q 036815          102 SLLHLDLSQNHIMD-VIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN-HITGWIPSELGNACDSLLEL  179 (1013)
Q Consensus       102 ~L~~L~Ls~n~i~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~~l~~L~~L  179 (1013)
                      .|++||||...|+. .....++.|.+|+.|.|.++++.+-+...++.-.+|+.|+|+.+ .++......++..|+.|.+|
T Consensus       186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L  265 (419)
T KOG2120|consen  186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL  265 (419)
T ss_pred             hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence            47788888877753 12233567788888888888888777777888888888888875 46644455666777788888


Q ss_pred             ECCCCCCCCcCC-ccccC-CCCCCEEEccCCC--CCCCCChhhhhcCCCCcEEEcccc-cCCCcCCcCCCCCCCcCEEEe
Q 036815          180 KLPHNNITGSFP-VTLSS-CSWLQLLDLSNNN--ISGPFPDSVLENLGSLESLILSNN-MISGSFPDSISSCKTLRIVDF  254 (1013)
Q Consensus       180 ~L~~n~l~~~~~-~~l~~-l~~L~~L~L~~N~--l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L  254 (1013)
                      +|+.|.++...- ....+ -++|+.|+|+++.  +...--..+...+++|.+|||++| .++......|.+++.|++|.+
T Consensus       266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSl  345 (419)
T KOG2120|consen  266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSL  345 (419)
T ss_pred             CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeeh
Confidence            888876653321 11222 2567777777763  221111234567778888888776 344444455666777777777


Q ss_pred             cCCe
Q 036815          255 SSNR  258 (1013)
Q Consensus       255 ~~N~  258 (1013)
                      +.|.
T Consensus       346 sRCY  349 (419)
T KOG2120|consen  346 SRCY  349 (419)
T ss_pred             hhhc
Confidence            7775

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.51  E-value=1.9e-09  Score=120.35  Aligned_cols=129  Identities=31%  Similarity=0.297  Sum_probs=96.4

Q ss_pred             CcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEE
Q 036815          101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK  180 (1013)
Q Consensus       101 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  180 (1013)
                      ..|...+.++|.+.- ...++.-++.|+.|||++|+++..  +.+..|+.|++|||++|.++ .+|..-...|. |+.|.
T Consensus       164 n~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  164 NKLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             hhHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence            357777888888764 455677788888888888888755  37788888888888888888 77766555554 88888


Q ss_pred             CCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCC
Q 036815          181 LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS  236 (1013)
Q Consensus       181 L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~  236 (1013)
                      +++|-++..  ..+.++.+|+.||+++|-|.+.-.-..+..+..|+.|+|.+|.+-
T Consensus       239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            888887744  356778888888888887765444444566677888888888774

>KOG4341 consensus F-box protein containing LRR [General function prediction only]

Probab=98.51  E-value=2.3e-09  Score=112.87  Aligned_cols=281  Identities=23%  Similarity=0.202  Sum_probs=174.6

Q ss_pred             CCcEEecCCCCcccccCcccc-cCCCCCcEEeCCCC-ccCCCCchhhhhCCCCccEEeCCCC-cccCccCCCCcCCCCCC
Q 036815           25 GLKQLELSSAGLVGLVPDNLF-SKLPNLVYLNASYN-NLTGFLPETLLSNSDKLELLDLSYN-NLTGSISGFSLNENSCN  101 (1013)
Q Consensus        25 ~l~~L~L~~~~i~~~~~~~~~-~~l~~L~~L~L~~n-~i~~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~~~~~~  101 (1013)
                      .++.|+|.+|+-++.-+-..| .++|++++|++.+| .|++..-.++-..|++|+.|+|..| .++..  .+......|+
T Consensus       139 ~lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~--~Lk~la~gC~  216 (483)
T KOG4341|consen  139 FLKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDV--SLKYLAEGCR  216 (483)
T ss_pred             ccccccccccccCCcchhhHHhhhCCchhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHH--HHHHHHHhhh
Confidence            378899999876554444434 67889999999988 5666555666778999999999884 34421  1122345788


Q ss_pred             cccEEECCCCC-CCCCCC-ccccCCCCCCEEecCCCccccc--CcccccCCCCCCEeeCcCC-cccCcCCccchhccCCC
Q 036815          102 SLLHLDLSQNH-IMDVIP-SSLSNCTKLKILNLSFNLLAGE--IPRTFGQLSSLQRLDLSNN-HITGWIPSELGNACDSL  176 (1013)
Q Consensus       102 ~L~~L~Ls~n~-i~~~~~-~~l~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~~l~~L  176 (1013)
                      +|++|+++++. |++-.- ..++++..++.+.+.+|.=.+.  +-..=+.+.-+.++++.+| .+++.--..+...+..|
T Consensus       217 kL~~lNlSwc~qi~~~gv~~~~rG~~~l~~~~~kGC~e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~~l  296 (483)
T KOG4341|consen  217 KLKYLNLSWCPQISGNGVQALQRGCKELEKLSLKGCLELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCHAL  296 (483)
T ss_pred             hHHHhhhccCchhhcCcchHHhccchhhhhhhhcccccccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhhHh
Confidence            99999999884 554222 2346677777777776522111  1111124455666666665 45544334455566778


Q ss_pred             cEEECCCC-CCCCcCCccc-cCCCCCCEEEccCCC-CCCCCChhhhhcCCCCcEEEcccccCCC--cCCcCCCCCCCcCE
Q 036815          177 LELKLPHN-NITGSFPVTL-SSCSWLQLLDLSNNN-ISGPFPDSVLENLGSLESLILSNNMISG--SFPDSISSCKTLRI  251 (1013)
Q Consensus       177 ~~L~L~~n-~l~~~~~~~l-~~l~~L~~L~L~~N~-l~~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~  251 (1013)
                      +.|+.+++ .+++..-..+ .++.+|+.|-++.++ +++.....+-.+.+.|+.+++.++....  .+...-.+++.|+.
T Consensus       297 q~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr~  376 (483)
T KOG4341|consen  297 QVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLRV  376 (483)
T ss_pred             hhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhcc
Confidence            88888875 4443333333 467888888888885 5544444455677888888888875431  13333345788888


Q ss_pred             EEecCCeecccCC----CCCCCCCCCCceEEcCCCcc-cccCCccccccCcccEEEeeCCc
Q 036815          252 VDFSSNRVSGIIP----PDICPGVSSLEELRLPDNLI-TGVIPGQLSECTQLKVIDLSLNY  307 (1013)
Q Consensus       252 L~L~~N~l~~~~~----~~~~~~l~~L~~L~L~~n~l-~~~~~~~~~~l~~L~~L~ls~N~  307 (1013)
                      |.+++|.......    .....++..|+.+.|+++.. ++..-..+..+++|+.+++-+++
T Consensus       377 lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q  437 (483)
T KOG4341|consen  377 LSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQ  437 (483)
T ss_pred             CChhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechh
Confidence            8888885432211    11112456677788888764 33444556777788887777665

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.51  E-value=3.1e-08  Score=99.59  Aligned_cols=209  Identities=20%  Similarity=0.163  Sum_probs=131.7

Q ss_pred             CcEEecCCCCcccccCcccc-cCCCCCcEEeCCCCccCCC-CchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcc
Q 036815           26 LKQLELSSAGLVGLVPDNLF-SKLPNLVYLNASYNNLTGF-LPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSL  103 (1013)
Q Consensus        26 l~~L~L~~~~i~~~~~~~~~-~~l~~L~~L~L~~n~i~~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L  103 (1013)
                      ++-|.|.+|.|.+.-....| +.+.++++|||.+|.|++- --..++.++|+|+.|+|++|.+...+..++   ....+|
T Consensus        47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp---~p~~nl  123 (418)
T KOG2982|consen   47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP---LPLKNL  123 (418)
T ss_pred             hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc---ccccce
Confidence            45677777777432222223 4577899999999999842 223567899999999999999986555544   235689


Q ss_pred             cEEECCCCCCCCC-CCccccCCCCCCEEecCCCcccc--cCcccccCC-CCCCEeeCcCCcccCcCC-ccchhccCCCcE
Q 036815          104 LHLDLSQNHIMDV-IPSSLSNCTKLKILNLSFNLLAG--EIPRTFGQL-SSLQRLDLSNNHITGWIP-SELGNACDSLLE  178 (1013)
Q Consensus       104 ~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~l~~--~~~~~~~~l-~~L~~L~Ls~n~l~~~~~-~~~~~~l~~L~~  178 (1013)
                      +.|-|.+..+.-. ....+..+|.+++|+++.|.+..  ......... +.+++|.+..|...-+.. ..+.+.++++..
T Consensus       124 ~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~s  203 (418)
T KOG2982|consen  124 RVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNS  203 (418)
T ss_pred             EEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchh
Confidence            9999988877532 33456788999999999995431  222222222 245555555443221100 112234567777


Q ss_pred             EECCCCCCCCcC-CccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCC
Q 036815          179 LKLPHNNITGSF-PVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG  237 (1013)
Q Consensus       179 L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  237 (1013)
                      +-+..|.+.... .+.+..++.+--|+|+.|+|.+.-....+.++++|..|.+++|.+.+
T Consensus       204 v~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  204 VFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             eeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            777777776432 23455566667777887777654444456667777777777777653

>PRK09902 hypothetical protein; Provisional

Probab=98.49  E-value=2.9e-06  Score=84.37  Aligned_cols=137  Identities=17%  Similarity=0.159  Sum_probs=102.3

Q ss_pred             cccCCcEEEEEEEcCCCEEEEEEeec-c--C---ccchHHHHHHHHHHhccCC--cceeeeccEEEe---C--CEEEEEE
Q 036815          743 GCGGFGEVFKATLKDGSSVAIKKLIR-L--S---CQGDREFMAEMETLGKIKH--RNLVPLLGYCKI---G--EERLLVY  809 (1013)
Q Consensus       743 G~G~~g~V~~~~~~~~~~vavK~~~~-~--~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~---~--~~~~lv~  809 (1013)
                      |+||-+.|+..... |+.+.+|+-.. .  +   +.....|.+|...+.++..  -.+.+.+ ++..   +  -..+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            67888899997765 55799997641 1  1   3356789999999999853  2355555 3322   1  2357999


Q ss_pred             EcccC-CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc--EEEeecccc
Q 036815          810 EFMKF-GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME--ARVSDFGMA  886 (1013)
Q Consensus       810 e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a  886 (1013)
                      |-++| .+|.+++.....    .+.+......++.++++.++-||+.   |+.|+|+.+.||+++.++.  ++++||.-+
T Consensus       105 e~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            97764 588888854322    1256777789999999999999999   9999999999999986666  999999876


Q ss_pred             ee
Q 036815          887 RL  888 (1013)
Q Consensus       887 ~~  888 (1013)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            54

>KOG4341 consensus F-box protein containing LRR [General function prediction only]

Probab=98.48  E-value=3.5e-09  Score=111.52  Aligned_cols=300  Identities=21%  Similarity=0.180  Sum_probs=197.6

Q ss_pred             CcceecccCCcccccc--cccccCCCCCcEEecCCCC-cccccCcccccCCCCCcEEeCCCC-ccCCCCchhhhhCCCCc
Q 036815            1 MLSVLKLSSNLFTLNS--TSLLQLPFGLKQLELSSAG-LVGLVPDNLFSKLPNLVYLNASYN-NLTGFLPETLLSNSDKL   76 (1013)
Q Consensus         1 ~l~~L~l~~n~~~~~~--~~~~~~~~~l~~L~L~~~~-i~~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~~l~~L   76 (1013)
                      ||+.|.|.+..=-...  ..+...+++++.|++.+|. |++..-..+-..+++|++|+|..| .|++..-..+..+|++|
T Consensus       139 ~lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la~gC~kL  218 (483)
T KOG4341|consen  139 FLKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLAEGCRKL  218 (483)
T ss_pred             ccccccccccccCCcchhhHHhhhCCchhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHHHhhhhH
Confidence            5788888877532222  2345678899999999985 443333334467899999999996 77766666677899999


Q ss_pred             cEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccc----cCCCCCCEEecCCC-cccccCcccc-cCCCC
Q 036815           77 ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL----SNCTKLKILNLSFN-LLAGEIPRTF-GQLSS  150 (1013)
Q Consensus        77 ~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l----~~l~~L~~L~L~~n-~l~~~~~~~~-~~l~~  150 (1013)
                      ++|++|++.-... .++.....++.+++.+.+.+|.=  ..-+.|    ..+..+.++++.+| .+++...-.+ ..+..
T Consensus       219 ~~lNlSwc~qi~~-~gv~~~~rG~~~l~~~~~kGC~e--~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~~  295 (483)
T KOG4341|consen  219 KYLNLSWCPQISG-NGVQALQRGCKELEKLSLKGCLE--LELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCHA  295 (483)
T ss_pred             HHhhhccCchhhc-CcchHHhccchhhhhhhhccccc--ccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhhH
Confidence            9999999865422 33344456777888888887632  112233    44566777777666 4454322222 25688


Q ss_pred             CCEeeCcCC-cccCcCCccchhccCCCcEEECCCCC-CCCcCCccc-cCCCCCCEEEccCCCCC-CCCChhhhhcCCCCc
Q 036815          151 LQRLDLSNN-HITGWIPSELGNACDSLLELKLPHNN-ITGSFPVTL-SSCSWLQLLDLSNNNIS-GPFPDSVLENLGSLE  226 (1013)
Q Consensus       151 L~~L~Ls~n-~l~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~l-~~l~~L~~L~L~~N~l~-~~~~~~~~~~l~~L~  226 (1013)
                      |+.|+.+++ .+++.+-..+...+.+|+.|-++.++ ++..-...+ .++..|+.+++..+... +.--.....+++.|+
T Consensus       296 lq~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr  375 (483)
T KOG4341|consen  296 LQVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLR  375 (483)
T ss_pred             hhhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhc
Confidence            999999886 46666666778888999999999985 554433334 46788999999988643 221223456788999


Q ss_pred             EEEcccccCC-CcC----CcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCc-cccc-CCccccccCccc
Q 036815          227 SLILSNNMIS-GSF----PDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNL-ITGV-IPGQLSECTQLK  299 (1013)
Q Consensus       227 ~L~L~~n~l~-~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~-l~~~-~~~~~~~l~~L~  299 (1013)
                      .|.++.+... +..    ...-..+..|..+.|+++.....-........++|+.+++.+++ ++.. +...-.++++++
T Consensus       376 ~lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q~vtk~~i~~~~~~lp~i~  455 (483)
T KOG4341|consen  376 VLSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQDVTKEAISRFATHLPNIK  455 (483)
T ss_pred             cCChhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechhhhhhhhhHHHHhhCccce
Confidence            9999988543 221    22234467899999999976644444444556788888888876 3322 222234566665


Q ss_pred             EEEe
Q 036815          300 VIDL  303 (1013)
Q Consensus       300 ~L~l  303 (1013)
                      +..+
T Consensus       456 v~a~  459 (483)
T KOG4341|consen  456 VHAY  459 (483)
T ss_pred             ehhh
Confidence            5443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1013
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-114
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-114
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-48
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-47
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-34
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-33
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-28
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-28
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-24
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		4e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-10
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		4e-10
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		5e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		5e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-10
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		6e-10
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		8e-09
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		7e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-09
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		9e-09
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		3e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-08
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		1e-08
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		1e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-08
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-08
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		3e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		1e-06
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		1e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-06
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		9e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		1e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
3oja_B	597	Crystal Structure Of Lrim1APL1C COMPLEX Length = 59		2e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-05
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		3e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-05
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		4e-05
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		4e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-05
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		5e-05
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		2e-04
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		5e-05
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		1e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-05
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		6e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-05
3t6q_A	606	Crystal Structure Of Mouse Rp105MD-1 Complex Length		9e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		1e-04
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		2e-04
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		3e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-04
3o6n_A	390	Crystal Structure Of Apl1 Leucine-Rich Repeat Domai		2e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
3soa_A	444	Full-Length Human Camkii Length = 444		2e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
3zyj_A	440	Netring1 In Complex With Ngl1 Length = 440		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  411 bits (1056), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 258/603 (42%), Positives = 345/603 (57%), Gaps = 18/603 (2%)
Query: 31  LSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSI 90
           +S A +VG V   L      L +L  S N ++G   +  +S    LE LD+S NN +  I
Sbjct: 160 ISGANVVGWV---LSDGCGELKHLAISGNKISG---DVDVSRCVNLEFLDVSSNNFSTGI 213
Query: 91  SGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSS 150
                    C++L HLD+S N +      ++S CT+LK+LN+S N   G IP     L S
Sbjct: 214 PFLG----DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKS 267
Query: 151 LQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNI 210
           LQ L L+ N  TG IP  L  ACD+L  L L  N+  G+ P    SCS L+ L LS+NN 
Sbjct: 268 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 327
Query: 211 SGPFPDSVLENLGSLESLILSNNMISGSFPDSISS-CKTLRIVDFSSNRVSGIIPPDICP 269
           SG  P   L  +  L+ L LS N  SG  P+S+++   +L  +D SSN  SG I P++C 
Sbjct: 328 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 387
Query: 270 G-VSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAW 328
              ++L+EL L +N  TG IP  LS C++L  + LS NYL+G+IP  LG L  L     W
Sbjct: 388 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 447
Query: 329 FNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEF 388
            N LEG+IP EL                +GEIP+ L +C+NL WISL+ N LTG+IP   
Sbjct: 448 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 507
Query: 389 SRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGF 448
            RL  LA+L+L NN F G IP ELG+C SL+WLDLN+N   G IP  + +Q G K    F
Sbjct: 508 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG-KIAANF 566
Query: 449 LSSNTLVFVRNVG--NSCKGVGGLLEFAGIRPERLLQIPTLKSCDF-ARMYSGPVLSLFT 505
           ++    V+++N G    C G G LLEF GIR E+L ++ T   C+  +R+Y G     F 
Sbjct: 567 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 626
Query: 506 QYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASH 565
              ++ +LD+SYN   G IP EIG M  L +L L HN +SG IP  +G LR L + D S 
Sbjct: 627 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 686
Query: 566 NRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECR 625
           N+L G+IP++ S L+ L +IDLSNN L+GPIP+ GQ  T P +++ NNPGLCG PLP C 
Sbjct: 687 NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCD 746
Query: 626 NGN 628
             N
Sbjct: 747 PSN 749

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  410 bits (1054), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 258/604 (42%), Positives = 345/604 (57%), Gaps = 18/604 (2%)
Query: 30  ELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGS 89
            +S A +VG V   L      L +L  S N ++G   +  +S    LE LD+S NN +  
Sbjct: 162 SISGANVVGWV---LSDGCGELKHLAISGNKISG---DVDVSRCVNLEFLDVSSNNFSTG 215
Query: 90  ISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLS 149
           I         C++L HLD+S N +      ++S CT+LK+LN+S N   G IP     L 
Sbjct: 216 IPFLG----DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLK 269
Query: 150 SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNN 209
           SLQ L L+ N  TG IP  L  ACD+L  L L  N+  G+ P    SCS L+ L LS+NN
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 210 ISGPFPDSVLENLGSLESLILSNNMISGSFPDSISS-CKTLRIVDFSSNRVSGIIPPDIC 268
            SG  P   L  +  L+ L LS N  SG  P+S+++   +L  +D SSN  SG I P++C
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389
Query: 269 PG-VSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIA 327
               ++L+EL L +N  TG IP  LS C++L  + LS NYL+G+IP  LG L  L     
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 328 WFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPE 387
           W N LEG+IP EL                +GEIP+ L +C+NL WISL+ N LTG+IP  
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 388 FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGG 447
             RL  LA+L+L NN F G IP ELG+C SL+WLDLN+N   G IP  + +Q G K    
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG-KIAAN 568
Query: 448 FLSSNTLVFVRNVG--NSCKGVGGLLEFAGIRPERLLQIPTLKSCDF-ARMYSGPVLSLF 504
           F++    V+++N G    C G G LLEF GIR E+L ++ T   C+  +R+Y G     F
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 505 TQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDAS 564
               ++ +LD+SYN   G IP EIG M  L +L L HN +SG IP  +G LR L + D S
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688
Query: 565 HNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPEC 624
            N+L G+IP++ S L+ L +IDLSNN L+GPIP+ GQ  T P +++ NNPGLCG PLP C
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC 748
Query: 625 RNGN 628
              N
Sbjct: 749 DPSN 752

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  189 bits (479), Expect = 8e-48,   Method: Composition-based stats.
 Identities = 109/298 (36%), Positives = 167/298 (56%), Gaps = 20/298 (6%)
Query: 720  QLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG-DREFM 778
            QL++    +L  A++ F  ++++G GGFG+V+K  L DG  VA+K+L     QG + +F 
Sbjct: 16   QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 779  AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
             E+E +    HRNL+ L G+C    ERLLVY +M  GS+   L  R +   Q  L W   
Sbjct: 76   TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKR 133
Query: 839  XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
                      L +LH +C P IIHRD+K++N+LLD E EA V DFG+A+L+   D H+  
Sbjct: 134  QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 193
Query: 899  STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD-----KDDFGDTNLVG 953
            + + G  G++ PEY  + + + K DV+ +GV+LLEL+TG+R  D      DD  D  L+ 
Sbjct: 194  A-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD--DVMLLD 250
Query: 954  WVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
            WVK  ++E K   ++D +L          + EEV++++   ++ L C    P +RP M
Sbjct: 251  WVKGLLKEKKLEALVDVDL------QGNYKDEEVEQLI---QVALLCTQSSPMERPKM 299

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  188 bits (477), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 111/298 (37%), Positives = 170/298 (57%), Gaps = 20/298 (6%)
Query: 720  QLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG-DREFM 778
            QL++    +L  A++ FS ++++G GGFG+V+K  L DG+ VA+K+L     QG + +F 
Sbjct: 24   QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 779  AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
             E+E +    HRNL+ L G+C    ERLLVY +M  GS+   L  R +   Q  L W   
Sbjct: 84   TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKR 141
Query: 839  XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
                      L +LH +C P IIHRD+K++N+LLD E EA V DFG+A+L+   D H+  
Sbjct: 142  QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 201
Query: 899  STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD-----KDDFGDTNLVG 953
            + + GT G++ PEY  + + + K DV+ +GV+LLEL+TG+R  D      DD  D  L+ 
Sbjct: 202  A-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD--DVMLLD 258
Query: 954  WVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
            WVK  ++E K   ++D +L          + EEV++++   ++ L C    P +RP M
Sbjct: 259  WVKGLLKEKKLEALVDVDL------QGNYKDEEVEQLI---QVALLCTQSSPMERPKM 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  144 bits (363), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 154/285 (54%), Gaps = 17/285 (5%)
Query: 729  LIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK 788
            L EATN F  + LIG G FG+V+K  L+DG+ VA+K+    S QG  EF  E+ETL   +
Sbjct: 34   LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 789  HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            H +LV L+G+C    E +L+Y++M+ G+L+  L+G         ++W+            
Sbjct: 94   HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARG 151
Query: 849  LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD-THLSVSTLAGTPGY 907
            L +LH      IIHRD+KS N+LLD     +++DFG+++  + LD THL    + GT GY
Sbjct: 152  LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLX-XVVKGTLGY 207
Query: 908  VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD-TNLVGWVKMKVREGKQME 966
            + PEY+   R T K DVYSFGVVL E+L  +    +    +  NL  W       G+  +
Sbjct: 208  IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 967  VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
            ++DP L       D+   E ++   ++ +  ++C+      RP+M
Sbjct: 268  IVDPNL------ADKIRPESLR---KFGDTAVKCLALSSEDRPSM 303

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  142 bits (357), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 99/285 (34%), Positives = 153/285 (53%), Gaps = 17/285 (5%)
Query: 729  LIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK 788
            L EATN F  + LIG G FG+V+K  L+DG+ VA+K+    S QG  EF  E+ETL   +
Sbjct: 34   LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 789  HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            H +LV L+G+C    E +L+Y++M+ G+L+  L+G         ++W+            
Sbjct: 94   HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS--MSWEQRLEICIGAARG 151
Query: 849  LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL-DTHLSVSTLAGTPGY 907
            L +LH      IIHRD+KS N+LLD     +++DFG+++  + L  THL    + GT GY
Sbjct: 152  LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLX-XVVKGTLGY 207
Query: 908  VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD-TNLVGWVKMKVREGKQME 966
            + PEY+   R T K DVYSFGVVL E+L  +    +    +  NL  W       G+  +
Sbjct: 208  IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 967  VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
            ++DP L       D+   E ++   ++ +  ++C+      RP+M
Sbjct: 268  IVDPNL------ADKIRPESLR---KFGDTAVKCLALSSEDRPSM 303

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  125 bits (313), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 94/303 (31%), Positives = 150/303 (49%), Gaps = 30/303 (9%)
Query: 720  QLRKLKFSQLIEATNGFSAESL------IGCGGFGEVFKATLKDGSSVAIKKLIRL---- 769
            +     F +L   TN F    +      +G GGFG V+K  + + ++VA+KKL  +    
Sbjct: 11   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 770  SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD 829
            + +  ++F  E++ + K +H NLV LLG+   G++  LVY +M  GSL +    R    D
Sbjct: 70   TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD----RLSCLD 125
Query: 830  QRI-LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL 888
                L+W             + FLH N   H IHRD+KS+N+LLD    A++SDFG+AR 
Sbjct: 126  GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 889  ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
                   +  S + GT  Y+ PE  +    T K D+YSFGVVLLE++TG    D+     
Sbjct: 183  SEKFAQTVMXSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
Query: 949  TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKR 1008
              L    +++  E    + ID       K  +++++  V+ M     +  QC+ +  +KR
Sbjct: 242  LLLDIKEEIEDEEKTIEDYID-------KKMNDADSTSVEAM---YSVASQCLHEKKNKR 291
Query: 1009 PNM 1011
            P++
Sbjct: 292  PDI 294

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  123 bits (309), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 93/303 (30%), Positives = 149/303 (49%), Gaps = 30/303 (9%)
Query: 720  QLRKLKFSQLIEATNGFSAESL------IGCGGFGEVFKATLKDGSSVAIKKLIRL---- 769
            +     F +L   TN F    +      +G GGFG V+K  + + ++VA+KKL  +    
Sbjct: 5    RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 63
Query: 770  SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD 829
            + +  ++F  E++ + K +H NLV LLG+   G++  LVY +M  GSL +    R    D
Sbjct: 64   TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD----RLSCLD 119
Query: 830  QRI-LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL 888
                L+W             + FLH N   H IHRD+KS+N+LLD    A++SDFG+AR 
Sbjct: 120  GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA 176
Query: 889  ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
                   +    + GT  Y+ PE  +    T K D+YSFGVVLLE++TG    D+     
Sbjct: 177  SEKFAQXVMXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 235
Query: 949  TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKR 1008
              L    +++  E    + ID       K  +++++  V+ M     +  QC+ +  +KR
Sbjct: 236  LLLDIKEEIEDEEKTIEDYID-------KKMNDADSTSVEAM---YSVASQCLHEKKNKR 285
Query: 1009 PNM 1011
            P++
Sbjct: 286  PDI 288

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  123 bits (308), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 93/303 (30%), Positives = 149/303 (49%), Gaps = 30/303 (9%)
Query: 720  QLRKLKFSQLIEATNGFSAESL------IGCGGFGEVFKATLKDGSSVAIKKLIRL---- 769
            +     F +L   TN F    +      +G GGFG V+K  + + ++VA+KKL  +    
Sbjct: 11   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 770  SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD 829
            + +  ++F  E++ + K +H NLV LLG+   G++  LVY +M  GSL +    R    D
Sbjct: 70   TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD----RLSCLD 125
Query: 830  QRI-LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL 888
                L+W             + FLH N   H IHRD+KS+N+LLD    A++SDFG+AR 
Sbjct: 126  GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 889  ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
                   +    + GT  Y+ PE  +    T K D+YSFGVVLLE++TG    D+     
Sbjct: 183  SEKFAQTVMXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
Query: 949  TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKR 1008
              L    +++  E    + ID       K  +++++  V+ M     +  QC+ +  +KR
Sbjct: 242  LLLDIKEEIEDEEKTIEDYID-------KKMNDADSTSVEAM---YSVASQCLHEKKNKR 291
Query: 1009 PNM 1011
            P++
Sbjct: 292  PDI 294

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 117/229 (51%), Gaps = 20/229 (8%)
Query: 720 QLRKLKFSQLIEATNGFSAESL------IGCGGFGEVFKATLKDGSSVAIKKLIRL---- 769
           +     F +L   TN F    +       G GGFG V+K  + + ++VA+KKL  +    
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 60
Query: 770 SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD 829
           + +  ++F  E++   K +H NLV LLG+   G++  LVY +   GSL +    R    D
Sbjct: 61  TEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLD----RLSCLD 116
Query: 830 QRI-LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL 888
               L+W             + FLH N   H IHRD+KS+N+LLD    A++SDFG+AR 
Sbjct: 117 GTPPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA 173
Query: 889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
                  +  S + GT  Y  PE  +    T K D+YSFGVVLLE++TG
Sbjct: 174 SEKFAQXVXXSRIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITG 221

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 130/242 (53%), Gaps = 17/242 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLVPLLGYC 799
           IG G FG V +A    GS VA+K L+      +R  EF+ E+  + +++H N+V  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
                  +V E++  GSL  +LH ++ AR+Q  L               + +LH N  P 
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQ--LDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           I+HR++KS N+L+D +   +V DFG++RL ++  T LS  + AGTP ++ PE  +     
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV---IDPELLLVT 976
            K DVYSFGV+L EL T ++P     +G+ N    V     + K++E+   ++P++  + 
Sbjct: 218 EKSDVYSFGVILWELATLQQP-----WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 977 KG 978
           +G
Sbjct: 273 EG 274

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 127/242 (52%), Gaps = 17/242 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLVPLLGYC 799
           IG G FG V +A    GS VA+K L+      +R  EF+ E+  + +++H N+V  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
                  +V E++  GSL  +LH ++ AR+Q  L               + +LH N  P 
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQ--LDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           I+HRD+KS N+L+D +   +V DFG++RL ++    L     AGTP ++ PE  +     
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV---IDPELLLVT 976
            K DVYSFGV+L EL T ++P     +G+ N    V     + K++E+   ++P++  + 
Sbjct: 218 EKSDVYSFGVILWELATLQQP-----WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 977 KG 978
           +G
Sbjct: 273 EG 274

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  103 bits (258), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 360 IPAELFSCSNLEWISLTG-NELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSL 418
           IP+ L +   L ++ + G N L G IPP  ++LT+L  L + +    G IP  L    +L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 419 VWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRP 478
           V LD + N L+G +PP +             S   LV +   GN           +G  P
Sbjct: 128 VTLDFSYNALSGTLPPSIS------------SLPNLVGITFDGN---------RISGAIP 166
Query: 479 ERLLQIPTL-KSCDFAR-MYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQV 536
           +       L  S   +R   +G +   F     L ++DLS N   G      G     Q 
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 537 LELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPI 596
           + LA N L+ ++   +G  +NL   D  +NR+ G +P+  + L FL  +++S N L G I
Sbjct: 226 IHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 597 PQRGQLSTLPASQYANNPGLCGVPLPEC 624
           PQ G L     S YANN  LCG PLP C
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 32/218 (14%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKL-------IRLSCQGDREFMAEMETLGKIKHRN 791
           E +IG GGFG+V++A    G  VA+K         I  + +  R+   E +    +KH N
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQ---EAKLFAMLKHPN 67
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           ++ L G C       LV EF + G L  VL G+    D  ++ W             + +
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI-LVNW------AVQIARGMNY 120
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEME--------ARVSDFGMARLISALDTHLSVS-TLA 902
           LH   I  IIHRD+KSSN+L+  ++E         +++DFG+AR     + H +   + A
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAA 175
Query: 903 GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           G   ++ PE  ++   +   DV+S+GV+L ELLTG+ P
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 21/279 (7%)
Query: 742  IGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
            +G G FG+VF A        +D   VA+K L   S    ++F  E E L  ++H+++V  
Sbjct: 26   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 796  LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
             G C  G   L+V+E+M+ G L   L  R+   D ++L               L  +   
Sbjct: 86   FGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 856  CIP--------HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
                       H +HRD+ + N L+   +  ++ DFGM+R I + D +           +
Sbjct: 144  VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 203
Query: 908  VPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME 966
            +PPE     + T + DV+SFGVVL E+ T GK+P  +    +T  +  +  + RE ++  
Sbjct: 204  MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ--LSNTEAIDCI-TQGRELERPR 260
Query: 967  VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFP 1005
               PE+  + +G  + E ++ +  ++ +   LQ +   P
Sbjct: 261  ACPPEVYAIMRGCWQREPQQ-RHSIKDVHARLQALAQAP 298

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 21/279 (7%)
Query: 742  IGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
            +G G FG+VF A        +D   VA+K L   S    ++F  E E L  ++H+++V  
Sbjct: 20   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 796  LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
             G C  G   L+V+E+M+ G L   L  R+   D ++L               L  +   
Sbjct: 80   FGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 856  CIP--------HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
                       H +HRD+ + N L+   +  ++ DFGM+R I + D +           +
Sbjct: 138  VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 197
Query: 908  VPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME 966
            +PPE     + T + DV+SFGVVL E+ T GK+P  +    +T  +  +  + RE ++  
Sbjct: 198  MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ--LSNTEAIDCI-TQGRELERPR 254
Query: 967  VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFP 1005
               PE+  + +G  + E ++ +  ++ +   LQ +   P
Sbjct: 255  ACPPEVYAIMRGCWQREPQQ-RHSIKDVHARLQALAQAP 292

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 21/279 (7%)
Query: 742  IGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
            +G G FG+VF A        +D   VA+K L   S    ++F  E E L  ++H+++V  
Sbjct: 49   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 796  LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
             G C  G   L+V+E+M+ G L   L  R+   D ++L               L  +   
Sbjct: 109  FGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 856  CIP--------HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
                       H +HRD+ + N L+   +  ++ DFGM+R I + D +           +
Sbjct: 167  VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 908  VPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME 966
            +PPE     + T + DV+SFGVVL E+ T GK+P  +    +T  +  +  + RE ++  
Sbjct: 227  MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ--LSNTEAIDCI-TQGRELERPR 283
Query: 967  VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFP 1005
               PE+  + +G  + E ++ +  ++ +   LQ +   P
Sbjct: 284  ACPPEVYAIMRGCWQREPQQ-RHSIKDVHARLQALAQAP 321

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 742 IGCGGFGEVFKAT------LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+VF A        KD   VA+K L   +    ++F  E E L  ++H ++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH-- 853
            G C  G+  ++V+E+MK G L + L  RA   D  IL  D               LH  
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFL--RAHGPDAMILV-DGQPRQAKGELGLSQMLHIA 139
Query: 854 --------HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP 905
                   +    H +HRD+ + N L+   +  ++ DFGM+R + + D +          
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            ++PPE     + T + DV+SFGV+L E+ T GK+P
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V      +   VAIK  IR     + +F+ E E + K+ H  LV L G C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQR-ILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                LV+EFM+ G L + L      R QR +   +            + +L   C   +
Sbjct: 72  QAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD+ + N L+      +VSDFGM R +  LD   + ST    P  +  PE +   R +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 920 AKGDVYSFGVVLLELLT-GKRPTD 942
           +K DV+SFGV++ E+ + GK P +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYE 204

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V      +   VAIK  IR     + +F+ E E + K+ H  LV L G C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQR-ILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                LV+EFM+ G L + L      R QR +   +            + +L   C   +
Sbjct: 77  QAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD+ + N L+      +VSDFGM R +  LD   + ST    P  +  PE +   R +
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 920 AKGDVYSFGVVLLELLT-GKRPTD 942
           +K DV+SFGV++ E+ + GK P +
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYE 209

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V      +   VAIK  IR     + +F+ E E + K+ H  LV L G C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQR-ILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                LV+EFM+ G L + L      R QR +   +            + +L   C   +
Sbjct: 74  QAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD+ + N L+      +VSDFGM R +  LD   + ST    P  +  PE +   R +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 920 AKGDVYSFGVVLLELLT-GKRPTD 942
           +K DV+SFGV++ E+ + GK P +
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYE 206

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 22/231 (9%)
Query: 726 FSQLIEATNGFSAESLIGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGDREFMA 779
           F Q I+  N      L G G FG+VF A        +D   VA+K L   S    ++F  
Sbjct: 6   FVQHIKRHNIVLKREL-GEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR 64
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRI------- 832
           E E L  ++H ++V   G C  G+  ++V+E+MK G L + L  RA   D  +       
Sbjct: 65  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNPP 122
Query: 833 --LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
             LT              + +L      H +HRD+ + N L+   +  ++ DFGM+R + 
Sbjct: 123 TELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 179
Query: 891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           + D +           ++PPE     + T + DV+S GVVL E+ T GK+P
Sbjct: 180 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V      +   VAIK  IR     + +F+ E E + K+ H  LV L G C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQR-ILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                LV EFM+ G L + L      R QR +   +            + +L   C   +
Sbjct: 75  QAPICLVTEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD+ + N L+      +VSDFGM R +  LD   + ST    P  +  PE +   R +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 920 AKGDVYSFGVVLLELLT-GKRPTD 942
           +K DV+SFGV++ E+ + GK P +
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYE 207

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V      +   VAIK  I+     + +F+ E E + K+ H  LV L G C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKT-IKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQR-ILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                LV+EFM+ G L + L      R QR +   +            + +L   C   +
Sbjct: 94  QAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD+ + N L+      +VSDFGM R +  LD   + ST    P  +  PE +   R +
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 920 AKGDVYSFGVVLLELLT-GKRPTD 942
           +K DV+SFGV++ E+ + GK P +
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYE 226

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 115/226 (50%), Gaps = 19/226 (8%)
Query: 724 LKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS-----VAIKKLIRLSCQGDR-EF 777
           LKF+  I  +   + + +IG G FGEV+K  LK  S      VAIK L     +  R +F
Sbjct: 35  LKFTTEIHPSC-VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF 93
Query: 778 MAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDX 837
           + E   +G+  H N++ L G     +  +++ E+M+ G+L++ L  R K  +  +L    
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVG 151
Query: 838 XXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS 897
                      L  +++      +HRD+ + N+L++  +  +VSDFG++R++   D   +
Sbjct: 152 MLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEAT 204
Query: 898 VSTLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            +T  G     +  PE     + T+  DV+SFG+V+ E++T G+RP
Sbjct: 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V      +   VAIK  IR     + +F+ E E + K+ H  LV L G C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQR-ILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                LV+EFM+ G L + L      R QR +   +            + +L       +
Sbjct: 74  QAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEE---ASV 124
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD+ + N L+      +VSDFGM R +  LD   + ST    P  +  PE +   R +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 920 AKGDVYSFGVVLLELLT-GKRPTD 942
           +K DV+SFGV++ E+ + GK P +
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYE 206

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+  T    + VAIK L +        F+ E + + K+KH  LV L  Y  +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQL--YAVV 73
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            EE + +V E+M  GSL + L    K  + R L               + ++      + 
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFL----KDGEGRALKLPNLVDMAAQVAAGMAYIERM---NY 126
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++S+N+L+ + +  +++DFG+ARLI   D   +    A  P  +  PE     R T
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIE--DNEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L EL+T  R
Sbjct: 185 IKSDVWSFGILLTELVTKGR 204

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 109/240 (45%), Gaps = 28/240 (11%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATL-KDGSSVAIKKLIRLSCQGD-------REFMAEMET 783
           A N    E  IG GGFG V K  L KD S VAIK LI    +G+       +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXX 843
           +  + H N+V L G   +     +V EF+  G L   L  +A       + W        
Sbjct: 77  MSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHP-----IKWSVKLRLML 129
Query: 844 XXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEME-----ARVSDFGMARLISALDTHLSV 898
                + ++  N  P I+HRD++S N+ L    E     A+V+DFG+    S    H SV
Sbjct: 130 DIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL----SQQSVH-SV 183
Query: 899 STLAGTPGYVPPEYY--QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK 956
           S L G   ++ PE    +    T K D YSF ++L  +LTG+ P D+  +G    +  ++
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 108/240 (45%), Gaps = 28/240 (11%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATL-KDGSSVAIKKLIRLSCQGD-------REFMAEMET 783
           A N    E  IG GGFG V K  L KD S VAIK LI    +G+       +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXX 843
           +  + H N+V L G   +     +V EF+  G L   L  +A       + W        
Sbjct: 77  MSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHP-----IKWSVKLRLML 129
Query: 844 XXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEME-----ARVSDFGMARLISALDTHLSV 898
                + ++  N  P I+HRD++S N+ L    E     A+V+DFG     S    H SV
Sbjct: 130 DIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----TSQQSVH-SV 183
Query: 899 STLAGTPGYVPPEYY--QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK 956
           S L G   ++ PE    +    T K D YSF ++L  +LTG+ P D+  +G    +  ++
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L  R       ++      
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG+AR++   D   + +
Sbjct: 154 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLARVLED-DPEAAYT 206
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
            +G G FG V     K    VA+K +I+     + EF  E +T+ K+ H  LV   G C  
Sbjct: 16   LGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 802  GEERLLVYEFMKFGSLEEVL--HGRAKARDQRI-LTWDXXXXXXXXXXXXLCFLHHNCIP 858
                 +V E++  G L   L  HG+     Q + + +D            + FL  +   
Sbjct: 75   EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG--------MAFLESH--- 123
Query: 859  HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFR 917
              IHRD+ + N L+D ++  +VSDFGM R +  LD     S     P  +  PE +  F+
Sbjct: 124  QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWSAPEVFHYFK 181
Query: 918  CTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
             ++K DV++FG+++ E+ + GK P D   + ++ +V    +KV +G ++    P L   T
Sbjct: 182  YSSKSDVWAFGILMWEVFSLGKMPYDL--YTNSEVV----LKVSQGHRL--YRPHLASDT 233
Query: 977  KGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                              +I   C  + P KRP   Q
Sbjct: 234  ----------------IYQIMYSCWHELPEKRPTFQQ 254

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 25  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 83
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L  R       ++      
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 141
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 142 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 194
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 195 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 8   EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L  R       ++      
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 124
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 125 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 177
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 108/240 (45%), Gaps = 28/240 (11%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATL-KDGSSVAIKKLIRLSCQGD-------REFMAEMET 783
           A N    E  IG GGFG V K  L KD S VAIK LI    +G+       +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXX 843
           +  + H N+V L G   +     +V EF+  G L   L  +A       + W        
Sbjct: 77  MSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHP-----IKWSVKLRLML 129
Query: 844 XXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEME-----ARVSDFGMARLISALDTHLSV 898
                + ++  N  P I+HRD++S N+ L    E     A+V+DF +    S    H SV
Sbjct: 130 DIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL----SQQSVH-SV 183
Query: 899 STLAGTPGYVPPEYY--QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK 956
           S L G   ++ PE    +    T K D YSF ++L  +LTG+ P D+  +G    +  ++
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L  R       ++      
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 154 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 206
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L  R       ++      
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 154 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 206
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L  R       ++      
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 154 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 206
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L  R       ++      
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 154 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 206
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 328
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM-- 382
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 383 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 439
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGR 462

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + KI+H  LV L  Y
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQL--Y 79
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 133
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 134 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGR 213

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 35  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 93
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L  R       ++      
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 151
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 152 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 204
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 205 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L    +  D +  T     
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQ-FTVIQLV 150
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    + +L        +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 151 GMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 206
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 114/224 (50%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L  R       ++      
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG+ R++   D   + +
Sbjct: 154 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLED-DPEAAYT 206
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 245
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM-- 299
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 300 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 356
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 245
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM-- 299
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 300 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 356
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGR 379

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLG 797
           E ++G G FG V KA  +    VAIK++     + +R+ F+ E+  L ++ H N+V L G
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYG 69
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
            C       LV E+ + GSL  VLHG   A      T              + +LH    
Sbjct: 70  ACL--NPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 858 PHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
             +IHRD+K  N+LL       ++ DFG     +A D    ++   G+  ++ PE ++  
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEVFEGS 179
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDK 943
             + K DV+S+G++L E++T ++P D+
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFDE 206

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 16  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 72
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 73  AVVSEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM-- 126
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 127 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 183
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 184 RFTIKSDVWSFGILLTELTTKGR 206

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLG 797
           E ++G G FG V KA  +    VAIK++     + +R+ F+ E+  L ++ H N+V L G
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
            C       LV E+ + GSL  VLHG   A      T              + +LH    
Sbjct: 69  ACL--NPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 858 PHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
             +IHRD+K  N+LL       ++ DFG     +A D    ++   G+  ++ PE ++  
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDK 943
             + K DV+S+G++L E++T ++P D+
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDE 205

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 133
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 134 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 76
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETG----KYLRLPQLVDMSAQIASGMAYVERM-- 130
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 131 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 187
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGR 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 245
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 246 AVVSEEPIYIVGEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM-- 299
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 300 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 356
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGR 379

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 739 ESLIGCGGFGEVFKATLK----DGSSVAIKKL-IRLSCQGDREFMAEMETLGKIKHRNLV 793
           E +IG G FGEV    LK       +VAIK L +  + +  R+F+ E   +G+  H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            L G    G+  ++V EFM+ G+L+  L  R       ++               L  + 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRYLADMG 165
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP---- 909
           +      +HRD+ + N+L++  +  +VSDFG++R+I   D   +V T  G  G +P    
Sbjct: 166 Y------VHRDLAARNILVNSNLVCKVSDFGLSRVIE--DDPEAVYTTTG--GKIPVRWT 215
Query: 910 -PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            PE  Q  + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 216 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 133
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 134 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 13  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 69
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 70  AVVSEEPIXIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM-- 123
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 124 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEXTARQGAKFPIKWTAPEAALYG 180
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 181 RFTIKSDVWSFGILLTELTTKGR 203

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 14  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 70
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 71  AVVSEEPIYIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 124
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 125 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 181
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 182 RFTIKSDVWSFGILLTELTTKGR 204

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 12  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 68
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 69  AVVSEEPIYIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 122
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 123 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 179
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 180 RFTIKSDVWSFGILLTELTTKGR 202

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 133
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 134 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEXTARQGAKFPIKWTAPEAALYG 190
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 76
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETG----KYLRLPQLVDMSAQIASGMAYVERM-- 130
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 131 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEWTARQGAKFPIKWTAPEAALYG 187
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGR 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 85
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 138
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 197 IKSDVWSFGILLTEIVTHGR 216

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 114/224 (50%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 8   EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E M+ GSL+  L  R       ++      
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGML 124
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 125 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 177
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 80  AVVSEEPIYIVCEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 133
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 134 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGR 213

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 79
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 132
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 191 IKSDVWSFGILLTEIVTHGR 210

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 114/224 (50%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E M+ GSL+  L  R       ++      
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  + +      +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 154 RGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 206
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 72
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 125
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 184 IKSDVWSFGILLTEIVTHGR 203

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 78
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 131
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 190 IKSDVWSFGILLTEIVTHGR 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 77
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 189 IKSDVWSFGILLTEIVTHGR 208

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 77
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 189 IKSDVWSFGILLTEIVTHGR 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 133
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD+ ++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 134 -NYVHRDLAAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMA 779
           +F++ ++ATN  S + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ 
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E M+ GSL+  L    +  D +  T     
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKHDAQ-FTVIQLV 150
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    + +L        +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 151 GMLRGIASGMKYLSDMG---AVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 206
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 145
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +  +  TL GT  Y
Sbjct: 146 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRT--TLCGTLDY 198
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 240

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 83
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 136
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 195 IKSDVWSFGILLTEIVTHGR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 82
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 135
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 194 IKSDVWSFGILLTEIVTHGR 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 87
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 140
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 199 IKSDVWSFGILLTEIVTHGR 218

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 740 SLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
            ++G G FG+  K T ++ G  + +K+LIR   +  R F+ E++ +  ++H N++  +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
               +    + E++K G+L  ++    K+ D +   W             + +LH     
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGII----KSMDSQ-YPWSQRVSFAKDIASGMAYLHSM--- 127
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH------------LSVSTLAGTPG 906
           +IIHRD+ S N L+       V+DFG+ARL+    T                 T+ G P 
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD------DFG 947
           ++ PE         K DV+SFG+VL E++ G+   D D      DFG
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFG 233

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 77
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 189 IKSDVWSFGILLTEIVTHGR 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 16/226 (7%)
Query: 718 QRQLRKLKFSQLI-EATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGD- 774
           +RQL+KL    L  +    F     +G G +G V+KA  K+ G  VAIK++     + D 
Sbjct: 12  RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDL 68
Query: 775 REFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT 834
           +E + E+  + +    ++V   G      +  +V E+   GS+ +++  R K      LT
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-----LT 123
Query: 835 WDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT 894
            D            L +LH       IHRD+K+ N+LL+ E  A+++DFG+A  ++  D 
Sbjct: 124 EDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT--DX 178
Query: 895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
               + + GTP ++ PE  Q        D++S G+  +E+  GK P
Sbjct: 179 MAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  G L + L G       + L               + ++     
Sbjct: 80  AVVSEEPIYIVMEYMSKGCLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 133
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 134 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGR 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 83
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 136
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 195 IKSDVWSFGILLTEIVTHGR 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 86
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 139
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 198 IKSDVWSFGILLTEIVTHGR 217

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  G L + L G       + L               + ++     
Sbjct: 80  AVVSEEPIYIVTEYMSKGCLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 133
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     
Sbjct: 134 -NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYG 190
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGR 213

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 136
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +  +  TL GT  Y
Sbjct: 137 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRT--TLCGTLDY 189
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 231

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+  T    + VAIK L +        F+ E + + K++H  LV L  Y
Sbjct: 190 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQL--Y 246
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + EE + +V E+M  GSL + L G       + L               + ++     
Sbjct: 247 AVVSEEPIYIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM-- 300
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + +HRD++++N+L+   +  +V+DFG+ RLI   D   +    A  P  +  PE     
Sbjct: 301 -NYVHRDLRAANILVGENLVCKVADFGLGRLIE--DNEYTARQGAKFPIKWTAPEAALYG 357
Query: 917 RCTAKGDVYSFGVVLLELLTGKR 939
           R T K DV+SFG++L EL T  R
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGR 380

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +  +  TL GT  Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRT--TLCGTLDY 172
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 73
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 126
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHR+++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 185 IKSDVWSFGILLTEIVTHGR 204

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG     S        +TL+GT  Y
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW----SCHAPSSRRTTLSGTLDY 173
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +  +  TL GT  Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRT--TLCGTLDY 175
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +  +  TL GT  Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRT--TLCGTLDY 177
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 123
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    +TL GT  Y
Sbjct: 124 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRTTLCGTLDY 176
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 218

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 118
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    +TL GT  Y
Sbjct: 119 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRTTLCGTLDY 171
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 213

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    +TL GT  Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRTTLCGTLDY 175
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLG 797
           +G G FG V+ A  K    + A+K L +   +    + +   E+E    ++H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
           Y        L+ E+   G++   L   +K  +QR  T+             L + H    
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCHSK-- 132
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             +IHRD+K  N+LL    E +++DFG +  + A  +  +  TL GT  Y+PPE  +   
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRT--TLCGTLDYLPPEXIEGRX 187
Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
              K D++S GV+  E L GK P + + + +T
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K+   + A+K L +   +    + +   E+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    + L GT  Y
Sbjct: 120 ALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRAALCGTLDY 172
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + DT
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDT 214

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +     TL GT  Y
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRD--TLCGTLDY 173
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L   A+  D  ++L +             +C  +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQY----------TSQICKGM 130
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ EF+ +GSL E L    +  D  ++L +             +C  +
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQY----------TSQICKGM 130
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 116
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    +TL GT  Y
Sbjct: 117 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRTTLCGTLDY 169
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 211

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 145
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +      L GT  Y
Sbjct: 146 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRD--DLCGTLDY 198
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 240

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G + + L   +K  +QR  T+            
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ITELAN 124
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +  +  TL GT  Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRT--TLCGTLDY 177
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +  +   L GT  Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRT--ELCGTLDY 172
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 121
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E ++++FG +  + A  +  +  TL GT  Y
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRT--TLCGTLDY 174
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E ++++FG +  + A  +    +TL GT  Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSS--RRTTLCGTLDY 175
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV+    K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
           +     +V E+M +G+L + L  R   R++  +T              + +L      + 
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYL--RECNREE--VTAVVLLYMATQISSAMEYLEKK---NF 151
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY--YQSFRC 918
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE   Y +F  
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTF-- 208
Query: 919 TAKGDVYSFGVVLLELLT 936
           + K DV++FGV+L E+ T
Sbjct: 209 SIKSDVWAFGVLLWEIAT 226

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +  +   L GT  Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA--LCGTLDY 175
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +  +++ ++              + +L      + 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +  +++ ++              + +L      + 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G  GEV+       + VA+K L + S   D  F+AE   + +++H+ LV L  Y  +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL--YAVV 77
Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            +E + ++ E+M+ GSL + L   +  +    LT +            + F+      + 
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           IHRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +  PE       T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIE--DAEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 920 AKGDVYSFGVVLLELLTGKR 939
            K DV+SFG++L E++T  R
Sbjct: 189 IKSDVWSFGILLTEIVTHGR 208

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FGEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +  +++ ++              + +L      + 
Sbjct: 78  REPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 130
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT  + +       +  PE     + + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 190 KSDVWAFGVLLWEIAT 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    + L GT  Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRTDLCGTLDY 172
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    + L GT  Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRAALCGTLDY 172
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 133
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 193 KSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 134
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 194 KSDVWAFGVLLWEIAT 209

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    + L GT  Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRTDLCGTLDY 172
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +  +++ ++              + +L      + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +  +++ ++              + +L      + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +  +++ ++              + +L      + 
Sbjct: 85  REPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 137
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +  +   L GT  Y
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRT--DLCGTLDY 173
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    + L GT  Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRTXLCGTLDY 172
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V I K++  + +  + F  E+  L K +H N++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM-T 102
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
            +   +V ++ +  SL + LH + + + Q     D            + +LH     +II
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQG----MDYLH---AKNII 154
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ------- 914
           HRDMKS+N+ L   +  ++ DFG+A + S       V    G+  ++ PE  +       
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRP 940
           SF    + DVYS+G+VL EL+TG+ P
Sbjct: 215 SF----QSDVYSYGIVLYELMTGELP 236

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 137
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEKK---NF 339
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHR++ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 399 KSDVWAFGVLLWEIAT 414

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 127
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 137
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 145
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 205 KSDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 137
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 132
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 136
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 196 KSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 132
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 134
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 194 KSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 134
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 194 KSDVWAFGVLLWEIAT 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +    + L GT  Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRTDLCGTLDY 177
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 78
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH      + + L               + +LH   I   I
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLI-----DIARQTARGMDYLHAKSI---I 130
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  +   ++ DFG+A + S          L+G+  ++ PE  +   S   
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLP 212

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 742 IGCGGFGEVFKAT------LKDGSSVAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLVP 794
           IG G FG VF+A        +  + VA+K L    S     +F  E   + +  + N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH------------------GRAKARDQRILTWD 836
           LLG C +G+   L++E+M +G L E L                    R  +     L+  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 837 XXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                       + +L        +HRD+ + N L+   M  +++DFG++R I + D + 
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
           +    A    ++PPE     R T + DV+++GVVL E+ +
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 26/244 (10%)
Query: 708 EPLSIN-VATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKK 765
           EPL+ +  A  Q QLR LK ++L           ++G G FG V+K   + +G +V I  
Sbjct: 18  EPLTPSGTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPV 70
Query: 766 LIRL-----SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEV 820
            I++       + + EFM E   +  + H +LV LLG C +     LV + M  G L E 
Sbjct: 71  AIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVC-LSPTIQLVTQLMPHGCLLEY 129
Query: 821 LH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEAR 879
           +H  +     Q +L W             + +L       ++HRD+ + NVL+      +
Sbjct: 130 VHEHKDNIGSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVK 180
Query: 880 VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GK 938
           ++DFG+ARL+   +   +         ++  E     + T + DV+S+GV + EL+T G 
Sbjct: 181 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGG 240
Query: 939 RPTD 942
           +P D
Sbjct: 241 KPYD 244

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 108/236 (45%), Gaps = 25/236 (10%)
Query: 715 ATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRL---- 769
           A  Q QLR LK ++L           ++G G FG V+K   + +G +V I   I++    
Sbjct: 3   APNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET 55
Query: 770 -SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKA 827
              + + EFM E   +  + H +LV LLG C +     LV + M  G L E +H  +   
Sbjct: 56  TGPKANVEFMDEALIMASMDHPHLVRLLGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNI 114
Query: 828 RDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
             Q +L W             + +L       ++HRD+ + NVL+      +++DFG+AR
Sbjct: 115 GSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 165
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
           L+   +   +         ++  E     + T + DV+S+GV + EL+T G +P D
Sbjct: 166 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 127
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 121
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +      L GT  Y
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRX--XLCGTLDY 174
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 739 ESLIGCGGFGEVFKATLKDGSS----VAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLV 793
           E +IG G FGEV    LK        VAIK L    + +  R+F++E   +G+  H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            L G        +++ EFM+ GSL+  L  R       ++               L  ++
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLADMN 155
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP---- 909
           +      +HRD+ + N+L++  +  +VSDFG++R +    +  + ++  G  G +P    
Sbjct: 156 Y------VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWT 207
Query: 910 -PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            PE  Q  + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 130
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +      L GT  Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRDDLCGTLDY 175
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 378
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHR++ + N L+      +V+DFG++RL++  DT+ + +       +  PE     + + 
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 438 KSDVWAFGVLLWEIAT 453

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 126
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 127 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 131
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 132 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 192 SLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +      L GT  Y
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRXXLCGTLDY 172
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 158
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 134
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 135 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 195 SLTESKFSVASDVWSFGVVLYELFT 219

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V+ A  +  G  VAI+++  L  Q  +E +  E+  + + K+ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
            +G+E  +V E++  GSL +V+        Q                  L FLH N    
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECLQALEFLHSN---Q 136
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS N+LL  +   +++DFG    I+   +  S  T+ GTP ++ PE        
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRKAYG 194
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E++ G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 34/236 (14%)
Query: 711 SINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT---LKD--GSSVAIKK 765
           S N+  F+   R LKF Q +            G G FG V       L+D  G  VA+KK
Sbjct: 19  SHNMTQFEE--RHLKFLQQL------------GKGNFGSVEMCRYDPLQDNTGEVVAVKK 64
Query: 766 LIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER--LLVYEFMKFGSLEEVLHG 823
           L   + +  R+F  E+E L  ++H N+V   G C     R   L+ E++ +GSL + L  
Sbjct: 65  LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK 124
Query: 824 RAKARDQ-RILTWDXXXXXXXXXXXXLCF-LHHNCIPHIIHRDMKSSNVLLDHEMEARVS 881
             +  D  ++L +             +C  + +      IHRD+ + N+L+++E   ++ 
Sbjct: 125 HKERIDHIKLLQY----------TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 174
Query: 882 DFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
           DFG+ +++        V     +P  +  PE     + +   DV+SFGVVL EL T
Sbjct: 175 DFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 125
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 126 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 127
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 132
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 133 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 193 SLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 113/224 (50%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS----VAIKKL-IRLSCQGDREFMA 779
           +F++ IEA+   + E +IG G FGEV    LK        VAIK L +  + +  R+F+ 
Sbjct: 14  EFAKEIEAS-CITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLG 72
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  ++V E+M+ GSL+  L    K  D +  T     
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL----KKNDGQ-FTVIQLV 127
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    + +L        +HRD+ + N+L++  +  +VSDFG++R++   D   + +
Sbjct: 128 GMLRGISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYT 183
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 184 TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 34/236 (14%)
Query: 711 SINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT---LKD--GSSVAIKK 765
           S N+  F+   R LKF Q +            G G FG V       L+D  G  VA+KK
Sbjct: 19  SHNMTQFEE--RHLKFLQQL------------GKGNFGSVEMCRYDPLQDNTGEVVAVKK 64
Query: 766 LIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER--LLVYEFMKFGSLEEVLHG 823
           L   + +  R+F  E+E L  ++H N+V   G C     R   L+ E++ +GSL + L  
Sbjct: 65  LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK 124
Query: 824 RAKARDQ-RILTWDXXXXXXXXXXXXLCF-LHHNCIPHIIHRDMKSSNVLLDHEMEARVS 881
             +  D  ++L +             +C  + +      IHRD+ + N+L+++E   ++ 
Sbjct: 125 HKERIDHIKLLQY----------TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 174
Query: 882 DFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
           DFG+ +++        V     +P  +  PE     + +   DV+SFGVVL EL T
Sbjct: 175 DFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +  +++ ++              + +L      + 
Sbjct: 78  REPPFYIIIEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 130
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT  + +       +  PE     + + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 190 KSDVWAFGVLLWEIAT 205

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 133
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHRD+ + N+L+++E   ++ DFG+ +++        V     +P  +  PE
Sbjct: 134 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 194 SLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS----VAIKKL-IRLSCQGDREFMA 779
           +F++ I+A+     E +IG G FGEV    LK        VAIK L    + +  R+F++
Sbjct: 21  EFAKEIDAS-CIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLS 79
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  +++ E+M+ GSL+  L    +  D R  T     
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL----RKNDGR-FTVIQLV 134
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    + +L        +HRD+ + N+L++  +  +VSDFGM+R++   D   + +
Sbjct: 135 GMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYT 190
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 191 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +  +++ ++              + +L      + 
Sbjct: 78  REPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 130
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT  + +       +  PE     + + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 190 KSDVWAFGVLLWEIAT 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G++   L   +K  +QR  T+            
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +      L GT  Y
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSS--RRXXLCGTLDY 175
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+ AT    + VA+K + +        F+AE   +  ++H  LV L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
               E   ++ EFM  GSL + L     ++       D            + F+      
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG----MAFIEQR--- 303
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFR 917
           + IHRD++++N+L+   +  +++DFG+AR+I   D   +    A  P  +  PE      
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 918 CTAKGDVYSFGVVLLELLTGKR 939
            T K DV+SFG++L+E++T  R
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGR 383

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 742 IGCGGFGEVFKAT---LKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G FG V       L+D  G  VA+KKL   + +  R+F  E+E L  ++H N+V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 797 GYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCF-L 852
           G C     R   L+ E++ +GSL + L    +  D  ++L +             +C  +
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----------TSQICKGM 128
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPE 911
            +      IHR++ + N+L+++E   ++ DFG+ +++     +  V     +P  +  PE
Sbjct: 129 EYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
                + +   DV+SFGVVL EL T
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 133
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT  + +       +  PE     + + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 193 KSDVWAFGVLLWEIAT 208

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 14/223 (6%)
Query: 731 EATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGD---REFMAEMETLGK 786
           E    F   +L+G G F  V++A ++  G  VAIK + + +       +    E++   +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 787 IKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXX 846
           +KH +++ L  Y +      LV E    G +   L  R K       + +          
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-----FSENEARHFMHQII 122
Query: 847 XXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
             + +LH + I   +HRD+  SN+LL   M  +++DFG+A  +     H    TL GTP 
Sbjct: 123 TGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPN 177
Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           Y+ PE         + DV+S G +   LL G+ P D D   +T
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EFM +G+L + L    +     ++               + +L      + 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAMEYLEKK---NF 137
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           IHRD+ + N L+      +V+DFG++RL++  DT  + +       +  PE     + + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 921 KGDVYSFGVVLLELLT 936
           K DV++FGV+L E+ T
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 18/224 (8%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS----VAIKKL-IRLSCQGDREFMA 779
           +F++ I+A+     E +IG G FGEV    LK        VAIK L    + +  R+F++
Sbjct: 6   EFAKEIDAS-CIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLS 64
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E   +G+  H N++ L G     +  +++ E+M+ GSL+  L    +  D R  T     
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL----RKNDGR-FTVIQLV 119
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    + +L        +HRD+ + N+L++  +  +VSDFGM+R++   D   + +
Sbjct: 120 GMLRGIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYT 175
Query: 900 TLAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T  G     +  PE     + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH      + + L               + +LH   I   I
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKLI-----DIARQTARGMDYLHAKSI---I 142
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  +   ++ DFG+A   S          L+G+  ++ PE  +   S   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 18/223 (8%)
Query: 726 FSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS----VAIKKL-IRLSCQGDREFMAE 780
           F++ I+A+     E +IG G FGEV    LK        VAIK L    + +  R+F++E
Sbjct: 1   FAKEIDASC-IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSE 59
Query: 781 METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXX 840
              +G+  H N++ L G     +  +++ E+M+ GSL+  L    +  D R  T      
Sbjct: 60  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL----RKNDGR-FTVIQLVG 114
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + +L        +HRD+ + N+L++  +  +VSDFGM+R++   D   + +T
Sbjct: 115 MLRGIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTT 170
Query: 901 LAGT--PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             G     +  PE     + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 171 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSC---QGDREFMA-EMETLGKIKHRNLVPLL 796
            +G GGF + F+ +  D   V   K++  S       RE M+ E+     + H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     LT                +LH N 
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKA-----LTEPEARYYLRQIVLGCQYLHRN- 140
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ ++E ++ DFG+A  +   D      TL GTP Y+ PE     
Sbjct: 141 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERK-KTLCGTPNYIAPEVLSKK 196
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
             + + DV+S G ++  LL GK P +     +T L
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 231

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKI 787
           A   F     +G G FG V+ A  K    + A+K L +   +    + +   E+E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           +H N++ L GY        L+ E+   G + + L   +K  +QR  T+            
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ITELAN 124
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L + H      +IHRD+K  N+LL    E +++DFG +  + A  +      L GT  Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRX--XLXGTLDY 177
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           +PPE  +      K D++S GV+  E L GK P + + + +T
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+ AT    + VA+K + +        F+AE   +  ++H  LV L  +
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--H 76
Query: 799 CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             + +E + ++ EFM  GSL + L     ++       D            + F+     
Sbjct: 77  AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG----MAFIEQR-- 130
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSF 916
            + IHRD++++N+L+   +  +++DFG+AR+I   D   +    A  P  +  PE     
Sbjct: 131 -NYIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFG 187
Query: 917 RCTAKGDVYSFGVVLLELLT-GKRP 940
             T K DV+SFG++L+E++T G+ P
Sbjct: 188 SFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSC---QGDREFMA-EMETLGKIKHRNLVPLL 796
            +G GGF + F+ +  D   V   K++  S       RE M+ E+     + H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     LT                +LH N 
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKA-----LTEPEARYYLRQIVLGCQYLHRN- 136
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ ++E ++ DFG+A  +   D      TL GTP Y+ PE     
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERK-KTLCGTPNYIAPEVLSKK 192
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
             + + DV+S G ++  LL GK P +     +T L
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 227

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 726 FSQLIEATNGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKL-IRLSCQGDREFMAE 780
           F++ IEA+     E +IG G  GEV    L+        VAIK L    + +  R+F++E
Sbjct: 42  FTREIEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSE 100
Query: 781 METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXX 840
              +G+  H N++ L G    G   ++V E+M+ GSL+  L  R       I+       
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLR 158
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   L  L +      +HRD+ + NVL+D  +  +VSDFG++R++         +T
Sbjct: 159 GVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTT 212
Query: 901 LAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               P  +  PE       ++  DV+SFGVV+ E+L  G+RP
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH      + + L               + +LH   I   I
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLI-----DIARQTARGMDYLHAKSI---I 142
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  +   ++ DFG+A   S          L+G+  ++ PE  +   S   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 742 IGCGGFGEVFKATL----KDGS--SVAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT     K+ +   VA+K L   +   ++E  M+E++ +  + +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA----RDQRILTWDXXXXXXXXXXXXL 849
            LLG C  G   L++ E+  +G L   L  +A+A     D R L               +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 850 CFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GY 907
            FL   NCI    HRD+ + NVLL +   A++ DFG+AR I   D++  V   A  P  +
Sbjct: 166 AFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARLPVKW 220
Query: 908 VPPEYYQSFRC--TAKGDVYSFGVVLLELLT 936
           + PE    F C  T + DV+S+G++L E+ +
Sbjct: 221 MAPE--SIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSC---QGDREFMA-EMETLGKIKHRNLVPLL 796
            +G GGF + F+ +  D   V   K++  S       RE M+ E+     + H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     LT                +LH N 
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKA-----LTEPEARYYLRQIVLGCQYLHRN- 136
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ ++E ++ DFG+A  +   D      TL GTP Y+ PE     
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERK-KTLCGTPNYIAPEVLSKK 192
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
             + + DV+S G ++  LL GK P +     +T L
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 227

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 69/226 (30%), Positives = 109/226 (48%), Gaps = 24/226 (10%)
Query: 726 FSQLIEATNGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKL-IRLSCQGDREFMAE 780
           F++ IEA+     E +IG G  GEV    L+        VAIK L    + +  R+F++E
Sbjct: 42  FTREIEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSE 100
Query: 781 METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXX 840
              +G+  H N++ L G    G   ++V E+M+ GSL+  L  R       I+       
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLR 158
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   L  L +      +HRD+ + NVL+D  +  +VSDFG++R++   D   + +T
Sbjct: 159 GVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTT 211
Query: 901 LAGTPGYVP-----PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
              T G +P     PE       ++  DV+SFGVV+ E+L  G+RP
Sbjct: 212 ---TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKHRNLV 793
           F+    IG G FGEVFK        V   K+I L    D     + E   L +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCFL 852
              G    G +  ++ E++  GS  ++L  RA   D+ +I T              L +L
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLL--RAGPFDEFQIAT------MLKEILKGLDYL 136
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           H       IHRD+K++NVLL  + + +++DFG+A  ++  DT +  +T  GTP ++ PE 
Sbjct: 137 HSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEV 191
Query: 913 YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            Q     +K D++S G+  +EL  G+ P
Sbjct: 192 IQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSC---QGDREFMA-EMETLGKIKHRNLVPLL 796
            +G GGF + F+ +  D   V   K++  S       RE M+ E+     + H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     LT                +LH N 
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKA-----LTEPEARYYLRQIVLGCQYLHRN- 160
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ ++E ++ DFG+A  +        V  L GTP Y+ PE     
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 216
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
             + + DV+S G ++  LL GK P +     +T L
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSC---QGDREFMA-EMETLGKIKHRNLVPLL 796
            +G GGF + F+ +  D   V   K++  S       RE M+ E+     + H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     LT                +LH N 
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKA-----LTEPEARYYLRQIVLGCQYLHRN- 158
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ ++E ++ DFG+A  +        V  L GTP Y+ PE     
Sbjct: 159 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 214
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
             + + DV+S G ++  LL GK P +     +T L
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 249

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 16/220 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREF---MAEMETLGKIKH 789
           + F    ++G G FG+V  A +K+ G   A+K L +     D +    M E   L   ++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 790 RNLVPLLGYCKIGEERLL-VYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
              +  L  C    +RL  V EF+  G L   +    +  + R   +             
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY------AAEIISA 136
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           L FLH   I   I+RD+K  NVLLDHE   +++DFGM +    +   ++ +T  GTP Y+
Sbjct: 137 LMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYI 191
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
            PE  Q        D ++ GV+L E+L G  P + ++  D
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 29/233 (12%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG+V     + G+ VA+K +   +    + F+AE   + +++H NLV LLG   I
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV--I 68
Query: 802 GEER---LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            EE+    +V E+M  GSL + L  R ++    +L  D            + +L  N   
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN--- 121
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFR 917
           + +HRD+ + NVL+  +  A+VSDFG+ +  S      S       P  +  PE  +  +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKK 175
Query: 918 CTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
            + K DV+SFG++L E+ + G+ P  +    D      V  +V +G +M+  D
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD 222

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 742 IGCGGFGEVFKATL----KDGS--SVAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT     K+ +   VA+K L   +   ++E  M+E++ +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA----RDQRILTWDXXXXXXXXXXXXL 849
            LLG C  G   L++ E+  +G L   L  +A+A     D R L               +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 850 CFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GY 907
            FL   NCI    HRD+ + NVLL +   A++ DFG+AR I   D++  V   A  P  +
Sbjct: 174 AFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARLPVKW 228
Query: 908 VPPEYYQSFRC--TAKGDVYSFGVVLLELLT 936
           + PE    F C  T + DV+S+G++L E+ +
Sbjct: 229 MAPE--SIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FG+V+KA  K+ S +A  K+I    + + E +M E++ L    H N+V LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EF   G+++ V+        +R LT              L +LH N    I
Sbjct: 105 YENNLWILIEFCAGGAVDAVM-----LELERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMA----RLISALDTHLSVSTLAGTPGYVPPEYY--- 913
           IHRD+K+ N+L   + + +++DFG++    R I   D+ +      GTP ++ PE     
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCE 210
Query: 914 --QSFRCTAKGDVYSFGVVLLELLTGKRP 940
             +      K DV+S G+ L+E+   + P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 75  APQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 126
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A + S          L+G+  ++ PE  +       
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP 208

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FG+V+KA  K+ S +A  K+I    + + E +M E++ L    H N+V LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EF   G+++ V+        +R LT              L +LH N    I
Sbjct: 105 YENNLWILIEFCAGGAVDAVM-----LELERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMA----RLISALDTHLSVSTLAGTPGYVPPEYY--- 913
           IHRD+K+ N+L   + + +++DFG++    R I   D+ +      GTP ++ PE     
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI------GTPYWMAPEVVMCE 210
Query: 914 --QSFRCTAKGDVYSFGVVLLELLTGKRP 940
             +      K DV+S G+ L+E+   + P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT++  G  VA+KK+  L  Q  RE +  E+  +   +H N+V +    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 800 KIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            +G+E  +V EF++ G+L +++ H R        +  +            L  LH   + 
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTR--------MNEEQIAAVCLAVLQALSVLHAQGV- 148
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
             IHRD+KS ++LL H+   ++SDFG    +S          L GTP ++ PE       
Sbjct: 149 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 204
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
             + D++S G++++E++ G+ P
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT++  G  VA+KK+  L  Q  RE +  E+  +   +H N+V +    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 800 KIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            +G+E  +V EF++ G+L +++ H R        +  +            L  LH   + 
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTR--------MNEEQIAAVCLAVLQALSVLHAQGV- 146
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
             IHRD+KS ++LL H+   ++SDFG    +S          L GTP ++ PE       
Sbjct: 147 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 202
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
             + D++S G++++E++ G+ P
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEPP 224

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT++  G  VA+KK+  L  Q  RE +  E+  +   +H N+V +    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 800 KIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            +G+E  +V EF++ G+L +++ H R        +  +            L  LH   + 
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTR--------MNEEQIAAVCLAVLQALSVLHAQGV- 268
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
             IHRD+KS ++LL H+   ++SDFG    +S          L GTP ++ PE       
Sbjct: 269 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 324
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
             + D++S G++++E++ G+ P
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V+ A  +  G  VAI+++  L  Q  +E +  E+  + + K+ N+V  L   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
            +G+E  +V E++  GSL +V+        Q                  L FLH N    
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECLQALEFLHSN---Q 137
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHR++KS N+LL  +   +++DFG    I+   +  S  T+ GTP ++ PE        
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRKAYG 195
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E++ G+ P
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPP 216

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 724 LKFSQLIEATNGFSAESLIGCGGFGEV----FKATLKDGSSVAIKKLIR-LSCQGDREFM 778
           ++F++ I+ +     E +IG G FGEV     KA  K  S VAIK L    + +  REF+
Sbjct: 5   MEFAKEIDVSY-VKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL 63
Query: 779 AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
           +E   +G+ +H N++ L G        +++ EFM+ G+L+  L  R       ++     
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGM 121
Query: 839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
                     L  + +      +HRD+ + N+L++  +  +VSDFG++R +    +  + 
Sbjct: 122 LRGIASGMRYLAEMSY------VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 899 STLAGTPGYVP-----PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++  G  G +P     PE     + T+  D +S+G+V+ E+++ G+RP
Sbjct: 176 TSSLG--GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 29/233 (12%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG+V     + G+ VA+K +   +    + F+AE   + +++H NLV LLG   I
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV--I 83
Query: 802 GEER---LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            EE+    +V E+M  GSL + L  R ++    +L  D            + +L  N   
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFR 917
           + +HRD+ + NVL+  +  A+VSDFG+ +  S      S       P  +  PE  +  +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKK 190
Query: 918 CTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
            + K DV+SFG++L E+ + G+ P  +    D      V  +V +G +M+  D
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD 237

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 29/233 (12%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG+V     + G+ VA+K +   +    + F+AE   + +++H NLV LLG   I
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV--I 255
Query: 802 GEER---LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            EE+    +V E+M  GSL + L  R ++    +L  D            + +L  N   
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFR 917
           + +HRD+ + NVL+  +  A+VSDFG+ +  S      S       P  +  PE  +  +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKK 362
Query: 918 CTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
            + K DV+SFG++L E+ + G+ P  +    D      V  +V +G +M+  D
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD 409

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT++  G  VA+KK+  L  Q  RE +  E+  +   +H N+V +    
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 800 KIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            +G+E  +V EF++ G+L +++ H R        +  +            L  LH   + 
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTR--------MNEEQIAAVCLAVLQALSVLHAQGV- 137
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
             IHRD+KS ++LL H+   ++SDFG    +S          L GTP ++ PE       
Sbjct: 138 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 193
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
             + D++S G++++E++ G+ P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V+ A  +  G  VAI+++  L  Q  +E +  E+  + + K+ N+V  L   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
            +G+E  +V E++  GSL +V+        Q                  L FLH N    
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECLQALEFLHSN---Q 137
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS N+LL  +   +++DFG    I+   +    S + GTP ++ PE        
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYG 195
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E++ G+ P
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V+ A  +  G  VAI+++  L  Q  +E +  E+  + + K+ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
            +G+E  +V E++  GSL +V+        Q                  L FLH N    
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECLQALEFLHSN---Q 136
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS N+LL  +   +++DFG    I+   +    S + GTP ++ PE        
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYG 194
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E++ G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V+ A  +  G  VAI+++  L  Q  +E +  E+  + + K+ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
            +G+E  +V E++  GSL +V+        Q                  L FLH N    
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECLQALEFLHSN---Q 136
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +IHRD+KS N+LL  +   +++DFG    I+   +    S + GTP ++ PE        
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAYG 194
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            K D++S G++ +E++ G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSC---QGDREFMA-EMETLGKIKHRNLVPLL 796
            +G GGF + F+ +  D   V   K++  S       RE M+ E+     + H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     LT                +LH N 
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKA-----LTEPEARYYLRQIVLGCQYLHRN- 134
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ ++E ++ DFG+A  +        V  L GTP Y+ PE     
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 190
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
             + + DV+S G ++  LL GK P +     +T L
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 225

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 112/233 (48%), Gaps = 29/233 (12%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG+V     + G+ VA+K +   +    + F+AE   + +++H NLV LLG   I
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV--I 74
Query: 802 GEER---LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            EE+    +V E+M  GSL + L  R ++    +L  D            + +L  N   
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN--- 127
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFR 917
           + +HRD+ + NVL+  +  A+VSDFG+ +  S      S       P  +  PE  +   
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREAA 181
Query: 918 CTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
            + K DV+SFG++L E+ + G+ P  +    D      V  +V +G +M+  D
Sbjct: 182 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD 228

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 79
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 131
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A + S          L+G+  ++ PE  +       
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLP 213

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT++  G  VA+KK+  L  Q  RE +  E+  +   +H N+V +    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 800 KIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            +G+E  +V EF++ G+L +++ H R        +  +            L  LH   + 
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTR--------MNEEQIAAVCLAVLQALSVLHAQGV- 141
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
             IHRD+KS ++LL H+   ++SDFG    +S          L GTP ++ PE       
Sbjct: 142 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 197
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
             + D++S G++++E++ G+ P
Sbjct: 198 GPEVDIWSLGIMVIEMVDGEPP 219

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT++  G  VA+KK+  L  Q  RE +  E+  +   +H N+V +    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 800 KIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
            +G+E  +V EF++ G+L +++ H R        +  +            L  LH   + 
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTR--------MNEEQIAAVCLAVLQALSVLHAQGV- 191
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
             IHRD+KS ++LL H+   ++SDFG    +S          L GTP ++ PE       
Sbjct: 192 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 247
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
             + D++S G++++E++ G+ P
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPP 269

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 126
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A + S          L+G+  ++ PE  +       
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 79
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 131
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A + S          L+G+  ++ PE  +       
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 76
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 128
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A + S          L+G+  ++ PE  +       
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLP 210

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNL 792
           +  +  IG G F +V  A  +  G  VA+K +   +L+    ++   E+  +  + H N+
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           V L    +  +   LV E+   G + + L  HGR K ++ R                 + 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR--------AKFRQIVSAVQ 128
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           + H     +I+HRD+K+ N+LLD +M  +++DFG +   +  +    + T  G+P Y  P
Sbjct: 129 YCHQK---YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN---KLDTFCGSPPYAAP 182
Query: 911 EYYQSFRCTA-KGDVYSFGVVLLELLTGKRPTD 942
           E +Q  +    + DV+S GV+L  L++G  P D
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLG 797
           +G G FG V+ A  +    + A+K L +   +    + +   E+E    ++H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
           Y        L+ E+   G++   L   ++  +QR  T+             L + H    
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANALSYCHSK-- 131
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             +IHRD+K  N+LL    E +++DFG +  + A  +    +TL GT  Y+PPE  +   
Sbjct: 132 -RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSS--RRTTLCGTLDYLPPEMIEGRM 186
Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
              K D++S GV+  E L G  P +   + +T
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQET 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRN 791
           + +  + +IG G    V  A        VAIK++    CQ    E + E++ + +  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVL-HGRAKARDQR-ILTWDXXXXXXXXXXXXL 849
           +V       + +E  LV + +  GS+ +++ H  AK   +  +L               L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTPG 906
            +LH N     IHRD+K+ N+LL  +   +++DFG++  ++    +  +    T  GTP 
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 907 YVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDK 943
           ++ PE  +  R    K D++SFG+  +EL TG  P  K
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FG+V+KA  K+ S +A  K+I    + + E +M E++ L    H N+V LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                 ++ EF   G+++ V+        +R LT              L +LH N    I
Sbjct: 105 YENNLWILIEFCAGGAVDAVM-----LELERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMA----RLISALDTHLSVSTLAGTPGYVPPEYY--- 913
           IHRD+K+ N+L   + + +++DFG++    R I   D  +      GTP ++ PE     
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI------GTPYWMAPEVVMCE 210
Query: 914 --QSFRCTAKGDVYSFGVVLLELLTGKRP 940
             +      K DV+S G+ L+E+   + P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 739 ESLIGCGGFGEV----FKATLKDGSSVAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLV 793
           E +IG G FGEV     KA  K  S VAIK L    + +  REF++E   +G+ +H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            L G        +++ EFM+ G+L+  L  R       ++               L  + 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAEMS 138
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH-LSVSTLAGT--PGYVPP 910
           +      +HRD+ + N+L++  +  +VSDFG++R +    +     S+L G     +  P
Sbjct: 139 Y------VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E     + T+  D +S+G+V+ E+++ G+RP
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FG+V+KA  K+  ++A  K+I    + + E ++ E+E L    H  +V LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
              +  ++ EF   G+++ ++         R LT              L FLH      I
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIM-----LELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY--QSFRC 918
           IHRD+K+ NVL+  E + R++DFG++     L T     +  GTP ++ PE    ++ + 
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 919 TA---KGDVYSFGVVLLELLTGKRP 940
           T    K D++S G+ L+E+   + P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FG+V+KA  K+  ++A  K+I    + + E ++ E+E L    H  +V LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
              +  ++ EF   G+++ ++         R LT              L FLH      I
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIM-----LELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 130
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY--QSFRC 918
           IHRD+K+ NVL+  E + R++DFG++     L T     +  GTP ++ PE    ++ + 
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 919 TA---KGDVYSFGVVLLELLTGKRP 940
           T    K D++S G+ L+E+   + P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRN 791
           + +  + +IG G    V  A        VAIK++    CQ    E + E++ + +  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVL-HGRAKARDQR-ILTWDXXXXXXXXXXXXL 849
           +V       + +E  LV + +  GS+ +++ H  AK   +  +L               L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTPG 906
            +LH N     IHRD+K+ N+LL  +   +++DFG++  ++    +  +    T  GTP 
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 907 YVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDK 943
           ++ PE  +  R    K D++SFG+  +EL TG  P  K
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 224

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 27/269 (10%)
Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
            +G G FGEV+     + + VA+K L +      + F+ E   +  ++H  LV L      
Sbjct: 21   LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 802  GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             E   ++ E+M  GSL + L    K+ +   +               + ++      + I
Sbjct: 80   EEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 132
Query: 862  HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRC-T 919
            HRD++++NVL+   +  +++DFG+AR+I   D   +    A  P  +  PE   +F C T
Sbjct: 133  HRDLRAANVLVSESLMCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAI-NFGCFT 189
Query: 920  AKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID---PELLLV 975
             K DV+SFG++L E++T GK P      G TN    V   + +G +M  ++    EL  +
Sbjct: 190  IKSDVWSFGILLYEIVTYGKIPYP----GRTN--ADVMTALSQGYRMPRVENCPDELYDI 243
Query: 976  TKGTDESEAEEVKEMVRYLEITLQCVDDF 1004
             K   + +AEE +    YL+  L   DDF
Sbjct: 244  MKMCWKEKAEE-RPTFDYLQSVL---DDF 268

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VA+K +   +L+    ++   E+  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
            +  +   LV E+   G + + L  HGR K ++ R                 + + H   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR--------AKFRQIVSAVQYCHQKF 133
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I   +HRD+K+ N+LLD +M  +++DFG +   +  +    + T  G+P Y  PE +Q  
Sbjct: 134 I---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCGSPPYAAPELFQGK 187
Query: 917 RCTA-KGDVYSFGVVLLELLTGKRPTD 942
           +    + DV+S GV+L  L++G  P D
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 739 ESLIGCGGFGEVFKATLKDGSS----VAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLV 793
           E +IG G FGEV    LK        VAIK L    + +  R+F++E   +G+  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            L G        +++ EFM+ GSL+  L  R       ++               L  ++
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLADMN 129
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP---- 909
           +      +HR + + N+L++  +  +VSDFG++R +    +  + ++  G  G +P    
Sbjct: 130 Y------VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWT 181
Query: 910 -PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            PE  Q  + T+  DV+S+G+V+ E+++ G+RP
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VA+K +   +L+    ++   E+  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
            +  +   LV E+   G + + L  HGR K ++ R                 + + H   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR--------AKFRQIVSAVQYCHQKF 133
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I   +HRD+K+ N+LLD +M  +++DFG +   +  +    + T  G+P Y  PE +Q  
Sbjct: 134 I---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCGSPPYAAPELFQGK 187
Query: 917 RCTA-KGDVYSFGVVLLELLTGKRPTD 942
           +    + DV+S GV+L  L++G  P D
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 101
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 153
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A + S          L+G+  ++ PE  +       
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLP 235

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 17/212 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLG 797
           +G G FG V+ A  +    + A+K L +   +    + +   E+E    ++H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
           Y        L+ E+   G++   L   ++  +QR  T+             L + H    
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANALSYCHSK-- 131
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             +IHRD+K  N+LL    E +++DFG +  + A  +     TL GT  Y+PPE  +   
Sbjct: 132 -RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSS--RRDTLCGTLDYLPPEMIEGRM 186
Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
              K D++S GV+  E L G  P +   + +T
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQET 218

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 102
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 154
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A + S          L+G+  ++ PE  +       
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLP 236

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 64/244 (26%), Positives = 118/244 (48%), Gaps = 21/244 (8%)
Query: 729 LIEATNGFSAESLIGCGGFGEVFKATL---KDGSSVAIKKLIRLSCQGD-REFMAEMETL 784
            ++  N   A+  +GCG FG V +      K    VAIK L + + + D  E M E + +
Sbjct: 5   FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 64
Query: 785 GKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXX 844
            ++ +  +V L+G C+  E  +LV E    G L + L G+   R++  +           
Sbjct: 65  HQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGK---REE--IPVSNVAELLHQ 118
Query: 845 XXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
               + +L      + +HRD+ + NVLL +   A++SDFG+++ + A D++ +  +    
Sbjct: 119 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 905 P-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREG 962
           P  +  PE     + +++ DV+S+GV + E L+ G++P  K    +      V   + +G
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQG 229
Query: 963 KQME 966
           K+ME
Sbjct: 230 KRME 233

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + FL  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKFL-- 150
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL-SVSTLAGTP---GYVPP 910
                 +HRD+ + N +LD +   +V+DFG+AR    LD    SV    G      ++  
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
           E  Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 241

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 27/269 (10%)
Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
            +G G FGEV+     + + VA+K L +      + F+ E   +  ++H  LV L      
Sbjct: 20   LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 802  GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             E   ++ EFM  GSL + L    K+ +   +               + ++      + I
Sbjct: 79   EEPIYIITEFMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 131
Query: 862  HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRC-T 919
            HRD++++NVL+   +  +++DFG+AR+I   D   +    A  P  +  PE   +F C T
Sbjct: 132  HRDLRAANVLVSESLMCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAI-NFGCFT 188
Query: 920  AKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREG---KQMEVIDPELLLV 975
             K +V+SFG++L E++T GK P      G TN    V   + +G    +ME    EL  +
Sbjct: 189  IKSNVWSFGILLYEIVTYGKIPYP----GRTN--ADVMSALSQGYRMPRMENCPDELYDI 242
Query: 976  TKGTDESEAEEVKEMVRYLEITLQCVDDF 1004
             K   + +AEE +    YL+  L   DDF
Sbjct: 243  MKMCWKEKAEE-RPTFDYLQSVL---DDF 267

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK +I+     + EF+ E + +  + H  LV L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 802 GEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                ++ E+M  G L   L   R + + Q++L               + +L        
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYLESK---QF 141
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           +HRD+ + N L++ +   +VSDFG++R +  LD   + S  +  P  + PPE     + +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 920 AKGDVYSFGVVLLELLT-GKRPTDK 943
           +K D+++FGV++ E+ + GK P ++
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VA++ +   +L+    ++   E+  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
            +  +   LV E+   G + + L  HGR K ++ R                 + + H   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR--------AKFRQIVSAVQYCHQKF 133
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I   +HRD+K+ N+LLD +M  +++DFG +   +  +    + T  G+P Y  PE +Q  
Sbjct: 134 I---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCGSPPYAAPELFQGK 187
Query: 917 RCTA-KGDVYSFGVVLLELLTGKRPTD 942
           +    + DV+S GV+L  L++G  P D
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 126
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A   S          L+G+  ++ PE  +       
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP 208

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFM----AEMETLGKIKHRNLVPL 795
           ++G GG  EV  A  L+D   VA+K ++R     D  F      E +    + H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 796 L----GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
                     G    +V E++   +L +++H       +R +               L F
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNF 131
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA---GTPGYV 908
            H N    IIHRD+K +N+++      +V DFG+AR I+  D+  SV+  A   GT  Y+
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYL 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            PE  +     A+ DVYS G VL E+LTG+ P   D
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFM----AEMETLGKIKHRNLVPL 795
           ++G GG  EV  A  L+D   VA+K ++R     D  F      E +    + H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 796 L----GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
                     G    +V E++   +L +++H       +R +               L F
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNF 131
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA---GTPGYV 908
            H N    IIHRD+K +N+++      +V DFG+AR I+  D+  SV+  A   GT  Y+
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYL 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            PE  +     A+ DVYS G VL E+LTG+ P   D
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK +I+     + EF+ E + +  + H  LV L G C  
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 802 GEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                ++ E+M  G L   L   R + + Q++L               + +L        
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYLESK---QF 125
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           +HRD+ + N L++ +   +VSDFG++R +  LD   + S  +  P  + PPE     + +
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 920 AKGDVYSFGVVLLELLT-GKRPTDK 943
           +K D+++FGV++ E+ + GK P ++
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYER 208

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK +I+     + EF+ E + +  + H  LV L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 802 GEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                ++ E+M  G L   L   R + + Q++L               + +L        
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYLESK---QF 126
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           +HRD+ + N L++ +   +VSDFG++R +  LD   + S  +  P  + PPE     + +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 920 AKGDVYSFGVVLLELLT-GKRPTDK 943
           +K D+++FGV++ E+ + GK P ++
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VAIK +   +L+    ++   E+  +  + H N+V L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
            +  +   L+ E+   G + + L  HGR K ++ R                 + + H   
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR--------SKFRQIVSAVQYCHQK- 130
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I+HRD+K+ N+LLD +M  +++DFG +   +       + T  G+P Y  PE +Q  
Sbjct: 131 --RIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 917 RCTA-KGDVYSFGVVLLELLTGKRPTD 942
           +    + DV+S GV+L  L++G  P D
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFM----AEMETLGKIKHRNLVPL 795
           ++G GG  EV  A  L+D   VA+K ++R     D  F      E +    + H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 796 L----GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
                     G    +V E++   +L +++H       +R +               L F
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNF 131
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA---GTPGYV 908
            H N    IIHRD+K +N+L+      +V DFG+AR I+  D+  SV   A   GT  Y+
Sbjct: 132 SHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIA--DSGNSVXQTAAVIGTAQYL 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            PE  +     A+ DVYS G VL E+LTG+ P   D
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 94
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 146
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A   S          L+G+  ++ PE  +       
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 207 SFQSDVYAFGIVLYELMTGQLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 102
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHII 861
             +  +V ++ +  SL   LH   + + + I   D            + +LH   I   I
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQG----MDYLHAKSI---I 154
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRC 918
           HRD+KS+N+ L  ++  ++ DFG+A   S          L+G+  ++ PE  +       
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           + + DVY+FG+VL EL+TG+ P
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLP 236

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 25/233 (10%)
Query: 718 QRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRL-----SC 771
           Q  LR LK ++L +         ++G G FG V+K   + DG +V I   I++     S 
Sbjct: 8   QALLRILKETELRKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP 60
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQ 830
           + ++E + E   +  +    +  LLG C +     LV + M +G L + V   R +   Q
Sbjct: 61  KANKEILDEAYVMAGVGSPYVSRLLGIC-LTSTVQLVTQLMPYGCLLDHVRENRGRLGSQ 119
Query: 831 RILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
            +L W             + +L       ++HRD+ + NVL+      +++DFG+ARL+ 
Sbjct: 120 DLLNW------CMQIAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 170
Query: 891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             +T            ++  E     R T + DV+S+GV + EL+T G +P D
Sbjct: 171 IDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK +I+     + EF+ E + +  + H  LV L G C  
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 802 GEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                ++ E+M  G L   L   R + + Q++L               + +L        
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYLESK---QF 132
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           +HRD+ + N L++ +   +VSDFG++R +  LD   + S  +  P  + PPE     + +
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 920 AKGDVYSFGVVLLELLT-GKRPTDK 943
           +K D+++FGV++ E+ + GK P ++
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYER 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK +I+     + EF+ E + +  + H  LV L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 802 GEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                ++ E+M  G L   L   R + + Q++L               + +L        
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYLESK---QF 141
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           +HRD+ + N L++ +   +VSDFG++R +  LD   + S  +  P  + PPE     + +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEETSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 920 AKGDVYSFGVVLLELLT-GKRPTDK 943
           +K D+++FGV++ E+ + GK P ++
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK +I+     + EF+ E + +  + H  LV L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 802 GEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                ++ E+M  G L   L   R + + Q++L               + +L        
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYLESK---QF 121
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           +HRD+ + N L++ +   +VSDFG++R +  LD   + S  +  P  + PPE     + +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 920 AKGDVYSFGVVLLELLT-GKRPTDK 943
           +K D+++FGV++ E+ + GK P ++
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYER 204

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L                  + +
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG--------MKY 167
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP---GYVPPE 911
                 +HRD+ + N +LD +   +V+DFG+AR +   + + SV    G      ++  E
Sbjct: 168 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-YYSVHNKTGAKLPVKWMALE 226
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
             Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 259

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 741 LIGCGGFGEVFKATL----KDGSS--VAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNL 792
           ++G G FG+V  AT     K G S  VA+K L   +   +RE  M+E++ + ++  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------------AKARDQRILTW 835
           V LLG C +     L++E+  +G L   L  +                  +  D  +LT+
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
           +            + FL        +HRD+ + NVL+ H    ++ DFG+AR I + D++
Sbjct: 172 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS-DSN 227
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
             V   A  P  ++ PE       T K DV+S+G++L E+ +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L                  + +
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG--------MKY 166
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP---GYVPPE 911
                 +HRD+ + N +LD +   +V+DFG+AR +   + + SV    G      ++  E
Sbjct: 167 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-YYSVHNKTGAKLPVKWMALE 225
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
             Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 258

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V  AT K  G  VA+KK+  L  Q  RE +  E+  +    H N+V +    
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
            +G+E  +V EF++ G+L +++    +  +++I T              L +LH+  +  
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAT------VCLSVLRALSYLHNQGV-- 162
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
            IHRD+KS ++LL  +   ++SDFG    +S          L GTP ++ PE        
Sbjct: 163 -IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKXLVGTPYWMAPEVISRLPYG 219
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
            + D++S G++++E++ G+ P
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPP 240

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK +I+     + EF+ E + +  + H  LV L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 802 GEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
                ++ E+M  G L   L   R + + Q++L               + +L        
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYLESK---QF 126
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
           +HRD+ + N L++ +   +VSDFG++R +  LD   + S  +  P  + PPE     + +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 920 AKGDVYSFGVVLLELLT-GKRPTDK 943
           +K D+++FGV++ E+ + GK P ++
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 128/268 (47%), Gaps = 25/268 (9%)
Query: 709 PLSINVATFQRQL---RKLKFSQL-IEATNGFSAESLIGCGGFGEVFKATL---KDGSSV 761
           P+ ++ + F+       +LK  +L ++  N   A+  +GCG FG V +      K    V
Sbjct: 307 PMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV 366
Query: 762 AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEV 820
           AIK L + + + D  E M E + + ++ +  +V L+G C+  E  +LV E    G L + 
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKF 425
Query: 821 LHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV 880
           L G+ +      +               + +L      + +HR++ + NVLL +   A++
Sbjct: 426 LVGKREE-----IPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKI 477
Query: 881 SDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GK 938
           SDFG+++ + A D++ +  +    P  +  PE     + +++ DV+S+GV + E L+ G+
Sbjct: 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 537
Query: 939 RPTDKDDFGDTNLVGWVKMKVREGKQME 966
           +P  K    +      V   + +GK+ME
Sbjct: 538 KPYKKMKGPE------VMAFIEQGKRME 559

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + FL  
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKFLAS 210
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL-SVSTLAGTP---GYVPP 910
                 +HRD+ + N +LD +   +V+DFG+AR     D    SV    G      ++  
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
           E  Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + +L  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKYL-- 149
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP---GYVPPE 911
                 +HRD+ + N +LD +   +V+DFG+AR +   + + SV    G      ++  E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-YYSVHNKTGAKLPVKWMALE 207
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
             Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L                  + +
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG--------MKY 140
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP---GYVPPE 911
                 +HRD+ + N +LD +   +V+DFG+AR +   + + SV    G      ++  E
Sbjct: 141 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-YYSVHNKTGAKLPVKWMALE 199
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
             Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 232

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VA+K +   +L+    ++   E+  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
            +  +   LV E+   G + + L  HGR K ++ R                 + + H   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR--------AKFRQIVSAVQYCHQKF 133
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I   +HRD+K+ N+LLD +M  +++DFG +   +  +    +    G P Y  PE +Q  
Sbjct: 134 I---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDAFCGAPPYAAPELFQGK 187
Query: 917 RCTA-KGDVYSFGVVLLELLTGKRPTD 942
           +    + DV+S GV+L  L++G  P D
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 37/220 (16%)
Query: 742 IGCGGFGEVFKATL----KDGS--SVAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT     K+ +   VA+K L   +   ++E  M+E++ +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            LLG C  G   L++ E+  +G L   L      R  R+L  D               LH
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR-----RKSRVLETDPAFAIANSTASTRDLLH 168
Query: 854 --------------HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                          NCI    HRD+ + NVLL +   A++ DFG+AR I   D++  V 
Sbjct: 169 FSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVK 223
Query: 900 TLAGTP-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT 936
             A  P  ++ PE    F C  T + DV+S+G++L E+ +
Sbjct: 224 GNARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + FL  
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKFL-- 154
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL-SVSTLAGTP---GYVPP 910
                 +HRD+ + N +LD +   +V+DFG+AR     D    SV    G      ++  
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
           E  Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 245

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + +L  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKYL-- 148
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP---GYVPPE 911
                 +HRD+ + N +LD +   +V+DFG+AR +   + + SV    G      ++  E
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-YYSVHNKTGAKLPVKWMALE 206
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
             Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 239

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + +L  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKYL-- 149
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP---GYVPPE 911
                 +HRD+ + N +LD +   +V+DFG+AR +   + + SV    G      ++  E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-YYSVHNKTGAKLPVKWMALE 207
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
             Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L                  + +
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG--------MKY 145
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP---GYVPPE 911
                 +HRD+ + N +LD +   +V+DFG+AR +   + + SV    G      ++  E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-YYSVHNKTGAKLPVKWMALE 204
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
             Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 742 IGCGGFGEVFKATL----KDGS--SVAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT     K+ +   VA+K L   +   ++E  M+E++ +  + +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA-----------------RDQRILTWD 836
            LLG C  G   L++ E+  +G L   L  +A+A                  D R L   
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 837 XXXXXXXXXXXXLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
                       + FL   NCI    HRD+ + NVLL +   A++ DFG+AR I   D++
Sbjct: 159 DLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSN 213
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
             V   A  P  ++ PE       T + DV+S+G++L E+ +
Sbjct: 214 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 740 SLIGCGGFGEVFKAT-LKDGSSVAIKKLIRL--SCQGDREFMA---EMETLGKIKHRNLV 793
            ++G G FG V K   + +G S+ I   I++     G + F A    M  +G + H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 794 PLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
            LLG C  G    LV +++  GSL + V   R     Q +L W             + +L
Sbjct: 97  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG------MYYL 149
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
             + +   +HR++ + NVLL    + +V+DFG+A L+   D  L  S       ++  E 
Sbjct: 150 EEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 913 YQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               + T + DV+S+GV + EL+T G  P
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + FL  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKFL-- 150
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL-SVSTLAGTP---GYVPP 910
                 +HRD+ + N +LD +   +V+DFG+AR     D    SV    G      ++  
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
           E  Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 241

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + FL  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKFL-- 149
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL-SVSTLAGTP---GYVPP 910
                 +HRD+ + N +LD +   +V+DFG+AR     D    SV    G      ++  
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
           E  Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + FL  
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKFL-- 147
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL-SVSTLAGTP---GYVPP 910
                 +HRD+ + N +LD +   +V+DFG+AR     D    SV    G      ++  
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
           E  Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 238

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + +L  
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKYL-- 147
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP---GYVPPE 911
                 +HRD+ + N +LD +   +V+DFG+AR +   + + SV    G      ++  E
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-YYSVHNKTGAKLPVKWMALE 205
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
             Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 238

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + +L  
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKYL-- 144
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP---GYVPPE 911
                 +HRD+ + N +LD +   +V+DFG+AR +   + + SV    G      ++  E
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-YYSVHNKTGAKLPVKWMALE 202
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
             Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + FL  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKFL-- 149
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL-SVSTLAGTP---GYVPP 910
                 +HRD+ + N +LD +   +V+DFG+AR     D    SV    G      ++  
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
           E  Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 741 LIGCGGFGEVFKATL--KDGSSV--AIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
           +IG G FG V+  TL   DG  +  A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 796 LGYCKIGE-ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LG C   E   L+V  +MK G L   +         + L               + +L  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKYL-- 148
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR-LISALDTHLSVSTLAGTP-GYVPPEY 912
                 +HRD+ + N +LD +   +V+DFG+AR +       +   T A  P  ++  E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 913 YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            Q+ + T K DV+SFGV+L EL+T   P   D
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 239

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK----------HR 790
           +G G FG+V     +  G  VA+K L       +R+ +  ++ +GKIK          H 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXX 848
           +++ L        +  +V E++  G L + +  HGR +  + R L               
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL------FQQILSAVD 125
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            C  H      ++HRD+K  NVLLD  M A+++DFG++ ++S  D    + T  G+P Y 
Sbjct: 126 YCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEF-LRTSCGSPNYA 177
Query: 909 PPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            PE          + D++S GV+L  LL G  P D +
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 37/220 (16%)
Query: 742 IGCGGFGEVFKATL----KDGS--SVAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT     K+ +   VA+K L   +   ++E  M+E++ +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            LLG C  G   L++ E+  +G L   L      R  R+L  D               LH
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR-----RKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 854 --------------HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                          NCI    HRD+ + NVLL +   A++ DFG+AR I   D++  V 
Sbjct: 169 FSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVK 223
Query: 900 TLAGTP-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT 936
             A  P  ++ PE    F C  T + DV+S+G++L E+ +
Sbjct: 224 GNARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D +   + 
Sbjct: 209 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 740 SLIGCGGFGEVFKAT-LKDGSSVAIKKLIRL--SCQGDREFMA---EMETLGKIKHRNLV 793
            ++G G FG V K   + +G S+ I   I++     G + F A    M  +G + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 794 PLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
            LLG C  G    LV +++  GSL + V   R     Q +L W             + +L
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG------MYYL 131
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
             + +   +HR++ + NVLL    + +V+DFG+A L+   D  L  S       ++  E 
Sbjct: 132 EEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 913 YQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               + T + DV+S+GV + EL+T G  P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS-VAIKKLIRLSCQGDREFMA-EME 782
           ++ Q  +  + +    ++G G F EV  A  K     VAIK + + + +G    M  E+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 783 TLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDXXXX 840
            L KIKH N+V L    + G    L+ + +  G L +  V  G    RD   L +     
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVL---LDHEMEARVSDFGMARLISALDTHLS 897
                     +LH      I+HRD+K  N+L   LD + +  +SDFG++++    D    
Sbjct: 129 VK--------YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP-TDKDD 945
           +ST  GTPGYV PE       +   D +S GV+   LL G  P  D++D
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 223

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRN 791
           + F   S +G G  G VFK + K    V  +KLI L  +     + + E++ L +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V   G      E  +  E M  GSL++VL    +  +Q +                L +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTY 181
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPP 910
           L       I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ P
Sbjct: 182 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSP 234
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLV 952
           E  Q    + + D++S G+ L+E+  G+ P    D  +  L+
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS-VAIKKLIRLSCQGDREFMA-EME 782
           ++ Q  +  + +    ++G G F EV  A  K     VAIK + + + +G    M  E+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 783 TLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDXXXX 840
            L KIKH N+V L    + G    L+ + +  G L +  V  G    RD   L +     
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVL---LDHEMEARVSDFGMARLISALDTHLS 897
                     +LH      I+HRD+K  N+L   LD + +  +SDFG++++    D    
Sbjct: 129 VK--------YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP-TDKDD 945
           +ST  GTPGYV PE       +   D +S GV+   LL G  P  D++D
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 223

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS-VAIKKLIRLSCQGDREFMA-EME 782
           ++ Q  +  + +    ++G G F EV  A  K     VAIK + + + +G    M  E+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 783 TLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDXXXX 840
            L KIKH N+V L    + G    L+ + +  G L +  V  G    RD   L +     
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVL---LDHEMEARVSDFGMARLISALDTHLS 897
                     +LH      I+HRD+K  N+L   LD + +  +SDFG++++    D    
Sbjct: 129 VK--------YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP-TDKDD 945
           +ST  GTPGYV PE       +   D +S GV+   LL G  P  D++D
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 223

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS-VAIKKLIRLSCQGDREFMA-EME 782
           ++ Q  +  + +    ++G G F EV  A  K     VAIK + + + +G    M  E+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 783 TLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDXXXX 840
            L KIKH N+V L    + G    L+ + +  G L +  V  G    RD   L +     
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVL---LDHEMEARVSDFGMARLISALDTHLS 897
                     +LH      I+HRD+K  N+L   LD + +  +SDFG++++    D    
Sbjct: 129 VK--------YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP-TDKDD 945
           +ST  GTPGYV PE       +   D +S GV+   LL G  P  D++D
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 223

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 90/308 (29%), Positives = 133/308 (43%), Gaps = 61/308 (19%)
Query: 734  NGFSAESLIGCGGFGEVFKATL-----KDGS-SVAIKKLIRLSCQGDRE-FMAEMETLGK 786
            N  S    +G G FG+V +AT       D + +VA+K L   +   +RE  M+E++ L  
Sbjct: 46   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 787  I-KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT----------- 834
            +  H N+V LLG C IG   L++ E+  +G L   L    + RD  I +           
Sbjct: 106  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR---RKRDSFICSKTSPAIMEDDE 162
Query: 835  ----WDXXXXXXXXXXXXLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
                 +            + FL   NCI    HRD+ + N+LL H    ++ DFG+AR I
Sbjct: 163  LALDLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARHI 218
Query: 890  SALDTHLSVSTLAGTP-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT-GKRPTDKDD 945
               D++  V   A  P  ++ PE    F C  T + DV+S+G+ L EL + G  P     
Sbjct: 219  KN-DSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--- 272
Query: 946  FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFP 1005
             G      + KM ++EG +M  + PE          + AE         +I   C D  P
Sbjct: 273  -GMPVDSKFYKM-IKEGFRM--LSPE---------HAPAE-------MYDIMKTCWDADP 312
Query: 1006 SKRPNMLQ 1013
             KRP   Q
Sbjct: 313  LKRPTFKQ 320

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 19/247 (7%)
Query: 702 KIDKEKEPLSINVATFQRQLRKLKFSQLIEATNG-----FSAESLIGCGGFGEVFKATLK 756
           KI + K  +S N   +   + K  + Q +E  +      +     +G G FG V + T +
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 757 DGSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG 815
              +    K +    + D+E +  E++T+  ++H  LV L    +   E +++YEFM  G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 816 SLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHE 875
            L E +     A +   ++ D            LC +H N   + +H D+K  N++   +
Sbjct: 240 ELFEKV-----ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTK 291
Query: 876 M--EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLE 933
              E ++ DFG   L + LD   SV    GT  +  PE  +        D++S GV+   
Sbjct: 292 RSNELKLIDFG---LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 934 LLTGKRP 940
           LL+G  P
Sbjct: 349 LLSGLSP 355

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VA+K +   +L+    ++   E+  +  + H N+V L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
            +  +   LV E+   G + + L  HG  K ++ R                 + + H   
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEAR--------AKFRQIVSAVQYCHQKF 126
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I   +HRD+K+ N+LLD +M  +++DFG +   +  +    + T  G+P Y  PE +Q  
Sbjct: 127 I---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCGSPPYAAPELFQGK 180
Query: 917 RCTA-KGDVYSFGVVLLELLTGKRPTD 942
           +    + DV+S GV+L  L++G  P D
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 736  FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKHRN 791
            F  E  IG G F EV++A  L DG  VA+KK+     +  +   + + E++ L ++ H N
Sbjct: 34   FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 792  LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
            ++          E  +V E    G L  ++    K +  R++               L  
Sbjct: 94   VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK--RLIPERTVWKYFVQLCSALEH 151
Query: 852  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            +H      ++HRD+K +NV +      ++ D G+ R  S+  T  +  +L GTP Y+ PE
Sbjct: 152  MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPE 206
Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT-NLVGWVKMKVREGKQMEVID- 969
                     K D++S G +L E+   + P     +GD  NL           K++E  D 
Sbjct: 207  RIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLC-------KKIEQCDY 255
Query: 970  PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
            P L        +  +EE++++V        C++  P KRP++
Sbjct: 256  PPL------PSDHYSEELRQLVN------MCINPDPEKRPDV 285

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           E  +G G FGEV+ AT    + VA+K + +        F+AE   +  ++H  LV L   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
               E   ++ EFM  GSL + L     ++       D            + F+      
Sbjct: 246 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG----MAFIEQR--- 297
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
           + IHRD++++N+L+   +  +++DFG+AR+ +                +  PE       
Sbjct: 298 NYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSF 346
Query: 919 TAKGDVYSFGVVLLELLTGKR 939
           T K DV+SFG++L+E++T  R
Sbjct: 347 TIKSDVWSFGILLMEIVTYGR 367

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VA++ +   +L+    ++   E+  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
            +  +   LV E+   G + + L  HGR K ++ R                 + + H   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR--------AKFRQIVSAVQYCHQKF 133
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I   +HRD+K+ N+LLD +M  +++DFG +   +  +    +    G+P Y  PE +Q  
Sbjct: 134 I---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDEFCGSPPYAAPELFQGK 187
Query: 917 RCTA-KGDVYSFGVVLLELLTGKRPTD 942
           +    + DV+S GV+L  L++G  P D
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VAIK +   +L+    ++   E+  +  + H N+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
            +  +   L+ E+   G + + L  HGR K ++ R                 + + H   
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR--------SKFRQIVSAVQYCHQK- 133
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I+HRD+K+ N+LLD +M  +++DFG +   +       +    G P Y  PE +Q  
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 917 RCTA-KGDVYSFGVVLLELLTGKRPTD 942
           +    + DV+S GV+L  L++G  P D
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 90/308 (29%), Positives = 133/308 (43%), Gaps = 61/308 (19%)
Query: 734  NGFSAESLIGCGGFGEVFKATL-----KDGS-SVAIKKLIRLSCQGDRE-FMAEMETLGK 786
            N  S    +G G FG+V +AT       D + +VA+K L   +   +RE  M+E++ L  
Sbjct: 23   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 787  I-KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT----------- 834
            +  H N+V LLG C IG   L++ E+  +G L   L    + RD  I +           
Sbjct: 83   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR---RKRDSFICSKTSPAIMEDDE 139
Query: 835  ----WDXXXXXXXXXXXXLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
                 +            + FL   NCI    HRD+ + N+LL H    ++ DFG+AR I
Sbjct: 140  LALDLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDI 195
Query: 890  SALDTHLSVSTLAGTP-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT-GKRPTDKDD 945
               D++  V   A  P  ++ PE    F C  T + DV+S+G+ L EL + G  P     
Sbjct: 196  KN-DSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--- 249
Query: 946  FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFP 1005
             G      + KM ++EG +M  + PE          + AE         +I   C D  P
Sbjct: 250  -GMPVDSKFYKM-IKEGFRM--LSPE---------HAPAE-------MYDIMKTCWDADP 289
Query: 1006 SKRPNMLQ 1013
             KRP   Q
Sbjct: 290  LKRPTFKQ 297

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 131/308 (42%), Gaps = 61/308 (19%)
Query: 734  NGFSAESLIGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGDRE-FMAEMETLGK 786
            N  S    +G G FG+V +AT           +VA+K L   +   +RE  M+E++ L  
Sbjct: 39   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 787  I-KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT----------- 834
            +  H N+V LLG C IG   L++ E+  +G L   L    + RD  I +           
Sbjct: 99   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR---RKRDSFICSKTSPAIMEDDE 155
Query: 835  ----WDXXXXXXXXXXXXLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
                 +            + FL   NCI    HRD+ + N+LL H    ++ DFG+AR I
Sbjct: 156  LALDLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDI 211
Query: 890  SALDTHLSVSTLAGTP-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT-GKRPTDKDD 945
               D++  V   A  P  ++ PE    F C  T + DV+S+G+ L EL + G  P     
Sbjct: 212  KN-DSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--- 265
Query: 946  FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFP 1005
             G      + KM ++EG +M  + PE          + AE         +I   C D  P
Sbjct: 266  -GMPVDSKFYKM-IKEGFRM--LSPE---------HAPAE-------MYDIMKTCWDADP 305
Query: 1006 SKRPNMLQ 1013
             KRP   Q
Sbjct: 306  LKRPTFKQ 313

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 17/229 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLGY 798
           IG G +G   K   K    + + K +      + E    ++E+  L ++KH N+V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY--Y 71
Query: 799 CKIGEER----LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
            +I +       +V E+ + G L  V+    K R      +              C    
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
           +    ++HRD+K +NV LD +   ++ DFG+AR+++  DT  +  T  GTP Y+ PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFA-KTFVGTPYYMSPEQMN 189
Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
                 K D++S G +L EL     P     F    L G    K+REGK
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTA--FSQKELAG----KIREGK 232

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R           +   ++++ + D    
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          CI    HRD+ + NVL+  +   +++DFG+AR I  +D +   + 
Sbjct: 197 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K+ H+N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K+ H+N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 90/308 (29%), Positives = 133/308 (43%), Gaps = 61/308 (19%)
Query: 734  NGFSAESLIGCGGFGEVFKATL-----KDGS-SVAIKKLIRLSCQGDRE-FMAEMETLGK 786
            N  S    +G G FG+V +AT       D + +VA+K L   +   +RE  M+E++ L  
Sbjct: 46   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 787  I-KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT----------- 834
            +  H N+V LLG C IG   L++ E+  +G L   L    + RD  I +           
Sbjct: 106  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR---RKRDSFICSKTSPAIMEDDE 162
Query: 835  ----WDXXXXXXXXXXXXLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
                 +            + FL   NCI    HRD+ + N+LL H    ++ DFG+AR I
Sbjct: 163  LALDLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDI 218
Query: 890  SALDTHLSVSTLAGTP-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT-GKRPTDKDD 945
               D++  V   A  P  ++ PE    F C  T + DV+S+G+ L EL + G  P     
Sbjct: 219  KN-DSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--- 272
Query: 946  FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFP 1005
             G      + KM ++EG +M  + PE          + AE         +I   C D  P
Sbjct: 273  -GMPVDSKFYKM-IKEGFRM--LSPE---------HAPAE-------MYDIMKTCWDADP 312
Query: 1006 SKRPNMLQ 1013
             KRP   Q
Sbjct: 313  LKRPTFKQ 320

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 131/308 (42%), Gaps = 61/308 (19%)
Query: 734  NGFSAESLIGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQGDRE-FMAEMETLGK 786
            N  S    +G G FG+V +AT           +VA+K L   +   +RE  M+E++ L  
Sbjct: 41   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 787  I-KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT----------- 834
            +  H N+V LLG C IG   L++ E+  +G L   L    + RD  I +           
Sbjct: 101  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR---RKRDSFICSKTSPAIMEDDE 157
Query: 835  ----WDXXXXXXXXXXXXLCFL-HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
                 +            + FL   NCI    HRD+ + N+LL H    ++ DFG+AR I
Sbjct: 158  LALDLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDI 213
Query: 890  SALDTHLSVSTLAGTP-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT-GKRPTDKDD 945
               D++  V   A  P  ++ PE    F C  T + DV+S+G+ L EL + G  P     
Sbjct: 214  KN-DSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--- 267
Query: 946  FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFP 1005
             G      + KM ++EG +M  + PE          + AE         +I   C D  P
Sbjct: 268  -GMPVDSKFYKM-IKEGFRM--LSPE---------HAPAE-------MYDIMKTCWDADP 307
Query: 1006 SKRPNMLQ 1013
             KRP   Q
Sbjct: 308  LKRPTFKQ 315

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRN 791
           + F   S +G G  G VFK + K    V  +KLI L  +     + + E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V   G      E  +  E M  GSL++VL    +  +Q +                L +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTY 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPP 910
           L       I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ P
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSP 172
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLV 952
           E  Q    + + D++S G+ L+E+  G+ P    D  +  L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRN 791
           + F   S +G G  G VFK + K    V  +KLI L  +     + + E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V   G      E  +  E M  GSL++VL    +  +Q +                L +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTY 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPP 910
           L       I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ P
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSP 172
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLV 952
           E  Q    + + D++S G+ L+E+  G+ P    D  +  L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRN 791
           + F   S +G G  G VFK + K    V  +KLI L  +     + + E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V   G      E  +  E M  GSL++VL    +  +Q +                L +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTY 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPP 910
           L       I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ P
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSP 172
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           E  Q    + + D++S G+ L+E+  G+ P    D
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      R++DFG+AR I+ +D +   + 
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R           +   ++++ + D    
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          CI    HRD+ + NVL+  +   +++DFG+AR I  +D +   + 
Sbjct: 149 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R           +   ++++ + D    
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          CI    HRD+ + NVL+  +   +++DFG+AR I  +D +   + 
Sbjct: 145 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R           +   ++++ + D    
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          CI    HRD+ + NVL+  +   +++DFG+AR I  +D +   + 
Sbjct: 156 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRN 791
           + F   S +G G  G VFK + K    V  +KLI L  +     + + E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V   G      E  +  E M  GSL++VL    +  +Q +                L +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTY 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPP 910
           L       I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ P
Sbjct: 120 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSP 172
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLV 952
           E  Q    + + D++S G+ L+E+  G+ P    D  +  L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRN 791
           + F   S +G G  G VFK + K    V  +KLI L  +     + + E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V   G      E  +  E M  GSL++VL    +  +Q +                L +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTY 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPP 910
           L       I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ P
Sbjct: 120 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSP 172
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLV 952
           E  Q    + + D++S G+ L+E+  G+ P    D  +  L+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R           +   ++++ + D    
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          CI    HRD+ + NVL+  +   +++DFG+AR I  +D +   + 
Sbjct: 156 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYC 799
           IG G  G V  A  K  G  VA+K ++ L  Q  RE +  E+  +   +H N+V +    
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
            +GEE  ++ EF++ G+L +++  + +  +++I T              L +LH   +  
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV-SQVRLNEEQIAT------VCEAVLQALAYLHAQGV-- 162
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
            IHRD+KS ++LL  +   ++SDFG    IS  D       L GTP ++ PE        
Sbjct: 163 -IHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVP-KRKXLVGTPYWMAPEVISRSLYA 219
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
            + D++S G++++E++ G+ P   D
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSD 244

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R           +   ++++ + D    
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          CI    HRD+ + NVL+  +   +++DFG+AR I  +D +   + 
Sbjct: 148 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRN 791
           + F   S +G G  G VFK + K    V  +KLI L  +     + + E++ L +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V   G      E  +  E M  GSL++VL    +  +Q +                L +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTY 146
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPP 910
           L       I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ P
Sbjct: 147 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSP 199
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLV 952
           E  Q    + + D++S G+ L+E+  G+ P    D  +  L+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 19/247 (7%)
Query: 702 KIDKEKEPLSINVATFQRQLRKLKFSQLIEATNG-----FSAESLIGCGGFGEVFKATLK 756
           KI + K  +S N   +   + K  + Q +E  +      +     +G G FG V + T +
Sbjct: 14  KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 73
Query: 757 DGSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG 815
              +    K +    + D+E +  E++T+  ++H  LV L    +   E +++YEFM  G
Sbjct: 74  ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 133
Query: 816 SLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHE 875
            L E +     A +   ++ D            LC +H N   + +H D+K  N++   +
Sbjct: 134 ELFEKV-----ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTK 185
Query: 876 M--EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLE 933
              E ++ DFG   L + LD   SV    GT  +  PE  +        D++S GV+   
Sbjct: 186 RSNELKLIDFG---LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 242
Query: 934 LLTGKRP 940
           LL+G  P
Sbjct: 243 LLSGLSP 249

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R           +   ++++ + D    
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          CI    HRD+ + NVL+  +   +++DFG+AR I  +D +   + 
Sbjct: 156 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R           +   ++++ + D    
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          CI    HRD+ + NVL+  +   +++DFG+AR I  +D +   + 
Sbjct: 141 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 742 IGCGGFGEVFKATL-----KDG-SSVAIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVP 794
           +G G FG+V KAT      + G ++VA+K L   +   + R+ ++E   L ++ H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA------------------RDQRILTWD 836
           L G C      LL+ E+ K+GSL   L    K                    D+R LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 837 XXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                       + +L       ++HRD+ + N+L+    + ++SDFG++R +   D+++
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
             S       ++  E       T + DV+SFGV+L E++T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR-----EFMAEMETLGKIKHRNLVPLL 796
           +G G FG V K   +    V    +  L  + +      E +AE   + ++ +  +V ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G C+  E  +LV E  + G L + L      +D+ I+               + +L  + 
Sbjct: 437 GICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEES- 488
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQS 915
             + +HRD+ + NVLL  +  A++SDFG+++ + A + +    T    P  +  PE    
Sbjct: 489 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++ ++K DV+SFGV++ E  + G++P
Sbjct: 547 YKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR-----EFMAEMETLGKIKHRNLVPLL 796
           +G G FG V K   +    V    +  L  + +      E +AE   + ++ +  +V ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G C+  E  +LV E  + G L + L      +D+ I+               + +L  + 
Sbjct: 438 GICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYLEES- 489
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQS 915
             + +HRD+ + NVLL  +  A++SDFG+++ + A + +    T    P  +  PE    
Sbjct: 490 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 547
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++ ++K DV+SFGV++ E  + G++P
Sbjct: 548 YKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL----KDG----SSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A      KD     + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R           +   ++++ + D    
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          CI    HRD+ + NVL+  +   +++DFG+AR I  +D     + 
Sbjct: 156 AYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ T
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D +   + 
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMAR I     +           ++PP
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 742 IGCGGFGE-VFKATLKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G FG+ +   + +DG    IK++   R+S +   E   E+  L  +KH N+V     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKA--RDQRILTWDXXXXXXXXXXXXLCF-LHHN 855
            +      +V ++ + G L + ++ +     ++ +IL W             +C  L H 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW----------FVQICLALKHV 141
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
               I+HRD+KS N+ L  +   ++ DFG+AR++++    L+ + + GTP Y+ PE  ++
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACI-GTPYYLSPEICEN 199
Query: 916 FRCTAKGDVYSFGVVLLELLTGK 938
                K D+++ G VL EL T K
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLK 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFM----AEMETLGKIKHRNLVPL 795
           ++G GG  EV  A  L+    VA+K ++R     D  F      E +    + H  +V +
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 94
Query: 796 L----GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
                     G    +V E++   +L +++H       +R +               L F
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNF 148
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA---GTPGYV 908
            H N    IIHRD+K +N+++      +V DFG+AR I+  D+  SV+  A   GT  Y+
Sbjct: 149 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYL 203
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            PE  +     A+ DVYS G VL E+LTG+ P   D
Sbjct: 204 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 239

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 742 IGCGGFGEV----FKATLKDGSS--VAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLV 793
           +G G FG+V    +  T  DG+   VA+K L +  C  Q    +  E++ L  + H +++
Sbjct: 22  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 794 PLLGYCK-IGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
              G C+  GE+ L LV E++  GSL + L   +    Q +L               + +
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-------FAQQICEGMAY 132
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VPP 910
           LH     H IHR++ + NVLLD++   ++ DFG+A+ +     +  V     +P +   P
Sbjct: 133 LHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E  + ++     DV+SFGV L ELLT
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 741 LIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
            +G GGF + ++ T  D   V     + K + L      +   E+     + + ++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     +T              + +LH+N 
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKA-----VTEPEARYFMRQTIQGVQYLHNN- 161
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ +M+ ++ DFG+A  I   D      TL GTP Y+ PE     
Sbjct: 162 --RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERK-KTLCGTPNYIAPEVLCKK 217
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP 970
             + + D++S G +L  LL GK P +     +T    ++++K  E      I+P
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET----YIRIKKNEYSVPRHINP 267

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D + + + 
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 776 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
           E +AE   + ++ +  +V ++G C+  E  +LV E  + G L + L      +D+ I+  
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE- 109
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
                        + +L  +   + +HRD+ + NVLL  +  A++SDFG+++ + A + +
Sbjct: 110 -----LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               T    P  +  PE    ++ ++K DV+SFGV++ E  + G++P
Sbjct: 162 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 776 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
           E +AE   + ++ +  +V ++G C+  E  +LV E  + G L + L      +D+ I+  
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE- 121
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
                        + +L  +   + +HRD+ + NVLL  +  A++SDFG+++ + A + +
Sbjct: 122 -----LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               T    P  +  PE    ++ ++K DV+SFGV++ E  + G++P
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 776 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
           E +AE   + ++ +  +V ++G C+  E  +LV E  + G L + L      +D+ I+  
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE- 131
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
                        + +L  +   + +HRD+ + NVLL  +  A++SDFG+++ + A + +
Sbjct: 132 -----LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               T    P  +  PE    ++ ++K DV+SFGV++ E  + G++P
Sbjct: 184 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 776 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
           E +AE   + ++ +  +V ++G C+  E  +LV E  + G L + L      +D+ I+  
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE- 131
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
                        + +L  +   + +HRD+ + NVLL  +  A++SDFG+++ + A + +
Sbjct: 132 -----LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               T    P  +  PE    ++ ++K DV+SFGV++ E  + G++P
Sbjct: 184 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 776 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
           E +AE   + ++ +  +V ++G C+  E  +LV E  + G L + L      +D+ I+  
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE- 111
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
                        + +L  +   + +HRD+ + NVLL  +  A++SDFG+++ + A + +
Sbjct: 112 -----LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               T    P  +  PE    ++ ++K DV+SFGV++ E  + G++P
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 776 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
           E +AE   + ++ +  +V ++G C+  E  +LV E  + G L + L      +D+ I+  
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE- 115
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
                        + +L  +   + +HRD+ + NVLL  +  A++SDFG+++ + A + +
Sbjct: 116 -----LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               T    P  +  PE    ++ ++K DV+SFGV++ E  + G++P
Sbjct: 168 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 776 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
           E +AE   + ++ +  +V ++G C+  E  +LV E  + G L + L      +D+ I+  
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE- 129
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
                        + +L  +   + +HRD+ + NVLL  +  A++SDFG+++ + A + +
Sbjct: 130 -----LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               T    P  +  PE    ++ ++K DV+SFGV++ E  + G++P
Sbjct: 182 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK----------HR 790
           +G G FG+V     +  G  VA+K L       +R+ +  ++ +GKIK          H 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXX 848
           +++ L        +  +V E++  G L + +  HGR +  + R L               
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL------FQQILSAVD 125
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            C  H      ++HRD+K  NVLLD  M A+++DFG++ ++S  D    +    G+P Y 
Sbjct: 126 YCHRHM-----VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEF-LRDSCGSPNYA 177
Query: 909 PPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            PE          + D++S GV+L  LL G  P D +
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFM----AEMETLGKIKHRNLVPL 795
           ++G GG  EV  A  L+    VA+K ++R     D  F      E +    + H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 796 LGYCKI----GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
               +     G    +V E++   +L +++H       +R +               L F
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNF 131
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA---GTPGYV 908
            H N    IIHRD+K +N+++      +V DFG+AR I+  D+  SV+  A   GT  Y+
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYL 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            PE  +     A+ DVYS G VL E+LTG+ P   D
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D +   + 
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           IG G FGEVF   L+  +++   K  R +   D   +F+ E   L +  H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
              +   +V E ++ G     L  R +    R+ T              + +L   C   
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKT---LLQMVGDAAAGMEYLESKCC-- 234
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRC 918
            IHRD+ + N L+  +   ++SDFGM+R   A   + +   L   P  +  PE     R 
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 919 TAKGDVYSFGVVLLELLT 936
           +++ DV+SFG++L E  +
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 742 IGCGGFGEV----FKATLKDGSS--VAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLV 793
           +G G FG+V    +  T  DG+   VA+K L +  C  Q    +  E++ L  + H +++
Sbjct: 22  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 794 PLLGYCK-IGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
              G C+  GE+ L LV E++  GSL + L   +    Q +L               + +
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-------FAQQICEGMAY 132
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VPP 910
           LH     H IHR++ + NVLLD++   ++ DFG+A+ +     +  V     +P +   P
Sbjct: 133 LHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E  + ++     DV+SFGV L ELLT
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRN 791
           + F   S +G G  G VFK + K    V  +KLI L  +     + + E++ L +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V   G      E  +  E M  GSL++VL    +  +Q +                L +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTY 138
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPP 910
           L       I+HRD+K SN+L++   E ++ DFG++ +LI ++      ++  GT  Y+ P
Sbjct: 139 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSP 191
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E  Q    + + D++S G+ L+E+  G+ P
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 742 IGCGGFGEVFKATL-----KDG-SSVAIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVP 794
           +G G FG+V KAT      + G ++VA+K L   +   + R+ ++E   L ++ H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA------------------RDQRILTWD 836
           L G C      LL+ E+ K+GSL   L    K                    D+R LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 837 XXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                       + +L       ++HRD+ + N+L+    + ++SDFG++R +   D+ +
Sbjct: 151 DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
             S       ++  E       T + DV+SFGV+L E++T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFM----AEMETLGKIKHRNLVPL 795
           ++G GG  EV  A  L+    VA+K ++R     D  F      E +    + H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 796 L----GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
                     G    +V E++   +L +++H       +R +               L F
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNF 131
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA---GTPGYV 908
            H N    IIHRD+K +N+++      +V DFG+AR I+  D+  SV+  A   GT  Y+
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYL 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            PE  +     A+ DVYS G VL E+LTG+ P   D
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSC---QGDREFMAEMETLGKIKH 789
           + F     IG G FG+V      D   + A+K + +  C      R    E++ +  ++H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             LV L    +  E+  +V + +  G L   L      +++ +  +             L
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF------ICELVMAL 128
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +L +     IIHRDMK  N+LLD      ++DF +A   + L     ++T+AGT  Y+ 
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA---AMLPRETQITTMAGTKPYMA 182
Query: 910 PEYYQSFRCTAKG---DVYSFGVVLLELLTGKRP 940
           PE + S +        D +S GV   ELL G+RP
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D +   + 
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 91/212 (42%), Gaps = 39/212 (18%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGD----REFMAEMETLGKIKHRNLVPLL 796
           IG G +G VFK   +D G  VAIKK   L  + D    +  + E+  L ++KH NLV LL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF--LESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH-HN 855
              +      LV+E+     L E+       R QR +               + F H HN
Sbjct: 69  EVFRRKRRLHLVFEYCDHTVLHEL------DRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS----------ALDTHLSVSTLAGTP 905
           CI    HRD+K  N+L+      ++ DFG ARL++          A   + S   L G  
Sbjct: 123 CI----HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
            Y PP            DV++ G V  ELL+G
Sbjct: 179 QYGPP-----------VDVWAIGCVFAELLSG 199

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 17/229 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLGY 798
           IG G +G   K   K    + + K +      + E    ++E+  L ++KH N+V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY--Y 71
Query: 799 CKIGEER----LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
            +I +       +V E+ + G L  V+    K R      +              C    
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
           +    ++HRD+K +NV LD +   ++ DFG+AR+++  DT  +     GTP Y+ PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFA-KAFVGTPYYMSPEQMN 189
Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
                 K D++S G +L EL     P     F    L G    K+REGK
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTA--FSQKELAG----KIREGK 232

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-----KHR 790
           F    +IG G + +V    LK    +   ++++     D E +  ++T   +      H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 791 NLVPLLGYCKIGEERLL-VYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
            LV L   C   E RL  V E++  G L  + H     + QR L  +            L
Sbjct: 114 FLVGLHS-CFQTESRLFFVIEYVNGGDL--MFH----MQRQRKLPEEHARFYSAEISLAL 166
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH   I   I+RD+K  NVLLD E   +++D+GM +    L    + ST  GTP Y+ 
Sbjct: 167 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 221
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD 942
           PE  +        D ++ GV++ E++ G+ P D
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLV 793
           F  +  +G G F EV  A  K  G   A+K + + + +G    +  E+  L KIKH N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
            L    +      LV + +  G L +  V  G    +D   L               + +
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLI--------RQVLDAVYY 135
Query: 852 LHHNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           LH      I+HRD+K  N+L    D E +  +SDFG++++    D    +ST  GTPGYV
Sbjct: 136 LHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV---MSTACGTPGYV 189
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP-TDKDD 945
            PE       +   D +S GV+   LL G  P  D++D
Sbjct: 190 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 227

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VA+K +   +L+    ++   E+     + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 799 CKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
            +  +   LV E+   G + + L  HGR K ++ R                 + + H   
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEAR--------AKFRQIVSAVQYCHQK- 132
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I+HRD+K+ N+LLD +   +++DFG +   +  +    +    G P Y  PE +Q  
Sbjct: 133 --FIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN---KLDAFCGAPPYAAPELFQGK 187
Query: 917 RCTA-KGDVYSFGVVLLELLTGKRPTD 942
           +    + DV+S GV+L  L++G  P D
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 742 IGCGGFGEVFKATL-----KDG-SSVAIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVP 794
           +G G FG+V KAT      + G ++VA+K L   +   + R+ ++E   L ++ H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA------------------RDQRILTWD 836
           L G C      LL+ E+ K+GSL   L    K                    D+R LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 837 XXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                       + +L       ++HRD+ + N+L+    + ++SDFG++R +   D+ +
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
             S       ++  E       T + DV+SFGV+L E++T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 734 NGFSAESLIGCGGFGEVFKATLK-DG--SSVAIKKLIRLSCQGD-REFMAEMETLGKIKH 789
           N    + +IG G FG+V KA +K DG     AIK++   + + D R+F  E+E L K+ H
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 790 R-NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
             N++ LLG C+      L  E+   G+L + L      R  R+L  D            
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL------RKSRVLETDPAFAIANSTAST 138
Query: 849 LC---FLHHNC----------IPHIIHRDMKSSNVLLDHEMEARVSDFGMAR----LISA 891
           L     LH                 IHRD+ + N+L+     A+++DFG++R     +  
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
               L V  +A     +    Y  +  T   DV+S+GV+L E+++
Sbjct: 199 TMGRLPVRWMA-----IESLNYSVY--TTNSDVWSYGVLLWEIVS 236

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 56/234 (23%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLV 793
           +  +  +G GGFG V +   +D G  VAIK+  + LS +    +  E++ + K+ H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 794 -----------------PLLG--YCKIGEERLLVYEF-----MKFGSLEEVLHGRAKARD 829
                            PLL   YC+ G+ R  + +F     +K G +  +L   + A  
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA-- 133
Query: 830 QRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMA 886
                              L +LH N    IIHRD+K  N++L      +  ++ D G A
Sbjct: 134 -------------------LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +    LD     +   GT  Y+ PE  +  + T   D +SFG +  E +TG RP
Sbjct: 172 K---ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 14/217 (6%)
Query: 726 FSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--T 783
           + Q ++    F+    IG G FGEVFK        V   K+I L    D     + E   
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 78
Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXX 843
           L +     +    G      +  ++ E++  GS  ++L       + +I T         
Sbjct: 79  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIAT------ILR 131
Query: 844 XXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG 903
                L +LH       IHRD+K++NVLL    E +++DFG+A  ++  DT +  +T  G
Sbjct: 132 EILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVG 186
Query: 904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           TP ++ PE  +     +K D++S G+  +EL  G+ P
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 56/234 (23%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIR-LSCQGDREFMAEMETLGKIKHRNLV 793
           +  +  +G GGFG V +   +D G  VAIK+  + LS +    +  E++ + K+ H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 794 -----------------PLLG--YCKIGEERLLVYEF-----MKFGSLEEVLHGRAKARD 829
                            PLL   YC+ G+ R  + +F     +K G +  +L   + A  
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA-- 134
Query: 830 QRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMA 886
                              L +LH N    IIHRD+K  N++L      +  ++ D G A
Sbjct: 135 -------------------LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 172
Query: 887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +    LD     +   GT  Y+ PE  +  + T   D +SFG +  E +TG RP
Sbjct: 173 K---ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 734 NGFSAESLIGCGGFGEVFKATLK-DG--SSVAIKKLIRLSCQGD-REFMAEMETLGKIKH 789
           N    + +IG G FG+V KA +K DG     AIK++   + + D R+F  E+E L K+ H
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 790 R-NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
             N++ LLG C+      L  E+   G+L + L      R  R+L  D            
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL------RKSRVLETDPAFAIANSTAST 128
Query: 849 LC---FLHHNC----------IPHIIHRDMKSSNVLLDHEMEARVSDFGMAR----LISA 891
           L     LH                 IHRD+ + N+L+     A+++DFG++R     +  
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 188
Query: 892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
               L V  +A     +    Y  +  T   DV+S+GV+L E+++
Sbjct: 189 TMGRLPVRWMA-----IESLNYSVY--TTNSDVWSYGVLLWEIVS 226

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 742 IGCGGFGEVFKATLK----DGS--SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +     D S   VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +G       R ++ E M  G L+  L   R +      L                 +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVS---DFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N   H IHRD+ + N LL      RV+   DFGMA+ I     +           ++PP
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E +     T+K D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 102/221 (46%), Gaps = 38/221 (17%)
Query: 745 GGFGEVFKATL-KDGSSVAIKKLI-RLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG 802
           G FG V+KA L  D  +V I  L  + S Q +RE  +   T G +KH NL+  +   K G
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFS---TPG-MKHENLLQFIAAEKRG 81
Query: 803 E----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC-- 856
                E  L+  F   GSL + L G        I+TW+            L +LH +   
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGN-------IITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 857 ------IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS----ALDTHLSVSTLAGTPG 906
                  P I HRD KS NVLL  ++ A ++DFG+A          DTH  V    GT  
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV----GTRR 190
Query: 907 YVPPEYYQ---SFRCTA--KGDVYSFGVVLLELLTGKRPTD 942
           Y+ PE  +   +F+  A  + D+Y+ G+VL EL++  +  D
Sbjct: 191 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSV-AIKKLIR--LSCQG-DREFMAEMETLGKIKHRNLVPLLG 797
           +G G FG V+ A  K    + A+K L +  L  +G + +   E+E    ++H N++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
           Y    +   L+ EF   G L + L    +  +QR  T+                LH+   
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA---------LHYCHE 132
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             +IHRD+K  N+L+ ++ E +++DFG     S     L    + GT  Y+PPE  +   
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRXMCGTLDYLPPEMIEGKT 188
Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
              K D++  GV+  E L G  P D     +T+
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 43/167 (25%), Positives = 84/167 (50%), Gaps = 12/167 (7%)
Query: 776 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
           E +AE   + ++ +  +V ++G C+  E  +LV E  + G L + L      +D+ I+  
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE- 115
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
                        + +L  +   + +HRD+ + NVLL  +  A++SDFG+++ + A +  
Sbjct: 116 -----LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX 167
Query: 896 LSVSTLAGTP-GYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               T    P  +  PE    ++ ++K DV+SFGV++ E  + G++P
Sbjct: 168 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 27/244 (11%)
Query: 712 INVATFQRQLRKLKFSQLIE---------ATNGFSAESLIGCGGFGEV----FKATLKDG 758
           ++VA F   L  + F++ ++           N F    ++G GGFGEV     +AT K  
Sbjct: 153 LSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMY 212
Query: 759 SSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLE 818
           +   ++K      +G+   + E + L K+  R +V L    +  +   LV   M  G L+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 819 -EVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEM 876
             + H G+A   + R + +              C L       I++RD+K  N+LLD   
Sbjct: 273 FHIYHMGQAGFPEARAVFY---------AAEICCGLEDLHRERIVYRDLKPENILLDDHG 323
Query: 877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
             R+SD G+A  +    T   +    GT GY+ PE  ++ R T   D ++ G +L E++ 
Sbjct: 324 HIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 937 GKRP 940
           G+ P
Sbjct: 381 GQSP 384

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSV-AIKKLIR--LSCQG-DREFMAEMETLGKIKHRNLVPLLG 797
           +G G FG V+ A  K    + A+K L +  L  +G + +   E+E    ++H N++ +  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
           Y    +   L+ EF   G L + L    +  +QR  T+                LH+   
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA---------LHYCHE 133
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             +IHRD+K  N+L+ ++ E +++DFG     S     L    + GT  Y+PPE  +   
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRXMCGTLDYLPPEMIEGKT 189
Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
              K D++  GV+  E L G  P D     +T+
Sbjct: 190 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 222

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D +   + 
Sbjct: 155 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D +   + 
Sbjct: 150 TYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D +   + 
Sbjct: 152 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           IG G FGEVF   L+  +++   K  R +   D   +F+ E   L +  H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
              +   +V E ++ G     L  R +    R+ T              + +L   C   
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKT---LLQMVGDAAAGMEYLESKCC-- 234
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRC 918
            IHRD+ + N L+  +   ++SDFGM+R   A     +   L   P  +  PE     R 
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 919 TAKGDVYSFGVVLLELLT 936
           +++ DV+SFG++L E  +
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D     + 
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-----KHR 790
           F    +IG G + +V    LK    +   K+++     D E +  ++T   +      H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 791 NLVPLLGYCKIGEERLL-VYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
            LV L   C   E RL  V E++  G L  + H     + QR L  +            L
Sbjct: 71  FLVGLHS-CFQTESRLFFVIEYVNGGDL--MFH----MQRQRKLPEEHARFYSAEISLAL 123
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH   I   I+RD+K  NVLLD E   +++D+GM +    L    + S   GTP Y+ 
Sbjct: 124 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIA 178
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD 942
           PE  +        D ++ GV++ E++ G+ P D
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++ E+   G+L E L  R            +  ++++   D    
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D     + 
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRN 791
           + F   S +G G  G VFK + K    V  +KLI L  +     + + E++ L +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V   G      E  +  E M  GSL++VL    +  +Q +                L +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKGLTY 122
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPP 910
           L       I+HRD+K SN+L++   E ++ DFG++ +LI  +      +   GT  Y+ P
Sbjct: 123 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM-----ANEFVGTRSYMSP 175
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E  Q    + + D++S G+ L+E+  G+ P
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKHRNLV 793
           F+    IG G FGEVFK        V   K+I L    D     + E   L +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
              G      +  ++ E++  GS  ++L       + +I T              L +LH
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIAT------ILREILKGLDYLH 121
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                  IHRD+K++NVLL    E +++DFG+A  ++  DT +  +T  GTP ++ PE  
Sbjct: 122 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 176
Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +     +K D++S G+  +EL  G+ P
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 730 IEATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGD-REFMAEMETLGKI 787
           + +++ F     +G G +  V+K   K  G  VA+K++   S +G     + E+  + ++
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           KH N+V L        +  LV+EFM    L++ +  R      R L  +           
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG---T 904
            L F H N    I+HRD+K  N+L++   + ++ DFG+AR        + V+T +    T
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-----IPVNTFSSEVVT 171
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  P+     R  +   D++S G +L E++TGK
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-----KHR 790
           F    +IG G + +V    LK    +   K+++     D E +  ++T   +      H 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 791 NLVPLLGYCKIGEERLL-VYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
            LV L   C   E RL  V E++  G L  + H     + QR L  +            L
Sbjct: 67  FLVGLHS-CFQTESRLFFVIEYVNGGDL--MFH----MQRQRKLPEEHARFYSAEISLAL 119
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH   I   I+RD+K  NVLLD E   +++D+GM +    L    + S   GTP Y+ 
Sbjct: 120 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIA 174
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD 942
           PE  +        D ++ GV++ E++ G+ P D
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 27/244 (11%)
Query: 712 INVATFQRQLRKLKFSQLIE---------ATNGFSAESLIGCGGFGEV----FKATLKDG 758
           ++VA F   L  + F++ ++           N F    ++G GGFGEV     +AT K  
Sbjct: 153 LSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMY 212
Query: 759 SSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLE 818
           +   ++K      +G+   + E + L K+  R +V L    +  +   LV   M  G L+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 819 -EVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEM 876
             + H G+A   + R + +              C L       I++RD+K  N+LLD   
Sbjct: 273 FHIYHMGQAGFPEARAVFY---------AAEICCGLEDLHRERIVYRDLKPENILLDDHG 323
Query: 877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
             R+SD G+A  +    T   +    GT GY+ PE  ++ R T   D ++ G +L E++ 
Sbjct: 324 HIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 937 GKRP 940
           G+ P
Sbjct: 381 GQSP 384

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 742 IGCGGFGEVFKATL----KDGS--SVAIKKLIRLSCQGDRE-FMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT     K+ +   VA+K L   +   ++E  M+E++ +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------AKARDQRILTWDXXXXXX 842
            LLG C  G   L++ E+  +G L   L  +           +   ++++ + D      
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 843 XXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA 902
                       NCI    HRD+ + NVLL +   A++ DFG+AR I   D++  V   A
Sbjct: 174 QVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNA 228
Query: 903 GTP-GYVPPEYYQSFRC--TAKGDVYSFGVVLLELLT 936
             P  ++ PE    F C  T + DV+S+G++L E+ +
Sbjct: 229 RLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-----KHR 790
           F    +IG G + +V    LK    +   K+++     D E +  ++T   +      H 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 791 NLVPLLGYCKIGEERLL-VYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
            LV L   C   E RL  V E++  G L  + H     + QR L  +            L
Sbjct: 82  FLVGLHS-CFQTESRLFFVIEYVNGGDL--MFH----MQRQRKLPEEHARFYSAEISLAL 134
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH   I   I+RD+K  NVLLD E   +++D+GM +    L    + S   GTP Y+ 
Sbjct: 135 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIA 189
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD 942
           PE  +        D ++ GV++ E++ G+ P D
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 19/234 (8%)
Query: 741 LIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
            +G GGF + ++ T  D   V     + K + L      +   E+     + + ++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     +T              + +LH+N 
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKA-----VTEPEARYFMRQTIQGVQYLHNN- 161
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ +M+ ++ DFG+A  I   D       L GTP Y+ PE     
Sbjct: 162 --RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERK-KXLCGTPNYIAPEVLCKK 217
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP 970
             + + D++S G +L  LL GK P +     +T    ++++K  E      I+P
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET----YIRIKKNEYSVPRHINP 267

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEME--TLGKIKH 789
           F    ++G G FG+VF      GS      A+K L + + +       +ME   L ++ H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             +V L    +   +  L+ +F++ G L        +   + + T +            L
Sbjct: 87  PFIVKLHYAFQTEGKLYLILDFLRGGDL------FTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
             LH      II+RD+K  N+LLD E   +++DFG+++   ++D      +  GT  Y+ 
Sbjct: 141 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMA 195
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           PE       T   D +SFGV++ E+LTG  P    D  +T
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 235

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++ +VY  +    + E ++   R  +R ++ L               L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRA 190
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEME--TLGKIKH 789
           F    ++G G FG+VF      GS      A+K L + + +       +ME   L ++ H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             +V L    +   +  L+ +F++ G L        +   + + T +            L
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDL------FTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
             LH      II+RD+K  N+LLD E   +++DFG+++   ++D      +  GT  Y+ 
Sbjct: 140 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMA 194
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           PE       T   D +SFGV++ E+LTG  P    D  +T
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 19/234 (8%)
Query: 741 LIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
            +G GGF + ++ T  D   V     + K + L      +   E+     + + ++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     +T              + +LH+N 
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKA-----VTEPEARYFMRQTIQGVQYLHNN- 161
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ +M+ ++ DFG+A  I   D       L GTP Y+ PE     
Sbjct: 162 --RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERK-KDLCGTPNYIAPEVLCKK 217
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP 970
             + + D++S G +L  LL GK P +     +T    ++++K  E      I+P
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET----YIRIKKNEYSVPRHINP 267

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D         G  G +P 
Sbjct: 138 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK-----GGKGLLPV 189
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 190 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 734 NGFSAESLIGCGGFGEVFKATLK-DG--SSVAIKKLIRLSCQGD-REFMAEMETLGKIKH 789
           N    + +IG G FG+V KA +K DG     AIK++   + + D R+F  E+E L K+ H
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 790 R-NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
             N++ LLG C+      L  E+   G+L + L      R  R+L  D            
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL------RKSRVLETDPAFAIANSTAST 135
Query: 849 LC---FLHHNC----------IPHIIHRDMKSSNVLLDHEMEARVSDFGMAR----LISA 891
           L     LH                 IHR++ + N+L+     A+++DFG++R     +  
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKK 195
Query: 892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
               L V  +A     +    Y  +  T   DV+S+GV+L E+++
Sbjct: 196 TMGRLPVRWMA-----IESLNYSVY--TTNSDVWSYGVLLWEIVS 233

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 19/234 (8%)
Query: 741 LIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
            +G GGF + ++ T  D   V     + K + L      +   E+     + + ++V   
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           G+ +  +   +V E  +  SL E LH R KA     +T              + +LH+N 
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLE-LHKRRKA-----VTEPEARYFMRQTIQGVQYLHNN- 145
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ +M+ ++ DFG+A  I   D       L GTP Y+ PE     
Sbjct: 146 --RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERK-KDLCGTPNYIAPEVLCKK 201
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP 970
             + + D++S G +L  LL GK P +     +T    ++++K  E      I+P
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET----YIRIKKNEYSVPRHINP 251

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEME--TLGKIKH 789
           F    ++G G FG+VF      GS      A+K L + + +       +ME   L ++ H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             +V L    +   +  L+ +F++ G L        +   + + T +            L
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDL------FTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
             LH      II+RD+K  N+LLD E   +++DFG+++   ++D      +  GT  Y+ 
Sbjct: 140 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMA 194
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           PE       T   D +SFGV++ E+LTG  P    D  +T
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++  +   G+L E L  R            +  ++++   D    
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D +   + 
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 123/281 (43%), Gaps = 30/281 (10%)
Query: 742  IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
            +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 794  PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRA------KARDQRILTWDXXXXXXXXXX 846
             LLG C K G   +++ EF KFG+L   L  +       K   +  LT +          
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 847  XXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
              + FL        IHRD+ + N+LL  +   ++ DFG+AR I     ++          
Sbjct: 155  KGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 907  YVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQM 965
            ++ PE       T + DV+SFGV+L E+ + G  P     +    +      +++EG +M
Sbjct: 212  WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFXRRLKEGTRM 266
Query: 966  EVID---PEL---LLVTKGTDESEAEEVKEMVRYLEITLQC 1000
               D   PE+   +L     + S+     E+V +L   LQ 
Sbjct: 267  RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 307

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 17/229 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLGY 798
           IG G +G   K   K    + + K +      + E    ++E+  L ++KH N+V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY--Y 71
Query: 799 CKIGEER----LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
            +I +       +V E+ + G L  V+    K R      +              C    
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
           +    ++HRD+K +NV LD +   ++ DFG+AR+++  +         GTP Y+ PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF--AKEFVGTPYYMSPEQMN 189
Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
                 K D++S G +L EL     P     F    L G    K+REGK
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTA--FSQKELAG----KIREGK 232

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 16/215 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEMETLG-KIKHR 790
           F    ++G G FG+VF A  K  +      A+KK + L        M E   L    +H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L  +    +  E    V E++  G L   +    K    R   +             L 
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY------AAEIILGLQ 133
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           FLH   I   ++RD+K  N+LLD +   +++DFGM +     D     +   GTP Y+ P
Sbjct: 134 FLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNEFCGTPDYIAP 188
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           E     +     D +SFGV+L E+L G+ P    D
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           F    LIG GGFG+VFKA  + DG +  IK++   + + +RE  A    L K+ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKA----LAKLDHVNIVH 68
Query: 795 LLGYCKIGEER-----------------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDX 837
             G C  G +                   +  EF   G+LE+ +  R   +  ++L  + 
Sbjct: 69  YNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 838 XXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS 897
                        ++H      +I+RD+K SN+ L    + ++ DFG   L+++L     
Sbjct: 128 FEQITKGVD----YIHSK---KLINRDLKPSNIFLVDTKQVKIGDFG---LVTSLKNDGK 177
Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELL 935
                GT  Y+ PE   S     + D+Y+ G++L ELL
Sbjct: 178 RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 17/220 (7%)
Query: 736 FSAESLIGCGGFGEVF---KATLKDGSSVAIKKLIRLSCQGDREFM---AEMETLGKIKH 789
           F    ++G G FG+VF   K T  D   +   K+++ +    R+ +    E + L  + H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             +V L    +   +  L+ +F++ G L        +   + + T +            L
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDL------FTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
             LH      II+RD+K  N+LLD E   +++DFG+++   A+D      +  GT  Y+ 
Sbjct: 144 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMA 198
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           PE       +   D +S+GV++ E+LTG  P    D  +T
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKET 238

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKHRNLV 793
           F+    IG G FGEVFK        V   K+I L    D     + E   L +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
              G      +  ++ E++  GS  ++L       + +I T              L +LH
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIAT------ILREILKGLDYLH 136
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                  IHRD+K++NVLL    E +++DFG+A  ++  DT +  +   GTP ++ PE  
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 191
Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +     +K D++S G+  +EL  G+ P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 197
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 742 IGCGGFGEVFKATL--------KDGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHRN 791
           +G G FG+V  A          K+  +VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRA-----------KARDQRILTWDXXXX 840
           ++ LLG C       ++  +   G+L E L  R            +  ++++   D    
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                          C    IHRD+ + NVL+      +++DFG+AR I+ +D +   + 
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 144 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 195
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 196 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 175 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 226
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 227 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 198
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 25/240 (10%)
Query: 711 SINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR- 768
           S+  A  Q  LR LK ++       F    ++G G FG V+K   + +G  V I   I+ 
Sbjct: 2   SMGEAPNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 769 ----LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHG 823
                S + ++E + E   +  + + ++  LLG C     +L++ + M FG L + V   
Sbjct: 55  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREH 113
Query: 824 RAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF 883
           +     Q +L W             + +L       ++HRD+ + NVL+      +++DF
Sbjct: 114 KDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 164
Query: 884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
           G+A+L+ A +             ++  E       T + DV+S+GV + EL+T G +P D
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 110/248 (44%), Gaps = 54/248 (21%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR---------------EFMAEMETLGK 786
           +G G +GEV     K+G S    K+I+ S Q D+               E   E+  L  
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKS-QFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 787 IKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD-------QRILTWDXXX 839
           + H N++ L    +  +   LV EF + G L E +  R K  +       ++IL+     
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS----- 157
Query: 840 XXXXXXXXXLCFLH-HNCIPHIIHRDMKSSNVLLDHE---MEARVSDFGMARLISALDTH 895
                    +C+LH HN    I+HRD+K  N+LL+++   +  ++ DFG++   S     
Sbjct: 158 --------GICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---D 202
Query: 896 LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWV 955
             +    GT  Y+ PE  +  +   K DV+S GV++  LL G  P     FG  N    +
Sbjct: 203 YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP-----FGGQNDQDII 256
Query: 956 KMKVREGK 963
           K KV +GK
Sbjct: 257 K-KVEKGK 263

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L++ + M FG L + V   +     Q +L W             
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRA------KARDQRILTWDXXXXXXXXXX 846
            LLG C K G   +++ EF KFG+L   L  +       K   +  LT +          
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 847 XXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
             + FL        IHRD+ + N+LL  +   ++ DFG+AR I     ++          
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
           ++ PE       T + DV+SFGV+L E+ +
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 722 RKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG--DREFMA 779
           +K K  +L    + F   S +G G  G V K   +    +  +KLI L  +     + + 
Sbjct: 6   QKAKVGEL--KDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR 63
Query: 780 EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX 839
           E++ L +     +V   G      E  +  E M  GSL++VL   AK   + IL      
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-EAKRIPEEILG----- 117
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSV 898
                    L +L       I+HRD+K SN+L++   E ++ DFG++ +LI ++      
Sbjct: 118 KVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----A 170
Query: 899 STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           ++  GT  Y+ PE  Q    + + D++S G+ L+EL  G+ P    D
Sbjct: 171 NSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPD 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L++ + M FG L + V   +     Q +L W             
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L++ + M FG L + V   +     Q +L W             
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 16/215 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV----AIKKLIRLSCQGDREFMAEMETLG-KIKHR 790
           F    ++G G FG+VF A  K  +      A+KK + L        M E   L    +H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L  +    +  E    V E++  G L   +    K    R   +             L 
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY------AAEIILGLQ 132
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           FLH   I   ++RD+K  N+LLD +   +++DFGM +     D     +   GTP Y+ P
Sbjct: 133 FLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNXFCGTPDYIAP 187
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           E     +     D +SFGV+L E+L G+ P    D
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L++ + M FG L + V   +     Q +L W             
Sbjct: 77  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 742 IGCGGFGEV----FKATLKDGSS--VAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVP 794
           +G G FG+V    +  T  DG+   VA+K L   +    R  +  E++ L  + H +++ 
Sbjct: 39  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 795 LLGYCK-IGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
             G C+  G   L LV E++  GSL + L   +    Q +L               + +L
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-------FAQQICEGMAYL 150
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VPPE 911
           H     H IHRD+ + NVLLD++   ++ DFG+A+ +        V     +P +   PE
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT 936
             + ++     DV+SFGV L ELLT
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 197
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 140 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 191
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L++ + M FG L + V   +     Q +L W             
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 204
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 106/240 (44%), Gaps = 25/240 (10%)
Query: 711 SINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR- 768
           S+  A  Q  LR LK ++       F    ++G G FG V+K   + +G  V I   I+ 
Sbjct: 2   SMGEAPNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 769 ----LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHG 823
                S + ++E + E   +  + + ++  LLG C     +L+  + M FG L + V   
Sbjct: 55  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREH 113
Query: 824 RAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF 883
           +     Q +L W             + +L       ++HRD+ + NVL+      +++DF
Sbjct: 114 KDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 164
Query: 884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
           G+A+L+ A +             ++  E       T + DV+S+GV + EL+T G +P D
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKHRNLV 793
           F+    IG G FGEVFK        V   K+I L    D     + E   L +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
              G      +  ++ E++  GS  ++L       + +I T              L +LH
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIAT------ILREILKGLDYLH 121
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                  IHRD+K++NVLL    E +++DFG+A  ++  DT +  +   GTP ++ PE  
Sbjct: 122 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 176
Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +     +K D++S G+  +EL  G+ P
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 107/258 (41%), Gaps = 37/258 (14%)
Query: 716 TFQRQLRKLKFSQLIE----------ATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIK 764
            FQ+ +   KF++  +            N FS   +IG GGFGEV+     D G   A+K
Sbjct: 161 VFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 765 ----KLIRLSCQGDREFMAEMETLGKIKHRN--LVPLLGYCKIGEERL-LVYEFMKFGSL 817
               K I++  QG+   + E   L  +   +   +  + Y     ++L  + + M  G L
Sbjct: 221 CLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 279
Query: 818 EEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHE 875
              L  HG     D R    +            +  L H     +++RD+K +N+LLD  
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEI-----------ILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 876 MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLEL 934
              R+SD G+A   S    H SV    GT GY+ PE  Q      +  D +S G +L +L
Sbjct: 329 GHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 935 LTGKRPTDKDDFGDTNLV 952
           L G  P  +    D + +
Sbjct: 385 LRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 107/258 (41%), Gaps = 37/258 (14%)
Query: 716 TFQRQLRKLKFSQLIE----------ATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIK 764
            FQ+ +   KF++  +            N FS   +IG GGFGEV+     D G   A+K
Sbjct: 161 VFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 765 ----KLIRLSCQGDREFMAEMETLGKIKHRN--LVPLLGYCKIGEERL-LVYEFMKFGSL 817
               K I++  QG+   + E   L  +   +   +  + Y     ++L  + + M  G L
Sbjct: 221 CLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 279
Query: 818 EEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHE 875
              L  HG     D R    +            +  L H     +++RD+K +N+LLD  
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEI-----------ILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 876 MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLEL 934
              R+SD G+A   S    H SV    GT GY+ PE  Q      +  D +S G +L +L
Sbjct: 329 GHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 935 LTGKRPTDKDDFGDTNLV 952
           L G  P  +    D + +
Sbjct: 385 LRGHSPFRQHKTKDKHEI 402

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++  VY  +    + E ++   R  +R ++ L               L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRA 190
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 102 PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 154
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 155 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 76
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++  VY  +    + E ++   R  +R ++ L               L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 137 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRA 191
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 239

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 107/258 (41%), Gaps = 37/258 (14%)
Query: 716 TFQRQLRKLKFSQLIE----------ATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIK 764
            FQ+ +   KF++  +            N FS   +IG GGFGEV+     D G   A+K
Sbjct: 160 VFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 219
Query: 765 ----KLIRLSCQGDREFMAEMETLGKIKHRN--LVPLLGYCKIGEERL-LVYEFMKFGSL 817
               K I++  QG+   + E   L  +   +   +  + Y     ++L  + + M  G L
Sbjct: 220 CLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 278
Query: 818 EEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHE 875
              L  HG     D R    +            +  L H     +++RD+K +N+LLD  
Sbjct: 279 HYHLSQHGVFSEADMRFYAAEI-----------ILGLEHMHNRFVVYRDLKPANILLDEH 327
Query: 876 MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLEL 934
              R+SD G+A   S    H SV    GT GY+ PE  Q      +  D +S G +L +L
Sbjct: 328 GHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 383
Query: 935 LTGKRPTDKDDFGDTNLV 952
           L G  P  +    D + +
Sbjct: 384 LRGHSPFRQHKTKDKHEI 401

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 107/258 (41%), Gaps = 37/258 (14%)
Query: 716 TFQRQLRKLKFSQLIE----------ATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIK 764
            FQ+ +   KF++  +            N FS   +IG GGFGEV+     D G   A+K
Sbjct: 161 VFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 765 ----KLIRLSCQGDREFMAEMETLGKIKHRN--LVPLLGYCKIGEERL-LVYEFMKFGSL 817
               K I++  QG+   + E   L  +   +   +  + Y     ++L  + + M  G L
Sbjct: 221 CLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 279
Query: 818 EEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHE 875
              L  HG     D R    +            +  L H     +++RD+K +N+LLD  
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEI-----------ILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 876 MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLEL 934
              R+SD G+A   S    H SV    GT GY+ PE  Q      +  D +S G +L +L
Sbjct: 329 GHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 935 LTGKRPTDKDDFGDTNLV 952
           L G  P  +    D + +
Sbjct: 385 LRGHSPFRQHKTKDKHEI 402

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D         G  G +P 
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD-----XXRKGGKGLLPV 198
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHRNLVPLL 796
           ++G G FG+V  A  K    + AIK L +     D +    M E   L  +     +  L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
             C    +RL  V E++  G L   +    K ++ + + +             L FLH  
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISIGLFFLHKR 139
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY--Y 913
            I   I+RD+K  NV+LD E   +++DFGM +    +   ++     GTP Y+ PE   Y
Sbjct: 140 GI---IYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPEIIAY 194
Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           Q +  +   D +++GV+L E+L G+ P D +D
Sbjct: 195 QPYGKSV--DWWAYGVLLYEMLAGQPPFDGED 224

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++  VY  +    + E ++   R  +R ++ L               L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRA 190
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 742 IGCGGFGEVFKATLK-DGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+V     +  G  VA+K L R     L   G  +   E++ L   +H +++ L
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG--KIRREIQNLKLFRHPHIIKL 81
Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
                   +  +V E++  G L + +  +GR   ++ R L                C  H
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL------FQQILSGVDYCHRH 135
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                 ++HRD+K  NVLLD  M A+++DFG++ ++S  +    +    G+P Y  PE  
Sbjct: 136 M-----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRXSCGSPNYAAPEVI 187
Query: 914 QSFRCTA--KGDVYSFGVVLLELLTGKRPTDKD 944
            S R  A  + D++S GV+L  LL G  P D D
Sbjct: 188 -SGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 83  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 135
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 136 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 94
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++  VY  +    + E ++   R  +R ++ L               L
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 155 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRA 209
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 257

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLV 793
           ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 171 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAP 225
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 272

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 83
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++  VY  +    + E ++   R  +R ++ L               L
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 144 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRA 198
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 246

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 35/213 (16%)
Query: 745 GGFGEVFKATLKDGSSVAIKKL-IRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE 803
           G FG V+KA L +   VA+K   I+       E+  E+ +L  +KH N++  +G  K G 
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGT 91
Query: 804 ----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC--- 856
               +  L+  F + GSL + L          +++W+            L +LH +    
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 857 ----IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI----SALDTHLSVSTLAGTPGYV 908
                P I HRD+KS NVLL + + A ++DFG+A       SA DTH  V    GT  Y+
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV----GTRRYM 200
Query: 909 PPEYYQ---SFRCTA--KGDVYSFGVVLLELLT 936
            PE  +   +F+  A  + D+Y+ G+VL EL +
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 87
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++  VY  +    + E ++   R  +R ++ L               L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 148 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRA 202
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 250

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLV 793
           ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 81
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 142 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 196
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 243

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 87  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 139
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 140 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLV 793
           ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 80
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 141 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAP 195
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 242

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++  VY  +    + E ++   R  +R ++ L               L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRA 190
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 20/239 (8%)
Query: 715 ATFQRQLRKLKFSQLIE---------ATNGFSAESLIGCGGFGEVF----KATLKDGSSV 761
           A FQ  L  L F + ++           + F    ++G GGFGEVF    KAT K  +  
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACK 216
Query: 762 AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVL 821
            + K      +G +  M E + L K+  R +V L    +   +  LV   M  G +    
Sbjct: 217 KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR--Y 274
Query: 822 HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVS 881
           H      D                   L  LH     +II+RD+K  NVLLD +   R+S
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRIS 331
Query: 882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           D G+A  + A  T       AGTPG++ PE           D ++ GV L E++  + P
Sbjct: 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 23/235 (9%)
Query: 719 RQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFM 778
           R L ++  S L +    F    L+G G +G+V+K        +A  K++ ++   + E  
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 779 AEMETLGKI-KHRNLVPLLG-YCK-----IGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
            E+  L K   HRN+    G + K     + ++  LV EF   GS+ +++    K     
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGN 124
Query: 832 ILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA 891
            L  +            L  LH +    +IHRD+K  NVLL    E ++ DFG++   + 
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQ 178
Query: 892 LDTHL-SVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRP 940
           LD  +   +T  GTP ++ PE              K D++S G+  +E+  G  P
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 87
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++  VY  +    + E ++   R  +R ++ L               L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 148 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRA 202
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 250

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 741 LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
           ++G G F EVF    +  G   A+K + +     D     E+  L KIKH N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
           +      LV + +  G L + +  R       + T              + +LH N I  
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHENGI-- 127
Query: 860 IIHRDMKSSNVLL---DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
            +HRD+K  N+L    +   +  ++DFG++++    + +  +ST  GTPGYV PE     
Sbjct: 128 -VHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQK 182
Query: 917 RCTAKGDVYSFGVVLLELLTGKRP 940
             +   D +S GV+   LL G  P
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNL 792
            ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 88
Query: 793 VPL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXL 849
           V L   +   GE++  VY  +    + E ++   R  +R ++ L               L
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       
Sbjct: 149 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRA 203
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
           P   + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 204 PELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 251

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R    +  +L   +              + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 143 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 194
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 195 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 20/239 (8%)
Query: 715 ATFQRQLRKLKFSQLIE---------ATNGFSAESLIGCGGFGEVF----KATLKDGSSV 761
           A FQ  L  L F + ++           + F    ++G GGFGEVF    KAT K  +  
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACK 216
Query: 762 AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVL 821
            + K      +G +  M E + L K+  R +V L    +   +  LV   M  G +    
Sbjct: 217 KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR--Y 274
Query: 822 HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVS 881
           H      D                   L  LH     +II+RD+K  NVLLD +   R+S
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRIS 331
Query: 882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           D G+A  + A  T       AGTPG++ PE           D ++ GV L E++  + P
Sbjct: 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLV 793
           ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 112
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 173 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 227
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 274

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRA------KARD--QRILTWDXXXXXXXX 844
            LLG C K G   +++ EF KFG+L   L  +       K  D  +  LT +        
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 845 XXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
               + FL        IHRD+ + N+LL  +   ++ DFG+AR I      +        
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
             ++ PE       T + DV+SFGV+L E+ +
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 74  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEG 126
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 127 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 15/228 (6%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
            ++   +IG G FG V++A L D G  VAIKK++    QG      E++ + K+ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 191
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLV 793
           ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 114
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 175 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 229
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 276

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLV 793
           ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 104
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 165 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 219
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 266

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 86/204 (42%), Gaps = 11/204 (5%)
Query: 741 LIGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           ++G GGFGEVF    KAT K  +   + K      +G +  M E + L K+  R +V L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
              +   +  LV   M  G +    H      D                   L  LH   
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIR--YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR- 308
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
             +II+RD+K  NVLLD +   R+SD G+A  + A  T       AGTPG++ PE     
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGE 364
Query: 917 RCTAKGDVYSFGVVLLELLTGKRP 940
                 D ++ GV L E++  + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLV 793
           ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 171 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 225
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 272

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLV 793
           ++   +IG G FG V++A L D G  VAIKK+++     D+ F   E++ + K+ H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 155
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 216 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 270
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 317

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 20/239 (8%)
Query: 715 ATFQRQLRKLKFSQLIE---------ATNGFSAESLIGCGGFGEVF----KATLKDGSSV 761
           A FQ  L  L F + ++           + F    ++G GGFGEVF    KAT K  +  
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACK 216
Query: 762 AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVL 821
            + K      +G +  M E + L K+  R +V L    +   +  LV   M  G +    
Sbjct: 217 KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR--Y 274
Query: 822 HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVS 881
           H      D                   L  LH     +II+RD+K  NVLLD +   R+S
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRIS 331
Query: 882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           D G+A  + A  T       AGTPG++ PE           D ++ GV L E++  + P
Sbjct: 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 71  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 15/228 (6%)
Query: 735 GFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
            ++   +IG G FG V++A L D G  VAIKK++    QG      E++ + K+ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 794 PL-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   GE++  VY  +    + E ++   R  +R ++ L               L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 191
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
              + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   +D       + VA+K +   +   +R EF+ E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARD---QRILTWDXXXXXXXXXXXXLC 850
           LLG    G+  L+V E M  G L+  L   R +A +   +   T              + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+       +HRD+ + N ++ H+   ++ DFGM R I   D +       G  G +P 
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 196
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   D++SFGVVL E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 742 IGCGGFGEV----FKATLKDGSS--VAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLV 793
           +G G FG+V    +  T  DG+   VA+K L +  C  Q    +  E+E L  + H ++V
Sbjct: 16  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKAL-KEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 794 PLLGYCK-IGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
              G C+  GE+ + LV E++  GSL + L        Q +L               + +
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-------FAQQICEGMAY 126
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VPP 910
           LH     H IHR + + NVLLD++   ++ DFG+A+ +     +  V     +P +   P
Sbjct: 127 LHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 183
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E  +  +     DV+SFGV L ELLT
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 742 IGCGGFGEV----FKATLKDGSS--VAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLV 793
           +G G FG+V    +  T  DG+   VA+K L +  C  Q    +  E+E L  + H ++V
Sbjct: 17  LGEGHFGKVSLYCYDPT-NDGTGEMVAVKAL-KEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 794 PLLGYCK-IGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
              G C+  GE+ + LV E++  GSL + L        Q +L               + +
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-------FAQQICEGMAY 127
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VPP 910
           LH     H IHR + + NVLLD++   ++ DFG+A+ +     +  V     +P +   P
Sbjct: 128 LHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 184
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT 936
           E  +  +     DV+SFGV L ELLT
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 145/319 (45%), Gaps = 49/319 (15%)
Query: 103 LLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT 162
           L+ + ++ N I D+ P  L+N T L  L L  N +    P     L++L RL+LS+N I+
Sbjct: 87  LVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS 142
Query: 163 GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
               S L     SL +L    N +T   P  L++ + L+ LD+S+N +S     SVL  L
Sbjct: 143 DI--SALS-GLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVSDI---SVLAKL 194
Query: 223 GSLESLILSNNMISGSFP--------------------DSISSCKTLRIVDFSSNRVSGI 262
            +LESLI +NN IS   P                     +++S   L  +D ++N++S +
Sbjct: 195 TNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNL 254
Query: 263 IPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHL 322
            P     G++ L EL+L  N I+ + P  L+  T L  ++L+ N L    P  +  L++L
Sbjct: 255 AP---LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNL 307
Query: 323 EQFIAWFNGLEGKIP-PELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELT 381
                +FN +    P   L                S      L + +N+ W+S   N+++
Sbjct: 308 TYLTLYFNNISDISPVSSLTKLQRLFFSNNKVSDVSS-----LANLTNINWLSAGHNQIS 362
Query: 382 GQIPPEFSRLTRLAVLQLG 400
              P   + LTR+   QLG
Sbjct: 363 DLTP--LANLTRIT--QLG 377

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 108/431 (25%), Positives = 173/431 (40%), Gaps = 99/431 (22%)
Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
           ++L ++   +N +T   P  L + + L  + ++NN I+   P   L NL +L  L L NN
Sbjct: 63  NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFNN 117
Query: 234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLS 293
            I+   P  + +   L  ++ SSN +S I       G++SL++L    N +T + P  L+
Sbjct: 118 QITDIDP--LKNLTNLNRLELSSNTISDI---SALSGLTSLQQLSFSSNQVTDLKP--LA 170
Query: 294 ECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXXX 353
             T L+ +D+S N +  S    L KL +LE  IA  N +    P  LG            
Sbjct: 171 NLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGI----------- 215
Query: 354 XXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELG 413
                         +NL+ +SL GN+L  +     + LT L  L L NN+     P  L 
Sbjct: 216 -------------LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LS 258
Query: 414 NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEF 473
             + L  L L +N ++              PL G  +   L    N            + 
Sbjct: 259 GLTKLTELKLGANQISN-----------ISPLAGLTALTNLELNEN------------QL 295
Query: 474 AGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA 533
             I P     I  LK+                    L YL L +N      P  +  +  
Sbjct: 296 EDISP-----ISNLKN--------------------LTYLTLYFNNISDISP--VSSLTK 328
Query: 534 LQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
           LQ L  ++N++S    SSL  L N+    A HN++    P   +NL+ + Q+ L++   T
Sbjct: 329 LQRLFFSNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 384
Query: 594 -GPIPQRGQLS 603
             P+  +  +S
Sbjct: 385 NAPVNYKANVS 395

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R    +  +L   +              + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 204
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVF----KATLKDG--SSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V+    K  +KD   + VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRIL---TWDXXXXXXXXXXXXLC 850
           LLG    G+  L++ E M  G L+  L   R +  +  +L   +              + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N  +  +   ++ DFGM R I   D +       G  G +P 
Sbjct: 140 YLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 191
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   DV+SFGVVL E+ T
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L++ + M FG L + V   +     Q +L W             
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG A+L+ A +             ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   +D       + VA+K +   +   +R EF+ E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARD---QRILTWDXXXXXXXXXXXXLC 850
           LLG    G+  L+V E M  G L+  L   R +A +   +   T              + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+       +HRD+ + N ++ H+   ++ DFGM R I   D +       G  G +P 
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 195
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   D++SFGVVL E+ +
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   +D       + VA+K +   +   +R EF+ E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARD---QRILTWDXXXXXXXXXXXXLC 850
           LLG    G+  L+V E M  G L+  L   R +A +   +   T              + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+       +HRD+ + N ++ H+   ++ DFGM R I   D         G  G +P 
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD-----XXRKGGKGLLPV 196
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   D++SFGVVL E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L++ + M FG L + V   +     Q +L W             
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG A+L+ A +             ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   +D       + VA+K +   +   +R EF+ E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARD---QRILTWDXXXXXXXXXXXXLC 850
           LLG    G+  L+V E M  G L+  L   R +A +   +   T              + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+       +HRD+ + N ++ H+   ++ DFGM R I   D         G  G +P 
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD-----XXRKGGKGLLPV 196
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   D++SFGVVL E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L++ + M FG L + V   +     Q +L W             
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG A+L+ A +             ++
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 145/319 (45%), Gaps = 49/319 (15%)
Query: 103 LLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT 162
           L+ + ++ N I D+ P  L+N T L  L L  N +    P     L++L RL+LS+N I+
Sbjct: 87  LVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS 142
Query: 163 GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
               S L     SL +L    N +T   P  L++ + L+ LD+S+N +S     SVL  L
Sbjct: 143 DI--SALS-GLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDI---SVLAKL 194
Query: 223 GSLESLILSNNMISGSFP--------------------DSISSCKTLRIVDFSSNRVSGI 262
            +LESLI +NN IS   P                     +++S   L  +D ++N++S +
Sbjct: 195 TNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNL 254
Query: 263 IPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHL 322
            P     G++ L EL+L  N I+ + P  L+  T L  ++L+ N L    P  +  L++L
Sbjct: 255 AP---LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNL 307
Query: 323 EQFIAWFNGLEGKIP-PELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELT 381
                +FN +    P   L                S      L + +N+ W+S   N+++
Sbjct: 308 TYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSS-----LANLTNINWLSAGHNQIS 362
Query: 382 GQIPPEFSRLTRLAVLQLG 400
              P   + LTR+   QLG
Sbjct: 363 DLTP--LANLTRIT--QLG 377

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 108/432 (25%), Positives = 172/432 (39%), Gaps = 99/432 (22%)
Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
            ++L ++   +N +T   P  L + + L  + ++NN I+   P   L NL +L  L L N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFN 116
Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
           N I+   P  + +   L  ++ SSN +S I       G++SL++L    N +T + P  L
Sbjct: 117 NQITDIDP--LKNLTNLNRLELSSNTISDI---SALSGLTSLQQLNFSSNQVTDLKP--L 169
Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXX 352
           +  T L+ +D+S N +  S    L KL +LE  IA  N +    P  LG           
Sbjct: 170 ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGI---------- 215
Query: 353 XXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
                          +NL+ +SL GN+L  +     + LT L  L L NN+     P  L
Sbjct: 216 --------------LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--L 257
Query: 413 GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLE 472
              + L  L L +N ++              PL G  +   L    N            +
Sbjct: 258 SGLTKLTELKLGANQISN-----------ISPLAGLTALTNLELNEN------------Q 294
Query: 473 FAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI 532
              I P     I  LK+                    L YL L +N      P  +  + 
Sbjct: 295 LEDISP-----ISNLKN--------------------LTYLTLYFNNISDISP--VSSLT 327
Query: 533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
            LQ L   +N++S    SSL  L N+    A HN++    P   +NL+ + Q+ L++   
Sbjct: 328 KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 383
Query: 593 T-GPIPQRGQLS 603
           T  P+  +  +S
Sbjct: 384 TNAPVNYKANVS 395

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   +D       + VA+K +   +   +R EF+ E   +      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARD---QRILTWDXXXXXXXXXXXXLC 850
           LLG    G+  L+V E M  G L+  L   R +A +   +   T              + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+       +HRD+ + N ++ H+   ++ DFGM R I   D         G  G +P 
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX-----XRKGGKGLLPV 193
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   D++SFGVVL E+ +
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG A+L+ A +             ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSS--------VAIKKLIRLSCQGDREFMAEMETLGKI 787
           F    ++G GG+G+VF+     G++        V  K +I  + +      AE   L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           KH  +V L+   + G +  L+ E++  G L   L        + I   D           
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL------EREGIFMEDTACFYLAEISM 132
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L  LH   I   I+RD+K  N++L+H+   +++DFG+ +   ++       T  GT  Y
Sbjct: 133 ALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEY 187
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           + PE           D +S G ++ ++LTG  P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG A+L+ A +             ++
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG A+L+ A +             ++
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 145/319 (45%), Gaps = 49/319 (15%)
Query: 103 LLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT 162
           L+ + ++ N I D+ P  L+N T L  L L  N +    P     L++L RL+LS+N I+
Sbjct: 87  LVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS 142
Query: 163 GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
               S L     SL +L    N +T   P  L++ + L+ LD+S+N +S     SVL  L
Sbjct: 143 DI--SALS-GLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVSDI---SVLAKL 194
Query: 223 GSLESLILSNNMISGSFP--------------------DSISSCKTLRIVDFSSNRVSGI 262
            +LESLI +NN IS   P                     +++S   L  +D ++N++S +
Sbjct: 195 TNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNL 254
Query: 263 IPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHL 322
            P     G++ L EL+L  N I+ + P  L+  T L  ++L+ N L    P  +  L++L
Sbjct: 255 AP---LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNL 307
Query: 323 EQFIAWFNGLEGKIP-PELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISLTGNELT 381
                +FN +    P   L                S      L + +N+ W+S   N+++
Sbjct: 308 TYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSS-----LANLTNINWLSAGHNQIS 362
Query: 382 GQIPPEFSRLTRLAVLQLG 400
              P   + LTR+   QLG
Sbjct: 363 DLTP--LANLTRIT--QLG 377

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 108/432 (25%), Positives = 172/432 (39%), Gaps = 99/432 (22%)
Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
            ++L ++   +N +T   P  L + + L  + ++NN I+   P   L NL +L  L L N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFN 116
Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
           N I+   P  + +   L  ++ SSN +S I       G++SL++L    N +T + P  L
Sbjct: 117 NQITDIDP--LKNLTNLNRLELSSNTISDI---SALSGLTSLQQLSFSSNQVTDLKP--L 169
Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXX 352
           +  T L+ +D+S N +  S    L KL +LE  IA  N +    P  LG           
Sbjct: 170 ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGI---------- 215
Query: 353 XXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
                          +NL+ +SL GN+L  +     + LT L  L L NN+     P  L
Sbjct: 216 --------------LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--L 257
Query: 413 GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLE 472
              + L  L L +N ++              PL G  +   L    N            +
Sbjct: 258 SGLTKLTELKLGANQISN-----------ISPLAGLTALTNLELNEN------------Q 294
Query: 473 FAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI 532
              I P     I  LK+                    L YL L +N      P  +  + 
Sbjct: 295 LEDISP-----ISNLKN--------------------LTYLTLYFNNISDISP--VSSLT 327
Query: 533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
            LQ L   +N++S    SSL  L N+    A HN++    P   +NL+ + Q+ L++   
Sbjct: 328 KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 383
Query: 593 T-GPIPQRGQLS 603
           T  P+  +  +S
Sbjct: 384 TNAPVNYKANVS 395

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 46/231 (19%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           F    LIG GGFG+VFKA  + DG +  I+++   + + +RE  A    L K+ H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKA----LAKLDHVNIVH 69
Query: 795 LLGYCKIGEER------------------------------LLVYEFMKFGSLEEVLHGR 824
             G C  G +                                +  EF   G+LE+ +  R
Sbjct: 70  YNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 825 AKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG 884
              +  ++L  +              ++H      +IHRD+K SN+ L    + ++ DFG
Sbjct: 129 RGEKLDKVLALELFEQITKGVD----YIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELL 935
              L+++L      +   GT  Y+ PE   S     + D+Y+ G++L ELL
Sbjct: 182 ---LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   +D       + VA+K +   +   +R EF+ E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARD---QRILTWDXXXXXXXXXXXXLC 850
           LLG    G+  L+V E M  G L+  L   R +A +   +   T              + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+       +HRD+ + N ++ H+   ++ DFGM R     D + +     G  G +P 
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETAYYRKGGKGLLPV 196
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   D++SFGVVL E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHRNLVPL 795
           L+G G +G V K   KD G  VAIKK   L    D+      M E++ L +++H NLV L
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH-H 854
           L  CK  +   LV+EF+    L++ L       D +++               + F H H
Sbjct: 90  LEVCKKKKRWYLVFEFVDHTILDD-LELFPNGLDYQVVQ-----KYLFQIINGIGFCHSH 143
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA----LDTHLSVSTLAGTPGYVPP 910
           N    IIHRD+K  N+L+      ++ DFG AR ++A     D  ++      T  Y  P
Sbjct: 144 N----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA------TRWYRAP 193
Query: 911 EYYQSFRCTAKG-DVYSFGVVLLELLTGKR--PTDKD 944
           E         K  DV++ G ++ E+  G+   P D D
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLI-----RLSCQGDREFMAEMETLGKIKH 789
           F    ++G G FG V+K   + +G  V I   I       S + ++E + E   +  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 111 PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 163
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 164 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMA-----EMETLGK 786
           ++ F  +SL+G G +G V  AT K  G  VAIKK+       D+   A     E++ L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----DKPLFALRTLREIKILKH 65
Query: 787 IKHRNLVPLLGYCKIGE-----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXX 841
            KH N++ +    +        E  ++ E M+   L  V+         ++L+ D     
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-------STQMLSDDHIQYF 117
Query: 842 XXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI--SALDTHLSVS 899
                  +  LH +   ++IHRD+K SN+L++   + +V DFG+AR+I  SA D      
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 900 TLAGTPGYVPPEYYQ-------SFRCTAKGDVYSFGVVLLELLTGKRP 940
             +G   YV   +Y+       S + +   DV+S G +L EL   +RP
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 740 SLIGCGGFGEVFKATLK--DGSSVAIK-KLIRLSCQGDRE---FMAEMETLGKIKHRNLV 793
            ++G G FG V +  LK  DG+S+ +  K ++L     RE   F++E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 794 PLLGYCKIGEER-----LLVYEFMKFGSLEE-VLHGRAKARDQRILTWDXXXXXXXXXXX 847
            LLG C     +     +++  FMK+G L   +L+ R +   + I               
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI-PLQTLLKFMVDIAL 158
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            + +L +    + +HRD+ + N +L  +M   V+DFG+++ I + D +           +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
           +  E       T+K DV++FGV + E+ T
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD------------QRILTWDXXXX 840
            LLG C K G   +++ EF KFG+L   L  R+K  +            +  LT +    
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FL        IHRD+ + N+LL  +   ++ DFG+AR I     ++    
Sbjct: 190 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ +
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++  G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L++ + M FG L + V   +     Q +L W             
Sbjct: 84  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++  G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD------------QRILTWDXXXX 840
            LLG C K G   +++ EF KFG+L   L  R+K  +            +  LT +    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FL        IHRD+ + N+LL  +   ++ DFG+AR I     ++    
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD------------QRILTWDXXXX 840
            LLG C K G   +++ EF KFG+L   L  R+K  +            +  LT +    
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FL        IHRD+ + N+LL  +   ++ DFG+AR I     ++    
Sbjct: 155 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ +
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKH 789
           F    ++  G FG V+K   + +G  V I   I+      S + ++E + E   +  + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
            ++  LLG C     +L+  + M FG L + V   +     Q +L W             
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + +L       ++HRD+ + NVL+      +++DFG+A+L+ A +             ++
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTD 942
             E       T + DV+S+GV + EL+T G +P D
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   +D       + VA+K +   +   +R EF+ E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARD---QRILTWDXXXXXXXXXXXXLC 850
           LLG    G+  L+V E M  G L+  L   R +A +   +   T              + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+       +HR++ + N ++ H+   ++ DFGM R I   D +       G  G +P 
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 196
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   D++SFGVVL E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
           H +++ L+   +      LV++ M+ G L + L  +        L+              
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEA 212
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           + FLH N   +I+HRD+K  N+LLD  M+ R+SDFG +     L+    +  L GTPGY+
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS---CHLEPGEKLRELCGTPGYL 266
Query: 909 PPEYYQ-SFRCTAKG-----DVYSFGVVLLELLTGKRP 940
            PE  + S   T  G     D+++ GV+L  LL G  P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 15/227 (6%)
Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           ++   +IG G FG V++A L D G  VAIKK++    QG      E++ + K+ H N+V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVR 77
Query: 795 L-LGYCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           L   +   GE++  VY  +    +   ++   R  +R ++ L               L +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           +H      I HRD+K  N+LLD +    ++ DFG A+ +  +    +VS +       P 
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPE 192
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM 957
             + +   T+  DV+S G VL ELL G+ P    D G   LV  +K+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVPL 795
           +G G FG+V    L +  S  ++++I+ +   DR      +  AE+E L  + H N++ +
Sbjct: 30  LGSGAFGDVH---LVEERSSGLERVIK-TINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 796 LGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
               +      +V E  + G L E ++  +A+ +    L+              L + H 
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGK---ALSEGYVAELMKQMMNALAYFHS 142
Query: 855 NCIPHIIHRDMKSSNVLLDH---EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
               H++H+D+K  N+L          ++ DFG+A L  + D H   +  AGT  Y+ PE
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEH--STNAAGTALYMAPE 196
Query: 912 YYQ---SFRCTAKGDVYSFGVVLLELLTGKRP 940
            ++   +F+C    D++S GVV+  LLTG  P
Sbjct: 197 VFKRDVTFKC----DIWSAGVVMYFLLTGCLP 224

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   +D       + VA+K +   +   +R EF+ E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARD---QRILTWDXXXXXXXXXXXXLC 850
           LLG    G+  L+V E M  G L+  L   R +A +   +   T              + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+       +HR++ + N ++ H+   ++ DFGM R I   D +       G  G +P 
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 197
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE  +    T   D++SFGVVL E+ +
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREF---MAEMETLGKIKHRN 791
           FS    IG G FG V+ A  +++   VAIKK+     Q + ++   + E+  L K++H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 792 LVPLLGYCKIGEER-LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
            +   G C + E    LV E+   GS  ++L    K   +  +               L 
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLA 168
Query: 851 FLH-HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           +LH HN    +IHRD+K+ N+LL      ++ DFG A +++        +   GTP ++ 
Sbjct: 169 YLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMA 218
Query: 910 PEYYQSF---RCTAKGDVYSFGVVLLELLTGKRP 940
           PE   +    +   K DV+S G+  +EL   K P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD-----------QRILTWDXXXXX 841
            LLG C K G   +++ EF KFG+L   L  R+K  +           +  LT +     
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 842 XXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
                  + FL        IHRD+ + N+LL  +   ++ DFG+AR I      +     
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 902 AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                ++ PE       T + DV+SFGV+L E+ +
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD------------QRILTWDXXXX 840
            LLG C K G   +++ EF KFG+L   L  R+K  +            +  LT +    
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FL        IHRD+ + N+LL  +   ++ DFG+AR I     ++    
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ +
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 211 KSSDLWALGCIIYQLVAGLPP 231

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD------------QRILTWDXXXX 840
            LLG C K G   +++ EF KFG+L   L  R+K  +            +  LT +    
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FL        IHRD+ + N+LL  +   ++ DFG+AR I     ++    
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ +
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREF---MAEMETLGKIKHRN 791
           FS    IG G FG V+ A  +++   VAIKK+     Q + ++   + E+  L K++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 792 LVPLLGYCKIGEER-LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
            +   G C + E    LV E+   GS  ++L    K   +  +               L 
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLA 129
Query: 851 FLH-HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           +LH HN    +IHRD+K+ N+LL      ++ DFG A +++        +   GTP ++ 
Sbjct: 130 YLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMA 179
Query: 910 PEYYQSF---RCTAKGDVYSFGVVLLELLTGKRP 940
           PE   +    +   K DV+S G+  +EL   K P
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 14/207 (6%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKHRNLV 793
           F+    IG G FGEV+K        V   K+I L    D     + E   L +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
              G      +  ++ E++  GS  ++L       +  I T              L +LH
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKP-GPLEETYIAT------ILREILKGLDYLH 133
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                  IHRD+K++NVLL  + + +++DFG+A  ++  DT +  +   GTP ++ PE  
Sbjct: 134 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 188
Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +      K D++S G+  +EL  G+ P
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 213 KSSDLWALGCIIYQLVAGLPP 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 211 KSSDLWALGCIIYQLVAGLPP 231

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 188 KSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 211 KSSDLWALGCIIYQLVAGLPP 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 190 KSSDLWALGCIIYQLVAGLPP 210

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 195 KSSDLWALGCIIYQLVAGLPP 215

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 189 KSSDLWALGCIIYQLVAGLPP 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 210 KSSDLWALGCIIYQLVAGLPP 230

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSS--------VAIKKLIRLSCQGDREFMAEMETLGKI 787
           F    ++G GG+G+VF+     G++        V  K +I  + +      AE   L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
           KH  +V L+   + G +  L+ E++  G L   L        + I   D           
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL------EREGIFMEDTACFYLAEISM 132
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L  LH   I   I+RD+K  N++L+H+   +++DFG+ +   ++          GT  Y
Sbjct: 133 ALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEY 187
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           + PE           D +S G ++ ++LTG  P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD------------QRILTWDXXXX 840
            LLG C K G   +++ EF KFG+L   L  R+K  +            +  LT +    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FL        IHRD+ + N+LL  +   ++ DFG+AR I      +    
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 191 KSSDLWALGCIIYQLVAGLPP 211

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD------------QRILTWDXXXX 840
            LLG C K G   +++ EF KFG+L   L  R+K  +            +  LT +    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FL        IHRD+ + N+LL  +   ++ DFG+AR I      +    
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD------------QRILTWDXXXX 840
            LLG C K G   +++ EF KFG+L   L  R+K  +            +  LT +    
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FL        IHRD+ + N+LL  +   ++ DFG+AR I      +    
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ +
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMA-----EMETLGK 786
           ++ F  +SL+G G +G V  AT K  G  VAIKK+       D+   A     E++ L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----DKPLFALRTLREIKILKH 65
Query: 787 IKHRNLVPLLGYCKIGE-----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXX 841
            KH N++ +    +        E  ++ E M+   L  V+         ++L+ D     
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-------STQMLSDDHIQYF 117
Query: 842 XXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI--SALDTHLSVS 899
                  +  LH +   ++IHRD+K SN+L++   + +V DFG+AR+I  SA D      
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 900 TLAGTPGYVPPEYYQ-------SFRCTAKGDVYSFGVVLLELLTGKRP 940
             +G   +V   +Y+       S + +   DV+S G +L EL   +RP
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 124
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 125 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-----FMAEMETLGKIKHRNLVPL 795
           IG G FGEVFKA   K G  VA+KK++    + ++E      + E++ L  +KH N+V L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 796 LGYCKIGEERL--------LVYEFMKF---GSLEEVLHGRAKARDQRILTWDXXXXXXXX 844
           +  C+              LV++F +    G L  VL     +  +R++           
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ---------M 133
Query: 845 XXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL--SVSTLA 902
               L ++H N    I+HRDMK++NVL+  +   +++DFG+AR  S              
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 903 GTPGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLT 936
            T  Y PPE     R      D++  G ++ E+ T
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 33/221 (14%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
           +G G +G V+K+   + G  VA+KK+    + S    R F   M       H N+V LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
             +   +R +   ++ F  +E  LH   +A    IL               + +LH   +
Sbjct: 77  VLRADNDRDV---YLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARL---ISALDTHLSVSTLAGTPG-------- 906
              +HRDMK SN+LL+ E   +V+DFG++R    I  +  ++ +S    T          
Sbjct: 131 ---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 907 --YVPPEYYQ-------SFRCTAKGDVYSFGVVLLELLTGK 938
             YV   +Y+       S + T   D++S G +L E+L GK
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 742 IGCGGFGEVFKA------TLKDGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NLV 793
           +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKARD------------QRILTWDXXXX 840
            LLG C K G   +++ EF KFG+L   L  R+K  +            +  LT +    
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FL        IHRD+ + N+LL  +   ++ DFG+AR I      +    
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
                 ++ PE       T + DV+SFGV+L E+ +
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIR-LSCQGDREFMAEMET--LGKIKHRNLVPLLG 797
           +G G FG+V  AT  K    VA+K + R L  + D     E E   L  ++H +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCI 857
                 + ++V E+      + ++  +    D+                  +C + +   
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDE----------GRRFFQQIICAIEYCHR 126
Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-SF 916
             I+HRD+K  N+LLD  +  +++DFG++ +++  D +  + T  G+P Y  PE      
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNF-LKTSCGSPNYAAPEVINGKL 183
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDF 946
               + DV+S G+VL  +L G+ P D D+F
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFD-DEF 212

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 731 EATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-----FMAEMETL 784
           +  + +   + IG G FGEVFKA   K G  VA+KK++    + ++E      + E++ L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKIL 71
Query: 785 GKIKHRNLVPLLGYCKIGEERL--------LVYEFMKF---GSLEEVLHGRAKARDQRIL 833
             +KH N+V L+  C+              LV++F +    G L  VL     +  +R++
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 131
Query: 834 TWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD 893
                          L ++H N    I+HRDMK++NVL+  +   +++DFG+AR  S   
Sbjct: 132 Q---------MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 894 THL--SVSTLAGTPGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLT 936
                       T  Y PPE     R      D++  G ++ E+ T
Sbjct: 180 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 731 EATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-----FMAEMETL 784
           +  + +   + IG G FGEVFKA   K G  VA+KK++    + ++E      + E++ L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKIL 71
Query: 785 GKIKHRNLVPLLGYCKIGEERL--------LVYEFMKF---GSLEEVLHGRAKARDQRIL 833
             +KH N+V L+  C+              LV++F +    G L  VL     +  +R++
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 131
Query: 834 TWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD 893
                          L ++H N    I+HRDMK++NVL+  +   +++DFG+AR  S   
Sbjct: 132 Q---------MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 894 THL--SVSTLAGTPGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLT 936
                       T  Y PPE     R      D++  G ++ E+ T
Sbjct: 180 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 17/220 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSS-VAIKKLIRLSCQGD---REFMAEMETLGKIKH 789
           + F     +G G FG V+ A  K     VA+K L +   + +    +   E+E    + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
            N++ L  Y        L+ E+   G L + L       +QR  T              L
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTAT------IMEELADAL 136
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            + H      +IHRD+K  N+LL  + E +++DFG     S     L   T+ GT  Y+P
Sbjct: 137 MYCHGK---KVIHRDIKPENLLLGLKGELKIADFGW----SVHAPSLRRKTMCGTLDYLP 189
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           PE  +      K D++  GV+  ELL G  P +     +T
Sbjct: 190 PEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNET 229

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 23/219 (10%)
Query: 736 FSAESLIGCGGFGEV-FKATLKDGSSVA---IKKLIRLSCQGDREFMAEMETLGKIKHRN 791
           F     +G G FG V    +  +G   A   +KK I +  +       E   L  + H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           ++ + G  +  ++  ++ ++++ G L  +L      + QR                 L +
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPN-PVAKFYAAEVCLALEY 121
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           LH      II+RD+K  N+LLD     +++DFG A+ +  +        L GTP Y+ PE
Sbjct: 122 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYXLCGTPDYIAPE 173
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
              +       D +SFG+++ E+L G  P     F D+N
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTP-----FYDSN 207

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 724 LKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD---REFMAE 780
           L F  L+E          +G G +G V+KA    G  VA+K+ IRL  + +      + E
Sbjct: 14  LYFQGLMEKYQKLEK---VGEGTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIRE 69
Query: 781 METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDXXX 839
           +  L ++ H N+V L+          LV+EFM+   L++VL   +   +D +I  +    
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIY---- 124
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS---ALDTHL 896
                     C  H      I+HRD+K  N+L++ +   +++DFG+AR         TH 
Sbjct: 125 LYQLLRGVAHCHQHR-----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            V+     P  +      S + +   D++S G +  E++TGK
Sbjct: 180 VVTLWYRAPDVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 124
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 125 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 125
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 126 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 724 LKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD---REFMAE 780
           L F  L+E          +G G +G V+KA    G  VA+K+ IRL  + +      + E
Sbjct: 14  LYFQGLMEKYQKLEK---VGEGTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIRE 69
Query: 781 METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDXXX 839
           +  L ++ H N+V L+          LV+EFM+   L++VL   +   +D +I  +    
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIY---- 124
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS---ALDTHL 896
                     C  H      I+HRD+K  N+L++ +   +++DFG+AR         TH 
Sbjct: 125 LYQLLRGVAHCHQHR-----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            V+     P  +      S + +   D++S G +  E++TGK
Sbjct: 180 VVTLWYRAPDVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 52/88 (59%), Gaps = 6/88 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY--YQSFR 917
           II+RD+K  NV+LD E   +++DFGM +    +   ++     GTP Y+ PE   YQ + 
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 199
Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDD 945
            +   D ++FGV+L E+L G+ P + +D
Sbjct: 200 KSV--DWWAFGVLLYEMLAGQAPFEGED 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 46/81 (56%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        ++  GT  YV PE       +
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 213 KSSDLWALGCIIYQLVAGLPP 233

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 54/299 (18%)
Query: 709 PLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLI 767
           PL  +++ + + LR           + +     +G G  GEV  A   K    VAIK + 
Sbjct: 2   PLGSHMSVYPKALR-----------DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS 50
Query: 768 R--LSCQGDRE------FMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEE 819
           +   +    RE         E+E L K+ H  ++ +  +    E+  +V E M+ G L +
Sbjct: 51  KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFD 109
Query: 820 VLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEME-- 877
            + G  + ++     +             + +LH N    IIHRD+K  NVLL  + E  
Sbjct: 110 KVVGNKRLKEATCKLY------FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDC 160
Query: 878 -ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKG---DVYSFGVVLLE 933
             +++DFG ++++   +T L + TL GTP Y+ PE   S          D +S GV+L  
Sbjct: 161 LIKITDFGHSKILG--ETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 217
Query: 934 LLTGKRP----------TDKDDFGDTNLVGWVKMKVREG-----KQMEVIDPELLLVTK 977
            L+G  P           D+   G  N +  V  +V E      K++ V+DP+    T+
Sbjct: 218 CLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 276

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 731 EATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-----FMAEMETL 784
           +  + +   + IG G FGEVFKA   K G  VA+KK++    + ++E      + E++ L
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKIL 70
Query: 785 GKIKHRNLVPLLGYCKIGEERL--------LVYEFMKF---GSLEEVLHGRAKARDQRIL 833
             +KH N+V L+  C+              LV++F +    G L  VL     +  +R++
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 834 TWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD 893
                          L ++H N    I+HRDMK++NVL+  +   +++DFG+AR  S   
Sbjct: 131 Q---------MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 894 THL--SVSTLAGTPGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLT 936
                       T  Y PPE     R      D++  G ++ E+ T
Sbjct: 179 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 52/88 (59%), Gaps = 6/88 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY--YQSFR 917
           II+RD+K  NV+LD E   +++DFGM +    +   ++     GTP Y+ PE   YQ + 
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 520
Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDD 945
            +   D ++FGV+L E+L G+ P + +D
Sbjct: 521 KSV--DWWAFGVLLYEMLAGQAPFEGED 546

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 734 NGFSAESLIGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH 789
           N F    L+G G FG+V     KAT +  +   +KK + ++       + E   L   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             L  L    +  +    V E+   G L    H       +R+ + D            L
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFYGAEIVSAL 261
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH     ++++RD+K  N++LD +   +++DFG+ +    +    ++ T  GTP Y+ 
Sbjct: 262 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 317
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +        D +  GVV+ E++ G+ P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 123
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 734 NGFSAESLIGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH 789
           N F    L+G G FG+V     KAT +  +   +KK + ++       + E   L   +H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             L  L    +  +    V E+   G L    H       +R+ + D            L
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFYGAEIVSAL 264
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH     ++++RD+K  N++LD +   +++DFG+ +    +    ++ T  GTP Y+ 
Sbjct: 265 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 320
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +        D +  GVV+ E++ G+ P
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 742 IGCGGFGEVFKA--TLKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G GG   V+ A  T+ +   VAIK +    R   +  + F  E+    ++ H+N+V ++
Sbjct: 19  LGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
              +  +   LV E+++  +L E +           + +             L  + H  
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINF---------TNQILDGIKHAH 128
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGTPGYVPPEYYQS 915
              I+HRD+K  N+L+D     ++ DFG+A+ +S  +T L+ +  + GT  Y  PE  + 
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 916 FRCTAKGDVYSFGVVLLELLTGKRP 940
                  D+YS G+VL E+L G+ P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 27/239 (11%)
Query: 709 PLSINVATFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKL 766
           P+S    TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL
Sbjct: 2   PMSQERPTFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 57
Query: 767 IR--LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR 824
            R   S    +    E+  L  +KH N++ LL                +F  +  V H  
Sbjct: 58  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLM 111
Query: 825 AKARDQRI----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV 880
               +  +    LT D            L ++H      IIHRD+K SN+ ++ + E ++
Sbjct: 112 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI 168
Query: 881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
            DFG+AR      T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 169 LDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 125
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 126 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 125
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 126 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 122
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 125
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 126 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 43/266 (16%)
Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSCQGDRE------FMAEMETLGKIKHRNL 792
           +G G  GEV  A   K    VAIK + +   +    RE         E+E L K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
           + +  +    E+  +V E M+ G L + + G  + ++     +             + +L
Sbjct: 78  IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY------FYQMLLAVQYL 130
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           H N    IIHRD+K  NVLL  + E    +++DFG ++++   +T L + TL GTP Y+ 
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL-MRTLCGTPTYLA 184
Query: 910 PEYYQSFRCTAKG---DVYSFGVVLLELLTGKRP----------TDKDDFGDTNLVGWVK 956
           PE   S          D +S GV+L   L+G  P           D+   G  N +  V 
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 957 MKVREG-----KQMEVIDPELLLVTK 977
            +V E      K++ V+DP+    T+
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTE 270

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 43/266 (16%)
Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSCQGDRE------FMAEMETLGKIKHRNL 792
           +G G  GEV  A   K    VAIK + +   +    RE         E+E L K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
           + +  +    E+  +V E M+ G L + + G  + ++     +             + +L
Sbjct: 78  IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY------FYQMLLAVQYL 130
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           H N    IIHRD+K  NVLL  + E    +++DFG ++++   +T L + TL GTP Y+ 
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL-MRTLCGTPTYLA 184
Query: 910 PEYYQSFRCTAKG---DVYSFGVVLLELLTGKRP----------TDKDDFGDTNLVGWVK 956
           PE   S          D +S GV+L   L+G  P           D+   G  N +  V 
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 957 MKVREG-----KQMEVIDPELLLVTK 977
            +V E      K++ V+DP+    T+
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTE 270

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMA-----EMETLGK 786
           ++ F  +SL+G G +G V  AT K  G  VAIKK+       D+   A     E++ L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----DKPLFALRTLREIKILKH 65
Query: 787 IKHRNLVPLLGYCKIGE-----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXX 841
            KH N++ +    +        E  ++ E M+   L  V+         ++L+ D     
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-------STQMLSDDHIQYF 117
Query: 842 XXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI--SALDTHLSVS 899
                  +  LH +   ++IHRD+K SN+L++   + +V DFG+AR+I  SA D      
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 900 TLAGTPGYVPPEYYQ-------SFRCTAKGDVYSFGVVLLELLTGKRP 940
             +G    V   +Y+       S + +   DV+S G +L EL   +RP
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 43/266 (16%)
Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSCQGDRE------FMAEMETLGKIKHRNL 792
           +G G  GEV  A   K    VAIK + +   +    RE         E+E L K+ H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
           + +  +    E+  +V E M+ G L + + G  + ++     +             + +L
Sbjct: 77  IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY------FYQMLLAVQYL 129
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           H N    IIHRD+K  NVLL  + E    +++DFG ++++   +T L + TL GTP Y+ 
Sbjct: 130 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL-MRTLCGTPTYLA 183
Query: 910 PEYYQSFRCTAKG---DVYSFGVVLLELLTGKRP----------TDKDDFGDTNLVGWVK 956
           PE   S          D +S GV+L   L+G  P           D+   G  N +  V 
Sbjct: 184 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 243
Query: 957 MKVREG-----KQMEVIDPELLLVTK 977
            +V E      K++ V+DP+    T+
Sbjct: 244 AEVSEKALDLVKKLLVVDPKARFTTE 269

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 43/266 (16%)
Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSCQGDRE------FMAEMETLGKIKHRNL 792
           +G G  GEV  A   K    VAIK + +   +    RE         E+E L K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
           + +  +    E+  +V E M+ G L + + G  + ++     +             + +L
Sbjct: 78  IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY------FYQMLLAVQYL 130
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           H N    IIHRD+K  NVLL  + E    +++DFG ++++   +T L + TL GTP Y+ 
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL-MRTLCGTPTYLA 184
Query: 910 PEYYQSFRCTAKG---DVYSFGVVLLELLTGKRP----------TDKDDFGDTNLVGWVK 956
           PE   S          D +S GV+L   L+G  P           D+   G  N +  V 
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 957 MKVREG-----KQMEVIDPELLLVTK 977
            +V E      K++ V+DP+    T+
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTE 270

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 123
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 124 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 124
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 125 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 93/340 (27%), Positives = 149/340 (43%), Gaps = 64/340 (18%)
Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
            N+L  ++ S N + D+ P  L N TKL  + ++ N +A   P     L++L  L L NN
Sbjct: 66  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 121
Query: 160 HITGWIPSELGNACDSLLELKLPHNNITG-------------SF--PVT----LSSCSWL 200
            IT   P  L N  + L  L+L  N I+              SF   VT    L++ + L
Sbjct: 122 QITDIDP--LKNLTN-LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 178
Query: 201 QLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP-------------------- 240
           + LD+S+N +S     SVL  L +LESLI +NN IS   P                    
Sbjct: 179 ERLDISSNKVSDI---SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI 235
Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
            +++S   L  +D ++N++S + P     G++ L EL+L  N I+ + P  L+  T L  
Sbjct: 236 GTLASLTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP--LAGLTALTN 290
Query: 301 IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEI 360
           ++L+ N L    P  +  L++L     +FN +    P                       
Sbjct: 291 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP----VSSLTKLQRLFFANNKVSD 344
Query: 361 PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG 400
            + L + +N+ W+S   N+++   P   + LTR+   QLG
Sbjct: 345 VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT--QLG 380

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 109/432 (25%), Positives = 173/432 (40%), Gaps = 100/432 (23%)
Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
            ++L ++   +N +T   P  L + + L  + ++NN I+   P   L NL +L  L L N
Sbjct: 66  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFN 120
Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
           N I+   P  + +   L  ++ SSN +S I       G++SL++L    N +T + P  L
Sbjct: 121 NQITDIDP--LKNLTNLNRLELSSNTISDI---SALSGLTSLQQLSF-GNQVTDLKP--L 172
Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXX 352
           +  T L+ +D+S N +  S    L KL +LE  IA  N +    P  LG           
Sbjct: 173 ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGI---------- 218
Query: 353 XXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
                          +NL+ +SL GN+L  +     + LT L  L L NN+     P  L
Sbjct: 219 --------------LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--L 260
Query: 413 GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLE 472
              + L  L L +N ++              PL G  +   L    N            +
Sbjct: 261 SGLTKLTELKLGANQISN-----------ISPLAGLTALTNLELNEN------------Q 297
Query: 473 FAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI 532
              I P     I  LK+                    L YL L +N      P  +  + 
Sbjct: 298 LEDISP-----ISNLKN--------------------LTYLTLYFNNISDISP--VSSLT 330
Query: 533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
            LQ L  A+N++S    SSL  L N+    A HN++    P   +NL+ + Q+ L++   
Sbjct: 331 KLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 386
Query: 593 T-GPIPQRGQLS 603
           T  P+  +  +S
Sbjct: 387 TNAPVNYKANVS 398

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 124
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 125 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIR----LSCQGDREFMAEMETLGK-IKHR 790
           F    +IG G FG+V  A  K        K+++    L  + ++  M+E   L K +KH 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
            LV L    +  ++   V +++  G L   L      + +R                 L 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHL------QRERCFLEPRARFYAAEIASALG 153
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           +LH     +I++RD+K  N+LLD +    ++DFG+ +    ++ + + ST  GTP Y+ P
Sbjct: 154 YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAP 208
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E           D +  G VL E+L G  P
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 93/340 (27%), Positives = 149/340 (43%), Gaps = 64/340 (18%)
Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
            N+L  ++ S N + D+ P  L N TKL  + ++ N +A   P     L++L  L L NN
Sbjct: 67  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122
Query: 160 HITGWIPSELGNACDSLLELKLPHNNITG-------------SF--PVT----LSSCSWL 200
            IT   P  L N  + L  L+L  N I+              SF   VT    L++ + L
Sbjct: 123 QITDIDP--LKNLTN-LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 179
Query: 201 QLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP-------------------- 240
           + LD+S+N +S     SVL  L +LESLI +NN IS   P                    
Sbjct: 180 ERLDISSNKVSDI---SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI 236
Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
            +++S   L  +D ++N++S + P     G++ L EL+L  N I+ + P  L+  T L  
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP--LAGLTALTN 291
Query: 301 IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEI 360
           ++L+ N L    P  +  L++L     +FN +    P                       
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP----VSSLTKLQRLFFYNNKVSD 345
Query: 361 PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG 400
            + L + +N+ W+S   N+++   P   + LTR+   QLG
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT--QLG 381

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 108/432 (25%), Positives = 172/432 (39%), Gaps = 100/432 (23%)
Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
            ++L ++   +N +T   P  L + + L  + ++NN I+   P   L NL +L  L L N
Sbjct: 67  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFN 121
Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
           N I+   P  + +   L  ++ SSN +S I       G++SL++L    N +T + P  L
Sbjct: 122 NQITDIDP--LKNLTNLNRLELSSNTISDI---SALSGLTSLQQLSF-GNQVTDLKP--L 173
Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXX 352
           +  T L+ +D+S N +  S    L KL +LE  IA  N +    P  LG           
Sbjct: 174 ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGI---------- 219
Query: 353 XXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
                          +NL+ +SL GN+L  +     + LT L  L L NN+     P  L
Sbjct: 220 --------------LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--L 261
Query: 413 GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLE 472
              + L  L L +N ++              PL G  +   L    N            +
Sbjct: 262 SGLTKLTELKLGANQISN-----------ISPLAGLTALTNLELNEN------------Q 298
Query: 473 FAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI 532
              I P     I  LK+                    L YL L +N      P  +  + 
Sbjct: 299 LEDISP-----ISNLKN--------------------LTYLTLYFNNISDISP--VSSLT 331
Query: 533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
            LQ L   +N++S    SSL  L N+    A HN++    P   +NL+ + Q+ L++   
Sbjct: 332 KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 593 T-GPIPQRGQLS 603
           T  P+  +  +S
Sbjct: 388 TNAPVNYKANVS 399

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 740 SLIGCGGFGEVFKA---TLKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           S +G G FG V       L D  G+ VA+K+L        R+F  E++ L  +    +V 
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 795 LLG--YCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCF 851
             G  Y     E  LV E++  G L + L   RA+    R+L +             +C 
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ----------ICK 122
Query: 852 -LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
            + +      +HRD+ + N+L++ E   +++DFG+A+L+  LD    V      PG  P 
Sbjct: 123 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDXXV---VREPGQSPI 178
Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT 936
               PE       + + DV+SFGVVL EL T
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/307 (21%), Positives = 125/307 (40%), Gaps = 41/307 (13%)
Query: 720  QLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQG 773
            Q ++ K  ++  +   F  E  +G   FG+V+K  L      +   +VAIK L +   +G
Sbjct: 14   QHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEG 70
Query: 774  --DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
                EF  E     +++H N+V LLG     +   +++ +   G L E L  R+   D  
Sbjct: 71   PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 130
Query: 832  ILTWDXXXXXXXXXXXXLCF-------LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG 884
                D            +         + +    H++H+D+ + NVL+  ++  ++SD G
Sbjct: 131  STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 190
Query: 885  MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
            + R + A D +  +        ++ PE     + +   D++S+GVVL E+ +        
Sbjct: 191  LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-------- 242
Query: 945  DFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDF 1004
             +G     G+    V E  +   + P         D+  A     M+       +C ++F
Sbjct: 243  -YGLQPYCGYSNQDVVEMIRNRQVLP-------CPDDCPAWVYALMI-------ECWNEF 287
Query: 1005 PSKRPNM 1011
            PS+RP  
Sbjct: 288  PSRRPRF 294

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 17/245 (6%)
Query: 735 GFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRNLV 793
            ++   +IG G FG VF+A L +   VAIKK+++     D+ F   E++ +  +KH N+V
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVV 95
Query: 794 PLLG-YCKIGEERLLVYEFMKFGSLEEVLH--GRAKARDQRILTWDXXXXXXXXXXXXLC 850
            L   +   G+++  V+  +    + E ++   R  A+ ++ +               L 
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H      I HRD+K  N+LLD      ++ DFG A+++ A +   +VS +       P
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSXICSRYYRAP 210
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK-MKVREGKQMEVI 968
              + +   T   D++S G V+ EL+ G+ P    + G   LV  +K +     +Q++ +
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTM 269
Query: 969 DPELL 973
           +P  +
Sbjct: 270 NPNYM 274

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 738 AESLIGCGGFGEVFKATLKDGSS----VAIKKLIRLS-CQGDREFMAEMETLGKIKHRNL 792
           ++ +IG G FG V+     D +      AIK L R++  Q    F+ E   +  + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 793 VPLLGYCKIGEERL--LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           + L+G   +  E L  ++  +M  G L + +        QR  T              + 
Sbjct: 85  LALIG-IMLPPEGLPHVLLPYMCHGDLLQFIRS-----PQRNPTVKDLISFGLQVARGME 138
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD-THLSVSTL--AGTP-G 906
           +L        +HRD+ + N +LD     +V+DFG+AR I  LD  + SV     A  P  
Sbjct: 139 YLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVK 193
Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +   E  Q++R T K DV+SFGV+L ELLT   P
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 45/81 (55%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        ++  GT  YV PE        
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 214 KSSDLWALGCIIYQLVAGLPP 234

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 740 SLIGCGGFGEVFKA---TLKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           S +G G FG V       L D  G+ VA+K+L        R+F  E++ L  +    +V 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 795 LLG--YCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCF 851
             G  Y    +   LV E++  G L + L   RA+    R+L +             +C 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ----------ICK 138
Query: 852 -LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VP 909
            + +      +HRD+ + N+L++ E   +++DFG+A+L+     +  V     +P +   
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLT 936
           PE       + + DV+SFGVVL EL T
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 122
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 123
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 45/81 (55%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        ++  GT  YV PE        
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 210 KSSDLWALGCIIYQLVAGLPP 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 740 SLIGCGGFGEVFKA---TLKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           S +G G FG V       L D  G+ VA+K+L        R+F  E++ L  +    +V 
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 795 LLG--YCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCF 851
             G  Y    +   LV E++  G L + L   RA+    R+L +             +C 
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ----------ICK 125
Query: 852 -LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VP 909
            + +      +HRD+ + N+L++ E   +++DFG+A+L+     +  V     +P +   
Sbjct: 126 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 185
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLT 936
           PE       + + DV+SFGVVL EL T
Sbjct: 186 PESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 740 SLIGCGGFGEVFKA---TLKD--GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           S +G G FG V       L D  G+ VA+K+L        R+F  E++ L  +    +V 
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 795 LLG--YCKIGEERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCF 851
             G  Y    +   LV E++  G L + L   RA+    R+L +             +C 
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ----------ICK 126
Query: 852 -LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VP 909
            + +      +HRD+ + N+L++ E   +++DFG+A+L+     +  V     +P +   
Sbjct: 127 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 186
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLT 936
           PE       + + DV+SFGVVL EL T
Sbjct: 187 PESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 91/341 (26%), Positives = 148/341 (43%), Gaps = 66/341 (19%)
Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
            N+L  ++ S N + D+ P  L N TKL  + ++ N +A   P     L++L  L L NN
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 160 HITGWIPSELGNACDSLLELKLPHNNITGSFPVT-------------------LSSCSWL 200
            IT   P  L N  + L  L+L  N I+    ++                   L++ + L
Sbjct: 118 QITDIDP--LKNLTN-LNRLELSSNTISDISALSGLTSLQQLNFGNQVTDLKPLANLTTL 174
Query: 201 QLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP-------------------- 240
           + LD+S+N +S     SVL  L +LESLI +NN IS   P                    
Sbjct: 175 ERLDISSNKVSDI---SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI 231
Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
            +++S   L  +D ++N++S + P     G++ L EL+L  N I+ + P  L+  T L  
Sbjct: 232 GTLASLTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP--LAGLTALTN 286
Query: 301 IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIP-PELGXXXXXXXXXXXXXXXSGE 359
           ++L+ N L    P  +  L++L     +FN +    P   L                S  
Sbjct: 287 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFSNNKVSDVSS- 343
Query: 360 IPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG 400
               L + +N+ W+S   N+++   P   + LTR+   QLG
Sbjct: 344 ----LANLTNINWLSAGHNQISDLTP--LANLTRIT--QLG 376

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 108/432 (25%), Positives = 173/432 (40%), Gaps = 100/432 (23%)
Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
            ++L ++   +N +T   P  L + + L  + ++NN I+   P   L NL +L  L L N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFN 116
Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
           N I+   P  + +   L  ++ SSN +S I       G++SL++L    N +T + P  L
Sbjct: 117 NQITDIDP--LKNLTNLNRLELSSNTISDI---SALSGLTSLQQLNF-GNQVTDLKP--L 168
Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXX 352
           +  T L+ +D+S N +  S    L KL +LE  IA  N +    P  LG           
Sbjct: 169 ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGI---------- 214
Query: 353 XXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
                          +NL+ +SL GN+L  +     + LT L  L L NN+     P  L
Sbjct: 215 --------------LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--L 256
Query: 413 GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLE 472
              + L  L L +N ++              PL G  +   L    N            +
Sbjct: 257 SGLTKLTELKLGANQISN-----------ISPLAGLTALTNLELNEN------------Q 293
Query: 473 FAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI 532
              I P     I  LK+                    L YL L +N      P  +  + 
Sbjct: 294 LEDISP-----ISNLKN--------------------LTYLTLYFNNISDISP--VSSLT 326
Query: 533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
            LQ L  ++N++S    SSL  L N+    A HN++    P   +NL+ + Q+ L++   
Sbjct: 327 KLQRLFFSNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 382
Query: 593 T-GPIPQRGQLS 603
           T  P+  +  +S
Sbjct: 383 TNAPVNYKANVS 394

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           IG G FGEV++   + G  VA+K     S + +R +  E E    +  +H N++  +   
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 800 K----IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
                   +  LV ++ + GSL + L       ++  +T +            L  LH  
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 856 CI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDT-HLSVSTLAGTPGYV 908
            +     P I HRD+KS N+L+       ++D G+A R  SA DT  ++ +   GT  Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 909 PPE---------YYQSFRCTAKGDVYSFGVVLLEL 934
            PE         +++SF+   + D+Y+ G+V  E+
Sbjct: 219 APEVLDDSINMKHFESFK---RADIYAMGLVFWEI 250

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 123
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 89/340 (26%), Positives = 147/340 (43%), Gaps = 64/340 (18%)
Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
            N+L  ++ S N + D+ P  L N TKL  + ++ N +A   P     L++L  L L NN
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 160 HITGWIPSELGNACDSLLELKLPHNNITGSFPVT-------------------LSSCSWL 200
            IT   P  L N  + L  L+L  N I+    ++                   L++ + L
Sbjct: 118 QITDIDP--LKNLTN-LNRLELSSNTISDISALSGLTSLQQLNFGNQVTDLKPLANLTTL 174
Query: 201 QLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP-------------------- 240
           + LD+S+N +S     SVL  L +LESLI +NN IS   P                    
Sbjct: 175 ERLDISSNKVSDI---SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI 231
Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
            +++S   L  +D ++N++S + P     G++ L EL+L  N I+ + P  L+  T L  
Sbjct: 232 GTLASLTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP--LAGLTALTN 286
Query: 301 IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEI 360
           ++L+ N L    P  +  L++L     +FN +    P                       
Sbjct: 287 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP----VSSLTKLQRLFFYNNKVSD 340
Query: 361 PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG 400
            + L + +N+ W+S   N+++   P   + LTR+   QLG
Sbjct: 341 VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT--QLG 376

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 108/432 (25%), Positives = 172/432 (39%), Gaps = 100/432 (23%)
Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
            ++L ++   +N +T   P  L + + L  + ++NN I+   P   L NL +L  L L N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFN 116
Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
           N I+   P  + +   L  ++ SSN +S I       G++SL++L    N +T + P  L
Sbjct: 117 NQITDIDP--LKNLTNLNRLELSSNTISDI---SALSGLTSLQQLNF-GNQVTDLKP--L 168
Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXX 352
           +  T L+ +D+S N +  S    L KL +LE  IA  N +    P  LG           
Sbjct: 169 ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGI---------- 214
Query: 353 XXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
                          +NL+ +SL GN+L  +     + LT L  L L NN+     P  L
Sbjct: 215 --------------LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--L 256
Query: 413 GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLE 472
              + L  L L +N ++              PL G  +   L    N            +
Sbjct: 257 SGLTKLTELKLGANQISN-----------ISPLAGLTALTNLELNEN------------Q 293
Query: 473 FAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI 532
              I P     I  LK+                    L YL L +N      P  +  + 
Sbjct: 294 LEDISP-----ISNLKN--------------------LTYLTLYFNNISDISP--VSSLT 326
Query: 533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
            LQ L   +N++S    SSL  L N+    A HN++    P   +NL+ + Q+ L++   
Sbjct: 327 KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 382
Query: 593 T-GPIPQRGQLS 603
           T  P+  +  +S
Sbjct: 383 TNAPVNYKANVS 394

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 15/211 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           N F    L+G G FG+V     K        K++R      ++ +A   T  ++      
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 794 PLLGYCKIG---EERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
           P L   K      +RL  V E+   G L    H       +R+ T +            L
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAEIVSAL 121
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH      +++RD+K  N++LD +   +++DFG+ +    +    ++ T  GTP Y+ 
Sbjct: 122 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 176
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +        D +  GVV+ E++ G+ P
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 730 IEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-K 788
           I+ T+G+  +  IG G +  V K  +   +++     +++  +  R+   E+E L +  +
Sbjct: 18  IQFTDGYEVKEDIGVGSYS-VCKRCIHKATNMEFA--VKIIDKSKRDPTEEIEILLRYGQ 74
Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
           H N++ L      G+   +V E MK G L +      K   Q+  +              
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLD------KILRQKFFSEREASAVLFTITKT 128
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEM----EARVSDFGMARLISALDTHLSVSTLAGT 904
           + +LH   +   +HRD+K SN+L   E       R+ DFG A+ + A +  L   T   T
Sbjct: 129 VEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM--TPCYT 183
Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
             +V PE  +     A  D++S GV+L  +LTG  P
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 779 AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
            E+E L K+ H  ++ +  +    E+  +V E M+ G L + + G  + ++     +   
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--- 258
Query: 839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTH 895
                     + +LH N    IIHRD+K  NVLL  + E    +++DFG ++++   +T 
Sbjct: 259 ---FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETS 310
Query: 896 LSVSTLAGTPGYVPPEYYQSFRCTAKG---DVYSFGVVLLELLTGKRP----------TD 942
           L + TL GTP Y+ PE   S          D +S GV+L   L+G  P           D
Sbjct: 311 L-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 369
Query: 943 KDDFGDTNLVGWVKMKVREG-----KQMEVIDPELLLVTK 977
           +   G  N +  V  +V E      K++ V+DP+    T+
Sbjct: 370 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 409

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           IG G FGEV++   + G  VA+K     S + +R +  E E    +  +H N++  +   
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 800 K----IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
                   +  LV ++ + GSL + L       ++  +T +            L  LH  
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHLHME 145
Query: 856 CI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDT-HLSVSTLAGTPGYV 908
            +     P I HRD+KS N+L+       ++D G+A R  SA DT  ++ +   GT  Y+
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 909 PPE---------YYQSFRCTAKGDVYSFGVVLLEL 934
            PE         +++SF+   + D+Y+ G+V  E+
Sbjct: 206 APEVLDDSINMKHFESFK---RADIYAMGLVFWEI 237

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 213 KSSDLWALGCIIYQLVAGLPP 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 211 KSSDLWALGCIIYQLVAGLPP 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 216 KSSDLWALGCIIYQLVAGLPP 236

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 218 KSSDLWALGCIIYQLVAGLPP 238

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLG-Y 798
           ++G G +G V+    L +   +AIK++     +  +    E+     +KH+N+V  LG +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 799 CKIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
            + G  ++ + E +  GSL  +L    G  K  +Q I  +             L +LH N
Sbjct: 75  SENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFY------TKQILEGLKYLHDN 127
Query: 856 CIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY- 913
               I+HRD+K  NVL++ +    ++SDFG ++ ++ ++      T  GT  Y+ PE   
Sbjct: 128 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIID 182
Query: 914 QSFRCTAKG-DVYSFGVVLLELLTGKRP 940
           +  R   K  D++S G  ++E+ TGK P
Sbjct: 183 KGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 213 KSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 214 KSSDLWALGCIIYQLVAGLPP 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 213 KSSDLWALGCIIYQLVAGLPP 233

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 779 AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
            E+E L K+ H  ++ +  +    E+  +V E M+ G L + + G  + ++     +   
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--- 244
Query: 839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTH 895
                     + +LH N    IIHRD+K  NVLL  + E    +++DFG ++++   +T 
Sbjct: 245 ---FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETS 296
Query: 896 LSVSTLAGTPGYVPPEYYQSFRCTAKG---DVYSFGVVLLELLTGKRP----------TD 942
           L + TL GTP Y+ PE   S          D +S GV+L   L+G  P           D
Sbjct: 297 L-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355
Query: 943 KDDFGDTNLVGWVKMKVREG-----KQMEVIDPELLLVTK 977
           +   G  N +  V  +V E      K++ V+DP+    T+
Sbjct: 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 395

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           IIHRD+K  N+LL+ +M  +++DFG A+++S        +   GT  YV PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D+++ G ++ +L+ G  P
Sbjct: 213 KSSDLWALGCIIYQLVAGLPP 233

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 758 GSSVAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLVPLLGYCKI--GEERLLVYEFMK 813
           G  VA+K L +    G+   +   E+E L  + H N+V   G C    G    L+ EF+ 
Sbjct: 50  GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 814 FGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLD 873
            GSL+E L      +++  +               + +L        +HRD+ + NVL++
Sbjct: 109 SGSLKEYL-----PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE 160
Query: 874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VPPEYYQSFRCTAKGDVYSFGVVLL 932
            E + ++ DFG+ + I       +V     +P +   PE     +     DV+SFGV L 
Sbjct: 161 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220
Query: 933 ELLT 936
           ELLT
Sbjct: 221 ELLT 224

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 15/216 (6%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           N F    L+G G FG+V     K        K++R      ++ +A   T  ++      
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 794 PLLGYCKIG---EERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
           P L   K      +RL  V E+   G L    H       +R+ T +            L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAEIVSAL 118
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH      +++RD+K  N++LD +   +++DFG+ +    +    ++ T  GTP Y+ 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 173
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PE  +        D +  GVV+ E++ G+ P    D
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 15/216 (6%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           N F    L+G G FG+V     K        K++R      ++ +A   T  ++      
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 794 PLLGYCKIG---EERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
           P L   K      +RL  V E+   G L    H       +R+ T +            L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAEIVSAL 118
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH      +++RD+K  N++LD +   +++DFG+ +    +    ++ T  GTP Y+ 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 173
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PE  +        D +  GVV+ E++ G+ P    D
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 741 LIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLG-Y 798
           ++G G +G V+    L +   +AIK++     +  +    E+     +KH+N+V  LG +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 799 CKIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
            + G  ++ + E +  GSL  +L    G  K  +Q I  +             L +LH N
Sbjct: 89  SENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFY------TKQILEGLKYLHDN 141
Query: 856 CIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY- 913
               I+HRD+K  NVL++ +    ++SDFG ++ ++ ++      T  GT  Y+ PE   
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIID 196
Query: 914 QSFRCTAKG-DVYSFGVVLLELLTGKRP 940
           +  R   K  D++S G  ++E+ TGK P
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 3   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 58
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 59  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 112
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 170 -----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S IG G +G V  A   K G  VA+KKL R   S 
Sbjct: 12  TFYRQELNK----TIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 121
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR 178
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 179 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 39/285 (13%)
Query: 742  IGCGGFGEVFKATL------KDGSSVAIKKLIRLSCQG--DREFMAEMETLGKIKHRNLV 793
            +G   FG+V+K  L      +   +VAIK L +   +G    EF  E     +++H N+V
Sbjct: 17   LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 794  PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF-- 851
             LLG     +   +++ +   G L E L  R+   D      D            +    
Sbjct: 76   CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 852  -----LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
                 + +    H++H+D+ + NVL+  ++  ++SD G+ R + A D +  +        
Sbjct: 136  QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 907  YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME 966
            ++ PE     + +   D++S+GVVL E+ +         +G     G+    V E  +  
Sbjct: 196  WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGLQPYCGYSNQDVVEMIRNR 246
Query: 967  VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
             + P         D+  A     M+       +C ++FPS+RP  
Sbjct: 247  QVLP-------CPDDCPAWVYALMI-------ECWNEFPSRRPRF 277

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 758 GSSVAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLVPLLGYCKI--GEERLLVYEFMK 813
           G  VA+K L +    G+   +   E+E L  + H N+V   G C    G    L+ EF+ 
Sbjct: 38  GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 96
Query: 814 FGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLD 873
            GSL+E L      +++  +               + +L        +HRD+ + NVL++
Sbjct: 97  SGSLKEYL-----PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE 148
Query: 874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGY-VPPEYYQSFRCTAKGDVYSFGVVLL 932
            E + ++ DFG+ + I       +V     +P +   PE     +     DV+SFGV L 
Sbjct: 149 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 208
Query: 933 ELLT 936
           ELLT
Sbjct: 209 ELLT 212

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 110/263 (41%), Gaps = 49/263 (18%)
Query: 693 QASHAATTWKIDKEKEPLSINVATFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVF 751
           +A  AA  + +  ++ P      TF RQ L K     + E    +   S +G G +G V 
Sbjct: 19  KAGSAAAPFTMSHKERP------TFYRQELNK----TIWEVPERYQTLSPVGSGAYGSVC 68
Query: 752 KA-TLKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV 808
            +  +K G  +A+KKL R   S    +    E+  L  +KH N++ LL            
Sbjct: 69  SSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV---------- 118
Query: 809 YEFMKFGSLEE------VLHGRAKARDQRI----LTWDXXXXXXXXXXXXLCFLHHNCIP 858
             F    SLEE      V H      +  +    LT D            L ++H     
Sbjct: 119 --FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 173
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY---YQS 915
            IIHRD+K SN+ ++ + E ++ DFG+AR      T   ++    T  Y  PE    +  
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 916 FRCTAKGDVYSFGVVLLELLTGK 938
           +  T   D++S G ++ ELLTG+
Sbjct: 229 YNMTV--DIWSVGCIMAELLTGR 249

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 122
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 18/223 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 122
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK 958
              A+  DV+S G+VL  +L G+ P D+          W + K
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKK 224

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 123
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 122
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 122
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 30/205 (14%)
Query: 748 GEVFKATLKDGSSVAIK--KLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK--IGE 803
           GE++K   + G+ + +K  K+   S +  R+F  E   L    H N++P+LG C+     
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 804 ERLLVYEFMKFGSLEEVLH-GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIH 862
              L+  +M +GSL  VLH G     DQ                  + FL H   P I  
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQ-----SQAVKFALDMARGMAFL-HTLEPLIPR 136
Query: 863 RDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG--TPGYVPPEYYQ-----S 915
             + S +V++D +M AR         IS  D   S  +      P +V PE  Q     +
Sbjct: 137 HALNSRSVMIDEDMTAR---------ISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 916 FRCTAKGDVYSFGVVLLELLTGKRP 940
            R +A  D++SF V+L EL+T + P
Sbjct: 188 NRRSA--DMWSFAVLLWELVTREVP 210

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+V  A     G  VA+K      L +   QG  E   E+  L  ++H +++ L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 73
Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
               K  +E ++V E+     L + +  R K  +Q    +              C  H  
Sbjct: 74  YDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRF----FQQIISAVEYCHRHK- 127
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ- 914
               I+HRD+K  N+LLD  +  +++DFG++ +++  D +  + T  G+P Y  PE    
Sbjct: 128 ----IVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNF-LKTSCGSPNYAAPEVISG 180
Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
                 + DV+S GV+L  +L  + P D +
Sbjct: 181 KLYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+V  A     G  VA+K      L +   QG  E   E+  L  ++H +++ L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 69
Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
               K  +E ++V E+     L + +  R K  +Q    +              C  H  
Sbjct: 70  YDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRF----FQQIISAVEYCHRHK- 123
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ- 914
               I+HRD+K  N+LLD  +  +++DFG++ +++  D +  + T  G+P Y  PE    
Sbjct: 124 ----IVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNF-LKTSCGSPNYAAPEVISG 176
Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
                 + DV+S GV+L  +L  + P D +
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 3   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 58
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 59  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 112
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 170 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 27/232 (11%)
Query: 716 TFQRQLRKLKFSQLI-EATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ    + ++ I E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 3   TFYRQ----ELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 58
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 59  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 112
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 113 VKCAKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 170 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+V  A     G  VA+K      L +   QG  E   E+  L  ++H +++ L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 79
Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
               K  +E ++V E+     L + +  R K  +Q    +              C  H  
Sbjct: 80  YDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRF----FQQIISAVEYCHRHK- 133
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ- 914
               I+HRD+K  N+LLD  +  +++DFG++ +++  D +  + T  G+P Y  PE    
Sbjct: 134 ----IVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNF-LKTSCGSPNYAAPEVISG 186
Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
                 + DV+S GV+L  +L  + P D +
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 98/233 (42%), Gaps = 29/233 (12%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAK----- 826
              +    E+  L  +KH N++ LL                +F  +  V H         
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 827 ARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA 886
            + Q+ LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+A
Sbjct: 117 VKXQK-LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLA 172
Query: 887 RLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
           R      T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 173 R-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G +GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHG-- 122
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 123 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+V  A     G  VA+K      L +   QG  E   E+  L  ++H +++ L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 78
Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
               K  +E ++V E+     L + +  R K  +Q    +              C  H  
Sbjct: 79  YDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRF----FQQIISAVEYCHRHK- 132
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ- 914
               I+HRD+K  N+LLD  +  +++DFG++ +++  D +  + T  G+P Y  PE    
Sbjct: 133 ----IVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNF-LKTSCGSPNYAAPEVISG 185
Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKD 944
                 + DV+S GV+L  +L  + P D +
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 27  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 136
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 137 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 194 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 12  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 121
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR 178
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 179 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 39/238 (16%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 14  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 123
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLTGK 938
                       T     GYV   +Y++              D++S G ++ ELLTG+
Sbjct: 181 -----------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 39/238 (16%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 14  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 123
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLTGK 938
                       T     GYV   +Y++              D++S G ++ ELLTG+
Sbjct: 181 -----------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYY-QSFRCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE    +       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 26  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 81
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 82  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 135
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 136 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 192
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 193 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 39/238 (16%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 14  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 123
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLTGK 938
                       T     GYV   +Y++              D++S G ++ ELLTG+
Sbjct: 181 -----------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIR---LSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           +G G +GEV     K        K+IR   +S   + + + E+  L  + H N++ L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 799 CKIGEERLLVYEFMKFGSL-EEVLHG-RAKARDQRILTWDXXXXXXXXXXXXLCFLH-HN 855
            +      LV E  K G L +E++H  +    D  ++               + +LH HN
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII--------KQVLSGVTYLHKHN 156
Query: 856 CIPHIIHRDMKSSNVLLD-HEMEA--RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
               I+HRD+K  N+LL+  E +A  ++ DFG++   +  +    +    GT  Y+ PE 
Sbjct: 157 ----IVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPEV 209
Query: 913 YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            +  +   K DV+S GV+L  LL G  P
Sbjct: 210 LRK-KYDEKCDVWSIGVILFILLAGYPP 236

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 734 NGFSAESLIGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH 789
           N F    L+G G FG+V     KAT +  +   +KK + ++       + E   L   +H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             L  L    +  +    V E+   G L    H       +R+ + D            L
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFYGAEIVSAL 121
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH     ++++RD+K  N++LD +   +++DFG+ +    +    ++    GTP Y+ 
Sbjct: 122 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 177
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +        D +  GVV+ E++ G+ P
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 25/173 (14%)
Query: 778 MAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWD 836
           + E++ L K+  H N++ L    +      LV++ MK G L + L       ++  L+  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL------TEKVTLSEK 124
Query: 837 XXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                       +C LH     +I+HRD+K  N+LLD +M  +++DFG +     LD   
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGE 178
Query: 897 SVSTLAGTPGYVPPEYYQSFRCT---------AKGDVYSFGVVLLELLTGKRP 940
            + ++ GTP Y+ PE  +   C+          + D++S GV++  LL G  P
Sbjct: 179 KLRSVCGTPSYLAPEIIE---CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 742 IGCGGFGEVFKATLKD--------GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           +G G F ++FK   ++         + V +K L +        F      + K+ H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
              G C  G+E +LV EF+KFGSL+  L    K ++   + W             + FL 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILW--KLEVAKQLAAAMHFLE 130
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG-----TPGYV 908
            N    +IH ++ + N+LL  E + +    G    I   D  +S++ L          +V
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKT---GNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 909 PPEYYQSFR-CTAKGDVYSFGVVLLELLTG 937
           PPE  ++ +      D +SFG  L E+ +G
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 18  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 127
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 128 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR 184
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 185 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
           +G G  GEV  A  +        K++ +    D       E+     + H N+V   G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 800 KIGEERLLVYEFMKFGSLEEVLH---GRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
           + G  + L  E+   G L + +    G  +   QR                 + +LH   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMAGVVYLHGIG 124
Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I    HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  +  
Sbjct: 125 I---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 917 RCTAKG-DVYSFGVVLLELLTGKRPTDK 943
              A+  DV+S G+VL  +L G+ P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 98/233 (42%), Gaps = 29/233 (12%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAK----- 826
              +    E+  L  +KH N++ LL                +F  +  V H         
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 827 ARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA 886
            + Q+ LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+A
Sbjct: 117 VKXQK-LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 172
Query: 887 RLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
           R      T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 173 R-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 734 NGFSAESLIGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH 789
           N F    L+G G FG+V     KAT +  +   +KK + ++       + E   L   +H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             L  L    +  +    V E+   G L    H       +R+ + D            L
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFYGAEIVSAL 123
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH     ++++RD+K  N++LD +   +++DFG+ +    +    ++    GTP Y+ 
Sbjct: 124 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 179
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +        D +  GVV+ E++ G+ P
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 15/211 (7%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           N F    L+G G FG+V     K        K++R      ++ +A   T  ++      
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 794 PLLGYCKIG---EERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
           P L   K      +RL  V E+   G L    H       +R+ T +            L
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAEIVSAL 123
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH      +++RD+K  N++LD +   +++DFG+ +    +    ++    GTP Y+ 
Sbjct: 124 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 178
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +        D +  GVV+ E++ G+ P
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 4   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 59
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 60  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 113
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 114 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 170
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 171 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 12  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 121
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 178
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 179 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 6   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 61
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 62  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 115
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 116 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 172
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 173 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 27  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 82
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 136
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 137 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 194 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 26  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 81
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 82  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 135
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 136 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 192
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 193 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 25/173 (14%)
Query: 778 MAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWD 836
           + E++ L K+  H N++ L    +      LV++ MK G L + L  +        L+  
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEK 111
Query: 837 XXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                       +C LH     +I+HRD+K  N+LLD +M  +++DFG +     LD   
Sbjct: 112 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGE 165
Query: 897 SVSTLAGTPGYVPPEYYQSFRCT---------AKGDVYSFGVVLLELLTGKRP 940
            +  + GTP Y+ PE  +   C+          + D++S GV++  LL G  P
Sbjct: 166 KLREVCGTPSYLAPEIIE---CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 9   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 118
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR 175
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 176 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 12  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 121
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 178
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 179 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 5   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 60
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 61  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 114
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 115 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 171
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 172 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 15/218 (6%)
Query: 729 LIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD-------REFMAE 780
           L  A   +   + IG G +G+VFKA  LK+G      K +R+    +       RE +A 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAV 64
Query: 781 METLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXX 840
           +  L   +H N+V L   C +          + F  +++ L        +  +  +    
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   L FLH +    ++HRD+K  N+L+    + +++DFG+AR+ S     +++++
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTS 178
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           +  T  Y  PE           D++S G +  E+   K
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 9   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 118
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 176 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 14  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 123
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 181 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 4   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 59
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 60  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 113
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 114 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 170
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 171 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 19  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 128
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 129 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 185
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 186 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FGEV +   K  G   A+KK +RL      E MA       +    +VPL G  +
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKK-VRLEVFRAEELMA----CAGLTSPRIVPLYGAVR 155
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            G    +  E ++ GSL +++      ++Q  L  D            L +LH      I
Sbjct: 156 EGPWVNIFMELLEGGSLGQLV------KEQGCLPEDRALYYLGQALEGLEYLHSR---RI 206
Query: 861 IHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVST---LAGTPGYVPPEYYQSF 916
           +H D+K+ NVLL  +   A + DFG A  +       S+ T   + GT  ++ PE     
Sbjct: 207 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266
Query: 917 RCTAKGDVYSFGVVLLELLTGKRP 940
            C AK DV+S   ++L +L G  P
Sbjct: 267 SCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 3   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 58
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 59  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 112
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 170 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 19  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 128
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 129 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 185
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 186 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 13  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 122
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR 179
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 180 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 13  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 122
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 179
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 180 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           +G G +G V  A   K G  VA+KKL R   S    +    E+  L  +KH N++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRI----LTWDXXXXXXXXXXXXLCFLHH 854
                         +F  +  V H      +  +    LT D            L ++H 
Sbjct: 100 FTPARS------LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 153
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                IIHRD+K SN+ ++ + E ++ DFG+AR      T   ++    T  Y  PE   
Sbjct: 154 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIML 205
Query: 915 SF-RCTAKGDVYSFGVVLLELLTGK 938
           ++       D++S G ++ ELLTG+
Sbjct: 206 NWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 30  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 139
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 140 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 196
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 197 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 20/208 (9%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD------REFMAEMETLGKIKHRNLVP 794
           ++G G FGEV++    +     I   ++ +C+ D       +FM+E   +  + H ++V 
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVK-TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L+G  +  E   ++ E   +G L     G    R++  L               + +L  
Sbjct: 90  LIGIIE-EEPTWIIMELYPYGEL-----GHYLERNKNSLKVLTLVLYSLQICKAMAYLES 143
Query: 855 -NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
            NC+    HRD+   N+L+      ++ DFG++R I   D +   S       ++ PE  
Sbjct: 144 INCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPESI 198
Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
              R T   DV+ F V + E+L+ GK+P
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 734 NGFSAESLIGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH 789
           N F    L+G G FG+V     KAT +  +   +KK + ++       + E   L   +H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             L  L    +  +    V E+   G L    H       +R+ + D            L
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFYGAEIVSAL 122
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH     ++++RD+K  N++LD +   +++DFG+ +    +    ++    GTP Y+ 
Sbjct: 123 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 178
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +        D +  GVV+ E++ G+ P
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 13  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 68
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 122
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 179
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 180 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD------REFMAEMETLGKIKHRNLV 793
             +G G F  V+KA  K+ + +   K I+L  + +      R  + E++ L ++ H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            LL          LV++FM+   LE ++       +  +LT              L +LH
Sbjct: 76  GLLDAFGHKSNISLVFDFME-TDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
            + I   +HRD+K +N+LLD     +++DFG+A+   + +       +  T  Y  PE  
Sbjct: 130 QHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELL 184
Query: 914 QSFRCTAKG-DVYSFGVVLLELL 935
              R    G D+++ G +L ELL
Sbjct: 185 FGARMYGVGVDMWAVGCILAELL 207

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 36/227 (15%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH----- 789
           F   +++G G FG+V KA    D    AIKK IR + +     ++E+  L  + H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 790 --------RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXX 841
                   RN V  +   K      +  E+ + G+L +++H       QR   W      
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYW----RL 121
Query: 842 XXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS------ALDTH 895
                  L ++H   I   IHRD+K  N+ +D     ++ DFG+A+ +        LD+ 
Sbjct: 122 FRQILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 896 ------LSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELL 935
                  ++++  GT  YV  E    +     K D+YS G++  E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 9   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 118
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 176 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 742 IGCGGFGEVFKATLKD--------GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           +G G F ++FK   ++         + V +K L +        F      + K+ H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
              G C  G+E +LV EF+KFGSL+  L    K ++   + W             + FL 
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYL---KKNKNCINILW--KLEVAKQLAWAMHFLE 130
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG-----TPGYV 908
            N    +IH ++ + N+LL  E + +    G    I   D  +S++ L          +V
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKT---GNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 909 PPEYYQSFR-CTAKGDVYSFGVVLLELLTG 937
           PPE  ++ +      D +SFG  L E+ +G
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 39/238 (16%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 30  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 139
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 140 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 196
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLTGK 938
                       T     GYV   +Y++              D++S G ++ ELLTG+
Sbjct: 197 -----------HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 18  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 127
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 128 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 184
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 185 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFM-AEMETLGKIKHRN 791
           ++ F  ES +G G    V++   K        K+++ +   D++ +  E+  L ++ H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPN 109
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
           ++ L    +   E  LV E +  G L +  V  G    RD                   +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD--------AADAVKQILEAV 161
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDH---EMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
            +LH N    I+HRD+K  N+L      +   +++DFG+++++   +  + + T+ GTPG
Sbjct: 162 AYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPG 215
Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
           Y  PE  +      + D++S G++   LL G  P   D+ GD
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF-YDERGD 256

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 27  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 136
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 137 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   +     T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 194 -----HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 20/208 (9%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD------REFMAEMETLGKIKHRNLVP 794
           ++G G FGEV++    +     I   ++ +C+ D       +FM+E   +  + H ++V 
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVK-TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L+G  +  E   ++ E   +G L     G    R++  L               + +L  
Sbjct: 78  LIGIIE-EEPTWIIMELYPYGEL-----GHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 855 -NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
            NC+    HRD+   N+L+      ++ DFG++R I   D +   S       ++ PE  
Sbjct: 132 INCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPESI 186
Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
              R T   DV+ F V + E+L+ GK+P
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 778 MAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWD 836
           + E++ L K+  H N++ L    +      LV++ MK G L + L       ++  L+  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL------TEKVTLSEK 124
Query: 837 XXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                       +C LH     +I+HRD+K  N+LLD +M  +++DFG +     LD   
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGE 178
Query: 897 SVSTLAGTPGYVPPEYYQSFRCT---------AKGDVYSFGVVLLELLTGKRP 940
            +  + GTP Y+ PE  +   C+          + D++S GV++  LL G  P
Sbjct: 179 KLREVCGTPSYLAPEIIE---CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 726 FSQLIEATN----GFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEM 781
           F+QL++        F    +IG G FGEV    +K+   +   K++        E +   
Sbjct: 78  FTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL-----NKWEMLKRA 132
Query: 782 ETLGKIKHRNL--------VPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRI 832
           ET    + R++        +  L Y    E  L LV ++   G L  +L   +K  D+  
Sbjct: 133 ETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDK-- 187
Query: 833 LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL 892
           L  D            +  +H     H +HRD+K  NVLLD     R++DFG    ++  
Sbjct: 188 LPEDMARFYIGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMND- 243
Query: 893 DTHLSVSTLAGTPGYVPPEYYQSF-----RCTAKGDVYSFGVVLLELLTGKRP 940
           D  +  S   GTP Y+ PE  Q+      +   + D +S GV + E+L G+ P
Sbjct: 244 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 58/221 (26%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLGY 798
           IG G +G V+KA    G + A+KK IRL  + +      + E+  L ++KH N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 799 CKIGEERLLVYEFMKF----------GSLEEV---------LHGRAKARDQRILTWDXXX 839
               +  +LV+E +            G LE V         L+G A   D+R+L      
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL------ 122
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS---ALDTHL 896
                                 HRD+K  N+L++ E E +++DFG+AR         TH 
Sbjct: 123 ----------------------HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
            V+     P  +      S + +   D++S G +  E++ G
Sbjct: 161 VVTLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 726 FSQLIEATN----GFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEM 781
           F+QL++        F    +IG G FGEV    +K+   +   K++        E +   
Sbjct: 62  FTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL-----NKWEMLKRA 116
Query: 782 ETLGKIKHRNL--------VPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRI 832
           ET    + R++        +  L Y    E  L LV ++   G L  +L   +K  D+  
Sbjct: 117 ETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDK-- 171
Query: 833 LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL 892
           L  D            +  +H     H +HRD+K  NVLLD     R++DFG    ++  
Sbjct: 172 LPEDMARFYIGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMND- 227
Query: 893 DTHLSVSTLAGTPGYVPPEYYQSF-----RCTAKGDVYSFGVVLLELLTGKRP 940
           D  +  S   GTP Y+ PE  Q+      +   + D +S GV + E+L G+ P
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 58/221 (26%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLGY 798
           IG G +G V+KA    G + A+KK IRL  + +      + E+  L ++KH N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 799 CKIGEERLLVYEFMKF----------GSLEEV---------LHGRAKARDQRILTWDXXX 839
               +  +LV+E +            G LE V         L+G A   D+R+L      
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL------ 122
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS---ALDTHL 896
                                 HRD+K  N+L++ E E +++DFG+AR         TH 
Sbjct: 123 ----------------------HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
            V+     P  +      S + +   D++S G +  E++ G
Sbjct: 161 VVTLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 16/231 (6%)
Query: 723 KLKFSQLIEATNGFSAESLIGCGGFGEVFKATLK--DGS--SVAIKKLIR--LSCQGDRE 776
           K K   ++     F+   ++G G FG V +A LK  DGS   VA+K L    ++     E
Sbjct: 12  KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE 71
Query: 777 FMAEMETLGKIKHRNLVPLLGYCKIGEER------LLVYEFMKFGSLEEVLHGRAKARDQ 830
           F+ E   + +  H ++  L+G       +      +++  FMK G L   L       + 
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 831 RILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
             L                C + +    + IHRD+ + N +L  +M   V+DFG++R I 
Sbjct: 132 FNLPLQTLVRFMVDIA---CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           + D +           ++  E       T   DV++FGV + E++T G+ P
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 13  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 122
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 179
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 180 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 15/216 (6%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           N F    L+G G FG+V     K        K++R      ++ +A   T  ++      
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 794 PLLGYCKIG---EERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
           P L   K      +RL  V E+   G L    H       +R+ T +            L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAEIVSAL 118
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH      +++RD+K  N++LD +   +++DFG+ +    +    ++    GTP Y+ 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 173
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PE  +        D +  GVV+ E++ G+ P    D
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 15/216 (6%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           N F    L+G G FG+V     K        K++R      ++ +A   T  ++      
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 794 PLLGYCKIG---EERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
           P L   K      +RL  V E+   G L    H       +R+ T +            L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAEIVSAL 118
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH      +++RD+K  N++LD +   +++DFG+ +    +    ++    GTP Y+ 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 173
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PE  +        D +  GVV+ E++ G+ P    D
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 745 GGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIG 802
           GGF  V++A  +  G   A+K+L+    + +R  + E+  + K+  H N+V       IG
Sbjct: 39  GGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98
Query: 803 EER--------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           +E         LL+ E  K G L E L    K   +  L+ D            +  +H 
Sbjct: 99  KEESDTGQAEFLLLTELCK-GQLVEFL---KKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL-DTHLSVSTLA---------GT 904
              P IIHRD+K  N+LL ++   ++ DFG A  IS   D   S    A          T
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 905 PGYVPPEY---YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           P Y  PE    Y +F    K D+++ G +L  L   + P
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 15/216 (6%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           N F    L+G G FG+V     K        K++R      ++ +A   T  ++      
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 794 PLLGYCKIG---EERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
           P L   K      +RL  V E+   G L    H       +R+ T +            L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAEIVSAL 118
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +LH      +++RD+K  N++LD +   +++DFG+ +    +    ++    GTP Y+ 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 173
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PE  +        D +  GVV+ E++ G+ P    D
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 58/221 (26%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLGY 798
           IG G +G V+KA    G + A+KK IRL  + +      + E+  L ++KH N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 799 CKIGEERLLVYEFMKF----------GSLEEV---------LHGRAKARDQRILTWDXXX 839
               +  +LV+E +            G LE V         L+G A   D+R+L      
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL------ 122
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS---ALDTHL 896
                                 HRD+K  N+L++ E E +++DFG+AR         TH 
Sbjct: 123 ----------------------HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 897 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
            V+     P  +      S + +   D++S G +  E++ G
Sbjct: 161 IVTLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ D+G+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD------REFMAEMETLGKIKHRNLVP 794
           ++G G FGEV++    +     I   ++ +C+ D       +FM+E   +  + H ++V 
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVK-TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L+G  +  E   ++ E   +G L   L      R++  L               + +L  
Sbjct: 74  LIGIIE-EEPTWIIMELYPYGELGHYLE-----RNKNSLKVLTLVLYSLQICKAMAYLES 127
Query: 855 -NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH-LSVSTLAGTPGYVPPEY 912
            NC+    HRD+   N+L+      ++ DFG++R I   D +  SV+ L     ++ PE 
Sbjct: 128 INCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPES 181
Query: 913 YQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               R T   DV+ F V + E+L+ GK+P
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGK 786
           E    F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKE 65
Query: 787 IKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXX 846
           + H N+V LL       +  LV+EF     L + L     A     +             
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 847 XXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAG 903
             L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+    
Sbjct: 121 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            P  +    Y S       D++S G +  E++T +
Sbjct: 178 APEILLGXKYYS----TAVDIWSLGCIFAEMVTRR 208

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 97/233 (41%), Gaps = 29/233 (12%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAK----- 826
              +    E+  L  +KH N++ LL                +F  +  V H         
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 827 ARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA 886
            + Q+ LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+ 
Sbjct: 117 VKSQK-LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLC 172
Query: 887 RLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
           R      T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 173 R-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 28/230 (12%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETL 784
           K  Q+      F    +IG G FGEV    LK+   V   K++        E +   ET 
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL-----NKWEMLKRAETA 119
Query: 785 GKIKHRNL--------VPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTW 835
              + R++        +  L Y    +  L LV ++   G L  +L   +K  D+  L  
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDR--LPE 174
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
           +            +  +H     H +HRD+K  N+L+D     R++DFG   L    D  
Sbjct: 175 EMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGT 230
Query: 896 LSVSTLAGTPGYVPPEYYQSF-----RCTAKGDVYSFGVVLLELLTGKRP 940
           +  S   GTP Y+ PE  Q+      R   + D +S GV + E+L G+ P
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FGEV +   K  G   A+KK +RL      E MA       +    +VPL G  +
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKK-VRLEVFRAEELMA----CAGLTSPRIVPLYGAVR 136
Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHI 860
            G    +  E ++ GSL +++      ++Q  L  D            L +LH      I
Sbjct: 137 EGPWVNIFMELLEGGSLGQLV------KEQGCLPEDRALYYLGQALEGLEYLHSR---RI 187
Query: 861 IHRDMKSSNVLLDHE-MEARVSDFGMARLISA---LDTHLSVSTLAGTPGYVPPEYYQSF 916
           +H D+K+ NVLL  +   A + DFG A  +         L+   + GT  ++ PE     
Sbjct: 188 LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247
Query: 917 RCTAKGDVYSFGVVLLELLTGKRP 940
            C AK DV+S   ++L +L G  P
Sbjct: 248 SCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL +   S 
Sbjct: 19  TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSI 74
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 128
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR
Sbjct: 129 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 185
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 186 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLG 797
           ++G G FGEV K   +        K+I  +   +++    + E+E L K+ H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ---RILTWDXXXXXXXXXXXXLCFLH- 853
             +      +V E    G L + +  R +  +    RI+               + ++H 
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---------QVFSGITYMHK 139
Query: 854 HNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           HN    I+HRD+K  N+LL   + + + ++ DFG++   +    +  +    GT  Y+ P
Sbjct: 140 HN----IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAP 192
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E  +      K DV+S GV+L  LL+G  P
Sbjct: 193 EVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLGY 798
           IG G +G VFKA  ++   +   K +RL    +      + E+  L ++KH+N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
               ++  LV+EF     L++         D  I+               L F H     
Sbjct: 70  LHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVK-----SFLFQLLKGLGFCHSR--- 120
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
           +++HRD+K  N+L++   E +++DFG+AR         S   +  T  Y PP+     + 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKL 178
Query: 919 TAKG-DVYSFGVVLLELLTGKRP 940
            +   D++S G +  EL    RP
Sbjct: 179 YSTSIDMWSAGCIFAELANAARP 201

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           I C  F  V       G +VA+KKL R         R +  E+  L  + H+N++ LL  
Sbjct: 39  IVCAAFDTVL------GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNV 91
Query: 799 C---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
               K  EE   VY  M+    +L +V+H          L +             LC + 
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM-----------LCGIK 140
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
           H     IIHRD+K SN+++  +   ++ DFG+AR      T+  ++    T  Y  PE  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVI 197
Query: 914 QSFRCTAKGDVYSFGVVLLELLTG 937
                 A  D++S G ++ EL+ G
Sbjct: 198 LGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLG 797
           ++G G FGEV K   +        K+I  +   +++    + E+E L K+ H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ---RILTWDXXXXXXXXXXXXLCFLH- 853
             +      +V E    G L + +  R +  +    RI+               + ++H 
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---------QVFSGITYMHK 139
Query: 854 HNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           HN    I+HRD+K  N+LL   + + + ++ DFG++   +    +  +    GT  Y+ P
Sbjct: 140 HN----IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAP 192
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E  +      K DV+S GV+L  LL+G  P
Sbjct: 193 EVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLG 797
           ++G G FGEV K   +        K+I  +   +++    + E+E L K+ H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ---RILTWDXXXXXXXXXXXXLCFLH- 853
             +      +V E    G L + +  R +  +    RI+               + ++H 
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---------QVFSGITYMHK 139
Query: 854 HNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           HN    I+HRD+K  N+LL   + + + ++ DFG++   +    +  +    GT  Y+ P
Sbjct: 140 HN----IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAP 192
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E  +      K DV+S GV+L  LL+G  P
Sbjct: 193 EVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 45/276 (16%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR--LSCQGDRE-FMAEMETLGKIK 788
           ++ +  + ++G G FGEV     K  G   A+K + +  +  + D+E  + E++ L ++ 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD---QRILTWDXXXXXXXXX 845
           H N++ L  + +      LV E    G L + +  R +  +    RI+            
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---------QV 141
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMARLISALDTHLSVSTLA 902
              + ++H N    I+HRD+K  N+LL+    +   R+ DFG       L TH   S   
Sbjct: 142 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG-------LSTHFEASKKM 191
Query: 903 ----GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK 958
               GT  Y+ PE         K DV+S GV+L  LL+G  P     F   N    +K K
Sbjct: 192 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP-----FNGANEYDILK-K 244
Query: 959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYL 994
           V +GK    + P+     K   ES  + +++M+ Y+
Sbjct: 245 VEKGKYTFEL-PQW----KKVSESAKDLIRKMLTYV 275

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 42/218 (19%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           IG G FGEV++   + G  VA+K     S + +R +  E E    +  +H N+   LG+ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI---LGFI 64
Query: 800 KIGE-------ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
                      +  LV ++ + GSL + L       ++  +T +            L  L
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHL 117
Query: 853 HHNCI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDT-HLSVSTLAGTP 905
           H   +     P I HRD+KS N+L+       ++D G+A R  SA DT  ++ +   GT 
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 906 GYVPPE---------YYQSFRCTAKGDVYSFGVVLLEL 934
            Y+ PE         +++SF+   + D+Y+ G+V  E+
Sbjct: 178 RYMAPEVLDDSINMKHFESFK---RADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 42/218 (19%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           IG G FGEV++   + G  VA+K     S + +R +  E E    +  +H N+   LG+ 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI---LGFI 63
Query: 800 KIGE-------ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
                      +  LV ++ + GSL + L       ++  +T +            L  L
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHL 116
Query: 853 HHNCI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDT-HLSVSTLAGTP 905
           H   +     P I HRD+KS N+L+       ++D G+A R  SA DT  ++ +   GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 906 GYVPPE---------YYQSFRCTAKGDVYSFGVVLLEL 934
            Y+ PE         +++SF+   + D+Y+ G+V  E+
Sbjct: 177 RYMAPEVLDDSINMKHFESFK---RADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 42/218 (19%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           IG G FGEV++   + G  VA+K     S + +R +  E E    +  +H N+   LG+ 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI---LGFI 69
Query: 800 KIGE-------ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
                      +  LV ++ + GSL + L       ++  +T +            L  L
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHL 122
Query: 853 HHNCI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDT-HLSVSTLAGTP 905
           H   +     P I HRD+KS N+L+       ++D G+A R  SA DT  ++ +   GT 
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 906 GYVPPE---------YYQSFRCTAKGDVYSFGVVLLEL 934
            Y+ PE         +++SF+   + D+Y+ G+V  E+
Sbjct: 183 RYMAPEVLDDSINMKHFESFK---RADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 42/218 (19%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           IG G FGEV++   + G  VA+K     S + +R +  E E    +  +H N+   LG+ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI---LGFI 66
Query: 800 KIGE-------ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
                      +  LV ++ + GSL + L       ++  +T +            L  L
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHL 119
Query: 853 HHNCI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDT-HLSVSTLAGTP 905
           H   +     P I HRD+KS N+L+       ++D G+A R  SA DT  ++ +   GT 
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 906 GYVPPE---------YYQSFRCTAKGDVYSFGVVLLEL 934
            Y+ PE         +++SF+   + D+Y+ G+V  E+
Sbjct: 180 RYMAPEVLDDSINMKHFESFK---RADIYAMGLVFWEI 214

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 68/297 (22%), Positives = 126/297 (42%), Gaps = 31/297 (10%)
Query: 729  LIEATNGFSAESLIGCGGFGEVFKA-TLKDGSS-VAIKKLIRLSCQGDREFM-------- 778
            L  A   +   + IG G +G+VFKA  LK+G   VA+K   R+  Q   E M        
Sbjct: 6    LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREV 62
Query: 779  AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
            A +  L   +H N+V L   C +          + F  +++ L        +  +  +  
Sbjct: 63   AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 839  XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
                      L FLH +    ++HRD+K  N+L+    + +++DFG+AR+ S     +++
Sbjct: 123  KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMAL 176
Query: 899  STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP-----TDKDDFGDTNLVG 953
            +++  T  Y  PE           D++S G +  E+   ++P     +D D  G   ++ 
Sbjct: 177  TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG--KILD 233
Query: 954  WVKMKVREGKQMEVIDPELLLVTKGTD--ESEAEEVKEMVRYLEITLQCVDDFPSKR 1008
             + +   E    +V  P     +K     E    ++ E+ +  ++ L+C+   P+KR
Sbjct: 234  VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKR 288

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 68/297 (22%), Positives = 126/297 (42%), Gaps = 31/297 (10%)
Query: 729  LIEATNGFSAESLIGCGGFGEVFKA-TLKDGSS-VAIKKLIRLSCQGDREFM-------- 778
            L  A   +   + IG G +G+VFKA  LK+G   VA+K   R+  Q   E M        
Sbjct: 6    LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREV 62
Query: 779  AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
            A +  L   +H N+V L   C +          + F  +++ L        +  +  +  
Sbjct: 63   AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 839  XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
                      L FLH +    ++HRD+K  N+L+    + +++DFG+AR+ S     +++
Sbjct: 123  KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMAL 176
Query: 899  STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP-----TDKDDFGDTNLVG 953
            +++  T  Y  PE           D++S G +  E+   ++P     +D D  G   ++ 
Sbjct: 177  TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG--KILD 233
Query: 954  WVKMKVREGKQMEVIDPELLLVTKGTD--ESEAEEVKEMVRYLEITLQCVDDFPSKR 1008
             + +   E    +V  P     +K     E    ++ E+ +  ++ L+C+   P+KR
Sbjct: 234  VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKR 288

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 730 IEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-K 788
           I+ T+G+  +  IG G +  V K  +   ++      +++  +  R+   E+E L +  +
Sbjct: 18  IQFTDGYEVKEDIGVGSYS-VCKRCIHKATNXEFA--VKIIDKSKRDPTEEIEILLRYGQ 74
Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXX 848
           H N++ L      G+   +V E  K G L +      K   Q+  +              
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLD------KILRQKFFSEREASAVLFTITKT 128
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEM----EARVSDFGMARLISALDTHLSVSTLAGT 904
           + +LH   +   +HRD+K SN+L   E       R+ DFG A+ + A +  L   T   T
Sbjct: 129 VEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLX--TPCYT 183
Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
             +V PE  +     A  D++S GV+L   LTG  P
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT---WDXXXXXXXXXXXX 848
           +V LL       +  LV+EF+             K  D   LT                 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTP 905
           L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+     P
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             +    Y S       D++S G +  E++T +
Sbjct: 173 EILLGXKYYS----TAVDIWSLGCIFAEMVTRR 201

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           I C  F  V       G +VA+KKL R         R +  E+  L  + H+N++ LL  
Sbjct: 37  IVCAAFDTVL------GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNV 89
Query: 799 C---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
               K  EE   VY  M+    +L +V+H          L +             LC + 
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM-----------LCGIK 138
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
           H     IIHRD+K SN+++  +   ++ DFG+AR  S   T+  ++    T  Y  PE  
Sbjct: 139 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS---TNFMMTPYVVTRYYRAPEVI 195
Query: 914 QSFRCTAKGDVYSFGVVLLELLTG 937
                    D++S G ++ EL+ G
Sbjct: 196 LGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 721 LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREF 777
           L+   F    +  + +     IG G +G V  A  +  G  VAIKK+          +  
Sbjct: 42  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT 101
Query: 778 MAEMETLGKIKHRNLV-------PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ 830
           + E++ L   KH N++       P + Y +  +   +V + M+   L +++H        
Sbjct: 102 LRELKILKHFKHDNIIAIKDILRPTVPYGEF-KSVYVVLDLME-SDLHQIIHS------S 153
Query: 831 RILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR--L 888
           + LT +            L ++H      +IHRD+K SN+L++   E ++ DFGMAR   
Sbjct: 154 QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 210
Query: 889 ISALDTHLSVSTLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKR 939
            S  +    ++    T  Y  PE   S    T   D++S G +  E+L  ++
Sbjct: 211 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ DF +AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGK 786
           E    F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKE 65
Query: 787 IKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXX 846
           + H N+V LL       +  LV+EF     L + L     A     +             
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 847 XXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAG 903
             L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+    
Sbjct: 121 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            P  +    Y S       D++S G +  E++T +
Sbjct: 178 APEILLGCKYYS----TAVDIWSLGCIFAEMVTRR 208

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 775 REFMAEMETLGKIKHRNLVPLLGYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQRI 832
            +   E+  L K+ H N+V L+       E    +V+E +  G + EV   +  + DQ  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 833 LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL 892
             +             + +LH+     IIHRD+K SN+L+  +   +++DFG++      
Sbjct: 141 FYFQDLIKG-------IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKG---DVYSFGVVLLELLTGKRP 940
           D  L  S   GTP ++ PE     R    G   DV++ GV L   + G+ P
Sbjct: 191 DALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 35/237 (14%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV--AIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           ++ E+ IG G +GEV K  ++ G+ +  A KK+ +   +    F  E+E +  + H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 794 PLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
            L    +   +  LV E    G L E V+H       +R+                + + 
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVH-------KRVFRESDAARIMKDVLSAVAYC 122
Query: 853 HHNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           H     ++ HRD+K  N L      +   ++ DFG+A   +       + T  GTP YV 
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA---ARFKPGKMMRTKVGTPYYVS 176
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTG----KRPTDKDDFGDTNLVGWVKMKVREG 962
           P+  +      + D +S GV++  LL G      PTD +          V +K+REG
Sbjct: 177 PQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXE----------VMLKIREG 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 42/225 (18%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G +G V   + A L+    VA+KKL R   S    R    E+  L  +KH N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 797 GYCKIG------EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
                        E  LV   M    L  ++  +A       L+ +            L 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKSQA-------LSDEHVQFLVYQLLRGLK 145
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           ++H   I   IHRD+K SNV ++ + E R+ DFG+AR     D  ++        GYV  
Sbjct: 146 YIHSAGI---IHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVAT 191
Query: 911 EYYQS-------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
            +Y++              D++S G ++ ELL GK      D+ D
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYID 236

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 35/237 (14%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV--AIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           ++ E+ IG G +GEV K  ++ G+ +  A KK+ +   +    F  E+E +  + H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 794 PLLGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
            L    +   +  LV E    G L E V+H       +R+                + + 
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVH-------KRVFRESDAARIMKDVLSAVAYC 139
Query: 853 HHNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           H     ++ HRD+K  N L      +   ++ DFG+A   +       + T  GTP YV 
Sbjct: 140 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA---ARFKPGKMMRTKVGTPYYVS 193
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTG----KRPTDKDDFGDTNLVGWVKMKVREG 962
           P+  +      + D +S GV++  LL G      PTD +          V +K+REG
Sbjct: 194 PQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXE----------VMLKIREG 239

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 36/215 (16%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           +G G +GEV++  L  G SVA+K     S + ++ +  E E    +  +H N++  +   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF---SSRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 800 KIGE----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
                   +  L+  + + GSL + L        ++ L               L  LH  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQ-------RQTLEPHLALRLAVSAACGLAHLHVE 124
Query: 856 CI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST--LAGTPGYV 908
                  P I HRD KS NVL+   ++  ++D G+A + S    +L +      GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 909 PPEY---------YQSFRCTAKGDVYSFGVVLLEL 934
            PE          ++S++ T   D+++FG+VL E+
Sbjct: 185 APEVLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           IG G +GEV+    + G  VA+K         +  +  E E    +  +H N++  +   
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 800 KIGE----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
             G     +  L+ ++ + GSL + L  ++   D + +               LC LH  
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSM-----LKLAYSSVSGLCHLHTE 153
Query: 856 CI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLISAL-DTHLSVSTLAGTPGYV 908
                  P I HRD+KS N+L+       ++D G+A + IS   +  +  +T  GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 909 PPEYYQS------FRCTAKGDVYSFGVVLLEL 934
           PPE          F+     D+YSFG++L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNL 792
           F     +G GGFG VF+A  K D  + AIK+ IRL  +     + M E++ L K++H  +
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 793 VPLLGYC--KIGEERLL-----VYEFMKFG-----SLEEVLHGRAKARDQRILTWDXXXX 840
           V        K   E+L      VY +++       +L++ ++GR    ++          
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE---RSVCLH 122
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
                   + FLH   +   +HRD+K SN+    +   +V DFG   L++A+D      T
Sbjct: 123 IFLQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFG---LVTAMDQDEEEQT 176
Query: 901 L-------------AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELL 935
           +              GT  Y+ PE       + K D++S G++L ELL
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++  FG+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 36/233 (15%)
Query: 730 IEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK 788
           +   + F   +++G G FG+V KA    D    AIKK IR + +     ++E+  L  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLN 60
Query: 789 H-------------RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
           H             RN V  +   K      +  E+ +  +L +++H       QR   W
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE-NLNQQRDEYW 119
Query: 836 DXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS----- 890
                        L ++H   I   IHRD+K  N+ +D     ++ DFG+A+ +      
Sbjct: 120 ----RLFRQILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 891 -ALDTH------LSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELL 935
             LD+        ++++  GT  YV  E    +     K D+YS G++  E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 14/214 (6%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIR-------LSCQGDREFMAEMETL 784
           AT+ +   + IG G +G V+KA           K +R       L     RE +A +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVRE-VALLRRL 60
Query: 785 GKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXX 844
              +H N+V L+  C        +   + F  +++ L           L  +        
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 845 XXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
               L FLH NCI   +HRD+K  N+L+      +++DFG+AR+ S     ++++ +  T
Sbjct: 121 FLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAPVVVT 174
Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             Y  PE           D++S G +  E+   K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 78  GV--ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESK 130
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 186
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 721 LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREF 777
           L+   F    +  + +     IG G +G V  A  +  G  VAIKK+          +  
Sbjct: 41  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT 100
Query: 778 MAEMETLGKIKHRNLV-------PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ 830
           + E++ L   KH N++       P + Y +  +   +V + M+   L +++H        
Sbjct: 101 LRELKILKHFKHDNIIAIKDILRPTVPYGEF-KSVYVVLDLME-SDLHQIIHS------S 152
Query: 831 RILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR--L 888
           + LT +            L ++H      +IHRD+K SN+L++   E ++ DFGMAR   
Sbjct: 153 QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209
Query: 889 ISALDTHLSVSTLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKR 939
            S  +    ++    T  Y  PE   S    T   D++S G +  E+L  ++
Sbjct: 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF+    L++ +   A       +               L F
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTG----IPLPLIKSYLFQLLQGLAF 121
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 174
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ D G+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 726 FSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLG 785
           + Q +  ++G+  +  IG G + E  +   K   +  ++  +++  +  R+   E+E L 
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHK---ATNMEYAVKVIDKSKRDPSEEIEILL 75
Query: 786 KI-KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXX 844
           +  +H N++ L      G+   LV E M+ G L +      K   Q+  +          
Sbjct: 76  RYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLD------KILRQKFFSEREASFVLHT 129
Query: 845 XXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEME----ARVSDFGMARLISALDTHLSVST 900
               + +LH   +   +HRD+K SN+L   E       R+ DFG A+ + A +  L   T
Sbjct: 130 IGKTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MT 184
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
              T  +V PE  +        D++S G++L  +L G  P
Sbjct: 185 PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 742 IGCGGFGEVFKATL-KDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           +G G +G V  A   + G+ VAIKKL R   S    +    E+  L  ++H N++ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 799 CKIGE------ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
               E      +  LV  FM  G+    L    K  + RI                L ++
Sbjct: 93  FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI------QFLVYQMLKGLRYI 144
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           H   I   IHRD+K  N+ ++ + E ++ DFG+AR     D+ +    +  T  Y  PE 
Sbjct: 145 HAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVV--TRWYRAPEV 196
Query: 913 YQSF-RCTAKGDVYSFGVVLLELLTGK 938
             ++ R T   D++S G ++ E++TGK
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 106 GV--ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESK 158
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 159 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 214
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 215 RRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 65  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTPGYV 908
            H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+     P  +
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 176
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
               Y S       D++S G +  E++T +
Sbjct: 177 LGCKYYS----TAVDIWSLGCIFAEMVTRR 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 63  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTPGYV 908
            H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+     P  +
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
               Y S       D++S G +  E++T +
Sbjct: 175 LGCKYYS----TAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 729 LIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETL 784
           L++  N F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L
Sbjct: 3   LVDMEN-FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLL 60
Query: 785 GKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXX 844
            ++ H N+V LL       +  LV+EF     L + L     A     +           
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 845 XXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTL 901
               L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+  
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 172
Query: 902 AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
              P  +    Y S       D++S G +  E++T +
Sbjct: 173 YRAPEILLGCKYYS----TAVDIWSLGCIFAEMVTRR 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT---WDXXXXXXXXXXXX 848
           +V LL       +  LV+EF+             K  D   LT                 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTP 905
           L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+     P
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             +    Y S       D++S G +  E++T +
Sbjct: 173 EILLGCKYYS----TAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT---WDXXXXXXXXXXXX 848
           +V LL       +  LV+EF+             K  D   LT                 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTP 905
           L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+     P
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             +    Y S       D++S G +  E++T +
Sbjct: 172 EILLGCKYYS----TAVDIWSLGCIFAEMVTRR 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF+    L++ +   A       +               L F
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTG----IPLPLIKSYLFQLLQGLAF 120
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 173
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTPGYV 908
            H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+     P  +
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
               Y S       D++S G +  E++T +
Sbjct: 176 LGCKYYS----TAVDIWSLGCIFAEMVTRR 201

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 17/217 (7%)
Query: 732 ATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKL---------IRLSCQGDREFMAEM 781
           AT+ +   + IG G +G V+KA     G  VA+K +           L     RE +A +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE-VALL 65
Query: 782 ETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXX 841
             L   +H N+V L+  C        +   + F  +++ L           L  +     
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 842 XXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
                  L FLH NCI   +HRD+K  N+L+      +++DFG+AR+ S     ++++ +
Sbjct: 126 MRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALTPV 179
Query: 902 AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             T  Y  PE           D++S G +  E+   K
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ D G+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 78  GV--ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESK 130
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 186
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 18/219 (8%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKH 789
           ++ +  +  +G G F  V +   K        K+I   +LS +  ++   E     K++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
            N+V L    +      LV++ +  G L E +  R         +              +
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESI 141
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPG 906
            + H N I   +HR++K  N+LL  + +    +++DFG+A  I   D+  +    AGTPG
Sbjct: 142 AYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSE-AWHGFAGTPG 195
Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           Y+ PE  +    +   D+++ GV+L  LL G  P   +D
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 83  GV--ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESK 135
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 136 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 191
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 14/214 (6%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIR-------LSCQGDREFMAEMETL 784
           AT+ +   + IG G +G V+KA           K +R       L     RE +A +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVRE-VALLRRL 60
Query: 785 GKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXX 844
              +H N+V L+  C        +   + F  +++ L           L  +        
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 845 XXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
               L FLH NCI   +HRD+K  N+L+      +++DFG+AR+ S     +++  +  T
Sbjct: 121 FLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVVT 174
Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             Y  PE           D++S G +  E+   K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 81  GV--ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESK 133
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 134 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 189
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 190 RRFTSASDVWMFGVCMWEILMHGVKP 215

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRN 791
           ++G+  +  IG G + E  +   K   +  ++  +++  +  R+   E+E L +  +H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHK---ATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPN 82
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           ++ L      G+   LV E M+ G L +      K   Q+  +              + +
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLD------KILRQKFFSEREASFVLHTIGKTVEY 136
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEME----ARVSDFGMARLISALDTHLSVSTLAGTPGY 907
           LH   +   +HRD+K SN+L   E       R+ DFG A+ + A +  L   T   T  +
Sbjct: 137 LHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTPCYTANF 191
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           V PE  +        D++S G++L  +L G  P
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 80  GV--ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESK 132
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 133 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 188
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 189 RRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT---WDXXXXXXXXXXXX 848
           +V LL       +  LV+EF+             K  D   LT                 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTP 905
           L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+     P
Sbjct: 116 LSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             +    Y S       D++S G +  E++T +
Sbjct: 173 EILLGCKYYS----TAVDIWSLGCIFAEMVTRR 201

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 75  GV--ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESK 127
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 128 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 183
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKP 209

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 78  GV--ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-----LYAYQLSTALAYLESK 130
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQ 914
                +HRD+ + NVL+      ++ DFG++R +   D+    ++    P  ++ PE   
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTXXKASKGKLPIKWMAPESIN 185
Query: 915 SFRCTAKGDVYSFGVVLLELLT-GKRP 940
             R T+  DV+ FGV + E+L  G +P
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF+    L++ +   A       +               L F
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTG----IPLPLIKSYLFQLLQGLAF 121
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 122 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 174
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKH 789
           ++ +  +  +G G F  V +   K        K+I   +LS +  ++   E     K++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 790 RNLVPLLGYCKIGEERL--LVYEFMKFGSLEEVLHGR-------AKARDQRILTWDXXXX 840
            N+V L  +  I EE    LV++ +  G L E +  R       A    Q+IL       
Sbjct: 65  PNIVRL--HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE------ 116
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLS 897
                   + + H N    I+HR++K  N+LL  + +    +++DFG+A  I   D+  +
Sbjct: 117 -------SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSE-A 163
Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
               AGTPGY+ PE  +    +   D+++ GV+L  LL G  P   +D
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKH 789
           ++ +  +  +G G F  V +   K        K+I   +LS +  ++   E     K++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 790 RNLVPLLGYCKIGEERL--LVYEFMKFGSLEEVLHGR-------AKARDQRILTWDXXXX 840
            N+V L  +  I EE    LV++ +  G L E +  R       A    Q+IL       
Sbjct: 64  PNIVRL--HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE------ 115
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLS 897
                   + + H N    I+HR++K  N+LL  + +    +++DFG+A  I   D+  +
Sbjct: 116 -------SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSE-A 162
Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
               AGTPGY+ PE  +    +   D+++ GV+L  LL G  P   +D
Sbjct: 163 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKH 789
           ++ +  +  +G G F  V +   K        K+I   +LS +  ++   E     K++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 790 RNLVPLLGYCKIGEERL--LVYEFMKFGSLEEVLHGR-------AKARDQRILTWDXXXX 840
            N+V L  +  I EE    LV++ +  G L E +  R       A    Q+IL       
Sbjct: 65  PNIVRL--HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE------ 116
Query: 841 XXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLS 897
                   + + H N    I+HR++K  N+LL  + +    +++DFG+A  I   D+  +
Sbjct: 117 -------SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSE-A 163
Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
               AGTPGY+ PE  +    +   D+++ GV+L  LL G  P   +D
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF+    L++ +   A       +               L F
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTG----IPLPLIKSYLFQLLQGLAF 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 172
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 67  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 174
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 27/232 (11%)
Query: 716 TFQRQ-LRKLKFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIR--LSC 771
           TF RQ L K     + E    +   S +G G +G V  A   K G  VA+KKL R   S 
Sbjct: 7   TFYRQELNK----TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 772 QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
              +    E+  L  +KH N++ LL                +F  +  V H      +  
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS------LEEFNDVYLVTHLMGADLNNI 116
Query: 832 I----LTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
           +    LT D            L ++H      IIHRD+K SN+ ++ + E ++ D G+AR
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR 173
Query: 888 LISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK 938
                 T   ++    T  Y  PE   ++       D++S G ++ ELLTG+
Sbjct: 174 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRNLVPLLGY 798
           IG G +G VFKA  ++   +   K +RL    +      + E+  L ++KH+N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIP 858
               ++  LV+EF     L++         D  I+               L F H     
Sbjct: 70  LHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVK-----SFLFQLLKGLGFCHSR--- 120
Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
           +++HRD+K  N+L++   E ++++FG+AR         S   +  T  Y PP+     + 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKL 178
Query: 919 TAKG-DVYSFGVVLLELLTGKRP----TDKDD 945
            +   D++S G +  EL    RP     D DD
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 42/225 (18%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G +G V   + A L+    VA+KKL R   S    R    E+  L  +KH N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 797 GYCKIG------EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
                        E  LV   M    L  ++  +A       L+ +            L 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQA-------LSDEHVQFLVYQLLRGLK 145
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           ++H   I   IHRD+K SNV ++ + E R+ DFG+AR     D  ++        GYV  
Sbjct: 146 YIHSAGI---IHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVAT 191
Query: 911 EYYQS-------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
            +Y++              D++S G ++ ELL GK      D+ D
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYID 236

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +GCGG G VF A   D    VAIKK++    Q  +  + E++ + ++ H N+V +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 801 IGEERL--------------LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXX 846
               +L              +V E+M+      +  G       R+  +           
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRG------ 132
Query: 847 XXLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHL-SVSTLAGT 904
             L ++H     +++HRD+K +N+ ++ E +  ++ DFG+AR++    +H   +S    T
Sbjct: 133 --LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  P    S     K  D+++ G +  E+LTGK
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 171
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT---WDXXXXXXXXXXXX 848
           +V LL       +  LV+EF+             K  D   LT                 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPG 906
           L F H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----W 168
Query: 907 YVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           Y  PE     +  +   D++S G +  E++T +
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT---WDXXXXXXXXXXXX 848
           +V LL       +  LV+EF+             K  D   LT                 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPG 906
           L F H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----W 167
Query: 907 YVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           Y  PE     +  +   D++S G +  E++T +
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 78  GV--ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-----LYAYQLSTALAYLESK 130
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 131 ---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 186
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 68  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 175
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 66  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 173
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 67  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 174
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 66  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 173
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 108/245 (44%), Gaps = 40/245 (16%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR--LSCQGDRE-FMAEMETLGKIK 788
           ++ +  + ++G G FGEV     K  G   A+K + +  +  + D+E  + E++ L ++ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD---QRILTWDXXXXXXXXX 845
           H N++ L  + +      LV E    G L + +  R +  +    RI+            
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---------QV 135
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMARLISALDTHLSVSTLA 902
              + ++H N    I+HRD+K  N+LL+    +   R+ DFG++       TH   S   
Sbjct: 136 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKM 185
Query: 903 ----GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK 958
               GT  Y+ PE         K DV+S GV+L  LL+G  P     F   N    +K K
Sbjct: 186 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP-----FNGANEYDILK-K 238
Query: 959 VREGK 963
           V +GK
Sbjct: 239 VEKGK 243

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 42/225 (18%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G +G V   + A L+    VA+KKL R   S    R    E+  L  +KH N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 797 GYCKIG------EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
                        E  LV   M    L  ++  +A       L+ +            L 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQA-------LSDEHVQFLVYQLLRGLK 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           ++H   I   IHRD+K SNV ++ + E R+ DFG+AR     D  ++        GYV  
Sbjct: 138 YIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMT--------GYVAT 183
Query: 911 EYYQS-------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
            +Y++              D++S G ++ ELL GK      D+ D
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYID 228

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 63  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 170
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 67  IVKLLDVIHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 174
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 171
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF+    L++ +   A       +               L F
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH-QDLKDFMDASALTG----IPLPLIKSYLFQLLQGLAF 118
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 171
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 64  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 171
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 65  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 172
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 66  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 173
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 65  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 172
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGD----REFMAEMETLGKIK 788
           +    L+G GGFG V+    + D   VAIK +   R+S  G+         E+  L K+ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 789 --HRNLVPLLGYCKIGEERLLVYEFMK-FGSLEEVLHGRAKARDQ--RILTWDXXXXXXX 843
                ++ LL + +  +  +L+ E M+    L + +  R   +++  R   W        
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 844 XXXXXLCFLHHNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLA 902
                 C   HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   
Sbjct: 130 ------C---HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFD 174
Query: 903 GTPGYVPPEYYQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
           GT  Y PPE+ +  R   +   V+S G++L +++ G  P + D+
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 218

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 14/214 (6%)
Query: 732 ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIR-------LSCQGDREFMAEMETL 784
           AT+ +   + IG G +G V+KA           K +R       L     RE +A +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVRE-VALLRRL 60
Query: 785 GKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXX 844
              +H N+V L+  C        +   + F  +++ L           L  +        
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 845 XXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
               L FLH NCI   +HRD+K  N+L+      +++DFG+AR+ S     +++  +  T
Sbjct: 121 FLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFPVVVT 174
Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             Y  PE           D++S G +  E+   K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 33/231 (14%)
Query: 731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR------LSCQGDREFMAEMET 783
           E    + + + +G G +G V  A  K  G  VAIKKL R       + +  RE +     
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----L 76
Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEF---MKF--GSLEEVLHGRAKARDQRILTWDXX 838
           L  ++H N++ LL            Y+F   M F    L++++  +      + L +   
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML 136
Query: 839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
                     L ++H   +   +HRD+K  N+ ++ + E ++ DFG+AR   A  T   V
Sbjct: 137 KG--------LKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 899 STLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
                T  Y  PE   S+       D++S G ++ E+LTGK      D+ D
Sbjct: 186 -----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 458 GV--ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-----LYAYQLSTALAYLESK 510
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 511 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 566
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           +V LL       +  LV+EF     L + L     A     +               L F
Sbjct: 65  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPGYVP 909
            H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     Y  
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----WYRA 172
Query: 910 PEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           PE     +  +   D++S G +  E++T +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 731 EATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKH 789
           E  +  + +  +G G FGEV +   K  G   A+KK +RL      E +A       +  
Sbjct: 55  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK-VRLEVFRVEELVA----CAGLSS 109
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             +VPL G  + G    +  E ++ GSL +++       + R L +             L
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY------LGQALEGL 163
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVST---LAGTP 905
            +LH      I+H D+K+ NVLL  +   A + DFG A  +       S+ T   + GT 
Sbjct: 164 EYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            ++ PE      C AK D++S   ++L +L G  P
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 19/235 (8%)
Query: 202 LLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSG 261
           LLDL NN I+    D   +NL +L +LIL NN IS   P + +    L  +  S N++  
Sbjct: 56  LLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE 114
Query: 262 IIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL------NGSIPQE 315
           +  P+  P   +L+ELR+ +N IT V     +   Q+ V++L  N L      NG+  Q 
Sbjct: 115 L--PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF-QG 169
Query: 316 LGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISL 375
           + KL ++         +   +PP L                     A L   +NL  + L
Sbjct: 170 MKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDA------ASLKGLNNLAKLGL 223
Query: 376 TGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG 430
           + N ++       +    L  L L NN+   ++PG L +   +  + L++NN++ 
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 19/235 (8%)
Query: 202 LLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSG 261
           LLDL NN I+    D   +NL +L +LIL NN IS   P + +    L  +  S N++  
Sbjct: 56  LLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE 114
Query: 262 IIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL------NGSIPQE 315
           +  P+  P   +L+ELR+ +N IT V     +   Q+ V++L  N L      NG+  Q 
Sbjct: 115 L--PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF-QG 169
Query: 316 LGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXXXXXXXXSGEIPAELFSCSNLEWISL 375
           + KL ++         +   +PP L                     A L   +NL  + L
Sbjct: 170 MKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDA------ASLKGLNNLAKLGL 223
Query: 376 TGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG 430
           + N ++       +    L  L L NN+   ++PG L +   +  + L++NN++ 
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 742 IGCGGFGEVFKATLKDGSSVAI-------KKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           IG G F  V+K  L   ++V +       +KL +   Q    F  E E L  ++H N+V 
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 795 LL----GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRIL-TWDXXXXXXXXXXXXL 849
                    K  +  +LV E    G+L+  L  R K    ++L +W             L
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLK-RFKVXKIKVLRSW------CRQILKGL 142
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            FLH    P IIHRD+K  N+ +       ++ D G+A L  A         + GTP + 
Sbjct: 143 QFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFX 197
Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            PE Y+  +     DVY+FG   LE  T + P
Sbjct: 198 APEXYEE-KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 108/245 (44%), Gaps = 40/245 (16%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR--LSCQGDRE-FMAEMETLGKIK 788
           ++ +  + ++G G FGEV     K  G   A+K + +  +  + D+E  + E++ L ++ 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD---QRILTWDXXXXXXXXX 845
           H N++ L  + +      LV E    G L + +  R +  +    RI+            
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII---------RQV 158
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMARLISALDTHLSVSTLA 902
              + ++H N    I+HRD+K  N+LL+    +   R+ DFG++       TH   S   
Sbjct: 159 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKM 208
Query: 903 ----GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK 958
               GT  Y+ PE         K DV+S GV+L  LL+G  P     F   N    +K K
Sbjct: 209 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP-----FNGANEYDILK-K 261
Query: 959 VREGK 963
           V +GK
Sbjct: 262 VEKGK 266

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 742 IGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHN 855
           G   I E  + ++ E    G L   L  R  + D   L               L +L   
Sbjct: 458 GV--ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-----LYAYQLSTALAYLESK 510
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+ + NVL+      ++ DFG++R +    T+   S       ++ PE    
Sbjct: 511 ---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 566
Query: 916 FRCTAKGDVYSFGVVLLELLT-GKRP 940
            R T+  DV+ FGV + E+L  G +P
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR--LSCQGDRE-FMAEMETLGKIK 788
           ++ +  + ++G G FGEV     K  G   A+K + +  +  + D+E  + E++ L ++ 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD---QRILTWDXXXXXXXXX 845
           H N++ L  + +      LV E    G L + +  R +  +    RI+            
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII---------RQV 159
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMARLISALDTHLSVSTLA 902
              + ++H N    I+HRD+K  N+LL+    +   R+ DFG++       TH   S   
Sbjct: 160 LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKM 209
Query: 903 ----GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
               GT  Y+ PE         K DV+S GV+L  LL+G
Sbjct: 210 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSG 247

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 33/231 (14%)
Query: 731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR------LSCQGDREFMAEMET 783
           E    + + + +G G +G V  A  K  G  VAIKKL R       + +  RE +     
Sbjct: 39  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----L 94
Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEF---MKF--GSLEEVLHGRAKARDQRILTWDXX 838
           L  ++H N++ LL            Y+F   M F    L++++         + L +   
Sbjct: 95  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQML 154
Query: 839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
                     L ++H   +   +HRD+K  N+ ++ + E ++ DFG+AR   A  T   V
Sbjct: 155 KG--------LKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 203
Query: 899 STLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD 948
                T  Y  PE   S+       D++S G ++ E+LTGK      D+ D
Sbjct: 204 -----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 249

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 731 EATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKH 789
           E  +  + +  +G G FGEV +   K  G   A+KK +RL      E +A       +  
Sbjct: 71  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK-VRLEVFRVEELVA----CAGLSS 125
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             +VPL G  + G    +  E ++ GSL +++      +    L  D            L
Sbjct: 126 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGL 179
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVST---LAGTP 905
            +LH      I+H D+K+ NVLL  +   A + DFG A  +       S+ T   + GT 
Sbjct: 180 EYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 236
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            ++ PE      C AK D++S   ++L +L G  P
Sbjct: 237 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +       +  TL GTP Y+ PE   S    
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAPEIILSKGYN 237
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 238 KAVDWWALGVLIYEMAAGYPP 258

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 21/221 (9%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKH 789
           T+ +     +G G F  V +   K  +     K+I   +LS +  ++   E      +KH
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 790 RNLVPLLGYCKIGEE--RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
            N+V L  +  I EE    LV++ +  G L E +  R          +            
Sbjct: 90  PNIVRL--HDSISEEGFHYLVFDLVTGGELFEDIVAR---------EYYSEADASHCIHQ 138
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGT 904
            L  ++H     I+HRD+K  N+LL  + +    +++DFG+A  I       +    AGT
Sbjct: 139 ILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGT 196
Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PGY+ PE  +        D+++ GV+L  LL G  P   +D
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDED 237

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 31/237 (13%)
Query: 717 FQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQG 773
           +++ ++K++  Q+      +    +IG G FGEV     K    V   KL+    +  + 
Sbjct: 60  YEKIVKKIRGLQM--KAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRS 117
Query: 774 DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL--VYEFMKFGSLEEVLHGRAKARDQR 831
           D  F  E   +    +   V  L +C   +++ L  V E+M  G L  ++          
Sbjct: 118 DSAFFWEERDIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--- 173
Query: 832 ILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA 891
              W             L  +H   +   IHRD+K  N+LLD     +++DFG    +  
Sbjct: 174 --KW--AKFYTAEVVLALDAIHSMGL---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 226
Query: 892 LDTHLSVSTLAGTPGYVPPEY--------YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
               +   T  GTP Y+ PE         Y    C    D +S GV L E+L G  P
Sbjct: 227 TGM-VHCDTAVGTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFLFEMLVGDTP 278

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 731 EATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKH 789
           E  +  + +  +G G FGEV +   K  G   A+KK +RL      E +A       +  
Sbjct: 69  EEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKK-VRLEVFRVEELVA----CAGLSS 123
Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             +VPL G  + G    +  E ++ GSL +++      +    L  D            L
Sbjct: 124 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGL 177
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVST---LAGTP 905
            +LH      I+H D+K+ NVLL  +   A + DFG A  +       S+ T   + GT 
Sbjct: 178 EYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 234
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            ++ PE      C AK D++S   ++L +L G  P
Sbjct: 235 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+ K IRL  + +      + E+  L ++ H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXK-IRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT---WDXXXXXXXXXXXX 848
           +V LL       +  LV+EF+             K  D   LT                 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTP 905
           L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+     P
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             +    Y S       D++S G +  E++T +
Sbjct: 173 EILLGCKYYS----TAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+ K IRL  + +      + E+  L ++ H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXK-IRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT---WDXXXXXXXXXXXX 848
           +V LL       +  LV+EF+             K  D   LT                 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVSTLAGTP 905
           L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+     P
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             +    Y S       D++S G +  E++T +
Sbjct: 172 EILLGCKYYS----TAVDIWSLGCIFAEMVTRR 200

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 34/214 (15%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           +G G +GEV++ + + G +VA+K     S + ++ +  E E    +  +H N++  +   
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 800 KIGEER----LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX--XXXXXXXXXLCFLH 853
                      L+  + + GSL + L         ++ T D              L  LH
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYL---------QLTTLDTVSCLRIVLSIASGLAHLH 151
Query: 854 HNCI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST--LAGTPG 906
                    P I HRD+KS N+L+    +  ++D G+A + S     L V      GT  
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 907 YVPPEYYQS------FRCTAKGDVYSFGVVLLEL 934
           Y+ PE          F    + D+++FG+VL E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG-DREFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILL 80
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR--LSCQGDRE-FMAEMETLGKIK 788
           ++ +  + ++G G FGEV     K  G   A+K + +  +  + D+E  + E++ L ++ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 789 HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD---QRILTWDXXXXXXXXX 845
           H N+  L  + +      LV E    G L + +  R +  +    RI+            
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII---------RQV 135
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMARLISALDTHLSVSTLA 902
              + + H N    I+HRD+K  N+LL+    +   R+ DFG++       TH   S   
Sbjct: 136 LSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKX 185
Query: 903 ----GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG 937
               GT  Y+ PE         K DV+S GV+L  LL+G
Sbjct: 186 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSG 223

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 104/250 (41%), Gaps = 36/250 (14%)
Query: 705 KEKEPLSINVATFQRQLRKLKFSQLI--EATNGFSAESLIGCGGFGEVFKATLKDGSSVA 762
           KEK+   IN     R L + KF+++I  E  N F A          +    T  +   ++
Sbjct: 24  KEKDKY-INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKIS 82
Query: 763 IKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLH 822
           IK           +F  E++ +  IK+   +   G     +E  ++YE+M+  S+ +   
Sbjct: 83  IK-------SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF-- 133
Query: 823 GRAKARDQRILTWDXXXXXXXXXXXXLC----------FLHHNCIPHIIHRDMKSSNVLL 872
                 D+     D             C          ++H+    +I HRD+K SN+L+
Sbjct: 134 ------DEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILM 185
Query: 873 DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY--QSFRCTAKGDVYSFGVV 930
           D     ++SDFG +  +  +D  +  S   GT  ++PPE++  +S    AK D++S G+ 
Sbjct: 186 DKNGRVKLSDFGESEYM--VDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 931 LLELLTGKRP 940
           L  +     P
Sbjct: 242 LYVMFYNVVP 251

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 34/214 (15%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           +G G +GEV++ + + G +VA+K     S + ++ +  E E    +  +H N++  +   
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 800 KIGEER----LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX--XXXXXXXXXLCFLH 853
                      L+  + + GSL + L         ++ T D              L  LH
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL---------QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 854 HNCI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST--LAGTPG 906
                    P I HRD+KS N+L+    +  ++D G+A + S     L V      GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 907 YVPPEYYQS------FRCTAKGDVYSFGVVLLEL 934
           Y+ PE          F    + D+++FG+VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +          TL GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           LAGTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 23/227 (10%)
Query: 732 ATNGF---SAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKI 787
           A N F   S   ++G G FG+V K            K+I+     D+E +  E+  + ++
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRIL--TWDXXXXXXXXX 845
            H NL+ L    +   + +LV E++  G L +           RI+  +++         
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFD-----------RIIDESYNLTELDTILF 192
Query: 846 XXXLCF-LHHNCIPHIIHRDMKSSNVLLDHE--MEARVSDFGMARLISALDTHLSVSTLA 902
              +C  + H    +I+H D+K  N+L  +    + ++ DFG+AR     +  L V+   
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-- 249
Query: 903 GTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           GTP ++ PE       +   D++S GV+   LL+G  P   D+  +T
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 34/214 (15%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYC 799
           +G G +GEV++ + + G +VA+K     S + ++ +  E E    +  +H N++  +   
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 800 KIGEER----LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXX--XXXXXXXXXLCFLH 853
                      L+  + + GSL + L         ++ T D              L  LH
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL---------QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 854 HNCI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST--LAGTPG 906
                    P I HRD+KS N+L+    +  ++D G+A + S     L V      GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 907 YVPPEYYQS------FRCTAKGDVYSFGVVLLEL 934
           Y+ PE          F    + D+++FG+VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGS----SVAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVP 794
           +G G FG V +      S    SVA+K L   +    +   +F+ E+  +  + HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L G   +     +V E    GSL + L      + Q                  + +L  
Sbjct: 80  LYGVV-LTPPMKMVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYY 913
                 IHRD+ + N+LL      ++ DFG+ R +   D H  +      P  +  PE  
Sbjct: 134 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++   +   D + FGV L E+ T G+ P
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +          TL GTP Y+ PE   S    
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEIILSKGYN 202
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 203 KAVDWWALGVLIYEMAAGYPP 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMA-RLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
           +IHRD+K SN+LLD   + ++ DFG++ RL+       S    AG   Y+ PE       
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS----AGCAAYMAPERIDPPDP 201
Query: 919 TA-----KGDVYSFGVVLLELLTGKRPTD--KDDF 946
           T      + DV+S G+ L+EL TG+ P    K DF
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 25  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 84
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 85  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 141
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 142 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 79  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 135
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGS----SVAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVP 794
           +G G FG V +      S    SVA+K L   +    +   +F+ E+  +  + HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L G   +     +V E    GSL + L      + Q                  + +L  
Sbjct: 86  LYGVV-LTPPMKMVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYY 913
                 IHRD+ + N+LL      ++ DFG+ R +   D H  +      P  +  PE  
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196
Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++   +   D + FGV L E+ T G+ P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 185
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 219

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 227
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 261

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 74
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 131
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 132 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 227
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 261

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 81
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 138
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 139 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 23  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 82
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 139
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 140 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 14  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 73
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 130
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 131 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 212
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 213
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH---LSNDHICYFLYQI 137
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 212
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGS----SVAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVP 794
           +G G FG V +      S    SVA+K L   +    +   +F+ E+  +  + HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L G   +     +V E    GSL + L      + Q                  + +L  
Sbjct: 86  LYGVV-LTPPMKMVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYY 913
                 IHRD+ + N+LL      ++ DFG+ R +   D H  +      P  +  PE  
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++   +   D + FGV L E+ T G+ P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 74
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 131
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 132 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 227
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 261

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 212
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 185
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 219

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 213
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 133
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 180
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 213
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGS----SVAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVP 794
           +G G FG V +      S    SVA+K L   +    +   +F+ E+  +  + HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L G   +     +V E    GSL + L      + Q                  + +L  
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYY 913
                 IHRD+ + N+LL      ++ DFG+ R +   D H  +      P  +  PE  
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++   +   D + FGV L E+ T G+ P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 154 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 207
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 241

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 130 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 183
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 217

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 213
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 212
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGS----SVAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVP 794
           +G G FG V +      S    SVA+K L   +    +   +F+ E+  +  + HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L G   +     +V E    GSL + L      + Q                  + +L  
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYY 913
                 IHRD+ + N+LL      ++ DFG+ R +   D H  +      P  +  PE  
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++   +   D + FGV L E+ T G+ P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 179 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 232
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 266

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 185
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 219

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 131 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 184
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 218

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 180
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGS----SVAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVP 794
           +G G FG V +      S    SVA+K L   +    +   +F+ E+  +  + HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L G   +     +V E    GSL + L      + Q                  + +L  
Sbjct: 80  LYGVV-LTPPMKMVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYY 913
                 IHRD+ + N+LL      ++ DFG+ R +   D H  +      P  +  PE  
Sbjct: 134 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++   +   D + FGV L E+ T G+ P
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 146 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 199
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 233

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 200
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 234

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 146 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 199
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 233

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 153
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 154 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 200
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 792 LVPLLGYCKIGEERLLVYE--------FMKFGSLEEVLHGRAKARDQRILTWDXXXXXXX 843
           +V LL       +  LV+E        FM   +L  +     K+   ++L          
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQ--------- 113
Query: 844 XXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA---LDTHLSVST 900
                L F H +    ++HRD+K  N+L++ E   +++DFG+AR         TH  V+ 
Sbjct: 114 ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
Query: 901 LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
               P  +    Y S       D++S G +  E++T +
Sbjct: 167 WYRAPEILLGCKYYS----TAVDIWSLGCIFAEMVTRR 200

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 166 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 219
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 854 HNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
           HNC   ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEW 200
Query: 913 YQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDD 945
            +  R   +   V+S G++L +++ G  P + D+
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 234

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 742 IGCGGFGEVFKATLKDGS----SVAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVP 794
           +G G FG V +      S    SVA+K L   +    +   +F+ E+  +  + HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L G   +     +V E    GSL + L      + Q                  + +L  
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYY 913
                 IHRD+ + N+LL      ++ DFG+ R +   D H  +      P  +  PE  
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 914 QSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           ++   +   D + FGV L E+ T G+ P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
           F     IG G +G V+KA  K  G  VA+KK IRL  + +      + E+  L ++ H N
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT---WDXXXXXXXXXXXX 848
           +V LL       +  LV+E         V     K  D   LT                 
Sbjct: 67  IVKLLDVIHTENKLYLVFE--------HVDQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHL-SVSTLAGTPG 906
           L F H +    ++HRD+K  N+L++ E   +++DFG+AR     + T+   V TL     
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL----W 171
Query: 907 YVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
           Y  PE     +  +   D++S G +  E++T +
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 25/228 (10%)
Query: 724 LKFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDR------E 776
           L F  ++E       E  +G G F  V K   K  G   A K + +      R      E
Sbjct: 18  LYFQSMVEDHYEMGEE--LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREE 75
Query: 777 FMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWD 836
              E+  L +I+H N++ L    +   + +L+ E +  G L + L       ++  LT D
Sbjct: 76  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL------AEKESLTED 129
Query: 837 XXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISAL 892
                       + +LH   I H    D+K  N+ LLD  +     ++ DFG+A  I A 
Sbjct: 130 EATQFLKQILDGVHYLHSKRIAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 186
Query: 893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +       + GTP +V PE         + D++S GV+   LL+G  P
Sbjct: 187 N---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 14/217 (6%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR--AKARDQRILTWDXXXXXXX 843
           + +H N++ +         R    E MK   L   L G    K    + L+ D       
Sbjct: 97  RFRHENIIGINDII-----RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLY 151
Query: 844 XXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LA 902
                L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T   
Sbjct: 152 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 903 GTPGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
            T  Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS-VSTLAGTPGYVPPEYYQSFRCTA 920
           HRD+K  N+L+  +  A + DFG+A   +  D  L+ +    GT  Y  PE +     T 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 921 KGDVYSFGVVLLELLTGKRPTDKDDF 946
           + D+Y+   VL E LTG  P   D  
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQL 240

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 47/202 (23%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V +          + K +++          E+  L   +HRN++ L    + 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH-HNCIPHI 860
            EE ++++EF+    + E ++  A   ++R +               L FLH HN    I
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIV-----SYVHQVCEALQFLHSHN----I 123
Query: 861 IHRDMKSSNVLLDHEMEA--RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
            H D++  N++      +  ++ +FG AR +   D   +   L   P Y  PE +Q    
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVV 180
Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
           +   D++S G ++  LL+G  P
Sbjct: 181 STATDMWSLGTLVYVLLSGINP 202

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 18/209 (8%)
Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR---LSCQGDREFMAEMETLGKIKHRN 791
           F     IG G FG V     ++ G+  A+K L +   +  +     + E   L  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           LV L    K      +V E+M  G +   L        +RI  +             L F
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHL--------RRIGRFSEPHARFYAAQIVLTF 154
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            + + +  +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE
Sbjct: 155 EYLHSLD-LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
              S       D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 18/209 (8%)
Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR---LSCQGDREFMAEMETLGKIKHRN 791
           F     IG G FG V     ++ G+  A+K L +   +  +     + E   L  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCF 851
           LV L    K      +V E+M  G +   L        +RI  +             L F
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHL--------RRIGRFSEPHARFYAAQIVLTF 154
Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            + + +  +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE
Sbjct: 155 EYLHSLD-LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
              S       D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 85/229 (37%), Gaps = 29/229 (12%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDREFMAEM 781
           K   L      +    +IG G FGEV     K    V   KL+    +  + D  F  E 
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 782 ETLGKIKHRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGR-AKARDQRILTWDXXX 839
             +    +   V  L Y    +  L +V E+M  G L  ++       +  R  T     
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYT----- 174
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  +H       IHRD+K  N+LLD     +++DFG    ++  +  +   
Sbjct: 175 ---AEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCD 227
Query: 900 TLAGTPGYVPPEY--------YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           T  GTP Y+ PE         Y    C    D +S GV L E+L G  P
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFLYEMLVGDTP 272

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 742 IGCGGFGEVFK----ATLKDGSSVAIKKLIRLSCQ----GDREFMAEMETLGKIKHRNLV 793
           +G G F  V K     T K+ ++  IKK  RLS         E   E+  L +I+H N++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKR-RLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            L    +   + +L+ E +  G L + L       ++  LT D            + +LH
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFL------AEKESLTEDEATQFLKQILDGVHYLH 132
Query: 854 HNCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
              I H    D+K  N+ LLD  +     ++ DFG+A  I A +       + GTP +V 
Sbjct: 133 SKRIAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVA 186
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE         + D++S GV+   LL+G  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 742 IGCGGFGEVFK----ATLKDGSSVAIKKLIRLSCQ----GDREFMAEMETLGKIKHRNLV 793
           +G G F  V K     T K+ ++  IKK  RLS         E   E+  L +I+H N++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKR-RLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            L    +   + +L+ E +  G L + L       ++  LT D            + +LH
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLA------EKESLTEDEATQFLKQILDGVHYLH 125
Query: 854 HNCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
              I H    D+K  N+ LLD  +     ++ DFG+A  I A +       + GTP +V 
Sbjct: 126 SKRIAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVA 179
Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE         + D++S GV+   LL+G  P
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHRNLV 793
           ++    IG G +G V  A      + VAIKK+     Q   +  + E++ L + +H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH 853
            +    +      +   ++    +E  L+   K++    L+ D            L ++H
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ---LSNDHICYFLYQILRGLKYIH 161
Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGTPGYVPPEY 912
                +++HRD+K SN+L++   + ++ DFG+AR+      H    T    T  Y  PE 
Sbjct: 162 S---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 913 YQSFRCTAKG-DVYSFGVVLLELLTGK 938
             + +   K  D++S G +L E+L+ +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 742 IGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
           +G G +GEV     K T  + +   IKK    +       + E+  L ++ H N++ L  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 798 YCKIGEERLLVYEFMKFGSL--EEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH-H 854
           + +      LV E  + G L  E +L  +    D  ++                 +LH H
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM--------KQVLSGTTYLHKH 140
Query: 855 NCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           N    I+HRD+K  N+LL+ +      ++ DFG++   +  +    +    GT  Y+ PE
Sbjct: 141 N----IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTAYYIAPE 193
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
             +  +   K DV+S GV+L  LL G  P
Sbjct: 194 VLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAI+K+     Q   +  + E++ L 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILL 80
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 85/229 (37%), Gaps = 29/229 (12%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDREFMAEM 781
           K   L      +    +IG G FGEV     K    V   KL+    +  + D  F  E 
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 782 ETLGKIKHRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGR-AKARDQRILTWDXXX 839
             +    +   V  L Y    +  L +V E+M  G L  ++       +  R  T     
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYT----- 179
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  +H       IHRD+K  N+LLD     +++DFG    ++  +  +   
Sbjct: 180 ---AEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCD 232
Query: 900 TLAGTPGYVPPEY--------YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           T  GTP Y+ PE         Y    C    D +S GV L E+L G  P
Sbjct: 233 TAVGTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFLYEMLVGDTP 277

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 137
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS-VSTLAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H   +     T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 81
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
           + +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 138
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS-VSTLAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H   +     T
Sbjct: 139 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 11/90 (12%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY------ 913
           IIHRD+K SN+LLD     ++ DFG++     L   ++ +  AG   Y+ PE        
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRPTDK 943
           Q +    + DV+S G+ L EL TG+ P  K
Sbjct: 204 QGY--DVRSDVWSLGITLYELATGRFPYPK 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 5/86 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKDD 945
              D ++ GV++ E+  G  P   D+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADE 242

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 218 KAVDWWALGVLIYEMAAGYPP 238

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 27/273 (9%)
Query: 56  ASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMD 115
            ++NNL  F   TL   S++L+L+ L      G  +G S       +L  LD+S+N I+ 
Sbjct: 74  GAFNNL--FNLRTLGLRSNRLKLIPL------GVFTGLS-------NLTKLDISENKIVI 118
Query: 116 VIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDS 175
           ++     +   LK L +  N L     R F  L+SL++L L   ++T  IP+E  +    
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHG 177
Query: 176 LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL---GSLESLILSN 232
           L+ L+L H NI      +      L++L++S+     P+ D++  N     +L SL +++
Sbjct: 178 LIVLRLRHLNINAIRDYSFKRLYRLKVLEISH----WPYLDTMTPNCLYGLNLTSLSITH 233
Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
             ++     ++     LR ++ S N +S  I   +   +  L+E++L    +  V P   
Sbjct: 234 CNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292
Query: 293 SECTQLKVIDLS---LNYLNGSIPQELGKLEHL 322
                L+V+++S   L  L  S+   +G LE L
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG+A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 85/229 (37%), Gaps = 29/229 (12%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLI---RLSCQGDREFMAEM 781
           K   L      +    +IG G FGEV     K    V   KL+    +  + D  F  E 
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 782 ETLGKIKHRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGR-AKARDQRILTWDXXX 839
             +    +   V  L Y    +  L +V E+M  G L  ++       +  R  T     
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYT----- 179
Query: 840 XXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                    L  +H       IHRD+K  N+LLD     +++DFG    ++  +  +   
Sbjct: 180 ---AEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCD 232
Query: 900 TLAGTPGYVPPEY--------YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           T  GTP Y+ PE         Y    C    D +S GV L E+L G  P
Sbjct: 233 TAVGTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFLYEMLVGDTP 277

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
             +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 135
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 26/199 (13%)
Query: 108 LSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPS 167
           L  N I  V  +S  +C  L IL L  N LAG     F  L+ L++LDLS+N     +  
Sbjct: 38  LHGNRISYVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVVDP 97
Query: 168 ELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLG---- 223
                   L  L L    +    P      + LQ L L +NN+    PD+   +LG    
Sbjct: 98  TTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQA-LPDNTFRDLGNLTH 156
Query: 224 --------------------SLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGII 263
                               SL+ L+L  N ++   P +      L  +   +N +S ++
Sbjct: 157 LFLHGNRIPSVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLS-ML 215
Query: 264 PPDICPGVSSLEELRLPDN 282
           P ++   + SL+ LRL DN
Sbjct: 216 PAEVLVPLRSLQYLRLNDN 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 10/215 (4%)
Query: 728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-REFMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXX 845
             +H N++ +    +      +   ++    +E  L+   K +    L+ D         
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQI 135
Query: 846 XXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGT 904
              L ++H     +++HRD+K SN+LL+   + ++ DFG+AR+      H    T    T
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 905 PGYVPPEYYQSFRCTAKG-DVYSFGVVLLELLTGK 938
             Y  PE   + +   K  D++S G +L E+L+ +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 209
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 210 KAVDWWALGVLIYEMAAGYPP 230

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 742 IGCGGFGEVF----KATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
           +G G +GEV     K T  + +   IKK    +       + E+  L ++ H N++ L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 798 YCKIGEERLLVYEFMKFGSL--EEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLH-H 854
           + +      LV E  + G L  E +L  +    D  ++                 +LH H
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM--------KQVLSGTTYLHKH 123
Query: 855 NCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           N    I+HRD+K  N+LL+ +      ++ DFG++   +  +    +    GT  Y+ PE
Sbjct: 124 N----IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTAYYIAPE 176
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
             +  +   K DV+S GV+L  LL G  P
Sbjct: 177 VLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 237
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFAD 262

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 209
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 210 KAVDWWALGVLIYEMAAGYPP 230

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 211
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 212 KAVDWWALGVLIYEMAAGYPP 232

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 218 KAVDWWALGVLIYEMAAGYPP 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIISL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 218 KAVDWWALGVLIYEMAAGYPP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 218 KAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 218 KAVDWWALGVLIYEMAAGYPP 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG+A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 237
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFAD 262

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 218 KAVDWWALGVLIYEMAAGYPP 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 217
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 218 KAVDWWALGVLIYEMAAGYPP 238

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 12/177 (6%)
Query: 773 GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFG--SLEEVLHGRAKARDQ 830
           G+     E++ L +++H+N++ L+      EE+  +Y  M++    ++E+L    + R  
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVL-YNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-- 105
Query: 831 RILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
                             L +LH      I+H+D+K  N+LL      ++S  G+A  + 
Sbjct: 106 --FPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTA--KGDVYSFGVVLLELLTGKRPTDKDD 945
                 +  T  G+P + PPE        +  K D++S GV L  + TG  P + D+
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 742 IGCGGFGEVFKA-TLKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           +G G F  V +   +  G   A K +   +LS +  ++   E      +KH N+V L  +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL--H 69
Query: 799 CKIGEE--RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNC 856
             I EE    LV++ +  G L E +  R          +             L  ++H  
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAR---------EYYSEADASHCIQQILESVNHCH 120
Query: 857 IPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
           +  I+HRD+K  N+LL  + +    +++DFG+A  I       +    AGTPGY+ PE  
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           +        D+++ GV+L  LL G  P   +D
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDED 210

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 35/219 (15%)
Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F  V +   L  G   A K +   +LS +  ++   E      +KH N+V L  +
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRL--H 69
Query: 799 CKIGEE--RLLVYEFMKFGSLEEVLHGRAKARD-------QRILTWDXXXXXXXXXXXXL 849
             I EE    LV++ +  G L E +  R    +       Q+IL                
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE--------------- 114
Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPG 906
             LH + +  ++HRD+K  N+LL  + +    +++DFG+A  I       +    AGTPG
Sbjct: 115 AVLHCHQM-GVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           Y+ PE  +        D+++ GV+L  LL G  P   +D
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S G ++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 21/221 (9%)
Query: 733 TNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKH 789
           T+ +     +G G F  V +   +  G   A K +   +LS +  ++   E      +KH
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 790 RNLVPLLGYCKIGEE--RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXX 847
            N+V L  +  I EE    LV++ +  G L E +  R          +            
Sbjct: 63  PNIVRL--HDSISEEGFHYLVFDLVTGGELFEDIVAR---------EYYSEADASHCIQQ 111
Query: 848 XLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGT 904
            L  ++H  +  I+HRD+K  N+LL  + +    +++DFG+A  I       +    AGT
Sbjct: 112 ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGT 169
Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PGY+ PE  +        D+++ GV+L  LL G  P   +D
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDED 210

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           ++HRD+K  N+LL  +++    +++DFG+A  I       +    AGTPGY+ PE  +  
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                 D+++ GV+L  LL G  P   +D
Sbjct: 200 PYGKPVDLWACGVILYILLVGYPPFWDED 228

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/319 (23%), Positives = 134/319 (42%), Gaps = 41/319 (12%)
Query: 716  TFQRQLRKLKFSQLIEAT--NGFSAESLIGCGGFGEVF---KATLKD-GSSVAIKKLIRL 769
            T + +LR    +   E      F    ++G G +G+VF   K +  D G   A+K L + 
Sbjct: 34   TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93
Query: 770  S----CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGR 824
            +     +       E + L  I+    +  L Y    E +L L+ +++  G L   L  R
Sbjct: 94   TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 153
Query: 825  AKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG 884
             +  +  +  +             +  L H     II+RD+K  N+LLD      ++DFG
Sbjct: 154  ERFTEHEVQIY---------VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 885  MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKG--DVYSFGVVLLELLTGKRPTD 942
            +++   A +T  +     GT  Y+ P+  +          D +S GV++ ELLTG  P  
Sbjct: 205  LSKEFVADETERAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263
Query: 943  KDDFGDTNLVGWVKMKVREG-----KQMEVIDPELL--LVTK------GTDESEAEEVKE 989
             D  G+ N    +  ++ +      ++M  +  +L+  L+ K      G    +A+E+KE
Sbjct: 264  VD--GEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321
Query: 990  MVRYLEITLQCVDDFPSKR 1008
             + + +I     DD  +K+
Sbjct: 322  HLFFQKINW---DDLAAKK 337

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 203
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 204 KAVDWWALGVLIYEMAAGYPP 224

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRPTDKD 944
              D ++ GV++ E+  G  P   D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 9/104 (8%)
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGY 907
           +LH N   +I+H D+K  N+LL       + ++ DFGM+R I        +  + GTP Y
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEY 199
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
           + PE       T   D+++ G++   LLT   P   +D  +T L
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL 243

>pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 124/285 (43%), Gaps = 55/285 (19%)
Query: 37  VGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNL---------- 86
           +  +P ++F  +P L  L    N+L+  LP  +  N+ KL  L +S NNL          
Sbjct: 111 IRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169
Query: 87  TGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFG 146
           T S+    L   S N L H+DLS      +IPS       L   N+S+NLL+     T  
Sbjct: 170 TTSLQNLQL---SSNRLTHVDLS------LIPS-------LFHANVSYNLLS-----TLA 208
Query: 147 QLSSLQRLDLSNNHIT---GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLL 203
              +++ LD S+N I    G +  EL         LKL HNN+T +    L +   L  +
Sbjct: 209 IPIAVEELDASHNSINVVRGPVNVELT-------ILKLQHNNLTDT--AWLLNYPGLVEV 259
Query: 204 DLSNNNISGPFPDSVLENLGSLESLILSNNMISG--SFPDSISSCKTLRIVDFSSNRVSG 261
           DLS N +        ++ +  LE L +SNN +     +   I    TL+++D S N +  
Sbjct: 260 DLSYNELEKIMYHPFVK-MQRLERLYISNNRLVALNLYGQPIP---TLKVLDLSHNHLLH 315
Query: 262 IIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLN 306
           +      P    LE L L  N    ++  +LS    LK + LS N
Sbjct: 316 VERNQ--PQFDRLENLYLDHN---SIVTLKLSTHHTLKNLTLSHN 355

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 736 FSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH----- 789
           F   +++G G FG+V KA    D    AIKK IR + +     ++E+  L  + H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 790 --------RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXX 841
                   RN V      K      +  E+ +  +L +++H       QR   W      
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE-NLNQQRDEYW----RL 121
Query: 842 XXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI-SALD------- 893
                  L ++H      IIHR++K  N+ +D     ++ DFG+A+ +  +LD       
Sbjct: 122 FRQILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 894 ----THLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELL 935
               +  ++++  GT  YV  E    +     K D YS G++  E +
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 25/179 (13%)
Query: 730 IEATNGFSAESLIGCGGFGEVFKATLKDGS-SVAIKKLIRL-----SCQGDREFMAEMET 783
           ++  + +  + LIG G +G V+ A  K+ + +VAIKK+ R+      C   +  + E+  
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDC---KRILREITI 80
Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHG-----RAKARDQRILTWDXX 838
           L ++K   ++ L        + ++  + +KF  L  VL       +   +    LT    
Sbjct: 81  LNRLKSDYIIRL-------HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHV 133
Query: 839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI-SALDTHL 896
                       F+H + I   IHRD+K +N LL+ +   ++ DFG+AR I S  D H+
Sbjct: 134 KTILYNLLLGEKFIHESGI---IHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHI 189

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 45/225 (20%)
Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAE--METLGKIKHRNLVPLLGY 798
           LIG G +G V+K +L D   VA+K     S    + F+ E  +  +  ++H N+   +  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFI-- 73
Query: 799 CKIGEER---------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXL 849
             +G+ER         LLV E+   GSL + L             W             L
Sbjct: 74  --VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-------DWVSSCRLAHSVTRGL 124
Query: 850 CFLH------HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA------RLISALDTHLS 897
            +LH       +  P I HRD+ S NVL+ ++    +SDFG++      RL+   +   +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 898 VSTLAGTPGYVPPEYYQSF-------RCTAKGDVYSFGVVLLELL 935
             +  GT  Y+ PE  +             + D+Y+ G++  E+ 
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 725 KFSQLIEATNGFSAESLIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMAEMET 783
           KF  + + T+      L+G G + +V  A +L++G   A+K + + +         E+ET
Sbjct: 9   KFEDMYKLTS-----ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVET 63
Query: 784 LGKIK-HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXX 842
           L + + ++N++ L+ + +      LV+E ++ GS+       A  + Q+           
Sbjct: 64  LYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSI------LAHIQKQKHFNEREASRVV 117
Query: 843 XXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALD-----T 894
                 L FLH      I HRD+K  N+L +   +    ++ DF +   +   +     T
Sbjct: 118 RDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 895 HLSVSTLAGTPGYVPPEYYQSFRCTA-----KGDVYSFGVVLLELLTGKRP 940
              ++T  G+  Y+ PE  + F   A     + D++S GVVL  +L+G  P
Sbjct: 175 TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+++D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIISKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S G ++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 10/182 (5%)
Query: 449 LSSNTLVFVRNVGNSCKGVGGL----LEFAGI--RPERLLQIPTLKSCDF--ARMYSGPV 500
           LS N L F      S  G   L    L F G+       L +  L+  DF  + +     
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE 413
Query: 501 LSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE-IPSSLGRLRNLG 559
            S+F   + L YLD+S+   R         + +L+VL++A N      +P     LRNL 
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 560 VFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTG-PIPQRGQLSTLPASQYANNPGLCG 618
             D S  +L+   P +F++LS L  +++++N+L   P     +L++L       NP  C 
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
Query: 619 VP 620
            P
Sbjct: 534 CP 535

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 23/175 (13%)
Query: 780 EMETLGKIK-HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
           E+E L + + HRN++ L+ + +  +   LV+E M+ GS+   +H R      R       
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR------RHFNELEA 113
Query: 839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTH 895
                     L FLH+     I HRD+K  N+L +H  +    ++ DFG+   I      
Sbjct: 114 SVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDC 170
Query: 896 LSVS-----TLAGTPGYVPPEYYQSFRCTA-----KGDVYSFGVVLLELLTGKRP 940
             +S     T  G+  Y+ PE  ++F   A     + D++S GV+L  LL+G  P
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ ++  G  P
Sbjct: 217 KAVDWWALGVLIYQMAAGYPP 237

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             L 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM-----------LV 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S GV++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 6/88 (6%)
Query: 860 IIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
           ++HRD+K  N+L+D +  E ++ DFG   L+   DT    +   GT  Y PPE+ +  R 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DT--VYTDFDGTRVYSPPEWIRYHRY 186
Query: 919 TAK-GDVYSFGVVLLELLTGKRPTDKDD 945
             +   V+S G++L +++ G  P + D+
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDE 214

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIISL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S G ++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 80/216 (37%), Gaps = 26/216 (12%)
Query: 108 LSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPS 167
           L  N I  V  +S   C  L IL L  N+LA      F  L+ L++LDLS+N     +  
Sbjct: 39  LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
Query: 168 ELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLES 227
              +    L  L L    +    P      + LQ L L +N +    PD    +LG+L  
Sbjct: 99  ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTH 157
Query: 228 LILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV 287
           L L  N IS                          +P     G+ SL+ L L  N +  V
Sbjct: 158 LFLHGNRISS-------------------------VPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 288 IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLE 323
            P    +  +L  + L  N L+    + L  L  L+
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 80/216 (37%), Gaps = 26/216 (12%)
Query: 108 LSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPS 167
           L  N I  V  +S   C  L IL L  N+LA      F  L+ L++LDLS+N     +  
Sbjct: 38  LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP 97
Query: 168 ELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLES 227
              +    L  L L    +    P      + LQ L L +N +    PD    +LG+L  
Sbjct: 98  ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTH 156
Query: 228 LILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV 287
           L L  N IS                          +P     G+ SL+ L L  N +  V
Sbjct: 157 LFLHGNRISS-------------------------VPERAFRGLHSLDRLLLHQNRVAHV 191
Query: 288 IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLE 323
            P    +  +L  + L  N L+    + L  L  L+
Sbjct: 192 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 227

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             L 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM-----------LV 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S GV++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 24/173 (13%)
Query: 730 IEATNGFSAESLIGCGGFGEVFKATLKDG-SSVAIKKLIRL-----SCQGDREFMAEMET 783
           +   + +  + LIG G +G V+ A  K+   +VAIKK+ R+      C   +  + E+  
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILREITI 78
Query: 784 LGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHG-----RAKARDQRILTWDXX 838
           L ++K   ++ L        + ++  + +KF  L  VL       +   +    LT +  
Sbjct: 79  LNRLKSDYIIRLY-------DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHI 131
Query: 839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA 891
                       F+H + I   IHRD+K +N LL+ +   +V DFG+AR I++
Sbjct: 132 KTILYNLLLGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLARTINS 181

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 25  GLKQLE---LSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           GL+QLE      + L  +   ++F  L NL+YL+ S+ + T      + +    LE+L +
Sbjct: 418 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH-TRVAFNGIFNGLSSLEVLKM 476
Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEI 141
           + N+   +       E    +L  LDLSQ  +  + P++ ++ + L++LN+S N      
Sbjct: 477 AGNSFQENFLPDIFTE--LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 534
Query: 142 PRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQ 201
              +  L+SLQ LD S NHI      EL +   SL  L L  N+    F  T    S+LQ
Sbjct: 535 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND----FACTCEHQSFLQ 590

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 12/189 (6%)
Query: 145 FGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNIT--GSFPVTLSSCSWLQL 202
           FG +S L+ LDLS N +     + LG   + L  L   H+N+     F V LS    L  
Sbjct: 394 FGTIS-LKYLDLSFNGVITMSSNFLG--LEQLEHLDFQHSNLKQMSEFSVFLS-LRNLIY 449
Query: 203 LDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSF-PDSISSCKTLRIVDFSSNRVSG 261
           LD+S+ +    F + +   L SLE L ++ N    +F PD  +  + L  +D S  ++  
Sbjct: 450 LDISHTHTRVAF-NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 508
Query: 262 IIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEH 321
           + P      +SSL+ L +  N    +          L+V+D SLN++  S  QE   L+H
Sbjct: 509 LSPTAF-NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE---LQH 564
Query: 322 LEQFIAWFN 330
               +A+ N
Sbjct: 565 FPSSLAFLN 573

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 25  GLKQLE---LSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           GL+QLE      + L  +   ++F  L NL+YL+ S+ + T      + +    LE+L +
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH-TRVAFNGIFNGLSSLEVLKM 452
Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEI 141
           + N+   +       E    +L  LDLSQ  +  + P++ ++ + L++LN+S N      
Sbjct: 453 AGNSFQENFLPDIFTE--LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510
Query: 142 PRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQ 201
              +  L+SLQ LD S NHI      EL +   SL  L L  N+    F  T    S+LQ
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND----FACTCEHQSFLQ 566

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 149 SSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNIT--GSFPVTLSSCSWLQLLDLS 206
           +SL+ LDLS N +     + LG   + L  L   H+N+     F V LS    L  LD+S
Sbjct: 373 TSLKYLDLSFNGVITMSSNFLG--LEQLEHLDFQHSNLKQMSEFSVFLS-LRNLIYLDIS 429
Query: 207 NNNISGPFPDSVLENLGSLESLILSNNMISGSF-PDSISSCKTLRIVDFSSNRVSGIIPP 265
           + +    F + +   L SLE L ++ N    +F PD  +  + L  +D S  ++  + P 
Sbjct: 430 HTHTRVAF-NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 266 DICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF 325
                +SSL+ L +  N    +          L+V+D SLN++  S  QE   L+H    
Sbjct: 489 AF-NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE---LQHFPSS 544
Query: 326 IAWFN 330
           +A+ N
Sbjct: 545 LAFLN 549

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 152 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 208
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 209 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 264
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 265 -------SEEVKMLIRNL 275

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 144 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 200
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 201 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 256
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 257 -------SEEVKMLIRNL 267

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 30/85 (35%), Positives = 40/85 (47%), Gaps = 6/85 (7%)
Query: 859 HIIHRDMKSSNVLLDHEMEAR--VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
            + HRD+K  N LLD     R  ++DFG ++   A   H    +  GTP Y+ PE     
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYIAPEVLLKK 191
Query: 917 RCTAK-GDVYSFGVVLLELLTGKRP 940
               K  DV+S GV L  +L G  P
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 142 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 198
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 199 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 254
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 255 -------SEEVKMLIRNL 265

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 73/204 (35%), Gaps = 19/204 (9%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG       K  + +   K I    + D     E+     ++H N+V        
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 802 GEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
                +V E+   G L E +   GR    + R                 +C         
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC--------- 136
Query: 860 IIHRDMKSSNVLLDHEMEAR--VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             HRD+K  N LLD     R  + DFG ++  S L  H    +  GTP Y+ PE      
Sbjct: 137 --HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL--HSQPKSTVGTPAYIAPEVLLKKE 191
Query: 918 CTAK-GDVYSFGVVLLELLTGKRP 940
              K  DV+S GV L  +L G  P
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 124/497 (24%), Positives = 180/497 (36%), Gaps = 90/497 (18%)
Query: 117 IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSL 176
           IP +L N T+   L  SFN L     RTF +L +L  LDL+   I  WI  +   +   L
Sbjct: 24  IPDTLPNTTEF--LEFSFNFLPTIHNRTFSRLMNLTFLDLTRCQI-NWIHEDTFQSHHQL 80
Query: 177 LELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS 236
             L L  N +      +L+    L+ L L    IS       + NL +LESL L +N IS
Sbjct: 81  STLVLTGNPLIFMAETSLNGPKSLKHLFLIQTGISN-LEFIPVHNLENLESLYLGSNHIS 139
Query: 237 G-SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEE-----LRLPDNLITGVIPG 290
              FP    + + L+++DF +N +  I   D+     SLE+     L    N + G+  G
Sbjct: 140 SIKFPKDFPA-RNLKVLDFQNNAIHYISREDM----RSLEQAINLSLNFNGNNVKGIELG 194
Query: 291 QLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGXXXXXXXXX 350
                     I  SLN+  G  P               FNGL+      L          
Sbjct: 195 AFD-----STIFQSLNF--GGTP----------NLSVIFNGLQNSTTQSLWLGTFEDIDD 237
Query: 351 XXXXXXSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPG 410
                   +   E+    ++E ++L  +  +      F   T+L  L L     KG +P 
Sbjct: 238 EDISSAMLKGLCEM----SVESLNLQEHRFSDISSTTFQCFTQLQELDLTATHLKG-LPS 292
Query: 411 ELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGL 470
            +   + L  L L+ N+           QL       F S   L    NV     GVG L
Sbjct: 293 GMKGLNLLKKLVLSVNHF---------DQLCQISAANFPSLTHLYIRGNVKKLHLGVGCL 343
Query: 471 LEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGK--IPDEI 528
                   E+L  + TL                          DLS+N          ++
Sbjct: 344 --------EKLGNLQTL--------------------------DLSHNDIEASDCCSLQL 369
Query: 529 GDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPES-FSNLSFL----- 582
            ++  LQ L L+HN+  G    +      L + D +  RL    P+S F NL FL     
Sbjct: 370 KNLSHLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHINAPQSPFQNLHFLQVLNL 429
Query: 583 --VQIDLSNNELTGPIP 597
               +D SN  L   +P
Sbjct: 430 TYCFLDTSNQHLLAGLP 446

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 143 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 199
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 200 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 255
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 256 -------SEEVKMLIRNL 266

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP Y+ P    S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPAIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 137 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 193
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 194 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 249
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 250 -------SEEVKMLIRNL 260

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLA------EKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPAFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 222

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 136 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 192
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 193 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 248
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 249 -------SEEVKMLIRNL 259

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 10/211 (4%)
Query: 734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNL 792
           + F  E + G G FG V     K  G SVAIKK+I+     +RE    M+ L  + H N+
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNI 81
Query: 793 VPLLGY-CKIGE-ERLLVYEFMKFGSLEEVLHG--RAKARDQRILTWDXXXXXXXXXXXX 848
           V L  Y   +GE +R  +Y  +    + + LH   R   R Q                  
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDH-EMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
           +  LH   + ++ HRD+K  NVL++  +   ++ DFG A+ +S   +  +V+ +      
Sbjct: 142 IGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVAYICSRYYR 198
Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            P   + +   T   D++S G +  E++ G+
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 16/209 (7%)
Query: 741 LIGCGGFGEVFKATLKD-GSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           +IG G F  V +   ++ G   A+K     K          +   E      +KH ++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           LL          +V+EFM    L   +  RA A    + +              L + H 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHD 148
Query: 855 NCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           N   +IIHRD+K  NVLL   ++    ++ DFG+A  I   ++ L      GTP ++ PE
Sbjct: 149 N---NIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFMAPE 203
Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
             +        DV+  GV+L  LL+G  P
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 238
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 239 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 294
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 295 -------SEEVKMLIRNL 305

>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 132/518 (25%), Positives = 198/518 (38%), Gaps = 64/518 (12%)
Query: 114 MDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNAC 173
           ++ IP +L N T+   L  SFN+L      TF +L +L  LDL+   I  WI  +   + 
Sbjct: 24  LNEIPGTLPNSTE--CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WIHEDTFQSQ 80
Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSV-LENLGSLESLILSN 232
             L  L L  N +       LS    L+ L      IS    D + L N  +LESL L +
Sbjct: 81  HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS--IDFIPLHNQKTLESLYLGS 138
Query: 233 NMISG-SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEE-----LRLPDNLITG 286
           N IS    P    + K L+++DF +N +  +   D+    SSL++     L L  N I G
Sbjct: 139 NHISSIKLPKGFPTEK-LKVLDFQNNAIHYLSKEDM----SSLQQATNLSLNLNGNDIAG 193
Query: 287 VIPGQLSECTQLKVIDLSLNY------------LNGSIPQE--LGKLEHLEQFIAWFNGL 332
           + PG          +  SLN+            L  S  Q   LG  E ++         
Sbjct: 194 IEPGAFD-----SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD--------- 239
Query: 333 EGKIPPEL--GXXXXXXXXXXXXXXXSGEIPAELFSC-SNLEWISLTGNELTGQIPPEFS 389
           +  I P +  G                  I +  F C S L+ + LT   L+ ++P    
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLV 298
Query: 390 RLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLG--------RQLG 441
            L+ L  L L  N+F+        N  SL  L +  N  T  +    G        R+L 
Sbjct: 299 GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN--TKRLELGTGCLENLENLRELD 356
Query: 442 AKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCD--FARMYSGP 499
                   S    + +RN+ +         E   ++ E   + P L+  D  F R+    
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 500 VLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQL-SGEI--PSSLGRLR 556
             S F     L+ L+LS++            + ALQ L L  N    G I   +SL  L 
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 557 NLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTG 594
            L +   S   L      +F++L  +  +DLS+N LT 
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 194
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 195 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 250
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 251 -------SEEVKMLIRNL 261

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 188 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 244
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 245 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 300
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 301 -------SEEVKMLIRNL 311

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 194
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D++S GV++  LL G  P    + G     G +K ++R G Q E  +PE   V 
Sbjct: 195 KYDKSCDMWSLGVIMYILLCG-YPPFYSNHGLAISPG-MKTRIRMG-QYEFPNPEWSEV- 250
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 251 -------SEEVKMLIRNL 261

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 89
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 138
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 195
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 175
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 232
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 87
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 136
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 137 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 193
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 194 EVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S G ++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 89
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 138
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 195
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 81
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 130
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 187
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 82
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 131
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 188
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 189 EVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 82
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 131
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 188
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 189 EVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S G ++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 25  GLKQLE---LSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           GL+QLE      + L  +   ++F  L NL+YL+ S+ + T      + +    LE+L +
Sbjct: 99  GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH-TRVAFNGIFNGLSSLEVLKM 157
Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEI 141
           + N+   +       E    +L  LDLSQ  +  + P++ ++ + L++LN+S N      
Sbjct: 158 AGNSFQENFLPDIFTE--LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 215
Query: 142 PRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQ 201
              +  L+SLQ LD S NHI      EL +   SL  L L  N+    F  T    S+LQ
Sbjct: 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND----FACTCEHQSFLQ 271

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA--GEIPRTFGQLSSLQRLDLSN 158
           +S   L+L  N +  +        T+L  L+LS N L+  G   ++    +SL+ LDLS 
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 159 NHITGWIPSELGNACDSLLELKLPHNNIT--GSFPVTLSSCSWLQLLDLSNNNISGPFPD 216
           N +     + LG   + L  L   H+N+     F V LS    L  LD+S+ +    F +
Sbjct: 88  NGVITMSSNFLG--LEQLEHLDFQHSNLKQMSEFSVFLS-LRNLIYLDISHTHTRVAF-N 143
Query: 217 SVLENLGSLESLILSNNMISGSF-PDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLE 275
            +   L SLE L ++ N    +F PD  +  + L  +D S  ++  + P      +SSL+
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF-NSLSSLQ 202
Query: 276 ELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFN 330
            L +  N    +          L+V+D SLN++  S  QE   L+H    +A+ N
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE---LQHFPSSLAFLN 254

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 9/153 (5%)
Query: 449 LSSNTLVFVRNVGNSCKGVGGL----LEFAGI--RPERLLQIPTLKSCDF--ARMYSGPV 500
           LSSN L F      S  G   L    L F G+       L +  L+  DF  + +     
Sbjct: 59  LSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE 118
Query: 501 LSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE-IPSSLGRLRNLG 559
            S+F   + L YLD+S+   R         + +L+VL++A N      +P     LRNL 
Sbjct: 119 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178
Query: 560 VFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
             D S  +L+   P +F++LS L  +++S+N  
Sbjct: 179 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 89
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 138
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 195
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S G ++ E++ G
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 175
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 232
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 860 IIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           I HRD+K  N+L   +      +++DFG A+  ++   H S++T   TP YV PE     
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 238
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
           +     D +S GV+   LL G  P    + G     G  K ++R G Q E  +PE   V 
Sbjct: 239 KYDKSCDXWSLGVIXYILLCG-YPPFYSNHGLAISPG-XKTRIRXG-QYEFPNPEWSEV- 294
Query: 977 KGTDESEAEEVKEMVRYL 994
                  +EEVK ++R L
Sbjct: 295 -------SEEVKXLIRNL 305

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 8/96 (8%)
Query: 861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
           +HRD+K  N+LLD     R++DFG    + A  T  S+  + GTP Y+ PE  Q+     
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGP 242
Query: 921 -------KGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
                  + D ++ GV   E+  G+ P   D   +T
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 86/207 (41%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 90
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 139
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   +     T  Y  P
Sbjct: 140 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPFVVTRYYRAP 196
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S G ++ E++ G
Sbjct: 197 EVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 71/204 (34%), Gaps = 19/204 (9%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG       K    +   K I      D     E+     ++H N+V        
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 802 GEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
                ++ E+   G L E +   GR    + R                 +C         
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC--------- 138
Query: 860 IIHRDMKSSNVLLDHEMEAR--VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             HRD+K  N LLD     R  + DFG ++  S L  H    +  GTP Y+ PE      
Sbjct: 139 --HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL--HSQPKSTVGTPAYIAPEVLLRQE 193
Query: 918 CTAK-GDVYSFGVVLLELLTGKRP 940
              K  DV+S GV L  +L G  P
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLA------EKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 222

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 50/239 (20%)
Query: 734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIR-----LSCQGDREFMAEMETLGKI 787
           + +    LIG G +G V +A  K +   VAIKK++R     + C   +  + E+  L ++
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILREIAILNRL 109
Query: 788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLH-----GRAKARDQRILTWDXXXXXX 842
            H ++V +L         ++  +  KF  L  VL       +   R    LT        
Sbjct: 110 NHDHVVKVLDI-------VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL 162
Query: 843 XXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL------------IS 890
                 + ++H   I   +HRD+K +N L++ +   +V DFG+AR             IS
Sbjct: 163 YNLLVGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 891 ALDTHLSVSTLAGTP-------GYVPPEYYQSFRC-------TAKGDVYSFGVVLLELL 935
             +  +++ T   T        G+V   +Y++          T   DV+S G +  ELL
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 860 IIHRDMKSSNVLL--DHEMEARVSDFGMARLISALDT--HLSVSTLAGTPGYVPPEYYQS 915
           I HRD+K  N L   +   E ++ DFG+++    L+   +  ++T AGTP +V PE   +
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 916 FRCTA--KGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
              +   K D +S GV+L  LL G  P    +  DT
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 23/210 (10%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E         + D++S GV+   LL+G  P
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
           +I+RD+K  N+L+D +   +V+DFG A+ +           L GTP  + PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEALAPEIILSKGYN 216
Query: 920 AKGDVYSFGVVLLELLTGKRP 940
              D ++ GV++ E+  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 124/285 (43%), Gaps = 55/285 (19%)
Query: 37  VGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNL---------- 86
           +  +P ++F  +P L  L    N+L+  LP  +  N+ KL  L +S NNL          
Sbjct: 105 IRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 163
Query: 87  TGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFG 146
           T S+    L   S N L H+DLS      +IPS       L   N+S+NLL+     T  
Sbjct: 164 TTSLQNLQL---SSNRLTHVDLS------LIPS-------LFHANVSYNLLS-----TLA 202
Query: 147 QLSSLQRLDLSNNHIT---GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLL 203
              +++ LD S+N I    G +  EL         LKL HNN+T +    L +   L  +
Sbjct: 203 IPIAVEELDASHNSINVVRGPVNVELT-------ILKLQHNNLTDT--AWLLNYPGLVEV 253
Query: 204 DLSNNNISGPFPDSVLENLGSLESLILSNNMISG--SFPDSISSCKTLRIVDFSSNRVSG 261
           DLS N +        ++ +  LE L +SNN +     +   I    TL+++D S N +  
Sbjct: 254 DLSYNELEKIMYHPFVK-MQRLERLYISNNRLVALNLYGQPIP---TLKVLDLSHNHLLH 309
Query: 262 IIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLN 306
           +      P    LE L L  N    ++  +LS    LK + LS N
Sbjct: 310 VERNQ--PQFDRLENLYLDHN---SIVTLKLSTHHTLKNLTLSHN 349

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 14/200 (7%)
Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGYC 799
           +G G +  V+K   K   ++   K IRL  +      A  E+  L  +KH N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHHNCIPH 859
              +   LV+E++    L++ L          I+               L + H      
Sbjct: 70  HTEKSLTLVFEYLD-KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---K 120
Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY-YQSFRC 918
           ++HRD+K  N+L++   E +++DFG+AR  S      +      T  Y PP+    S   
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDY 178
Query: 919 TAKGDVYSFGVVLLELLTGK 938
           + + D++  G +  E+ TG+
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMA------EMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R  ++      E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
                I H D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           E         + D++S GV+   LL+G  P      GDT
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDT 221

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             LC
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM-----------LC 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPEVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S G ++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLA------EKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 222

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 860 IIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
           ++HR++K  N+LL  +++    +++DFG+A  I       +    AGTPGY+ PE  +  
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                 D+++ GV+L  LL G  P   +D
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPFWDED 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 132 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 185
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 221

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 222

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 28/208 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L    +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIISL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             L 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM-----------LX 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           E           D++S G ++ E++  K
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 132 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 185
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 221

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 112/265 (42%), Gaps = 52/265 (19%)
Query: 714 VATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT--LKDG--SSVAIKKLIRL 769
           +A  ++ + KL +  + + +N F  E  IG G F  V+ AT  L+ G    +A+K LI  
Sbjct: 2   LAGVKKDIEKL-YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT 60
Query: 770 SCQGDREFMAEMETLGKIKHRNLVPLLGYC-KIGEERLLVYEFMKFGSLEEVLHGRAKAR 828
           S        AE++ L     ++ V  + YC +  +  ++   +++  S  ++L+      
Sbjct: 61  S--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS----- 113
Query: 829 DQRILTWDXXXXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEMEAR-VSDFGMA- 886
               L++             L  +H      I+HRD+K SN L +  ++   + DFG+A 
Sbjct: 114 ----LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166
Query: 887 ----------RLISA---------------LDTHLSVSTLAGTPGYVPPEYYQSFRC--- 918
                     + + +               L     V+  AGTPG+  PE     +C   
Sbjct: 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT--KCPNQ 224
Query: 919 TAKGDVYSFGVVLLELLTGKRPTDK 943
           T   D++S GV+ L LL+G+ P  K
Sbjct: 225 TTAIDMWSAGVIFLSLLSGRYPFYK 249

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 780 EMETLGKIK-HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXX 838
           E+E L + + HRN++ L+ + +  +   LV+E M+ GS+   +H R      R       
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR------RHFNELEA 113
Query: 839 XXXXXXXXXXLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTH 895
                     L FLH+     I HRD+K  N+L +H  +    ++ DF +   I      
Sbjct: 114 SVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 896 LSVS-----TLAGTPGYVPPEYYQSFRCTA-----KGDVYSFGVVLLELLTGKRP 940
             +S     T  G+  Y+ PE  ++F   A     + D++S GV+L  LL+G  P
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 222

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 28/207 (13%)
Query: 742 IGCGGFGEV---FKATLKDGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G  G V   + A L+   +VAIKKL R         R +  E+  +  + H+N++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGL 88
Query: 796 LGYC---KIGEERLLVYEFMKF--GSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLC 850
           L      K  EE   VY  M+    +L +V+           L +             L 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM-----------LV 137
Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            + H     IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTG 937
           E           D++S G ++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIK--KLIRLSCQGDREFMAEMETLGKIK-HRNL 792
           +S    IG GG  +VF+   +     AIK   L     Q    +  E+  L K++ H + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 793 VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFL 852
           +  L   +I ++   +Y  M+ G+++  L+   K + + I  W+                
Sbjct: 118 IIRLYDYEITDQ--YIYMVMECGNID--LNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH 172
Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
            H     I+H D+K +N L+   M  ++ DFG+A  +    T +   +  GT  Y+PPE 
Sbjct: 173 QHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 913 YQSFRCTAKG-----------DVYSFGVVLLELLTGKRP 940
            +    + +            DV+S G +L  +  GK P
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 388 FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGG 447
           F  L  L +LQL  N  +    G     ++L  L+L  N LT              P G 
Sbjct: 84  FKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT------------TIPNGA 131
Query: 448 FLSSNTL--VFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLS--L 503
           F+  + L  +++RN       +  +  +A  R      IP+L+  D   +     +S   
Sbjct: 132 FVYLSKLKELWLRN-----NPIESIPSYAFNR------IPSLRRLDLGELKRLSYISEGA 180
Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDA 563
           F     L YL+L+    R +IP+ +  +I L  L+L+ N LS   P S   L +L     
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238
Query: 564 SHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
             +++Q     +F NL  LV+I+L++N LT
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLT 268

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 22/217 (10%)
Query: 742 IGCGGFGEV-FKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC- 799
           +G GGF  V     L DG   A+K+++    Q   E   E +      H N++ L+ YC 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 800 ---KIGEERLLVYEFMKFGSLEEVLHGRAKARDQ-RILTWDXXXXXXXXXXXXLCFLHHN 855
                  E  L+  F K G+L   +    + +D+   LT D            L  +H  
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFG-MARLISALDTHLSVSTLAG------TPGYV 908
                 HRD+K +N+LL  E +  + D G M +    ++      TL        T  Y 
Sbjct: 154 GYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 909 PPEYYQ-SFRCT--AKGDVYSFGVVLLELLTGKRPTD 942
            PE +     C    + DV+S G VL  ++ G+ P D
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 222

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDXXXXXXXXXXXXLCFLHH 854
           L    +   + +L+ E +  G L + L       ++  LT +            + +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 855 NCIPHIIHRDMKSSNV-LLDHEM---EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             I H    D+K  N+ LLD  +     ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 LQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           E         + D++S GV+   LL+G  P      GDT 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTK 222
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1013
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	0.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-152
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-141
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-129
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-122
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-71
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-11
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-126
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-117
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-109
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-106
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-96
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-95
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-86
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-71
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-65
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-60
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-97
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-83
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-49
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-46
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-33
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-96
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-93
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-87
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-78
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-67
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-60
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-29
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-86
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-80
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-52
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-81
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-71
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-70
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-64
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-61
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-48
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-40
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-80
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-68
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-63
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-50
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-42
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-79
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-72
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-70
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-39
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-27
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-05
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-71
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-63
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-61
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-55
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-39
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-36
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-63
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-57
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-56
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-62
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-50
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-60
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-45
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-09
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-60
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-57
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-55
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-54
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-52
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-48
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-18
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-50
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-50
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-48
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-40
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-19
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-46
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-25
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-48
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-47
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-48
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-48
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-38
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-47
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-46
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-30
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-44
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-38
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-44
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-40
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-25
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-43
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-41
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-37
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-40
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-05
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-40
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-37
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-34
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-32
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-37
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-09
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-36
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-36
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-35
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-35
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-33
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-05
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-12
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-34
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-34
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-33
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-34
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-34
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-34
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-20
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-15
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-13
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-33
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-33
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-31
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-28
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-06
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-32
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-31
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-31
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-29
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-27
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-27
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-31
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-31
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-04
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-31
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-31
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-27
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-24
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-08
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-30
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-30
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-29
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-24
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-23
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-20
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-28
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-28
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-25
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-24
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-23
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-11
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-28
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-28
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-28
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-26
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-06
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-26
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-26
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-05
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-24
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-24
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-22
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-21
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-21
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-06
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-24
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-22
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-22
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-23
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-23
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-06
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-22
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-22
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-06
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-21
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-21
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-19
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-07
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-21
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-21
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-20
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-08
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-19
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-19
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-17
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-15
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-18
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-17
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-15
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-05
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-09
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-15
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-15
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-15
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-15
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-13
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	7e-13
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-07
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-15
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-15
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-13
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-15
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-15
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-04
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-13
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	5e-13
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-13
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	1e-12
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-10
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	8e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-11
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-11
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-11
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-10
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-04
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	3e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	9e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	7e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-04
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	2e-05
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	3e-05
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	9e-05
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	3e-04
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	4e-05
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	1e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	8e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  618 bits (1597), Expect = 0.0
 Identities = 272/652 (41%), Positives = 365/652 (55%), Gaps = 20/652 (3%)

Query: 2   LSVLKLSSNLFT--LNSTSLLQLPFGLKQLELSSAGLVGLVPDNL--FSKLPNLVYLNAS 57
           L  L +SSN        +  L+L   L+ L+LS+  + G              L +L  S
Sbjct: 128 LKFLNVSSNTLDFPGKVSGGLKLNS-LEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186

Query: 58  YNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVI 117
            N ++G +    +S    LE LD+S NN +  I         C++L HLD+S N +    
Sbjct: 187 GNKISGDVD---VSRCVNLEFLDVSSNNFSTGIPFLG----DCSALQHLDISGNKLSGDF 239

Query: 118 PSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLL 177
             ++S CT+LK+LN+S N   G IP     L SLQ L L+ N  TG IP  L  ACD+L 
Sbjct: 240 SRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297

Query: 178 ELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG 237
            L L  N+  G+ P    SCS L+ L LS+NN SG  P   L  +  L+ L LS N  SG
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357

Query: 238 SFPDSISSCKT-LRIVDFSSNRVSGIIPPDICPGV-SSLEELRLPDNLITGVIPGQLSEC 295
             P+S+++    L  +D SSN  SG I P++C    ++L+EL L +N  TG IP  LS C
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417

Query: 296 TQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNK 355
           ++L  + LS NYL+G+IP  LG L  L     W N LEG+IP EL   K L+ LIL+ N 
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477

Query: 356 LSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNC 415
           L+GEIP+ L +C+NL WISL+ N LTG+IP    RL  LA+L+L NN F G IP ELG+C
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537

Query: 416 SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS--CKGVGGLLEF 473
            SL+WLDLN+N   G IP  + +Q G      F++    V+++N G    C G G LLEF
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQSGKI-AANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596

Query: 474 AGIRPERLLQIPTLKSCDFA-RMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI 532
            GIR E+L ++ T   C+   R+Y G     F    ++ +LD+SYN   G IP EIG M 
Sbjct: 597 QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP 656

Query: 533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
            L +L L HN +SG IP  +G LR L + D S N+L G+IP++ S L+ L +IDLSNN L
Sbjct: 657 YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716

Query: 593 TGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGNNQPALNPSVDAARHGH 644
           +GPIP+ GQ  T P +++ NNPGLCG PLP C   N     +       H H
Sbjct: 717 SGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHHHHHH 768

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  468 bits (1206), Expect = e-152
 Identities = 174/611 (28%), Positives = 256/611 (41%), Gaps = 62/611 (10%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNL-FSKLPNLVYLNASYNN 60
           L  L LS++    + +        L  L+LS   L G V           L +LN S N 
Sbjct: 79  LESLFLSNSHINGSVSGFKCSA-SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNT 137

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           L      +     + LE+LDLS N+++G+     +  + C  L HL +S N I   +   
Sbjct: 138 LDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-- 195

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
           +S C  L+ L++S N  +  IP   G  S+LQ LD+S N ++G     +   C  L  L 
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIST-CTELKLLN 253

Query: 181 LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
           +  N   G  P        LQ L L+ N  +G  PD +     +L  L LS N   G+ P
Sbjct: 254 ISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311

Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECT-QLK 299
               SC  L  +  SSN  SG +P D    +  L+ L L  N  +G +P  L+  +  L 
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLL 371

Query: 300 VIDLSLNYLNGSIPQELGK--LEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS 357
            +DLS N  +G I   L +     L++     NG  GKIPP L  C  L  L L+ N LS
Sbjct: 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431

Query: 358 GEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSS 417
           G IP+ L S S L  + L  N L G+IP E   +  L  L L  N   GEIP  L NC++
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491

Query: 418 LVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIR 477
           L W+ L++N LTG+IP  +GR          L +                          
Sbjct: 492 LNWISLSNNRLTGEIPKWIGR----------LEN-------------------------- 515

Query: 478 PERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVL 537
               L I  L +  F    SG + +     ++L +LDL+ N F G IP  +      Q  
Sbjct: 516 ----LAILKLSNNSF----SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK----QSG 563

Query: 538 ELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQ--GQIPESFSNLSFLVQIDLSNNELTGP 595
           ++A N ++G+    +           + N L+  G   E  + LS     ++++    G 
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623

Query: 596 IP-QRGQLSTL 605
                    ++
Sbjct: 624 TSPTFDNNGSM 634

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  440 bits (1134), Expect = e-141
 Identities = 182/560 (32%), Positives = 263/560 (46%), Gaps = 67/560 (11%)

Query: 50  NLVYLNASYNNLTGFLPE--TLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLD 107
            +  ++ S   L        + L +   LE L LS +++ GS+SGF        SL  LD
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFK----CSASLTSLD 106

Query: 108 LSQNHIMDVIPS--SLSNCTKLKILNLSFNLLAGEIPRT-FGQLSSLQRLDLSNNHITGW 164
           LS+N +   + +  SL +C+ LK LN+S N L      +   +L+SL+ LDLS N I+G 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 165 IPSELG--NACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
                   + C  L  L +  N I+G     +S C  L+ LD+S+NN S   P   L + 
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF--LGDC 222

Query: 223 GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
            +L+ L +S N +SG F  +IS+C  L++++ SSN+  G IPP       SL+ L L +N
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPL---KSLQYLSLAEN 279

Query: 283 LITGVIPGQLS-ECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE-L 340
             TG IP  LS  C  L  +DLS N+  G++P   G    LE      N   G++P + L
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339

Query: 341 GKCKNLKDLILNNNKLSGEIPAELFSCS-NLEWISLTGNELTGQIPPEFSR--LTRLAVL 397
            K + LK L L+ N+ SGE+P  L + S +L  + L+ N  +G I P   +     L  L
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399

Query: 398 QLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFV 457
            L NN F G+IP  L NCS LV L L+ N L+G IP  LG     + L   L  N L   
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL--KLWLNML--- 454

Query: 458 RNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSY 517
                                                   G +       +TLE L L +
Sbjct: 455 ---------------------------------------EGEIPQELMYVKTLETLILDF 475

Query: 518 NQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFS 577
           N   G+IP  + +   L  + L++N+L+GEIP  +GRL NL +   S+N   G IP    
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535

Query: 578 NLSFLVQIDLSNNELTGPIP 597
           +   L+ +DL+ N   G IP
Sbjct: 536 DCRSLIWLDLNTNLFNGTIP 555

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  410 bits (1056), Expect = e-129
 Identities = 162/545 (29%), Positives = 228/545 (41%), Gaps = 63/545 (11%)

Query: 72  NSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILN 131
             DK+  +DLS   L    S  S +  S   L  L LS +HI   +         L  L+
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106

Query: 132 LSFNLLAGEIP--RTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           LS N L+G +    + G  S L+ L++S+N +        G   +SL  L L  N+I+G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 190 FPVTL---SSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSC 246
             V       C  L+ L +S N ISG      +    +LE L +S+N  S   P  +  C
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIP-FLGDC 222

Query: 247 KTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLN 306
             L+ +D S N++SG     I    + L+ L +  N   G IP        L+ + L+ N
Sbjct: 223 SALQHLDISGNKLSGDFSRAIS-TCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAEN 279

Query: 307 YLNGSIPQEL-GKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAE-L 364
              G IP  L G  + L       N   G +PP  G C  L+ L L++N  SGE+P + L
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339

Query: 365 FSCSNLEWISLTGNELTGQIPPEFSRLT-RLAVLQLGNNRFKGEIPGELGNC--SSLVWL 421
                L+ + L+ NE +G++P   + L+  L  L L +N F G I   L     ++L  L
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399

Query: 422 DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL 481
            L +N  TG IPP L        L   LS N L                           
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSL--HLSFNYL--------------------------- 430

Query: 482 LQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH 541
                          SG + S       L  L L  N   G+IP E+  +  L+ L L  
Sbjct: 431 ---------------SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475

Query: 542 NQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQR-G 600
           N L+GEIPS L    NL     S+NRL G+IP+    L  L  + LSNN  +G IP   G
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535

Query: 601 QLSTL 605
              +L
Sbjct: 536 DCRSL 540

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  390 bits (1004), Expect = e-122
 Identities = 146/436 (33%), Positives = 214/436 (49%), Gaps = 12/436 (2%)

Query: 1   MLSVLKLSSNLFTLN-STSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYN 59
            L+ L LS N F              L+ L LSS    G +P +   K+  L  L+ S+N
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSL-LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353

Query: 60  NLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPS 119
             +G LPE+L + S  L  LDLS NN +G I   +L +N  N+L  L L  N     IP 
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILP-NLCQNPKNTLQELYLQNNGFTGKIPP 412

Query: 120 SLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL 179
           +LSNC++L  L+LSFN L+G IP + G LS L+ L L  N + G IP EL     +L  L
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY-VKTLETL 471

Query: 180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSF 239
            L  N++TG  P  LS+C+ L  + LSNN ++G  P   +  L +L  L LSNN  SG+ 
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW-IGRLENLAILKLSNNSFSGNI 530

Query: 240 PDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLK 299
           P  +  C++L  +D ++N  +G IP  +       +  ++  N I G     +      K
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMF-----KQSGKIAANFIAGKRYVYIKNDGMKK 585

Query: 300 VIDLSLNYLN--GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS 357
               + N L   G   ++L +L              G   P      ++  L ++ N LS
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645

Query: 358 GEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSS 417
           G IP E+ S   L  ++L  N+++G IP E   L  L +L L +N+  G IP  +   + 
Sbjct: 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM 705

Query: 418 LVWLDLNSNNLTGDIP 433
           L  +DL++NNL+G IP
Sbjct: 706 LTEIDLSNNNLSGPIP 721

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  252 bits (646), Expect = 1e-71
 Identities = 99/357 (27%), Positives = 147/357 (41%), Gaps = 39/357 (10%)

Query: 1   MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            L  L LS N  +                        G +P +L   L  L  L    N 
Sbjct: 419 ELVSLHLSFNYLS------------------------GTIPSSL-GSLSKLRDLKLWLNM 453

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           L G +P+  L     LE L L +N+LTG I    L  ++C +L  + LS N +   IP  
Sbjct: 454 LEGEIPQE-LMYVKTLETLILDFNDLTGEIPS-GL--SNCTNLNWISLSNNRLTGEIPKW 509

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
           +     L IL LS N  +G IP   G   SL  LDL+ N   G IP+ +          K
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK-----QSGK 564

Query: 181 LPHNNITGSFPVTLSSCSWLQLLDLSNN--NISGPFPDSVLENLGSLESLILSNNMISGS 238
           +  N I G   V + +    +    + N     G   +  L  L +     +++ +  G 
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ-LNRLSTRNPCNITSRVYGGH 623

Query: 239 FPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQL 298
              +  +  ++  +D S N +SG IP +I   +  L  L L  N I+G IP ++ +   L
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEIG-SMPYLFILNLGHNDISGSIPDEVGDLRGL 682

Query: 299 KVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNK 355
            ++DLS N L+G IPQ +  L  L +     N L G I PE+G+ +        NN 
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI-PEMGQFETFPPAKFLNNP 738

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 65.7 bits (161), Expect = 6e-11
 Identities = 19/76 (25%), Positives = 34/76 (44%), Gaps = 4/76 (5%)

Query: 534 LQVLELAHNQLS---GEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
           +  ++L+   L+     + SSL  L  L     S++ + G +   F   + L  +DLS N
Sbjct: 52  VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRN 110

Query: 591 ELTGPIPQRGQLSTLP 606
            L+GP+     L +  
Sbjct: 111 SLSGPVTTLTSLGSCS 126

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  385 bits (991), Expect = e-126
 Identities = 115/299 (38%), Positives = 181/299 (60%), Gaps = 18/299 (6%)

Query: 720  QLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG-DREFM 778
            QL++    +L  A++ FS ++++G GGFG+V+K  L DG+ VA+K+L     QG + +F 
Sbjct: 16   QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 779  AEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDAR 838
             E+E +    HRNL+ L G+C    ERLLVY +M  GS+   L  R +++    L W  R
Sbjct: 76   TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP--LDWPKR 133

Query: 839  KKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
            ++IA G+A+GL +LH +C P IIHRD+K++N+LLD E EA V DFG+A+L+   DTH  V
Sbjct: 134  QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--V 191

Query: 899  ST-LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG---DTNLVGW 954
            +T + GT G++ PEY  + + + K DV+ +GV+LLEL+TG+R  D        D  L+ W
Sbjct: 192  TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 955  VKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            VK  ++E K   ++D +L       +  +    +E+ + +++ L C    P +RP M +
Sbjct: 252  VKGLLKEKKLEALVDVDL-----QGNYKD----EEVEQLIQVALLCTQSSPMERPKMSE 301

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  362 bits (931), Expect = e-117
 Identities = 106/295 (35%), Positives = 163/295 (55%), Gaps = 19/295 (6%)

Query: 720  QLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA 779
            +  ++    L EATN F  + LIG G FG+V+K  L+DG+ VA+K+    S QG  EF  
Sbjct: 25   ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84

Query: 780  EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK 839
            E+ETL   +H +LV L+G+C    E +L+Y++M+ G+L+  L+G         ++W+ R 
Sbjct: 85   EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG--SDLPTMSMSWEQRL 142

Query: 840  KIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD-THLSV 898
            +I  GAA+GL +LH      IIHRD+KS N+LLD     +++DFG+++  + LD TH  +
Sbjct: 143  EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH--L 197

Query: 899  ST-LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD-DFGDTNLVGWVK 956
            ST + GT GY+ PEY+   R T K DVYSFGVVL E+L  +    +       NL  W  
Sbjct: 198  STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257

Query: 957  MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
                 G+  +++DP L          E      + ++ +  ++C+      RP+M
Sbjct: 258  ESHNNGQLEQIVDPNL----ADKIRPE-----SLRKFGDTAVKCLALSSEDRPSM 303

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  339 bits (871), Expect = e-109
 Identities = 99/305 (32%), Positives = 154/305 (50%), Gaps = 34/305 (11%)

Query: 720  QLRKLKFSQLIEATNGFSAE------SLIGCGGFGEVFKATLKDGSSVAIKKL----IRL 769
            +     F +L   TN F         + +G GGFG V+K  + + ++VA+KKL       
Sbjct: 11   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 770  SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD 829
            + +  ++F  E++ + K +H NLV LLG+   G++  LVY +M  GSL + L        
Sbjct: 70   TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL---DG 126

Query: 830  QRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
               L+W  R KIA+GAA G+ FLH N     IHRD+KS+N+LLD    A++SDFG+AR  
Sbjct: 127  TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 890  SALD-THLSVST-LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG 947
                 T   +++ + GT  Y+ PE  +    T K D+YSFGVVLLE++TG    D+    
Sbjct: 184  EKFAQTV--MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR-E 239

Query: 948  DTNLVGWVKMKVREGKQME-VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPS 1006
               L+   +    E K +E  ID ++             +   +     +  QC+ +  +
Sbjct: 240  PQLLLDIKEEIEDEEKTIEDYIDKKM----------NDADSTSVEAMYSVASQCLHEKKN 289

Query: 1007 KRPNM 1011
            KRP++
Sbjct: 290  KRPDI 294

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  346 bits (889), Expect = e-106
 Identities = 146/626 (23%), Positives = 224/626 (35%), Gaps = 55/626 (8%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           LP  +  L L+   L  L   N F++   L  L+  +N ++  L   L      L++L+L
Sbjct: 23  LPTNITVLNLTHNQLRRLPAAN-FTRYSQLTSLDVGFNTISK-LEPELCQKLPMLKVLNL 80

Query: 82  SYNNLTGSISG-FSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGE 140
            +N L+      F+     C +L  L L  N I  +  +       L  L+LS N L+  
Sbjct: 81  QHNELSQLSDKTFA----FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136

Query: 141 IPRTFGQLSSLQRLDLSNNHITGWIPSELGN-ACDSLLELKLPHNNITGSFPVTLSSCSW 199
              T  QL +LQ L LSNN I      EL   A  SL +L+L  N I    P    +   
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196

Query: 200 LQLLDLSNNNISGPFPDSVLENLG--SLESLILSNNMISGSFPDSISSCK--TLRIVDFS 255
           L  L L+N  +     + +   L   S+ +L LSN+ +S +   +    K   L ++D S
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256

Query: 256 SNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDL---------SLN 306
            N ++ +        +  LE   L  N I  +    L     ++ ++L         SL 
Sbjct: 257 YNNLNVVGNDSFA-WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315

Query: 307 YLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS-GEIPAELF 365
            L          L+ LE      N + G          NLK L L+N+  S   +  E F
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375

Query: 366 S---CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPG-ELGNCSSLVWL 421
                S L  ++LT N+++      FS L  L VL LG N    E+ G E     ++  +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435

Query: 422 DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL 481
            L+ N                     F    +L  +     + K V         +P R 
Sbjct: 436 YLSYNKYLQLTR------------NSFALVPSLQRLMLRRVALKNVDSSPSP--FQPLRN 481

Query: 482 LQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ--------FRGKIPDEIGDMIA 533
           L I  L + +     +     +    + LE LDL +N           G     +  +  
Sbjct: 482 LTILDLSNNNI----ANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537

Query: 534 LQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
           L +L L  N            L  L + D   N L       F+N   L  ++L  N +T
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT 597

Query: 594 GPIPQ--RGQLSTLPASQYANNPGLC 617
               +        L       NP  C
Sbjct: 598 SVEKKVFGPAFRNLTELDMRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  318 bits (816), Expect = 4e-96
 Identities = 119/556 (21%), Positives = 207/556 (37%), Gaps = 55/556 (9%)

Query: 50  NLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISG-FSLNENSCNSLLHLDL 108
           +    + S+  LT  +P+ L +N   + +L+L++N L    +  F+      + L  LD+
Sbjct: 5   SHEVADCSHLKLTQ-VPDDLPTN---ITVLNLTHNQLRRLPAANFT----RYSQLTSLDV 56

Query: 109 SQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSE 168
             N I  + P        LK+LNL  N L+    +TF   ++L  L L +N I     + 
Sbjct: 57  GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116

Query: 169 LGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLG--SLE 226
                 +L+ L L HN ++ +   T      LQ L LSNN I        L+     SL+
Sbjct: 117 FVK-QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSLK 174

Query: 227 SLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGV--SSLEELRLPDNLI 284
            L LS+N I    P    +   L  +  ++ ++   +   +C  +  +S+  L L ++ +
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234

Query: 285 TGVIPGQLSEC--TQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK 342
           +            T L ++DLS N LN         L  LE F   +N ++      L  
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294

Query: 343 CKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNN 402
             N++ L L                 +    S++   L       F  L  L  L + +N
Sbjct: 295 LFNVRYLNLKR---------------SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339

Query: 403 RFKGEIPGELGNCSSLVWLDLNSNNLT-GDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVG 461
              G          +L +L L+++  +   +       L   PL      + L   +N  
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL------HILNLTKN-- 391

Query: 462 NSCKGVGGLLEFAGIRPERLLQIPTLKSCDFA--RMYSGPVLSLFTQYQTLEYLDLSYNQ 519
                     + + I  +    +  L+  D     +        +   + +  + LSYN+
Sbjct: 392 ----------KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441

Query: 520 FRGKIPDEIGDMIALQVLELAHNQLSG--EIPSSLGRLRNLGVFDASHNRLQGQIPESFS 577
           +     +    + +LQ L L    L      PS    LRNL + D S+N +     +   
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501

Query: 578 NLSFLVQIDLSNNELT 593
            L  L  +DL +N L 
Sbjct: 502 GLEKLEILDLQHNNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  315 bits (808), Expect = 5e-95
 Identities = 122/639 (19%), Positives = 200/639 (31%), Gaps = 112/639 (17%)

Query: 2   LSVLKLSSN-LFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           L+ L L SN +  + +   ++    L  L+LS  GL          +L NL  L  S N 
Sbjct: 99  LTELHLMSNSIQKIKNNPFVKQKN-LITLDLSHNGLSST-KLGTQVQLENLQELLLSNNK 156

Query: 61  LTGFLPETL-LSNSDKLELLDLSYNNLTGSISG-FSLNENSCNSLLHLDLSQNHIMDVIP 118
           +     E L +  +  L+ L+LS N +     G F     +   L  L L+   +   + 
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH----AIGRLFGLFLNNVQLGPSLT 212

Query: 119 SSLS---NCTKLKILNLSFNLLAGEIPRTFGQL--SSLQRLDLSNNHITGWIPSELGNAC 173
             L      T ++ L+LS + L+     TF  L  ++L  LDLS N++            
Sbjct: 213 EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAW-L 271

Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPF--------PDSVLENLGSL 225
             L    L +NNI   F  +L     ++ L+L  +               D   + L  L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331

Query: 226 ESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGI-IPPDICPGV--SSLEELRLPDN 282
           E L + +N I G   +  +    L+ +  S++  S   +  +    +  S L  L L  N
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391

Query: 283 LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK 342
            I+ +     S    L+V+DL LN +   +                          E   
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELT-----------------------GQEWRG 428

Query: 343 CKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTG--QIPPEFSRLTRLAVLQLG 400
            +N+ ++ L+ NK             +L+ + L    L      P  F  L  L +L L 
Sbjct: 429 LENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488

Query: 401 NNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNV 460
           NN         L     L  LD                          L  N L  +   
Sbjct: 489 NNNIANINDDMLEGLEKLEILD--------------------------LQHNNLARLWKH 522

Query: 461 GNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQF 520
            N                                   G  +        L  L+L  N F
Sbjct: 523 ANP----------------------------------GGPIYFLKGLSHLHILNLESNGF 548

Query: 521 RGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFS-NL 579
                +   D+  L++++L  N L+    S      +L   +   N +     + F    
Sbjct: 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608

Query: 580 SFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCG 618
             L ++D+  N                   + N P L  
Sbjct: 609 RNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSS 647

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  292 bits (749), Expect = 1e-86
 Identities = 102/515 (19%), Positives = 177/515 (34%), Gaps = 39/515 (7%)

Query: 102 SLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHI 161
           S    D S   +  V     +N   + +LNL+ N L       F + S L  LD+  N I
Sbjct: 5   SHEVADCSHLKLTQVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 162 TGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLEN 221
           +   P         L  L L HN ++     T + C+ L  L L +N+I     ++    
Sbjct: 62  SKLEPELCQK-LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVK 119

Query: 222 LGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGV-SSLEELRLP 280
             +L +L LS+N +S +   +    + L+ +  S+N++  +   ++     SSL++L L 
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 281 DNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELG---KLEHLEQFIAWFNGLEGKIP 337
            N I    PG      +L  + L+   L  S+ ++L        +       + L     
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239

Query: 338 PELGKCK--NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLA 395
                 K  NL  L L+ N L+            LE+  L  N +          L  + 
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299

Query: 396 VLQLGNN---------RFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLG 446
            L L  +                        L  L++  N++ G         +  K L 
Sbjct: 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL- 358

Query: 447 GFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQ 506
             LS++          +   +              L I  L     +++ S      F+ 
Sbjct: 359 -SLSNSFTSLRTLTNETFVSL----------AHSPLHILNLTKNKISKIESD----AFSW 403

Query: 507 YQTLEYLDLSYNQFRGKIP-DEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASH 565
              LE LDL  N+   ++   E   +  +  + L++N+      +S   + +L       
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463

Query: 566 NRLQG--QIPESFSNLSFLVQIDLSNNELTGPIPQ 598
             L+     P  F  L  L  +DLSNN +      
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  248 bits (635), Expect = 9e-71
 Identities = 90/470 (19%), Positives = 164/470 (34%), Gaps = 33/470 (7%)

Query: 150 SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNN 209
           S +  D S+  +T  +P +L     ++  L L HN +        +  S L  LD+  N 
Sbjct: 5   SHEVADCSHLKLTQ-VPDDLPT---NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 210 ISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICP 269
           IS      + + L  L+ L L +N +S     + + C  L  +   SN +  I       
Sbjct: 61  ISK-LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV- 118

Query: 270 GVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELG--KLEHLEQFIA 327
              +L  L L  N ++    G   +   L+ + LS N +     +EL       L++   
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178

Query: 328 WFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF---SCSNLEWISLTGNELTGQI 384
             N ++   P        L  L LNN +L   +  +L    + +++  +SL+ ++L+   
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238

Query: 385 PPEFS--RLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA 442
              F   + T L +L L  N               L +  L  NN+              
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS--------- 289

Query: 443 KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMY-SGPVL 501
                      + ++    +  K    L     I       +  L+  +       G   
Sbjct: 290 ---HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346

Query: 502 SLFTQYQTLEYLDLSYNQFRGKIPDEIG----DMIALQVLELAHNQLSGEIPSSLGRLRN 557
           ++FT    L+YL LS +    +              L +L L  N++S     +   L +
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406

Query: 558 LGVFDASHNRLQGQIP-ESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLP 606
           L V D   N +  ++  + +  L  + +I LS N+           + +P
Sbjct: 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR--NSFALVP 454

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  232 bits (593), Expect = 4e-65
 Identities = 97/477 (20%), Positives = 162/477 (33%), Gaps = 89/477 (18%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPF-GLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYN 59
           +  L LS++  +  ++T+ L L +  L  L+LS   L  +  ++ F+ LP L Y    YN
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV-GNDSFAWLPQLEYFFLEYN 282

Query: 60  NLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNE------NSCNSLLHLDLSQNHI 113
           N+      +L      +  L+L  +    SIS  SL +           L HL++  N I
Sbjct: 283 NIQHLFSHSL-HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341

Query: 114 MDVIPSSLSNCT----------------------------KLKILNLSFNLLAGEIPRTF 145
             +  +  +                                L ILNL+ N ++      F
Sbjct: 342 PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401

Query: 146 GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL 205
             L  L+ LDL  N I   +  +     +++ E+ L +N        + +    LQ L L
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461

Query: 206 SNNNISG-PFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP 264
               +       S  + L +L  L LSNN I+    D +   + L I+D   N ++    
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA---- 517

Query: 265 PDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQ 324
                        RL  +   G     L   + L +++L  N  +    +    L     
Sbjct: 518 -------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL----- 559

Query: 325 FIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQI 384
                                LK + L  N L+    +   +  +L+ ++L  N +T   
Sbjct: 560 -------------------FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600

Query: 385 PPEFSR-LTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQL 440
              F      L  L +  N F          C S+ W  +N  N T    P L    
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFD-------CTCESIAWF-VNWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  218 bits (558), Expect = 2e-60
 Identities = 75/438 (17%), Positives = 120/438 (27%), Gaps = 89/438 (20%)

Query: 1   MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            L    L                                                  YNN
Sbjct: 273 QLEYFFL-------------------------------------------------EYNN 283

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           +      + L     +  L+L  +                       +S   +  +   S
Sbjct: 284 IQHLFSHS-LHGLFNVRYLNLKRS------------------FTKQSISLASLPKIDDFS 324

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSE---LGNACDSLL 177
                 L+ LN+  N + G     F  L +L+ L LSN+  +    +    +  A   L 
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384

Query: 178 ELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG 237
            L L  N I+       S    L++LDL  N I           L ++  + LS N    
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444

Query: 238 SFPDSISSCKTLRIVDFSSNRVSGI-IPPDICPGVSSLEELRLPDNLITGVIPGQLSECT 296
              +S +   +L+ +      +  +   P     + +L  L L +N I  +    L    
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504

Query: 297 QLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKL 356
           +L+++DL  N L                   W +   G     L    +L  L L +N  
Sbjct: 505 KLEILDLQHNNLARL----------------WKHANPGGPIYFLKGLSHLHILNLESNGF 548

Query: 357 SGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELG-NC 415
                        L+ I L  N L       F+    L  L L  N          G   
Sbjct: 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608

Query: 416 SSLVWLDLNSNNLTGDIP 433
            +L  LD+  N       
Sbjct: 609 RNLTELDMRFNPFDCTCE 626

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  319 bits (819), Expect = 2e-97
 Identities = 117/620 (18%), Positives = 209/620 (33%), Gaps = 89/620 (14%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           ++   +  N + +       LPF  K L+LS   L  L   + F   P L  L+ S   +
Sbjct: 10  ITYQCMELNFYKIPD----NLPFSTKNLDLSFNPLRHLGSYS-FFSFPELQVLDLSRCEI 64

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISG-FSLNENSCNSLLHLDLSQNHIMDVIPSS 120
              + +    +   L  L L+ N +     G FS      +SL  L   + ++  +    
Sbjct: 65  QT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFS----GLSSLQKLVAVETNLASLENFP 119

Query: 121 LSNCTKLKILNLSFNLLAG-EIPRTFGQLSSLQRLDLSNNHITGWIPSELGNAC---DSL 176
           + +   LK LN++ NL+   ++P  F  L++L+ LDLS+N I     ++L          
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179

Query: 177 LELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS 236
           L L L  N +    P        L  L L NN  S     + ++ L  LE   L      
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238

Query: 237 GSF------PDSISSCKTLRI--VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVI 288
                      ++     L I     +          D+   ++++    L    I  V 
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298

Query: 289 PGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD 348
               S     + ++L           +L  L+ L      F   +G          +L+ 
Sbjct: 299 D--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEF 351

Query: 349 LILNNNKLS--GEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKG 406
           L L+ N LS  G      F  ++L+++ L+ N +   +   F  L +L  L   ++  K 
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410

Query: 407 EIPGE-LGNCSSLVWLDLNSNNLTGDIPPRLG-----RQLGAKPLGGFLSSNTLVFVRNV 460
                   +  +L++LD++  +                 L        ++ N+       
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL-------KMAGNSFQ----- 458

Query: 461 GNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQF 520
                            P+                       +FT+ + L +LDLS  Q 
Sbjct: 459 -------------ENFLPD-----------------------IFTELRNLTFLDLSQCQL 482

Query: 521 RGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL- 579
               P     + +LQVL ++HN            L +L V D S N +     +   +  
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542

Query: 580 SFLVQIDLSNNELTGPIPQR 599
           S L  ++L+ N+       +
Sbjct: 543 SSLAFLNLTQNDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  281 bits (722), Expect = 1e-83
 Identities = 107/633 (16%), Positives = 184/633 (29%), Gaps = 108/633 (17%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
              L LS N    L S S    P  L+ L+LS   +  +     +  L +L  L  + N 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFP-ELQVLDLSRCEIQTIEDG-AYQSLSHLSTLILTGNP 87

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPS 119
           +   L     S    L+ L     NL    +    +     +L  L+++ N I    +P 
Sbjct: 88  IQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGH---LKTLKELNVAHNLIQSFKLPE 143

Query: 120 SLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQ----RLDLSNNHITGWIPSELGNACDS 175
             SN T L+ L+LS N +          L  +      LDLS N +    P         
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI--R 201

Query: 176 LLELKLPHNNITGSFP-VTLSSCSWLQLLDLSNNNISG-----PFPDSVLENLGSLESLI 229
           L +L L +N  + +     +   + L++  L             F  S LE L +L    
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261

Query: 230 LSNNMISGSF---PDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITG 286
                +        D  +    +      S  +  +            + L L +     
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN---FGWQHLELVNCKFGQ 318

Query: 287 VIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGL--EGKIPPELGKCK 344
               +L    +L     +     G        L  LE      NGL  +G          
Sbjct: 319 FPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNR 403
           +LK L L+ N +   + +       LE +    + L        F  L  L  L + +  
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432

Query: 404 FKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGN 462
            +    G     SSL  L +  N+   +  P +  +L     L   LS   L        
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL--DLSQCQL-------- 482

Query: 463 SCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRG 522
                                                  + F    +L+ L++S+N F  
Sbjct: 483 ----------------------------------EQLSPTAFNSLSSLQVLNMSHNNFFS 508

Query: 523 KIPDEIGDMIALQVLELAHNQLSGEIPSSLGRL-RNLGVFDASHNRLQG----------- 570
                   + +LQVL+ + N +       L     +L   + + N               
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 568

Query: 571 ---------------QIPESFSNLSFLVQIDLS 588
                            P     +  ++ ++++
Sbjct: 569 KDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  185 bits (471), Expect = 1e-49
 Identities = 86/491 (17%), Positives = 139/491 (28%), Gaps = 102/491 (20%)

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
           +     +    +  N    +IP       S + LDLS N +         +    L  L 
Sbjct: 4   VEVVPNITYQCMELNFY--KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFS-FPELQVLD 58

Query: 181 LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
           L    I         S S L  L L+ N I           L SL+ L+     ++    
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
             I   KTL+ ++ + N +     P+    +++LE L L  N I  +    L    Q+ +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177

Query: 301 IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
           ++LSL+     +                       I P   K   L  L L NN  S  +
Sbjct: 178 LNLSLDLSLNPM---------------------NFIQPGAFKEIRLHKLTLRNNFDSLNV 216

Query: 361 PAELF-SCSNLEWISLTGNELTGQI---PPEFSRLTRLAVLQLGNNRFKGEIPGELGNCS 416
                   + LE   L   E   +      + S L  L  L +   R             
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR------------- 263

Query: 417 SLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGI 476
                 L   +   D    L             + ++   V                   
Sbjct: 264 ------LAYLDYYLDDIIDL--------FNCLTNVSSFSLVSV----------------- 292

Query: 477 RPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQV 536
               + ++      DF+  +              ++L+L   +F          +    +
Sbjct: 293 ---TIERVK-----DFSYNFG------------WQHLELVNCKFGQ-----FPTLKLKSL 327

Query: 537 LELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQ--GQIPESFSNLSFLVQIDLSNNELTG 594
             L      G    S   L +L   D S N L   G   +S    + L  +DLS N +  
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387

Query: 595 PIPQRGQLSTL 605
                  L  L
Sbjct: 388 MSSNFLGLEQL 398

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  175 bits (446), Expect = 2e-46
 Identities = 72/397 (18%), Positives = 130/397 (32%), Gaps = 36/397 (9%)

Query: 219 LENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELR 278
           +E + ++    +  N      PD++    + + +D S N +  +           L+ L 
Sbjct: 4   VEVVPNITYQCMELNFYK--IPDNLPF--STKNLDLSFNPLRHLGSYSFF-SFPELQVLD 58

Query: 279 LPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPP 338
           L    I  +  G     + L  + L+ N +          L  L++ +A    L      
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118

Query: 339 ELGKCKNLKDLILNNNKL-SGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRL--- 394
            +G  K LK+L + +N + S ++P    + +NLE + L+ N++      +   L ++   
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178

Query: 395 -AVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNT 453
              L L  N      PG       L  L L +N  + ++                     
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTC-----------IQGLAG 226

Query: 454 LVFVRNVGNSCKGVGGLLEFAGIRPERL----LQIPTLKSCDFARMYSGPVLSLFTQYQT 509
           L   R V    +  G L +F     E L    ++   L   D+   Y   ++ LF     
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY---YLDDIIDLFNCLTN 283

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQ 569
           +    L           +       Q LEL + +        L  L+ L     +    +
Sbjct: 284 VSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL-----TFTSNK 336

Query: 570 GQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLP 606
           G    S  +L  L  +DLS N L+             
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  134 bits (339), Expect = 8e-33
 Identities = 53/337 (15%), Positives = 95/337 (28%), Gaps = 41/337 (12%)

Query: 292 LSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLIL 351
           +     +    + LN+    IP  L      +     FN L             L+ L L
Sbjct: 4   VEVVPNITYQCMELNFY--KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 352 NNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGE 411
           +  ++         S S+L  + LTGN +       FS L+ L  L              
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 412 LGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLL 471
           +G+  +L  L++  N +     P               +   L    N            
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEY--------FSNLTNLEHLDLSSNK----------- 160

Query: 472 EFAGIRPERLLQIPTLKSCDFAR-----MYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPD 526
               I    L  +  +   + +        +      F + + L  L L  N     +  
Sbjct: 161 -IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMK 218

Query: 527 EIGDMIA-LQVLELAHNQLSGE------IPSSLGRLRNLGVFDASHNRL---QGQIPESF 576
                +A L+V  L   +   E        S+L  L NL + +     L      I + F
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278

Query: 577 SNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANN 613
           + L+ +    L +  +   +            +  N 
Sbjct: 279 NCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNC 314

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  316 bits (812), Expect = 5e-96
 Identities = 81/596 (13%), Positives = 168/596 (28%), Gaps = 82/596 (13%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETL---LSNSDKLELLDLS 82
           +  L L   G  G VPD    +L  L  L    +             +S +   E     
Sbjct: 83  VTGLSLEGFGASGRVPDA-IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141

Query: 83  YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIP 142
             +   +           + L+   ++ +     I  S     K   +    N +   + 
Sbjct: 142 RMHYQKTFVD-YDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVS 199

Query: 143 RTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQL 202
           +   +L+ L++  + N+        E              +     +  +   +   L  
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWE------NENSEYAQQYKTEDLKWDNLKDLTD 253

Query: 203 LDLSNNNISGPFPDSVLENLGSLESLILSNNMI--------SGSFPDSISSCKTLRIVDF 254
           +++ N       P   L+ L  ++ + ++ N                     + ++I+  
Sbjct: 254 VEVYNCPNLTKLPTF-LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312

Query: 255 SSNR-VSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP 313
             N   +  +   +   +  L  L    N + G +P       +L  ++L+ N +     
Sbjct: 313 GYNNLKTFPVETSLQ-KMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPA 370

Query: 314 QELGKLEHLEQFIAWFNGLEGKIPP--ELGKCKNLKDLILNNNKLSG-------EIPAEL 364
              G  E +E      N L+  IP   +      +  +  + N++          +    
Sbjct: 371 NFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429

Query: 365 FSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKG-------EIPGELGNCSS 417
           F   N+  I+L+ N+++      FS  + L+ + L  N           +      N   
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489

Query: 418 LVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIR 477
           L  +DL  N LT  +                     +    N             F+   
Sbjct: 490 LTSIDLRFNKLTK-LSDDFR-------ATTLPYLVGIDLSYN------------SFSKF- 528

Query: 478 PERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVL 537
           P + L   TLK              +          D   N+   + P+ I    +L  L
Sbjct: 529 PTQPLNSSTLK-----------GFGI------RNQRDAQGNRTLREWPEGITLCPSLTQL 571

Query: 538 ELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
           ++  N +   +   +    N+ V D   N                    L  ++  
Sbjct: 572 QIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  308 bits (790), Expect = 7e-93
 Identities = 91/589 (15%), Positives = 182/589 (30%), Gaps = 83/589 (14%)

Query: 38  GLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNE 97
           G  P    +    +  L+      +G +P+  +    +LE+L L  +    +   F    
Sbjct: 70  GAQPGVSLNSNGRVTGLSLEGFGASGRVPDA-IGQLTELEVLALGSHGEKVNERLFGPKG 128

Query: 98  -NSCNSLLHLDLSQNHIMDVIPSSLS--NCTKLKILNLSFNLLAGEIPRTFGQLSSLQRL 154
            ++  S       + H            + + L    ++ +     I ++        ++
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188

Query: 155 DLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPF 214
              +N+IT  +   +      L +  + ++                +  +          
Sbjct: 189 GQLSNNITF-VSKAVMR-LTKLRQFYMGNSPFVAENICEA-----WENENSEYAQQYKTE 241

Query: 215 PDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNR-VSGIIPPDIC----- 268
                +NL  L  + + N       P  + +   +++++ + NR +SG    D       
Sbjct: 242 DLK-WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300

Query: 269 -PGVSSLEELRLPDN-LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFI 326
            P    ++ + +  N L T  +   L +  +L +++   N L G +P   G    L    
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359

Query: 327 AWFNGLEGKIPPEL-GKCKNLKDLILNNNKLSGEIPAELF--SCSNLEWISLTGNELTG- 382
             +N +   IP    G  + +++L   +NKL   IP      S S +  I  + NE+   
Sbjct: 360 LAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417

Query: 383 ------QIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRL 436
                  + P   +   ++ + L NN+            S L  ++L  N LT  IP   
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNS 476

Query: 437 GRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFA--R 494
            +                                        E       L S D    +
Sbjct: 477 LKDE-------------------------------------NENFKNTYLLTSIDLRFNK 499

Query: 495 MYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLEL------AHNQLSGEI 548
           +         T    L  +DLSYN F    P +  +   L+   +        N+   E 
Sbjct: 500 LTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558

Query: 549 PSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIP 597
           P  +    +L       N ++    +   N+S L   D+ +N       
Sbjct: 559 PEGITLCPSLTQLQIGSNDIRKVNEKITPNISVL---DIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  292 bits (749), Expect = 5e-87
 Identities = 85/572 (14%), Positives = 169/572 (29%), Gaps = 90/572 (15%)

Query: 60  NLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHI----MD 115
           ++ G  P   L+++ ++  L L     +G +            L  L L  +        
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ---LTELEVLALGSHGEKVNERL 123

Query: 116 VIPSSLSNCTKLKILNLSFNLLAGEIPRTFG--QLSSLQRLDLSNNHITGWIPSELGNAC 173
             P  +S     +                      S L +  ++++     I        
Sbjct: 124 FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI-T 182

Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
               ++    NNIT      +   + L+   + N+           EN            
Sbjct: 183 LKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN------SEYA 235

Query: 234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV------ 287
               +      + K L  V+  +      +P  +   +  ++ + +  N           
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDD 294

Query: 288 --IPGQLSECTQLKVIDLSLNYL-NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCK 344
                      ++++I +  N L    +   L K++ L      +N LEG   P  G   
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEI 353

Query: 345 NLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPP--EFSRLTRLAVLQLGN 401
            L  L L  N+++  IPA        +E +S   N+L   IP   +   ++ ++ +    
Sbjct: 354 KLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411

Query: 402 NRFKG-------EIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGF-LSSNT 453
           N            +        ++  ++L++N ++   P  L       PL    L  N 
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK-FPKELFSTG--SPLSSINLMGN- 467

Query: 454 LVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYL 513
                                 I    L                      F     L  +
Sbjct: 468 ------------------MLTEIPKNSLKDEN----------------ENFKNTYLLTSI 493

Query: 514 DLSYNQFRGKIPDEI--GDMIALQVLELAHNQLSGEIPSSLGRLRNLGVF------DASH 565
           DL +N+    + D+     +  L  ++L++N  S   P+       L  F      DA  
Sbjct: 494 DLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551

Query: 566 NRLQGQIPESFSNLSFLVQIDLSNNELTGPIP 597
           NR   + PE  +    L Q+ + +N++   + 
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRK-VN 582

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  267 bits (685), Expect = 4e-78
 Identities = 89/567 (15%), Positives = 175/567 (30%), Gaps = 100/567 (17%)

Query: 65  LPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNC 124
           L  T     D L L ++ ++ L G             +  + +   +        SL++ 
Sbjct: 22  LSRTAEYIKDYLALKEI-WDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN 80

Query: 125 TKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHN 184
            ++  L+L     +G +P   GQL+ L+ L L ++                         
Sbjct: 81  GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV--------------------- 119

Query: 185 NITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSV-LENLGSLESLILSNNMISGSFPDSI 243
           N     P  +S+    +       +    F D    E+   L    ++++    S   S 
Sbjct: 120 NERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179

Query: 244 SSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDL 303
                   +   SN ++ +    +   ++ L +  + ++            C   +  + 
Sbjct: 180 RITLKDTQIGQLSNNITFV-SKAVM-RLTKLRQFYMGNSPFVAENI-----CEAWENENS 232

Query: 304 SLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKL------- 356
                  +   +   L+ L     +      K+P  L     ++ + +  N+        
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292

Query: 357 -SGEIPAELFSCSNLEWISLTGNEL-TGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGN 414
              +  A+      ++ I +  N L T  +     ++ +L +L+   N+ +G++P   G+
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGS 351

Query: 415 CSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSS-NTLVFVRNVGNSCKGVGGLLEF 473
              L  L+L  N +T  IP             GF      L F  N              
Sbjct: 352 EIKLASLNLAYNQITE-IPANFC---------GFTEQVENLSFAHN-------------- 387

Query: 474 AGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRG-------KIPD 526
                 +L  IP +                      +  +D SYN+           +  
Sbjct: 388 ------KLKYIPNIFD--------------AKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427

Query: 527 EIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQG-------QIPESFSNL 579
                I +  + L++NQ+S            L   +   N L            E+F N 
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487

Query: 580 SFLVQIDLSNNELTGPIPQRGQLSTLP 606
             L  IDL  N+LT  +    + +TLP
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  262 bits (672), Expect = 3e-76
 Identities = 76/586 (12%), Positives = 156/586 (26%), Gaps = 110/586 (18%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFG----LKQLELSSAGLVGLVPDNL-FSKLPNLVYLNA 56
           L VL L S+   +N               +Q +           D        +L+    
Sbjct: 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCI 166

Query: 57  SYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV 116
           + +     + +     + K   +    NN+T               L    +  +  +  
Sbjct: 167 NSDPQQKSIKK-SSRITLKDTQIGQLSNNITFVSKAVM----RLTKLRQFYMGNSPFVAE 221

Query: 117 IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSL 176
                      +  N  +          +  L  L  +++ N      +P+ L      +
Sbjct: 222 NICEA-----WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA-LPEM 275

Query: 177 LELKLPHNNIT--------GSFPVTLSSCSWLQLLDLSNNNI-SGPFPDSVLENLGSLES 227
             + +  N                       +Q++ +  NN+ + P   S L+ +  L  
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETS-LQKMKKLGM 334

Query: 228 LILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV 287
           L    N + G    +  S   L  ++ + N+++  IP + C     +E L    N +  +
Sbjct: 335 LECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYI 392

Query: 288 IPG-QLSECTQLKVIDLSLNYLNG-------SIPQELGKLEHLEQFIAWFNGLEGKIPPE 339
                    + +  ID S N +          +     K  ++       N +       
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452

Query: 340 LGKCKNLKDLILNNNKLSG-------EIPAELFSCSNLEWISLTGNELTGQIPPE--FSR 390
                 L  + L  N L+        +      +   L  I L  N+LT  +  +   + 
Sbjct: 453 FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATT 511

Query: 391 LTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLN------SNNLTGDIPPRLG-----RQ 439
           L  L  + L  N F    P +  N S+L    +        N    + P  +       Q
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ 570

Query: 440 LGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGP 499
           L        + SN                            + ++               
Sbjct: 571 L-------QIGSN---------------------------DIRKVNE------------- 583

Query: 500 VLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLS 545
              +      +  LD+  N         +   I   +  L +++  
Sbjct: 584 --KITPN---ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  238 bits (608), Expect = 2e-67
 Identities = 70/444 (15%), Positives = 142/444 (31%), Gaps = 61/444 (13%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFG----LKQLELSSAGLVGLVPDNLFSKLPNLVYLNAS 57
           +     + N           L +     L  +E+ +   +  +P  L   LP +  +N +
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL-KALPEMQLINVA 281

Query: 58  YNNLTGFLPETL-------LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQ 110
            N                     +K++++ + YNNL       SL       L  L+   
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ--KMKKLGMLECLY 339

Query: 111 NHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELG 170
           N +   +P+   +  KL  LNL++N +        G    ++ L  ++N +   IP+   
Sbjct: 340 NQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFD 397

Query: 171 NA-CDSLLELKLPHNNITG-------SFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
                 +  +   +N I             T      +  ++LSNN IS  FP  +    
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK-FPKELFSTG 456

Query: 223 GSLESLILSNNMISG-------SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPG-VSSL 274
             L S+ L  NM++           ++  +   L  +D   N+++  +  D     +  L
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYL 515

Query: 275 EELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEG 334
             + L  N  +   P Q    + LK   +                          N    
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG------------------NRTLR 556

Query: 335 KIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRL 394
           + P  +  C +L  L + +N +   +  ++    N+  + +  N                
Sbjct: 557 EWPEGITLCPSLTQLQIGSNDIRK-VNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEA 613

Query: 395 AVLQLGNNRFKGEIPGELGNCSSL 418
            +  L  ++       ++  C +L
Sbjct: 614 GMYMLFYDK-----TQDIRGCDAL 632

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  218 bits (557), Expect = 1e-60
 Identities = 74/442 (16%), Positives = 136/442 (30%), Gaps = 57/442 (12%)

Query: 176 LLELKLPHNNITGSF--PVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
           L E+    N    S     T    +W    +L      G  P   L + G +  L L   
Sbjct: 35  LKEIWDALNGKNWSQQGFGTQPGANWNFNKELDM---WGAQPGVSLNSNGRVTGLSLEGF 91

Query: 234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLS 293
             SG  PD+I     L ++   S+            G+S+         +        + 
Sbjct: 92  GASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVD 151

Query: 294 ECTQLKVIDLSLNYLN-----GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD 348
              +    DL  + +N      SI +         Q     N +   +   + +   L+ 
Sbjct: 152 YDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQ 210

Query: 349 LILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEI 408
             + N+    E   E +   N E+              ++  L  L  +++ N     ++
Sbjct: 211 FYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYNCPNLTKL 265

Query: 409 PGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVG 468
           P  L     +  +++  N        +L     A           ++++    N+     
Sbjct: 266 PTFLKALPEMQLINVACNRGIS--GEQLKDDWQALADAPVGEKIQIIYIGY--NN----- 316

Query: 469 GLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI 528
                                     + + PV +   + + L  L+  YNQ  G      
Sbjct: 317 --------------------------LKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAF 349

Query: 529 GDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFS--NLSFLVQID 586
           G  I L  L LA+NQ++    +  G    +     +HN+L+  IP  F   ++S +  ID
Sbjct: 350 GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAID 408

Query: 587 LSNNELTGPIPQRGQLSTLPAS 608
            S NE+            L  +
Sbjct: 409 FSYNEIGSVDG--KNFDPLDPT 428

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  123 bits (310), Expect = 4e-29
 Identities = 28/271 (10%), Positives = 65/271 (23%), Gaps = 66/271 (24%)

Query: 366 SCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKG----EIPGELGNCSSLVWL 421
           S   +  +SL G   +G++P    +LT L VL LG++  K       P  +    S    
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138

Query: 422 DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL 481
                +          R+  +  +   ++S+                             
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQ--------------------------- 171

Query: 482 LQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH 541
                             +            +    N     +   +  +  L+   + +
Sbjct: 172 ---------------QKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGN 215

Query: 542 NQLSGE-------------------IPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFL 582
           +    E                          L++L   +  +     ++P     L  +
Sbjct: 216 SPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275

Query: 583 VQIDLSNNELTGPIPQRGQLSTLPASQYANN 613
             I+++ N        +     L  +     
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEK 306

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  288 bits (739), Expect = 6e-86
 Identities = 107/584 (18%), Positives = 193/584 (33%), Gaps = 69/584 (11%)

Query: 27  KQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNL 86
           K     + GL   +P  L     +   L  S+N L   +  T  S    L  LDL+   +
Sbjct: 15  KTYNCENLGLNE-IPGTLP---NSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQI 69

Query: 87  TGSISG-FSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
                  F     S + L  L L+ N ++ +  ++LS    LK L      ++       
Sbjct: 70  YWIHEDTFQ----SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125

Query: 146 GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQL--L 203
               +L+ L L +NHI+     +     + L  L   +N I       +SS        L
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184

Query: 204 DLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCK--TLRIVDFSSNRVSG 261
           +L+ N+I+G  P     +    +SL              + +    +L +  F       
Sbjct: 185 NLNGNDIAGIEPG--AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242

Query: 262 IIPPDICP-GVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLE 320
           I P         S+E + L  +    +        + L+ +DL+  +L+  +P  L  L 
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLS 301

Query: 321 HLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNE 379
            L++ +   N  E           +L  L +  N    E+         NL  + L+ ++
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361

Query: 380 LT--GQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLG 437
           +        +   L+ L  L L  N            C  L  LDL    L         
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ--- 418

Query: 438 RQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYS 497
                     F + + L  +    +                     +       F  + +
Sbjct: 419 --------SPFQNLHLLKVLNLSHS--------------------LLDISSEQLFDGLPA 450

Query: 498 GPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIG---DMIALQVLELAHNQLSGEIPSSLGR 554
                       L++L+L  N F      +      +  L++L L+   LS     +   
Sbjct: 451 ------------LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498

Query: 555 LRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQ 598
           L+ +   D SHNRL     E+ S+L  +  ++L++N ++  +P 
Sbjct: 499 LKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPS 541

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  272 bits (698), Expect = 3e-80
 Identities = 118/605 (19%), Positives = 209/605 (34%), Gaps = 68/605 (11%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
              L+ S N+   + +T+  +L   L  L+L+   +  +  ++ F     L  L  + N 
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLIN-LTFLDLTRCQIYWI-HEDTFQSQHRLDTLVLTANP 92

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           L   + ET LS    L+ L      ++ SI    L+  +  +L  L L  NHI  +    
Sbjct: 93  LIF-MAETALSGPKALKHLFFIQTGIS-SIDFIPLH--NQKTLESLYLGSNHISSIKLPK 148

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQR--LDLSNNHITGWIPSELGNACDSLLE 178
                KLK+L+   N +          L       L+L+ N I G I     +       
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFD-SAVFQS 206

Query: 179 LKLPHNNITGSFPVTLSSCS--WLQLLDLSNNNISGPFPDSVLENLG--SLESLILSNNM 234
           L              L + +   L L    + +       +V E L   S+ES+ L  + 
Sbjct: 207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED-ISPAVFEGLCEMSVESINLQKHY 265

Query: 235 ISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSE 294
                 ++      L+ +D ++  +S + P  +  G+S+L++L L  N    +     S 
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLSEL-PSGLV-GLSTLKKLVLSANKFENLCQISASN 323

Query: 295 CTQLKVIDLSLNYLNGSI-PQELGKLEHLEQFIAWFNGLE--GKIPPELGKCKNLKDLIL 351
              L  + +  N     +    L  LE+L +     + +E       +L    +L+ L L
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383

Query: 352 NNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPG 410
           + N+           C  LE + L    L  +     F  L  L VL L ++        
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443

Query: 411 ELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGL 470
                 +L  L+L  N+                       +N+L  +             
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNI---------------QKTNSLQTLGR----------- 477

Query: 471 LEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGD 530
                      L+I  L  CD + +        FT  + + ++DLS+N+      + +  
Sbjct: 478 -----------LEILVLSFCDLSSIDQH----AFTSLKMMNHVDLSHNRLTSSSIEALSH 522

Query: 531 MIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
           +  +  L LA N +S  +PS L  L      +   N L      + SN+ FL     +  
Sbjct: 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC----TCSNIYFLEWYKENMQ 577

Query: 591 ELTGP 595
           +L   
Sbjct: 578 KLEDT 582

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  194 bits (494), Expect = 2e-52
 Identities = 87/365 (23%), Positives = 144/365 (39%), Gaps = 25/365 (6%)

Query: 2   LSVLKLSSN-LFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           +  + L  +  F ++S +      GL++L+L++  L  L   +    L  L  L  S N 
Sbjct: 256 VESINLQKHYFFNISSNTFHCFS-GLQELDLTATHLSEL--PSGLVGLSTLKKLVLSANK 312

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHI--MDVIP 118
               L +   SN   L  L +  N     +    L   +  +L  LDLS + I   D   
Sbjct: 313 FEN-LCQISASNFPSLTHLSIKGNTKRLELGTGCLE--NLENLRELDLSHDDIETSDCCN 369

Query: 119 SSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLE 178
             L N + L+ LNLS+N         F +   L+ LDL+   +              L  
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429

Query: 179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISG--PFPDSVLENLGSLESLILSNNMIS 236
           L L H+ +  S          LQ L+L  N+         + L+ LG LE L+LS   +S
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489

Query: 237 GSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECT 296
                + +S K +  VD S NR++     +    +  +  L L  N I+ ++P  L   +
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547

Query: 297 QLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIP-PELGKCK---NLKDLILN 352
           Q + I+L  N L+ +             F+ W+     K+   E   C+    L+ + L+
Sbjct: 548 QQRTINLRQNPLDCTC--------SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLS 599

Query: 353 NNKLS 357
           +  LS
Sbjct: 600 DVTLS 604

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  266 bits (683), Expect = 1e-81
 Identities = 87/345 (25%), Positives = 130/345 (37%), Gaps = 68/345 (19%)

Query: 281 DNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPEL 340
           +    GV+    ++  ++  +DLS   L    P                      IP  L
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP----------------------IPSSL 72

Query: 341 GKCKNLKDLIL-NNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQL 399
                L  L +   N L G IP  +   + L ++ +T   ++G IP   S++  L  L  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 400 GNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRN 459
             N   G +P  + +  +LV +  + N ++G IP   G           +S N L     
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS-FSKLFTSMTISRNRLT---- 187

Query: 460 VGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ 519
            G                      IP      FA +              L ++DLS N 
Sbjct: 188 -GK---------------------IPP----TFANL-------------NLAFVDLSRNM 208

Query: 520 FRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL 579
             G      G     Q + LA N L+ ++   +G  +NL   D  +NR+ G +P+  + L
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQL 267

Query: 580 SFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPEC 624
            FL  +++S N L G IPQ G L     S YANN  LCG PLP C
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  238 bits (611), Expect = 2e-71
 Identities = 90/307 (29%), Positives = 133/307 (43%), Gaps = 14/307 (4%)

Query: 117 IPSSLSNCTKL----KILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITG--WIPSELG 170
           I   L N T L       +       G +  T  Q   +  LDLS  ++     IPS L 
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 171 NACDSLLELKLPH-NNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLI 229
           N    L  L +   NN+ G  P  ++  + L  L +++ N+SG  PD  L  + +L +L 
Sbjct: 74  N-LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQIKTLVTLD 131

Query: 230 LSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIP 289
            S N +SG+ P SISS   L  + F  NR+SG IP            + +  N +TG IP
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191

Query: 290 GQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDL 349
              +    L  +DLS N L G      G  ++ ++     N L   +  ++G  KNL  L
Sbjct: 192 PTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGL 249

Query: 350 ILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIP 409
            L NN++ G +P  L     L  ++++ N L G+IP     L R  V    NN+     P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

Query: 410 GELGNCS 416
             L  C+
Sbjct: 309 --LPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  234 bits (600), Expect = 6e-70
 Identities = 75/284 (26%), Positives = 121/284 (42%), Gaps = 10/284 (3%)

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGE--IPRTFGQLSSLQRLDLSN-NHIT 162
            D      + V+  + +   ++  L+LS   L     IP +   L  L  L +   N++ 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 163 GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
           G IP  +      L  L + H N++G+ P  LS    L  LD S N +SG  P S + +L
Sbjct: 91  GPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS-ISSL 148

Query: 223 GSLESLILSNNMISGSFPDSISSCKTL-RIVDFSSNRVSGIIPPDICPGVSSLEELRLPD 281
            +L  +    N ISG+ PDS  S   L   +  S NR++G IPP       +L  + L  
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF--ANLNLAFVDLSR 206

Query: 282 NLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELG 341
           N++ G            + I L+ N L   +  ++G  ++L       N + G +P  L 
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT 265

Query: 342 KCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIP 385
           + K L  L ++ N L GEIP +  +    +  +   N+     P
Sbjct: 266 QLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  219 bits (560), Expect = 2e-64
 Identities = 65/258 (25%), Positives = 109/258 (42%), Gaps = 12/258 (4%)

Query: 189 SFPVTLSSC----SWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSF--PDS 242
                L +     SWL   D  N    G   D+       + +L LS   +   +  P S
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDT-DTQTYRVNNLDLSGLNLPKPYPIPSS 71

Query: 243 ISSCKTLRIVDFSS-NRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
           +++   L  +     N + G IPP I   ++ L  L +    ++G IP  LS+   L  +
Sbjct: 72  LANLPYLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNL-KDLILNNNKLSGEI 360
           D S N L+G++P  +  L +L       N + G IP   G    L   + ++ N+L+G+I
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 361 PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
           P    +  NL ++ L+ N L G     F        + L  N    ++  ++G   +L  
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248

Query: 421 LDLNSNNLTGDIPPRLGR 438
           LDL +N + G +P  L +
Sbjct: 249 LDLRNNRIYGTLPQGLTQ 266

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  211 bits (540), Expect = 1e-61
 Identities = 76/342 (22%), Positives = 130/342 (38%), Gaps = 65/342 (19%)

Query: 31  LSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTG--FLPETLLSNSDKLELLDLS-YNNLT 87
             +   +G++ D   ++   +  L+ S  NL     +P +L +N   L  L +   NNL 
Sbjct: 33  CCNRTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSL-ANLPYLNFLYIGGINNLV 90

Query: 88  GSI-SGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFG 146
           G I    +        L +L ++  ++   IP  LS    L  L+ S+N L+G +P +  
Sbjct: 91  GPIPPAIA----KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146

Query: 147 QLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLS 206
            L +L  +    N I+G IP   G+    L                          + +S
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGS-FSKL-----------------------FTSMTIS 182

Query: 207 NNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPD 266
            N ++G  P +   NL +L  + LS NM+ G       S K  + +  + N ++  +   
Sbjct: 183 RNRLTGKIPPT-FANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-- 238

Query: 267 ICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFI 326
                                   ++     L  +DL  N + G++PQ L +L+ L    
Sbjct: 239 ------------------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 327 AWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCS 368
             FN L G+I P+ G  +        NNK     P  L +C+
Sbjct: 275 VSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP--LPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  175 bits (445), Expect = 1e-48
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 13/210 (6%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
           L  L ++   + G +PD L S++  LV L+ SYN L+G LP + +S+   L  +    N 
Sbjct: 103 LHYLYITHTNVSGAIPDFL-SQIKTLVTLDFSYNALSGTLPPS-ISSLPNLVGITFDGNR 160

Query: 86  LTGSI-SGFSLNENSCNSLL-HLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPR 143
           ++G+I   +     S + L   + +S+N +   IP + +N   L  ++LS N+L G+   
Sbjct: 161 ISGAIPDSYG----SFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV 215

Query: 144 TFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLL 203
            FG   + Q++ L+ N +   +   +G    +L  L L +N I G+ P  L+   +L  L
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGK-VGL-SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273

Query: 204 DLSNNNISGPFPDSVLENLGSLESLILSNN 233
           ++S NN+ G  P     NL   +    +NN
Sbjct: 274 NVSFNNLCGEIPQG--GNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  149 bits (380), Expect = 5e-40
 Identities = 62/256 (24%), Positives = 91/256 (35%), Gaps = 54/256 (21%)

Query: 359 EIPAELFSCSNLE-W---ISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGE--IPGEL 412
           +I  +L + + L  W            G +    ++  R+  L L          IP  L
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 413 GNCSSLVWLDL-NSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLL 471
            N   L +L +   NNL G IPP + +      L  +++   +                 
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL--YITHTNV----------------- 113

Query: 472 EFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDM 531
                                    SG +    +Q +TL  LD SYN   G +P  I  +
Sbjct: 114 -------------------------SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 532 IALQVLELAHNQLSGEIPSSLGRLRNLGVF-DASHNRLQGQIPESFSNLSFLVQIDLSNN 590
             L  +    N++SG IP S G    L      S NRL G+IP +F+NL+ L  +DLS N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207

Query: 591 ELTGPIPQR-GQLSTL 605
            L G      G     
Sbjct: 208 MLEGDASVLFGSDKNT 223

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 28/159 (17%), Positives = 39/159 (24%), Gaps = 79/159 (49%)

Query: 1   MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
               + L+                                                  N+
Sbjct: 222 NTQKIHLAK-------------------------------------------------NS 232

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           L   L +  +  S  L  LDL  N + G+                           +P  
Sbjct: 233 LAFDLGK--VGLSKNLNGLDLRNNRIYGT---------------------------LPQG 263

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
           L+    L  LN+SFN L GEIP   G L        +NN
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  273 bits (701), Expect = 1e-80
 Identities = 114/571 (19%), Positives = 193/571 (33%), Gaps = 55/571 (9%)

Query: 40  VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISG-FSLNEN 98
           VPD++     +   ++ S+N L   L     SN  +L+ LDLS   +       +     
Sbjct: 26  VPDDIP---SSTKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWH---- 77

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSN 158
             + L +L L+ N I    P S S  T L+ L      LA       GQL +L++L++++
Sbjct: 78  GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAH 137

Query: 159 NHITGWIPSELGNACDSLLELKLPHNNITG----SFPVTLSSCSWLQLLDLSNNNISGPF 214
           N I         +   +L+ + L +N I             +      LD+S N I    
Sbjct: 138 NFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-I 196

Query: 215 PDSVLENLGSLESLILSNNMISGS-FPDSISSCKTLRIVDFSSNRVSG-----IIPPDIC 268
            D   + +  L  L L  N  S +     + +   L +               I  P I 
Sbjct: 197 QDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255

Query: 269 PGVSSL--EELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFI 326
            G+  +  +E RL           +      +  + L+   +     +++ K    +   
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLS 313

Query: 327 AWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPP 386
                L+   P        LK L L  NK S  I  +  +  +L ++ L+ N L+     
Sbjct: 314 IIRCQLKQ-FPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCC 368

Query: 387 EFSRL--TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKP 444
            +S L    L  L L  N     +         L  LD   + L                
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEF---------- 417

Query: 445 LGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFA--RMYSGPVLS 502
              FLS   L+++     +                  L + +L +   A        + +
Sbjct: 418 -SAFLSLEKLLYLDISYTN---------TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467

Query: 503 LFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFD 562
           +F     L +LDLS  Q           +  LQ+L ++HN L     S   +L +L   D
Sbjct: 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527

Query: 563 ASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
            S NR++            L   +L+NN + 
Sbjct: 528 CSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  240 bits (614), Expect = 1e-68
 Identities = 95/469 (20%), Positives = 154/469 (32%), Gaps = 36/469 (7%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           LS L L+ N     S         L+ L      L  L       +L  L  LN ++N +
Sbjct: 82  LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL-ESFPIGQLITLKKLNVAHNFI 140

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISG-FSLNENSCNSLLHLDLSQNHIMDVIPSS 120
                    SN   L  +DLSYN +             +    L LD+S N I  +   +
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA 200

Query: 121 LSNCTKLKILNLSFNLLAGEIPRT-FGQLSSLQRLDLS------NNHITGWIPSELGNAC 173
                KL  L L  N  +  I +T    L+ L    L         ++  + PS +   C
Sbjct: 201 FQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259

Query: 174 D-SLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVL------------- 219
           D ++ E +L + N      V     + +  + L+  +I                      
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL 319

Query: 220 -----ENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP-PDICPGVSS 273
                 +L  L+SL L+ N  S SF     +  +L  +D S N +S          G +S
Sbjct: 320 KQFPTLDLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377

Query: 274 LEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQE-LGKLEHLEQFIAWFNGL 332
           L  L L  N    ++        +L+ +D   + L           LE L      +   
Sbjct: 378 LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436

Query: 333 EGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPEFSRL 391
           +           +L  L +  N       + +F+  +NL ++ L+  +L       F  L
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496

Query: 392 TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQL 440
            RL +L + +N              SL  LD + N +       L    
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFP 544

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  225 bits (575), Expect = 2e-63
 Identities = 100/574 (17%), Positives = 172/574 (29%), Gaps = 111/574 (19%)

Query: 41  PDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISG-FSLNENS 99
            +     +PN+         L+  +P+ + S+    + +DLS+N L    S  FS    +
Sbjct: 4   LNPCIEVVPNIT-YQCMDQKLSK-VPDDIPSS---TKNIDLSFNPLKILKSYSFS----N 54

Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
            + L  LDLS+  I  +   +      L  L L+ N +    P +F  L+SL+ L     
Sbjct: 55  FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114

Query: 160 HITGWIPSELGNACDSLLELKLPHNNITG-SFPVTLSSCSWLQLLDLSNNNISGPFPDSV 218
            +       +G    +L +L + HN I     P   S+ + L  +DLS N I      + 
Sbjct: 115 KLASLESFPIGQ-LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVND 172

Query: 219 LENLG----SLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSL 274
           L+ L        SL +S N I     D       L  +    N  S  I       ++ L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231

Query: 275 EELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEG 334
              RL                            L    P  +  L  +            
Sbjct: 232 HVHRLILGEF------------------KDERNLEIFEPSIMEGLCDV------------ 261

Query: 335 KIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRL 394
                      + +  L       +   +    +N+  +SL G  +      +  +  + 
Sbjct: 262 ----------TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKW 309

Query: 395 AVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTL 454
             L +   + K + P    +   L  L L  N  +          L    L   LS N  
Sbjct: 310 QSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGSISFKKVALPSL--SYL--DLSRN-- 360

Query: 455 VFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLD 514
                                        +     C ++ +             +L +LD
Sbjct: 361 ----------------------------ALSFSGCCSYSDL----------GTNSLRHLD 382

Query: 515 LSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIP-SSLGRLRNLGVFDASHNRLQGQIP 573
           LS+N     +      +  LQ L+  H+ L      S+   L  L   D S+   +    
Sbjct: 383 LSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 574 ESFSNLSFLVQIDLSNNELTGPIPQR--GQLSTL 605
             F  L+ L  + ++ N              + L
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  187 bits (476), Expect = 3e-50
 Identities = 62/308 (20%), Positives = 107/308 (34%), Gaps = 18/308 (5%)

Query: 2   LSVLKLSSN-LFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           +   +L+    F+ +      L   +  + L+   +  L       K      L+     
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLAN-VSAMSLAGVSIKYLED---VPKHFKWQSLSIIRCQ 318

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           L  F    L      L+ L L+ N  + S    +L      SL +LDLS+N +      S
Sbjct: 319 LKQFPTLDLPF----LKSLTLTMNKGSISFKKVALP-----SLSYLDLSRNALSFSGCCS 369

Query: 121 LSN--CTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLE 178
            S+     L+ L+LSFN     +   F  L  LQ LD  ++ +          + + LL 
Sbjct: 370 YSDLGTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428

Query: 179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGS 238
           L + + N    F       + L  L ++ N+       +V  N  +L  L LS   +   
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488

Query: 239 FPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQL 298
                 +   L++++ S N +   +       + SL  L    N I             L
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSL 547

Query: 299 KVIDLSLN 306
              +L+ N
Sbjct: 548 AFFNLTNN 555

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  163 bits (414), Expect = 3e-42
 Identities = 78/474 (16%), Positives = 144/474 (30%), Gaps = 97/474 (20%)

Query: 139 GEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCS 198
           G +      + ++      +  ++  +P ++ +   S   + L  N +      + S+ S
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLSK-VPDDIPS---STKNIDLSFNPLKILKSYSFSNFS 56

Query: 199 WLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNR 258
            LQ LDLS   I     D     L  L +LIL+ N I    P S S   +L  +     +
Sbjct: 57  ELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115

Query: 259 VSGIIPPDICPGVSSLEELRLPDNLITGV-IPGQLSECTQLKVIDLSLNYLNGSIPQELG 317
           ++ +    I   + +L++L +  N I    +P   S  T L  +DLS NY+      +L 
Sbjct: 116 LASLESFPIG-QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 318 KLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTG 377
            L                        +    L ++ N +   I  + F    L  ++L G
Sbjct: 175 FLRENP--------------------QVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRG 213

Query: 378 NELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRL 436
           N  +  I       L  L V +L    F                   +  NL     P +
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEF------------------KDERNLE-IFEPSI 254

Query: 437 GRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMY 496
              L        ++ +                                 +     F  + 
Sbjct: 255 MEGLCD------VTIDEFRLTYT-----------------------NDFSDDIVKFHCLA 285

Query: 497 SGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLR 556
           +            +  + L+    +    +++      Q L +   QL       L  L+
Sbjct: 286 N------------VSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK 331

Query: 557 NLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQY 610
           +L     + N+    I      L  L  +DLS N L+             + ++
Sbjct: 332 SL---TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  275 bits (706), Expect = 4e-79
 Identities = 93/598 (15%), Positives = 180/598 (30%), Gaps = 88/598 (14%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
           +  L L+  G  G VPD    +L  L  L+   ++ T              ++ +   + 
Sbjct: 325 VTGLSLAGFGAKGRVPDA-IGQLTELKVLSFGTHSETVSGRLFGDEEL-TPDMSEERKHR 382

Query: 86  LTGSISGFSLNENSCNSLLHLDLSQNHIMD------VIPSSLSNCTKLKILNLSFNLLAG 139
           +        L+ +    L   DL Q+ I        +   S  +    +I NL+  +   
Sbjct: 383 IRMHYKKMFLDYDQ--RLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI--T 438

Query: 140 EIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSW 199
            I +   +L+ LQ +  +N+  T    +          +    +     +  ++ S+   
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAV------DWEDANSDYAKQYENEELSWSNLKD 492

Query: 200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG---------SFPDSISSCKTLR 250
           L  ++L N       PD  L +L  L+SL ++ N                D   +   ++
Sbjct: 493 LTDVELYNCPNMTQLPDF-LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551

Query: 251 IVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG 310
           I     N +           +  L  L    N +  +         +L  + L  N +  
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA--FGTNVKLTDLKLDYNQIE- 608

Query: 311 SIPQELGK-LEHLEQFIAWFNGLEGKIPP--ELGKCKNLKDLILNNNKLSGEIP-----A 362
            IP++     + +E      N L+  IP          +  +  + NK+  E        
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667

Query: 363 ELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK-------GEIPGELGNC 415
           + +   N   ++L+ NE+       F+  + ++ + L NN              G   N 
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727

Query: 416 SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAG 475
             L  +DL  N LT  +                   + +    N             F+ 
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFR-------ATTLPYLSNMDVSYN------------CFSS 767

Query: 476 IRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQ 535
             P + L    LK              +          D   N+   + P  I    +L 
Sbjct: 768 F-PTQPLNSSQLK-----------AFGI------RHQRDAEGNRILRQWPTGITTCPSLI 809

Query: 536 VLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
            L++  N +  ++   L     L + D + N        S           L  ++  
Sbjct: 810 QLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  256 bits (655), Expect = 3e-72
 Identities = 85/571 (14%), Positives = 160/571 (28%), Gaps = 83/571 (14%)

Query: 65  LPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH---LDLSQNHIMDVIPSSL 121
           L ET     D   L  + +  L G    +     +          +   +   D     L
Sbjct: 261 LKETAEYIKDYKALKAI-WEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL 319

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
            N  ++  L+L+     G +P   GQL+ L+ L    +  T              +  + 
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNIS-----GPFPDSVLENLGSLESLILSNNMIS 236
            H        + L     L L DL  + I+      P       +L   +   L+N    
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR--I 437

Query: 237 GSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECT 296
                +I     L+I+ F+++  +              E+                S   
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIA------VDWEDANSDYAKQYENEELSWSNLK 491

Query: 297 QLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEG---------KIPPELGKCKNLK 347
            L  ++L        +P  L  L  L+      N             ++  +      ++
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551

Query: 348 DLILNNNKLSGEIPAE--LFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK 405
              +  N L  E PA   L     L  +    N++       F    +L  L+L  N+ +
Sbjct: 552 IFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE 608

Query: 406 GEIPGELG-NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSC 464
            EIP +       +  L  + N L   IP                   ++ F  N     
Sbjct: 609 -EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFN-------AKSVYVMGSVDFSYN----- 654

Query: 465 KGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKI 524
                  +           +                     +      + LSYN+ +   
Sbjct: 655 -------KIGSEGRNISCSMDDY------------------KGINASTVTLSYNEIQKFP 689

Query: 525 PDEIGDMIALQVLELAHNQLS-------GEIPSSLGRLRNLGVFDASHNRLQGQIPES-- 575
            +       +  + L++N ++            +      L   D   N+L   + +   
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFR 748

Query: 576 FSNLSFLVQIDLSNNELTGPIPQR-GQLSTL 605
            + L +L  +D+S N  +   P +    S L
Sbjct: 749 ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQL 778

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  252 bits (644), Expect = 1e-70
 Identities = 67/467 (14%), Positives = 137/467 (29%), Gaps = 41/467 (8%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           L VL   ++  T++              E     +              L   +   + +
Sbjct: 349 LKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
                   +    ++ L D    NLT  I+  S        L  +  + +       +  
Sbjct: 409 NRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF-----TYD 463

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
           +     +  N  +         ++  L  L  ++L N      +P  L +    L  L +
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD-LPELQSLNI 522

Query: 182 PHNNITG---------SFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
             N                    +   +Q+  +  NN+      + L+ +  L  L   +
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH 582

Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPG-Q 291
           N +     ++  +   L  +    N++   IP D C     +E L    N +  +     
Sbjct: 583 NKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFN 639

Query: 292 LSECTQLKVIDLSLNYL-----NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNL 346
                 +  +D S N +     N S   +  K  +       +N ++            +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699

Query: 347 KDLILNNNKLS-------GEIPAELFSCSNLEWISLTGNELTGQIPPE--FSRLTRLAVL 397
             +IL+NN ++               +   L  I L  N+LT  +  +   + L  L+ +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNM 758

Query: 398 QLGNNRFKGEIPGELGNCSSLVWLDL------NSNNLTGDIPPRLGR 438
            +  N F    P +  N S L    +        N +    P  +  
Sbjct: 759 DVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  156 bits (397), Expect = 2e-39
 Identities = 48/280 (17%), Positives = 91/280 (32%), Gaps = 29/280 (10%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           L+ LKL  N               ++ L  S   L  +        +  +  ++ SYN +
Sbjct: 597 LTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKI 656

Query: 62  TGFLPETLLSNSD----KLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHI---- 113
                    S  D        + LSYN +    +         + +  + LS N +    
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT---GSPISTIILSNNLMTSIP 713

Query: 114 ---MDVIPSSLSNCTKLKILNLSFNLLAGEIPR--TFGQLSSLQRLDLSNNHITGWIPSE 168
              +     +  N   L  ++L FN L   +        L  L  +D+S N  +   P++
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771

Query: 169 LGNACDSLLELKLPH------NNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
             N    L    + H      N I   +P  +++C  L  L + +N+I     + +   L
Sbjct: 772 PLN-SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQL 829

Query: 223 GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGI 262
                L +++N        S+       +     ++   I
Sbjct: 830 ---YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  118 bits (298), Expect = 2e-27
 Identities = 26/256 (10%), Positives = 69/256 (26%), Gaps = 22/256 (8%)

Query: 354 NKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELG 413
           +    +   +L +   +  +SL G    G++P    +LT L VL  G +           
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 414 NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEF 473
              +    +   + +                                      +    E 
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYD---QRLNLSD-----------LLQDAINRNPEM 414

Query: 474 AGIRPERLLQIPTLK-SCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI 532
             I+ +  + +   +      R+          +   L+ +  + + F           +
Sbjct: 415 KPIKKDSRISLKDTQIGNLTNRITFIS--KAIQRLTKLQIIYFANSPFTYDNI-----AV 467

Query: 533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
             +     + +       S   L++L   +  +     Q+P+   +L  L  ++++ N  
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527

Query: 593 TGPIPQRGQLSTLPAS 608
                 +   + L   
Sbjct: 528 ISAAQLKADWTRLADD 543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 8/66 (12%), Positives = 20/66 (30%)

Query: 541 HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRG 600
            +    +    L     +     +    +G++P++   L+ L  +    +  T      G
Sbjct: 308 LDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367

Query: 601 QLSTLP 606
                P
Sbjct: 368 DEELTP 373

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  239 bits (611), Expect = 2e-71
 Identities = 75/307 (24%), Positives = 121/307 (39%), Gaps = 39/307 (12%)

Query: 729  LIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGK 786
            L   +       +   G FG V+KA L     VA+K       Q  + +  E E  +L  
Sbjct: 19   LYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF---PIQDKQSWQNEYEVYSLPG 74

Query: 787  IKHRNLVPLLGYCKIGE----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIA 842
            +KH N++  +G  K G     +  L+  F + GSL + L          +++W+    IA
Sbjct: 75   MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-------VVSWNELCHIA 127

Query: 843  RGAAKGLCFLHHNCI-------PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH 895
               A+GL +LH +         P I HRD+KS NVLL + + A ++DFG+A    A  + 
Sbjct: 128  ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 896  LSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKD-DFGDT 949
                   GT  Y+ PE  +           + D+Y+ G+VL EL +     D   D    
Sbjct: 188  GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 950  NLVGWVKMKVREGKQMEVIDPELLLVTKGTD---ESEAEEVKEMVRYLEITLQCVDDFPS 1006
                 +      G+   + D + ++V K          ++   M    E   +C D    
Sbjct: 248  PFEEEI------GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 1007 KRPNMLQ 1013
             R +   
Sbjct: 302  ARLSAGC 308

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  221 bits (566), Expect = 2e-63
 Identities = 106/412 (25%), Positives = 171/412 (41%), Gaps = 41/412 (9%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
             +  L    +   V     + L  +  L A    +        +   + L  ++ S N 
Sbjct: 26  KMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKSIDG---VEYLNNLTQINFSNNQ 79

Query: 86  LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
           LT  I+       +   L+ + ++ N I D+ P  L+N T L  L L  N +    P   
Sbjct: 80  LT-DITPLK----NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 130

Query: 146 GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL 205
             L++L RL+LS+N I+    S L     SL +L    N +T   P  L++ + L+ LD+
Sbjct: 131 KNLTNLNRLELSSNTISD--ISALSG-LTSLQQLSF-GNQVTDLKP--LANLTTLERLDI 184

Query: 206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPP 265
           S+N +S     SVL  L +LESLI +NN IS   P  +     L  +  + N++  I   
Sbjct: 185 SSNKVSDI---SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL 239

Query: 266 DICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF 325
                +++L +L L +N I+ + P  LS  T+L  + L  N ++   P  L  L  L   
Sbjct: 240 A---SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292

Query: 326 IAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIP 385
               N LE      +   KNL  L L  N +S   P  + S + L+ +    N+++    
Sbjct: 293 ELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--V 346

Query: 386 PEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLG 437
              + LT +  L  G+N+     P  L N + +  L LN    T        
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKA 396

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  214 bits (548), Expect = 5e-61
 Identities = 103/390 (26%), Positives = 166/390 (42%), Gaps = 39/390 (10%)

Query: 45  FSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLL 104
            + L   +       N+T  + +T L     +  L      +  SI G        N+L 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVSQTDLDQ---VTTLQADRLGIK-SIDGVE----YLNNLT 71

Query: 105 HLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGW 164
            ++ S N + D+ P  L N TKL  + ++ N +A   P     L++L  L L NN IT  
Sbjct: 72  QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD- 126

Query: 165 IPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGS 224
               L N   +L  L+L  N I+      LS  + LQ L    N ++   P   L NL +
Sbjct: 127 -IDPLKN-LTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP---LANLTT 178

Query: 225 LESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLI 284
           LE L +S+N +S      ++    L  +  ++N++S I P  I     +L+EL L  N +
Sbjct: 179 LERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILT---NLDELSLNGNQL 233

Query: 285 TGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCK 344
             +    L+  T L  +DL+ N ++   P  L  L  L +     N +       L    
Sbjct: 234 KDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLT 287

Query: 345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRF 404
            L +L LN N+L    P  + +  NL +++L  N ++   P   S LT+L  L   NN+ 
Sbjct: 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343

Query: 405 KGEIPGELGNCSSLVWLDLNSNNLTGDIPP 434
                  L N +++ WL    N ++ D+ P
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQIS-DLTP 370

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  202 bits (516), Expect = 1e-56
 Identities = 110/496 (22%), Positives = 180/496 (36%), Gaps = 83/496 (16%)

Query: 102 SLLHLDLSQ-NHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNH 160
            L    ++Q   I  +     +   +     L    +   +      L  +  L      
Sbjct: 2   PLGSATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57

Query: 161 ITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLE 220
           I       +    ++L ++   +N +T   P  L + + L  + ++NN I+   P   L 
Sbjct: 58  IK--SIDGVEY-LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LA 109

Query: 221 NLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLP 280
           NL +L  L L NN I+    D + +   L  ++ SSN +S I       G++SL++L   
Sbjct: 110 NLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALS---GLTSLQQLSF- 163

Query: 281 DNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPEL 340
            N +T + P  L+  T L+ +D+S N +  S    L KL +LE  IA  N +   I P L
Sbjct: 164 GNQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISD-ITP-L 217

Query: 341 GKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG 400
           G   NL +L LN N+L       L S +NL  + L  N+++       S LT+L  L+LG
Sbjct: 218 GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLG 273

Query: 401 NNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNV 460
            N+     P  L   ++L  L+LN N L  DI           P+    +   L    N 
Sbjct: 274 ANQISNISP--LAGLTALTNLELNENQLE-DIS----------PISNLKNLTYLTLYFN- 319

Query: 461 GNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQF 520
                               +  I  + S                    L+ L    N+ 
Sbjct: 320 -------------------NISDISPVSSL-----------------TKLQRLFFYNNKV 343

Query: 521 RGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLS 580
                  + ++  +  L   HNQ+S   P  L  L  +     +            +N+S
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399

Query: 581 FLVQIDLSNNELTGPI 596
               +      L  P 
Sbjct: 400 IPNTVKNVTGALIAPA 415

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  197 bits (504), Expect = 4e-55
 Identities = 107/536 (19%), Positives = 184/536 (34%), Gaps = 100/536 (18%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
            +   +     L   N+T ++S     +   + +  L   +  I       +     L  
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS-----QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQ 72

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           +N S N L    P     L+ L  + ++NN I     + L N   +L  L L +N IT  
Sbjct: 73  INFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLAN-LTNLTGLTLFNNQITDI 127

Query: 190 FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTL 249
            P  L + + L  L+LS+N IS     S L  L SL+ L   N +        +++  TL
Sbjct: 128 DP--LKNLTNLNRLELSSNTISDI---SALSGLTSLQQLSFGNQVTD---LKPLANLTTL 179

Query: 250 RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN 309
             +D SSN+VS I        +++LE L   +N I+ + P  L   T L  + L+ N L 
Sbjct: 180 ERLDISSNKVSDISVLA---KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234

Query: 310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSN 369
                                         L    NL DL L NN++S   P  L   + 
Sbjct: 235 D--------------------------IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 266

Query: 370 LEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
           L  + L  N+++       + LT L  L+L  N+ +   P  + N  +L +L L  NN++
Sbjct: 267 LTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS 322

Query: 430 GDIPPRLGRQLGAKPLGG-------FLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLL 482
                         P+         F  +N +  V ++ N                   +
Sbjct: 323 DIS-----------PVSSLTKLQRLFFYNNKVSDVSSLANLTN----------------I 355

Query: 483 QIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHN 542
              +      +       L+       +  L L+   +     +   ++     ++    
Sbjct: 356 NWLSAGHNQISD------LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409

Query: 543 QLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQ 598
            L    P+++    +    D + N       E     S  V I       +G + Q
Sbjct: 410 ALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQ 462

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  189 bits (482), Expect = 4e-52
 Identities = 99/453 (21%), Positives = 166/453 (36%), Gaps = 60/453 (13%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           ++ L+       + S   ++    L Q+  S+  L  + P      L  LV +  + N +
Sbjct: 48  VTTLQADRLG--IKSIDGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQI 102

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIP--- 118
               P   L+N   L  L L  N +T  I        +  +L  L+LS N I D+     
Sbjct: 103 ADITP---LANLTNLTGLTLFNNQIT-DIDPLK----NLTNLNRLELSSNTISDISALSG 154

Query: 119 ----------------SSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT 162
                             L+N T L+ L++S N ++        +L++L+ L  +NN I+
Sbjct: 155 LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS 212

Query: 163 GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
              P  LG    +L EL L  N +      TL+S + L  LDL+NN IS   P   L  L
Sbjct: 213 DITP--LGI-LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP---LSGL 264

Query: 223 GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
             L  L L  N IS      ++    L  ++ + N++  I P      + +L  L L  N
Sbjct: 265 TKLTELKLGANQISNI--SPLAGLTALTNLELNENQLEDISP---ISNLKNLTYLTLYFN 319

Query: 283 LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK 342
            I+ + P  +S  T+L+ +    N ++      L  L ++    A  N +       L  
Sbjct: 320 NISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLAN 373

Query: 343 CKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNN 402
              +  L LN+   +        + S    +      L    P   S         +  N
Sbjct: 374 LTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWN 431

Query: 403 --RFKGEIPGELGNCSSLVWLDLNSNNLTGDIP 433
              +  E+       S  V +   +   +G + 
Sbjct: 432 LPSYTNEVSYTF---SQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  152 bits (386), Expect = 1e-39
 Identities = 86/424 (20%), Positives = 147/424 (34%), Gaps = 100/424 (23%)

Query: 175 SLLELKLPHNN-ITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
            L    +  +  I   F    ++ +      L   N++         +L  + +L     
Sbjct: 2   PLGSATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRL 56

Query: 234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLS 293
            I     D +     L  ++FS+N+++ I P      ++ L ++ + +N I  + P  L+
Sbjct: 57  GIKS--IDGVEYLNNLTQINFSNNQLTDITPLK---NLTKLVDILMNNNQIADITP--LA 109

Query: 294 ECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNN 353
             T L  + L  N +    P                          L    NL  L L++
Sbjct: 110 NLTNLTGLTLFNNQITDIDP--------------------------LKNLTNLNRLELSS 143

Query: 354 NKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELG 413
           N +S    + L   ++L+ +S  GN++T   P   + LT L  L + +N+        L 
Sbjct: 144 NTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLA 196

Query: 414 NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEF 473
             ++L  L   +N ++ DI P          LG   + + L    N              
Sbjct: 197 KLTNLESLIATNNQIS-DITP----------LGILTNLDELSLNGN-------------- 231

Query: 474 AGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA 533
                 +L  I TL S                    L  LDL+ NQ     P  +  +  
Sbjct: 232 ------QLKDIGTLASL-----------------TNLTDLDLANNQISNLAP--LSGLTK 266

Query: 534 LQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
           L  L+L  NQ+S   P  L  L  L   + + N+L+       SNL  L  + L  N ++
Sbjct: 267 LTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNIS 322

Query: 594 GPIP 597
              P
Sbjct: 323 DISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  141 bits (358), Expect = 6e-36
 Identities = 77/376 (20%), Positives = 128/376 (34%), Gaps = 73/376 (19%)

Query: 223 GSLESL-ILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPD 281
           G L S  I  +  I+  F D+  +             V+  +       +  +  L+   
Sbjct: 1   GPLGSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADR 55

Query: 282 NLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELG 341
             I  +    +     L  I+ S N L    P  L  L  L   +   N +       L 
Sbjct: 56  LGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLA 109

Query: 342 KCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGN 401
              NL  L L NN+++   P  L + +NL  + L+ N ++       S LT L  L  GN
Sbjct: 110 NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGN 165

Query: 402 NRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVG 461
                +    L N ++L  LD++SN ++ DI            L    +  +L+   N  
Sbjct: 166 QVTDLK---PLANLTTLERLDISSNKVS-DISV----------LAKLTNLESLIATNN-- 209

Query: 462 NSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFR 521
                             ++  I  L                      L+ L L+ NQ +
Sbjct: 210 ------------------QISDITPLGIL-----------------TNLDELSLNGNQLK 234

Query: 522 GKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSF 581
                 +  +  L  L+LA+NQ+S   P  L  L  L       N++        + L+ 
Sbjct: 235 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTA 288

Query: 582 LVQIDLSNNELTGPIP 597
           L  ++L+ N+L    P
Sbjct: 289 LTNLELNENQLEDISP 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 23/105 (21%), Positives = 46/105 (43%), Gaps = 7/105 (6%)

Query: 501 LSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGV 560
           +        L  ++ S NQ     P  + ++  L  + + +NQ++   P  L  L NL  
Sbjct: 61  IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116

Query: 561 FDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTL 605
               +N++    P    NL+ L +++LS+N ++        L++L
Sbjct: 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISAL-SGLTSL 158

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 55.4 bits (134), Expect = 5e-08
 Identities = 20/96 (20%), Positives = 35/96 (36%), Gaps = 7/96 (7%)

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQ 569
                L        +     D+  +  L+     +       +  L NL   + S+N+L 
Sbjct: 26  KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLT 81

Query: 570 GQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTL 605
              P    NL+ LV I ++NN++    P    L+ L
Sbjct: 82  DITP--LKNLTKLVDILMNNNQIADITPL-ANLTNL 114

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  228 bits (583), Expect = 8e-63
 Identities = 132/624 (21%), Positives = 212/624 (33%), Gaps = 94/624 (15%)

Query: 17  TSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKL 76
           T + Q+    ++L LS   +  +   + F  L  L  L          + +    N   L
Sbjct: 17  TQVPQVLNTTERLLLSFNYIRTV-TASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75

Query: 77  ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVI--PSSLSNCTKLKILNLSF 134
            +LDL  + +   +   +        L  L L    + D +       N   L  L+LS 
Sbjct: 76  RILDLGSSKIY-FLHPDAF--QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132

Query: 135 NLLAG-EIPRTFGQLSSLQRLDLSNNHITGWIPSELGN-ACDSLLELKLPHNNITGSFPV 192
           N +    +  +FG+L+SL+ +D S+N I      EL      +L    L  N++     V
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192

Query: 193 TLSSCSW------LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSC 246
               C        L++LD+S N  +                    +N IS S   S+   
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITG-------------NFSNAISKSQAFSLILA 239

Query: 247 KTLRIVDFSSNRVSGIIPPDICPGV--SSLEELRLPDNLITGVIPGQLSECTQLKVIDLS 304
             +    F  + +      +   G+  SS+  L L    +  +          LKV++L+
Sbjct: 240 HHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298

Query: 305 LNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAEL 364
            N +N  I  E             F GL            NL+ L L+ N L  E+ +  
Sbjct: 299 YNKIN-KIADEA------------FYGL-----------DNLQVLNLSYNLLG-ELYSSN 333

Query: 365 FS-CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL 423
           F     + +I L  N +       F  L +L  L L +N         +    S+  + L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFL 388

Query: 424 NSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQ 483
           + N L   +P               L++N +    N   +   +  LL          LQ
Sbjct: 389 SGNKLV-TLPK------------INLTANLIHLSENRLENLDILYFLLRV------PHLQ 429

Query: 484 IPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI-----GDMIALQVLE 538
           I  L    F+           ++  +LE L L  N  +     E+       +  LQVL 
Sbjct: 430 ILILNQNRFSSC---SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486

Query: 539 LAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESF-SNLSFLVQIDLSNNELTGPIP 597
           L HN L+   P     L  L     + NRL         +NL  L   D+S N+L  P P
Sbjct: 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEIL---DISRNQLLAPNP 543

Query: 598 QRGQLSTLPASQYANNPGLCGVPL 621
                 +L      +N  +C   L
Sbjct: 544 D--VFVSLSVLDITHNKFICECEL 565

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  210 bits (537), Expect = 9e-57
 Identities = 109/550 (19%), Positives = 196/550 (35%), Gaps = 72/550 (13%)

Query: 77  ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNL 136
            +    + NLT      +       +   L LS N+I  V  SS     +L++L L    
Sbjct: 7   RIAFYRFCNLTQVPQVLN-------TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQY 59

Query: 137 LAGEI-PRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLS 195
               I    F  L +L+ LDL ++ I  ++  +                           
Sbjct: 60  TPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPD------------------------AFQ 94

Query: 196 SCSWLQLLDLSNNNISGPF-PDSVLENLGSLESLILSNNMISG-SFPDSISSCKTLRIVD 253
               L  L L    +S     D    NL +L  L LS N I       S     +L+ +D
Sbjct: 95  GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154

Query: 254 FSSNRVSGIIPPDICP-GVSSLEELRLPDNLITGVIPGQLSECTQ------LKVIDLS-- 304
           FSSN++  +   ++ P    +L    L  N +   +     +C        L+++D+S  
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214

Query: 305 ----------LNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPEL--GKCK-NLKDLIL 351
                      N ++ S    L    H+      F+ ++         G  + +++ L L
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDL 273

Query: 352 NNNKLSGEIPAELFSC-SNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPG 410
           ++  +   + + +F    +L+ ++L  N++       F  L  L VL L  N        
Sbjct: 274 SHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332

Query: 411 ELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGG 469
                  + ++DL  N++   I  +  + L   + L   L  N L  +  + +       
Sbjct: 333 NFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTL--DLRDNALTTIHFIPSIPDIFLS 389

Query: 470 LLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI- 528
             +   +    L     L      R+ +  +L    +   L+ L L+ N+F     D+  
Sbjct: 390 GNKLVTLPKINLT--ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447

Query: 529 GDMIALQVLELAHNQLSGEIPSSLGR-----LRNLGVFDASHNRLQGQIPESFSNLSFLV 583
            +  +L+ L L  N L     + L       L +L V   +HN L    P  FS+L+ L 
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507

Query: 584 QIDLSNNELT 593
            + L++N LT
Sbjct: 508 GLSLNSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  210 bits (535), Expect = 2e-56
 Identities = 101/454 (22%), Positives = 164/454 (36%), Gaps = 37/454 (8%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGL-VGLVPDNLFSKLPNLVYLNASYNN 60
           L +L L S+          Q  F L +L L   GL   ++ D  F  L  L  L+ S N 
Sbjct: 75  LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           +            + L+ +D S N +   +    L      +L    L+ N +   +   
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193

Query: 121 LSNCTK------LKILNLSFNLLAGEIPRTFGQ------------LSSLQRLDLSNNHIT 162
              C        L+IL++S N    +I   F                 +       ++I 
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253

Query: 163 GWIPSELGNACD-SLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLEN 221
               +        S+  L L H  +         +   L++L+L+ N I+    D     
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK-IADEAFYG 312

Query: 222 LGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPD 281
           L +L+ L LS N++   +  +      +  +D   N ++ II       +  L+ L L D
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRD 371

Query: 282 NLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELG 341
           N +T      +     +  I LS N L  ++P+       +         L   I   L 
Sbjct: 372 NALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENL--DILYFLL 423

Query: 342 KCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-----FSRLTRLA 395
           +  +L+ LILN N+ S     +  S   +LE + L  N L      E     F  L+ L 
Sbjct: 424 RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ 483

Query: 396 VLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
           VL L +N      PG   + ++L  L LNSN LT
Sbjct: 484 VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  160 bits (406), Expect = 2e-40
 Identities = 80/408 (19%), Positives = 147/408 (36%), Gaps = 43/408 (10%)

Query: 196 SCSWLQ-LLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDF 254
           SCS+   +      N++      V + L + E L+LS N I      S    + L++++ 
Sbjct: 1   SCSFDGRIAFYRFCNLT-----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLEL 55

Query: 255 SSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQ 314
            S      I  +    + +L  L L  + I  + P        L  + L    L+ ++ +
Sbjct: 56  GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115

Query: 315 ELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWI 373
           +            +F  L           K L  L L+ N++        F   ++L+ I
Sbjct: 116 D-----------GYFRNL-----------KALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153

Query: 374 SLTGNELTGQIPPEFSRLT--RLAVLQLGNNRFKGEIPGELGNCS------SLVWLDLNS 425
             + N++      E   L    L+   L  N     +  + G C        L  LD++ 
Sbjct: 154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213

Query: 426 NNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIP 485
           N  T DI       +        + ++ ++      ++ K       FAG+    +  + 
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT-FAGLARSSVRHL- 271

Query: 486 TLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLS 545
            L       + S     +F   + L+ L+L+YN+      +    +  LQVL L++N L 
Sbjct: 272 DLSHGFVFSLNSR----VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

Query: 546 GEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
               S+   L  +   D   N +     ++F  L  L  +DL +N LT
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 99.5 bits (248), Expect = 2e-21
 Identities = 50/233 (21%), Positives = 89/233 (38%), Gaps = 16/233 (6%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           +  + LS N       +L ++      + LS   L  L       ++P+L  L  + N  
Sbjct: 383 IPDIFLSGN----KLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNE--NSCNSLLHLDLSQNHIMDVIPS 119
           +    +   S +  LE L L  N L  +       +     + L  L L+ N++  + P 
Sbjct: 439 SSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498

Query: 120 SLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL 179
             S+ T L+ L+L+ N L           ++L+ LD+S N +    P    +    L  L
Sbjct: 499 VFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVS----LSVL 552

Query: 180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
            + HN     F       +++  L+ +N  I+GP  D       S   + L +
Sbjct: 553 DITHNK----FICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFS 601

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  222 bits (567), Expect = 2e-62
 Identities = 124/581 (21%), Positives = 204/581 (35%), Gaps = 95/581 (16%)

Query: 47  KLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHL 106
            +PN+ Y      N    +P+ L  +    + LDLS+N L   +  +S    S   L  L
Sbjct: 6   VVPNITY-QCMELNFYK-IPDNLPFS---TKNLDLSFNPLR-HLGSYSFF--SFPELQVL 57

Query: 107 DLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIP 166
           DLS+  I  +   +  + + L  L L+ N +       F  LSSLQ+L     ++     
Sbjct: 58  DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 167 SELGNACDSLLELKLPHNNIT-GSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL 225
             +G+   +L EL + HN I     P   S+ + L+ LDLS+N I      + L  L  +
Sbjct: 118 FPIGH-LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQM 175

Query: 226 E----SLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL-- 279
                SL LS N ++            L  +   +N  S  +      G++ LE  RL  
Sbjct: 176 PLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234

Query: 280 ----PDNLITGVIPGQLSECTQLKVIDLSLNYLNGS---IPQELGKLEHLEQFIAWFNGL 332
                +  +       L     L + +  L YL+     I      L ++  F      +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 333 EGKIPPELG--------------------KCKNLKDLILNNNKLSGEIPAELFSCSNLEW 372
           E ++                         K K+LK L   +NK      +E+    +LE+
Sbjct: 295 E-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-NAFSEV-DLPSLEF 351

Query: 373 ISLTGNELT--GQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG 430
           + L+ N L+  G         T L  L L  N     +         L  LD   +NL  
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK- 409

Query: 431 DIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSC 490
            +               FLS   L+++                               + 
Sbjct: 410 QMSEF----------SVFLSLRNLIYLDISHT--------------------HTRVAFNG 439

Query: 491 DFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI-GDMIALQVLELAHNQLSGEIP 549
            F  + S            LE L ++ N F+     +I  ++  L  L+L+  QL    P
Sbjct: 440 IFNGLSS------------LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 550 SSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
           ++   L +L V + + N+L+      F  L+ L +I L  N
Sbjct: 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  187 bits (477), Expect = 1e-50
 Identities = 99/445 (22%), Positives = 165/445 (37%), Gaps = 32/445 (7%)

Query: 2   LSVLKLSSN-LFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           LS L L+ N + +L   +   L   L++L      L  L  +     L  L  LN ++N 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASL-ENFPIGHLKTLKELNVAHNL 135

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISG-FSLNENSCNSLLHLDLSQNHIMDVIPS 119
           +  F      SN   LE LDLS N +         +        L LDLS N +  + P 
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195

Query: 120 SLSNCTKLKILNLSFNLLAGEIPRT-FGQLSSLQRLDL------SNNHITGWIPSELGNA 172
           +     +L  L L  N  +  + +T    L+ L+   L      +  ++  +  S L   
Sbjct: 196 AFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254

Query: 173 CD-SLLELKLPHNNITGS-FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLIL 230
           C+ ++ E +L + +          +  + +    L +  I      S       LE +  
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314

Query: 231 SNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLIT--GVI 288
                      S      L+ + F+SN+          P   SLE L L  N ++  G  
Sbjct: 315 KFGQFPTLKLKS------LKRLTFTSNKGGNAFSEVDLP---SLEFLDLSRNGLSFKGCC 365

Query: 289 PGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE--LGKCKNL 346
                  T LK +DLS N +  ++      LE LE      + L+ ++         +NL
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNL 423

Query: 347 KDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRF 404
             L +++          +F+  S+LE + + GN       P+ F+ L  L  L L   + 
Sbjct: 424 IYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482

Query: 405 KGEIPGELGNCSSLVWLDLNSNNLT 429
           +   P    + SSL  L++ SN L 
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLK 507

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  155 bits (394), Expect = 6e-40
 Identities = 66/376 (17%), Positives = 131/376 (34%), Gaps = 71/376 (18%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLP-FGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           L   +   NL   + ++L  L    +++  L+          +LF+ L N+   +     
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           +      +       LEL++  +                  SL  L  + N   +    S
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFP---------TLKLKSLKRLTFTSNKGGNAF--S 342

Query: 121 LSNCTKLKILNLSFNLLA--GEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLE 178
             +   L+ L+LS N L+  G   ++    +SL+ LDLS N +                 
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI---------------- 386

Query: 179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGS 238
                     +          L+ LD  ++N+      SV  +L +L  L +S+     +
Sbjct: 387 ----------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 239 FPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQL 298
           F    +   +L ++  + N       PDI   + +L  L L    +  + P   +  + L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496

Query: 299 KVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG 358
           +V++++ N L  S+P  +            F+ L            +L+ + L+ N    
Sbjct: 497 QVLNMASNQLK-SVPDGI------------FDRL-----------TSLQKIWLHTNPWDC 532

Query: 359 EIPAELFSCSNLEWIS 374
                  SC  ++++S
Sbjct: 533 -------SCPRIDYLS 541

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 89.4 bits (222), Expect = 2e-18
 Identities = 55/304 (18%), Positives = 87/304 (28%), Gaps = 54/304 (17%)

Query: 299 KVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG 358
                        IP  L      +     FN L             L+ L L+  ++  
Sbjct: 10  ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65

Query: 359 EIPAELFS-CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSS 417
            I    +   S+L  + LTGN +       FS L+ L  L              +G+  +
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 418 LVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGI 476
           L  L++  N +     P     L   + L   LSSN                        
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHL--DLSSN------------------------ 159

Query: 477 RPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQV 536
                 +I ++   D   ++  P+L+L         LDLS N     I       I L  
Sbjct: 160 ------KIQSIYCTDLRVLHQMPLLNL--------SLDLSLNPMN-FIQPGAFKEIRLHK 204

Query: 537 LELAHNQLSGEIP-------SSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSN 589
           L L +N  S  +        + L   R +     +   L+     +   L  L   +   
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 590 NELT 593
             L 
Sbjct: 265 AYLD 268

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  208 bits (531), Expect = 5e-60
 Identities = 87/405 (21%), Positives = 157/405 (38%), Gaps = 59/405 (14%)

Query: 25  GLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYN 84
           G   L    A +  + PD   + L   +       ++T  + +  L +   +  L ++  
Sbjct: 1   GAATLATLPAPINQIFPD---ADLAEGIRAVLQKASVTDVVTQEELES---ITKLVVAGE 54

Query: 85  NLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRT 144
            +  SI G         +L +L+L+ N I D+ P  LSN  KL  L +  N +       
Sbjct: 55  KVA-SIQGIE----YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISA 105

Query: 145 FGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLD 204
              L++L+ L L+ ++I+    S L N    +  L L  N+   S    LS+ + L  L 
Sbjct: 106 LQNLTNLRELYLNEDNISD--ISPLAN-LTKMYSLNLGANHNL-SDLSPLSNMTGLNYLT 161

Query: 205 LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP 264
           ++ + +    P   + NL  L SL L+ N I       ++S  +L       N+++ I P
Sbjct: 162 VTESKVKDVTP---IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITP 216

Query: 265 PDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQ 324
                 ++ L  L++ +N IT + P  L+  +QL  +++  N ++               
Sbjct: 217 VA---NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-------------- 257

Query: 325 FIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQI 384
                          +     LK L + +N++S    + L + S L  + L  N+L  + 
Sbjct: 258 ------------INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNED 303

Query: 385 PPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
                 LT L  L L  N      P  L + S +   D  +  + 
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  180 bits (459), Expect = 3e-50
 Identities = 74/332 (22%), Positives = 135/332 (40%), Gaps = 28/332 (8%)

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           L      I  + P   ++  +     L    +   +     +L S+ +L ++   +    
Sbjct: 5   LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-- 58

Query: 166 PSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL 225
              +     +L  L L  N IT   P  LS+   L  L +  N I+     S L+NL +L
Sbjct: 59  IQGIEY-LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI---SALQNLTNL 112

Query: 226 ESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLIT 285
             L L+ + IS      +++   +  ++  +N     + P +   ++ L  L + ++ + 
Sbjct: 113 RELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LS-NMTGLNYLTVTESKVK 168

Query: 286 GVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKN 345
            V P  ++  T L  + L+ N +    P  L  L  L  F A+ N +    P  +     
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222

Query: 346 LKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK 405
           L  L + NNK++   P  L + S L W+ +  N+++         LT+L +L +G+N+  
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278

Query: 406 GEIPGELGNCSSLVWLDLNSNNLTGDIPPRLG 437
                 L N S L  L LN+N L  +    +G
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIG 308

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  180 bits (459), Expect = 3e-50
 Identities = 79/356 (22%), Positives = 144/356 (40%), Gaps = 33/356 (9%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
                L     T +  +  +L   + +L ++   +  +        L NL YLN + N +
Sbjct: 24  GIRAVLQKASVT-DVVTQEELE-SITKLVVAGEKVASIQG---IEYLTNLEYLNLNGNQI 78

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
           T   P   LSN  KL  L +  N +T  IS       +  +L  L L++++I D+ P  L
Sbjct: 79  TDISP---LSNLVKLTNLYIGTNKIT-DISALQ----NLTNLRELYLNEDNISDISP--L 128

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
           +N TK+  LNL  N    ++      ++ L  L ++ + +     + + N    L  L L
Sbjct: 129 ANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD--VTPIAN-LTDLYSLSL 184

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
            +N I    P  L+S + L       N I+     + + N+  L SL + NN I+     
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDI---TPVANMTRLNSLKIGNNKITDL--S 237

Query: 242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
            +++   L  ++  +N++S I        ++ L+ L +  N I+ +    L+  +QL  +
Sbjct: 238 PLANLSQLTWLEIGTNQISDINAVK---DLTKLKMLNVGSNQISDISV--LNNLSQLNSL 292

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS 357
            L+ N L     + +G L +L       N +    P  L     +      N  + 
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  173 bits (441), Expect = 7e-48
 Identities = 76/418 (18%), Positives = 138/418 (33%), Gaps = 73/418 (17%)

Query: 176 LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI 235
              L      I   FP   +  +      L   +++        E L S+  L+++   +
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT---QEELESITKLVVAGEKV 56

Query: 236 SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSEC 295
           +      I     L  ++ + N+++ I P      +  L  L +  N IT +    L   
Sbjct: 57  AS--IQGIEYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKITDISA--LQNL 109

Query: 296 TQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNK 355
           T L+ + L+ + ++   P  L  L  +       N         L     L  L +  +K
Sbjct: 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESK 166

Query: 356 LSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNC 415
           +    P  + + ++L  +SL  N++    P   + LT L       N+     P  + N 
Sbjct: 167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220

Query: 416 SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAG 475
           + L  L + +N +T D+           PL        L    N                
Sbjct: 221 TRLNSLKIGNNKIT-DLS----------PLANLSQLTWLEIGTN---------------- 253

Query: 476 IRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQ 535
               ++  I  +K                     L+ L++  NQ        + ++  L 
Sbjct: 254 ----QISDINAVKDL-----------------TKLKMLNVGSNQISD--ISVLNNLSQLN 290

Query: 536 VLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
            L L +NQL  E    +G L NL     S N +    P   ++LS +   D +N  + 
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  167 bits (425), Expect = 1e-45
 Identities = 74/398 (18%), Positives = 142/398 (35%), Gaps = 71/398 (17%)

Query: 200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRV 259
              L      I+  FPD+   +L      +L    ++     +    +++  +  +  +V
Sbjct: 2   AATLATLPAPINQIFPDA---DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV 56

Query: 260 SGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKL 319
           + I   +      +LE L L  N IT + P  LS   +L  + +  N +  +    L  L
Sbjct: 57  ASIQGIEYLT---NLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNL 109

Query: 320 EHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNE 379
            +L +     + +       L     +  L L  N    ++   L + + L ++++T ++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESK 166

Query: 380 LTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQ 439
           +        + LT L  L L  N+ +   P  L + +SL +     N +T DI P     
Sbjct: 167 VKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT-DITP----- 216

Query: 440 LGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGP 499
                +      N+L    N                    ++  +  L +          
Sbjct: 217 -----VANMTRLNSLKIGNN--------------------KITDLSPLANL--------- 242

Query: 500 VLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLG 559
                     L +L++  NQ      + + D+  L++L +  NQ+S    S L  L  L 
Sbjct: 243 --------SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLN 290

Query: 560 VFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIP 597
               ++N+L  +  E    L+ L  + LS N +T   P
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 58.7 bits (143), Expect = 4e-09
 Identities = 30/212 (14%), Positives = 62/212 (29%), Gaps = 56/212 (26%)

Query: 394 LAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNT 453
            A L           P    + +  +   L   ++T  +                 S   
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT-----------QEELESITK 48

Query: 454 LVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYL 513
           LV                        ++  I  ++                     LEYL
Sbjct: 49  LVVAGE--------------------KVASIQGIEYL-----------------TNLEYL 71

Query: 514 DLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIP 573
           +L+ NQ     P  + +++ L  L +  N+++    S+L  L NL     + + +     
Sbjct: 72  NLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--I 125

Query: 574 ESFSNLSFLVQIDLSNNELTGPIPQRGQLSTL 605
              +NL+ +  ++L  N     +     ++ L
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLSPLSNMTGL 157

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  206 bits (527), Expect = 6e-60
 Identities = 86/274 (31%), Positives = 133/274 (48%), Gaps = 32/274 (11%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
            IG G FG V +A    GS VA+K L+      +   EF+ E+  + +++H N+V  +G  
Sbjct: 45   IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
                   +V E++  GSL  +LH   K+  +  L    R  +A   AKG+ +LH N  P 
Sbjct: 104  TQPPNLSIVTEYLSRGSLYRLLH---KSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159

Query: 860  IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
            I+HR++KS N+L+D +   +V DFG++RL +   T LS  + AGTP ++ PE  +     
Sbjct: 160  IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 920  AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGT 979
             K DVYSFGV+L EL T ++P     +G+ N    V     + K++E+  P         
Sbjct: 218  EKSDVYSFGVILWELATLQQP-----WGNLNPAQVVAAVGFKCKRLEI--PR------NL 264

Query: 980  DESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            +               I   C  + P KRP+   
Sbjct: 265  NPQ----------VAAIIEGCWTNEPWKRPSFAT 288

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  201 bits (512), Expect = 5e-58
 Identities = 72/274 (26%), Positives = 118/274 (43%), Gaps = 38/274 (13%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
            +G G FG V KA  +    VAIK++   S    + F+ E+  L ++ H N+V L G C  
Sbjct: 16   VGRGAFGVVCKAKWR-AKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGACL- 71

Query: 802  GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
                 LV E+ + GSL  VLHG          T           ++G+ +LH      +I
Sbjct: 72   -NPVCLVMEYAEGGSLYNVLHGA---EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 862  HRDMKSSNVLLDHEME-ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
            HRD+K  N+LL       ++ DFG A  I    T        G+  ++ PE ++    + 
Sbjct: 128  HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPEVFEGSNYSE 182

Query: 921  KGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGW-VKMKVREGKQMEVIDPELLLVTKGT 979
            K DV+S+G++L E++T ++P     F +     + +   V  G +  +I        K  
Sbjct: 183  KCDVFSWGIILWEVITRRKP-----FDEIGGPAFRIMWAVHNGTRPPLI--------KNL 229

Query: 980  DESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
             +              +  +C    PS+RP+M +
Sbjct: 230  PKP----------IESLMTRCWSKDPSQRPSMEE 253

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  199 bits (507), Expect = 1e-57
 Identities = 80/290 (27%), Positives = 123/290 (42%), Gaps = 49/290 (16%)

Query: 739  ESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-------REFMAEMETLGKIKHR 790
            E  IG GGFG V K  L  D S VAIK LI    +G+       +EF  E+  +  + H 
Sbjct: 24   EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 791  NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            N+V L G         +V EF+  G L   L  +A       + W  + ++    A G+ 
Sbjct: 84   NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIE 136

Query: 851  FLHHNCIPHIIHRDMKSSNVLLDHEME-----ARVSDFGMARLISALDTHLSVSTLAGTP 905
            ++  N  P I+HRD++S N+ L    E     A+V+DFG+++      +  SVS L G  
Sbjct: 137  YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNF 190

Query: 906  GYVPPE--YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
             ++ PE    +    T K D YSF ++L  +LTG+ P D+  +G    +  +     EG 
Sbjct: 191  QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI---REEGL 247

Query: 964  QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            +  +         +              R   +   C    P KRP+   
Sbjct: 248  RPTIP--------EDCPP----------RLRNVIELCWSGDPKKRPHFSY 279

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  197 bits (502), Expect = 5e-57
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 47/284 (16%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD----REFMAEMETLGKIKHRNLVPLLG 797
            IG GGFG+V++A    G  VA+K       +           E +    +KH N++ L G
Sbjct: 15   IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 798  YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             C       LV EF + G L  VL G+        +  D     A   A+G+ +LH   I
Sbjct: 74   VCLKEPNLCLVMEFARGGPLNRVLSGKR-------IPPDILVNWAVQIARGMNYLHDEAI 126

Query: 858  PHIIHRDMKSSNVLLDHEMEAR--------VSDFGMARLISALDTHLSVSTLAGTPGYVP 909
              IIHRD+KSSN+L+  ++E          ++DFG+AR         +  + AG   ++ 
Sbjct: 127  VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----RTTKMSAAGAYAWMA 182

Query: 910  PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
            PE  ++   +   DV+S+GV+L ELLTG+ P     F   + +            + +  
Sbjct: 183  PEVIRASMFSKGSDVWSYGVLLWELLTGEVP-----FRGIDGLAVAYGVAMNKLALPI-- 235

Query: 970  PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            P          E           + ++   C +  P  RP+   
Sbjct: 236  PS------TCPEP----------FAKLMEDCWNPDPHSRPSFTN 263

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  194 bits (494), Expect = 4e-55
 Identities = 61/311 (19%), Positives = 111/311 (35%), Gaps = 44/311 (14%)

Query: 732  ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKH 789
              +      LIG G +G V+K +L D   VA+K     S    + F+ E     +  ++H
Sbjct: 11   DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEH 66

Query: 790  RNLVPLLGYCKIGE-----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARG 844
             N+   +   +        E LLV E+   GSL + L             W +  ++A  
Sbjct: 67   DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-------LHTSDWVSSCRLAHS 119

Query: 845  AAKGLCFLH------HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA------L 892
              +GL +LH       +  P I HRD+ S NVL+ ++    +SDFG++  ++        
Sbjct: 120  VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 893  DTHLSVSTLAGTPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
            +   +  +  GT  Y+ PE  +             + D+Y+ G++  E+          +
Sbjct: 180  EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239

Query: 946  FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGT----DESEAEEVKEMVRYLEITLQCV 1001
                  + +           ++     L+  +       E+  E    +    E    C 
Sbjct: 240  SVPEYQMAFQTEVGNHPTFEDMQV---LVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 1002 DDFPSKRPNML 1012
            D     R    
Sbjct: 297  DQDAEARLTAQ 307

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  191 bits (488), Expect = 4e-55
 Identities = 64/279 (22%), Positives = 106/279 (37%), Gaps = 43/279 (15%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
            +     GE++K   + G+ + +K L          R+F  E   L    H N++P+LG C
Sbjct: 18   LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 800  KIGEERLL--VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
            +         +  +M +GSL  VLH         ++      K A   A+G+ FLH    
Sbjct: 77   QSPPAPHPTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLH-TLE 131

Query: 858  PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ--- 914
            P I    + S +V++D +M AR+S   +                   P +V PE  Q   
Sbjct: 132  PLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPEALQKKP 184

Query: 915  SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL 974
                    D++SF V+L EL+T + P     F D + +        EG +  +  P    
Sbjct: 185  EDTNRRSADMWSFAVLLWELVTREVP-----FADLSNMEIGMKVALEGLRPTI--PP--- 234

Query: 975  VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
               G                ++   C+++ P+KRP    
Sbjct: 235  ---GISPH----------VSKLMKICMNEDPAKRPKFDM 260

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  192 bits (489), Expect = 9e-55
 Identities = 71/288 (24%), Positives = 121/288 (42%), Gaps = 43/288 (14%)

Query: 739  ESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
              ++G G FG+  K T ++ G  + +K+LIR   +  R F+ E++ +  ++H N++  +G
Sbjct: 15   GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 798  YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
                 +    + E++K G+L  ++             W  R   A+  A G+ +LH    
Sbjct: 75   VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIASGMAYLHSM-- 127

Query: 858  PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH------------LSVSTLAGTP 905
             +IIHRD+ S N L+       V+DFG+ARL+    T                 T+ G P
Sbjct: 128  -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 906  GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQM 965
             ++ PE         K DV+SFG+VL E++         D+    +     + VR     
Sbjct: 187  YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYLPRTMD--FGLNVRGFLDR 242

Query: 966  EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                P           S          +  IT++C D  P KRP+ ++
Sbjct: 243  YC--PP------NCPPS----------FFPITVRCCDLDPEKRPSFVK 272

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  198 bits (506), Expect = 1e-54
 Identities = 106/555 (19%), Positives = 194/555 (34%), Gaps = 65/555 (11%)

Query: 49  PNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDL 108
                 +    + T  +P  L +    ++ LDLS+N +T  I    L   +C +L  L L
Sbjct: 5   DASGVCDGRSRSFT-SIPSGLTAA---MKSLDLSFNKIT-YIGHGDL--RACANLQVLIL 57

Query: 109 SQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSE 168
             + I  +   +  +   L+ L+LS N L+      FG LSSL+ L+L  N       + 
Sbjct: 58  KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 169 LGNACDSLLELKLPHNNITGSFPV-TLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLES 227
           L     +L  L++ +            +  + L  L++   ++   +    L+++  +  
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHH 176

Query: 228 LILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV 287
           L L  +  +           ++R ++     ++        P       ++      + +
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLAR-FQFSPLPVDEVSSPMKKLAFRGSVL 235

Query: 288 IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK--CKN 345
                +E  +L    L L+ +           +     +  FN  E  +  ELGK     
Sbjct: 236 TDESFNELLKLLRYILELSEVE--------FDDCTLNGLGDFNPSESDVVSELGKVETVT 287

Query: 346 LKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRF 404
           ++ L +    L  ++         ++ I++  +++   +P      L  L  L L  N  
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLM 346

Query: 405 KGEI---PGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGG-FLSSNTLVFVRNV 460
             E        G   SL  L L+ N+L   +       L  K L    +S NT      +
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTF---HPM 402

Query: 461 GNSCKGVGGLLEFAGIRPERLL-----QIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDL 515
            +SC+    +           L      I  +K+C                 QTLE LD+
Sbjct: 403 PDSCQWPEKMRF---------LNLSSTGIRVVKTCIP---------------QTLEVLDV 438

Query: 516 SYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPES 575
           S N            +  LQ L ++ N+L   +P +      L V   S N+L+      
Sbjct: 439 SNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGI 492

Query: 576 FSNLSFLVQIDLSNN 590
           F  L+ L +I L  N
Sbjct: 493 FDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  191 bits (487), Expect = 5e-52
 Identities = 98/571 (17%), Positives = 184/571 (32%), Gaps = 107/571 (18%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           L   +K L+LS   +  +          NL  L    + +   +      +   LE LDL
Sbjct: 24  LTAAMKSLDLSFNKITYI-GHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDL 81

Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPSSLSNCTKLKILNLSFNLLAGE 140
           S N+L+ S+S         +SL +L+L  N    + + S   N T L+ L +       E
Sbjct: 82  SDNHLS-SLSSSWFG--PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSE 138

Query: 141 IPR-TFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSW 199
           I R  F  L+SL  L++    +     S+   +   +  L L  +       +     S 
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197

Query: 200 LQLLDLSNNNISG--PFPDSVLENLGSLESLILSNNMISG-------SFPDSISSCKTLR 250
           ++ L+L + N++     P  V E    ++ L    ++++             I     + 
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257

Query: 251 IVDFSSNRVSGIIPPDI-------CPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDL 303
             D + N +    P +             ++  L +P   +   +    S   ++K I +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317

Query: 304 SLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI--- 360
             + +   +P                  L           K+L+ L L+ N +  E    
Sbjct: 318 ENSKVF-LVPCSF------------SQHL-----------KSLEFLDLSENLMVEEYLKN 353

Query: 361 PAELFSCSNLEWISLTGNELT--GQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSL 418
            A   +  +L+ + L+ N L    +       L  L  L +  N F   +P        +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412

Query: 419 VWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRP 478
            +L+L+S  +   +   + + L        +S+N L                        
Sbjct: 413 RFLNLSSTGIR-VVKTCIPQTLEVL----DVSNNNLD----------------------- 444

Query: 479 ERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLE 538
                                  S       L+ L +S N+ +  +PD       L V++
Sbjct: 445 -----------------------SFSLFLPRLQELYISRNKLK-TLPDASL-FPVLLVMK 479

Query: 539 LAHNQLSGEIPSSLGRLRNLGVFDASHNRLQ 569
           ++ NQL         RL +L       N   
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  178 bits (454), Expect = 8e-48
 Identities = 80/451 (17%), Positives = 148/451 (32%), Gaps = 35/451 (7%)

Query: 2   LSVLKLSSN-LFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           L  L LS N L +L+S+    L   LK L L       L   +LF  L NL  L      
Sbjct: 76  LEHLDLSDNHLSSLSSSWFGPLS-SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
               +     +    L  L++   +L  +    SL   S   + HL L  +    ++   
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSL--KSIRDIHHLTLHLSESAFLLEIF 191

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIP------SELGNACD 174
               + ++ L L    LA               +       +           +L     
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251

Query: 175 SLLELKLPHNNITG------SFPVTLSSCSWLQLLDLSNNNISG----PFPDSVLENLGS 224
            L E++     + G      S    +S    ++ + +   +I          +V   L  
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311

Query: 225 LESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICP--GVSSLEELRLPDN 282
           ++ + + N+ +           K+L  +D S N +      +        SL+ L L  N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371

Query: 283 LIT--GVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPEL 340
            +         L     L  +D+S N  +  +P      E +        G+   +   +
Sbjct: 372 HLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI 429

Query: 341 GKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG 400
              + L+ L ++NN L       L     L+ + ++ N+L   +P        L V+++ 
Sbjct: 430 --PQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLK-TLPDASL-FPVLLVMKIS 481

Query: 401 NNRFKGEIPGELGNCSSLVWLDLNSNNLTGD 431
            N+ K    G     +SL  + L++N     
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  153 bits (388), Expect = 3e-39
 Identities = 69/408 (16%), Positives = 147/408 (36%), Gaps = 20/408 (4%)

Query: 196 SCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS 255
           SC    + D  + + +   P  +   +   +SL LS N I+      + +C  L+++   
Sbjct: 3   SCDASGVCDGRSRSFTS-IPSGLTAAM---KSLDLSFNKITYIGHGDLRACANLQVLILK 58

Query: 256 SNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG-SIPQ 314
           S+R++ I   D    + SLE L L DN ++ +        + LK ++L  N      +  
Sbjct: 59  SSRINTI-EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 315 ELGKLEHLEQ-FIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-SCSNLEW 372
               L +L+   I            +     +L +L +    L     ++   S  ++  
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHH 176

Query: 373 ISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDI 432
           ++L  +E    +      L+ +  L+L +          L        +   +   +  +
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS-VL 235

Query: 433 PPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDF 492
                 +L  K L   L  + + F     N   G     E   +     ++  T++    
Sbjct: 236 TDESFNEL-LKLLRYILELSEVEFDDCTLNG-LGDFNPSESDVVSELGKVETVTIRRLHI 293

Query: 493 ARMYSGPVLS-LFTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEI-- 548
            + Y    LS +++  + ++ + +  ++    +P      + +L+ L+L+ N +  E   
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLK 352

Query: 549 -PSSLGRLRNLGVFDASHNRLQ--GQIPESFSNLSFLVQIDLSNNELT 593
             +  G   +L     S N L+   +  E    L  L  +D+S N   
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 87.9 bits (218), Expect = 6e-18
 Identities = 60/336 (17%), Positives = 103/336 (30%), Gaps = 53/336 (15%)

Query: 295 CTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE-LGKCKNLKDLILNN 353
           C    V D        SIP  L     ++     FN +   I    L  C NL+ LIL +
Sbjct: 4   CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKS 59

Query: 354 NKLSGEIPAELFSC-SNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKG-EIPG 410
           ++++  I  + F    +LE + L+ N L+  +    F  L+ L  L L  N ++   +  
Sbjct: 60  SRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 411 ELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGL 470
              N ++L  L + +     +I              G  S N L                
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRID--------FAGLTSLNELEIKAL----------- 158

Query: 471 LEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGD 530
                        +   +S     +              + +L L  ++    +      
Sbjct: 159 ------------SLRNYQSQSLKSIRD------------IHHLTLHLSESAFLLEIFADI 194

Query: 531 MIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
           + +++ LEL    L+    S L              R      ESF+ L  L++  L  +
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254

Query: 591 ELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRN 626
           E+         L     S+      L  V     R 
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  186 bits (475), Expect = 3e-53
 Identities = 72/278 (25%), Positives = 118/278 (42%), Gaps = 37/278 (13%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
            IG G FG V+K        VA+K L   +      + F  E+  L K +H N++  +GY 
Sbjct: 32   IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 800  KIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
                 +L +V ++ +  SL   LH       +          IAR  A+G+ +LH     
Sbjct: 90   T--APQLAIVTQWCEGSSLYHHLHAS-----ETKFEMKKLIDIARQTARGMDYLHAK--- 139

Query: 859  HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE---YYQS 915
             IIHRD+KS+N+ L  +   ++ DFG+A   S          L+G+  ++ PE      S
Sbjct: 140  SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 916  FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV 975
               + + DVY+FG+VL EL+TG+ P     + + N    +   V  G       P+L  V
Sbjct: 200  NPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIEMVGRGSLS----PDLSKV 250

Query: 976  TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                 +              +  +C+     +RP+  +
Sbjct: 251  RSNCPKR----------MKRLMAECLKKKRDERPSFPR 278

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (456), Expect = 2e-50
 Identities = 59/302 (19%), Positives = 109/302 (36%), Gaps = 49/302 (16%)

Query: 739  ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKHRNLVPLL 796
               +G G +GEV++ + + G +VA+K     S + ++ +  E E      ++H N++  +
Sbjct: 13   LECVGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 797  GYCKIGE----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
                       +  L+  + + GSL + L           L   +  +I    A GL  L
Sbjct: 69   ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-------LTTLDTVSCLRIVLSIASGLAHL 121

Query: 853  H-----HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH--LSVSTLAGTP 905
            H         P I HRD+KS N+L+    +  ++D G+A + S       +  +   GT 
Sbjct: 122  HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 906  GYVPPE------YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD-----FGDTNLVGW 954
             Y+ PE          F    + D+++FG+VL E+          +     F D      
Sbjct: 182  RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV---- 237

Query: 955  VKMKVREGKQMEVIDPELLLVTKG---TDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
                          D   ++          +       +    ++  +C    PS R   
Sbjct: 238  -------PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

Query: 1012 LQ 1013
            L+
Sbjct: 291  LR 292

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  178 bits (453), Expect = 7e-50
 Identities = 57/286 (19%), Positives = 106/286 (37%), Gaps = 48/286 (16%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYC 799
            IG G FG+V+         VAI+ +       D  + F  E+    + +H N+V  +G C
Sbjct: 41   IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
                   ++    K  +L  V+        + +L  +  ++IA+   KG+ +LH      
Sbjct: 99   MSPPHLAIITSLCKGRTLYSVVRDA-----KIVLDVNKTRQIAQEIVKGMGYLHA---KG 150

Query: 860  IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL---AGTPGYVPPEYYQSF 916
            I+H+D+KS NV  D   +  ++DFG+  +   L        L    G   ++ PE  +  
Sbjct: 151  ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 917  R---------CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV 967
                       +   DV++ G +  EL   + P     F        +  ++  G +  +
Sbjct: 210  SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-----FKTQPAE-AIIWQMGTGMKPNL 263

Query: 968  IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                +            +E+       +I L C      +RP   +
Sbjct: 264  SQIGM-----------GKEIS------DILLFCWAFEQEERPTFTK 292

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  180 bits (458), Expect = 9e-50
 Identities = 75/372 (20%), Positives = 142/372 (38%), Gaps = 24/372 (6%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
            +        D+  +  T  +  F   + + N+   +    + +  +  + L +  ++++
Sbjct: 15  SNLQYDCVFYDVHIDMQTQDVY-FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           LNL+   +       F    ++Q+L +  N I   +P  +      L  L L  N+++  
Sbjct: 74  LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSL 132

Query: 190 FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTL 249
                 +   L  L +SNNN+     D   +   SL++L LS+N ++     S+    +L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSL 188

Query: 250 RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN 309
              + S N +S +          ++EEL    N I  V         +L ++ L  N L 
Sbjct: 189 FHANVSYNLLSTL------AIPIAVEELDASHNSINVVRGPVNV---ELTILKLQHNNLT 239

Query: 310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPE-LGKCKNLKDLILNNNKLSGEIPAELFSCS 368
                 L     L +    +N LE KI      K + L+ L ++NN+L   +        
Sbjct: 240 -DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295

Query: 369 NLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNL 428
            L+ + L+ N L   +     +  RL  L L +N     +   L    +L  L L+ N+ 
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351

Query: 429 TGDIPPRLGRQL 440
             +    L R +
Sbjct: 352 DCNSLRALFRNV 363

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  176 bits (447), Expect = 3e-48
 Identities = 74/399 (18%), Positives = 145/399 (36%), Gaps = 54/399 (13%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           + +   + +++       L      K +   ++ +  L P  L      +  LN +   +
Sbjct: 26  VHIDMQTQDVYFGFEDITLN---NQKIVTFKNSTMRKL-PAALLDSFRQVELLNLNDLQI 81

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
              +     + +  ++ L + +N +   +        +   L  L L +N +  +     
Sbjct: 82  E-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF--QNVPLLTVLVLERNDLSSLPRGIF 137

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
            N  KL  L++S N L      TF   +SLQ L LS+N +T  +     +   SL    +
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL---SLIPSLFHANV 193

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
            +N ++     TL+    ++ LD S+N+I+      V      L  L L +N ++     
Sbjct: 194 SYNLLS-----TLAIPIAVEELDASHNSINV-VRGPVNVE---LTILKLQHNNLTD--TA 242

Query: 242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
            + +   L  VD S N +   I       +  LE L + +N +   +         LKV+
Sbjct: 243 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
           DLS N+L                           +     +   L++L L++N +   + 
Sbjct: 301 DLSHNHLL-------------------------HVERNQPQFDRLENLYLDHNSIV-TLK 334

Query: 362 AELFSCSNLEWISLTGNELTG-QIPPEFSRLTRLAVLQL 399
                   L+ ++L+ N+     +   F  + R AV   
Sbjct: 335 LSTH--HTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA 371

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  151 bits (384), Expect = 6e-40
 Identities = 77/463 (16%), Positives = 151/463 (32%), Gaps = 100/463 (21%)

Query: 165 IPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGS 224
           I S L   C    ++ +        F     + +  +++   N+ +    P ++L++   
Sbjct: 13  IDSNLQYDC-VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQ 70

Query: 225 LESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLI 284
           +E L L++  I      + +   T++ +    N +   +PP +   V  L  L L  N +
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129

Query: 285 TGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCK 344
           + +  G      +L  + +S N L   I  +             F               
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT------------FQAT-----------T 165

Query: 345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRF 404
           +L++L L++N+L+  +   L    +L   +++ N L+       +    +  L   +N  
Sbjct: 166 SLQNLQLSSNRLT-HVDLSLIP--SLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 217

Query: 405 KGEIPGELGNCSSLVWLDLNSNNLTGDIP-----PRLGRQLGAKPLGGFLSSNTLVFVRN 459
              + G +     L  L L  NNLT D       P L  ++        LS N       
Sbjct: 218 N-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGL-VEV-------DLSYN------- 258

Query: 460 VGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ 519
                                  ++  +    F +M              LE L +S N+
Sbjct: 259 -----------------------ELEKIMYHPFVKMQR------------LERLYISNNR 283

Query: 520 FRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL 579
               +      +  L+VL+L+HN L   +  +  +   L      HN +   +    S  
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTH 338

Query: 580 SFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLP 622
             L  + LS+N+       R     +      +    C +   
Sbjct: 339 HTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQ 380

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 88.9 bits (221), Expect = 7e-19
 Identities = 52/298 (17%), Positives = 89/298 (29%), Gaps = 62/298 (20%)

Query: 311 SIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSN 369
            I   L                +     E     N K +   N+ +  ++PA L      
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 370 LEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNL 428
           +E ++L   ++  +I    F+    +  L +G N  +   P    N   L  L L  N+L
Sbjct: 71  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129

Query: 429 TGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTL 487
           +  +P  +         L   +S+N                            L +I   
Sbjct: 130 S-SLPRGIFHNTPKLTTL--SMSNN---------------------------NLERIED- 158

Query: 488 KSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE 547
                           F    +L+ L LS N+    +      + +L    +++N LS  
Sbjct: 159 --------------DTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-- 199

Query: 548 IPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTL 605
              +L     +   DASHN +          L+ L    L +N LT           L
Sbjct: 200 ---TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNLT-DTAWLLNYPGL 250

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  178 bits (454), Expect = 1e-49
 Identities = 62/297 (20%), Positives = 109/297 (36%), Gaps = 39/297 (13%)

Query: 739  ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKHRNLVPLL 796
               IG G +GEV+    + G  VA+K         +  +  E E      ++H N++  +
Sbjct: 42   VKQIGKGRYGEVWMGKWR-GEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 797  GYCKIGEER----LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
                 G        L+ ++ + GSL + L           L   +  K+A  +  GLC L
Sbjct: 98   AADIKGTGSWTQLYLITDYHENGSLYDYLK-------STTLDAKSMLKLAYSSVSGLCHL 150

Query: 853  H-----HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH--LSVSTLAGTP 905
            H         P I HRD+KS N+L+       ++D G+A    +      +  +T  GT 
Sbjct: 151  HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 906  GYVPPE------YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKV 959
             Y+PPE          F+     D+YSFG++L E+          +         V    
Sbjct: 211  RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270

Query: 960  REGKQMEVIDPELLLVTKG---TDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                  E++        K    +  +     + + +  ++  +C    P+ R   L+
Sbjct: 271  SYEDMREIV------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  180 bits (459), Expect = 3e-49
 Identities = 102/554 (18%), Positives = 185/554 (33%), Gaps = 142/554 (25%)

Query: 64  FLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCN--SLLHLDLSQNHIMDVIPSSL 121
           F+    +SN+   E L    +NLT       +   + N  S      + +      P   
Sbjct: 2   FINPRNVSNTFLQEPL-RHSSNLT------EMPVEAENVKSKTEYYNAWSEWERNAPPGN 54

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
               ++ +  L   L                 L+L+N  ++  +P    +    L  L  
Sbjct: 55  GEQREMAVSRLRDCLD-----------RQAHELELNNLGLSS-LPELPPH----LESLVA 98

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
             N++T   P    S   L + + +   +S        +    LE L +SNN +    P+
Sbjct: 99  SCNSLT-ELPELPQSLKSLLVDNNNLKALS--------DLPPLLEYLGVSNNQLE-KLPE 148

Query: 242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
            + +   L+I+D  +N +   +P        SLE +   +N +   +P +L     L  I
Sbjct: 149 -LQNSSFLKIIDVDNNSLK-KLPDLP----PSLEFIAAGNNQLE-ELP-ELQNLPFLTAI 200

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
               N L   +P     LE +   +A  N LE    PEL     L  +  +NN L   +P
Sbjct: 201 YADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLP 253

Query: 362 AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL 421
                  +LE +++  N LT  +P     LT L V +   +      P       +L +L
Sbjct: 254 DLP---PSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYL 302

Query: 422 DLNSNNLTGDIPPRLG--RQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPE 479
           + +SN +   +        +L        +S+N                           
Sbjct: 303 NASSNEIR-SLCDLPPSLEEL-------NVSNN--------------------------- 327

Query: 480 RLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLEL 539
           +L+++P L                      LE L  S+N    ++P+   +   L+ L +
Sbjct: 328 KLIELPAL-------------------PPRLERLIASFNHLA-EVPELPQN---LKQLHV 364

Query: 540 AHNQLSGEIPSSLGRLR----------------NLGVFDASHNRLQGQIPESFSNLSFLV 583
            +N L  E P     +                 NL       N L+ + P+   ++  L 
Sbjct: 365 EYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL- 421

Query: 584 QIDLSNNELTGPIP 597
              +++  +  P  
Sbjct: 422 --RMNSERVVDPYE 433

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  180 bits (458), Expect = 5e-49
 Identities = 92/536 (17%), Positives = 175/536 (32%), Gaps = 125/536 (23%)

Query: 45  FSKLPNLVYLNASYNNLTGFLPETLLSNSD------------KLELLDLSYNNLTGSISG 92
              + +      +++      P       +            +   L+L+   L+ S+  
Sbjct: 30  AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLP- 87

Query: 93  FSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQ 152
                     L  L  S N + + +P    +   L + N +   L+   P        L+
Sbjct: 88  -----ELPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPP-------LLE 134

Query: 153 RLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISG 212
            L +SNN +   +P EL N    L  + + +N++    P    S   L+ +   NN +  
Sbjct: 135 YLGVSNNQLEK-LP-ELQN-SSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEE 187

Query: 213 PFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVS 272
             P+  L+NL  L ++   NN +    PD   S +++      +N +     P++   + 
Sbjct: 188 -LPE--LQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPEL-QNLP 237

Query: 273 SLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGL 332
            L  +   +NL+   +P        L V D  L      +P+    L  L+     F+GL
Sbjct: 238 FLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLT----DLPELPQSLTFLDVSENIFSGL 292

Query: 333 EGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLT 392
               P       NL  L  ++N++   +        +LE ++++ N+L  ++P    RL 
Sbjct: 293 SELPP-------NLYYLNASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELPALPPRLE 340

Query: 393 RLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSN 452
           R   L    N    E+P    N   L  L +  N L  + P           +     ++
Sbjct: 341 R---LIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPES------VEDLRMNS 386

Query: 453 TLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEY 512
                                       L ++P L                    Q L+ 
Sbjct: 387 ---------------------------HLAEVPELP-------------------QNLKQ 400

Query: 513 LDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRL 568
           L +  N  R + PD      +++ L +   ++      +      L      H+  
Sbjct: 401 LHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  172 bits (437), Expect = 2e-46
 Identities = 89/444 (20%), Positives = 157/444 (35%), Gaps = 79/444 (17%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
              L+L++       +SL +LP  L+ L  S   L  L    L   L +L+  N +   L
Sbjct: 73  AHELELNNL----GLSSLPELPPHLESLVASCNSLTEL--PELPQSLKSLLVDNNNLKAL 126

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
           +   P         LE L +S N L   +        + + L  +D+  N +   +P   
Sbjct: 127 SDLPP--------LLEYLGVSNNQLE-KLPELQ----NSSFLKIIDVDNNSLKK-LPDLP 172

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
            +   L+ +    N L  E+P     L  L  +   NN +   +P    +    L  +  
Sbjct: 173 PS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPDLPLS----LESIVA 222

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
            +N +    P  L +  +L  +   NN +      ++ +   SLE+L + +N ++   P+
Sbjct: 223 GNNILE-ELP-ELQNLPFLTTIYADNNLLK-----TLPDLPPSLEALNVRDNYLT-DLPE 274

Query: 242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
              S   L + +   + +S + P        +L  L    N I   +         L+ +
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPP--------NLYYLNASSNEIR-SLCDLP---PSLEEL 322

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
           ++S N L   +P    +LE L   IA FN L  ++P       NLK L +  N L  E P
Sbjct: 323 NVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFP 373

Query: 362 AELFS----------------CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK 405
               S                  NL+ + +  N L  + P     +  L   ++ + R  
Sbjct: 374 DIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVV 429

Query: 406 GEIPGELGNCSSLVWLDLNSNNLT 429
                       L       ++  
Sbjct: 430 DPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  165 bits (419), Expect = 5e-44
 Identities = 105/482 (21%), Positives = 168/482 (34%), Gaps = 114/482 (23%)

Query: 114 MDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNAC 173
           M + P ++SN    + L  S NL   E+P     + S      + +      P   G   
Sbjct: 1   MFINPRNVSNTFLQEPLRHSSNL--TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQR 58

Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
           + +   +L                     L+L+N  +S     S+ E    LESL+ S N
Sbjct: 59  E-MAVSRLRDCLDRQ-----------AHELELNNLGLS-----SLPELPPHLESLVASCN 101

Query: 234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLS 293
            ++   P+   S K+L + + +   +S + P         LE L + +N +  +    L 
Sbjct: 102 SLT-ELPELPQSLKSLLVDNNNLKALSDLPP--------LLEYLGVSNNQLEKLPE--LQ 150

Query: 294 ECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNN 353
             + LK+ID+  N L   +P     LE +    A  N LE    PEL     L  +  +N
Sbjct: 151 NSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE--ELPELQNLPFLTAIYADN 204

Query: 354 NKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELG 413
           N L  ++P       +LE I    N L                          E+P EL 
Sbjct: 205 NSLK-KLPDLP---LSLESIVAGNNILE-------------------------ELP-ELQ 234

Query: 414 NCSSLVWLDLNSNNLTGDIPPRLG--RQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLL 471
           N   L  +  ++N L   +P        L        +  N L  +              
Sbjct: 235 NLPFLTTIYADNNLLK-TLPDLPPSLEAL-------NVRDNYLTDLPE------------ 274

Query: 472 EFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDM 531
                         +L   D +      +  L      L YL+ S N+ R  + D     
Sbjct: 275 -----------LPQSLTFLDVSENIFSGLSELPPN---LYYLNASSNEIR-SLCDLPP-- 317

Query: 532 IALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNE 591
            +L+ L +++N+L  E+P+   RL  L    AS N L  ++PE   NL  L    +  N 
Sbjct: 318 -SLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQNLKQL---HVEYNP 368

Query: 592 LT 593
           L 
Sbjct: 369 LR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  110 bits (276), Expect = 2e-25
 Identities = 63/380 (16%), Positives = 120/380 (31%), Gaps = 92/380 (24%)

Query: 221 NLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLP 280
           +   L+  +  ++ ++   P    + K+      + +      PP        +   RL 
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQ-REMAVSRLR 66

Query: 281 DNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPEL 340
           D L             Q   ++L+   L+ S+P+    LE L                  
Sbjct: 67  DCL-----------DRQAHELELNNLGLS-SLPELPPHLESL------------------ 96

Query: 341 GKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG 400
                    + + N L+ E+P    S  +L   +     L+   P        L  L + 
Sbjct: 97  ---------VASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVS 139

Query: 401 NNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLG--RQLGAKPLGGFLSSNTLVFVR 458
           NN+ + ++P EL N S L  +D+++N+L   +P        +          +N L  + 
Sbjct: 140 NNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA-------AGNNQLEELP 189

Query: 459 NVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYN 518
            + N                   L      +             L     +LE +    N
Sbjct: 190 ELQNLPF----------------LTAIYADNNSLK--------KLPDLPLSLESIVAGNN 225

Query: 519 QFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSN 578
               +   E+ ++  L  +   +N L   +P     L  L   +   N L   +PE   +
Sbjct: 226 IL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPELPQS 278

Query: 579 LSFLVQIDLSNNELTGPIPQ 598
           L+FL   +   + L+   P 
Sbjct: 279 LTFLDVSENIFSGLSELPPN 298

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  100 bits (251), Expect = 2e-22
 Identities = 57/282 (20%), Positives = 107/282 (37%), Gaps = 57/282 (20%)

Query: 336 IPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLA 395
           I P       L++ + +++ L+ E+P E  +  +        +E     PP       +A
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 396 VLQLGNNRFKG------------EIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAK 443
           V +L +   +              +P    +   L  L  + N+LT ++P          
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPELPPH---LESLVASCNSLT-ELPELPQS----- 112

Query: 444 PLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSL 503
                L S  L+   N   +   +  LLE+ G+   +L ++P L++              
Sbjct: 113 -----LKS--LLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNS------------- 152

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDA 563
                 L+ +D+  N  + K+PD      +L+ +   +NQL  E+P  L  L  L    A
Sbjct: 153 ----SFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYA 202

Query: 564 SHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTL 605
            +N L+ ++P+   +L  +      NN L   +P+   L  L
Sbjct: 203 DNNSLK-KLPDLPLSLESI---VAGNNILEE-LPELQNLPFL 239

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  179 bits (456), Expect = 1e-48
 Identities = 73/424 (17%), Positives = 130/424 (30%), Gaps = 35/424 (8%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
            K  +++ + L      +L     N+  L+ S N L+       L+   KLELL+LS N 
Sbjct: 12  YKIEKVTDSSLKQA-LASLRQSAWNVKELDLSGNPLSQISAAD-LAPFTKLELLNLSSNV 69

Query: 86  LTGSISGFS---------LNEN------SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKIL 130
           L                 LN N         S+  L  + N+I  V  S        K +
Sbjct: 70  LY-ETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNI 125

Query: 131 NLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSF 190
            L+ N +        G  S +Q LDL  N I     +EL  + D+L  L L +N I    
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DV 184

Query: 191 PVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLR 250
                  + L+ LDLS+N ++        ++   +  + L NN +      ++   + L 
Sbjct: 185 K-GQVVFAKLKTLDLSSNKLAF-MGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240

Query: 251 IVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG 310
             D   N        D       ++ +      +  +      ECT   +          
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCED 298

Query: 311 SIPQELGKLEHLEQFIAWFNGLEG----KIPPELGKCKNLKDLILNNNKLSGEIPAELFS 366
                  +L  L++        +G    ++  E       +++     +    +  ++  
Sbjct: 299 LPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQVTL 357

Query: 367 -CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNS 425
                  +      L  Q+         L          + E+       S L  L    
Sbjct: 358 RKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIV 416

Query: 426 NNLT 429
               
Sbjct: 417 KRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  175 bits (445), Expect = 4e-47
 Identities = 86/512 (16%), Positives = 160/512 (31%), Gaps = 69/512 (13%)

Query: 101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNH 160
           N      ++ + +   + S   +   +K L+LS N L+          + L+ L+LS+N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 161 ITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLE 220
           +      +L +   +L  L L +N +       L     ++ L  +NNNIS     S  +
Sbjct: 70  LYE--TLDLES-LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ 120

Query: 221 NLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLP 280
                +++ L+NN I+            ++ +D   N +  +   ++     +LE L L 
Sbjct: 121 G---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 281 DNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPEL 340
            N I   + GQ+    +LK +DLS N L                           + PE 
Sbjct: 178 YNFIY-DVKGQVV-FAKLKTLDLSSNKLA-------------------------FMGPEF 210

Query: 341 GKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNEL-TGQIPPEFSRLTRLAVLQL 399
                +  + L NNKL   I   L    NLE   L GN    G +   FS+  R+    +
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTV 267

Query: 400 GNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRN 459
                K         C+        +        P   R +        L       +  
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI-------ALKRKEHALLSG 320

Query: 460 VGNSCKGVGGLLEFAGIRPERLL----QIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDL 515
            G+  + +         R   +     Q  T+      R  +               L+ 
Sbjct: 321 QGSETERLECER-ENQARQREIDALKEQYRTVIDQVTLRKQA------------KITLEQ 367

Query: 516 SYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRL-QGQIPE 574
                  ++ +       L            E+  +      L +  A   R  +  + +
Sbjct: 368 KKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQ 426

Query: 575 SFSNLSFLVQIDLSNNELTGPIPQRGQLSTLP 606
                + +   D+  ++ T    +  +L  L 
Sbjct: 427 QSVQNNAIRDWDMYQHKETQLAEENARLKKLN 458

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  149 bits (379), Expect = 1e-38
 Identities = 54/362 (14%), Positives = 112/362 (30%), Gaps = 23/362 (6%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           +  L  ++N  +  S S  Q   G K + L++  +  L  D        + YL+   N +
Sbjct: 101 IETLHAANNNISRVSCSRGQ---GKKNIYLANNKITML-RDLDEGCRSRVQYLDLKLNEI 156

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
                  L ++SD LE L+L YN +   + G  +       L  LDLS N +   +    
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV----FAKLKTLDLSSNKLAF-MGPEF 210

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
            +   +  ++L  N L   I +      +L+  DL  N        +  +    +    +
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--V 267

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
               +          C+   L            P    + L +L+    +     GS  +
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSETE 326

Query: 242 SISS----CKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQ 297
            +          R +D    +    +   +     +   L      +   +        +
Sbjct: 327 RLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385

Query: 298 LKVIDLSLNYLNG--SIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNK 355
           L                 +E   L+ L   +  +   E  +  +  +   ++D  +  +K
Sbjct: 386 LDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE--EMYVEQQSVQNNAIRDWDMYQHK 443

Query: 356 LS 357
            +
Sbjct: 444 ET 445

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  174 bits (444), Expect = 2e-48
 Identities = 60/297 (20%), Positives = 113/297 (38%), Gaps = 39/297 (13%)

Query: 739  ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEME--TLGKIKHRNLVPLL 796
            +  IG G FGEV++   + G  VA+K     S + +R +  E E      ++H N++  +
Sbjct: 47   QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 797  GYCKIGE----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
                       +  LV ++ + GSL + L+       +  +T +   K+A   A GL  L
Sbjct: 103  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHL 155

Query: 853  H-----HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH--LSVSTLAGTP 905
            H         P I HRD+KS N+L+       ++D G+A    +      ++ +   GT 
Sbjct: 156  HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 906  GYVPPE------YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKV 959
             Y+ PE        + F    + D+Y+ G+V  E+          +         V    
Sbjct: 216  RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS-- 273

Query: 960  REGKQMEVIDPELLLVTKG---TDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                   V +   ++  +       +  +  + +    +I  +C     + R   L+
Sbjct: 274  ----DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  177 bits (450), Expect = 9e-48
 Identities = 66/367 (17%), Positives = 136/367 (37%), Gaps = 62/367 (16%)

Query: 40  VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENS 99
           VP+ +         L+   N +   L +   ++   LE L+L+ N ++ ++   + N  +
Sbjct: 26  VPEGIP---TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS-AVEPGAFN--N 78

Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
             +L  L L  N +  +     +  + L  L++S N +   +   F  L +L+ L++ +N
Sbjct: 79  LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138

Query: 160 HITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVL 219
            +                   + H           S  + L+ L L   N++   P   L
Sbjct: 139 DLV-----------------YISHR--------AFSGLNSLEQLTLEKCNLTS-IPTEAL 172

Query: 220 ENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL 279
            +L  L  L L +  I+     S      L++++ S       + P+   G  +L  L +
Sbjct: 173 SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG-LNLTSLSI 231

Query: 280 PDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE 339
               +T V    +     L+ ++LS N            +  +E   +  + L       
Sbjct: 232 THCNLTAVPYLAVRHLVYLRFLNLSYN-----------PISTIEG--SMLHEL------- 271

Query: 340 LGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTRLAVL 397
                 L+++ L   +L+  +    F   + L  ++++GN+LT  +    F  +  L  L
Sbjct: 272 ----LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETL 325

Query: 398 QLGNNRF 404
            L +N  
Sbjct: 326 ILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  147 bits (373), Expect = 8e-38
 Identities = 61/256 (23%), Positives = 97/256 (37%), Gaps = 7/256 (2%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           L  L L SN   L    +      L +L++S   +V L  D +F  L NL  L    N+L
Sbjct: 82  LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVIL-LDYMFQDLYNLKSLEVGDNDL 140

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
             ++     S  + LE L L   NLT SI   +L  +  + L+ L L   +I  +   S 
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEAL--SHLHGLIVLRLRHLNINAIRDYSF 196

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
               +LK+L +S       +        +L  L +++ ++T  +P         L  L L
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNL 255

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
            +N I+      L     LQ + L    ++          L  L  L +S N ++     
Sbjct: 256 SYNPISTIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSGNQLTTLEES 314

Query: 242 SISSCKTLRIVDFSSN 257
              S   L  +   SN
Sbjct: 315 VFHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  140 bits (354), Expect = 2e-35
 Identities = 79/422 (18%), Positives = 131/422 (31%), Gaps = 103/422 (24%)

Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
                +         + P  + +    +LLDL  N I          +   LE L L+ N
Sbjct: 11  AQDRAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIKT-LNQDEFASFPHLEELELNEN 66

Query: 234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLS 293
           ++S                          + P     + +L  L L  N +  +  G  +
Sbjct: 67  IVS-------------------------AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT 101

Query: 294 ECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNN 353
             + L  +D+S N +   +   +            F  L            NLK L + +
Sbjct: 102 GLSNLTKLDISENKIV-ILLDYM------------FQDL-----------YNLKSLEVGD 137

Query: 354 NKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGE 411
           N L   I    FS  ++LE ++L    LT  IP E  S L  L VL+L +          
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYS 195

Query: 412 LGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLL 471
                 L  L+++       + P     L    L   ++                     
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL--SITHC------------------- 234

Query: 472 EFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI-GD 530
                    L  +P                        L +L+LSYN     I   +  +
Sbjct: 235 --------NLTAVPY---------------LAVRHLVYLRFLNLSYNPIS-TIEGSMLHE 270

Query: 531 MIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
           ++ LQ ++L   QL+   P +   L  L V + S N+L       F ++  L  + L +N
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330

Query: 591 EL 592
            L
Sbjct: 331 PL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  121 bits (306), Expect = 3e-29
 Identities = 74/397 (18%), Positives = 133/397 (33%), Gaps = 88/397 (22%)

Query: 223 GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
               +++        + P+ I +    R++D   NR+   +  D       LEEL L +N
Sbjct: 11  AQDRAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIK-TLNQDEFASFPHLEELELNEN 66

Query: 283 LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK 342
           +++ V PG  +    L+ + L  N L   IP  +            F GL          
Sbjct: 67  IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGV------------FTGL---------- 103

Query: 343 CKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLG 400
             NL  L ++ NK+   +   +F    NL+ + +  N+L   I    FS L  L  L L 
Sbjct: 104 -SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLE 160

Query: 401 NNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNV 460
                      L +   L+ L L   N+                    +   +   +   
Sbjct: 161 KCNLTSIPTEALSHLHGLIVLRLRHLNIN------------------AIRDYSFKRLYR- 201

Query: 461 GNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQF 520
                                L++  +    +    +   L        L  L +++   
Sbjct: 202 ---------------------LKVLEISHWPYLDTMTPNCLYGLN----LTSLSITHCNL 236

Query: 521 RGKIPDE-IGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL 579
              +P   +  ++ L+ L L++N +S    S L  L  L        +L    P +F  L
Sbjct: 237 T-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL 295

Query: 580 SFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGL 616
           ++L  +++S N          QL+TL  S + +   L
Sbjct: 296 NYLRVLNVSGN----------QLTTLEESVFHSVGNL 322

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  177 bits (451), Expect = 4e-47
 Identities = 75/377 (19%), Positives = 141/377 (37%), Gaps = 24/377 (6%)

Query: 65  LPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNC 124
                 +        D+  +  T  +  F   + + N+   +    + +  +  + L + 
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVY-FGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 74

Query: 125 TKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHN 184
            ++++LNL+   +       F    ++Q+L +  N I   +P  +      L  L L  N
Sbjct: 75  RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERN 133

Query: 185 NITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSIS 244
           +++        +   L  L +SNNN+     D   +   SL++L LS+N ++       S
Sbjct: 134 DLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDL--S 189

Query: 245 SCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLS 304
              +L   + S N +S +          ++EEL    N I  V         +L ++ L 
Sbjct: 190 LIPSLFHANVSYNLLSTL------AIPIAVEELDASHNSINVVRGPV---NVELTILKLQ 240

Query: 305 LNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE-LGKCKNLKDLILNNNKLSGEIPAE 363
            N L       L     L +    +N LE KI      K + L+ L ++NN+L   +   
Sbjct: 241 HNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLY 296

Query: 364 LFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL 423
                 L+ + L+ N L   +     +  RL  L L +N     +   L    +L  L L
Sbjct: 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTL 352

Query: 424 NSNNLTGDIPPRLGRQL 440
           + N+   +    L R +
Sbjct: 353 SHNDWDCNSLRALFRNV 369

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  162 bits (412), Expect = 4e-42
 Identities = 71/403 (17%), Positives = 139/403 (34%), Gaps = 77/403 (19%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
             ++   ++    L +  L      ++ L L+   +  +     F+    +  L   +N 
Sbjct: 53  QKIVTFKNSTMRKLPAALLDSFRQ-VELLNLNDLQIEEI-DTYAFAYAHTIQKLYMGFNA 110

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           +  +LP  +  N   L +L L  N+L+ S+     +      L  L +S N++  +   +
Sbjct: 111 IR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP--KLTTLSMSNNNLERIEDDT 166

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
               T L+ L LS N L   +      + SL   ++S N ++  +   +     ++ EL 
Sbjct: 167 FQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPI-----AVEELD 217

Query: 181 LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
             HN+I             L +L L +NN++     + L N   L  + LS N +     
Sbjct: 218 ASHNSINVVRGPVNVE---LTILKLQHNNLTDT---AWLLNYPGLVEVDLSYNELE---- 267

Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
                                 I       +  LE L + +N +   +         LKV
Sbjct: 268 ---------------------KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305

Query: 301 IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
           +DLS N+L                           +     +   L++L L++N +   +
Sbjct: 306 LDLSHNHLL-------------------------HVERNQPQFDRLENLYLDHNSIV-TL 339

Query: 361 PAELFSCSNLEWISLTGNELTG-QIPPEFSRLTRLAVLQLGNN 402
                    L+ ++L+ N+     +   F  + R AV     +
Sbjct: 340 KLSTH--HTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  132 bits (333), Expect = 3e-32
 Identities = 64/420 (15%), Positives = 124/420 (29%), Gaps = 70/420 (16%)

Query: 131 NLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACD-----SLLELKLPHNN 185
              +N+   +        +        + HI      ++    +     +   +   ++ 
Sbjct: 4   QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHID-MQTQDVYFGFEDITLNNQKIVTFKNST 62

Query: 186 ITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISS 245
           +       L S   ++LL+L++  I             +++ L +  N I    P    +
Sbjct: 63  MRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 121

Query: 246 CKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSL 305
              L ++    N +S  +P  I      L  L + +N +  +        T L+ + LS 
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 180

Query: 306 NYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF 365
           N L   +   L  +  L      +N L       L     +++L  ++N ++  +   + 
Sbjct: 181 NRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN 231

Query: 366 SCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNS 425
               L  + L  N LT            L  + L  N  +  +         L  L +++
Sbjct: 232 --VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287

Query: 426 NNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIP 485
           N L   +          K L   LS N                            LL + 
Sbjct: 288 NRLV-ALNLYGQPIPTLKVL--DLSHN---------------------------HLLHVE 317

Query: 486 TLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLS 545
                               Q+  LE L L +N     +   +     L+ L L+HN   
Sbjct: 318 ----------------RNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 49.2 bits (117), Expect = 6e-06
 Identities = 6/86 (6%), Positives = 32/86 (37%), Gaps = 2/86 (2%)

Query: 510 LEYLDLSYNQFRGKIPD--EIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNR 567
             + D+  +     +    E   +   +++   ++ +     + L   R + + + +  +
Sbjct: 27  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86

Query: 568 LQGQIPESFSNLSFLVQIDLSNNELT 593
           ++     +F+    + ++ +  N + 
Sbjct: 87  IEEIDTYAFAYAHTIQKLYMGFNAIR 112

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  166 bits (423), Expect = 8e-46
 Identities = 71/341 (20%), Positives = 126/341 (36%), Gaps = 44/341 (12%)

Query: 101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNH 160
           N      ++ + +   + S   +   +K L+LS N L+          + L+ L+LS+N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 161 ITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLE 220
           +      +L +   +L  L L +N +       L     ++ L  +NNNIS     S  +
Sbjct: 70  LYE--TLDLES-LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ 120

Query: 221 NLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLP 280
                +++ L+NN I+            ++ +D   N +  +   ++     +LE L L 
Sbjct: 121 G---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 281 DNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPEL 340
            N I   + GQ+    +LK +DLS N L                           + PE 
Sbjct: 178 YNFIY-DVKGQVV-FAKLKTLDLSSNKLA-------------------------FMGPEF 210

Query: 341 GKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELT-GQIPPEFSRLTRLAVLQL 399
                +  + L NNKL   I   L    NLE   L GN    G +   FS+  R+  +  
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269

Query: 400 GNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQL 440
              +   ++ G+     ++  L         D+P     +L
Sbjct: 270 QTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  134 bits (339), Expect = 1e-34
 Identities = 53/310 (17%), Positives = 108/310 (34%), Gaps = 33/310 (10%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           +  L LS N  + +++  L      L+ L LSS  L   +       L  L  L+ + N 
Sbjct: 36  VKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD---LESLSTLRTLDLNNNY 91

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           +        L     +E L  + NN++       ++ +      ++ L+ N I  +    
Sbjct: 92  V------QELLVGPSIETLHAANNNIS------RVSCSRGQGKKNIYLANNKITMLRDLD 139

Query: 121 LSNCTKLKILNLSFNLLAG-EIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL 179
               ++++ L+L  N +             +L+ L+L  N I   +  ++      L  L
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV--FAKLKTL 196

Query: 180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS-GS 238
            L  N +         S + +  + L NN +      + L    +LE   L  N    G+
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKA-LRFSQNLEHFDLRGNGFHCGT 253

Query: 239 FPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQL 298
             D  S  + ++ V   + +       + C    ++  L          +P   +     
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEEC----TVPTLGHYGAYCCEDLPAPFA----D 305

Query: 299 KVIDLSLNYL 308
           ++I L  ++ 
Sbjct: 306 RLIALGHHHH 315

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  121 bits (305), Expect = 4e-30
 Identities = 56/313 (17%), Positives = 109/313 (34%), Gaps = 42/313 (13%)

Query: 311 SIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNL 370
           +I +        +      + L+  +        N+K+L L+ N LS    A+L   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 371 EWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG 430
           E ++L+ N L      +   L+ L  L L NN  +     EL    S+  L   +NN++ 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 431 DIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSC 490
            +    G+    K +  +L++N +                     +R         ++  
Sbjct: 113 RVSCSRGQGK--KNI--YLANNKIT-------------------MLRDLDEGCRSRVQYL 149

Query: 491 DFA--RMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEI 548
           D     + +     L     TLE+L+L YN     +  ++     L+ L+L+ N+L+  +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FM 206

Query: 549 PSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRG-----QLS 603
                    +      +N+L   I ++      L   DL  N       +       ++ 
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265

Query: 604 TLPASQYANNPGL 616
           T+         G 
Sbjct: 266 TVAKQTVKKLTGQ 278

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  164 bits (418), Expect = 9e-44
 Identities = 76/404 (18%), Positives = 141/404 (34%), Gaps = 49/404 (12%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
                 ++  +      +   +L  L  L+   +++T     T +     L  L  + NN
Sbjct: 20  FASEVAAAFEMQATDTIS-EEQLATLTSLDCHNSSITDM---TGIEKLTGLTKLICTSNN 75

Query: 86  LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
           +T      +L+ +   +L +L    N + ++    ++  TKL  LN   N L  ++    
Sbjct: 76  IT------TLDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLD--V 123

Query: 146 GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL 205
            Q   L  L+ + N +T    S        L EL    N         ++  + L  LD 
Sbjct: 124 SQNPLLTYLNCARNTLTEIDVSHNTQ----LTELDCHLNKKITKLD--VTPQTQLTTLDC 177

Query: 206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPP 265
           S N I+    +  +     L  L    N I+      ++    L  +D SSN+++ I   
Sbjct: 178 SFNKIT----ELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI--- 227

Query: 266 DICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF 325
           D+ P ++ L       N +T +    LS+ T L  I   L  ++ +   +L   +     
Sbjct: 228 DVTP-LTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ----- 281

Query: 326 IAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIP 385
                G       ++     L  L      ++ E+   L     L ++ L   ELT ++ 
Sbjct: 282 ---AEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD 334

Query: 386 PEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
              S  T+L  L   N   + +    +G   +L           
Sbjct: 335 --VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI 374

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  149 bits (378), Expect = 1e-38
 Identities = 82/434 (18%), Positives = 145/434 (33%), Gaps = 80/434 (18%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           L+ L   ++  T + T + +L  GL +L  +S  +  L      S+  NL YL    N L
Sbjct: 44  LTSLDCHNSSIT-DMTGIEKLT-GLTKLICTSNNITTLD----LSQNTNLTYLACDSNKL 97

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
           T  L    ++   KL  L+   N LT       L+ +    L +L+ ++N + ++    +
Sbjct: 98  TN-LD---VTPLTKLTYLNCDTNKLT------KLDVSQNPLLTYLNCARNTLTEI---DV 144

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
           S+ T+L  L+   N    ++       + L  LD S N IT                   
Sbjct: 145 SHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE------------------ 184

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
                     + +S    L  L+   NNI+       L     L  L  S+N ++     
Sbjct: 185 ----------LDVSQNKLLNRLNCDTNNITKL----DLNQNIQLTFLDCSSNKLT-EID- 228

Query: 242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
            ++    L   D S N ++  +          L  L      +  +    L+  TQL   
Sbjct: 229 -VTPLTQLTYFDCSVNPLT-ELDVSTLS---KLTTLHCIQTDLLEI---DLTHNTQLI-- 278

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
                        ++     L        G+  ++   L +   L  L LNN +L+ E+ 
Sbjct: 279 YFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD 334

Query: 362 AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV-- 419
                 + L+ +S     +         ++  L        +    +P E    +SL   
Sbjct: 335 VS--HNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIA 389

Query: 420 ----WLDLNSNNLT 429
                LD   N + 
Sbjct: 390 VSPDLLDQFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  127 bits (322), Expect = 2e-31
 Identities = 67/449 (14%), Positives = 153/449 (34%), Gaps = 63/449 (14%)

Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
           D+          +  +  ++    + L  LD  N++I+     + +E L  L  LI ++N
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM---TGIEKLTGLTKLICTSN 74

Query: 234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLS 293
            I+ +    +S    L  +   SN+++ +   D+   ++ L  L    N +T +    +S
Sbjct: 75  NIT-TLD--LSQNTNLTYLACDSNKLTNL---DVT-PLTKLTYLNCDTNKLTKL---DVS 124

Query: 294 ECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNN 353
           +   L  ++ + N L         +L  L       +  +     ++     L  L  + 
Sbjct: 125 QNPLLTYLNCARNTLTEIDVSHNTQLTEL-----DCHLNKKITKLDVTPQTQLTTLDCSF 179

Query: 354 NKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELG 413
           NK++ E+   +     L  ++   N +T     + ++  +L  L   +N+   EI   + 
Sbjct: 180 NKIT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VT 230

Query: 414 NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEF 473
             + L + D + N LT ++      +L    L        L+ + ++ ++ +    L+ F
Sbjct: 231 PLTQLTYFDCSVNPLT-ELDVSTLSKL--TTL--HCIQTDLLEI-DLTHNTQ----LIYF 280

Query: 474 AGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA 533
                 +      +K  D                  L  LD        ++   +     
Sbjct: 281 ------QAEGCRKIKELDVTHNTQ------------LYLLDCQAAGIT-ELD--LSQNPK 319

Query: 534 LQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
           L  L L + +L+ E+   +     L      +  +Q         +  L     +  +  
Sbjct: 320 LVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI 374

Query: 594 GPIPQRGQLSTLPASQYANNPGLCGVPLP 622
               +    ++L  +   +     G P+ 
Sbjct: 375 TMPKETLTNNSLTIAVSPDLLDQFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  102 bits (255), Expect = 7e-23
 Identities = 58/334 (17%), Positives = 106/334 (31%), Gaps = 65/334 (19%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           L+ L    N   +    +      L  L+ S   +  L      S+   L  LN   NN+
Sbjct: 150 LTELDCHLNKK-ITKLDVTPQT-QLTTLDCSFNKITELD----VSQNKLLNRLNCDTNNI 203

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
           T  L    L+ + +L  LD S N LT       ++      L + D S N + ++    +
Sbjct: 204 TK-LD---LNQNIQLTFLDCSSNKLT------EIDVTPLTQLTYFDCSVNPLTEL---DV 250

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
           S  +KL  L+                   L  +DL++N                L+  + 
Sbjct: 251 STLSKLTTLHCIQT--------------DLLEIDLTHN--------------TQLIYFQA 282

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
                     + ++  + L LLD     I+    +  L     L  L L+N  ++     
Sbjct: 283 EGCRKIKE--LDVTHNTQLYLLDCQAAGIT----ELDLSQNPKLVYLYLNNTELT-ELD- 334

Query: 242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPG-----QLSECT 296
            +S    L+ +   +  +           + +L      +     +         L+   
Sbjct: 335 -VSHNTKLKSLSCVNAHIQDF---SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAV 390

Query: 297 QLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFN 330
              ++D   N +N   P + G  +     I W N
Sbjct: 391 SPDLLDQFGNPMN-IEPGDGGVYDQATNTITWEN 423

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 35/198 (17%), Positives = 64/198 (32%), Gaps = 19/198 (9%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFG----LKQLELSSAGLVGLVPDNLFSKLPNLVYLNAS 57
           L+               + +L       L  L+  +AG+  L      S+ P LVYL  +
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELD----LSQNPKLVYLYLN 326

Query: 58  YNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVI 117
              LT  L    +S++ KL+ L     ++    S          +L +   ++   + + 
Sbjct: 327 NTELTE-LD---VSHNTKLKSLSCVNAHIQ-DFSSVG----KIPALNNNFEAEGQTITMP 377

Query: 118 PSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLL 177
             +L+N      + +S +LL         +       D + N IT    S    A     
Sbjct: 378 KETLTN--NSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTF 435

Query: 178 ELKLPHNNITGSFPVTLS 195
             +      T + P    
Sbjct: 436 TSENGAIVGTVTTPFEAP 453

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  168 bits (426), Expect = 9e-44
 Identities = 80/396 (20%), Positives = 138/396 (34%), Gaps = 59/396 (14%)

Query: 74  DKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLS 133
           +   +L++  + LT      +L +     +  L +  N++   +P+       L+ L +S
Sbjct: 40  NGNAVLNVGESGLT------TLPDCLPAHITTLVIPDNNLTS-LPALPPE---LRTLEVS 89

Query: 134 FNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVT 193
            N L   +P     L  L        H+              L +L +  N +T S PV 
Sbjct: 90  GNQLT-SLPVLPPGLLELSIFSNPLTHLPALP--------SGLCKLWIFGNQLT-SLPVL 139

Query: 194 LSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVD 253
                 LQ L +S+N ++     S+      L  L   NN ++ S P   S  + L    
Sbjct: 140 PPG---LQELSVSDNQLA-----SLPALPSELCKLWAYNNQLT-SLPMLPSGLQEL---S 187

Query: 254 FSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP 313
            S N+++  +P         L +L   +N +T  +P   +  + LK + +S N L  S+P
Sbjct: 188 VSDNQLA-SLPTLPS----ELYKLWAYNNRLT-SLP---ALPSGLKELIVSGNRLT-SLP 237

Query: 314 QELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWI 373
               +L+ L       N L   +P        L  L +  N+L+  +P  L   S+   +
Sbjct: 238 VLPSELKELM---VSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTV 289

Query: 374 SLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV-----WLDLNSNNL 428
           +L GN L+ +       +T          RF            +L      WL       
Sbjct: 290 NLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE 349

Query: 429 TG--DIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGN 462
               D     G++  A      L  + L    N   
Sbjct: 350 PAPADRWHMFGQEDNADAF--SLFLDRLSETENFIK 383

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  156 bits (397), Expect = 5e-40
 Identities = 86/471 (18%), Positives = 160/471 (33%), Gaps = 53/471 (11%)

Query: 94  SLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQR 153
            +     N    L++ ++ +   +P  L     +  L +  N L   +P    +   L+ 
Sbjct: 33  KMRACLNNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALPPE---LRT 85

Query: 154 LDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP 213
           L++S N +T  +P         L     P  ++    P   S    L  L +  N ++  
Sbjct: 86  LEVSGNQLTS-LPVLPPG-LLELSIFSNPLTHL----PALPSG---LCKLWIFGNQLT-- 134

Query: 214 FPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSS 273
              S+      L+ L +S+N ++ S P   S    L      +N+++  +P       S 
Sbjct: 135 ---SLPVLPPGLQELSVSDNQLA-SLPALPSELCKLWA---YNNQLTS-LPMLP----SG 182

Query: 274 LEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLE 333
           L+EL + DN +   +P   SE  +L   +  L     S+P     L+ L   I   N L 
Sbjct: 183 LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLT----SLPALPSGLKEL---IVSGNRLT 234

Query: 334 GKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTR 393
             +P        LK+L+++ N+L+  +P      S L  +S+  N+LT ++P     L+ 
Sbjct: 235 S-LPVLPS---ELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSS 285

Query: 394 LAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNT 453
              + L  N    E   +     +                    R+  A  L        
Sbjct: 286 ETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVP 344

Query: 454 LVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYL 513
                        + G  + A      L ++   ++      +   + S   Q    E L
Sbjct: 345 AREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDEAL 404

Query: 514 DLSYNQFRGKIPDEIGDMIAL-----QVLELAHNQLSGEIPSSLGRLRNLG 559
             +      +      D +       + ++L HN   G+  + L  L   G
Sbjct: 405 RANTFAMATEATSSCEDRVTFFLHQMKNVQLVHNAEKGQYDNDLAALVATG 455

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  139 bits (352), Expect = 2e-34
 Identities = 78/370 (21%), Positives = 125/370 (33%), Gaps = 54/370 (14%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
            +VL +  +  T     L      +  L +    L  L P       P L  L  S N L
Sbjct: 42  NAVLNVGESGLTTLPDCLPA---HITTLVIPDNNLTSL-PALP----PELRTLEVSGNQL 93

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
           T  LP  L     +L +      +L    S           L  L +  N +   +P   
Sbjct: 94  T-SLPV-LPPGLLELSIFSNPLTHLPALPS----------GLCKLWIFGNQLTS-LPVLP 140

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
                L+ L++S N LA  +P    +   L +L   NN +T  +P         L EL +
Sbjct: 141 PG---LQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLTS-LPMLPSG----LQELSV 188

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
             N +  S P   S    L  L   NN ++     S+      L+ LI+S N ++ S P 
Sbjct: 189 SDNQLA-SLPTLPSE---LYKLWAYNNRLT-----SLPALPSGLKELIVSGNRLT-SLPV 238

Query: 242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
             S    L+ +  S NR++  +P       S L  L +  N +T  +P  L   +    +
Sbjct: 239 LPSE---LKELMVSGNRLT-SLPMLP----SGLLSLSVYRNQLT-RLPESLIHLSSETTV 289

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
           +L  N L+    Q L ++     +       +        + + L       + L     
Sbjct: 290 NLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL--AAADWLVPARE 347

Query: 362 AELFSCSNLE 371
            E        
Sbjct: 348 GEPAPADRWH 357

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (332), Expect = 7e-32
 Identities = 75/440 (17%), Positives = 133/440 (30%), Gaps = 122/440 (27%)

Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
            +    L +  + +T + P  L   + +  L + +NN++     S+      L +L +S 
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-----SLPALPPELRTLEVSG 90

Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
           N ++ S P        L I       +  +         S L +L +  N +T  +P   
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHLPALP--------SGLCKLWIFGNQLT-SLPVLP 140

Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILN 352
                L+ + +S N L  S+P                                L  L   
Sbjct: 141 ---PGLQELSVSDNQLA-SLPALPS---------------------------ELCKLWAY 169

Query: 353 NNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
           NN+L+  +P      S L+ +S++ N+L   +P   S L +L      NNR    +P   
Sbjct: 170 NNQLT-SLPMLP---SGLQELSVSDNQLA-SLPTLPSELYKLWAY---NNRLT-SLPALP 220

Query: 413 GNCSSLVWLDLNSNNLTGDIPPRLG--RQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGL 470
                L  L ++ N LT  +P      ++L        +S N                  
Sbjct: 221 SG---LKELIVSGNRLT-SLPVLPSELKEL-------MVSGN------------------ 251

Query: 471 LEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGD 530
                    RL  +P L S                    L  L +  NQ   ++P+ +  
Sbjct: 252 ---------RLTSLPMLPS-------------------GLLSLSVYRNQLT-RLPESLIH 282

Query: 531 MIALQVLELAHNQLSGEIPSSLGRLRNLGVFD---ASHNRLQGQIPESFSNLSFLVQIDL 587
           + +   + L  N LS     +L  + +   +       +      P     L       L
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL 342

Query: 588 SNNELTGPIPQRGQLSTLPA 607
                  P     +      
Sbjct: 343 VPAREGEPA-PADRWHMFGQ 361

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  112 bits (281), Expect = 1e-25
 Identities = 66/339 (19%), Positives = 105/339 (30%), Gaps = 101/339 (29%)

Query: 272 SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNG 331
           +    L + ++ +T  +P  L     +  + +  N L  S+P    +L  LE      N 
Sbjct: 40  NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92

Query: 332 LEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRL 391
           L   +P        L         L           S L  + + GN+LT  +P     L
Sbjct: 93  LT-SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLPPGL 143

Query: 392 TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLG--RQLGAKPLGGFL 449
             L    + +N+    +P        L  L   +N LT  +P      ++L        +
Sbjct: 144 QEL---SVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQELS-------V 188

Query: 450 SSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQT 509
           S N                           +L  +PTL S                    
Sbjct: 189 SDN---------------------------QLASLPTLPS-------------------E 202

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQ 569
           L  L    N+    +P        L+ L ++ N+L+  +P     L+ L     S NRL 
Sbjct: 203 LYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLPVLPSELKEL---MVSGNRLT 254

Query: 570 GQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPAS 608
             +P   S L  L    +  N          QL+ LP S
Sbjct: 255 -SLPMLPSGLLSL---SVYRN----------QLTRLPES 279

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 62.2 bits (151), Expect = 6e-10
 Identities = 34/210 (16%), Positives = 63/210 (30%), Gaps = 65/210 (30%)

Query: 398 QLGNNRFKGEIPGELGNC--SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLV 455
               +R +  +  ++  C  +    L++  + LT  +P  L   +    L   +  N   
Sbjct: 20  PAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPAHI--TTL--VIPDN--- 71

Query: 456 FVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDL 515
                                    L  +P                +L  +   L  L++
Sbjct: 72  ------------------------NLTSLP----------------ALPPE---LRTLEV 88

Query: 516 SYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPES 575
           S NQ    +P     ++ L +       L   +PS L +L          N+L   +P  
Sbjct: 89  SGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKL------WIFGNQLT-SLPVL 139

Query: 576 FSNLSFLVQIDLSNNELTGPIPQRGQLSTL 605
              L  L    +S+N+L        +L  L
Sbjct: 140 PPGLQEL---SVSDNQLASLPALPSELCKL 166

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  159 bits (405), Expect = 3e-43
 Identities = 58/314 (18%), Positives = 118/314 (37%), Gaps = 24/314 (7%)

Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
            +   +L    +  +      LS   +    + +    A          ++ Q    +  
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGR 66

Query: 160 HITGWIPSELGNACD-SLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSV 218
            +       L +A     + L+L    +   FP      S LQ + +    +    PD+ 
Sbjct: 67  ALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDT- 122

Query: 219 LENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDIC--------PG 270
           ++    LE+L L+ N +  + P SI+S   LR +   +      +P  +          G
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181

Query: 271 VSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF-IAWF 329
           + +L+ LRL    I   +P  ++    LK + +  + L+ ++   +  L  LE+  +   
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239

Query: 330 NGLEGKIPPELGKCKNLKDLIL-NNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEF 388
             L    PP  G    LK LIL + + L   +P ++   + LE + L G     ++P   
Sbjct: 240 TALR-NYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297

Query: 389 SRLTRLAVLQLGNN 402
           ++L    ++ +  +
Sbjct: 298 AQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  152 bits (385), Expect = 1e-40
 Identities = 53/343 (15%), Positives = 110/343 (32%), Gaps = 27/343 (7%)

Query: 114 MDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNAC 173
           M        + +  + L    +           Q       D +  H          N  
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQAN-- 54

Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQL--LDLSNNNISGPFPDSVLENLGSLESLILS 231
            +  +++        +    L   +      L+L +  +   FPD     L  L+ + + 
Sbjct: 55  SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQ-AFRLSHLQHMTID 112

Query: 232 NNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL---------RLPDN 282
              +    PD++     L  +  + N +   +P  I   ++ L EL          LP+ 
Sbjct: 113 AAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIA-SLNRLRELSIRACPELTELPEP 169

Query: 283 LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK 342
           L +    G+      L+ + L    +  S+P  +  L++L+      + L   + P +  
Sbjct: 170 LASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227

Query: 343 CKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTG-NELTGQIPPEFSRLTRLAVLQLGN 401
              L++L L         P      + L+ + L   + L   +P +  RLT+L  L L  
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRG 286

Query: 402 NRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKP 444
                 +P  +    +   + +   +L   +         A+P
Sbjct: 287 CVNLSRLPSLIAQLPANCIILV-PPHLQAQLDQHRPVARPAEP 328

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  143 bits (363), Expect = 8e-38
 Identities = 55/348 (15%), Positives = 98/348 (28%), Gaps = 45/348 (12%)

Query: 272 SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNG 331
           S  E L    +         LS+  +    D +                + +        
Sbjct: 12  SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGRA 67

Query: 332 LEGKIPPELGKCK--NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFS 389
           L+      L          L L +  L  + P + F  S+L+ +++    L  ++P    
Sbjct: 68  LK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124

Query: 390 RLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGG-- 447
           +   L  L L  N  +  +P  + + + L  L + +     ++P  L     +    G  
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183

Query: 448 -----FLSSNTLVFVRNVGNSCKGVGGL--LEFAGIRPERLLQIPTLKSCDFARMYSGPV 500
                 L    +  +         +  L  L+   IR   L  +          +     
Sbjct: 184 NLQSLRLEWTGIRSL------PASIANLQNLKSLKIRNSPLSALGP----AIHHLPK--- 230

Query: 501 LSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH-NQLSGEIPSSLGRLRNLG 559
                    LE LDL         P   G    L+ L L   + L   +P  + RL  L 
Sbjct: 231 ---------LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLE 280

Query: 560 VFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPA 607
             D        ++P   + L     I +  +        R      PA
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR--PVARPA 326

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  142 bits (360), Expect = 2e-37
 Identities = 58/366 (15%), Positives = 111/366 (30%), Gaps = 57/366 (15%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLE-LSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
              L          ST+L      L Q +   +A           +   N      +   
Sbjct: 14  RENLYFQ------GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRA 67

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           L         +       L+L    L                               P  
Sbjct: 68  LKATADLLEDATQPGRVALELRSVPLP----------------------------QFPDQ 99

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
               + L+ + +    L  E+P T  Q + L+ L L+ N +   +P+ + +  + L EL 
Sbjct: 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIAS-LNRLRELS 156

Query: 181 LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
           +         P  L+S                       + L +L+SL L    I  S P
Sbjct: 157 IRACPELTELPEPLASTDASG----------------EHQGLVNLQSLRLEWTGIR-SLP 199

Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
            SI++ + L+ +   ++ +S  + P I   +  LEEL L         P        LK 
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIH-HLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257

Query: 301 IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
           + L       ++P ++ +L  LE+          ++P  + +      +++  +  +   
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317

Query: 361 PAELFS 366
                +
Sbjct: 318 QHRPVA 323

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  115 bits (290), Expect = 4e-28
 Identities = 45/316 (14%), Positives = 85/316 (26%), Gaps = 56/316 (17%)

Query: 295 CTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNN 354
            +  + +    +         L + +                        N +       
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 355 KLSGEIPAELFSCS--NLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
            L       L   +      + L    L  Q P +  RL+ L  + +       E+P  +
Sbjct: 67  ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123

Query: 413 GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLE 472
              + L  L L  N L   +P  +            L+   L  +               
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIAS----------LNR--LRELSIRACP--------- 161

Query: 473 FAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI 532
                   L ++P         + S            L+ L L +   R  +P  I ++ 
Sbjct: 162 -------ELTELP-------EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQ 206

Query: 533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
            L+ L++ ++ LS  +  ++  L  L   D          P  F   + L ++ L +   
Sbjct: 207 NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS- 264

Query: 593 TGPIPQRGQLSTLPAS 608
                    L TLP  
Sbjct: 265 --------NLLTLPLD 272

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  154 bits (392), Expect = 1e-41
 Identities = 71/338 (21%), Positives = 135/338 (39%), Gaps = 50/338 (14%)

Query: 76  LELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFN 135
           L ++  S   L        + ++       LDL  N I ++      N   L  L L  N
Sbjct: 33  LRVVQCSDLGLE------KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86

Query: 136 LLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLS 195
            ++   P  F  L  L+RL LS N +   +P ++     +L EL++  N IT       +
Sbjct: 87  KISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM---PKTLQELRVHENEITKVRKSVFN 142

Query: 196 SCSWLQLLDLSNNNI-SGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDF 254
             + + +++L  N + S    +   + +  L  + +++  I+ + P  +    +L  +  
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHL 199

Query: 255 SSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQ 314
             N+++  +      G+++L +L L  N I+ V  G L+    L+ + L+ N L      
Sbjct: 200 DGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV----- 253

Query: 315 ELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-------SC 367
                               K+P  L   K ++ + L+NN +S  I +  F         
Sbjct: 254 --------------------KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKK 292

Query: 368 SNLEWISLTGNELT-GQIPPE-FSRLTRLAVLQLGNNR 403
           ++   +SL  N +   +I P  F  +   A +QLGN +
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  142 bits (360), Expect = 3e-37
 Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 25/291 (8%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            ++L L +N  T +       L   L  L L +  +   +    F+ L  L  L  S N 
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQ 111

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVI--P 118
           L   LPE +      L+ L +  N +T  +     N    N ++ ++L  N +       
Sbjct: 112 LKE-LPEKMPKT---LQELRVHENEIT-KVRKSVFNG--LNQMIVVELGTNPLKSSGIEN 164

Query: 119 SSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLE 178
            +     KL  + ++   +   IP+  G   SL  L L  N IT  + +      ++L +
Sbjct: 165 GAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITK-VDAASLKGLNNLAK 220

Query: 179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS-- 236
           L L  N+I+     +L++   L+ L L+NN +        L +   ++ + L NN IS  
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV--KVPGGLADHKYIQVVYLHNNNISAI 278

Query: 237 --GSF--PDSISSCKTLRIVDFSSNRVSGI-IPPDICPGVSSLEELRLPDN 282
               F  P   +   +   V   SN V    I P     V     ++L + 
Sbjct: 279 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  125 bits (316), Expect = 2e-31
 Identities = 80/364 (21%), Positives = 129/364 (35%), Gaps = 78/364 (21%)

Query: 183 HNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDS 242
              +    P  L       LLDL NN I+    D   +NL +L +LIL NN IS   P +
Sbjct: 40  DLGLE-KVPKDLPP--DTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGA 95

Query: 243 ISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVID 302
            +    L  +  S N++  +  P+  P   +L+ELR+ +N IT V     +   Q+ V++
Sbjct: 96  FAPLVKLERLYLSKNQLKEL--PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVE 151

Query: 303 LSLNYL-NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
           L  N L +  I                F G+           K L  + + +  ++  IP
Sbjct: 152 LGTNPLKSSGIENG------------AFQGM-----------KKLSYIRIADTNIT-TIP 187

Query: 362 AELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
             L    +L  + L GN++T ++       L  LA L L  N       G L N   L  
Sbjct: 188 QGLPP--SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 244

Query: 421 LDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
           L LN+N L   +P  L      + +  +L +N                            
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQVV--YLHNN---------------------------- 273

Query: 481 LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFR-GKIPDEI-GDMIALQVLE 538
              I  + S DF            T+  +   + L  N  +  +I       +     ++
Sbjct: 274 --NISAIGSNDFCP------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325

Query: 539 LAHN 542
           L + 
Sbjct: 326 LGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  116 bits (292), Expect = 2e-28
 Identities = 67/368 (18%), Positives = 120/368 (32%), Gaps = 89/368 (24%)

Query: 249 LRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL 308
           LR+V  S   +  + P D+ P       L L +N IT +  G       L  + L  N +
Sbjct: 33  LRVVQCSDLGLEKV-PKDL-P--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 309 NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCS 368
           +  I                F  L             L+ L L+ N+L  E+P ++    
Sbjct: 89  S-KISPGA------------FAPL-----------VKLERLYLSKNQLK-ELPEKMPK-- 121

Query: 369 NLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEI--PGELGNCSSLVWLDLNS 425
            L+ + +  NE+T ++    F+ L ++ V++LG N  K      G       L ++ +  
Sbjct: 122 TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180

Query: 426 NNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIP 485
            N+T  IP  L   L    L   L  N                              +I 
Sbjct: 181 TNIT-TIPQGLPPSL--TEL--HLDGN------------------------------KIT 205

Query: 486 TLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLS 545
            + +     + +            L  L LS+N         + +   L+ L L +N+L 
Sbjct: 206 KVDAASLKGLNN------------LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253

Query: 546 GEIPSSLGRLRNLGVFDASHNRLQG------QIPESFSNLSFLVQIDLSNNELTGPIPQR 599
            ++P  L   + + V    +N +          P   +  +    + L +N +     Q 
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312

Query: 600 GQLSTLPA 607
                +  
Sbjct: 313 STFRCVYV 320

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 44/235 (18%), Positives = 85/235 (36%), Gaps = 38/235 (16%)

Query: 365 FSCS-NLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL 423
           F C  +L  +  +   L  ++P +    T   +L L NN+      G+  N  +L  L L
Sbjct: 27  FRCQCHLRVVQCSDLGLE-KVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLIL 83

Query: 424 NSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLL 482
            +N ++  I P     L   + L  +LS N L  +            +     ++  R+ 
Sbjct: 84  INNKIS-KISPGAFAPLVKLERL--YLSKNQLKELPE---------KM--PKTLQELRVH 129

Query: 483 --QIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFR-GKIPDEI-GDMIALQVLE 538
             +I  ++   F  +              +  ++L  N  +   I +     M  L  + 
Sbjct: 130 ENEITKVRKSVFNGLNQ------------MIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177

Query: 539 LAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
           +A   ++  IP  L    +L       N++      S   L+ L ++ LS N ++
Sbjct: 178 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 5/108 (4%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEI-GDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFD 562
           F   + L  L L  N+   KI       ++ L+ L L+ NQL  E+P  +   + L    
Sbjct: 72  FKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELR 127

Query: 563 ASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQY 610
              N +       F+ L+ ++ ++L  N L     + G    +    Y
Sbjct: 128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 175

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  155 bits (393), Expect = 2e-40
 Identities = 89/434 (20%), Positives = 152/434 (35%), Gaps = 68/434 (15%)

Query: 17  TSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKL 76
             + +LP  +  ++LS   +  L  +  FS+L +L +L          +          L
Sbjct: 23  HQVPELPAHVNYVDLSLNSIAEL-NETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 77  ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVI--PSSLSNCTKLKILNLSF 134
            +L L YN     +   +   N   +L  L L+Q ++   +   +     T L++L L  
Sbjct: 82  IILKLDYNQFL-QLETGAF--NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138

Query: 135 NLLAGEIPRT-FGQLSSLQRLDLSNNHITGWIPSE--LGNACDSLLELKLPHNNITGSFP 191
           N +    P + F  +     LDL+ N +   I  E  L         L+L    +     
Sbjct: 139 NNIKKIQPASFFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLRLSSITLQDMNE 197

Query: 192 VTLSS--------CSWLQLLDLSNNNISGPFPDSV--LENLGSLESLILSNNMISGSFPD 241
             L           + +  LDLS N                  ++SLILSN+   GS   
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257

Query: 242 SIS------------SCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIP 289
             +                ++  D S +++   +   +    + LE+L L  N I  +  
Sbjct: 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDD 316

Query: 290 GQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDL 349
                 T L  ++LS N+L GSI   +            F  L             L+ L
Sbjct: 317 NAFWGLTHLLKLNLSQNFL-GSIDSRM------------FENL-----------DKLEVL 352

Query: 350 ILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGE 407
            L+ N +   +  + F    NL+ ++L  N+L   +P   F RLT L  + L  N +   
Sbjct: 353 DLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 410

Query: 408 IPGELGNCSSLVWL 421
                  C  + +L
Sbjct: 411 -------CPRIDYL 417

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  132 bits (334), Expect = 5e-33
 Identities = 68/334 (20%), Positives = 120/334 (35%), Gaps = 32/334 (9%)

Query: 125 TKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHN 184
             +  ++LS N +A     +F +L  LQ L +        I +       SL+ LKL +N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 185 NITGSFPVTLSSCSWLQLLDLSNNNISGPF-PDSVLENLGSLESLILSNNMISGSFPDSI 243
                     +  + L++L L+  N+ G     +  + L SLE L+L +N I    P S 
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 244 -SSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL----------PDNLITGVIPGQL 292
             + +   ++D + N+V   I  +            L           +  +     G  
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCK-------- 344
            + T +  +DLS N    S+ +         +  +        +    G           
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268

Query: 345 -------NLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTRLA 395
                   +K   L+ +K+   +   +FS  ++LE ++L  NE+  +I    F  LT L 
Sbjct: 269 FKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLL 326

Query: 396 VLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
            L L  N           N   L  LDL+ N++ 
Sbjct: 327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  124 bits (312), Expect = 4e-30
 Identities = 84/413 (20%), Positives = 141/413 (34%), Gaps = 53/413 (12%)

Query: 224 SLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNL 283
            +  + LS N I+     S S  + L+ +         +I  +   G+SSL  L+L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 284 ITGVIPGQLSECTQLKVIDLSLNYLNGS-IPQELGKLEHLEQFIAWFNGLEGKIPPELGK 342
              +  G  +    L+V+ L+   L+G+ +                F  L          
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNF------------FKPL---------- 128

Query: 343 CKNLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLG 400
             +L+ L+L +N +    PA  F +      + LT N++   I  E            L 
Sbjct: 129 -TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLR 186

Query: 401 ----------NNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGG-FL 449
                           E  G     +S+  LDL+ N     +  R    +    +    L
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246

Query: 450 SSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQT 509
           S++  +       + K       F G+    +     L       +       +F+ +  
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFT-FKGLEASGVKTC-DLSKSKIFALLKS----VFSHFTD 300

Query: 510 LEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRL 568
           LE L L+ N+   KI D     +  L  L L+ N L          L  L V D S+N +
Sbjct: 301 LEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359

Query: 569 QGQIPE-SFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQY---ANNPGLC 617
           +  + + SF  L  L ++ L  N+L   +P  G    L + Q      NP  C
Sbjct: 360 R-ALGDQSFLGLPNLKELALDTNQLKS-VP-DGIFDRLTSLQKIWLHTNPWDC 409

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  113 bits (284), Expect = 2e-26
 Identities = 77/433 (17%), Positives = 135/433 (31%), Gaps = 81/433 (18%)

Query: 178 ELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG 237
            + L  N+I      + S    LQ L +          ++    L SL  L L  N    
Sbjct: 34  YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ 93

Query: 238 SFPDSISSCKTLRIVDFSSNRV-SGIIPPDICPGVSSLEELRLPDNLITGVIPGQL-SEC 295
               + +    L ++  +   +   ++  +    ++SLE L L DN I  + P       
Sbjct: 94  LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM 153

Query: 296 TQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNK 355
            +  V+DL+ N +  SI +E                 +GK    L          +N   
Sbjct: 154 RRFHVLDLTFNKVK-SICEED------------LLNFQGKHFTLLRLSSI-TLQDMNEYW 199

Query: 356 LSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQ-------------LGNN 402
           L  E     F  +++  + L+GN     +   F        +Q              G+ 
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259

Query: 403 RFKGEIPGELGN--CSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRN 459
            FK            S +   DL+ + +   +   +       + L   L+ N       
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL--TLAQN------- 309

Query: 460 VGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ 519
                                  +I  +    F  +              L  L+LS N 
Sbjct: 310 -----------------------EINKIDDNAFWGLTH------------LLKLNLSQNF 334

Query: 520 FRGKIPDEIGD-MIALQVLELAHNQLSGEIPS-SLGRLRNLGVFDASHNRLQGQIPESFS 577
             G I   + + +  L+VL+L++N +   +   S   L NL       N+L+      F 
Sbjct: 335 L-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFD 392

Query: 578 NLSFLVQIDLSNN 590
            L+ L +I L  N
Sbjct: 393 RLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 89.4 bits (222), Expect = 1e-18
 Identities = 51/276 (18%), Positives = 79/276 (28%), Gaps = 70/276 (25%)

Query: 2   LSVLKLSSNLFT---------LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLV 52
             VL L+ N                    L      L+  +   +G        K  ++ 
Sbjct: 156 FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215

Query: 53  YLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENS-----------CN 101
            L+ S N     + +         ++  L  +N     S F                  +
Sbjct: 216 TLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS 275

Query: 102 SLLHLDLSQNHIMDV---IPSSLSN---------------------CTKLKILNLSFNLL 137
            +   DLS++ I  +   + S  ++                      T L  LNLS N L
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335

Query: 138 AGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSC 197
                R F  L  L+ LDLS NHI                   L           +    
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHIRA-----------------LGDQ--------SFLGL 370

Query: 198 SWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
             L+ L L  N +    PD + + L SL+ + L  N
Sbjct: 371 PNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.0 bits (143), Expect = 4e-09
 Identities = 39/246 (15%), Positives = 71/246 (28%), Gaps = 58/246 (23%)

Query: 368 SNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNS 425
           +++ ++ L+ N +  ++    FSRL  L  L++        I        SSL+ L L+ 
Sbjct: 30  AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 426 NNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQI 484
           N     +       L   + L   L+   L                             +
Sbjct: 89  NQFL-QLETGAFNGLANLEVL--TLTQCNL-------------------------DGAVL 120

Query: 485 PTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQ 543
                            + F    +LE L L  N  +   P      M    VL+L  N+
Sbjct: 121 SG---------------NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165

Query: 544 LSGEIPSSLGRLRNLGV----------FDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
           +       L   +               D +   L  +   +    + +  +DLS N   
Sbjct: 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225

Query: 594 GPIPQR 599
             + +R
Sbjct: 226 ESMAKR 231

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.9 bits (109), Expect = 6e-05
 Identities = 35/230 (15%), Positives = 58/230 (25%), Gaps = 48/230 (20%)

Query: 392 TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLS 450
             +  + L  N               L +L +        I     R L +   L   L 
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL--KLD 87

Query: 451 SNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTL 510
            N                           + LQ+ T                 F     L
Sbjct: 88  YN---------------------------QFLQLET---------------GAFNGLANL 105

Query: 511 EYLDLSYNQFRG-KIPDEI-GDMIALQVLELAHNQLSGEIPSSL-GRLRNLGVFDASHNR 567
           E L L+     G  +       + +L++L L  N +    P+S    +R   V D + N+
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165

Query: 568 LQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLC 617
           ++    E   N        L  + +T        L          N  + 
Sbjct: 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  151 bits (384), Expect = 5e-40
 Identities = 67/282 (23%), Positives = 112/282 (39%), Gaps = 49/282 (17%)

Query: 742  IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPLLGYC 799
            IG G FGEVF   L+  +  VA+K          + +F+ E   L +  H N+V L+G C
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
               +   +V E ++ G     L           L      ++   AA G+ +L       
Sbjct: 182  TQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGMEYLESK---C 233

Query: 860  IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----PEYYQ 914
             IHRD+ + N L+  +   ++SDFGM+R  +       V   +G    VP     PE   
Sbjct: 234  CIHRDLAARNCLVTEKNVLKISDFGMSREEAD-----GVYAASGGLRQVPVKWTAPEALN 288

Query: 915  SFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID--PE 971
              R +++ DV+SFG++L E  + G  P        +N     +  V +G ++   +  P+
Sbjct: 289  YGRYSSESDVWSFGILLWETFSLGASPYP----NLSNQQ--TREFVEKGGRLPCPELCPD 342

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
             +                   +  +  QC    P +RP+   
Sbjct: 343  AV-------------------F-RLMEQCWAYEPGQRPSFST 364

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  142 bits (361), Expect = 2e-37
 Identities = 70/313 (22%), Positives = 121/313 (38%), Gaps = 26/313 (8%)

Query: 102 SLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHI 161
            L  +  S   +   +P  +S      +L+L  N ++      F  L  L  L L NN I
Sbjct: 34  HLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 162 TGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLEN 221
           +  I  +  +    L +L +  N++    P   SS   L  L + +N I    P  V   
Sbjct: 91  SK-IHEKAFSPLRKLQKLYISKNHLVEIPPNLPSS---LVELRIHDNRIRK-VPKGVFSG 145

Query: 222 LGSLESLILSNNMI-SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLP 280
           L ++  + +  N + +  F         L  +  S  +++G IP D+     +L EL L 
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL---PETLNELHLD 201

Query: 281 DNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQE-LGKLEHLEQFIAWFNGLEGKIPPE 339
            N I  +    L   ++L  + L  N +   I    L  L  L +     N L  ++P  
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAG 259

Query: 340 LGKCKNLKDLILNNNKLSGEIPAELFS-------CSNLEWISLTGNELT-GQIPPE-FSR 390
           L   K L+ + L+ N ++ ++    F         +    ISL  N +   ++ P  F  
Sbjct: 260 LPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

Query: 391 LTRLAVLQLGNNR 403
           +T    +Q GN +
Sbjct: 319 VTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  133 bits (336), Expect = 4e-34
 Identities = 64/290 (22%), Positives = 106/290 (36%), Gaps = 24/290 (8%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
            ++L L +N  + L       L   L  L L +  +   + +  FS L  L  L  S N+
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQ-HLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNH 113

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPS 119
           L   +P  L S+   L  L +  N +   +     +     ++  +++  N + +     
Sbjct: 114 LVE-IPPNLPSS---LVELRIHDNRIR-KVPKGVFSG--LRNMNCIEMGGNPLENSGFEP 166

Query: 120 SLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL 179
              +  KL  L +S   L   IP+      +L  L L +N I   I  E       L  L
Sbjct: 167 GAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222

Query: 180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS--- 236
            L HN I      +LS    L+ L L NN +S   P + L +L  L+ + L  N I+   
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VP-AGLPDLKLLQVVYLHTNNITKVG 280

Query: 237 -GSFPDSISSCKT--LRIVDFSSNRVSGI-IPPDICPGVSSLEELRLPDN 282
              F       K      +   +N V    + P     V+    ++  + 
Sbjct: 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  128 bits (325), Expect = 1e-32
 Identities = 75/362 (20%), Positives = 126/362 (34%), Gaps = 86/362 (23%)

Query: 76  LELLDLSYNNLTGSI-SGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSF 134
           L ++  S   L  ++    S +         LDL  N I ++          L  L L  
Sbjct: 35  LRVVQCSDLGLK-AVPKEISPD------TTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87

Query: 135 NLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTL 194
           N ++    + F  L  LQ+L +S NH+   IP  L     SL+EL++  N I        
Sbjct: 88  NKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL---PSSLVELRIHDNRIRKVPKGVF 143

Query: 195 SSCSWLQLLDLSNNNI-SGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVD 253
           S    +  +++  N + +  F     + L  L  L +S   ++G                
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG---------------- 186

Query: 254 FSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP 313
                    IP D+     +L EL L  N I  +    L   ++L  + L  N       
Sbjct: 187 ---------IPKDL---PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN------- 227

Query: 314 QELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWI 373
               ++  +E      + L             L++L L+NNKLS  +PA L     L+ +
Sbjct: 228 ----QIRMIENGS--LSFL-----------PTLRELHLDNNKLS-RVPAGLPDLKLLQVV 269

Query: 374 SLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT-GDI 432
            L  N +T                ++G N F     G     +    + L +N +   ++
Sbjct: 270 YLHTNNIT----------------KVGVNDFCP--VGFGVKRAYYNGISLFNNPVPYWEV 311

Query: 433 PP 434
            P
Sbjct: 312 QP 313

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  107 bits (269), Expect = 2e-25
 Identities = 73/377 (19%), Positives = 120/377 (31%), Gaps = 93/377 (24%)

Query: 249 LRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL 308
           LR+V  S   +  +  P           L L +N I+ +          L  + L  N +
Sbjct: 35  LRVVQCSDLGLKAV--PKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 309 NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCS 368
           +  I ++             F+ L           + L+ L ++ N L  EIP  L S  
Sbjct: 91  S-KIHEKA------------FSPL-----------RKLQKLYISKNHLV-EIPPNLPS-- 123

Query: 369 NLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFK-GEIPGELGNCSSLVWLDLNSN 426
           +L  + +  N +  ++P   FS L  +  +++G N  +         +   L +L ++  
Sbjct: 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182

Query: 427 NLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPT 486
            LT  IP  L   L           N L    N                       +I  
Sbjct: 183 KLT-GIPKDLPETL-----------NELHLDHN-----------------------KIQA 207

Query: 487 LKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI-GDMIALQVLELAHNQLS 545
           ++  D  R               L  L L +NQ R  I +     +  L+ L L +N+LS
Sbjct: 208 IELEDLLRYSK------------LYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254

Query: 546 GEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSF------LVQIDLSNNELTGPIPQR 599
             +P+ L  L+ L V     N +       F  + F         I L NN +     Q 
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313

Query: 600 GQLSTLPASQY---ANN 613
                +         N 
Sbjct: 314 ATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 45/235 (19%), Positives = 82/235 (34%), Gaps = 39/235 (16%)

Query: 365 FSCS-NLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL 423
           F C  +L  +  +   L   +P E S  T L  L L NN        +      L  L L
Sbjct: 29  FGCHCHLRVVQCSDLGLK-AVPKEISPDTTL--LDLQNNDISELRKDDFKGLQHLYALVL 85

Query: 424 NSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLL 482
            +N ++  I  +    L   + L  ++S N LV +            L   + +   R+ 
Sbjct: 86  VNNKIS-KIHEKAFSPLRKLQKL--YISKNHLVEIPP---------NL--PSSLVELRIH 131

Query: 483 --QIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFR-GKIPDEIGDMIALQVLEL 539
             +I  +    F+ + +            +  +++  N            D + L  L +
Sbjct: 132 DNRIRKVPKGVFSGLRN------------MNCIEMGGNPLENSGFEPGAFDGLKLNYLRI 179

Query: 540 AHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE-SFSNLSFLVQIDLSNNELT 593
           +  +L+  IP  L     L      HN++Q  I        S L ++ L +N++ 
Sbjct: 180 SEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR 230

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  146 bits (370), Expect = 3e-37
 Identities = 102/556 (18%), Positives = 180/556 (32%), Gaps = 97/556 (17%)

Query: 40  VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISG-FSLNEN 98
           VP +L         LN S N ++  L  + + +  KL +L +S+N +       F  N+ 
Sbjct: 15  VPKDLSQ---KTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQE 70

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRT--FGQLSSLQRLDL 156
               L +LDLS N ++ +          LK L+LSFN     +P    FG +S L+ L L
Sbjct: 71  ----LEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGL 122

Query: 157 SNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQL-LDLSNNNISGPFP 215
           S  H+       + +   S + L L         P  L   +   L +    N       
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182

Query: 216 DSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLE 275
           D  ++ + +LE   +   +        +S    L+     SN               +L 
Sbjct: 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN--------------LTLN 228

Query: 276 ELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGK 335
            +    N    ++  QL   T +    +S   L G +            F      L   
Sbjct: 229 NIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQL--------DFRDFDYSGTSL--- 275

Query: 336 IPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLA 395
                   K L    + ++             SN+   + T +          S+++   
Sbjct: 276 --------KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327

Query: 396 VLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGF-LSSNTL 454
            L   NN     +    G+ + L  L L  N L  ++          K L    +S N++
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSV 386

Query: 455 VFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLD 514
            +    G+                                          +  ++L  L+
Sbjct: 387 SYDEKKGD-----------------------------------------CSWTKSLLSLN 405

Query: 515 LSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE 574
           +S N     I   +     ++VL+L  N++   IP  + +L  L   + + N+L+     
Sbjct: 406 MSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDG 462

Query: 575 SFSNLSFLVQIDLSNN 590
            F  L+ L +I L  N
Sbjct: 463 IFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  131 bits (330), Expect = 4e-32
 Identities = 75/443 (16%), Positives = 156/443 (35%), Gaps = 49/443 (11%)

Query: 2   LSVLKLSSN-LFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           L  L LS N L  ++    + L    K L+LS      L     F  +  L +L  S  +
Sbjct: 71  LEYLDLSHNKLVKISCHPTVNL----KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH 126

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
           L        +++ +  ++L +             L + +  SL  +  +      ++  S
Sbjct: 127 LEK-SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVS 185

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQR------LDLSNNHITGWIPSELGNACD 174
           +     L++ N+   L   +       L+ LQ       L L+N   T      +     
Sbjct: 186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVW 245

Query: 175 --SLLELKLPHNNITG-----SFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLES 227
             ++    + +  + G      F  + +S   L +  + ++    P    + E   ++  
Sbjct: 246 HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP-QSYIYEIFSNMNI 304

Query: 228 LILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV 287
              + +          S       +DFS+N ++     + C  ++ LE L L  N +  +
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD-TVFENCGHLTELETLILQMNQLKEL 363

Query: 288 --IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKN 345
             I    ++   L+ +D+S N ++    +               +             K+
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGD------------CSWT-----------KS 400

Query: 346 LKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK 405
           L  L +++N L+  I   L     ++ + L  N++   IP +  +L  L  L + +N+ K
Sbjct: 401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457

Query: 406 GEIPGELGNCSSLVWLDLNSNNL 428
               G     +SL  + L++N  
Sbjct: 458 SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  130 bits (328), Expect = 8e-32
 Identities = 77/426 (18%), Positives = 148/426 (34%), Gaps = 28/426 (6%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           L      L +S   +  L   +    L  L  L  S+N +   L  ++   + +LE LDL
Sbjct: 19  LSQKTTILNISQNYISEL-WTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDL 76

Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPSSLSNCTKLKILNLSFNLLAGE 140
           S+N L        ++ +   +L HLDLS N    + I     N ++LK L LS   L   
Sbjct: 77  SHNKLV------KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS 130

Query: 141 IPRTFGQLSSLQ-RLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFP----VTLS 195
                  L+  +  L L   +     P  L +     L +  P N            T++
Sbjct: 131 SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVA 190

Query: 196 SCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSIS-----SCKTLR 250
           +     +  +  +N    F   + +   + +   L+ N I  ++   I         T+ 
Sbjct: 191 NLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVW 250

Query: 251 IVDFSSNRVSGII----PPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLN 306
               S+ ++ G +           + +L   ++  ++            + + + + +++
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310

Query: 307 YLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG-EIPAELF 365
                      K+          N L   +    G    L+ LIL  N+L      AE+ 
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370

Query: 366 SC-SNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL 423
           +   +L+ + ++ N ++        S    L  L + +N     I   L     +  LDL
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDL 428

Query: 424 NSNNLT 429
           +SN + 
Sbjct: 429 HSNKIK 434

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 93.8 bits (233), Expect = 6e-20
 Identities = 62/395 (15%), Positives = 118/395 (29%), Gaps = 40/395 (10%)

Query: 202 LLDLSNNNISGPFPDSVLENL-GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVS 260
           L+D S N +       V ++L      L +S N IS  +   I S   LRI+  S NR+ 
Sbjct: 4   LVDRSKNGLI-----HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ 58

Query: 261 GIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLE 320
            +    +      LE L L  N +  +          LK +DLS N  + ++P       
Sbjct: 59  YL-DISVFKFNQELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFD-ALP------- 106

Query: 321 HLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNEL 380
                          I  E G    LK L L+   L       +   +  + + + G   
Sbjct: 107 ---------------ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151

Query: 381 TGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQL 440
             +  PE   L       L       +    + + S     +L  +N+   +        
Sbjct: 152 GEKEDPEG--LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYF 209

Query: 441 GAKPLGGFLSSNTLVF-VRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGP 499
            +       +       + N+  +      +L+         +   ++ +          
Sbjct: 210 LSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT---VWYFSISNVKLQGQLDFR 266

Query: 500 VLSL-FTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNL 558
                 T  + L    +  + F             + +     +           ++   
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326

Query: 559 GVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
              D S+N L   + E+  +L+ L  + L  N+L 
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 58.3 bits (141), Expect = 7e-09
 Identities = 23/98 (23%), Positives = 38/98 (38%), Gaps = 4/98 (4%)

Query: 509 TLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRL 568
               L++S N        +I  +  L++L ++HN++     S     + L   D SHN+L
Sbjct: 22  KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81

Query: 569 QGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLP 606
                    NL  L   DLS N     +P   +   + 
Sbjct: 82  VKISCHPTVNLKHL---DLSFNAFDA-LPICKEFGNMS 115

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  139 bits (352), Expect = 1e-36
 Identities = 66/278 (23%), Positives = 113/278 (40%), Gaps = 44/278 (15%)

Query: 741  LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLL 796
             IG G F  V+K    +    VA  + ++       E   F  E E L  ++H N+V   
Sbjct: 33   EIGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 797  GYCKI---GEERLLVY-EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
               +    G++ +++  E M  G+L+  L      +  +++     +   R   KGL FL
Sbjct: 92   DSWESTVKGKKCIVLVTELMTSGTLKTYL------KRFKVMKIKVLRSWCRQILKGLQFL 145

Query: 853  HHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            H    P IIHRD+K  N+ +       ++ D G+A L  A         + GTP ++ PE
Sbjct: 146  H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPE 200

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE 971
             Y+  +     DVY+FG+ +LE+ T + P     + +      +  +V  G +       
Sbjct: 201  MYEE-KYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASF--- 251

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
                    D+    EVKE++        C+     +R 
Sbjct: 252  --------DKVAIPEVKEIIE------GCIRQNKDERY 275

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (348), Expect = 2e-36
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     K    VA+K + +     + EF  E +T+ K+ H  LV   G C  
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
                +V E++  G L   L    K  +   L      ++     +G+ FL  +     I
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL-----EMCYDVCEGMAFLESH---QFI 126

Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV---PPE--YYQSF 916
           HRD+ + N L+D ++  +VSDFGM R +  LD     S     P  V    PE  +Y  +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFP--VKWSAPEVFHYFKY 182

Query: 917 RCTAKGDVYSFGVVLLELLT-GKRP 940
             ++K DV++FG+++ E+ + GK P
Sbjct: 183 --SSKSDVWAFGILMWEVFSLGKMP 205

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  137 bits (347), Expect = 3e-36
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG V      +   VAIK + R     + +F+ E E + K+ H  LV L G C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
                LV EFM+ G L + L  +        L       +     +G+ +L       +I
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL-----GMCLDVCEGMAYLEEA---CVI 126

Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV---PPE--YYQSF 916
           HRD+ + N L+      +VSDFGM R +  LD   + ST    P  V    PE   +  +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFP--VKWASPEVFSFSRY 182

Query: 917 RCTAKGDVYSFGVVLLELLT-GKRP 940
             ++K DV+SFGV++ E+ + GK P
Sbjct: 183 --SSKSDVWSFGVLMWEVFSEGKIP 205

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  143 bits (363), Expect = 4e-36
 Identities = 88/506 (17%), Positives = 167/506 (33%), Gaps = 41/506 (8%)

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSN 158
           S      +D S  ++  V P  L    + K L+LS N ++         LS L+ L LS+
Sbjct: 29  SNELESMVDYSNRNLTHV-PKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSH 85

Query: 159 NHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSV 218
           N I   +   +      L  L + HN +       ++S   L+ LDLS N+         
Sbjct: 86  NRIRS-LDFHVFLFNQDLEYLDVSHNRLQNISCCPMAS---LRHLDLSFNDFDVLPVCKE 141

Query: 219 LENLGSLESLILSNNMISGSFPDSISSCKTLRI-VDFSSNRVSGIIPPDICPGVSSLEEL 277
             NL  L  L LS           ++      I +D  S  + G     +    +++  L
Sbjct: 142 FGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201

Query: 278 RL-PDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQEL-------GKLEHLEQFIAWF 329
              P++L +  +   ++    L++ ++ LN  N                L ++       
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261

Query: 330 NGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSN-----LEWISLTGNELTGQI 384
                    +    + ++ L + N  ++  I  E F+ S      L    +         
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321

Query: 385 PPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKP 444
              +S    + +  L  +           + SS  +L+   N  T               
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT------------DSV 369

Query: 445 LGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLF 504
             G  +   L  +    N  K    +         + +            + S       
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKNFFKV-----ALMTKNMSSLETLDVSLNSLNSHAYDRTC 424

Query: 505 TQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDAS 564
              +++  L+LS N   G +   +     ++VL+L +N++   IP  +  L+ L   + +
Sbjct: 425 AWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVA 481

Query: 565 HNRLQGQIPESFSNLSFLVQIDLSNN 590
            N+L+      F  L+ L  I L +N
Sbjct: 482 SNQLKSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  118 bits (298), Expect = 7e-28
 Identities = 86/438 (19%), Positives = 148/438 (33%), Gaps = 54/438 (12%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           LP   K L LS   +  L   +  S L  L  L  S+N +   L   +   +  LE LD+
Sbjct: 50  LPPRTKALSLSQNSISELRMPD-ISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107

Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS--LSNCTKLKILNLSFNLLAG 139
           S+N L  +IS   +      SL HLDLS N   DV+P      N TKL  L LS      
Sbjct: 108 SHNRLQ-NISCCPMA-----SLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGLSAAKFRQ 160

Query: 140 EIPRTFGQLS-SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNN-ITGSFPVTLSSC 197
                   L  S   LDL + HI G     L     ++L L    N+  +    +++++ 
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220

Query: 198 SWLQLLDLSNNNISGPFPDSVLENL---GSLESLILSNNMISGSFPDSISSC------KT 248
             LQL ++  N+ +     + L  L    +L ++ L +   +      +         + 
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280

Query: 249 LRIVDFSSNRVSGIIPPDICPG-VSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNY 307
           L I + +                + SL    + + +         S   ++ +  LS++ 
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340

Query: 308 LNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSC 367
                        H+                      +   L    N  + +   +  S 
Sbjct: 341 T---------PFIHMVCP---------------PSPSSFTFLNFTQNVFT-DSVFQGCST 375

Query: 368 -SNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK----GEIPGELGNCSSLVWLD 422
              L+ + L  N L             ++ L+  +                   S++ L+
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434

Query: 423 LNSNNLTGDIPPRLGRQL 440
           L+SN LTG +   L  ++
Sbjct: 435 LSSNMLTGSVFRCLPPKV 452

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  118 bits (296), Expect = 1e-27
 Identities = 82/464 (17%), Positives = 156/464 (33%), Gaps = 71/464 (15%)

Query: 2   LSVLKLSSNLFT-----------------LNSTSLLQLPFG----LKQLELSSAGLVGLV 40
           L VL+LS N                    ++   L  +       L+ L+LS      L 
Sbjct: 78  LRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLP 137

Query: 41  PDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSC 100
               F  L  L +L  S           +        LLDL   ++ G  +      N+ 
Sbjct: 138 VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT- 196

Query: 101 NSLLHLDLSQNHIMDVIPS-SLSNCTKLKILNLSFNLLAGEIPRTF----GQLSSLQRLD 155
            ++LHL    N +  V  + S++    L++ N+  N    +   TF     +  +L  + 
Sbjct: 197 -TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255

Query: 156 LSNNHITGWIPSELGNA--CDSLLELKLPHNNITG-----SFPVTLSSCSWLQLLDLSNN 208
           L +   T     +L        +  L + +  IT       F  + ++   L +  + N 
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315

Query: 209 NISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDIC 268
                  +++      +   +LS +           S  +   ++F+ N  +       C
Sbjct: 316 VFL-FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD-SVFQGC 373

Query: 269 PGVSSLEELRLPDNLITGV--IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFI 326
             +  L+ L L  N +     +       + L+ +D+SLN LN                 
Sbjct: 374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA------ 427

Query: 327 AWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSC--SNLEWISLTGNELTGQI 384
                            +++  L L++N L       +F C    ++ + L  N +   I
Sbjct: 428 -----------------ESILVLNLSSNML----TGSVFRCLPPKVKVLDLHNNRIM-SI 465

Query: 385 PPEFSRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNSNN 427
           P + + L  L  L + +N+ K  +P G     +SL ++ L+ N 
Sbjct: 466 PKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 79.9 bits (197), Expect = 2e-15
 Identities = 63/443 (14%), Positives = 122/443 (27%), Gaps = 64/443 (14%)

Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
            +    +   + N+T   P  L      + L LS N+IS       +  L  L  L LS+
Sbjct: 30  NELESMVDYSNRNLT-HVPKDLPPR--TKALSLSQNSISE-LRMPDISFLSELRVLRLSH 85

Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
           N I                           +   +      LE L +  N +  +    +
Sbjct: 86  NRIRS-------------------------LDFHVFLFNQDLEYLDVSHNRLQNISCCPM 120

Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILN 352
                L+ +DLS N  +  +P                      +  E G    L  L L+
Sbjct: 121 ---ASLRHLDLSFNDFD-VLP----------------------VCKEFGNLTKLTFLGLS 154

Query: 353 NNKLSGEIPAELFSCSNLEWISLTGNELTGQ-IPPEFSRLTRLAVLQLGNNRFKGEIPGE 411
             K   ++     +  +L  I L       +    E  ++    VL L  +         
Sbjct: 155 AAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213

Query: 412 LGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLL 471
             + ++L  L L++  L  +   RL   L     G  L + TL  +         +    
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273

Query: 472 EFAGIRPERLLQIPTLKSCDFARMYSGPVLSL-FTQYQTLEYLDLSYNQFRGKIPDEIGD 530
                   R ++   + +            +   T  ++L    +    F          
Sbjct: 274 W------PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327

Query: 531 MIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
              + +  L+ +              +    + + N     + +  S L  L  + L  N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387

Query: 591 ELTGPIPQRGQLSTLPASQYANN 613
            L            + + +  + 
Sbjct: 388 GLKNFFKVALMTKNMSSLETLDV 410

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  138 bits (349), Expect = 6e-36
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 25/216 (11%)

Query: 742 IGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +    +      VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            +G       R ++ E M  G L+  L   R +      L       +AR  A G  +L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARV---SDFGMARLISALDTHLSVSTLAGTPGYVP- 909
            N   H IHRD+ + N LL      RV    DFGMAR I             G    +P 
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-----YRKGGCAMLPV 209

Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               PE +     T+K D +SFGV+L E+ + G  P
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  136 bits (345), Expect = 8e-36
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FG V     +    VAIK + +     + EF+ E + +  + H  LV L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
                ++ E+M  G L   L         + L      ++ +   + + +L        +
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLL-----EMCKDVCEAMEYLESK---QFL 142

Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV---PPE--YYQSF 916
           HRD+ + N L++ +   +VSDFG++R +  LD   + S  +  P  V   PPE   Y  F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFP--VRWSPPEVLMYSKF 198

Query: 917 RCTAKGDVYSFGVVLLELLT-GKRP 940
             ++K D+++FGV++ E+ + GK P
Sbjct: 199 --SSKSDIWAFGVLMWEIYSLGKMP 221

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  141 bits (356), Expect = 9e-36
 Identities = 77/283 (27%), Positives = 122/283 (43%), Gaps = 49/283 (17%)

Query: 739  ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
            E  +G G FGEV+  T    + VAIK L   +   +  F+ E + + K++H  LV L   
Sbjct: 189  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 247

Query: 799  CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
                E   +V E+M  GSL + L    K    + L       +A   A G+ ++      
Sbjct: 248  V-SEEPIYIVTEYMSKGSLLDFL----KGETGKYLRLPQLVDMAAQIASGMAYVERM--- 299

Query: 859  HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFR 917
            + +HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     R
Sbjct: 300  NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 918  CTAKGDVYSFGVVLLELLT-GKRP----TDKDDFGDTNLVGWVKMKVREGKQMEVID--P 970
             T K DV+SFG++L EL T G+ P     +++          V  +V  G +M      P
Sbjct: 358  FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------VLDQVERGYRMPCPPECP 407

Query: 971  ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            E L                   + ++  QC    P +RP    
Sbjct: 408  ESL-------------------H-DLMCQCWRKEPEERPTFEY 430

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  137 bits (347), Expect = 1e-35
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 34/215 (15%)

Query: 742 IGCGGFGEVFKATLKDGS-----SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPL 795
           +G G FG V+K             VAIK+L   +      E + E   +  + + ++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDARKKIARGAAKGLCFL-H 853
           LG C +     L+ + M FG L + +   +     Q +L W          AKG+ +L  
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLED 135

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP---- 909
              +    HRD+ + NVL+      +++DFG+A+L+ A +            G VP    
Sbjct: 136 RRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWM 186

Query: 910 -PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             E   ++ +  T + DV+S+GV + EL+T G +P
Sbjct: 187 ALESILHRIY--THQSDVWSYGVTVWELMTFGSKP 219

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  136 bits (344), Expect = 2e-35
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 742 IGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPLL 796
           IG G FG V+  TL D        A+K L R++  G+  +F+ E   +    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 797 GYCKIGEE-RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
           G C   E   L+V  +MK G L   +         + L            AKG+ +L   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKYLASK 147

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----P 910
                +HRD+ + N +LD +   +V+DFG+AR +   + +   +    T   +P      
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 201

Query: 911 E--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E    Q F  T K DV+SFGV+L EL+T G  P
Sbjct: 202 ESLQTQKF--TTKSDVWSFGVLLWELMTRGAPP 232

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (356), Expect = 2e-35
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 49/281 (17%)

Query: 742  IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
            +G G +GEV++   K  S +VA+K L   + + + EF+ E   + +IKH NLV LLG C 
Sbjct: 228  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286

Query: 801  IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
                  ++ EFM +G+L + L    +  +++ ++      +A   +  + +L      + 
Sbjct: 287  REPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339

Query: 861  IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 919
            IHR++ + N L+      +V+DFG++RL++      +    A  P  +  PE     + +
Sbjct: 340  IHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 920  AKGDVYSFGVVLLELLT-GKRP----TDKDDFGDTNLVGWVKMKVREGKQMEVID--PEL 972
             K DV++FGV+L E+ T G  P                  V   + +  +ME  +  PE 
Sbjct: 398  IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMERPEGCPEK 447

Query: 973  LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            +                   Y E+   C    PS RP+  +
Sbjct: 448  V-------------------Y-ELMRACWQWNPSDRPSFAE 468

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  136 bits (345), Expect = 2e-35
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 30/239 (12%)

Query: 739 ESLIGCGGFGEVFKATLK-----DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
            S +G G FG V            G+ VA+K+L        R+F  E++ L  +    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 794 PLLGYCKIGEER--LLVYEFMKFGSLEEVLHG-RAKARDQRILTWDARKKIARGAAKGLC 850
              G       +   LV E++  G L + L   RA+    R+L +      +    KG+ 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQICKGME 141

Query: 851 FLH-HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV- 908
           +L    C    +HRD+ + N+L++ E   +++DFG+A+L+     +  V     +P  + 
Sbjct: 142 YLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP--IF 195

Query: 909 --PPE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP-TDKDDFGDTNLVGWVKMKVRE 961
              PE      F  + + DV+SFGVVL EL T   +  +   +F            +  
Sbjct: 196 WYAPESLSDNIF--SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  134 bits (340), Expect = 3e-35
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 21/205 (10%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           +G G FGEV+       + VA+K L +        F+AE   + +++H+ LV L      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T 78

Query: 802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
            E   ++ E+M+ GSL + L    K      LT +    +A   A+G+ F+      + I
Sbjct: 79  QEPIYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 862 HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV---PPE--YYQSF 916
           HRD++++N+L+   +  +++DFG+ARLI   D   +    A  P  +    PE   Y +F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFP--IKWTAPEAINYGTF 187

Query: 917 RCTAKGDVYSFGVVLLELLT-GKRP 940
             T K DV+SFG++L E++T G+ P
Sbjct: 188 --TIKSDVWSFGILLTEIVTHGRIP 210

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  139 bits (351), Expect = 4e-35
 Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 14/258 (5%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
             ++  +  GL   VP  +     N  YLN   NN+   +      +   LE+L L  N+
Sbjct: 56  FSKVVCTRRGLSE-VPQGIP---SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110

Query: 86  LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
           +   I   +   N   SL  L+L  N +  +   +    +KL+ L L  N +       F
Sbjct: 111 IR-QIEVGAF--NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAF 167

Query: 146 GQLSSLQRLDLS-NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLD 204
            ++ SL RLDL     +  +I         +L  L L   NI    P  L+    L+ L+
Sbjct: 168 NRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELE 224

Query: 205 LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP 264
           +S N+            L SL+ L + N+ +S    ++     +L  ++ + N +S  +P
Sbjct: 225 MSGNHFPE-IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LP 282

Query: 265 PDICPGVSSLEELRLPDN 282
            D+   +  L EL L  N
Sbjct: 283 HDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  133 bits (337), Expect = 2e-33
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 12/234 (5%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
              L L  N    + + +   L   L+ L+L    +  +     F+ L +L  L    N 
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQI-EVGAFNGLASLNTLELFDNW 134

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQ-NHIMDVIPS 119
           LT  +P        KL  L L  N +  SI  ++   N   SL+ LDL +   +  +   
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF--NRVPSLMRLDLGELKKLEYISEG 190

Query: 120 SLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL 179
           +      LK LNL    +  ++P     L  L+ L++S NH    I     +   SL +L
Sbjct: 191 AFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKL 247

Query: 180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
            + ++ ++          + L  L+L++NN+S   P  +   L  L  L L +N
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  128 bits (323), Expect = 2e-31
 Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 36/283 (12%)

Query: 73  SDKLELLDLSYNNLTGSI-SGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILN 131
           S++   +  +   L+  +  G   N        +L+L +N+I  +   +  +   L++L 
Sbjct: 53  SNQFSKVVCTRRGLS-EVPQGIPSN------TRYLNLMENNIQMIQADTFRHLHHLEVLQ 105

Query: 132 LSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFP 191
           L  N +       F  L+SL  L+L +N +T  IPS        L EL L +N I     
Sbjct: 106 LGRNSIRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPS 164

Query: 192 VTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRI 251
              +    L  LDL          +   E L +L+ L L    I      +++    L  
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEE 222

Query: 252 VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS 311
           ++ S N     I P    G+SSL++L + ++ ++ +          L  ++L+ N L+ S
Sbjct: 223 LEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-S 280

Query: 312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNN 354
           +P +L            F  L           + L +L L++N
Sbjct: 281 LPHDL------------FTPL-----------RYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  101 bits (254), Expect = 1e-22
 Identities = 49/264 (18%), Positives = 84/264 (31%), Gaps = 58/264 (21%)

Query: 173 CDS-LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS 231
           C +   ++      ++   P  + S    + L+L  NNI          +L  LE L L 
Sbjct: 52  CSNQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQM-IQADTFRHLHHLEVLQLG 107

Query: 232 NNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQ 291
            N I      + +   +L  ++   N ++ +IP      +S L EL L +N I  +    
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYA 166

Query: 292 LSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLIL 351
            +    L  +DL                                                
Sbjct: 167 FNRVPSLMRLDLG----------------------------------------------- 179

Query: 352 NNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPG 410
              KL   I    F    NL++++L    +     P  + L  L  L++  N F    PG
Sbjct: 180 ELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPG 236

Query: 411 ELGNCSSLVWLDLNSNNLTGDIPP 434
                SSL  L + ++ ++  I  
Sbjct: 237 SFHGLSSLKKLWVMNSQVS-LIER 259

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 96.4 bits (240), Expect = 5e-21
 Identities = 64/333 (19%), Positives = 111/333 (33%), Gaps = 82/333 (24%)

Query: 265 PDICPGV----SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLE 320
           P  CP V    +   ++      ++  +P  +   +  + ++L  N +   I  +     
Sbjct: 43  PQNCPSVCSCSNQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-MIQADT---- 94

Query: 321 HLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNE 379
                   F  L            +L+ L L  N +  +I    F+  ++L  + L  N 
Sbjct: 95  --------FRHL-----------HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134

Query: 380 LTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGR 438
           LT  IP   F  L++L  L L NN  +           SL+ LDL        I      
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193

Query: 439 QLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYS 497
            L   K L   L                               +  +P            
Sbjct: 194 GLFNLKYL--NLGMC---------------------------NIKDMPN----------- 213

Query: 498 GPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRN 557
                  T    LE L++S N F    P     + +L+ L + ++Q+S    ++   L +
Sbjct: 214 ------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS 267

Query: 558 LGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
           L   + +HN L     + F+ L +LV++ L +N
Sbjct: 268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 94.0 bits (234), Expect = 3e-20
 Identities = 62/279 (22%), Positives = 110/279 (39%), Gaps = 38/279 (13%)

Query: 345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNR 403
               ++     LS E+P  + S  N  +++L  N +   I  + F  L  L VLQLG N 
Sbjct: 55  QFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110

Query: 404 FKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGN 462
            +    G     +SL  L+L  N LT  IP      L   + L  +L +N +  + +   
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLREL--WLRNNPIESIPS--Y 165

Query: 463 SCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRG 522
           +   V  L+       ++L  I                   F     L+YL+L     + 
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISE---------------GAFEGLFNLKYLNLGMCNIK- 209

Query: 523 KIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFL 582
            +P+ +  ++ L+ LE++ N      P S   L +L      ++++      +F  L+ L
Sbjct: 210 DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268

Query: 583 VQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPL 621
           V+++L++N           LS+LP   +     L  + L
Sbjct: 269 VELNLAHN----------NLSSLPHDLFTPLRYLVELHL 297

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 89.4 bits (222), Expect = 9e-19
 Identities = 69/329 (20%), Positives = 104/329 (31%), Gaps = 89/329 (27%)

Query: 249 LRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL 308
              V  +   +S + P  I P  S+   L L +N I  +          L+V+ L  N +
Sbjct: 56  FSKVVCTRRGLSEV-PQGI-P--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 309 NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSC- 367
              I                FNGL            +L  L L +N L+  IP+  F   
Sbjct: 112 R-QIEVGA------------FNGL-----------ASLNTLELFDNWLT-VIPSGAFEYL 146

Query: 368 SNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGN-NRFKGEIPGELGNCSSLVWLDLNS 425
           S L  + L  N +   IP   F+R+  L  L LG   + +    G      +L +L+L  
Sbjct: 147 SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205

Query: 426 NNLTGDIP-----PRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
            N+  D+P       L  +L        +S N                            
Sbjct: 206 CNIK-DMPNLTPLVGL-EEL-------EMSGN---------------------------- 228

Query: 481 LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA 540
               P ++   F  + S            L+ L +  +Q      +    + +L  L LA
Sbjct: 229 --HFPEIRPGSFHGLSS------------LKKLWVMNSQVSLIERNAFDGLASLVELNLA 274

Query: 541 HNQLSGEIPSSLGRLRNLGVFDASHNRLQ 569
           HN LS         LR L      HN   
Sbjct: 275 HNNLSSLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 4/86 (4%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           L  L++S N F  +   S   L   LK+L + ++ +   +  N F  L +LV LN ++NN
Sbjct: 220 LEELEMSGNHFPEIRPGSFHGLS-SLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNN 277

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNL 86
           L+  LP  L +    L  L L +N  
Sbjct: 278 LS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 16/87 (18%), Positives = 32/87 (36%), Gaps = 3/87 (3%)

Query: 507 YQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHN 566
                 +  +      ++P  I      + L L  N +      +   L +L V     N
Sbjct: 53  SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 567 RLQGQIPESFSNLSFLVQIDLSNNELT 593
            ++     +F+ L+ L  ++L +N LT
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT 136

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (346), Expect = 4e-35
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 739 ESLIGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLV 793
             +IG G FG V+  TL D        A+K L R++  G+  +F+ E   +    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 794 PLLGYCKIGEE-RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
            LLG C   E   L+V  +MK G L   +         + L            AKG+ FL
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKFL 208

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP--- 909
                   +HRD+ + N +LD +   +V+DFG+AR +   +     S    T   +P   
Sbjct: 209 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD---SVHNKTGAKLPVKW 262

Query: 910 --PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
              E    Q F  T K DV+SFGV+L EL+T G  P
Sbjct: 263 MALESLQTQKF--TTKSDVWSFGVLLWELMTRGAPP 296

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  136 bits (344), Expect = 6e-35
 Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 25/216 (11%)

Query: 742 IGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FGEV++  +    +      VA+K L  +  + D  +F+ E   + K  H+N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            +G       R ++ E M  G L+  L   R +      L       +AR  A G  +L 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARV---SDFGMARLISALDTHLSVSTLAGTPGYVP- 909
            N   H IHRD+ + N LL      RV    DFGMAR I             G    +P 
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-----YRKGGCAMLPV 250

Query: 910 ----PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               PE +     T+K D +SFGV+L E+ + G  P
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  133 bits (338), Expect = 7e-35
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 27/209 (12%)

Query: 742 IGCGGFGEVFKATLKDGS-SVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G +GEV++   K  S +VA+K L +       EF+ E   + +IKH NLV LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL-HHNCIPH 859
                 ++ EFM +G+L + L    +  +++ ++      +A   +  + +L   N    
Sbjct: 80  REPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----PE--Y 912
            IHRD+ + N L+      +V+DFG++RL++  DT+      A      P     PE   
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY-----TAHAGAKFPIKWTAPESLA 185

Query: 913 YQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           Y  F  + K DV++FGV+L E+ T G  P
Sbjct: 186 YNKF--SIKSDVWAFGVLLWEIATYGMSP 212

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (338), Expect = 8e-35
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 27/213 (12%)

Query: 742 IGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPLL 796
           IG G FG V+     D +      AIK L R++       F+ E   +  + H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 797 GYCKIGEERLL-VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
           G     E     +  +M  G L + +    +    + L            A+G+ +L   
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI-----SFGLQVARGMEYLAEQ 143

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----P 910
                +HRD+ + N +LD     +V+DFG+AR I   + +   S        +P      
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY---SVQQHRHARLPVKWTAL 197

Query: 911 E--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E      F  T K DV+SFGV+L ELLT G  P
Sbjct: 198 ESLQTYRF--TTKSDVWSFGVLLWELLTRGAPP 228

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  133 bits (338), Expect = 1e-34
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 742 IGCGGFGEVFKATLKDGSS----VAIKKL-IRLSCQGDR-EFMAEMETLGKIKHRNLVPL 795
           +G G FG V +  LK        VA+K + +  S Q +  EF++E   +    H N++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 796 LGYC-----KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           LG C     +   + +++  FMK+G L   L         + +      K     A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L +    + +HRD+ + N +L  +M   V+DFG+++ I + D +       G    +P 
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-----RQGRIAKMPV 213

Query: 910 ----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
                E    + +  T+K DV++FGV + E+ T G  P
Sbjct: 214 KWIAIESLADRVY--TSKSDVWAFGVTMWEIATRGMTP 249

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  137 bits (347), Expect = 1e-34
 Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 53/282 (18%)

Query: 739  ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
            E  +G G FGEV+ AT    + VA+K + +        F+AE   +  ++H  LV L   
Sbjct: 193  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 799  CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
                E   ++ EFM  GSL + L    K+ +            +   A+G+ F+      
Sbjct: 252  V-TKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 303

Query: 859  HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV---PPEYYQS 915
            + IHRD++++N+L+   +  +++DFG+AR+I   D   +    A  P  +    PE    
Sbjct: 304  NYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFP--IKWTAPEAINF 359

Query: 916  FRCTAKGDVYSFGVVLLELLT-GKRP----TDKDDFGDTNLVGWVKMKVREGKQMEVID- 969
               T K DV+SFG++L+E++T G+ P    ++ +          V   +  G +M   + 
Sbjct: 360  GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----------VIRALERGYRMPRPEN 409

Query: 970  -PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010
             PE L                   Y  I ++C  + P +RP 
Sbjct: 410  CPEEL-------------------Y-NIMMRCWKNRPEERPT 431

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (350), Expect = 1e-34
 Identities = 76/280 (27%), Positives = 121/280 (43%), Gaps = 49/280 (17%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
            +G G FGEV+  T    + VAIK L   +   +  F+ E + + K++H  LV L      
Sbjct: 275  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV-S 332

Query: 802  GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
             E   +V E+M  GSL + L    K    + L       +A   A G+ ++      + +
Sbjct: 333  EEPIYIVTEYMSKGSLLDFL----KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385

Query: 862  HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEYYQSFRCTA 920
            HRD++++N+L+   +  +V+DFG+ARLI   D   +    A  P  +  PE     R T 
Sbjct: 386  HRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 921  KGDVYSFGVVLLELLT-GKRP----TDKDDFGDTNLVGWVKMKVREGKQMEVID--PELL 973
            K DV+SFG++L EL T G+ P     +++          V  +V  G +M      PE L
Sbjct: 444  KSDVWSFGILLTELTTKGRVPYPGMVNRE----------VLDQVERGYRMPCPPECPESL 493

Query: 974  LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                               + ++  QC    P +RP    
Sbjct: 494  -------------------H-DLMCQCWRKEPEERPTFEY 513

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  134 bits (339), Expect = 1e-34
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 29/218 (13%)

Query: 742 IGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG V++   K          VAIK +   +   +R EF+ E   + +    ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGR----AKARDQRILTWDARKKIARGAAKGLC 850
           LLG    G+  L++ E M  G L+  L       A        +     ++A   A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D         G  G +P 
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPV 204

Query: 910 ----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               PE      F  T   DV+SFGVVL E+ T  ++P
Sbjct: 205 RWMSPESLKDGVF--TTYSDVWSFGVVLWEIATLAEQP 240

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  133 bits (337), Expect = 1e-34
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 34/223 (15%)

Query: 742 IGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+VF A   + S       VA+K L   +    ++F  E E L  ++H ++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK----------IARGA 845
            G C  G+  ++V+E+MK G L + L          +     + K          IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP 905
           A G+ +L      H +HRD+ + N L+   +  ++ DFGM+R + + D +       G  
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-----RVGGH 194

Query: 906 GYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             +P     PE   Y+ F  T + DV+SFGV+L E+ T GK+P
Sbjct: 195 TMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIFTYGKQP 235

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  132 bits (334), Expect = 2e-34
 Identities = 55/210 (26%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 739 ESLIGCGGFGEVFKATLKDGS---SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +  +GCG FG V +   +       VAIK L + + + D  E M E + + ++ +  +V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L+G C+  E  +LV E    G L + L G+ +      +      ++    + G+ +L  
Sbjct: 75  LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMKYLEE 128

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV---PPE 911
               + +HRD+ + NVLL +   A++SDFG+++ + A D++ +  +    P  +    PE
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP--LKWYAPE 183

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
                + +++ DV+S+GV + E L+ G++P
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (337), Expect = 2e-34
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 33/222 (14%)

Query: 742 IGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           +G G FG+VF A   +         VA+K L   S    ++F  E E L  ++H+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK---------IARGAA 846
            G C  G   L+V+E+M+ G L   L              D             +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 847 KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
            G+ +L      H +HRD+ + N L+   +  ++ DFGM+R I + D         G   
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-----YRVGGRT 220

Query: 907 YVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            +P     PE   Y+ F  T + DV+SFGVVL E+ T GK+P
Sbjct: 221 MLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIFTYGKQP 260

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  132 bits (334), Expect = 3e-34
 Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 31/216 (14%)

Query: 739 ESLIGCGGFGEVFKATLKDGSS---VAIK--KLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           +  +G G FG V K   +       VA+K  K          E +AE   + ++ +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL- 852
            ++G C+  E  +LV E  + G L + L      +  R +      ++    + G+ +L 
Sbjct: 82  RMIGICE-AESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVSMGMKYLE 134

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP--- 909
             N +    HRD+ + NVLL  +  A++SDFG+++ + A + +      A T G  P   
Sbjct: 135 ESNFV----HRDLAARNVLLVTQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKW 186

Query: 910 --PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             PE   Y  F  ++K DV+SFGV++ E  + G++P
Sbjct: 187 YAPECINYYKF--SSKSDVWSFGVLMWEAFSYGQKP 220

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  132 bits (334), Expect = 3e-34
 Identities = 62/242 (25%), Positives = 96/242 (39%), Gaps = 15/242 (6%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGF-LPETLLSNSDKLELLD 80
           +P    +LEL S  L  L P  +F KL  L  L+ S N L+           +  L+ LD
Sbjct: 26  IPSSATRLELESNKLQSL-PHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 81  LSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL-SNCTKLKILNLSFNLLAG 139
           LS+N +    S F         L HLD   +++  +   S+  +   L  L++S      
Sbjct: 85  LSFNGVITMSSNFL----GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 140

Query: 140 EIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSW 199
                F  LSSL+ L ++ N        ++     +L  L L    +    P   +S S 
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200

Query: 200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS----GSFPDSISSCKTLRIVDFS 255
           LQ+L++S+NN          + L SL+ L  S N I            SS   L  ++ +
Sbjct: 201 LQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS---LAFLNLT 256

Query: 256 SN 257
            N
Sbjct: 257 QN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  128 bits (325), Expect = 5e-33
 Identities = 55/283 (19%), Positives = 106/283 (37%), Gaps = 33/283 (11%)

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSN 158
           SC+    +  +   +  V P+ +   +    L L  N L       F +L+ L +L LS+
Sbjct: 6   SCSGT-EIRCNSKGLTSV-PTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSS 61

Query: 159 NHITGW-IPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDS 217
           N ++     S+      SL  L L  N +  +          L+ LD  ++N+      S
Sbjct: 62  NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS 120

Query: 218 VLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL 277
           V  +L +L  L +S+     +F    +   +L ++  + N       PDI   + +L  L
Sbjct: 121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180

Query: 278 RLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIP 337
            L    +  + P   +  + L+V+++S N    S+                +  L     
Sbjct: 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFP------------YKCL----- 222

Query: 338 PELGKCKNLKDLILNNNKLSGEIPAELFS--CSNLEWISLTGN 378
                  +L+ L  + N +      +      S+L +++LT N
Sbjct: 223 ------NSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  113 bits (285), Expect = 1e-27
 Identities = 51/283 (18%), Positives = 95/283 (33%), Gaps = 57/283 (20%)

Query: 150 SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNN 209
           S   +  ++  +T  +P+ +     S   L+L  N +           + L  L LS+N 
Sbjct: 8   SGTEIRCNSKGLTS-VPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63

Query: 210 IS-GPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDIC 268
           +S             SL+ L LS N +  +   +    + L  +DF  + +  +    + 
Sbjct: 64  LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122

Query: 269 PGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAW 328
             + +L  L +          G                                      
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNG-------------------------------------I 145

Query: 329 FNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE 387
           FNGL            +L+ L +  N        ++F+   NL ++ L+  +L  Q+ P 
Sbjct: 146 FNGLS-----------SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 193

Query: 388 -FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
            F+ L+ L VL + +N F           +SL  LD + N++ 
Sbjct: 194 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  110 bits (276), Expect = 2e-26
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 20/219 (9%)

Query: 2   LSVLKLSSNLFT---LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASY 58
           L+ L LSSN  +     S S       LK L+LS  G++ +  +  F  L  L +L+  +
Sbjct: 54  LTKLSLSSNGLSFKGCCSQSDFGTT-SLKYLDLSFNGVITMSSN--FLGLEQLEHLDFQH 110

Query: 59  NNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIP 118
           +NL      ++  +   L  LD+S+ +            N  +SL  L ++ N   +   
Sbjct: 111 SNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF--NGLSSLEVLKMAGNSFQENFL 167

Query: 119 S-SLSNCTKLKILNLSFNLLAGEIPR-TFGQLSSLQRLDLSNNHITGWIPSELGNACDSL 176
               +    L  L+LS   L  ++    F  LSSLQ L++S+N+    + +      +SL
Sbjct: 168 PDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSL 225

Query: 177 LELKLPHNNIT----GSFPVTLSSCSWLQLLDLSNNNIS 211
             L    N+I            SS   L  L+L+ N+ +
Sbjct: 226 QVLDYSLNHIMTSKKQELQHFPSS---LAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 93.5 bits (233), Expect = 7e-21
 Identities = 55/282 (19%), Positives = 92/282 (32%), Gaps = 57/282 (20%)

Query: 345 NLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQ--IPPEFSRLTRLAVLQLGN 401
           +   L L +NKL   +P  +F   + L  +SL+ N L+ +          T L  L L  
Sbjct: 29  SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87

Query: 402 NRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVG 461
           N     +         L  LD   +NL   +               FLS   L+++    
Sbjct: 88  NGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF----------SVFLSLRNLIYLDISH 135

Query: 462 NSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFR 521
                                      +  F  + S            LE L ++ N F+
Sbjct: 136 T--------------------HTRVAFNGIFNGLSS------------LEVLKMAGNSFQ 163

Query: 522 GKIPDEI-GDMIALQVLELAHNQLSGEIPS-SLGRLRNLGVFDASHNRLQGQIPESFSNL 579
                +I  ++  L  L+L+  QL  ++   +   L +L V + SHN         +  L
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222

Query: 580 SFLVQIDLSNNELTGPIPQRGQLSTLPASQY----ANNPGLC 617
           + L  +D S N +     +  +L   P+S        N   C
Sbjct: 223 NSLQVLDYSLNHIMT-SKK-QELQHFPSSLAFLNLTQNDFAC 262

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  132 bits (333), Expect = 4e-34
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 48/225 (21%)

Query: 742 IGCGGFGEVFKATLKDGSS--------VAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
           +G G F ++FK   ++           V +K L +        F      + K+ H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
              G C  G+E +LV EF+KFGSL+  L       +          ++A+  A  + FL 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL-----EVAKQLAAAMHFLE 130

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEAR--------VSDFGMARLISALDTHLSVSTLAGTP 905
            N    +IH ++ + N+LL  E + +        +SD G++  +   D            
Sbjct: 131 EN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------------ 175

Query: 906 GY------VPPE---YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
                   VPPE     ++       D +SFG  L E+ + G +P
Sbjct: 176 ILQERIPWVPPECIENPKNL--NLATDKWSFGTTLWEICSGGDKP 218

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  132 bits (333), Expect = 4e-34
 Identities = 64/240 (26%), Positives = 100/240 (41%), Gaps = 31/240 (12%)

Query: 739 ESLIGCGGFGEVFKATLK-----DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
              +G G FG V            G  VA+KKL   + +  R+F  E+E L  ++H N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 794 PLLGYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
              G C     R   L+ E++ +GSL + L    +  D   L      +      KG+ +
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-----QYTSQICKGMEY 129

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-- 909
           L        IHRD+ + N+L+++E   ++ DFG+ +++        V      PG  P  
Sbjct: 130 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIF 182

Query: 910 ---PE--YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVG---WVKMKVRE 961
              PE      F  +   DV+SFGVVL EL T    +         ++G     +M V  
Sbjct: 183 WYAPESLTESKF--SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (334), Expect = 5e-34
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 30/219 (13%)

Query: 742 IGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGDR--EFMAEMETLGKIKHRNLVPL 795
           +G G FG V +A LK        VA+K L           EF+ E   + +  H ++  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 796 LGYCKIGEER------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
           +G       +      +++  FMK G L   L       +   L      +     A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            +L      + IHRD+ + N +L  +M   V+DFG++R I + D +       G    +P
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----RQGCASKLP 202

Query: 910 -----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
                 E      +  T   DV++FGV + E++T G+ P
Sbjct: 203 VKWLALESLADNLY--TVHSDVWAFGVTMWEIMTRGQTP 239

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  131 bits (332), Expect = 5e-34
 Identities = 64/250 (25%), Positives = 99/250 (39%), Gaps = 34/250 (13%)

Query: 739 ESLIGCGGFGEVFKATLK-----DGSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNL 792
              +G G FG+V            G  VA+K L   S      +   E+E L  + H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 793 VPLLGYC--KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           V   G C    G    L+ EF+  GSL+E L       + +        K A    KG+ 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL-----KYAVQICKGMD 140

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV-- 908
           +L        +HRD+ + NVL++ E + ++ DFG+ + I     + +V     +P  V  
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP--VFW 195

Query: 909 -PPE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGW--------VK 956
             PE      F      DV+SFGV L ELLT     +         +           + 
Sbjct: 196 YAPECLMQSKF--YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253

Query: 957 MKVREGKQME 966
             ++EGK++ 
Sbjct: 254 NTLKEGKRLP 263

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  132 bits (334), Expect = 6e-34
 Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 31/240 (12%)

Query: 739 ESLIGCGGFGEVFKATL-----KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV 793
              +G G FG V            G  VA+KKL   + +  R+F  E+E L  ++H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 794 PLLGYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
              G C     R   L+ E++ +GSL + L    +  D   L      +      KG+ +
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-----QYTSQICKGMEY 160

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-- 909
           L        IHRD+ + N+L+++E   ++ DFG+ +++     +  V      PG  P  
Sbjct: 161 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIF 213

Query: 910 ---PE--YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVG---WVKMKVRE 961
              PE      F  +   DV+SFGVVL EL T    +         ++G     +M V  
Sbjct: 214 WYAPESLTESKF--SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  137 bits (346), Expect = 7e-34
 Identities = 76/397 (19%), Positives = 140/397 (35%), Gaps = 48/397 (12%)

Query: 40  VPDNLFSKLPNLVYLNASY---NNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLN 96
              + FS               N     L E L++       L L+  NL+      SL 
Sbjct: 25  TYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ---FSELQLNRLNLS------SLP 75

Query: 97  ENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDL 156
           +N    +  L+++QN +   +P   ++   L+ L+   N L+  +P       SL+ LD+
Sbjct: 76  DNLPPQITVLEITQNAL-ISLPELPAS---LEYLDACDNRLS-TLPELPA---SLKHLDV 127

Query: 157 SNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPD 216
            NN +T  +P         L  +   +N +T   P   +S   L++L + NN ++     
Sbjct: 128 DNNQLT-MLPELPAL----LEYINADNNQLT-MLPELPTS---LEVLSVRNNQLT----- 173

Query: 217 SVLENLGSLESLILSNNMISGSFPDSISSCKTLR----IVDFSSNRVSGIIPPDICPGVS 272
            + E   SLE+L +S N++  S P                    NR++  IP +I   + 
Sbjct: 174 FLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENIL-SLD 230

Query: 273 SLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGL 332
               + L DN ++  I   LS+ T          Y + S  Q+     H     A     
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWF 288

Query: 333 EGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLT 392
                 ++ +  +  +   + N  S      L    +    S    ++   +     +L+
Sbjct: 289 PENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVAAWLE----KLS 343

Query: 393 RLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
             A L+  +     +      +  +L W +L    L 
Sbjct: 344 ASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  137 bits (346), Expect = 7e-34
 Identities = 78/472 (16%), Positives = 145/472 (30%), Gaps = 95/472 (20%)

Query: 101 NSLLHLDLSQNHIMDV---IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLS 157
           N  L  +   N I        S+     K  +   + N     +      ++    L L+
Sbjct: 10  NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLN 67

Query: 158 NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDS 217
             +++  +P  L      +  L++  N +  S P   +S   L+ LD  +N +S     +
Sbjct: 68  RLNLSS-LPDNLPP---QITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-----T 114

Query: 218 VLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL 277
           + E   SL+ L + NN ++   P+  +  + +   +  +N+++ + P       +SLE L
Sbjct: 115 LPELPASLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLTML-PELP----TSLEVL 165

Query: 278 RLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIP 337
            + +N +T  +P        L+ +D+S N L  S+P    +  H E+   +F        
Sbjct: 166 SVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR------- 213

Query: 338 PELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVL 397
                           N+++  IP  + S      I L  N L+ +I    S+ T     
Sbjct: 214 -------------CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259

Query: 398 QLGNNRFKGEIPGELGNCSSLV-----WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSN 452
                 F      +      L      W   N  +    I      +  A     FL   
Sbjct: 260 HGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRL 319

Query: 453 TLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEY 512
           +                                  +           V +   +      
Sbjct: 320 S-----------------------DTVSARNTSGFRE---------QVAAWLEKLSASAE 347

Query: 513 LDLSYNQFRGKIPDEIGDMIA-----LQVLELAHNQLSGEIPSSLGRLRNLG 559
           L            +   D +A     L+   L H    G   +  G L +LG
Sbjct: 348 LRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLG 399

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  105 bits (262), Expect = 2e-23
 Identities = 57/323 (17%), Positives = 101/323 (31%), Gaps = 80/323 (24%)

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKC--KNLKDLILNNNKLSGE 359
           +   N ++G+        +  E+          +    L +C      +L LN   LS  
Sbjct: 16  NSFYNTISGTYADYFSAWDKWEKQALPGENRN-EAVSLLKECLINQFSELQLNRLNLS-S 73

Query: 360 IPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV 419
           +P  L     +  + +T N L   +P   + L  L      +NR    +P    +   L 
Sbjct: 74  LPDNLPP--QITVLEITQNALI-SLPELPASLEYL---DACDNRLS-TLPELPAS---LK 123

Query: 420 WLDLNSNNLTGDIPPRLG--RQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIR 477
            LD+++N LT  +P        +          +N L  +                    
Sbjct: 124 HLDVDNNQLT-MLPELPALLEYIN-------ADNNQLTML-------------------- 155

Query: 478 PERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVL 537
           PE                             +LE L +  NQ    +P+      +L+ L
Sbjct: 156 PELP--------------------------TSLEVLSVRNNQLT-FLPELPE---SLEAL 185

Query: 538 ELAHNQLSGEIPSSLGRLRNL----GVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
           +++ N L   +P+   R  +       F    NR+   IPE+  +L     I L +N L+
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243

Query: 594 GPIPQRGQLSTLPASQYANNPGL 616
             I +     T     +      
Sbjct: 244 SRIRESLSQQTAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 99.3 bits (247), Expect = 1e-21
 Identities = 52/218 (23%), Positives = 82/218 (37%), Gaps = 40/218 (18%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLP----NLVYLNAS 57
           ++VL+++ N       SL +LP  L+ L+           DN  S LP    +L +L+  
Sbjct: 82  ITVLEITQNALI----SLPELPASLEYLDAC---------DNRLSTLPELPASLKHLDVD 128

Query: 58  YNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVI 117
            N LT  LPE        LE ++   N LT       L E    SL  L +  N +   +
Sbjct: 129 NNQLT-MLPELP----ALLEYINADNNQLT------MLPE-LPTSLEVLSVRNNQLTF-L 175

Query: 118 PSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQR----LDLSNNHITGWIPSELGNAC 173
           P    +   L+ L++S NLL   +P    +    +          N IT  IP  + +  
Sbjct: 176 PELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILS-L 229

Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNIS 211
           D    + L  N ++     +LS  +            S
Sbjct: 230 DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 95.8 bits (238), Expect = 2e-20
 Identities = 61/371 (16%), Positives = 104/371 (28%), Gaps = 105/371 (28%)

Query: 251 IVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSEC--TQLKVIDLSLNYL 308
             +   N +SG    D        E+  LP           L EC   Q   + L+   L
Sbjct: 14  SQNSFYNTISGT-YADYFSAWDKWEKQALPGENRN-EAVSLLKECLINQFSELQLNRLNL 71

Query: 309 NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCS 368
           + S+P  L                             +  L +  N L   +P      +
Sbjct: 72  S-SLPDNLPP--------------------------QITVLEITQNALI-SLPELP---A 100

Query: 369 NLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNL 428
           +LE++    N L+  +P   + L  L    + NN+    +P        L +++ ++N L
Sbjct: 101 SLEYLDACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPAL---LEYINADNNQL 152

Query: 429 TGDIPPRLG--RQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPT 486
           T  +P        L        + +N L F+                    PE       
Sbjct: 153 T-MLPELPTSLEVL-------SVRNNQLTFL--------------------PELP----- 179

Query: 487 LKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQ----VLELAHN 542
                                ++LE LD+S N     +P         +          N
Sbjct: 180 ---------------------ESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCREN 217

Query: 543 QLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQL 602
           +++  IP ++  L          N L  +I ES S  +            +    Q+  L
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276

Query: 603 STLPASQYANN 613
               A      
Sbjct: 277 HRPLADAVTAW 287

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 77.7 bits (191), Expect = 9e-15
 Identities = 41/182 (22%), Positives = 69/182 (37%), Gaps = 25/182 (13%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGL-----------VPDNLFSKLP- 49
           L  L    N  +    +L +LP  LK L++ +  L  L             +N  + LP 
Sbjct: 102 LEYLDACDNRLS----TLPELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLPE 157

Query: 50  ---NLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHL 106
              +L  L+   N LT FLPE      + LE LD+S N L    +    N +S  + +  
Sbjct: 158 LPTSLEVLSVRNNQLT-FLPELP----ESLEALDVSTNLLESLPAVPVRNHHSEETEIFF 212

Query: 107 DLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIP 166
              +N I   IP ++ +      + L  N L+  I  +  Q ++         + +    
Sbjct: 213 RCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271

Query: 167 SE 168
            +
Sbjct: 272 QQ 273

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 71.2 bits (174), Expect = 8e-13
 Identities = 51/265 (19%), Positives = 84/265 (31%), Gaps = 88/265 (33%)

Query: 343 CKNLKDLILN--NNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG 400
             N   L  N   N +S    A+ FS                     + +  + A+    
Sbjct: 7   INNNFSLSQNSFYNTIS-GTYADYFSA--------------------WDKWEKQALPGEN 45

Query: 401 NNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNV 460
            N     +   L   +    L LN  NL+  +P  L  Q+    L   ++ N        
Sbjct: 46  RNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLPPQI--TVL--EITQN-------- 90

Query: 461 GNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQF 520
                               L+ +P                 L      LEYLD   N+ 
Sbjct: 91  -------------------ALISLP----------------ELPAS---LEYLDACDNRL 112

Query: 521 RGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLS 580
              +P+       L+ L++ +NQL+  +P     L  +   +A +N+L   +PE  ++L 
Sbjct: 113 S-TLPELPAS---LKHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPTSLE 163

Query: 581 FLVQIDLSNNELTGPIPQRGQLSTL 605
            L    + NN+LT        L  L
Sbjct: 164 VL---SVRNNQLTFLPELPESLEAL 185

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  130 bits (329), Expect = 9e-34
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 33/209 (15%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
           IG G FG+V     + G+ VA+K +   +    + F+AE   + +++H NLV LLG    
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85

Query: 802 GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL-HHNCIPH 859
            +  L +V E+M  GSL + L    ++R + +L  D   K +    + + +L  +N +  
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV-- 139

Query: 860 IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----PE--Y 912
             HRD+ + NVL+  +  A+VSDFG+ +     +   +  T     G +P     PE   
Sbjct: 140 --HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT-----GKLPVKWTAPEALR 187

Query: 913 YQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            + F  + K DV+SFG++L E+ + G+ P
Sbjct: 188 EKKF--STKSDVWSFGILLWEIYSFGRVP 214

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  132 bits (333), Expect = 1e-33
 Identities = 62/254 (24%), Positives = 109/254 (42%), Gaps = 49/254 (19%)

Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT            VA+K L   +   ++   M+E++ +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK--------KIARGA 845
            LLG C  G   L++ E+  +G L   L  +++  +       A            +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP 905
           A+G+ FL      + IHRD+ + NVLL +   A++ DFG+AR I     +     +    
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-----IVKGN 225

Query: 906 GYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP-----TDKDDFGDTNLV 952
             +P     PE  +   +  T + DV+S+G++L E+ + G  P      +          
Sbjct: 226 ARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-------- 275

Query: 953 GWVKMKVREGKQME 966
                 V++G QM 
Sbjct: 276 --FYKLVKDGYQMA 287

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  131 bits (331), Expect = 1e-33
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 27/215 (12%)

Query: 739 ESLIGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLV 793
           E +IG G  GEV    L+        VAIK L     +  R +F++E   +G+  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            L G    G   ++V E+M+ GSL+  L           L       + RG   G+ +L 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV-----GMLRGVGAGMRYLS 168

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP---- 909
                  +HRD+ + NVL+D  +  +VSDFG++R++   D   +  T  G  G +P    
Sbjct: 169 DL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDPDAAYTTTG--GKIPIRWT 221

Query: 910 -PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            PE   +++F  ++  DV+SFGVV+ E+L  G+RP
Sbjct: 222 APEAIAFRTF--SSASDVWSFGVVMWEVLAYGERP 254

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (339), Expect = 1e-33
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 57/282 (20%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
            IG G FG+V     + G+ VA+K +   +    + F+AE   + +++H NLV LLG    
Sbjct: 201  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 802  GEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
             +  L +V E+M  GSL + L    ++R + +L  D   K +    + + +L  N   + 
Sbjct: 258  EKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310

Query: 861  IHRDMKSSNVLLDHEMEARVSDFGMARLI--SALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
            +HRD+ + NVL+  +  A+VSDFG+ +    +     L V   A       PE  +  + 
Sbjct: 311  VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA-------PEALREKKF 363

Query: 919  TAKGDVYSFGVVLLELLT-GKRP----TDKDDFGDTNLVGWVKMKVREGKQMEVID--PE 971
            + K DV+SFG++L E+ + G+ P      KD          V  +V +G +M+  D  P 
Sbjct: 364  STKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------VVPRVEKGYKMDAPDGCPP 413

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
             +                   Y ++   C     + RP  LQ
Sbjct: 414  AV-------------------Y-DVMKNCWHLDAATRPTFLQ 435

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  134 bits (338), Expect = 2e-33
 Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 12/234 (5%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
             +L L  N    +   S   L   L+ L+LS   +  +     F+ L NL  L    N 
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLR-HLEILQLSRNHIRTI-EIGAFNGLANLNTLELFDNR 123

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQ-NHIMDVIPS 119
           LT  +P        KL+ L L  N +  SI  ++   N   SL  LDL +   +  +   
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF--NRIPSLRRLDLGELKRLSYISEG 179

Query: 120 SLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL 179
           +    + L+ LNL+   L  EIP     L  L  LDLS NH++  I          L +L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKL 236

Query: 180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
            +  + I         +   L  ++L++NN++   P  +   L  LE + L +N
Sbjct: 237 WMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  126 bits (317), Expect = 8e-31
 Identities = 64/283 (22%), Positives = 108/283 (38%), Gaps = 36/283 (12%)

Query: 73  SDKLELLDLSYNNLTGSI-SGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILN 131
           S++   +     NL   +  G S N         L+L +N I  +  +S  +   L+IL 
Sbjct: 42  SNQFSKVICVRKNLR-EVPDGISTN------TRLLNLHENQIQIIKVNSFKHLRHLEILQ 94

Query: 132 LSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFP 191
           LS N +       F  L++L  L+L +N +T  IP+        L EL L +N I     
Sbjct: 95  LSRNHIRTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIESIPS 153

Query: 192 VTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRI 251
              +    L+ LDL          +   E L +L  L L+   +      +++    L  
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL--REIPNLTPLIKLDE 211

Query: 252 VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS 311
           +D S N +S  I P    G+  L++L +  + I  +          L  I+L+ N L   
Sbjct: 212 LDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-L 269

Query: 312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNN 354
           +P +L            F  L            +L+ + L++N
Sbjct: 270 LPHDL------------FTPL-----------HHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  119 bits (300), Expect = 1e-28
 Identities = 61/337 (18%), Positives = 107/337 (31%), Gaps = 86/337 (25%)

Query: 99  SC-NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLS 157
           SC N    +   + ++   +P  +S  T  ++LNL  N +      +F  L  L+ L LS
Sbjct: 40  SCSNQFSKVICVRKNL-REVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLS 96

Query: 158 NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDS 217
            NHI                   +             +  + L  L+L +N ++   P+ 
Sbjct: 97  RNHIR-----------------TIE--------IGAFNGLANLNTLELFDNRLTT-IPNG 130

Query: 218 VLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL 277
               L  L+ L L NN I                           IP      + SL  L
Sbjct: 131 AFVYLSKLKELWLRNNPIE-------------------------SIPSYAFNRIPSLRRL 165

Query: 278 RLPD-NLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKI 336
            L +   ++ +  G     + L+ ++L++             L  +              
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMC-----------NLREI-------------- 200

Query: 337 PPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTRL 394
            P L     L +L L+ N LS  I    F    +L+ + +  +++   I    F  L  L
Sbjct: 201 -PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSL 257

Query: 395 AVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGD 431
             + L +N               L  + L+ N    +
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  101 bits (254), Expect = 8e-23
 Identities = 56/288 (19%), Positives = 93/288 (32%), Gaps = 61/288 (21%)

Query: 173 CDS-LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS 231
           C +   ++     N+    P  +S+    +LL+L  N I      +  ++L  LE L LS
Sbjct: 41  CSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQI-IKVNSFKHLRHLEILQLS 96

Query: 232 NNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQ 291
            N I      + +    L  ++   NR++  IP      +S L+EL L +N I  +    
Sbjct: 97  RNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYA 155

Query: 292 LSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLIL 351
            +    L+ +DL                                                
Sbjct: 156 FNRIPSLRRLDLG----------------------------------------------- 168

Query: 352 NNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPG 410
              +LS  I    F   SNL +++L    L     P  + L +L  L L  N      PG
Sbjct: 169 ELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPG 225

Query: 411 ELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFV 457
                  L  L +  + +   I       L +   +   L+ N L  +
Sbjct: 226 SFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEI--NLAHNNLTLL 270

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 94.0 bits (234), Expect = 3e-20
 Identities = 68/330 (20%), Positives = 108/330 (32%), Gaps = 82/330 (24%)

Query: 268 CPGV----SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLE 323
           CP V    +   ++      +   +P  +S  T  ++++L  N +   I           
Sbjct: 35  CPSVCSCSNQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNS------- 83

Query: 324 QFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTG 382
                F  L           ++L+ L L+ N +   I    F+  +NL  + L  N LT 
Sbjct: 84  -----FKHL-----------RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT- 125

Query: 383 QIPPE-FSRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNSNNLTGDIPPRLGRQL 440
            IP   F  L++L  L L NN  +  IP        SL  LDL        I        
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA---- 180

Query: 441 GAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPV 500
                 G  +   L                          L +IP               
Sbjct: 181 ----FEGLSNLRYLNLAMC--------------------NLREIPN-------------- 202

Query: 501 LSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGV 560
               T    L+ LDLS N      P     ++ LQ L +  +Q+     ++   L++L  
Sbjct: 203 ---LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE 259

Query: 561 FDASHNRLQGQIPESFSNLSFLVQIDLSNN 590
            + +HN L     + F+ L  L +I L +N
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 90.6 bits (225), Expect = 4e-19
 Identities = 66/279 (23%), Positives = 107/279 (38%), Gaps = 38/279 (13%)

Query: 345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNR 403
               +I     L  E+P  + +  N   ++L  N++   I    F  L  L +LQL  N 
Sbjct: 44  QFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99

Query: 404 FKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGN 462
            +    G     ++L  L+L  N LT  IP      L   K L  +L +N +  + +   
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKEL--WLRNNPIESIPS--Y 154

Query: 463 SCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRG 522
           +   +  L        +RL  I                   F     L YL+L+    R 
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISE---------------GAFEGLSNLRYLNLAMCNLR- 198

Query: 523 KIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFL 582
           +IP+ +  +I L  L+L+ N LS   P S   L +L       +++Q     +F NL  L
Sbjct: 199 EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257

Query: 583 VQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPL 621
           V+I+L++N           L+ LP   +     L  + L
Sbjct: 258 VEINLAHN----------NLTLLPHDLFTPLHHLERIHL 286

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 87.9 bits (218), Expect = 3e-18
 Identities = 66/325 (20%), Positives = 109/325 (33%), Gaps = 79/325 (24%)

Query: 223 GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
                +I     +    PD IS+    R+++   N++  II  +    +  LE L+L  N
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98

Query: 283 LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK 342
            I  +  G  +    L  ++L  N L  +IP               F  L          
Sbjct: 99  HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNG------------AFVYL---------- 135

Query: 343 CKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTG-NELTGQIPPE-FSRLTRLAVLQL 399
              LK+L L NN +   IP+  F+   +L  + L     L+  I    F  L+ L  L L
Sbjct: 136 -SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNL 192

Query: 400 GNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRN 459
                + EIP  L     L  LDL+ N+L+          +      G +    L  +++
Sbjct: 193 AMCNLR-EIP-NLTPLIKLDELDLSGNHLS---------AIRPGSFQGLMHLQKLWMIQS 241

Query: 460 VGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ 519
                                  QI  ++   F  + S            L  ++L++N 
Sbjct: 242 -----------------------QIQVIERNAFDNLQS------------LVEINLAHNN 266

Query: 520 FRGKIPDEIGDMIALQVLELAHNQL 544
                 D    +  L+ + L HN  
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 4/86 (4%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           L  L LS N  + +   S   L   L++L +  + +   +  N F  L +LV +N ++NN
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLM-HLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNN 266

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNL 86
           LT  LP  L +    LE + L +N  
Sbjct: 267 LT-LLPHDLFTPLHHLERIHLHHNPW 291

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (330), Expect = 2e-33
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 28/212 (13%)

Query: 742 IGCGGFGEVFKATLKDGS-----SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPL 795
           +G G FG V+K             VAIK+L   +      E + E   +  + + ++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           LG C +     L+ + M FG L + +   +     Q +L W          AKG+ +L  
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLED 135

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP----- 909
                ++HRD+ + NVL+      +++DFG+A+L+ A +            G VP     
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMA 187

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            E       T + DV+S+GV + EL+T G +P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  129 bits (327), Expect = 2e-33
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 35/224 (15%)

Query: 742 IGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G   FG+V+K  L   +       VAIK L   +    R EF  E     +++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK----------IARG 844
           LLG     +   +++ +   G L E L  R+   D      D   K          +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 845 AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
            A G+ +L  +   H++H+D+ + NVL+  ++  ++SD G+ R + A D           
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY-----YKLLG 188

Query: 905 PGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
              +P     PE   Y  F  +   D++S+GVVL E+ + G +P
Sbjct: 189 NSLLPIRWMAPEAIMYGKF--SIDSDIWSYGVVLWEVFSYGLQP 230

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  130 bits (329), Expect = 2e-33
 Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 24/211 (11%)

Query: 739 ESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA----EMETLGKIKHRNLV 793
             L+G GG G+V++A        VA+K L+  +   D  F      E  T G+++  ++V
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 794 PLLGYCKIGEERLLVYEFMKF---GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           P+  +   GE    +Y  M+      L  +L  +        L       I R     L 
Sbjct: 98  PIHDF---GEIDGQLYVDMRLINGVDLAAMLRRQGP------LAPPRAVAIVRQIGSALD 148

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL-SVSTLAGTPGYVP 909
             H        HRD+K  N+L+  +  A + DFG+A   +  D  L  +    GT  Y+ 
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMA 203

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE +     T + D+Y+   VL E LTG  P
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPP 234

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  129 bits (327), Expect = 2e-33
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 26/219 (11%)

Query: 739 ESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA----EMETLGKIKHRNLV 793
              +G GG   V+ A        VAIK  I +  +   E +     E+    ++ H+N+V
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 794 PLLGYCKIGEERLLVY---EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            ++      EE    Y   E+++  +L E +           L+ D           G+ 
Sbjct: 75  SMIDV---DEEDDCYYLVMEYIEGPTLSEYIESHGP------LSVDTAINFTNQILDGIK 125

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
             H      I+HRD+K  N+L+D     ++ DFG+A+ +S   +    + + GT  Y  P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSP 181

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           E  +        D+YS G+VL E+L G+ P +    G+T
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFN----GET 216

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  130 bits (329), Expect = 3e-33
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 19/205 (9%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
            +G G FGEV +    + G   A+KK +RL      E    +     +    +VPL G  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKK-VRLEVFRVEE----LVACAGLSSPRIVPLYGAV 119

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
           + G    +  E ++ GSL +++      +    L  D        A +GL +LH      
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGLEYLHTR---R 170

Query: 860 IIHRDMKSSNVLLDHE-MEARVSDFGMARLISAL---DTHLSVSTLAGTPGYVPPEYYQS 915
           I+H D+K+ NVLL  +   A + DFG A  +       + L+   + GT  ++ PE    
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 916 FRCTAKGDVYSFGVVLLELLTGKRP 940
             C AK D++S   ++L +L G  P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  129 bits (327), Expect = 5e-33
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 742 IGCGGFGEVFKATLKDGS-----SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPL 795
           +G G FG V K             V IK +   S +         M  +G + H ++V L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
           LG C  G    LV +++  GSL + +     A   ++L            AKG+ +L  +
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLL-----NWGVQIAKGMYYLEEH 134

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----P 910
               ++HR++ + NVLL    + +V+DFG+A L+   D       L  +    P      
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEAKTPIKWMAL 186

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E     + T + DV+S+GV + EL+T G  P
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  129 bits (327), Expect = 5e-33
 Identities = 67/213 (31%), Positives = 115/213 (53%), Gaps = 28/213 (13%)

Query: 742 IGCGGFGEVFKATLKDGS-----SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPL 795
           IG G FGEV+K  LK  S      VAIK L     +  R +F+ E   +G+  H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
            G     +  +++ E+M+ G+L++ L    + +D    +      + RG A G+ +L + 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL----REKDGE-FSVLQLVGMLRGIAAGMKYLANM 166

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----P 910
              + +HRD+ + N+L++  +  +VSDFG++R++   D   +  T +G  G +P     P
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSG--GKIPIRWTAP 219

Query: 911 E--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E   Y+ F  T+  DV+SFG+V+ E++T G+RP
Sbjct: 220 EAISYRKF--TSASDVWSFGIVMWEVMTYGERP 250

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  128 bits (324), Expect = 6e-33
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 26/212 (12%)

Query: 742 IGCGGFGEVFKATLKDGSS----VAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVP 794
           +G G FG V +      S     VA+K L   +    +   +F+ E+  +  + HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L G   +     +V E    GSL + L           L+     + A   A+G+ +L  
Sbjct: 86  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYLES 139

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP----- 909
                 IHRD+ + N+LL      ++ DFG+ R +   D H     +      VP     
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAWCA 192

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           PE  ++   +   D + FGV L E+ T G+ P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  130 bits (328), Expect = 6e-33
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 24/229 (10%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLL 796
            IG G FG+       +DG    IK+ I +S    +E      E+  L  +KH N+V   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKE-INISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKAR--DQRILTWDARKKIARGAAKGLCFLHH 854
              +      +V ++ + G L + ++ +      + +IL W             L  +H 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD 143

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                I+HRD+KS N+ L  +   ++ DFG+AR++++  T        GTP Y+ PE  +
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICE 198

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
           +     K D+++ G VL EL T K       F   ++   + +K+  G 
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA-----FEAGSMKN-LVLKIISGS 241

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  129 bits (326), Expect = 8e-33
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 38/227 (16%)

Query: 742 IGCGGFGEVFKATLKDGSS--------VAIKKLIRLSCQGDR-EFMAEMETLGKI-KHRN 791
           +G G FG+V  A               VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK----------KI 841
           ++ LLG C       ++ E+   G+L E L  R     +     +               
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 842 ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
               A+G+ +L        IHRD+ + NVL+      +++DFG+AR I+ +D +      
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-----K 214

Query: 902 AGTPGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             T G +P     PE  + + +  T + DV+SFGV++ E+ T G  P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFTLGGSP 259

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  128 bits (324), Expect = 9e-33
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 38/227 (16%)

Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKI-KHRNLV 793
           +G G FG+V +AT           +VA+K L   +   +R   M+E++ L  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK------------KI 841
            LLG C IG   L++ E+  +G L   L  +  +      +    +              
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 842 ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
           +   AKG+ FL      + IHRD+ + N+LL H    ++ DFG+AR I     +     +
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-----V 202

Query: 902 AGTPGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
                 +P     PE  +   +  T + DV+S+G+ L EL + G  P
Sbjct: 203 VKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFSLGSSP 247

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  128 bits (325), Expect = 1e-32
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 36/225 (16%)

Query: 739 ESLIGCGGFGEVFKATLKDGSS---VAIKKLIRLSCQGDR-EFMAEMETLGKI-KHRNLV 793
           + +IG G FG+V KA +K        AIK++   + + D  +F  E+E L K+  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGR----------AKARDQRILTWDARKKIAR 843
            LLG C+      L  E+   G+L + L                     L+       A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 844 GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG 903
             A+G+ +L        IHRD+ + N+L+     A+++DFG++R             +  
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKK 198

Query: 904 TPGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           T G +P      E   Y  +  T   DV+S+GV+L E+++ G  P
Sbjct: 199 TMGRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIVSLGGTP 241

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  130 bits (327), Expect = 1e-32
 Identities = 33/332 (9%), Positives = 71/332 (21%), Gaps = 58/332 (17%)

Query: 715  ATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLI---RLS 770
              + +       S L +          +  G    VF     +     A+K        S
Sbjct: 43   TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102

Query: 771  CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG--------------------------EE 804
                           ++   +        ++                             
Sbjct: 103  RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 805  RLLVYEFMKFGSLEEVLHG-RAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHR 863
             LL+        LE +          +      A   +     +    L       ++H 
Sbjct: 163  YLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218

Query: 864  DMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC--TAK 921
                 N+ +  +    + D      +            +    Y P E+  +     T  
Sbjct: 219  HFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHA 273

Query: 922  GDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDE 981
             + +  G+ +  +     P     FG          K    +              G+  
Sbjct: 274  LNAWQLGLSIYRVWCLFLP-----FGLVTPGIKGSWKRPSLRVPGTDSLAF-----GSCT 323

Query: 982  SEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
               + VK ++      L   D    +R   L+
Sbjct: 324  PLPDFVKTLIGRF---LN-FD--RRRRLLPLE 349

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  128 bits (323), Expect = 1e-32
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 25/232 (10%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD----REFMAEMETLGKIKHRNLVPL 795
            IG G F EV++A  L DG  VA+KK +++    D     + + E++ L ++ H N++  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKK-VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD----QRILTWDARKKIARGAAKGLCF 851
                   E  +V E    G L  ++    K +     + +  +             L  
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY------FVQLCSALEH 151

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           +H      ++HRD+K +NV +      ++ D G+ R  S+  T     +L GTP Y+ PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPE 206

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
                    K D++S G +L E+   + P   D     +L      K+ +  
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC----KKIEQCD 254

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  133 bits (336), Expect = 2e-32
 Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 17/209 (8%)

Query: 739 ESLIGCGGFGEVFKATLKDGS---SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +  +GCG FG V +   +       VAIK L + + + D  E M E + + ++ +  +V 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL-H 853
           L+G C+  E  +LV E    G L + L G+ +      +      ++    + G+ +L  
Sbjct: 401 LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMKYLEE 454

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP-GYVPPEY 912
            N +    HR++ + NVLL +   A++SDFG+++ + A D++ +  +    P  +  PE 
Sbjct: 455 KNFV----HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510

Query: 913 YQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               + +++ DV+S+GV + E L+ G++P
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (320), Expect = 3e-32
 Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 30/224 (13%)

Query: 739 ESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA----EMETLGKIKHRNLV 793
             ++G GG  EV  A  L+D   VA+K L R     D  F      E +    + H  +V
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 794 PLLGYCKIGEERL-------LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA 846
            +      GE          +V E++   +L +++H          +T     ++   A 
Sbjct: 76  AVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADAC 126

Query: 847 KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL-SVSTLAGTP 905
           + L F H N    IIHRD+K +N+++      +V DFG+AR I+     +   + + GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
            Y+ PE  +     A+ DVYS G VL E+LTG+ P      GD+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDS 223

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (320), Expect = 3e-32
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 43/232 (18%)

Query: 742 IGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           +G G FG+V KAT            VA+K L   +   +  + ++E   L ++ H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK--------------- 839
           L G C      LL+ E+ K+GSL   L    K     + +  +R                
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 840 ---KIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                A   ++G+ +L       ++HRD+ + N+L+    + ++SDFG++R +   D++ 
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206

Query: 897 SVSTLAGTPGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               +  + G +P      E  +   +  T + DV+SFGV+L E++T G  P
Sbjct: 207 ----VKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVTLGGNP 252

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  128 bits (324), Expect = 3e-32
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 38/227 (16%)

Query: 742 IGCGGFGEVFKATLKDGSS--------VAIKKLIRLSCQGDR-EFMAEMETLGKI-KHRN 791
           +G G FG+V  A               VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK----------KI 841
           ++ LLG C       ++ E+   G+L E L  R     +     +               
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 842 ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
               A+G+ +L        IHRD+ + NVL+      +++DFG+AR I+ +D +      
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-----K 260

Query: 902 AGTPGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             T G +P     PE  + + +  T + DV+SFGV++ E+ T G  P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFTLGGSP 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  128 bits (324), Expect = 4e-32
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 38/227 (16%)

Query: 742 IGCGGFGEVFKATLKD--------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKI-KHRN 791
           +G G FG+V  A             + VA+K L   + + D  + ++EME +  I KH+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK----------KI 841
           ++ LLG C       ++ E+   G+L E L  R     +                     
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 842 ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
           A   A+G+ +L        IHRD+ + NVL+  +   +++DFG+AR I  +D +      
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-----K 248

Query: 902 AGTPGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             T G +P     PE  + + +  T + DV+SFGV+L E+ T G  P
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSP 293

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  128 bits (323), Expect = 4e-32
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 23/213 (10%)

Query: 739 ESLIGCGGFGEVFKATLKDGS----SVAIKKL-IRLSCQGDREFMAEMETLGKIKHRNLV 793
           + ++G G FGEV    LK  S    SVAIK L +  + +  R+F+ E   +G+  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            L G     +  ++V E+M+ GSL+  L           L       + RG A G+ +L 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-----GMLRGIASGMKYLS 164

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP---- 909
                  +HRD+ + N+L++  +  +VSDFG+ R++   D   +  T  G  G +P    
Sbjct: 165 DM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRG--GKIPIRWT 217

Query: 910 -PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
            PE     + T+  DV+S+G+VL E+++ G+RP
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  125 bits (316), Expect = 5e-32
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 19/231 (8%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLL 796
            IG G +G   K     DG  +  K+ +      + E    ++E+  L ++KH N+V   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKE-LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 797 G--YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH- 853
                +      +V E+ + G L  V+      ++++ L  +   ++       L   H 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 854 -HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
             +    ++HRD+K +NV LD +   ++ DFG+AR+++         T  GTP Y+ PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQ 187

Query: 913 YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
                   K D++S G +L EL     P     F   +    +  K+REGK
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAFSQKE-LAGKIREGK 232

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  125 bits (317), Expect = 8e-32
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 32/218 (14%)

Query: 739 ESLIGCGGFGEVFKATLKD-----GSSVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNL 792
              +G G FG+V            G  VA+K L   +    R  +  E++ L  + H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 793 VPLLGYC--KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           +   G C         LV E++  GSL + L         ++L +      A+   +G+ 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLF------AQQICEGMA 148

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP- 909
           +LH     H IHRD+ + NVLLD++   ++ DFG+A+ +     +  V       G  P 
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR----EDGDSPV 201

Query: 910 ----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               PE      F      DV+SFGV L ELLT     
Sbjct: 202 FWYAPECLKEYKF--YYASDVWSFGVTLYELLTHCDSS 237

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  124 bits (314), Expect = 1e-31
 Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 28/211 (13%)

Query: 742 IGCGGFGEVFKATLKDGS----SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPLL 796
           IG G FG+V +           +VAIK     +    R +F+ E  T+ +  H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL-HHN 855
           G         ++ E    G L   L  R  + D   L        A   +  L +L    
Sbjct: 83  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESKR 136

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----P 910
            +    HRD+ + NVL+      ++ DFG++R +     +        + G +P     P
Sbjct: 137 FV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAP 186

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E     R T+  DV+ FGV + E+L  G +P
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  124 bits (314), Expect = 1e-31
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 31/222 (13%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLV- 793
           F    LIG GGFG+VFKA    DG +  IK+ ++ + +   +   E++ L K+ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNE---KAEREVKALAKLDHVNIVH 68

Query: 794 ------------PLLGYCKIGEERLLVY---EFMKFGSLEEVLHGRAKARDQRILTWDAR 838
                                 +   ++   EF   G+LE+ +  R   +  ++L     
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL--- 125

Query: 839 KKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
            ++     KG+ ++H      +I+RD+K SN+ L    + ++ DFG+     +L      
Sbjct: 126 -ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178

Query: 899 STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +   GT  Y+ PE   S     + D+Y+ G++L ELL     
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  124 bits (314), Expect = 1e-31
 Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 25/256 (9%)

Query: 46  SKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH 105
             L N + + A  +N+T  +     ++ D +  L      +T +I G        N+L+ 
Sbjct: 16  PALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVT-TIEGVQ----YLNNLIG 67

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           L+L  N I D+  + L N TK+  L LS N L  +       L S++ LDL++  IT   
Sbjct: 68  LELKDNQITDL--APLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 166 PSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL 225
           P  L     +L  L L  N IT   P  L+  + LQ L + N  +S     + L NL  L
Sbjct: 124 P--LAG-LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD---LTPLANLSKL 175

Query: 226 ESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLIT 285
            +L   +N IS      ++S   L  V   +N++S + P       S+L  + L +  IT
Sbjct: 176 TTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP---LANTSNLFIVTLTNQTIT 230

Query: 286 GVIPGQLSECTQLKVI 301
                  +      V+
Sbjct: 231 NQPVFYNNNLVVPNVV 246

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  117 bits (296), Expect = 4e-29
 Identities = 59/284 (20%), Positives = 113/284 (39%), Gaps = 28/284 (9%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
             ++    + +   V     + L  +  L+A    +T       +   + L  L+L  N 
Sbjct: 21  AIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTIEG---VQYLNNLIGLELKDNQ 74

Query: 86  LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
           +T  ++       +   +  L+LS N + +V  S+++    +K L+L+   +    P   
Sbjct: 75  IT-DLAPLK----NLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP--L 125

Query: 146 GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL 205
             LS+LQ L L  N IT    S L     +L  L + +  ++   P  L++ S L  L  
Sbjct: 126 AGLSNLQVLYLDLNQITNI--SPLAG-LTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180

Query: 206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPP 265
            +N IS     S L +L +L  + L NN IS      +++   L IV  ++  ++   P 
Sbjct: 181 DDNKISDI---SPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITN-QPV 234

Query: 266 DICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN 309
                +     ++ P      + P  +S+       +L+ N  +
Sbjct: 235 FYNNNLVVPNVVKGPSGAP--IAPATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  112 bits (283), Expect = 2e-27
 Identities = 49/277 (17%), Positives = 107/277 (38%), Gaps = 26/277 (9%)

Query: 111 NHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELG 170
             I  + P           +    + +   +      L  +  L      +T      + 
Sbjct: 7   TAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQ 60

Query: 171 NACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLIL 230
              ++L+ L+L  N IT   P  L + + +  L+LS N +        +  L S+++L L
Sbjct: 61  Y-LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSA---IAGLQSIKTLDL 114

Query: 231 SNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPG 290
           ++  I+   P  ++    L+++    N+++ I P     G+++L+ L + +  ++ + P 
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA---GLTNLQYLSIGNAQVSDLTP- 168

Query: 291 QLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLI 350
            L+  ++L  +    N ++  I   L  L +L +     N +   + P L    NL  + 
Sbjct: 169 -LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVT 223

Query: 351 LNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE 387
           L N  ++ +        +NL   ++        I P 
Sbjct: 224 LTNQTITNQPVFYN---NNLVVPNVVKGPSGAPIAPA 257

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  112 bits (282), Expect = 3e-27
 Identities = 51/253 (20%), Positives = 91/253 (35%), Gaps = 24/253 (9%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
                    +    +N+T      +      + +  L      +  +    +     L  
Sbjct: 15  DPALANAIKIAAGKSNVT-DTVTQA----DLDGITTLSAFGTGVTTI--EGVQYLNNLIG 67

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           L L  N +    P     L+ +  L+LS N +     S +     S+  L L    IT  
Sbjct: 68  LELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAG-LQSIKTLDLTSTQITDV 122

Query: 190 FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTL 249
            P  L+  S LQ+L L  N I+     S L  L +L+ L + N  +S      +++   L
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNI---SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKL 175

Query: 250 RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN 309
             +    N++S I P      + +L E+ L +N I+ V P  L+  + L ++ L+   + 
Sbjct: 176 TTLKADDNKISDISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230

Query: 310 GSIPQELGKLEHL 322
                    L   
Sbjct: 231 NQPVFYNNNLVVP 243

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  106 bits (266), Expect = 4e-25
 Identities = 57/261 (21%), Positives = 104/261 (39%), Gaps = 25/261 (9%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           ++ L        + +   +Q    L  LEL    +  L P      L  +  L  S N L
Sbjct: 43  ITTLSAFGTG--VTTIEGVQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSGNPL 97

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
                   ++    ++ LDL+   +T  ++  +      ++L  L L  N I ++  S L
Sbjct: 98  KNVSA---IAGLQSIKTLDLTSTQIT-DVTPLA----GLSNLQVLYLDLNQITNI--SPL 147

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
           +  T L+ L++    ++   P     LS L  L   +N I+    S L +   +L+E+ L
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD--ISPLAS-LPNLIEVHL 202

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
            +N I+   P  L++ S L ++ L+N  I+      V  N   +   ++     +   P 
Sbjct: 203 KNNQISDVSP--LANTSNLFIVTLTNQTITNQ---PVFYNNNLVVPNVVKGPSGAPIAPA 257

Query: 242 SISSCKTLRIVDFSSNRVSGI 262
           +IS   T    + + N  S I
Sbjct: 258 TISDNGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  104 bits (261), Expect = 1e-24
 Identities = 49/254 (19%), Positives = 100/254 (39%), Gaps = 23/254 (9%)

Query: 181 LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP 240
                I   FP    + +    +    +N++         +L  + +L      ++    
Sbjct: 4   TQPTAINVIFP--DPALANAIKIAAGKSNVTDT---VTQADLDGITTLSAFGTGVTTI-- 56

Query: 241 DSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKV 300
           + +     L  ++   N+++ + P      ++ + EL L  N +  V    ++    +K 
Sbjct: 57  EGVQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSGNPLKNVSA--IAGLQSIKT 111

Query: 301 IDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
           +DL+   +    P  L  L +L+      N +   I P L    NL+ L + N ++S ++
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DL 166

Query: 361 PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
              L + S L  +    N+++  I P  + L  L  + L NN+     P  L N S+L  
Sbjct: 167 TP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221

Query: 421 LDLNSNNLTGDIPP 434
           + L +  +T + P 
Sbjct: 222 VTLTNQTIT-NQPV 234

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 52/318 (16%), Positives = 100/318 (31%), Gaps = 64/318 (20%)

Query: 279 LPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPP 338
                I  + P           I    + +  ++ Q    L+ +    A+  G+   I  
Sbjct: 4   TQPTAINVIFP--DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG 58

Query: 339 ELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQ 398
            +    NL  L L +N+++ ++   L + + +  + L+GN L   +    + L  +  L 
Sbjct: 59  -VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLD 113

Query: 399 LGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVR 458
           L + +     P  L   S+L  L L+ N +T +I P          L G  +   L    
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP----------LAGLTNLQYLSIGN 160

Query: 459 NVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYN 518
                                ++  +  L +                    L  L    N
Sbjct: 161 A--------------------QVSDLTPLANL-----------------SKLTTLKADDN 183

Query: 519 QFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSN 578
           +    I   +  +  L  + L +NQ+S    S L    NL +   ++  +  Q     +N
Sbjct: 184 KIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNN 239

Query: 579 LSFLVQIDLSNNELTGPI 596
           L     +   +     P 
Sbjct: 240 LVVPNVVKGPSGAPIAPA 257

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 75.9 bits (187), Expect = 6e-15
 Identities = 52/298 (17%), Positives = 95/298 (31%), Gaps = 62/298 (20%)

Query: 316 LGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISL 375
              L +  +  A  + +             +  L      ++  I   +   +NL  + L
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70

Query: 376 TGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPR 435
             N++T  + P    LT++  L+L  N  K  +   +    S+  LDL S  +T D+ P 
Sbjct: 71  KDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT-DVTP- 124

Query: 436 LGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARM 495
                    L G  +   L    N                    ++  I  L        
Sbjct: 125 ---------LAGLSNLQVLYLDLN--------------------QITNISPLAGL----- 150

Query: 496 YSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRL 555
                         L+YL +   Q    +   + ++  L  L+   N++S +I S L  L
Sbjct: 151 ------------TNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS-DI-SPLASL 194

Query: 556 RNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANN 613
            NL      +N++        +N S L  + L+N  +T           +P      +
Sbjct: 195 PNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPS 250

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (315), Expect = 2e-31
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 37/226 (16%)

Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKI-KHRNLV 793
           +G G FG+V +A            +VA+K L   +   +    M+E++ L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 794 PLLGYC-KIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDARKK---------IA 842
            LLG C K G   +++ EF KFG+L   L   R +    ++   D  K           +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 843 RGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA 902
              AKG+ FL        IHRD+ + N+LL  +   ++ DFG+AR I     +     + 
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-----VR 206

Query: 903 GTPGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
                +P     PE  + + +  T + DV+SFGV+L E+ + G  P
Sbjct: 207 KGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASP 250

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  125 bits (316), Expect = 2e-31
 Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 43/232 (18%)

Query: 742 IGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDR-EFMAEMETLGKI-KHRNLV 793
           +G G FG+V  AT    S       VA+K L   +   +R   M+E++ + ++  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK-------------- 839
            LLG C +     L++E+  +G L   L  + +   +  + ++ +K              
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 840 ---KIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
                A   AKG+ FL        +HRD+ + NVL+ H    ++ DFG+AR I +   + 
Sbjct: 173 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY- 228

Query: 897 SVSTLAGTPGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
               +      +P     PE  +   +  T K DV+S+G++L E+ + G  P
Sbjct: 229 ----VVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIFSLGVNP 274

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  125 bits (315), Expect = 2e-31
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 43/232 (18%)

Query: 742 IGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVP 794
           IG G FG VF+A             VA+K L   +    + +F  E   + +  + N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK--------------- 839
           LLG C +G+   L++E+M +G L E L   +      +   D                  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 840 ---KIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHL 896
               IAR  A G+ +L        +HRD+ + N L+   M  +++DFG++R I + D + 
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230

Query: 897 SVSTLAGTPGYVP-----PE--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
                A     +P     PE  +Y  +  T + DV+++GVVL E+ + G +P
Sbjct: 231 ----KADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFSYGLQP 276

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  124 bits (314), Expect = 4e-31
 Identities = 60/313 (19%), Positives = 114/313 (36%), Gaps = 25/313 (7%)

Query: 94  SLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQR 153
           +    SC+       S   + + IPS L+    +K L+LS N +         +  +LQ 
Sbjct: 24  NQASLSCDRNGICKGSSGSL-NSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQA 80

Query: 154 LDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP 213
           L L++N I   I  +  ++  SL  L L +N ++          S L  L+L  N     
Sbjct: 81  LVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTL 139

Query: 214 FPDSVLENLGSLESLILSNNMISGSFPDSI-SSCKTLRIVDFSSNRVSGIIPPDICPGVS 272
              S+  +L  L+ L + N            +    L  ++  ++ +     P     + 
Sbjct: 140 GETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS-YEPKSLKSIQ 198

Query: 273 SLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGL 332
           ++  L L       ++   +   + ++ ++L    L+     EL   E         N L
Sbjct: 199 NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE--------TNSL 250

Query: 333 EGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRL 391
             K           +++ + +  L  ++   L   S L  +  + N+L   +P   F RL
Sbjct: 251 IKKF--------TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRL 300

Query: 392 TRLAVLQLGNNRF 404
           T L  + L  N +
Sbjct: 301 TSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  114 bits (287), Expect = 2e-27
 Identities = 53/263 (20%), Positives = 99/263 (37%), Gaps = 36/263 (13%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           +  L LS+N  T ++++ L +    L+ L L+S G+  +  ++ FS L +L +L+ SYN 
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGINTI-EEDSFSSLGSLEHLDLSYNY 111

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLT-----------GSISGFSLNEN----------- 98
           L+  L  +       L  L+L  N                +    +              
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 99  -SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLS 157
                L  L++  + +    P SL +   +  L L        +       SS++ L+L 
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230

Query: 158 NNHITGWIPSELGN-------ACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNI 210
           +  +  +  SEL            +   +K+   ++       L+  S L  L+ S N +
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289

Query: 211 SGPFPDSVLENLGSLESLILSNN 233
               PD + + L SL+ + L  N
Sbjct: 290 KS-VPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 99.8 bits (249), Expect = 1e-22
 Identities = 65/351 (18%), Positives = 128/351 (36%), Gaps = 73/351 (20%)

Query: 245 SCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLS 304
           SC    I   SS  ++ I P  +     +++ L L +N IT +    L  C  L+ + L+
Sbjct: 29  SCDRNGICKGSSGSLNSI-PSGLTE---AVKSLDLSNNRITYISNSDLQRCVNLQALVLT 84

Query: 305 LNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAEL 364
            N +N +I ++             F+ L            +L+ L L+ N LS  + +  
Sbjct: 85  SNGIN-TIEEDS------------FSSL-----------GSLEHLDLSYNYLS-NLSSSW 119

Query: 365 FS-CSNLEWISLTGNELTGQIPPE--FSRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVW 420
           F   S+L +++L GN     +     FS LT+L +L++GN     +I   +    + L  
Sbjct: 120 FKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178

Query: 421 LDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
           L++++++L     P               S   +  +                       
Sbjct: 179 LEIDASDLQ-SYEP-----------KSLKSIQNVSHLILHMK------------------ 208

Query: 481 LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA 540
             Q   L         S   L L    +  +     +++      + +      + +++ 
Sbjct: 209 --QHILLLEIFVDVTSSVECLEL----RDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262

Query: 541 HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPES-FSNLSFLVQIDLSNN 590
              L  ++   L ++  L   + S N+L+  +P+  F  L+ L +I L  N
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 56/283 (19%), Positives = 98/283 (34%), Gaps = 43/283 (15%)

Query: 345 NLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNN 402
            +K L L+NN+++  I       C NL+ + LT N +   I  + FS L  L  L L  N
Sbjct: 53  AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 403 RFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGN 462
                        SSL +L+L  N         L   L    +    + +T   ++    
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR--- 167

Query: 463 SCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRG 522
                     FAG+     L+   + + D                Q + +L L   Q   
Sbjct: 168 ---KD-----FAGLT---FLEELEIDASDLQSYEPK----SLKSIQNVSHLILHMKQHI- 211

Query: 523 KIPDEIGD-MIALQVLELAHNQLSG----EIPS----SLGRLRNLGVFDASHNRLQGQIP 573
            + +   D   +++ LEL    L      E+ +    SL +         +   L  Q+ 
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270

Query: 574 ESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGL 616
           +  + +S L++++ S N          QL ++P   +     L
Sbjct: 271 KLLNQISGLLELEFSRN----------QLKSVPDGIFDRLTSL 303

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 42/231 (18%), Positives = 71/231 (30%), Gaps = 51/231 (22%)

Query: 366 SCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNS 425
           SC        +   L   IP   +   +   L L NNR       +L  C +L  L L S
Sbjct: 29  SCDRNGICKGSSGSLN-SIPSGLTEAVK--SLDLSNNRITYISNSDLQRCVNLQALVLTS 85

Query: 426 NNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQI 484
           N +   I       LG+ + L   LS N                            L  +
Sbjct: 86  NGIN-TIEEDSFSSLGSLEHLD--LSYN---------------------------YLSNL 115

Query: 485 PTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI-GDMIALQVLELAHNQ 543
            +               S F    +L +L+L  N ++      +   +  LQ+L + +  
Sbjct: 116 SS---------------SWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160

Query: 544 LSGEIPS-SLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
              +I       L  L   +   + LQ   P+S  ++  +  + L   +  
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 16/94 (17%), Positives = 36/94 (38%), Gaps = 11/94 (11%)

Query: 2   LSVLKLSSN-LFTLNSTSLLQLPFG-------LKQLELSSAGLVGLVPDNLFSKLPNLVY 53
           +  L+L    L T + + L              + ++++   L  ++   L +++  L+ 
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK--LLNQISGLLE 281

Query: 54  LNASYNNLTGFLPETLLSNSDKLELLDLSYNNLT 87
           L  S N L   +P+ +      L+ + L  N   
Sbjct: 282 LEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  123 bits (311), Expect = 4e-31
 Identities = 61/293 (20%), Positives = 104/293 (35%), Gaps = 42/293 (14%)

Query: 736  FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
            +     +G GGF  V     L DG   A+K+++    Q   E   E +      H N++ 
Sbjct: 31   YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 795  LLGYCKI----GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            L+ YC        E  L+  F K G+L   +  R K +   +        +  G  +GL 
Sbjct: 91   LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLTEDQILW-LLLGICRGLE 148

Query: 851  FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR-LISALDTHLSVSTLA------G 903
             +H        HRD+K +N+LL  E +  + D G        ++      TL        
Sbjct: 149  AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 904  TPGYVPPE---YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
            T  Y  PE            + DV+S G VL  ++ G+ P     +      G       
Sbjct: 206  TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-----YDMVFQKGDSVALAV 260

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            + +      P             +  + +++  +   +  VD  P +RP++  
Sbjct: 261  QNQLSIPQSPRH-----------SSALWQLLNSM---MT-VD--PHQRPHIPL 296

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  123 bits (311), Expect = 5e-31
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 26/215 (12%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIK--KLIRLSCQGDREFMAEMETLGKIKHRNL--VPLL 796
            IG GG  +VF+   +     AIK   L     Q    +  E+  L K++  +   + L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            Y    +   +V E      L   L      + ++ +    RK   +   + +  +H + 
Sbjct: 95  DYEITDQYIYMVMECGN-IDLNSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQH- 146

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE----- 911
              I+H D+K +N L+   M  ++ DFG+A  +    T +   +  GT  Y+PPE     
Sbjct: 147 --GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 912 ------YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                      + + K DV+S G +L  +  GK P
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  122 bits (308), Expect = 6e-31
 Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 32/213 (15%)

Query: 742 IGCGGFGEVFKATLKDGS----SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLVPLL 796
           +G G FGEV++    +      +VA+K   +     ++ +FM+E   +  + H ++V L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVL-HGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
           G  +  E   ++ E   +G L   L   +   +   ++ +      +    K + +L   
Sbjct: 80  GIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY------SLQICKAMAYLESI 132

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP-----P 910
              + +HRD+   N+L+      ++ DFG++R I   D +        +   +P     P
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY------KASVTRLPIKWMSP 183

Query: 911 E--YYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
           E   ++ F  T   DV+ F V + E+L+ GK+P
Sbjct: 184 ESINFRRF--TTASDVWMFAVCMWEILSFGKQP 214

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (309), Expect = 7e-31
 Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 40/248 (16%)

Query: 741 LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLV---- 793
            +G GGFG VF+A  K D  + AIK+ IRL  +     + M E++ L K++H  +V    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 794 -----PLLGYCKIGEERLLVY---EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGA 845
                      +    ++ +Y   +  +  +L++ ++GR                I    
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR---CTIEERERSVCLHIFLQI 127

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS----------ALDTH 895
           A+ + FLH      ++HRD+K SN+    +   +V DFG+   +            +  +
Sbjct: 128 AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 896 LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWV 955
              +   GT  Y+ PE       + K D++S G++L ELL    P     F         
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P-----FSTQMERVRT 236

Query: 956 KMKVREGK 963
              VR  K
Sbjct: 237 LTDVRNLK 244

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  128 bits (322), Expect = 7e-31
 Identities = 53/284 (18%), Positives = 107/284 (37%), Gaps = 28/284 (9%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
           + +    S  +  + PD         +  N    ++T  +     +  + ++ +  + ++
Sbjct: 1   MGETITVSTPIKQIFPD---DAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSD 54

Query: 86  LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
           +  S+ G         ++  L L+ N + D+    L+N   L  L L  N +  ++  + 
Sbjct: 55  IK-SVQGIQ----YLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLS-SL 105

Query: 146 GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL 205
             L  L+ L L +N I+    + L +    L  L L +N IT      LS  + L  L L
Sbjct: 106 KDLKKLKSLSLEHNGIS--DINGLVH-LPQLESLYLGNNKITD--ITVLSRLTKLDTLSL 160

Query: 206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPP 265
            +N IS       L  L  L++L LS N IS     +++  K L +++  S         
Sbjct: 161 EDNQISDI---VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPIN 215

Query: 266 DICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN 309
                +     ++  D  +    P  +S+    +  ++  +   
Sbjct: 216 HQSN-LVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  118 bits (296), Expect = 1e-27
 Identities = 55/327 (16%), Positives = 103/327 (31%), Gaps = 71/327 (21%)

Query: 103 LLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT 162
           +         I  + P       +    NL    +   +     +L+S+ ++  +N+ I 
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 163 GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
                                 ++ G     +     +  L L+ N ++   P   L NL
Sbjct: 57  ----------------------SVQG-----IQYLPNVTKLFLNGNKLTDIKP---LTNL 86

Query: 223 GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
            +L  L L  N I      S+   K L+ +    N +S I      P    LE L L +N
Sbjct: 87  KNLGWLFLDENKIKD--LSSLKDLKKLKSLSLEHNGISDINGLVHLP---QLESLYLGNN 141

Query: 283 LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK 342
            IT +    LS  T+L  + L  N           ++  +                 L  
Sbjct: 142 KITDITV--LSRLTKLDTLSLEDN-----------QISDIV---------------PLAG 173

Query: 343 CKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNN 402
              L++L L+ N +S ++   L    NL+ + L   E   +     S L     ++  + 
Sbjct: 174 LTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231

Query: 403 RFKGEIPGELGNCSSLVWLDLNSNNLT 429
                 P  + +       ++  +   
Sbjct: 232 SL--VTPEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  108 bits (271), Expect = 2e-24
 Identities = 56/250 (22%), Positives = 94/250 (37%), Gaps = 23/250 (9%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           +  +  +++     S   +Q    + +L L+   L  + P    + L NL +L    N +
Sbjct: 45  IDQIIANNSDIK--SVQGIQYLPNVTKLFLNGNKLTDIKP---LTNLKNLGWLFLDENKI 99

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
                   L +  KL+ L L +N ++  I+G          L  L L  N I D+  + L
Sbjct: 100 KDLSS---LKDLKKLKSLSLEHNGIS-DINGLV----HLPQLESLYLGNNKITDI--TVL 149

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
           S  TKL  L+L  N ++ +I      L+ LQ L LS NHI+      L     +L  L+L
Sbjct: 150 SRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL--RALAG-LKNLDVLEL 204

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDS---VLENLGSLESLILSNNMISGS 238
                        S+      +  ++ ++  P   S     E       L    N +S  
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFI 264

Query: 239 FPDSISSCKT 248
           F   ++  K 
Sbjct: 265 FYQPVTIGKA 274

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 87.5 bits (216), Expect = 9e-18
 Identities = 58/324 (17%), Positives = 99/324 (30%), Gaps = 86/324 (26%)

Query: 274 LEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLE 333
           + E       I  + P       +    +L    +  ++ Q   +L  ++Q IA  + ++
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56

Query: 334 GKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTR 393
             +   +    N+  L LN NKL+                          I P  + L  
Sbjct: 57  -SVQG-IQYLPNVTKLFLNGNKLT-------------------------DIKP-LTNLKN 88

Query: 394 LAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNT 453
           L  L L  N+ K ++   L +   L  L L  N ++ DI            L       +
Sbjct: 89  LGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING----------LVHLPQLES 135

Query: 454 LVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYL 513
           L    N                    ++  I  L                      L+ L
Sbjct: 136 LYLGNN--------------------KITDITVLSRL-----------------TKLDTL 158

Query: 514 DLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIP 573
            L  NQ    I   +  +  LQ L L+ N +S ++  +L  L+NL V +        +  
Sbjct: 159 SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPI 214

Query: 574 ESFSNLSFLVQIDLSNNELTGPIP 597
              SNL     +  ++  L  P  
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPEI 238

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.8 bits (209), Expect = 5e-17
 Identities = 43/213 (20%), Positives = 70/213 (32%), Gaps = 23/213 (10%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           L  L L  N    + +SL  L   LK L L   G+  +        LP L  L    N +
Sbjct: 89  LGWLFLDENKIK-DLSSLKDLK-KLKSLSLEHNGISDING---LVHLPQLESLYLGNNKI 143

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
           T       LS   KL+ L L  N ++  I   +        L +L LS+NHI D+   +L
Sbjct: 144 TDITV---LSRLTKLDTLSLEDNQIS-DIVPLA----GLTKLQNLYLSKNHISDL--RAL 193

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
           +    L +L L       +       L     +  ++  +            +       
Sbjct: 194 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP----- 248

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPF 214
              N+    P   +  S++    ++       F
Sbjct: 249 ---NVKWHLPEFTNEVSFIFYQPVTIGKAKARF 278

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 72.1 bits (176), Expect = 5e-13
 Identities = 43/265 (16%), Positives = 75/265 (28%), Gaps = 61/265 (23%)

Query: 335 KIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRL 394
           +I P            L    ++  +       ++++ I    +++   +      L  +
Sbjct: 13  QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNV 67

Query: 395 AVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTL 454
             L L  N+   +I   L N  +L WL L+ N +  D+            L       +L
Sbjct: 68  TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS----------LKDLKKLKSL 114

Query: 455 VFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLD 514
               N                     +  I  L                      LE L 
Sbjct: 115 SLEHN--------------------GISDINGLVHLP-----------------QLESLY 137

Query: 515 LSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE 574
           L  N+        +  +  L  L L  NQ+S +I   L  L  L     S N +      
Sbjct: 138 LGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS--DLR 191

Query: 575 SFSNLSFLVQIDLSNNELTGPIPQR 599
           + + L  L  ++L + E        
Sbjct: 192 ALAGLKNLDVLELFSQECLNKPINH 216

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 58.2 bits (140), Expect = 1e-08
 Identities = 36/262 (13%), Positives = 76/262 (29%), Gaps = 84/262 (32%)

Query: 346 LKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK 405
           + + I  +  +                          QI P            L      
Sbjct: 1   MGETITVSTPIK-------------------------QIFP-DDAFAETIKDNLKKKSVT 34

Query: 406 GEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCK 465
             +       +S+  +  N++++   +          + +    +   L    N      
Sbjct: 35  DAVT--QNELNSIDQIIANNSDIK-SV----------QGIQYLPNVTKLFLNGN------ 75

Query: 466 GVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIP 525
                         +L  I  L +                  + L +L L  N+ +  + 
Sbjct: 76  --------------KLTDIKPLTNL-----------------KNLGWLFLDENKIK-DL- 102

Query: 526 DEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQI 585
             + D+  L+ L L HN +S +I + L  L  L      +N++        S L+ L  +
Sbjct: 103 SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTL 158

Query: 586 DLSNNELT--GPIPQRGQLSTL 605
            L +N+++   P+    +L  L
Sbjct: 159 SLEDNQISDIVPLAGLTKLQNL 180

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  122 bits (308), Expect = 9e-31
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
           ++G G +G V+    L +   +AIK++     +  +    E+     +KH+N+V  LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 800 KIGEERLLVYEFMKFGSLEEVL---HGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
                  +  E +  GSL  +L    G  K  +Q I          +   +GL +LH N 
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI------GFYTKQILEGLKYLHDN- 141

Query: 857 IPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
              I+HRD+K  NVL++ +    ++SDFG ++ ++ ++      T  GT  Y+ PE    
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDK 197

Query: 916 FR--CTAKGDVYSFGVVLLELLTGKRP 940
                    D++S G  ++E+ TGK P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (323), Expect = 1e-30
 Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 28/214 (13%)

Query: 739 ESLIGCGGFGEVFKATLKDGS----SVAIKKLIRLSCQGDR-EFMAEMETLGKIKHRNLV 793
              IG G FG+V +           +VAIK     +    R +F+ E  T+ +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            L+G         ++ E    G L   L  R  + D   L        A   +  L +L 
Sbjct: 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-----LYAYQLSTALAYLE 508

Query: 854 -HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP--- 909
               +    HRD+ + NVL+      ++ DFG++R +     +        + G +P   
Sbjct: 509 SKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKW 558

Query: 910 --PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             PE     R T+  DV+ FGV + E+L  G +P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  123 bits (311), Expect = 1e-30
 Identities = 39/315 (12%), Positives = 86/315 (27%), Gaps = 80/315 (25%)

Query: 741  LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE----------------------- 776
            ++G        +AT  + G S  +                                    
Sbjct: 80   VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 777  -----FMAEMETLGKIKHRNLVPLLGYCKIGE--ERLLVYEFMKFGSLEEVLHGRAKARD 829
                 F+   + +   + + ++ +    +      R  +Y  M+           + +  
Sbjct: 140  KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 830  QRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
             + L   AR ++     + L  LHH     ++H  ++  +++LD      ++ F      
Sbjct: 200  HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 890  SALDTHLSVSTLAGTPGYVPPEYYQSFRC-----------TAKGDVYSFGVVLLELLTGK 938
             A          + + G+ PPE                  T   D ++ G+V+  +    
Sbjct: 257  GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 939  RPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITL 998
             P           +G  +   R  K +    P              + V+ ++      L
Sbjct: 311  LP-----ITKDAALGGSEWIFRSCKNI----P--------------QPVRALLEGF---L 344

Query: 999  QCVDDFPSKRPNMLQ 1013
            +        R   LQ
Sbjct: 345  R-YP--KEDRLLPLQ 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  125 bits (316), Expect = 2e-30
 Identities = 81/440 (18%), Positives = 146/440 (33%), Gaps = 64/440 (14%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLE--------LSSAGLVGLVPDNLFSKLPNLVY 53
           +  L +      L+     +L   L+Q +        L+ A    +   +     P L  
Sbjct: 5   IQSLDIQCE--ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDIS--SALRVNPALAE 60

Query: 54  LNASYNNLTG----FLPETLLSNSDKLELLDLSYNNLTG-SISGFSLNENSCNSLLHLDL 108
           LN   N L       + + L + S K++ L L    LTG      S    +  +L  L L
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 109 SQNHIMD-----VIPSSLSNCTKLKILNLSFNLL----AGEIPRTFGQLSSLQRLDLSNN 159
           S N + D     +    L    +L+ L L +  L       +          + L +SNN
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 160 HITG----WIPSELGNACDSLLELKLPHNNIT----GSFPVTLSSCSWLQLLDLSNNNIS 211
            I       +   L ++   L  LKL    +T          ++S + L+ L L +N + 
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240

Query: 212 GP----FPDSVLENLGSLESLILSNNMIS----GSFPDSISSCKTLRIVDFSSNRVSGII 263
                     +L     L +L +    I+    G     + + ++L+ +  + N +    
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300

Query: 264 PPDICPGV----SSLEELRLPDNLITGV----IPGQLSECTQLKVIDLSLNYLNGSIPQE 315
              +C  +      LE L +     T          L++   L  + +S N L  +  +E
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE 360

Query: 316 LGK-LEH----LEQFIAWFNGLEGK----IPPELGKCKNLKDLILNNNKLSGEIPAELF- 365
           L + L      L         +       +   L    +L++L L+NN L      +L  
Sbjct: 361 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 420

Query: 366 ----SCSNLEWISLTGNELT 381
                   LE + L     +
Sbjct: 421 SVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  121 bits (305), Expect = 4e-29
 Identities = 83/466 (17%), Positives = 153/466 (32%), Gaps = 76/466 (16%)

Query: 50  NLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLT-GSISGFSLNENSCNSLLHLDL 108
           ++  L+     L+      LL    + +++ L    LT       S       +L  L+L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 109 SQNHIMDVIPSSLSNC-----TKLKILNLSFNLL----AGEIPRTFGQLSSLQRLDLSNN 159
             N + DV    +         K++ L+L    L     G +  T   L +LQ L LS+N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 160 HITG----WIPSELGNACDSLLELKLPHNNIT----GSFPVTLSSCSWLQLLDLSNNNIS 211
            +       +   L +    L +L+L + +++          L +    + L +SNN+I+
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

Query: 212 GPFPDSVLENLG--------SLESLILSNNMIS----GSFPDSISSCKTLRIVDFSSNRV 259
               ++ +  L          LE+L L +  ++          ++S  +LR +   SN++
Sbjct: 184 ----EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239

Query: 260 SGIIPPDICPGV----SSLEELRLPDNLITGV----IPGQLSECTQLKVIDLSLNYLNGS 311
             +   ++CPG+    S L  L + +  IT      +   L     LK + L+ N L   
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299

Query: 312 IPQELGKL-----EHLEQFIAWFNGLEGK----IPPELGKCKNLKDLILNNNKLSGEIPA 362
             + L +        LE                    L + + L +L ++NN+L      
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG-V 358

Query: 363 ELFS------CSNLEWISLTGNELTGQ----IPPEFSRLTRLAVLQLGNNRFKGEIPGEL 412
                      S L  + L   +++      +         L  L L NN        +L
Sbjct: 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 418

Query: 413 G-----NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNT 453
                     L  L L     + +             L        
Sbjct: 419 VESVRQPGCLLEQLVLYDIYWSEE---------MEDRLQALEKDKP 455

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  106 bits (266), Expect = 3e-24
 Identities = 80/458 (17%), Positives = 150/458 (32%), Gaps = 67/458 (14%)

Query: 149 SSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNIT----GSFPVTLSSCSWLQLLD 204
             +Q LD+    ++    +EL         ++L    +T          L     L  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 205 LSNNNISGPFPDSVLENLG--------SLESLILSNNMIS----GSFPDSISSCKTLRIV 252
           L +N +     D  +  +          ++ L L N  ++    G    ++ +  TL+ +
Sbjct: 63  LRSNELG----DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118

Query: 253 DFSSNRVSGIIPPDICPGV----SSLEELRLPDNLITGVIPGQLSE----CTQLKVIDLS 304
             S N +       +C G+      LE+L+L    ++      L+         K + +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178

Query: 305 LNYLNGSIPQELGK-LEH----LEQFIAWFNGLEGK----IPPELGKCKNLKDLILNNNK 355
            N +N +  + L + L+     LE       G+       +   +    +L++L L +NK
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238

Query: 356 LSGE-----IPAELFSCSNLEWISLTGNELTGQ----IPPEFSRLTRLAVLQLGNNRFKG 406
           L         P  L   S L  + +    +T +    +         L  L L  N    
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298

Query: 407 E-----IPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVG 461
           E         L     L  L + S + T                   L+ N  +    + 
Sbjct: 299 EGARLLCETLLEPGCQLESLWVKSCSFTAA---------CCSHFSSVLAQNRFLLELQIS 349

Query: 462 NSCKGVGGLLEFAG--IRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ 519
           N+     G+ E      +P  +L++  L  CD +      + +      +L  LDLS N 
Sbjct: 350 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409

Query: 520 FRGKIPDEIGDMIA-----LQVLELAHNQLSGEIPSSL 552
                  ++ + +      L+ L L     S E+   L
Sbjct: 410 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 447

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  102 bits (257), Expect = 5e-23
 Identities = 73/348 (20%), Positives = 122/348 (35%), Gaps = 50/348 (14%)

Query: 2   LSVLKLSSNLFTLN-----STSLLQLPFGLKQLELSS-----AGLVGLVPDNLFSKLPNL 51
           L  L LS NL            LL     L++L+L       A    L    +    P+ 
Sbjct: 115 LQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS--VLRAKPDF 172

Query: 52  VYLNASYNNLTG----FLPETLLSNSDKLELLDLSYNNLTG-SISGFSLNENSCNSLLHL 106
             L  S N++       L + L  +  +LE L L    +T  +         S  SL  L
Sbjct: 173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL 232

Query: 107 DLSQNHIMD-----VIPSSLSNCTKLKILNLSFNLL----AGEIPRTFGQLSSLQRLDLS 157
            L  N + D     + P  L   ++L+ L +    +     G++ R      SL+ L L+
Sbjct: 233 ALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 292

Query: 158 NNHITG----WIPSELGNACDSLLELKLPHNNITG----SFPVTLSSCSWLQLLDLSNNN 209
            N +       +   L      L  L +   + T      F   L+   +L  L +SNN 
Sbjct: 293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR 352

Query: 210 ISGP----FPDSVLENLGSLESLILSNNMIS----GSFPDSISSCKTLRIVDFSSNRVSG 261
           +           + +    L  L L++  +S     S   ++ +  +LR +D S+N +  
Sbjct: 353 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412

Query: 262 IIPPDICPGV----SSLEELRLPDNLITGVIPGQLSE----CTQLKVI 301
                +   V      LE+L L D   +  +  +L         L+VI
Sbjct: 413 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 93.5 bits (233), Expect = 5e-20
 Identities = 86/449 (19%), Positives = 157/449 (34%), Gaps = 68/449 (15%)

Query: 200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS----GSFPDSISSCKTLRIVDFS 255
           +Q LD+    +S      +L  L   + + L +  ++         ++     L  ++  
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 256 SNRVSGIIPPDICPGVSS----LEELRLPDNLIT----GVIPGQLSECTQLKVIDLSLNY 307
           SN +  +    +  G+ +    +++L L +  +T    GV+   L     L+ + LS N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 308 LNGSIPQELGKLE-----HLEQFIAWFNGLEGK----IPPELGKCKNLKDLILNNNKLSG 358
           L  +  Q L +        LE+    +  L       +   L    + K+L ++NN ++ 
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184

Query: 359 EIPAEL-----FSCSNLEWISLTGNELTGQ----IPPEFSRLTRLAVLQLGNNRFKGE-- 407
                L      S   LE + L    +T      +    +    L  L LG+N+      
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244

Query: 408 ---IPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGN-- 462
               PG L   S L  L +    +T           G   L   L +   +   ++    
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAK---------GCGDLCRVLRAKESLKELSLAGNE 295

Query: 463 -SCKGVGGLLEFAGIRPERLLQIPTLKSC---DFARMYSGPVLSLFTQYQTLEYLDLSYN 518
              +G   L E   + P   L+   +KSC        +   VL+   Q + L  L +S N
Sbjct: 296 LGDEGARLLCE-TLLEPGCQLESLWVKSCSFTAACCSHFSSVLA---QNRFLLELQISNN 351

Query: 519 QFRGKIPDEIGDMIA-----LQVLELAHNQLSGE----IPSSLGRLRNLGVFDASHNRLQ 569
           +       E+   +      L+VL LA   +S      + ++L    +L   D S+N L 
Sbjct: 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

Query: 570 GQ----IPESF-SNLSFLVQIDLSNNELT 593
                 + ES       L Q+ L +   +
Sbjct: 412 DAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (309), Expect = 2e-30
 Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 26/301 (8%)

Query: 718  QRQLRKLKFSQLIEATNGFSAESL-----IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ 772
            Q++ R   F    +       +       +G G  G VFK + K    V  +KLI L  +
Sbjct: 12   QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71

Query: 773  GD--REFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ 830
                 + + E++ L +     +V   G      E  +  E M  GSL++VL  +A    +
Sbjct: 72   PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE 130

Query: 831  RILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA-RLI 889
            +IL      K++    KGL +L       I+HRD+K SN+L++   E ++ DFG++ +LI
Sbjct: 131  QIL-----GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183

Query: 890  SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
             ++      ++  GT  Y+ PE  Q    + + D++S G+ L+E+  G+ P         
Sbjct: 184  DSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP-----IPPP 233

Query: 950  NLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
            +      M   + +      P               + +  +   E+    V++ P K P
Sbjct: 234  DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293

Query: 1010 N 1010
            +
Sbjct: 294  S 294

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (305), Expect = 3e-30
 Identities = 61/226 (26%), Positives = 91/226 (40%), Gaps = 25/226 (11%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGY 798
           ++G G    VF+   K  G   AIK    +S     +  M E E L K+ H+N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 799 CKIGEERL--LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            +    R   L+ EF   GSL  VL   + A     L       + R    G+  L  N 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY---GLPESEFLIVLRDVVGGMNHLREN- 131

Query: 857 IPHIIHRDMKSSNVLL----DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
              I+HR++K  N++     D +   +++DFG AR +   D      +L GT  Y+ P+ 
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFV--SLYGTEEYLHPDM 186

Query: 913 YQSFRC--------TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           Y+             A  D++S GV      TG  P    +    N
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  121 bits (306), Expect = 3e-30
 Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 26/215 (12%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIK--KLIRLSCQGDREFMAEMETLGKIKHRNL--VPLL 796
            IG GG  +VF+   +     AIK   L     Q    +  E+  L K++  +   + L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            Y    +   +V E      L   L      + ++ +    RK   +   + +  +H + 
Sbjct: 76  DYEITDQYIYMVMECGN-IDLNSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQH- 127

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE----- 911
              I+H D+K +N L+  +   ++ DFG+A  +    T +   +  GT  Y+PPE     
Sbjct: 128 --GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 912 ------YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                      + + K DV+S G +L  +  GK P
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  122 bits (307), Expect = 5e-30
 Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 26/215 (12%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIK--KLIRLSCQGDREFMAEMETLGKIKHRNL--VPLL 796
            IG GG  +VF+   +     AIK   L     Q    +  E+  L K++  +   + L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            Y    +   +V E      L   L  +        +    RK   +   + +  +H + 
Sbjct: 123 DYEITDQYIYMVMECGN-IDLNSWLKKKKS------IDPWERKSYWKNMLEAVHTIHQH- 174

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE----- 911
              I+H D+K +N L+  +   ++ DFG+A  +    T +   +  G   Y+PPE     
Sbjct: 175 --GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 912 ------YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                      + + K DV+S G +L  +  GK P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (303), Expect = 6e-30
 Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 19/210 (9%)

Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDRE---FMAEMETLGKI-KHR 790
           F   S +G G +GEVFK   K DG   A+K+      +G ++    +AE+ +  K+ +H 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
             V L    + G    L  E     SL++             L         R     L 
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHCE-----AWGASLPEAQVWGYLRDTLLALA 171

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            LH      ++H D+K +N+ L      ++ DFG+   +             G P Y+ P
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG---EVQEGDPRYMAP 225

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E  Q        DV+S G+ +LE+      
Sbjct: 226 ELLQG-SYGTAADVFSLGLTILEVACNMEL 254

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  119 bits (300), Expect = 6e-30
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 19/215 (8%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIR--LSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
           L+G G F  V++A  +  G  VAIK + +  +   G  +    E++   ++KH +++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            Y +      LV E    G +   L  R K         +AR  +      G+ +LH + 
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFM-HQIITGMLYLHSH- 131

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              I+HRD+  SN+LL   M  +++DFG+A  +          TL GTP Y+ PE     
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPEIATRS 187

Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
               + DV+S G +   LL G+ P     F    +
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPP-----FDTDTV 217

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  122 bits (308), Expect = 6e-30
 Identities = 36/262 (13%), Positives = 77/262 (29%), Gaps = 47/262 (17%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEME-------TLGKIKH--- 789
           ++G        +AT  + G S  +  +   + +     + +M+        L  IK+   
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVH-VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 790 ----------RNLVPLLGYCKIGE-----------ERLLVYEFMKFGSLEEVLHGRAKAR 828
                      +LV      K+              R  +Y  M+           + + 
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 829 DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL 888
             + L   AR ++     + L  LHH     ++H  ++  +++LD      ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 889 ISALDTHLSVSTLAGTPGYVPPE-----YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK 943
             A      +      P            +     T   D ++ G+ +  +     P   
Sbjct: 261 DGA-SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--- 316

Query: 944 DDFGDTNLVGWVKMKVREGKQM 965
               D   +G  +   R  K +
Sbjct: 317 --NTDDAALGGSEWIFRSCKNI 336

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (317), Expect = 6e-30
 Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 39/216 (18%)

Query: 739 ESLIGCGGFGEVFKA--TLKDGSSVAIKKLIRLSCQGDREFMA----EMETLGKIKHRNL 792
           +  I  GG G ++ A     +G  V +K L+     GD E  A    E + L ++ H ++
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 793 VPLLGYCKIGEERL--------LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARG 844
           V +  +    E           +V E++   SL+     +        L           
Sbjct: 142 VQIFNF---VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--------LPVAEAIAYLLE 190

Query: 845 AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
               L +LH      +++ D+K  N++L  E + ++ D G    I+      S   L GT
Sbjct: 191 ILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGT 240

Query: 905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PG+  PE  ++   T   D+Y+ G  L  L      
Sbjct: 241 PGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT 275

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (299), Expect = 1e-29
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 15/207 (7%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLV 793
           ++    IG G  G V+ A  +  G  VAI++ + L  Q  +E  + E+  + + K+ N+V
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
             L    +G+E  +V E++  GSL +V+        Q I        + R   + L FLH
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-IAA------VCRECLQALEFLH 133

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
            N    +IHRD+KS N+LL  +   +++DFG    I+        ST+ GTP ++ PE  
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVV 188

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
                  K D++S G++ +E++ G+ P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  118 bits (298), Expect = 2e-29
 Identities = 52/234 (22%), Positives = 99/234 (42%), Gaps = 46/234 (19%)

Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           F   +++G G FG+V KA    D    AIKK IR + +     ++E+  L  + H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 795 LLG----------YCKIGEERLLVY---EFMKFGSLEEVLHGRAKARDQRILTWDARKKI 841
                             +++  ++   E+ + G+L +++H     + +     D   ++
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR-----DEYWRL 121

Query: 842 ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV--- 898
            R   + L ++H      IIHRD+K  N+ +D     ++ DFG+A+ +      L +   
Sbjct: 122 FRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 899 ---------STLAGTPGYVPPE------YYQSFRCTAKGDVYSFGVVLLELLTG 937
                    ++  GT  YV  E      +Y       K D+YS G++  E++  
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP 227

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  117 bits (295), Expect = 3e-29
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 21/215 (9%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKL----IRLSCQGDREFMAEMETLGKIKHRNLVPL 795
            +G G FG V+ A  K     +A+K L    +  +    +    E+E    ++H N++ L
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRL 74

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
            GY      R+ L+ E+   G++   L      +  +         I    A  L + H 
Sbjct: 75  YGYFH-DATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITE-LANALSYCHS 127

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                +IHRD+K  N+LL    E +++DFG     S        + L GT  Y+PPE  +
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIE 180

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
                 K D++S GV+  E L GK P + + + +T
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  119 bits (301), Expect = 4e-29
 Identities = 62/234 (26%), Positives = 93/234 (39%), Gaps = 25/234 (10%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGY 798
           ++G G    VF+   K  G   AIK    +S     +  M E E L K+ H+N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 799 CKIGEERL--LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            +    R   L+ EF   GSL  VL   + A     L       + R    G+  L  N 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVLRDVVGGMNHLREN- 131

Query: 857 IPHIIHRDMKSSNVLL----DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
              I+HR++K  N++     D +   +++DFG AR +   D      +L GT  Y+ P+ 
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFV--SLYGTEEYLHPDM 186

Query: 913 YQSFRC--------TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK 958
           Y+             A  D++S GV      TG  P    +    N     K+ 
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  118 bits (297), Expect = 4e-29
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 15/207 (7%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLV 793
             +   IG G  G V  A     G  VA+K  + L  Q  RE    E+  +   +H N+V
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKM-MDLRKQQRRELLFNEVVIMRDYQHFNVV 105

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            +     +GEE  ++ EF++ G+L +++        Q  L  +    +     + L +LH
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVS-------QVRLNEEQIATVCEAVLQALAYLH 158

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                 +IHRD+KS ++LL  +   ++SDFG    IS         +L GTP ++ PE  
Sbjct: 159 AQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--KDVPKRKSLVGTPYWMAPEVI 213

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
                  + D++S G++++E++ G+ P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (292), Expect = 9e-29
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 20/215 (9%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIR--LSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
            +G GGF + F+ +        A K + +  L     RE    E+     + H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
           G+ +  +   +V E  +  SL E+       R + +   +AR  + R    G  +LH N 
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYL-RQIVLGCQYLHRN- 134

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ ++E ++ DFG+A  +           L GTP Y+ PE     
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKK 190

Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
             + + DV+S G ++  LL GK P     F  + L
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPP-----FETSCL 220

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  116 bits (293), Expect = 1e-28
 Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 23/236 (9%)

Query: 718 QRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE 776
            R L ++  S L +    F    L+G G +G+V+K   +K G   AIK  + ++   + E
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEE 66

Query: 777 FMAEMETLGKI-KHRNLVPLLG-YCKIGEERL-----LVYEFMKFGSLEEVLHGRAKARD 829
              E+  L K   HRN+    G + K     +     LV EF   GS+ +++    K   
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTK 122

Query: 830 QRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
              L  +    I R   +GL  LH +    +IHRD+K  NVLL    E ++ DFG++  +
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

Query: 890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCT-----AKGDVYSFGVVLLELLTGKRP 940
               T    +T  GTP ++ PE              K D++S G+  +E+  G  P
Sbjct: 180 D--RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  115 bits (290), Expect = 1e-28
 Identities = 52/264 (19%), Positives = 102/264 (38%), Gaps = 25/264 (9%)

Query: 46  SKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH 105
                 +  N    ++T  +     +  + ++ +  + +++  S+ G         ++  
Sbjct: 21  DAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIK-SVQGIQ----YLPNVTK 72

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           L L+ N + D+    L+N   L  L L  N +  ++  +   L  L+ L L +N I+   
Sbjct: 73  LFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISDIN 128

Query: 166 PSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL 225
              L +    L  L L +N IT      LS  + L  L L +N IS       L  L  L
Sbjct: 129 G--LVH-LPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI---VPLAGLTKL 180

Query: 226 ESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLIT 285
           ++L LS N IS     +++  K L +++  S       P +    +     ++  D  + 
Sbjct: 181 QNLYLSKNHISD--LRALAGLKNLDVLELFSQECLN-KPINHQSNLVVPNTVKNTDGSL- 236

Query: 286 GVIPGQLSECTQLKVIDLSLNYLN 309
            V P  +S+    +  ++  +   
Sbjct: 237 -VTPEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  107 bits (269), Expect = 1e-25
 Identities = 49/255 (19%), Positives = 82/255 (32%), Gaps = 46/255 (18%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
                +    +L   ++T      +      NS+  +  + + I  V    +     +  
Sbjct: 20  DDAFAETIKDNLKKKSVT-DAVTQN----ELNSIDQIIANNSDIKSV--QGIQYLPNVTK 72

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           L L+ N L    P     L +L  L L  N +                       +++  
Sbjct: 73  LFLNGNKLTDIKP--LANLKNLGWLFLDENKVK----------------------DLSS- 107

Query: 190 FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTL 249
               L     L+ L L +N IS     + L +L  LESL L NN I+      +S    L
Sbjct: 108 ----LKDLKKLKSLSLEHNGISDI---NGLVHLPQLESLYLGNNKITD--ITVLSRLTKL 158

Query: 250 RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN 309
             +    N++S I+P         L+ L L  N I+ +    L+    L V++L      
Sbjct: 159 DTLSLEDNQISDIVPLAGLT---KLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECL 213

Query: 310 GSIPQELGKLEHLEQ 324
                    L     
Sbjct: 214 NKPINHQSNLVVPNT 228

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  102 bits (256), Expect = 6e-24
 Identities = 51/248 (20%), Positives = 86/248 (34%), Gaps = 25/248 (10%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
                L     T            + Q+  +++ +  +        LPN+  L  + N L
Sbjct: 26  TIKDNLKKKSVT--DAVTQNELNSIDQIIANNSDIKSVQG---IQYLPNVTKLFLNGNKL 80

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
           T   P   L+N   L  L L  N +   +S           L  L L  N I D+  + L
Sbjct: 81  TDIKP---LANLKNLGWLFLDENKVK-DLSSLK----DLKKLKSLSLEHNGISDI--NGL 130

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
            +  +L+ L L  N +         +L+ L  L L +N I+      L      L  L L
Sbjct: 131 VHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD--IVPLAG-LTKLQNLYL 185

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD 241
             N+I+      L+    L +L+L +       P +   NL    ++  ++  +    P+
Sbjct: 186 SKNHISDLRA--LAGLKNLDVLELFSQECLNK-PINHQSNLVVPNTVKNTDGSLVT--PE 240

Query: 242 SISSCKTL 249
            IS     
Sbjct: 241 IISDDGDY 248

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 99.4 bits (248), Expect = 5e-23
 Identities = 52/295 (17%), Positives = 95/295 (32%), Gaps = 69/295 (23%)

Query: 108 LSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPS 167
                I  +         +    NL    +   +     +L+S+ ++  +N+ I      
Sbjct: 9   TVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK----- 59

Query: 168 ELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLES 227
                            ++ G     +     +  L L+ N ++   P   L NL +L  
Sbjct: 60  -----------------SVQG-----IQYLPNVTKLFLNGNKLTDIKP---LANLKNLGW 94

Query: 228 LILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV 287
           L L  N +      S+   K L+ +    N +S I      P    LE L L +N IT +
Sbjct: 95  LFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDINGLVHLP---QLESLYLGNNKITDI 149

Query: 288 IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLK 347
               LS  T+L  + L  N           ++  +                 L     L+
Sbjct: 150 TV--LSRLTKLDTLSLEDN-----------QISDIV---------------PLAGLTKLQ 181

Query: 348 DLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNN 402
           +L L+ N +S ++   L    NL+ + L   E   +     S L     ++  + 
Sbjct: 182 NLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 46/232 (19%), Positives = 86/232 (37%), Gaps = 20/232 (8%)

Query: 205 LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP 264
                I   F D             L    ++     + +   ++  +  +++ +  +  
Sbjct: 9   TVPTPIKQIFSDDAFAET---IKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG 63

Query: 265 PDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQ 324
               P   ++ +L L  N +T + P  L+    L  + L  N +   +   L  L+ L+ 
Sbjct: 64  IQYLP---NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKS 116

Query: 325 FIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQI 384
                NG+   I   L     L+ L L NNK++ +I   L   + L+ +SL  N+++  I
Sbjct: 117 LSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI 171

Query: 385 PPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRL 436
            P  + LT+L  L L  N    ++   L    +L  L+L S           
Sbjct: 172 VP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQ 220

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 51/280 (18%), Positives = 89/280 (31%), Gaps = 60/280 (21%)

Query: 316 LGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISL 375
                   +       +   +     +  ++  +I NN+ +   +   +    N+  + L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75

Query: 376 TGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPR 435
            GN+LT  I P  + L  L  L L  N+ K ++   L +   L  L L  N ++ DI   
Sbjct: 76  NGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING- 129

Query: 436 LGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARM 495
                    L       +L    N                    ++  I  L        
Sbjct: 130 ---------LVHLPQLESLYLGNN--------------------KITDITVLSRL----- 155

Query: 496 YSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRL 555
                         L+ L L  NQ    I   +  +  LQ L L+ N +S ++  +L  L
Sbjct: 156 ------------TKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGL 199

Query: 556 RNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGP 595
           +NL V +        +     SNL     +  ++  L  P
Sbjct: 200 KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 60/317 (18%), Positives = 101/317 (31%), Gaps = 68/317 (21%)

Query: 276 ELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGK 335
           E       I  +         +    +L    +  ++ Q   +L  ++Q IA  + ++  
Sbjct: 6   ETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-S 60

Query: 336 IPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLA 395
           +   +    N+  L LN NKL+ +I   L +  NL W+ L  N++   +      L +L 
Sbjct: 61  VQG-IQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLSS-LKDLKKLK 115

Query: 396 VLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLV 455
            L L +N    +I G L +   L  L L  NN   DI            L      +TL 
Sbjct: 116 SLSLEHNGIS-DING-LVHLPQLESLYL-GNNKITDI----------TVLSRLTKLDTLS 162

Query: 456 FVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDL 515
              N                    ++  I  L                      L+ L L
Sbjct: 163 LEDN--------------------QISDIVPLAGL-----------------TKLQNLYL 185

Query: 516 SYNQFRGKIPD--EIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIP 573
           S N     I D   +  +  L VLEL   +   +  +    L        +   L    P
Sbjct: 186 SKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--P 239

Query: 574 ESFSNLSFLVQIDLSNN 590
           E  S+     + ++  +
Sbjct: 240 EIISDDGDYEKPNVKWH 256

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  116 bits (293), Expect = 2e-28
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 20/215 (9%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIR--LSCQGDRE-FMAEMETLGKIKHRNLVPLL 796
            +G GGF + F+ +        A K + +  L     RE    E+     + H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
           G+ +  +   +V E  +  SL E+       R + +   +AR  + R    G  +LH N 
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYL-RQIVLGCQYLHRN- 160

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              +IHRD+K  N+ L+ ++E ++ DFG+A  +           L GTP Y+ PE     
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKK 216

Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
             + + DV+S G ++  LL GK P     F  + L
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPP-----FETSCL 246

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  116 bits (292), Expect = 2e-28
 Identities = 65/300 (21%), Positives = 120/300 (40%), Gaps = 59/300 (19%)

Query: 739  ESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLL 796
              ++  GGF  V++A  +  G   A+K+L+    + +R  + E+  + K+  H N+V   
Sbjct: 33   RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 797  GYCKIGEER--------LLVYEFMKFGSLEEVLHGRAKAR--DQRILTWDARKKIARGAA 846
                IG+E         LL+ E  K   +E +    ++       +L      KI     
Sbjct: 93   SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL------KIFYQTC 146

Query: 847  KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL----ISALDTHLSVSTLA 902
            + +  +H    P IIHRD+K  N+LL ++   ++ DFG A           +    + + 
Sbjct: 147  RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 903  ------GTPGYVPPE---YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVG 953
                   TP Y  PE    Y +F    K D+++ G +L  L   + P     F D     
Sbjct: 206  EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-----FEDGA--- 257

Query: 954  WVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
              K+++  GK            +    +++      ++R +   LQ V+  P +R ++ +
Sbjct: 258  --KLRIVNGK-----------YSIPPHDTQYTVFHSLIRAM---LQ-VN--PEERLSIAE 298

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  116 bits (293), Expect = 2e-28
 Identities = 47/225 (20%), Positives = 89/225 (39%), Gaps = 28/225 (12%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA-----------------EMETL 784
           +  G F ++     KD    A+KK  +   +  R+F                   E++ +
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 785 GKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDARKKIA 842
             IK+   +   G     +E  ++YE+M+  S+ +               +     K I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 843 RGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA 902
           +       ++H+    +I HRD+K SN+L+D     ++SDFG +  +   D  +      
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKI--KGSR 211

Query: 903 GTPGYVPPEYYQSFRCT--AKGDVYSFGVVLLELLTGKRPTDKDD 945
           GT  ++PPE++ +      AK D++S G+ L  +     P     
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  114 bits (288), Expect = 3e-28
 Identities = 48/233 (20%), Positives = 73/233 (31%), Gaps = 32/233 (13%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
              + L  N  + + + S       L  L L S  L   +    F+ L  L  L+ S N 
Sbjct: 34  SQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNA 91

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS 120
               +         +L  L L    L   +           +L +L L  N +  +   +
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLF--RGLAALQYLYLQDNALQALPDDT 148

Query: 121 LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
             +   L  L L  N ++    R F  L SL RL L  N +   +               
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPH------------ 195

Query: 181 LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
                              L  L L  NN+S   P   L  L +L+ L L++N
Sbjct: 196 ------------AFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  113 bits (286), Expect = 5e-28
 Identities = 53/205 (25%), Positives = 82/205 (40%), Gaps = 2/205 (0%)

Query: 102 SLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHI 161
           +   + L  N I  V  +S   C  L IL L  N+LA      F  L+ L++LDLS+N  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 162 TGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLEN 221
              +     +    L  L L    +    P      + LQ L L +N +    PD    +
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRD 151

Query: 222 LGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPD 281
           LG+L  L L  N IS     +     +L  +    NRV+  + P     +  L  L L  
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210

Query: 282 NLITGVIPGQLSECTQLKVIDLSLN 306
           N ++ +    L+    L+ + L+ N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  108 bits (273), Expect = 2e-26
 Identities = 54/256 (21%), Positives = 96/256 (37%), Gaps = 54/256 (21%)

Query: 149 SSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNN 208
           ++ QR+ L  N I+  +P+    AC +L  L L  N +        +  + L+ LDLS+N
Sbjct: 32  AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 209 NISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDIC 268
                   +    LG L +L L    +                           + P + 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQ-------------------------ELGPGLF 125

Query: 269 PGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAW 328
            G+++L+ L L DN +  +      +   L  + L  N ++ S+P+              
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERA------------ 172

Query: 329 FNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE 387
           F GL            +L  L+L+ N+++  +    F     L  + L  N L+  +P E
Sbjct: 173 FRGL-----------HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219

Query: 388 -FSRLTRLAVLQLGNN 402
             + L  L  L+L +N
Sbjct: 220 ALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  103 bits (258), Expect = 3e-24
 Identities = 55/248 (22%), Positives = 89/248 (35%), Gaps = 32/248 (12%)

Query: 183 HNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDS 242
              +  + PV + +    Q + L  N IS   P +      +L  L L +N+++     +
Sbjct: 20  QQGLQ-AVPVGIPA--ASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 243 ISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVID 302
            +    L  +D S N     + P    G+  L  L L    +  + PG       L+ + 
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135

Query: 303 LSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPA 362
           L  N L  ++P +             F  L            NL  L L+ N++S  +P 
Sbjct: 136 LQDNALQ-ALPDD------------TFRDL-----------GNLTHLFLHGNRIS-SVPE 170

Query: 363 ELFS-CSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
             F    +L+ + L  N +   + P  F  L RL  L L  N         L    +L +
Sbjct: 171 RAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229

Query: 421 LDLNSNNL 428
           L LN N  
Sbjct: 230 LRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 53/272 (19%), Positives = 82/272 (30%), Gaps = 60/272 (22%)

Query: 352 NNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGE 411
               L   +P  + +    + I L GN ++      F     L +L L +N         
Sbjct: 19  PQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 412 LGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGGL 470
               + L  LDL+ N     + P     LG    L   L                     
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL--HLDRC------------------ 115

Query: 471 LEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI-G 529
                        +  L    F  + +            L+YL L  N  +  +PD+   
Sbjct: 116 ------------GLQELGPGLFRGLAA------------LQYLYLQDNALQ-ALPDDTFR 150

Query: 530 DMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSN 589
           D+  L  L L  N++S     +   L +L       NR+    P +F +L  L+ + L  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 590 NELTGPIPQRGQLSTLPASQYANNPGLCGVPL 621
           N           LS LP    A    L  + L
Sbjct: 211 N----------NLSALPTEALAPLRALQYLRL 232

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 48.1 bits (115), Expect = 7e-06
 Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 4/86 (4%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           L+ L L  N  + +   +   L   L +L L    +  +   + F  L  L+ L    NN
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLH-SLDRLLLHQNRVAHV-HPHAFRDLGRLMTLYLFANN 212

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNL 86
           L+  LP   L+    L+ L L+ N  
Sbjct: 213 LS-ALPTEALAPLRALQYLRLNDNPW 237

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (288), Expect = 4e-28
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 14/207 (6%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLV 793
           F+    IG G FGEVFK    +    VAIK +     + + E    E+  L +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
              G      +  ++ E++  GS  ++L        Q I T      I R   KGL +LH
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-IAT------ILREILKGLDYLH 136

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                  IHRD+K++NVLL    E +++DFG+A  ++  DT +  +T  GTP ++ PE  
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 191

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +     +K D++S G+  +EL  G+ P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  114 bits (287), Expect = 4e-28
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 26/217 (11%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKL----IRLSCQGDREFMAEMETLGKIKHRNLVPL 795
            +G G FG V+ A  K     +A+K L    +       +    E+E    ++H N++ +
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
             Y     +R+ L+ EF   G L + L      +  R     +   +    A  L + H 
Sbjct: 80  YNYFH-DRKRIYLMLEFAPRGELYKEL-----QKHGRFDEQRSATFMEE-LADALHYCHE 132

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                +IHRD+K  N+L+ ++ E +++DFG +    +L       T+ GT  Y+PPE  +
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----TMCGTLDYLPPEMIE 185

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
                 K D++  GV+  E L G  P     F   + 
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP-----FDSPSH 217

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  114 bits (287), Expect = 5e-28
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 18/212 (8%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLV 793
           +     +G G FG+V+KA   + G+  A K  I    + + E ++ E+E L    H  +V
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKV-IETKSEEELEDYIVEIEILATCDHPYIV 79

Query: 794 PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
            LLG      +  ++ EF   G+++ ++         R LT    + + R   + L FLH
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-----DRGLTEPQIQVVCRQMLEALNFLH 134

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE-- 911
                 IIHRD+K+ NVL+  E + R++DFG++       T     +  GTP ++ PE  
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMAPEVV 189

Query: 912 ---YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                +      K D++S G+ L+E+   + P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  118 bits (297), Expect = 1e-27
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 20/215 (9%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLL--- 796
           +G GGFG V +   +D G  VAIK+  +     +RE +  E++ + K+ H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 797 ---GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
                    +  LL  E+ + G L + L+          L     + +    +  L +LH
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC---GLKEGPIRTLLSDISSALRYLH 138

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEAR---VSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N    IIHRD+K  N++L    +     + D G A+ +      L  +   GT  Y+ P
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGEL-CTEFVGTLQYLAP 192

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           E  +  + T   D +SFG +  E +TG RP   + 
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  112 bits (283), Expect = 2e-27
 Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 19/230 (8%)

Query: 718 QRQLRKLKFSQLIEATNG------FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLS 770
            R   + +  +L E +        F     +G G +G V+KA   + G  VAIK+ + + 
Sbjct: 7   LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-VPVE 65

Query: 771 CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQ 830
               +E + E+  + +    ++V   G      +  +V E+   GS+ +++  R      
Sbjct: 66  -SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-----N 119

Query: 831 RILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
           + LT D    I +   KGL +LH       IHRD+K+ N+LL+ E  A+++DFG+A  ++
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176

Query: 891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
             DT    +T+ GTP ++ PE  Q        D++S G+  +E+  GK P
Sbjct: 177 --DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  111 bits (280), Expect = 4e-27
 Identities = 43/230 (18%), Positives = 78/230 (33%), Gaps = 37/230 (16%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKI-KHR 790
           F     IG G FG VFK     DG   AIK+  +    G  +    + E+     + +H 
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           ++V         +  L+  E+   GSL + +      R          K +     +GL 
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVS-------------------DFGMARLISA 891
           ++H      ++H D+K SN+ +        +                   D G    IS 
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185

Query: 892 LDTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELLTGKRP 940
                S     G   ++  E  Q ++    K D+++  + ++     +  
Sbjct: 186 -----SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  112 bits (281), Expect = 1e-26
 Identities = 45/209 (21%), Positives = 76/209 (36%), Gaps = 19/209 (9%)

Query: 743 GCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREF---MAEMETLGKIKHRNLVPLLGY 798
           G      V  A     G  V +++ I L    +        E+       H N+VP    
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRR-INLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
                E  +V  FM +GS ++++           +   A   I +G  K L ++HH    
Sbjct: 95  FIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLKALDYIHHM--- 147

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT-----HLSVSTLAGTPGYVPPEYY 913
             +HR +K+S++L+  + +  +S       + +        H           ++ PE  
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207

Query: 914 QSFRC--TAKGDVYSFGVVLLELLTGKRP 940
           Q       AK D+YS G+   EL  G  P
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVP 236

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  110 bits (278), Expect = 1e-26
 Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 16/207 (7%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGK-IKHRNLVPLLGY 798
           IG G +G V K   K    +   K IR +      ++ + +++ + +      +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
                +  +  E M   S ++         D  I   +   KI     K L  L  N   
Sbjct: 90  LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVI-PEEILGKITLATVKALNHLKENL-- 145

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHLSVSTLAGTPGYVPPEYYQSFR 917
            IIHRD+K SN+LLD     ++ DFG    IS  L   ++ +  AG   Y+ PE      
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFG----ISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201

Query: 918 C----TAKGDVYSFGVVLLELLTGKRP 940
                  + DV+S G+ L EL TG+ P
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFP 228

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (278), Expect = 2e-26
 Identities = 46/314 (14%), Positives = 98/314 (31%), Gaps = 26/314 (8%)

Query: 703 IDKEKEPLSI--NVATFQRQLRKLKFSQLIEATNG-FSAESLIGCGGFGEVFKATLKD-- 757
           +    +P+S   N   +Q +L  +K     +  +       L+G G F +V++AT  D  
Sbjct: 31  LSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90

Query: 758 ----GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK 813
                    +K     +          ME L        +            +LV E   
Sbjct: 91  DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150

Query: 814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD 873
           +G+L   ++   K   ++++        A      +  +H      IIH D+K  N +L 
Sbjct: 151 YGTLLNAIN-LYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILG 206

Query: 874 HEMEA-----------RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKG 922
           +                + D G +  +         +    T G+   E   +     + 
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266

Query: 923 DVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDES 982
           D +     +  +L G     K++ G+    G  +         E     +L +       
Sbjct: 267 DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFH-VMLNIPDCHHLP 325

Query: 983 EAEEVKE-MVRYLE 995
             + +++ + +  +
Sbjct: 326 SLDLLRQKLKKVFQ 339

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  112 bits (282), Expect = 2e-26
 Identities = 49/226 (21%), Positives = 96/226 (42%), Gaps = 28/226 (12%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVP 794
           F  + ++G G  G +    + D   VA+K+++            E++ L +  +H N++ 
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIR 82

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
                K  + + +  E     +L+E +  +  A        +    + +    GL  LH 
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL----EPI-TLLQQTTSGLAHLHS 136

Query: 855 NCIPHIIHRDMKSSNVLL-----DHEMEARVSDFGMARLISALDTHLSV-STLAGTPGYV 908
               +I+HRD+K  N+L+       +++A +SDFG+ + ++      S  S + GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 909 PPEYYQSF---RCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTN 950
            PE          T   D++S G V   +++ G  P     FG + 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-----FGKSL 234

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  109 bits (274), Expect = 3e-26
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 13/208 (6%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYC 799
           IG G    V  A        VAIK++    CQ   +  + E++ + +  H N+V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIA---RGAAKGLCFLHHNC 856
            + +E  LV + +  GS+ +++       + +    D    IA   R   +GL +LH N 
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLEYLHKN- 140

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS---TLAGTPGYVPPEYY 913
               IHRD+K+ N+LL  +   +++DFG++  ++            T  GTP ++ PE  
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198

Query: 914 QSFRC-TAKGDVYSFGVVLLELLTGKRP 940
           +  R    K D++SFG+  +EL TG  P
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAP 226

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (272), Expect = 5e-26
 Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 17/207 (8%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGK-IKHRNLVPLLGY 798
           +G G +G V K        +   K IR +      +  + +++   + +     V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
                +  +  E M   SL++    +      + +  D   KIA    K L  LH     
Sbjct: 75  LFREGDVWICMELMD-TSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-- 129

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHLSVSTLAGTPGYVPPE----YY 913
            +IHRD+K SNVL++   + ++ DFG    IS  L   ++    AG   Y+ PE      
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFG----ISGYLVDDVAKDIDAGCKPYMAPERINPEL 185

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
                + K D++S G+ ++EL   + P
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFP 212

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (273), Expect = 5e-26
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 21/208 (10%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD--REFMAEMETLGK-IKHRNLVPLLGY 798
           +G G  G+V+K   +    V   K +R S   +  +  + +++ + K      +V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
                +  +  E M     E++         +RIL      K+     K L +L      
Sbjct: 93  FITNTDVFIAMELMG-TCAEKLKKRMQGPIPERIL-----GKMTVAIVKALYYLKEK--H 144

Query: 859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLISA-LDTHLSVSTLAGTPGYVPPEYYQSFR 917
            +IHRD+K SN+LLD   + ++ DFG    IS  L    +    AG   Y+ PE      
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFG----ISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 918 C-----TAKGDVYSFGVVLLELLTGKRP 940
                   + DV+S G+ L+EL TG+ P
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFP 228

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  108 bits (271), Expect = 8e-26
 Identities = 52/252 (20%), Positives = 82/252 (32%), Gaps = 25/252 (9%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFG---LKQLELSSAGLVGLVPDNLFS-KLPNLVYLNAS 57
           L  L + +               G   L++L L +  + G  P  L     P+L  LN  
Sbjct: 70  LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129

Query: 58  YNNLTG---FLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIM 114
             +      +L E        L++L ++  +                +L  LDLS N  +
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV---RVFPALSTLDLSDNPEL 186

Query: 115 DVIPSSLSNC----TKLKILNLSFNLLA---GEIPRTFGQLSSLQRLDLSNNHITGWIPS 167
                  + C      L++L L    +    G           LQ LDLS+N +     +
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

Query: 168 ELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISG-PFPDSVLENLGSLE 226
              +    L  L L    +        +    L +LDLS N +   P PD     L  + 
Sbjct: 247 PSCDWPSQLNSLNLSFTGLKQVPKGLPAK---LSVLDLSYNRLDRNPSPDE----LPQVG 299

Query: 227 SLILSNNMISGS 238
           +L L  N    S
Sbjct: 300 NLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  106 bits (266), Expect = 3e-25
 Identities = 58/278 (20%), Positives = 89/278 (32%), Gaps = 20/278 (7%)

Query: 60  NLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPS 119
           N  G     L      LE L    +          + ++   SL  L +    I   I  
Sbjct: 29  NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSL--SLKRLTVRAARIPSRILF 86

Query: 120 SLS---NCTKLKILNLSFNLLAGEIPRTFGQLS--SLQRLDLSNNHITG---WIPSELGN 171
                   + L+ L L    + G  P    + +   L  L+L N        W+      
Sbjct: 87  GALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQW 146

Query: 172 ACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFP---DSVLENLGSLESL 228
               L  L +   +        +     L  LDLS+N   G              +L+ L
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206

Query: 229 ILSNNM---ISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLIT 285
            L N      SG      ++   L+ +D S N +        C   S L  L L    + 
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266

Query: 286 GVIPGQLSECTQLKVIDLSLNYLNG-SIPQELGKLEHL 322
            V  G  +   +L V+DLS N L+    P EL ++ +L
Sbjct: 267 QVPKGLPA---KLSVLDLSYNRLDRNPSPDELPQVGNL 301

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 97.7 bits (243), Expect = 3e-22
 Identities = 56/282 (19%), Positives = 84/282 (29%), Gaps = 21/282 (7%)

Query: 165 IPSELGNACDSLLELKLPHNNITGSFPVT-LSSCSWLQLLDLSNNNISGPFPDSVLENLG 223
              EL     SL  L    +        T +     L+ L +    I        L  LG
Sbjct: 34  ADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLG 93

Query: 224 --SLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVS-----SLEE 276
              L+ L L N  ++G+ P  +       +   +   VS          +       L+ 
Sbjct: 94  ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153

Query: 277 LRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSI-------PQELGKLEHLEQFIAWF 329
           L +           Q+     L  +DLS N   G         P +   L+ L    A  
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213

Query: 330 NGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPEF 388
               G           L+ L L++N L     A      S L  ++L+   L  Q+P   
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272

Query: 389 SRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG 430
               +L+VL L  NR     P        +  L L  N    
Sbjct: 273 PA--KLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 61/351 (17%), Positives = 99/351 (28%), Gaps = 76/351 (21%)

Query: 206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDS-ISSCKTLRIVDFSSNRVSGIIP 264
           S  N  G     +     SLE L+   +  +     + I    +L+ +   + R+   I 
Sbjct: 26  SAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRIL 85

Query: 265 PDI--CPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHL 322
                  G+S L+EL L +  +TG  P  L E T   +  L+L  ++             
Sbjct: 86  FGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS------------W 133

Query: 323 EQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTG 382
               AW   L+  + P       LK L +           ++     L  + L+ N   G
Sbjct: 134 ATRDAWLAELQQWLKP------GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187

Query: 383 QI-------PPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPR 435
           +        P +F  L  LA+   G     G           L  LDL+ N+L       
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA- 246

Query: 436 LGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARM 495
                           + L  +                          +  +        
Sbjct: 247 ----------PSCDWPSQLNSLNLSFT--------------------GLKQVPKGLP--- 273

Query: 496 YSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSG 546
                         L  LDLSYN+     P    ++  +  L L  N    
Sbjct: 274 ------------AKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 51/291 (17%), Positives = 90/291 (30%), Gaps = 29/291 (9%)

Query: 289 PGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD 348
            G  S    LK +D   +    +   +   L+ L    A            +     L++
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99

Query: 349 LILNNNKLSGEIPAELFSCS--NLEWISLTGNELTGQIPPEFSRL-----TRLAVLQLGN 401
           L L N +++G  P  L   +  +L  ++L             + L       L VL +  
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQ 158

Query: 402 NRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVG 461
                    ++    +L  LDL+ N   G+        + A     F +   L       
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGL-----ISALCPLKFPTLQVLALRNAGM 213

Query: 462 NSCKGVGGLLEFAGIRPERLLQIPTLKSCDFA--RMYSGPVLSLFTQYQTLEYLDLSYNQ 519
            +  GV   L               L+  D +   +              L  L+LS+  
Sbjct: 214 ETPSGVCSAL---------AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 520 FRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQG 570
            + ++P  +     L VL+L++N+L    PS    L  +G      N    
Sbjct: 265 LK-QVPKGLPA--KLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 39/240 (16%), Positives = 66/240 (27%), Gaps = 48/240 (20%)

Query: 373 ISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPG---ELGNCSSLVWLDLNSNNLT 429
           +     E       +  +   L  L +   R    I      +   S L  L L +  +T
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 430 GDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKS 489
           G  PP L                 ++ +RNV  +             R   L ++     
Sbjct: 109 GTAPPPLLE--------ATGPDLNILNLRNVSWA------------TRDAWLAELQQWLK 148

Query: 490 CDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEI- 548
                               L+ L ++         +++    AL  L+L+ N   GE  
Sbjct: 149 ------------------PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

Query: 549 ------PSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQL 602
                 P     L+ L + +A      G      +    L  +DLS+N L          
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 29/161 (18%), Positives = 48/161 (29%), Gaps = 15/161 (9%)

Query: 457 VRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLS 516
           VR      + + G L   GI     LQ  TL++ +     + P   L      L  L+L 
Sbjct: 75  VRAARIPSRILFGALRVLGISG---LQELTLENLEVTG--TAPPPLLEATGPDLNILNLR 129

Query: 517 YNQFRGKIPDEIGDMI-----ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQ 571
              +       + ++       L+VL +A           +     L   D S N   G+
Sbjct: 130 NVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 572 IPESFS----NLSFLVQIDLSNNELTGPIPQRGQLSTLPAS 608
                +        L  + L N  +  P      L+     
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ 229

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score =  103 bits (258), Expect = 2e-24
 Identities = 44/191 (23%), Positives = 75/191 (39%), Gaps = 21/191 (10%)

Query: 46  SKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH 105
             L N V  N    ++T  +          ++  +   +N+  S++G         +L  
Sbjct: 16  PGLANAVKQNLGKQSVTDLVS---QKELSGVQNFNGDNSNIQ-SLAGMQ----FFTNLKE 67

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           L LS N I D+  S L + TKL+ L+++ N L   +       + L RL L NN +    
Sbjct: 68  LHLSHNQISDL--SPLKDLTKLEELSVNRNRLK-NLN--GIPSACLSRLFLDNNELRD-- 120

Query: 166 PSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL 225
              L +   +L  L + +N +       L   S L++LDL  N I+       L  L  +
Sbjct: 121 TDSLIH-LKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNT---GGLTRLKKV 174

Query: 226 ESLILSNNMIS 236
             + L+     
Sbjct: 175 NWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 95.9 bits (239), Expect = 6e-22
 Identities = 38/244 (15%), Positives = 82/244 (33%), Gaps = 31/244 (12%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
                     +L   ++T  +          + + + +   ++I  +  + +   T LK 
Sbjct: 15  DPGLANAVKQNLGKQSVT-DLVSQK----ELSGVQNFNGDNSNIQSL--AGMQFFTNLKE 67

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           L+LS N ++ ++      L+ L+ L ++ N +              L  L L +N +   
Sbjct: 68  LHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSAC----LSRLFLDNNELRD- 120

Query: 190 FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTL 249
              +L     L++L + NN +       +L  L  LE L L  N I+      ++  K +
Sbjct: 121 -TDSLIHLKNLEILSIRNNKLKSI---VMLGFLSKLEVLDLHGNEITN--TGGLTRLKKV 174

Query: 250 RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNL----ITGVIPGQLSECTQLKVIDLSL 305
             +D +  +            V    EL + + +       + P  +S         +  
Sbjct: 175 NWIDLTGQKCVN-------EPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLW 227

Query: 306 NYLN 309
               
Sbjct: 228 ELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 43/225 (19%), Positives = 78/225 (34%), Gaps = 26/225 (11%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
             +  L    +  LV      +L  +   N   +N+        +     L+ L LS+N 
Sbjct: 21  AVKQNLGKQSVTDLVS---QKELSGVQNFNGDNSNIQSLAG---MQFFTNLKELHLSHNQ 74

Query: 86  LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
           ++  +S           L  L +++N + ++  + + +   L  L L  N L      + 
Sbjct: 75  IS-DLSPLK----DLTKLEELSVNRNRLKNL--NGIPSAC-LSRLFLDNNEL--RDTDSL 124

Query: 146 GQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL 205
             L +L+ L + NN +       LG     L  L L  N IT +    L+    +  +DL
Sbjct: 125 IHLKNLEILSIRNNKLK--SIVMLGF-LSKLEVLDLHGNEITNTGG--LTRLKKVNWIDL 179

Query: 206 SNNNISGPFPDSVLENLGSLESL-ILSNNMISGSFPDSISSCKTL 249
           +        P      L    ++       IS   P  IS+  + 
Sbjct: 180 TGQKCVNE-PVKYQPELYITNTVKDPDGRWIS---PYYISNGGSY 220

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 45/199 (22%), Positives = 75/199 (37%), Gaps = 20/199 (10%)

Query: 108 LSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPS 167
                I  V P            NL    +   +     +LS +Q  +  N++I     +
Sbjct: 4   QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--SLA 57

Query: 168 ELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLES 227
            +     +L EL L HN I+   P  L   + L+ L ++ N +      + + +   L  
Sbjct: 58  GMQF-FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL---NGIPSA-CLSR 110

Query: 228 LILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV 287
           L L NN +     DS+   K L I+   +N++  I+          LE L L  N IT  
Sbjct: 111 LFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVMLGFLS---KLEVLDLHGNEITNT 165

Query: 288 IPGQLSECTQLKVIDLSLN 306
               L+   ++  IDL+  
Sbjct: 166 GG--LTRLKKVNWIDLTGQ 182

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 47/252 (18%), Positives = 84/252 (33%), Gaps = 21/252 (8%)

Query: 178 ELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG 237
           E       I   FP      +     +L   +++        + L  +++    N+ I  
Sbjct: 1   ESIQRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS---QKELSGVQNFNGDNSNIQS 55

Query: 238 SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQ 297
                +     L+ +  S N++S + P         LEEL +  N +  +          
Sbjct: 56  --LAGMQFFTNLKELHLSHNQISDLSPLKDLT---KLEELSVNRNRLKNLNGI---PSAC 107

Query: 298 LKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS 357
           L  + L  N L       L  L++LE      N L+  I   LG    L+ L L+ N+++
Sbjct: 108 LSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT 163

Query: 358 GEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSS 417
                 L     + WI LTG +   +       L     ++  + R+    P  + N  S
Sbjct: 164 -NTG-GLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGS 219

Query: 418 LVWLDLNSNNLT 429
            V   +      
Sbjct: 220 YVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 32/159 (20%), Positives = 62/159 (38%), Gaps = 14/159 (8%)

Query: 276 ELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGK 335
           E       I  V P            +L    +   + Q+  +L  ++ F    + ++  
Sbjct: 1   ESIQRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-S 55

Query: 336 IPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLA 395
           +   +    NLK+L L++N++S ++   L   + LE +S+  N L   +         L+
Sbjct: 56  LAG-MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNG--IPSACLS 109

Query: 396 VLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPP 434
            L L NN  + +    L +  +L  L + +N L   I  
Sbjct: 110 RLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SIVM 145

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 36/257 (14%), Positives = 76/257 (29%), Gaps = 59/257 (22%)

Query: 340 LGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQL 399
                N     L    ++  +       S ++  +   + +   +       T L  L L
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70

Query: 400 GNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRN 459
            +N+   ++   L + + L  L +N N L  ++                + S  L  +  
Sbjct: 71  SHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNG--------------IPSACLSRLFL 113

Query: 460 VGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ 519
             N                  L    +L                    + LE L +  N+
Sbjct: 114 DNN-----------------ELRDTDSLIHL-----------------KNLEILSIRNNK 139

Query: 520 FRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL 579
            +  I   +G +  L+VL+L  N+++      L RL+ +   D +  +   +  +    L
Sbjct: 140 LK-SI-VMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPEL 195

Query: 580 SFLVQIDLSNNELTGPI 596
                +   +     P 
Sbjct: 196 YITNTVKDPDGRWISPY 212

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 29/153 (18%), Positives = 54/153 (35%), Gaps = 17/153 (11%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           LS L L +N    ++ SL+ L   L+ L + +  L  +V       L  L  L+   N +
Sbjct: 108 LSRLFLDNNELR-DTDSLIHLK-NLEILSIRNNKLKSIVM---LGFLSKLEVLDLHGNEI 162

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVI-PSS 120
           T       L+   K+  +DL+           +        L   +  ++     I P  
Sbjct: 163 TNTGG---LTRLKKVNWIDLTGQKCV------NEPVKYQPELYITNTVKDPDGRWISPYY 213

Query: 121 LSNCTKLKILNLSFNLLA--GEIPRTFGQLSSL 151
           +SN        + + L     E+   F +  ++
Sbjct: 214 ISNGGSYVDGCVLWELPVYTDEVSYKFSEYINV 246

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  106 bits (265), Expect = 3e-24
 Identities = 60/304 (19%), Positives = 113/304 (37%), Gaps = 54/304 (17%)

Query: 736  FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVP 794
              +E ++G G  G V       G  VA+K+++          + E++ L +   H N++ 
Sbjct: 17   VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIR 73

Query: 795  LLGYCKIGEERLLVYEFMKFGSLEEVL--HGRAKARDQRILTWDARKKIARGAAKGLCFL 852
                        +  E     +L++++     +    +    ++    + R  A G+  L
Sbjct: 74   YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHL 131

Query: 853  HHNCIPHIIHRDMKSSNVLLDHE-------------MEARVSDFGMARLISALDTHLS-- 897
            H      IIHRD+K  N+L+                +   +SDFG+ + + +  +     
Sbjct: 132  HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 898  VSTLAGTPGYVPPE-------YYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDT 949
            ++  +GT G+  PE            R T   D++S G V   +L+ GK P     FGD 
Sbjct: 189  LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP-----FGDK 243

Query: 950  NLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
                  +  +  G         L  +    D S   E  +++  +   +   D  P KRP
Sbjct: 244  YS---RESNIIRGI------FSLDEMKCLHDRSLIAEATDLISQM---ID-HD--PLKRP 288

Query: 1010 NMLQ 1013
              ++
Sbjct: 289  TAMK 292

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (260), Expect = 4e-24
 Identities = 65/318 (20%), Positives = 109/318 (34%), Gaps = 70/318 (22%)

Query: 742  IGCGGFGEVFKATLKD-GSSVAIK----KLIRLSCQGDRE-FMAEMETLGKIKHRNLVPL 795
            IG G +G V  A      +  AIK      IR     D E    E+  + K+ H N+  L
Sbjct: 34   IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 796  LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIA------------- 842
                +  +   LV E    G L + L+        +      + +I              
Sbjct: 94   YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 843  --------------RGAAK-------GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV- 880
                          +  +         L +LH+     I HRD+K  N L        + 
Sbjct: 154  IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 881  -SDFGMARLISALDTH--LSVSTLAGTPGYVPPE--YYQSFRCTAKGDVYSFGVVLLELL 935
              DFG+++    L+      ++T AGTP +V PE     +     K D +S GV+L  LL
Sbjct: 211  LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 936  TGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLE 995
             G  P     F   N       +V   K +   +P   +++           ++++  L 
Sbjct: 271  MGAVP-----FPGVNDAD-TISQVLNKK-LCFENPNYNVLS--------PLARDLLSNL- 314

Query: 996  ITLQCVDDFPSKRPNMLQ 1013
              L   +    +R + ++
Sbjct: 315  --L-NRN--VDERFDAMR 327

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  102 bits (256), Expect = 6e-24
 Identities = 62/247 (25%), Positives = 96/247 (38%), Gaps = 55/247 (22%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIK-----KLIRLSCQGDREFMA--------------- 779
            IG G +G V  A    D +  A+K     KLIR +    R                   
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 780 ------EMETLGKIKHRNLVPLLGYCKIG---EERL-LVYEFMKFGSL-EEVLHGRAKAR 828
                 E+  L K+ H N+V L     +    E+ L +V+E +  G + E          
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137

Query: 829 DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL 888
             R           +   KG+ +LH+     IIHRD+K SN+L+  +   +++DFG++  
Sbjct: 138 QAR--------FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCT---AKGDVYSFGVVLLELLTGKRPTDKDD 945
               D  L  S   GTP ++ PE     R        DV++ GV L   + G+ P     
Sbjct: 187 FKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP----- 239

Query: 946 FGDTNLV 952
           F D  ++
Sbjct: 240 FMDERIM 246

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (265), Expect = 9e-24
 Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 15/216 (6%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHRN 791
           F    ++G GGFGEVF   +K    + A KKL +   +  + +   M E + L K+  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 792 LVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWD-ARKKIARGAAKGL 849
           +V L  Y    +  L LV   M  G +    H      D        A    A+    GL
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
             LH     +II+RD+K  NVLLD +   R+SD G+A  + A  T       AGTPG++ 
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMA 357

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PE           D ++ GV L E++  + P     
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score =  102 bits (256), Expect = 1e-23
 Identities = 36/235 (15%), Positives = 78/235 (33%), Gaps = 13/235 (5%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
              L+        +   +       L+++E+S   ++ ++  ++FS LP L  +     N
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPS- 119
              ++      N   L+ L +S   +   +       +     + LD+  N  +  I   
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSL--QKVLLDIQDNINIHTIERN 147

Query: 120 SLSNCT-KLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLE 178
           S    + +  IL L+ N +       F      +     NN++   +P+++ +     + 
Sbjct: 148 SFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVI 206

Query: 179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
           L +    I       L +   L+     N            E L +L    L+  
Sbjct: 207 LDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL-----EKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 98.4 bits (245), Expect = 3e-22
 Identities = 42/246 (17%), Positives = 81/246 (32%), Gaps = 16/246 (6%)

Query: 40  VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENS 99
           +P +L     N + L      L   + +   S    LE +++S N++   I     +   
Sbjct: 24  IPSDLP---RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79

Query: 100 CNSLLHLDLSQ-NHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPR-TFGQLSSLQRLDLS 157
              L  + + + N+++ + P +  N   L+ L +S   +   +P            LD+ 
Sbjct: 80  --KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQ 136

Query: 158 -NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPD 216
            N +I     +         + L L  N I        +     +L    NNN+    P+
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEE-LPN 195

Query: 217 SVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEE 276
            V         L +S   I       + + K LR     + +   +   +      +L E
Sbjct: 196 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKK--LPTLEKLV---ALME 250

Query: 277 LRLPDN 282
             L   
Sbjct: 251 ASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 98.4 bits (245), Expect = 3e-22
 Identities = 40/252 (15%), Positives = 81/252 (32%), Gaps = 16/252 (6%)

Query: 77  ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNL 136
            +     + +T       +  +   + + L      +  +   + S    L+ + +S N 
Sbjct: 12  RVFLCQESKVT------EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65

Query: 137 LAGEIPR-TFGQLSSLQRLDLSN-NHITGWIPSELGNACDSLLELKLPHNNITGSFPVTL 194
           +   I    F  L  L  + +   N++  +I  E      +L  L + +  I     V  
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHK 124

Query: 195 SSCSWLQLLDLSNNNISGPFPDSVLENLGS-LESLILSNNMISGSFPDSISSCKTLRIVD 253
                  LLD+ +N        +    L      L L+ N I      + +  +   +  
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184

Query: 254 FSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP 313
             +N +   +P D+  G S    L +    I  +    L    +L+    S   L   +P
Sbjct: 185 SDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK-KLP 240

Query: 314 --QELGKLEHLE 323
             ++L  L    
Sbjct: 241 TLEKLVALMEAS 252

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 94.1 bits (234), Expect = 9e-21
 Identities = 46/279 (16%), Positives = 84/279 (30%), Gaps = 54/279 (19%)

Query: 150 SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNN 209
           S +      + +T  IPS+L     + +EL+     +        S    L+ +++S N+
Sbjct: 10  SNRVFLCQESKVTE-IPSDLPR---NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65

Query: 210 ISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICP 269
           +       V  NL  L  + +                          N +   I P+   
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIEKA-----------------------NNLL-YINPEAFQ 101

Query: 270 GVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWF 329
            + +L+ L + +  I  +         Q  ++D+  N    +I +              F
Sbjct: 102 NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS------------F 149

Query: 330 NGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE- 387
            GL                L LN N +  EI    F+     E      N L  ++P + 
Sbjct: 150 VGL----------SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDV 197

Query: 388 FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN 426
           F   +   +L +   R        L N   L      + 
Sbjct: 198 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 73.7 bits (181), Expect = 5e-14
 Identities = 47/267 (17%), Positives = 85/267 (31%), Gaps = 50/267 (18%)

Query: 344 KNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGN 401
           +N  +L     KL   I    FS   +LE I ++ N++   I  + FS L +L  +++  
Sbjct: 30  RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88

Query: 402 -NRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNV 460
            N      P    N  +L +L +++  +   +P               + S   V +   
Sbjct: 89  ANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD-----------VHKIHSLQKVLLDIQ 136

Query: 461 GNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQF 520
            N                   + I T++   F  +                 L L+ N  
Sbjct: 137 DN-------------------INIHTIERNSFVGLSF-----------ESVILWLNKNGI 166

Query: 521 RGKIPDEIGDMIALQVLELAH-NQLSGEIPS-SLGRLRNLGVFDASHNRLQGQIPESFSN 578
           + +I +   +   L  L L+  N L  E+P+          + D S  R+         N
Sbjct: 167 Q-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224

Query: 579 LSFLVQIDLSNNELTGPIPQRGQLSTL 605
           L  L      N +    + +   L   
Sbjct: 225 LKKLRARSTYNLKKLPTLEKLVALMEA 251

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  102 bits (257), Expect = 2e-23
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)

Query: 677 RARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGF 736
           R+   EA+EV     L       + +       +    A F  ++   K   +       
Sbjct: 33  RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT-V 91

Query: 737 SAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVP 794
           S   ++G G FG+V K      G  +A K +I+     D+E    E+  + ++ H NL+ 
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L    +   + +LV E++  G L +    R       +   D      +   +G+  +H 
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFD----RIIDESYNLTELDTI-LFMKQICEGIRHMHQ 205

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARV--SDFGMARLISALDTHLSVSTLAGTPGYVPPE- 911
               +I+H D+K  N+L  +    ++   DFG+AR          +    GTP ++ PE 
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPEV 259

Query: 912 ----YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
               +  SF      D++S GV+   LL+G  P
Sbjct: 260 VNYDFV-SFPT----DMWSVGVIAYMLLSGLSP 287

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (262), Expect = 2e-23
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHRN 791
           F    ++G GGFGEV    ++    + A KKL +   +  +     + E + L K+  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 792 LVPLLGYCKIGEERL-LVYEFMKFGSLEEVLH--GRAKARDQRILTWDARKKIARGAAKG 848
           +V  L Y    ++ L LV   M  G L+  ++  G+A   + R     A    A     G
Sbjct: 246 VVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR-----AVFYAAE-ICCG 298

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           L  LH      I++RD+K  N+LLD     R+SD G+A  +    T   +    GT GY+
Sbjct: 299 LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYM 352

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
            PE  ++ R T   D ++ G +L E++ G+ P  +  
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (252), Expect = 3e-23
 Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 42/230 (18%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           L+G G +G+V +    +     A+K     KL R+   G+     E++ L +++H+N++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIP-NGEANVKKEIQLLRRLRHKNVIQ 70

Query: 795 LLGYCKIGEER----LLVYEFMKFGSLE---EVLHGRAKARDQRILTWDARKK----IAR 843
           L     +  E      +V E+   G  E    V   R            A       I  
Sbjct: 71  L--VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP-------VCQAHGYFCQLID- 120

Query: 844 GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG 903
               GL +LH      I+H+D+K  N+LL      ++S  G+A  +       +  T  G
Sbjct: 121 ----GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173

Query: 904 TPGYVPPEYYQSFRC--TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
           +P + PPE           K D++S GV L  + TG  P     F   N+
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-----FEGDNI 218

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (253), Expect = 3e-23
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 24/213 (11%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE----FMAEMETLGKIKHR 790
           FS    IG G FG V+ A  +++   VAIKK +  S +   E     + E+  L K++H 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKK-MSYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           N +   G         LV E+   GS  ++L        ++ L       +  GA +GL 
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-----KKPLQEVEIAAVTHGALQGLA 168

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           +LH +   ++IHRD+K+ N+LL      ++ DFG A +++        ++  GTP ++ P
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAP 219

Query: 911 E---YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E        +   K DV+S G+  +EL   K P
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 56/236 (23%), Positives = 85/236 (36%), Gaps = 39/236 (16%)

Query: 4   VLKLSSNLFT-LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLT 62
            L LS N    L S S    P  L+ L+LS   +  +  D  +  L +L  L  + N + 
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPE-LQVLDLSRCEIQTI-EDGAYQSLSHLSTLILTGNPIQ 89

Query: 63  GFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLS 122
             L     S    L+ L     NL  S+                              + 
Sbjct: 90  -SLALGAFSGLSSLQKLVAVETNLA-SLE--------------------------NFPIG 121

Query: 123 NCTKLKILNLSFN-LLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSE----LGNACDSLL 177
           +   LK LN++ N + + ++P  F  L++L+ LDLS+N I   I       L       L
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNL 180

Query: 178 ELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
            L L  N +             L+ L L  N +    PD + + L SL+ + L  N
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 20/216 (9%)

Query: 76  LELLDLSYNNLTGSISGFSLNEN---SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNL 132
            + LDLS+N L        L      S   L  LDLS+  I  +   +  + + L  L L
Sbjct: 30  TKNLDLSFNPLR------HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83

Query: 133 SFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPV 192
           + N +       F  LSSLQ+L     ++   + +       +L EL + HN I  SF +
Sbjct: 84  TGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQ-SFKL 141

Query: 193 --TLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLE----SLILSNNMISGSFPDSISSC 246
               S+ + L+ LDLS+N I      + L  L  +     SL LS N ++          
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSI-YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199

Query: 247 KTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
             L+ +   +N++   +P  I   ++SL+++ L  N
Sbjct: 200 IRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 11/211 (5%)

Query: 102 SLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHI 161
           S  +LDLS N +  +   S  +  +L++L+LS   +       +  LS L  L L+ N I
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 162 TGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNI-SGPFPDSVLE 220
              +     +   SL +L     N+       +     L+ L++++N I S   P+    
Sbjct: 89  QS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE-YFS 146

Query: 221 NLGSLESLILSNNMIS----GSFPDSISSCKTLRIV-DFSSNRVSGIIPPDICPGVSSLE 275
           NL +LE L LS+N I           +     L +  D S N ++  I P     +  L+
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDL-RVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI-RLK 203

Query: 276 ELRLPDNLITGVIPGQLSECTQLKVIDLSLN 306
           EL L  N +  V  G     T L+ I L  N
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 65/263 (24%), Positives = 97/263 (36%), Gaps = 51/263 (19%)

Query: 117 IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSL 176
           IP +L      K L+LSFN L      +F     LQ LDLS   I   I      A  SL
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIED---GAYQSL 75

Query: 177 LELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS 236
                                  L  L L+ N I           L SL+ L+     ++
Sbjct: 76  SH---------------------LSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA 113

Query: 237 GSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECT 296
                 I   KTL+ ++ + N +     P+    +++LE L L  N I  +    L    
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173

Query: 297 QLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKL 356
           Q+ +++LSL  L+                    N +   I P   K   LK+L L+ N+L
Sbjct: 174 QMPLLNLSL-DLSL-------------------NPMN-FIQPGAFKEIRLKELALDTNQL 212

Query: 357 SGEIPAELF-SCSNLEWISLTGN 378
              +P  +F   ++L+ I L  N
Sbjct: 213 K-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 46/165 (27%), Positives = 63/165 (38%), Gaps = 15/165 (9%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           LS L L+ N     +         L++L      L  L  +     L  L  LN ++N +
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL-ENFPIGHLKTLKELNVAHNLI 136

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSL-------LHLDLSQNHIM 114
             F      SN   LE LDLS N +       S+       L       L LDLS N + 
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ------SIYCTDLRVLHQMPLLNLSLDLSLNPM- 189

Query: 115 DVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
           + I        +LK L L  N L       F +L+SLQ++ L  N
Sbjct: 190 NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 49/259 (18%), Positives = 84/259 (32%), Gaps = 66/259 (25%)

Query: 345 NLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNN 402
           + K+L L+ N L   + +  F S   L+ + L+  E+   I    +  L+ L+ L L  N
Sbjct: 29  STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 403 RFKGEIPGELGNCSSLVWLDLNSNNLTG------DIPPRLGRQLGAKPLGGFLSSNTLVF 456
             +    G     SSL  L     NL             L ++L        ++ N    
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL-KEL-------NVAHN---- 134

Query: 457 VRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLS 516
                                      I +             +   F+    LE+LDLS
Sbjct: 135 --------------------------LIQSF-----------KLPEYFSNLTNLEHLDLS 157

Query: 517 YNQFRGKIPDEIGD-MIALQV----LELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQ 571
            N+ +  I       +  + +    L+L+ N ++  I     +   L       N+L+  
Sbjct: 158 SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSV 215

Query: 572 IPESFSNLSFLVQIDLSNN 590
               F  L+ L +I L  N
Sbjct: 216 PDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 56.9 bits (138), Expect = 7e-09
 Identities = 41/229 (17%), Positives = 77/229 (33%), Gaps = 42/229 (18%)

Query: 396 VLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTL 454
            L L  N  +        +   L  LDL+   +   I     + L     L   L+ N +
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL--ILTGNPI 88

Query: 455 VFVRNVGNSCKGVGGLLEFAGIRPERL--LQIPTLKSCDFARMYSGPVLSLFTQYQTLEY 512
             +                 G     L  LQ       + A + + P        +TL+ 
Sbjct: 89  QSLA---------------LGA-FSGLSSLQKLVAVETNLASLENFP----IGHLKTLKE 128

Query: 513 LDLSYNQFRGKIPDEI-GDMIALQVLELAHNQLSGEIPSSLGRLRNLGVF----DASHNR 567
           L++++N  +     E   ++  L+ L+L+ N++     + L  L  + +     D S N 
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 568 LQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGL 616
           +    P +F  +  L ++ L  N          QL ++P   +     L
Sbjct: 189 MNFIQPGAFKEIR-LKELALDTN----------QLKSVPDGIFDRLTSL 226

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 48.0 bits (115), Expect = 7e-06
 Identities = 21/85 (24%), Positives = 35/85 (41%)

Query: 509 TLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRL 568
           + + LDLS+N  R            LQVL+L+  ++      +   L +L     + N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 569 QGQIPESFSNLSFLVQIDLSNNELT 593
           Q     +FS LS L ++      L 
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLA 113

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  100 bits (252), Expect = 7e-23
 Identities = 56/245 (22%), Positives = 95/245 (38%), Gaps = 21/245 (8%)

Query: 705 KEKEPLSINVATFQRQLRKLKFSQLIEATNG-----FSAESLIGCGGFGEVFKATLKD-G 758
           K   P   +   F   + K    Q +E   G     +     +G G FG V +   K  G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 759 SSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL 817
                K  I      D+     E+  + ++ H  L+ L    +   E +L+ EF+  G L
Sbjct: 77  RVFVAK-FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135

Query: 818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME 877
            +    R  A D ++   +      R A +GL  +H +    I+H D+K  N++ + +  
Sbjct: 136 FD----RIAAEDYKMSEAEVI-NYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKA 187

Query: 878 ARV--SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELL 935
           + V   DFG+A  +   +    V     T  +  PE           D+++ GV+   LL
Sbjct: 188 SSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244

Query: 936 TGKRP 940
           +G  P
Sbjct: 245 SGLSP 249

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (256), Expect = 7e-23
 Identities = 68/278 (24%), Positives = 115/278 (41%), Gaps = 40/278 (14%)

Query: 742  IGCGGFGEVFKATLK-DGSSVAIKKLI--RLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
            +G G +GEV     K      AIK +    +S   + + + E+  L  + H N++ L  +
Sbjct: 45   LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 799  CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
             +      LV E  K G L +        R +          I +    G+ +LH +   
Sbjct: 105  FEDKRNYYLVMECYKGGELFD----EIIHRMK--FNEVDAAVIIKQVLSGVTYLHKH--- 155

Query: 859  HIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
            +I+HRD+K  N+LL+ + +    ++ DFG++ +         +    GT  Y+ PE  + 
Sbjct: 156  NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRK 212

Query: 916  FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV 975
             +   K DV+S GV+L  LL G  P     FG       +  KV +GK      PE   V
Sbjct: 213  -KYDEKCDVWSIGVILFILLAGYPP-----FGGQTDQE-ILRKVEKGK-YTFDSPEWKNV 264

Query: 976  TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            +        E  K++++ +   L   D    +R +  Q
Sbjct: 265  S--------EGAKDLIKQM---L-QFD--SQRRISAQQ 288

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  102 bits (256), Expect = 1e-22
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 23/249 (9%)

Query: 702 KIDKEKEPLSINVATFQRQLRKLKFSQLIEATNG-----FSAESLIGCGGFGEVFKATLK 756
           KI + K  +S N   +   + K  + Q +E  +      +     +G G FG V + T +
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 757 D-GSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF 814
             G++ A K  +    + D+E +  E++T+  ++H  LV L    +   E +++YEFM  
Sbjct: 180 ATGNNFAAK-FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238

Query: 815 GSL-EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD 873
           G L E+V     K      ++ D   +  R   KGLC +H N   + +H D+K  N++  
Sbjct: 239 GELFEKVADEHNK------MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFT 289

Query: 874 HEMEARV--SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVL 931
            +    +   DFG+   +   D   SV    GT  +  PE  +        D++S GV+ 
Sbjct: 290 TKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

Query: 932 LELLTGKRP 940
             LL+G  P
Sbjct: 347 YILLSGLSP 355

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 30/169 (17%), Positives = 62/169 (36%), Gaps = 14/169 (8%)

Query: 45  FSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLL 104
            +++ +L Y+  +  N+T       +  +  ++ L ++  + T + +  S      ++L 
Sbjct: 40  EAQMNSLTYITLANINVTDLTG---IEYAHNIKDLTINNIHAT-NYNPIS----GLSNLE 91

Query: 105 HLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLS-NNHITG 163
            L +    +      +LS  T L +L++S +     I      L  +  +DLS N  IT 
Sbjct: 92  RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151

Query: 164 WIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISG 212
                L      L  L +  + +       +     L  L   +  I G
Sbjct: 152 --IMPLKT-LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 40/180 (22%), Positives = 72/180 (40%), Gaps = 11/180 (6%)

Query: 84  NNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPR 143
           N L G  S  ++ E   NSL ++ L+  ++ D+  + +     +K L ++        P 
Sbjct: 27  NGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP- 83

Query: 144 TFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLL 203
               LS+L+RL +    +T      L     SL  L + H+    S    +++   +  +
Sbjct: 84  -ISGLSNLERLRIMGKDVTSDKIPNLSG-LTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 204 DLSNNN-ISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGI 262
           DLS N  I+   P   L+ L  L+SL +  + +       I     L  +   S  + G 
Sbjct: 142 DLSYNGAITDIMP---LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 35/188 (18%), Positives = 73/188 (38%), Gaps = 17/188 (9%)

Query: 102 SLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHI 161
           + L+  L Q+   ++  + +++   L  + L+   +            +++ L ++N H 
Sbjct: 24  AYLNGLLGQSSTANITEAQMNS---LTYITLANINVTDLTG--IEYAHNIKDLTINNIHA 78

Query: 162 TGWIP-SELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLE 220
           T + P S L N    L  L++   ++T      LS  + L LLD+S++        + + 
Sbjct: 79  TNYNPISGLSN----LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL-TKIN 133

Query: 221 NLGSLESLILS-NNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL 279
            L  + S+ LS N  I+      + +   L+ ++   + V              L +L  
Sbjct: 134 TLPKVNSIDLSYNGAITD--IMPLKTLPELKSLNIQFDGVHDYRG---IEDFPKLNQLYA 188

Query: 280 PDNLITGV 287
               I G 
Sbjct: 189 FSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 34/208 (16%), Positives = 72/208 (34%), Gaps = 13/208 (6%)

Query: 223 GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
           G+ E   L  +  + + PDS  + K         +  + I    +    +SL  + L + 
Sbjct: 1   GAAEQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTANITEAQM----NSLTYITLANI 54

Query: 283 LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK 342
            +T +    +     +K + ++  +     P  +  L +LE+       +     P L  
Sbjct: 55  NVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSG 110

Query: 343 CKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNN 402
             +L  L ++++     I  ++ +   +  I L+ N     I P    L  L  L +  +
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFD 169

Query: 403 RFKGEIPGELGNCSSLVWLDLNSNNLTG 430
                    + +   L  L   S  + G
Sbjct: 170 GVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 40/254 (15%), Positives = 85/254 (33%), Gaps = 65/254 (25%)

Query: 107 DLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIP 166
            L  +     IP   S         L  +  A     T  Q++SL  + L+N ++T    
Sbjct: 7   GLKASQDNVNIP--DSTFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT---- 57

Query: 167 SELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLE 226
                             ++TG     +     ++ L ++N + +     + +  L +LE
Sbjct: 58  ------------------DLTG-----IEYAHNIKDLTINNIHATNY---NPISGLSNLE 91

Query: 227 SLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN-LIT 285
            L +    ++     ++S   +L ++D S +     I   I   +  +  + L  N  IT
Sbjct: 92  RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN-TLPKVNSIDLSYNGAIT 150

Query: 286 GVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKN 345
            ++P  L    +LK +++  + ++            +E F                    
Sbjct: 151 DIMP--LKTLPELKSLNIQFDGVH--------DYRGIEDF------------------PK 182

Query: 346 LKDLILNNNKLSGE 359
           L  L   +  + G+
Sbjct: 183 LNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 23/200 (11%), Positives = 68/200 (34%), Gaps = 14/200 (7%)

Query: 204 DLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGII 263
            L  +  +   PDS  +      + +L  +  +     + +   +L  +  ++  V+ + 
Sbjct: 7   GLKASQDNVNIPDSTFKAY---LNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLT 60

Query: 264 PPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLE 323
             +      ++++L + +   T   P  +S  + L+ + +    +       L  L  L 
Sbjct: 61  GIEYAH---NIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115

Query: 324 QFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQ 383
                 +  +  I  ++     +  + L+ N    +I   L +   L+ +++  + +   
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY 174

Query: 384 IPPEFSRLTRLAVLQLGNNR 403
                    +L  L   +  
Sbjct: 175 RG--IEDFPKLNQLYAFSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 28/136 (20%), Positives = 54/136 (39%), Gaps = 5/136 (3%)

Query: 299 KVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG 358
             ++  L   + +      ++  L         +   +   +    N+KDL +NN   + 
Sbjct: 24  AYLNGLLGQ-SSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN 80

Query: 359 EIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSL 418
             P  +   SNLE + + G ++T    P  S LT L +L + ++     I  ++     +
Sbjct: 81  YNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV 138

Query: 419 VWLDLNSNNLTGDIPP 434
             +DL+ N    DI P
Sbjct: 139 NSIDLSYNGAITDIMP 154

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 14/93 (15%), Positives = 34/93 (36%), Gaps = 1/93 (1%)

Query: 501 LSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGV 560
            +  +    LE L +            +  + +L +L+++H+     I + +  L  +  
Sbjct: 81  YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140

Query: 561 FDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
            D S+N     I      L  L  +++  + + 
Sbjct: 141 IDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 18/81 (22%), Positives = 34/81 (41%), Gaps = 2/81 (2%)

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQ 569
           ++ L ++        P  I  +  L+ L +    ++ +   +L  L +L + D SH+   
Sbjct: 68  IKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125

Query: 570 GQIPESFSNLSFLVQIDLSNN 590
             I    + L  +  IDLS N
Sbjct: 126 DSILTKINTLPKVNSIDLSYN 146

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 29/230 (12%), Positives = 62/230 (26%), Gaps = 51/230 (22%)

Query: 318 KLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTG 377
                + ++    G          +  +L  + L N  ++     E     N++ +++  
Sbjct: 18  PDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINN 75

Query: 378 NELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLG 437
              T    P  S L+ L  L++       +    L   +SL  LD++ +     I     
Sbjct: 76  IHATN-YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL---- 129

Query: 438 RQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYS 497
                  +      N++    N                        I  +          
Sbjct: 130 -----TKINTLPKVNSIDLSYN----------------------GAITDIMP-------- 154

Query: 498 GPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE 547
              L    +   L+ L++ ++         I D   L  L      + G+
Sbjct: 155 ---LKTLPE---LKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 26/227 (11%), Positives = 67/227 (29%), Gaps = 51/227 (22%)

Query: 368 SNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNN 427
           S  +         +       +++  L  + L N     ++ G +    ++  L +N+ +
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIH 77

Query: 428 LTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTL 487
            T +            P+ G  +   L  +                          +   
Sbjct: 78  AT-NY----------NPISGLSNLERLRIMGK-----------------------DV--- 100

Query: 488 KSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE 547
                    +   +   +   +L  LD+S++     I  +I  +  +  ++L++N    +
Sbjct: 101 ---------TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151

Query: 548 IPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTG 594
           I   L  L  L   +   + +         +   L Q+   +  + G
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 31/227 (13%), Positives = 64/227 (28%), Gaps = 54/227 (23%)

Query: 344 KNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNR 403
           K   + +L  +  +    A++   ++L +I+L    +T  +         +  L + N  
Sbjct: 23  KAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIH 77

Query: 404 FKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS 463
                P  +   S+L  L +   ++T D  P L        L   +S +           
Sbjct: 78  ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL--DISHSAH--------- 124

Query: 464 CKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGK 523
                                               +L+       +  +DLSYN     
Sbjct: 125 ---------------------------------DDSILTKINTLPKVNSIDLSYNGAITD 151

Query: 524 IPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQG 570
           I   +  +  L+ L +  + +       +     L    A    + G
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (252), Expect = 3e-22
 Identities = 72/279 (25%), Positives = 119/279 (42%), Gaps = 41/279 (14%)

Query: 742  IGCGGFGEVFKATLK-DGSSVAIKKLI--RLSCQGDRE-FMAEMETLGKIKHRNLVPLLG 797
            +G G FGEV     K  G   A+K +   ++  + D+E  + E++ L ++ H N++ L  
Sbjct: 34   LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 798  YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
            + +      LV E    G L +       +R +   +     +I R    G+ ++H N  
Sbjct: 94   FFEDKGYFYLVGEVYTGGELFD----EIISRKR--FSEVDAARIIRQVLSGITYMHKN-- 145

Query: 858  PHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
              I+HRD+K  N+LL+ + +    R+ DFG++    A      +    GT  Y+ PE   
Sbjct: 146  -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLH 201

Query: 915  SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL 974
                  K DV+S GV+L  LL+G  P     F   N    +  KV +GK      P+   
Sbjct: 202  G-TYDEKCDVWSTGVILYILLSGCPP-----FNGANEYD-ILKKVEKGK-YTFELPQWKK 253

Query: 975  VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            V+        E  K+++R +   L      PS R +   
Sbjct: 254  VS--------ESAKDLIRKM---L-TYV--PSMRISARD 278

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 29/219 (13%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIR--LSCQGDREFMA----EMETLGKIKHR--N 791
           L+G GGFG V+    + D   VAIK + +  +S  G+         E+  L K+      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 792 LVPLLGYCKIGEERLLVYEFMK-FGSLEE--VLHGRAKARDQRILTWDARKKIARGAAKG 848
           ++ LL + +  +  +L+ E  +    L +     G  +          AR        + 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARS-FFWQVLEA 161

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
           +   H+     ++HRD+K  N+L+D    E ++ DFG   L+   DT    +   GT  Y
Sbjct: 162 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVY--TDFDGTRVY 214

Query: 908 VPPEYYQSFRCTA-KGDVYSFGVVLLELLTGKRPTDKDD 945
            PPE+ +  R       V+S G++L +++ G  P + D+
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 97.3 bits (243), Expect = 4e-22
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 19/212 (8%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKL-----IRLSCQGDREFMAEMETLGKIKH 789
           F    ++G G F  V  A     S   AIK L     I+ + +       E + + ++ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPY-VTRERDVMSRLDH 89

Query: 790 RNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
              V L    +  +E+L     + K G L + +      +         R   A      
Sbjct: 90  PFFVKLYFTFQ-DDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAE-IVSA 142

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           L +LH      IIHRD+K  N+LL+ +M  +++DFG A+++S        ++  GT  YV
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            PE           D+++ G ++ +L+ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.2 bits (245), Expect = 6e-22
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 21/213 (9%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHRN 791
           F     IG G FG+V      D   + A+K + +  C    E      E++ +  ++H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 792 LVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           LV L  Y    EE + +V + +  G L   L      ++        +  I       L 
Sbjct: 77  LVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ-----QNVHFKEETVKLFICE-LVMALD 129

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           +L +     IIHRDMK  N+LLD      ++DF +A ++         +T+AGT  Y+ P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183

Query: 911 EYYQSFRCTAKG---DVYSFGVVLLELLTGKRP 940
           E + S +        D +S GV   ELL G+RP
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 96.6 bits (241), Expect = 7e-22
 Identities = 52/227 (22%), Positives = 84/227 (37%), Gaps = 43/227 (18%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK----------- 788
           L+G GGFG VF    L D   VAIK + R    G     + +                  
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG----WSPLSDSVTCPLEVALLWKVGA 93

Query: 789 ---HRNLVPLLGYCKIGEERLLVYEFMKFGSLEE-----VLHGRAKARDQRILTWDARKK 840
              H  ++ LL + +  E  +LV E       ++        G         L     + 
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGP--------LGEGPSRC 143

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMARLISALDTHLSVS 899
                   +   H      ++HRD+K  N+L+D     A++ DFG   L+   D     +
Sbjct: 144 FFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPY--T 196

Query: 900 TLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDKDD 945
              GT  Y PPE+    +       V+S G++L +++ G  P ++D 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 97.4 bits (243), Expect = 7e-22
 Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 23/219 (10%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G F  V +   ++ G   A+K     K          +   E      +KH ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 796 LGYCKIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L          +V+EFM    L  E++    +A    + +        R   + L + H 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIV---KRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           N   +IIHRD+K   VLL  +  +   ++  FG+A  +   ++ L      GTP ++ PE
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHFMAPE 203

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
             +        DV+  GV+L  LL+G  P     F  T 
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLP-----FYGTK 237

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 33/214 (15%), Positives = 58/214 (27%), Gaps = 50/214 (23%)

Query: 739 ESLIGCGGFGEVFKATLKD---GSSVAIKKLIRLSCQGD----REFMAEMETLGKIKHRN 791
               G     + ++A   D      VA+   +           +E ++    L +I    
Sbjct: 36  LIFHGGVPPLQFWQAL--DTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           +  +L         L+V E+++ GSL+EV             +     +  +  A     
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADA 144

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            H      +       S V         VS  G   L                P  +P  
Sbjct: 145 AHRA---GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA 179

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                    + D+   G  L  LL  + P  +  
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAG 206

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 95.3 bits (237), Expect = 4e-21
 Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 14/175 (8%)

Query: 40  VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENS 99
           VP +L         L+ S+NNL+    E   +    L  L LS+N+L   IS  +     
Sbjct: 33  VPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFV--P 86

Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPR-TFGQLSSLQRLDLSN 158
             +L +LDLS NH+  +     S+   L++L L  N +   + R  F  ++ LQ+L LS 
Sbjct: 87  VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145

Query: 159 NHITGWIPSELGNACDSLLELK---LPHNNITGSFPVTLSSCSWLQL--LDLSNN 208
           N I+   P EL    + L +L    L  N +       L          L L NN
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 88.4 bits (219), Expect = 8e-19
 Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 9/168 (5%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           LP     L+LS   L  L  +   ++L NL  L  S+N+L  F+          L  LDL
Sbjct: 37  LPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDL 95

Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEI 141
           S N+L  ++  F  ++    +L  L L  NHI+ V  ++  +  +L+ L LS N ++   
Sbjct: 96  SSNHLH-TLDEFLFSDLQ--ALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152

Query: 142 PRTFG---QLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLP-HNN 185
                   +L  L  LDLS+N +   +P        + ++  L  HNN
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 44/211 (20%), Positives = 73/211 (34%), Gaps = 56/211 (26%)

Query: 200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRV 259
             LLDLS+NN+S    +     L +L SL+LS+N ++                       
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN----------------------- 77

Query: 260 SGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKL 319
              I  +    V +L  L L  N +  +     S+   L+V+ L  N            +
Sbjct: 78  --FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN-----------HI 124

Query: 320 EHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSC----SNLEWISL 375
             +++    F  +             L+ L L+ N++S   P EL         L  + L
Sbjct: 125 VVVDRNA--FEDM-----------AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDL 170

Query: 376 TGNELTGQIPPEFSRLTRLAV--LQLGNNRF 404
           + N+L      +  +L       L L NN  
Sbjct: 171 SSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 43/199 (21%), Positives = 85/199 (42%), Gaps = 35/199 (17%)

Query: 238 SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQ 297
           + P S+ S     ++D S N +S +        +++L  L L  N +  +          
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89

Query: 298 LKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS 357
           L+ +DLS N+L+ ++ + L            F+ L+            L+ L+L NN + 
Sbjct: 90  LRYLDLSSNHLH-TLDEFL------------FSDLQ-----------ALEVLLLYNNHIV 125

Query: 358 GEIPAELFS-CSNLEWISLTGNELTGQIPPE----FSRLTRLAVLQLGNNRFKGEIPGEL 412
             +    F   + L+ + L+ N+++ + P E     ++L +L +L L +N+ K     +L
Sbjct: 126 -VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183

Query: 413 GNCSSLVW--LDLNSNNLT 429
               + V   L L++N L 
Sbjct: 184 QKLPAWVKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 22/92 (23%), Positives = 41/92 (44%), Gaps = 4/92 (4%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEI-GDMIALQVLELAHNQLSGEIPS-SLGRLRNLGVF 561
            T+   L  L LS+N     I  E    +  L+ L+L+ N L   +       L+ L V 
Sbjct: 60  PTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVL 117

Query: 562 DASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
              +N +      +F +++ L ++ LS N+++
Sbjct: 118 LLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 35/123 (28%), Positives = 53/123 (43%), Gaps = 12/123 (9%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEI-GDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFD 562
           F     L YLDLS N     + + +  D+ AL+VL L +N +     ++   +  L    
Sbjct: 84  FVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142

Query: 563 ASHNRLQGQIPESFSN---LSFLVQIDLSNNELTGPIPQRGQLSTLPASQYA-----NNP 614
            S N++     E   +   L  L+ +DLS+N+L   +P    L  LPA         NNP
Sbjct: 143 LSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK-LP-LTDLQKLPAWVKNGLYLHNNP 200

Query: 615 GLC 617
             C
Sbjct: 201 LEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 27/88 (30%), Positives = 38/88 (43%), Gaps = 5/88 (5%)

Query: 509 TLEYLDLSYNQFRGKIPDEI--GDMIALQVLELAHNQLSGEIPS-SLGRLRNLGVFDASH 565
               LDLS+N    ++  E     +  L  L L+HN L+  I S +   + NL   D S 
Sbjct: 40  YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 566 NRLQGQIPESFSNLSFLVQIDLSNNELT 593
           N L       FS+L  L  + L NN + 
Sbjct: 98  NHLHTLDEFLFSDLQALEVLLLYNNHIV 125

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 46/214 (21%), Positives = 75/214 (35%), Gaps = 57/214 (26%)

Query: 352 NNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE--FSRLTRLAVLQLGNNRFKGEIP 409
           +  +L   +P  L S      + L+ N L+ ++  E   +RLT L  L L +N       
Sbjct: 26  SKQQLP-NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISS 81

Query: 410 GELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVG 468
                  +L +LDL+SN+L   +   L   L A + L   L +N +V V           
Sbjct: 82  EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVL--LLYNNHIVVVDR--------- 129

Query: 469 GLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI 528
                                            + F     L+ L LS NQ   + P E+
Sbjct: 130 ---------------------------------NAFEDMAQLQKLYLSQNQIS-RFPVEL 155

Query: 529 ----GDMIALQVLELAHNQLSGEIPSSLGRLRNL 558
                 +  L +L+L+ N+L     + L +L   
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 97.1 bits (242), Expect = 4e-21
 Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 46/281 (16%)

Query: 742  IGCGGFGEVFKATLK-DGSSVAIKKLI--RLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
            +G G FGEV K   +      A+K +       +     + E+E L K+ H N++ L   
Sbjct: 30   LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 799  CKIGEERLLVY---EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
                E+    Y   E    G L +        R +   +     +I +    G+ ++H +
Sbjct: 90   L---EDSSSFYIVGELYTGGELFD----EIIKRKR--FSEHDAARIIKQVFSGITYMHKH 140

Query: 856  CIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
               +I+HRD+K  N+LL+ + +    ++ DFG++           +    GT  Y+ PE 
Sbjct: 141  ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEV 194

Query: 913  YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL 972
             +      K DV+S GV+L  LL+G  P     F   N    +  +V  GK      P+ 
Sbjct: 195  LRG-TYDEKCDVWSAGVILYILLSGTPP-----FYGKNEYD-ILKRVETGK-YAFDLPQW 246

Query: 973  LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
              ++        ++ K+++R +   L      PS R    Q
Sbjct: 247  RTIS--------DDAKDLIRKM---L-TFH--PSLRITATQ 273

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 36/231 (15%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
            +G G +GEV  A       +VA+K     + +       +E    +     + H N+V 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK----IARGAAKGLC 850
             G+ + G  + L  E+   G L + +       D  +   DA++     +A     G+ 
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-----GVV 119

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           +LH      I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV P
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 911 E-----YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK 956
           E      + +       DV+S G+VL  +L G+ P D+          W +
Sbjct: 177 ELLKRREFHA----EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 94.2 bits (235), Expect = 5e-21
 Identities = 43/208 (20%), Positives = 79/208 (37%), Gaps = 27/208 (12%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
           +G G FG V +        +   K  +++          E+  L   +HRN++ L    +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
             EE ++++EF+    + E    R       +   +          + L FLH +   +I
Sbjct: 72  SMEELVMIFEFISGLDIFE----RINTSAFELNEREIV-SYVHQVCEALQFLHSH---NI 123

Query: 861 IHRDMKSSNVLLDHEMEARV--SDFGMARLISALDTHLSVSTLAGTPGYVPPE------Y 912
            H D++  N++      + +   +FG AR +       +   L   P Y  PE       
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 913 YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
             S       D++S G ++  LL+G  P
Sbjct: 181 --STAT----DMWSLGTLVYVLLSGINP 202

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 38/230 (16%), Positives = 83/230 (36%), Gaps = 14/230 (6%)

Query: 79  LDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
             ++  ++   I           S   L L + H+  +   + SN   +  + +S ++  
Sbjct: 16  FRVTCKDIQ-RIPSLP------PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTL 68

Query: 139 GEIPR-TFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFP--VTLS 195
            ++   +F  LS +  +++ N     +I  +       L  L + +  +   FP    + 
Sbjct: 69  QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127

Query: 196 SCSWLQLLDLSNNNISGPFPDSVLENLGS-LESLILSNNMISGSFPDSISSCKTLRIVDF 254
           S     +L++++N      P +  + L +   +L L NN  + S      +   L  V  
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186

Query: 255 SSNRVSGIIPPDICPG-VSSLEELRLPDNLITGVIPGQLSECTQLKVIDL 303
           + N+   +I  D   G  S    L +    +T +    L    +L   + 
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 46/188 (24%), Positives = 76/188 (40%), Gaps = 12/188 (6%)

Query: 2   LSVLKLSSN--LFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYN 59
           +S + +S +  L  L S S   L   +  +E+ +   +  +  +   +LP L +L     
Sbjct: 57  ISRIYVSIDVTLQQLESHSFYNLS-KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115

Query: 60  NLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPS 119
            L  F   T + ++D   +L+++ N    SI   +     CN  L L L  N     +  
Sbjct: 116 GLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ-GLCNETLTLKLYNNGFT-SVQG 173

Query: 120 SLSNCTKLKILNLSFNLLAGEIPR-TFGQL-SSLQRLDLSNNHITGWIPSELGNACDSLL 177
              N TKL  + L+ N     I +  FG + S    LD+S   +T  +PS      + L 
Sbjct: 174 YAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS---KGLEHLK 229

Query: 178 ELKLPHNN 185
           EL    N 
Sbjct: 230 ELIA-RNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 46/218 (21%), Positives = 76/218 (34%), Gaps = 13/218 (5%)

Query: 17  TSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKL 76
             +  LP   + L+L    L  + P + FS LPN+  +  S +     L      N  K+
Sbjct: 24  QRIPSLPPSTQTLKLIETHLRTI-PSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV 82

Query: 77  ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIP--SSLSNCTKLKILNLSF 134
             +++        I   +L       L  L +    +  + P  + + +     IL ++ 
Sbjct: 83  THIEIRNTRNLTYIDPDAL--KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139

Query: 135 NLLAGEIP-RTFGQLSSLQR-LDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPV 192
           N     IP   F  L +    L L NN  T  +     N    L  + L  N        
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGT-KLDAVYLNKNKYLTVIDK 197

Query: 193 TL--SSCSWLQLLDLSNNNISGPFPDSVLENLGSLESL 228
                  S   LLD+S  +++   P   LE+L  L + 
Sbjct: 198 DAFGGVYSGPSLLDVSQTSVTA-LPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 35/246 (14%), Positives = 77/246 (31%), Gaps = 35/246 (14%)

Query: 196 SCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS 255
            C   +   ++  +I       +     S ++L L    +      + S+   +  +  S
Sbjct: 9   ECHQEEDFRVTCKDIQ-----RIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63

Query: 256 SNRVSGIIPPDICPGVSSLEELRLPDN-LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQ 314
            +     +       +S +  + + +   +T + P  L E   LK + +           
Sbjct: 64  IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT-------- 115

Query: 315 ELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS--CSNLEW 372
               L+        ++                  L + +N     IP   F   C+    
Sbjct: 116 ---GLKMFPDLTKVYS------------TDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160

Query: 373 ISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL--GNCSSLVWLDLNSNNLTG 430
           + L  N  T  +       T+L  + L  N++   I  +   G  S    LD++  ++T 
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT- 218

Query: 431 DIPPRL 436
            +P + 
Sbjct: 219 ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 40/289 (13%), Positives = 80/289 (27%), Gaps = 78/289 (26%)

Query: 245 SCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLS 304
            C        +   +  I  P + P   S + L+L +  +  +     S    +  I +S
Sbjct: 9   ECHQEEDFRVTCKDIQRI--PSLPP---STQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63

Query: 305 LNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAEL 364
           ++            L+ LE     F  L             +  + + N +    I  + 
Sbjct: 64  ID----------VTLQQLESHS--FYNL-----------SKVTHIEIRNTRNLTYIDPDA 100

Query: 365 FS-CSNLEWISLTGNELTGQIPPE--FSRLTRLAVLQLGNNRFKGEIPGEL--GNCSSLV 419
                 L+++ +    L    P            +L++ +N +   IP     G C+  +
Sbjct: 101 LKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159

Query: 420 WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPE 479
            L L +N  T  +            +  +L+ N                           
Sbjct: 160 TLKLYNNGFT-SVQGYAFNGTKLDAV--YLNKNK-------------------------- 190

Query: 480 RLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI 528
               +  +    F  +YSG              LD+S       +P + 
Sbjct: 191 ---YLTVIDKDAFGGVYSG-----------PSLLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 41/280 (14%), Positives = 83/280 (29%), Gaps = 56/280 (20%)

Query: 343 CKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGN 401
           C   +D  +    +   IP+      + + + L    L   IP   FS L  ++ + +  
Sbjct: 10  CHQEEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64

Query: 402 NRFKGEIP-GELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNV 460
           +    ++      N S +  +++ +      I P                          
Sbjct: 65  DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA------------------------ 100

Query: 461 GNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQF 520
                          +    LL+   + +         P L+          L+++ N +
Sbjct: 101 ------------LKELP---LLKFLGIFNTGLKMF---PDLTKVYSTDIFFILEITDNPY 142

Query: 521 RGKIPDEI--GDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE-SFS 577
              IP     G       L+L +N  +  +         L     + N+    I + +F 
Sbjct: 143 MTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG 201

Query: 578 NL-SFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGL 616
            + S    +D+S   +T  +P +G L  L      N   L
Sbjct: 202 GVYSGPSLLDVSQTSVTA-LPSKG-LEHLKELIARNTWTL 239

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 30/232 (12%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYC 799
           +G G FG+V     +  G    IK + +   Q   E   AE+E L  + H N++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 800 KIGEERLLVYEFMKFGSL-EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
           +      +V E  + G L E ++   +     + L+     ++ +     L + H     
Sbjct: 90  EDYHNMYIVMETCEGGELLERIV---SAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143

Query: 859 HIIHRDMKSSNVLL---DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE---- 911
           H++H+D+K  N+L          ++ DFG+A L  + +     +  AGT  Y+ PE    
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFKR 200

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
              +F+C    D++S GVV+  LLTG  P     F  T+L   V+ K    +
Sbjct: 201 DV-TFKC----DIWSAGVVMYFLLTGCLP-----FTGTSLEE-VQQKATYKE 241

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 93.0 bits (232), Expect = 1e-20
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 37/214 (17%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE----FMA--EMETLGKIKHRNLVP 794
           +G G +  V+K      G  VA+K+ ++L    D E      A  E+  + ++KH N+V 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKE-VKL----DSEEGTPSTAIREISLMKELKHENIVR 67

Query: 795 LLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           L       E +L LV+EFM    L++ +  R      R L  +  K       +GL F H
Sbjct: 68  LYDVI-HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD---THLSVSTLAGTPGYVPP 910
            N    I+HRD+K  N+L++   + ++ DFG+AR         +   V TL     Y  P
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE-VVTL----WYRAP 177

Query: 911 E------YYQSFRCTAKGDVYSFGVVLLELLTGK 938
           +       Y     +   D++S G +L E++TGK
Sbjct: 178 DVLMGSRTY-----STSIDIWSCGCILAEMITGK 206

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 34/232 (14%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           IG G F +V  A  +  G  VAIK + +  L+    ++   E+  +  + H N+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 799 CKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
            +  +   L+ E+   G + +  V HGR K ++ R           R     + + H   
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR--------SKFRQIVSAVQYCHQK- 133

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE----- 911
              I+HRD+K+ N+LLD +M  +++DFG +   +     L      G P Y  PE     
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKL--DAFCGAPPYAAPELFQGK 188

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
            Y       + DV+S GV+L  L++G  P     F   NL    + +V  GK
Sbjct: 189 KYDG----PEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRE-RVLRGK 230

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE---FMA--EMETLGKIKHRNLVPL 795
           +G G +G V K   KD G  VAIKK    S   D +    +A  E++ L +++H NLV L
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKK-FLES--DDDKMVKKIAMREIKLLKQLRHENLVNL 89

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L  CK  ++R  LV+EF+   ++ + L       D +++     +K       G+ F H 
Sbjct: 90  LEVCK-KKKRWYLVFEFVDH-TILDDLELFPNGLDYQVV-----QKYLFQIINGIGFCHS 142

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD---THLSVSTLAGTPGYVPPE 911
           +   +IIHRD+K  N+L+      ++ DFG AR ++A         V+T      Y  PE
Sbjct: 143 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE-VATRW----YRAPE 194

Query: 912 Y-YQSFRCTAKGDVYSFGVVLLELLTGK 938
                 +     DV++ G ++ E+  G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.5 bits (238), Expect = 2e-20
 Identities = 75/332 (22%), Positives = 127/332 (38%), Gaps = 59/332 (17%)

Query: 702  KIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSS 760
                 +E L          +   K    I  +  +     +G G +GEV     K   S 
Sbjct: 6    HHSSGRENLYFQGIAINPGMYVRKKEGKIGES--YFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 761  VAIKKL------------IRLSCQGDRE-FMAEMETLGKIKHRNLVPLLGYCKIGEERL- 806
             AIK +               + +   E    E+  L  + H N++ L       E++  
Sbjct: 64   KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF---EDKKY 120

Query: 807  --LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRD 864
              LV EF + G L E    +   R +          I +    G+C+LH +   +I+HRD
Sbjct: 121  FYLVTEFYEGGELFE----QIINRHK--FDECDAANIMKQILSGICYLHKH---NIVHRD 171

Query: 865  MKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAK 921
            +K  N+LL+++      ++ DFG++   S       +    GT  Y+ PE  +  +   K
Sbjct: 172  IKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEK 227

Query: 922  GDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDE 981
             DV+S GV++  LL G  P     FG  N    +  KV +GK       +   ++     
Sbjct: 228  CDVWSCGVIMYILLCGYPP-----FGGQNDQD-IIKKVEKGK-YYFDFNDWKNIS----- 275

Query: 982  SEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
               +E KE+++ +   L   D   +KR    +
Sbjct: 276  ---DEAKELIKLM---L-TYD--YNKRCTAEE 298

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 94.4 bits (235), Expect = 2e-20
 Identities = 64/240 (26%), Positives = 100/240 (41%), Gaps = 39/240 (16%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIR--LSCQGDRE------FMAEMETLGKIKHRNL 792
           +G G  GEV  A  +     VAI+ + +   +    RE         E+E L K+ H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 793 VPLLGYCKIGEERL-LVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAKGL 849
           + +  +     E   +V E M+ G L +  V + R        L     K         +
Sbjct: 203 IKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKR--------LKEATCKLYFYQMLLAV 252

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPG 906
            +LH N    IIHRD+K  NVLL  + E    +++DFG ++++        + TL GTP 
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPT 306

Query: 907 YVPPEYYQSFRCTAKG---DVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
           Y+ PE   S          D +S GV+L   L+G  P   +     +L    K ++  GK
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQVSL----KDQITSGK 361

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 36/231 (15%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIK-----KLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
            +G G +GEV  A       +VA+K     + +       +E    +     + H N+V 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK----IARGAAKGLC 850
             G+ + G  + L  E+   G L + +       D  +   DA++     +A     G+ 
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-----GVV 119

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           +LH      I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV P
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 911 E-----YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK 956
           E      + +       DV+S G+VL  +L G+ P D+          W +
Sbjct: 177 ELLKRREFHA----EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 93.1 bits (232), Expect = 2e-20
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 49/224 (21%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE---FMA--EMETLGKIKHRNLVPL 795
           IG G FGEVFKA   K G  VA+KK + +  + ++E     A  E++ L  +KH N+V L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKK-VLM--ENEKEGFPITALREIKILQLLKHENVVNL 81

Query: 796 LGYCKIGEERL--------LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK 847
           +  C+              LV++F      E  L G       +  T    K++ +    
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVK-FTLSEIKRVMQMLLN 135

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD-------THLSVST 900
           GL ++H N    I+HRDMK++NVL+  +   +++DFG+AR  S          T+  V T
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR-VVT 191

Query: 901 LAGTPGYVPPE------YYQSFRCTAKGDVYSFGVVLLELLTGK 938
           L     Y PPE       Y         D++  G ++ E+ T  
Sbjct: 192 L----WYRPPELLLGERDY-----GPPIDLWGAGCIMAEMWTRS 226

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 65/241 (26%), Positives = 107/241 (44%), Gaps = 49/241 (20%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK----------H 789
            +G G FG+V        G  VA+K L       +R+ +  ++ +GKIK          H
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQNLKLFRH 70

Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAK 847
            +++ L        +  +V E++  G L +    HGR +  +       AR+   +    
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-------ARRLF-QQILS 122

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            + + H +    ++HRD+K  NVLLD  M A+++DFG++ ++S     L   T  G+P Y
Sbjct: 123 AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFL--RTSCGSPNY 176

Query: 908 VPPE-----YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG 962
             PE      Y       + D++S GV+L  LL G  P     F D ++    K K+R G
Sbjct: 177 AAPEVISGRLYAG----PEVDIWSCGVILYALLCGTLP-----FDDEHVPTLFK-KIRGG 226

Query: 963 K 963
            
Sbjct: 227 V 227

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 92.2 bits (230), Expect = 2e-20
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 42/214 (19%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD-------REFMAEMETLGKIKHRNLVP 794
           +G G +G V+KA    G  VA+K+ IRL  + +       RE    +  L ++ H N+V 
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIRE----ISLLKELHHPNIVS 83

Query: 795 LLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           L+      E  L LV+EFM+   L++VL           +     K       +G+   H
Sbjct: 84  LIDVI-HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQI-----KIYLYQLLRGVAHCH 136

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD---THLSVSTLAGTPGYVPP 910
            +    I+HRD+K  N+L++ +   +++DFG+AR         TH  V TL     Y  P
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE-VVTL----WYRAP 188

Query: 911 E------YYQSFRCTAKGDVYSFGVVLLELLTGK 938
           +       Y     +   D++S G +  E++TGK
Sbjct: 189 DVLMGSKKY-----STSVDIWSIGCIFAEMITGK 217

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 36/223 (16%)

Query: 739 ESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLL 796
           E ++G G    V            A+K + +           E+E L + + HRN++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT------WDARKKIARGAAKGLC 850
            + +  +   LV+E M+ GS+              I         +A   + +  A  L 
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILS-----------HIHKRRHFNELEASV-VVQDVASALD 125

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVS-----TLA 902
           FLH+     I HRD+K  N+L +H  +    ++ DF +   I        +S     T  
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 903 GTPGYVPPEYYQSFRCTAKG-----DVYSFGVVLLELLTGKRP 940
           G+  Y+ PE  ++F   A       D++S GV+L  LL+G  P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 67/278 (24%), Positives = 106/278 (38%), Gaps = 42/278 (15%)

Query: 742  IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
            IG G +GEV  A  K      A KK+ +   +    F  E+E +  + H N++ L    +
Sbjct: 17   IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 801  IGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
               +  LV E    G L E  V     +  D       A + I +     + + H     
Sbjct: 77   DNTDIYLVMELCTGGELFERVVHKRVFRESD-------AAR-IMKDVLSAVAYCHKL--- 125

Query: 859  HIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
            ++ HRD+K  N L   +      ++ DFG+A             T  GTP YV P+  + 
Sbjct: 126  NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEG 182

Query: 916  FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV 975
                 + D +S GV++  LL G  P     F        +  K+REG      + + L V
Sbjct: 183  -LYGPECDEWSAGVMMYVLLCGYPP-----FSAPTDSEVML-KIREGT-FTFPEKDWLNV 234

Query: 976  TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            +         + + ++R L   L      P +R   LQ
Sbjct: 235  S--------PQAESLIRRL---L-TKS--PKQRITSLQ 258

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 23/210 (10%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIK-----KLIRLSCQGDRE-FMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K     +L        RE    E+  L +I+H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L    +   + +L+ E +  G L +        ++   LT D   +  +    G+ +LH 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFD----FLAEKES--LTEDEATQFLKQILDGVHYLHS 126

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEA----RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
                I H D+K  N++L  +       ++ DFG+A  I   +       + GTP +V P
Sbjct: 127 K---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNIFGTPEFVAP 180

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E         + D++S GV+   LL+G  P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.7 bits (238), Expect = 3e-20
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 23/214 (10%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIK--- 788
           FS   +IG GGFGEV+     D   + A+K L +   +  +     + E   L  +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 789 HRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK 847
              +V +  Y     ++L  + + M  G L   L      +       D R   A     
Sbjct: 251 CPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAE-IIL 303

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
           GL  +H+     +++RD+K +N+LLD     R+SD G+A   S    H       GT GY
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGY 356

Query: 908 VPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRP 940
           + PE  Q      +  D +S G +L +LL G  P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 44/280 (15%)

Query: 742  IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE--FMAEMETLGKIKHRNLVPLLGY 798
            +G G FGEV K   +      A+K + + S +       + E+E L K+ H N++ L   
Sbjct: 30   LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 799  CKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
             +      +V E    G L +  +   R    D       A + I +    G+ ++H + 
Sbjct: 90   LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD-------AAR-IIKQVFSGITYMHKH- 140

Query: 857  IPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
              +I+HRD+K  N+LL+ + +    ++ DFG++                GT  Y+ PE  
Sbjct: 141  --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVL 195

Query: 914  QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL 973
            +      K DV+S GV+L  LL+G  P     F   N    +  +V  GK      P+  
Sbjct: 196  RG-TYDEKCDVWSAGVILYILLSGTPP-----FYGKNEYD-ILKRVETGK-YAFDLPQWR 247

Query: 974  LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
             ++        ++ K+++R +   L      PS R    Q
Sbjct: 248  TIS--------DDAKDLIRKM---L-TFH--PSLRITATQ 273

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 33/218 (15%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIK--------KLIRLSCQGDRE-FMAEMETLGKIK-HR 790
           +G G    V +   K      A+K               Q  RE  + E++ L K+  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAKG 848
           N++ L    +      LV++ MK G L +          ++        RK I R   + 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE-------TRK-IMRALLEV 136

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           +C LH     +I+HRD+K  N+LLD +M  +++DFG +  +   +    +  + GTP Y+
Sbjct: 137 ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYL 190

Query: 909 PPE------YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
            PE               + D++S GV++  LL G  P
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 91.9 bits (228), Expect = 4e-20
 Identities = 44/254 (17%), Positives = 85/254 (33%), Gaps = 42/254 (16%)

Query: 770  SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD 829
            S         ++  +     +N V  L          +  +  +  +L++ ++ R    D
Sbjct: 101  SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 830  QRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
            +          I    A+ + FLH      ++HRD+K SN+    +   +V DFG+   +
Sbjct: 161  REH---GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214

Query: 890  ----------SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKR 939
                      + +  + + +   GT  Y+ PE       + K D++S G++L ELL    
Sbjct: 215  DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-- 272

Query: 940  PTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQ 999
                  F        +   VR  K                   +  +   MV+       
Sbjct: 273  ------FSTQMERVRIITDVRNLK----FPLLF--------TQKYPQEHMMVQ------D 308

Query: 1000 CVDDFPSKRPNMLQ 1013
             +   P++RP    
Sbjct: 309  MLSPSPTERPEATD 322

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 27/220 (12%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIK-----KLIRLSCQGDRE-FMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K     +         RE    E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L    +   + +L+ E +  G L +        ++   L+ +      +    G+ +LH 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFD----FLAQKES--LSEEEATSFIKQILDGVNYLHT 133

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEA----RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
                I H D+K  N++L  +       ++ DFG+A  I   +  +    + GTP +V P
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAP 187

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP----TDKDDF 946
           E         + D++S GV+   LL+G  P    T ++  
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 90.3 bits (225), Expect = 7e-20
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 33/212 (15%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD-------REFMAEMETLGKIKHRNLV 793
           IG G +G VFKA   +    VA+K+ +RL    +       RE    +  L ++KH+N+V
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKR-VRLDDDDEGVPSSALRE----ICLLKELKHKNIV 64

Query: 794 PLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
            L       +++L LV+EF     L++             L  +  K       KGL F 
Sbjct: 65  RLHDVL-HSDKKLTLVFEFCDQ-DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFC 117

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD---THLSVSTLAGTPGYVP 909
           H     +++HRD+K  N+L++   E ++++FG+AR         +   V TL     Y P
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTL----WYRP 169

Query: 910 PEY-YQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           P+  + +   +   D++S G +  EL    RP
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 91.2 bits (227), Expect = 9e-20
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 34/226 (15%)

Query: 731 EATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKH 789
           +  + F  E + G G FG V     K  G SVAIKK+I+     +RE    M+ L  + H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH 78

Query: 790 RNLVPLLGYCKIGEER-------LLVYEFMKFGSLEEVLHG--RAKARDQRILTWDARKK 840
            N+V L  Y     ER        +V E++      + LH   R   R Q        K 
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIKV 133

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMARLISALDTHLSVS 899
                 + +  LH   + ++ HRD+K  NVL++      ++ DFG A+ +S  + +++  
Sbjct: 134 FLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA-- 190

Query: 900 TLAGTPGYVPPEYYQ-------SFRCTAKGDVYSFGVVLLELLTGK 938
                  Y+   YY+       +   T   D++S G +  E++ G+
Sbjct: 191 -------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 23/210 (10%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIK-----KLIRLSCQGDREFMA-EMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K     +         RE +  E+  L +I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L    +   + +L+ E +  G L +        ++   LT +   +  +    G+ +LH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFD----FLAEKES--LTEEEATEFLKQILNGVYYLHS 132

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEA----RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
                I H D+K  N++L          ++ DFG+A  I   D       + GTP +V P
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E         + D++S GV+   LL+G  P
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 89.9 bits (224), Expect = 1e-19
 Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 29/210 (13%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
           ++G G F EVF    +  G   A+K + +     D     E+  L KIKH N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT------WDARKKIARGAAKGLCFLH 853
           +      LV + +  G L +           RIL        DA   + +     + +LH
Sbjct: 76  ESTTHYYLVMQLVSGGELFD-----------RILERGVYTEKDAS-LVIQQVLSAVKYLH 123

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N    I+HRD+K  N+L     E     ++DFG++++    +  +  ST  GTPGYV P
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIM--STACGTPGYVAP 176

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E       +   D +S GV+   LL G  P
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 90.7 bits (226), Expect = 1e-19
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 28/209 (13%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE----FMA--EMETLGKIKHRNLVP 794
           +G G F  V+KA        VAIKK I+L  + + +      A  E++ L ++ H N++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKK-IKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 795 LLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           LL      +  + LV++FM+   LE ++   +      +LT    K       +GL +LH
Sbjct: 77  LLD-AFGHKSNISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH 129

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD---THLSVSTLAGTPGYVPP 910
            +    I+HRD+K +N+LLD     +++DFG+A+   + +   TH  V T      Y  P
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTR----WYRAP 181

Query: 911 EY-YQSFRCTAKGDVYSFGVVLLELLTGK 938
           E  + +       D+++ G +L ELL   
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 89.1 bits (222), Expect = 2e-19
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 42/214 (19%)

Query: 742 IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD-------REFMAEMETLGKIKHRNLVP 794
           IG G +G V+KA    G + A+KK IRL  + +       RE    +  L ++KH N+V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIRE----ISILKELKHSNIVK 64

Query: 795 LLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           L       ++RL LV+E +    L+++L       +         K        G+ + H
Sbjct: 65  LYDVI-HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTA-----KSFLLQLLNGIAYCH 117

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD---THLSVSTLAGTPGYVPP 910
                 ++HRD+K  N+L++ E E +++DFG+AR         TH  + TL     Y  P
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-IVTL----WYRAP 169

Query: 911 E------YYQSFRCTAKGDVYSFGVVLLELLTGK 938
           +       Y     +   D++S G +  E++ G 
Sbjct: 170 DVLMGSKKY-----STTIDIWSVGCIFAEMVNGT 198

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.5 bits (223), Expect = 2e-19
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 29/208 (13%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE---FMA--EMETLGKIKHRNLVPL 795
           IG G +G VFK   +D G  VAIKK    S   D      +A  E+  L ++KH NLV L
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKK-FLES--EDDPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L   +  + RL LV+E+    ++   L    +   + ++     K I     + + F H 
Sbjct: 68  LEVFR-RKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLV-----KSITWQTLQAVNFCHK 120

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD---THLSVSTLAGTPGYVPPE 911
           +   + IHRD+K  N+L+      ++ DFG ARL++          V+T      Y  PE
Sbjct: 121 H---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE-VATR----WYRSPE 172

Query: 912 Y-YQSFRCTAKGDVYSFGVVLLELLTGK 938
                 +     DV++ G V  ELL+G 
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 90.2 bits (224), Expect = 3e-19
 Identities = 65/349 (18%), Positives = 105/349 (30%), Gaps = 84/349 (24%)

Query: 102 SLLHLDLSQNHIMDV----IPSSLSNCTKLKILNLSFNLL----AGEIPRTFGQLSSLQR 153
           S+    L  + I       + + L     +K + LS N +    A  +         L+ 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 154 LDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP 213
            + S+    G +  E+  A   LL+               L  C  L  + LS+N     
Sbjct: 65  AEFSDIFT-GRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDNAFG-- 107

Query: 214 FPDSV------LENLGSLESLILSNNMIS-------------GSFPDSISSCKTLRIVDF 254
            P +       L     LE L L NN +               +      +   LR +  
Sbjct: 108 -PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166

Query: 255 SSNRVSGIIPPDICPGV---SSLEELRLPDNLIT-----GVIPGQLSECTQLKVIDLSLN 306
             NR+      +          L  +++  N I       ++   L+ C +LKV+DL  N
Sbjct: 167 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN 226

Query: 307 YLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE----IPA 362
                    L                       L    NL++L LN+  LS      +  
Sbjct: 227 TFTHLGSSALAIA--------------------LKSWPNLRELGLNDCLLSARGAAAVVD 266

Query: 363 ELFSCSN--LEWISLTGNELTGQIPPEFSR-----LTRLAVLQLGNNRF 404
                 N  L+ + L  NE+               +  L  L+L  NRF
Sbjct: 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 50/312 (16%), Positives = 93/312 (29%), Gaps = 56/312 (17%)

Query: 51  LVYLNASYNNLTG----FLPETLLSNSDKLELLDLSYNNLTGSISGFSLNE--NSCNSLL 104
           +   +   + +T      +   LL +   ++ + LS N + G+ +   L+E   S   L 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDS-VKEIVLSGNTI-GTEAARWLSENIASKKDLE 63

Query: 105 HLDLSQNHI----------MDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQL----SS 150
             + S              + ++  +L  C KL  + LS N                 + 
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 151 LQRLDLSNNHIT------------GWIPSELGNACDSLLELKLPHNNITG----SFPVTL 194
           L+ L L NN +                 ++       L  +    N +       +  T 
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183

Query: 195 SSCSWLQLLDLSNNNIS----GPFPDSVLENLGSLESLILSNNMISG----SFPDSISSC 246
            S   L  + +  N I            L     L+ L L +N  +     +   ++ S 
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243

Query: 247 KTLRIVDFSSNRVSGIIPPDICPGV-----SSLEELRLPDNLITGVIPGQLSE-----CT 296
             LR +  +   +S      +           L+ LRL  N I       L         
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303

Query: 297 QLKVIDLSLNYL 308
            L  ++L+ N  
Sbjct: 304 DLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 77.1 bits (190), Expect = 6e-15
 Identities = 67/383 (17%), Positives = 111/383 (28%), Gaps = 109/383 (28%)

Query: 200 LQLLDLSNNNISGPFPD------SVLENLGSLESLILSNNMISG----SFPDSISSCKTL 249
           ++   L  + I+    +      +VL    S++ ++LS N I         ++I+S K L
Sbjct: 6   IEGKSLKLDAIT---TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62

Query: 250 RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN 309
            I +FS     G +  +I   +  L +               L +C +L  + LS N   
Sbjct: 63  EIAEFSDIFT-GRVKDEIPEALRLLLQA--------------LLKCPKLHTVRLSDNAFG 107

Query: 310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE---------- 359
            +  + L                       L K   L+ L L+NN L  +          
Sbjct: 108 PTAQEPLIDF--------------------LSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147

Query: 360 ---IPAELFSCSNLEWISLTGNELTGQ----IPPEFSRLTRLAVLQLGNNRFKGE----- 407
              +  +  +   L  I    N L           F     L  +++  N  + E     
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207

Query: 408 IPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGV 467
           +   L  C  L  LDL  N  T           G+  L   L S   +    + +     
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHL---------GSSALAIALKSWPNLRELGLNDCLLSA 258

Query: 468 GGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDE 527
            G                     +                  L+ L L YN+        
Sbjct: 259 RGAAAVVD----------AFSKLEN---------------IGLQTLRLQYNEIELDAVRT 293

Query: 528 IGDMIA-----LQVLELAHNQLS 545
           +  +I      L  LEL  N+ S
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 74.7 bits (184), Expect = 3e-14
 Identities = 45/226 (19%), Positives = 66/226 (29%), Gaps = 35/226 (15%)

Query: 46  SKLPNLVYLNASYNNLT--GFLP-ETLLSNSDKLELLDLSYNNLTG----------SISG 92
            K P L  +  S N        P    LS    LE L L  N L                
Sbjct: 91  LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELA 150

Query: 93  FSLNENSCNSLLHLDLSQNHI----MDVIPSSLSNCTKLKILNLSFNLLAGE-----IPR 143
            +    +   L  +   +N +    M     +  +   L  + +  N +  E     +  
Sbjct: 151 VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLE 210

Query: 144 TFGQLSSLQRLDLSNNHITGWIPSELGNA---CDSLLELKLPHNNITGSFPVTLSSC--- 197
                  L+ LDL +N  T    S L  A     +L EL L    ++      +      
Sbjct: 211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK 270

Query: 198 ---SWLQLLDLSNNNISGP----FPDSVLENLGSLESLILSNNMIS 236
                LQ L L  N I           + E +  L  L L+ N  S
Sbjct: 271 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 62/396 (15%), Positives = 111/396 (28%), Gaps = 110/396 (27%)

Query: 224 SLESLILSNNMISG----SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL 279
           S+E   L  + I+     S    +    +++ +  S N +              L E   
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGT-------EAARWLSEN-- 55

Query: 280 PDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE 339
                       ++    L++ + S  +      +    L  L Q               
Sbjct: 56  ------------IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ--------------A 89

Query: 340 LGKCKNLKDLILNNNKLSGE----IPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLA 395
           L KC  L  + L++N         +   L   + LE + L  N L  Q           A
Sbjct: 90  LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ-----------A 138

Query: 396 VLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSN-TL 454
             ++     +  +  +  N   L  +    N L              K       S+  L
Sbjct: 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG---------SMKEWAKTFQSHRLL 189

Query: 455 VFVRNVGN--SCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEY 512
             V+ V N    +G+  LL               L  C                 Q L+ 
Sbjct: 190 HTVKMVQNGIRPEGIEHLLLEG------------LAYC-----------------QELKV 220

Query: 513 LDLSYNQFRGKIPDEIGDMIA----LQVLELAHNQLSGE----IPSSLGRLRN--LGVFD 562
           LDL  N F       +   +     L+ L L    LS      +  +  +L N  L    
Sbjct: 221 LDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 280

Query: 563 ASHNRLQGQ----IPESF-SNLSFLVQIDLSNNELT 593
             +N ++      +       +  L+ ++L+ N  +
Sbjct: 281 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 30/214 (14%), Positives = 64/214 (29%), Gaps = 46/214 (21%)

Query: 412 LGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLL 471
           +    S+    L  + +T +           K +   L  +  V    +  +  G     
Sbjct: 1   MAR-FSIEGKSLKLDAITTE---------DEKSVFAVLLEDDSVKEIVLSGNTIGTEAAR 50

Query: 472 EFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQ-----------YQTLEYLDLSYNQF 520
             +    E +     L+  +F+ +++G V     +              L  + LS N F
Sbjct: 51  WLS----ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 106

Query: 521 RGKIPDEIGDMIA----LQVLELAHNQLSGE-------------IPSSLGRLRNLGVFDA 563
                + + D ++    L+ L L +N L  +             +         L     
Sbjct: 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166

Query: 564 SHNRLQGQ----IPESFSNLSFLVQIDLSNNELT 593
             NRL+        ++F +   L  + +  N + 
Sbjct: 167 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 91.0 bits (226), Expect = 4e-19
 Identities = 62/241 (25%), Positives = 108/241 (44%), Gaps = 49/241 (20%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK----------H 789
            +G G FG+V        G  VA+K L       +R+ +  ++ +GKI+          H
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKIL-------NRQKIRSLDVVGKIRREIQNLKLFRH 75

Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAK 847
            +++ L        +  +V E++  G L +    +GR   ++       +R+   +    
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE-------SRRLF-QQILS 127

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
           G+ + H +    ++HRD+K  NVLLD  M A+++DFG++ ++S     L   T  G+P Y
Sbjct: 128 GVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFL--RTSCGSPNY 181

Query: 908 VPPE-----YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG 962
             PE      Y       + D++S GV+L  LL G  P     F D ++    K K+ +G
Sbjct: 182 AAPEVISGRLYAG----PEVDIWSSGVILYALLCGTLP-----FDDDHVPTLFK-KICDG 231

Query: 963 K 963
            
Sbjct: 232 I 232

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 29/212 (13%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKL-IRLSCQGDRE-FMAEMETLGKIKHR-NLVPLLG 797
           +G G F  V +   K  G   A K L  R   Q  R   + E+  L   K    ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             +   E +L+ E+   G +              +++ +   ++ +   +G+ +LH N  
Sbjct: 97  VYENTSEIILILEYAAGGEIFS----LCLPELAEMVSENDVIRLIKQILEGVYYLHQN-- 150

Query: 858 PHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPE--- 911
            +I+H D+K  N+LL         ++ DFGM+R I        +  + GTP Y+ PE   
Sbjct: 151 -NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYLAPEILN 206

Query: 912 ---YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                 +       D+++ G++   LLT   P
Sbjct: 207 YDPI--TTAT----DMWNIGIIAYMLLTHTSP 232

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 39/240 (16%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIR--LSCQGDRE------FMAEMETLGKIKHRNL 792
           +G G  GEV  A  +     VAIK + +   +    RE         E+E L K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 793 VPLLGYCKIGEERL-LVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAKGL 849
           + +  +     E   +V E M+ G L +  V + R K    ++       ++       +
Sbjct: 78  IKIKNF--FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----YQML----LAV 127

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPG 906
            +LH N    IIHRD+K  NVLL  + E    +++DFG ++++   +T L + TL GTP 
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL-MRTLCGTPT 181

Query: 907 YVPPEYYQSFRCTAKG---DVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
           Y+ PE   S          D +S GV+L   L+G  P     F +      +K ++  GK
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-----FSEHRTQVSLKDQITSGK 236

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 47/282 (16%)

Query: 676 MRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNG 735
           M  R +     +    +Q   A  + K+ ++K+  S          +     Q +     
Sbjct: 1   MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDG-SKVTTVVATPGQGPDRPQEVS---- 55

Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLV 793
           ++   +IG G FG V++A L D G  VAIKK +      D+ F   E++ + K+ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQ----DKRFKNRELQIMRKLDHCNIV 110

Query: 794 PLLGYCKIGEERL------LVYEFMKFGSLEEVLHGRAKARDQR--ILTWDARKKIARGA 845
            L  +     E+       LV +++      E ++  A+   +    L     K      
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165

Query: 846 AKGLCFLH-HNCIPHIIHRDMKSSNVLLDHEMEA-RVSDFGMARLISALDTHLS-VSTLA 902
            + L ++H       I HRD+K  N+LLD +    ++ DFG A+ +   + ++S + +  
Sbjct: 166 FRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221

Query: 903 GTPGYVPPE------YYQSFRCTAKGDVYSFGVVLLELLTGK 938
               Y  PE       Y     T+  DV+S G VL ELL G+
Sbjct: 222 ----YRAPELIFGATDY-----TSSIDVWSAGCVLAELLLGQ 254

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 89.3 bits (222), Expect = 4e-19
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 23/210 (10%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIK-----KLIRLSCQGDRE-FMAEMETLGKIKHRNLVP 794
           +G G F  V K   K  G   A K     +         RE    E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 795 LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
           L    +   + +L+ E +  G L +        ++   L+ +      +    G+ +LH 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFD----FLAQKES--LSEEEATSFIKQILDGVNYLHT 133

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEA----RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
                I H D+K  N++L  +       ++ DFG+A  I   +  +    + GTP +V P
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAP 187

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E         + D++S GV+   LL+G  P
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP 217

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 89.7 bits (223), Expect = 5e-19
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 41/226 (18%)

Query: 731 EATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA-EMETLGKIKH 789
           +    ++   +IG G FG VF+A L +   VAIKK +      D+ F   E++ +  +KH
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK-VLQ----DKRFKNRELQIMRIVKH 91

Query: 790 RNLVPLLGY-----CKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQR--ILTWDARKKI 841
            N+V L  +      K  E  L LV E++      E ++  ++   +    +     K  
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLY 146

Query: 842 ARGAAKGLCFLH-HNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMARLISALDTHLS-V 898
                + L ++H       I HRD+K  N+LLD      ++ DFG A+++ A + ++S +
Sbjct: 147 MYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202

Query: 899 STLAGTPGYVPPE------YYQSFRCTAKGDVYSFGVVLLELLTGK 938
            +      Y  PE       Y     T   D++S G V+ EL+ G+
Sbjct: 203 CSRY----YRAPELIFGATNY-----TTNIDIWSTGCVMAELMQGQ 239

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 89.8 bits (223), Expect = 6e-19
 Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 22/216 (10%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDRE---FMAEMETLGKIKHRN 791
           F    +IG G FGEV    LK+   V A+K L +       E   F  E + L     + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 792 LVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWD-ARKKIARGAAKGL 849
           +  L  Y    +  L LV ++   G L  +L     ++ +  L  + AR  +A      +
Sbjct: 136 ITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-----SKFEDRLPEEMARFYLAE-MVIAI 188

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
             +H     H +HRD+K  N+L+D     R++DFG    +    T  S S   GTP Y+ 
Sbjct: 189 DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SVAVGTPDYIS 244

Query: 910 PEYYQSFRCTAKG-----DVYSFGVVLLELLTGKRP 940
           PE  Q+            D +S GV + E+L G+ P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 32/217 (14%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIK-------KLIRLSCQGDRE-FMAEMETLGKIK-HRN 791
           IG G    V +   +  G   A+K       +L     +  RE    E   L ++  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAKGL 849
           ++ L+   +      LV++ M+ G L +          ++        R  I R   + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKE-------TRS-IMRSLLEAV 213

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
            FLH N   +I+HRD+K  N+LLD  M+ R+SDFG +  +   +    +  L GTPGY+ 
Sbjct: 214 SFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLA 267

Query: 910 PE-YYQSFRCTAKG-----DVYSFGVVLLELLTGKRP 940
           PE    S   T  G     D+++ GV+L  LL G  P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 68/289 (23%), Positives = 107/289 (37%), Gaps = 57/289 (19%)

Query: 742  IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYC 799
            +G G F    K   K    + A+K + +      ++   E+  L   + H N+V L    
Sbjct: 19   LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT------WDARKKIARGAAKGLCFLH 853
                   LV E +  G L E           RI         +A   I R     +  +H
Sbjct: 76   HDQLHTFLVMELLNGGELFE-----------RIKKKKHFSETEASY-IMRKLVSAVSHMH 123

Query: 854  HNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
                  ++HRD+K  N+L   E +    ++ DFG ARL    +  L   T   T  Y  P
Sbjct: 124  DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAP 178

Query: 911  E-----YYQSFRCTAKGDVYSFGVVLLELLTGKRP-TDKDDFGDTNLVGWVKMKVREGKQ 964
            E      Y    C    D++S GV+L  +L+G+ P    D          +  K+++G  
Sbjct: 179  ELLNQNGY-DESC----DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD- 232

Query: 965  MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                      V+        +E K++++ L   L  VD  P+KR  M  
Sbjct: 233  FSFEGEAWKNVS--------QEAKDLIQGL---L-TVD--PNKRLKMSG 267

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 58/212 (27%), Positives = 83/212 (39%), Gaps = 22/212 (10%)

Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLL 796
           +IG G F EV    +K    V A+K + +       E   F  E + L     R +  L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
            +    E  L LV E+   G L  +L        +RI    AR  +A      +  +H  
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAE-IVMAIDSVHRL 181

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                +HRD+K  N+LLD     R++DFG    + A  T  S     GTP Y+ PE  Q+
Sbjct: 182 ---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS-LVAVGTPDYLSPEILQA 237

Query: 916 FRCTAKGDVY-------SFGVVLLELLTGKRP 940
                    Y       + GV   E+  G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 88.6 bits (220), Expect = 2e-18
 Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 28/277 (10%)

Query: 675 AMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATN 734
              A +  A+ +K   + +    + +   +   E + +++A  + ++   +F  L     
Sbjct: 99  WTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYL----- 153

Query: 735 GFSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHR 790
                 L+G G FG+V     K      A+K L +       E    + E   L   +H 
Sbjct: 154 -----KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208

Query: 791 NLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
            L  L  Y     +RL  V E+   G L   L      R++      AR   A      L
Sbjct: 209 FLTALK-YSFQTHDRLCFVMEYANGGELFFHLS-----RERVFSEDRARFYGAE-IVSAL 261

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYV 908
            +LH     ++++RD+K  N++LD +   +++DFG+ +  I    T   + T  GTP Y+
Sbjct: 262 DYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYL 316

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
            PE  +        D +  GVV+ E++ G+ P    D
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 33/215 (15%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD----------REFMAEMETLGKIKHR 790
           IG G +G V+KA     G  VA+K  +R+   G           RE +A +  L   +H 
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKS-VRVPNGGGGGGGLPISTVRE-VALLRRLEAFEHP 74

Query: 791 NLVPLL----GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGA 845
           N+V L+          E ++ LV+E +     ++ L           L  +  K + R  
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHV-----DQDLRTYLDKAPPPGLPAETIKDLMRQF 129

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD--THLSVSTLAG 903
            +GL FLH N    I+HRD+K  N+L+      +++DFG+AR+ S     T + V TL  
Sbjct: 130 LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV-VVTL-- 183

Query: 904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
              Y  PE           D++S G +  E+   K
Sbjct: 184 --WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 87.3 bits (216), Expect = 2e-18
 Identities = 60/274 (21%), Positives = 94/274 (34%), Gaps = 83/274 (30%)

Query: 742 IGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQGDR-EFMAEMETLGKI-KHRNLV 793
           +G G FG+V +A            +VA+K L   +   +    M+E++ L  I  H N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 794 PLLG--------------YCKIG--------------EERLLVYEFMKFGSLEEVLHGRA 825
            LLG              +CK G                +     F +       +    
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 826 KAR---------------------------------DQRILTWDARKKIARGAAKGLCFL 852
           K R                                  +  LT +     +   AKG+ FL
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP--- 909
                   IHRD+ + N+LL  +   ++ DFG+AR I     +     +      +P   
Sbjct: 210 ASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKW 261

Query: 910 --PEYYQSFRCTAKGDVYSFGVVLLELLT-GKRP 940
             PE       T + DV+SFGV+L E+ + G  P
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 50/241 (20%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK----------H 789
            +G G FG+V  AT  K    VA+K +        R+ + + +   +++          H
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFI-------SRQLLKKSDMHMRVEREISYLKLLRH 68

Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKKIARGAAK 847
            +++ L        + ++V E+   G L +  V   R    +        R+   +    
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDE-------GRRFF-QQIIC 119

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            + + H +    I+HRD+K  N+LLD  +  +++DFG++ +++     L   T  G+P Y
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFL--KTSCGSPNY 173

Query: 908 VPPE-----YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG 962
             PE      Y       + DV+S G+VL  +L G+ P     F D  +    K KV   
Sbjct: 174 AAPEVINGKLYAG----PEVDVWSCGIVLYVMLVGRLP-----FDDEFIPNLFK-KVNSC 223

Query: 963 K 963
            
Sbjct: 224 V 224

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 86.7 bits (215), Expect = 2e-18
 Identities = 50/229 (21%), Positives = 86/229 (37%), Gaps = 39/229 (17%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIK-----KLIRLSCQGDREFMA---EMETLGK 786
           +S  S +G G FG V+ A   +    V +K     K++      D +      E+  L +
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 787 IKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEE-----VLHGRAKARDQRILTWDARKKI 841
           ++H N++ +L   +      LV E    G   +       H R                I
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGL--DLFAFIDRHPRLDEPLAS--------YI 135

Query: 842 ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
            R     + +L       IIHRD+K  N+++  +   ++ DFG A  +          T 
Sbjct: 136 FRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLF--YTF 189

Query: 902 AGTPGYVPPE-----YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
            GT  Y  PE      Y+      + +++S GV L  L+  + P  + +
Sbjct: 190 CGTIEYCAPEVLMGNPYRG----PELEMWSLGVTLYTLVFEENPFCELE 234

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDRE------FMAEMETLGKIKHRNLVP 794
           +G G +  V+K   K   + VA+K+ IRL    + E       + E+  L  +KH N+V 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKE-IRL----EHEEGAPCTAIREVSLLKDLKHANIVT 64

Query: 795 LLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           L       E+ L LV+E++    L++ L          I+     K       +GL + H
Sbjct: 65  LHDII-HTEKSLTLVFEYLDK-DLKQYLDDC-----GNIINMHNVKLFLFQLLRGLAYCH 117

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD---THLSVSTLAGTPGYVPP 910
                 ++HRD+K  N+L++   E +++DFG+AR  S       +  V TL     Y PP
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE-VVTL----WYRPP 169

Query: 911 EY-YQSFRCTAKGDVYSFGVVLLELLTGK 938
           +    S   + + D++  G +  E+ TG+
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 69/286 (24%), Positives = 119/286 (41%), Gaps = 50/286 (17%)

Query: 741  LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
            ++G G  G+V +   +  G   A+K L        +E     +  G     ++V +L   
Sbjct: 36   VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QEVDHHWQASG---GPHIVCILDVY 91

Query: 800  ----KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT-WDARKKIARGAAKGLCFLHH 854
                      L++ E M+ G L      R + R  +  T  +A + I R     + FLH 
Sbjct: 92   ENMHHGKRCLLIIMECMEGGELFS----RIQERGDQAFTEREAAE-IMRDIGTAIQFLHS 146

Query: 855  NCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            +   +I HRD+K  N+L   + +    +++DFG A+      T  ++ T   TP YV PE
Sbjct: 147  H---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPE 199

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRP----TDKDDFGDTNLVGWVKMKVREGKQMEV 967
                 +     D++S GV++  LL G  P    T +           +K ++R G+    
Sbjct: 200  VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG------MKRRIRLGQ-YGF 252

Query: 968  IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
             +PE   V+        E+ K+++R L   L   D  P++R  + Q
Sbjct: 253  PNPEWSEVS--------EDAKQLIRLL---L-KTD--PTERLTITQ 284

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 86.1 bits (214), Expect = 3e-18
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 742 IGCGGFGEVFKA--TLKDGSSVAIKKLIRLSCQGD-------REFMAEMETLGKIKHRNL 792
           IG G +G+VFKA      G  VA+K+ +R+    +       RE +A +  L   +H N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKR-VRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNV 76

Query: 793 VPLL----GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK 847
           V L           E +L LV+E +     ++ L        +  +  +  K +     +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHV-----DQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD--THLSVSTLAGTP 905
           GL FLH +    ++HRD+K  N+L+    + +++DFG+AR+ S     T + V TL    
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTL---- 183

Query: 906 GYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            Y  PE           D++S G +  E+   K
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 85.3 bits (212), Expect = 3e-18
 Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 30/211 (14%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLI--RLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           +G G F  V +   K  G   A K +   +LS +  ++   E     K++H N+V L   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT------WDARKKIARGAAKGLCFL 852
            +      LV++ +  G L E            I+        DA     +   + + + 
Sbjct: 74  IQEESFHYLVFDLVTGGELFE-----------DIVAREFYSEADASH-CIQQILESIAYC 121

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           H N    I+HR++K  N+LL  + +    +++DFG+A  ++  +        AGTPGY+ 
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLS 175

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +    +   D+++ GV+L  LL G  P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 86.8 bits (215), Expect = 5e-18
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 40/221 (18%)

Query: 742 IGCGGFGEVFKATLKD---GSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLL 796
           +G G +G V+KA  KD       A+K++    +S    RE    +  L ++KH N++ L 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84

Query: 797 GYCKI-GEERL-LVYEFMK--FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
                  + ++ L++++ +     + +        +    L     K +      G+ +L
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEAR----VSDFGMARLISALD---THLS--VSTLAG 903
           H N    ++HRD+K +N+L+  E   R    ++D G ARL ++       L   V T   
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF-- 199

Query: 904 TPGYVPPE------YYQSFRCTAKGDVYSFGVVLLELLTGK 938
              Y  PE      +Y     T   D+++ G +  ELLT +
Sbjct: 200 --WYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 85.8 bits (213), Expect = 5e-18
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 33/211 (15%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGK-IKHRNLVPLLGYC 799
           IG G +    +   K      A+K + +       E    +E L +  +H N++ L    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKDVY 85

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT------WDARKKIARGAAKGLCFLH 853
             G+   +V E MK G L +           +IL        +A   +     K + +LH
Sbjct: 86  DDGKYVYVVTELMKGGELLD-----------KILRQKFFSEREASA-VLFTITKTVEYLH 133

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEA----RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
                 ++HRD+K SN+L   E       R+ DFG A+ + A +  L   T   T  +V 
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM--TPCYTANFVA 188

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           PE  +     A  D++S GV+L  +LTG  P
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.9 bits (213), Expect = 8e-18
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 23/262 (8%)

Query: 688 MLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGF 747
           +L+ L A      +   ++ + +   ++ ++  + K++  ++      +    +IG G F
Sbjct: 25  LLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRM--KAEDYEVVKVIGRGAF 82

Query: 748 GEVFKATLKDGSSV-AIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLGYCKIGE 803
           GEV     K    V A+K L +       +   F  E + +       +V L  Y    +
Sbjct: 83  GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDD 141

Query: 804 ERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIH 862
             L +V E+M  G L  ++       +  +    AR   A      L  +H       IH
Sbjct: 142 RYLYMVMEYMPGGDLVNLM------SNYDVPEKWARFYTAEVVL-ALDAIHSM---GFIH 191

Query: 863 RDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS----FRC 918
           RD+K  N+LLD     +++DFG    ++         T  GTP Y+ PE  +S       
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC-DTAVGTPDYISPEVLKSQGGDGYY 250

Query: 919 TAKGDVYSFGVVLLELLTGKRP 940
             + D +S GV L E+L G  P
Sbjct: 251 GRECDWWSVGVFLYEMLVGDTP 272

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.0 bits (211), Expect = 8e-18
 Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 18/209 (8%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHRN 791
           F     +G G FG V     K+  +  A+K L +      ++    + E   L  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           LV L    K      +V E++  G +   L      R     +    +  A        +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEY 156

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           LH      +I+RD+K  N+L+D +   +V+DFG A+ +    T     TL GTP  + PE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TW----TLCGTPEALAPE 208

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
              S       D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 86.2 bits (214), Expect = 9e-18
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 29/216 (13%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
           +G G F  V +      G   A   +    LS +  ++   E      +KH N+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT------WDARKKIARGAAKGLCFL 852
                   L+++ +  G L E            I+        DA     +   + +   
Sbjct: 79  ISEEGHHYLIFDLVTGGELFE-----------DIVAREYYSEADASH-CIQQILEAVLHC 126

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           H      ++HR++K  N+LL  +++    +++DFG+A  +            AGTPGY+ 
Sbjct: 127 HQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYLS 181

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PE  +        D+++ GV+L  LL G  P   +D
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 59/356 (16%), Positives = 110/356 (30%), Gaps = 61/356 (17%)

Query: 44  LFSKLPNLVYLNASYNNLTG----FLPETLLSNSDKLELLDLSYNNLT--GSISGFSLNE 97
             S    +  L+ S NNL       L +   +    +  L+LS N+L    S     +  
Sbjct: 17  FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76

Query: 98  NSCNSLLHLDLSQNHIMD----VIPSSLSNC-TKLKILNLSFNLLAGEIPRTFGQL---- 148
               ++  L+LS N +       +  +L+     + +L+L +N  + +    F Q     
Sbjct: 77  AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136

Query: 149 -SSLQRLDLSNNHITG----WIPSELGNACDSLLELKLPHNNITGSFPVTLSS-----CS 198
            +S+  L+L  N +       +   L     ++  L L  NN+       L+       +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196

Query: 199 WLQLLDLSNNNIS----GPFPDSVLENLGSLESLILSNNMISGS----FPDSISSCKTLR 250
            +  LDLS N +                  + SL L  N + G           S K L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256

Query: 251 IVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG 310
            V    + V  +            + L                   ++ ++D +   ++ 
Sbjct: 257 TVYLDYDIVKNM-------SKEQCKALGA-----------AFPNIQKIILVDKNGKEIHP 298

Query: 311 SIPQEL--------GKLE--HLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKL 356
           S    +        GK +   L      F         +L     L++ I     L
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 61/351 (17%), Positives = 120/351 (34%), Gaps = 64/351 (18%)

Query: 2   LSVLKLSSNLFTLN-----STSLLQLPFGLKQLELSSAGL----VGLVPDNLFSKLPNLV 52
           ++ L LS N            +    P  +  L LS   L       +   L +   N+ 
Sbjct: 24  VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83

Query: 53  YLNASYNNLTG----FLPETLLSNSDKLELLDLSYNNLT-GSISGFSLNENSCN-SLLHL 106
            LN S N L+      L +TL +    + +LDL +N+ +  S S F    ++   S+  L
Sbjct: 84  SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL 143

Query: 107 DLSQNHI----MDVIPSSLSNC-TKLKILNLSFNLL----AGEIPRTFGQL-SSLQRLDL 156
           +L  N +     D +   L+     +  LNL  N L      E+ +    + +S+  LDL
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDL 203

Query: 157 SNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPD 216
           S N +        G    + L                      +  L+L  N + GP  +
Sbjct: 204 SANLL--------GLKSYAELAYIFSSIPNH------------VVSLNLCLNCLHGPSLE 243

Query: 217 ---SVLENLGSLESLILSNNMISGSFPD-------SISSCKTLRIVDFSSNRVSGIIPPD 266
               + ++L  L+++ L  +++     +       +  + + + +VD +   +       
Sbjct: 244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP 303

Query: 267 ICPGV----SSLEELRLPDNLITGV-----IPGQLSECTQLKVIDLSLNYL 308
           I   +       +   L +  +            L+   +L+    +   L
Sbjct: 304 ISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 52/364 (14%), Positives = 103/364 (28%), Gaps = 66/364 (18%)

Query: 194 LSSCSWLQLLDLSNNNISGPFPDSV-------LENLGSLESLILSNNMISGSFPDSISS- 245
            S    +  LDLS NN+      S             S+ SL LS N +     D +   
Sbjct: 18  TSIPHGVTSLDLSLNNLY---SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI 74

Query: 246 ----CKTLRIVDFSSNRVSGIIPPDICPGV----SSLEELRLPDNLIT-----GVIPGQL 292
                  +  ++ S N +S     ++   +     ++  L L  N  +            
Sbjct: 75  LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFS 134

Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILN 352
           +    +  ++L  N L      EL +             L            N+  L L 
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQ------------ILA-------AIPANVNSLNLR 175

Query: 353 NNKLSGEIPAELFS-----CSNLEWISLTGNELTGQIPPEFSRL-----TRLAVLQLGNN 402
            N L+ +  AEL        +++  + L+ N L  +   E + +       +  L L  N
Sbjct: 176 GNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLN 235

Query: 403 RFKGE----IPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVR 458
              G     +     +   L  + L   ++  ++          K LG    +   + + 
Sbjct: 236 CLHGPSLENLKLLKDSLKHLQTVYL-DYDIVKNMSKE-----QCKALGAAFPNIQKIILV 289

Query: 459 NVGNSCKGVGGLLEFAGI--RPERLLQIPTLKS-CDFARMYSGPVLSLFTQYQTLEYLDL 515
           +           +  + +         +P+L + C          +        L     
Sbjct: 290 DKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQ 349

Query: 516 SYNQ 519
           +   
Sbjct: 350 TCKP 353

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 60/339 (17%), Positives = 109/339 (32%), Gaps = 98/339 (28%)

Query: 292 LSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCK-NLKDLI 350
            S    +  +DLSLN L      EL +                           ++  L 
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQA--------------------FANTPASVTSLN 57

Query: 351 LNNNKLSGEIPAELFS-----CSNLEWISLTGNELTGQIPPEFSRL-----TRLAVLQLG 400
           L+ N L  +   EL        +N+  ++L+GN L+ +   E  +        + VL LG
Sbjct: 58  LSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLG 117

Query: 401 NNRFKGEIPGELG-----NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSN--- 452
            N F  +   E         +S+  L+L  N+L             +  L   L++    
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK---------SSDELIQILAAIPAN 168

Query: 453 --TLVFVRN-VGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQT 509
             +L    N + +  K    L +F             L S                   +
Sbjct: 169 VNSLNLRGNNLAS--KNCAELAKF-------------LASIP----------------AS 197

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIA-----LQVLELAHNQLSGE----IPSSLGRLRNLGV 560
           +  LDLS N    K   E+  + +     +  L L  N L G     +      L++L  
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257

Query: 561 FDASHNRLQGQ-------IPESFSNLSFLVQIDLSNNEL 592
               ++ ++         +  +F N+  ++ +D +  E+
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 50/236 (21%), Positives = 88/236 (37%), Gaps = 41/236 (17%)

Query: 726 FSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLG 785
            ++L    + ++ +  I  G +G V      +G  VAIK++      G    +     L 
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 786 K-----------IKHRNLVPLL-----GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARD 829
           K             H N++ L             +  LV E M+   L +V+H +     
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ----- 127

Query: 830 QRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI 889
           + +++    +        GL  LH      ++HRD+   N+LL    +  + DF +AR  
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 890 SALDTHLSVSTLAGTPGYVPPEYY-------QSFRCTAKGDVYSFGVVLLELLTGK 938
           +A D + +         YV   +Y       Q    T   D++S G V+ E+   K
Sbjct: 185 TA-DANKT--------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 30/210 (14%)

Query: 741 LIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
            +G G    V++   K      A+K L +   +       E+  L ++ H N++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIF 117

Query: 800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT------WDARKKIARGAAKGLCFLH 853
           +   E  LV E +  G L +           RI+        DA     +   + + +LH
Sbjct: 118 ETPTEISLVLELVTGGELFD-----------RIVEKGYYSERDAAD-AVKQILEAVAYLH 165

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N    I+HRD+K  N+L          +++DFG+++++        + T+ GTPGY  P
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAP 219

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E  +      + D++S G++   LL G  P
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 53/228 (23%), Positives = 85/228 (37%), Gaps = 38/228 (16%)

Query: 98  NSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLS 157
               S L ++  + ++   +P  L       IL+LS NLL      T    + L +L+L 
Sbjct: 8   KVA-SHLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 158 NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDS 217
              +T  +  +       L  L L HN +  S P+   +   L +LD+S N ++   P  
Sbjct: 64  RAELTK-LQVDGTLP--VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLG 118

Query: 218 VLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL 277
            L  LG L+ L L  N +                           +PP +      LE+L
Sbjct: 119 ALRGLGELQELYLKGNELK-------------------------TLPPGLLTPTPKLEKL 153

Query: 278 RLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQ---ELGKLEHL 322
            L +N +T +  G L+    L  + L  N L  +IP+       L   
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 48/187 (25%), Positives = 70/187 (37%), Gaps = 10/187 (5%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           LP     L LS   L              L  LN     LT    +  L     L  LDL
Sbjct: 29  LPKDTTILHLSENLLYTF-SLATLMPYTRLTQLNLDRAELTKLQVDGTLPV---LGTLDL 84

Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEI 141
           S+N L            +  +L  LD+S N +  +   +L    +L+ L L  N L    
Sbjct: 85  SHNQLQSLPLLGQ----TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140

Query: 142 PRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQ 201
           P        L++L L+NN++T  +P+ L N  ++L  L L  N++  + P        L 
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198

Query: 202 LLDLSNN 208
              L  N
Sbjct: 199 FAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 48/209 (22%), Positives = 74/209 (35%), Gaps = 14/209 (6%)

Query: 221 NLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLP 280
            + S   +      ++ + P  +       I+  S N +            + L +L L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLY-TFSLATLMPYTRLTQLNLD 63

Query: 281 DNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPEL 340
              +T +          L  +DLS N L  S+P     L  L      FN L   +P   
Sbjct: 64  RAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119

Query: 341 -GKCKNLKDLILNNNKLSGEIPAELFSC-SNLEWISLTGNELTGQIPPE-FSRLTRLAVL 397
                 L++L L  N+L   +P  L +    LE +SL  N LT ++P    + L  L  L
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177

Query: 398 QLGNNRFKGEIPGELGNCSSLVWLDLNSN 426
            L  N     IP        L +  L+ N
Sbjct: 178 LLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 53/263 (20%), Positives = 85/263 (32%), Gaps = 61/263 (23%)

Query: 361 PAELFSCS-NLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV 419
           P    S   +   ++     LT  +PP+  + T   +L L  N         L   + L 
Sbjct: 2   PICEVSKVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLT 58

Query: 420 WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPE 479
            L+L+              +L    + G L     + + +  N                 
Sbjct: 59  QLNLDRA------------ELTKLQVDGTLPVLGTLDLSH--N----------------- 87

Query: 480 RLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLE 538
           +L  +P                 L      L  LD+S+N+    +P      +  LQ L 
Sbjct: 88  QLQSLP----------------LLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY 130

Query: 539 LAHNQLSGEIPSSL-GRLRNLGVFDASHNRLQGQIPES-FSNLSFLVQIDLSNNELTGPI 596
           L  N+L   +P  L      L     ++N L  ++P    + L  L  + L  N L   I
Sbjct: 131 LKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-I 187

Query: 597 PQRG--QLSTLPASQYANNPGLC 617
           P +G      LP +    NP LC
Sbjct: 188 P-KGFFGSHLLPFAFLHGNPWLC 209

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 52/249 (20%), Positives = 82/249 (32%), Gaps = 57/249 (22%)

Query: 345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRF 404
           +  ++  +   L+  +P +L    +   + L+ N L           TRL  L L     
Sbjct: 11  SHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 405 KGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNS 463
             ++    G    L  LDL+ N L   +P  LG+ L A   L   +S N           
Sbjct: 68  T-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPL-LGQTLPALTVLD--VSFN----------- 110

Query: 464 CKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGK 523
                              ++ +L                      L+ L L  N+ +  
Sbjct: 111 -------------------RLTSLPL------------GALRGLGELQELYLKGNELK-T 138

Query: 524 IPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLRNLGVFDASHNRLQGQIPESFSNLSF 581
           +P  +      L+ L LA+N L+ E+P+ L   L NL       N L   IP+ F     
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHL 196

Query: 582 LVQIDLSNN 590
           L    L  N
Sbjct: 197 LPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 53/301 (17%), Positives = 77/301 (25%), Gaps = 103/301 (34%)

Query: 244 SSCKT-LRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVID 302
            S       V+     ++ + PPD+ P       L L +NL+       L   T+L  ++
Sbjct: 6   VSKVASHLEVNCDKRNLTAL-PPDL-P--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 303 LSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPA 362
           L    L                 +     L             L  L L++N+L      
Sbjct: 62  LDRAEL---------------TKLQVDGTL-----------PVLGTLDLSHNQLQ----- 90

Query: 363 ELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLD 422
                                +P     L  L VL +  NR      G L     L  L 
Sbjct: 91  --------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130

Query: 423 LNSNNLTGDIPPRLGRQLGA-KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL 481
           L  N L   +PP L       + L   L++N                            L
Sbjct: 131 LKGNELK-TLPPGLLTPTPKLEKL--SLANN---------------------------NL 160

Query: 482 LQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH 541
            ++P                 L    + L+ L L  N     IP        L    L  
Sbjct: 161 TELPA---------------GLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHG 204

Query: 542 N 542
           N
Sbjct: 205 N 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 35/112 (31%), Positives = 49/112 (43%), Gaps = 10/112 (8%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           L+VL +S N  T      L+    L++L L    L  L P  L +  P L  L+ + NNL
Sbjct: 102 LTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL-PPGLLTPTPKLEKLSLANNNL 160

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISG--FSLNENSCNSLLHLDLSQN 111
           T  LP  LL+  + L+ L L  N+L  +I    F       + L    L  N
Sbjct: 161 TE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS-----HLLPFAFLHGN 205

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 58/216 (26%), Positives = 87/216 (40%), Gaps = 39/216 (18%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           +P   K+L+L S  L  L P   F +L  L  L  + N L   LP  +      LE L +
Sbjct: 35  IPADTKKLDLQSNKLSSL-PSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWV 92

Query: 82  SYNNLTGSISGFSLNEN---SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
           + N L       +L         +L  L L +N +  + P    + TKL  L+L +N L 
Sbjct: 93  TDNKLQ------ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146

Query: 139 GEIP-RTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSC 197
             +P   F +L+SL+ L L NN +   +P     A D L                     
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLK-RVPE---GAFDKL--------------------- 180

Query: 198 SWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
           + L+ L L NN +    P+   ++L  L+ L L  N
Sbjct: 181 TELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 53/229 (23%), Positives = 84/229 (36%), Gaps = 54/229 (23%)

Query: 200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRV 259
            + LDL +N +S   P      L  L  L L++N +                        
Sbjct: 39  TKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQT---------------------- 75

Query: 260 SGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKL 319
              +P  I   + +LE L + DN +  +  G   +   L  + L  N L  S+P  +   
Sbjct: 76  ---LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRV--- 128

Query: 320 EHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGN 378
                    F+ L             L  L L  N+L   +P  +F   ++L+ + L  N
Sbjct: 129 ---------FDSL-----------TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNN 167

Query: 379 ELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN 426
           +L  ++P   F +LT L  L+L NN+ K    G   +   L  L L  N
Sbjct: 168 QLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 21/198 (10%)

Query: 117 IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSL 176
           IPS++      K L+L  N L+    + F +L+ L+ L L++N +   +P+        L
Sbjct: 31  IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPA---GIFKEL 84

Query: 177 LELK---LPHNNITGSFPV-TLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
             L+   +  N +  + P+        L  L L  N +    P  V ++L  L  L L  
Sbjct: 85  KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGY 142

Query: 233 NMI----SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVI 288
           N +     G F D ++S K LR+    +N++   +P      ++ L+ L+L +N +  V 
Sbjct: 143 NELQSLPKGVF-DKLTSLKELRL---YNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVP 197

Query: 289 PGQLSECTQLKVIDLSLN 306
            G      +LK++ L  N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 50/162 (30%), Positives = 67/162 (41%), Gaps = 13/162 (8%)

Query: 2   LSVLKLSSN-LFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN 60
           L +L L+ N L TL +    +L   L+ L ++   L  L P  +F +L NL  L    N 
Sbjct: 63  LRLLYLNDNKLQTLPAGIFKELK-NLETLWVTDNKLQAL-PIGVFDQLVNLAELRLDRNQ 120

Query: 61  LTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCN---SLLHLDLSQNHIMDVI 117
           L   LP  +  +  KL  L L YN L       SL +   +   SL  L L  N +  V 
Sbjct: 121 LK-SLPPRVFDSLTKLTYLSLGYNELQ------SLPKGVFDKLTSLKELRLYNNQLKRVP 173

Query: 118 PSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
             +    T+LK L L  N L       F  L  L+ L L  N
Sbjct: 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 13/190 (6%)

Query: 245 SC-KTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDL 303
           SC      VD SS +++ I P +I P  +  ++L L  N ++ +        T+L+++ L
Sbjct: 13  SCNNNKNSVDCSSKKLTAI-PSNI-P--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYL 68

Query: 304 SLNYLNGSIPQEL-GKLEHLEQFIAWFNGLEGKIPPEL-GKCKNLKDLILNNNKLSGEIP 361
           + N L  ++P  +  +L++LE      N L+  +P  +  +  NL +L L+ N+L   +P
Sbjct: 69  NDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLP 125

Query: 362 AELF-SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV 419
             +F S + L ++SL  NEL   +P   F +LT L  L+L NN+ K    G     + L 
Sbjct: 126 PRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELK 184

Query: 420 WLDLNSNNLT 429
            L L++N L 
Sbjct: 185 TLKLDNNQLK 194

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 57/268 (21%), Positives = 92/268 (34%), Gaps = 58/268 (21%)

Query: 353 NNKLSGEIPAELFSCSN-LEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGE 411
           N  L  +    + SC+N    +  +  +LT  IP      T+   L L +N+        
Sbjct: 1   NEAL-CKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIPADTK--KLDLQSNKLSSLPSKA 56

Query: 412 LGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLL 471
               + L  L LN N L   +P            G F     L  +    N         
Sbjct: 57  FHRLTKLRLLYLNDNKLQ-TLPA-----------GIFKELKNLETLWVTDN--------- 95

Query: 472 EFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGD- 530
                   +L  +P                 +F Q   L  L L  NQ +  +P  + D 
Sbjct: 96  --------KLQALPI---------------GVFDQLVNLAELRLDRNQLK-SLPPRVFDS 131

Query: 531 MIALQVLELAHNQLSGEIPSSL-GRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSN 589
           +  L  L L +N+L   +P  +  +L +L      +N+L+     +F  L+ L  + L N
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190

Query: 590 NELTGPIPQRGQLSTLPASQYA---NNP 614
           N+L   +P  G   +L   +      NP
Sbjct: 191 NQLKR-VP-EGAFDSLEKLKMLQLQENP 216

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 83.5 bits (207), Expect = 4e-17
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 28/210 (13%)

Query: 742 IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQG-DRE-FMAEMETLGKIKHRNLVPLLGY 798
           +G G F  V +   K  G   A K +        D +    E     K++H N+V L   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 799 CKIGEERLLVYEFMKFGSLEE--VLHGR---AKARDQRILTWDARKKIARGAAKGLCFLH 853
            +      LV++ +  G L E  V       A A               +   + + + H
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-----------CIQQILESIAYCH 145

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            N    I+HR++K  N+LL  + +    +++DFG+A  +   +   +    AGTPGY+ P
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSP 199

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           E  +    +   D+++ GV+L  LL G  P
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.7 bits (205), Expect = 5e-17
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 49/220 (22%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD-------REFMAEMETLGKIKHRNLV 793
           +G G +GEV+KA       +VAIK+ IRL  + +       RE    +  L +++HRN++
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKR-IRLEHEEEGVPGTAIRE----VSLLKELQHRNII 96

Query: 794 PLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
            L         RL L++E+ +   L++ +           ++    K        G+ F 
Sbjct: 97  ELKSVI-HHNHRLHLIFEYAEN-DLKKYMD------KNPDVSMRVIKSFLYQLINGVNFC 148

Query: 853 HHNCIPHIIHRDMKSSNVLLDHEMEAR-----VSDFGMARLISALD---THLSVSTLAGT 904
           H       +HRD+K  N+LL     +      + DFG+AR         TH  + TL   
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE-IITL--- 201

Query: 905 PGYVPPE------YYQSFRCTAKGDVYSFGVVLLELLTGK 938
             Y PPE      +Y     +   D++S   +  E+L   
Sbjct: 202 -WYRPPEILLGSRHY-----STSVDIWSIACIWAEMLMKT 235

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 82.7 bits (205), Expect = 5e-17
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 19/211 (9%)

Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKIKHRNLVPLL 796
           L+G G FG+V     K      A+K L +       E    + E   L   +H  L  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 797 GYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
            Y     +RL  V E+   G L   L      R++      AR   A      L +LH  
Sbjct: 72  -YAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAE-IVSALEYLHSR 124

Query: 856 CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYYQ 914
               +++RD+K  N++LD +   +++DFG+ +  IS   T   + T  GTP Y+ PE  +
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLE 178

Query: 915 SFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                   D +  GVV+ E++ G+ P    D
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.9 bits (205), Expect = 9e-17
 Identities = 68/285 (23%), Positives = 121/285 (42%), Gaps = 49/285 (17%)

Query: 742  IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYC 799
            +G G  G+V +   K      A+K L             E+E   +  +  ++V ++   
Sbjct: 70   LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 124

Query: 800  ---KIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILT-WDARKKIARGAAKGLCFLHH 854
                 G + L +V E +  G L      R + R  +  T  +A + I +   + + +LH 
Sbjct: 125  ENLYAGRKCLLIVMECLDGGELFS----RIQDRGDQAFTEREASE-IMKSIGEAIQYLHS 179

Query: 855  NCIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
                +I HRD+K  N+L   +      +++DFG A+      +H S++T   TP YV PE
Sbjct: 180  I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---TSHNSLTTPCYTPYYVAPE 233

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGW---VKMKVREGKQMEVI 968
                 +     D++S GV++  LL G  P     F   + +     +K ++R G+  E  
Sbjct: 234  VLGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQ-YEFP 287

Query: 969  DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            +PE   V+        EEVK ++R     L   +  P++R  + +
Sbjct: 288  NPEWSEVS--------EEVKMLIR----NLLKTE--PTQRMTITE 318

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.6 bits (204), Expect = 2e-16
 Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 44/216 (20%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIR-----LSCQGD-REFMAEMETLGKIKHRNLVP 794
           IG G  G V  A       +VAIKKL R        +   RE +     +  + H+N++ 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNIIS 125

Query: 795 LL------GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
           LL         +  ++  LV E M   +L +V+           L +    ++  G    
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLY----QMLCG---- 176

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           +  LH      IIHRD+K SN+++  +   ++ DFG+AR         +  T      YV
Sbjct: 177 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFMMTPYV 224

Query: 909 ------PPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
                  PE           D++S G ++ E++  K
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 82.9 bits (204), Expect = 2e-16
 Identities = 43/240 (17%), Positives = 79/240 (32%), Gaps = 39/240 (16%)

Query: 3   SVLKLSSNLFTLNSTSL-LQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
              + S+    L    L ++    L+    S   L  L P+N +  L  ++ + A  + L
Sbjct: 340 CWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRA-LDPL 398

Query: 62  TGFLPETLLSNSDKLELLD-----LSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV 116
                +  L     L+ +D        +  +  +   S+ +     +  L L+   +  +
Sbjct: 399 L--YEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL 456

Query: 117 IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSL 176
               L     +  L+LS N L   +P     L  L+ L  S+N +               
Sbjct: 457 --CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-------------- 499

Query: 177 LELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS 236
                   N+ G     +++   LQ L L NN +        L +   L  L L  N + 
Sbjct: 500 --------NVDG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 75.6 bits (185), Expect = 4e-14
 Identities = 51/337 (15%), Positives = 99/337 (29%), Gaps = 54/337 (16%)

Query: 123 NCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLP 182
            C  +       ++          ++ +L  +         W   +  N    +    LP
Sbjct: 246 CCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLP 305

Query: 183 HNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLI---LSNNMISGSF 239
             ++    P       W          +    P+    +  + E L    LS    +   
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364

Query: 240 PDSISSCKTLRIVDFSSNRVSGII------------PPDICPGVSSLEEL--------RL 279
              + SCK L+ ++  +      I              +     S+L+ +          
Sbjct: 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424

Query: 280 PDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE 339
             +           E   ++V+ L+   L  ++   L +L  +       N L   +PP 
Sbjct: 425 LRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPA 481

Query: 340 LGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQL 399
           L   + L+ L  ++N L                 ++             + L RL  L L
Sbjct: 482 LAALRCLEVLQASDNALE----------------NV----------DGVANLPRLQELLL 515

Query: 400 GNNRFKG-EIPGELGNCSSLVWLDLNSNNLTGDIPPR 435
            NNR +       L +C  LV L+L  N+L  +   +
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.7 bits (175), Expect = 7e-13
 Identities = 54/301 (17%), Positives = 96/301 (31%), Gaps = 25/301 (8%)

Query: 316 LGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISL 375
           L  ++     + W        P  +  C      + +             S S  E + L
Sbjct: 275 LLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL 334

Query: 376 TGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNN--LTGDIP 433
                      + +   +L   +L   +    +  EL +C  L  L+  +    LT  + 
Sbjct: 335 KDRPECW--CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL 391

Query: 434 PRLGRQLGAKPLGGFLSSN--TLVFVRNVGN----SCKGVGGLLEFAGIRPERLLQIPTL 487
            R    L  +       S    +  +R        S   +   +        R+L    L
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH---L 448

Query: 488 KSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE 547
              D         L    Q   + +LDLS+N+ R  +P  +  +  L+VL+ + N L   
Sbjct: 449 AHKDLTV------LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-N 500

Query: 548 IPSSLGRLRNLGVFDASHNRLQG-QIPESFSNLSFLVQIDLSNNELTGPIPQRGQL-STL 605
           +   +  L  L      +NRLQ     +   +   LV ++L  N L      + +L   L
Sbjct: 501 VDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 559

Query: 606 P 606
           P
Sbjct: 560 P 560

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 44.0 bits (103), Expect = 2e-04
 Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 4/86 (4%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           ++ L LS N       +L  L   L+ L+ S   L  +      + LP L  L    N L
Sbjct: 465 VTHLDLSHNRLRALPPALAALR-CLEVLQASDNALENVDG---VANLPRLQELLLCNNRL 520

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLT 87
                   L +  +L LL+L  N+L 
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 79.9 bits (198), Expect = 4e-16
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 26/213 (12%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKL-----IRLSCQGDRE-FMAEMETLGKIK 788
           F     +G G FG V     +      A+K L     +RL      E    E   L  + 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK---QVEHTNDERLMLSIVT 64

Query: 789 HRNLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAK 847
           H  ++ + G  +   +++ ++ ++++ G L      R   + QR     A+   A     
Sbjct: 65  HPFIIRMWGTFQ-DAQQIFMIMDYIEGGEL--FSLLR---KSQRFPNPVAKFYAAE-VCL 117

Query: 848 GLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
            L +LH      II+RD+K  N+LLD     +++DFG A+ +  + T+    TL GTP Y
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TY----TLCGTPDY 169

Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           + PE   +       D +SFG+++ E+L G  P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.7 bits (197), Expect = 6e-16
 Identities = 51/227 (22%), Positives = 85/227 (37%), Gaps = 44/227 (19%)

Query: 731 EATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR-----LSCQGD-REFMAEMET 783
                +     IG G  G V  A       +VAIKKL R        +   RE +     
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----L 77

Query: 784 LGKIKHRNLVPLL------GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDA 837
           +  + H+N++ LL         +  ++  +V E M   +L +V+           L  + 
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--------LDHER 128

Query: 838 RKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS 897
              +      G+  LH      IIHRD+K SN+++  +   ++ DFG+AR         +
Sbjct: 129 MSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------T 176

Query: 898 VSTLAGTPGYV------PPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
             T      YV       PE           D++S G ++ E++ G 
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 79.2 bits (196), Expect = 7e-16
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 20/212 (9%)

Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGK-IKHRNLVPL 795
           ++G G FG+VF A  K  +   AIK L +     D +    M E   L    +H  L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
                  +E L  V E++  G L   +         +     A    A     GL FLH 
Sbjct: 84  F-CTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAE-IILGLQFLHS 136

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYY 913
                I++RD+K  N+LLD +   +++DFGM +  +         +T  GTP Y+ PE  
Sbjct: 137 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEIL 190

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
              +     D +SFGV+L E+L G+ P    D
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.2 bits (200), Expect = 8e-16
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 20/217 (9%)

Query: 736 FSAESLIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKI-KHR 790
           F+   ++G G FG+V  +  K    + A+K L +     D +    M E   L    K  
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 791 NLVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
            L  L   C    +RL  V E++  G L   +      +  R     A    A   A GL
Sbjct: 403 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAE-IAIGL 455

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYV 908
            FL       II+RD+K  NV+LD E   +++DFGM +  I    T     T  GTP Y+
Sbjct: 456 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYI 509

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
            PE           D ++FGV+L E+L G+ P + +D
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 79.6 bits (197), Expect = 8e-16
 Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGK-IKHRNLVPL 795
           +IG G FG+V  A  K      A+K L + +    +E    M+E   L K +KH  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
             +     ++L  V +++  G L   L      R++  L   AR   A   A  L +LH 
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAE-IASALGYLHS 157

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYY 913
               +I++RD+K  N+LLD +    ++DFG+ +  I    T    ST  GTP Y+ PE  
Sbjct: 158 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVL 211

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                    D +  G VL E+L G  P    +
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 79.4 bits (196), Expect = 9e-16
 Identities = 46/221 (20%), Positives = 89/221 (40%), Gaps = 35/221 (15%)

Query: 740 SLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK---------- 788
             +G G F  V+ A  + + + VA+K ++R           E++ L ++           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 789 -HRNLVPLLGY----CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIAR 843
              +++ LL +       G   ++V+E +   +L  ++    K  + R +     K+I++
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLG-ENLLALI----KKYEHRGIPLIYVKQISK 138

Query: 844 GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA------RVSDFGMARLISALDTHLS 897
               GL ++H  C   IIH D+K  NVL++           +++D G     +A      
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEH 191

Query: 898 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
            +    T  Y  PE           D++S   ++ EL+TG 
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 45/223 (20%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLI---RLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
           +GCGG G VF A        VAIKK++     S +       E++ + ++ H N+V +  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--HALR-EIKIIRRLDHDNIVKVFE 75

Query: 798 YCKIGEERL--------------LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIAR 843
                  +L              +V E+M     E  L    +      L  +  +    
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGP---LLEEHARLFMY 127

Query: 844 GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVSTLA 902
              +GL ++H     +++HRD+K +N+ ++ E +  ++ DFG+AR++    +H    +  
Sbjct: 128 QLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS-- 182

Query: 903 GTPGYVPPEYY-------QSFRCTAKGDVYSFGVVLLELLTGK 938
                +  ++Y            T   D+++ G +  E+LTGK
Sbjct: 183 ---EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 57/252 (22%), Positives = 98/252 (38%), Gaps = 42/252 (16%)

Query: 705 KEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAI 763
                ++   A     +R   F    +    ++  S IG G +G V  A    +   VAI
Sbjct: 2   HHHHHMAAAAAAGPEMVRGQVF----DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAI 57

Query: 764 KKLIRLSCQGD-----REFMAEMETLGKIKHRNLVPLLGYCKIGEERL-----LVYEFMK 813
           KK+     Q       RE       L + +H N++ +    +           +V + M 
Sbjct: 58  KKISPFEHQTYCQRTLREIK----ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM- 112

Query: 814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD 873
               E  L+   K +    L+ D          +GL ++H     +++HRD+K SN+LL+
Sbjct: 113 ----ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLN 162

Query: 874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY-------QSFRCTAKGDVYS 926
              + ++ DFG+AR+      H    T      YV   +Y        S   T   D++S
Sbjct: 163 TTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYRAPEIMLNSKGYTKSIDIWS 217

Query: 927 FGVVLLELLTGK 938
            G +L E+L+ +
Sbjct: 218 VGCILAEMLSNR 229

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 40/194 (20%), Positives = 73/194 (37%), Gaps = 40/194 (20%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
             +    E   +  + +   I       ++  +  HL LS N+I  +  SSLS    L+I
Sbjct: 17  RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRI 74

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           L+L  NL+  +I        +L+ L +S N I                       +++G 
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQIA----------------------SLSG- 110

Query: 190 FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDS------- 242
               +     L++L +SNN I+       L  L  LE L+L+ N +   + ++       
Sbjct: 111 ----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYR 166

Query: 243 ---ISSCKTLRIVD 253
              +     L+ +D
Sbjct: 167 IEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 41/162 (25%), Positives = 65/162 (40%), Gaps = 22/162 (13%)

Query: 5   LKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGF 64
           L            +L  L    K L LS+  +  +   +L S + NL  L+   N +   
Sbjct: 30  LHGMIPPIEKMDATLSTLK-ACKHLALSTNNIEKI--SSL-SGMENLRILSLGRNLIKKI 85

Query: 65  LPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIP-SSLSN 123
             E L + +D LE L +SYN +  S+SG         +L  L +S N I +      L+ 
Sbjct: 86  --ENLDAVADTLEELWISYNQIA-SLSGIE----KLVNLRVLYMSNNKITNWGEIDKLAA 138

Query: 124 CTKLKILNLSFNLLAGEIPRTFG----------QLSSLQRLD 155
             KL+ L L+ N L  +                +L +L++LD
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 61.2 bits (149), Expect = 9e-11
 Identities = 38/174 (21%), Positives = 63/174 (36%), Gaps = 34/174 (19%)

Query: 148 LSSLQRLDLSNNH--ITGWIPSELGNACDSLLELKLPHNNIT---GSFPVTLSSCSWLQL 202
            +  ++++L      I   + + L     +   L L  NNI          LS    L++
Sbjct: 22  ATEAEKVELHGMIPPIEK-MDATLST-LKACKHLALSTNNIEKISS-----LSGMENLRI 74

Query: 203 LDLSNNNISGPFPDSVLENL----GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNR 258
           L L  N I        +ENL     +LE L +S N I+      I     LR++  S+N+
Sbjct: 75  LSLGRNLIK------KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNK 126

Query: 259 VSGIIPPDICPGVSSLEELRLPDNLITGVIPGQ----------LSECTQLKVID 302
           ++     D    +  LE+L L  N +                 +     LK +D
Sbjct: 127 ITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 6/101 (5%)

Query: 329 FNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEF 388
              +E K+   L   K  K L L+ N +  +I + L    NL  +SL  N +  +I    
Sbjct: 34  IPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLD 89

Query: 389 SRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
           +    L  L +  N+    + G +    +L  L +++N +T
Sbjct: 90  AVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 21/84 (25%), Positives = 37/84 (44%), Gaps = 5/84 (5%)

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQ 569
            ++L LS N    KI   +  M  L++L L  N +  +I +       L     S+N++ 
Sbjct: 50  CKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106

Query: 570 GQIPESFSNLSFLVQIDLSNNELT 593
             +      L  L  + +SNN++T
Sbjct: 107 -SL-SGIEKLVNLRVLYMSNNKIT 128

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 46/228 (20%)

Query: 731 EATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR-----LSCQGD-REFMAEMET 783
           E    +     +G G +G V  A   + G+ VAIKKL R     L  +   RE       
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----L 77

Query: 784 LGKIKHRNLVPLL------GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDA 837
           L  ++H N++ LL             +  LV  FM    L +++           L  D 
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMK-------HEKLGEDR 129

Query: 838 RKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLS 897
            + +     KGL ++H      IIHRD+K  N+ ++ + E ++ DFG+AR   +  T   
Sbjct: 130 IQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--- 183

Query: 898 VSTLAGTPGYVPPEYY-------QSFRCTAKGDVYSFGVVLLELLTGK 938
                   GYV   +Y          R T   D++S G ++ E++TGK
Sbjct: 184 --------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 45/232 (19%)

Query: 726 FSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR-----LSCQGDREFMA 779
                E    + + + +G G +G V  A   + G  VAIKKL R     +  +  R +  
Sbjct: 16  NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK--RAYR- 72

Query: 780 EMETLGKIKHRNLVPLL------GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRIL 833
           E+  L  ++H N++ LL         +   +  LV  FM     +  L      +     
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLK----F 123

Query: 834 TWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD 893
           + +  + +     KGL ++H      ++HRD+K  N+ ++ + E ++ DFG+AR   A  
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180

Query: 894 THLSVSTLAGTPGYVPPEYY-------QSFRCTAKGDVYSFGVVLLELLTGK 938
           T           GYV   +Y                D++S G ++ E+LTGK
Sbjct: 181 T-----------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 741 LIGCGGFGEVF---KATLKDGSSV-AIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVP 794
           ++G G FG+VF   K +  D   + A+K L    L  +       E + L ++ H  +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 795 LLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
           L  Y    E +L L+ +F++ G L   L      ++      D +  +A   A  L  LH
Sbjct: 91  LH-YAFQTEGKLYLILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLAE-LALALDHLH 143

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                 II+RD+K  N+LLD E   +++DFG+++   ++D      +  GT  Y+ PE  
Sbjct: 144 SL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVV 198

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                T   D +SFGV++ E+LTG  P    D
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 79.6 bits (196), Expect = 2e-15
 Identities = 76/521 (14%), Positives = 161/521 (30%), Gaps = 81/521 (15%)

Query: 30  ELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGS 89
            ++ A      PD L  + PNL  L               L    +  + +L   N  G 
Sbjct: 54  HVTMALCYTATPDRLSRRFPNLRSLK--------------LKGKPRAAMFNLIPENWGGY 99

Query: 90  IS-GFSLNENSCNSLLHLDLSQNHIMDVIPSSL--SNCTKLKILNLSF-NLLAGEIPRTF 145
           ++   +   N+   L  +   +  + D+    L  +    L+ L L   +    +   + 
Sbjct: 100 VTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSI 159

Query: 146 GQ-LSSLQRLDLSNN---HITGWIPSELGNACDSLLELKLPHNNITG----SFPVTLSSC 197
                 ++ L +  +      G    EL     SL  L                    +C
Sbjct: 160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219

Query: 198 SWLQLLDLSN-NNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSS 256
             L  + + +   +          NL       L+ ++       ++   + L  +  S 
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLS- 278

Query: 257 NRVSGIIPPDICPGVSSLEELRLPD-NLITGVIPGQLSECTQLKVIDLSLNYLN----GS 311
             +     P + P  + + +L L    L T      + +C  L+V++   N +       
Sbjct: 279 -YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEV 336

Query: 312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE-IPAELFSCSNL 370
           + Q   +L+ L                 + +  + + +      +S   + A    C  L
Sbjct: 337 LAQYCKQLKRL----------------RIERGADEQGMEDEEGLVSQRGLIALAQGCQEL 380

Query: 371 EWISLTGNELTGQ----IPPEFSRLTRLAVLQLGNNRFKGEIPGELG------NCSSLVW 420
           E++++  +++T +    I      L    ++ L       ++P + G       C  L  
Sbjct: 381 EYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR 440

Query: 421 LDL--NSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRP 478
                    LT           G   +G +  +   + +  VG S +G+         R 
Sbjct: 441 FAFYLRQGGLTDL---------GLSYIGQYSPNVRWMLLGYVGESDEGLMEFS-----RG 486

Query: 479 ERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ 519
              LQ   ++ C F+      + +  T+  +L YL +   +
Sbjct: 487 CPNLQKLEMRGCCFSER---AIAAAVTKLPSLRYLWVQGYR 524

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 73.1 bits (179), Expect = 2e-13
 Identities = 47/332 (14%), Positives = 96/332 (28%), Gaps = 33/332 (9%)

Query: 2   LSVLKLS-SNLFTLNSTSLLQLPFGLKQL-ELSSAGLVGLVPDNLFSKLPNLVYLNASYN 59
           L VL    +    ++   L  +    + L  +       L     F    NL        
Sbjct: 194 LEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSL 253

Query: 60  NLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIM-DVIP 118
           N    +PE  ++     +L  L  + +  +     +       +  LDL    +  +   
Sbjct: 254 NEDIGMPEKYMNLVFPRKLCRLGLSYMGPN--EMPILFPFAAQIRKLDLLYALLETEDHC 311

Query: 119 SSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSE---------- 168
           + +  C  L++L     +    +         L+RL +        +  E          
Sbjct: 312 TLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLI 371

Query: 169 -LGNACDSLLELKLPHNNIT----GSFPVTLSSCSWLQLLDLSN-NNISGPFPD----SV 218
            L   C  L  + +  ++IT     S    L +    +L+ L     I+    D    S+
Sbjct: 372 ALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSL 431

Query: 219 LENLGSLESLILSNNMISGSFPDSI-----SSCKTLRIVDFSSNRVSGIIPPDICPGVSS 273
           L     L           G   D            +R +       S     +   G  +
Sbjct: 432 LIGCKKLRRFAFYLR--QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPN 489

Query: 274 LEELRLPDNLITGV-IPGQLSECTQLKVIDLS 304
           L++L +     +   I   +++   L+ + + 
Sbjct: 490 LQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQ 521

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 71.5 bits (175), Expect = 7e-13
 Identities = 42/284 (14%), Positives = 75/284 (26%), Gaps = 30/284 (10%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
                L+ ++        L  P  L +L LS  G   +    LF     +  L+  Y  L
Sbjct: 248 FCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEM--PILFPFAAQIRKLDLLYALL 305

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
                 TL+     LE+L+           G  +    C  L  L + +      +    
Sbjct: 306 ETEDHCTLIQKCPNLEVLETRN---VIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEE 362

Query: 122 S------------NCTKLKILNLSFNLL----AGEIPRTFGQLSSLQRLDLSN-NHITGW 164
                         C +L+ + +  + +       I      L   + + L     IT  
Sbjct: 363 GLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL 422

Query: 165 IPSE----LGNACDSLLELKLPHN--NIT-GSFPVTLSSCSWLQLLDLSNNNISGPFPDS 217
                   L   C  L           +T             ++ + L     S      
Sbjct: 423 PLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482

Query: 218 VLENLGSLESLILSNNMISGSFPDSI-SSCKTLRIVDFSSNRVS 260
                 +L+ L +     S     +  +   +LR +     R S
Sbjct: 483 FSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 53.0 bits (127), Expect = 4e-07
 Identities = 66/502 (13%), Positives = 134/502 (26%), Gaps = 68/502 (13%)

Query: 143 RTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTL-------- 194
           R + ++ S  R  ++        P  L     +L  LKL        F +          
Sbjct: 42  RRWFKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVT 101

Query: 195 -------SSCSWLQLLDLSNNNISGPFPDSVLENLG-----SLESLILSN-NMISGSFPD 241
                  ++   L+ +      +S    D  L+ L       LE+L L   +  +     
Sbjct: 102 PWVTEISNNLRQLKSVHFRRMIVS----DLDLDRLAKARADDLETLKLDKCSGFTTDGLL 157

Query: 242 SISS-CKTLRIVDFSSNRVSGIIPP---DICPGVSSLEELRLPDNLITGV----IPGQLS 293
           SI + C+ ++ +    +  S        ++    +SLE L         +    +     
Sbjct: 158 SIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217

Query: 294 ECTQLKVIDLSLNYL--NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLIL 351
            C  L  + +    +       +    LE         +    +    L   + L  L L
Sbjct: 218 NCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL 277

Query: 352 NNNKLSGEIPAELFSCSNLEWISLTGNEL-TGQIPPEFSRLTRLAVLQLGNNRFKGEIPG 410
           +    +  +P      + +  + L    L T        +   L VL+  N      +  
Sbjct: 278 SYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEV 336

Query: 411 ELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFV-------RNVGNS 463
               C  L  L +        +    G           +S   L+ +         +   
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGL----------VSQRGLIALAQGCQELEYMAVY 386

Query: 464 CKGVG--GLLEFAGIRPE-RLLQIPTLKSCDFARMYSG--PVLSLFTQYQTLEYLDLSYN 518
              +    L             ++  L   +          V SL    + L        
Sbjct: 387 VSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR 446

Query: 519 QFRGKIPDEIGDMIA-----LQVLELAHNQLSGE-IPSSLGRLRNLGVFDASHNRLQGQ- 571
             +G + D     I      ++ + L +   S E +        NL   +        + 
Sbjct: 447 --QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERA 504

Query: 572 IPESFSNLSFLVQIDLSNNELT 593
           I  + + L  L  + +     +
Sbjct: 505 IAAAVTKLPSLRYLWVQGYRAS 526

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 46/213 (21%), Positives = 86/213 (40%), Gaps = 40/213 (18%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-------HRNLV 793
           +G G + EVF+A  + +   V +K L        +    + +   +IK         N++
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKK-KIKREIKILENLRGGPNII 94

Query: 794 PLLGYCKIGEER--LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            L    K    R   LV+E +     +++          + LT    +       K L +
Sbjct: 95  TLADIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDY 145

Query: 852 LH-HNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTH-LSVSTLAGTPGYV 908
            H       I+HRD+K  NV++DHE  + R+ D+G+A        + + V++      + 
Sbjct: 146 CHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY----FK 197

Query: 909 PPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRP 940
            PE    ++      D++S G +L  ++  K P
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 77.7 bits (192), Expect = 3e-15
 Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 20/212 (9%)

Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKI-KHRNLVPL 795
           ++G G FG+V  A +K+   + A+K L +     D +    M E   L     H  L  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
              C    +RL  V EF+  G L   +      + +R     AR   A      L FLH 
Sbjct: 90  F-CCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAE-IISALMFLHD 142

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYY 913
                II+RD+K  NVLLDHE   +++DFGM +  I    T    +T  GTP Y+ PE  
Sbjct: 143 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPEIL 196

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           Q        D ++ GV+L E+L G  P + ++
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 79.2 bits (195), Expect = 3e-15
 Identities = 74/457 (16%), Positives = 144/457 (31%), Gaps = 60/457 (13%)

Query: 31  LSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSI 90
               G V    + + S    L  +      +T    E +  +    ++L LS        
Sbjct: 87  DGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE---GF 143

Query: 91  SGFSLNE--NSCNSLLHLDLSQNHIMDVIPSSLS----NCTKLKILNLSF---NLLAGEI 141
           S   L     +C +L  LDL ++ + DV    LS      T L  LN+S     +    +
Sbjct: 144 STDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSAL 203

Query: 142 PRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPH------------------ 183
            R   +  +L+ L L+   +     + L      L EL                      
Sbjct: 204 ERLVTRCPNLKSLKLNRA-VPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262

Query: 184 -----------NNIT-GSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS 231
                       +      P   S CS L  L+LS   +       +L     L+ L + 
Sbjct: 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322

Query: 232 NNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVS--SLEELRLPDNLITGVIP 289
           + +         S+CK LR +    +        +    ++   L  + +    +  V  
Sbjct: 323 DYIEDAGLEVLASTCKDLRELRVFPSEP---FVMEPNVALTEQGLVSVSMGCPKLESV-- 377

Query: 290 GQLSECTQLKVIDLSLNYLNGSIPQ----ELGKLEHLEQFIAWFNGLEGKIPPELGKCKN 345
             L  C Q+   + +L  +  + P      L  +E           L+      +  CK+
Sbjct: 378 --LYFCRQMT--NAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKD 433

Query: 346 LKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQ-IPPEFSRLTRLAVLQLGNNRF 404
           L+ L L+                 +E +S+     +   +    S    L  L++ +  F
Sbjct: 434 LRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493

Query: 405 KGE-IPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQL 440
             + +        ++  L ++S +++      LG+++
Sbjct: 494 GDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKM 530

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 71.9 bits (176), Expect = 6e-13
 Identities = 68/389 (17%), Positives = 131/389 (33%), Gaps = 60/389 (15%)

Query: 2   LSVLKLSSNLFT-LNSTSLLQLPFGLKQLE-LSSAGLVGLVPD----NLFSKLPNLVYLN 55
           L  L L  +    ++   L   P     L  L+ + L   V       L ++ PNL  L 
Sbjct: 158 LKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLK 217

Query: 56  ASYN-NLTGFLPETLLSNSDKLELLDLSYNNL---TGSISGFSLNENSCNSLLHLDLSQN 111
            +    L       LL  + +LE L              SG S+  + C  L  L    +
Sbjct: 218 LNRAVPLEKLAT--LLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275

Query: 112 HIMDVIPSSLSNCTKLKILNLSF-NLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELG 170
            +   +P+  S C++L  LNLS+  + + ++ +   Q   LQRL + +  I       L 
Sbjct: 276 AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLA 334

Query: 171 NACDSLLELKLPH---------NNITGSFPVTLS-SCSWLQLLDLSNNNISGPFPDSVLE 220
           + C  L EL++             +T    V++S  C  L+ +      ++    ++ L 
Sbjct: 335 STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT----NAALI 390

Query: 221 NLG----SLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEE 276
            +     ++    L                 TL  +D             I      L  
Sbjct: 391 TIARNRPNMTRFRLC------IIEPKAPDYLTLEPLDIGFGA--------IVEHCKDLRR 436

Query: 277 LRLPDNLITGVIPGQLSECTQLKVIDLS--------LNYLNGSIPQELGKLEHLEQFIAW 328
           L L   L   V     +   +++++ ++        ++++          L  LE  I  
Sbjct: 437 LSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCD----SLRKLE--IRD 490

Query: 329 FNGLEGKIPPELGKCKNLKDLILNNNKLS 357
               +  +     K + ++ L +++  +S
Sbjct: 491 CPFGDKALLANASKLETMRSLWMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 66.5 bits (162), Expect = 3e-11
 Identities = 47/330 (14%), Positives = 106/330 (32%), Gaps = 36/330 (10%)

Query: 120 SLSNCTKLKILNLSFNLLAGEIPRTFGQLSS----LQRLDLSNNHITGWIPSELGNACDS 175
            L         NL  +   G +      +SS    L+ + L    +T      +  +  +
Sbjct: 72  ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKN 131

Query: 176 LLELKLPH-NNITGSFPVTLSS-CSWLQLLDLSNNNISGPFPDSV---LENLGSLESLIL 230
              L L      +      +++ C  L+ LDL  +++       +    +   SL SL +
Sbjct: 132 FKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI 191

Query: 231 SN--NMISGSFPDSI-SSCKTLRIVDFSSNR-VSGIIPPDICPGVSSLEELRL------P 280
           S   + +S S  + + + C  L+ +  +    +  +    +      LEEL         
Sbjct: 192 SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLAT--LLQRAPQLEELGTGGYTAEV 249

Query: 281 DNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF-IAWFNGLEGKIPPE 339
              +   +   LS C +L+ +    + +   +P        L    +++       +   
Sbjct: 250 RPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKL 309

Query: 340 LGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQL 399
           L +C  L+ L + +      +     +C +L  + +  +E    +      LT   ++ +
Sbjct: 310 LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSE--PFVMEPNVALTEQGLVSV 367

Query: 400 GNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
                          C  L  +      +T
Sbjct: 368 SM------------GCPKLESVLYFCRQMT 385

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 63.4 bits (154), Expect = 2e-10
 Identities = 45/277 (16%), Positives = 93/277 (33%), Gaps = 39/277 (14%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLE-------LSSAGLVGLVPDNLFSKLPNLVYL 54
           L+ L LS    T+ S  L++L     +L+       +  AGL  L      S   +L  L
Sbjct: 291 LTTLNLSYA--TVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLA-----STCKDLREL 343

Query: 55  N---------ASYNNLTGFLPETLLSNSDKLELLDLSYNNLTG-SISGFSLNENSCNSLL 104
                          LT     ++     KLE +      +T  ++   + N     ++ 
Sbjct: 344 RVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARN---RPNMT 400

Query: 105 HLDLS----------QNHIMDV-IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQR 153
              L               +D+   + + +C  L+ L+LS  L              ++ 
Sbjct: 401 RFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEM 460

Query: 154 LDLSNNHITGWIPSELGNACDSLLELKLPH-NNITGSFPVTLSSCSWLQLLDLSNNNISG 212
           L ++    +      + + CDSL +L++        +     S    ++ L +S+ ++S 
Sbjct: 461 LSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520

Query: 213 PFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTL 249
                + + +  L   ++       S P+S    +  
Sbjct: 521 GACKLLGQKMPKLNVEVIDERGAPDSRPESCPVERVF 557

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.4 bits (189), Expect = 5e-15
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 21/214 (9%)

Query: 741 LIGCGGFGEVF---KATLKDGSSV----AIKKLIRLSCQGDREF-MAEMETLGKIKHRNL 792
           ++G GG+G+VF   K T  +   +     +KK + +    D     AE   L ++KH  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 793 VPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           V L+ Y      +L L+ E++  G L   L      R+   +   A   +A   +  L  
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGELFMQLE-----REGIFMEDTACFYLAE-ISMALGH 136

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           LH      II+RD+K  N++L+H+   +++DFG+ +   ++       T  GT  Y+ PE
Sbjct: 137 LHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGTIEYMAPE 191

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                      D +S G ++ ++LTG  P   ++
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.9 bits (190), Expect = 5e-15
 Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 20/212 (9%)

Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKI-KHRNLVPL 795
           ++G G FG+V  +  K    + A+K L +     D +    M E   L    K   L  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
              C    +RL  V E++  G L   +      +  R     A    A   A GL FL  
Sbjct: 87  H-SCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAE-IAIGLFFLQS 139

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYY 913
                II+RD+K  NV+LD E   +++DFGM +  I    T     T  GTP Y+ PE  
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEII 193

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                    D ++FGV+L E+L G+ P + +D
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 76.6 bits (189), Expect = 6e-15
 Identities = 57/225 (25%), Positives = 80/225 (35%), Gaps = 42/225 (18%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
            IG G FG             VA+K + R     D     E+     ++H N+V      
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 800 KIGEERLLVYEFMKFGSLEE--VLHGRAKARDQRILTWDARKK----IARGAAKGLCFLH 853
                  ++ E+   G L E     GR    +       AR      ++     G+ + H
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDE-------ARFFFQQLLS-----GVSYCH 133

Query: 854 HNCIPHIIHRDMKSSNVLLDHEMEAR--VSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
                 I HRD+K  N LLD     R  + DFG ++  S L +     +  GTP Y+ PE
Sbjct: 134 SM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQP--KSTVGTPAYIAPE 187

Query: 912 -----YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL 951
                 Y         DV+S GV L  +L G  P     F D   
Sbjct: 188 VLLRQEYDG----KIADVWSCGVTLYVMLVGAYP-----FEDPEE 223

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 72.4 bits (178), Expect = 8e-15
 Identities = 31/155 (20%), Positives = 56/155 (36%), Gaps = 15/155 (9%)

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           + L+   I     +  +N  + + L+L    +   I      L     +D S+N I    
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--- 55

Query: 166 PSELGN--ACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLG 223
             +L        L  L + +N I         +   L  L L+NN++        L +L 
Sbjct: 56  --KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 113

Query: 224 SLESLILSNNMISGSFPD----SISSCKTLRIVDF 254
           SL  L +  N ++ +        I     +R++DF
Sbjct: 114 SLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 147

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 25/120 (20%), Positives = 43/120 (35%), Gaps = 10/120 (8%)

Query: 45  FSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLL 104
           ++       L+     +     E L +  D+ + +D S N +   + GF         L 
Sbjct: 15  YTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIR-KLDGFP----LLRRLK 67

Query: 105 HLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA--GEIPRTFGQLSSLQRLDLSNNHIT 162
            L ++ N I  +          L  L L+ N L   G++      L SL  L +  N +T
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 27/140 (19%), Positives = 49/140 (35%), Gaps = 13/140 (9%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
            +N+ +   LDL    +   I        + +    +D S N I  +         +LK 
Sbjct: 15  YTNAVRDRELDLRGYKIP-VIENL---GATLDQFDAIDFSDNEIRKL--DGFPLLRRLKT 68

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGN--ACDSLLELKLPHNNIT 187
           L ++ N +          L  L  L L+NN +      +L    +  SL  L +  N +T
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL--GDLDPLASLKSLTYLCILRNPVT 126

Query: 188 GSF---PVTLSSCSWLQLLD 204
                    +     +++LD
Sbjct: 127 NKKHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 29/156 (18%), Positives = 54/156 (34%), Gaps = 18/156 (11%)

Query: 154 LDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP 213
           + L+   I     +          EL L    I        ++      +D S+N I   
Sbjct: 2   VKLTAELIEQ---AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-- 55

Query: 214 FPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSS 273
                   L  L++L+++NN I         +   L  +  ++N +  +   D    + S
Sbjct: 56  -KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114

Query: 274 LEELRLPDNLITG-------VIPGQLSECTQLKVID 302
           L  L +  N +T        VI     +  Q++V+D
Sbjct: 115 LTYLCILRNPVTNKKHYRLYVI----YKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 3/92 (3%)

Query: 338 PELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVL 397
            +       ++L L   K+   I     +    + I  + NE+  ++   F  L RL  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69

Query: 398 QLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
            + NNR      G       L  L L +N+L 
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.4 bits (134), Expect = 7e-09
 Identities = 24/156 (15%), Positives = 59/156 (37%), Gaps = 14/156 (8%)

Query: 4   VLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTG 63
           ++KL++ L    +          ++L+L    +  +  +NL + L     ++ S N +  
Sbjct: 1   MVKLTAELIE-QAAQYTNAV-RDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIRK 56

Query: 64  FLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPSSLS 122
                      +L+ L ++ N +   I        +   L  L L+ N ++++     L+
Sbjct: 57  L---DGFPLLRRLKTLLVNNNRIC-RIGEGLD--QALPDLTELILTNNSLVELGDLDPLA 110

Query: 123 NCTKLKILNLSFNLLAGEI---PRTFGQLSSLQRLD 155
           +   L  L +  N +  +         ++  ++ LD
Sbjct: 111 SLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 27/112 (24%), Positives = 42/112 (37%), Gaps = 6/112 (5%)

Query: 272 SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNG 331
               EL L    I  VI    +   Q   ID S N +   +      L  L+  +   N 
Sbjct: 19  VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNR 75

Query: 332 LEGKIPPELGKCKNLKDLILNNNKLS--GEIPAELFSCSNLEWISLTGNELT 381
           +            +L +LIL NN L   G++   L S  +L ++ +  N +T
Sbjct: 76  ICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 33/180 (18%), Positives = 56/180 (31%), Gaps = 62/180 (34%)

Query: 179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGS----LESLILSNNM 234
           +KL    I  +     ++    + LDL    I       V+ENLG+     +++  S+N 
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP------VIENLGATLDQFDAIDFSDNE 53

Query: 235 ISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSE 294
           I              ++  F   R               L+ L + +N I  +  G    
Sbjct: 54  IR-------------KLDGFPLLR--------------RLKTLLVNNNRICRIGEGLDQA 86

Query: 295 CTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNN 354
              L  + L+ N         L +L  L+                L   K+L  L +  N
Sbjct: 87  LPDLTELILTNN--------SLVELGDLD---------------PLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 17/92 (18%), Positives = 36/92 (39%), Gaps = 3/92 (3%)

Query: 503 LFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFD 562
           L       + +D S N+ R K+      +  L+ L + +N++          L +L    
Sbjct: 37  LGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94

Query: 563 ASHNRLQG-QIPESFSNLSFLVQIDLSNNELT 593
            ++N L      +  ++L  L  + +  N +T
Sbjct: 95  LTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.2 bits (188), Expect = 9e-15
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 46/217 (21%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIR-----LSCQGD-REFMAEMETLGKIKHRNLVP 794
           +G G +G V  A   K G  VA+KKL R     +  +   RE       L  +KH N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLKHMKHENVIG 92

Query: 795 LL------GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
           LL         +   +  LV   M    L  ++  +        LT D  + +     +G
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQ-------KLTDDHVQFLIYQILRG 144

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
           L ++H      IIHRD+K SN+ ++ + E ++ DFG+AR  +   T           GYV
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----------GYV 190

Query: 909 PPEYY-------QSFRCTAKGDVYSFGVVLLELLTGK 938
              +Y                D++S G ++ ELLTG+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.7 bits (187), Expect = 1e-14
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 20/207 (9%)

Query: 741 LIGCGGFGEVFKATLKDGSSV-AIKKLIRLSCQGDREF---MAEMETLGKI-KHRNLVPL 795
           +IG G + +V    LK    + A+K + +     D +      E     +   H  LV L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 796 LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
              C   E RL  V E++  G L   +      R +++    AR   A   +  L +LH 
Sbjct: 76  H-SCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAE-ISLALNYLHE 128

Query: 855 NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYY 913
                II+RD+K  NVLLD E   +++D+GM +  +   DT    ST  GTP Y+ PE  
Sbjct: 129 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEIL 182

Query: 914 QSFRCTAKGDVYSFGVVLLELLTGKRP 940
           +        D ++ GV++ E++ G+ P
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 27/244 (11%)

Query: 704 DKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSV-A 762
             E+E  ++N     +    L           F    +IG G + +V    LK    + A
Sbjct: 29  GIEEEKEAMNTRESGKASSSLGLQD-------FDLLRVIGRGSYAKVLLVRLKKTDRIYA 81

Query: 763 IKKLIRLSCQGDREF---MAEMETLGKI-KHRNLVPLLGYCKIGEERL-LVYEFMKFGSL 817
           ++ + +     D +      E     +   H  LV L   C   E RL  V E++  G L
Sbjct: 82  MRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL 140

Query: 818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME 877
              +      R +++    AR   A   +  L +LH      II+RD+K  NVLLD E  
Sbjct: 141 MFHMQ-----RQRKLPEEHARFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSEGH 191

Query: 878 ARVSDFGMARL-ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT 936
            +++D+GM +  +   DT    ST  GTP Y+ PE  +        D ++ GV++ E++ 
Sbjct: 192 IKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248

Query: 937 GKRP 940
           G+ P
Sbjct: 249 GRSP 252

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 35/142 (24%), Positives = 57/142 (40%), Gaps = 12/142 (8%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           +P    +L L++     L    +F KLP L  +N S N +T  + E     +  +  + L
Sbjct: 30  IPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILL 88

Query: 82  SYNNLTGSISGFSLNEN---SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
           + N L       ++         SL  L L  N I  V   S    + +++L+L  N + 
Sbjct: 89  TSNRLE------NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142

Query: 139 GEIPR-TFGQLSSLQRLDLSNN 159
             +    F  L SL  L+L  N
Sbjct: 143 -TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 37/157 (23%), Positives = 61/157 (38%), Gaps = 28/157 (17%)

Query: 77  ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNL 136
             L L+ N  T  +    + +     L  ++ S N I D+   +    + +  + L+ N 
Sbjct: 35  AELRLNNNEFT-VLEATGIFKK-LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92

Query: 137 LAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSS 196
           L     + F  L SL+ L L +N IT                  + +     SF + LSS
Sbjct: 93  LENVQHKMFKGLESLKTLMLRSNRIT-----------------CVGN----DSF-IGLSS 130

Query: 197 CSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
              ++LL L +N I+        + L SL +L L  N
Sbjct: 131 ---VRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 32/167 (19%)

Query: 263 IPPDICPGVSSLEELRLPDNLITGVIP-GQLSECTQLKVIDLSLNYLNGSIPQELGKLEH 321
           IP  I P      ELRL +N  T +   G   +  QL+ I+ S N           K+  
Sbjct: 26  IPEHI-P--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN-----------KITD 71

Query: 322 LEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNEL 380
           +E+    F G              + +++L +N+L   +  ++F    +L+ + L  N +
Sbjct: 72  IEEGA--FEGA-----------SGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI 117

Query: 381 TGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN 426
           T  +  + F  L+ + +L L +N+     PG      SL  L+L +N
Sbjct: 118 T-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 31/179 (17%), Positives = 56/179 (31%), Gaps = 51/179 (28%)

Query: 201 QLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVS 260
             L L+NN  +      + + L  L  +  SNN I+                        
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD----------------------- 71

Query: 261 GIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLE 320
             I      G S + E+ L  N +  V          LK + L  N +   +  +     
Sbjct: 72  --IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDS---- 124

Query: 321 HLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGN 378
                   F GL            +++ L L +N+++  +    F +  +L  ++L  N
Sbjct: 125 --------FIGL-----------SSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 24/121 (19%), Positives = 46/121 (38%), Gaps = 9/121 (7%)

Query: 499 PVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLR 556
               +F +   L  ++ S N+    I +   +    +  + L  N+L   +   +   L 
Sbjct: 48  EATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLE 105

Query: 557 NLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQY---ANN 613
           +L       NR+     +SF  LS +  + L +N++T  +   G   TL +        N
Sbjct: 106 SLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVA-PGAFDTLHSLSTLNLLAN 163

Query: 614 P 614
           P
Sbjct: 164 P 164

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 4/88 (4%)

Query: 344 KNLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGN 401
             L+ +  +NNK++ +I    F   S +  I LT N L   +  + F  L  L  L L +
Sbjct: 57  PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRS 114

Query: 402 NRFKGEIPGELGNCSSLVWLDLNSNNLT 429
           NR            SS+  L L  N +T
Sbjct: 115 NRITCVGNDSFIGLSSVRLLSLYDNQIT 142

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 24/101 (23%), Positives = 39/101 (38%), Gaps = 10/101 (9%)

Query: 336 IPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTR 393
           IP          +L LNNN+ +      +F     L  I+ + N++T  I    F   + 
Sbjct: 30  IPQ------YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 394 LAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPP 434
           +  + L +NR +           SL  L L SN +T  +  
Sbjct: 83  VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGN 122

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 17/87 (19%), Positives = 35/87 (40%), Gaps = 1/87 (1%)

Query: 508 QTLEYLDLSYNQFRGKIPDEI-GDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHN 566
           Q    L L+ N+F       I   +  L+ +  ++N+++     +      +     + N
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 567 RLQGQIPESFSNLSFLVQIDLSNNELT 593
           RL+    + F  L  L  + L +N +T
Sbjct: 92  RLENVQHKMFKGLESLKTLMLRSNRIT 118

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 32/178 (17%)

Query: 251 IVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG 310
           IVD     ++ I P ++ P   ++ E+RL  N I  + PG  S   +L+ IDLS N ++ 
Sbjct: 15  IVDCRGKGLTEI-PTNL-P--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS- 69

Query: 311 SIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-SCSN 369
            +  +             F GL           ++L  L+L  NK++ E+P  LF    +
Sbjct: 70  ELAPDA------------FQGL-----------RSLNSLVLYGNKIT-ELPKSLFEGLFS 105

Query: 370 LEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN 426
           L+ + L  N++   +  + F  L  L +L L +N+ +    G      ++  + L  N
Sbjct: 106 LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 32/130 (24%), Positives = 49/130 (37%), Gaps = 4/130 (3%)

Query: 79  LDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
           + L  N +   I   + +      L  +DLS N I ++ P +      L  L L  N + 
Sbjct: 37  IRLEQNTIK-VIPPGAFS--PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 139 GEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCS 198
                 F  L SLQ L L+ N I   +  +      +L  L L  N +      T S   
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 199 WLQLLDLSNN 208
            +Q + L+ N
Sbjct: 153 AIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 33/149 (22%), Positives = 57/149 (38%), Gaps = 16/149 (10%)

Query: 40  VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENS 99
           +P NL      +  +    N +   +P    S   KL  +DLS N ++       L  ++
Sbjct: 26  IPTNLP---ETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS------ELAPDA 75

Query: 100 CN---SLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPR-TFGQLSSLQRLD 155
                SL  L L  N I ++  S       L++L L+ N +   +    F  L +L  L 
Sbjct: 76  FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLS 134

Query: 156 LSNNHITGWIPSELGNACDSLLELKLPHN 184
           L +N +   I     +   ++  + L  N
Sbjct: 135 LYDNKLQT-IAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 36/130 (27%), Positives = 62/130 (47%), Gaps = 4/130 (3%)

Query: 178 ELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG 237
           E++L  N I    P   S    L+ +DLSNN IS        + L SL SL+L  N I+ 
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 238 SFPDSI-SSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECT 296
             P S+     +L+++  ++N+++  +  D    + +L  L L DN +  +  G  S   
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 297 QLKVIDLSLN 306
            ++ + L+ N
Sbjct: 153 AIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 9/119 (7%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLRNLGVF 561
           F+ Y+ L  +DLS NQ   ++  +    + +L  L L  N+++ E+P SL   L +L + 
Sbjct: 52  FSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLL 109

Query: 562 DASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQY---ANNPGLC 617
             + N++     ++F +L  L  + L +N+L   I  +G  S L A Q    A NP +C
Sbjct: 110 LLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT-IA-KGTFSPLRAIQTMHLAQNPFIC 166

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 4/88 (4%)

Query: 344 KNLKDLILNNNKLSGEIPAELFSC-SNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGN 401
           K L+ + L+NN++S E+  + F    +L  + L GN++T ++P   F  L  L +L L  
Sbjct: 56  KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNA 113

Query: 402 NRFKGEIPGELGNCSSLVWLDLNSNNLT 429
           N+          +  +L  L L  N L 
Sbjct: 114 NKINCLRVDAFQDLHNLNLLSLYDNKLQ 141

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 39/156 (25%), Positives = 61/156 (39%), Gaps = 27/156 (17%)

Query: 224 SLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNL 283
           ++  + L  N I    P + S  K LR +D S+N++S  + PD   G+ SL  L L  N 
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNK 91

Query: 284 ITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKC 343
           IT +          L+++ L+ N +N  +  +             F  L           
Sbjct: 92  ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDA------------FQDL----------- 127

Query: 344 KNLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGN 378
            NL  L L +NKL   I    F     ++ + L  N
Sbjct: 128 HNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 19/86 (22%), Positives = 37/86 (43%), Gaps = 2/86 (2%)

Query: 509 TLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPS-SLGRLRNLGVFDASHNR 567
           T+  + L  N  +   P        L+ ++L++NQ+S E+   +   LR+L       N+
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91

Query: 568 LQGQIPESFSNLSFLVQIDLSNNELT 593
           +       F  L  L  + L+ N++ 
Sbjct: 92  ITELPKSLFEGLFSLQLLLLNANKIN 117

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.0 bits (182), Expect = 5e-14
 Identities = 45/254 (17%), Positives = 93/254 (36%), Gaps = 74/254 (29%)

Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMA-EMETLGKIKHRNLV 793
           +S    +G G FG V +    + G   A+KK+++     D  +   E++ +  + H N++
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNII 63

Query: 794 PLLGYCKIGEERL--------------------------------------LVYEFMKFG 815
            L+ Y     +                                        ++ E++   
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV--- 120

Query: 816 SLEEVLHG--RAKARDQRILTWDARKKIARGAAKGLCFLH-HNCIPHIIHRDMKSSNVLL 872
              + LH   ++  R  R +  +          + + F+H       I HRD+K  N+L+
Sbjct: 121 --PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHRDIKPQNLLV 174

Query: 873 DHEM-EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS----FRC---TAKGDV 924
           + +    ++ DFG A+ +   +  ++         Y+   +Y++          T   D+
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVA---------YICSRFYRAPELMLGATEYTPSIDL 225

Query: 925 YSFGVVLLELLTGK 938
           +S G V  EL+ GK
Sbjct: 226 WSIGCVFGELILGK 239

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.1 bits (180), Expect = 8e-14
 Identities = 65/292 (22%), Positives = 108/292 (36%), Gaps = 36/292 (12%)

Query: 674 IAMRARRKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEAT 733
           +A      E E      +   S                +  A       K+         
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN----- 55

Query: 734 NGFSAESLIGCGGFGEVF---KATLKDGSSV-AIK---KLIRLSCQGDREF-MAEMETLG 785
             F    ++G G +G+VF   K +  D   + A+K   K   +      E    E + L 
Sbjct: 56  --FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 786 KIKHRN-LVPLLGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIAR 843
            I+    LV L  Y    E +L L+ +++  G L   L     ++ +R    + +  +  
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL-----SQRERFTEHEVQIYVGE 167

Query: 844 GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG 903
                L  LH      II+RD+K  N+LLD      ++DFG+++   A +T  +     G
Sbjct: 168 -IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YDFCG 222

Query: 904 TPGYVPPEYYQSFRCTAKG-----DVYSFGVVLLELLTGKRPTDKDDFGDTN 950
           T  Y+ P+  +       G     D +S GV++ ELLTG  P   D   ++ 
Sbjct: 223 TIEYMAPDIVRGGD---SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 35/217 (16%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD-----REFMAEMETLGKIKHRNLVPL 795
           +G G +G V  AT    G  VAIKK+             RE       L   KH N++ +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKHFKHENIITI 74

Query: 796 L-----GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
                    +   E  ++ E M     +  LH        ++L+ D  +       + + 
Sbjct: 75  FNIQRPDSFENFNEVYIIQELM-----QTDLHRVIST---QMLSDDHIQYFIYQTLRAVK 126

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTP--GYV 908
            LH +   ++IHRD+K SN+L++   + +V DFG+AR+I       S  T   +    +V
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 909 PPEYY-------QSFRCTAKGDVYSFGVVLLELLTGK 938
              +Y        S + +   DV+S G +L EL   +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 70.9 bits (174), Expect = 5e-13
 Identities = 53/282 (18%), Positives = 93/282 (32%), Gaps = 52/282 (18%)

Query: 2   LSVLKLSSNLFTLNSTS-----LLQLPFGLKQLELSSAGL--VGLVPDNLFSKLPNLVYL 54
           L  L L+    T    +     L      L ++ L+S  L   GL    L         L
Sbjct: 74  LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRT--LLPVFLRARKL 131

Query: 55  NASYNNLT----GFLPETLLSNSDKLELLDLSYNNLTGS----ISGFSLNENSCNSLLHL 106
               N+L       L + LL +  ++  L LS N LT +    +    L  N+  S+ HL
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLME-GLAGNT--SVTHL 188

Query: 107 DLSQNHIMDV----IPSSLSNCTKLKILNLSFNLL----AGEIPRTFGQLSSLQRLDLSN 158
            L    + D     + + L    +L+ LN+++N      A  + R   +  SL+ L L  
Sbjct: 189 SLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYF 248

Query: 159 NHIT----GWIPSELG-NACDSLLELKLPHNNITGSF----------------PVTLSSC 197
           N ++      +    G     + + + L        +                   +   
Sbjct: 249 NELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRH 308

Query: 198 SWLQLLDLSNNNISGPFPDSVLENL---GSLESLILSNNMIS 236
             L L DL ++  +   P    + L   G + +L+       
Sbjct: 309 LELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 51/396 (12%), Positives = 110/396 (27%), Gaps = 81/396 (20%)

Query: 92  GFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNL----LAGEIPRTFGQ 147
                  + ++L +    +  +  +    L     L  L   +       + E+      
Sbjct: 17  QLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV------ 70

Query: 148 LSSLQRLDLSNNHIT--GW--IPSELGNACDSLLELKLPHNNITGSFPVTLSSC-SWLQL 202
           LSSL++L+L+   +T      + + LG+   +L E+ L    +  +   TL       + 
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 203 LDLSNNNISGPFPDSVLENLGS--------LESLILSNNMISGS----FPDSISSCKTLR 250
           L L  N++         ++L          + +L LSNN ++ +      + ++   ++ 
Sbjct: 131 LGLQLNSLG----PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT 186

Query: 251 IVDFSSNRVS--GIIPPDICPGV---SSLEELRLPDNLITGV----IPGQLSECTQLKVI 301
            +      +   G+    +   +     L+EL +  N         +     E   L+++
Sbjct: 187 HLSLLHTGLGDEGLE--LLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELL 244

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
            L  N L+    Q L  L                      +      + L       E  
Sbjct: 245 HLYFNELSSEGRQVLRDLG------------------GAAEGGARVVVSLTEGTAVSEYW 286

Query: 362 AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNC----SS 417
           + + S       S     +         R   L +  L ++R     P            
Sbjct: 287 SVILSEVQRNLNSWDRARV--------QRHLELLLRDLEDSRGATLNPWRKAQLLRVEGE 338

Query: 418 LVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNT 453
           +  L     +                          
Sbjct: 339 VRALLEQLGSSGSP---------SGSWSHPQFEKGA 365

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 70.5 bits (173), Expect = 8e-13
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 37/215 (17%)

Query: 740 SLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHR------NL 792
            +IG G FG+V KA   K    VA+K ++R   +  R+   E+  L  ++ +      N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 793 VPLLGY-------CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGA 845
           + +L         C       + +E +   +L E++    K    +  +    +K A   
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSM-NLYELI----KKNKFQGFSLPLVRKFAHSI 209

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA--RVSDFGMARLISALDTHLSVSTLAG 903
            + L  LH N    IIH D+K  N+LL  +  +  +V DFG     S+   H  V T   
Sbjct: 210 LQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG-----SSCYEHQRVYTYIQ 261

Query: 904 TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
           +  Y  PE     R     D++S G +L ELLTG 
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 45/249 (18%), Positives = 87/249 (34%), Gaps = 19/249 (7%)

Query: 15  NSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSD 74
               +         +           P         + +++ S + +       +LS   
Sbjct: 59  LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 118

Query: 75  KLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQ-NHIMDVIPSSL-SNCTKLKILNL 132
           KL+ L L    L+  I          ++L+ L+LS  +   +    +L S+C++L  LNL
Sbjct: 119 KLQNLSLEGLRLSDPIVNTLAK---NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 175

Query: 133 SFNLL---AGEIPRTFGQLSSLQRLDLS--NNHITGWIPSELGNACDSLLELKLPH-NNI 186
           S+                  ++ +L+LS    ++     S L   C +L+ L L     +
Sbjct: 176 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 235

Query: 187 TGSFPVTLSSCSWLQLLDLSN-NNISGPFPDSVLENLG---SLESLILSNNMISGSFPDS 242
                      ++LQ L LS   +I        L  LG   +L++L +   +  G+    
Sbjct: 236 KNDCFQEFFQLNYLQHLSLSRCYDII----PETLLELGEIPTLKTLQVFGIVPDGTLQLL 291

Query: 243 ISSCKTLRI 251
             +   L+I
Sbjct: 292 KEALPHLQI 300

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 41/205 (20%), Positives = 74/205 (36%), Gaps = 16/205 (7%)

Query: 64  FLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSN 123
           F+ + L  +     +  +  +N    +S      + C+ L +L L    + D I ++L+ 
Sbjct: 81  FMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK 140

Query: 124 CTKLKILNLSF--NLLAGEIPRTFGQLSSLQRLDLSN-NHITGW-IPSELGNACDSLLEL 179
            + L  LNLS         +       S L  L+LS     T   +   + +  +++ +L
Sbjct: 141 NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL 200

Query: 180 KLP--HNNITGSFPVTLS-SCSWLQLLDLSN-NNISGPFPDSVLENLGS---LESLILSN 232
            L     N+  S   TL   C  L  LDLS+   +     +   +       L+ L LS 
Sbjct: 201 NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK----NDCFQEFFQLNYLQHLSLSR 256

Query: 233 -NMISGSFPDSISSCKTLRIVDFSS 256
              I       +    TL+ +    
Sbjct: 257 CYDIIPETLLELGEIPTLKTLQVFG 281

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 54.5 bits (131), Expect = 8e-08
 Identities = 50/318 (15%), Positives = 100/318 (31%), Gaps = 46/318 (14%)

Query: 94  SLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIP-RTFGQLSSLQ 152
                + +  L   L      ++ P          ++         + P         +Q
Sbjct: 38  RWYRLASDESLWQTLDLTG-KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQ 96

Query: 153 RLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSN-NNIS 211
            +DLSN+ I       + + C  L  L L    ++     TL+  S L  L+LS  +  S
Sbjct: 97  HMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 156

Query: 212 GPFPDSVLENLGSLESLILS--NNMISGSFPDSISS-CKTLRIVDFS--SNRVSGIIPPD 266
                ++L +   L+ L LS   +        +++   +T+  ++ S     +       
Sbjct: 157 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 216

Query: 267 ICPGVSSLEELRLPD-NLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF 325
           +     +L  L L D  ++      +  +   L+ + LS                     
Sbjct: 217 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS--------------------- 255

Query: 326 IAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIP 385
                 +  +   ELG+   LK L +      G +     +  +L+ I+           
Sbjct: 256 --RCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-INC---------- 302

Query: 386 PEFSRLTRLAVLQLGNNR 403
              S  T +A   +GN +
Sbjct: 303 ---SHFTTIARPTIGNKK 317

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 50/246 (20%), Positives = 94/246 (38%), Gaps = 17/246 (6%)

Query: 69  LLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLK 128
           L S+    + LDL+  NL   ++G  L+      ++     ++ +   +    S   +++
Sbjct: 42  LASDESLWQTLDLTGKNLHPDVTGRLLS----QGVIAFRCPRSFMDQPLAEHFS-PFRVQ 96

Query: 129 ILNLSF-NLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPH-NNI 186
            ++LS   +    +     Q S LQ L L    ++  I + L     +L+ L L   +  
Sbjct: 97  HMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK-NSNLVRLNLSGCSGF 155

Query: 187 TGSFPVTL-SSCSWLQLLDLSN-NNIS-GPFPDSVLENLGSLESLILS--NNMISGSFPD 241
           +     TL SSCS L  L+LS   + +      +V     ++  L LS     +  S   
Sbjct: 156 SEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS 215

Query: 242 SIS-SCKTLRIVDFSS-NRVSGIIPPDICPGVSSLEELRLPD-NLITGVIPGQLSECTQL 298
           ++   C  L  +D S    +      +    ++ L+ L L     I      +L E   L
Sbjct: 216 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ-LNYLQHLSLSRCYDIIPETLLELGEIPTL 274

Query: 299 KVIDLS 304
           K + + 
Sbjct: 275 KTLQVF 280

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 45/242 (18%), Positives = 85/242 (35%), Gaps = 17/242 (7%)

Query: 194 LSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVD 253
            S  S  Q LDL+  N+       +L     + +     + +     +  S    ++ +D
Sbjct: 43  ASDESLWQTLDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFS-PFRVQHMD 99

Query: 254 FSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLS-LNYLN--- 309
            S++ +       I    S L+ L L    ++  I   L++ + L  ++LS  +  +   
Sbjct: 100 LSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA 159

Query: 310 -GSIPQELGKLEHLEQFIAWFNGLEGKIPPEL--GKCKNLKDLILN--NNKLSGE-IPAE 363
             ++     +L+ L   ++W      K          + +  L L+     L    +   
Sbjct: 160 LQTLLSSCSRLDELN--LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL 217

Query: 364 LFSCSNLEWISLTG-NELTGQIPPEFSRLTRLAVLQL-GNNRFKGEIPGELGNCSSLVWL 421
           +  C NL  + L+    L      EF +L  L  L L        E   ELG   +L  L
Sbjct: 218 VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 277

Query: 422 DL 423
            +
Sbjct: 278 QV 279

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 43/226 (19%)

Query: 733 TNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR----LSCQGDREFMAEMETLGKI 787
            + +  +SLIG G FG+V KA    +   VAIK +I+       Q       E+  L  +
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQA----QIEVRLLELM 107

Query: 788 KHR------NLVPLLGY-------CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILT 834
                     +V L  +       C       LV+E + + +L ++L    +  + R ++
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLC-------LVFEMLSY-NLYDLL----RNTNFRGVS 155

Query: 835 WDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA--RVSDFGMARLISAL 892
            +  +K A+     L FL    +  IIH D+K  N+LL +   +  ++ DFG     S+ 
Sbjct: 156 LNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFG-----SSC 209

Query: 893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK 938
                +     +  Y  PE           D++S G +L+E+ TG+
Sbjct: 210 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.9 bits (169), Expect = 3e-12
 Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 49/235 (20%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR-----LSCQ-GDRE--FMAEMETLGK 786
           +     +G G +G V+K+   + G  VA+KK+          Q   RE   + E+     
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS---- 66

Query: 787 IKHRNLVPLLGYCKI--GEERLLVYEFMKFGS-LEEVLHGRAKARDQRILTWDARKKIAR 843
             H N+V LL   +     +  LV+++M   + L  V+          IL    ++ +  
Sbjct: 67  -GHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRA-------NILEPVHKQYVVY 116

Query: 844 GAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG 903
              K + +LH      ++HRDMK SN+LL+ E   +V+DFG++R    +    +   L+ 
Sbjct: 117 QLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 904 TPGYVPPEYYQSF--------------------RCTAKGDVYSFGVVLLELLTGK 938
                  +  Q                      + T   D++S G +L E+L GK
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 54/246 (21%), Positives = 90/246 (36%), Gaps = 61/246 (24%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIR-----LSCQGDREFMAEMETLGKIKHRNLVPL 795
           IG G +G V+ A       +VAIKK+ R     + C+  R    E+  L ++K   ++ L
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK--RILR-EITILNRLKSDYIIRL 90

Query: 796 LGYCKIGEERL-----LVYEFMKFGS-LEEVLHGRAKARDQR-------ILTWDARKKIA 842
                  +        +V E     S L+++        ++        +L         
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNLL--------- 139

Query: 843 RGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLA 902
                G  F+H +    IIHRD+K +N LL+ +   +V DFG+AR I++      V+ L 
Sbjct: 140 ----LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 903 GTP--------------GYVPPEYY-------QSFRCTAKGDVYSFGVVLLELLTGKRPT 941
                             +V   +Y            T   D++S G +  ELL   +  
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252

Query: 942 DKDDFG 947
             D   
Sbjct: 253 INDPTN 258

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 62.5 bits (152), Expect = 2e-11
 Identities = 33/143 (23%), Positives = 55/143 (38%), Gaps = 10/143 (6%)

Query: 21  QLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLD 80
           + P  +++L L +        + L ++  NL +L+     L      + L    KL+ L+
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV---SNLPKLPKLKKLE 77

Query: 81  LSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPSSLSNCTKLKILNLSFNLLAG 139
           LS N +     G  +      +L HL+LS N + D+     L     LK L+L    +  
Sbjct: 78  LSENRIF---GGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN 134

Query: 140 EI---PRTFGQLSSLQRLDLSNN 159
                   F  L  L  LD  + 
Sbjct: 135 LNDYRESVFKLLPQLTYLDGYDR 157

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 36/161 (22%), Positives = 58/161 (36%), Gaps = 28/161 (17%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
           L N     + +L  +N   +            +L  L L    ++ V  S+L    KLK 
Sbjct: 18  LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKK 75

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS 189
           L LS N + G +     +L +L  L+LS N +              +  L+         
Sbjct: 76  LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK------------DISTLE--------- 114

Query: 190 FPVTLSSCSWLQLLDLSNNNISGP--FPDSVLENLGSLESL 228
               L     L+ LDL N  ++    + +SV + L  L  L
Sbjct: 115 ---PLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 5/101 (4%)

Query: 332 LEGKIPPELGK--CKNLKDLILNNNKLS-GEIPAELFSCSNLEWISLTGNELTGQIPPEF 388
           ++ +I  EL       +++L+L+N K + G+I        NLE++SL    L   +    
Sbjct: 10  MKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-L 67

Query: 389 SRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
            +L +L  L+L  NR  G +        +L  L+L+ N L 
Sbjct: 68  PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 33/142 (23%), Positives = 50/142 (35%), Gaps = 16/142 (11%)

Query: 149 SSLQRLDLSNNHITGWIPSELGNACDSL---LELKLPHNNITGSFPVTLSSCSWLQLLDL 205
           S    +D+        I  EL N   +    L L    +N  G      +    L+ L L
Sbjct: 3   SGSSGMDMKRR-----IHLELRNRTPAAVRELVLDNCKSND-GKIEGLTAEFVNLEFLSL 56

Query: 206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPP 265
            N  +      S L  L  L+ L LS N I G           L  ++ S N++  I   
Sbjct: 57  INVGLISV---SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--S 111

Query: 266 DICP--GVSSLEELRLPDNLIT 285
            + P   +  L+ L L +  +T
Sbjct: 112 TLEPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 28/109 (25%), Positives = 44/109 (40%), Gaps = 6/109 (5%)

Query: 297 QLKVIDLSLNYLN-GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNK 355
            ++ + L     N G I     +  +LE       GL   +   L K   LK L L+ N+
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82

Query: 356 LSGEIPAELFSCSNLEWISLTGNELT--GQIPPEFSRLTRLAVLQLGNN 402
           + G +        NL  ++L+GN+L     + P   +L  L  L L N 
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 27/135 (20%)

Query: 221 NLGSLESLILSNNMIS-GSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL 279
              ++  L+L N   + G      +    L  +   +  +  +      P +  L++L L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV---SNLPKLPKLKKLEL 78

Query: 280 PDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE 339
            +N I G +     +   L  ++LS N L      ++  LE L+                
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLK-----DISTLEPLK---------------- 117

Query: 340 LGKCKNLKDLILNNN 354
             K + LK L L N 
Sbjct: 118 --KLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 3/87 (3%)

Query: 508 QTLEYLDLSYNQFR-GKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHN 566
             +  L L   +   GKI     + + L+ L L +  L   + S+L +L  L   + S N
Sbjct: 24  AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSEN 81

Query: 567 RLQGQIPESFSNLSFLVQIDLSNNELT 593
           R+ G +      L  L  ++LS N+L 
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 36/139 (25%), Positives = 57/139 (41%), Gaps = 10/139 (7%)

Query: 21  QLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLD 80
           + P  +K+L L ++       + L  +   L +L+     LT       L   +KL+ L+
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI---ANLPKLNKLKKLE 70

Query: 81  LSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPSSLSNCTKLKILNLSFNLLAG 139
           LS N ++G +   +     C +L HL+LS N I D+     L     LK L+L    +  
Sbjct: 71  LSDNRVSGGLEVLAEK---CPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN 127

Query: 140 EI---PRTFGQLSSLQRLD 155
                   F  L  L  LD
Sbjct: 128 LNDYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 58.1 bits (141), Expect = 5e-10
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 5/101 (4%)

Query: 332 LEGKIPPELGK--CKNLKDLILNNNKLS-GEIPAELFSCSNLEWISLTGNELTGQIPPEF 388
           +  +I  EL      ++K+L+L+N++ + G++         LE++S     LT  I    
Sbjct: 3   MGRRIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-L 60

Query: 389 SRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
            +L +L  L+L +NR  G +      C +L  L+L+ N + 
Sbjct: 61  PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 25/121 (20%), Positives = 43/121 (35%), Gaps = 4/121 (3%)

Query: 67  ETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTK 126
           E        ++ L L  +             +    L  L      +  +  ++L    K
Sbjct: 10  ELRNRTPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNK 65

Query: 127 LKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNI 186
           LK L LS N ++G +     +  +L  L+LS N I      E     ++L  L L +  +
Sbjct: 66  LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125

Query: 187 T 187
           T
Sbjct: 126 T 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 28/123 (22%), Positives = 49/123 (39%), Gaps = 5/123 (4%)

Query: 165 IPSELGN-ACDSLLELKLPHNNIT-GSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
           I  EL N     + EL L ++    G           L+ L   N  ++     + L  L
Sbjct: 7   IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI---ANLPKL 63

Query: 223 GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
             L+ L LS+N +SG        C  L  ++ S N++  +   +    + +L+ L L + 
Sbjct: 64  NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

Query: 283 LIT 285
            +T
Sbjct: 124 EVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 31/134 (23%), Positives = 52/134 (38%), Gaps = 30/134 (22%)

Query: 272 SSLEELRLPDNLIT-GVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFN 330
           S ++EL L ++    G + G   E  +L+ +              L  + +L        
Sbjct: 17  SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV--------GLTSIANLP------- 61

Query: 331 GLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELT--GQIPPEF 388
                      K   LK L L++N++SG +      C NL  ++L+GN++     I P  
Sbjct: 62  -----------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-L 109

Query: 389 SRLTRLAVLQLGNN 402
            +L  L  L L N 
Sbjct: 110 KKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.7 bits (119), Expect = 3e-07
 Identities = 28/136 (20%), Positives = 53/136 (38%), Gaps = 27/136 (19%)

Query: 220 ENLGSLESLILSNNMIS-GSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELR 278
                ++ L+L N+  + G         + L  +   +  ++ I      P ++ L++L 
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI---ANLPKLNKLKKLE 70

Query: 279 LPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPP 338
           L DN ++G +     +C  L  ++LS N +      +L  +E L+               
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK-----DLSTIEPLK--------------- 110

Query: 339 ELGKCKNLKDLILNNN 354
              K +NLK L L N 
Sbjct: 111 ---KLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 27/104 (25%), Positives = 48/104 (46%), Gaps = 3/104 (2%)

Query: 491 DFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPS 550
           D +R   G +  L  +++ LE+L          I + +  +  L+ LEL+ N++SG +  
Sbjct: 25  DNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEV 82

Query: 551 SLGRLRNLGVFDASHNRLQG-QIPESFSNLSFLVQIDLSNNELT 593
              +  NL   + S N+++     E    L  L  +DL N E+T
Sbjct: 83  LAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 64.5 bits (157), Expect = 8e-11
 Identities = 38/186 (20%), Positives = 73/186 (39%), Gaps = 26/186 (13%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMA-----EMETLGKIKHRNLVPL 795
           IG G +G V +A    +   VAIKK++R+    +          E+  L ++ H ++V +
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKV 117

Query: 796 LGYCKIGEERL-----LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
           L      +        +V E       +       +      LT    K +      G+ 
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVY--LTELHIKTLLYNLLVGVK 170

Query: 851 FLH-HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
           ++H       I+HRD+K +N L++ +   +V DFG+AR +   +   S   ++     + 
Sbjct: 171 YVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 910 PEYYQS 915
              +  
Sbjct: 227 LVTFPH 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.7 bits (154), Expect = 8e-11
 Identities = 33/210 (15%), Positives = 54/210 (25%), Gaps = 46/210 (21%)

Query: 719 RQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGD---- 774
            Q   + FS  +  T        IG G FGEVF+      + VAIK  I +         
Sbjct: 6   SQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKI-IAIEGPDLVNGS 62

Query: 775 -----REFMAEMETLGKI---------KHRNLVPLLGYC----KIGEERLLVYEFMKFGS 816
                 E + E+    ++         +    + L              L  ++      
Sbjct: 63  HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122

Query: 817 LEEVLHGRAKARDQ-------------------RILTWDARKKIARGAAKGLCFLHHNCI 857
                       DQ                   ++ +    K I       L     +  
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL- 181

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMAR 887
               HRD+   NVLL      ++      +
Sbjct: 182 -RFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.9 bits (157), Expect = 1e-10
 Identities = 84/481 (17%), Positives = 153/481 (31%), Gaps = 129/481 (26%)

Query: 4   VLKLSSNLFTLNSTSLLQLPFGL----KQ---LE-LSSAGLVGLVPDNLFSKLPNLVYLN 55
            LKL   L  L     + +  G+    K    L+   S  +   +   +F       +LN
Sbjct: 137 YLKLRQALLELRPAKNVLI-DGVLGSGKTWVALDVCLSYKVQCKMDFKIF-------WLN 188

Query: 56  ASY-----------NNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLL 104
                           L   +     S SD    + L  +++   +     ++   N LL
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248

Query: 105 HLDLSQNHIMDVIPSSLSNCTKLKILNLSFN-----LLAGEIPRTFGQLSSLQRLDLSNN 159
            L        +V           K  N +FN     LL     +    LS+     +S +
Sbjct: 249 VLL-------NV-------QNA-KAWN-AFNLSCKILLTTRFKQVTDFLSAATTTHISLD 292

Query: 160 HIT-GWIPSELGNACDSLLELK---LPHNNITGSFPVTLS---------SCSWLQLLDLS 206
           H +    P E+ +     L+ +   LP   +T + P  LS           +W     ++
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN-PRRLSIIAESIRDGLATWDNWKHVN 351

Query: 207 NNNISGPFPDSVLENLGSLE------SLILSNNMISGSFPDS--ISSCKTLRIV--DFSS 256
            + ++     S L  L   E       L +        FP S  I +   L ++  D   
Sbjct: 352 CDKLTTIIESS-LNVLEPAEYRKMFDRLSV--------FPPSAHIPT-ILLSLIWFDVIK 401

Query: 257 NRVSGIIPPDICPGVSSLEELRLPDNLITGVIPG-QLSECTQL--------KVI------ 301
           + V  ++  +      SL E +  ++ I+  IP   L    +L         ++      
Sbjct: 402 SDVMVVV--NKLHK-YSLVEKQPKESTIS--IPSIYLELKVKLENEYALHRSIVDHYNIP 456

Query: 302 ------DLSLNYLNGSIPQELG----KLEHLEQFIAW------FNGLEGKI---PPELGK 342
                 DL   YL+      +G     +EH E+   +      F  LE KI         
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516

Query: 343 CKNLKDLILNNNKLSGEI----PA-ELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVL 397
             ++ + +         I    P  E    + L+++      L   I  +++ L R+A++
Sbjct: 517 SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL---ICSKYTDLLRIALM 573

Query: 398 Q 398
            
Sbjct: 574 A 574

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.2 bits (132), Expect = 1e-07
 Identities = 76/509 (14%), Positives = 141/509 (27%), Gaps = 145/509 (28%)

Query: 505 TQYQTLEYLD-LSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE-------IPSSLGRLR 556
           T     +Y D LS  +        + +     V ++  + LS E          ++    
Sbjct: 11  TGEHQYQYKDILSVFE-----DAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL 65

Query: 557 NLGVFDASHNRLQGQIPESF------SNLSFLV-QIDLSNNELTGP----IPQRGQLSTL 605
            L  F    ++ Q ++ + F       N  FL+  I     + +      I QR +L   
Sbjct: 66  RL--FWTLLSK-QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL--- 119

Query: 606 PASQYANNPGLC--GVPLPEC----RNGNNQPALNPSVDAARHGHRVAAAAWANSIVMG- 658
               Y +N       V   +     R    +  L P+ +    G             +  
Sbjct: 120 ----YNDNQVFAKYNVSRLQPYLKLRQALLE--LRPAKNVLIDG-------------VLG 160

Query: 659 ----VLISIASIC----IL------IVWAIAMRARRKEAEEVKMLNSL--QASHAATTWK 702
                +     +C    +       I W + ++        ++ML  L  Q     T+  
Sbjct: 161 SGKTWVA--LDVCLSYKVQCKMDFKIFW-LNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217

Query: 703 IDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVA 762
                  L I+    Q +LR+L  S+  E         L+            L +   V 
Sbjct: 218 DHSSNIKLRIHSI--QAELRRLLKSKPYE-------NCLL-----------VLLN---VQ 254

Query: 763 IKKLIR---LSCQ-----GDREFMAEMETLGKIKHRNLVPLL-GYCKIGEERLLV-YEFM 812
             K      LSC+       ++ + +  +     H +L            + LL+ Y   
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQ-VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313

Query: 813 KFGSL-EEVLHGR--------AKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHR 863
           +   L  EVL              RD  + TWD              + H NC    +  
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRD-GLATWDN-------------WKHVNCDK--LTT 357

Query: 864 DMKSS-NVLLDHEMEARVSDFGMARLISALDTHLSVSTLA----GTPGYVPPEYYQSF-- 916
            ++SS NVL   E         +         H+    L+                    
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSVFP----PSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413

Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
               +       + +  +    +   +++
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENE 442

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.3 bits (127), Expect = 4e-07
 Identities = 106/748 (14%), Positives = 208/748 (27%), Gaps = 249/748 (33%)

Query: 155 DLSNNHITGWIPSELGNA-CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP 213
           +     +     S L     D ++  K   + ++G+  +          L      +   
Sbjct: 32  NFDCKDVQDMPKSILSKEEIDHIIMSK---DAVSGTLRL-------FWTLLSKQEEMVQK 81

Query: 214 FPDSVLE-NLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVS 272
           F + VL  N   L S I +                  R   ++ N+V           VS
Sbjct: 82  FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ---RDRLYNDNQV---FAKY---NVS 132

Query: 273 SLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGL 332
            L+                     +L+              Q L +L    + +   +G+
Sbjct: 133 RLQPY------------------LKLR--------------QALLELRP-AKNVL-IDGV 158

Query: 333 EGKIPPELGK-CKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRL 391
            G      GK    +   +  + K+  ++  ++F      W++L  N  +    PE    
Sbjct: 159 LG-----SGKTW--VALDVCLSYKVQCKMDFKIF------WLNL-KNCNS----PE---- 196

Query: 392 TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSS 451
               VL++         P           + L  +     I   L R L +KP       
Sbjct: 197 ---TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH----SIQAELRRLLKSKPY-----E 244

Query: 452 NTLVFVRNVGNS---------CKGVGGLL---EFAGIRPERLLQIPTLKSCDFARMYSGP 499
           N L+ + NV N+         CK    +L    F  +          L +     +    
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCK----ILLTTRFKQV-------TDFLSAATTTHISLDH 293

Query: 500 VLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLG 559
                T  +    L    +     +P E      L       + ++  I   L    N  
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPRE-----VLTTNPRRLSIIAESIRDGLATWDNWK 348

Query: 560 VFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGV 619
               + ++L   I  S + L               P   R          +        V
Sbjct: 349 --HVNCDKLTTIIESSLNVLE--------------PAEYR--------KMFDR----LSV 380

Query: 620 PLPECRNGNNQPALNPSVDAARHGHRVAAAAWANSIVMGVLISIASICILIVWAIAMRAR 679
             P                                      I    + ++  W       
Sbjct: 381 -FPP----------------------------------SAHIPTILLSLI--W-----FD 398

Query: 680 RKEAEEVKMLNSLQASHAATTWKIDKEKEPLSINVATFQRQLRKLKFS-------QLIEA 732
             +++ + ++N L          ++K+ +  +I++ +   +L K+K          +++ 
Sbjct: 399 VIKSDVMVVVNKLHKYSL-----VEKQPKESTISIPSIYLEL-KVKLENEYALHRSIVDH 452

Query: 733 TN---GFSAESLIGCGGFGEVFK------ATLKDGSSVAIKKLIRLSCQGDREFMAEMET 783
            N    F ++ LI        +         ++    + + +++ L    D  F+     
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL----DFRFLE---- 504

Query: 784 LGKIKH--------RNLVPLLG----YCK-IGE-----ERLLVYEFMKF-GSLEEVLHGR 824
             KI+H         +++  L     Y   I +     ER LV   + F   +EE L   
Sbjct: 505 -QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER-LVNAILDFLPKIEENLI-C 561

Query: 825 AKARD--QRILTW-------DARKKIAR 843
           +K  D  +  L         +A K++ R
Sbjct: 562 SKYTDLLRIALMAEDEAIFEEAHKQVQR 589

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 49/220 (22%), Positives = 81/220 (36%), Gaps = 27/220 (12%)

Query: 21  QLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLD 80
                  +  L    +   V  N  + +  ++  N+   ++ G            +  L 
Sbjct: 16  DAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLP------NVRYLA 69

Query: 81  LSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGE 140
           L  N L   IS          +L +L L+ N +  +        T LK L L  N L   
Sbjct: 70  LGGNKLH-DISAL----KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSL 124

Query: 141 IPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK---LPHNNITGSFPV----T 193
               F +L++L  L+L++N +   +P       D L  L    L +N +  S P      
Sbjct: 125 PDGVFDKLTNLTYLNLAHNQLQS-LPK---GVFDKLTNLTELDLSYNQLQ-SLPEGVFDK 179

Query: 194 LSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
           L+    L+ L L  N +    PD V + L SL+ + L +N
Sbjct: 180 LTQ---LKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 53/238 (22%), Positives = 94/238 (39%), Gaps = 47/238 (19%)

Query: 196 SCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS 255
                   +L   +++          L S++ +I +N+ I  S    I     +R +   
Sbjct: 18  FAE-TIKANLKKKSVTDAVTQ---NELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALG 71

Query: 256 SNRVSGIIPPDICPGV----SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS 311
            N++  I             ++L  L L  N +  +  G   + T LK + L  N     
Sbjct: 72  GNKLHDI-------SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN----- 119

Query: 312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-SCSNL 370
                 +L+ L   +  F+ L            NL  L L +N+L   +P  +F   +NL
Sbjct: 120 ------QLQSLPDGV--FDKL-----------TNLTYLNLAHNQLQ-SLPKGVFDKLTNL 159

Query: 371 EWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNSN 426
             + L+ N+L   +P   F +LT+L  L+L  N+ K  +P G     +SL ++ L+ N
Sbjct: 160 TELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 23/198 (11%)

Query: 238 SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQ 297
            FPD     +T++  +     V+  +  +    ++S++++   ++ I  V  G +     
Sbjct: 12  IFPDDAF-AETIK-ANLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSV-QG-IQYLPN 64

Query: 298 LKVIDLSLNYLNGSIPQELG---KLEHLEQFIAWFNGLEGKIPPEL-GKCKNLKDLILNN 353
           ++ + L  N L      ++    +L +L   I   N L+  +P  +  K  NLK+L+L  
Sbjct: 65  VRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVE 118

Query: 354 NKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIP-G 410
           N+L   +P  +F   +NL +++L  N+L   +P   F +LT L  L L  N+ +  +P G
Sbjct: 119 NQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEG 175

Query: 411 ELGNCSSLVWLDLNSNNL 428
                + L  L L  N L
Sbjct: 176 VFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 48/250 (19%), Positives = 89/250 (35%), Gaps = 62/250 (24%)

Query: 347 KDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKG 406
               L    ++ +   +    ++++ I    +++          L  +  L LG N+   
Sbjct: 22  IKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH- 76

Query: 407 EIPGELGNCSSLV---WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS 463
               ++     L    +L L  N            QL + P G F     L  +  V N 
Sbjct: 77  ----DISALKELTNLTYLILTGN------------QLQSLPNGVFDKLTNLKELVLVEN- 119

Query: 464 CKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGK 523
                              Q+ +L               +F +   L YL+L++NQ +  
Sbjct: 120 -------------------QLQSLPD------------GVFDKLTNLTYLNLAHNQLQ-S 147

Query: 524 IPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLRNLGVFDASHNRLQGQIPE-SFSNLS 580
           +P  + D +  L  L+L++NQL   +P  +  +L  L       N+L+  +P+  F  L+
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLT 205

Query: 581 FLVQIDLSNN 590
            L  I L +N
Sbjct: 206 SLQYIWLHDN 215

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 62.7 bits (151), Expect = 2e-10
 Identities = 28/185 (15%), Positives = 70/185 (37%), Gaps = 18/185 (9%)

Query: 9   SNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTG-FLPE 67
           S +  ++ + +L     L  L++     + +         PNL  L      L    + +
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGK----KPRPNLKSLEIISGGLPDSVVED 212

Query: 68  TLLSNSDKLELLDLSYNN----LTGSISGFS--LNENSCNSLLHLDLSQNHIMDVIPSSL 121
            L S+   LE L L          G ++ F    +++   +L  L +      +V+    
Sbjct: 213 ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272

Query: 122 SNC---TKLKILNLSFNLL----AGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACD 174
                  +L+ +++S  +L    A  +     ++  L+ +++  N+++  +  EL  +  
Sbjct: 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLP 332

Query: 175 SLLEL 179
             +++
Sbjct: 333 MKIDV 337

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 56.1 bits (134), Expect = 2e-08
 Identities = 22/177 (12%), Positives = 54/177 (30%), Gaps = 23/177 (12%)

Query: 69  LLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNH-----IMDVIPSSLSN 123
           +L     L  L +   N        S+ +    +L  L++         + D++ S L N
Sbjct: 167 VLDAMPLLNNLKIKGTN------NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220

Query: 124 CTKLKILNLSFNLLAGEIPRTF------GQLSSLQRLDLSNNHITGWIPSELGNA--CDS 175
             KL +     +         F       +  +L+ L + +      +      +     
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280

Query: 176 LLELKLPHNNITGS----FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESL 228
           L  + +    +T          +     L+ +++  N +S      + ++L     +
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 53.4 bits (127), Expect = 2e-07
 Identities = 21/155 (13%), Positives = 52/155 (33%), Gaps = 19/155 (12%)

Query: 98  NSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFG--QLSSLQRLD 155
           ++   L +L +   + + +      N   LK L +    L   +        L +L++L 
Sbjct: 169 DAMPLLNNLKIKGTNNLSIGKKPRPN---LKSLEIISGGLPDSVVEDILGSDLPNLEKLV 225

Query: 156 LS--------NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSW---LQLLD 204
           L         +  +  + P    +   +L  L +                     L+ +D
Sbjct: 226 LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285

Query: 205 LSNNNISGPFPDSVLENLGS---LESLILSNNMIS 236
           +S   ++      +L+++     L+ + +  N +S
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.5 bits (122), Expect = 7e-07
 Identities = 28/210 (13%), Positives = 63/210 (30%), Gaps = 36/210 (17%)

Query: 249 LRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL 308
              +DF    +S I   D+ P + ++  L       T  +         LK +++    L
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGL 205

Query: 309 NGSIPQELGK-----LEHLEQFIAWFNGLEGKIPPEL------GKCKNLKDLILNNNKLS 357
             S+ +++       LE L  ++   +                 +  NLK L + + +  
Sbjct: 206 PDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQ 265

Query: 358 GEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGE----IPGELG 413
             +         L                      +L  + +       E    +   + 
Sbjct: 266 NVVVEMFLESDIL---------------------PQLETMDISAGVLTDEGARLLLDHVD 304

Query: 414 NCSSLVWLDLNSNNLTGDIPPRLGRQLGAK 443
               L ++++  N L+ ++   L + L  K
Sbjct: 305 KIKHLKFINMKYNYLSDEMKKELQKSLPMK 334

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 42/181 (23%), Positives = 68/181 (37%), Gaps = 16/181 (8%)

Query: 252 VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS 311
           VD     +  + P  I P  +  E+L L    +  +        T+L  ++L  N L  +
Sbjct: 19  VDCQGKSLDSV-PSGI-P--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QT 73

Query: 312 IP----QELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-S 366
           +      +L +L  L         L   +   L     L  L L  N+L   +P+ +F  
Sbjct: 74  LSAGVFDDLTELGTLGLANNQLASLPLGVFDHL---TQLDKLYLGGNQLK-SLPSGVFDR 129

Query: 367 CSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNS 425
            + L+ + L  N+L   IP   F +LT L  L L  N+ +    G       L  + L  
Sbjct: 130 LTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188

Query: 426 N 426
           N
Sbjct: 189 N 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 42/159 (26%), Positives = 60/159 (37%), Gaps = 13/159 (8%)

Query: 5   LKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGF 64
           L L S      S +  +    L  L L    L  L    +F  L  L  L  + N L   
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL-SAGVFDDLTELGTLGLANNQLA-S 97

Query: 65  LPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLL---HLDLSQNHIMDVIPSSL 121
           LP  +  +  +L+ L L  N L       SL     + L     L L+ N +  +   + 
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK------SLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151

Query: 122 SNCTKLKILNLSFNLLAGEIPR-TFGQLSSLQRLDLSNN 159
              T L+ L+LS N L   +P   F +L  LQ + L  N
Sbjct: 152 DKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 15/153 (9%)

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           LDL    +  +  ++    TKL  LNL +N L       F  L+ L  L L+NN +   +
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-L 98

Query: 166 PSELGNACDSLLELKLPHNNIT----GSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLEN 221
           P  + +    L +L L  N +     G F       + L+ L L+ N +    P    + 
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQLKSLPSGVF----DRLTKLKELRLNTNQLQS-IPAGAFDK 153

Query: 222 LGSLESLILSNNMIS----GSFPDSISSCKTLR 250
           L +L++L LS N +     G+F D +   +T+ 
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAF-DRLGKLQTIT 185

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 13/160 (8%)

Query: 128 KILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNIT 187
           + L+L    LA     TF  L+ L  L+L  N +   + + + +    L  L L +N + 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96

Query: 188 GSFPVTL-SSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS----GSFPDS 242
            S P+ +    + L  L L  N +    P  V + L  L+ L L+ N +     G+F D 
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAF-DK 153

Query: 243 ISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
           +++ +TL     S+N++   +P      +  L+ + L  N
Sbjct: 154 LTNLQTL---SLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 46/209 (22%), Positives = 65/209 (31%), Gaps = 50/209 (23%)

Query: 384 IPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAK 443
           +P      T    L L +              + L WL+L+ N            QL   
Sbjct: 29  VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYN------------QLQTL 74

Query: 444 PLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSL 503
             G F     L  +    N                    Q+ +L               +
Sbjct: 75  SAGVFDDLTELGTLGLANN--------------------QLASLPL------------GV 102

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLRNLGVF 561
           F     L+ L L  NQ +  +P  + D +  L+ L L  NQL   IP+    +L NL   
Sbjct: 103 FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTL 160

Query: 562 DASHNRLQGQIPESFSNLSFLVQIDLSNN 590
             S N+LQ     +F  L  L  I L  N
Sbjct: 161 SLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 24/90 (26%), Positives = 36/90 (40%), Gaps = 3/90 (3%)

Query: 347 KDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFK 405
           + L L +  L+    A     + L W++L  N+L   +    F  LT L  L L NN+  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 406 GEIPGELGNCSSLVWLDLNSNNLTGDIPPR 435
               G   + + L  L L  N L   +P  
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLKS-LPSG 125

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 6/93 (6%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLRNLGVF 561
           F     L +L+L YNQ +  +   + D +  L  L LA+NQL+  +P  +   L  L   
Sbjct: 55  FRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKL 112

Query: 562 DASHNRLQGQIPES-FSNLSFLVQIDLSNNELT 593
               N+L+  +P   F  L+ L ++ L+ N+L 
Sbjct: 113 YLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ 144

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 21/83 (25%), Positives = 31/83 (37%)

Query: 511 EYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQG 570
           E LDL               +  L  L L +NQL          L  LG    ++N+L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 571 QIPESFSNLSFLVQIDLSNNELT 593
                F +L+ L ++ L  N+L 
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK 120

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 50/247 (20%), Positives = 81/247 (32%), Gaps = 79/247 (31%)

Query: 740 SLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHR---- 790
             +G G FG V     + +    A+K ++R      +++      E + L KI++     
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVK-VVR----NIKKYTRSAKIEADILKKIQNDDINN 95

Query: 791 -NLVPLLGY-------CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIA 842
            N+V   G        C       L++E +   SL E++       +      +  K   
Sbjct: 96  NNIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEII----TRNNYNGFHIEDIKLYC 143

Query: 843 RGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA------------------------ 878
               K L +L       + H D+K  N+LLD                             
Sbjct: 144 IEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 879 -RVSDFGMARLISALDTHLSVSTLAGTPGYVPPE------YYQSFRCTAKGDVYSFGVVL 931
            ++ DFG      A        ++  T  Y  PE      +          D++SFG VL
Sbjct: 201 IKLIDFG-----CATFKSDYHGSIINTRQYRAPEVILNLGW--DVSS----DMWSFGCVL 249

Query: 932 LELLTGK 938
            EL TG 
Sbjct: 250 AELYTGS 256

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 55/293 (18%), Positives = 105/293 (35%), Gaps = 68/293 (23%)

Query: 741 LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDR-----------EFMAEMETLGKIKH 789
            IG GGFG ++ A +    SV       +  +              +  A+ E + K   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 790 RNLVPLLG-----YCKIGEERLLVYEFM---KFG-SLEEVLHGRAKARDQRILTWDARK- 839
              +  LG        + ++    Y FM   +FG  L++            I   +A++ 
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK------------IYEANAKRF 149

Query: 840 ------KIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV--SDFGMARLISA 891
                 +++      L ++H +     +H D+K+SN+LL+++   +V   D+G+A     
Sbjct: 150 SRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 892 LDTHL-----SVSTLAGTPGYVPPE----YYQSFRCTAKGDVYSFGVVLLELLTGKRPTD 942
              H            GT  +   +       S R    GD+   G  +++ LTG  P  
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR----GDLEILGYCMIQWLTGHLPW- 261

Query: 943 KDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLE 995
           +D+  D   V     K+R  + +  +  +                 E+ +Y+E
Sbjct: 262 EDNLKDPKYVR--DSKIRYRENIASLM-DKCFPAANAPG-------EIAKYME 304

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 61/284 (21%), Positives = 107/284 (37%), Gaps = 68/284 (23%)

Query: 742  IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
            +G G  G+V +   K      A+K L        RE              ++V ++   +
Sbjct: 26   LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-REVELHWRASQ---CPHIVRIVDVYE 81

Query: 801  IGEER----LLVYEFMKFGSLEEVLHGRAKARDQRILT-WDARKKIARGAAKGLCFLHHN 855
                     L+V E +  G L      R + R  +  T  +A + I +   + + +LH  
Sbjct: 82   NLYAGRKCLLIVMECLDGGELFS----RIQDRGDQAFTEREASE-IMKSIGEAIQYLHSI 136

Query: 856  CIPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
               +I HRD+K  N+L   +      +++DFG A+                   Y     
Sbjct: 137  ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-----------TGE--KYDKS-- 178

Query: 913  YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGW---VKMKVREGKQMEVID 969
                 C    D++S GV++  LL G  P     F   + +     +K ++R G+  E  +
Sbjct: 179  -----C----DMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQ-YEFPN 223

Query: 970  PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            PE   V+        EEVK ++R L   L   +  P++R  + +
Sbjct: 224  PEWSEVS--------EEVKMLIRNL---L-KTE--PTQRMTITE 253

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.6 bits (141), Expect = 4e-09
 Identities = 20/111 (18%), Positives = 37/111 (33%), Gaps = 4/111 (3%)

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPR-TFGQLSSLQRLDLS 157
             +    L  +++  +D     L     L  L +        +       L  L+ L + 
Sbjct: 6   CPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 158 NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNN 208
            + +  ++  +  +    L  L L  N +      T+   S LQ L LS N
Sbjct: 65  KSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.8 bits (139), Expect = 6e-09
 Identities = 19/110 (17%), Positives = 34/110 (30%), Gaps = 3/110 (2%)

Query: 124 CTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPH 183
                 L  + +    +         +L  L + N      +          L  L +  
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 184 NNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
           + +    P        L  L+LS N +        ++ L SL+ L+LS N
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGL-SLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.8 bits (139), Expect = 8e-09
 Identities = 20/96 (20%), Positives = 36/96 (37%), Gaps = 4/96 (4%)

Query: 336 IPPELGKCKNLKDLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPE-FSRLTR 393
               L   +NL +L + N +    +          L  +++  + L   + P+ F    R
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 394 LAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT 429
           L+ L L  N  +  +  +     SL  L L+ N L 
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.1 bits (137), Expect = 1e-08
 Identities = 20/110 (18%), Positives = 36/110 (32%), Gaps = 4/110 (3%)

Query: 485 PTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDE-IGDMIALQVLELAHNQ 543
            +   C          L      + L  L +   Q    +    +  +  L+ L +  + 
Sbjct: 10  SSGLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 544 LSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
           L    P +      L   + S N L+    ++   LS L ++ LS N L 
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.7 bits (136), Expect = 2e-08
 Identities = 22/111 (19%), Positives = 36/111 (32%), Gaps = 3/111 (2%)

Query: 172 ACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS 231
                  L+   +         L     L  L + N           L  LG L +L + 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 232 NNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
            + +    PD+      L  ++ S N +   +      G+ SL+EL L  N
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGL-SLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 19/95 (20%), Positives = 33/95 (34%), Gaps = 1/95 (1%)

Query: 524 IPDEIGDMIALQVLELAHNQLSGEIPS-SLGRLRNLGVFDASHNRLQGQIPESFSNLSFL 582
               +     L  L + + Q    +    L  L  L       + L+   P++F     L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 583 VQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLC 617
            +++LS N L     +  Q  +L     + NP  C
Sbjct: 83  SRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.9 bits (134), Expect = 3e-08
 Identities = 32/135 (23%), Positives = 47/135 (34%), Gaps = 14/135 (10%)

Query: 70  LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI 129
           L  ++ L  L +        +    L       L +L + ++ +  V P +     +L  
Sbjct: 27  LPGAENLTELYIENQQHLQHLELRDLR--GLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84

Query: 130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACD-SLLELKLPHNNITG 188
           LNLSFN L     +T   L SLQ L LS N +           C  +L  L+       G
Sbjct: 85  LNLSFNALESLSWKTVQGL-SLQELVLSGNPLH----------CSCALRWLQRWEEEGLG 133

Query: 189 SFPVTLSSCSWLQLL 203
             P     C     L
Sbjct: 134 GVPEQKLQCHGQGPL 148

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 12/85 (14%), Positives = 25/85 (29%), Gaps = 2/85 (2%)

Query: 353 NNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGE 411
               + +    L    NL  + +   +    +       L  L  L +  +  +   P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 412 LGNCSSLVWLDLNSNNLTGDIPPRL 436
                 L  L+L+ N L   +  + 
Sbjct: 76  FHFTPRLSRLNLSFNALES-LSWKT 99

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.2 bits (101), Expect = 3e-04
 Identities = 12/79 (15%), Positives = 27/79 (34%), Gaps = 1/79 (1%)

Query: 238 SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQ 297
                +   + L  +   + +    +      G+  L  L +  + +  V P       +
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 298 LKVIDLSLNYLNGSIPQEL 316
           L  ++LS N L  S+  + 
Sbjct: 82  LSRLNLSFNALE-SLSWKT 99

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.5 bits (142), Expect = 5e-09
 Identities = 55/242 (22%), Positives = 86/242 (35%), Gaps = 73/242 (30%)

Query: 740 SLIGCGGFGEVFKA--TLKDGSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHR--- 790
             +G G FG+V +     +  S VA+K +IR       ++      E+  L KIK +   
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALK-IIR----NVGKYREAARLEINVLKKIKEKDKE 79

Query: 791 ---NLVPLLGY-------CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
                V +  +       C       + +E +   +  E L    K  + +       + 
Sbjct: 80  NKFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFL----KENNFQPYPLPHVRH 127

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA-------------------RVS 881
           +A      L FLH N    + H D+K  N+L  +                       RV+
Sbjct: 128 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 882 DFGMARLISALDTHLSVSTLAGTPGYVPPE-----YYQSFRCTAKGDVYSFGVVLLELLT 936
           DFG     SA   H   +T+  T  Y PPE      + +  C    DV+S G +L E   
Sbjct: 185 DFG-----SATFDHEHHTTIVATRHYRPPEVILELGW-AQPC----DVWSIGCILFEYYR 234

Query: 937 GK 938
           G 
Sbjct: 235 GF 236

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 51/234 (21%), Positives = 90/234 (38%), Gaps = 31/234 (13%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVP-LLG 797
           IG G FG+++  T +  G  VAIK     +   Q   E     + +        +P +  
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-KIYKMMQGGVG---IPTIRW 72

Query: 798 YCKIGEERLLVYEFMKFG-SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
               G+  ++V E +  G SLE++ +  ++    + +   A + I+R     + ++H   
Sbjct: 73  CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISR-----IEYIHSK- 124

Query: 857 IPHIIHRDMKSSNVLLDHEMEA---RVSDFGMARLISALDTHLSVST-----LAGTPGYV 908
             + IHRD+K  N L+    +     + DFG+A+      TH  +       L GT  Y 
Sbjct: 125 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP----TDKDDFGDTNLVGWVKMK 958
               +     + + D+ S G VL+    G  P               +   KM 
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 46/231 (19%), Positives = 78/231 (33%), Gaps = 42/231 (18%)

Query: 739 ESLIGCGGFGEVFKAT-LKDGSSVAIK--KLIRLSC-QGDREF-----MAEMETLGKIKH 789
              IG GGFG ++ A         A    K+          E      +A+ + + K   
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 790 RNLVPLLG-----YCKIGEERLLVYEFM---KFG-SLEEVLHGRAKARDQRILTWDARKK 840
           R  +  LG        + E +   Y FM   + G  L+++                   +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKIS------GQNGTFKKSTVLQ 155

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV--SDFGMARLISALDTHL-- 896
           +       L ++H N     +H D+K++N+LL ++   +V  +D+G++        H   
Sbjct: 156 LGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212

Query: 897 ---SVSTLAGTPGYVP----PEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                    GT  +           S R     DV   G  +L  L GK P
Sbjct: 213 QENPRKGHNGTIEFTSLDAHKGVALSRR----SDVEILGYCMLRWLCGKLP 259

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 38/140 (27%), Positives = 51/140 (36%), Gaps = 12/140 (8%)

Query: 23  PFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS 82
           P   + L L    +  L    +F  L NL  L    N L   LP  +  +  +L +LDL 
Sbjct: 39  PTNAQILYLHDNQITKL-EPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLG 96

Query: 83  YNNLTGSISGFSLNE---NSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAG 139
            N LT       L     +    L  L +  N +   +P  +   T L  L L  N L  
Sbjct: 97  TNQLT------VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKS 149

Query: 140 EIPRTFGQLSSLQRLDLSNN 159
                F +LSSL    L  N
Sbjct: 150 IPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 49/176 (27%), Positives = 72/176 (40%), Gaps = 31/176 (17%)

Query: 252 VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS 311
           VD  S R + + P  I P  ++ + L L DN IT + PG       LK + L  N L  +
Sbjct: 24  VDCRSKRHASV-PAGI-P--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-A 78

Query: 312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-SCSNL 370
           +P  +            F+ L             L  L L  N+L+  +P+ +F    +L
Sbjct: 79  LPVGV------------FDSL-----------TQLTVLDLGTNQLT-VLPSAVFDRLVHL 114

Query: 371 EWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN 426
           + + +  N+LT  +P    RLT L  L L  N+ K    G     SSL    L  N
Sbjct: 115 KELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 37/128 (28%), Positives = 50/128 (39%), Gaps = 3/128 (2%)

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           L L  N I  + P    +   LK L L  N L       F  L+ L  LDL  N +T  +
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV-L 103

Query: 166 PSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL 225
           PS + +    L EL +  N +T   P  +   + L  L L  N +    P    + L SL
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSSL 161

Query: 226 ESLILSNN 233
               L  N
Sbjct: 162 THAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 3/88 (3%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSLGRLRNLGVFD 562
           F     L  LDL  NQ    +P  + D ++ L+ L +  N+L+ E+P  + RL +L    
Sbjct: 84  FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141

Query: 563 ASHNRLQGQIPESFSNLSFLVQIDLSNN 590
              N+L+     +F  LS L    L  N
Sbjct: 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.3 bits (105), Expect = 8e-05
 Identities = 25/84 (29%), Positives = 38/84 (45%), Gaps = 2/84 (2%)

Query: 347 KDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFK 405
           + L L++N+++   P    S  NL+ + L  N+L   +P   F  LT+L VL LG N+  
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 406 GEIPGELGNCSSLVWLDLNSNNLT 429
                       L  L +  N LT
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT 125

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 3/90 (3%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSLGRLRNLGVFD 562
           F     L+ L L  NQ    +P  + D +  L VL+L  NQL+    +   RL +L    
Sbjct: 60  FDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF 118

Query: 563 ASHNRLQGQIPESFSNLSFLVQIDLSNNEL 592
              N+L   +P     L+ L  + L  N+L
Sbjct: 119 MCCNKLTE-LPRGIERLTHLTHLALDQNQL 147

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 38/233 (16%), Positives = 78/233 (33%), Gaps = 49/233 (21%)

Query: 742 IGCGGFGEVFKAT---------LKDGSSVAIK----------KLIRLSCQGDREFMAEME 782
                 G +++A                 ++K          +            + + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 783 TLGKIKHRNLVPLLGYCKIGEERLLVYEFM---KFG-SLEEVLHGRAKARDQRILTWDAR 838
            L        +P      + +++   Y F+     G SL+  L        + +L+  + 
Sbjct: 110 KLYSTPLLA-IPTCMGFGVHQDK---YRFLVLPSLGRSLQSAL----DVSPKHVLSERSV 161

Query: 839 KKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV--SDFGMARLISALDTHL 896
            ++A      L FLH N     +H ++ + N+ +D E +++V  + +G A        H+
Sbjct: 162 LQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 897 -----SVSTLAGTPGYVPPE----YYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
                S S   G   ++  +       S R     D+ S G  +L+ L G  P
Sbjct: 219 AYVEGSRSPHEGDLEFISMDLHKGCGPSRR----SDLQSLGYCMLKWLYGFLP 267

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.7 bits (135), Expect = 3e-08
 Identities = 53/242 (21%), Positives = 83/242 (34%), Gaps = 73/242 (30%)

Query: 740 SLIGCGGFGEVFKA--TLKDGSSVAIKKLIRLSCQGDREF----MAEMETLGKIKHR--- 790
             +G G FG+V +       G  VA+K +++        +     +E++ L  +      
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVK-IVK----NVDRYCEAARSEIQVLEHLNTTDPN 74

Query: 791 ---NLVPLLGY-------CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKK 840
                V +L +       C       +V+E +   S  + +    K         D  +K
Sbjct: 75  STFRCVQMLEWFEHHGHIC-------IVFELLGL-STYDFI----KENGFLPFRLDHIRK 122

Query: 841 IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA-------------------RVS 881
           +A    K + FLH N    + H D+K  N+L                          +V 
Sbjct: 123 MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 882 DFGMARLISALDTHLSVSTLAGTPGYVPPE-----YYQSFRCTAKGDVYSFGVVLLELLT 936
           DFG     SA       STL  T  Y  PE      + S  C    DV+S G +L+E   
Sbjct: 180 DFG-----SATYDDEHHSTLVSTRHYRAPEVILALGW-SQPC----DVWSIGCILIEYYL 229

Query: 937 GK 938
           G 
Sbjct: 230 GF 231

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 27/128 (21%)

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           L L  N    ++P  LSN   L +++LS N ++    ++F  ++ L  L LS N +   I
Sbjct: 36  LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-I 93

Query: 166 PSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL 225
           P       D L                       L+LL L  N+IS   P+    +L +L
Sbjct: 94  PP---RTFDGLKS---------------------LRLLSLHGNDISV-VPEGAFNDLSAL 128

Query: 226 ESLILSNN 233
             L +  N
Sbjct: 129 SHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 6/94 (6%)

Query: 336 IPPELGKCKNLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSRLTR 393
           +P EL   K+L  + L+NN++S  +  + F + + L  + L+ N L   IPP  F  L  
Sbjct: 46  VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKS 103

Query: 394 LAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNSN 426
           L +L L  N     +P G   + S+L  L + +N
Sbjct: 104 LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 49.6 bits (119), Expect = 9e-07
 Identities = 32/83 (38%), Positives = 38/83 (45%), Gaps = 4/83 (4%)

Query: 79  LDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
           L L  N  T      S    +   L  +DLS N I  +   S SN T+L  L LS+N L 
Sbjct: 36  LYLDGNQFTLVPKELS----NYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91

Query: 139 GEIPRTFGQLSSLQRLDLSNNHI 161
              PRTF  L SL+ L L  N I
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDI 114

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 12/93 (12%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPS----SLGRLRNL 558
            + Y+ L  +DLS N+    + ++    M  L  L L++N+L   IP      L  LR L
Sbjct: 50  LSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLL 107

Query: 559 GVFDASHNRLQGQIPE-SFSNLSFLVQIDLSNN 590
            +     N +   +PE +F++LS L  + +  N
Sbjct: 108 SLHG---NDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 1/84 (1%)

Query: 509 TLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRL 568
            +  L L  NQF   +P E+ +   L +++L++N++S     S   +  L     S+NRL
Sbjct: 32  DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90

Query: 569 QGQIPESFSNLSFLVQIDLSNNEL 592
           +   P +F  L  L  + L  N++
Sbjct: 91  RCIPPRTFDGLKSLRLLSLHGNDI 114

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 31/110 (28%), Positives = 46/110 (41%), Gaps = 10/110 (9%)

Query: 4   VLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTG 63
            L L  N FTL    L      L  ++LS+  +  L  +  FS +  L+ L  SYN L  
Sbjct: 35  ELYLDGNQFTLVPKELSNYKH-LTLIDLSNNRISTL-SNQSFSNMTQLLTLILSYNRLRC 92

Query: 64  FLPETLLSNSDKLELLDLSYNNLTGSI--SGFSLNENSCNSLLHLDLSQN 111
            +P         L LL L  N+++  +    F    N  ++L HL +  N
Sbjct: 93  -IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAF----NDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 20/59 (33%), Positives = 32/59 (54%), Gaps = 1/59 (1%)

Query: 535 QVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT 593
             L L  NQ +  +P  L   ++L + D S+NR+     +SFSN++ L+ + LS N L 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 27/212 (12%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVP-LLG 797
           IG G FGE++  T ++    VAIK     +   Q   E       L        +P +  
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES-KIYRILQGGTG---IPNVRW 70

Query: 798 YCKIGEERLLVYEFMKFG-SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
           +   G+  +LV + +  G SLE++ +  ++    + +   A + I R     + F+H   
Sbjct: 71  FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINR-----VEFVHSK- 122

Query: 857 IPHIIHRDMKSSNVLLDHEMEAR---VSDFGMARLISALDTHLSVS-----TLAGTPGYV 908
               +HRD+K  N L+     A    + DFG+A+      TH  +       L GT  Y 
Sbjct: 123 --SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
               +     + + D+ S G VL+  L G  P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 34/150 (22%), Positives = 58/150 (38%), Gaps = 34/150 (22%)

Query: 15  NSTSLLQLPFGL----KQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLL 70
               L ++P  +     +L L+   L  +  D LF +LP+LV L    N LTG +     
Sbjct: 16  TGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAF 74

Query: 71  SNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKIL 130
             +  ++ L L  N +        ++      L                      +LK L
Sbjct: 75  EGASHIQELQLGENKIK------EISNKMFLGL---------------------HQLKTL 107

Query: 131 NLSFNLLAGEIPR-TFGQLSSLQRLDLSNN 159
           NL  N ++  +   +F  L+SL  L+L++N
Sbjct: 108 NLYDNQISC-VMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 6/96 (6%)

Query: 335 KIPPE--LGKCKNLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSR 390
           +I  +   G+  +L  L L  N+L+  I    F   S+++ + L  N++  +I  + F  
Sbjct: 43  RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLG 100

Query: 391 LTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN 426
           L +L  L L +N+    +PG   + +SL  L+L SN
Sbjct: 101 LHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 34/129 (26%), Positives = 48/129 (37%), Gaps = 27/129 (20%)

Query: 106 LDLSQNHIMDVIPSSL-SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGW 164
           L L+ N +  +    L      L  L L  N L G  P  F   S +Q L L  N I   
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-- 91

Query: 165 IPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGS 224
                          ++ +      F + L     L+ L+L +N IS        E+L S
Sbjct: 92  ---------------EISN----KMF-LGLHQ---LKTLNLYDNQISC-VMPGSFEHLNS 127

Query: 225 LESLILSNN 233
           L SL L++N
Sbjct: 128 LTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 25/98 (25%), Positives = 46/98 (46%), Gaps = 12/98 (12%)

Query: 499 PVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPS----SLG 553
               LF +   L  L+L  NQ    I     +    +Q L+L  N++  EI +     L 
Sbjct: 45  SSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLH 102

Query: 554 RLRNLGVFDASHNRLQGQIPE-SFSNLSFLVQIDLSNN 590
           +L+ L ++D   N++   +   SF +L+ L  ++L++N
Sbjct: 103 QLKTLNLYD---NQISC-VMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 6/102 (5%)

Query: 152 QRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNIS 211
             L L++N +       L      L++L+L  N +TG  P      S +Q L L  N I 
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91

Query: 212 GPFPDSVLENLGSLESLILSNNMIS----GSFPDSISSCKTL 249
               + +   L  L++L L +N IS    GSF + ++S  +L
Sbjct: 92  E-ISNKMFLGLHQLKTLNLYDNQISCVMPGSF-EHLNSLTSL 131

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.1 bits (97), Expect = 6e-04
 Identities = 27/126 (21%), Positives = 44/126 (34%), Gaps = 30/126 (23%)

Query: 201 QLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVS 260
             L L++N +     D +   L  L  L L  N ++G                       
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG----------------------- 68

Query: 261 GIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQ----EL 316
             I P+   G S ++EL+L +N I  +         QLK ++L  N ++  +       L
Sbjct: 69  --IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHL 125

Query: 317 GKLEHL 322
             L  L
Sbjct: 126 NSLTSL 131

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Length = 329

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 58/372 (15%), Positives = 111/372 (29%), Gaps = 75/372 (20%)

Query: 27  KQLELSSAG-LVGLVPDNLFSKLPNLVYLNASYNNLTGFLPET----LLSNSDKLELLDL 81
           K   +S  G L+ ++ +   + + +L         LTG L       L      L++LD+
Sbjct: 5   KTYYVSKPGTLISMMTEEEANSITHLT--------LTGKLNAEDFRHLRDEFPSLKVLDI 56

Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL--------SNCTKLKILNLS 133
           S   +              N   ++ ++      V   +              L+ + LS
Sbjct: 57  SNAEIKMYSGK---AGTYPNGKFYIYMANF----VPAYAFSNVVNGVTKGKQTLEKVILS 109

Query: 134 FNLLAGEI-PRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPV 192
             +    I    F    +L+   +        +P  L    DS+  + +P  +       
Sbjct: 110 EKIK--NIEDAAFKGCDNLKICQIRKKTAPNLLPEAL---ADSVTAIFIPLGSSDAYRFK 164

Query: 193 TL------SSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS---GSFPDSI 243
                        L+              D +++       +             F    
Sbjct: 165 NRWEHFAFIEGEPLETTIQVGAMGK--LEDEIMKAGLQPRDINFLTIEGKLDNADFKLIR 222

Query: 244 SSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL-SECTQLKVID 302
                L  +D S    +  IP         L +++LP NL T  I  ++ S C +L    
Sbjct: 223 DYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHNLKT--IGQRVFSNCGRLAG-- 277

Query: 303 LSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPA 362
            +L      +P  +  +E        F G           C NL+ ++   +K++  +  
Sbjct: 278 -TLE-----LPASVTAIEF-----GAFMG-----------CDNLRYVLATGDKIT-TLGD 314

Query: 363 ELFS-CSNLEWI 373
           ELF      + I
Sbjct: 315 ELFGNGVPSKLI 326

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.2 bits (125), Expect = 5e-07
 Identities = 50/276 (18%), Positives = 91/276 (32%), Gaps = 80/276 (28%)

Query: 740 SLIGCGGFGEVFKA-TLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK--------HR 790
             +G G F  V+ +  ++    VA+K +++ +       + E+  L  ++          
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 791 NLVPLLGYCKI----GEERLLVYEFMKFG-SLEEVLHGRAKARDQRILTWDARKKIARGA 845
            +V LL   KI    G    +V+E +  G  L + +       + + L     KKI +  
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWI----IKSNYQGLPLPCVKKIIQQV 155

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLL--------------------------------- 872
            +GL +LH  C   IIH D+K  N+LL                                 
Sbjct: 156 LQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 873 ----------------DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
                             +++ +++D G A     +  H   +    T  Y   E     
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHF--TEDIQTRQYRSLEVLIGS 268

Query: 917 RCTAKGDVYSFGVVLLELLTGKR---PTDKDDFGDT 949
                 D++S   +  EL TG     P   +++   
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 41/141 (29%), Positives = 60/141 (42%), Gaps = 13/141 (9%)

Query: 23  PFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS 82
           P     L+L +  L  L P+ +F +L +L  L    N L   LP  + +    L  L+LS
Sbjct: 27  PAQTTYLDLETNSLKSL-PNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLS 84

Query: 83  YNNLTGSISGFSLNE---NSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAG 139
            N L       SL     +    L  L L+ N +  +        T+LK L L  N L  
Sbjct: 85  TNQLQ------SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS 138

Query: 140 EIPR-TFGQLSSLQRLDLSNN 159
            +P   F +L+SLQ + L +N
Sbjct: 139 -VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 32/177 (18%)

Query: 252 VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS 311
           V+  S   + + P  I    +    L L  N +  +  G   E T L  + L  N     
Sbjct: 12  VECYSQGRTSV-PTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN----- 62

Query: 312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF-SCSNL 370
                 KL+ L   +  FN L            +L  L L+ N+L   +P  +F   + L
Sbjct: 63  ------KLQSLPNGV--FNKL-----------TSLTYLNLSTNQLQ-SLPNGVFDKLTQL 102

Query: 371 EWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN 426
           + ++L  N+L   +P   F +LT+L  L+L  N+ K    G     +SL ++ L+ N
Sbjct: 103 KELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 39/132 (29%), Positives = 57/132 (43%), Gaps = 10/132 (7%)

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           LDL  N +  +        T L  L L  N L       F +L+SL  L+LS N +   +
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-L 91

Query: 166 PSELGNACDSLLELKLPHNNITGSFPV----TLSSCSWLQLLDLSNNNISGPFPDSVLEN 221
           P+ + +    L EL L  N +  S P      L+    L+ L L  N +    PD V + 
Sbjct: 92  PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ---LKDLRLYQNQLKS-VPDGVFDR 146

Query: 222 LGSLESLILSNN 233
           L SL+ + L +N
Sbjct: 147 LTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 23/83 (27%), Positives = 33/83 (39%)

Query: 347 KDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKG 406
             L L  N L           ++L  + L GN+L       F++LT L  L L  N+ + 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 407 EIPGELGNCSSLVWLDLNSNNLT 429
              G     + L  L LN+N L 
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQ 113

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 36/130 (27%), Positives = 58/130 (44%), Gaps = 9/130 (6%)

Query: 125 TKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHN 184
            +   L+L  N L       F +L+SL +L L  N +   +P+ + N   SL  L L  N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTN 86

Query: 185 NITGSFPVTL-SSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI----SGSF 239
            +  S P  +    + L+ L L+ N +    PD V + L  L+ L L  N +     G F
Sbjct: 87  QLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVF 144

Query: 240 PDSISSCKTL 249
            D ++S + +
Sbjct: 145 -DRLTSLQYI 153

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLRNLGVF 561
           F +  +L YL+LS NQ +  +P+ + D +  L+ L L  NQL   +P  +  +L  L   
Sbjct: 72  FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDL 129

Query: 562 DASHNRLQGQIPE-SFSNLSFLVQIDLSNN 590
               N+L+  +P+  F  L+ L  I L +N
Sbjct: 130 RLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 34/195 (17%), Positives = 60/195 (30%), Gaps = 19/195 (9%)

Query: 71  SNSDKLELLDLSYNNLTGSISGFSLNENSCN-SLLHLDLSQNHIMDVIPSSLSNC--TKL 127
             S    L  ++Y  L       S+  NS       L+  +   ++ +   +S       
Sbjct: 70  DASTASALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQ 129

Query: 128 KILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNIT 187
           + L+L   L +            L R       +       +      LL L L +N + 
Sbjct: 130 QALDLK-GLRSDPDLVAQNIDVVLNRRSCMAATLRI-----IEENIPELLSLNLSNNRLY 183

Query: 188 G--SFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDS--- 242
                   +     L++L+LS N +        ++ L  LE L L  N +  +F D    
Sbjct: 184 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTY 242

Query: 243 ----ISSCKTLRIVD 253
                     L  +D
Sbjct: 243 ISAIRERFPKLLRLD 257

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 51/236 (21%), Positives = 90/236 (38%), Gaps = 33/236 (13%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIK--KLIRLSCQGDREFMAEMETLGKIKHRNLVP-LLG 797
           IG G FG +F+ T L +   VAIK       + Q   E+    + L        +P +  
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY-RTYKLLAGCTG---IPNVYY 73

Query: 798 YCKIGEERLLVYEFMKFG-SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
           + + G   +LV + +  G SLE++L    +    + +   A++ +AR     +  +H   
Sbjct: 74  FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLAR-----VQSIHEK- 125

Query: 857 IPHIIHRDMKSSNVLLDHEMEAR-----VSDFGMARLISALDTHL-----SVSTLAGTPG 906
              +++RD+K  N L+            V DFGM +      T           L+GT  
Sbjct: 126 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 907 YVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP----TDKDDFGDTNLVGWVKMK 958
           Y+    +     + + D+ + G V +  L G  P        +      +G  K  
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 48/218 (22%), Positives = 85/218 (38%), Gaps = 37/218 (16%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIK--KLIRLSCQGDREFMAEMETLGKIKHRNLVP-LLG 797
           IGCG FGE+     L     VAIK   +   + Q       E     ++   + +P +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ----LHLEYRFYKQLGSGDGIPQVYY 72

Query: 798 YCKIGEERLLVYEFMKFG-SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
           +   G+   +V E +  G SLE++     +    + +   A + I+R     + ++H   
Sbjct: 73  FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISR-----MEYVHSK- 124

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVS-----DFGMARLISALDTHLSVS-----TLAGTPG 906
             ++I+RD+K  N L+              DF +A+     +T   +      +L GT  
Sbjct: 125 --NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182

Query: 907 YVPP----EYYQSFRCTAKGDVYSFGVVLLELLTGKRP 940
           Y+         QS R     D+ + G + +  L G  P
Sbjct: 183 YMSINTHLGKEQSRR----DDLEALGHMFMYFLRGSLP 216

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 24/84 (28%), Positives = 40/84 (47%), Gaps = 4/84 (4%)

Query: 345 NLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNN 402
            L  L L+ N++   +P  +F   + L  + L  N+L   +P   F +LT+L  L L  N
Sbjct: 53  QLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTN 110

Query: 403 RFKGEIPGELGNCSSLVWLDLNSN 426
           + K    G     +SL  + L++N
Sbjct: 111 QLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 29/128 (22%), Positives = 47/128 (36%), Gaps = 26/128 (20%)

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           L+L  N +  +        T+L  L+LS N +       F +L+ L  L L  N +   +
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS-L 91

Query: 166 PSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL 225
           P+      D L +                     L+ L L  N +    PD + + L SL
Sbjct: 92  PN---GVFDKLTQ---------------------LKELALDTNQLKS-VPDGIFDRLTSL 126

Query: 226 ESLILSNN 233
           + + L  N
Sbjct: 127 QKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 41/138 (29%), Positives = 55/138 (39%), Gaps = 31/138 (22%)

Query: 23  PFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS 82
           P    +LEL S  L  L P  +F KL  L  L+ S N +   LP+ +     KL +L L 
Sbjct: 27  PSSATRLELESNKLQSL-PHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLH 84

Query: 83  YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIP 142
            N L       SL     + L                     T+LK L L  N L   +P
Sbjct: 85  ENKLQ------SLPNGVFDKL---------------------TQLKELALDTNQLKS-VP 116

Query: 143 R-TFGQLSSLQRLDLSNN 159
              F +L+SLQ++ L  N
Sbjct: 117 DGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 4/86 (4%)

Query: 509 TLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNR 567
           +   L+L  N+ +  +P  + D +  L  L L+ NQ+         +L  L +     N+
Sbjct: 29  SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87

Query: 568 LQGQIPES-FSNLSFLVQIDLSNNEL 592
           LQ  +P   F  L+ L ++ L  N+L
Sbjct: 88  LQ-SLPNGVFDKLTQLKELALDTNQL 112

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 4/89 (4%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLRNLGVF 561
           F +   L  L LS NQ +  +PD + D +  L +L L  N+L   +P+ +  +L  L   
Sbjct: 48  FDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKEL 105

Query: 562 DASHNRLQGQIPESFSNLSFLVQIDLSNN 590
               N+L+      F  L+ L +I L  N
Sbjct: 106 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 19/133 (14%), Positives = 41/133 (30%), Gaps = 21/133 (15%)

Query: 49  PNLVYLNASYNNLTG-----FLPETLLSNSDKLELLDLSYNNLT--GSIS-GFSLNENSC 100
           P+L  +N +              E L +N+  ++   +         + +    L  N+ 
Sbjct: 36  PDLEEVNLNNIMNIPVPTLKACAEALKTNT-YVKKFSIVGTRSNDPVAFALAEMLKVNN- 93

Query: 101 NSLLHLDLSQNHIMDV----IPSSLSNCTKLKILNLSFNLL------AGEIPRTFGQLSS 150
            +L  L++  N I       +  +L + T L  L +             EI     + ++
Sbjct: 94  -TLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTT 152

Query: 151 LQRLDLSNNHITG 163
           L +          
Sbjct: 153 LLKFGYHFTQQGP 165

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 21/133 (15%), Positives = 46/133 (34%), Gaps = 18/133 (13%)

Query: 98  NSCNSLLHLDLSQ-NHIMD----VIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQL---- 148
           N+   L  ++L+   +I          +L   T +K  ++        +     ++    
Sbjct: 33  NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVN 92

Query: 149 SSLQRLDLSNNHITGWIPSELGNA---CDSLLELKLPHNNITGSFPV------TLSSCSW 199
           ++L+ L++ +N I+G     L  A     SL+EL++ + +      V       L   + 
Sbjct: 93  NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTT 152

Query: 200 LQLLDLSNNNISG 212
           L            
Sbjct: 153 LLKFGYHFTQQGP 165

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 43.4 bits (103), Expect = 9e-05
 Identities = 19/144 (13%), Positives = 46/144 (31%), Gaps = 21/144 (14%)

Query: 113 IMDVIPSSLSNCTKLKILNLS-FNLLAGEIPRTFGQL----SSLQRLDLSNNHITGWIPS 167
           + + +    +N   L+ +NL+    +     +   +     + +++  +        +  
Sbjct: 24  VEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF 83

Query: 168 ELGNAC---DSLLELKLPHNNITGSFPVTLSSC----SWLQLLDLSNNNISGPFPDSVLE 220
            L       ++L  L +  N I+GS  + L       + L  L + N   S P  ++V  
Sbjct: 84  ALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQ--SQPLGNNVEM 141

Query: 221 NLG-------SLESLILSNNMISG 237
            +        +L            
Sbjct: 142 EIANMLEKNTTLLKFGYHFTQQGP 165

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 14/102 (13%)

Query: 51  LVYLNASYNNLTGF----LPETLLSNSDKLELLDLSYNNLTG----SISGFSLNENSCNS 102
           +   +             L E L  N+  L+ L++  N ++G    ++   +L  N+   
Sbjct: 67  VKKFSIVGTRSNDPVAFALAEMLKVNN-TLKSLNVESNFISGSGILALVE-ALQSNTSLI 124

Query: 103 LLHLDLSQNHIMDV----IPSSLSNCTKLKILNLSFNLLAGE 140
            L +D     + +     I + L   T L      F      
Sbjct: 125 ELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGPR 166

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Length = 401

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 36/276 (13%), Positives = 83/276 (30%), Gaps = 65/276 (23%)

Query: 116 VIPSSL--------SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPS 167
           V PS+L          C  LK  +LS   +  ++P +    + ++ + L    +      
Sbjct: 163 VFPSTLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LK----- 215

Query: 168 ELGNA----CDSLLELKLPHNNIT----GSFPVTLSSCSWLQLLDLSNNNISGPFPDSVL 219
           E+G+        L  +++P  N++     +F         +  + L N   +        
Sbjct: 216 EIGSQAFLKTSQLKTIEIP-ENVSTIGQEAF----RESG-ITTVKLPNGVTN--IASRAF 267

Query: 220 ENLGSLESLILSNNMISGSFPDSI-----SSCKTLRIVDFSSNRVSGIIPPDICPGVSSL 274
                L  +    +  +      I       C  L   +   + +  I+   +  G   +
Sbjct: 268 YYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPES-IR-ILGQGLLGGNRKV 325

Query: 275 EELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEG 334
            +L +P N+    I       T +K +      + G+ P ++ +         W+     
Sbjct: 326 TQLTIPANVTQ--INFSAFNNTGIKEV-----KVEGTTPPQVFE-------KVWYGF--- 368

Query: 335 KIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNL 370
                     ++  + +     S E         + 
Sbjct: 369 --------PDDITVIRVPAE--SVEKYKNANGWRDF 394

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 24/142 (16%), Positives = 45/142 (31%), Gaps = 21/142 (14%)

Query: 91  SGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSS 150
           +           +  +D + + IM +    +     ++ + L               +  
Sbjct: 51  NHLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC----------HYIE- 99

Query: 151 LQRLDLSNNHITGWIPSELGNACDSLLELKLPHN-NITGSFPVTLSSCSWLQLLDLSNNN 209
               D     +     S+L N   S+LE+++    N+T    + L     L+ L LS+  
Sbjct: 100 ----DGCLERL-----SQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150

Query: 210 ISGPFPDSVLENLGSLESLILS 231
                   V     SL SL L 
Sbjct: 151 GVKEKEKIVQAFKTSLPSLELK 172

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 6/85 (7%)

Query: 345 NLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNN 402
           + + L LNNN+++ ++   +F    NL+ +    N+LT  IP   F +LT+L  L L +N
Sbjct: 34  DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91

Query: 403 RFKGEIP-GELGNCSSLVWLDLNSN 426
             K  IP G   N  SL  + L +N
Sbjct: 92  HLKS-IPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 6/85 (7%)

Query: 509 TLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLRNLGVFDASHN 566
             + L L+ NQ   K+   + D ++ LQ L    N+L+  IP+ +  +L  L   D + N
Sbjct: 34  DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91

Query: 567 RLQGQIPE-SFSNLSFLVQIDLSNN 590
            L+  IP  +F NL  L  I L NN
Sbjct: 92  HLKS-IPRGAFDNLKSLTHIYLYNN 115

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 6/85 (7%)

Query: 345 NLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNN 402
             + L L +N+++ ++   +F   + L  + L  N+LT  +P   F +LT+L  L L +N
Sbjct: 31  TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88

Query: 403 RFKGEIP-GELGNCSSLVWLDLNSN 426
           + K  IP G   N  SL  + L +N
Sbjct: 89  QLKS-IPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 6/85 (7%)

Query: 509 TLEYLDLSYNQFRGKIPDEIGD-MIALQVLELAHNQLSGEIPSSL-GRLRNLGVFDASHN 566
           T + L L  NQ   K+   + D +  L  L+L +NQL+  +P+ +  +L  L     + N
Sbjct: 31  TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88

Query: 567 RLQGQIPE-SFSNLSFLVQIDLSNN 590
           +L+  IP  +F NL  L  I L NN
Sbjct: 89  QLKS-IPRGAFDNLKSLTHIWLLNN 112

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	1013
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.94
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.94
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.94
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.9
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.9
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.89
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.89
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.87
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.86
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.86
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.86
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.85
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.85
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.84
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.84
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.79
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.77
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.76
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.75
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.75
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.75
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.75
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.75
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.74
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.73
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.69
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.69
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.68
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.67
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.62
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.6
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.58
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.58
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.57
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.54
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.53
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.51
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.5
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.5
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.46
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.41
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.38
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.38
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.36
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.34
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.33
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.3
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.27
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.17
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.13
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.13
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.1
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.05
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.85
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.81
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.79
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.79
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.48
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.44
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.38
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.38
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.37
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.35
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.32
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.28
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.1
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.09
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.89
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.87
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.85
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.81
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.72
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.68
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.55
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.55
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.38
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.37
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.28
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.06
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.01
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.0
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.92
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.61
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.51
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.36
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.32
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.24
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.44
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.86
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	91.54
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.33
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.48

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=6.7e-77  Score=736.99  Aligned_cols=621  Identities=43%  Similarity=0.713  Sum_probs=518.7

Q ss_pred             CcceecccCCcccccccc--cccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhh--hhCCCCc
Q 036815            1 MLSVLKLSSNLFTLNSTS--LLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETL--LSNSDKL   76 (1013)
Q Consensus         1 ~l~~L~l~~n~~~~~~~~--~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~--~~~l~~L   76 (1013)
                      .|++|||++|.++...+.  .+...++|++|+|++|.+.+.+|...+.++++|++|+|++|.+++..+..+  +.++++|
T Consensus       101 ~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L  180 (768)
T 3rgz_A          101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL  180 (768)
T ss_dssp             TCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTC
T ss_pred             CCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCC
Confidence            478899999998854333  566677899999999988777777666788888888888888876655442  5566666


Q ss_pred             cEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccC---------
Q 036815           77 ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQ---------  147 (1013)
Q Consensus        77 ~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~---------  147 (1013)
                      ++|+|++|++++....     ..+++|++|+|++|.+++.+|. +.++++|++|++++|++++..|..|..         
T Consensus       181 ~~L~Ls~n~l~~~~~~-----~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L  254 (768)
T 3rgz_A          181 KHLAISGNKISGDVDV-----SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI  254 (768)
T ss_dssp             CEEECCSSEEESCCBC-----TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEEC
T ss_pred             CEEECCCCcccccCCc-----ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEEC
Confidence            6666666666532221     2345555555555555544443 555555555555555555444444444         


Q ss_pred             -------------CCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 036815          148 -------------LSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPF  214 (1013)
Q Consensus       148 -------------l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  214 (1013)
                                   +++|++|++++|.+++.+|..++..+++|++|+|++|++++..|..+..+++|++|++++|++++.+
T Consensus       255 s~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~i  334 (768)
T 3rgz_A          255 SSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL  334 (768)
T ss_dssp             CSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred             CCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcC
Confidence                         4555555555555556677777776788999999999998888889999999999999999998888


Q ss_pred             ChhhhhcCCCCcEEEcccccCCCcCCcCCCCCC-CcCEEEecCCeecccCCCCCCCC-CCCCceEEcCCCcccccCCccc
Q 036815          215 PDSVLENLGSLESLILSNNMISGSFPDSISSCK-TLRIVDFSSNRVSGIIPPDICPG-VSSLEELRLPDNLITGVIPGQL  292 (1013)
Q Consensus       215 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~  292 (1013)
                      |...+..+++|++|++++|++++.+|..+..++ +|+.|++++|++++.++..++.. +++|++|++++|.+++.+|..+
T Consensus       335 p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l  414 (768)
T 3rgz_A          335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL  414 (768)
T ss_dssp             CHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGG
T ss_pred             CHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHH
Confidence            888788899999999999999888898888887 99999999999998877776542 7789999999999999999999


Q ss_pred             cccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCe
Q 036815          293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEW  372 (1013)
Q Consensus       293 ~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  372 (1013)
                      +++++|++|++++|++++.+|..++++++|+.|++++|.+.+.+|..++.+++|++|++++|++++.+|..+..+++|++
T Consensus       415 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  494 (768)
T 3rgz_A          415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW  494 (768)
T ss_dssp             GGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred             hcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCC
Q 036815          373 ISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSN  452 (1013)
Q Consensus       373 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~  452 (1013)
                      |+|++|++++.+|.+++.+++|+.|+|++|+++|.+|..++++++|++||+++|+++|.+|.+++........ .+....
T Consensus       495 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~-~~~~~~  573 (768)
T 3rgz_A          495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAA-NFIAGK  573 (768)
T ss_dssp             EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCC-STTCSC
T ss_pred             EEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhh-hccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999998876554432 223334


Q ss_pred             ceEEEeccCC--CccCCCcccccccCCcccccccCccccccccc-cccCcccccccCCCccCEEEccCCcccccCChhhh
Q 036815          453 TLVFVRNVGN--SCKGVGGLLEFAGIRPERLLQIPTLKSCDFAR-MYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIG  529 (1013)
Q Consensus       453 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~  529 (1013)
                      .+.+..+.+.  .|...+..+++.++.+..+..++.+..+++.. ...|.+|..+..+++|++||||+|+++|.+|.+|+
T Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~  653 (768)
T 3rgz_A          574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG  653 (768)
T ss_dssp             EEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGG
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHh
Confidence            4555554432  34444455677788888888888887777774 56788899999999999999999999999999999


Q ss_pred             CCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCCCCCCCCCCccc
Q 036815          530 DMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQ  609 (1013)
Q Consensus       530 ~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~~~~~~~~  609 (1013)
                      .+++|++|+|++|+++|.||.+|+++++|+.||||+|+++|.||..++.++.|+.||||+|+|+|.||..+++.+++..+
T Consensus       654 ~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~  733 (768)
T 3rgz_A          654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAK  733 (768)
T ss_dssp             GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGG
T ss_pred             ccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCC
Q 036815          610 YANNPGLCGVPLPECRNGN  628 (1013)
Q Consensus       610 ~~~n~~lc~~~~~~~~~~~  628 (1013)
                      |.|||+|||.|+++|....
T Consensus       734 ~~gN~~Lcg~~l~~C~~~~  752 (768)
T 3rgz_A          734 FLNNPGLCGYPLPRCDPSN  752 (768)
T ss_dssp             GCSCTEEESTTSCCCCSCC
T ss_pred             hcCCchhcCCCCcCCCCCc
Confidence            9999999999999997543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=9.1e-67  Score=646.26  Aligned_cols=580  Identities=33%  Similarity=0.472  Sum_probs=408.6

Q ss_pred             CcceecccCCcccc----cccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCch-hhhhCCCC
Q 036815            1 MLSVLKLSSNLFTL----NSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPE-TLLSNSDK   75 (1013)
Q Consensus         1 ~l~~L~l~~n~~~~----~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~~l~~   75 (1013)
                      +++.|||+++.++.    +++.+ .....|+.++++.+++.. +|. .|..+++|++|+|++|.+++.+|. ..+..+++
T Consensus        51 ~v~~L~L~~~~l~g~~~~l~~~l-~~L~~L~~l~~~~~~~~~-l~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~  127 (768)
T 3rgz_A           51 KVTSIDLSSKPLNVGFSAVSSSL-LSLTGLESLFLSNSHING-SVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSG  127 (768)
T ss_dssp             EEEEEECTTSCCCEEHHHHHHHT-TTCTTCCEEECTTSCEEE-CCC-CCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTT
T ss_pred             cEEEEECCCCCcCCccCccChhH-hccCcccccCCcCCCcCC-Cch-hhccCCCCCEEECCCCcCCCcCCChHHHhCCCC
Confidence            36778888888775    44433 333567777777776643 333 367777777777777777765554 13567777


Q ss_pred             ccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCcc---ccCCCCCCEEecCCCcccccCcccccCCCCCC
Q 036815           76 LELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS---LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQ  152 (1013)
Q Consensus        76 L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~---l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  152 (1013)
                      |++|+|++|.+++.....  ....+++|++|||++|.+++..+..   +.++++|++|++++|++++..+  +..+++|+
T Consensus       128 L~~L~Ls~n~l~~~~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~  203 (768)
T 3rgz_A          128 LKFLNVSSNTLDFPGKVS--GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLE  203 (768)
T ss_dssp             CCEEECCSSEEECCSSCC--SCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCC
T ss_pred             CCEEECcCCccCCcCCHH--HhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCC
Confidence            777777777776433221  1134667777777777777766655   6777777777777777765544  36677777


Q ss_pred             EeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEccc
Q 036815          153 RLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN  232 (1013)
Q Consensus       153 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~  232 (1013)
                      +|++++|.+++.+|.  +..+++|++|+|++|++++..|..+..+++|++|++++|.+++.+|..   .+++|++|++++
T Consensus       204 ~L~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~  278 (768)
T 3rgz_A          204 FLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAE  278 (768)
T ss_dssp             EEECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCS
T ss_pred             EEECcCCcCCCCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcC
Confidence            777777777755554  344577777777777777777777777777777777777776655542   566777777777


Q ss_pred             ccCCCcCCcCCCCC-CCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCcc-ccccCcccEEEeeCCccCC
Q 036815          233 NMISGSFPDSISSC-KTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQ-LSECTQLKVIDLSLNYLNG  310 (1013)
Q Consensus       233 n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~ls~N~l~~  310 (1013)
                      |++++.+|..+... ++|++|++++|.+++.+|.. +..+++|++|++++|.+++.+|.. +..+++|++|++++|++++
T Consensus       279 n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~  357 (768)
T 3rgz_A          279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF-FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG  357 (768)
T ss_dssp             SEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG-GGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEE
T ss_pred             CccCCccCHHHHhhcCcCCEEECcCCcCCCccchH-HhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCc
Confidence            77776666666654 77777777777776554433 355677777777777776666644 6677777777777777776


Q ss_pred             CCCcccccCc-chHHHHhhhccccCCCCcCcCC--CCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChh
Q 036815          311 SIPQELGKLE-HLEQFIAWFNGLEGKIPPELGK--CKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE  387 (1013)
Q Consensus       311 ~~p~~l~~l~-~L~~L~l~~n~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  387 (1013)
                      .+|..+.++. +|+.|++++|.+++.+|..+..  +++|++|++++|++++.+|..+..+++|++|+|++|++++.+|..
T Consensus       358 ~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  437 (768)
T 3rgz_A          358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS  437 (768)
T ss_dssp             CCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGG
T ss_pred             cccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHH
Confidence            7777777666 6777777777777666666665  666777777777777677777777777777777777777777777


Q ss_pred             hhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCC
Q 036815          388 FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGV  467 (1013)
Q Consensus       388 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (1013)
                      ++.+++|+.|++++|++++.+|..+..+++|++|++++|+++|.+|..++....+..+            .-.++.    
T Consensus       438 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L------------~L~~N~----  501 (768)
T 3rgz_A          438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI------------SLSNNR----  501 (768)
T ss_dssp             GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE------------ECCSSC----
T ss_pred             HhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEE------------EccCCc----
Confidence            7777777777777777777777777777777777777777777777666554332211            111111    


Q ss_pred             CcccccccCCcccccccCccccccccccc-cCcccccccCCCccCEEEccCCcccccCChhh------------------
Q 036815          468 GGLLEFAGIRPERLLQIPTLKSCDFARMY-SGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEI------------------  528 (1013)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i------------------  528 (1013)
                           +.+..|..+..++.|+.++++++. .+.+|..+..+++|++||+++|+++|.+|.++                  
T Consensus       502 -----l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~  576 (768)
T 3rgz_A          502 -----LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV  576 (768)
T ss_dssp             -----CCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEE
T ss_pred             -----cCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccc
Confidence                 122334555666677777776653 34667777777777777777777777777654                  


Q ss_pred             ----------------------------------------------------hCCCCCcEEecCCCccCCCCcccccCCC
Q 036815          529 ----------------------------------------------------GDMIALQVLELAHNQLSGEIPSSLGRLR  556 (1013)
Q Consensus       529 ----------------------------------------------------~~l~~L~~L~L~~n~l~g~ip~~~~~l~  556 (1013)
                                                                          +.+.+|++|+|++|+++|.||.+|++++
T Consensus       577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~  656 (768)
T 3rgz_A          577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP  656 (768)
T ss_dssp             EEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCT
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccc
Confidence                                                                4467899999999999999999999999


Q ss_pred             CcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCC-CCCCCCCCcccccCCC
Q 036815          557 NLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQ-RGQLSTLPASQYANNP  614 (1013)
Q Consensus       557 ~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~  614 (1013)
                      +|+.|+||+|+++|.||..+++++.|+.||||+|+++|.+|. ...+..+..+.+.+|+
T Consensus       657 ~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~  715 (768)
T 3rgz_A          657 YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN  715 (768)
T ss_dssp             TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred             cCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence            999999999999999999999999999999999999999996 4677788888888885

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.1e-56  Score=551.52  Aligned_cols=590  Identities=24%  Similarity=0.254  Sum_probs=476.1

Q ss_pred             ceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCC
Q 036815            3 SVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS   82 (1013)
Q Consensus         3 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls   82 (1013)
                      +.+|+++++++.+|..   .++++++|+|++|++.+ ++...|.++++|++|+|++|.+++ ++...+..+++|++|+|+
T Consensus         7 ~~~~cs~~~L~~ip~~---~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~   81 (680)
T 1ziw_A            7 EVADCSHLKLTQVPDD---LPTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISK-LEPELCQKLPMLKVLNLQ   81 (680)
T ss_dssp             SEEECCSSCCSSCCSC---SCTTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCC-CCTTHHHHCTTCCEEECC
T ss_pred             CeeECCCCCccccccc---cCCCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCc-cCHHHHhcccCcCEEECC
Confidence            4689999999999976   56889999999999977 677789999999999999999985 444567899999999999


Q ss_pred             CCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCccc
Q 036815           83 YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT  162 (1013)
Q Consensus        83 ~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  162 (1013)
                      +|+++..+...   ...+++|++|+|++|.++++.+..|.++++|++|++++|.+++..+..+.++++|++|++++|.++
T Consensus        82 ~n~l~~l~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  158 (680)
T 1ziw_A           82 HNELSQLSDKT---FAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ  158 (680)
T ss_dssp             SSCCCCCCTTT---TTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC
T ss_pred             CCccCccChhh---hccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc
Confidence            99999665532   246889999999999999988899999999999999999999998999999999999999999999


Q ss_pred             CcCCccch-hccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhh--hcCCCCcEEEcccccCCCcC
Q 036815          163 GWIPSELG-NACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVL--ENLGSLESLILSNNMISGSF  239 (1013)
Q Consensus       163 ~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~--~~l~~L~~L~L~~n~l~~~~  239 (1013)
                      +..+..+. ..+++|++|++++|++++..+..+..+.+|+.|++++|.+.+.....+.  -..++|++|++++|.+++..
T Consensus       159 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~  238 (680)
T 1ziw_A          159 ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS  238 (680)
T ss_dssp             CBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEEC
T ss_pred             ccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccC
Confidence            54443332 1347899999999999999999999999999999988877532211111  12478999999999998888


Q ss_pred             CcCCCCCCC--cCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCC-----CC
Q 036815          240 PDSISSCKT--LRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG-----SI  312 (1013)
Q Consensus       240 ~~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~-----~~  312 (1013)
                      +..+..++.  |+.|++++|++++. ++..+..+++|++|++++|.+++..|..+..+++|+.|++++|...+     .+
T Consensus       239 ~~~~~~l~~~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~l  317 (680)
T 1ziw_A          239 NTTFLGLKWTNLTMLDLSYNNLNVV-GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL  317 (680)
T ss_dssp             TTTTGGGGGSCCCEEECTTSCCCEE-CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------C
T ss_pred             hhHhhccCcCCCCEEECCCCCcCcc-CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccc
Confidence            888887754  99999999988844 44556778899999999999988888889999999999998876554     23


Q ss_pred             Cc----ccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccccc-C-chhhcC--CCCCCeEEecCCccCCCC
Q 036815          313 PQ----ELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE-I-PAELFS--CSNLEWISLTGNELTGQI  384 (1013)
Q Consensus       313 p~----~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~-p~~l~~--l~~L~~L~L~~N~l~~~~  384 (1013)
                      |.    .+..+++|+.|++++|.+.+..+..|..+++|++|++++|.+... + +..+..  .++|+.|++++|++++..
T Consensus       318 p~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~  397 (680)
T 1ziw_A          318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE  397 (680)
T ss_dssp             CEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC
T ss_pred             cccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC
Confidence            33    677888899999999999888888889999999999998876432 2 223333  357899999999998888


Q ss_pred             ChhhhccCCCceEEccCCeeeeecC-CCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCC
Q 036815          385 PPEFSRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS  463 (1013)
Q Consensus       385 p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (1013)
                      |..|..+++|+.|+|++|++++.+| ..+.++++|++|++++|++++..|..+.....+.            .+.-..+.
T Consensus       398 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~------------~L~l~~n~  465 (680)
T 1ziw_A          398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ------------RLMLRRVA  465 (680)
T ss_dssp             TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCC------------EEECTTSC
T ss_pred             hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccc------------cchhcccc
Confidence            8888889999999999999987776 5788889999999999988876666655433222            22222222


Q ss_pred             ccCCCcccccccCCcccccccCccccccccccccCccc-ccccCCCccCEEEccCCcccccC----C----hhhhCCCCC
Q 036815          464 CKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVL-SLFTQYQTLEYLDLSYNQFRGKI----P----DEIGDMIAL  534 (1013)
Q Consensus       464 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~L~~L~ls~N~l~g~i----P----~~i~~l~~L  534 (1013)
                      +..       .+..+..+..++.|+.++++++....++ ..|..+++|++|||++|++++..    |    ..++.+++|
T Consensus       466 l~~-------~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L  538 (680)
T 1ziw_A          466 LKN-------VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL  538 (680)
T ss_dssp             CBC-------TTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTC
T ss_pred             ccc-------cccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCC
Confidence            211       1234556677888899999887665554 56889999999999999998531    2    247999999


Q ss_pred             cEEecCCCccCCCCcc-cccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCCC-C-CCCCCCccccc
Q 036815          535 QVLELAHNQLSGEIPS-SLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQR-G-QLSTLPASQYA  611 (1013)
Q Consensus       535 ~~L~L~~n~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~-~-~~~~~~~~~~~  611 (1013)
                      ++|+|++|+++ .+|. .|+++++|+.|+|++|++++..|..|..++.|+.|+|++|++++.+|.. + .+.++....+.
T Consensus       539 ~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~  617 (680)
T 1ziw_A          539 HILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR  617 (680)
T ss_dssp             CEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECT
T ss_pred             CEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEcc
Confidence            99999999999 6775 6899999999999999999766677899999999999999999987753 2 56788889999


Q ss_pred             CCCCCCCCCC
Q 036815          612 NNPGLCGVPL  621 (1013)
Q Consensus       612 ~n~~lc~~~~  621 (1013)
                      |||..|..+.
T Consensus       618 ~N~~~c~c~~  627 (680)
T 1ziw_A          618 FNPFDCTCES  627 (680)
T ss_dssp             TCCCCBCCCC
T ss_pred             CCCcccCCcc
Confidence            9999998653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=9.5e-56  Score=543.29  Aligned_cols=546  Identities=22%  Similarity=0.243  Sum_probs=444.8

Q ss_pred             CcceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEe
Q 036815            1 MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLD   80 (1013)
Q Consensus         1 ~l~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~   80 (1013)
                      .|+.|+|++|+++.+++..+...++|++|+|++|.+.+ ++...|.++++|++|+|++|.++ .+|...+.++++|++|+
T Consensus        26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~  103 (680)
T 1ziw_A           26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK-LEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELH  103 (680)
T ss_dssp             TCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCC-CCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEE
T ss_pred             CCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCc-cCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEE
Confidence            47899999999999999888888899999999999977 45567899999999999999998 67777789999999999


Q ss_pred             CCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCccccc--CCCCCCEeeCcC
Q 036815           81 LSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFG--QLSSLQRLDLSN  158 (1013)
Q Consensus        81 Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~Ls~  158 (1013)
                      |++|++++.....   ...+++|++|+|++|.+++..+..+.++++|++|++++|++++..+..+.  .+++|++|++++
T Consensus       104 L~~n~l~~~~~~~---~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~  180 (680)
T 1ziw_A          104 LMSNSIQKIKNNP---FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS  180 (680)
T ss_dssp             CCSSCCCCCCSCT---TTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTT
T ss_pred             CCCCccCccChhH---ccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCC
Confidence            9999998665432   24688999999999999999999999999999999999999988777665  568999999999


Q ss_pred             CcccCcCCccchh--------------------------ccCCCcEEECCCCCCCCcCCccccCCCC--CCEEEccCCCC
Q 036815          159 NHITGWIPSELGN--------------------------ACDSLLELKLPHNNITGSFPVTLSSCSW--LQLLDLSNNNI  210 (1013)
Q Consensus       159 n~l~~~~~~~~~~--------------------------~l~~L~~L~L~~n~l~~~~~~~l~~l~~--L~~L~L~~N~l  210 (1013)
                      |.+++..|..+..                          ..++|++|++++|.+++..+..+.+++.  |++|++++|++
T Consensus       181 n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l  260 (680)
T 1ziw_A          181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL  260 (680)
T ss_dssp             CCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCC
T ss_pred             CcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCc
Confidence            9998555543322                          1156788888888888888888887755  99999999988


Q ss_pred             CCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeeccc--------CCCCCCCCCCCCceEEcCCC
Q 036815          211 SGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGI--------IPPDICPGVSSLEELRLPDN  282 (1013)
Q Consensus       211 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--------~~~~~~~~l~~L~~L~L~~n  282 (1013)
                      ++. +...+..+++|++|++++|++++..+..+..+++|+.|++++|...+.        +....+..+++|++|++++|
T Consensus       261 ~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n  339 (680)
T 1ziw_A          261 NVV-GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN  339 (680)
T ss_dssp             CEE-CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSC
T ss_pred             Ccc-CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCC
Confidence            844 444568888999999999999888888888999999999988754432        22235567888999999999


Q ss_pred             cccccCCccccccCcccEEEeeCCccCCC-C-CcccccC--cchHHHHhhhccccCCCCcCcCCCCCCceEECccccccc
Q 036815          283 LITGVIPGQLSECTQLKVIDLSLNYLNGS-I-PQELGKL--EHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG  358 (1013)
Q Consensus       283 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~-~-p~~l~~l--~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  358 (1013)
                      .+++..+..|..+++|++|++++|.+... + +..+..+  +.|+.|++++|.+++..|..|..+++|++|+|++|.+++
T Consensus       340 ~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  419 (680)
T 1ziw_A          340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ  419 (680)
T ss_dssp             CBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEE
T ss_pred             ccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCcc
Confidence            99988888888999999999998876532 1 2233333  578888899999988888889999999999999999887


Q ss_pred             cCc-hhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeee--eecCCCCcCCCCCcEEEccCCcCCcCCCch
Q 036815          359 EIP-AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK--GEIPGELGNCSSLVWLDLNSNNLTGDIPPR  435 (1013)
Q Consensus       359 ~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  435 (1013)
                      .+| ..+..+++|++|++++|++.+..+..|..+++|+.|++++|.++  +.+|..+.++++|++|++++|++++..|..
T Consensus       420 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~  499 (680)
T 1ziw_A          420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM  499 (680)
T ss_dssp             ECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred             ccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhh
Confidence            666 67888899999999999988888888888999999999999887  567888899999999999999888655544


Q ss_pred             hhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccC-----c----ccccccC
Q 036815          436 LGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSG-----P----VLSLFTQ  506 (1013)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-----~----~~~~~~~  506 (1013)
                      +....                                             .|+.++++++...     .    ....+..
T Consensus       500 ~~~l~---------------------------------------------~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~  534 (680)
T 1ziw_A          500 LEGLE---------------------------------------------KLEILDLQHNNLARLWKHANPGGPIYFLKG  534 (680)
T ss_dssp             TTTCT---------------------------------------------TCCEEECCSSCCGGGGSTTSTTSCCCTTTT
T ss_pred             hcccc---------------------------------------------ccCEEeCCCCCccccchhhccCCcchhhcC
Confidence            44322                                             2222222222111     1    1234778


Q ss_pred             CCccCEEEccCCcccccCCh-hhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCccccc-CCCcceE
Q 036815          507 YQTLEYLDLSYNQFRGKIPD-EIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFS-NLSFLVQ  584 (1013)
Q Consensus       507 ~~~L~~L~ls~N~l~g~iP~-~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~l~~  584 (1013)
                      +++|++|||++|+++ .+|. .++.+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..+. .+++|+.
T Consensus       535 l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~  613 (680)
T 1ziw_A          535 LSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE  613 (680)
T ss_dssp             CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSE
T ss_pred             CCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCE
Confidence            899999999999999 6775 589999999999999999965555678999999999999999998888887 7899999


Q ss_pred             EECcCCCCCCcCCC
Q 036815          585 IDLSNNELTGPIPQ  598 (1013)
Q Consensus       585 l~l~~n~l~~~~p~  598 (1013)
                      +++++|++.+..+.
T Consensus       614 l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          614 LDMRFNPFDCTCES  627 (680)
T ss_dssp             EECTTCCCCBCCCC
T ss_pred             EEccCCCcccCCcc
Confidence            99999999987653

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.7e-55  Score=531.95  Aligned_cols=531  Identities=20%  Similarity=0.192  Sum_probs=321.4

Q ss_pred             ceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCC
Q 036815            3 SVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS   82 (1013)
Q Consensus         3 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls   82 (1013)
                      +.+|+++..++.+|..   ++..+++|+|++|.|.+ ++...|.++++|++|+|++|.+++ +++..+.++++|++|+|+
T Consensus        15 ~~~~c~~~~l~~iP~~---l~~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls   89 (606)
T 3t6q_A           15 KTYNCENLGLNEIPGT---LPNSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLT   89 (606)
T ss_dssp             TEEECTTSCCSSCCTT---SCTTCCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECT
T ss_pred             ceEECCCCCcccCcCC---CCCcCcEEEccCCccCc-CChhHhccCccceEEECCCCccce-eChhhccCccccCeeeCC
Confidence            4688999999999976   67789999999999977 556679999999999999999985 444557899999999999


Q ss_pred             CCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCccc
Q 036815           83 YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT  162 (1013)
Q Consensus        83 ~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  162 (1013)
                      +|++++..+..   ...+++|++|+|++|.|+++.+..+.++++|++|++++|++++.....+..+++|++|++++|.++
T Consensus        90 ~n~l~~~~~~~---~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  166 (606)
T 3t6q_A           90 ANPLIFMAETA---LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH  166 (606)
T ss_dssp             TCCCSEECTTT---TSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC
T ss_pred             CCcccccChhh---hcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc
Confidence            99998654432   246889999999999999988888999999999999999999766556667999999999999999


Q ss_pred             CcCCccchhccCCCc--EEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCC---
Q 036815          163 GWIPSELGNACDSLL--ELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG---  237 (1013)
Q Consensus       163 ~~~~~~~~~~l~~L~--~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~---  237 (1013)
                       .++...+..+++|+  +|++++|.+++..+..+.. .+|+.|++++|...    ...+..+.++....+.-+.+.+   
T Consensus       167 -~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~----~~~~~~l~~~~l~~l~~~~~~~~~~  240 (606)
T 3t6q_A          167 -YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNL----LVIFKGLKNSTIQSLWLGTFEDMDD  240 (606)
T ss_dssp             -EECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCH----HHHHHHTTTCEEEEEECCCCTTSCC
T ss_pred             -ccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhH----HHHhhhccccchhheechhhccccc
Confidence             45444455678898  9999999999887776654 68999999988621    1223334433332222221111   


Q ss_pred             --cCCcCCCCCC--CcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCC
Q 036815          238 --SFPDSISSCK--TLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP  313 (1013)
Q Consensus       238 --~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  313 (1013)
                        ..+..+..+.  +|+.|++++|.++ .++...+..+++|++|++++|.++ .+|..+..+++|++|++++|.+++..|
T Consensus       241 ~~i~~~~~~~l~~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~  318 (606)
T 3t6q_A          241 EDISPAVFEGLCEMSVESINLQKHYFF-NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ  318 (606)
T ss_dssp             CCCCGGGGGGGGGSEEEEEECTTCCCS-SCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGG
T ss_pred             cccChhHhchhhcCceeEEEeecCccC-ccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCch
Confidence              1111122221  4555555555554 333344444555555555555555 344445555555555555555554444


Q ss_pred             cccccCcchHHHHhhhccccCCCCc-CcCCCCCCceEECccccccccC--chhhcCCCCCCeEEecCCccCCCCChhhhc
Q 036815          314 QELGKLEHLEQFIAWFNGLEGKIPP-ELGKCKNLKDLILNNNKLSGEI--PAELFSCSNLEWISLTGNELTGQIPPEFSR  390 (1013)
Q Consensus       314 ~~l~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  390 (1013)
                      ..++.+++|+.|++++|.+.+.+|. .+..+++|++|++++|.+++..  |..+..+++|++|++++|++++..|..|..
T Consensus       319 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  398 (606)
T 3t6q_A          319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE  398 (606)
T ss_dssp             GCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTT
T ss_pred             hhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcC
Confidence            4555555555555555555444433 2555555555555555555433  445555555555555555555555555555


Q ss_pred             cCCCceEEccCCeeeeecCCC-CcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCc
Q 036815          391 LTRLAVLQLGNNRFKGEIPGE-LGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGG  469 (1013)
Q Consensus       391 l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  469 (1013)
                      +++|+.|++++|++++..|.. +.++++|++|++++|.+++..|..++..                              
T Consensus       399 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l------------------------------  448 (606)
T 3t6q_A          399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL------------------------------  448 (606)
T ss_dssp             CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTC------------------------------
T ss_pred             CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCC------------------------------
Confidence            555555555555555444333 5555555555555555544333222110                              


Q ss_pred             ccccccCCcccccccCccccccccccccC----cccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccC
Q 036815          470 LLEFAGIRPERLLQIPTLKSCDFARMYSG----PVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLS  545 (1013)
Q Consensus       470 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~  545 (1013)
                                     +.|+.++++++...    ..+..+..+++|++|++++|++++..|..++.+++|++|+|++|+++
T Consensus       449 ---------------~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  513 (606)
T 3t6q_A          449 ---------------PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT  513 (606)
T ss_dssp             ---------------TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             ---------------CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccC
Confidence                           00000000000000    00012233344555555555555555555555555555555555555


Q ss_pred             CCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCc
Q 036815          546 GEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGP  595 (1013)
Q Consensus       546 g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~  595 (1013)
                      +.+|..+.++++| .|+|++|++++.+|..+..+++|+.+++++|++++.
T Consensus       514 ~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  562 (606)
T 3t6q_A          514 SSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT  562 (606)
T ss_dssp             GGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred             cCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence            5555555555555 555555555555555555555555555555555443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.9e-54  Score=522.86  Aligned_cols=530  Identities=19%  Similarity=0.198  Sum_probs=399.6

Q ss_pred             ceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCC
Q 036815            3 SVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS   82 (1013)
Q Consensus         3 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls   82 (1013)
                      +.++++++.++.+|..   .++++++|+|++|++.+ ++...|.++++|++|+|++|.+++ +++..+.++++|++|+|+
T Consensus        14 ~~~~c~~~~l~~ip~~---~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~-i~~~~~~~l~~L~~L~Ls   88 (606)
T 3vq2_A           14 ITYQCMDQKLSKVPDD---IPSSTKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHHLSNLILT   88 (606)
T ss_dssp             TEEECTTSCCSSCCTT---SCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECT
T ss_pred             CceEccCCCcccCCCC---CCCCcCEEECCCCCcCE-eChhhccCCccCcEEeCCCCcccc-cCHHHhhchhhcCEeECC
Confidence            4689999999999986   56889999999999977 566679999999999999999984 545567899999999999


Q ss_pred             CCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccc-cCcccccCCCCCCEeeCcCCcc
Q 036815           83 YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAG-EIPRTFGQLSSLQRLDLSNNHI  161 (1013)
Q Consensus        83 ~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l  161 (1013)
                      +|++++..+..   ...+++|++|+|++|.++++.+..+.++++|++|++++|++++ .+|..|+++++|++|++++|.+
T Consensus        89 ~n~l~~~~p~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l  165 (606)
T 3vq2_A           89 GNPIQSFSPGS---FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI  165 (606)
T ss_dssp             TCCCCCCCTTS---STTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCC
T ss_pred             CCcccccChhh---cCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcc
Confidence            99998764432   2578899999999999999888899999999999999999986 4689999999999999999999


Q ss_pred             cCcCCccchhccCCC----cEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCC
Q 036815          162 TGWIPSELGNACDSL----LELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG  237 (1013)
Q Consensus       162 ~~~~~~~~~~~l~~L----~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  237 (1013)
                      ++..+..+ ..+++|    .+|++++|.+++..+..+... +|++|++++|.+.+......+.++++|+.+++..+.+.+
T Consensus       166 ~~~~~~~~-~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~  243 (606)
T 3vq2_A          166 QTITVNDL-QFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD  243 (606)
T ss_dssp             CEECTTTT-HHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred             eecChhhh-hhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccccc
Confidence            95444444 334544    489999999998777776665 899999999998755555667889999999887655442


Q ss_pred             c------CCcCCCCCC--CcCEEEe-cCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCcc
Q 036815          238 S------FPDSISSCK--TLRIVDF-SSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL  308 (1013)
Q Consensus       238 ~------~~~~~~~l~--~L~~L~L-~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l  308 (1013)
                      .      .+..+..+.  .++.+++ ..|.+.+.++.  +..+++|+.|++++|.+.. +| .+..+++|+.|++++|.+
T Consensus       244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~--~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l  319 (606)
T 3vq2_A          244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK--FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL  319 (606)
T ss_dssp             SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS--CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC
T ss_pred             CCcccccChHHhhhhhhccHhheeccccccccccccc--cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC
Confidence            1      111222222  4566666 66677766655  6678888888888888864 44 778888888888888888


Q ss_pred             CCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccccc--CchhhcCCCCCCeEEecCCccCCCCCh
Q 036815          309 NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE--IPAELFSCSNLEWISLTGNELTGQIPP  386 (1013)
Q Consensus       309 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~  386 (1013)
                       +.+| .+ .+++|+.|++++|...+..  .++.+++|++|++++|++++.  .|..+..+++|++|++++|.++ .+|.
T Consensus       320 -~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~  393 (606)
T 3vq2_A          320 -KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSA  393 (606)
T ss_dssp             -SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECC
T ss_pred             -cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchh
Confidence             4777 44 8888888888888655433  677888888888888888765  3778888888888888888888 4667


Q ss_pred             hhhccCCCceEEccCCeeeeecC-CCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCcc
Q 036815          387 EFSRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCK  465 (1013)
Q Consensus       387 ~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (1013)
                      .+..+++|+.|++++|++.+..| ..+.++++|++|++++|++++..|..+                             
T Consensus       394 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----------------------------  444 (606)
T 3vq2_A          394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF-----------------------------  444 (606)
T ss_dssp             CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTT-----------------------------
T ss_pred             hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhh-----------------------------
Confidence            88888888888888888887776 678888888888888888876655433                             


Q ss_pred             CCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccc-cCChhhhCCCCCcEEecCCCcc
Q 036815          466 GVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRG-KIPDEIGDMIALQVLELAHNQL  544 (1013)
Q Consensus       466 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g-~iP~~i~~l~~L~~L~L~~n~l  544 (1013)
                                                             ..+++|++|++++|++++ .+|..++.+++|++|+|++|++
T Consensus       445 ---------------------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  485 (606)
T 3vq2_A          445 ---------------------------------------LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL  485 (606)
T ss_dssp             ---------------------------------------TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             ---------------------------------------cCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcC
Confidence                                                   223456666666666665 3566666666666666666666


Q ss_pred             CCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCCCCCCC-CCCcccccCCCCCCCCC
Q 036815          545 SGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLS-TLPASQYANNPGLCGVP  620 (1013)
Q Consensus       545 ~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~~-~~~~~~~~~n~~lc~~~  620 (1013)
                      ++.+|..++++++|+.|+|++|++++.+|..+..+++|+.|+|++|+++..++....+. .+....+.|||..|..+
T Consensus       486 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          486 EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             CccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            66566666666666666666666666666666666666666666666664333333333 35555666666666544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-54  Score=536.92  Aligned_cols=526  Identities=22%  Similarity=0.213  Sum_probs=389.4

Q ss_pred             eecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCC
Q 036815            4 VLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSY   83 (1013)
Q Consensus         4 ~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~   83 (1013)
                      ..|.++++++.+|.    .++++++|+|++|.|.+ ++...|.++++|++|+|++|.+.+.++...+.++++|++|+|++
T Consensus         8 ~~dcs~~~L~~vP~----lp~~l~~LdLs~N~i~~-i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~   82 (844)
T 3j0a_A            8 IAFYRFCNLTQVPQ----VLNTTERLLLSFNYIRT-VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS   82 (844)
T ss_dssp             EEEESCCCSSCCCS----SCTTCCEEEEESCCCCE-ECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred             EEEccCCCCCCCCC----CCCCcCEEECCCCcCCc-cChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence            57889999999997    77889999999999977 45566999999999999999766677677789999999999999


Q ss_pred             CcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCcc--ccCCCCCCEEecCCCcccccCc-ccccCCCCCCEeeCcCCc
Q 036815           84 NNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS--LSNCTKLKILNLSFNLLAGEIP-RTFGQLSSLQRLDLSNNH  160 (1013)
Q Consensus        84 n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~--l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~  160 (1013)
                      |++++..+..+   ..+++|++|+|++|.+++..+..  |.++++|++|+|++|.+++..+ ..|+++++|++|++++|.
T Consensus        83 N~l~~~~p~~~---~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~  159 (844)
T 3j0a_A           83 SKIYFLHPDAF---QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ  159 (844)
T ss_dssp             CCCCEECTTSS---CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSC
T ss_pred             CcCcccCHhHc---cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCc
Confidence            99987644333   47889999999999999866554  8999999999999999987655 579999999999999999


Q ss_pred             ccCcCCccchhcc--CCCcEEECCCCCCCCcCCccccCCCC------CCEEEccCCCCCCCCChhhhhcC--CCCcEEEc
Q 036815          161 ITGWIPSELGNAC--DSLLELKLPHNNITGSFPVTLSSCSW------LQLLDLSNNNISGPFPDSVLENL--GSLESLIL  230 (1013)
Q Consensus       161 l~~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~------L~~L~L~~N~l~~~~~~~~~~~l--~~L~~L~L  230 (1013)
                      +++..+..+.. +  ++|+.|+|++|.+.+..+..+..+.+      |++|++++|.+++.++..+...+  .+++.|.+
T Consensus       160 i~~~~~~~l~~-l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l  238 (844)
T 3j0a_A          160 IFLVCEHELEP-LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL  238 (844)
T ss_dssp             CCCCCSGGGHH-HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEEC
T ss_pred             CCeeCHHHccc-ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceec
Confidence            99666665543 3  78999999999999888887777665      99999999999877776654433  56788887


Q ss_pred             ccc---------cCCCcCCcCCCCC--CCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCccc
Q 036815          231 SNN---------MISGSFPDSISSC--KTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLK  299 (1013)
Q Consensus       231 ~~n---------~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  299 (1013)
                      +.+         .+.+.....+..+  ++|+.|++++|.+.+ +++..+..+++|+.|+|++|.+++..+..|..+++|+
T Consensus       239 ~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~  317 (844)
T 3j0a_A          239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ  317 (844)
T ss_dssp             CSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCE-ECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCC
T ss_pred             ccccccccccccccCCCChhhhhccccCCccEEECCCCcccc-cChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCC
Confidence            733         3333333444443  688899999998874 4556667788899999999998888888888889999


Q ss_pred             EEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCc
Q 036815          300 VIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNE  379 (1013)
Q Consensus       300 ~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  379 (1013)
                      +|++++|.+++..|..+..+++|+.|++++|.+.+..+..|..+++|++|+|++|.+++ ++    .+++|+.|++++|+
T Consensus       318 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~~N~  392 (844)
T 3j0a_A          318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLSGNK  392 (844)
T ss_dssp             EEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEESCC
T ss_pred             EEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccCCCC
Confidence            99999999887778888888889999999888887777788888899999999988873 33    37888889999988


Q ss_pred             cCCCCChhhhccCCCceEEccCCeeeeecC-CCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEe
Q 036815          380 LTGQIPPEFSRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVR  458 (1013)
Q Consensus       380 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  458 (1013)
                      ++ .+|..   ...++.|++++|++++... ..+.++++|++|+|++|++++..+....                     
T Consensus       393 l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---------------------  447 (844)
T 3j0a_A          393 LV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP---------------------  447 (844)
T ss_dssp             CC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSS---------------------
T ss_pred             cc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccc---------------------
Confidence            88 55654   4568888888888874311 2245788888888888888754322110                     


Q ss_pred             ccCCCccCCCcccccccCCcccccccCcccccccccccc------CcccccccCCCccCEEEccCCcccccCChhhhCCC
Q 036815          459 NVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYS------GPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI  532 (1013)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~  532 (1013)
                                             ...+.|+.++++++..      +..+..|..+++|++|||++|++++..|..++.++
T Consensus       448 -----------------------~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  504 (844)
T 3j0a_A          448 -----------------------SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT  504 (844)
T ss_dssp             -----------------------CSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCC
T ss_pred             -----------------------ccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchh
Confidence                                   0011122222222111      12233455556666666666666655555566666


Q ss_pred             CCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCC
Q 036815          533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIP  597 (1013)
Q Consensus       533 ~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p  597 (1013)
                      +|+.|+|++|+|++..|..+.  ++|+.|||++|+|+|.+|..+.   .|+.+++++|++.+..+
T Consensus       505 ~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          505 ALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECE  564 (844)
T ss_dssp             SCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSS
T ss_pred             hhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccccc
Confidence            666666666666643333333  5666666666666666665443   45566666666655443

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.2e-53  Score=515.15  Aligned_cols=533  Identities=21%  Similarity=0.222  Sum_probs=434.1

Q ss_pred             CcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccE
Q 036815           26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH  105 (1013)
Q Consensus        26 l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~  105 (1013)
                      -+.++.++.++.. +|..+-   +++++|+|++|.|+ .+++..+.++++|++|+|++|++++..+..+   ..+++|++
T Consensus        14 ~~~~~c~~~~l~~-iP~~l~---~~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~---~~l~~L~~   85 (606)
T 3t6q_A           14 NKTYNCENLGLNE-IPGTLP---NSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTF---QSQHRLDT   85 (606)
T ss_dssp             TTEEECTTSCCSS-CCTTSC---TTCCEEECTTCCCS-EECTTTSTTCTTCSEEECTTCCCCEECTTTT---TTCTTCCE
T ss_pred             CceEECCCCCccc-CcCCCC---CcCcEEEccCCccC-cCChhHhccCccceEEECCCCccceeChhhc---cCccccCe
Confidence            3478888888855 676542   36899999999998 4444567889999999999999886544322   46788999


Q ss_pred             EECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCC
Q 036815          106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNN  185 (1013)
Q Consensus       106 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~  185 (1013)
                      |+|++|.++++.|..|.++++|++|++++|++++..+..|+++++|++|++++|.+++.....+.. +++|++|++++|+
T Consensus        86 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~  164 (606)
T 3t6q_A           86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQNNA  164 (606)
T ss_dssp             EECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCC-CTTCCEEECCSSC
T ss_pred             eeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccC-CcccCEEEcccCc
Confidence            999999998888888999999999999999998777788889999999999999988422233333 7889999999999


Q ss_pred             CCCcCCccccCCCCCC--EEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecc--
Q 036815          186 ITGSFPVTLSSCSWLQ--LLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSG--  261 (1013)
Q Consensus       186 l~~~~~~~l~~l~~L~--~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--  261 (1013)
                      +++..+..+..+++|+  .|++++|.+++..+. .+. ..+|++|++++|..   .+..+..+..+....+..+.+.+  
T Consensus       165 l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~-~~~-~~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~  239 (606)
T 3t6q_A          165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG-AFD-SAVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMD  239 (606)
T ss_dssp             CCEECHHHHHTTTTCCSEEEECTTCCCCEECTT-TTT-TCEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSC
T ss_pred             ccccChhhhhhhcccceeEEecCCCccCccChh-Hhh-hccccccccCCchh---HHHHhhhccccchhheechhhcccc
Confidence            9888888888888888  888999988854443 333 46788999988862   33344444444444443332221  


Q ss_pred             --cCCCCCCCCCC--CCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCC
Q 036815          262 --IIPPDICPGVS--SLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIP  337 (1013)
Q Consensus       262 --~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p  337 (1013)
                        .++...+.++.  +|+.|++++|.+++..+..|..+++|++|++++|.++ .+|..+.++++|+.|++++|.+.+..|
T Consensus       240 ~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~  318 (606)
T 3t6q_A          240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ  318 (606)
T ss_dssp             CCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGG
T ss_pred             ccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCch
Confidence              12223333333  7999999999999988888999999999999999999 899999999999999999999998888


Q ss_pred             cCcCCCCCCceEECccccccccCchh-hcCCCCCCeEEecCCccCCCC--ChhhhccCCCceEEccCCeeeeecCCCCcC
Q 036815          338 PELGKCKNLKDLILNNNKLSGEIPAE-LFSCSNLEWISLTGNELTGQI--PPEFSRLTRLAVLQLGNNRFKGEIPGELGN  414 (1013)
Q Consensus       338 ~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  414 (1013)
                      ..+..+++|++|++++|.+.+.+|.. +..+++|++|++++|.+++..  |..+..+++|+.|++++|++.+..|..+.+
T Consensus       319 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  398 (606)
T 3t6q_A          319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE  398 (606)
T ss_dssp             GCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTT
T ss_pred             hhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcC
Confidence            99999999999999999998777654 889999999999999999665  788999999999999999999999999999


Q ss_pred             CCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccc
Q 036815          415 CSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFAR  494 (1013)
Q Consensus       415 l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  494 (1013)
                      +++|++|++++|++++..|...                                            +..++.|+.+++++
T Consensus       399 l~~L~~L~l~~n~l~~~~~~~~--------------------------------------------~~~l~~L~~L~l~~  434 (606)
T 3t6q_A          399 CPQLELLDLAFTRLKVKDAQSP--------------------------------------------FQNLHLLKVLNLSH  434 (606)
T ss_dssp             CTTCSEEECTTCCEECCTTCCT--------------------------------------------TTTCTTCCEEECTT
T ss_pred             CccCCeEECCCCcCCCcccchh--------------------------------------------hhCcccCCEEECCC
Confidence            9999999999999987665431                                            12234455555555


Q ss_pred             ccc-CcccccccCCCccCEEEccCCcccc---cCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccC
Q 036815          495 MYS-GPVLSLFTQYQTLEYLDLSYNQFRG---KIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQG  570 (1013)
Q Consensus       495 ~~~-~~~~~~~~~~~~L~~L~ls~N~l~g---~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g  570 (1013)
                      +.. +..+..+..+++|++|++++|++++   ..+..++.+++|++|+|++|++++..|..++.+++|+.|+|++|++++
T Consensus       435 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  514 (606)
T 3t6q_A          435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS  514 (606)
T ss_dssp             CCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCG
T ss_pred             CccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCc
Confidence            433 3346778889999999999999987   334679999999999999999998889999999999999999999999


Q ss_pred             CCcccccCCCcceEEECcCCCCCCcCCC-CCCCCCCCcccccCCCCCCC
Q 036815          571 QIPESFSNLSFLVQIDLSNNELTGPIPQ-RGQLSTLPASQYANNPGLCG  618 (1013)
Q Consensus       571 ~~p~~~~~l~~l~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~lc~  618 (1013)
                      .+|..+.+++.| .|+|++|++++.+|. ...+..+....+.|||..|.
T Consensus       515 ~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  562 (606)
T 3t6q_A          515 SSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT  562 (606)
T ss_dssp             GGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred             CChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence            999999999999 999999999998886 35677888899999998874

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=5.7e-53  Score=511.57  Aligned_cols=512  Identities=21%  Similarity=0.213  Sum_probs=441.9

Q ss_pred             CcceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEe
Q 036815            1 MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLD   80 (1013)
Q Consensus         1 ~l~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~   80 (1013)
                      .|+.|+|++|+++.+++..+...++|++|+|++|++.+ ++...|.++++|++|+|++|.+++..| ..+.++++|++|+
T Consensus        33 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-i~~~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~  110 (606)
T 3vq2_A           33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQSFSP-GSFSGLTSLENLV  110 (606)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCCCCT-TSSTTCTTCCEEE
T ss_pred             CcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccc-cCHHHhhchhhcCEeECCCCcccccCh-hhcCCcccCCEEE
Confidence            47899999999999999889888999999999999977 556679999999999999999985444 5578999999999


Q ss_pred             CCCCcccCccCCCCcCCCCCCcccEEECCCCCCCC-CCCccccCCCCCCEEecCCCcccccCcccccCCCCCC----Eee
Q 036815           81 LSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMD-VIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQ----RLD  155 (1013)
Q Consensus        81 Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~  155 (1013)
                      |++|++++.....   ...+++|++|+|++|.+++ .+|..|.++++|++|++++|++++..+..|+.+++|+    +|+
T Consensus       111 L~~n~l~~~~~~~---~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~  187 (606)
T 3vq2_A          111 AVETKLASLESFP---IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD  187 (606)
T ss_dssp             CTTSCCCCSSSSC---CTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEE
T ss_pred             ccCCccccccccc---cCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceee
Confidence            9999998655332   3578899999999999987 4589999999999999999999988888888776665    899


Q ss_pred             CcCCcccCcCCccchhccCCCcEEECCCCCCC-CcCCccccCCCCCCEEEccCCCCCC-----CCChhhhhcCC--CCcE
Q 036815          156 LSNNHITGWIPSELGNACDSLLELKLPHNNIT-GSFPVTLSSCSWLQLLDLSNNNISG-----PFPDSVLENLG--SLES  227 (1013)
Q Consensus       156 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~-----~~~~~~~~~l~--~L~~  227 (1013)
                      +++|.++ .++...+... +|++|++++|.++ +..+..+.++++|+.+++..+.+.+     .++...+..+.  .++.
T Consensus       188 l~~n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~  265 (606)
T 3vq2_A          188 MSLNPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE  265 (606)
T ss_dssp             CTTCCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEE
T ss_pred             ccCCCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhh
Confidence            9999999 6777777654 8999999999987 4567788999999999987665432     13333333333  3667


Q ss_pred             EEc-ccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCC
Q 036815          228 LIL-SNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLN  306 (1013)
Q Consensus       228 L~L-~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N  306 (1013)
                      +++ ..|.+.+..|. +..+++|+.|++++|.+. .++  .+..+++|+.|++++|.+ +.+| .+ .+++|+.|++++|
T Consensus       266 l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~--~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n  338 (606)
T 3vq2_A          266 FRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE--DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMN  338 (606)
T ss_dssp             EEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC--CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESC
T ss_pred             eeccccccccccccc-cccCCCCCEEEecCccch-hhh--hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCC
Confidence            777 67788877776 899999999999999997 455  556789999999999999 5677 45 9999999999999


Q ss_pred             ccCCCCCcccccCcchHHHHhhhccccCC--CCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCC
Q 036815          307 YLNGSIPQELGKLEHLEQFIAWFNGLEGK--IPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQI  384 (1013)
Q Consensus       307 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  384 (1013)
                      +..+.+  .+..+++|+.|++++|.+++.  .|..+..+++|++|++++|.++ .+|..+..+++|++|++++|++.+..
T Consensus       339 ~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~  415 (606)
T 3vq2_A          339 KGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVT  415 (606)
T ss_dssp             SSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTT
T ss_pred             cCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCcc
Confidence            765444  677999999999999999866  4889999999999999999998 57789999999999999999999887


Q ss_pred             C-hhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcC-CCchhhhccCCCCCCCcccCCceEEEeccCC
Q 036815          385 P-PEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGD-IPPRLGRQLGAKPLGGFLSSNTLVFVRNVGN  462 (1013)
Q Consensus       385 p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (1013)
                      | ..+..+++|+.|++++|++++..|..+.++++|++|++++|++++. +|.                            
T Consensus       416 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~----------------------------  467 (606)
T 3vq2_A          416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN----------------------------  467 (606)
T ss_dssp             TTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECS----------------------------
T ss_pred             ChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHH----------------------------
Confidence            7 6899999999999999999999999999999999999999998763 332                            


Q ss_pred             CccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCC
Q 036815          463 SCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHN  542 (1013)
Q Consensus       463 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n  542 (1013)
                                                              .+..+++|++|+|++|++++.+|..++.+++|++|+|++|
T Consensus       468 ----------------------------------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N  507 (606)
T 3vq2_A          468 ----------------------------------------VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN  507 (606)
T ss_dssp             ----------------------------------------CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             ----------------------------------------hhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCC
Confidence                                                    2445678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccCCCCcceEecCCccccCCCcccccCCC-cceEEECcCCCCCCcCCC
Q 036815          543 QLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLS-FLVQIDLSNNELTGPIPQ  598 (1013)
Q Consensus       543 ~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-~l~~l~l~~n~l~~~~p~  598 (1013)
                      ++++.+|..++++++|+.|+|++|+++ .+|..+..++ +|+.|++++|++.+..|.
T Consensus       508 ~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          508 NLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             CCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             cCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            999888999999999999999999999 7999899997 599999999999987663

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=9.8e-52  Score=517.02  Aligned_cols=515  Identities=22%  Similarity=0.242  Sum_probs=421.6

Q ss_pred             CcceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEe
Q 036815            1 MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLD   80 (1013)
Q Consensus         1 ~l~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~   80 (1013)
                      .|+.|||++|+++.+.+..+...++|++|+|++|...+.++...|.++++|++|+|++|.+++..| ..+.++++|++|+
T Consensus        25 ~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~  103 (844)
T 3j0a_A           25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP-DAFQGLFHLFELR  103 (844)
T ss_dssp             TCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT-TSSCSCSSCCCEE
T ss_pred             CcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH-hHccCCcccCEee
Confidence            478999999999999888899999999999999977677877889999999999999999985444 5578999999999


Q ss_pred             CCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCC-ccccCCCCCCEEecCCCcccccCcccccCC--CCCCEeeCc
Q 036815           81 LSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIP-SSLSNCTKLKILNLSFNLLAGEIPRTFGQL--SSLQRLDLS  157 (1013)
Q Consensus        81 Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls  157 (1013)
                      |++|.+++.... ......+++|++|+|++|.+++..+ ..|.++++|++|+|++|.+++..+..+..+  ++|+.|+++
T Consensus       104 Ls~n~l~~~~~~-~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~  182 (844)
T 3j0a_A          104 LYFCGLSDAVLK-DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA  182 (844)
T ss_dssp             CTTCCCSSCCST-TCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred             CcCCCCCccccc-CccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence            999999863222 1113578999999999999998765 579999999999999999999889999887  899999999


Q ss_pred             CCcccCcCCccchhccC------CCcEEECCCCCCCCcCCccccCC---CCCCEEEccCCCCCC--------CCChhhhh
Q 036815          158 NNHITGWIPSELGNACD------SLLELKLPHNNITGSFPVTLSSC---SWLQLLDLSNNNISG--------PFPDSVLE  220 (1013)
Q Consensus       158 ~n~l~~~~~~~~~~~l~------~L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~L~~N~l~~--------~~~~~~~~  220 (1013)
                      +|.+.+..|..+.. ++      +|++|++++|.+++..+..+...   .+++.|.++.+.+..        ......+.
T Consensus       183 ~n~l~~~~~~~~~~-~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~  261 (844)
T 3j0a_A          183 ANSLYSRVSVDWGK-CMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA  261 (844)
T ss_dssp             CSBSCCCCCCCCCS-SSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTT
T ss_pred             CCccccccccchhh-cCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhh
Confidence            99999777765443 23      49999999999998877766543   678888887443221        11222334


Q ss_pred             cC--CCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcc
Q 036815          221 NL--GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQL  298 (1013)
Q Consensus       221 ~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  298 (1013)
                      ++  ++|++|++++|.+.+..+..+..+++|+.|++++|++++. ++..+.++++|+.|+|++|.+++..+..+..+++|
T Consensus       262 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  340 (844)
T 3j0a_A          262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKI-ADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV  340 (844)
T ss_dssp             TTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEE-CTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTC
T ss_pred             ccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCC-ChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCC
Confidence            43  6899999999999988889999999999999999999854 45566789999999999999998889999999999


Q ss_pred             cEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCC
Q 036815          299 KVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGN  378 (1013)
Q Consensus       299 ~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  378 (1013)
                      +.|++++|.+.+..+..|..+++|+.|++++|.+++     +..+++|+.|++++|+++ .+|..   ..+++.|++++|
T Consensus       341 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-----i~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N  411 (844)
T 3j0a_A          341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSEN  411 (844)
T ss_dssp             CEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-----CSSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSC
T ss_pred             CEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-----ccCCCCcchhccCCCCcc-ccccc---ccccceeecccC
Confidence            999999999998778889999999999999999973     334889999999999998 56654   468999999999


Q ss_pred             ccCCCC-ChhhhccCCCceEEccCCeeeeecCC-CCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEE
Q 036815          379 ELTGQI-PPEFSRLTRLAVLQLGNNRFKGEIPG-ELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVF  456 (1013)
Q Consensus       379 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~  456 (1013)
                      ++++.. +..+..+++|+.|+|++|++++..+. .+..+++|++|+|++|.+++..+...                    
T Consensus       412 ~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~--------------------  471 (844)
T 3j0a_A          412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL--------------------  471 (844)
T ss_dssp             CCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCC--------------------
T ss_pred             ccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccccccccc--------------------
Confidence            999642 33466899999999999999865443 35678999999999999975432111                    


Q ss_pred             EeccCCCccCCCcccccccCCcccccccCccccccccccccCcc-cccccCCCccCEEEccCCcccccCChhhhCCCCCc
Q 036815          457 VRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPV-LSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQ  535 (1013)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~  535 (1013)
                                          .+..+..++.|+.++++++....+ +..|..+++|+.|||++|+|++..|..+.  ++|+
T Consensus       472 --------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~  529 (844)
T 3j0a_A          472 --------------------CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLE  529 (844)
T ss_dssp             --------------------CSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCC
T ss_pred             --------------------chhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cccc
Confidence                                112234556777778877654444 56688999999999999999975555555  8999


Q ss_pred             EEecCCCccCCCCcccccCCCCcceEecCCccccCCCc
Q 036815          536 VLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIP  573 (1013)
Q Consensus       536 ~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p  573 (1013)
                      +|+|++|+|+|.+|..+   .+|+.|++++|.+.+..+
T Consensus       530 ~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          530 ILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECE  564 (844)
T ss_dssp             EEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSS
T ss_pred             EEECCCCcCCCCChhHh---CCcCEEEecCCCcccccc
Confidence            99999999999999775   478999999999987554

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-49  Score=476.89  Aligned_cols=510  Identities=21%  Similarity=0.229  Sum_probs=413.4

Q ss_pred             ceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCC
Q 036815            3 SVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS   82 (1013)
Q Consensus         3 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls   82 (1013)
                      +..+.++.+++.+|..   .++++++|+|++|++.+ ++...|.++++|++|+|++|.++ .++...+.++++|++|+|+
T Consensus        10 ~~~~c~~~~l~~ip~~---l~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~   84 (570)
T 2z63_A           10 ITYQCMELNFYKIPDN---LPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT   84 (570)
T ss_dssp             TEEECCSSCCSSCCSS---SCSSCCEEECCSCCCCE-ECTTTTTTCSSCCEEECTTCCCC-EECTTTTTTCTTCCEEECT
T ss_pred             cEEEeCCCCccccCCC---ccccccEEEccCCccCc-cChhHhhCCCCceEEECCCCcCC-ccCcccccCchhCCEEeCc
Confidence            3578888999999985   67789999999999976 56667999999999999999998 4566678899999999999


Q ss_pred             CCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCccccc-CcccccCCCCCCEeeCcCCcc
Q 036815           83 YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGE-IPRTFGQLSSLQRLDLSNNHI  161 (1013)
Q Consensus        83 ~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l  161 (1013)
                      +|+++......+   ..+++|++|++++|+++++.+..+.++++|++|++++|.+++. .|..|+++++|++|++++|.+
T Consensus        85 ~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l  161 (570)
T 2z63_A           85 GNPIQSLALGAF---SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI  161 (570)
T ss_dssp             TCCCCEECTTTT---TTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred             CCcCCccCHhhh---cCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcc
Confidence            999986654322   4688999999999999998777899999999999999999874 689999999999999999999


Q ss_pred             cCcCCccchhccCCC----cEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCC-
Q 036815          162 TGWIPSELGNACDSL----LELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS-  236 (1013)
Q Consensus       162 ~~~~~~~~~~~l~~L----~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~-  236 (1013)
                      ++ ++...+..+++|    ++|++++|.+++..+..+..+ +|+.|++++|..........+..+++++.+.+..+.+. 
T Consensus       162 ~~-~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~  239 (570)
T 2z63_A          162 QS-IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN  239 (570)
T ss_dssp             CE-ECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC
T ss_pred             ce-ecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccC
Confidence            94 444444556788    899999999998888888766 89999999996553333345677888887766544332 


Q ss_pred             -----CcCCcCCCCCC--CcCEEEecCC-eecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCcc
Q 036815          237 -----GSFPDSISSCK--TLRIVDFSSN-RVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL  308 (1013)
Q Consensus       237 -----~~~~~~~~~l~--~L~~L~L~~N-~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l  308 (1013)
                           ......+..++  .++.+++++| .+.+..+ ..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+
T Consensus       240 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~-~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~  316 (570)
T 2z63_A          240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII-DLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKF  316 (570)
T ss_dssp             CSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCST-TTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBC
T ss_pred             chhhhhcchhhhccccccchhhhhhhcchhhhhhch-hhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcc
Confidence                 11222333333  3567777777 6664443 44566788888888888888 467777777 888888888888


Q ss_pred             CCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccC--chhhcCCCCCCeEEecCCccCCCCCh
Q 036815          309 NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI--PAELFSCSNLEWISLTGNELTGQIPP  386 (1013)
Q Consensus       309 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~  386 (1013)
                      . .+|.  ..+++|+.|++.+|.+.+..+.  ..+++|++|++++|++++..  |..+..+++|++|++++|.+++ +|.
T Consensus       317 ~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~  390 (570)
T 2z63_A          317 G-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS  390 (570)
T ss_dssp             S-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEE
T ss_pred             c-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-ccc
Confidence            8 6665  4677888888888888766654  77889999999999988543  7788889999999999999884 444


Q ss_pred             hhhccCCCceEEccCCeeeeecC-CCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCcc
Q 036815          387 EFSRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCK  465 (1013)
Q Consensus       387 ~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (1013)
                      .+..+++|+.|++++|++.+..| ..+.++++|++|++++|.+++..|..                              
T Consensus       391 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------------------------------  440 (570)
T 2z63_A          391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI------------------------------  440 (570)
T ss_dssp             EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTT------------------------------
T ss_pred             cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhh------------------------------
Confidence            58889999999999999987666 46888999999999999887654432                              


Q ss_pred             CCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCccc-ccCChhhhCCCCCcEEecCCCcc
Q 036815          466 GVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFR-GKIPDEIGDMIALQVLELAHNQL  544 (1013)
Q Consensus       466 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~-g~iP~~i~~l~~L~~L~L~~n~l  544 (1013)
                                                            +..+++|++|++++|+++ +.+|..++.+++|++|+|++|++
T Consensus       441 --------------------------------------~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l  482 (570)
T 2z63_A          441 --------------------------------------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  482 (570)
T ss_dssp             --------------------------------------TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             --------------------------------------hhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCcc
Confidence                                                  334567999999999998 68999999999999999999999


Q ss_pred             CCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCCC
Q 036815          545 SGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQR  599 (1013)
Q Consensus       545 ~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~  599 (1013)
                      ++..|.+++++++|+.|++++|++++..|..+.++++|+.|++++|+++|..|..
T Consensus       483 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             ccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            9888999999999999999999999888888999999999999999999988864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.2e-50  Score=430.64  Aligned_cols=246  Identities=20%  Similarity=0.273  Sum_probs=204.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||+||+|+++ +++.||||++.+.   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999986 6899999998653   2233467899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||+|.+++....      .+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+
T Consensus       112 Ey~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~  182 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL  182 (311)
T ss_dssp             CCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence            9999999999997543      389999999999999999999999   9999999999999999999999999999987


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ............+||+.|||||++.+..|+.++||||+||++|||++|+.||...+     ..+....... +..  .++
T Consensus       183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~-~~~--~~p  254 (311)
T 4aw0_A          183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIFAKIIK-LEY--DFP  254 (311)
T ss_dssp             CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHH-TCC--CCC
T ss_pred             CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHc-CCC--CCC
Confidence            65444444556789999999999999999999999999999999999999997643     1111221111 111  011


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.       .++          .+.+++.+||+.||++|||++|
T Consensus       255 ~~-------~s~----------~~~dli~~lL~~dp~~R~t~~e  281 (311)
T 4aw0_A          255 EK-------FFP----------KARDLVEKLLVLDATKRLGCEE  281 (311)
T ss_dssp             TT-------CCH----------HHHHHHHHHSCSSGGGSTTSGG
T ss_pred             cc-------cCH----------HHHHHHHHHccCCHhHCcChHH
Confidence            11       111          2458999999999999999875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-50  Score=435.43  Aligned_cols=253  Identities=28%  Similarity=0.445  Sum_probs=203.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|.+.+.||+|+||+||+|++.      +++.||||++........++|.+|++++++++|||||+++|+|.+++..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45788899999999999999874      367899999877666666789999999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhccccc-------CCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEE
Q 036815          808 VYEFMKFGSLEEVLHGRAK-------ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                      |||||++|+|.++++....       ......++|.++..|+.||++||+|||++   +||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence            9999999999999975431       12334599999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHH
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKV  959 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  959 (1013)
                      +|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||.....     .+.+ ..+
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~-~~i  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVI-ECI  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHH-HHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH-HHH
Confidence            99999987655444333445679999999999999999999999999999999999 8999976431     1111 222


Q ss_pred             hcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..... ++       ..+          ..+.+++.+||+.||++||||+|
T Consensus       244 ~~~~~~~~-p~-------~~~----------~~~~~li~~cl~~dP~~RPs~~~  279 (299)
T 4asz_A          244 TQGRVLQR-PR-------TCP----------QEVYELMLGCWQREPHMRKNIKG  279 (299)
T ss_dssp             HHTCCCCC-CT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HcCCCCCC-Cc-------cch----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            22222111 11       111          12568999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.6e-50  Score=435.34  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=202.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      +.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888999999999999999986 68999999997655555677899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      +||+|.+++...       .+++..++.++.||+.||+|||++   +||||||||+|||++.++++||+|||+|+.+...
T Consensus       154 ~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          154 EGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             TTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999642       289999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      ..  ......||+.|||||++.+..|+.++||||+||++|||++|+.||.+...     .+.... +..........+  
T Consensus       224 ~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~-i~~~~~~~~~~~--  293 (346)
T 4fih_A          224 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKM-IRDNLPPRLKNL--  293 (346)
T ss_dssp             SC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHH-HHHSSCCCCSCG--
T ss_pred             CC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHH-HHcCCCCCCCcc--
Confidence            22  23457899999999999999999999999999999999999999976321     111111 111111100000  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ...+          ..+.+++.+||+.||++|||++|
T Consensus       294 ----~~~s----------~~~~dli~~~L~~dP~~R~ta~e  320 (346)
T 4fih_A          294 ----HKVS----------PSLKGFLDRLLVRDPAQRATAAE  320 (346)
T ss_dssp             ----GGSC----------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ----ccCC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence                0011          12568999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=435.13  Aligned_cols=253  Identities=28%  Similarity=0.431  Sum_probs=196.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|.+.++||+|+||+||+|+++      +++.||||++........++|.+|++++++++|||||+++|+|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34677789999999999999874      467899999876666666789999999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccC---------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          808 VYEFMKFGSLEEVLHGRAKA---------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      |||||++|+|.++++.....         ....+++|.++..|+.|||+||+|||++   +||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence            99999999999999764321         1234599999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ||+|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||.....     .+.+ .
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~-~  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEAI-D  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----HHHH-H
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----HHHH-H
Confidence            9999999997755444444455679999999999999999999999999999999999 8999975431     1111 1


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+..+..... ++       ..+          ..+.+++.+||+.||++||||+|
T Consensus       272 ~i~~g~~~~~-p~-------~~~----------~~~~~li~~cl~~dP~~RPs~~e  309 (329)
T 4aoj_A          272 CITQGRELER-PR-------ACP----------PEVYAIMRGCWQREPQQRHSIKD  309 (329)
T ss_dssp             HHHHTCCCCC-CT-------TCC----------HHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             HHHcCCCCCC-cc-------ccc----------HHHHHHHHHHcCcChhHCcCHHH
Confidence            2222221111 11       111          12568999999999999999864

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.3e-48  Score=465.36  Aligned_cols=482  Identities=21%  Similarity=0.202  Sum_probs=326.0

Q ss_pred             ecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCC
Q 036815            5 LKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYN   84 (1013)
Q Consensus         5 L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n   84 (1013)
                      .|+++|.++.+|..   .+++|++|+|++|++.+ ++...|.++++|++|+|++|.+++ ++...+..++          
T Consensus        10 c~~~~~~l~~ip~~---~~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~----------   74 (549)
T 2z81_A           10 CDGRSRSFTSIPSG---LTAAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRINT-IEGDAFYSLG----------   74 (549)
T ss_dssp             EECTTSCCSSCCSC---CCTTCCEEECCSSCCCE-ECSSTTSSCTTCCEEECTTSCCCE-ECTTTTTTCT----------
T ss_pred             EECCCCcccccccc---CCCCccEEECcCCccCc-cChhhhhcCCcccEEECCCCCcCc-cChhhccccc----------
Confidence            45555555555553   22445555555555544 233345555555555555555552 2222334444          


Q ss_pred             cccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCccccc-CcccccCCCCCCEeeCcCCcccC
Q 036815           85 NLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGE-IPRTFGQLSSLQRLDLSNNHITG  163 (1013)
Q Consensus        85 ~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~  163 (1013)
                                       +|++|+|++|+++++.+..|.++++|++|++++|++++. .+..|+++++|++|++++|.+.+
T Consensus        75 -----------------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~  137 (549)
T 2z81_A           75 -----------------SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS  137 (549)
T ss_dssp             -----------------TCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC
T ss_pred             -----------------cCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCcccc
Confidence                             455555555555555555566666666666666666542 34556666666666666666333


Q ss_pred             cCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcC--C-
Q 036815          164 WIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSF--P-  240 (1013)
Q Consensus       164 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~-  240 (1013)
                      .+|...+..+++|++|++++|++++..|..+..+++|++|+++.|.+. .++...+..+++|++|++++|++++..  + 
T Consensus       138 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  216 (549)
T 2z81_A          138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPL  216 (549)
T ss_dssp             EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCC
T ss_pred             ccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCcccccccccc
Confidence            555444444566666666666666666666666667777777766665 455555556667777777777666431  1 


Q ss_pred             cCCCCCCCcCEEEecCCeecccCCCCC---CCCCCCCceEEcCCCcccccC------CccccccCcccEEEeeCCccCCC
Q 036815          241 DSISSCKTLRIVDFSSNRVSGIIPPDI---CPGVSSLEELRLPDNLITGVI------PGQLSECTQLKVIDLSLNYLNGS  311 (1013)
Q Consensus       241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~~l~~L~~L~L~~n~l~~~~------~~~~~~l~~L~~L~ls~N~l~~~  311 (1013)
                      .....+++|+.|++++|.+++..+..+   ...+++|+.+++++|.+.+..      ...+..+++|+.|++.++.+...
T Consensus       217 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~  296 (549)
T 2z81_A          217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF  296 (549)
T ss_dssp             SSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCG
T ss_pred             chhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchh
Confidence            122345667777777776654332211   233556677777777665431      12345667777777777765531


Q ss_pred             -----CCcccccCcchHHHHhhhccccCCCCcCc-CCCCCCceEECccccccccCch---hhcCCCCCCeEEecCCccCC
Q 036815          312 -----IPQELGKLEHLEQFIAWFNGLEGKIPPEL-GKCKNLKDLILNNNKLSGEIPA---ELFSCSNLEWISLTGNELTG  382 (1013)
Q Consensus       312 -----~p~~l~~l~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~---~l~~l~~L~~L~L~~N~l~~  382 (1013)
                           ++..+....+|+.|++++|.+. .+|..+ ..+++|++|+|++|++++.+|.   .+..+++|++|+|++|++++
T Consensus       297 ~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  375 (549)
T 2z81_A          297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS  375 (549)
T ss_dssp             GGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCC
T ss_pred             hhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccc
Confidence                 2222334456777777777776 566655 5789999999999999987754   37788999999999999985


Q ss_pred             CCC--hhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEecc
Q 036815          383 QIP--PEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNV  460 (1013)
Q Consensus       383 ~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (1013)
                      ..+  ..+..+++|+.|++++|+++ .+|..+..+++|++|++++|++++ +|..+                        
T Consensus       376 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~------------------------  429 (549)
T 2z81_A          376 MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI------------------------  429 (549)
T ss_dssp             HHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS------------------------
T ss_pred             cccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh------------------------
Confidence            432  46889999999999999999 789999999999999999998862 22110                        


Q ss_pred             CCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecC
Q 036815          461 GNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA  540 (1013)
Q Consensus       461 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~  540 (1013)
                                                                    .++|++||+++|++++. +   +.+++|++|+|+
T Consensus       430 ----------------------------------------------~~~L~~L~Ls~N~l~~~-~---~~l~~L~~L~Ls  459 (549)
T 2z81_A          430 ----------------------------------------------PQTLEVLDVSNNNLDSF-S---LFLPRLQELYIS  459 (549)
T ss_dssp             ----------------------------------------------CTTCSEEECCSSCCSCC-C---CCCTTCCEEECC
T ss_pred             ----------------------------------------------cCCceEEECCCCChhhh-c---ccCChhcEEECC
Confidence                                                          13689999999999964 3   578999999999


Q ss_pred             CCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCC
Q 036815          541 HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQ  598 (1013)
Q Consensus       541 ~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~  598 (1013)
                      +|+++ .||. .+.+++|+.|+|++|++++.+|..+..+++|+.|++++|++++..|.
T Consensus       460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            99999 8997 57899999999999999999899999999999999999999998874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-49  Score=433.66  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=196.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999986 68999999986543  2234678999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      ||+||+|.+++.....    ..+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+...
T Consensus       104 y~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             CCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             CCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999965432    3378999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...  .......||+.|||||++.+..|+.++||||+||++|||+||+.||.+..     ..+.+..... +.... ++.
T Consensus       177 ~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~-~~~~~-~~~  247 (350)
T 4b9d_A          177 STV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIIS-GSFPP-VSL  247 (350)
T ss_dssp             HHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHH-TCCCC-CCT
T ss_pred             CCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHc-CCCCC-CCc
Confidence            321  12234679999999999999999999999999999999999999997643     1222222221 11111 111


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       .+          ..+.+++.+||+.||++|||++|
T Consensus       248 ~-------~s----------~~~~~li~~~L~~dP~~R~s~~e  273 (350)
T 4b9d_A          248 H-------YS----------YDLRSLVSQLFKRNPRDRPSVNS  273 (350)
T ss_dssp             T-------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             c-------CC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            1       11          12568999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-49  Score=428.65  Aligned_cols=252  Identities=24%  Similarity=0.385  Sum_probs=202.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++++.+.||+|+||+||+|++.      +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3566789999999999999863      46789999986543 2335789999999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCC----------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc
Q 036815          808 VYEFMKFGSLEEVLHGRAKAR----------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME  877 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  877 (1013)
                      |||||++|+|.+++.......          ....++|..+..|+.|||+||+|||++   +||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            999999999999997543211          123589999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHH
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~  956 (1013)
                      +||+|||+|+.....+.........||++|||||++.+..++.++|||||||++|||+| |+.||.+...  ....    
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~----  257 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVV----  257 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHH----
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHH----
Confidence            99999999997755444434455679999999999999999999999999999999999 8999976431  1122    


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..+..... ++.       .+          ..+.+++.+||+.||++||||+|
T Consensus       258 ~~i~~~~~~~~-p~~-------~~----------~~~~~li~~C~~~dP~~RPs~~e  296 (308)
T 4gt4_A          258 EMIRNRQVLPC-PDD-------CP----------AWVYALMIECWNEFPSRRPRFKD  296 (308)
T ss_dssp             HHHHTTCCCCC-CTT-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHcCCCCCC-ccc-------ch----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            22222222111 111       11          12568999999999999999864

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=461.17  Aligned_cols=509  Identities=23%  Similarity=0.247  Sum_probs=421.7

Q ss_pred             CcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccE
Q 036815           26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH  105 (1013)
Q Consensus        26 l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~  105 (1013)
                      .+.++.++.+++. +|..+   .+++++|+|++|.++ .++...+.++++|++|+|++|++++.....+   ..+++|++
T Consensus         9 ~~~~~c~~~~l~~-ip~~l---~~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~---~~l~~L~~   80 (570)
T 2z63_A            9 NITYQCMELNFYK-IPDNL---PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAY---QSLSHLST   80 (570)
T ss_dssp             TTEEECCSSCCSS-CCSSS---CSSCCEEECCSCCCC-EECTTTTTTCSSCCEEECTTCCCCEECTTTT---TTCTTCCE
T ss_pred             CcEEEeCCCCccc-cCCCc---cccccEEEccCCccC-ccChhHhhCCCCceEEECCCCcCCccCcccc---cCchhCCE
Confidence            4567888877855 67653   357999999999998 4555567899999999999999986654322   46789999


Q ss_pred             EECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccC-cCCccchhccCCCcEEECCCC
Q 036815          106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITG-WIPSELGNACDSLLELKLPHN  184 (1013)
Q Consensus       106 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~~l~~L~~L~L~~n  184 (1013)
                      |+|++|.++++.+..|.++++|++|++++|++++..+..|+++++|++|++++|.+++ .+|..+. .+++|++|++++|
T Consensus        81 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~-~l~~L~~L~l~~n  159 (570)
T 2z63_A           81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS-NLTNLEHLDLSSN  159 (570)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGG-GCTTCCEEECTTS
T ss_pred             EeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhc-ccCCCCEEeCcCC
Confidence            9999999999888999999999999999999997776679999999999999999985 3566654 4699999999999


Q ss_pred             CCCCcCCccccCCCCC----CEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCC-cCCcCCCCCCCcCEEEecCCee
Q 036815          185 NITGSFPVTLSSCSWL----QLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG-SFPDSISSCKTLRIVDFSSNRV  259 (1013)
Q Consensus       185 ~l~~~~~~~l~~l~~L----~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l  259 (1013)
                      ++++..+..+..+++|    +.|++++|.+++ ++...+... +|++|++++|.... ..+..+..++.++.+.+....+
T Consensus       160 ~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~-~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~  237 (570)
T 2z63_A          160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF  237 (570)
T ss_dssp             CCCEECGGGGHHHHTCTTCCCEEECTTCCCCE-ECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEEC
T ss_pred             ccceecHHHccchhccchhhhhcccCCCCcee-cCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccc
Confidence            9998888888888888    899999999984 444445544 79999999885432 2345566777777766654332


Q ss_pred             cc-----cCCCCCCCCCCC--CceEEcCCC-cccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhcc
Q 036815          260 SG-----IIPPDICPGVSS--LEELRLPDN-LITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNG  331 (1013)
Q Consensus       260 ~~-----~~~~~~~~~l~~--L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~  331 (1013)
                      ..     .++...+.++.+  ++.+++.++ .+.+..+..+..+++|+.|++++|.++ .+|..+..+ +|+.|++.+|.
T Consensus       238 ~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~  315 (570)
T 2z63_A          238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCK  315 (570)
T ss_dssp             CCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCB
T ss_pred             cCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCc
Confidence            21     233344444443  567778877 788888999999999999999999998 789999998 99999999999


Q ss_pred             ccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCC--ChhhhccCCCceEEccCCeeeeecC
Q 036815          332 LEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQI--PPEFSRLTRLAVLQLGNNRFKGEIP  409 (1013)
Q Consensus       332 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p  409 (1013)
                      +. .+|.  ..+++|+.|++++|.+.+..+.  ..+++|++|++++|.+++..  |..+..+++|+.|++++|++.+..+
T Consensus       316 ~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  390 (570)
T 2z63_A          316 FG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS  390 (570)
T ss_dssp             CS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE
T ss_pred             cc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc
Confidence            98 6665  5789999999999999876665  78899999999999998554  7889999999999999999996544


Q ss_pred             CCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCcccc
Q 036815          410 GELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKS  489 (1013)
Q Consensus       410 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  489 (1013)
                       .+.++++|++|++++|.+++..|.                                                       
T Consensus       391 -~~~~l~~L~~L~l~~n~l~~~~~~-------------------------------------------------------  414 (570)
T 2z63_A          391 -NFLGLEQLEHLDFQHSNLKQMSEF-------------------------------------------------------  414 (570)
T ss_dssp             -EEETCTTCCEEECTTSEEESCTTS-------------------------------------------------------
T ss_pred             -cccccCCCCEEEccCCccccccch-------------------------------------------------------
Confidence             499999999999999988765431                                                       


Q ss_pred             ccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccC-CCCcccccCCCCcceEecCCccc
Q 036815          490 CDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLS-GEIPSSLGRLRNLGVFDASHNRL  568 (1013)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~-g~ip~~~~~l~~L~~L~ls~N~l  568 (1013)
                                  ..+..+++|++|++++|++++.+|..++.+++|++|+|++|+++ |.+|..++.+++|+.|+|++|++
T Consensus       415 ------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l  482 (570)
T 2z63_A          415 ------------SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  482 (570)
T ss_dssp             ------------CTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             ------------hhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCcc
Confidence                        12334678999999999999999999999999999999999998 67999999999999999999999


Q ss_pred             cCCCcccccCCCcceEEECcCCCCCCcCCC-CCCCCCCCcccccCCCCCCCCC
Q 036815          569 QGQIPESFSNLSFLVQIDLSNNELTGPIPQ-RGQLSTLPASQYANNPGLCGVP  620 (1013)
Q Consensus       569 ~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~lc~~~  620 (1013)
                      ++..|..+..+++|+.|++++|++++.+|. ...+..+....+.+|+.-|..|
T Consensus       483 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            998899999999999999999999998876 4678888999999999877543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.3e-49  Score=423.15  Aligned_cols=250  Identities=29%  Similarity=0.443  Sum_probs=190.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||+||+|+++  ..||||++....  ....+.|.+|++++++++|||||+++|++.+ +..|+||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            46778899999999999999875  369999875432  2334679999999999999999999998864 568999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      |+||+|.++++...     ..+++.++..|+.|||+||+|||++   +||||||||+|||+++++.+||+|||+|+....
T Consensus       113 ~~gGsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          113 CEGSSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             CSSCBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             CCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99999999997432     2389999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS---FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ...........||+.|||||++.+   ..|+.++|||||||++|||+||+.||.....     ...+...+..+...   
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----~~~~~~~~~~~~~~---  256 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----RDQIIFMVGRGYAS---  256 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHTTCCC---
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcCCCC---
Confidence            444444456789999999999864   4689999999999999999999999975331     11122222222111   


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       |.........+          ..+.+++.+||+.||++||||+|
T Consensus       257 -p~~~~~~~~~~----------~~l~~li~~cl~~dP~~RPs~~e  290 (307)
T 3omv_A          257 -PDLSKLYKNCP----------KAMKRLVADCVKKVKEERPLFPQ  290 (307)
T ss_dssp             -CCSTTSCTTSC----------HHHHHHHHHHTCSSSTTSCCHHH
T ss_pred             -CCcccccccch----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence             11100011111          12568999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=436.87  Aligned_cols=247  Identities=23%  Similarity=0.364  Sum_probs=203.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .+.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            356999999999999999999986 6899999999766656667799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      |+||+|.+++...       .+++..++.++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.+..
T Consensus       230 ~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          230 LEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             CTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            9999999999642       289999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ..  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+...     .+.... +........-.+ 
T Consensus       300 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~-i~~~~~~~~~~~-  370 (423)
T 4fie_A          300 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKM-IRDNLPPRLKNL-  370 (423)
T ss_dssp             SC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHH-HHHSCCCCCSCT-
T ss_pred             CC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHH-HHcCCCCCCccc-
Confidence            22  223456899999999999999999999999999999999999999975321     111111 111111000000 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ...+          ..+.+|+.+||+.||++||||+|
T Consensus       371 -----~~~s----------~~~~dli~~~L~~dP~~R~ta~e  397 (423)
T 4fie_A          371 -----HKVS----------PSLKGFLDRLLVRDPAQRATAAE  397 (423)
T ss_dssp             -----TSSC----------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             -----ccCC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence                 0111          12568999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-48  Score=424.36  Aligned_cols=244  Identities=25%  Similarity=0.333  Sum_probs=195.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      +.|++.++||+|+||+||+|+++ +|+.||||++.....     ..+|+.++++++|||||++++++.+++..|+|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45778889999999999999986 689999999864322     247999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-cEEEeecccceeccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMARLISA  891 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~  891 (1013)
                      +||+|.+++....      .+++..++.++.||+.||+|||++   +||||||||+|||++.++ ++||+|||+|+.+..
T Consensus       133 ~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          133 EGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             TTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            9999999997543      389999999999999999999999   999999999999999987 699999999998754


Q ss_pred             cCcc---eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          892 LDTH---LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       892 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....   .......||+.|||||++.+..|+.++||||+||++|||+||+.||......+. ... +   .........+
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~-i---~~~~~~~~~~  278 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLK-I---ASEPPPIREI  278 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHH-H---HHSCCGGGGS
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHH-H---HcCCCCchhc
Confidence            3221   122346799999999999999999999999999999999999999986543322 111 1   1111111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ++.+       +          ..+.+++.+||+.||++||||+|
T Consensus       279 ~~~~-------s----------~~~~~li~~~L~~dP~~R~sa~e  306 (336)
T 4g3f_A          279 PPSC-------A----------PLTAQAIQEGLRKEPVHRASAME  306 (336)
T ss_dssp             CTTS-------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CccC-------C----------HHHHHHHHHHccCCHhHCcCHHH
Confidence            1111       1          12558999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2e-48  Score=416.28  Aligned_cols=241  Identities=27%  Similarity=0.388  Sum_probs=191.2

Q ss_pred             CCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEe----CCEEEEEE
Q 036815          737 SAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKI----GEERLLVY  809 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  809 (1013)
                      ++.+.||+|+||+||+|++. +++.||+|++....  ....+.|.+|++++++++|||||+++++|.+    +...|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999986 58899999986532  2234679999999999999999999999865    34579999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCcccEEeCC-CCcEEEeecccc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH--IIHRDMKSSNVLLDH-EMEARVSDFGMA  886 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~-~~~~kl~Dfg~a  886 (1013)
                      |||+||+|.+++....      .+++..++.++.||+.||+|||++   +  ||||||||+|||++. ++.+||+|||+|
T Consensus       109 Ey~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             ECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             eCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            9999999999997543      389999999999999999999998   7  999999999999985 789999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +.....    ......||+.|||||++.+ .|+.++|||||||++|||+||+.||.....    ..... ..+..+....
T Consensus       180 ~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~-~~i~~~~~~~  249 (290)
T 3fpq_A          180 TLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIY-RRVTSGVKPA  249 (290)
T ss_dssp             GGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHH-HHHTTTCCCG
T ss_pred             EeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHH-HHHHcCCCCC
Confidence            854321    2345689999999999875 699999999999999999999999975321    11111 2222222111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+++.       .+          ..+.+++.+||+.||++|||++|
T Consensus       250 ~~~~~-------~~----------~~~~~li~~~L~~dP~~R~s~~e  279 (290)
T 3fpq_A          250 SFDKV-------AI----------PEVKEIIEGCIRQNKDERYSIKD  279 (290)
T ss_dssp             GGGGC-------CC----------HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCcc-------CC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            11111       11          12558999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.3e-48  Score=410.56  Aligned_cols=241  Identities=22%  Similarity=0.355  Sum_probs=185.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||+|++.+..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999986 68999999986532   223467899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+ +|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+|+..
T Consensus        93 Ey~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             ECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             eCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeec
Confidence            999 579999987543      389999999999999999999999   9999999999999999999999999999875


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Cccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEV  967 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~  967 (1013)
                      ....   ......||+.|||||++.+..+ +.++||||+||++|||+||+.||....     .....+..... ......
T Consensus       163 ~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~~~~~~~p~~  234 (275)
T 3hyh_A          163 TDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNISNGVYTLPKF  234 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCCCCTT
T ss_pred             CCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCCCCCCC
Confidence            4322   2345689999999999998876 579999999999999999999997532     22222221111 111111


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +++                     .+.+++.+||+.||++|||++|
T Consensus       235 ~s~---------------------~~~~li~~~L~~dP~~R~s~~e  259 (275)
T 3hyh_A          235 LSP---------------------GAAGLIKRMLIVNPLNRISIHE  259 (275)
T ss_dssp             SCH---------------------HHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCH---------------------HHHHHHHHHccCChhHCcCHHH
Confidence            111                     2458999999999999999864

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.6e-47  Score=458.09  Aligned_cols=469  Identities=18%  Similarity=0.180  Sum_probs=362.9

Q ss_pred             CcceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEe
Q 036815            1 MLSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLD   80 (1013)
Q Consensus         1 ~l~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~   80 (1013)
                      .|+.|||++|+++.+++..+...++|++|+|++|++.+ ++...|.++++|++|+|++|.++ .++...+..+++|++|+
T Consensus        27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~  104 (549)
T 2z81_A           27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLN  104 (549)
T ss_dssp             TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCC-SCCHHHHTTCTTCCEEE
T ss_pred             CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCc-cChhhccccccCCEEECCCCccC-ccCHHHhccCCCCcEEE
Confidence            47899999999999988888888899999999999977 56667999999999999999998 55666678999999999


Q ss_pred             CCCCcccCccCCCCcCCCCCCcccEEECCCCC-CCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCC
Q 036815           81 LSYNNLTGSISGFSLNENSCNSLLHLDLSQNH-IMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN  159 (1013)
Q Consensus        81 Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~-i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n  159 (1013)
                      |++|++++...  ......+++|++|++++|. +.++.+..|.++++|++|++++|++++..|..+..+++|++|++++|
T Consensus       105 Ls~n~l~~~~~--~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n  182 (549)
T 2z81_A          105 LMGNPYQTLGV--TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS  182 (549)
T ss_dssp             CTTCCCSSSCS--SCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred             CCCCcccccch--hhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccC
Confidence            99999985321  1123568899999999998 56665678999999999999999999889999999999999999999


Q ss_pred             cccCcCCccchhccCCCcEEECCCCCCCCcC---CccccCCCCCCEEEccCCCCCCCCChhh---hhcCCCCcEEEcccc
Q 036815          160 HITGWIPSELGNACDSLLELKLPHNNITGSF---PVTLSSCSWLQLLDLSNNNISGPFPDSV---LENLGSLESLILSNN  233 (1013)
Q Consensus       160 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~---~~~l~~l~~L~~L~L~~N~l~~~~~~~~---~~~l~~L~~L~L~~n  233 (1013)
                      .+. .+|..++..+++|++|++++|++++..   ......+++|+.|++++|.+++..+..+   +..+++|+.|++++|
T Consensus       183 ~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~  261 (549)
T 2z81_A          183 ESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDC  261 (549)
T ss_dssp             BST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESC
T ss_pred             ccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccc
Confidence            987 677776666789999999999988652   2233457788888888888764433322   345677888888887


Q ss_pred             cCCCcC------CcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCc
Q 036815          234 MISGSF------PDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNY  307 (1013)
Q Consensus       234 ~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~  307 (1013)
                      .+.+..      ...+..+.+|+.|++.++.+.....   +..                 ++..+...++|+.|++++|.
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~---~~~-----------------l~~~~~~~~~L~~L~l~~n~  321 (549)
T 2z81_A          262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL---FYD-----------------LSTVYSLLEKVKRITVENSK  321 (549)
T ss_dssp             EEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG---SCC-----------------CCHHHHHSTTCCEEEEESSC
T ss_pred             cccccccccccchhhhhhhcccccccccccccchhhh---ccc-----------------chhhhhhcccceEEEeccCc
Confidence            765421      1233445566666666665442110   000                 11112223455555555555


Q ss_pred             cCCCCCccc-ccCcchHHHHhhhccccCCCC---cCcCCCCCCceEECccccccccCc--hhhcCCCCCCeEEecCCccC
Q 036815          308 LNGSIPQEL-GKLEHLEQFIAWFNGLEGKIP---PELGKCKNLKDLILNNNKLSGEIP--AELFSCSNLEWISLTGNELT  381 (1013)
Q Consensus       308 l~~~~p~~l-~~l~~L~~L~l~~n~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~  381 (1013)
                      +. .+|..+ ..+++|+.|++++|.+++.+|   ..++.+++|++|+|++|++++..+  ..+..+++|++|++++|+++
T Consensus       322 l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~  400 (549)
T 2z81_A          322 VF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH  400 (549)
T ss_dssp             CC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred             cc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc
Confidence            54 444444 345555555555555554442   347788999999999999985432  56889999999999999999


Q ss_pred             CCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccC
Q 036815          382 GQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVG  461 (1013)
Q Consensus       382 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (1013)
                       .+|..+..+++|+.|++++|+++ .+|..+  .++|++||+++|++++.+                             
T Consensus       401 -~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~-----------------------------  447 (549)
T 2z81_A          401 -PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS-----------------------------  447 (549)
T ss_dssp             -CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC-----------------------------
T ss_pred             -cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc-----------------------------
Confidence             78999999999999999999998 566655  369999999999987531                             


Q ss_pred             CCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCC
Q 036815          462 NSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH  541 (1013)
Q Consensus       462 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~  541 (1013)
                                                                 ..+++|++|||++|+++ .+|. .+.+++|++|+|++
T Consensus       448 -------------------------------------------~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~  482 (549)
T 2z81_A          448 -------------------------------------------LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISR  482 (549)
T ss_dssp             -------------------------------------------CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCS
T ss_pred             -------------------------------------------ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCC
Confidence                                                       12457999999999999 8997 57899999999999


Q ss_pred             CccCCCCcccccCCCCcceEecCCccccCCCc
Q 036815          542 NQLSGEIPSSLGRLRNLGVFDASHNRLQGQIP  573 (1013)
Q Consensus       542 n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p  573 (1013)
                      |++++.+|..++.+++|+.|++++|.++|..|
T Consensus       483 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          483 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             SCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             CccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            99999888899999999999999999999887

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-48  Score=417.23  Aligned_cols=242  Identities=25%  Similarity=0.322  Sum_probs=192.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||+||+|+..    .++.||+|++.+..  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46999999999999999999873    46889999986532  2233468899999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||++||+|.+++....      .+++..++.++.||+.||+|||++   +||||||||+|||++.++++||+|||+|+
T Consensus       104 vmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~  174 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK  174 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred             EEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccce
Confidence            999999999999997543      389999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Ccccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  966 (1013)
                      ......  .......||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.     .+........ .....
T Consensus       175 ~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~~~~~~p~  247 (304)
T 3ubd_A          175 ESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMTMILKAKLGMPQ  247 (304)
T ss_dssp             C-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCT
T ss_pred             eccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHHHHHcCCCCCCC
Confidence            654322  223456899999999999999999999999999999999999999976431     2222221111 11111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      .+++                     .+.+++.+||+.||++|||+.
T Consensus       248 ~~s~---------------------~~~~li~~~L~~dP~~R~ta~  272 (304)
T 3ubd_A          248 FLSP---------------------EAQSLLRMLFKRNPANRLGAG  272 (304)
T ss_dssp             TSCH---------------------HHHHHHHHHTCSSGGGSTTCS
T ss_pred             cCCH---------------------HHHHHHHHHcccCHHHCCCCC
Confidence            1111                     245899999999999999974

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=451.93  Aligned_cols=452  Identities=21%  Similarity=0.221  Sum_probs=345.7

Q ss_pred             cEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeC
Q 036815           77 ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDL  156 (1013)
Q Consensus        77 ~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  156 (1013)
                      +.|++++|+++.++..++      ++|++|+|++|.|+++.+..|.++++|++|+|++|++++..|..|+++++|++|++
T Consensus         3 ~~l~ls~n~l~~ip~~~~------~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L   76 (520)
T 2z7x_B            3 FLVDRSKNGLIHVPKDLS------QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDL   76 (520)
T ss_dssp             CEEECTTSCCSSCCCSCC------TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEEC
T ss_pred             ceEecCCCCccccccccc------ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEec
Confidence            467888888875544332      67888888888888888888999999999999999998888888999999999999


Q ss_pred             cCCcccCcCCccchhccCCCcEEECCCCCCCCc-CCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCC--cEEEcccc
Q 036815          157 SNNHITGWIPSELGNACDSLLELKLPHNNITGS-FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL--ESLILSNN  233 (1013)
Q Consensus       157 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L--~~L~L~~n  233 (1013)
                      ++|+++ .+|..   .+++|++|+|++|++++. .|..++++++|++|++++|++++    ..+..+++|  ++|++++|
T Consensus        77 s~N~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n  148 (520)
T 2z7x_B           77 SHNKLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLG  148 (520)
T ss_dssp             CSSCCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEEC
T ss_pred             CCCcee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeecc
Confidence            999998 67766   578999999999999874 67889999999999999999874    336777888  99999999


Q ss_pred             cC--CCcCCcCCCCCC-CcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCc-------ccccCCccccccCcccEEEe
Q 036815          234 MI--SGSFPDSISSCK-TLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNL-------ITGVIPGQLSECTQLKVIDL  303 (1013)
Q Consensus       234 ~l--~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L~l  303 (1013)
                      .+  .+..|..+..+. ....+++++|.+.+.++...+..+++|+.|++++|.       +.+.++ .++.+++|+.|++
T Consensus       149 ~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l  227 (520)
T 2z7x_B          149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTL  227 (520)
T ss_dssp             TTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEE
T ss_pred             cccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccc
Confidence            98  777777777765 345678888888888888888889999999999987       666665 7888899999999


Q ss_pred             eCCccCCCCCcccc---cCcchHHHHhhhccccCCCCcCc-----CCCCCCceEECccccccccCc-hhhcCC---CCCC
Q 036815          304 SLNYLNGSIPQELG---KLEHLEQFIAWFNGLEGKIPPEL-----GKCKNLKDLILNNNKLSGEIP-AELFSC---SNLE  371 (1013)
Q Consensus       304 s~N~l~~~~p~~l~---~l~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~l~~l---~~L~  371 (1013)
                      ++|.+++..+..+.   ..++|+.|++++|.+++.+|..+     +++++|+.+++++|.+  .+| ..+..+   .+|+
T Consensus       228 ~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~  305 (520)
T 2z7x_B          228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIK  305 (520)
T ss_dssp             EEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCS
T ss_pred             cccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCcee
Confidence            99888754332222   13578888888888888888888     8888888888888888  455 555554   6788


Q ss_pred             eEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCc--CCCchhhhccCCCCCCCcc
Q 036815          372 WISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG--DIPPRLGRQLGAKPLGGFL  449 (1013)
Q Consensus       372 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~~~~~~~~~~~~  449 (1013)
                      .|++++|.+.+..  .+..+++|++|++++|++++.+|..++++++|++|++++|++++  .+|                
T Consensus       306 ~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~----------------  367 (520)
T 2z7x_B          306 NFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA----------------  367 (520)
T ss_dssp             EEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHH----------------
T ss_pred             EEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccch----------------
Confidence            8888888886432  12578888888888888888788888888888888888888764  222                


Q ss_pred             cCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChh-h
Q 036815          450 SSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDE-I  528 (1013)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~-i  528 (1013)
                                                                          ..+..+++|++||+++|++++.+|.. +
T Consensus       368 ----------------------------------------------------~~~~~l~~L~~L~Ls~N~l~~~l~~~~~  395 (520)
T 2z7x_B          368 ----------------------------------------------------EMTTQMKSLQQLDISQNSVSYDEKKGDC  395 (520)
T ss_dssp             ----------------------------------------------------HHHTTCTTCCEEECCSSCCBCCGGGCSC
T ss_pred             ----------------------------------------------------HHHhhCCCCCEEECCCCcCCcccccchh
Confidence                                                                22344566777777777777656654 6


Q ss_pred             hCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCC-CCCCCCCCc
Q 036815          529 GDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQ-RGQLSTLPA  607 (1013)
Q Consensus       529 ~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~-~~~~~~~~~  607 (1013)
                      ..+++|++|+|++|++++.+|..+.  ++|+.|+|++|+++ .+|..+..++.|+.|++++|++++..+. ...+..+..
T Consensus       396 ~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~  472 (520)
T 2z7x_B          396 SWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQK  472 (520)
T ss_dssp             CCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccE
Confidence            6677777777777777776766654  67777777777776 6777766777777777777777743333 455566666


Q ss_pred             ccccCCCCCCC
Q 036815          608 SQYANNPGLCG  618 (1013)
Q Consensus       608 ~~~~~n~~lc~  618 (1013)
                      ..+.+|+.-|.
T Consensus       473 L~l~~N~~~c~  483 (520)
T 2z7x_B          473 IWLHTNPWDCS  483 (520)
T ss_dssp             EECCSSCBCCC
T ss_pred             EECcCCCCccc
Confidence            66777766553

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.4e-47  Score=450.00  Aligned_cols=460  Identities=20%  Similarity=0.191  Sum_probs=269.6

Q ss_pred             ceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCC
Q 036815            3 SVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS   82 (1013)
Q Consensus         3 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls   82 (1013)
                      +.||+++|+++.+|..+.   ++|++|+|++|++.+ ++...|.++++|++|+|++|.+++ +++..+.++++|++|+|+
T Consensus         3 ~~l~ls~n~l~~ip~~~~---~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls   77 (520)
T 2z7x_B            3 FLVDRSKNGLIHVPKDLS---QKTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLS   77 (520)
T ss_dssp             CEEECTTSCCSSCCCSCC---TTCSEEECCSSCCCC-CCHHHHTTCTTCCEEECCSSCCCE-EEGGGGTTCTTCCEEECC
T ss_pred             ceEecCCCCccccccccc---ccccEEECCCCcccc-cChhhccccccccEEecCCCccCC-cChHHhhcccCCCEEecC
Confidence            467888888888876533   678888888888765 454567788888888888888874 333456777788888888


Q ss_pred             CCcccCccCCCCcCCCCCCcccEEECCCCCCCCC-CCccccCCCCCCEEecCCCcccccCcccccCCCCC--CEeeCcCC
Q 036815           83 YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSL--QRLDLSNN  159 (1013)
Q Consensus        83 ~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~Ls~n  159 (1013)
                      +|+++.++..      .+++|++|+|++|.++++ .|..|.++++|++|++++|++++   ..+..+++|  ++|++++|
T Consensus        78 ~N~l~~lp~~------~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n  148 (520)
T 2z7x_B           78 HNKLVKISCH------PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLG  148 (520)
T ss_dssp             SSCCCEEECC------CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEEC
T ss_pred             CCceeecCcc------ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecc
Confidence            8877743322      456677777777777653 45666667777777777766654   234555555  66666666


Q ss_pred             cc--cCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEccccc---
Q 036815          160 HI--TGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNM---  234 (1013)
Q Consensus       160 ~l--~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~---  234 (1013)
                      .+  ++..|..+...-.+...+                        ++++|.+.+.++...+..+++|+.|++++|.   
T Consensus       149 ~l~~~~~~~~~l~~l~~~~l~l------------------------~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  204 (520)
T 2z7x_B          149 ETYGEKEDPEGLQDFNTESLHI------------------------VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN  204 (520)
T ss_dssp             TTTTSSCCTTTTTTCCEEEEEE------------------------ECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTT
T ss_pred             cccccccccccccccccceEEE------------------------EeccCcchhhhhhhhhhcccceeecccccccccc
Confidence            66  434443332211122233                        4444444444444444445555555555544   


Q ss_pred             ----CCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCC--CCCCCceEEcCCCcccccCCccc-----cccCcccEEEe
Q 036815          235 ----ISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICP--GVSSLEELRLPDNLITGVIPGQL-----SECTQLKVIDL  303 (1013)
Q Consensus       235 ----l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~l  303 (1013)
                          +.+.++ .++.+++|+.|++++|.+++..+..+..  ..++|++|++++|++++.+|..+     ..++.|+.+++
T Consensus       205 ~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l  283 (520)
T 2z7x_B          205 KCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV  283 (520)
T ss_dssp             TTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEE
T ss_pred             ccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccc
Confidence                332222 4455555555555555554321111100  02345555555555555555555     56666666666


Q ss_pred             eCCccCCCCC-cccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCC
Q 036815          304 SLNYLNGSIP-QELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTG  382 (1013)
Q Consensus       304 s~N~l~~~~p-~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  382 (1013)
                      ++|.+  .+| ..+..+                     ..-.+|+.|++++|.+... + ....+++|++|++++|++++
T Consensus       284 ~~n~~--~~p~~~~~~~---------------------~~~~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~Ls~n~l~~  338 (520)
T 2z7x_B          284 VSDVF--GFPQSYIYEI---------------------FSNMNIKNFTVSGTRMVHM-L-CPSKISPFLHLDFSNNLLTD  338 (520)
T ss_dssp             EECCC--CSCTHHHHHH---------------------HHTCCCSEEEEESSCCCCC-C-CCSSCCCCCEEECCSSCCCT
T ss_pred             cccce--ecchhhhhcc---------------------cccCceeEEEcCCCccccc-c-chhhCCcccEEEeECCccCh
Confidence            66666  333 222221                     0013456666666665421 1 11455666666666666666


Q ss_pred             CCChhhhccCCCceEEccCCeeee--ecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEecc
Q 036815          383 QIPPEFSRLTRLAVLQLGNNRFKG--EIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNV  460 (1013)
Q Consensus       383 ~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (1013)
                      .+|..++.+++|+.|+|++|++++  .+|..+.++++|++|++++|++++.+|..                         
T Consensus       339 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~-------------------------  393 (520)
T 2z7x_B          339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG-------------------------  393 (520)
T ss_dssp             TTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGC-------------------------
T ss_pred             hhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccc-------------------------
Confidence            666666666666666666666664  44455666666666666666666444321                         


Q ss_pred             CCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecC
Q 036815          461 GNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA  540 (1013)
Q Consensus       461 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~  540 (1013)
                                                                .+..+++|++|++++|++++.+|..+.  ++|++|+|+
T Consensus       394 ------------------------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls  429 (520)
T 2z7x_B          394 ------------------------------------------DCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLH  429 (520)
T ss_dssp             ------------------------------------------SCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECC
T ss_pred             ------------------------------------------hhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECC
Confidence                                                      012234566677777777666666554  567777777


Q ss_pred             CCccCCCCcccccCCCCcceEecCCccccCCCccc-ccCCCcceEEECcCCCCCCcCC
Q 036815          541 HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPES-FSNLSFLVQIDLSNNELTGPIP  597 (1013)
Q Consensus       541 ~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~l~~l~l~~n~l~~~~p  597 (1013)
                      +|+++ .+|..+..+++|+.|+|++|+++ .+|.. +..+++|+.|++++|++++..+
T Consensus       430 ~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          430 SNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             SSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence            77777 67776667777777777777776 45554 6677777777777777776544

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=8.9e-47  Score=456.27  Aligned_cols=357  Identities=22%  Similarity=0.309  Sum_probs=269.6

Q ss_pred             CCcccccCcccccCCCCCCEeeCcCCcccCc-----------------CCccch-hccCCCcEEECCCCCCCCcCCcccc
Q 036815          134 FNLLAGEIPRTFGQLSSLQRLDLSNNHITGW-----------------IPSELG-NACDSLLELKLPHNNITGSFPVTLS  195 (1013)
Q Consensus       134 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-----------------~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~l~  195 (1013)
                      .|++++ +|..|+++++|++|+|++|.+++.                 +|..+. ..+++|++|+|++|++.+.+|..+.
T Consensus       192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~  270 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK  270 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred             cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence            577877 778888888888888888888864                 777665 2357888888888888878888888


Q ss_pred             CCCCCCEEEccCCC-CCC-CCChhhhhcC------CCCcEEEcccccCCCcCCc--CCCCCCCcCEEEecCCeecccCCC
Q 036815          196 SCSWLQLLDLSNNN-ISG-PFPDSVLENL------GSLESLILSNNMISGSFPD--SISSCKTLRIVDFSSNRVSGIIPP  265 (1013)
Q Consensus       196 ~l~~L~~L~L~~N~-l~~-~~~~~~~~~l------~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~  265 (1013)
                      ++++|++|++++|+ +++ .+|..+ ..+      ++|++|++++|+++ .+|.  .++.+++|+.|++++|++++.+| 
T Consensus       271 ~l~~L~~L~Ls~n~~l~~~~lp~~~-~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-  347 (636)
T 4eco_A          271 ALPEMQLINVACNRGISGEQLKDDW-QALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-  347 (636)
T ss_dssp             TCSSCCEEECTTCTTSCHHHHHHHH-HHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-
T ss_pred             cCCCCCEEECcCCCCCccccchHHH-HhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-
Confidence            88888888888887 776 566553 333      77888888888887 6776  77777788888888877776666 


Q ss_pred             CCCCCCCCCceEEcCCCcccccCCccccccCc-ccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCC-
Q 036815          266 DICPGVSSLEELRLPDNLITGVIPGQLSECTQ-LKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKC-  343 (1013)
Q Consensus       266 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l-  343 (1013)
                       .+..+++|+.|++++|+++ .+|..+..+++ |+.|++++|.++ .+|                        ..++.+ 
T Consensus       348 -~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp------------------------~~~~~~~  400 (636)
T 4eco_A          348 -AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIP------------------------NIFDAKS  400 (636)
T ss_dssp             -CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCC------------------------SCCCTTC
T ss_pred             -hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccc------------------------hhhhhcc
Confidence             4456677777777777777 56666777777 777777777776 444                        344433 


Q ss_pred             -CCCceEECccccccccCchhhc-------CCCCCCeEEecCCccCCCCChh-hhccCCCceEEccCCeeeeecCCCCcC
Q 036815          344 -KNLKDLILNNNKLSGEIPAELF-------SCSNLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGEIPGELGN  414 (1013)
Q Consensus       344 -~~L~~L~L~~N~l~~~~p~~l~-------~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~  414 (1013)
                       ++|++|++++|++++.+|..+.       .+++|++|+|++|+++ .+|.. +..+++|+.|+|++|+++ .+|..+..
T Consensus       401 l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~  478 (636)
T 4eco_A          401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLK  478 (636)
T ss_dssp             SSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSE
T ss_pred             cCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhc
Confidence             3677888888888777777776       6778888888888888 44544 455788888888888887 66655433


Q ss_pred             --------CCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCc
Q 036815          415 --------CSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPT  486 (1013)
Q Consensus       415 --------l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (1013)
                              +++|++|+|++|+++ .+|..+..                                                
T Consensus       479 ~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~------------------------------------------------  509 (636)
T 4eco_A          479 DENENFKNTYLLTSIDLRFNKLT-KLSDDFRA------------------------------------------------  509 (636)
T ss_dssp             ETTEECTTGGGCCEEECCSSCCC-BCCGGGST------------------------------------------------
T ss_pred             cccccccccCCccEEECcCCcCC-ccChhhhh------------------------------------------------
Confidence                    238888888888887 55543210                                                


Q ss_pred             cccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEec------CCCccCCCCcccccCCCCcce
Q 036815          487 LKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLEL------AHNQLSGEIPSSLGRLRNLGV  560 (1013)
Q Consensus       487 l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L------~~n~l~g~ip~~~~~l~~L~~  560 (1013)
                                        ..+++|++|||++|++++ +|.+++.+++|++|+|      ++|++.|.+|..++++++|+.
T Consensus       510 ------------------~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~  570 (636)
T 4eco_A          510 ------------------TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ  570 (636)
T ss_dssp             ------------------TTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCE
T ss_pred             ------------------ccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCE
Confidence                              134678889999999986 8888888999999988      568889999999999999999


Q ss_pred             EecCCccccCCCcccccCCCcceEEECcCCCCCC
Q 036815          561 FDASHNRLQGQIPESFSNLSFLVQIDLSNNELTG  594 (1013)
Q Consensus       561 L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~  594 (1013)
                      |+|++|++ +.||..+.  +.|+.|+|++|++..
T Consensus       571 L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          571 LQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS  601 (636)
T ss_dssp             EECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred             EECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence            99999999 68998876  789999999997764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-47  Score=420.07  Aligned_cols=258  Identities=28%  Similarity=0.410  Sum_probs=205.2

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCcc-chHHHHHHHHHHhccCC-cceeeeccEEEe
Q 036815          730 IEATNGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKH-RNLVPLLGYCKI  801 (1013)
Q Consensus       730 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~niv~l~~~~~~  801 (1013)
                      +...++|++.+.||+|+||+||+|++..      ++.||||++...... ..+.|.+|++++.+++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            3445789999999999999999998753      357999988654433 34679999999999965 899999999976


Q ss_pred             C-CEEEEEEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccE
Q 036815          802 G-EERLLVYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNV  870 (1013)
Q Consensus       802 ~-~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  870 (1013)
                      . +..|+|||||++|+|.++++.....          .....+++..+..++.|||+||+|||++   +||||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence            4 5689999999999999999754321          1134589999999999999999999999   999999999999


Q ss_pred             EeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCc
Q 036815          871 LLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDT  949 (1013)
Q Consensus       871 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~  949 (1013)
                      |+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ 
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-  295 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  295 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999998765444445556789999999999999999999999999999999998 999997643221 


Q ss_pred             cHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          950 NLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       950 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          .+...+..+......+        ..+          ..+.+++.+||+.||++||||+|
T Consensus       296 ----~~~~~i~~g~~~~~p~--------~~~----------~~~~~li~~c~~~dP~~RPt~~e  337 (353)
T 4ase_A          296 ----EFCRRLKEGTRMRAPD--------YTT----------PEMYQTMLDCWHGEPSQRPTFSE  337 (353)
T ss_dssp             ----HHHHHHHHTCCCCCCT--------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----HHHHHHHcCCCCCCCc--------cCC----------HHHHHHHHHHcCcChhHCcCHHH
Confidence                1222222222211110        011          12568999999999999999864

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=8.9e-48  Score=464.99  Aligned_cols=443  Identities=19%  Similarity=0.278  Sum_probs=355.4

Q ss_pred             CcccEEECCCCCCCCCCCccccCCCCCCEEecCCCccc------c------cCcccccCCCCCCEeeCcCCcccCcCCcc
Q 036815          101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA------G------EIPRTFGQLSSLQRLDLSNNHITGWIPSE  168 (1013)
Q Consensus       101 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~------~------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~  168 (1013)
                      ..++.|+|++|.+.+.+|..|+++++|++|+|++|.+.      +      .+|...  +..|+ +++++|.+.+.+|..
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~  157 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED  157 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence            46888999999998888899999999999999999762      1      112111  34455 777777777666666


Q ss_pred             chhccCCCcEEECC--------------------CCCCCCcCCccccCCCCCCEEEccCCCCCCC---------------
Q 036815          169 LGNACDSLLELKLP--------------------HNNITGSFPVTLSSCSWLQLLDLSNNNISGP---------------  213 (1013)
Q Consensus       169 ~~~~l~~L~~L~L~--------------------~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~---------------  213 (1013)
                      +...+..+..+++.                    +|++++ +|..++++++|++|+|++|.+++.               
T Consensus       158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~  236 (636)
T 4eco_A          158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ  236 (636)
T ss_dssp             SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHH
T ss_pred             HHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhc
Confidence            55444333333333                    577887 788888899999999999988864               


Q ss_pred             --CChhhhh--cCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCe-ecc-cCCCCCCC-----CCCCCceEEcCCC
Q 036815          214 --FPDSVLE--NLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNR-VSG-IIPPDICP-----GVSSLEELRLPDN  282 (1013)
Q Consensus       214 --~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~-----~l~~L~~L~L~~n  282 (1013)
                        +|..+ .  ++++|++|+|++|++.+.+|..++++++|++|++++|+ +++ .+|..+..     .+++|++|++++|
T Consensus       237 ~~ip~~l-~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n  315 (636)
T 4eco_A          237 QYKTEDL-KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN  315 (636)
T ss_dssp             HHTTSCC-CGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred             ccCchhh-hhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCC
Confidence              66653 4  78889999999998888888888888999999999987 876 56554421     2378889999999


Q ss_pred             cccccCCc--cccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCC-CceEECcccccccc
Q 036815          283 LITGVIPG--QLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKN-LKDLILNNNKLSGE  359 (1013)
Q Consensus       283 ~l~~~~~~--~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~  359 (1013)
                      +++ .+|.  .++++++|+.|++++|.++|.+| .++.+++|+.|++++|.++ .+|..++.+++ |++|++++|+++ .
T Consensus       316 ~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~  391 (636)
T 4eco_A          316 NLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-Y  391 (636)
T ss_dssp             CCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-S
T ss_pred             cCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-c
Confidence            888 7777  88888899999999999888888 8888888999999988888 78888888888 999999999988 7


Q ss_pred             CchhhcCCC--CCCeEEecCCccCCCCChhhh-------ccCCCceEEccCCeeeeecCCCC-cCCCCCcEEEccCCcCC
Q 036815          360 IPAELFSCS--NLEWISLTGNELTGQIPPEFS-------RLTRLAVLQLGNNRFKGEIPGEL-GNCSSLVWLDLNSNNLT  429 (1013)
Q Consensus       360 ~p~~l~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~  429 (1013)
                      +|..+..++  +|++|++++|++++.+|..|.       .+++|+.|+|++|+++ .+|..+ ..+++|++|+|++|+++
T Consensus       392 lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~  470 (636)
T 4eco_A          392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT  470 (636)
T ss_dssp             CCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS
T ss_pred             cchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC
Confidence            888777655  899999999999988888888       7888999999999998 566554 46889999999999888


Q ss_pred             cCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCc
Q 036815          430 GDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQT  509 (1013)
Q Consensus       430 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  509 (1013)
                       .+|..+...                                                            ....+..+++
T Consensus       471 -~i~~~~~~~------------------------------------------------------------~~~~~~~l~~  489 (636)
T 4eco_A          471 -EIPKNSLKD------------------------------------------------------------ENENFKNTYL  489 (636)
T ss_dssp             -BCCSSSSEE------------------------------------------------------------TTEECTTGGG
T ss_pred             -CcCHHHhcc------------------------------------------------------------ccccccccCC
Confidence             666542210                                                            0011233458


Q ss_pred             cCEEEccCCcccccCChhhh--CCCCCcEEecCCCccCCCCcccccCCCCcceEec------CCccccCCCcccccCCCc
Q 036815          510 LEYLDLSYNQFRGKIPDEIG--DMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDA------SHNRLQGQIPESFSNLSF  581 (1013)
Q Consensus       510 L~~L~ls~N~l~g~iP~~i~--~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~l------s~N~l~g~~p~~~~~l~~  581 (1013)
                      |++|||++|+++ .+|..++  .+++|+.|+|++|++++ +|..++++++|+.|+|      ++|++.|.+|..+..+++
T Consensus       490 L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~  567 (636)
T 4eco_A          490 LTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS  567 (636)
T ss_dssp             CCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSS
T ss_pred             ccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCC
Confidence            999999999999 8999998  99999999999999997 9999999999999999      568899999999999999


Q ss_pred             ceEEECcCCCCCCcCCCCCCCCCCCcccccCCCCCCC
Q 036815          582 LVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCG  618 (1013)
Q Consensus       582 l~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~lc~  618 (1013)
                      |+.|+|++|++ +.+|..- ...+..+.+.+|+..|-
T Consensus       568 L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~~  602 (636)
T 4eco_A          568 LTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNISI  602 (636)
T ss_dssp             CCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCEE
T ss_pred             CCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCccc
Confidence            99999999999 7788753 26888888999987663

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-46  Score=409.17  Aligned_cols=258  Identities=23%  Similarity=0.318  Sum_probs=189.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCC----EEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE----ERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  809 (1013)
                      ++|.+.+.||+|+||+||+|++. |+.||||++.... .....+..|+..+.+++|||||+++++|.+++    ..|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            45778899999999999999985 8999999885422 11222344555667889999999999998653    579999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC-----IPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      |||++|+|.++++..       .++|..+.+++.|+++||+|||+++     .++||||||||+|||++.++++||+|||
T Consensus        81 Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             ECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999743       3899999999999999999999752     3589999999999999999999999999


Q ss_pred             cceeccccCcce--eeeeeccCCCccCcccccCC------CCCccchhHhHHHHHHHHHcCCCCCCCCCCCC--------
Q 036815          885 MARLISALDTHL--SVSTLAGTPGYVPPEYYQSF------RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD--------  948 (1013)
Q Consensus       885 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~--------  948 (1013)
                      +|+.........  ......||+.|||||++.+.      .++.++|||||||++|||+||++||......+        
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            998875433322  22346799999999998764      46789999999999999999988775432211        


Q ss_pred             --ccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          949 --TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       949 --~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        .....+... .........++...            ...+....+.+++.+||+.||++||||+|
T Consensus       234 ~~~~~~~~~~~-~~~~~~rp~~p~~~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~e  287 (303)
T 3hmm_A          234 SDPSVEEMRKV-VCEQKLRPNIPNRW------------QSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             SSCCHHHHHHH-HTTSCCCCCCCGGG------------GSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             ccchHHHHHHH-HhcccCCCCCCccc------------cchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence              111222221 11111111111110            01122334678999999999999999864

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.6e-44  Score=438.86  Aligned_cols=529  Identities=22%  Similarity=0.218  Sum_probs=389.5

Q ss_pred             eecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCC
Q 036815            4 VLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSY   83 (1013)
Q Consensus         4 ~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~   83 (1013)
                      ..+.++.+++.+|+.   +|+++++|+|++|+|+. ++...|.++++|++|+|++|+|+ .++..+|.++++|++|+|++
T Consensus        35 ~~~c~~~~l~~vP~~---lp~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~  109 (635)
T 4g8a_A           35 TYQCMELNFYKIPDN---LPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG  109 (635)
T ss_dssp             EEECTTSCCSSCCSS---SCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTT
T ss_pred             EEECCCCCcCccCCC---CCcCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccC
Confidence            356778889999985   78899999999999976 67788999999999999999998 67777789999999999999


Q ss_pred             CcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCccccc-CcccccCCCCCCEeeCcCCccc
Q 036815           84 NNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGE-IPRTFGQLSSLQRLDLSNNHIT  162 (1013)
Q Consensus        84 n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~  162 (1013)
                      |+|+..+...+   ..+++|++|+|++|+|+++.+..|+++++|++|+|++|++++. .|..++.+++|++|++++|+++
T Consensus       110 N~l~~l~~~~f---~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~  186 (635)
T 4g8a_A          110 NPIQSLALGAF---SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ  186 (635)
T ss_dssp             CCCCEECGGGG---TTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CcCCCCCHHHh---cCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccc
Confidence            99987665433   4688999999999999998888899999999999999999864 5788899999999999999999


Q ss_pred             CcCCccchhccCC----CcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccC---
Q 036815          163 GWIPSELGNACDS----LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI---  235 (1013)
Q Consensus       163 ~~~~~~~~~~l~~----L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l---  235 (1013)
                      +..+..+ ..+.+    +..++++.|.++.+.+..+. ...++.+++.+|.....+....+..+..++...+..+..   
T Consensus       187 ~~~~~~l-~~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~  264 (635)
T 4g8a_A          187 SIYCTDL-RVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE  264 (635)
T ss_dssp             EECGGGG-HHHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTS
T ss_pred             ccccccc-cchhhhhhhhhhhhcccCcccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccc
Confidence            5444443 33333    45799999999976665554 446788999998766445556677888888777754433   


Q ss_pred             ---CCcCCcCCCCCCCcCEEEecCCeeccc--CCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCC
Q 036815          236 ---SGSFPDSISSCKTLRIVDFSSNRVSGI--IPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG  310 (1013)
Q Consensus       236 ---~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~  310 (1013)
                         .......+..+..+...++..+.....  .....+..+.+++.+.+.++.+....  .+.....|+.|++++|.+.+
T Consensus       265 ~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~  342 (635)
T 4g8a_A          265 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQ  342 (635)
T ss_dssp             CCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESS
T ss_pred             cccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccC
Confidence               222334455555666666654432211  11233445677888888888877543  35667789999999998875


Q ss_pred             CCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccc--cCchhhcCCCCCCeEEecCCccCCCCChhh
Q 036815          311 SIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG--EIPAELFSCSNLEWISLTGNELTGQIPPEF  388 (1013)
Q Consensus       311 ~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  388 (1013)
                      ..+..   +..|+.+.+..|....  +.....+++|+.|++++|.+..  ..+..+..+.+|+.|+++.|.+. ..+..+
T Consensus       343 ~~~~~---l~~L~~l~l~~n~~~~--~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~  416 (635)
T 4g8a_A          343 FPTLK---LKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNF  416 (635)
T ss_dssp             CCCCB---CTTCCEEEEESCCSCC--BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCC
T ss_pred             cCccc---chhhhhcccccccCCC--Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccc
Confidence            44433   4455566666666653  3345578888899998888753  45667778888888888888877 456677


Q ss_pred             hccCCCceEEccCCeeeeecC-CCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCC
Q 036815          389 SRLTRLAVLQLGNNRFKGEIP-GELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGV  467 (1013)
Q Consensus       389 ~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (1013)
                      ..+++|+.+++..|......+ ..+..+++|+.++++.|.+++..|..                                
T Consensus       417 ~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~--------------------------------  464 (635)
T 4g8a_A          417 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI--------------------------------  464 (635)
T ss_dssp             TTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTT--------------------------------
T ss_pred             cccccccchhhhhccccccccccccccccccccccccccccccccccc--------------------------------
Confidence            888888888888888775554 45678888888888888887654432                                


Q ss_pred             CcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcc-cccCChhhhCCCCCcEEecCCCccCC
Q 036815          468 GGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQF-RGKIPDEIGDMIALQVLELAHNQLSG  546 (1013)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l-~g~iP~~i~~l~~L~~L~L~~n~l~g  546 (1013)
                                                          +..++.|+.|++++|++ .+.+|..++.+++|++|+|++|+|++
T Consensus       465 ------------------------------------~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~  508 (635)
T 4g8a_A          465 ------------------------------------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ  508 (635)
T ss_dssp             ------------------------------------TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred             ------------------------------------cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCC
Confidence                                                22345567777777764 33466677777777777777777776


Q ss_pred             CCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCCC-CCC-CCCCcccccCCCCCCC
Q 036815          547 EIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQR-GQL-STLPASQYANNPGLCG  618 (1013)
Q Consensus       547 ~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~-~~~-~~~~~~~~~~n~~lc~  618 (1013)
                      ..|..|+++++|++|+|++|+|++..|..|..+++|+.|||++|++++.+|.. ..+ .++..+...|||.-|.
T Consensus       509 l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          509 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             cChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            66777777777777777777777666677777777777777777777776653 333 4566666777777774

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.3e-46  Score=401.85  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=183.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCC--------
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGE--------  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  803 (1013)
                      ++|++.+.||+|+||+||+|+++ +++.||||++...... ..+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35889999999999999999986 6899999998654332 3467899999999999999999999986543        


Q ss_pred             ----EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEE
Q 036815          804 ----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEAR  879 (1013)
Q Consensus       804 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  879 (1013)
                          ..|+||||++||+|.+++......   ...++..++.++.||++||+|||++   +||||||||+|||++.++.+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence                368999999999999999754321   2256677889999999999999999   999999999999999999999


Q ss_pred             EeecccceeccccCcce----------eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCc
Q 036815          880 VSDFGMARLISALDTHL----------SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT  949 (1013)
Q Consensus       880 l~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~  949 (1013)
                      |+|||+|+.+.......          ......||+.|||||++.+..|+.++||||+||++|||++   ||....    
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----  231 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----  231 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----
Confidence            99999998765432211          1234579999999999999999999999999999999996   775311    


Q ss_pred             cHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          950 NLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       950 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...... .........    +..           .   .......+++.+||+.||++|||++|
T Consensus       232 ~~~~~~-~~~~~~~~p----~~~-----------~---~~~~~~~~li~~~L~~dP~~Rps~~e  276 (299)
T 4g31_A          232 ERVRTL-TDVRNLKFP----PLF-----------T---QKYPCEYVMVQDMLSPSPMERPEAIN  276 (299)
T ss_dssp             HHHHHH-HHHHTTCCC----HHH-----------H---HHCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHH-HHHhcCCCC----CCC-----------c---ccCHHHHHHHHHHcCCChhHCcCHHH
Confidence            111111 111111111    100           0   11122457999999999999999864

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=9.4e-44  Score=433.93  Aligned_cols=511  Identities=21%  Similarity=0.190  Sum_probs=416.3

Q ss_pred             cceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeC
Q 036815            2 LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL   81 (1013)
Q Consensus         2 l~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~L   81 (1013)
                      ++.|||++|+|+.+++..|...++|++|+|++|+|.+ +++++|.++++|++|+|++|+|+ .+|...|.++++|++|+|
T Consensus        54 ~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~-i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           54 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEEC
T ss_pred             CCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCC-cChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEEC
Confidence            6899999999999999999999999999999999976 78888999999999999999998 677788999999999999


Q ss_pred             CCCcccCccCCCCcCCCCCCcccEEECCCCCCCCC-CCccccCCCCCCEEecCCCcccccCcccccCCCCC----CEeeC
Q 036815           82 SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSL----QRLDL  156 (1013)
Q Consensus        82 s~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L  156 (1013)
                      ++|++++.....   ...+++|++|+|++|.++.+ .|..+..+++|++|++++|++++..+..|..+.++    ..+++
T Consensus       132 s~N~l~~l~~~~---~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~l  208 (635)
T 4g8a_A          132 VETNLASLENFP---IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL  208 (635)
T ss_dssp             TTSCCCCSTTCC---CTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred             CCCcCCCCChhh---hhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhc
Confidence            999999765543   25788999999999999875 57788999999999999999998888888766544    47899


Q ss_pred             cCCcccCcCCccchhccCCCcEEECCCCCCCC-cCCccccCCCCCCEEEccCCCCCC-----CCChhhhhcCCCCcEEEc
Q 036815          157 SNNHITGWIPSELGNACDSLLELKLPHNNITG-SFPVTLSSCSWLQLLDLSNNNISG-----PFPDSVLENLGSLESLIL  230 (1013)
Q Consensus       157 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~-----~~~~~~~~~l~~L~~L~L  230 (1013)
                      +.|.++ .++...+.. ..+..+++.+|.... ..+..+..+..++...+..+....     ......+..+..+....+
T Consensus       209 s~n~l~-~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l  286 (635)
T 4g8a_A          209 SLNPMN-FIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF  286 (635)
T ss_dssp             TTCCCC-EECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEE
T ss_pred             ccCccc-ccCcccccc-hhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhh
Confidence            999998 566665554 467889998886553 334456777888877765443221     122233455666777766


Q ss_pred             ccccCCC---cCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCc
Q 036815          231 SNNMISG---SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNY  307 (1013)
Q Consensus       231 ~~n~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~  307 (1013)
                      ..+....   .....+..+.+++.+++.+|.+....+   +.....++.|++.+|.+....+   ..+..|+.++++.|.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~---~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~  360 (635)
T 4g8a_A          287 RLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNK  360 (635)
T ss_dssp             EEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGG---GGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCC
T ss_pred             hhhhhcccccchhhhhhhhcccccccccccccccccc---cccchhhhhhhcccccccCcCc---ccchhhhhccccccc
Confidence            6554432   234556667889999999998874322   2345678999999998876544   356778899999998


Q ss_pred             cCCCCCcccccCcchHHHHhhhccccC--CCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCC
Q 036815          308 LNGSIPQELGKLEHLEQFIAWFNGLEG--KIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIP  385 (1013)
Q Consensus       308 l~~~~p~~l~~l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  385 (1013)
                      +...  .....+++|+.++++.|.+..  ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.+++++|+.....+
T Consensus       361 ~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~  437 (635)
T 4g8a_A          361 GGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE  437 (635)
T ss_dssp             SCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTS
T ss_pred             CCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccc
Confidence            7643  345578889999999988753  45667778899999999999988 566778899999999999998775554


Q ss_pred             -hhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCc
Q 036815          386 -PEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSC  464 (1013)
Q Consensus       386 -~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (1013)
                       ..|..+++++.++++.|.+.+..|..+..+++|++|+|++|++...+                                
T Consensus       438 ~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~--------------------------------  485 (635)
T 4g8a_A          438 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF--------------------------------  485 (635)
T ss_dssp             SCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE--------------------------------
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhhccccccc--------------------------------
Confidence             56889999999999999999999999999999999999999754321                                


Q ss_pred             cCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCcc
Q 036815          465 KGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQL  544 (1013)
Q Consensus       465 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l  544 (1013)
                                                         .|..|..+++|++|||++|++++..|..|+++++|++|+|++|+|
T Consensus       486 -----------------------------------~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l  530 (635)
T 4g8a_A          486 -----------------------------------LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF  530 (635)
T ss_dssp             -----------------------------------ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             -----------------------------------CchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcC
Confidence                                               123345668899999999999999999999999999999999999


Q ss_pred             CCCCcccccCCCCcceEecCCccccCCCcccccCC-CcceEEECcCCCCCCc
Q 036815          545 SGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL-SFLVQIDLSNNELTGP  595 (1013)
Q Consensus       545 ~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~~l~~l~l~~n~l~~~  595 (1013)
                      ++..|..|.++++|++|||++|+|++..|..+..+ ++|+.|+|++|++++.
T Consensus       531 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          531 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             CBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            98888899999999999999999999999999998 6899999999999874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.3e-44  Score=442.89  Aligned_cols=415  Identities=20%  Similarity=0.237  Sum_probs=344.9

Q ss_pred             CcccEEECCCCCCCCCCCccccCCCCCCEEec-CCCcccccCccc-----------------------------------
Q 036815          101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNL-SFNLLAGEIPRT-----------------------------------  144 (1013)
Q Consensus       101 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L-~~n~l~~~~~~~-----------------------------------  144 (1013)
                      ..++.|+|++|.+.+.+|..|+++++|++|+| ++|.+.+..+-.                                   
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            46889999999999888999999999999999 888776542211                                   


Q ss_pred             ----------------ccCCCCCCEeeCcC--CcccCcCCccchhccCCCcEEECCCCCCCC-----------------c
Q 036815          145 ----------------FGQLSSLQRLDLSN--NHITGWIPSELGNACDSLLELKLPHNNITG-----------------S  189 (1013)
Q Consensus       145 ----------------~~~l~~L~~L~Ls~--n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~  189 (1013)
                                      ......++.+.++.  |.+++ +|..+.. +++|++|+|++|++++                 .
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~-L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~  480 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQR-LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY  480 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhc-CCCCCEEECcCCcCCCCccccccccccccccccc
Confidence                            01223445555554  88885 8877654 6899999999999998                 2


Q ss_pred             CCcccc--CCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEccccc-CCC-cCCcCCCCC-------CCcCEEEecCCe
Q 036815          190 FPVTLS--SCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNM-ISG-SFPDSISSC-------KTLRIVDFSSNR  258 (1013)
Q Consensus       190 ~~~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l-------~~L~~L~L~~N~  258 (1013)
                      +|..++  ++++|++|+|++|.+.+.+|.. +.++++|++|+|++|+ +++ .+|..++.+       ++|+.|++++|+
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~-l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~  559 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDF-LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN  559 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGG-GGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHH-HhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCc
Confidence            777777  9999999999999988888854 6889999999999998 887 677655554       499999999999


Q ss_pred             ecccCCC-CCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcc-hHHHHhhhccccCCC
Q 036815          259 VSGIIPP-DICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEH-LEQFIAWFNGLEGKI  336 (1013)
Q Consensus       259 l~~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~-L~~L~l~~n~l~~~~  336 (1013)
                      ++ .+|. ..+..+++|+.|+|++|.++ .+| .++.+++|+.|++++|+++ .+|..+.++++ |+.|++++|.++ .+
T Consensus       560 L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~l  634 (876)
T 4ecn_A          560 LE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI  634 (876)
T ss_dssp             CC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SC
T ss_pred             CC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cC
Confidence            98 6665 24567899999999999999 777 8999999999999999999 89999999999 999999999998 78


Q ss_pred             CcCcCCCCC--CceEECccccccccCchh---hc--CCCCCCeEEecCCccCCCCChhh-hccCCCceEEccCCeeeeec
Q 036815          337 PPELGKCKN--LKDLILNNNKLSGEIPAE---LF--SCSNLEWISLTGNELTGQIPPEF-SRLTRLAVLQLGNNRFKGEI  408 (1013)
Q Consensus       337 p~~~~~l~~--L~~L~L~~N~l~~~~p~~---l~--~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~  408 (1013)
                      |..+..++.  |+.|+|++|++++.+|..   +.  .+++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+++ .+
T Consensus       635 p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~i  712 (876)
T 4ecn_A          635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SI  712 (876)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CC
T ss_pred             chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-cc
Confidence            888887765  999999999999876643   22  3458999999999999 677665 58999999999999999 77


Q ss_pred             CCCCcCC--------CCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCccc
Q 036815          409 PGELGNC--------SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER  480 (1013)
Q Consensus       409 p~~~~~l--------~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  480 (1013)
                      |..+...        ++|++|+|++|+++ .+|..+..                                          
T Consensus       713 p~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~------------------------------------------  749 (876)
T 4ecn_A          713 PENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA------------------------------------------  749 (876)
T ss_dssp             CTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGST------------------------------------------
T ss_pred             ChHHhccccccccccCCccEEECCCCCCc-cchHHhhh------------------------------------------
Confidence            8766543        39999999999998 56644320                                          


Q ss_pred             ccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCC------CccCCCCcccccC
Q 036815          481 LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAH------NQLSGEIPSSLGR  554 (1013)
Q Consensus       481 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~------n~l~g~ip~~~~~  554 (1013)
                                              ..+++|+.|+|++|++++ +|.+++.+++|+.|+|++      |+++|.+|.+|++
T Consensus       750 ------------------------~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~  804 (876)
T 4ecn_A          750 ------------------------TTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT  804 (876)
T ss_dssp             ------------------------TTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGG
T ss_pred             ------------------------ccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhc
Confidence                                    135679999999999996 999999999999999976      8899999999999


Q ss_pred             CCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcC
Q 036815          555 LRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPI  596 (1013)
Q Consensus       555 l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~  596 (1013)
                      +++|+.|+|++|++ +.||..+.  ++|+.|||++|++...-
T Consensus       805 L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~  843 (876)
T 4ecn_A          805 CPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISID  843 (876)
T ss_dssp             CSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEE
T ss_pred             CCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccC
Confidence            99999999999999 79999876  69999999999987644

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=5.3e-44  Score=427.67  Aligned_cols=455  Identities=20%  Similarity=0.190  Sum_probs=236.2

Q ss_pred             CCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCE
Q 036815           74 DKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQR  153 (1013)
Q Consensus        74 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  153 (1013)
                      ...+.+++++|+++.++..+      .++|++|+|++|.|+++.+..|.++++|++|+|++|++++..|.+|.++++|++
T Consensus        31 ~~~~~l~ls~~~L~~ip~~~------~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  104 (562)
T 3a79_B           31 ELESMVDYSNRNLTHVPKDL------PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY  104 (562)
T ss_dssp             --CCEEECTTSCCCSCCTTS------CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred             CCCcEEEcCCCCCccCCCCC------CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCE
Confidence            33466666666666444322      256667777777776666666777777777777777777666666777777777


Q ss_pred             eeCcCCcccCcCCccchhccCCCcEEECCCCCCCCc-CCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCC--cEEEc
Q 036815          154 LDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS-FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSL--ESLIL  230 (1013)
Q Consensus       154 L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L--~~L~L  230 (1013)
                      |++++|.++ .+|..   .+++|++|+|++|++++. .|..|.++++|++|++++|++++.    .+..+++|  ++|++
T Consensus       105 L~Ls~N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~L~L~~L~L  176 (562)
T 3a79_B          105 LDVSHNRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL----DLLPVAHLHLSCILL  176 (562)
T ss_dssp             EECTTSCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT----TTGGGTTSCEEEEEE
T ss_pred             EECCCCcCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC----chhhhhhceeeEEEe
Confidence            777777776 56655   356777777777777653 246677777777777777776631    13344444  77777


Q ss_pred             ccccC--CCcCCcCCCCCC-CcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCc-----ccccCCccccccCcccEEE
Q 036815          231 SNNMI--SGSFPDSISSCK-TLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNL-----ITGVIPGQLSECTQLKVID  302 (1013)
Q Consensus       231 ~~n~l--~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~-----l~~~~~~~~~~l~~L~~L~  302 (1013)
                      ++|++  ++..|..+..+. ..-.+++++|.+.+.++...+..+++|+.|++++|.     +.+. ...+..++.|+.|+
T Consensus       177 ~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~  255 (562)
T 3a79_B          177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVT  255 (562)
T ss_dssp             EESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEE
T ss_pred             ecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEE
Confidence            77776  555565555543 112446666666655555555556666666666663     1111 12344445555555


Q ss_pred             eeCCccCCCC----CcccccCcchHHHHhhhccccCCCCcCc-----CCCCCCceEECccccccccCc-hhhcC---CCC
Q 036815          303 LSLNYLNGSI----PQELGKLEHLEQFIAWFNGLEGKIPPEL-----GKCKNLKDLILNNNKLSGEIP-AELFS---CSN  369 (1013)
Q Consensus       303 ls~N~l~~~~----p~~l~~l~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~l~~---l~~  369 (1013)
                      ++++.+.+..    +..+ ...+|+.|++++|.+++.+|..+     .+++.|+.++++.|.+  .+| ..+..   ..+
T Consensus       256 L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~  332 (562)
T 3a79_B          256 LQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMN  332 (562)
T ss_dssp             EEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCC
T ss_pred             ecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCc
Confidence            5554443211    1111 12245555555555555555544     4444444444444444  222 12211   134


Q ss_pred             CCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcC--CCchhhhccCCCCCCC
Q 036815          370 LEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGD--IPPRLGRQLGAKPLGG  447 (1013)
Q Consensus       370 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~~~~~~~~~~  447 (1013)
                      |+.|++++|.+....  ....+++|++|++++|++++.+|..+.++++|++|++++|++++.  +|..++          
T Consensus       333 L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~----------  400 (562)
T 3a79_B          333 IKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK----------  400 (562)
T ss_dssp             CSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTT----------
T ss_pred             ceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhc----------
Confidence            555555555443111  013444555555555555544455555555555555555544421  000000          


Q ss_pred             cccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCc-cc-ccccCCCccCEEEccCCcccccCC
Q 036815          448 FLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGP-VL-SLFTQYQTLEYLDLSYNQFRGKIP  525 (1013)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~-~~~~~~~~L~~L~ls~N~l~g~iP  525 (1013)
                                                         .++.|+.++++++.... +| ..+..+++|++|++++|++++.+|
T Consensus       401 -----------------------------------~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  445 (562)
T 3a79_B          401 -----------------------------------NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF  445 (562)
T ss_dssp             -----------------------------------TCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGG
T ss_pred             -----------------------------------CCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchh
Confidence                                               00000001111000000 00 012233456666666666665555


Q ss_pred             hhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCccc-ccCCCcceEEECcCCCCCCcCC
Q 036815          526 DEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPES-FSNLSFLVQIDLSNNELTGPIP  597 (1013)
Q Consensus       526 ~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~l~~l~l~~n~l~~~~p  597 (1013)
                      ..+.  ++|++|+|++|+++ .||..+..+++|+.|+|++|+|+ .+|.. +..+++|+.|++++|++++..|
T Consensus       446 ~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          446 RCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             SSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             hhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            5443  45666666666666 56665556666666666666665 45544 5566666666666666665444

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=4.7e-44  Score=428.12  Aligned_cols=460  Identities=20%  Similarity=0.173  Sum_probs=282.9

Q ss_pred             ceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCC
Q 036815            3 SVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS   82 (1013)
Q Consensus         3 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls   82 (1013)
                      +.+|+++|+++.+|..   .++++++|+|++|++.+ ++...|.++++|++|+|++|.|++ ++...+.++++|++|+|+
T Consensus        34 ~~l~ls~~~L~~ip~~---~~~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls  108 (562)
T 3a79_B           34 SMVDYSNRNLTHVPKD---LPPRTKALSLSQNSISE-LRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVS  108 (562)
T ss_dssp             CEEECTTSCCCSCCTT---SCTTCCEEECCSSCCCC-CCGGGTTTCTTCCEEECCSCCCCE-ECTTTTTTCTTCCEEECT
T ss_pred             cEEEcCCCCCccCCCC---CCCCcCEEECCCCCccc-cChhhhccCCCccEEECCCCCCCc-CCHHHhCCCCCCCEEECC
Confidence            3566666666666654   23556666666666654 344456666666666666666653 333345566666666666


Q ss_pred             CCcccCccCCCCcCCCCCCcccEEECCCCCCCCCC-CccccCCCCCCEEecCCCcccccCcccccCCCCC--CEeeCcCC
Q 036815           83 YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVI-PSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSL--QRLDLSNN  159 (1013)
Q Consensus        83 ~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~Ls~n  159 (1013)
                      +|+++..+..      .+++|++|+|++|+++++. |..|.++++|++|++++|++++.   .+..+++|  ++|++++|
T Consensus       109 ~N~l~~lp~~------~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n  179 (562)
T 3a79_B          109 HNRLQNISCC------PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLV  179 (562)
T ss_dssp             TSCCCEECSC------CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEES
T ss_pred             CCcCCccCcc------ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecc
Confidence            6666533222      3556666666666665532 35566666666666666666542   23333333  66666666


Q ss_pred             cc--cCcCCccchhccCCCcEEECCCCCCCCcCCc-cccCCCCCCEEEccCCCCCC-CCC--hhhhhcCCCCcEEEcccc
Q 036815          160 HI--TGWIPSELGNACDSLLELKLPHNNITGSFPV-TLSSCSWLQLLDLSNNNISG-PFP--DSVLENLGSLESLILSNN  233 (1013)
Q Consensus       160 ~l--~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~N~l~~-~~~--~~~~~~l~~L~~L~L~~n  233 (1013)
                      .+  ++..|..+...-.+...+++++|.+.+..+. .+..+++|+.|++++|+..- .++  ...+..+++|+.|+++++
T Consensus       180 ~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~  259 (562)
T 3a79_B          180 SYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI  259 (562)
T ss_dssp             SCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEE
T ss_pred             cccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCC
Confidence            55  4444443332111122445555555443322 33445555555555553110 000  012344455555555554


Q ss_pred             cCCCcC----CcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccC
Q 036815          234 MISGSF----PDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN  309 (1013)
Q Consensus       234 ~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~  309 (1013)
                      .+++..    +..+ ..++|++|++++|.+++.+|..++...                    ..+++.|+.++++.|.+ 
T Consensus       260 ~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~--------------------~~~L~~L~~~~~~~~~~-  317 (562)
T 3a79_B          260 ETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYS--------------------ETALKSLMIEHVKNQVF-  317 (562)
T ss_dssp             EECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCC--------------------SCSCCEEEEEEEEECCC-
T ss_pred             cCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcc--------------------cccchheehhhccccee-
Confidence            443210    0001 112455555555555444444332100                    04444444444444444 


Q ss_pred             CCCC-cccccC---cchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCC--
Q 036815          310 GSIP-QELGKL---EHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQ--  383 (1013)
Q Consensus       310 ~~~p-~~l~~l---~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--  383 (1013)
                       .+| ..+..+   .+|+.|++++|.+....  ....+++|++|++++|++++.+|..+..+++|++|+|++|++++.  
T Consensus       318 -~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  394 (562)
T 3a79_B          318 -LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK  394 (562)
T ss_dssp             -SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH
T ss_pred             -ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCccc
Confidence             233 122111   33445555555543211  126788999999999999988999999999999999999999963  


Q ss_pred             CChhhhccCCCceEEccCCeeeeecCC-CCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCC
Q 036815          384 IPPEFSRLTRLAVLQLGNNRFKGEIPG-ELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGN  462 (1013)
Q Consensus       384 ~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (1013)
                      +|..+..+++|+.|+|++|++++.+|. .+..+++|++|++++|++++.+|..+.                         
T Consensus       395 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-------------------------  449 (562)
T 3a79_B          395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP-------------------------  449 (562)
T ss_dssp             HHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-------------------------
T ss_pred             chhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-------------------------
Confidence            356789999999999999999975665 488999999999999999865543210                         


Q ss_pred             CccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCC
Q 036815          463 SCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHN  542 (1013)
Q Consensus       463 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n  542 (1013)
                                                                   ++|++|||++|+++ .+|.++..+++|++|+|++|
T Consensus       450 ---------------------------------------------~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N  483 (562)
T 3a79_B          450 ---------------------------------------------PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN  483 (562)
T ss_dssp             ---------------------------------------------TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSS
T ss_pred             ---------------------------------------------CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCC
Confidence                                                         46899999999999 89999999999999999999


Q ss_pred             ccCCCCccc-ccCCCCcceEecCCccccCCCc
Q 036815          543 QLSGEIPSS-LGRLRNLGVFDASHNRLQGQIP  573 (1013)
Q Consensus       543 ~l~g~ip~~-~~~l~~L~~L~ls~N~l~g~~p  573 (1013)
                      +++ .+|.. +..+++|+.|++++|.+++..|
T Consensus       484 ~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          484 QLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            999 78887 9999999999999999998776

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.7e-44  Score=438.06  Aligned_cols=377  Identities=20%  Similarity=0.240  Sum_probs=273.5

Q ss_pred             CcccccCcccccCCCCCCEeeCcCCcccC-----------------cCCccc-hhccCCCcEEECCCCCCCCcCCccccC
Q 036815          135 NLLAGEIPRTFGQLSSLQRLDLSNNHITG-----------------WIPSEL-GNACDSLLELKLPHNNITGSFPVTLSS  196 (1013)
Q Consensus       135 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-----------------~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~l~~  196 (1013)
                      |++++ +|..|+++++|++|+|++|.+++                 .+|..+ +..+++|++|+|++|++.+.+|..+.+
T Consensus       435 N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~  513 (876)
T 4ecn_A          435 NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD  513 (876)
T ss_dssp             CEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGG
T ss_pred             Ccccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhC
Confidence            55554 45555555555555555555554                 256555 234566666666666666666666666


Q ss_pred             CCCCCEEEccCCC-CCC-CCChhh------hhcCCCCcEEEcccccCCCcCCc--CCCCCCCcCEEEecCCeecccCCCC
Q 036815          197 CSWLQLLDLSNNN-ISG-PFPDSV------LENLGSLESLILSNNMISGSFPD--SISSCKTLRIVDFSSNRVSGIIPPD  266 (1013)
Q Consensus       197 l~~L~~L~L~~N~-l~~-~~~~~~------~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~  266 (1013)
                      +++|+.|+|++|+ +++ .+|..+      +..+++|++|+|++|+++ .+|.  .++++++|+.|++++|+++ .+|  
T Consensus       514 L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp--  589 (876)
T 4ecn_A          514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE--  589 (876)
T ss_dssp             CSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC--
T ss_pred             CCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch--
Confidence            6666666666666 654 444432      122346777777777666 5666  6666677777777777666 555  


Q ss_pred             CCCCCCCCceEEcCCCcccccCCccccccCc-ccEEEeeCCccCCCCCcccccCcc--hHHHHhhhccccCCCCc---Cc
Q 036815          267 ICPGVSSLEELRLPDNLITGVIPGQLSECTQ-LKVIDLSLNYLNGSIPQELGKLEH--LEQFIAWFNGLEGKIPP---EL  340 (1013)
Q Consensus       267 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~ls~N~l~~~~p~~l~~l~~--L~~L~l~~n~l~~~~p~---~~  340 (1013)
                      .+..+++|+.|+|++|.++ .+|..+..+++ |+.|++++|.++ .+|..+..+..  |+.|++++|.+.+.+|.   .+
T Consensus       590 ~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l  667 (876)
T 4ecn_A          590 AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM  667 (876)
T ss_dssp             CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCT
T ss_pred             hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhh
Confidence            4456666777777777766 56666666666 777777777776 66666665543  77777777777665443   22


Q ss_pred             C--CCCCCceEECccccccccCchhhc-CCCCCCeEEecCCccCCCCChhhhc--------cCCCceEEccCCeeeeecC
Q 036815          341 G--KCKNLKDLILNNNKLSGEIPAELF-SCSNLEWISLTGNELTGQIPPEFSR--------LTRLAVLQLGNNRFKGEIP  409 (1013)
Q Consensus       341 ~--~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~--------l~~L~~L~L~~N~l~~~~p  409 (1013)
                      .  .+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+++ .+|..+..        +++|+.|+|++|+++ .+|
T Consensus       668 ~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp  744 (876)
T 4ecn_A          668 DDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS  744 (876)
T ss_dssp             TTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCC
T ss_pred             ccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cch
Confidence            2  3458999999999999 6776665 8999999999999999 77766543        338999999999999 889


Q ss_pred             CCCc--CCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCcc
Q 036815          410 GELG--NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTL  487 (1013)
Q Consensus       410 ~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  487 (1013)
                      ..+.  .+++|+.|+|++|++++ +|..++                                                  
T Consensus       745 ~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~--------------------------------------------------  773 (876)
T 4ecn_A          745 DDFRATTLPYLSNMDVSYNCFSS-FPTQPL--------------------------------------------------  773 (876)
T ss_dssp             GGGSTTTCTTCCEEECCSSCCSS-CCCGGG--------------------------------------------------
T ss_pred             HHhhhccCCCcCEEEeCCCCCCc-cchhhh--------------------------------------------------
Confidence            9887  99999999999999987 665443                                                  


Q ss_pred             ccccccccccCcccccccCCCccCEEEccC------CcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceE
Q 036815          488 KSCDFARMYSGPVLSLFTQYQTLEYLDLSY------NQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVF  561 (1013)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~------N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L  561 (1013)
                                        .+++|+.|+|++      |++.+.+|.+++.+++|+.|+|++|++ +.||..+.  ++|+.|
T Consensus       774 ------------------~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~L  832 (876)
T 4ecn_A          774 ------------------NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYIL  832 (876)
T ss_dssp             ------------------GCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEE
T ss_pred             ------------------cCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEE
Confidence                              345688888865      889999999999999999999999999 69999987  699999


Q ss_pred             ecCCccccCCCcccccCCCcceEEECcCCCCC
Q 036815          562 DASHNRLQGQIPESFSNLSFLVQIDLSNNELT  593 (1013)
Q Consensus       562 ~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~  593 (1013)
                      ||++|++...-+..+.....+..+.|++|++.
T Consensus       833 dLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          833 DIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             ECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred             ECCCCCCCccChHHccccccchheeecCCCcc
Confidence            99999998666677776667778888888765

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-44  Score=401.39  Aligned_cols=200  Identities=28%  Similarity=0.414  Sum_probs=171.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  806 (1013)
                      ..++|++.+.||+|+||+||+|+++    .++.||+|++.+.  ....++.+|+++++++ +||||+++++++.+.++.|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            3578999999999999999999864    3678999988553  3356788999999998 6999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeeccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGM  885 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~  885 (1013)
                      +||||++||+|.+++.         .+++.+++.+++|++.||+|||++   |||||||||+|||++.+ +.+||+|||+
T Consensus        97 lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            9999999999999983         288999999999999999999999   99999999999999877 7999999999


Q ss_pred             ceeccccCc--------------------------ceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCC
Q 036815          886 ARLISALDT--------------------------HLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGK  938 (1013)
Q Consensus       886 a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~  938 (1013)
                      |+.......                          ........||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            986543211                          0112345799999999999775 5899999999999999999999


Q ss_pred             CCCCCCC
Q 036815          939 RPTDKDD  945 (1013)
Q Consensus       939 ~pf~~~~  945 (1013)
                      .||....
T Consensus       245 ~Pf~~~~  251 (361)
T 4f9c_A          245 YPFYKAS  251 (361)
T ss_dssp             SSSSCCS
T ss_pred             CCCCCCC
Confidence            9997543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=400.69  Aligned_cols=202  Identities=26%  Similarity=0.431  Sum_probs=172.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEe------CCE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKI------GEE  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  804 (1013)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....  ...+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999986 689999999864332  234568899999999999999999998764      357


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+|||||+ |+|.+++...      ..+++..++.+++||+.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence            899999997 6799999643      2489999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccC--cceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          885 MARLISALD--THLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       885 ~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +|+.+....  .........||+.|||||++.+. .++.++||||+||++|||++|++||.+.+
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~  267 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN  267 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence            998764322  12233457899999999998775 56899999999999999999999998643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-42  Score=404.47  Aligned_cols=242  Identities=24%  Similarity=0.339  Sum_probs=194.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHH---HHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMA---EMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.++||+|+||+||+|+++ +|+.||+|++.+..   ......+.+   ++.+++.++|||||+++++|.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999987 68999999986432   122233333   456677789999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||++||+|.+++....      .+++..++.++.||+.||+|||++   +||||||||+|||++.+|++||+|||+|
T Consensus       269 lVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEeccccee
Confidence            9999999999999997543      389999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-cCcc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-EGKQ  964 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~  964 (1013)
                      +.+....    ....+||+.|||||++. +..|+.++||||+||++|||++|++||.+....+  ..+....... ....
T Consensus       340 ~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~~~~~~~  413 (689)
T 3v5w_A          340 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVEL  413 (689)
T ss_dssp             EECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHHHCCCCC
T ss_pred             eecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcCCCCCC
Confidence            8765322    23568999999999996 4579999999999999999999999997644332  1222221111 1111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      ...+++                     .+.+++.+||+.||++|++.
T Consensus       414 p~~~S~---------------------~a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          414 PDSFSP---------------------ELRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             CTTSCH---------------------HHHHHHHHHTCSCGGGCTTC
T ss_pred             CccCCH---------------------HHHHHHHHHccCCHhHCCCC
Confidence            111111                     24589999999999999984

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.8e-43  Score=413.57  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=203.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+++..|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57999999999999999999986 68999999987665556677899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC--CcEEEeecccceecc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE--MEARVSDFGMARLIS  890 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~a~~~~  890 (1013)
                      +||+|.+++....     ..+++..++.++.||+.||+|||++   +|+||||||+||+++.+  +.+||+|||+|+.+.
T Consensus       237 ~gg~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          237 SGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             CCCBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             CCCcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999996432     2389999999999999999999999   99999999999999864  899999999999875


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-CccccccC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEVID  969 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~d  969 (1013)
                      ..   .......||+.|||||++.+..|+.++||||+||++|||++|+.||.+...     .+........ ........
T Consensus       309 ~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~~  380 (573)
T 3uto_A          309 PK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNVKSCDWNMDDSAF  380 (573)
T ss_dssp             TT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTCCCCCSGGG
T ss_pred             CC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHhCCCCCCcccc
Confidence            42   234456899999999999999999999999999999999999999976431     1111111111 11111000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             ...+          ..+.+|+.+||+.||++|||++|
T Consensus       381 -------~~~s----------~~~~dli~~~L~~dp~~R~t~~e  407 (573)
T 3uto_A          381 -------SGIS----------EDGKDFIRKLLLADPNTRMTIHQ  407 (573)
T ss_dssp             -------TTSC----------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             -------cCCC----------HHHHHHHHHHccCChhHCcCHHH
Confidence                   0111          12458999999999999999864

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.5e-40  Score=387.71  Aligned_cols=375  Identities=19%  Similarity=0.196  Sum_probs=267.7

Q ss_pred             EeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEccc
Q 036815          153 RLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN  232 (1013)
Q Consensus       153 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~  232 (1013)
                      .++.+++.++ .+|. +   .++|++|+|++|.+++..|..|.++++|++|++++|.+.+.++...+.++++|++|+|++
T Consensus        14 ~~~c~~~~l~-~lp~-l---~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           14 NAICINRGLH-QVPE-L---PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             EEECCSSCCS-SCCC-C---CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             ccCcCCCCcc-cCCC-C---CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            3445555554 4444 1   145555555555555555555566666666666666555444444455566666666666


Q ss_pred             ccCCCcCCcCCCCCCCcCEEEecCCeecccC-CCCCCCCCCCCceEEcCCCcccccCCcc-ccccCcccEEEeeCCccCC
Q 036815          233 NMISGSFPDSISSCKTLRIVDFSSNRVSGII-PPDICPGVSSLEELRLPDNLITGVIPGQ-LSECTQLKVIDLSLNYLNG  310 (1013)
Q Consensus       233 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~ls~N~l~~  310 (1013)
                      |++++..|..++++++|++|++++|++++.. ....+..+++|++|++++|.+++..|.. +.++++|++|++++|.+++
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            6665555556666666666666666655422 2233445566666666666666555544 5566666666666666665


Q ss_pred             CCCcccccC--cchHHHHhhhccccCCCCcC--------cCCCCCCceEECccccccccCchhhcCC---CCCCeEEecC
Q 036815          311 SIPQELGKL--EHLEQFIAWFNGLEGKIPPE--------LGKCKNLKDLILNNNKLSGEIPAELFSC---SNLEWISLTG  377 (1013)
Q Consensus       311 ~~p~~l~~l--~~L~~L~l~~n~l~~~~p~~--------~~~l~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~L~~  377 (1013)
                      ..|..+..+  .+|+.|++..|.+.+..+..        +..+++|++|++++|++++..|..+..+   ++|+.|++++
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~  248 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN  248 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTT
T ss_pred             cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecc
Confidence            555555554  45566666666665433332        4467889999999999998888887655   8899999999


Q ss_pred             CccCCC----------CChhhhcc--CCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCC
Q 036815          378 NELTGQ----------IPPEFSRL--TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPL  445 (1013)
Q Consensus       378 N~l~~~----------~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~  445 (1013)
                      |.+.+.          .+..+..+  ++|+.|++++|++++..|..+.++++|++|+|++|++++..|..          
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~----------  318 (455)
T 3v47_A          249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA----------  318 (455)
T ss_dssp             CTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT----------
T ss_pred             ccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhH----------
Confidence            865532          22333333  68999999999999999999999999999999999988654433          


Q ss_pred             CCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCC
Q 036815          446 GGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIP  525 (1013)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP  525 (1013)
                                                                                |..+++|++|+|++|++++..|
T Consensus       319 ----------------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~~  340 (455)
T 3v47_A          319 ----------------------------------------------------------FWGLTHLLKLNLSQNFLGSIDS  340 (455)
T ss_dssp             ----------------------------------------------------------TTTCTTCCEEECCSSCCCEECG
T ss_pred             ----------------------------------------------------------hcCcccCCEEECCCCccCCcCh
Confidence                                                                      3345789999999999998889


Q ss_pred             hhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCCCC
Q 036815          526 DEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRG  600 (1013)
Q Consensus       526 ~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~  600 (1013)
                      ..++.+++|++|+|++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|++++|++++.+|...
T Consensus       341 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          341 RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             GGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             hHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence            999999999999999999998889999999999999999999997666778999999999999999999998654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7e-42  Score=378.95  Aligned_cols=276  Identities=37%  Similarity=0.629  Sum_probs=224.3

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCC
Q 036815          724 LKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       724 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  803 (1013)
                      +++.++...+++|++.+.||+|+||.||+|++++++.||+|++........+.+.+|++++++++||||+++++++.+++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34445556789999999999999999999998889999999887665566678999999999999999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..++||||+++|+|.+++.....  ....+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             eEEEEEEcCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            99999999999999999865432  233589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC-CccHHHHHHHHHhcC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG-DTNLVGWVKMKVREG  962 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~  962 (1013)
                      |+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......|.......+
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            9998755433333334456899999999999889999999999999999999999999865433 234556655555555


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .....+++....   ....      .....+.+++.+||+.||++|||++|
T Consensus       264 ~~~~~~~~~~~~---~~~~------~~~~~l~~li~~~l~~dP~~Rps~~e  305 (321)
T 2qkw_B          264 QLEQIVDPNLAD---KIRP------ESLRKFGDTAVKCLALSSEDRPSMGD  305 (321)
T ss_dssp             CCCSSSSSSCTT---CSCH------HHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cHHHhcChhhcc---ccCH------HHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            554544443321   1111      12335678999999999999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-41  Score=377.86  Aligned_cols=283  Identities=40%  Similarity=0.714  Sum_probs=229.2

Q ss_pred             hhccccCHHHHHHHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeecc
Q 036815          719 RQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLG  797 (1013)
Q Consensus       719 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~  797 (1013)
                      .+.+.+++.++...+++|++.+.||+|+||.||+|+..+++.||||++...... ....+.+|++++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            345678899999999999999999999999999999888999999988654322 2346899999999999999999999


Q ss_pred             EEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc
Q 036815          798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME  877 (1013)
Q Consensus       798 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  877 (1013)
                      ++.+++..++||||+++|+|.+++.....  ....+++..+..++.|++.||+|||+++.++|+||||||+||+++.++.
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            99999999999999999999999976543  2345899999999999999999999987779999999999999999999


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC---CCCCccHHHH
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD---DFGDTNLVGW  954 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~---~~~~~~~~~~  954 (1013)
                      +||+|||+++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...   .........|
T Consensus       173 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             EEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             EEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            99999999987654332 2233456999999999999889999999999999999999999999631   2234455666


Q ss_pred             HHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          955 VKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       955 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.............+....   ....      ......+.+++.+||+.||++|||++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~l~~li~~cl~~dP~~Rps~~e  301 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQ---GNYK------DEEVEQLIQVALLCTQSSPMERPKMSE  301 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCT---TSCC------HHHHHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred             HHHHhhchhhhhhcChhhc---cccC------HHHHHHHHHHHHHHhCcCCccCCCHHH
Confidence            6655555444444443331   1111      122345779999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.4e-41  Score=364.88  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=202.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            467999999999999999999975 6899999998766666677899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++|+|.+++...       .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        99 ~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           99 LAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             CTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999999643       288999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .................++.
T Consensus       169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~  241 (297)
T 3fxz_A          169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTPELQNPEK  241 (297)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSCCCSCGGG
T ss_pred             ccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCCCccc
Confidence            322  23456799999999999999999999999999999999999999975321     11111111111110000111


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +       +          ..+.+++.+||+.||++|||++|
T Consensus       242 ~-------~----------~~~~~li~~~l~~dp~~Rps~~e  266 (297)
T 3fxz_A          242 L-------S----------AIFRDFLNRCLEMDVEKRGSAKE  266 (297)
T ss_dssp             S-------C----------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             c-------C----------HHHHHHHHHHccCChhHCcCHHH
Confidence            0       0          12568999999999999999864

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.3e-40  Score=384.45  Aligned_cols=402  Identities=23%  Similarity=0.309  Sum_probs=232.9

Q ss_pred             CCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcc
Q 036815           24 FGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSL  103 (1013)
Q Consensus        24 ~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L  103 (1013)
                      ..|++|++++|++ +.+|.. +.++++|++|++++|.+++.+|.. +..+.+|+.+++++|..              .++
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~-i~~L~~L~~L~l~~n~~~~~~p~~-~~~l~~L~~l~l~~c~~--------------~~l   73 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVE-AENVKSKTEYYNAWSEWERNAPPG-NGEQREMAVSRLRDCLD--------------RQA   73 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTT-SCCCHHHHHHHHHHHHH--------------HTC
T ss_pred             ccchhhhcccCch-hhCChh-HhcccchhhhhccCCcccccCCcc-cccchhcchhhhhhhhc--------------cCC
Confidence            4588888888888 557765 678888888888888887777754 35556665555554432              246


Q ss_pred             cEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCC
Q 036815          104 LHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPH  183 (1013)
Q Consensus       104 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~  183 (1013)
                      ++|++++|.++++ |. +  .++|++|++++|++++ +|..   +++|++|++++|.++ .++..    .++|++|++++
T Consensus        74 ~~L~l~~~~l~~l-p~-~--~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~  140 (454)
T 1jl5_A           74 HELELNNLGLSSL-PE-L--PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSN  140 (454)
T ss_dssp             SEEECTTSCCSCC-CS-C--CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCS
T ss_pred             CEEEecCCccccC-CC-C--cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcC
Confidence            7777777777763 22 1  3577788888887775 4432   367888888888877 34432    25788888888


Q ss_pred             CCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccC
Q 036815          184 NNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGII  263 (1013)
Q Consensus       184 n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  263 (1013)
                      |++++ +| .+.++++|++|++++|++++ +|..    .++|++|++++|++++ +| .++.+++|+.|++++|++++ +
T Consensus       141 n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l  210 (454)
T 1jl5_A          141 NQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-L  210 (454)
T ss_dssp             SCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-C
T ss_pred             CCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-C
Confidence            88886 44 58888888888888888873 5542    3578888888888885 45 57888888888888888874 3


Q ss_pred             CCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCC
Q 036815          264 PPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKC  343 (1013)
Q Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l  343 (1013)
                      |..    .++|++|++++|.++ .+| .++.+++|+.|++++|++++ +|..                           +
T Consensus       211 ~~~----~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---------------------------~  256 (454)
T 1jl5_A          211 PDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---------------------------P  256 (454)
T ss_dssp             CCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---------------------------C
T ss_pred             CCC----cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---------------------------c
Confidence            322    247888888888887 455 37788888888888887773 3321                           1


Q ss_pred             CCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEc
Q 036815          344 KNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL  423 (1013)
Q Consensus       344 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  423 (1013)
                      ++|++|++++|++++ +|..   .++|++|++++|++++ +|..   .++|+.|++++|++++ ++..   .++|++|++
T Consensus       257 ~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~L  324 (454)
T 1jl5_A          257 PSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNV  324 (454)
T ss_dssp             TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEEC
T ss_pred             cccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEEC
Confidence            466777777777764 4443   2567777777777764 2211   1467777777777764 3321   147777777


Q ss_pred             cCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCccccc
Q 036815          424 NSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSL  503 (1013)
Q Consensus       424 ~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  503 (1013)
                      ++|++++ +|..                                                                    
T Consensus       325 s~N~l~~-lp~~--------------------------------------------------------------------  335 (454)
T 1jl5_A          325 SNNKLIE-LPAL--------------------------------------------------------------------  335 (454)
T ss_dssp             CSSCCSC-CCCC--------------------------------------------------------------------
T ss_pred             CCCcccc-cccc--------------------------------------------------------------------
Confidence            7777764 3321                                                                    


Q ss_pred             ccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCC--CCcccccCCCCcceEecCCccccCCCcccccCCCc
Q 036815          504 FTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSG--EIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSF  581 (1013)
Q Consensus       504 ~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g--~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~  581 (1013)
                         +++|++||+++|+++ .+|.   .+++|++|+|++|+++|  .+|.+++.|        +.|.+.|.+|..   +++
T Consensus       336 ---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~  397 (454)
T 1jl5_A          336 ---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQN  397 (454)
T ss_dssp             ---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC--------------
T ss_pred             ---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCc
Confidence               134677777777777 5666   46777777777777776  666655433        345666666653   356


Q ss_pred             ceEEECcCCCCCC--cCCC
Q 036815          582 LVQIDLSNNELTG--PIPQ  598 (1013)
Q Consensus       582 l~~l~l~~n~l~~--~~p~  598 (1013)
                      |+.|++++|+++|  .+|.
T Consensus       398 L~~L~ls~N~l~~~~~iP~  416 (454)
T 1jl5_A          398 LKQLHVETNPLREFPDIPE  416 (454)
T ss_dssp             -------------------
T ss_pred             CCEEECCCCcCCccccchh
Confidence            6777777777776  5553

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.8e-40  Score=385.45  Aligned_cols=385  Identities=19%  Similarity=0.178  Sum_probs=237.1

Q ss_pred             eecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCC
Q 036815            4 VLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSY   83 (1013)
Q Consensus         4 ~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~   83 (1013)
                      .++.+++.++.+|.    .+++|++|+|++|.+.+ ++...|.++++|++|+|++|.+.+.++...+.++++|++|+|++
T Consensus        14 ~~~c~~~~l~~lp~----l~~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           14 NAICINRGLHQVPE----LPAHVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             EEECCSSCCSSCCC----CCTTCCEEECCSSCCCE-ECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             ccCcCCCCcccCCC----CCCccCEEEecCCccCc-CChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            45666777777765    45667777777777755 33445677777777777777766555555566666666666666


Q ss_pred             CcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCcc--ccCCCCCCEEecCCCcccccCccc-ccCCCCCCEeeCcCCc
Q 036815           84 NNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSS--LSNCTKLKILNLSFNLLAGEIPRT-FGQLSSLQRLDLSNNH  160 (1013)
Q Consensus        84 n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~--l~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~  160 (1013)
                      |++++..+..   ...+++|++|+|++|.+++..+..  |.++++|++|+|++|++++..|.. |.++++|++|++++|.
T Consensus        89 n~l~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~  165 (455)
T 3v47_A           89 NQFLQLETGA---FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK  165 (455)
T ss_dssp             CTTCEECTTT---TTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred             CccCccChhh---ccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence            6665432221   124455666666666655433322  555555666666666555554443 5555555666665555


Q ss_pred             ccCcCCccchhc-cCCCcEEECCCCCCCCcCCccc--------cCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcc
Q 036815          161 ITGWIPSELGNA-CDSLLELKLPHNNITGSFPVTL--------SSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS  231 (1013)
Q Consensus       161 l~~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~l--------~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~  231 (1013)
                      +++..+..+... ..+|+.|++++|.+.+..+..+        ..+++|++|++++|++++..+..+...+         
T Consensus       166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~---------  236 (455)
T 3v47_A          166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAI---------  236 (455)
T ss_dssp             BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHT---------
T ss_pred             ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccc---------
Confidence            554333333221 1345555555555554333221        2334455555555555433333222211         


Q ss_pred             cccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccc--cCcccEEEeeCCccC
Q 036815          232 NNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSE--CTQLKVIDLSLNYLN  309 (1013)
Q Consensus       232 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--l~~L~~L~ls~N~l~  309 (1013)
                                   ..++|+.|++++|.+.+...               ..+.+.+..+..+..  .++|+.|++++|.++
T Consensus       237 -------------~~~~L~~L~l~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~  288 (455)
T 3v47_A          237 -------------AGTKIQSLILSNSYNMGSSF---------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF  288 (455)
T ss_dssp             -------------TTCCEEEEECTTCTTTSCCT---------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCC
T ss_pred             -------------cccceeeEeecccccccccc---------------chhhhccCcccccccccccCceEEEecCcccc
Confidence                         01344444444443321100               011111111111221  244555555555555


Q ss_pred             CCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhh
Q 036815          310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFS  389 (1013)
Q Consensus       310 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  389 (1013)
                      +..|..++.+++|+.|++++|.+++..|..|+.+++|++|+|++|++++..|..+..+++|++|+|++|++++..|..|.
T Consensus       289 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  368 (455)
T 3v47_A          289 ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL  368 (455)
T ss_dssp             EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred             ccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcc
Confidence            55555555555555555555555556677888899999999999999988899999999999999999999988899999


Q ss_pred             ccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCC
Q 036815          390 RLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       390 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  433 (1013)
                      .+++|++|+|++|++++..+..+..+++|++|++++|+++|.+|
T Consensus       369 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            99999999999999997666678999999999999999999998

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=3.5e-40  Score=380.78  Aligned_cols=384  Identities=26%  Similarity=0.314  Sum_probs=253.6

Q ss_pred             CcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCC-------------CCEeeCcCCcccCcCCc
Q 036815          101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSS-------------LQRLDLSNNHITGWIPS  167 (1013)
Q Consensus       101 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-------------L~~L~Ls~n~l~~~~~~  167 (1013)
                      +.|++|++++|.+ +.+|..++++++|++|++++|.+.+..|..++.+++             +++|++++|.++ .+|.
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~   88 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE   88 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCS
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCC
Confidence            4567777777777 446667777777777777777777777777777665             488999999888 4555


Q ss_pred             cchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCC
Q 036815          168 ELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCK  247 (1013)
Q Consensus       168 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  247 (1013)
                      .    .++|++|++++|++++ +|..   .++|++|++++|++++ ++.    ..++|++|++++|++++ +| .+++++
T Consensus        89 ~----~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~----~~~~L~~L~L~~n~l~~-lp-~~~~l~  153 (454)
T 1jl5_A           89 L----PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSD----LPPLLEYLGVSNNQLEK-LP-ELQNSS  153 (454)
T ss_dssp             C----CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCS----CCTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred             C----cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccC----CCCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence            2    3688999999998886 4433   3788999999998873 432    12689999999999885 66 588899


Q ss_pred             CcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHh
Q 036815          248 TLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIA  327 (1013)
Q Consensus       248 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l  327 (1013)
                      +|++|++++|++++ +|..    ..+|++|++++|++++ +| .++.+++|+.|++++|.+++ +|...   .+|+.|++
T Consensus       154 ~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l  222 (454)
T 1jl5_A          154 FLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVA  222 (454)
T ss_dssp             TCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEEC
T ss_pred             CCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEEC
Confidence            99999999998874 4432    3588999999999886 45 58889999999999998884 55433   46677777


Q ss_pred             hhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeee
Q 036815          328 WFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGE  407 (1013)
Q Consensus       328 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  407 (1013)
                      ++|.++ .+| .++.+++|++|++++|++++ +|..   +++|++|++++|++++ +|..   +++|+.|++++|++++ 
T Consensus       223 ~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-  291 (454)
T 1jl5_A          223 GNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-  291 (454)
T ss_dssp             CSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-
T ss_pred             cCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-
Confidence            777777 566 47778888888888888874 4542   3678888888888874 5543   3677888888888775 


Q ss_pred             cCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCcc
Q 036815          408 IPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTL  487 (1013)
Q Consensus       408 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  487 (1013)
                      +|..   .++|++|++++|++++ +|.                                                     
T Consensus       292 l~~~---~~~L~~L~l~~N~l~~-i~~-----------------------------------------------------  314 (454)
T 1jl5_A          292 LSEL---PPNLYYLNASSNEIRS-LCD-----------------------------------------------------  314 (454)
T ss_dssp             ESCC---CTTCCEEECCSSCCSE-ECC-----------------------------------------------------
T ss_pred             ccCc---CCcCCEEECcCCcCCc-ccC-----------------------------------------------------
Confidence            2321   2577888888877653 110                                                     


Q ss_pred             ccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCcc
Q 036815          488 KSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNR  567 (1013)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~  567 (1013)
                                        ..++|++|++++|++++ +|..   +++|++|+|++|+++ .+|.   .+++|+.|++++|+
T Consensus       315 ------------------~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~  368 (454)
T 1jl5_A          315 ------------------LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNP  368 (454)
T ss_dssp             ------------------CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSC
T ss_pred             ------------------CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCC
Confidence                              01368999999999995 8875   588999999999999 6888   57999999999999


Q ss_pred             ccC--CCcccccCCCcceEEECcCCCCCCcCCCCCCCCCCCcccccCCCCC
Q 036815          568 LQG--QIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGL  616 (1013)
Q Consensus       568 l~g--~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~l  616 (1013)
                      ++|  .+|.++..        |+.|++.|.+|..  +..+..+.+.+|+-.
T Consensus       369 l~~l~~ip~~l~~--------L~~n~~~~~i~~~--~~~L~~L~ls~N~l~  409 (454)
T 1jl5_A          369 LREFPDIPESVED--------LRMNSHLAEVPEL--PQNLKQLHVETNPLR  409 (454)
T ss_dssp             CSSCCCCCTTCCE--------EECCC-------------------------
T ss_pred             CCcCCCChHHHHh--------hhhcccccccccc--cCcCCEEECCCCcCC
Confidence            998  78887653        3468889988874  456777778888643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.8e-40  Score=363.34  Aligned_cols=244  Identities=25%  Similarity=0.384  Sum_probs=199.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....  ....+.+.+|++++++++||||+++++++...+..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            357999999999999999999984 78999999986542  233456889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        94 e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             CCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             ECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            9999999999996543      288999999999999999999999   9999999999999999999999999999866


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCC-ccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCT-AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....   ......||+.|+|||++.+..++ .++||||+||++|||++|+.||.+..     .......... +...  +
T Consensus       165 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~-~~~~--~  233 (328)
T 3fe3_A          165 TVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERVLR-GKYR--I  233 (328)
T ss_dssp             SSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHH-CCCC--C
T ss_pred             CCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh-CCCC--C
Confidence            4322   23456799999999999887765 79999999999999999999997643     2222222111 1110  0


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +..       .+          ..+.+++.+||+.||++|||++|
T Consensus       234 p~~-------~s----------~~~~~li~~~L~~dP~~R~t~~e  261 (328)
T 3fe3_A          234 PFY-------MS----------TDCENLLKRFLVLNPIKRGTLEQ  261 (328)
T ss_dssp             CTT-------SC----------HHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             CCC-------CC----------HHHHHHHHHHCCCChhHCcCHHH
Confidence            000       01          12558999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.6e-40  Score=361.78  Aligned_cols=258  Identities=24%  Similarity=0.339  Sum_probs=207.7

Q ss_pred             cccCHHHHHHHhcC----------CCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCc
Q 036815          722 RKLKFSQLIEATNG----------FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHR  790 (1013)
Q Consensus       722 ~~~~~~~~~~~~~~----------y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  790 (1013)
                      ..++++++..+++.          |...+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45667777776654          667789999999999999987 7999999998766666677899999999999999


Q ss_pred             ceeeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccE
Q 036815          791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNV  870 (1013)
Q Consensus       791 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  870 (1013)
                      ||+++++++..++..++||||+++++|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  172 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI  172 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9999999999999999999999999999998632       389999999999999999999999   999999999999


Q ss_pred             EeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCcc
Q 036815          871 LLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN  950 (1013)
Q Consensus       871 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~  950 (1013)
                      +++.++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....    
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----  246 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----  246 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----
T ss_pred             EECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence            999999999999999987654222  22346799999999999999999999999999999999999999975321    


Q ss_pred             HHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          951 LVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       951 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ...... +..........+.      ..+          ..+.+++.+||+.||++|||++|
T Consensus       247 -~~~~~~-~~~~~~~~~~~~~------~~~----------~~l~~li~~~l~~dp~~Rps~~e  291 (321)
T 2c30_A          247 -VQAMKR-LRDSPPPKLKNSH------KVS----------PVLRDFLERMLVRDPQERATAQE  291 (321)
T ss_dssp             -HHHHHH-HHHSSCCCCTTGG------GSC----------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             -HHHHHH-HhcCCCCCcCccc------cCC----------HHHHHHHHHHccCChhhCcCHHH
Confidence             111111 1111111000000      000          12568999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=361.46  Aligned_cols=250  Identities=27%  Similarity=0.466  Sum_probs=200.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56889999999999999999986 58899999887666666778999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++....     ..+++.++..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           90 KGGTLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             TTCBHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             CCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999997532     2389999999999999999999999   9999999999999999999999999999876432


Q ss_pred             Ccce------------eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh
Q 036815          893 DTHL------------SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR  960 (1013)
Q Consensus       893 ~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  960 (1013)
                      ....            ......||+.|+|||++.+..++.++|||||||++|||++|..||...................
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            2211            1114578999999999999999999999999999999999999987543222111000111111


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. .....++                     .+.+++.+||+.||++|||++|
T Consensus       242 ~~-~~~~~~~---------------------~l~~li~~~l~~dP~~Rps~~~  272 (310)
T 3s95_A          242 RY-CPPNCPP---------------------SFFPITVRCCDLDPEKRPSFVK  272 (310)
T ss_dssp             HT-CCTTCCT---------------------THHHHHHHHTCSSGGGSCCHHH
T ss_pred             cc-CCCCCCH---------------------HHHHHHHHHccCChhhCcCHHH
Confidence            00 0011111                     2568999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.9e-40  Score=365.32  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=199.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57999999999999999999987 789999998854332 2235688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++|+|.+++...      ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.+..
T Consensus        87 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           87 CSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             CTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             CCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            9999999998643      2389999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............|....... .....++ 
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~-  235 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKID-  235 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-TTGGGSC-
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-CccccCC-
Confidence            333333445679999999999987765 7789999999999999999999986554333333222211100 0001111 


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                          ..+.+++.+||+.||++|||++|
T Consensus       236 --------------------~~~~~li~~~L~~dP~~R~t~~e  258 (323)
T 3tki_A          236 --------------------SAPLALLHKILVENPSARITIPD  258 (323)
T ss_dssp             --------------------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             --------------------HHHHHHHHHHccCChhhCcCHHH
Confidence                                12458999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-39  Score=358.51  Aligned_cols=239  Identities=23%  Similarity=0.312  Sum_probs=196.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|++.+.   .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56899999999999999999987 6899999998653   2234467889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        85 E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           85 EYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             ECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            9999999999996533      388999999999999999999999   9999999999999999999999999999864


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Ccccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  968 (1013)
                      ...  ........||+.|+|||++.+..++.++||||+||++|||++|+.||....     ........... ......+
T Consensus       156 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~p~~~  228 (337)
T 1o6l_A          156 ISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEEIRFPRTL  228 (337)
T ss_dssp             CCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCTTS
T ss_pred             ccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCCCCCCCC
Confidence            321  122345679999999999999999999999999999999999999997532     11222221111 1111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1009 (1013)
                      +                     ..+.+++.+||+.||++||
T Consensus       229 s---------------------~~~~~li~~lL~~dP~~R~  248 (337)
T 1o6l_A          229 S---------------------PEAKSLLAGLLKKDPKQRL  248 (337)
T ss_dssp             C---------------------HHHHHHHHHHTCSSTTTST
T ss_pred             C---------------------HHHHHHHHHHhhcCHHHhc
Confidence            1                     1246899999999999999

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.7e-40  Score=366.41  Aligned_cols=248  Identities=22%  Similarity=0.296  Sum_probs=200.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc------chHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ------GDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      .++|++.+.||+|+||.||+|+++ +|+.||+|.+.+....      ..+.+.+|+.++++++||||+++++++.++...
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999987 6899999988654322      246789999999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC----cEEEe
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM----EARVS  881 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~  881 (1013)
                      |+||||++||+|.+++...      ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++    .+||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEE
Confidence            9999999999999999643      2389999999999999999999999   999999999999998877    79999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      |||+++......   ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+...     .+.... +..
T Consensus       162 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~~~~~~-i~~  232 (361)
T 2yab_A          162 DFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLAN-ITA  232 (361)
T ss_dssp             CCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHH-HHT
T ss_pred             ecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH-HHh
Confidence            999998765422   23345799999999999999999999999999999999999999976421     111111 111


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...  ..++...   ...+          ..+.+++.+||+.||++|||++|
T Consensus       233 ~~~--~~~~~~~---~~~s----------~~~~~li~~~L~~dP~~R~t~~e  269 (361)
T 2yab_A          233 VSY--DFDEEFF---SQTS----------ELAKDFIRKLLVKETRKRLTIQE  269 (361)
T ss_dssp             TCC--CCCHHHH---TTSC----------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cCC--CCCchhc---cCCC----------HHHHHHHHHHCCCChhHCcCHHH
Confidence            110  0111110   0011          12568999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.4e-39  Score=353.00  Aligned_cols=274  Identities=36%  Similarity=0.600  Sum_probs=215.4

Q ss_pred             ccccCHHHHHHHhcCCCCC------CeecccCCcEEEEEEEcCCCEEEEEEeeccC----ccchHHHHHHHHHHhccCCc
Q 036815          721 LRKLKFSQLIEATNGFSAE------SLIGCGGFGEVFKATLKDGSSVAIKKLIRLS----CQGDREFMAEMETLGKIKHR  790 (1013)
Q Consensus       721 ~~~~~~~~~~~~~~~y~~~------~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~  790 (1013)
                      ...+++.++..++++|...      +.||+|+||.||+|+. +++.||+|++....    ....+.+.+|++++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4568889999999998877      9999999999999987 58899999886432    22346789999999999999


Q ss_pred             ceeeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccE
Q 036815          791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNV  870 (1013)
Q Consensus       791 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  870 (1013)
                      ||+++++++.+++..++||||+++++|.+++.....   ...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Ni  164 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANI  164 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence            999999999999999999999999999999974322   23489999999999999999999999   999999999999


Q ss_pred             EeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCcc
Q 036815          871 LLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN  950 (1013)
Q Consensus       871 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~  950 (1013)
                      +++.++.+||+|||+++...............|++.|+|||++.+ .++.++|||||||++|+|++|+.||....... .
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~  242 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-L  242 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-B
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-H
Confidence            999999999999999987654433333345678999999998875 57899999999999999999999998654332 2


Q ss_pred             HHHHHHHHHhcC-ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          951 LVGWVKMKVREG-KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       951 ~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+........ ...+.+++.+.    ....      .....+.+++.+||+.||++|||++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~------~~~~~l~~li~~cl~~~p~~Rps~~~  296 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKMN----DADS------TSVEAMYSVASQCLHEKKNKRPDIKK  296 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSCS----CCCH------HHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHHHHhhhhhhhhhhhcccccc----ccch------HHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            223332222211 11122222110    1111      12234678999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3e-39  Score=355.46  Aligned_cols=203  Identities=25%  Similarity=0.350  Sum_probs=173.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||+||+|++.+++.||+|++......  ....+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            3679999999999999999999988999999988543222  23678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++ ++.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       100 ~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A          100 FMEK-DLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             CCSE-EHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             CCCC-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            9985 8888876432     2389999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      ...  .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus       171 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  225 (311)
T 3niz_A          171 IPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD  225 (311)
T ss_dssp             SCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred             CCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence            322  22334578999999999876 5689999999999999999999999986543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-39  Score=358.51  Aligned_cols=249  Identities=32%  Similarity=0.499  Sum_probs=190.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||+||+|++. ++.||||++......  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            457999999999999999999874 889999988654322  23568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH--IIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |+++|+|.+++.....   ...+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.+||+|||+++.
T Consensus       115 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             cCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999999975321   23489999999999999999999999   8  99999999999999999999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+............. +
T Consensus       189 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~~~~~-~  260 (309)
T 3p86_A          189 KAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----AQVVAAVGFKCKRLE-I  260 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----HHHHHHHHHSCCCCC-C
T ss_pred             cccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCCCCC-C
Confidence            4332  1223346789999999999999999999999999999999999999975321     111111111111111 1


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +..       .+          ..+.+++.+||+.||++|||++|
T Consensus       261 ~~~-------~~----------~~l~~li~~~l~~dP~~Rps~~~  288 (309)
T 3p86_A          261 PRN-------LN----------PQVAAIIEGCWTNEPWKRPSFAT  288 (309)
T ss_dssp             CTT-------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             Ccc-------CC----------HHHHHHHHHHccCChhhCcCHHH
Confidence            111       11          12568999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=361.27  Aligned_cols=242  Identities=26%  Similarity=0.353  Sum_probs=194.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .++|++.+.||+|+||+||+|+++ +++.||+|++.+.   .....+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999987 5899999998653   222345678899999988 79999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||++||+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+|+
T Consensus       102 v~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence            999999999999997543      389999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-cccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-KQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  966 (1013)
                      ....  .........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+......... ....
T Consensus       173 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~~~~p~  245 (353)
T 3txo_A          173 EGIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDEVVYPT  245 (353)
T ss_dssp             CSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCT
T ss_pred             eccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCCCCC
Confidence            5432  12233456799999999999998999999999999999999999999976431     12222211111 1111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .++                     ..+.+++.+||+.||++||++
T Consensus       246 ~~~---------------------~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          246 WLH---------------------EDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             TSC---------------------HHHHHHHHHHTCSSGGGSTTS
T ss_pred             CCC---------------------HHHHHHHHHHhhhCHHHccCC
Confidence            111                     124589999999999999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.2e-39  Score=357.61  Aligned_cols=244  Identities=26%  Similarity=0.345  Sum_probs=198.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  806 (1013)
                      ..++|++.+.||+|+||.||+|+++ +++.||+|++.+..   ....+.+..|.+++.++ +||||+++++++.+.+..|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            3578999999999999999999987 57899999886532   23345678899999887 8999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||++||+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++++||+|||+|
T Consensus        95 lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            9999999999999997533      289999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Cccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQM  965 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  965 (1013)
                      +......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.     .+........ ....
T Consensus       166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~p  238 (345)
T 1xjd_A          166 KENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSIRMDNPFYP  238 (345)
T ss_dssp             BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC
T ss_pred             hhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCCCCCC
Confidence            8643222  123456799999999999999999999999999999999999999975431     1111111111 1111


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ..++                     ..+.+++.+||+.||++||++.
T Consensus       239 ~~~s---------------------~~~~~li~~lL~~dp~~R~~~~  264 (345)
T 1xjd_A          239 RWLE---------------------KEAKDLLVKLFVREPEKRLGVR  264 (345)
T ss_dssp             TTSC---------------------HHHHHHHHHHSCSSGGGSBTTB
T ss_pred             cccC---------------------HHHHHHHHHHhcCCHhHcCCCh
Confidence            1111                     1256899999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.9e-39  Score=363.19  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=197.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.++||+|+||+||+|+++ +++.||+|++.+....   ..+.+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            56999999999999999999987 5778999988654322   234578899999887 899999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||++||+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+|+.
T Consensus       132 ~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            99999999999997543      389999999999999999999999   999999999999999999999999999985


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC---ccHHHHHHHHHhcCccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD---TNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~  965 (1013)
                      ....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+   .....+....+......
T Consensus       203 ~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~  280 (396)
T 4dc2_A          203 GLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR  280 (396)
T ss_dssp             CCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC
T ss_pred             cccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC
Confidence            3221  222345689999999999999999999999999999999999999997543221   11122222222211110


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                        +++.       .+          ..+.+++.+||+.||++||++
T Consensus       281 --~p~~-------~s----------~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 --IPRS-------LS----------VKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --CCTT-------SC----------HHHHHHHHHHTCSCTTTSTTC
T ss_pred             --CCCc-------CC----------HHHHHHHHHHhcCCHhHcCCC
Confidence              0110       11          125689999999999999997

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.5e-40  Score=364.99  Aligned_cols=259  Identities=27%  Similarity=0.351  Sum_probs=197.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCC----EEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE----ERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  808 (1013)
                      .++|++.+.||+|+||+||+|++. ++.||||++... ........+|+.++++++||||+++++++.++.    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            357999999999999999999986 789999987543 233445667899999999999999999998743    47999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCcccEEeCCCCcEEEe
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC-------IPHIIHRDMKSSNVLLDHEMEARVS  881 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlkp~Nill~~~~~~kl~  881 (1013)
                      |||+++|+|.+++...       .+++..++.++.|++.||+|||+.+       .++|+||||||+||+++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999642       2899999999999999999999852       2389999999999999999999999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCcc------
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN------  950 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~------  950 (1013)
                      |||+|+...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||.........      
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999987765443333344678999999999886     35667899999999999999999999865432211      


Q ss_pred             -----HHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          951 -----LVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       951 -----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ...+...... ......+...            .........+.+++.+||+.||++||||+|
T Consensus       254 ~~~~~~~~~~~~~~~-~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (322)
T 3soc_A          254 GQHPSLEDMQEVVVH-KKKRPVLRDY------------WQKHAGMAMLCETIEECWDHDAEARLSAGC  308 (322)
T ss_dssp             CSSCCHHHHHHHHTT-SCCCCCCCGG------------GGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccCCchhhhhhhhhc-ccCCCCcccc------------ccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence                 1111111111 1111111100            001112334779999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.1e-39  Score=365.12  Aligned_cols=253  Identities=27%  Similarity=0.431  Sum_probs=200.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc--------CCCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeCC
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK--------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  803 (1013)
                      ++|++.+.||+|+||.||+|++.        ++..||+|++..... ...+.+.+|+++++++ +||||+++++++.+++
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            57889999999999999999863        345799998865432 2345789999999999 8999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ..|+||||+++|+|.+++......          .....+++..++.++.||+.||+|||++   +|+||||||+||+++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence            999999999999999999765321          1123489999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLV  952 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~  952 (1013)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  ...
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~~  315 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--ELF  315 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence            999999999999987654333323334567789999999999999999999999999999999 99999764321  111


Q ss_pred             HHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          953 GWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       953 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .    .+..+.... .+..       ..          ..+.+++.+||+.||++|||++|
T Consensus       316 ~----~~~~~~~~~-~~~~-------~~----------~~l~~li~~~l~~dP~~Rpt~~e  354 (370)
T 2psq_A          316 K----LLKEGHRMD-KPAN-------CT----------NELYMMMRDCWHAVPSQRPTFKQ  354 (370)
T ss_dssp             H----HHHTTCCCC-CCTT-------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             H----HHhcCCCCC-CCCC-------CC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            1    111111111 0100       01          12568999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-38  Score=350.55  Aligned_cols=237  Identities=22%  Similarity=0.348  Sum_probs=195.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56899999999999999999986 68999999886532   233466889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             CCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceec
Confidence            9999999999997533      388999999999999999999999   9999999999999999999999999999875


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-cccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-KQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  968 (1013)
                      ...     .....||+.|+|||++.+..++.++||||+||++|||++|+.||....     ............ .....+
T Consensus       157 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~p~~~  226 (318)
T 1fot_A          157 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAELRFPPFF  226 (318)
T ss_dssp             SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCCCCCCTTS
T ss_pred             CCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCCCCCCC
Confidence            431     234579999999999999999999999999999999999999997532     112222212111 111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      +                     ..+.+++.+||+.||++||+
T Consensus       227 ~---------------------~~~~~li~~lL~~dp~~R~~  247 (318)
T 1fot_A          227 N---------------------EDVKDLLSRLITRDLSQRLG  247 (318)
T ss_dssp             C---------------------HHHHHHHHHHTCSCTTTCTT
T ss_pred             C---------------------HHHHHHHHHHhccCHHHcCC
Confidence            1                     12568999999999999993

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=358.85  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=198.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc------chHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ------GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|.+......      ..+.+.+|++++++++||||+++++++.++...+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46899999999999999999986 6899999988653321      3567999999999999999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC----cEEEee
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM----EARVSD  882 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~D  882 (1013)
                      +||||+++++|.+++...      ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|
T Consensus        91 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEcCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            999999999999999643      2389999999999999999999999   999999999999999887    899999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      ||+++.......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.....     .+.........
T Consensus       162 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~~  233 (326)
T 2y0a_A          162 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANVSAVN  233 (326)
T ss_dssp             CTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHTC
T ss_pred             CCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHHhcC
Confidence            999987653222   2345799999999999999999999999999999999999999975321     11111111110


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..   .++...   ...          ...+.+++.+||+.||++|||++|
T Consensus       234 ~~---~~~~~~---~~~----------~~~~~~li~~~L~~dP~~Rpt~~e  268 (326)
T 2y0a_A          234 YE---FEDEYF---SNT----------SALAKDFIRRLLVKDPKKRMTIQD  268 (326)
T ss_dssp             CC---CCHHHH---TTS----------CHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CC---cCcccc---ccC----------CHHHHHHHHHHccCChhhCCCHHH
Confidence            00   000000   000          112568999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-38  Score=355.00  Aligned_cols=248  Identities=23%  Similarity=0.320  Sum_probs=197.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++.+....   ..+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46899999999999999999987 5788999998654322   235578899999988 899999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+|+.
T Consensus        89 ~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccc
Confidence            99999999999997533      389999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCc---cHHHHHHHHHhcCccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT---NLVGWVKMKVREGKQM  965 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~  965 (1013)
                      .....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||........   .........+......
T Consensus       160 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~  237 (345)
T 3a8x_A          160 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR  237 (345)
T ss_dssp             SCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC
T ss_pred             ccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC
Confidence            43211  223456799999999999999999999999999999999999999975332211   1111121112111110


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                        +++.       .+          ..+.+++.+||+.||++||++
T Consensus       238 --~p~~-------~s----------~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 --IPRS-------LS----------VKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             --CCTT-------SC----------HHHHHHHHHHTCSSTTTSTTC
T ss_pred             --CCCC-------CC----------HHHHHHHHHHhcCCHhHCCCC
Confidence              1110       11          125689999999999999997

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.9e-39  Score=354.95  Aligned_cols=206  Identities=27%  Similarity=0.408  Sum_probs=164.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999976 689999998865432 234678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |++ |+|.+++...........+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999 59999987654433344589999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ....  ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3221  2234578999999999876 46899999999999999999999999764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.7e-39  Score=362.93  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++.....  ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999986 689999998865432  23456889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC---cEEEeecccc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM---EARVSDFGMA  886 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a  886 (1013)
                      ||+++|+|.+++...      ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++   .+||+|||++
T Consensus       108 e~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             CCCCSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             ecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            999999999998643      2389999999999999999999999   999999999999998654   5999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +......   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.     .+.... +..+... 
T Consensus       179 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~-i~~~~~~-  248 (362)
T 2bdw_A          179 IEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQ-IKAGAYD-  248 (362)
T ss_dssp             BCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHHTCCC-
T ss_pred             eEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH-HHhCCCC-
Confidence            8765322   22346799999999999999999999999999999999999999975321     111111 1111110 


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+..    ...+          ..+.+++.+||+.||++|||++|
T Consensus       249 ~~~~~~----~~~~----------~~~~~li~~~L~~dP~~R~t~~e  281 (362)
T 2bdw_A          249 YPSPEW----DTVT----------PEAKSLIDSMLTVNPKKRITADQ  281 (362)
T ss_dssp             CCTTGG----GGSC----------HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCcccc----cCCC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            000000    0000          12568999999999999999864

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=5.7e-38  Score=362.54  Aligned_cols=317  Identities=20%  Similarity=0.197  Sum_probs=219.8

Q ss_pred             cccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccC
Q 036815           44 LFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSN  123 (1013)
Q Consensus        44 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~  123 (1013)
                      .+..+++|++|++++|.+++ +|.  +..+++|++|+|++|++++..      ...+++|++|++++|.++++ +  +.+
T Consensus        37 ~~~~l~~L~~L~Ls~n~l~~-~~~--l~~l~~L~~L~Ls~n~l~~~~------~~~l~~L~~L~Ls~N~l~~~-~--~~~  104 (457)
T 3bz5_A           37 SEEQLATLTSLDCHNSSITD-MTG--IEKLTGLTKLICTSNNITTLD------LSQNTNLTYLACDSNKLTNL-D--VTP  104 (457)
T ss_dssp             EHHHHTTCCEEECCSSCCCC-CTT--GGGCTTCSEEECCSSCCSCCC------CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred             ChhHcCCCCEEEccCCCccc-Chh--hcccCCCCEEEccCCcCCeEc------cccCCCCCEEECcCCCCcee-e--cCC
Confidence            35667777777777777774 342  567777777777777777531      34567777777777777764 2  777


Q ss_pred             CCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEE
Q 036815          124 CTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLL  203 (1013)
Q Consensus       124 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  203 (1013)
                      +++|++|++++|++++. +  ++.+++|++|++++|++++ ++   ...+++|++|++++|+..+..  .+..+++|++|
T Consensus       105 l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~---l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L  175 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE-ID---VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTL  175 (457)
T ss_dssp             CTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC-CC---CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEE
T ss_pred             CCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccce-ec---cccCCcCCEEECCCCCccccc--ccccCCcCCEE
Confidence            77777788877777753 2  6777777777777777773 43   234577777777777443333  36677777788


Q ss_pred             EccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCc
Q 036815          204 DLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNL  283 (1013)
Q Consensus       204 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~  283 (1013)
                      ++++|++++ +|   +..+++|+.|++++|++++.   .++.+++|+.|++++|++++ +|   +..+++|+.|++++|+
T Consensus       176 ~ls~n~l~~-l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip---~~~l~~L~~L~l~~N~  244 (457)
T 3bz5_A          176 DCSFNKITE-LD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID---VTPLTQLTYFDCSVNP  244 (457)
T ss_dssp             ECCSSCCCC-CC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC---CTTCTTCSEEECCSSC
T ss_pred             ECCCCccce-ec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC---ccccCCCCEEEeeCCc
Confidence            887777774 44   46677777888877777753   36777777777777777775 33   4566777777777777


Q ss_pred             ccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchh
Q 036815          284 ITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAE  363 (1013)
Q Consensus       284 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  363 (1013)
                      +++..   ++.+++|+.|++++|.+.              .+++++|.+.+.+|  ++.+++|+.|++++|...+.+|. 
T Consensus       245 l~~~~---~~~l~~L~~L~l~~n~L~--------------~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~-  304 (457)
T 3bz5_A          245 LTELD---VSTLSKLTTLHCIQTDLL--------------EIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC-  304 (457)
T ss_dssp             CSCCC---CTTCTTCCEEECTTCCCS--------------CCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC-
T ss_pred             CCCcC---HHHCCCCCEEeccCCCCC--------------EEECCCCccCCccc--ccccccCCEEECCCCcccceecc-
Confidence            77653   445667777777766443              45566666666555  46677888888888887777664 


Q ss_pred             hcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCc
Q 036815          364 LFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG  430 (1013)
Q Consensus       364 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  430 (1013)
                        ..++|+.|++++|             ++|+.|++++|++++ ++  ++++++|++||+++|++++
T Consensus       305 --~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~  353 (457)
T 3bz5_A          305 --QAAGITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD  353 (457)
T ss_dssp             --TTCCCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB
T ss_pred             --CCCcceEechhhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC
Confidence              3455666666555             578888888888886 33  7788888888888888774

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=363.64  Aligned_cols=249  Identities=20%  Similarity=0.279  Sum_probs=200.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357999999999999999999986 6889999988665555566789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC--CCcEEEeecccceec
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH--EMEARVSDFGMARLI  889 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~  889 (1013)
                      +++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.  ++.+||+|||+|+..
T Consensus       130 ~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          130 LSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             CCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999986432     2489999999999999999999999   9999999999999974  477999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ....   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+...........   .+
T Consensus       202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~i~~~~~~---~~  270 (387)
T 1kob_A          202 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNVKRCDWE---FD  270 (387)
T ss_dssp             CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHCCCC---CC
T ss_pred             CCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC---CC
Confidence            5422   22345799999999999999999999999999999999999999976321     1111111111100   01


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +...   ...+          ..+.+++.+||+.||++|||++|
T Consensus       271 ~~~~---~~~s----------~~~~~li~~~L~~dP~~Rpt~~e  301 (387)
T 1kob_A          271 EDAF---SSVS----------PEAKDFIKNLLQKEPRKRLTVHD  301 (387)
T ss_dssp             SSTT---TTSC----------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             cccc---ccCC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            0000   0011          12568999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-39  Score=356.87  Aligned_cols=248  Identities=20%  Similarity=0.252  Sum_probs=199.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|.+.. .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec-CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467999999999999999999987 577899997753 334456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC--CCcEEEeecccceec
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH--EMEARVSDFGMARLI  889 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~  889 (1013)
                      ++||+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.  ++.+||+|||+++..
T Consensus        83 ~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           83 ISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            99999999996432     2489999999999999999999999   9999999999999987  789999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ....   ......||+.|+|||++.+..++.++||||+||++|+|++|..||.....     .+...........   .+
T Consensus       155 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~---~~  223 (321)
T 1tki_A          155 KPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIENIMNAEYT---FD  223 (321)
T ss_dssp             CTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCC---CC
T ss_pred             CCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHcCCCC---CC
Confidence            5422   23456789999999999998899999999999999999999999975321     1222221111110   01


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +...   ...          ...+.+++.+||+.||++|||++|
T Consensus       224 ~~~~---~~~----------s~~~~~li~~~L~~dp~~Rpt~~e  254 (321)
T 1tki_A          224 EEAF---KEI----------SIEAMDFVDRLLVKERKSRMTASE  254 (321)
T ss_dssp             HHHH---TTS----------CHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             hhhh---ccC----------CHHHHHHHHHHcCCChhHCcCHHH
Confidence            1000   000          113568999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.7e-39  Score=366.74  Aligned_cols=209  Identities=26%  Similarity=0.340  Sum_probs=179.4

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEeC
Q 036815          727 SQLIEATNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKIG  802 (1013)
Q Consensus       727 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  802 (1013)
                      .++....++|++.++||+|+||+||+|+++. ++.||+|++.+...   .....+.+|..++..++||||++++++|.++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            3444456789999999999999999999874 67899998864221   1223488999999999999999999999999


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      +..|+||||++||+|.+++....     ..+++..++.++.|++.||+|||+.   +||||||||+||+++.++.+||+|
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            99999999999999999997532     2389999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ||+|+...... ........||+.|+|||++.     ...++.++||||+||++|||++|+.||...
T Consensus       219 FGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~  284 (437)
T 4aw2_A          219 FGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  284 (437)
T ss_dssp             CTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             hhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence            99998764422 22233467999999999987     567899999999999999999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-39  Score=368.57  Aligned_cols=254  Identities=23%  Similarity=0.296  Sum_probs=199.5

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCC
Q 036815          728 QLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       728 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  803 (1013)
                      ++....++|++.+.||+|+||+||+|+++ +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            33445678999999999999999999987 57899999886421   122345789999999999999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..|+||||++||+|.+++...       .+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+||
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence            999999999999999998643       288999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCC----CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHH
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR----CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKV  959 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  959 (1013)
                      |+|+...... ........||+.|+|||++.+..    ++.++||||+||++|||++|+.||...+.     ........
T Consensus       213 G~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~  286 (410)
T 3v8s_A          213 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIM  286 (410)
T ss_dssp             TTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHH
T ss_pred             ceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhHHHHHH
Confidence            9998765422 22334568999999999997655    78999999999999999999999975431     11111111


Q ss_pred             hcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCC--CCCCCC
Q 036815          960 REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSK--RPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~e 1013 (1013)
                      .........+.      ...+          ..+.+++.+||+.+|++  ||+++|
T Consensus       287 ~~~~~~~~p~~------~~~s----------~~~~~li~~lL~~~~~rlgR~~~~e  326 (410)
T 3v8s_A          287 NHKNSLTFPDD------NDIS----------KEAKNLICAFLTDREVRLGRNGVEE  326 (410)
T ss_dssp             THHHHCCCCTT------CCCC----------HHHHHHHHHHSSCGGGCTTSSCHHH
T ss_pred             hccccccCCCc------cccc----------HHHHHHHHHHccChhhhCCCCCHHH
Confidence            10000000000      0011          12458999999999998  999754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=371.17  Aligned_cols=249  Identities=21%  Similarity=0.291  Sum_probs=197.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....  ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            457999999999999999999986 688999998865432  23456899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC---CCCcEEEeecccc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMA  886 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a  886 (1013)
                      ||++||+|.+.+....      .+++..+..++.||+.||+|||++   +|+||||||+||+++   .++.+||+|||+|
T Consensus        90 E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           90 DLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             CCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            9999999999987543      389999999999999999999999   999999999999998   4678999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +......  .......||+.|+|||++.+..++.++||||+||++|+|++|..||.....     .+.... +..+... 
T Consensus       161 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~~-i~~~~~~-  231 (444)
T 3soa_A          161 IEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQQ-IKAGAYD-  231 (444)
T ss_dssp             BCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH-HHHTCCC-
T ss_pred             EEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-HHhCCCC-
Confidence            8765322  223346799999999999999999999999999999999999999975331     111111 1111110 


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+..    ...+          ..+.+++.+||+.||++|||++|
T Consensus       232 ~~~~~~----~~~s----------~~~~~li~~~L~~dP~~Rpta~e  264 (444)
T 3soa_A          232 FPSPEW----DTVT----------PEAKDLINKMLTINPSKRITAAE  264 (444)
T ss_dssp             CCTTTT----TTSC----------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCcccc----ccCC----------HHHHHHHHHHcCCChhHCCCHHH
Confidence            000000    0011          12568999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=355.62  Aligned_cols=243  Identities=24%  Similarity=0.321  Sum_probs=197.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56899999999999999999987 57899999886432   233467889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+.||+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        95 e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             CCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            9999999999997432      389999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Cccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQS---FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQM  965 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  965 (1013)
                      ...   .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||.......  ........... ....
T Consensus       166 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~p  240 (384)
T 4fr4_A          166 PRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFETTVVTYP  240 (384)
T ss_dssp             CTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHHCCCCCC
T ss_pred             cCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhhcccCCC
Confidence            432   22345679999999999864   458999999999999999999999997644322  22222221111 1111


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      ..++                     ..+.+++.+||+.||++||++
T Consensus       241 ~~~s---------------------~~~~~li~~lL~~dP~~R~s~  265 (384)
T 4fr4_A          241 SAWS---------------------QEMVSLLKKLLEPNPDQRFSQ  265 (384)
T ss_dssp             TTSC---------------------HHHHHHHHHHSCSSGGGSCCS
T ss_pred             CcCC---------------------HHHHHHHHHHhcCCHhHhccc
Confidence            1111                     125689999999999999984

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.2e-39  Score=354.34  Aligned_cols=242  Identities=23%  Similarity=0.352  Sum_probs=195.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999985 68999999885421   223457899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+ +|+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        89 E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             CCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             ECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            999 689999886543      389999999999999999999999   9999999999999999999999999999866


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....   ......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||..........      .....  ....
T Consensus       159 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~------~i~~~--~~~~  227 (336)
T 3h4j_B          159 TDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK------KVNSC--VYVM  227 (336)
T ss_dssp             TTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC------CCCSS--CCCC
T ss_pred             cCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH------HHHcC--CCCC
Confidence            4322   2234579999999999988776 689999999999999999999997643322100      00000  0000


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +       ...+          ..+.+++.+||+.||++|||++|
T Consensus       228 p-------~~~s----------~~~~~li~~~L~~dP~~Rpt~~e  255 (336)
T 3h4j_B          228 P-------DFLS----------PGAQSLIRRMIVADPMQRITIQE  255 (336)
T ss_dssp             C-------TTSC----------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             c-------ccCC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            0       0011          12558999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.1e-39  Score=352.43  Aligned_cols=249  Identities=22%  Similarity=0.366  Sum_probs=193.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.......   .+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            367999999999999999999986 68899999885543322   35688999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        90 ~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             EECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred             EeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence            99999999999997543      389999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ........... .... 
T Consensus       161 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~-~~~~-  232 (294)
T 4eqm_A          161 LSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----VSIAIKHIQDS-VPNV-  232 (294)
T ss_dssp             C--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----HHHHHHHHSSC-CCCH-
T ss_pred             ccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhhcc-CCCc-
Confidence            54322 1223345789999999999999999999999999999999999999976431     11111111111 1000 


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      ....   ....+          ..+.+++.+|++.||++||+.
T Consensus       233 ~~~~---~~~~~----------~~l~~li~~~l~~dp~~R~~~  262 (294)
T 4eqm_A          233 TTDV---RKDIP----------QSLSNVILRATEKDKANRYKT  262 (294)
T ss_dssp             HHHS---CTTSC----------HHHHHHHHHHSCSSGGGSCSS
T ss_pred             chhc---ccCCC----------HHHHHHHHHHhcCCHhHcccc
Confidence            0000   01111          125689999999999999954

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-38  Score=353.49  Aligned_cols=242  Identities=25%  Similarity=0.306  Sum_probs=197.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++.+..   ....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467999999999999999999987 47889999886532   23346688999999988 89999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||++||+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+|+
T Consensus        99 v~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            999999999999997543      289999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-cccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-KQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  966 (1013)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+......... ....
T Consensus       170 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~~p~  242 (353)
T 2i0e_A          170 ENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIMEHNVAYPK  242 (353)
T ss_dssp             CCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCT
T ss_pred             ccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhCCCCCCC
Confidence            54321  122345679999999999999999999999999999999999999997532     112222211111 1111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .++                     ..+.+++.+||+.||++||++
T Consensus       243 ~~s---------------------~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          243 SMS---------------------KEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             TSC---------------------HHHHHHHHHHTCSCTTSCTTC
T ss_pred             CCC---------------------HHHHHHHHHHhhcCHHHcCCC
Confidence            111                     125689999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.4e-38  Score=352.92  Aligned_cols=238  Identities=24%  Similarity=0.276  Sum_probs=196.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56899999999999999999986 68999999886432   233467889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       121 e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             ECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceec
Confidence            9999999999997543      289999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ...     .....||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+....... +...  ++
T Consensus       192 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~-~~~~--~p  258 (350)
T 1rdq_E          192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVS-GKVR--FP  258 (350)
T ss_dssp             SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHH-CCCC--CC
T ss_pred             cCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHHHHHc-CCCC--CC
Confidence            432     234578999999999999999999999999999999999999997532     1122221111 1110  01


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      +.       .+          ..+.+++.+||+.||++||+
T Consensus       259 ~~-------~~----------~~~~~li~~lL~~dp~~R~~  282 (350)
T 1rdq_E          259 SH-------FS----------SDLKDLLRNLLQVDLTKRFG  282 (350)
T ss_dssp             TT-------CC----------HHHHHHHHHHSCSCTTTCTT
T ss_pred             CC-------CC----------HHHHHHHHHHhhcCHHhccC
Confidence            11       11          12568999999999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-38  Score=367.65  Aligned_cols=251  Identities=26%  Similarity=0.341  Sum_probs=203.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||.||+|+++ +|+.||+|++.+..   ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999986 68999999986532   22346788999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||++||+|.+++.....  ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+++.
T Consensus       264 mE~~~gg~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             ECCCTTCBHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEeccCCCHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeee
Confidence            999999999999975432  123489999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-ccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-KQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  967 (1013)
                      ......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+........ .....
T Consensus       339 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~~~~p~~  415 (543)
T 3c4z_A          339 LKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQAVTYPDK  415 (543)
T ss_dssp             CCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCCCCCCTT
T ss_pred             ccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhcccCCCcc
Confidence            653222  1234579999999999999999999999999999999999999998654322 1222222222111 11111


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      +++                     .+.+++.+||+.||++||++.
T Consensus       416 ~s~---------------------~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          416 FSP---------------------ASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             SCH---------------------HHHHHHHHHSCSSGGGSCCCB
T ss_pred             cCH---------------------HHHHHHHHhccCCHhHCCCCc
Confidence            111                     245899999999999999874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=351.27  Aligned_cols=269  Identities=23%  Similarity=0.290  Sum_probs=201.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCC--EEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE--ERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  809 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57899999999999999999987 58999999886533 233567889999999999999999999998755  779999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe----CCCCcEEEeeccc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL----DHEMEARVSDFGM  885 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~  885 (1013)
                      ||+++++|.+++.....   ...+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+
T Consensus        89 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eCCCCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            99999999999975432   22389999999999999999999999   99999999999999    7888899999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCccccc--------CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQ--------SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      |+.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||................
T Consensus       163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          163 ARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             ceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            987654322   23456899999999986        5788999999999999999999999997644333222222221


Q ss_pred             HHhcCc-ccccc-C--hhhhcccCCCCh--hhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGK-QMEVI-D--PELLLVTKGTDE--SEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~-~~~~~-d--~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...... ....+ .  ............  ......  ...+.+++.+||+.||++|||++|
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~ll~~~L~~dP~~R~s~~e  299 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGL--QVLLTPVLANILEADQEKCWGFDQ  299 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHH--HHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhH--HHHhHHHHHHhccCChhhhccHHH
Confidence            111110 00000 0  000000000000  001111  223568999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.7e-38  Score=348.63  Aligned_cols=254  Identities=23%  Similarity=0.378  Sum_probs=195.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhc--cCCcceeeeccEEEe----CCEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGK--IKHRNLVPLLGYCKI----GEERL  806 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~  806 (1013)
                      .++|++.+.||+|+||+||+|++ +++.||||++..   .....+.+|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999998 589999998753   234556677777766  799999999998754    34579


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCcccEEeCCCCcE
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH--------HNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      +||||+++|+|.+++...       .+++..++.++.|++.||+|||        +.   +|+||||||+||+++.++.+
T Consensus        83 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred             EehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence            999999999999999532       3899999999999999999999        77   99999999999999999999


Q ss_pred             EEeecccceeccccCccee--eeeeccCCCccCcccccCC------CCCccchhHhHHHHHHHHHcC----------CCC
Q 036815          879 RVSDFGMARLISALDTHLS--VSTLAGTPGYVPPEYYQSF------RCTAKGDVYSFGVVLLELLTG----------KRP  940 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~p  940 (1013)
                      ||+|||+|+..........  .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            9999999987654332211  2234799999999999876      556799999999999999999          888


Q ss_pred             CCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          941 TDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       941 f~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      |......................... ++....            .......+.+++.+||+.||++||||+|
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------------~~~~~~~l~~li~~cl~~dP~~Rps~~~  292 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQRPN-IPNRWF------------SDPTLTSLAKLMKECWYQNPSARLTALR  292 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCC-CCGGGG------------GSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             ccccCCCCcchhhhhHHHhccCCCCC-CChhhc------------cCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence            87654444433333332222211111 111100            0012234679999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-38  Score=356.68  Aligned_cols=251  Identities=23%  Similarity=0.296  Sum_probs=198.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-----ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-----CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++....     ....+.+.+|++++++++||||+++++++.+++..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46999999999999999999986 68999999885321     2245779999999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc---EEEeecc
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFG  884 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg  884 (1013)
                      ||||+++++|.+++.....  ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.   +||+|||
T Consensus       104 v~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999988865432  123489999999999999999999999   9999999999999987654   9999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||....      ......... +..
T Consensus       179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~i~~-~~~  249 (351)
T 3c0i_A          179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ERLFEGIIK-GKY  249 (351)
T ss_dssp             TCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HHHHHHHHH-TCC
T ss_pred             ceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HHHHHHHHc-CCC
Confidence            998765422  12334579999999999999999999999999999999999999997531      111111111 111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .  .++...   ...          ...+.+++.+||+.||++|||++|
T Consensus       250 ~--~~~~~~---~~~----------s~~~~~li~~~L~~dP~~R~s~~e  283 (351)
T 3c0i_A          250 K--MNPRQW---SHI----------SESAKDLVRRMLMLDPAERITVYE  283 (351)
T ss_dssp             C--CCHHHH---TTS----------CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             C--CCcccc---ccC----------CHHHHHHHHHHCCCChhHCcCHHH
Confidence            0  011100   000          113568999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.4e-39  Score=350.23  Aligned_cols=245  Identities=24%  Similarity=0.367  Sum_probs=190.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--------------------------chHHHHHHHHHHhc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--------------------------GDREFMAEMETLGK  786 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~  786 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++......                          ..+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57999999999999999999986 5788999988643211                          12458899999999


Q ss_pred             cCCcceeeeccEEEe--CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 036815          787 IKHRNLVPLLGYCKI--GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRD  864 (1013)
Q Consensus       787 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  864 (1013)
                      ++||||+++++++.+  .+..++||||+++++|.+++.       ...+++..++.++.|++.||+|||++   +|+|||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D  162 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRD  162 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            999999999999986  568899999999999987543       23489999999999999999999999   999999


Q ss_pred             CCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCC---CCccchhHhHHHHHHHHHcCCCCC
Q 036815          865 MKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR---CTAKGDVYSFGVVLLELLTGKRPT  941 (1013)
Q Consensus       865 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf  941 (1013)
                      |||+||+++.++.+||+|||+++.......  ......||+.|+|||++.+..   ++.++||||+||++|||++|+.||
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  240 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF  240 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            999999999999999999999987654322  233467999999999997665   478899999999999999999999


Q ss_pred             CCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          942 DKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       942 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....     ...+... +..........+.       .+          ..+.+++.+||+.||++|||++|
T Consensus       241 ~~~~-----~~~~~~~-~~~~~~~~~~~~~-------~~----------~~l~~li~~~l~~dp~~R~s~~e  289 (298)
T 2zv2_A          241 MDER-----IMCLHSK-IKSQALEFPDQPD-------IA----------EDLKDLITRMLDKNPESRIVVPE  289 (298)
T ss_dssp             CCSS-----HHHHHHH-HHHCCCCCCSSSC-------CC----------HHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             CCcc-----HHHHHHH-HhcccCCCCCccc-------cC----------HHHHHHHHHHhhcChhhCCCHHH
Confidence            7532     1222211 1111110000000       11          12568999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-38  Score=347.23  Aligned_cols=199  Identities=27%  Similarity=0.364  Sum_probs=170.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||+|++......  ....+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999986 5889999998654322  23678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++ ++.+.+....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~~-~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             CCSE-EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             cCCC-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            9986 5655554322     2389999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      ...  .......||+.|+|||++.+.. ++.++||||+||++|||++|..||..
T Consensus       153 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          153 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             SCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             Ccc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence            322  2233457899999999987765 79999999999999999999888654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.1e-38  Score=355.76  Aligned_cols=249  Identities=21%  Similarity=0.277  Sum_probs=189.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999987 68999999886533 3346788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc--EEEeecccceec
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME--ARVSDFGMARLI  889 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~~  889 (1013)
                      +++|+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.  +||+|||+|+..
T Consensus        98 ~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           98 ASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             CCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            99999999996533      289999999999999999999999   9999999999999987765  999999999753


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCcc-chhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAK-GDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ...   .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........ ...............   
T Consensus       169 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~---  241 (361)
T 3uc3_A          169 VLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKYSI---  241 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTCCCC---
T ss_pred             ccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCCCCC---
Confidence            321   22234579999999999988877655 8999999999999999999986443222 222222222111100   


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +...     ..+          ..+.+++.+||+.||++|||++|
T Consensus       242 ~~~~-----~~s----------~~~~~li~~~L~~dP~~Rps~~e  271 (361)
T 3uc3_A          242 PDDI-----RIS----------PECCHLISRIFVADPATRISIPE  271 (361)
T ss_dssp             CTTS-----CCC----------HHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             CCcC-----CCC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            0000     001          12568999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-38  Score=341.70  Aligned_cols=247  Identities=28%  Similarity=0.463  Sum_probs=199.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.+.||+|+||.||+|+++++..||+|++... ....+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            3578999999999999999999988889999987543 334577999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++.....
T Consensus        86 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           86 SNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             CCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999996542     2489999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      . ........+++.|+|||++.+..++.++||||+|+++|||++ |+.||.....     ...... ...+...  ..+.
T Consensus       158 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~-~~~~~~~--~~~~  228 (268)
T 3sxs_A          158 Q-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----SEVVLK-VSQGHRL--YRPH  228 (268)
T ss_dssp             C-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHH-HHTTCCC--CCCT
T ss_pred             h-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----HHHHHH-HHcCCCC--CCCC
Confidence            2 222233456778999999998899999999999999999999 9999875331     111111 1111110  0010


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .      .+          ..+.+++.+||+.||++|||++|
T Consensus       229 ~------~~----------~~l~~li~~~l~~~p~~Rps~~~  254 (268)
T 3sxs_A          229 L------AS----------DTIYQIMYSCWHELPEKRPTFQQ  254 (268)
T ss_dssp             T------SC----------HHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             c------Ch----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            0      00          12568999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3e-38  Score=349.40  Aligned_cols=245  Identities=24%  Similarity=0.324  Sum_probs=175.5

Q ss_pred             CCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEEEcccCCC
Q 036815          739 ESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYEFMKFGS  816 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  816 (1013)
                      .+.||+|+||.||+|++. +++.||||++.+   .....+.+|+.+++++. ||||+++++++.++...|+||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999986 689999998854   23567889999999997 9999999999999999999999999999


Q ss_pred             HHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC---cEEEeecccceeccccC
Q 036815          817 LEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM---EARVSDFGMARLISALD  893 (1013)
Q Consensus       817 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~  893 (1013)
                      |.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++   .+||+|||+++......
T Consensus        93 L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           93 LFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             HHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             HHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            999997542      389999999999999999999999   999999999999998765   89999999998654322


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC--ccHHHHHHHHHhcCccccccChh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD--TNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                        .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ....+.. ..+..+...  .+..
T Consensus       164 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~~~--~~~~  238 (325)
T 3kn6_A          164 --QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFS--FEGE  238 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTCCC--CCSH
T ss_pred             --CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCCCC--CCcc
Confidence              22344568999999999999999999999999999999999999998644321  1112222 222222111  0000


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .           ..  .....+.+++.+||+.||++|||++|
T Consensus       239 ~-----------~~--~~s~~~~~li~~~L~~dP~~Rpt~~e  267 (325)
T 3kn6_A          239 A-----------WK--NVSQEAKDLIQGLLTVDPNKRLKMSG  267 (325)
T ss_dssp             H-----------HH--TSCHHHHHHHHHHHCCCTTTCCCTTT
T ss_pred             c-----------cc--CCCHHHHHHHHHHCCCChhHCCCHHH
Confidence            0           00  00123568999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.8e-39  Score=348.13  Aligned_cols=200  Identities=24%  Similarity=0.352  Sum_probs=170.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||+||+|++.+++.||+|++.....  ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            47889999999999999999998899999999854332  2246788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++ +|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             CSE-EHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             cCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            985 9999886432     2388999999999999999999999   999999999999999999999999999986543


Q ss_pred             cCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ..  .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       153 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          153 PV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            21  12234568999999999876 45899999999999999999999999764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=353.27  Aligned_cols=249  Identities=28%  Similarity=0.429  Sum_probs=195.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .++|++.+.||+|+||.||+|++.    .+..||||++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357889999999999999999985    34469999886542 2334678999999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       128 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EeeCCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            999999999999996432     2389999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCc-ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          888 LISALDT-HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       888 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      ....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.....     ...... +..+...
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~-~~~~~~~  273 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----RDVISS-VEEGYRL  273 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HHHHHH-HHTTCCC
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHH-HHcCCCC
Confidence            7654322 122233456778999999998899999999999999999999 9999975321     111111 1111111


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . .+.       ..+          ..+.+++.+||+.||++|||++|
T Consensus       274 ~-~~~-------~~~----------~~l~~li~~~l~~dp~~Rps~~e  303 (325)
T 3kul_A          274 P-APM-------GCP----------HALHQLMLDCWHKDRAQRPRFSQ  303 (325)
T ss_dssp             C-CCT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C-CCC-------CcC----------HHHHHHHHHHccCChhhCcCHHH
Confidence            0 000       011          12568999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.6e-39  Score=358.30  Aligned_cols=260  Identities=23%  Similarity=0.273  Sum_probs=198.1

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc-----CccchHHHHHHHHHHhccCCcceeeeccEEEeCC
Q 036815          730 IEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL-----SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       730 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  803 (1013)
                      ....++|++.+.||+|+||.||+|++. +++.||+|++...     .....+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            445678999999999999999999986 6789999988543     2334567899999999999999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCC----------------------------------CCccccHHHHHHHHHHHHHHH
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKAR----------------------------------DQRILTWDARKKIARGAAKGL  849 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~----------------------------------~~~~l~~~~~~~i~~~i~~~L  849 (1013)
                      ..++||||+++|+|.+++.......                                  ....+++..++.++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            9999999999999999996321110                                  122357888999999999999


Q ss_pred             HHHHhcCCCCeEecCCCcccEEeCCCC--cEEEeecccceeccccCcc--eeeeeeccCCCccCcccccC--CCCCccch
Q 036815          850 CFLHHNCIPHIIHRDMKSSNVLLDHEM--EARVSDFGMARLISALDTH--LSVSTLAGTPGYVPPEYYQS--FRCTAKGD  923 (1013)
Q Consensus       850 ~~LH~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~D  923 (1013)
                      +|||++   +|+||||||+||+++.++  .+||+|||+++.+......  .......||+.|+|||++.+  ..++.++|
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999   999999999999998776  8999999999876442221  12345679999999999875  67899999


Q ss_pred             hHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccC
Q 036815          924 VYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDD 1003 (1013)
Q Consensus       924 vwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 1003 (1013)
                      ||||||++|||++|+.||.....     .+.............  .+...    ..+          ..+.+++.+||+.
T Consensus       259 iwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~--~~~~~----~~~----------~~~~~li~~~l~~  317 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVND-----ADTISQVLNKKLCFE--NPNYN----VLS----------PLARDLLSNLLNR  317 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCTT--SGGGG----GSC----------HHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcccccC--Ccccc----cCC----------HHHHHHHHHHcCC
Confidence            99999999999999999975431     111222221111111  01000    000          1256899999999


Q ss_pred             CCCCCCCCCC
Q 036815         1004 FPSKRPNMLQ 1013 (1013)
Q Consensus      1004 dP~~RPt~~e 1013 (1013)
                      ||++|||++|
T Consensus       318 ~p~~Rps~~~  327 (345)
T 3hko_A          318 NVDERFDAMR  327 (345)
T ss_dssp             CTTTSCCHHH
T ss_pred             ChhHCCCHHH
Confidence            9999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-38  Score=355.19  Aligned_cols=243  Identities=25%  Similarity=0.328  Sum_probs=189.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHH-HhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMET-LGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++.+...   .....+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56999999999999999999987 578899999865432   223456677776 5678999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||++||+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+++.
T Consensus       118 ~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            99999999999997533      378899999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+...........   +
T Consensus       189 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~---~  258 (373)
T 2r5t_A          189 NIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNKPLQ---L  258 (373)
T ss_dssp             GBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHHHHHHHSCCC---C
T ss_pred             cccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcccC---C
Confidence            4321  122345679999999999999999999999999999999999999997532     12222222211100   1


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ++.+       +          ..+.+++.+||+.||++||++.
T Consensus       259 ~~~~-------~----------~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          259 KPNI-------T----------NSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             CSSS-------C----------HHHHHHHHHHTCSSGGGSTTTT
T ss_pred             CCCC-------C----------HHHHHHHHHHcccCHHhCCCCC
Confidence            1111       1          1245899999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-38  Score=343.74  Aligned_cols=246  Identities=27%  Similarity=0.461  Sum_probs=198.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||.||+|++.+++.||+|++... ....+++.+|++++++++||||+++++++.+++..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            468889999999999999999988899999988643 3345779999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        89 ~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           89 HGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             TCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCcHHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999996432     2489999999999999999999999   99999999999999999999999999998654321


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                       ........+++.|+|||++.+..++.++||||+||++|||++ |+.||.....     .+.... ...+..  ...+..
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----~~~~~~-~~~~~~--~~~~~~  231 (269)
T 4hcu_A          161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVED-ISTGFR--LYKPRL  231 (269)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH-HHTTCC--CCCCTT
T ss_pred             -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH-HhcCcc--CCCCCc
Confidence             112223456778999999998999999999999999999999 9999875331     111211 111110  001110


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            .+          ..+.+++.+||+.||++|||++|
T Consensus       232 ------~~----------~~~~~li~~~l~~~p~~Rps~~~  256 (269)
T 4hcu_A          232 ------AS----------THVYQIMNHCWRERPEDRPAFSR  256 (269)
T ss_dssp             ------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------CC----------HHHHHHHHHHccCCcccCcCHHH
Confidence                  00          12568999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=357.69  Aligned_cols=247  Identities=22%  Similarity=0.362  Sum_probs=182.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467999999999999999999987 57899999886432  346688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCcEEEeeccccee
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EMEARVSDFGMARL  888 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a~~  888 (1013)
                      +++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++.
T Consensus       130 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          130 VTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             CCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999996432      389999999999999999999999   9999999999999975   88999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .... .+...... ..
T Consensus       201 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~-~i~~~~~~-~~  271 (349)
T 2w4o_A          201 VEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ----FMFR-RILNCEYY-FI  271 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH----HHHH-HHHTTCCC-CC
T ss_pred             cCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH----HHHH-HHHhCCCc-cC
Confidence            5432   12234578999999999999999999999999999999999999997543211    1111 11111110 00


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+..    ...+          ..+.+++.+||+.||++|||++|
T Consensus       272 ~~~~----~~~~----------~~~~~li~~~L~~dP~~Rpt~~e  302 (349)
T 2w4o_A          272 SPWW----DEVS----------LNAKDLVRKLIVLDPKKRLTTFQ  302 (349)
T ss_dssp             TTTT----TTSC----------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             Cchh----hhCC----------HHHHHHHHHHccCChhhCcCHHH
Confidence            0000    0011          12568999999999999999864

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=4.6e-38  Score=363.36  Aligned_cols=354  Identities=20%  Similarity=0.213  Sum_probs=235.9

Q ss_pred             CCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcE
Q 036815           99 SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLE  178 (1013)
Q Consensus        99 ~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~  178 (1013)
                      .+++|++|++++|.++++ | .+..+++|++|++++|++++. +  ++.+++|++|++++|.+++ ++   +..+++|++
T Consensus        40 ~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~---~~~l~~L~~  110 (457)
T 3bz5_A           40 QLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD---VTPLTKLTY  110 (457)
T ss_dssp             HHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC---CTTCTTCCE
T ss_pred             HcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee---cCCCCcCCE
Confidence            456677777777777664 3 466667777777777776653 2  6666667777777776663 33   233566666


Q ss_pred             EECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCe
Q 036815          179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNR  258 (1013)
Q Consensus       179 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  258 (1013)
                      |++++|++++. +  +..+++|++|++++|++++ ++   +..+++|++|++++|+..+.+  .+..+++|+.|++++|+
T Consensus       111 L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~---l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~  181 (457)
T 3bz5_A          111 LNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE-ID---VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNK  181 (457)
T ss_dssp             EECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC-CC---CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCee-c--CCCCCcCCEEECCCCccce-ec---cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCc
Confidence            66666666653 2  5566666666666666653 32   345566666666666433232  35555566666666665


Q ss_pred             ecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCc
Q 036815          259 VSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPP  338 (1013)
Q Consensus       259 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~  338 (1013)
                      +++ ++   +..+++|+.|++++|.+++.   .++.+++|+.|++++|+++                        + +| 
T Consensus       182 l~~-l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~------------------------~-ip-  228 (457)
T 3bz5_A          182 ITE-LD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT------------------------E-ID-  228 (457)
T ss_dssp             CCC-CC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCS------------------------C-CC-
T ss_pred             cce-ec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccc------------------------c-cC-
Confidence            553 22   33455555555555555543   2445555555555555554                        2 33 


Q ss_pred             CcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCC
Q 036815          339 ELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSL  418 (1013)
Q Consensus       339 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  418 (1013)
                       ++.+++|++|++++|++++. |  +..+++|+.|++++|              +|+.|++++|.+.|.+|  ++++++|
T Consensus       229 -~~~l~~L~~L~l~~N~l~~~-~--~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L  288 (457)
T 3bz5_A          229 -VTPLTQLTYFDCSVNPLTEL-D--VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKI  288 (457)
T ss_dssp             -CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTC
T ss_pred             -ccccCCCCEEEeeCCcCCCc-C--HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccC
Confidence             56677788888888888754 3  456677888887765              45678888998888887  5688999


Q ss_pred             cEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccC
Q 036815          419 VWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSG  498 (1013)
Q Consensus       419 ~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  498 (1013)
                      ++|++++|.+.|.+|....                                                .++.++       
T Consensus       289 ~~L~Ls~n~~l~~l~~~~~------------------------------------------------~L~~L~-------  313 (457)
T 3bz5_A          289 KELDVTHNTQLYLLDCQAA------------------------------------------------GITELD-------  313 (457)
T ss_dssp             CCCCCTTCTTCCEEECTTC------------------------------------------------CCSCCC-------
T ss_pred             CEEECCCCcccceeccCCC------------------------------------------------cceEec-------
Confidence            9999999988877663211                                                111122       


Q ss_pred             cccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccC
Q 036815          499 PVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSN  578 (1013)
Q Consensus       499 ~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~  578 (1013)
                           +...++|++|++++|+|+| +|  ++.+++|+.|++++|+++|        ++.|..|++++|+++|.     .+
T Consensus       314 -----l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~  372 (457)
T 3bz5_A          314 -----LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQ  372 (457)
T ss_dssp             -----CTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EE
T ss_pred             -----hhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ce
Confidence                 2234679999999999997 54  9999999999999999996        35678889999999986     35


Q ss_pred             CCcceEEECcCCCCCCcCCCC
Q 036815          579 LSFLVQIDLSNNELTGPIPQR  599 (1013)
Q Consensus       579 l~~l~~l~l~~n~l~~~~p~~  599 (1013)
                      +..|..+++++|+|+|.||..
T Consensus       373 ~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          373 TITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             EEECCCBCCBTTBEEEECCTT
T ss_pred             eeecCccccccCcEEEEcChh
Confidence            567888999999999999963

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-38  Score=353.24  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=184.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcCC----CEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKDG----SSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      ..++|++.+.||+|+||.||+|++...    ..||+|++...  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            356899999999999999999997643    27999987543  233456789999999999999999999999876655


Q ss_pred             ------EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEE
Q 036815          806 ------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEAR  879 (1013)
Q Consensus       806 ------~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  879 (1013)
                            ++||||+++|+|.+++...........+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999997654433334589999999999999999999999   999999999999999999999


Q ss_pred             EeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHH
Q 036815          880 VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMK  958 (1013)
Q Consensus       880 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  958 (1013)
                      |+|||+|+...............+++.|+|||++.+..++.++||||+||++|||++ |+.||......  ...   ...
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~---~~~  252 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIY---NYL  252 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH---HHH
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHH---HHH
Confidence            999999987654433333344567889999999999999999999999999999999 99999764321  111   111


Q ss_pred             HhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       959 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. +.... .++..       .          ..+.+++.+||+.||++|||++|
T Consensus       253 ~~-~~~~~-~~~~~-------~----------~~l~~li~~~l~~dp~~Rps~~~  288 (323)
T 3qup_A          253 IG-GNRLK-QPPEC-------M----------EEVYDLMYQCWSADPKQRPSFTC  288 (323)
T ss_dssp             HT-TCCCC-CCTTC-------C----------HHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             hc-CCCCC-CCCcc-------C----------HHHHHHHHHHccCChhhCcCHHH
Confidence            11 11110 01110       0          12568999999999999999753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-39  Score=358.57  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=189.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCC----E
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGE----E  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  804 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.......   ...+.+|++++++++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            367999999999999999999985 68899999886543222   346889999999999999999999987644    3


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+||||+++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             cEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence            499999999999999997543      389999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcc-eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          885 MARLISALDTH-LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       885 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      +++........ .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ............
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~~  236 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDP  236 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCC
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCC
Confidence            99876543221 222345689999999999999999999999999999999999999975431     111222222111


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ..    +...  ....+          ..+.+++.+||+.||++||++.
T Consensus       237 ~~----~~~~--~~~~~----------~~l~~li~~~l~~dP~~R~~~~  269 (311)
T 3ork_A          237 IP----PSAR--HEGLS----------ADLDAVVLKALAKNPENRYQTA  269 (311)
T ss_dssp             CC----HHHH--STTCC----------HHHHHHHHHHTCSSGGGSCSSH
T ss_pred             CC----cccc--cCCCC----------HHHHHHHHHHHhcCHhhChhhH
Confidence            11    0000  00011          1256899999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.8e-39  Score=364.54  Aligned_cols=248  Identities=26%  Similarity=0.377  Sum_probs=196.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||||.+..... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            56888999999999999999987 689999998764322 2234688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++|+|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       194 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          194 VQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             CTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999997432     2388999999999999999999999   999999999999999999999999999986543


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...........+++.|+|||++.+..++.++|||||||++|||++ |..||.....  .    .+...+..+.....  +
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~----~~~~~~~~~~~~~~--~  337 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--Q----QTREFVEKGGRLPC--P  337 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--H----HHHHHHHTTCCCCC--C
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--H----HHHHHHHcCCCCCC--C
Confidence            211111122335678999999998899999999999999999998 9999875331  1    11122222211110  0


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .      ..+          ..+.+++.+||+.||++|||++|
T Consensus       338 ~------~~~----------~~l~~li~~cl~~dP~~Rps~~~  364 (377)
T 3cbl_A          338 E------LCP----------DAVFRLMEQCWAYEPGQRPSFST  364 (377)
T ss_dssp             T------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C------CCC----------HHHHHHHHHHcCCCchhCcCHHH
Confidence            0      011          12568999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.1e-38  Score=343.14  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=200.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            56899999999999999999986 689999998864332 3346789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++...      ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        87 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           87 CSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             CTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999988643      2389999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...........|++.|+|||++.+..+ +.++||||+||++|||++|+.||............|...... ......++ 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-  235 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKID-  235 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-STTGGGSC-
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-cCchhhcC-
Confidence            333223345678999999999987665 778999999999999999999998754433322222211000 00000011 


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                                          ..+.+++.+||+.||++|||++|
T Consensus       236 --------------------~~~~~li~~~l~~~p~~Rps~~~  258 (276)
T 2yex_A          236 --------------------SAPLALLHKILVENPSARITIPD  258 (276)
T ss_dssp             --------------------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             --------------------HHHHHHHHHHCCCCchhCCCHHH
Confidence                                12568999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-38  Score=345.04  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=199.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|++. ++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            356999999999999999999987 4678999998776666678899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe---CCCCcEEEeeccccee
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARL  888 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~  888 (1013)
                      +++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++..
T Consensus        88 ~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           88 CTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             CCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            99999999986543      389999999999999999999999   99999999999999   7889999999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      .....   ......||+.|+|||++.+. ++.++||||+||++|||++|+.||.....     .+.... ...+....  
T Consensus       159 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~~~~~--  226 (277)
T 3f3z_A          159 FKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-----SEVMLK-IREGTFTF--  226 (277)
T ss_dssp             CCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHHCCCCC--
T ss_pred             ccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-----HHHHHH-HHhCCCCC--
Confidence            65332   22345789999999998764 89999999999999999999999975331     111111 11111100  


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +....   ...          ...+.+++.+||+.||++|||+.|
T Consensus       227 ~~~~~---~~~----------~~~~~~li~~~l~~dp~~R~s~~~  258 (277)
T 3f3z_A          227 PEKDW---LNV----------SPQAESLIRRLLTKSPKQRITSLQ  258 (277)
T ss_dssp             CHHHH---TTS----------CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             Cchhh---hcC----------CHHHHHHHHHHccCChhhCcCHHH
Confidence            00000   000          113568999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.1e-38  Score=349.88  Aligned_cols=243  Identities=23%  Similarity=0.327  Sum_probs=187.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEE----cCCCEEEEEEeeccC----ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATL----KDGSSVAIKKLIRLS----CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      ++|++.+.||+|+||.||+|+.    .+++.||+|++.+..    ......+.+|++++++++||||+++++++.+++..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5699999999999999999997    368999999886532    22345678899999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      |+||||+++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            99999999999999997533      378999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      ++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ........... . 
T Consensus       168 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~-~-  238 (327)
T 3a62_A          168 CKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTIDKILKCK-L-  238 (327)
T ss_dssp             C------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTC-C-
T ss_pred             ccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCC-C-
Confidence            97543211  122345789999999999999999999999999999999999999975331     11122111111 0 


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                       .+++.+       +          ..+.+++.+||+.||++||++.
T Consensus       239 -~~p~~~-------~----------~~~~~li~~~L~~dp~~R~~~~  267 (327)
T 3a62_A          239 -NLPPYL-------T----------QEARDLLKKLLKRNAASRLGAG  267 (327)
T ss_dssp             -CCCTTS-------C----------HHHHHHHHHHSCSCGGGSTTSS
T ss_pred             -CCCCCC-------C----------HHHHHHHHHHHhcCHhhccCCC
Confidence             011110       0          1256899999999999999653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.5e-38  Score=369.17  Aligned_cols=247  Identities=26%  Similarity=0.328  Sum_probs=200.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++.+..   ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999986 68999999986532   23346688999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||++||+|.+++.....    ..+++..++.++.||+.||+|||++   +||||||||+||+++.++++||+|||+|+.
T Consensus       263 mEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence            999999999999975432    3389999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Cccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~  967 (1013)
                      .....   ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ........... ......
T Consensus       336 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~~~~~~p~~  411 (576)
T 2acx_A          336 VPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEVPEEYSER  411 (576)
T ss_dssp             CCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHHCCCCCCTT
T ss_pred             cccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhcccccCCcc
Confidence            65322   23345799999999999998999999999999999999999999986543221 11111111111 111111


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      +++                     .+.+++.+||+.||++||++
T Consensus       412 ~s~---------------------~~~dLI~~lL~~dP~~R~g~  434 (576)
T 2acx_A          412 FSP---------------------QARSLCSQLLCKDPAERLGC  434 (576)
T ss_dssp             SCH---------------------HHHHHHHHHTCSSGGGSTTC
T ss_pred             CCH---------------------HHHHHHHHhccCCHHHcCCC
Confidence            111                     25689999999999999954

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.6e-38  Score=344.40  Aligned_cols=245  Identities=33%  Similarity=0.537  Sum_probs=193.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccch-------HHHHHHHHHHhccCCcceeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD-------REFMAEMETLGKIKHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  804 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........       +.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367999999999999999999985 689999998854332221       67899999999999999999999986655 


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCcccEEeCCCCc-----
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH--IIHRDMKSSNVLLDHEME-----  877 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~-----  877 (1013)
                       ++||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.     
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             -eEEEEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCcee
Confidence             69999999999999886432     3489999999999999999999999   8  999999999999988776     


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccc--cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHH
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY--QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWV  955 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~  955 (1013)
                      +||+|||+++....     ......||+.|+|||++  ....++.++||||+||++|||++|+.||.........   +.
T Consensus       168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~  239 (287)
T 4f0f_A          168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK---FI  239 (287)
T ss_dssp             EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH---HH
T ss_pred             EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH---HH
Confidence            99999999975432     23346789999999998  4556789999999999999999999999865433221   11


Q ss_pred             HHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          956 KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       956 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .......... ...+..       +          ..+.+++.+||+.||++|||++|
T Consensus       240 ~~~~~~~~~~-~~~~~~-------~----------~~l~~li~~~l~~dp~~Rps~~~  279 (287)
T 4f0f_A          240 NMIREEGLRP-TIPEDC-------P----------PRLRNVIELCWSGDPKKRPHFSY  279 (287)
T ss_dssp             HHHHHSCCCC-CCCTTS-------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHhccCCCC-CCCccc-------C----------HHHHHHHHHHhcCChhhCcCHHH
Confidence            2111111111 111111       1          12568999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3e-38  Score=359.56  Aligned_cols=207  Identities=22%  Similarity=0.285  Sum_probs=177.7

Q ss_pred             hcCCCCCCeeccc--CCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCG--GFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .++|++.+.||+|  +||.||+|++. +++.||||++.....  ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999987 689999999865432  223568889999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++.....    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||.+.
T Consensus       104 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            9999999999999975422    2389999999999999999999999   99999999999999999999999999987


Q ss_pred             eccccCcc-----eeeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          888 LISALDTH-----LSVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       888 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      ........     .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||.....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  242 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA  242 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            65322111     11123468899999999987  6789999999999999999999999986543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=359.20  Aligned_cols=243  Identities=22%  Similarity=0.295  Sum_probs=191.0

Q ss_pred             CCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          739 ESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      .+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999986 6899999998765555667899999999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe--CCCCcEEEeecccceeccccCcc
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL--DHEMEARVSDFGMARLISALDTH  895 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~  895 (1013)
                      .+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||++  +.++.+||+|||+++....... 
T Consensus       174 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-  244 (373)
T 2x4f_A          174 FDRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-  244 (373)
T ss_dssp             HHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence            99886432     2388999999999999999999999   99999999999999  5678999999999987654322 


Q ss_pred             eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcc
Q 036815          896 LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV  975 (1013)
Q Consensus       896 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  975 (1013)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+...........  ..+...   
T Consensus       245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~~--~~~~~~---  312 (373)
T 2x4f_A          245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----AETLNNILACRWD--LEDEEF---  312 (373)
T ss_dssp             --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCC--SCSGGG---
T ss_pred             --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhccCC--CChhhh---
Confidence              2345699999999999999999999999999999999999999976431     1111211111100  000000   


Q ss_pred             cCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          976 TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       976 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ...+          ..+.+++.+||+.||++|||++|
T Consensus       313 -~~~~----------~~~~~li~~~L~~dp~~Rps~~e  339 (373)
T 2x4f_A          313 -QDIS----------EEAKEFISKLLIKEKSWRISASE  339 (373)
T ss_dssp             -TTSC----------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             -ccCC----------HHHHHHHHHHcCCChhhCCCHHH
Confidence             0011          12568999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.6e-38  Score=362.24  Aligned_cols=243  Identities=24%  Similarity=0.394  Sum_probs=198.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|.+.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57999999999999999999987 78999999986432   123457899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        96 E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           96 EYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             ECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            9999999999996432      389999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....     ...... +..+...  .
T Consensus       167 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~~-i~~~~~~--~  235 (476)
T 2y94_A          167 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFKK-ICDGIFY--T  235 (476)
T ss_dssp             CTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHHH-HHTTCCC--C
T ss_pred             cccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHHH-HhcCCcC--C
Confidence            5322   2334579999999999988765 6899999999999999999999976432     111111 1111110  0


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.       ..+          ..+.+++.+||+.||++|||++|
T Consensus       236 p~-------~~s----------~~~~~Li~~~L~~dP~~Rpt~~e  263 (476)
T 2y94_A          236 PQ-------YLN----------PSVISLLKHMLQVDPMKRATIKD  263 (476)
T ss_dssp             CT-------TCC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             Cc-------cCC----------HHHHHHHHHHcCCCchhCcCHHH
Confidence            00       001          12568999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-38  Score=359.37  Aligned_cols=248  Identities=28%  Similarity=0.443  Sum_probs=185.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|++.    ++..||||++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57999999999999999999875    46789999886532 23346799999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|+|.+++....     ..+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       125 ~e~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999997432     2489999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcc-eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          889 ISALDTH-LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       889 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....     .+... .+..+....
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~~-~i~~~~~~~  270 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIK-AVDEGYRLP  270 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHHH-HHHTTEECC
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH-HHHcCCCCC
Confidence            6542211 11222345778999999999999999999999999999998 9999975321     11111 111111100


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ...       .          ...+.+++.+||+.||++|||++|
T Consensus       271 ~-~~~-------~----------~~~l~~li~~cl~~dp~~RPs~~~  299 (373)
T 2qol_A          271 P-PMD-------C----------PAALYQLMLDCWQKDRNNRPKFEQ  299 (373)
T ss_dssp             C-CTT-------C----------BHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C-Ccc-------c----------cHHHHHHHHHHhCcChhhCcCHHH
Confidence            0 000       0          113568999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.5e-38  Score=350.59  Aligned_cols=252  Identities=19%  Similarity=0.208  Sum_probs=198.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||||.+....  ..+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            367999999999999999999975 68899999875432  234588999999999 99999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc-----EEEeeccc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME-----ARVSDFGM  885 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfg~  885 (1013)
                      |+ +++|.+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+
T Consensus        86 ~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             CC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             eC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            99 899999997532     2489999999999999999999999   9999999999999999887     99999999


Q ss_pred             ceeccccCcce-----eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh
Q 036815          886 ARLISALDTHL-----SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR  960 (1013)
Q Consensus       886 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  960 (1013)
                      |+.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ..+.......
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~  234 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQKIGD  234 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHHHHh
Confidence            98765433211     1235679999999999999999999999999999999999999998754322  2221111110


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ..  ....+..             ......+.+++.+|++.||.+||++++
T Consensus       235 ~-~~--~~~~~~~-------------~~~~p~~~~li~~~l~~~p~~RP~~~~  271 (330)
T 2izr_A          235 T-KR--ATPIEVL-------------CENFPEMATYLRYVRRLDFFEKPDYDY  271 (330)
T ss_dssp             H-HH--HSCHHHH-------------TTTCHHHHHHHHHHHHCCTTCCCCHHH
T ss_pred             h-hc--cCCHHHH-------------hccChHHHHHHHHHHhCCCCCCCCHHH
Confidence            0 00  0000000             000013678999999999999999753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-39  Score=360.94  Aligned_cols=253  Identities=28%  Similarity=0.406  Sum_probs=199.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeecc-CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRL-SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||+||+|++.      +++.||||++... .......+.+|+.++++++||||+++++++.++...+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56889999999999999999953      4568999988543 2333457889999999999999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccC-CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC---cEEEee
Q 036815          807 LVYEFMKFGSLEEVLHGRAKA-RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM---EARVSD  882 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~D  882 (1013)
                      +||||+++|+|.+++...... .....+++..++.++.|++.||+|||++   +|+||||||+||+++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            999999999999999765432 1224589999999999999999999999   999999999999999555   599999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      ||+|+...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....     .+.... +..
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~~~~~~-i~~  301 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEF-VTS  301 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHH-HHT
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-HHc
Confidence            999986543333333344567899999999999999999999999999999998 9999975431     112221 111


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +..... +.       ...          ..+.+++.+||+.||++|||++|
T Consensus       302 ~~~~~~-~~-------~~~----------~~l~~li~~~l~~dP~~Rps~~e  335 (367)
T 3l9p_A          302 GGRMDP-PK-------NCP----------GPVYRIMTQCWQHQPEDRPNFAI  335 (367)
T ss_dssp             TCCCCC-CT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCC-Cc-------cCC----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence            111110 00       011          12568999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.7e-39  Score=359.98  Aligned_cols=260  Identities=28%  Similarity=0.410  Sum_probs=202.5

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCcc-chHHHHHHHHHHhcc-CCcceeeeccEE
Q 036815          728 QLIEATNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKI-KHRNLVPLLGYC  799 (1013)
Q Consensus       728 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~  799 (1013)
                      +.....++|++.+.||+|+||.||+|++.      +++.||||++...... ..+.+.+|+++++++ +||||+++++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            33445678999999999999999999842      4578999988654332 345689999999999 799999999999


Q ss_pred             EeCC-EEEEEEEcccCCCHHHHhcccccCC--------------------------------------------------
Q 036815          800 KIGE-ERLLVYEFMKFGSLEEVLHGRAKAR--------------------------------------------------  828 (1013)
Q Consensus       800 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~--------------------------------------------------  828 (1013)
                      .+.+ ..++||||+++|+|.+++.......                                                  
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8754 4899999999999999997653210                                                  


Q ss_pred             ----------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceee
Q 036815          829 ----------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV  898 (1013)
Q Consensus       829 ----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  898 (1013)
                                ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...........
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                      012389999999999999999999999   9999999999999999999999999999876554444444


Q ss_pred             eeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccC
Q 036815          899 STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK  977 (1013)
Q Consensus       899 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  977 (1013)
                      ....||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.     .......+..... +.       
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~~~~-~~-------  319 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRA-PD-------  319 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----HHHHHHHTCCCCC-CT-------
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-----HHHHHHcCCCCCC-CC-------
Confidence            55678999999999999999999999999999999998 9999976443211     1111111111110 00       


Q ss_pred             CCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          978 GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       978 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...          ..+.+++.+||+.||++||||+|
T Consensus       320 ~~~----------~~l~~li~~~l~~dP~~Rps~~e  345 (359)
T 3vhe_A          320 YTT----------PEMYQTMLDCWHGEPSQRPTFSE  345 (359)
T ss_dssp             TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCC----------HHHHHHHHHHccCChhhCCCHHH
Confidence            001          12568999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.7e-38  Score=342.72  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=197.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....  ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999986 588999998865332  23466889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc---EEEeecccc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMA  886 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~a  886 (1013)
                      ||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||.+
T Consensus        85 e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~  155 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  155 (284)
T ss_dssp             CCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             ecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence            9999999999886543      389999999999999999999999   9999999999999987655   999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ........   .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.....     ...... ...+... 
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~-~~~~~~~-  225 (284)
T 3kk8_A          156 IEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQ-IKAGAYD-  225 (284)
T ss_dssp             EECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHHTCCC-
T ss_pred             EEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHHHHH-HHhcccc-
Confidence            87653222   2345789999999999999999999999999999999999999975321     111111 1111110 


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+..    ...+          ..+.+++.+||++||++|||++|
T Consensus       226 ~~~~~~----~~~~----------~~~~~li~~~l~~dp~~Rps~~~  258 (284)
T 3kk8_A          226 YPSPEW----DTVT----------PEAKSLIDSMLTVNPKKRITADQ  258 (284)
T ss_dssp             CCTTTT----TTSC----------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCchhh----cccC----------HHHHHHHHHHcccChhhCCCHHH
Confidence            000000    0011          12568999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=354.33  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=189.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc--cchHHHHHHHHHHhccCC--cceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKH--RNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||.||+|.+.+++.||||++.....  ...+.+.+|++++++++|  |||+++++++.++...++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            457999999999999999999998899999998864332  223678999999999976  9999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      || +.+++|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++.
T Consensus        88 ~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             Ee-CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            99 56789999997543      388999999999999999999999   999999999999997 57899999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccC-----------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQS-----------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ..............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....    .......
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~  232 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKLHA  232 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----HHHHHHH
Confidence            654333333345679999999999864           6788999999999999999999999975321    1111111


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ......... .+.       ...          ..+.+++.+||+.||++|||++|
T Consensus       233 ~~~~~~~~~-~~~-------~~~----------~~l~~li~~~L~~dp~~Rpt~~e  270 (343)
T 3dbq_A          233 IIDPNHEIE-FPD-------IPE----------KDLQDVLKCCLKRDPKQRISIPE  270 (343)
T ss_dssp             HHCTTSCCC-CCC-------CSC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HhcCCcccC-Ccc-------cCC----------HHHHHHHHHHcCCChhHCCCHHH
Confidence            111111100 000       000          12568999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-38  Score=348.18  Aligned_cols=202  Identities=26%  Similarity=0.424  Sum_probs=170.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-----cCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATL-----KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  806 (1013)
                      ++|++.+.||+|+||+||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5788999999999999999984     2578999999876555555789999999999999999999999865  34589


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        90 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             EEEEeCCCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            9999999999999997543     2389999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcc-eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          887 RLISALDTH-LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       887 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      +........ .......++..|+|||++.+..++.++||||+||++|||++|..||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence            876543221 112234567789999999999999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=357.19  Aligned_cols=254  Identities=28%  Similarity=0.421  Sum_probs=201.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc--------CCCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeC
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK--------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIG  802 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  802 (1013)
                      .++|++.+.||+|+||.||+|++.        .+..||+|++..... ...+.+.+|+++++++ +||||+++++++.++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            357889999999999999999863        235799998865432 2336789999999999 999999999999999


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL  872 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  872 (1013)
                      +..++||||+++|+|.+++......          .....+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            9999999999999999999765421          1124589999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccH
Q 036815          873 DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNL  951 (1013)
Q Consensus       873 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~  951 (1013)
                      +.++.+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||++ |..||....     .
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-----~  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----V  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----H
Confidence            9999999999999987654433333344567889999999999999999999999999999999 999987543     1


Q ss_pred             HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          952 VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       952 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+... .+..+..... +.       ...          ..+.+++.+||+.||++|||++|
T Consensus       300 ~~~~~-~~~~~~~~~~-~~-------~~~----------~~l~~li~~~l~~dP~~Rps~~e  342 (382)
T 3tt0_A          300 EELFK-LLKEGHRMDK-PS-------NCT----------NELYMMMRDCWHAVPSQRPTFKQ  342 (382)
T ss_dssp             HHHHH-HHHTTCCCCC-CS-------SCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHH-HHHcCCCCCC-Cc-------cCC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            12222 1222111111 00       011          12568999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-39  Score=362.40  Aligned_cols=210  Identities=24%  Similarity=0.301  Sum_probs=180.2

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCCcceeeeccEEEe
Q 036815          726 FSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKHRNLVPLLGYCKI  801 (1013)
Q Consensus       726 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  801 (1013)
                      +.+.....++|++.+.||+|+||.||+|+.+ +++.||+|++.+...   ...+.+.+|..++.+++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3344445688999999999999999999986 689999999864321   122447899999999999999999999999


Q ss_pred             CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEe
Q 036815          802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVS  881 (1013)
Q Consensus       802 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  881 (1013)
                      .+..|+||||++||+|.+++....     ..+++..++.++.||+.||+|||++   +||||||||+||+++.++++||+
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence            999999999999999999997532     2389999999999999999999999   99999999999999999999999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCccccc-------CCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-------SFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |||+|+....... .......||+.|+|||++.       +..++.++||||+||++|||++|+.||...
T Consensus       205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  273 (412)
T 2vd5_A          205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD  273 (412)
T ss_dssp             CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence            9999987654222 2223467999999999987       457899999999999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-38  Score=353.26  Aligned_cols=256  Identities=26%  Similarity=0.419  Sum_probs=200.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCC
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  803 (1013)
                      ..++|++.+.||+|+||.||+|++.      +++.||+|.+.... ....+.+.+|+.+++++ +||||+++++++..++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3467999999999999999999972      35679999886432 23346789999999999 8999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccC-----------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKA-----------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMK  866 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  866 (1013)
                      ..++||||+++|+|.+++......                 .....+++..++.++.|++.||+|||++   +|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            999999999999999999764321                 0113479999999999999999999999   99999999


Q ss_pred             cccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCC
Q 036815          867 SSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDD  945 (1013)
Q Consensus       867 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~  945 (1013)
                      |+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987765444444445667889999999998899999999999999999998 999997643


Q ss_pred             CCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          946 FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       946 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ... ....    ....+.... .+..       .+          ..+.+++.+||+.||++|||++|
T Consensus       280 ~~~-~~~~----~~~~~~~~~-~~~~-------~~----------~~l~~li~~~l~~dp~~Rps~~~  324 (344)
T 1rjb_A          280 VDA-NFYK----LIQNGFKMD-QPFY-------AT----------EEIYIIMQSCWAFDSRKRPSFPN  324 (344)
T ss_dssp             CSH-HHHH----HHHTTCCCC-CCTT-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cHH-HHHH----HHhcCCCCC-CCCC-------CC----------HHHHHHHHHHcCCCchhCcCHHH
Confidence            221 1111    111111110 0000       00          12568999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.6e-38  Score=346.44  Aligned_cols=256  Identities=22%  Similarity=0.291  Sum_probs=193.8

Q ss_pred             cCCCCC-CeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAE-SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++. +.||+|+||.||+|++. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..|+|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            568874 78999999999999975 6899999998766555677899999999985 79999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc---EEEeecccce
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMAR  887 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~a~  887 (1013)
                      |+++|+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||+++
T Consensus        92 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             CCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             cCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999997543      388999999999999999999999   9999999999999998776   9999999998


Q ss_pred             eccccCc-----ceeeeeeccCCCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccH------
Q 036815          888 LISALDT-----HLSVSTLAGTPGYVPPEYYQS-----FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL------  951 (1013)
Q Consensus       888 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~------  951 (1013)
                      .......     ........||+.|+|||++.+     ..++.++||||+||++|||++|+.||......+...      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            6542211     111223568999999999875     568899999999999999999999998754332110      


Q ss_pred             ---HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          952 ---VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       952 ---~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         .......+..+...  .+....   ...          ...+.+++.+||+.||++|||++|
T Consensus       243 ~~~~~~~~~~i~~~~~~--~~~~~~---~~~----------~~~~~~li~~~L~~dP~~Rps~~e  292 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYE--FPDKDW---AHI----------SCAAKDLISKLLVRDAKQRLSAAQ  292 (316)
T ss_dssp             HHHHHHHHHHHHHCCCC--CCHHHH---TTS----------CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhHHHHHHHHHhccCcc--cCchhc---ccC----------CHHHHHHHHHHhhCChhhCCCHHH
Confidence               00111111111110  000000   000          123568999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.4e-38  Score=348.51  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=201.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      .++|++.+.||+|+||.||+|++.      +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            457899999999999999999872      347899998864332 2346788999999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCC------------------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKAR------------------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKS  867 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  867 (1013)
                      ++||||+++++|.+++.......                  ....+++..++.++.|+++||+|||++   +|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            99999999999999997654311                  224589999999999999999999999   999999999


Q ss_pred             ccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCC
Q 036815          868 SNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDF  946 (1013)
Q Consensus       868 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~  946 (1013)
                      +||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987755443333344567889999999998899999999999999999999 9999976432


Q ss_pred             CCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          947 GDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       947 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .  .....    ...+.... .+..       .+          ..+.+++.+||+.||++|||++|
T Consensus       259 ~--~~~~~----~~~~~~~~-~~~~-------~~----------~~~~~li~~~l~~dp~~Rps~~~  301 (314)
T 2ivs_A          259 E--RLFNL----LKTGHRME-RPDN-------CS----------EEMYRLMLQCWKQEPDKRPVFAD  301 (314)
T ss_dssp             G--GHHHH----HHTTCCCC-CCTT-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             H--HHHHH----hhcCCcCC-CCcc-------CC----------HHHHHHHHHHccCChhhCcCHHH
Confidence            1  11111    11111111 0000       11          12568999999999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.5e-38  Score=351.00  Aligned_cols=247  Identities=24%  Similarity=0.419  Sum_probs=189.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCE----EEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSS----VAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||+||+|++. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56889999999999999999975 3443    5777764332 334577999999999999999999999998755 779


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |+||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus        94 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEECCTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence            999999999999997543     2389999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+    ..+....
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~----~~~~~~~  239 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL----EKGERLP  239 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH----HTTCCCC
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHH----HcCCCCC
Confidence            7765444333444567889999999999999999999999999999999 99999764321  222211    1111111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ++..                 ...+.+++.+||+.||++|||++|
T Consensus       240 ~-~~~~-----------------~~~~~~li~~~l~~~p~~Rps~~e  268 (327)
T 3poz_A          240 Q-PPIC-----------------TIDVYMIMVKCWMIDADSRPKFRE  268 (327)
T ss_dssp             C-CTTB-----------------CHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred             C-CccC-----------------CHHHHHHHHHHcCCChhhCCCHHH
Confidence            0 0000                 013568999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.5e-38  Score=339.72  Aligned_cols=242  Identities=25%  Similarity=0.403  Sum_probs=194.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            357999999999999999999987 56789999885432   22346788999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        88 ~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecccccc
Confidence            99999999999996543      288999999999999999999999   999999999999999999999999999865


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-cCccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-EGKQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~  967 (1013)
                      ....    ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....     .+....... .......
T Consensus       159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~  229 (279)
T 3fdn_A          159 APSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRVEFTFPDF  229 (279)
T ss_dssp             C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCCCCTT
T ss_pred             CCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHHHHhCCCCCCCc
Confidence            4321    22345789999999999999999999999999999999999999975321     111111111 1111111


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+                     ..+.+++.+||+.||++|||++|
T Consensus       230 ~~---------------------~~~~~li~~~l~~~p~~Rps~~e  254 (279)
T 3fdn_A          230 VT---------------------EGARDLISRLLKHNPSQRPMLRE  254 (279)
T ss_dssp             SC---------------------HHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CC---------------------HHHHHHHHHHhccChhhCCCHHH
Confidence            11                     12458999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=9.9e-38  Score=354.93  Aligned_cols=248  Identities=22%  Similarity=0.299  Sum_probs=185.8

Q ss_pred             cCCCCC-CeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhc-cCCcceeeeccEEEe----CCEEE
Q 036815          734 NGFSAE-SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGK-IKHRNLVPLLGYCKI----GEERL  806 (1013)
Q Consensus       734 ~~y~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~  806 (1013)
                      ++|.+. ++||+|+||+||+|++. +++.||||++..     ...+.+|++++.+ .+||||+++++++..    ....|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999986 688999998742     3467788888754 489999999999875    56789


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCcEEEeec
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EMEARVSDF  883 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Df  883 (1013)
                      +||||++||+|.+++....    ...+++..++.++.||+.||+|||++   +|+||||||+||+++.   ++.+||+||
T Consensus       136 lv~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeCCCCcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence            9999999999999997543    23489999999999999999999999   9999999999999998   788999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      |+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||............  ...+..+.
T Consensus       209 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~i~~~~  283 (400)
T 1nxk_A          209 GFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KTRIRMGQ  283 (400)
T ss_dssp             TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH--HHHHHHTC
T ss_pred             ccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH--HHHHHcCc
Confidence            999865432   2234567899999999999999999999999999999999999999865432211101  11111111


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. ...+..    ...+          ..+.+++.+||+.||++|||++|
T Consensus       284 ~~-~~~~~~----~~~s----------~~~~~li~~~L~~dP~~Rpt~~e  318 (400)
T 1nxk_A          284 YE-FPNPEW----SEVS----------EEVKMLIRNLLKTEPTQRMTITE  318 (400)
T ss_dssp             CC-CCTTTT----TTSC----------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             cc-CCCccc----ccCC----------HHHHHHHHHHCCCChhHCcCHHH
Confidence            10 000000    0011          12568999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.2e-38  Score=350.04  Aligned_cols=248  Identities=23%  Similarity=0.325  Sum_probs=192.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCC--------
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGE--------  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  803 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            56899999999999999999987 789999999864332 34567999999999999999999999986543        


Q ss_pred             -------------------------------------------------EEEEEEEcccCCCHHHHhcccccCCCCcccc
Q 036815          804 -------------------------------------------------ERLLVYEFMKFGSLEEVLHGRAKARDQRILT  834 (1013)
Q Consensus       804 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~  834 (1013)
                                                                       ..++||||+++++|.+++.....   ....+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~  162 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LEDRE  162 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---GGGSC
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---ccchh
Confidence                                                             37999999999999999976442   23357


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcc----------eeeeeeccC
Q 036815          835 WDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTH----------LSVSTLAGT  904 (1013)
Q Consensus       835 ~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt  904 (1013)
                      +..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++........          .......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            778899999999999999999   9999999999999999999999999999877543221          112345699


Q ss_pred             CCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhH
Q 036815          905 PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEA  984 (1013)
Q Consensus       905 ~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  984 (1013)
                      +.|+|||++.+..++.++||||+||++|||++|..|+..       ... ............                . 
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~-~~~~~~~~~~~~----------------~-  294 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVR-IITDVRNLKFPL----------------L-  294 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHH-HHHHHHTTCCCH----------------H-
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHH-HHHHhhccCCCc----------------c-
Confidence            999999999999999999999999999999998776421       011 111111111100                0 


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          985 EEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       985 ~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .......+.+++.+||+.||++|||++|
T Consensus       295 -~~~~~~~~~~li~~~l~~~p~~Rps~~~  322 (332)
T 3qd2_B          295 -FTQKYPQEHMMVQDMLSPSPTERPEATD  322 (332)
T ss_dssp             -HHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred             -cccCChhHHHHHHHHccCCCCcCCCHHH
Confidence             0011123468999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.9e-37  Score=338.93  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=198.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357899999999999999999987 57889999876532   22346688999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....      .+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||.++.
T Consensus        94 ~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  164 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK  164 (294)
T ss_dssp             EECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCcee
Confidence            99999999999986432      388999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-cCccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-EGKQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~  967 (1013)
                      ......  ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....     .+....... .......
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~  237 (294)
T 2rku_A          165 VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRIKKNEYSIPKH  237 (294)
T ss_dssp             CCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTCCCCCTT
T ss_pred             cccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhhccCCCccc
Confidence            643222  22345789999999999998999999999999999999999999975331     111111111 1111111


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ++                     ..+.+++.+||+.||++|||++|
T Consensus       238 ~~---------------------~~~~~li~~~l~~~p~~Rps~~~  262 (294)
T 2rku_A          238 IN---------------------PVAASLIQKMLQTDPTARPTINE  262 (294)
T ss_dssp             SC---------------------HHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             cC---------------------HHHHHHHHHHcccChhhCcCHHH
Confidence            11                     12568999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-37  Score=344.60  Aligned_cols=248  Identities=22%  Similarity=0.292  Sum_probs=199.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc------chHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ------GDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|.+......      ..+.+.+|++++++++||||+++++++.+++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356999999999999999999987 6899999988654322      356799999999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC----cEEEe
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM----EARVS  881 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~  881 (1013)
                      ++||||+++++|.+++...      ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    .+||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEc
Confidence            9999999999999999643      2389999999999999999999999   999999999999999887    79999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      |||+++......   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....     .+....... 
T Consensus       162 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~-  232 (321)
T 2a2a_A          162 DFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANITS-  232 (321)
T ss_dssp             CCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHT-
T ss_pred             cCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHh-
Confidence            999998765422   22345689999999999999999999999999999999999999975321     111111111 


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...  ..++...   ...+          ..+.+++.+||+.||++|||++|
T Consensus       233 ~~~--~~~~~~~---~~~~----------~~~~~li~~~l~~dp~~Rps~~e  269 (321)
T 2a2a_A          233 VSY--DFDEEFF---SHTS----------ELAKDFIRKLLVKETRKRLTIQE  269 (321)
T ss_dssp             TCC--CCCHHHH---TTCC----------HHHHHHHHTTSCSSTTTSCCHHH
T ss_pred             ccc--ccChhhh---cccC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            110  0111110   0011          12568999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-38  Score=353.15  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=200.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  804 (1013)
                      ..++|++.+.||+|+||.||+|++..      ++.||+|++..... ...+.+.+|++++++++||||+++++++.+++.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            35789999999999999999999853      37899998865432 234678999999999999999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCC------------------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKAR------------------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMK  866 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  866 (1013)
                      .++||||+++|+|.+++.......                  ....+++.+++.++.|+++||+|||++   +|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            999999999999999997643211                  124589999999999999999999999   99999999


Q ss_pred             cccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCC
Q 036815          867 SSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDD  945 (1013)
Q Consensus       867 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~  945 (1013)
                      |+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999987654333233345568899999999998899999999999999999999 999997532


Q ss_pred             CCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          946 FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       946 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .     .+.. ..+..+.... .++       ..+          ..+.+++.+||+.||++|||++|
T Consensus       282 ~-----~~~~-~~~~~~~~~~-~~~-------~~~----------~~l~~li~~~l~~~p~~Rps~~~  325 (343)
T 1luf_A          282 H-----EEVI-YYVRDGNILA-CPE-------NCP----------LELYNLMRLCWSKLPADRPSFCS  325 (343)
T ss_dssp             H-----HHHH-HHHHTTCCCC-CCT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             h-----HHHH-HHHhCCCcCC-CCC-------CCC----------HHHHHHHHHHcccCcccCCCHHH
Confidence            1     1111 1222222111 011       111          12568999999999999999854

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.9e-38  Score=342.31  Aligned_cols=247  Identities=23%  Similarity=0.400  Sum_probs=195.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            35688999999999999999999988899999876433 34577999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       102 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A          102 ANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             TTCBHHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             CCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999997532     2389999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      . ........+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....     ..... .+..+...  ..+.
T Consensus       174 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----~~~~~-~~~~~~~~--~~~~  244 (283)
T 3gen_A          174 E-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAE-HIAQGLRL--YRPH  244 (283)
T ss_dssp             H-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHH-HHHTTCCC--CCCT
T ss_pred             c-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----hHHHH-HHhcccCC--CCCC
Confidence            1 111223456778999999998899999999999999999998 9999975331     11111 11111100  0010


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .      .+          ..+.+++.+||+.||++|||++|
T Consensus       245 ~------~~----------~~l~~li~~~l~~~p~~Rps~~~  270 (283)
T 3gen_A          245 L------AS----------EKVYTIMYSCWHEKADERPTFKI  270 (283)
T ss_dssp             T------CC----------HHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             c------CC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            0      00          12568999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.8e-38  Score=342.79  Aligned_cols=252  Identities=20%  Similarity=0.223  Sum_probs=198.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ..+.+.+|+++++++ +|++++++++++.++...++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            467999999999999999999974 68899999875432  334578899999999 79999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc-----EEEeeccc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME-----ARVSDFGM  885 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfg~  885 (1013)
                      |+ +++|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.     +||+|||+
T Consensus        87 ~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             CC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ec-CCCHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            99 899999997532     2389999999999999999999999   9999999999999987776     99999999


Q ss_pred             ceeccccCcc-----eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCcc-HHHHHHHHH
Q 036815          886 ARLISALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN-LVGWVKMKV  959 (1013)
Q Consensus       886 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~  959 (1013)
                      ++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            9876543221     1234567999999999999999999999999999999999999999875432211 111111111


Q ss_pred             hcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....... ..       ...+          ..+.+++.+||+.||++|||++|
T Consensus       238 ~~~~~~~-~~-------~~~~----------~~l~~li~~~l~~dp~~RP~~~~  273 (298)
T 1csn_A          238 QSTPLRE-LC-------AGFP----------EEFYKYMHYARNLAFDATPDYDY  273 (298)
T ss_dssp             HHSCHHH-HT-------TTSC----------HHHHHHHHHHHHCCTTCCCCHHH
T ss_pred             cCccHHH-HH-------hhCc----------HHHHHHHHHHhcCCcccCCCHHH
Confidence            1010000 00       0111          13568999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.8e-38  Score=347.95  Aligned_cols=255  Identities=29%  Similarity=0.464  Sum_probs=201.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE------cCCCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATL------KDGSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  804 (1013)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++.+++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35789999999999999999985      2467899998865433 2346789999999999 99999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccC------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKA------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL  872 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  872 (1013)
                      .++||||+++|+|.+++......            .....+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            99999999999999999764321            1123489999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccH
Q 036815          873 DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNL  951 (1013)
Q Consensus       873 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~  951 (1013)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ..
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-HH
Confidence            9999999999999987765444333444567889999999999899999999999999999999 999997643221 11


Q ss_pred             HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          952 VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       952 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...    ........ .+..       .+          ..+.+++.+||+.||++|||++|
T Consensus       258 ~~~----~~~~~~~~-~~~~-------~~----------~~l~~li~~~l~~dp~~Rps~~e  297 (313)
T 1t46_A          258 YKM----IKEGFRML-SPEH-------AP----------AEMYDIMKTCWDADPLKRPTFKQ  297 (313)
T ss_dssp             HHH----HHHTCCCC-CCTT-------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHH----hccCCCCC-Cccc-------CC----------HHHHHHHHHHcCCCchhCcCHHH
Confidence            111    11111000 0000       00          12568999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.3e-38  Score=352.78  Aligned_cols=207  Identities=25%  Similarity=0.320  Sum_probs=178.3

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-----Ccceeeecc
Q 036815          724 LKFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-----HRNLVPLLG  797 (1013)
Q Consensus       724 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~  797 (1013)
                      +++.+.....++|++.+.||+|+||+||+|++. +++.||||++.. .....+.+..|+++++++.     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            344444445688999999999999999999985 688999998753 2334466788999999986     999999999


Q ss_pred             EEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---
Q 036815          798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---  874 (1013)
Q Consensus       798 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---  874 (1013)
                      ++...+..++||||+ +++|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.   
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence            999999999999999 8999999975432    2388999999999999999999999   9999999999999975   


Q ss_pred             ----------------------CCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHH
Q 036815          875 ----------------------EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLL  932 (1013)
Q Consensus       875 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  932 (1013)
                                            ++.+||+|||+|+.....     .....||+.|+|||++.+..++.++||||+||++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                  788999999999865432     23457899999999999999999999999999999


Q ss_pred             HHHcCCCCCCCC
Q 036815          933 ELLTGKRPTDKD  944 (1013)
Q Consensus       933 elltg~~pf~~~  944 (1013)
                      ||++|+.||...
T Consensus       251 ell~g~~pf~~~  262 (360)
T 3llt_A          251 ELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHSSCSCCCS
T ss_pred             HHHHCCCCCCCC
Confidence            999999999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-38  Score=365.15  Aligned_cols=240  Identities=23%  Similarity=0.310  Sum_probs=187.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...   .......+.+|++++++++||||+++++++.+.+..|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            357999999999999999999986 6899999988643   223335678899999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |||+++|+|.+++....      .+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||+|+
T Consensus       227 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            99999999999996533      38999999999999999999998 7   99999999999999999999999999997


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Ccccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  966 (1013)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .......... .....
T Consensus       298 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~p~  370 (446)
T 4ejn_A          298 EGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEIRFPR  370 (446)
T ss_dssp             TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCT
T ss_pred             eccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCCCCCCc
Confidence            54322  2223456799999999999999999999999999999999999999975331     1122221111 11111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1009 (1013)
                      .++                     ..+.+++.+||+.||++||
T Consensus       371 ~~~---------------------~~~~~li~~~L~~dP~~R~  392 (446)
T 4ejn_A          371 TLG---------------------PEAKSLLSGLLKKDPKQRL  392 (446)
T ss_dssp             TSC---------------------HHHHHHHHHHTCSSTTTST
T ss_pred             cCC---------------------HHHHHHHHHHcccCHHHhC
Confidence            111                     1256899999999999999

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.8e-37  Score=345.40  Aligned_cols=245  Identities=24%  Similarity=0.395  Sum_probs=199.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|.+.+.||+|+||.||+|++. +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357899999999999999999987 47889999876532   22346688999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       120 ~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  190 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK  190 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence            99999999999986532      389999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ......  ......|++.|+|||++.+..++.++|||||||++|||++|+.||.....    ...+.............+
T Consensus       191 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~  264 (335)
T 2owb_A          191 VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKNEYSIPKHI  264 (335)
T ss_dssp             CCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCTTS
T ss_pred             cccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHhcCCCCCCccC
Confidence            643222  23345789999999999998999999999999999999999999975321    111111111111111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ++                     .+.+++.+||+.||++|||++|
T Consensus       265 ~~---------------------~~~~li~~~l~~dp~~Rps~~e  288 (335)
T 2owb_A          265 NP---------------------VAASLIQKMLQTDPTARPTINE  288 (335)
T ss_dssp             CH---------------------HHHHHHHHHTCSSGGGSCCGGG
T ss_pred             CH---------------------HHHHHHHHHccCChhHCcCHHH
Confidence            11                     2458999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=344.87  Aligned_cols=241  Identities=24%  Similarity=0.350  Sum_probs=187.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.++||+|+||+||+|++. +++.||||++......  .......|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            56999999999999999999987 7899999987543222  233455566665555 8999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+ +++|.+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       137 e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             ECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             ecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            999 579999886543     2489999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ....   ......||+.|+|||++.+ .++.++|||||||++|||++|..||...       ..|..  ...+..    .
T Consensus       208 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~--~~~~~~----~  270 (311)
T 3p1a_A          208 GTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-------EGWQQ--LRQGYL----P  270 (311)
T ss_dssp             C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-------HHHHH--HTTTCC----C
T ss_pred             ccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHH--HhccCC----C
Confidence            4322   2234568999999999876 7899999999999999999997776531       11111  111111    1


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +...   ...          ...+.+++.+||++||++|||++|
T Consensus       271 ~~~~---~~~----------~~~l~~li~~~L~~dP~~Rpt~~e  301 (311)
T 3p1a_A          271 PEFT---AGL----------SSELRSVLVMMLEPDPKLRATAEA  301 (311)
T ss_dssp             HHHH---TTS----------CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cccc---cCC----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence            1110   000          123668999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.5e-38  Score=363.44  Aligned_cols=198  Identities=26%  Similarity=0.340  Sum_probs=165.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeC------C
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG------E  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  803 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467999999999999999999986 5889999998653  223346788999999999999999999999654      4


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..|+||||+++ ++.+.+..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence            67999999986 56666632        278999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |+|+.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+
T Consensus       209 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~  267 (464)
T 3ttj_A          209 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  267 (464)
T ss_dssp             CCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999876432   22345679999999999999999999999999999999999999997643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.6e-38  Score=339.55  Aligned_cols=245  Identities=26%  Similarity=0.425  Sum_probs=177.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            56899999999999999999985 78999999885432   122367899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++....     ..+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||.++..
T Consensus        91 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             ECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            9999999999997432     3489999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .....  ......|++.|+|||++.+..++.++||||+||++|||++|+.||........     ... ...   .....
T Consensus       163 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~-~~~---~~~~~  231 (278)
T 3cok_A          163 KMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNK-VVL---ADYEM  231 (278)
T ss_dssp             C------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS---SCCCC
T ss_pred             cCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHH-Hhh---cccCC
Confidence            43221  22345689999999999998999999999999999999999999986443211     000 000   00000


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +      ...+          ..+.+++.+||+.||++|||++|
T Consensus       232 ~------~~~~----------~~~~~li~~~l~~dp~~Rps~~~  259 (278)
T 3cok_A          232 P------SFLS----------IEAKDLIHQLLRRNPADRLSLSS  259 (278)
T ss_dssp             C------TTSC----------HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             c------cccC----------HHHHHHHHHHcccCHhhCCCHHH
Confidence            0      0001          12568999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.9e-38  Score=349.22  Aligned_cols=247  Identities=26%  Similarity=0.387  Sum_probs=192.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCE----EEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSS----VAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||+||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            56889999999999999999976 3443    7777664332 223356788999999999999999999986 456889


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus        92 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             EEEeCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence            999999999999997532     2488899999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...............++..|+|||++.+..++.++|||||||++|||++ |+.||......  .....+... .......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~-~~~~~~~  240 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKG-ERLAQPQ  240 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTT-CBCCCCT
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcC-CCCCCCC
Confidence            8765444444455678889999999998999999999999999999999 99999864322  122111110 0111111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+++                     +.+++.+||+.||++|||++|
T Consensus       241 ~~~~~---------------------~~~li~~~l~~dp~~Rps~~e  266 (325)
T 3kex_A          241 ICTID---------------------VYMVMVKCWMIDENIRPTFKE  266 (325)
T ss_dssp             TBCTT---------------------TTHHHHHHTCSCTTTSCCHHH
T ss_pred             cCcHH---------------------HHHHHHHHcCCChhhCcCHHH
Confidence            11111                     458999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.8e-38  Score=340.07  Aligned_cols=245  Identities=31%  Similarity=0.446  Sum_probs=184.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc----cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC----QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. ++.||+|++.....    ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57889999999999999999986 88999998754322    22467889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC--------CCcEEEe
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH--------EMEARVS  881 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--------~~~~kl~  881 (1013)
                      ||+++++|.+++..       ..+++..++.++.|++.||+|||++...+|+||||||+||+++.        ++.+||+
T Consensus        86 e~~~~~~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           86 EFARGGPLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             ECCTTEEHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EcCCCCCHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            99999999999853       23899999999999999999999991112999999999999986        6789999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      |||.++......    .....|++.|+|||++.+..++.++||||+|+++|||++|+.||.....     ...... ...
T Consensus       159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~  228 (271)
T 3dtc_A          159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----LAVAYG-VAM  228 (271)
T ss_dssp             CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----HHHHHH-HHT
T ss_pred             cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHh-hhc
Confidence            999998654322    2245689999999999999999999999999999999999999975321     111111 111


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .......+...       +          ..+.+++.+||+.||++|||++|
T Consensus       229 ~~~~~~~~~~~-------~----------~~~~~li~~~l~~~p~~Rps~~e  263 (271)
T 3dtc_A          229 NKLALPIPSTC-------P----------EPFAKLMEDCWNPDPHSRPSFTN  263 (271)
T ss_dssp             SCCCCCCCTTC-------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCccc-------C----------HHHHHHHHHHhcCCcccCcCHHH
Confidence            11111111110       1          12568999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-38  Score=346.39  Aligned_cols=202  Identities=28%  Similarity=0.404  Sum_probs=170.8

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-----cchHHHHHHHHHHhccC---CcceeeeccEEEeC
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-----QGDREFMAEMETLGKIK---HRNLVPLLGYCKIG  802 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  802 (1013)
                      ..++|++.+.||+|+||+||+|++. +++.||+|++.....     .....+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3578999999999999999999975 689999998864321     22356778888877774   99999999999875


Q ss_pred             C-----EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc
Q 036815          803 E-----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME  877 (1013)
Q Consensus       803 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  877 (1013)
                      .     ..++||||++ ++|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            5     5799999998 599999975432    2389999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +||+|||+|+......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       159 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          159 VKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             EEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             EEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999998654322   224467899999999999999999999999999999999999999764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.1e-38  Score=355.67  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=190.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc--cchHHHHHHHHHHhccC--CcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC--QGDREFMAEMETLGKIK--HRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|.+.+++.||||++.....  ...+.+.+|++++++++  ||||+++++++..++..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            46999999999999999999988899999998865332  23467899999999996  599999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      | +.+++|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++ ++.+||+|||+++.+
T Consensus       136 E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             E-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             e-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            9 56789999997543      378889999999999999999999   999999999999995 579999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccC-----------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHH
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQS-----------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK  958 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  958 (1013)
                      .............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....    ........
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~~~  280 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKLHAI  280 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHH
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----HHHHHHHH
Confidence            54333323345679999999999865           3688999999999999999999999975321    11112211


Q ss_pred             HhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       959 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ........ .+.       ...          ..+.+++.+||+.||++|||++|
T Consensus       281 ~~~~~~~~-~~~-------~~~----------~~~~~li~~~L~~dP~~Rps~~e  317 (390)
T 2zmd_A          281 IDPNHEIE-FPD-------IPE----------KDLQDVLKCCLKRDPKQRISIPE  317 (390)
T ss_dssp             HCTTSCCC-CCC-------CSC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hCccccCC-CCc-------cch----------HHHHHHHHHHcccChhhCCCHHH
Confidence            11111100 000       000          12568999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.3e-38  Score=342.45  Aligned_cols=241  Identities=24%  Similarity=0.383  Sum_probs=193.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-C-------CEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-G-------SSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      ++|++.+.||+|+||+||+|++.. +       ..||+|++........+.+.+|++++++++||||+++++++.+++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            568899999999999999998763 3       46999988766666678899999999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc--------
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME--------  877 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------  877 (1013)
                      ++||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.        
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             EEEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            99999999999999997532     2388999999999999999999999   9999999999999998887        


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~  956 (1013)
                      +||+|||.++....      .....+++.|+|||++.+ ..++.++||||+||++|||++|..|+.....    ......
T Consensus       160 ~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~  229 (289)
T 4fvq_A          160 IKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD----SQRKLQ  229 (289)
T ss_dssp             EEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----HHHHHH
T ss_pred             eeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc----hHHHHH
Confidence            99999999875432      123457899999999987 6789999999999999999996555433211    111111


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ............++                     .+.+++.+||+.||++|||++|
T Consensus       230 ~~~~~~~~~~~~~~---------------------~l~~li~~~l~~dp~~Rps~~~  265 (289)
T 4fvq_A          230 FYEDRHQLPAPKAA---------------------ELANLINNCMDYEPDHRPSFRA  265 (289)
T ss_dssp             HHHTTCCCCCCSSC---------------------TTHHHHHHHSCSSGGGSCCHHH
T ss_pred             HhhccCCCCCCCCH---------------------HHHHHHHHHcCCChhHCcCHHH
Confidence            11111111111111                     1458999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-37  Score=354.28  Aligned_cols=203  Identities=27%  Similarity=0.450  Sum_probs=163.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccC-CcceeeeccEEEeCC--EE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGE--ER  805 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~  805 (1013)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+++++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            3578999999999999999999986 6899999988543  2233456789999999997 999999999997644  68


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      |+||||++ ++|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            99999998 5899998642       388999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccC-------------------cceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          886 ARLISALD-------------------THLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       886 a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |+.+....                   .........||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.+
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            98753211                   1112334679999999999876 678999999999999999999999998643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=349.52  Aligned_cols=238  Identities=21%  Similarity=0.288  Sum_probs=194.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--------chHHHHHHHHHHhccCCcceeeeccEEEeCC
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--------GDREFMAEMETLGKIKHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  803 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||||++......        ..+.+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            467999999999999999999976 6788999988654321        2235778999999999999999999999999


Q ss_pred             EEEEEEEcccCC-CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          804 ERLLVYEFMKFG-SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       804 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      ..++||||+.+| +|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence            999999999776 9999996543      389999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      ||+++.......   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......          ...
T Consensus       174 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------~~~  240 (335)
T 3dls_A          174 FGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----------EAA  240 (335)
T ss_dssp             CTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------TTC
T ss_pred             cccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------hhc
Confidence            999987654322   234579999999999988776 789999999999999999999996421000          000


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ......+           +          ..+.+++.+||++||++|||++|
T Consensus       241 ~~~~~~~-----------~----------~~l~~li~~~L~~dP~~Rps~~e  271 (335)
T 3dls_A          241 IHPPYLV-----------S----------KELMSLVSGLLQPVPERRTTLEK  271 (335)
T ss_dssp             CCCSSCC-----------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCccc-----------C----------HHHHHHHHHHccCChhhCcCHHH
Confidence            0000001           1          12568999999999999999864

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.6e-36  Score=353.81  Aligned_cols=279  Identities=30%  Similarity=0.401  Sum_probs=139.0

Q ss_pred             CCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCC
Q 036815           73 SDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQ  152 (1013)
Q Consensus        73 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  152 (1013)
                      +++|+.|++++|.+.....     ...+++|++|+|++|.++++.+  +.++++|++|++++|++++..+  +.++++|+
T Consensus        45 l~~l~~L~l~~~~i~~l~~-----~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~  115 (466)
T 1o6v_A           45 LDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLT  115 (466)
T ss_dssp             HHTCCEEECCSSCCCCCTT-----GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred             hccccEEecCCCCCccCcc-----hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCC
Confidence            3456666666666653221     1235566666666666665433  5666666666666666654433  55666666


Q ss_pred             EeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEccc
Q 036815          153 RLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN  232 (1013)
Q Consensus       153 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~  232 (1013)
                      +|++++|.++ .++.  +..+++|++|++++|.+++..  .+..+++|++|+++ |.+.+ ++.  +..+++|++|++++
T Consensus       116 ~L~L~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~-~~~--~~~l~~L~~L~l~~  186 (466)
T 1o6v_A          116 GLTLFNNQIT-DIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTD-LKP--LANLTTLERLDISS  186 (466)
T ss_dssp             EEECCSSCCC-CCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCC-CGG--GTTCTTCCEEECCS
T ss_pred             EEECCCCCCC-CChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccC-chh--hccCCCCCEEECcC
Confidence            6666666555 2222  233445555555555544321  24444445555543 22221 111  34444444444444


Q ss_pred             ccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCC
Q 036815          233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSI  312 (1013)
Q Consensus       233 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  312 (1013)
                      |.+++.  ..+.                         .+++|+.|++++|.+++..+  ++.+++|+.|++++|.+++. 
T Consensus       187 n~l~~~--~~l~-------------------------~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-  236 (466)
T 1o6v_A          187 NKVSDI--SVLA-------------------------KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-  236 (466)
T ss_dssp             SCCCCC--GGGG-------------------------GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-
T ss_pred             CcCCCC--hhhc-------------------------cCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-
Confidence            444321  1233                         34445555555555444333  44555566666655555421 


Q ss_pred             CcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccC
Q 036815          313 PQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLT  392 (1013)
Q Consensus       313 p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  392 (1013)
                                               +.+..+++|++|++++|.+++..|  +..+++|++|++++|.+++..+  +..++
T Consensus       237 -------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~  287 (466)
T 1o6v_A          237 -------------------------GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLT  287 (466)
T ss_dssp             -------------------------GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred             -------------------------hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCC
Confidence                                     123344555555555555553322  5555555555555555553222  55555


Q ss_pred             CCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCc
Q 036815          393 RLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG  430 (1013)
Q Consensus       393 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  430 (1013)
                      +|+.|++++|++++..|  +..+++|++|++++|++++
T Consensus       288 ~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~  323 (466)
T 1o6v_A          288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD  323 (466)
T ss_dssp             TCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSC
T ss_pred             ccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCC
Confidence            55555555555554322  5555666666666665543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-38  Score=351.58  Aligned_cols=246  Identities=24%  Similarity=0.305  Sum_probs=194.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEE----cCCCEEEEEEeeccC----ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCE
Q 036815          734 NGFSAESLIGCGGFGEVFKATL----KDGSSVAIKKLIRLS----CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  804 (1013)
                      ++|++.+.||+|+||.||+|+.    .+++.||||++....    ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5699999999999999999998    368999999885432    22345577899999999 69999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .++||||+++|+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             EEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence            999999999999999997543      388999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      +++.+..... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ ...+........
T Consensus       205 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~  282 (355)
T 1vzo_A          205 LSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE  282 (355)
T ss_dssp             EEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC
T ss_pred             CCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccC
Confidence            9987643222 12234579999999999985  3578899999999999999999999986543322 222222222211


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      ..   .++.+       +          ..+.+++.+||+.||++||+
T Consensus       283 ~~---~~~~~-------~----------~~~~~li~~~L~~dP~~R~~  310 (355)
T 1vzo_A          283 PP---YPQEM-------S----------ALAKDLIQRLLMKDPKKRLG  310 (355)
T ss_dssp             CC---CCTTS-------C----------HHHHHHHHHHTCSSGGGSTT
T ss_pred             CC---CCccc-------C----------HHHHHHHHHHhhhCHHHhcC
Confidence            10   01111       0          12558999999999999993

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=340.55  Aligned_cols=201  Identities=28%  Similarity=0.390  Sum_probs=169.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||+|++......  ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999999986 5899999988554322  23567899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++...
T Consensus        83 ~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           83 YCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             CCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             eCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            999999999886432      389999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ....  ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  207 (311)
T 4agu_A          154 GPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS  207 (311)
T ss_dssp             --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             Cccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            3222  2234578999999999876 678999999999999999999999997643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-37  Score=336.99  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=192.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46889999999999999999986 68899999886543 23457799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe---CCCCcEEEeeccccee
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARL  888 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~  888 (1013)
                      +++|+|.+++.....  ....+++..++.++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++.
T Consensus       102 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          102 CEGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CSCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             CCCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999864321  123489999999999999999999999   99999999999999   4567899999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      .....   ......|++.|+|||++. ..++.++||||+||++|||++|+.||.....     .+...............
T Consensus       177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~  247 (285)
T 3is5_A          177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----EEVQQKATYKEPNYAVE  247 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCC-
T ss_pred             cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----HHHHhhhccCCcccccc
Confidence            64322   223457899999999986 4688999999999999999999999976431     11111111111110000


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       ....          ..+.+++.+||+.||++|||++|
T Consensus       248 ~-------~~~~----------~~~~~li~~~L~~dP~~Rps~~e  275 (285)
T 3is5_A          248 C-------RPLT----------PQAVDLLKQMLTKDPERRPSAAQ  275 (285)
T ss_dssp             --------CCCC----------HHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             c-------CcCC----------HHHHHHHHHHccCChhhCcCHHH
Confidence            0       0001          12568999999999999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3e-38  Score=366.18  Aligned_cols=247  Identities=27%  Similarity=0.440  Sum_probs=197.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.+.||+|+||.||+|+++++..||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            35688899999999999999999888899999886533 45678999999999999999999999986 66789999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++.....    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       265 ~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          265 AKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             TTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             CCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999999975421    2378899999999999999999999   9999999999999999999999999999875432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      . ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.....     .+.... +..+.....  +.
T Consensus       338 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~-i~~~~~~~~--~~  408 (454)
T 1qcf_A          338 E-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEVIRA-LERGYRMPR--PE  408 (454)
T ss_dssp             H-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHH-HHHTCCCCC--CT
T ss_pred             c-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-HHcCCCCCC--CC
Confidence            1 111123346778999999998899999999999999999999 9999975331     111111 111111110  00


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..+          ..+.+++.+||+.||++|||++|
T Consensus       409 ------~~~----------~~l~~li~~cl~~dp~~RPt~~~  434 (454)
T 1qcf_A          409 ------NCP----------EELYNIMMRCWKNRPEERPTFEY  434 (454)
T ss_dssp             ------TSC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------CCC----------HHHHHHHHHHccCChhHCcCHHH
Confidence                  011          12568999999999999999863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.8e-37  Score=358.97  Aligned_cols=242  Identities=29%  Similarity=0.469  Sum_probs=194.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCC-EEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE-ERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|.+. ++.||||++....  ..+.+.+|++++++++||||+++++++.+.. ..|+||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            356888999999999999999986 7899999886433  4578999999999999999999999987765 78999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++|+|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       269 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             CTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999975432    2378999999999999999999999   999999999999999999999999999985432


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      .     .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+  ....    +..+..... ++
T Consensus       342 ~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~----i~~~~~~~~-p~  409 (450)
T 1k9a_A          342 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR----VEKGYKMDA-PD  409 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHH----HHTTCCCCC-CT
T ss_pred             c-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHcCCCCCC-CC
Confidence            1     122357889999999999999999999999999999998 999998654322  2211    222211110 00


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             ..+          ..+.+++.+||+.||++|||++|
T Consensus       410 -------~~~----------~~l~~li~~cl~~dp~~Rpt~~~  435 (450)
T 1k9a_A          410 -------GCP----------PAVYDVMKNCWHLDAATRPTFLQ  435 (450)
T ss_dssp             -------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -------cCC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence                   111          12568999999999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.5e-38  Score=347.13  Aligned_cols=248  Identities=23%  Similarity=0.306  Sum_probs=194.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|+++ +++.||+|.+.+...    ...+|++++.++ +||||+++++++.+++..|+|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457999999999999999999987 578999998865432    235688888888 79999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC----CcEEEeecccc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE----MEARVSDFGMA  886 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a  886 (1013)
                      |++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||++..+    +.+||+|||++
T Consensus        97 ~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           97 LMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             CCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            999999999996432      389999999999999999999999   99999999999998543    35999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ....+.... +..+....
T Consensus       168 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~-i~~~~~~~  242 (342)
T 2qr7_A          168 KQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILAR-IGSGKFSL  242 (342)
T ss_dssp             EECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHH-HHHCCCCC
T ss_pred             ccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHH-HccCCccc
Confidence            87654222  23346789999999999888899999999999999999999999975332  122222222 22221110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        ....   ....+          ..+.+++.+||+.||++|||++|
T Consensus       243 --~~~~---~~~~s----------~~~~~li~~~L~~dP~~R~t~~~  274 (342)
T 2qr7_A          243 --SGGY---WNSVS----------DTAKDLVSKMLHVDPHQRLTAAL  274 (342)
T ss_dssp             --CSTT---TTTSC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             --Cccc---cccCC----------HHHHHHHHHHCCCChhHCcCHHH
Confidence              0000   00011          12568999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.8e-38  Score=350.26  Aligned_cols=257  Identities=16%  Similarity=0.204  Sum_probs=190.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccCcc-----------chHHHHHHHHHHhccCCcceeeecc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLSCQ-----------GDREFMAEMETLGKIKHRNLVPLLG  797 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  797 (1013)
                      .++|++.+.||+|+||.||+|++.    ++..||+|+.......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999986    4688999988654321           1234667888999999999999999


Q ss_pred             EEEe----CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          798 YCKI----GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       798 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ++..    ....|+||||+ +++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG  185 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence            9988    77899999999 899999997543      489999999999999999999999   999999999999999


Q ss_pred             CCC--cEEEeecccceeccccCcce-----eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 036815          874 HEM--EARVSDFGMARLISALDTHL-----SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDF  946 (1013)
Q Consensus       874 ~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~  946 (1013)
                      .++  .+||+|||+|+.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            887  99999999998764322111     11345789999999999999999999999999999999999999965322


Q ss_pred             CCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          947 GDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       947 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..... .........     .+++..........        ....+.+++.+||+.||++|||++|
T Consensus       266 ~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~  318 (345)
T 2v62_A          266 DPVAV-QTAKTNLLD-----ELPQSVLKWAPSGS--------SCCEIAQFLVCAHSLAYDEKPNYQA  318 (345)
T ss_dssp             CHHHH-HHHHHHHHH-----TTTHHHHHHSCTTS--------CCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             ccHHH-HHHHHhhcc-----cccHHHHhhccccc--------cHHHHHHHHHHHhhcCcccCCCHHH
Confidence            21111 111111111     11111100000000        0113668999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.9e-38  Score=348.52  Aligned_cols=242  Identities=26%  Similarity=0.388  Sum_probs=193.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +.|++.+.||+|+||+||+|++. +++.||||++.......   .+.+.+|++++++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45888999999999999999975 68899999886543222   356889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+. |++.+++....     ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       134 e~~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             ECCS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             ecCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence            9998 68888875332     2389999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...      ....||+.|+|||++.   +..++.++|||||||++|||++|+.||....     ............ ...
T Consensus       205 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~-~~~  272 (348)
T 1u5q_A          205 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNE-SPA  272 (348)
T ss_dssp             SSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSC-CCC
T ss_pred             CCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcC-CCC
Confidence            432      2356899999999984   5678999999999999999999999987532     111122111111 111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....       ..+          ..+.+++.+||+.||++|||++|
T Consensus       273 ~~~~-------~~~----------~~l~~li~~~l~~dP~~Rps~~~  302 (348)
T 1u5q_A          273 LQSG-------HWS----------EYFRNFVDSCLQKIPQDRPTSEV  302 (348)
T ss_dssp             CCCT-------TSC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCC-------CCC----------HHHHHHHHHHcccChhhCcCHHH
Confidence            0000       001          12568999999999999999864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-37  Score=342.92  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=188.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|++++++++||||+++++++.+++..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            56999999999999999999985 68999999886432   223456889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++.....  ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       112 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             ECCCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             ecCCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            99999999999965322  123488999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .....  ......|++.|+|||++.+..++.++|||||||++|||++|+.||......   ...+... ...........
T Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-~~~~~~~~~~~  260 (310)
T 2wqm_A          187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK-IEQCDYPPLPS  260 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHH-HHTTCSCCCCT
T ss_pred             cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHH-hhcccCCCCcc
Confidence            43221  223456899999999999999999999999999999999999999764322   1222221 22111111100


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       ..+          ..+.+++.+||+.||++|||++|
T Consensus       261 ~-------~~~----------~~l~~li~~~l~~dp~~Rps~~~  287 (310)
T 2wqm_A          261 D-------HYS----------EELRQLVNMCINPDPEKRPDVTY  287 (310)
T ss_dssp             T-------TSC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             c-------ccC----------HHHHHHHHHHcCCChhhCCCHHH
Confidence            0       001          12568999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.8e-38  Score=344.11  Aligned_cols=247  Identities=25%  Similarity=0.380  Sum_probs=195.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|.+........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            356899999999999999999986 6899999998765544556789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe---CCCCcEEEeeccccee
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMARL  888 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~  888 (1013)
                      +++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++.
T Consensus        88 ~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           88 VSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             CCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             CCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            99999999986533      388999999999999999999999   99999999999999   7789999999999976


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....    ......|++.|+|||++.+..++.++||||+||++|||++|+.||.....     ...... +..+...  .
T Consensus       159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~-i~~~~~~--~  226 (304)
T 2jam_A          159 EQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFEK-IKEGYYE--F  226 (304)
T ss_dssp             CCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHH-HHHCCCC--C
T ss_pred             cCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH-HHcCCCC--C
Confidence            4322    12234689999999999999999999999999999999999999975321     111111 1111110  0


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +...   ....+          ..+.+++.+||+.||++|||++|
T Consensus       227 ~~~~---~~~~~----------~~~~~li~~~l~~dp~~Rps~~~  258 (304)
T 2jam_A          227 ESPF---WDDIS----------ESAKDFICHLLEKDPNERYTCEK  258 (304)
T ss_dssp             CTTT---TTTSC----------HHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             Cccc---cccCC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            0000   00011          12568999999999999999864

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.9e-36  Score=351.62  Aligned_cols=347  Identities=30%  Similarity=0.444  Sum_probs=242.9

Q ss_pred             CCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEE
Q 036815          100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL  179 (1013)
Q Consensus       100 ~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  179 (1013)
                      +++++.|++++|.+..+ + .+..+++|++|++++|.+++..+  +.++++|++|++++|.++                 
T Consensus        45 l~~l~~L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~-----------------  103 (466)
T 1o6v_A           45 LDQVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-----------------  103 (466)
T ss_dssp             HHTCCEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-----------------
T ss_pred             hccccEEecCCCCCccC-c-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccc-----------------
Confidence            34566666666666553 2 35556666666666666654432  556666666666666555                 


Q ss_pred             ECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCee
Q 036815          180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRV  259 (1013)
Q Consensus       180 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  259 (1013)
                              +..+  +..+++|++|++++|.+++ ++.  +..+++|++|++++|.+++ + ..+..+++|+.|+++ |.+
T Consensus       104 --------~~~~--~~~l~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~-~~~  167 (466)
T 1o6v_A          104 --------DITP--LANLTNLTGLTLFNNQITD-IDP--LKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLSFG-NQV  167 (466)
T ss_dssp             --------CCGG--GTTCTTCCEEECCSSCCCC-CGG--GTTCTTCSEEEEEEEEECC-C-GGGTTCTTCSEEEEE-ESC
T ss_pred             --------cChh--hcCCCCCCEEECCCCCCCC-ChH--HcCCCCCCEEECCCCccCC-C-hhhccCCcccEeecC-Ccc
Confidence                    2222  3444444444444444442 221  3445555555555555442 1 134455555555553 222


Q ss_pred             cccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcC
Q 036815          260 SGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE  339 (1013)
Q Consensus       260 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~  339 (1013)
                      .+..   .+..+++|+.|++++|.+++.  ..+..+++|+.|++++|.+++..|                          
T Consensus       168 ~~~~---~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--------------------------  216 (466)
T 1o6v_A          168 TDLK---PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--------------------------  216 (466)
T ss_dssp             CCCG---GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--------------------------
T ss_pred             cCch---hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--------------------------
Confidence            2111   134455566666666665543  246778888888888887764221                          


Q ss_pred             cCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCc
Q 036815          340 LGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV  419 (1013)
Q Consensus       340 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  419 (1013)
                      ++.+++|+.|++++|++++ + ..+..+++|++|++++|.+++..|  +..+++|+.|++++|++++..|  +..+++|+
T Consensus       217 ~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~  290 (466)
T 1o6v_A          217 LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT  290 (466)
T ss_dssp             GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccC
Confidence            4557889999999999985 3 468899999999999999996554  8999999999999999996544  88999999


Q ss_pred             EEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCc
Q 036815          420 WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGP  499 (1013)
Q Consensus       420 ~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  499 (1013)
                      +|++++|++++..|                                                                  
T Consensus       291 ~L~L~~n~l~~~~~------------------------------------------------------------------  304 (466)
T 1o6v_A          291 NLELNENQLEDISP------------------------------------------------------------------  304 (466)
T ss_dssp             EEECCSSCCSCCGG------------------------------------------------------------------
T ss_pred             eEEcCCCcccCchh------------------------------------------------------------------
Confidence            99999998875221                                                                  


Q ss_pred             ccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCC
Q 036815          500 VLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL  579 (1013)
Q Consensus       500 ~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l  579 (1013)
                          +..+++|++|++++|++++..|  ++.+++|++|++++|++++.  ..++++++|+.|++++|++++.+|  +..+
T Consensus       305 ----~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l  374 (466)
T 1o6v_A          305 ----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANL  374 (466)
T ss_dssp             ----GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTC
T ss_pred             ----hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcC
Confidence                2235679999999999997655  88999999999999999964  579999999999999999998887  8999


Q ss_pred             CcceEEECcCCCCCCcC
Q 036815          580 SFLVQIDLSNNELTGPI  596 (1013)
Q Consensus       580 ~~l~~l~l~~n~l~~~~  596 (1013)
                      +.|+.|++++|++++.+
T Consensus       375 ~~L~~L~l~~n~~~~~p  391 (466)
T 1o6v_A          375 TRITQLGLNDQAWTNAP  391 (466)
T ss_dssp             TTCCEEECCCEEEECCC
T ss_pred             CCCCEEeccCCcccCCc
Confidence            99999999999999853

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-37  Score=345.74  Aligned_cols=254  Identities=27%  Similarity=0.438  Sum_probs=199.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc--------CCCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeC
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK--------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIG  802 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  802 (1013)
                      .++|++.+.||+|+||.||+|++.        +++.||+|++..... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367899999999999999999873        467899998865432 2346688999999999 899999999999999


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCC----------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKAR----------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL  872 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  872 (1013)
                      +..++||||+++|+|.+++.......          ....+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            99999999999999999997654211          123489999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccH
Q 036815          873 DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNL  951 (1013)
Q Consensus       873 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~  951 (1013)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||....     .
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~  265 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V  265 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-----H
Confidence            9999999999999987755433333344567889999999998889999999999999999999 999987532     1


Q ss_pred             HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          952 VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       952 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+.... ...+.... .+..       ..          ..+.+++.+||+.||++|||++|
T Consensus       266 ~~~~~~-~~~~~~~~-~~~~-------~~----------~~l~~li~~~l~~dp~~Rps~~e  308 (334)
T 2pvf_A          266 EELFKL-LKEGHRMD-KPAN-------CT----------NELYMMMRDCWHAVPSQRPTFKQ  308 (334)
T ss_dssp             HHHHHH-HHHTCCCC-CCTT-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHH-HhcCCCCC-CCcc-------CC----------HHHHHHHHHHccCChhhCcCHHH
Confidence            122211 11111111 0000       11          12568999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-37  Score=356.63  Aligned_cols=249  Identities=26%  Similarity=0.364  Sum_probs=186.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--------cchHHHHHHHHHHhccCCcceeeeccEEEeC
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--------QGDREFMAEMETLGKIKHRNLVPLLGYCKIG  802 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  802 (1013)
                      ..++|.+.+.||+|+||+||+|.+. +++.||+|++.....        .....+.+|++++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3578999999999999999999986 578999998864321        11224789999999999999999999975 5


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC---cEE
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM---EAR  879 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~k  879 (1013)
                      +..|+||||+++|+|.+++...      ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++   .+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             CceEEEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence            5689999999999999988643      2389999999999999999999999   999999999999997544   599


Q ss_pred             EeecccceeccccCcceeeeeeccCCCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 036815          880 VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS---FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       880 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~  956 (1013)
                      |+|||+|+.....   .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||........ ....+ 
T Consensus       283 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i-  357 (419)
T 3i6u_A          283 ITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQI-  357 (419)
T ss_dssp             ECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHH-
T ss_pred             EeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHH-
Confidence            9999999876432   22345679999999999853   5788899999999999999999999976433222 22111 


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         ..+...  ..+...   ...          ...+.+++.+||+.||++|||++|
T Consensus       358 ---~~~~~~--~~~~~~---~~~----------~~~~~~li~~~L~~dP~~Rps~~e  396 (419)
T 3i6u_A          358 ---TSGKYN--FIPEVW---AEV----------SEKALDLVKKLLVVDPKARFTTEE  396 (419)
T ss_dssp             ---HTTCCC--CCHHHH---TTS----------CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ---hcCCCC--CCchhh---ccc----------CHHHHHHHHHHccCChhHCcCHHH
Confidence               111110  001100   000          123568999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-37  Score=335.24  Aligned_cols=242  Identities=24%  Similarity=0.355  Sum_probs=197.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56899999999999999999987 56789999885432   223467899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        94 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             CCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            9999999999997543      388999999999999999999999   9999999999999999999999999999765


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ....    .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....     ......... ...  .++
T Consensus       165 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~-~~~--~~~  232 (284)
T 2vgo_A          165 PSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----TETHRRIVN-VDL--KFP  232 (284)
T ss_dssp             SSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHT-TCC--CCC
T ss_pred             cccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----hHHHHHHhc-ccc--CCC
Confidence            4321    2345689999999999999999999999999999999999999975321     111111111 110  001


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.       .+          ..+.+++.+||+.||++|||++|
T Consensus       233 ~~-------~~----------~~~~~li~~~l~~~p~~Rps~~~  259 (284)
T 2vgo_A          233 PF-------LS----------DGSKDLISKLLRYHPPQRLPLKG  259 (284)
T ss_dssp             TT-------SC----------HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             Cc-------CC----------HHHHHHHHHHhhcCHhhCCCHHH
Confidence            10       01          12568999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=344.52  Aligned_cols=247  Identities=24%  Similarity=0.416  Sum_probs=187.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCE----EEEEEeecc-CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSS----VAIKKLIRL-SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57999999999999999999975 4443    567766433 3344678999999999999999999999998755 789


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      |+||+.+|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        94 v~~~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             EEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            999999999999997543     2388999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||......  .....+    ..+....
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~----~~~~~~~  239 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL----EKGERLP  239 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH----HTTCCCC
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCCCCC
Confidence            7654443333344567889999999999999999999999999999999 99999764322  222211    1111111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ++..       +          ..+.+++.+||+.||++|||++|
T Consensus       240 ~-~~~~-------~----------~~l~~li~~~l~~dp~~Rps~~e  268 (327)
T 3lzb_A          240 Q-PPIC-------T----------IDVYMIMRKCWMIDADSRPKFRE  268 (327)
T ss_dssp             C-CTTB-------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C-CccC-------C----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            0 0000       0          12568999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-37  Score=342.31  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=188.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcC----CCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCE-
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKD----GSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE-  804 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  804 (1013)
                      ..++|.+.+.||+|+||.||+|++..    ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+. 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            45679999999999999999998752    34799998754322  233568899999999999999999999977543 


Q ss_pred             ----EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEE
Q 036815          805 ----RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       805 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                          .++||||+++|+|.+++...........+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence                499999999999999996544333445699999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHH
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKV  959 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  959 (1013)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......  .....    .
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~----~  262 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDY----L  262 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH----H
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHH----H
Confidence            99999987654333333344567889999999999999999999999999999999 88998754321  11111    1


Q ss_pred             hcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..... ++.       .+          ..+.+++.+||+.||++|||++|
T Consensus       263 ~~~~~~~~-~~~-------~~----------~~l~~li~~~l~~dp~~Rps~~~  298 (313)
T 3brb_A          263 LHGHRLKQ-PED-------CL----------DELYEIMYSCWRTDPLDRPTFSV  298 (313)
T ss_dssp             HTTCCCCC-BTT-------CC----------HHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             HcCCCCCC-Ccc-------cc----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            11111110 010       11          12568999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.3e-38  Score=347.53  Aligned_cols=200  Identities=23%  Similarity=0.345  Sum_probs=164.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||+|++......  ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            467999999999999999999976 6889999988543322  2356789999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC-----CCCcEEEeecc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD-----HEMEARVSDFG  884 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-----~~~~~kl~Dfg  884 (1013)
                      ||++ |+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++     .++.+||+|||
T Consensus       113 e~~~-~~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             ECCS-EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             ecCC-CCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            9998 49999997543      288999999999999999999999   999999999999994     55569999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +|+......  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            998764322  223345689999999999874 4899999999999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.9e-38  Score=365.93  Aligned_cols=247  Identities=26%  Similarity=0.429  Sum_probs=198.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||.||+|+++. +..||||++... ....+++.+|++++++++||||++++++|.+.+..++||||+
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            458888999999999999999874 788999987643 334678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++.....    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       299 ~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          299 TYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             TTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             CCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999975332    3388999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      . ........+++.|+|||++.+..++.++|||||||++|||++ |..||......  ...+.+    ..+..... +. 
T Consensus       372 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~----~~~~~~~~-~~-  442 (495)
T 1opk_A          372 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELL----EKDYRMER-PE-  442 (495)
T ss_dssp             C-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH----HTTCCCCC-CT-
T ss_pred             c-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----HcCCCCCC-CC-
Confidence            1 222223446778999999998899999999999999999999 99999764321  122221    11111110 00 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..+          ..+.+++.+||+.||++|||++|
T Consensus       443 ------~~~----------~~l~~li~~cl~~dP~~RPs~~e  468 (495)
T 1opk_A          443 ------GCP----------EKVYELMRACWQWNPSDRPSFAE  468 (495)
T ss_dssp             ------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------CCC----------HHHHHHHHHHcCcChhHCcCHHH
Confidence                  011          12568999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.2e-37  Score=334.20  Aligned_cols=247  Identities=24%  Similarity=0.335  Sum_probs=195.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc------cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC------QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|.+.....      ...+.+.+|++++++++||||+++++++.++...+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46899999999999999999987 689999998865322      13577999999999999999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC----cEEEee
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM----EARVSD  882 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~D  882 (1013)
                      +||||+++++|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++    .+||+|
T Consensus        85 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence            9999999999999996432      389999999999999999999999   999999999999998877    899999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      ||.++......   ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....     .+.... ....
T Consensus       156 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~-~~~~  226 (283)
T 3bhy_A          156 FGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----QETLTN-ISAV  226 (283)
T ss_dssp             CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH-HHTT
T ss_pred             cccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----HHHHHH-hHhc
Confidence            99998764322   22345689999999999999999999999999999999999999975321     111111 1111


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..  ..++...   ...          ...+.+++.+||+.||++|||++|
T Consensus       227 ~~--~~~~~~~---~~~----------~~~~~~li~~~l~~dp~~Rps~~~  262 (283)
T 3bhy_A          227 NY--DFDEEYF---SNT----------SELAKDFIRRLLVKDPKRRMTIAQ  262 (283)
T ss_dssp             CC--CCCHHHH---TTC----------CHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             cc--CCcchhc---ccC----------CHHHHHHHHHHccCCHhHCcCHHH
Confidence            10  0011110   000          113568999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.1e-38  Score=346.83  Aligned_cols=257  Identities=21%  Similarity=0.298  Sum_probs=197.9

Q ss_pred             HHHHHHHhcCCCCC-CeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhcc-CCcceeeeccEEE
Q 036815          726 FSQLIEATNGFSAE-SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKI-KHRNLVPLLGYCK  800 (1013)
Q Consensus       726 ~~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  800 (1013)
                      +.......++|.+. +.||+|+||.||+|++. +++.||+|++....  ......+.+|+.+++++ +||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33344455678887 89999999999999987 68999999886532  23357789999999999 5699999999999


Q ss_pred             eCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCc
Q 036815          801 IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EME  877 (1013)
Q Consensus       801 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~  877 (1013)
                      +.+..++||||+++|+|.+++....    ...+++..++.++.|++.||+|||++   +|+||||||+||+++.   ++.
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence            9999999999999999999985432    23489999999999999999999999   9999999999999998   789


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      +||+|||+++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||......    ..+...
T Consensus       173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i  245 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ----ETYLNI  245 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH
T ss_pred             EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHH
Confidence            9999999998764322   223457999999999999999999999999999999999999999753311    111111


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ............+.       ..          ..+.+++.+||+.||++|||++|
T Consensus       246 ~~~~~~~~~~~~~~-------~~----------~~~~~li~~~L~~dP~~Rpt~~~  284 (327)
T 3lm5_A          246 SQVNVDYSEETFSS-------VS----------QLATDFIQSLLVKNPEKRPTAEI  284 (327)
T ss_dssp             HHTCCCCCTTTTTT-------SC----------HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HhcccccCchhhcc-------cC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            11111111100000       01          12568999999999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.2e-38  Score=357.39  Aligned_cols=242  Identities=17%  Similarity=0.166  Sum_probs=185.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHH---HHhccCCcceeeec-------cE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEME---TLGKIKHRNLVPLL-------GY  798 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  798 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||||++...   .....+.+.+|++   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467889999999999999999974 6899999998643   2234467899995   45555899999999       56


Q ss_pred             EEeCC-----------------EEEEEEEcccCCCHHHHhcccccCCC-CccccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 036815          799 CKIGE-----------------ERLLVYEFMKFGSLEEVLHGRAKARD-QRILTWDARKKIARGAAKGLCFLHHNCIPHI  860 (1013)
Q Consensus       799 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  860 (1013)
                      +.+.+                 ..|+||||+ +|+|.+++........ ...+++..++.++.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55443                 278999999 5799999976433222 34567789999999999999999999   99


Q ss_pred             EecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCC-----------CCCccchhHhHHH
Q 036815          861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-----------RCTAKGDVYSFGV  929 (1013)
Q Consensus       861 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~  929 (1013)
                      +||||||+||+++.++.+||+|||+|+....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     2334567 999999999887           8999999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCC
Q 036815          930 VLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009 (1013)
Q Consensus       930 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1009 (1013)
                      ++|||++|+.||..........              ....     .....+          ..+.+++.+||+.||++||
T Consensus       302 il~elltg~~Pf~~~~~~~~~~--------------~~~~-----~~~~~~----------~~~~~li~~~L~~dp~~Rp  352 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSE--------------WIFR-----SCKNIP----------QPVRALLEGFLRYPKEDRL  352 (377)
T ss_dssp             HHHHHHHSSCCC------CCSG--------------GGGS-----SCCCCC----------HHHHHHHHHHTCSSGGGCC
T ss_pred             HHHHHHHCCCCCcccccccchh--------------hhhh-----hccCCC----------HHHHHHHHHHcCCCchhCC
Confidence            9999999999997543221100              0000     000111          1256899999999999999


Q ss_pred             CCCC
Q 036815         1010 NMLQ 1013 (1013)
Q Consensus      1010 t~~e 1013 (1013)
                      |++|
T Consensus       353 t~~e  356 (377)
T 3byv_A          353 LPLQ  356 (377)
T ss_dssp             CHHH
T ss_pred             CHHH
Confidence            9864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-37  Score=337.81  Aligned_cols=247  Identities=23%  Similarity=0.400  Sum_probs=183.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC----CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD----GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .++|++.+.||+|+||.||+|++..    +..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3578899999999999999999753    34689998754322 23467899999999999999999999984 567889


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        93 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence            999999999999997432     2388999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ....... .......+++.|+|||++.+..++.++||||+||++|||++ |..||......  .....+    ..+....
T Consensus       165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i----~~~~~~~  237 (281)
T 1mp8_A          165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI----ENGERLP  237 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH----HTTCCCC
T ss_pred             ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHH----HcCCCCC
Confidence            7643221 12233456788999999998899999999999999999997 99999764321  121111    1111110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .++.       .+          ..+.+++.+||+.||++|||++|
T Consensus       238 -~~~~-------~~----------~~l~~li~~~l~~~p~~Rps~~~  266 (281)
T 1mp8_A          238 -MPPN-------CP----------PTLYSLMTKCWAYDPSRRPRFTE  266 (281)
T ss_dssp             -CCTT-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCCC-------CC----------HHHHHHHHHHccCChhhCcCHHH
Confidence             1111       11          12568999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-37  Score=337.99  Aligned_cols=251  Identities=28%  Similarity=0.433  Sum_probs=183.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|++.  ..||+|++.....  ...+.+.+|++++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467999999999999999999864  4699998754332  2346789999999999999999999965 4566899999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       100 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A          100 WCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             CCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             ecCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence            999999999996432     3489999999999999999999999   99999999999999999999999999998665


Q ss_pred             ccCcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      ............||+.|+|||++.   +..++.++||||+||++|||++|+.||......    .. .......+.....
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~-~~~~~~~~~~~~~  246 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQ-IIEMVGRGSLSPD  246 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH----HH-HHHHHHHTSCCCC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH----HH-HHHHhcccccCcc
Confidence            433333344567999999999986   667888999999999999999999999754321    11 1111211111111


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ........+          ..+.+++.+||+.||++|||++|
T Consensus       247 ----~~~~~~~~~----------~~l~~li~~~l~~~p~~Rps~~e  278 (289)
T 3og7_A          247 ----LSKVRSNCP----------KRMKRLMAECLKKKRDERPSFPR  278 (289)
T ss_dssp             ----TTSSCTTSC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----hhhccccCC----------HHHHHHHHHHccCChhhCCCHHH
Confidence                000001111          13668999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.6e-38  Score=351.84  Aligned_cols=258  Identities=17%  Similarity=0.216  Sum_probs=192.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCccc-----------hHHHHHHHHHHhccCCcceeee
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSCQG-----------DREFMAEMETLGKIKHRNLVPL  795 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l  795 (1013)
                      .++|++.+.||+|+||.||+|++..      ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4579999999999999999999864      4789999875433211           1223455666777889999999


Q ss_pred             ccEEEeC----CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEE
Q 036815          796 LGYCKIG----EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVL  871 (1013)
Q Consensus       796 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  871 (1013)
                      ++++...    ...|+||||+ +++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil  184 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL  184 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence            9998764    4579999999 899999997532     3489999999999999999999999   9999999999999


Q ss_pred             eC--CCCcEEEeecccceeccccCcce-----eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          872 LD--HEMEARVSDFGMARLISALDTHL-----SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       872 l~--~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ++  .++.+||+|||+|+.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99  88999999999998765432211     112345999999999999999999999999999999999999999853


Q ss_pred             CCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          945 DFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       945 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. ......+....... .....+++.+.  ....+          ..+.+++..|++.||++||+++|
T Consensus       265 ~~-~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~----------~~~~~li~~cl~~~p~~RP~~~~  319 (364)
T 3op5_A          265 LK-DPKYVRDSKIRYRE-NIASLMDKCFP--AANAP----------GEIAKYMETVKLLDYTEKPLYEN  319 (364)
T ss_dssp             TT-CHHHHHHHHHHHHH-CHHHHHHHHSC--TTCCC----------HHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             cc-CHHHHHHHHHHhhh-hHHHHHHHhcc--cccCH----------HHHHHHHHHHhcCCCCCCCCHHH
Confidence            32 22222222222111 11111111110  00111          13668999999999999999753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.6e-37  Score=335.64  Aligned_cols=245  Identities=26%  Similarity=0.384  Sum_probs=199.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .+.|++.+.||+|+||.||+|++. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356889999999999999999976 688999998865432 335778999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.+++..       ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++...
T Consensus       101 ~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A          101 YLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             CCTTEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             eCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence            9999999999853       2389999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...  .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ...... ........ +..
T Consensus       171 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~-~~~~~~~~-~~~  241 (303)
T 3a7i_A          171 DTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----MKVLFL-IPKNNPPT-LEG  241 (303)
T ss_dssp             TTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHH-HHHSCCCC-CCS
T ss_pred             ccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----HHHHHH-hhcCCCCC-Ccc
Confidence            322  223345789999999999999999999999999999999999999875321     111111 11111110 110


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             ..+          ..+.+++.+||+.||++|||++|
T Consensus       242 -------~~~----------~~l~~li~~~l~~dp~~Rps~~~  267 (303)
T 3a7i_A          242 -------NYS----------KPLKEFVEACLNKEPSFRPTAKE  267 (303)
T ss_dssp             -------SCC----------HHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             -------ccC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence                   111          12568999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=353.41  Aligned_cols=272  Identities=23%  Similarity=0.276  Sum_probs=200.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCC--EEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGE--ERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  808 (1013)
                      .++|++.++||+|+||+||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357999999999999999999987 589999999865332 33467889999999999999999999998755  77999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe----CCCCcEEEeecc
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL----DHEMEARVSDFG  884 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg  884 (1013)
                      |||+++|+|.+++.....   ...+++..++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|||
T Consensus        88 ~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EecCCCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            999999999999975432   22389999999999999999999999   99999999999999    778889999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccC--------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQS--------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~  956 (1013)
                      +|+.......   .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||...............
T Consensus       162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  238 (396)
T 4eut_A          162 AARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK  238 (396)
T ss_dssp             GCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred             CceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence            9987654222   234578999999999865        56788999999999999999999999765443333222222


Q ss_pred             HHHhcCc-cccccC---hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGK-QMEVID---PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~-~~~~~d---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....... ......   .......................+.+++.+||+.||++|||++|
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence            2111110 000000   00000000000000000111223568999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=347.75  Aligned_cols=201  Identities=24%  Similarity=0.388  Sum_probs=165.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc-hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG-DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....... ...+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999987 68899999885432221 12456799999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      ++ |+|.+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             CS-EEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cc-cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            98 58999886532     3488999999999999999999999   999999999999999999999999999986543


Q ss_pred             cCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ..  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       153 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (324)
T 3mtl_A          153 PT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST  205 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             Cc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            22  22334568999999999876 568999999999999999999999997643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-37  Score=350.58  Aligned_cols=200  Identities=27%  Similarity=0.415  Sum_probs=174.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357999999999999999999987 68899999886542 2334678999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.+++....      .+++..+..++.|++.||+|||+.+  +|+||||||+||+++.++.+||+|||+++...
T Consensus       112 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999997543      2889999999999999999999831  89999999999999999999999999997653


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ..    ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       184 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          184 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             HH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             cc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            21    123457899999999999999999999999999999999999999764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-37  Score=343.80  Aligned_cols=201  Identities=29%  Similarity=0.437  Sum_probs=169.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++......  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            56999999999999999999987 5899999988654332  23557899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       105 ~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          105 FVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             CCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             cCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            999999988865332      389999999999999999999999   99999999999999999999999999998654


Q ss_pred             ccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ...  .......|++.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus       176 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (331)
T 4aaa_A          176 APG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS  229 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            322  223345789999999998875 78999999999999999999999997643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-37  Score=334.59  Aligned_cols=246  Identities=27%  Similarity=0.454  Sum_probs=197.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            4688899999999999999999888899999886543 345779999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +++|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++......
T Consensus        87 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           87 HGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             TCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCcHHHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            999999997532     2378999999999999999999999   99999999999999999999999999998654311


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                       ........+++.|+|||++.+..++.++||||+|+++|||++ |+.||....     ..+.... +..+...  ..+..
T Consensus       159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~-i~~~~~~--~~~~~  229 (267)
T 3t9t_A          159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVED-ISTGFRL--YKPRL  229 (267)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHH-HHTTCCC--CCCTT
T ss_pred             -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-----HHHHHHH-HhcCCcC--CCCcc
Confidence             111223456778999999998899999999999999999999 899987532     1111211 1111110  00100


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            .+          ..+.+++.+||+.||++|||++|
T Consensus       230 ------~~----------~~l~~li~~~l~~~p~~Rps~~~  254 (267)
T 3t9t_A          230 ------AS----------THVYQIMNHCWRERPEDRPAFSR  254 (267)
T ss_dssp             ------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------Cc----------HHHHHHHHHHccCChhhCcCHHH
Confidence                  00          12568999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2e-37  Score=363.55  Aligned_cols=246  Identities=25%  Similarity=0.369  Sum_probs=192.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++....  ......+.+|++++++++||||+++++++.+....|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999987 68899999886543  3335778999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC---CcEEEeecccce
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE---MEARVSDFGMAR  887 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~  887 (1013)
                      |+++|+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++..   +.+||+|||+|+
T Consensus       117 ~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          117 CYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             CCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999886543      288999999999999999999999   99999999999999764   559999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      ......   ......||+.|+|||++. ..++.++||||+||++|+|++|..||.....     .+.... +..+.... 
T Consensus       188 ~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~-i~~~~~~~-  256 (494)
T 3lij_A          188 VFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILRK-VEKGKYTF-  256 (494)
T ss_dssp             ECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHHTCCCC-
T ss_pred             ECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH-HHhCCCCC-
Confidence            765422   233457999999999986 4689999999999999999999999976431     112221 11111100 


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..    ...+          ..+.+++.+||+.||++|||++|
T Consensus       257 ~~~~~----~~~s----------~~~~~li~~~L~~dp~~R~s~~e  288 (494)
T 3lij_A          257 DSPEW----KNVS----------EGAKDLIKQMLQFDSQRRISAQQ  288 (494)
T ss_dssp             CSGGG----TTSC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             Cchhc----ccCC----------HHHHHHHHHHCCCChhhCccHHH
Confidence            01110    0111          12568999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=334.33  Aligned_cols=248  Identities=22%  Similarity=0.362  Sum_probs=193.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC----ccchHHHHHHHHHHhccCCcceeeeccEEE--eCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS----CQGDREFMAEMETLGKIKHRNLVPLLGYCK--IGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  805 (1013)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....    ....+.+.+|++++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999986 68899999886432    233567899999999999999999999984  45578


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||++++ +.+++....    ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~  155 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGV  155 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEehhccCC-HHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccc
Confidence            9999999976 777776432    23489999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCCC--CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSFR--CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      ++...............|++.|+|||++.+..  ++.++||||+||++|||++|+.||....     ..+.... +..+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~-i~~~~  229 (305)
T 2wtk_C          156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFEN-IGKGS  229 (305)
T ss_dssp             CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHH-HHHCC
T ss_pred             ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHH-HhcCC
Confidence            98765433333444567899999999987644  4779999999999999999999997532     1222211 11111


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..  ++.       ...          ..+.+++.+||+.||++|||++|
T Consensus       230 ~~--~~~-------~~~----------~~l~~li~~~l~~dp~~Rps~~~  260 (305)
T 2wtk_C          230 YA--IPG-------DCG----------PPLSDLLKGMLEYEPAKRFSIRQ  260 (305)
T ss_dssp             CC--CCS-------SSC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CC--CCC-------ccC----------HHHHHHHHHHccCChhhCCCHHH
Confidence            10  000       011          12568999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.3e-37  Score=337.48  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=187.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.......   .+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999986 67889999886543222   36788999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       113 ~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             EECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             EEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            99999999999997542      388999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc-cccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK-QMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  967 (1013)
                      ..... ........|++.|+|||++.+..++.++||||||+++|||++|+.||.....      ........... ....
T Consensus       184 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~  256 (309)
T 2h34_A          184 TTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------SVMGAHINQAIPRPST  256 (309)
T ss_dssp             --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------HHHHHHHHSCCCCGGG
T ss_pred             ccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------HHHHHHhccCCCCccc
Confidence            54322 1222345689999999999999999999999999999999999999975321      11122222111 1111


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCC-CCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP-NML 1012 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ 1012 (1013)
                      ..+.       .+.          .+.+++.+||+.||++|| |++
T Consensus       257 ~~~~-------~~~----------~l~~li~~~l~~dP~~Rp~s~~  285 (309)
T 2h34_A          257 VRPG-------IPV----------AFDAVIARGMAKNPEDRYVTCG  285 (309)
T ss_dssp             TSTT-------CCT----------HHHHHHHHHTCSSGGGSCSSHH
T ss_pred             cCCC-------CCH----------HHHHHHHHhccCCHHHHHHhHH
Confidence            1111       111          256899999999999999 654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-37  Score=363.64  Aligned_cols=246  Identities=24%  Similarity=0.390  Sum_probs=195.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||||++...  .......+.+|++++++++||||+++++++.+....|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            46999999999999999999986 6899999988543  23345778999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC---CCCcEEEeecccce
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMAR  887 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~  887 (1013)
                      |+++|+|.+.+....      .+++..++.++.|++.||+|||++   +|+||||||+||+++   .++.+||+|||+|+
T Consensus       102 ~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          102 LYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             CCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999886543      389999999999999999999999   999999999999995   45679999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      .....   .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....     .+.... +..+.....
T Consensus       173 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~-i~~~~~~~~  242 (486)
T 3mwu_A          173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKR-VETGKYAFD  242 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHHTCCCSC
T ss_pred             ECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH-HHhCCCCCC
Confidence            65432   22344579999999999876 589999999999999999999999976431     111111 111111100


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . +..    ...+          ..+.+++.+||+.||++|||++|
T Consensus       243 ~-~~~----~~~s----------~~~~~li~~~L~~dp~~R~t~~~  273 (486)
T 3mwu_A          243 L-PQW----RTIS----------DDAKDLIRKMLTFHPSLRITATQ  273 (486)
T ss_dssp             S-GGG----GGSC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             C-ccc----CCCC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            0 000    0001          12568999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.9e-37  Score=358.92  Aligned_cols=247  Identities=29%  Similarity=0.439  Sum_probs=192.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.+.||+|+||.||+|++.++..||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            35688889999999999999999888889999886533 345789999999999999999999999876 6789999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++.....    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       261 ~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          261 SKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             TTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             cCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999964321    2388999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      . ........++..|+|||++.+..++.++|||||||++|||++ |+.||.....     .+... .+..+.... .++.
T Consensus       334 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~-~i~~~~~~~-~~~~  405 (452)
T 1fmk_A          334 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLD-QVERGYRMP-CPPE  405 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHH-HHHTTCCCC-CCTT
T ss_pred             c-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHH-HHHcCCCCC-CCCC
Confidence            2 112223456789999999998899999999999999999999 9999975321     11111 122221111 0110


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             .+          ..+.+++.+||+.||++|||++|
T Consensus       406 -------~~----------~~l~~li~~cl~~dP~~Rpt~~~  430 (452)
T 1fmk_A          406 -------CP----------ESLHDLMCQCWRKEPEERPTFEY  430 (452)
T ss_dssp             -------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -------CC----------HHHHHHHHHHccCChhhCcCHHH
Confidence                   11          12568999999999999999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.3e-37  Score=354.02  Aligned_cols=200  Identities=28%  Similarity=0.399  Sum_probs=166.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC-----CE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG-----EE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  804 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||||++....  ....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999986 57889999986532  22346789999999999999999999998765     57


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+||||++ ++|.+++...      ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCC-cCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence            899999997 5999999643      2389999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcc--------------------eeeeeeccCCCccCcccc-cCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          885 MARLISALDTH--------------------LSVSTLAGTPGYVPPEYY-QSFRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       885 ~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      +|+........                    .......||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            99876543211                    123456789999999986 56679999999999999999998655543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-37  Score=335.64  Aligned_cols=242  Identities=26%  Similarity=0.383  Sum_probs=192.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC--CEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+++ ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            46899999999999999999986 8899999886543  23345789999999999999999999999876  7789999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCcccEEeCCCCcEEEeecccce
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH--IIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||+++|+|.+++....    ...+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.++++|||++.
T Consensus        89 e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             ECCTTCBHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             cccCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence            9999999999997533    23489999999999999999999998   8  9999999999999999999999998875


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCc---cchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA---KGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      ....       ....||+.|+|||++.+..++.   ++||||+||++|||++|+.||.....     .............
T Consensus       162 ~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~  229 (271)
T 3kmu_A          162 SFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKVALEGLR  229 (271)
T ss_dssp             TTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----HHHHHHHHHSCCC
T ss_pred             eecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----HHHHHHHHhcCCC
Confidence            4322       2346789999999998765544   79999999999999999999975321     1111222211111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. .++.       .+          ..+.+++.+||+.||++|||++|
T Consensus       230 ~~-~~~~-------~~----------~~~~~li~~~l~~~p~~Rps~~~  260 (271)
T 3kmu_A          230 PT-IPPG-------IS----------PHVSKLMKICMNEDPAKRPKFDM  260 (271)
T ss_dssp             CC-CCTT-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CC-CCCC-------CC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            11 1111       11          12568999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-37  Score=343.28  Aligned_cols=258  Identities=28%  Similarity=0.413  Sum_probs=201.5

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCcc-chHHHHHHHHHHhcc-CCcceeeeccEEEe
Q 036815          730 IEATNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKI-KHRNLVPLLGYCKI  801 (1013)
Q Consensus       730 ~~~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  801 (1013)
                      ....++|++.+.||+|+||.||+|++.      +++.||+|++...... ..+.+.+|+++++++ +||||+++++++..
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            334578999999999999999999852      4578999988654332 345789999999999 79999999999877


Q ss_pred             CC-EEEEEEEcccCCCHHHHhcccccCC----------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccE
Q 036815          802 GE-ERLLVYEFMKFGSLEEVLHGRAKAR----------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNV  870 (1013)
Q Consensus       802 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  870 (1013)
                      .+ ..++||||+++|+|.+++.......          ....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Ni  179 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  179 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceE
Confidence            54 5899999999999999997543210          012388999999999999999999999   999999999999


Q ss_pred             EeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCc
Q 036815          871 LLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDT  949 (1013)
Q Consensus       871 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~  949 (1013)
                      +++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||....... 
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-  258 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  258 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH-
Confidence            999999999999999987655444444445678899999999999999999999999999999998 999997643221 


Q ss_pred             cHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          950 NLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       950 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .    .......+..... +.       ...          ..+.+++.+||+.||++|||++|
T Consensus       259 ~----~~~~~~~~~~~~~-~~-------~~~----------~~l~~li~~~l~~dp~~Rps~~e  300 (316)
T 2xir_A          259 E----FCRRLKEGTRMRA-PD-------YTT----------PEMYQTMLDCWHGEPSQRPTFSE  300 (316)
T ss_dssp             H----HHHHHHHTCCCCC-CT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             H----HHHHhccCccCCC-CC-------CCC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            1    1111111111110 00       001          12568999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-37  Score=345.27  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=200.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCC
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  803 (1013)
                      ...++|++.+.||+|+||.||+|++.      +++.||+|++..... .....+.+|++++++++||||+++++++.+++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            34577999999999999999999865      367899998865432 23456889999999999999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccC----CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEE
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKA----RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEAR  879 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  879 (1013)
                      ..++||||+++|+|.+++......    .....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence            999999999999999999753211    1113468999999999999999999999   999999999999999999999


Q ss_pred             EeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHH
Q 036815          880 VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMK  958 (1013)
Q Consensus       880 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  958 (1013)
                      |+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||....     ....... 
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~-  252 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQVLRF-  252 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----HHHHHHH-
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-----HHHHHHH-
Confidence            999999987654333222334457889999999998899999999999999999999 899987532     1111111 


Q ss_pred             HhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       959 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+..... ..       ..+          ..+.+++.+||+.||++|||++|
T Consensus       253 ~~~~~~~~~-~~-------~~~----------~~l~~li~~~l~~dp~~Rps~~e  289 (322)
T 1p4o_A          253 VMEGGLLDK-PD-------NCP----------DMLFELMRMCWQYNPKMRPSFLE  289 (322)
T ss_dssp             HHTTCCCCC-CT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHcCCcCCC-CC-------CCC----------HHHHHHHHHHcCCCcccCcCHHH
Confidence            111111110 00       011          12568999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.5e-37  Score=345.83  Aligned_cols=269  Identities=25%  Similarity=0.346  Sum_probs=196.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEe--------C
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKI--------G  802 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  802 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.....  .....+.+|++++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57999999999999999999985 789999998854332  234678899999999999999999999977        4


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      +..++||||+++ ++.+.+....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence            468999999985 7777775432     2389999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCc--ceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHH
Q 036815          883 FGMARLISALDT--HLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKV  959 (1013)
Q Consensus       883 fg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  959 (1013)
                      ||+|+.+.....  ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....  ......+....
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~  245 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLC  245 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHH
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHh
Confidence            999987653221  222344578999999999876 4579999999999999999999999986431  11111121111


Q ss_pred             hcCcc--ccccC-hhhh---cccCCCChhhHHHHHH---HHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REGKQ--MEVID-PELL---LVTKGTDESEAEEVKE---MVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~--~~~~d-~~~~---~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .....  ....+ .+..   ................   -..+.+++.+||+.||++|||++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  308 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD  308 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence            11110  00000 0000   0001111111111111   123679999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3e-37  Score=338.86  Aligned_cols=201  Identities=28%  Similarity=0.384  Sum_probs=171.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-----cCCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeC--CEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATL-----KDGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG--EER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  805 (1013)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588899999999999999984     357899999886433 23347789999999999999999999999876  568


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||+++++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            99999999999999996432     2389999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcc-eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          886 ARLISALDTH-LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       886 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      ++........ .......+|..|+|||++.+..++.++||||+||++|||++|..|+.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            9877543322 22334567888999999999999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.9e-37  Score=331.15  Aligned_cols=243  Identities=24%  Similarity=0.398  Sum_probs=189.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57999999999999999999987 78999999885432   223467889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++++|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+...
T Consensus        91 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             ECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             eccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            9999999999997543      288999999999999999999999   9999999999999999999999999999875


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ....   ......+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||....     ...... .+..+...  .
T Consensus       162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~-~~~~~~~~--~  230 (276)
T 2h6d_A          162 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VPTLFK-KIRGGVFY--I  230 (276)
T ss_dssp             CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH-HHHHCCCC--C
T ss_pred             CCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHH-HhhcCccc--C
Confidence            4322   1234568999999999987765 689999999999999999999997532     111111 11111100  0


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +..       ..          ..+.+++.+||+.||++|||++|
T Consensus       231 ~~~-------~~----------~~l~~li~~~l~~~p~~Rps~~~  258 (276)
T 2h6d_A          231 PEY-------LN----------RSVATLLMHMLQVDPLKRATIKD  258 (276)
T ss_dssp             CTT-------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             chh-------cC----------HHHHHHHHHHccCChhhCCCHHH
Confidence            000       00          12568999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.4e-37  Score=333.66  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=193.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      +|....+||+|+||.||+|++. +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4556679999999999999985 678999999876655556789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-CCcEEEeecccceecccc
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-EMEARVSDFGMARLISAL  892 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~  892 (1013)
                      +++|.+++.....   ...+++..+..++.|++.||+|||++   +|+||||||+||+++. ++.+||+|||.++.....
T Consensus       103 ~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          103 GGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             EEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             CCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9999999975422   23367889999999999999999999   9999999999999987 899999999999876432


Q ss_pred             CcceeeeeeccCCCccCcccccCCC--CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFR--CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ..  ......|++.|+|||++.+..  ++.++|||||||++|||++|+.||.......   ..........  ....++.
T Consensus       177 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~--~~~~~~~  249 (295)
T 2clq_A          177 NP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMFK--VHPEIPE  249 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHHHC--CCCCCCT
T ss_pred             CC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhcccc--ccccccc
Confidence            21  223457899999999987643  7899999999999999999999997432111   1111111110  0000111


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       .+          ..+.+++.+||+.||++|||++|
T Consensus       250 ~-------~~----------~~~~~li~~~l~~dp~~Rps~~~  275 (295)
T 2clq_A          250 S-------MS----------AEAKAFILKCFEPDPDKRACAND  275 (295)
T ss_dssp             T-------SC----------HHHHHHHHHTTCSSTTTSCCHHH
T ss_pred             c-------CC----------HHHHHHHHHHccCChhhCCCHHH
Confidence            0       01          12568999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.6e-37  Score=347.44  Aligned_cols=205  Identities=17%  Similarity=0.226  Sum_probs=177.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEE------EcCCCEEEEEEeeccCccchHHHHHHHHHHhccC---CcceeeeccEEEeC
Q 036815          732 ATNGFSAESLIGCGGFGEVFKAT------LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK---HRNLVPLLGYCKIG  802 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  802 (1013)
                      ..++|++.+.||+|+||+||+|+      ..+++.||+|++...   ...++.+|++++++++   |+||+++++++..+
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35679999999999999999994      346889999987543   4567788888888886   99999999999999


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC--------
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH--------  874 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--------  874 (1013)
                      +..|+||||+++|+|.+++...... ....+++..++.++.|++.||+|||++   +||||||||+||+++.        
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999754321 234589999999999999999999999   9999999999999998        


Q ss_pred             ---CCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          875 ---EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       875 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                         ++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence               899999999999876544444455667899999999999999999999999999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=339.43  Aligned_cols=245  Identities=28%  Similarity=0.451  Sum_probs=186.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||.||+|++. ++.||+|++..  ....+.+.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            46888999999999999999986 78899998753  234567899999999999999999999876  34789999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc-EEEeecccceecccc
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME-ARVSDFGMARLISAL  892 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~a~~~~~~  892 (1013)
                      +|+|.+++.....   ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus        83 ~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           83 GGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             TCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             CCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999975432   223788999999999999999999932229999999999999998886 799999999765321


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...... ...+..... .+  
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~-~~~~~~~~~-~~--  227 (307)
T 2eva_A          160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRIMWA-VHNGTRPPL-IK--  227 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---HHHHHH-HHTTCCCCC-BT--
T ss_pred             -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---HHHHHH-HhcCCCCCc-cc--
Confidence                 223468999999999999999999999999999999999999997543221   111111 111111110 00  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..+          ..+.+++.+||+.||++|||++|
T Consensus       228 -----~~~----------~~l~~li~~~l~~dp~~Rps~~e  253 (307)
T 2eva_A          228 -----NLP----------KPIESLMTRCWSKDPSQRPSMEE  253 (307)
T ss_dssp             -----TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -----ccC----------HHHHHHHHHHhcCChhhCcCHHH
Confidence                 111          12568999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-37  Score=346.31  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=200.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC------CCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD------GSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  804 (1013)
                      .++|++.+.||+|+||.||+|.+..      ...||+|.+..... ...+.+.+|+++++++ +||||+++++++.+++.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            4689999999999999999999752      24799998865432 2346689999999999 89999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCC--------CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKAR--------DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                      .++||||+++|+|.+++.......        ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence            999999999999999997543110        123478999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHH
Q 036815          877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWV  955 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  955 (1013)
                      .+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~  280 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKLV  280 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHHHHH
Confidence            999999999987654443333445567889999999998899999999999999999999 999997643221 111111


Q ss_pred             HHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          956 KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       956 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          .......  .+.      ..+          ..+.+++.+||+.||++|||++|
T Consensus       281 ----~~~~~~~--~~~------~~~----------~~l~~li~~~l~~~p~~Rps~~~  316 (333)
T 2i1m_A          281 ----KDGYQMA--QPA------FAP----------KNIYSIMQACWALEPTHRPTFQQ  316 (333)
T ss_dssp             ----HHTCCCC--CCT------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----hcCCCCC--CCC------CCC----------HHHHHHHHHHhccChhhCcCHHH
Confidence                1111100  000      000          12568999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-37  Score=360.87  Aligned_cols=194  Identities=27%  Similarity=0.419  Sum_probs=153.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC-----CE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG-----EE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  804 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||||++....  ....+.+.+|++++++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999986 68999999986532  22346788999999999999999999998443     56


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+||||++ ++|.+++...      ..+++..++.++.||+.||+|||+.   +||||||||+|||++.++.+||+|||
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeccc-cchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence            899999986 6899998643      2389999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcc-------------------------eeeeeeccCCCccCcccc-cCCCCCccchhHhHHHHHHHHHc
Q 036815          885 MARLISALDTH-------------------------LSVSTLAGTPGYVPPEYY-QSFRCTAKGDVYSFGVVLLELLT  936 (1013)
Q Consensus       885 ~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt  936 (1013)
                      +|+........                         .......||+.|+|||++ .+..++.++||||+||++|||++
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            99876432211                         123445789999999986 56679999999999999999999

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.1e-37  Score=341.44  Aligned_cols=256  Identities=23%  Similarity=0.356  Sum_probs=200.1

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhc--cCCcceeeeccEEEeCC----E
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGK--IKHRNLVPLLGYCKIGE----E  804 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~  804 (1013)
                      ...++|++.+.||+|+||.||+|++. ++.||+|++..   ...+.+.+|.+++..  ++||||+++++++....    .
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            34568999999999999999999985 89999998753   335667889999887  68999999999998765    7


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCcccEEeCCCC
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH--------HNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                      .++||||+++|+|.+++...       .+++..++.++.|++.||+|||        +.   +|+||||||+||+++.++
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             eEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence            89999999999999999642       2899999999999999999999        77   999999999999999999


Q ss_pred             cEEEeecccceeccccCcce--eeeeeccCCCccCcccccCC------CCCccchhHhHHHHHHHHHcC----------C
Q 036815          877 EARVSDFGMARLISALDTHL--SVSTLAGTPGYVPPEYYQSF------RCTAKGDVYSFGVVLLELLTG----------K  938 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~  938 (1013)
                      .+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            99999999998765433221  22345789999999998765      344789999999999999999          7


Q ss_pred             CCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          939 RPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       939 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .||............+........ ....++...            ........+.+++.+||+.||++|||++|
T Consensus       265 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMRKVVCEQK-LRPNIPNRW------------QSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSC-CCCCCCGGG------------GTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cCccccCcCcccHHHHHHHHHHHH-hCCCCcccc------------cchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence            788765544444444443322211 111111110            00112334678999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2e-37  Score=344.05  Aligned_cols=202  Identities=25%  Similarity=0.352  Sum_probs=175.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-----cCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEE--eCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATL-----KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK--IGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5689999999999999999984     357899999987665555677999999999999999999999886  456789


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||+++++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       103 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence            9999999999999997532     2389999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcce-eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          887 RLISALDTHL-SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       887 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      +......... ......+++.|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  232 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS  232 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            8765433221 22334578889999999998999999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3e-37  Score=347.12  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=198.3

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc--------chHHHHHHHHHHhcc-CCcceeeeccEE
Q 036815          730 IEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ--------GDREFMAEMETLGKI-KHRNLVPLLGYC  799 (1013)
Q Consensus       730 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~~  799 (1013)
                      ....++|++.+.||+|+||.||+|++. +|+.||||++......        ..+.+.+|+++++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            344567999999999999999999986 6899999988653311        134578899999999 799999999999


Q ss_pred             EeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEE
Q 036815          800 KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEAR  879 (1013)
Q Consensus       800 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  879 (1013)
                      ...+..|+||||++|++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999997432      389999999999999999999999   999999999999999999999


Q ss_pred             EeecccceeccccCcceeeeeeccCCCccCcccccC------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHH
Q 036815          880 VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVG  953 (1013)
Q Consensus       880 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~  953 (1013)
                      |+|||++.......   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||....     ...
T Consensus       241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~~~  312 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----QIL  312 (365)
T ss_dssp             ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHH
T ss_pred             EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----HHH
Confidence            99999998765432   2334679999999999863      358889999999999999999999997532     111


Q ss_pred             HHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          954 WVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       954 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .... +..+.... ..+..    ...          ...+.+++.+||+.||++|||++|
T Consensus       313 ~~~~-i~~~~~~~-~~~~~----~~~----------~~~~~~li~~~L~~dP~~Rps~~e  356 (365)
T 2y7j_A          313 MLRM-IMEGQYQF-SSPEW----DDR----------SSTVKDLISRLLQVDPEARLTAEQ  356 (365)
T ss_dssp             HHHH-HHHTCCCC-CHHHH----SSS----------CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHH-HHhCCCCC-CCccc----ccC----------CHHHHHHHHHHcCCChhHCcCHHH
Confidence            1111 11111100 00000    000          113568999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6e-37  Score=334.14  Aligned_cols=244  Identities=26%  Similarity=0.380  Sum_probs=192.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEe----CCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKI----GEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  806 (1013)
                      +.|++.+.||+|+||.||+|.+. ++..||+|++....  ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34777889999999999999986 57889999886432  2334678999999999999999999999865    45689


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCcccEEeC-CCCcEEEeec
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH--IIHRDMKSSNVLLD-HEMEARVSDF  883 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Df  883 (1013)
                      +||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +  |+||||||+||+++ .++.+||+||
T Consensus       106 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            9999999999999997532      388999999999999999999998   8  99999999999998 7899999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      |++......    ......|++.|+|||++.+ .++.++||||+||++|+|++|+.||.....    ....... ...+.
T Consensus       177 g~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~-~~~~~  246 (290)
T 1t4h_A          177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRR-VTSGV  246 (290)
T ss_dssp             TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHH-HTTTC
T ss_pred             CCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc----HHHHHHH-HhccC
Confidence            999754332    1234568999999998875 589999999999999999999999975321    1222221 11111


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .....+..       ..          ..+.+++.+||+.||++|||++|
T Consensus       247 ~~~~~~~~-------~~----------~~l~~li~~~l~~dp~~Rps~~e  279 (290)
T 1t4h_A          247 KPASFDKV-------AI----------PEVKEIIEGCIRQNKDERYSIKD  279 (290)
T ss_dssp             CCGGGGGC-------CC----------HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CccccCCC-------CC----------HHHHHHHHHHccCChhhCCCHHH
Confidence            11111111       00          12568999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.7e-37  Score=337.22  Aligned_cols=249  Identities=26%  Similarity=0.386  Sum_probs=193.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++..++..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467999999999999999999987 5889999988766556667899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        98 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           98 CPGGAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CTTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             CCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999986432     2389999999999999999999999   999999999999999999999999998764321


Q ss_pred             cCcceeeeeeccCCCccCcccc-----cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYY-----QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      .  ........|++.|+|||++     .+..++.++|||||||++|+|++|+.||.....     ........... ...
T Consensus       170 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~-~~~  241 (302)
T 2j7t_A          170 T--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSD-PPT  241 (302)
T ss_dssp             H--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSC-CCC
T ss_pred             c--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----HHHHHHHhccC-Ccc
Confidence            1  1112345689999999998     466789999999999999999999999875321     11111111111 111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+..      .+          ..+.+++.+||+.||++|||++|
T Consensus       242 ~~~~~~------~~----------~~l~~li~~~l~~dp~~Rps~~~  272 (302)
T 2j7t_A          242 LLTPSK------WS----------VEFRDFLKIALDKNPETRPSAAQ  272 (302)
T ss_dssp             CSSGGG------SC----------HHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             cCCccc------cC----------HHHHHHHHHHcccChhhCCCHHH
Confidence            111100      00          12568999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=343.57  Aligned_cols=254  Identities=23%  Similarity=0.284  Sum_probs=194.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe----CCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI----GEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  807 (1013)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            357999999999999999999984 789999998876555566789999999999999999999999863    347799


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++.....  ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++
T Consensus       108 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEeCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            9999999999999975432  234489999999999999999999999   99999999999999999999999999987


Q ss_pred             eccccCcc-------eeeeeeccCCCccCcccccCCC---CCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 036815          888 LISALDTH-------LSVSTLAGTPGYVPPEYYQSFR---CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       888 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ........       .......||+.|+|||++.+..   ++.++|||||||++|||++|+.||................
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            65321110       0012345799999999987554   6889999999999999999999986421111111111111


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ..... ..+       ..+          ..+.+++.+||+.||++|||++|
T Consensus       263 ----~~~~~-~~~-------~~~----------~~l~~li~~~l~~dp~~Rps~~~  296 (317)
T 2buj_A          263 ----QLSIP-QSP-------RHS----------SALWQLLNSMMTVDPHQRPHIPL  296 (317)
T ss_dssp             ----C--CC-CCT-------TSC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----cCCCC-ccc-------cCC----------HHHHHHHHHHhhcChhhCCCHHH
Confidence                00000 000       001          12568999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.2e-37  Score=333.93  Aligned_cols=252  Identities=22%  Similarity=0.298  Sum_probs=192.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEE-EeCCEEEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC-KIGEERLLVY  809 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  809 (1013)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+|++++++++|++++..++++ ..++..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4578999999999999999999974 68899999764432  223578899999999988877776655 5677889999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe---CCCCcEEEeecccc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMA  886 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a  886 (1013)
                      ||+ +++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus        85 e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             ECC-CCBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             Ecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            999 899999996432     2389999999999999999999999   99999999999999   78899999999999


Q ss_pred             eeccccCcc-----eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCc-cH-HHHHHHHH
Q 036815          887 RLISALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT-NL-VGWVKMKV  959 (1013)
Q Consensus       887 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-~~-~~~~~~~~  959 (1013)
                      +........     .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .. ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            876543321     122356789999999999999999999999999999999999999986443321 11 11111111


Q ss_pred             hcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. .. ....       ...+          ..+.+++.+||+.||++|||++|
T Consensus       236 ~~-~~-~~~~-------~~~~----------~~l~~li~~~l~~~p~~Rpt~~~  270 (296)
T 4hgt_A          236 ST-PI-EVLC-------KGYP----------SEFATYLNFCRSLRFDDKPDYSY  270 (296)
T ss_dssp             HS-CH-HHHT-------TTSC----------HHHHHHHHHHHTSCTTCCCCHHH
T ss_pred             cc-hh-hhhh-------ccCC----------HHHHHHHHHHHhcCCCCCCCHHH
Confidence            11 00 0000       0001          13568999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-37  Score=364.97  Aligned_cols=246  Identities=26%  Similarity=0.408  Sum_probs=197.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56999999999999999999987 78999999986532   334577999999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe---CCCCcEEEeecccc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMA  886 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a  886 (1013)
                      ||+.+|+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+|
T Consensus       106 e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             CCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             ecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999986543      389999999999999999999999   99999999999999   56789999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +.+....   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....     .+.... +..+....
T Consensus       177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~-i~~~~~~~  246 (484)
T 3nyv_A          177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YDILKK-VEKGKYTF  246 (484)
T ss_dssp             HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHHCCCCC
T ss_pred             EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH-HHcCCCCC
Confidence            8764322   2234579999999999876 689999999999999999999999976431     111111 11111110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. +..    ...+          ..+.+++.+||+.||++|||++|
T Consensus       247 ~~-~~~----~~~s----------~~~~~li~~~L~~dp~~R~s~~e  278 (484)
T 3nyv_A          247 EL-PQW----KKVS----------ESAKDLIRKMLTYVPSMRISARD  278 (484)
T ss_dssp             CS-GGG----GGSC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CC-ccc----ccCC----------HHHHHHHHHHCCCChhHCcCHHH
Confidence            00 000    0001          12568999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.1e-37  Score=333.45  Aligned_cols=247  Identities=26%  Similarity=0.411  Sum_probs=196.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            35688999999999999999999888899999875433 34678999999999999999999999886 45689999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....    ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++.....
T Consensus        90 ~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           90 ENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             TTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             CCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            9999999996432    12489999999999999999999999   9999999999999999999999999999876532


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      . ........+++.|+|||++.+..++.++||||+||++|||++ |+.||.....     .+.... ...+.... .+. 
T Consensus       163 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~-~~~~~~~~-~~~-  233 (279)
T 1qpc_A          163 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQN-LERGYRMV-RPD-  233 (279)
T ss_dssp             C-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHH-HHTTCCCC-CCT-
T ss_pred             c-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----HHHHHH-HhcccCCC-Ccc-
Confidence            2 112223456788999999998889999999999999999999 9999875321     111111 11111100 000 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..+          ..+.+++.+|++.||++|||++|
T Consensus       234 ------~~~----------~~l~~li~~~l~~~p~~Rps~~~  259 (279)
T 1qpc_A          234 ------NCP----------EELYQLMRLCWKERPEDRPTFDY  259 (279)
T ss_dssp             ------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------ccc----------HHHHHHHHHHhccChhhCCCHHH
Confidence                  011          13568999999999999999853

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-36  Score=338.64  Aligned_cols=257  Identities=24%  Similarity=0.371  Sum_probs=191.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhcc--CCcceeeeccEEEeC----CEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI--KHRNLVPLLGYCKIG----EERL  806 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~~  806 (1013)
                      .++|++.+.||+|+||.||+|++. ++.||||++...   ....+.+|.+++...  +||||+++++++...    ...+
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            467999999999999999999986 899999987532   234455666666555  899999999999887    7889


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCcccEEeCCCCcEEEe
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC-----IPHIIHRDMKSSNVLLDHEMEARVS  881 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~  881 (1013)
                      +||||+++|+|.+++...       .+++..++.++.|++.||+|||+++     .++|+||||||+||+++.++.+||+
T Consensus       112 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            999999999999999643       3899999999999999999999752     2389999999999999999999999


Q ss_pred             ecccceeccccCcce--eeeeeccCCCccCcccccCCCCCcc------chhHhHHHHHHHHHcC----------CCCCCC
Q 036815          882 DFGMARLISALDTHL--SVSTLAGTPGYVPPEYYQSFRCTAK------GDVYSFGVVLLELLTG----------KRPTDK  943 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg----------~~pf~~  943 (1013)
                      |||+|+.+.......  ......||+.|+|||++.+...+.+      +|||||||++|||++|          +.||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            999998764432221  1224579999999999987766655      9999999999999999          666655


Q ss_pred             CCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          944 DDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       944 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..........+.... .........+....            .......+.+++.+||+.||++|||++|
T Consensus       265 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          265 LVPSDPSYEDMREIV-CIKKLRPSFPNRWS------------SDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             TSCSSCCHHHHHHHH-TTSCCCCCCCGGGG------------GSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hcCCCCchhhhHHHH-hhhccCccccccch------------hhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence            433333333222221 11111111111100            0012234678999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-37  Score=346.16  Aligned_cols=202  Identities=28%  Similarity=0.381  Sum_probs=167.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc-----chHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ-----GDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++......     ..+.+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3578999999999999999999986 5899999988543221     124678999999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||+++ +|.+++....     ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             EEEEEcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence            999999996 8988886432     2378888999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ++......  .......||+.|+|||++.+. .++.++||||+||++|||++|.+||...
T Consensus       159 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          159 AKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             GSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            98764322  223345789999999998754 5889999999999999999999998764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=347.93  Aligned_cols=253  Identities=16%  Similarity=0.176  Sum_probs=194.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC---------CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceee----------
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD---------GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP----------  794 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  794 (1013)
                      ++|++.+.||+|+||.||+|++..         ++.||+|.+...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            679999999999999999999864         788999987543     46789999999999999988          


Q ss_pred             -----eccEEEe-CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcc
Q 036815          795 -----LLGYCKI-GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSS  868 (1013)
Q Consensus       795 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  868 (1013)
                           +++++.. +...++||||+ +++|.+++....    ...+++..++.++.|++.||+|||++   +|+||||||+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~  188 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE  188 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence                 5667766 67889999999 899999997542    23489999999999999999999999   9999999999


Q ss_pred             cEEeCCCC--cEEEeecccceeccccCcce-----eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCC
Q 036815          869 NVLLDHEM--EARVSDFGMARLISALDTHL-----SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPT  941 (1013)
Q Consensus       869 Nill~~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf  941 (1013)
                      ||+++.++  .+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  89999999998765432211     113347899999999999999999999999999999999999999


Q ss_pred             CCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          942 DKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       942 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ......................  ...+....  ....+          ..+.+++.+||+.||++|||++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~----------~~l~~li~~~l~~dp~~Rps~~~  326 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPG--PFVGPCGH--WIRPS----------ETLQKYLKVVMALTYEEKPPYAM  326 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCC--CEECTTSC--EECCC----------HHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             ccCCcCHHHHHHHHHhccCChh--hhhhhccc--cCCCc----------HHHHHHHHHHHhCChhhCCCHHH
Confidence            8654222222222222111111  11110000  00011          12568999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-36  Score=367.28  Aligned_cols=242  Identities=25%  Similarity=0.308  Sum_probs=198.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .++|++.+.||+|+||.||+|+++ +++.||||++.+.   .....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467999999999999999999987 5788999998643   223346678899999988 79999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||++||+|.+++....      .+++..++.++.||+.||+|||++   +||||||||+|||++.++++||+|||+|+
T Consensus       420 V~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence            999999999999997543      289999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC-cccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG-KQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  966 (1013)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.     .+......... ....
T Consensus       491 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~p~  563 (674)
T 3pfq_A          491 ENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHNVAYPK  563 (674)
T ss_dssp             ECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHSSCCCCCT
T ss_pred             ccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhCCCCCCc
Confidence            643222  223456899999999999999999999999999999999999999976431     22222222111 1111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .++                     ..+.+++.+||+.||++||++
T Consensus       564 ~~s---------------------~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          564 SMS---------------------KEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             TSC---------------------HHHHHHHHHHSCSSSTTCTTC
T ss_pred             cCC---------------------HHHHHHHHHHccCCHHHCCCC
Confidence            111                     125689999999999999997

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-36  Score=332.87  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=195.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEE-EeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC-KIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ..+.+.+|++++++++|++++..+.++ .+++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            468999999999999999999984 78899999875433  234688999999999988877666655 56778899999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC---CCCcEEEeecccce
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMAR  887 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~  887 (1013)
                      |+ +++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++   .++.+||+|||+++
T Consensus        86 ~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             CC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            99 899999996332     2389999999999999999999999   999999999999994   78899999999998


Q ss_pred             eccccCcce-----eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCc-cH-HHHHHHHHh
Q 036815          888 LISALDTHL-----SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT-NL-VGWVKMKVR  960 (1013)
Q Consensus       888 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-~~-~~~~~~~~~  960 (1013)
                      .........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            765433211     12356799999999999999999999999999999999999999986443221 11 111111111


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. . ....       ...+          ..+.+++.+||+.||++|||++|
T Consensus       237 ~~-~-~~~~-------~~~~----------~~l~~li~~~l~~dp~~Rps~~~  270 (296)
T 3uzp_A          237 TP-I-EVLC-------KGYP----------SEFATYLNFCRSLRFDDKPDYSY  270 (296)
T ss_dssp             SC-H-HHHT-------TTSC----------HHHHHHHHHHHTSCTTCCCCHHH
T ss_pred             Cc-h-HHHH-------hhCC----------HHHHHHHHHHHhcCcCcCCCHHH
Confidence            10 0 0000       0011          12568999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.4e-37  Score=362.58  Aligned_cols=247  Identities=26%  Similarity=0.360  Sum_probs=195.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-------------cchHHHHHHHHHHhccCCcceeeeccE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-------------QGDREFMAEMETLGKIKHRNLVPLLGY  798 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~  798 (1013)
                      .++|++.+.||+|+||+||+|+++ +++.||+|++.....             ...+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            568999999999999999999987 578999998865321             234678999999999999999999999


Q ss_pred             EEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC--
Q 036815          799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM--  876 (1013)
Q Consensus       799 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~--  876 (1013)
                      +.++...|+||||+++|+|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++  
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence            999999999999999999999986543      389999999999999999999999   999999999999998776  


Q ss_pred             -cEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHH
Q 036815          877 -EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWV  955 (1013)
Q Consensus       877 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~  955 (1013)
                       .+||+|||+|+......   ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.....     .+..
T Consensus       186 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~  256 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND-----QDII  256 (504)
T ss_dssp             SSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred             ccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence             69999999998765422   2334579999999999874 689999999999999999999999976431     1222


Q ss_pred             HHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          956 KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       956 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. +..+....  +...   ....+          ..+.+++.+||++||++|||++|
T Consensus       257 ~~-i~~~~~~~--~~~~---~~~~s----------~~~~~li~~~L~~dp~~R~t~~e  298 (504)
T 3q5i_A          257 KK-VEKGKYYF--DFND---WKNIS----------DEAKELIKLMLTYDYNKRCTAEE  298 (504)
T ss_dssp             HH-HHHCCCCC--CHHH---HTTSC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HH-HHcCCCCC--Cccc---cCCCC----------HHHHHHHHHHcCCChhHCCCHHH
Confidence            21 11111110  0000   00011          13568999999999999999864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.8e-37  Score=333.96  Aligned_cols=238  Identities=26%  Similarity=0.423  Sum_probs=193.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe----------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI----------  801 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  801 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....    ..+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            356899999999999999999987 78999999886432    356789999999999999999998854          


Q ss_pred             ------CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC
Q 036815          802 ------GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE  875 (1013)
Q Consensus       802 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  875 (1013)
                            ....++||||+++++|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence                  3457999999999999999975432    3489999999999999999999999   99999999999999999


Q ss_pred             CcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHH
Q 036815          876 MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWV  955 (1013)
Q Consensus       876 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~  955 (1013)
                      +.+||+|||+++.......   .....|++.|+|||++.+..++.++|||||||++|||++|..||...       ..+.
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~  228 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFF  228 (284)
T ss_dssp             TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHH
T ss_pred             CCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHH
Confidence            9999999999987654322   23456899999999999999999999999999999999999886421       1111


Q ss_pred             HHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          956 KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       956 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ..........+++                     .+.+++.+||+.||++|||++|
T Consensus       229 ~-~~~~~~~~~~~~~---------------------~~~~li~~~l~~dp~~Rps~~e  264 (284)
T 2a19_B          229 T-DLRDGIISDIFDK---------------------KEKTLLQKLLSKKPEDRPNTSE  264 (284)
T ss_dssp             H-HHHTTCCCTTSCH---------------------HHHHHHHHHTCSSGGGSCCHHH
T ss_pred             H-HhhcccccccCCH---------------------HHHHHHHHHccCChhhCcCHHH
Confidence            1 1111111111111                     2458999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.6e-37  Score=332.74  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=191.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC----CCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD----GSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .++|++.+.||+|+||.||+|++..    +..||+|.+.... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3578899999999999999998753    2359999876542 2335678999999999999999999999865 45689


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++++|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++
T Consensus        90 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             EEecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence            999999999999996532     2388999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+.    .+....
T Consensus       162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~----~~~~~~  234 (281)
T 3cc6_A          162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLE----KGDRLP  234 (281)
T ss_dssp             CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHH----HTCCCC
T ss_pred             ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHh----cCCCCC
Confidence            7643221 12234456789999999998899999999999999999998 99999753321  1111111    111100


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . +.       ..+          ..+.+++.+||+.||++|||++|
T Consensus       235 ~-~~-------~~~----------~~l~~li~~~l~~~p~~Rps~~e  263 (281)
T 3cc6_A          235 K-PD-------LCP----------PVLYTLMTRCWDYDPSDRPRFTE  263 (281)
T ss_dssp             C-CT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C-CC-------CCC----------HHHHHHHHHHccCCchhCcCHHH
Confidence            0 00       001          12568999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.3e-37  Score=344.79  Aligned_cols=197  Identities=25%  Similarity=0.329  Sum_probs=162.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCC------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE------  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  803 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999986 68899999886532  223456889999999999999999999997654      


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..|+||||+++ +|.+++..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence            78999999984 78888742        278899999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |+|+.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       172 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          172 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             CC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999865432   1223457899999999999999999999999999999999999999764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-37  Score=344.54  Aligned_cols=198  Identities=27%  Similarity=0.425  Sum_probs=170.6

Q ss_pred             CCCCCeecccCCcEEEEEEEc-----CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEEE
Q 036815          736 FSAESLIGCGGFGEVFKATLK-----DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERLL  807 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  807 (1013)
                      |++.+.||+|+||+||+|.+.     +++.||||++..... ...+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999998753     578899998865432 334668999999999999999999999987  467899


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++...       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       113 v~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence            99999999999999643       288999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcc-eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          888 LISALDTH-LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       888 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      ........ .......++..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            87543322 122345678889999999998999999999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.6e-37  Score=332.87  Aligned_cols=243  Identities=21%  Similarity=0.367  Sum_probs=192.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....  .....++.+|+..+.++ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            457999999999999999999987 78999999886532  23456788999999999 999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-------------
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-------------  875 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-------------  875 (1013)
                      |||+++++|.+++......  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.+             
T Consensus        90 ~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred             EEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            9999999999999754321  13489999999999999999999999   99999999999999844             


Q ss_pred             ------CcEEEeecccceeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCC
Q 036815          876 ------MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD  948 (1013)
Q Consensus       876 ------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~  948 (1013)
                            ..+||+|||.++......      ...||+.|+|||++.+. .++.++||||+||++|||++|.+|+....   
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---  235 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---  235 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence                  479999999998765322      23589999999999765 66789999999999999999988764321   


Q ss_pred             ccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          949 TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          .+..  ...+.... +++.       .+          ..+.+++.+||+.||++|||++|
T Consensus       236 ----~~~~--~~~~~~~~-~~~~-------~~----------~~~~~li~~~l~~dp~~Rps~~~  276 (289)
T 1x8b_A          236 ----QWHE--IRQGRLPR-IPQV-------LS----------QEFTELLKVMIHPDPERRPSAMA  276 (289)
T ss_dssp             ----HHHH--HHTTCCCC-CSSC-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----HHHH--HHcCCCCC-CCcc-------cC----------HHHHHHHHHHhCCCcccCCCHHH
Confidence                1111  11111111 1111       11          12568999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-36  Score=342.84  Aligned_cols=197  Identities=29%  Similarity=0.423  Sum_probs=165.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCC------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGE------  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  803 (1013)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.....  ...+.+.+|++++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999985 689999999854322  22456889999999999999999999997653      


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..|+||||+ +++|.+++...       .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence            469999999 78999998642       288999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |+|+.....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+
T Consensus       173 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  230 (367)
T 1cm8_A          173 GLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  230 (367)
T ss_dssp             TTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999875432     234578999999999877 678999999999999999999999998643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-37  Score=332.36  Aligned_cols=247  Identities=26%  Similarity=0.442  Sum_probs=194.1

Q ss_pred             cCCCCCC-eecccCCcEEEEEEEc---CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAES-LIGCGGFGEVFKATLK---DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|.+.+ .||+|+||.||+|.+.   +++.||+|++..... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3466665 9999999999999864   577899998865432 3356789999999999999999999999 55678999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++++|.+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        88 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEeCCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence            99999999999996432     3489999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcce-eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          889 ISALDTHL-SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       889 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ........ ......+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....  .....    .+..+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~----~i~~~~~~~  233 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMA----FIEQGKRME  233 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHH----HHHTTCCCC
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHH----HHhcCCcCC
Confidence            75433221 1223456789999999998889999999999999999998 9999975432  11111    111111111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .++.       .+          ..+.+++.+||+.||++|||++|
T Consensus       234 -~~~~-------~~----------~~l~~li~~~l~~~p~~Rps~~~  262 (287)
T 1u59_A          234 -CPPE-------CP----------PELYALMSDCWIYKWEDRPDFLT  262 (287)
T ss_dssp             -CCTT-------CC----------HHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             -CCCC-------cC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence             1111       11          12568999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-37  Score=345.39  Aligned_cols=247  Identities=29%  Similarity=0.448  Sum_probs=182.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC--C--CEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEe-CCEEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD--G--SSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKI-GEERLLV  808 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  808 (1013)
                      .|++.+.||+|+||.||+|++.+  +  ..||+|.+..... ...+++.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46777899999999999998742  2  3588998754332 334678999999999999999999998754 5578999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|+|.+++....     ..+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       170 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  241 (373)
T ss_dssp             EECCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EECCCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence            99999999999996432     2378999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcc--eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          889 ISALDTH--LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       889 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      .......  .......+++.|+|||++.+..++.++|||||||++|||++ |.+||......+  ....+    ..+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~----~~~~~~  315 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL----LQGRRL  315 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHH----HTTCCC
T ss_pred             ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHH----HcCCCC
Confidence            6432211  11233457789999999999999999999999999999999 677776543222  22211    111111


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .  .+.      ..+          ..+.+++.+||+.||++|||++|
T Consensus       316 ~--~p~------~~~----------~~l~~li~~cl~~dp~~RPs~~e  345 (373)
T 3c1x_A          316 L--QPE------YCP----------DPLYEVMLKCWHPKAEMRPSFSE  345 (373)
T ss_dssp             C--CCT------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C--CCC------CCC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            0  010      011          12568999999999999999864

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6.3e-37  Score=336.70  Aligned_cols=259  Identities=35%  Similarity=0.572  Sum_probs=226.9

Q ss_pred             cccEEEeeCCccCC--CCCcccccCcchHHHHhhh-ccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeE
Q 036815          297 QLKVIDLSLNYLNG--SIPQELGKLEHLEQFIAWF-NGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWI  373 (1013)
Q Consensus       297 ~L~~L~ls~N~l~~--~~p~~l~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  373 (1013)
                      +++.|++++|.+++  .+|..++++++|+.|++++ |.+.+.+|..|+++++|++|+|++|++++.+|..+..+++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            45555555555555  5555555555555555552 55566777788888999999999999999999999999999999


Q ss_pred             EecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCC-CCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCC
Q 036815          374 SLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCS-SLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSN  452 (1013)
Q Consensus       374 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~  452 (1013)
                      +|++|.+++.+|..|..+++|++|+|++|++++.+|..+.+++ +|++|++++|++++.+|..++               
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~---------------  195 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA---------------  195 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGG---------------
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHh---------------
Confidence            9999999999999999999999999999999999999999998 999999999999887776543               


Q ss_pred             ceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCC
Q 036815          453 TLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI  532 (1013)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~  532 (1013)
                                                                           .++ |++|++++|++++.+|..++.++
T Consensus       196 -----------------------------------------------------~l~-L~~L~Ls~N~l~~~~~~~~~~l~  221 (313)
T 1ogq_A          196 -----------------------------------------------------NLN-LAFVDLSRNMLEGDASVLFGSDK  221 (313)
T ss_dssp             -----------------------------------------------------GCC-CSEEECCSSEEEECCGGGCCTTS
T ss_pred             -----------------------------------------------------CCc-ccEEECcCCcccCcCCHHHhcCC
Confidence                                                                 223 89999999999999999999999


Q ss_pred             CCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCCCCCCCCCCcccccC
Q 036815          533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYAN  612 (1013)
Q Consensus       533 ~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~  612 (1013)
                      +|++|+|++|++++.+|. +..+++|+.|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|..+++.++..+.+.|
T Consensus       222 ~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~  300 (313)
T 1ogq_A          222 NTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN  300 (313)
T ss_dssp             CCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCS
T ss_pred             CCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcC
Confidence            999999999999977766 8999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCC
Q 036815          613 NPGLCGVPLPECR  625 (1013)
Q Consensus       613 n~~lc~~~~~~~~  625 (1013)
                      |+++||.|++.|.
T Consensus       301 N~~lc~~p~~~C~  313 (313)
T 1ogq_A          301 NKCLCGSPLPACT  313 (313)
T ss_dssp             SSEEESTTSSCCC
T ss_pred             CCCccCCCCCCCC
Confidence            9999999998883

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=332.60  Aligned_cols=248  Identities=27%  Similarity=0.417  Sum_probs=194.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++...  ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4568999999999999999999987 5899999988643  235678999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.+++....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++...
T Consensus       105 ~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          105 YCGAGSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             CCTTEEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             cCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            999999999986322     2389999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...  .......|++.|+|||++.+..++.++||||+||++|+|++|+.||.....     ......... ........+
T Consensus       177 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~~~~~~~  248 (314)
T 3com_A          177 DTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----MRAIFMIPT-NPPPTFRKP  248 (314)
T ss_dssp             TTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH-SCCCCCSSG
T ss_pred             hhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhc-CCCcccCCc
Confidence            322  122345789999999999999999999999999999999999999975321     111111111 111110001


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..      .+          ..+.+++.+||+.||++|||++|
T Consensus       249 ~~------~~----------~~l~~li~~~l~~dp~~Rpt~~~  275 (314)
T 3com_A          249 EL------WS----------DNFTDFVKQCLVKSPEQRATATQ  275 (314)
T ss_dssp             GG------SC----------HHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             cc------CC----------HHHHHHHHHHccCChhhCcCHHH
Confidence            00      00          12568999999999999999864

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-36  Score=354.10  Aligned_cols=348  Identities=22%  Similarity=0.268  Sum_probs=265.8

Q ss_pred             CcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEec
Q 036815          176 LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS  255 (1013)
Q Consensus       176 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  255 (1013)
                      -+.+++++++++. +|..+.  ++++.|+|++|++++ ++...|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus        13 ~~~v~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~   88 (477)
T 2id5_A           13 DRAVLCHRKRFVA-VPEGIP--TETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR   88 (477)
T ss_dssp             TTEEECCSCCCSS-CCSCCC--TTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcCc-CCCCCC--CCCcEEECCCCccce-ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence            3567777777774 343332  467778888887773 444446777777788877777776667777777777777777


Q ss_pred             CCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCC
Q 036815          256 SNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGK  335 (1013)
Q Consensus       256 ~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~  335 (1013)
                      +|+++ .++...+.++++|++|+|++|.+++..+..|..+++|+.|++++|.+++                        .
T Consensus        89 ~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~------------------------~  143 (477)
T 2id5_A           89 SNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY------------------------I  143 (477)
T ss_dssp             SSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE------------------------E
T ss_pred             CCcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccce------------------------e
Confidence            77776 5555566667777777777777776666677777777777777776653                        3


Q ss_pred             CCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCC
Q 036815          336 IPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNC  415 (1013)
Q Consensus       336 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  415 (1013)
                      .+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|..+...
T Consensus       144 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~  223 (477)
T 2id5_A          144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG  223 (477)
T ss_dssp             CTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTT
T ss_pred             ChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccC
Confidence            45567778888889999988887666778888999999999999887777788888999999999988888888887777


Q ss_pred             CCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCcccccccccc
Q 036815          416 SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARM  495 (1013)
Q Consensus       416 ~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  495 (1013)
                      .+|++|+|++|++++ +|..                                                            
T Consensus       224 ~~L~~L~l~~n~l~~-~~~~------------------------------------------------------------  242 (477)
T 2id5_A          224 LNLTSLSITHCNLTA-VPYL------------------------------------------------------------  242 (477)
T ss_dssp             CCCSEEEEESSCCCS-CCHH------------------------------------------------------------
T ss_pred             ccccEEECcCCcccc-cCHH------------------------------------------------------------
Confidence            889999999998873 3321                                                            


Q ss_pred             ccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCccc
Q 036815          496 YSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPES  575 (1013)
Q Consensus       496 ~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~  575 (1013)
                             .+..+++|++|||++|++++..+..++.+.+|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..
T Consensus       243 -------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  315 (477)
T 2id5_A          243 -------AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV  315 (477)
T ss_dssp             -------HHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGG
T ss_pred             -------HhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhH
Confidence                   2334577999999999999877888999999999999999999888999999999999999999999777778


Q ss_pred             ccCCCcceEEECcCCCCCCcCCCCCCCCCCCcccccCCCCCCCCC
Q 036815          576 FSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVP  620 (1013)
Q Consensus       576 ~~~l~~l~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~  620 (1013)
                      |..+++|+.|+|++|++++..+....+.......+.++...|..|
T Consensus       316 ~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          316 FHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             BSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             cCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            899999999999999998765432222223334566777777654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-37  Score=342.01  Aligned_cols=256  Identities=25%  Similarity=0.386  Sum_probs=193.7

Q ss_pred             CHHHHHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEe-
Q 036815          725 KFSQLIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKI-  801 (1013)
Q Consensus       725 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  801 (1013)
                      .+.++....++|++.+.||+|+||.||+|++. +++.||+|++... ....+.+.+|+.+++++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            33444456788999999999999999999985 6889999987543 33457789999999999 89999999999977 


Q ss_pred             -----CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC
Q 036815          802 -----GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM  876 (1013)
Q Consensus       802 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  876 (1013)
                           .+..++||||+++++|.+++....    ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence                 468899999999999999997542    23488999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceeccccCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccH
Q 036815          877 EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL  951 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~  951 (1013)
                      .+||+|||++.......  .......|++.|+|||++.     +..++.++|||||||++|+|++|+.||.....     
T Consensus       167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----  239 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----  239 (326)
T ss_dssp             CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred             CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----
Confidence            99999999998654321  1223457899999999986     56788999999999999999999999965321     


Q ss_pred             HHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          952 VGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       952 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...... ............       ..+          ..+.+++.+||+.||++|||++|
T Consensus       240 ~~~~~~-~~~~~~~~~~~~-------~~~----------~~l~~li~~~l~~dp~~Rps~~~  283 (326)
T 2x7f_A          240 MRALFL-IPRNPAPRLKSK-------KWS----------KKFQSFIESCLVKNHSQRPATEQ  283 (326)
T ss_dssp             HHHHHH-HHHSCCCCCSCS-------CSC----------HHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HHHHHH-hhcCccccCCcc-------ccC----------HHHHHHHHHHhccChhhCCCHHH
Confidence            111111 111111111010       011          12568999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-36  Score=337.76  Aligned_cols=193  Identities=23%  Similarity=0.337  Sum_probs=170.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEe--CCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKI--GEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++..   ...+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            57999999999999999999975 688999998753   34577899999999997 9999999999987  66789999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-cEEEeeccccee
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMARL  888 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~  888 (1013)
                      ||+++++|.+++..         +++..++.++.|++.||+|||++   +|+||||||+||+++.++ .+||+|||+|+.
T Consensus       113 e~~~~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT---------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             ECCCCCCHHHHGGG---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eccCchhHHHHHHh---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            99999999999842         78899999999999999999999   999999999999999776 899999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ......   .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       181 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~  234 (330)
T 3nsz_A          181 YHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  234 (330)
T ss_dssp             CCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             cCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            654322   234578999999999877 67899999999999999999999999654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.2e-37  Score=333.77  Aligned_cols=248  Identities=26%  Similarity=0.427  Sum_probs=200.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC-CCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++.. .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            4578899999999999999999874 78899998754 333457789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +++++|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++....
T Consensus        91 ~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           91 MTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             CTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             CCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999975332    3489999999999999999999999   999999999999999999999999999987653


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      .. ........+++.|+|||++.+..++.++||||+|+++|+|++ |..||......  .....+.    ...... .+.
T Consensus       164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~----~~~~~~-~~~  235 (288)
T 3kfa_A          164 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLE----KDYRME-RPE  235 (288)
T ss_dssp             SS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHH----TTCCCC-CCT
T ss_pred             Cc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh----ccCCCC-CCC
Confidence            32 223334567889999999998899999999999999999999 99998764321  1111111    111000 000


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       .+          ..+.+++.+||+.||++|||++|
T Consensus       236 ~-------~~----------~~l~~li~~~l~~dp~~Rps~~~  261 (288)
T 3kfa_A          236 G-------CP----------EKVYELMRACWQWNPSDRPSFAE  261 (288)
T ss_dssp             T-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C-------CC----------HHHHHHHHHHhCCChhhCcCHHH
Confidence            0       11          12568999999999999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.2e-37  Score=341.51  Aligned_cols=254  Identities=28%  Similarity=0.400  Sum_probs=194.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE------cCCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATL------KDGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++.... .....++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            35799999999999999999984      257789999885432 23446789999999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCC-CCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCcEEEe
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKAR-DQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EMEARVS  881 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~  881 (1013)
                      |+||||+++++|.+++....... ....+++..++.++.|++.||+|||++   +|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999997654321 224489999999999999999999999   9999999999999984   4469999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHh
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVR  960 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  960 (1013)
                      |||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||.....     .+.... +.
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~-~~  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEF-VT  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHH-HH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----HHHHHH-Hh
Confidence            9999986544333333344567889999999998899999999999999999998 9999875321     111111 11


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+.... ..+       ..+          ..+.+++.+||+.||++|||++|
T Consensus       260 ~~~~~~-~~~-------~~~----------~~l~~li~~~l~~dp~~Rps~~~  294 (327)
T 2yfx_A          260 SGGRMD-PPK-------NCP----------GPVYRIMTQCWQHQPEDRPNFAI  294 (327)
T ss_dssp             TTCCCC-CCT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCCC-CCC-------CCC----------HHHHHHHHHHhcCChhhCcCHHH
Confidence            111111 000       011          12568999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.8e-37  Score=333.77  Aligned_cols=250  Identities=26%  Similarity=0.355  Sum_probs=195.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  807 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+  +...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357899999999999999999986 68999999886533  2234668999999999999999999998854  568899


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCcccEEeCCCCcEEEee
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH-----IIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      ||||+++++|.+++.....  ....+++..++.++.|++.||+|||+.   +     |+||||||+||+++.++.+||+|
T Consensus        85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred             EEeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            9999999999999975432  223489999999999999999999999   8     99999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      ||.++.......  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.....     .... ..+..+
T Consensus       160 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~-~~i~~~  231 (279)
T 2w5a_A          160 FGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELA-GKIREG  231 (279)
T ss_dssp             CCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-HHHHHT
T ss_pred             Cchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHH-HHHhhc
Confidence            999976543221  12235689999999999998999999999999999999999999975421     1111 112222


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .... ++..       .+          ..+.+++.+||+.||++|||++|
T Consensus       232 ~~~~-~~~~-------~~----------~~l~~li~~~l~~~p~~Rps~~~  264 (279)
T 2w5a_A          232 KFRR-IPYR-------YS----------DELNEIITRMLNLKDYHRPSVEE  264 (279)
T ss_dssp             CCCC-CCTT-------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cccc-CCcc-------cC----------HHHHHHHHHHcCCCcccCCCHHH
Confidence            2111 1110       11          12568999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.4e-37  Score=335.35  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=191.7

Q ss_pred             hcCCCCCC-eecccCCcEEEEEEEc---CCCEEEEEEeeccCcc--chHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          733 TNGFSAES-LIGCGGFGEVFKATLK---DGSSVAIKKLIRLSCQ--GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       733 ~~~y~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      .++|++.+ .||+|+||.||+|.+.   +++.||||++......  ..+++.+|++++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677877 9999999999999653   4678999988654322  246789999999999999999999998 567789


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        94 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            9999999999999997532      388999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcce-eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          887 RLISALDTHL-SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       887 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      +......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....     .. +...+..+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~-~~~~~~~~~~  238 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SE-VTAMLEKGER  238 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-HHHHHHTTCC
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HH-HHHHHHcCCC
Confidence            8765433221 1223456788999999998889999999999999999999 9999975331     11 1111222111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. .++.       .+          ..+.+++.+||+.||++|||++|
T Consensus       239 ~~-~~~~-------~~----------~~l~~li~~~l~~dp~~Rps~~~  269 (291)
T 1xbb_A          239 MG-CPAG-------CP----------REMYDLMNLCWTYDVENRPGFAA  269 (291)
T ss_dssp             CC-CCTT-------CC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CC-CCCC-------CC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            11 0110       11          12568999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.1e-37  Score=343.12  Aligned_cols=266  Identities=19%  Similarity=0.265  Sum_probs=198.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccc-----------------hHHHHHHHHHHhccCCcceeee
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG-----------------DREFMAEMETLGKIKHRNLVPL  795 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  795 (1013)
                      .++|++.+.||+|+||.||+|++ +++.||+|++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36799999999999999999999 89999999886432211                 1789999999999999999999


Q ss_pred             ccEEEeCCEEEEEEEcccCCCHHHHhcccccC--CCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEe
Q 036815          796 LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA--RDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLL  872 (1013)
Q Consensus       796 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill  872 (1013)
                      ++++.+.+..++||||+++++|.+++......  .....+++..++.++.|++.||+|||+ .   +|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence            99999999999999999999999983321111  113458999999999999999999999 8   99999999999999


Q ss_pred             CCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCC-CCCc-cchhHhHHHHHHHHHcCCCCCCCCCCCCcc
Q 036815          873 DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTA-KGDVYSFGVVLLELLTGKRPTDKDDFGDTN  950 (1013)
Q Consensus       873 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~pf~~~~~~~~~  950 (1013)
                      +.++.+||+|||.++.....    ......|++.|+|||++.+. .++. ++||||+||++|||++|+.||......   
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---  258 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---  258 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence            99999999999999876432    23456789999999999877 6666 999999999999999999999864321   


Q ss_pred             HHHHHHHHHhcCccccccCh--hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          951 LVGWVKMKVREGKQMEVIDP--ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       951 ~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .+.... +..+......+.  ..........  ..........+.+++.+||+.||++|||++|
T Consensus       259 -~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  319 (348)
T 2pml_X          259 -VELFNN-IRTKNIEYPLDRNHFLYPLTNKKS--TCSNNFLSNEDIDFLKLFLRKNPAERITSED  319 (348)
T ss_dssp             -HHHHHH-HTSCCCCCCCSSSSSTTTTCC----------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             -HHHHHH-HhccCcCCccchhhhhcccccccc--ccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence             111111 111111100000  0000000000  0000000123568999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.8e-37  Score=343.84  Aligned_cols=207  Identities=23%  Similarity=0.354  Sum_probs=170.2

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccc-----------hHHHHHHHHHHhccCCcceee
Q 036815          726 FSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQG-----------DREFMAEMETLGKIKHRNLVP  794 (1013)
Q Consensus       726 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  794 (1013)
                      +.++....++|++.+.||+|+||.||+|++.+++.||||++.......           .+.+.+|++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            456777889999999999999999999999889999999885432211           267899999999999999999


Q ss_pred             eccEEEe-----CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCccc
Q 036815          795 LLGYCKI-----GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSN  869 (1013)
Q Consensus       795 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  869 (1013)
                      +++++..     ....|+||||++ |+|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  164 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN  164 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence            9999854     336799999998 68888886432     3489999999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          870 VLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       870 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |+++.++.+||+|||+++......   ......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             EEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            999999999999999997543322   2234578999999999876 67899999999999999999999999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-36  Score=333.60  Aligned_cols=248  Identities=28%  Similarity=0.442  Sum_probs=189.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCC----CEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEE-eCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDG----SSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCK-IGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l  807 (1013)
                      .+|++.+.||+|+||.||+|++.++    ..||+|.+..... ...+.+.+|++++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4688899999999999999987532    2588888765332 23467899999999999999999999865 4567899


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       105 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             EEeCCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            999999999999996432     3378999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCc--ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          888 LISALDT--HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       888 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      .......  ........+|+.|+|||.+.+..++.++||||+||++|||++ |.+||......+  .....   . .+..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~---~-~~~~  250 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL---L-QGRR  250 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHH---H-TTCC
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHH---h-cCCC
Confidence            7643221  122334567889999999999999999999999999999999 555655433221  11111   1 1111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .  ..+.      ..+          ..+.+++.+||+.||++|||++|
T Consensus       251 ~--~~~~------~~~----------~~l~~li~~~l~~~p~~Rps~~e  281 (298)
T 3f66_A          251 L--LQPE------YCP----------DPLYEVMLKCWHPKAEMRPSFSE  281 (298)
T ss_dssp             C--CCCT------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C--CCCc------cCC----------HHHHHHHHHHcCCChhhCcCHHH
Confidence            0  0000      001          12568999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.6e-37  Score=338.64  Aligned_cols=248  Identities=26%  Similarity=0.371  Sum_probs=190.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--------cchHHHHHHHHHHhccCCcceeeeccEEEeCC
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--------QGDREFMAEMETLGKIKHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  803 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||||.+.....        .....+.+|++++++++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            457999999999999999999986 578999998754321        11235789999999999999999999987655


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc---EEE
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARV  880 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl  880 (1013)
                       .|+||||+++++|.+++...      ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.   +||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             -eEEEEecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEE
Confidence             89999999999999998643      2389999999999999999999999   9999999999999987654   999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      +|||+++......   ......||+.|+|||++.   +..++.++|||||||++|+|++|+.||........ ....+. 
T Consensus       159 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~-  233 (322)
T 2ycf_A          159 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQIT-  233 (322)
T ss_dssp             CCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHH-
T ss_pred             ccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHH-
Confidence            9999998764321   123456899999999973   56788999999999999999999999976443222 222111 


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         .+...  ..+...   ...          ...+.+++.+||+.||++|||++|
T Consensus       234 ---~~~~~--~~~~~~---~~~----------~~~~~~li~~~l~~dP~~Rps~~~  271 (322)
T 2ycf_A          234 ---SGKYN--FIPEVW---AEV----------SEKALDLVKKLLVVDPKARFTTEE  271 (322)
T ss_dssp             ---HTCCC--CCHHHH---TTS----------CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ---hCccc--cCchhh---hhc----------CHHHHHHHHHHcccCHhhCCCHHH
Confidence               11110  011110   000          123568999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-36  Score=341.39  Aligned_cols=202  Identities=25%  Similarity=0.388  Sum_probs=172.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeC-----CEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIG-----EER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  805 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999986 6788999988643322 236788999999999999999999998764     368


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      |+||||++ |+|.+++...       .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEcccC-cCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            99999998 5999988642       289999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcce-eeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          886 ARLISALDTHL-SVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       886 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ++......... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  236 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  236 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence            98765432211 1234578999999998654 458999999999999999999999997654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-36  Score=336.54  Aligned_cols=248  Identities=26%  Similarity=0.442  Sum_probs=188.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-----CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-----GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.+.||+|+||.||+|++..     +..||+|.+..... .....+.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467788999999999999998753     23599998864332 234568899999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       124 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            999999999999996532     2389999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcc-eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          888 LISALDTH-LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       888 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      ........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....     .+... .+..+...
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~-~~~~~~~~  269 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMK-AINDGFRL  269 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH-HHHTTCCC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHHH-HHHCCCcC
Confidence            76532211 11223446788999999999999999999999999999999 9999975321     11111 11111111


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. +..       .          ...+.+++.+||+.||++|||++|
T Consensus       270 ~~-~~~-------~----------~~~l~~li~~~l~~~p~~Rps~~~  299 (333)
T 1mqb_A          270 PT-PMD-------C----------PSAIYQLMMQCWQQERARRPKFAD  299 (333)
T ss_dssp             CC-CTT-------C----------BHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CC-ccc-------C----------CHHHHHHHHHHcCCChhhCcCHHH
Confidence            00 000       0          012568999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-36  Score=343.69  Aligned_cols=201  Identities=22%  Similarity=0.344  Sum_probs=167.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeC-------
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG-------  802 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  802 (1013)
                      ...++|++.+.||+|+||+||+|++. +++.||+|++.....    ...+|+++++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            45678999999999999999999985 689999998864322    234799999999999999999998543       


Q ss_pred             -------------------------------CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHH
Q 036815          803 -------------------------------EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF  851 (1013)
Q Consensus       803 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~  851 (1013)
                                                     ...++||||++ |+|.+.+.....  ....+++..++.++.|+++||+|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHH
Confidence                                           34789999999 588887764322  22348999999999999999999


Q ss_pred             HHhcCCCCeEecCCCcccEEeC-CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHH
Q 036815          852 LHHNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGV  929 (1013)
Q Consensus       852 LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~  929 (1013)
                      ||++   +|+||||||+||+++ .++.+||+|||+|+.......   .....+|+.|+|||++.+. .++.++||||+||
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            9999   999999999999997 688999999999987644322   2345689999999998765 4899999999999


Q ss_pred             HHHHHHcCCCCCCCC
Q 036815          930 VLLELLTGKRPTDKD  944 (1013)
Q Consensus       930 il~elltg~~pf~~~  944 (1013)
                      ++|||++|+.||.+.
T Consensus       231 il~ell~g~~pf~~~  245 (383)
T 3eb0_A          231 VFGELILGKPLFSGE  245 (383)
T ss_dssp             HHHHHHHSSCSSCCS
T ss_pred             HHHHHHhCCCCCCCC
Confidence            999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-36  Score=333.69  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=196.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---------cchHHHHHHHHHHhccC-CcceeeeccEEEe
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---------QGDREFMAEMETLGKIK-HRNLVPLLGYCKI  801 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  801 (1013)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++.....         ...+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            467999999999999999999986 578999998864321         12356789999999995 9999999999999


Q ss_pred             CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEe
Q 036815          802 GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVS  881 (1013)
Q Consensus       802 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  881 (1013)
                      ++..++||||+++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence            999999999999999999997532      389999999999999999999999   99999999999999999999999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCccccc------CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHH
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ------SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWV  955 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~  955 (1013)
                      |||.++......   ......+++.|+|||++.      ...++.++||||+|+++|||++|+.||....     .....
T Consensus       167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~  238 (298)
T 1phk_A          167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLML  238 (298)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH
T ss_pred             cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-----HHHHH
Confidence            999998765322   223456899999999985      4568899999999999999999999997532     11111


Q ss_pred             HHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          956 KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       956 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..... +.... ..+..    ...          ...+.+++.+||+.||++|||++|
T Consensus       239 ~~~~~-~~~~~-~~~~~----~~~----------~~~l~~li~~~l~~dp~~Rps~~~  280 (298)
T 1phk_A          239 RMIMS-GNYQF-GSPEW----DDY----------SDTVKDLVSRFLVVQPQKRYTAEE  280 (298)
T ss_dssp             HHHHH-TCCCC-CTTTG----GGS----------CHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HHHhc-CCccc-Ccccc----ccc----------CHHHHHHHHHHccCCcccCCCHHH
Confidence            11111 11100 00000    000          112568999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-36  Score=332.68  Aligned_cols=248  Identities=26%  Similarity=0.385  Sum_probs=190.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEcC-C---CEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEE-EEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLKD-G---SSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER-LLV  808 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  808 (1013)
                      .|.+.++||+|+||+||+|++.+ +   ..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667899999999999998643 2   2699998765333 2346788999999999999999999999876655 999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+.+|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       102 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EecccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            99999999999996532     3478999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCc--ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          889 ISALDT--HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       889 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ......  ........+++.|+|||.+.+..++.++||||+||++|+|++|..|+..... .......+.    ......
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~----~~~~~~  248 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLA----QGRRLP  248 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHH----TTCCCC
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhh----cCCCCC
Confidence            543221  1222345678899999999999999999999999999999996665443221 111121111    111110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . +.       ..+          ..+.+++.+||+.||++|||++|
T Consensus       249 ~-~~-------~~~----------~~l~~li~~~l~~~p~~Rps~~~  277 (298)
T 3pls_A          249 Q-PE-------YCP----------DSLYQVMQQCWEADPAVRPTFRV  277 (298)
T ss_dssp             C-CT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C-Cc-------cch----------HHHHHHHHHHccCChhhCcCHHH
Confidence            0 00       001          12568999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=337.81  Aligned_cols=202  Identities=26%  Similarity=0.426  Sum_probs=173.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-----cCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCC--EEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATL-----KDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE--ERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  806 (1013)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5688999999999999999984     358899999987655555678999999999999999999999987644  679


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||+++++|.+++....     ..+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       121 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             EEECCCTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             EEEECCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence            9999999999999997542     2388999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCccee-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          887 RLISALDTHLS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       887 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      +.......... .....++..|+|||++.+..++.++||||+||++|||++|..||..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            87754332211 2234567789999999988899999999999999999999999763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.2e-36  Score=335.78  Aligned_cols=250  Identities=28%  Similarity=0.452  Sum_probs=192.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCE--EEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSS--VAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|++. ++..  ||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            46899999999999999999976 4554  4888876432 23345689999999999 899999999999999999999


Q ss_pred             EEcccCCCHHHHhccccc----------CCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          809 YEFMKFGSLEEVLHGRAK----------ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      |||+++++|.+++.....          ......+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            999999999999975431          01223589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  957 (1013)
                      ||+|||+++....   ........+++.|+|||++.+..++.++||||+||++|||++ |+.||.....     .+... 
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~-  252 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYE-  252 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH-
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHHHH-
Confidence            9999999974322   111233457889999999998889999999999999999998 9999975431     11111 


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+..+.... .+..       .+          ..+.+++.+||+.||++|||++|
T Consensus       253 ~~~~~~~~~-~~~~-------~~----------~~l~~li~~~l~~dp~~Rps~~e  290 (327)
T 1fvr_A          253 KLPQGYRLE-KPLN-------CD----------DEVYDLMRQCWREKPYERPSFAQ  290 (327)
T ss_dssp             HGGGTCCCC-CCTT-------BC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HhhcCCCCC-CCCC-------CC----------HHHHHHHHHHccCChhhCcCHHH
Confidence            122111110 0000       00          12568999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-36  Score=341.86  Aligned_cols=197  Identities=29%  Similarity=0.431  Sum_probs=153.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeC------C
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIG------E  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  803 (1013)
                      .++|++.+.||+|+||.||+|++. +|+.||||++....  ....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            368999999999999999999975 68899999885432  22346788999999999999999999998654      5


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      ..|+|+|++ +++|.+++..       ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCEEEEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             eEEEEeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence            679999999 5899988853       2389999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |+++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+
T Consensus       177 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  234 (367)
T 2fst_X          177 GLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  234 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999865421     234578999999999876 678999999999999999999999997643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.5e-37  Score=361.43  Aligned_cols=247  Identities=29%  Similarity=0.441  Sum_probs=196.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++|++.+.||+|+||.||+|++.++..||||++.... ...++|.+|++++++++||||+++++++.+ +..|+||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            35688899999999999999999888889999886533 345789999999999999999999999866 6789999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++.....    ..+++..++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||+++.....
T Consensus       344 ~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          344 SKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             TTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             cCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            99999999964321    2388999999999999999999999   9999999999999999999999999999865421


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      . ........++..|+|||++.+..++.++|||||||++|||++ |+.||.....     .+... .+..+..... ++.
T Consensus       417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~~~~~-~i~~~~~~~~-~~~  488 (535)
T 2h8h_A          417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLD-QVERGYRMPC-PPE  488 (535)
T ss_dssp             H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----HHHHH-HHHTTCCCCC-CTT
T ss_pred             c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH-HHHcCCCCCC-CCC
Confidence            1 111123346778999999998899999999999999999999 9999975321     11111 1222211110 100


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             ..          ..+.+++.+||+.||++|||++|
T Consensus       489 -------~~----------~~l~~li~~cl~~dP~~RPt~~~  513 (535)
T 2h8h_A          489 -------CP----------ESLHDLMCQCWRKEPEERPTFEY  513 (535)
T ss_dssp             -------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -------CC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence                   11          12568999999999999999863

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.8e-36  Score=345.48  Aligned_cols=251  Identities=22%  Similarity=0.296  Sum_probs=194.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCC-cceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH-RNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.++||+|+||.||+|++. +++.||||++.....  ..++.+|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            468999999999999999999975 689999997654332  3457899999999976 556666666777889999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe---CCCCcEEEeecccce
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL---DHEMEARVSDFGMAR  887 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~  887 (1013)
                      |+ +++|.+++....     ..+++..++.|+.||+.||+|||++   +||||||||+||++   +.++.+||+|||+++
T Consensus        84 ~~-g~sL~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             CC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CC-CCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            99 899999996432     2389999999999999999999999   99999999999999   588999999999998


Q ss_pred             eccccCcce-----eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCcc--HHHHHHHHHh
Q 036815          888 LISALDTHL-----SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN--LVGWVKMKVR  960 (1013)
Q Consensus       888 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~  960 (1013)
                      .+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  +..+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            875433221     123567999999999999999999999999999999999999999875432211  1111111111


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ....     .+   .....          ..+.+++.+||+.||++||+++|
T Consensus       235 -~~~~-----~l---~~~~p----------~~l~~li~~cl~~dP~~RPs~~e  268 (483)
T 3sv0_A          235 -TSIE-----AL---CRGYP----------TEFASYFHYCRSLRFDDKPDYSY  268 (483)
T ss_dssp             -SCHH-----HH---HTTSC----------HHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             -ccHH-----HH---hcCCc----------HHHHHHHHHHhcCChhhCcCHHH
Confidence             0000     00   01111          13678999999999999999753

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.3e-37  Score=348.43  Aligned_cols=250  Identities=10%  Similarity=0.035  Sum_probs=174.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhcc--CCcceeeec-------cEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKI--KHRNLVPLL-------GYCK  800 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~  800 (1013)
                      .+|++.+.||+|+||.||+|++. +++.||+|++.....   ...+.+.+|+++++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888999999999999999986 688999999876443   2235577885544444  699988755       4444


Q ss_pred             eC-----------------CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHH------HHHHHHHHHHHHHHHhcCC
Q 036815          801 IG-----------------EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDAR------KKIARGAAKGLCFLHHNCI  857 (1013)
Q Consensus       801 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~  857 (1013)
                      ..                 ...|+||||++ |+|.+++.....     .+++..+      ..++.||+.||+|||++  
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--  213 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK--  213 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence            33                 34799999999 899999976432     1344444      67789999999999999  


Q ss_pred             CCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHH
Q 036815          858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELL  935 (1013)
Q Consensus       858 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell  935 (1013)
                       +|+||||||+||+++.++.+||+|||+|+.....     .....+|+.|+|||++.+  ..++.++|||||||++|||+
T Consensus       214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell  287 (371)
T 3q60_A          214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW  287 (371)
T ss_dssp             -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred             -CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence             9999999999999999999999999999875421     124467799999999987  78999999999999999999


Q ss_pred             cCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          936 TGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       936 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +|+.||..........  |...............+.    ....+          ..+.+++.+||+.||++|||++|
T Consensus       288 tg~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~----------~~~~~li~~~L~~dP~~Rpt~~e  349 (371)
T 3q60_A          288 CLFLPFGLVTPGIKGS--WKRPSLRVPGTDSLAFGS----CTPLP----------DFVKTLIGRFLNFDRRRRLLPLE  349 (371)
T ss_dssp             HSSCSTTBCCTTCTTC--CCBCCTTSCCCCSCCCTT----SSCCC----------HHHHHHHHHHTCSSTTTCCCHHH
T ss_pred             hCCCCCCCcCcccccc--hhhhhhhhccccccchhh----ccCCC----------HHHHHHHHHHcCCChhhCCCHHH
Confidence            9999998753321100  000000000000000000    00111          12568999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.3e-37  Score=335.52  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=180.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            468999999999999999999875 68899999875432 2334668899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccC--CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          811 FMKFGSLEEVLHGRAKA--RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |+++++|.+++......  .....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++.
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            99999999998642211  1233489999999999999999999999   999999999999999999999999999976


Q ss_pred             ccccCc---ceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          889 ISALDT---HLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       889 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      ......   ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......  .   ..........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~~~~~~~  245 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--V---LMLTLQNDPP  245 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--H---HHHHHTSSCC
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--H---HHHHhccCCC
Confidence            543221   111234578999999999875 568899999999999999999999997643211  1   1111111100


Q ss_pred             -c-c-ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 -M-E-VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 -~-~-~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       . . ..++..   ....+          ..+.+++.+||+.||++|||++|
T Consensus       246 ~~~~~~~~~~~---~~~~~----------~~~~~li~~~l~~dp~~Rps~~~  284 (303)
T 2vwi_A          246 SLETGVQDKEM---LKKYG----------KSFRKMISLCLQKDPEKRPTAAE  284 (303)
T ss_dssp             CTTC-----CC---CCCCC----------HHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             ccccccccchh---hhhhh----------HHHHHHHHHHccCChhhCcCHHH
Confidence             0 0 000000   01111          12568999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-36  Score=332.19  Aligned_cols=251  Identities=23%  Similarity=0.307  Sum_probs=180.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc-ch-HHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ-GD-REFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...... .. +.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            367999999999999999999985 6889999988653222 22 23445555678889999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++ |+|.+++.....  ....+++..++.++.|++.||+|||+++  +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             ECCS-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             ehhc-cchHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9998 588888754322  1234899999999999999999999852  8999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccc----cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYY----QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      ....   ......||+.|+|||++    .+..++.++||||+||++|||++|+.||.......   . ........... 
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~-~~~~~~~~~~~-  232 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF---Q-QLKQVVEEPSP-  232 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH---H-HHHHHHHSCCC-
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH---H-HHHHHhccCCC-
Confidence            4322   22334689999999996    56678999999999999999999999997532211   1 11111111111 


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ......       .+          ..+.+++.+||+.||++|||++|
T Consensus       233 ~~~~~~-------~~----------~~~~~li~~~l~~~p~~Rpt~~e  263 (290)
T 3fme_A          233 QLPADK-------FS----------AEFVDFTSQCLKKNSKERPTYPE  263 (290)
T ss_dssp             CCCTTT-------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             Cccccc-------CC----------HHHHHHHHHHhhcChhhCcCHHH
Confidence            000000       01          12568999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-36  Score=335.63  Aligned_cols=250  Identities=21%  Similarity=0.289  Sum_probs=189.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc--cchHHHHHHHHHHhccC--CcceeeeccEEEeCCEEE
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC--QGDREFMAEMETLGKIK--HRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~  806 (1013)
                      ...++|++.+.||+|+||.||+|++.+++.||+|++.....  ...+.+.+|++++++++  ||||+++++++..++..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            34567999999999999999999998899999998864332  23467899999999997  599999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||| +.+++|.+++....      .+++..++.++.|+++||+|||++   +|+||||||+||++++ +.+||+|||++
T Consensus       105 lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~  173 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIA  173 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred             EEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccc
Confidence            9999 56789999997543      378999999999999999999999   9999999999999964 89999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccC-----------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHH
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQS-----------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWV  955 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~  955 (1013)
                      +...............|++.|+|||++.+           ..++.++|||||||++|||++|+.||.....    .....
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~  249 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKL  249 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----HHHHH
Confidence            87654333323345578999999999875           4688899999999999999999999975321    11111


Q ss_pred             HHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          956 KMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       956 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ........... .+.       ...          ..+.+++.+||+.||++|||++|
T Consensus       250 ~~~~~~~~~~~-~~~-------~~~----------~~l~~li~~~l~~dp~~Rps~~e  289 (313)
T 3cek_A          250 HAIIDPNHEIE-FPD-------IPE----------KDLQDVLKCCLKRDPKQRISIPE  289 (313)
T ss_dssp             HHHHCTTSCCC-CCC-------CSC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHhcccccC-Ccc-------cch----------HHHHHHHHHHccCCcccCcCHHH
Confidence            11111111100 000       000          12568999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.5e-36  Score=343.13  Aligned_cols=199  Identities=27%  Similarity=0.334  Sum_probs=164.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCC------EEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGE------ERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  807 (1013)
                      .+|++.+.||+|+||+||+|++..+..||+|++......    ..+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468999999999999999999987778999998653322    236999999999999999999986533      3789


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC-CCCcEEEeecccc
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD-HEMEARVSDFGMA  886 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a  886 (1013)
                      ||||++++. .+.+.....  ....+++..++.++.|+++||+|||++   +|+||||||+||+++ .++.+||+|||+|
T Consensus       116 v~e~~~~~l-~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          116 VLEYVPETV-YRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEECCSEEH-HHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EeeccCccH-HHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            999999654 433332111  123489999999999999999999999   999999999999999 7899999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +.......   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..
T Consensus       190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  246 (394)
T 4e7w_A          190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES  246 (394)
T ss_dssp             EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            87643322   2345789999999998765 58999999999999999999999998643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.1e-37  Score=342.49  Aligned_cols=200  Identities=27%  Similarity=0.430  Sum_probs=161.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHH--HhccCCcceeeeccEEEe-----CCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMET--LGKIKHRNLVPLLGYCKI-----GEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|+. +++.||||++...   ....+..|.++  +..++||||+++++++..     ....+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            5799999999999999999987 5899999987542   23444455555  445899999999986543     23678


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCcccEEeCCCCcEEE
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC------IPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                      +||||+++|+|.+++....       .++..++.++.|+++||+|||+.+      .++|+||||||+||+++.++.+||
T Consensus        89 lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            9999999999999996432       588899999999999999999863      238999999999999999999999


Q ss_pred             eecccceeccccCc------ceeeeeeccCCCccCcccccC-------CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          881 SDFGMARLISALDT------HLSVSTLAGTPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +|||+|+.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||...
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            99999987653221      112224569999999999986       45678999999999999999997776543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-36  Score=329.53  Aligned_cols=241  Identities=29%  Similarity=0.467  Sum_probs=186.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeC-CEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG-EERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||.||+|++. ++.||+|.+...  ...+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            56899999999999999999885 889999987543  3456789999999999999999999987654 4789999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++++|.+++....    ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        98 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           98 AKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             TTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             CCCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            9999999996532    12378899999999999999999999   9999999999999999999999999999765432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                           .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||......  ..   .. ....+.... .+. 
T Consensus       171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~---~~-~~~~~~~~~-~~~-  237 (278)
T 1byg_A          171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DV---VP-RVEKGYKMD-APD-  237 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GH---HH-HHTTTCCCC-CCT-
T ss_pred             -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HH---HH-HHhcCCCCC-Ccc-
Confidence                 123457889999999998899999999999999999998 99999764321  11   11 111111110 000 


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..+          ..+.+++.+||+.||++|||++|
T Consensus       238 ------~~~----------~~l~~li~~~l~~~p~~Rps~~~  263 (278)
T 1byg_A          238 ------GCP----------PAVYEVMKNCWHLDAAMRPSFLQ  263 (278)
T ss_dssp             ------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------cCC----------HHHHHHHHHHhcCChhhCCCHHH
Confidence                  111          12568999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=338.05  Aligned_cols=246  Identities=25%  Similarity=0.327  Sum_probs=177.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEE--------eCC
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCK--------IGE  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~  803 (1013)
                      .+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            57899999999999999999986 68999999987665556677899999999996 999999999984        334


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCcccEEeCCCCcEEEe
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH--IIHRDMKSSNVLLDHEMEARVS  881 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~  881 (1013)
                      ..++||||++ |+|.+++.....   ...+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||+
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             eEEEEEEecC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence            5799999997 799998864322   23489999999999999999999998   8  9999999999999999999999


Q ss_pred             ecccceeccccCcce----------eeeeeccCCCccCcccc---cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC
Q 036815          882 DFGMARLISALDTHL----------SVSTLAGTPGYVPPEYY---QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGD  948 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~  948 (1013)
                      |||+++.........          ......||+.|+|||++   .+..++.++|||||||++|||++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            999998765422211          11134589999999998   56778999999999999999999999997532211


Q ss_pred             ccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          949 TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ....... ........+                     .+.+++.+||+.||++|||++|
T Consensus       261 -----~~~~~~~-~~~~~~~~~---------------------~~~~li~~~l~~~p~~Rps~~e  298 (337)
T 3ll6_A          261 -----IVNGKYS-IPPHDTQYT---------------------VFHSLIRAMLQVNPEERLSIAE  298 (337)
T ss_dssp             ----------CC-CCTTCCSSG---------------------GGHHHHHHHSCSSGGGSCCHHH
T ss_pred             -----hhcCccc-CCcccccch---------------------HHHHHHHHHccCChhhCcCHHH
Confidence                 1111000 000000000                     1458999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-36  Score=360.63  Aligned_cols=245  Identities=26%  Similarity=0.442  Sum_probs=188.7

Q ss_pred             CCCCC-eecccCCcEEEEEEEc---CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          736 FSAES-LIGCGGFGEVFKATLK---DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       736 y~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +.+.+ .||+|+||.||+|.+.   ++..||||++..... ...+++.+|++++++++||||+++++++.. +..++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            33444 7999999999999875   456799998865432 345789999999999999999999999876 56899999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++|+|.+++....     ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+...
T Consensus       416 ~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             CCTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             eCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999999999996432     3489999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcce-eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          891 ALDTHL-SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       891 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      ...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....  ....    ..+..+..... 
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~----~~i~~~~~~~~-  560 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVM----AFIEQGKRMEC-  560 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHH----HHHHTTCCCCC-
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHH----HHHHcCCCCCC-
Confidence            332211 1223345689999999998999999999999999999998 9999976432  1111    12222221111 


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ++.       ..          ..+.+++.+||+.||++|||++|
T Consensus       561 p~~-------~~----------~~l~~li~~cl~~dP~~RPs~~~  588 (613)
T 2ozo_A          561 PPE-------CP----------PELYALMSDCWIYKWEDRPDFLT  588 (613)
T ss_dssp             CTT-------CC----------HHHHHHHHHTTCSSTTTSCCHHH
T ss_pred             CCc-------CC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            110       11          12568999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=348.64  Aligned_cols=205  Identities=23%  Similarity=0.349  Sum_probs=156.5

Q ss_pred             CCCC-CCeecccCCcEEEEEEEc---CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEEEE
Q 036815          735 GFSA-ESLIGCGGFGEVFKATLK---DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERLLV  808 (1013)
Q Consensus       735 ~y~~-~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  808 (1013)
                      .|++ .++||+|+||+||+|+++   +++.||+|++...  .....+.+|++++++++||||+++++++..  +...|+|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4665 568999999999999976   4788999988543  234578899999999999999999999955  6789999


Q ss_pred             EEcccCCCHHHHhcccccC---CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe----CCCCcEEEe
Q 036815          809 YEFMKFGSLEEVLHGRAKA---RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL----DHEMEARVS  881 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~  881 (1013)
                      |||++ ++|.+++......   .....+++..++.++.||+.||+|||++   +|+||||||+||++    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99998 5888877533211   1223489999999999999999999999   99999999999999    677899999


Q ss_pred             ecccceeccccCc-ceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          882 DFGMARLISALDT-HLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       882 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |||+|+.+..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999987653221 1223456789999999998874 58999999999999999999999997654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-36  Score=331.67  Aligned_cols=248  Identities=24%  Similarity=0.375  Sum_probs=186.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc--CCC--EEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK--DGS--SVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|++.  +++  .||+|++....   ....+.+.+|++++++++||||+++++++.++. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            56899999999999999999864  233  68999875432   233467899999999999999999999987655 88


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||+++++|.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        97 ~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eeEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence            9999999999999997532     2388999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcce-eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          887 RLISALDTHL-SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       887 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      +......... ......++..|+|||++.+..++.++||||+|+++|||++ |+.||....     ..+...........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~~  243 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQILHKIDKEGER  243 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTSCCC
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-----HHHHHHHHHccCCC
Confidence            8775433222 2233457788999999998889999999999999999999 999997543     12222222221111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. ...       ..+          ..+.+++.+||+.||++|||++|
T Consensus       244 ~~-~~~-------~~~----------~~l~~li~~~l~~~p~~Rps~~~  274 (291)
T 1u46_A          244 LP-RPE-------DCP----------QDIYNVMVQCWAHKPEDRPTFVA  274 (291)
T ss_dssp             CC-CCT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CC-CCc-------CcC----------HHHHHHHHHHccCCcccCcCHHH
Confidence            11 000       011          12568999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-36  Score=341.22  Aligned_cols=207  Identities=26%  Similarity=0.318  Sum_probs=159.5

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCE---
Q 036815          729 LIEATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE---  804 (1013)
Q Consensus       729 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  804 (1013)
                      .....++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|++.++.++||||+++++++...+.   
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            3455689999999999999999999986 68999999885533 233456778888899999999999999866332   


Q ss_pred             ----EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCcccEEeCC-CCc
Q 036815          805 ----RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH--HNCIPHIIHRDMKSSNVLLDH-EME  877 (1013)
Q Consensus       805 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~Nill~~-~~~  877 (1013)
                          .++||||+++ ++.+.+.....  ....+++..+..++.|++.|+.|||  ++   +|+||||||+||+++. ++.
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence                7899999996 55555432211  2234889999999999999999999  88   9999999999999997 899


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  236 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN  236 (360)
T ss_dssp             EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence            99999999987654322   2345689999999998654 48999999999999999999999998643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.6e-36  Score=328.45  Aligned_cols=247  Identities=25%  Similarity=0.392  Sum_probs=195.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            457999999999999999999986 68999999886532  234577899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC---CcEEEeecccc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE---MEARVSDFGMA  886 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a  886 (1013)
                      ||+++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.+   +.+||+|||++
T Consensus       101 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             CCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999886533      388999999999999999999999   99999999999999764   46999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +.......   .....+++.|+|||++.+ .++.++||||+|+++|+|++|+.||....     ....... +..+....
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~-~~~~~~~~  241 (287)
T 2wei_A          172 TCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----EYDILKR-VETGKYAF  241 (287)
T ss_dssp             GTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH-HHHCCCCC
T ss_pred             eeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-----HHHHHHH-HHcCCCCC
Confidence            86543221   223458889999999876 48899999999999999999999997532     1111221 11111110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. +..    ...+          ..+.+++.+||+.||++|||++|
T Consensus       242 ~~-~~~----~~~~----------~~~~~li~~~l~~dp~~Rps~~e  273 (287)
T 2wei_A          242 DL-PQW----RTIS----------DDAKDLIRKMLTFHPSLRITATQ  273 (287)
T ss_dssp             CS-GGG----TTSC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             Cc-hhh----hhcC----------HHHHHHHHHHcccChhhCcCHHH
Confidence            00 000    0011          12568999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-35  Score=340.80  Aligned_cols=199  Identities=27%  Similarity=0.341  Sum_probs=172.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc------CCcceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI------KHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  805 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||||++.. .....+.+.+|+++++.+      .|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999986 578999998754 223346678888888877      577999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc--EEEeec
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME--ARVSDF  883 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Df  883 (1013)
                      ++||||++ ++|.+++.....    ..+++..++.++.||+.||+|||++   +||||||||+||+++.++.  +||+||
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             EEEEeccC-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            99999997 699999875432    2389999999999999999999999   9999999999999999987  999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      |+|+.....     .....||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus       247 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          247 GSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999764322     234578999999999999999999999999999999999999997643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.6e-36  Score=330.64  Aligned_cols=201  Identities=25%  Similarity=0.401  Sum_probs=164.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEE-----------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK-----------  800 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  800 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367999999999999999999987 48899999887655555678899999999999999999999873           


Q ss_pred             ---eCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC-CCC
Q 036815          801 ---IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD-HEM  876 (1013)
Q Consensus       801 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~  876 (1013)
                         +....++||||++ |+|.+++..       ..+++..++.++.|++.||+|||++   +|+||||||+||+++ .++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence               3467899999998 699999853       2388999999999999999999999   999999999999997 567


Q ss_pred             cEEEeecccceeccccCc-ceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          877 EARVSDFGMARLISALDT-HLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       877 ~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            999999999987643211 112234567899999998765 67899999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.8e-36  Score=332.92  Aligned_cols=248  Identities=24%  Similarity=0.342  Sum_probs=165.9

Q ss_pred             hcCCCCCC-eecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHH-HHHhccCCcceeeeccEEEe----CCEE
Q 036815          733 TNGFSAES-LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEM-ETLGKIKHRNLVPLLGYCKI----GEER  805 (1013)
Q Consensus       733 ~~~y~~~~-~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~----~~~~  805 (1013)
                      .++|.+.+ +||+|+||.||+|++. +++.||+|++...     ....+|+ ..++.++||||+++++++..    +...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            45788854 6999999999999987 6899999987542     2222333 34566799999999999876    4457


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCcEEEee
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EMEARVSD  882 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~D  882 (1013)
                      ++||||+++|+|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence            999999999999999975432    3489999999999999999999999   9999999999999986   45599999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      ||+++.....    ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.......... . ........
T Consensus       175 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~-~~~~~~~~  248 (336)
T 3fhr_A          175 FGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-G-MKRRIRLG  248 (336)
T ss_dssp             CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             cccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-h-HHHhhhcc
Confidence            9999865432    2234568999999999998899999999999999999999999997643221100 0 00000000


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .. ....+..    ...+          ..+.+++.+||+.||++|||++|
T Consensus       249 ~~-~~~~~~~----~~~~----------~~~~~li~~~L~~dP~~Rpt~~e  284 (336)
T 3fhr_A          249 QY-GFPNPEW----SEVS----------EDAKQLIRLLLKTDPTERLTITQ  284 (336)
T ss_dssp             ---CCCTTTS----TTCC----------HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             cc-ccCchhh----ccCC----------HHHHHHHHHHCCCChhHCcCHHH
Confidence            00 0000000    0011          12568999999999999999864

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-35  Score=345.45  Aligned_cols=320  Identities=21%  Similarity=0.194  Sum_probs=148.2

Q ss_pred             cEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEe
Q 036815           52 VYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILN  131 (1013)
Q Consensus        52 ~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~  131 (1013)
                      +.++.++++++ .+|..+   .++++.|+|++|++++.....   ...+++|++|+|++|.|+++.|..|.++++|++|+
T Consensus        14 ~~v~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~~~~~~---~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~   86 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDE---FASFPHLEELELNENIVSAVEPGAFNNLFNLRTLG   86 (477)
T ss_dssp             TEEECCSCCCS-SCCSCC---CTTCSEEECCSSCCCEECTTT---TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CEEEeCCCCcC-cCCCCC---CCCCcEEECCCCccceECHhH---ccCCCCCCEEECCCCccCEeChhhhhCCccCCEEE
Confidence            34555555554 344322   234555555555555332211   12344555555555555554455555555555555


Q ss_pred             cCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCC
Q 036815          132 LSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNIS  211 (1013)
Q Consensus       132 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~  211 (1013)
                      |++|+++.+.+..|.++++|++|+|++|.+++ ++...+..+++|++|+|++|.+++..+..|.++++|++|++++|+++
T Consensus        87 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  165 (477)
T 2id5_A           87 LRSNRLKLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT  165 (477)
T ss_dssp             CCSSCCCSCCTTSSTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred             CCCCcCCccCcccccCCCCCCEEECCCCcccc-CChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence            55555554444445555555555555555542 22222233455555555555555444445555555555555555554


Q ss_pred             CCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCcc
Q 036815          212 GPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQ  291 (1013)
Q Consensus       212 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  291 (1013)
                       .++...+..+++|+.|++++|.+.+..+..+..+++|+.|++++|...                         +.++..
T Consensus       166 -~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~-------------------------~~~~~~  219 (477)
T 2id5_A          166 -SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL-------------------------DTMTPN  219 (477)
T ss_dssp             -SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC-------------------------CEECTT
T ss_pred             -ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc-------------------------cccCcc
Confidence             334444444555555555555554444444444444444444444433                         333333


Q ss_pred             ccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCC
Q 036815          292 LSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLE  371 (1013)
Q Consensus       292 ~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  371 (1013)
                      .....+|+.|++++|.+++..+..+..+++|+.|++++|.+++..+..|..+++|+.|+|++|++++..|..+..+++|+
T Consensus       220 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  299 (477)
T 2id5_A          220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR  299 (477)
T ss_dssp             TTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCC
T ss_pred             cccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCC
Confidence            33334555555555555521112222222222222222222222333444445555555555555544445555555555


Q ss_pred             eEEecCCccCCCCChhhhccCCCceEEccCCeee
Q 036815          372 WISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK  405 (1013)
Q Consensus       372 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  405 (1013)
                      .|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       300 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  333 (477)
T 2id5_A          300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA  333 (477)
T ss_dssp             EEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred             EEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence            5555555555433344444555555555555544

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-36  Score=331.64  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=185.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe----------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI----------  801 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  801 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||+|++... ....+.+.+|++++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457899999999999999999986 7899999988542 2334678899999999999999999998865          


Q ss_pred             ---CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          802 ---GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       802 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                         ....|+||||+++|+|.+++....     ..+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence               356799999999999999997432     3478899999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCc------------ceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          879 RVSDFGMARLISALDT------------HLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ||+|||.++.......            ........|++.|+|||++.+. .++.++||||+||++|||++   ||... 
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-  231 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-  231 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-
Confidence            9999999986543210            1122345689999999998764 68999999999999999998   54321 


Q ss_pred             CCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          946 FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       946 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         ......... ......  ..++..       ....      ...+.+++.+||+.||++|||++|
T Consensus       232 ---~~~~~~~~~-~~~~~~--~~~~~~-------~~~~------~~~~~~li~~~l~~dp~~Rps~~~  280 (303)
T 1zy4_A          232 ---MERVNILKK-LRSVSI--EFPPDF-------DDNK------MKVEKKIIRLLIDHDPNKRPGART  280 (303)
T ss_dssp             ---HHHHHHHHH-HHSTTC--CCCTTC-------CTTT------SHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ---hhHHHHHHh-cccccc--ccCccc-------cccc------hHHHHHHHHHHHhcCcccCcCHHH
Confidence               011111111 111100  011111       0000      112568999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.9e-36  Score=359.57  Aligned_cols=240  Identities=24%  Similarity=0.404  Sum_probs=186.2

Q ss_pred             CeecccCCcEEEEEEEc---CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLK---DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||.||+|.+.   .++.||||++.....  ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999764   457899998865332  235789999999999999999999999864 568899999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++..++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||+|+.+.....
T Consensus       454 g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          454 GPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             CCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            99999996432      388999999999999999999999   999999999999999999999999999987654322


Q ss_pred             c-eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          895 H-LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       895 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      . .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....     .+ +...+..+..... +.  
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~-~~~~i~~~~~~~~-p~--  595 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SE-VTAMLEKGERMGC-PA--  595 (635)
T ss_dssp             ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-HHHHHHTTCCCCC-CT--
T ss_pred             ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HH-HHHHHHcCCCCCC-CC--
Confidence            1 12233456788999999999999999999999999999998 9999976431     11 1122222221111 10  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..+          ..+.+++.+||+.||++|||++|
T Consensus       596 -----~~~----------~~l~~li~~cl~~dP~~RPs~~~  621 (635)
T 4fl3_A          596 -----GCP----------REMYDLMNLCWTYDVENRPGFAA  621 (635)
T ss_dssp             -----TCC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             -----CCC----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence                 011          12568999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.2e-36  Score=344.16  Aligned_cols=198  Identities=28%  Similarity=0.370  Sum_probs=163.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeC----C--EEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG----E--ERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~  806 (1013)
                      .+|++.+.||+|+||.||+|++. +++.||||++....    +...+|++++++++||||+++++++...    +  ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888999999999999999986 58999999886432    2234799999999999999999988542    2  357


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEeeccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGM  885 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~  885 (1013)
                      +||||+++ ++.+.+.....  ....+++..++.++.||++||+|||++   +|+||||||+||+++.+ +.+||+|||+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence            99999985 67666643221  123489999999999999999999999   99999999999999965 5789999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |+.......   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.
T Consensus       204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~  260 (420)
T 1j1b_A          204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  260 (420)
T ss_dssp             CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            987643222   2345789999999998764 7899999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-35  Score=330.31  Aligned_cols=202  Identities=26%  Similarity=0.390  Sum_probs=171.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc--CCCEEEEEEeeccCc--cchHHHHHHHHHHhcc---CCcceeeeccEEE----
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK--DGSSVAIKKLIRLSC--QGDREFMAEMETLGKI---KHRNLVPLLGYCK----  800 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  800 (1013)
                      +.++|++.+.||+|+||.||+|++.  +++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3578999999999999999999984  578899998854322  2234567788877766   8999999999987    


Q ss_pred             -eCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEE
Q 036815          801 -IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEAR  879 (1013)
Q Consensus       801 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  879 (1013)
                       .....++||||++ |+|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence             4567899999998 699999975432    2388999999999999999999999   999999999999999999999


Q ss_pred             EeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          880 VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       880 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |+|||.++......   ......|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       161 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (326)
T 1blx_A          161 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  222 (326)
T ss_dssp             ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             EecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999998654322   223457899999999999999999999999999999999999999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.6e-36  Score=335.97  Aligned_cols=202  Identities=28%  Similarity=0.439  Sum_probs=169.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeC-----CEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIG-----EER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  805 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467999999999999999999986 688999998854332 2345678999999999999999999988654     678


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      ++||||++ ++|.+++...       .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            99999998 5899998642       389999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccccCcce--------eeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          886 ARLISALDTHL--------SVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       886 a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ++.........        ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            98765322111        1223468999999998754 678999999999999999999999998643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.2e-36  Score=344.29  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=180.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      +.|.+.+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.+++..|+||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345567889999999998777778999999987542   245678999999886 8999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCC-ccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-------------CcE
Q 036815          813 KFGSLEEVLHGRAKARDQ-RILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-------------MEA  878 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-------------~~~  878 (1013)
                      + |+|.+++......... ...++..++.++.||+.||+|||++   +|+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 6999999765432211 1123445678999999999999999   99999999999999754             489


Q ss_pred             EEeecccceeccccCcce--eeeeeccCCCccCcccccC-------CCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCC
Q 036815          879 RVSDFGMARLISALDTHL--SVSTLAGTPGYVPPEYYQS-------FRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGD  948 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~  948 (1013)
                      ||+|||+|+.........  ......||+.|+|||++.+       ..++.++||||+||++|||++ |+.||...... 
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-  246 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-  246 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence            999999998775432211  1234579999999999875       678999999999999999999 99999653211 


Q ss_pred             ccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          949 TNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        ...+.....   . .... +..      ...      .....+.+++.+||+.||++||||+|
T Consensus       247 --~~~i~~~~~---~-~~~~-~~~------~~~------~~~~~~~~li~~~L~~dP~~Rps~~e  292 (434)
T 2rio_A          247 --ESNIIRGIF---S-LDEM-KCL------HDR------SLIAEATDLISQMIDHDPLKRPTAMK  292 (434)
T ss_dssp             --HHHHHHTCC---C-CCCC-TTC------CCH------HHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --HHHHhcCCC---C-cccc-ccc------ccc------cchHHHHHHHHHHhhCChhhCCCHHH
Confidence              111111100   0 0000 000      000      01123568999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-35  Score=336.35  Aligned_cols=200  Identities=26%  Similarity=0.330  Sum_probs=169.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-Cc-----ceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HR-----NLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~  805 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||||++... .....++..|+++++.++ |+     +|+++++++...+..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            468999999999999999999987 5788999987532 233456778888888874 44     599999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC--CCCcEEEeec
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD--HEMEARVSDF  883 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Df  883 (1013)
                      ++||||++ ++|.+++.....    ..+++..++.++.|++.||+|||++ ..+||||||||+||+++  .++.+||+||
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             EEEEecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999997 599999975432    2389999999999999999999952 12899999999999995  4778999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |+|+.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999876432     23457899999999999999999999999999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.9e-36  Score=338.49  Aligned_cols=195  Identities=28%  Similarity=0.423  Sum_probs=166.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEE----
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER----  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  805 (1013)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467999999999999999999986 688999998865322  2246788999999999999999999999876654    


Q ss_pred             --EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          806 --LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       806 --~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                        ++||||++ ++|.+++..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred             eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence              99999998 688888732        288999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |+++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       189 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          189 GLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             TCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999865421     234578999999999887 68899999999999999999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.5e-36  Score=329.91  Aligned_cols=237  Identities=24%  Similarity=0.422  Sum_probs=191.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc------chHHHHHHHHHHhccC--CcceeeeccEEEeCC
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ------GDREFMAEMETLGKIK--HRNLVPLLGYCKIGE  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  803 (1013)
                      .++|++.+.||+|+||.||+|++. +++.||||++......      ..+.+.+|+.++++++  ||||+++++++..++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            467999999999999999999975 6789999988654322      1245678999999996  599999999999999


Q ss_pred             EEEEEEEcccC-CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC-CCCcEEEe
Q 036815          804 ERLLVYEFMKF-GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD-HEMEARVS  881 (1013)
Q Consensus       804 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~  881 (1013)
                      ..++|||++.+ ++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++ .++.+||+
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             cEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999986 89999997533      388999999999999999999999   999999999999999 78999999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR  960 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  960 (1013)
                      |||+++......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....       ..    ..
T Consensus       193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~----~~  257 (320)
T 3a99_A          193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EI----IR  257 (320)
T ss_dssp             CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH----HH
T ss_pred             eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hh----hc
Confidence            999998765322    234568999999999887665 678999999999999999999986421       11    11


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ....  ..+       ..+          ..+.+++.+||+.||++|||++|
T Consensus       258 -~~~~--~~~-------~~~----------~~~~~li~~~l~~dp~~Rps~~~  290 (320)
T 3a99_A          258 -GQVF--FRQ-------RVS----------SECQHLIRWCLALRPSDRPTFEE  290 (320)
T ss_dssp             -CCCC--CSS-------CCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -cccc--ccc-------cCC----------HHHHHHHHHHccCChhhCcCHHH
Confidence             0000  000       111          12568999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=327.14  Aligned_cols=239  Identities=24%  Similarity=0.386  Sum_probs=184.6

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc------chHHHHHHHHHHhcc----CCcceeeeccEE
Q 036815          731 EATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ------GDREFMAEMETLGKI----KHRNLVPLLGYC  799 (1013)
Q Consensus       731 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~~  799 (1013)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++......      ....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34578999999999999999999875 6889999988543321      123356799999988    899999999999


Q ss_pred             EeCCEEEEEEEc-ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC-CCCc
Q 036815          800 KIGEERLLVYEF-MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD-HEME  877 (1013)
Q Consensus       800 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~  877 (1013)
                      .+.+..++|||| +.+++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++ .++.
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence            999999999999 78999999997533      389999999999999999999999   999999999999999 8899


Q ss_pred             EEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCC-ccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 036815          878 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT-AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       878 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~  956 (1013)
                      +||+|||+++......    .....|++.|+|||++.+..+. .++||||+||++|||++|+.||....       +...
T Consensus       179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~  247 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILE  247 (312)
T ss_dssp             EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH
T ss_pred             EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhh
Confidence            9999999998765322    2345689999999998776664 58999999999999999999986421       1110


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         ........++                     ..+.+++.+||+.||++|||++|
T Consensus       248 ---~~~~~~~~~~---------------------~~~~~li~~~l~~~p~~Rps~~e  280 (312)
T 2iwi_A          248 ---AELHFPAHVS---------------------PDCCALIRRCLAPKPSSRPSLEE  280 (312)
T ss_dssp             ---TCCCCCTTSC---------------------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ---hccCCcccCC---------------------HHHHHHHHHHccCChhhCcCHHH
Confidence               1101101111                     12568999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.9e-36  Score=331.95  Aligned_cols=247  Identities=22%  Similarity=0.362  Sum_probs=188.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||.||+|++..  .||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4679999999999999999999863  49999875432  2223557889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++++|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++...
T Consensus       110 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             CCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             cccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            999999999996432     3488999999999999999999999   999999999999998 6799999999987653


Q ss_pred             ccCc---ceeeeeeccCCCccCcccccC---------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHH
Q 036815          891 ALDT---HLSVSTLAGTPGYVPPEYYQS---------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK  958 (1013)
Q Consensus       891 ~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  958 (1013)
                      ....   ........|++.|+|||++.+         ..++.++|||||||++|||++|+.||.....     ..... .
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~-~  254 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----EAIIW-Q  254 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----HHHHH-H
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH-H
Confidence            2211   112234468899999999864         4578899999999999999999999975331     11111 1


Q ss_pred             HhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          959 VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       959 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+........       ..+.          .+.+++.+||+.||++|||++|
T Consensus       255 ~~~~~~~~~~~~-------~~~~----------~l~~li~~~l~~~p~~Rpt~~~  292 (319)
T 2y4i_B          255 MGTGMKPNLSQI-------GMGK----------EISDILLFCWAFEQEERPTFTK  292 (319)
T ss_dssp             HHTTCCCCCCCS-------SCCT----------THHHHHHHHHCSSTTTSCCHHH
T ss_pred             hccCCCCCCCcC-------CCCH----------HHHHHHHHHhcCChhhCcCHHH
Confidence            111111111110       0111          2568999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.8e-35  Score=324.55  Aligned_cols=198  Identities=25%  Similarity=0.351  Sum_probs=171.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE-c-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcc------eeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATL-K-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN------LVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  804 (1013)
                      .++|++.+.||+|+||.||+|.+ . +++.||+|++... ....+.+.+|+++++.++|++      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35799999999999999999997 3 5788999987532 233567889999999987664      9999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC----------
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH----------  874 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----------  874 (1013)
                      .++||||+ +++|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.          
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            99999999 7899999975432    3488999999999999999999999   9999999999999987          


Q ss_pred             ---------CCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          875 ---------EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       875 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                               ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                     668999999999865432     23457899999999999999999999999999999999999999764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-35  Score=338.11  Aligned_cols=202  Identities=23%  Similarity=0.289  Sum_probs=169.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC--------CcceeeeccEEE---
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK--------HRNLVPLLGYCK---  800 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  800 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||+|++... ....+.+.+|++++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            368999999999999999999976 5788999987532 334567889999999985        788999999987   


Q ss_pred             -eCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC---
Q 036815          801 -IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM---  876 (1013)
Q Consensus       801 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---  876 (1013)
                       .+...++||||+. +++.+++....    ...+++..++.++.||+.||+|||+++  +|+||||||+||+++.++   
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKSN----YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence             4567899999995 66666665332    134899999999999999999999953  899999999999999775   


Q ss_pred             ----------------------------------------------cEEEeecccceeccccCcceeeeeeccCCCccCc
Q 036815          877 ----------------------------------------------EARVSDFGMARLISALDTHLSVSTLAGTPGYVPP  910 (1013)
Q Consensus       877 ----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  910 (1013)
                                                                    .+||+|||.|+.....     .....||+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP  262 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence                                                          7999999999876432     2345789999999


Q ss_pred             ccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC
Q 036815          911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFG  947 (1013)
Q Consensus       911 E~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~  947 (1013)
                      |++.+..++.++|||||||++|||++|+.||......
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  299 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE  299 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence            9999999999999999999999999999999865443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=326.44  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=172.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc-h-HHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG-D-REFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||||++....... . +.+.++..+++.++||||+++++++.+++..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            56888999999999999999986 68999999986543222 2 234445566888899999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |+ ++.+..+....     ...+++..++.++.|+++||+|||+ .   +|+||||||+||+++.++.+||+|||+++..
T Consensus       105 ~~-~~~~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          105 LM-GTCAEKLKKRM-----QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             CC-SEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             cc-CCcHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            99 45565555322     1238899999999999999999998 6   8999999999999999999999999999765


Q ss_pred             cccCcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      ....   ......+++.|+|||++.     +..++.++|||||||++|||++|+.||.....    ..............
T Consensus       176 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~  248 (318)
T 2dyl_A          176 VDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----DFEVLTKVLQEEPP  248 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHHHHHSCCC
T ss_pred             cCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----cHHHHHHHhccCCC
Confidence            4322   223456899999999984     55688899999999999999999999975321    11112222221111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .....       ...+          ..+.+++.+||+.||++|||++|
T Consensus       249 ~~~~~-------~~~~----------~~l~~li~~~l~~dp~~Rps~~~  280 (318)
T 2dyl_A          249 LLPGH-------MGFS----------GDFQSFVKDCLTKDHRKRPKYNK  280 (318)
T ss_dssp             CCCSS-------SCCC----------HHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             CCCcc-------CCCC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            00000       0011          12568999999999999999864

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.6e-34  Score=325.26  Aligned_cols=309  Identities=22%  Similarity=0.233  Sum_probs=172.8

Q ss_pred             CCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEE
Q 036815          149 SSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESL  228 (1013)
Q Consensus       149 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  228 (1013)
                      ++++.|++++|.++ .+|..++..+++|++|+|++|.+++..+..|..+++|++|++++|.++ .++...+..+++|++|
T Consensus        45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred             CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCEE
Confidence            44555555555554 444444444455555555555555444445555555555555555554 2333334445555555


Q ss_pred             EcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCcc
Q 036815          229 ILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL  308 (1013)
Q Consensus       229 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l  308 (1013)
                      ++++|+++...+..+..+++|++|++++|.++ .+++..+..+++|++|++++|.+++.   .+..+++|+.|++++|.+
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l  198 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL  198 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccC-ccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence            55555555322223344555555555555544 22233334445555555555555433   244556666777766665


Q ss_pred             CCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhh
Q 036815          309 NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEF  388 (1013)
Q Consensus       309 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  388 (1013)
                      ++                             +...++|+.|++++|.+.. +|...  .++|+.|++++|.+++.  ..+
T Consensus       199 ~~-----------------------------~~~~~~L~~L~l~~n~l~~-~~~~~--~~~L~~L~l~~n~l~~~--~~l  244 (390)
T 3o6n_A          199 ST-----------------------------LAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTDT--AWL  244 (390)
T ss_dssp             SE-----------------------------EECCSSCSEEECCSSCCCE-EECCC--CSSCCEEECCSSCCCCC--GGG
T ss_pred             cc-----------------------------cCCCCcceEEECCCCeeee-ccccc--cccccEEECCCCCCccc--HHH
Confidence            52                             1112457777777777763 34332  36777777777777743  567


Q ss_pred             hccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCC
Q 036815          389 SRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVG  468 (1013)
Q Consensus       389 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (1013)
                      ..+++|+.|+|++|++++..|..+.++++|++|+|++|++++. |.                                  
T Consensus       245 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~----------------------------------  289 (390)
T 3o6n_A          245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NL----------------------------------  289 (390)
T ss_dssp             GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEE-EC----------------------------------
T ss_pred             cCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCccc-Cc----------------------------------
Confidence            7777777788877777777777777777777777777766531 11                                  


Q ss_pred             cccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCC
Q 036815          469 GLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEI  548 (1013)
Q Consensus       469 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~i  548 (1013)
                                                        .+..+++|++|||++|+++ .+|..++.+++|++|+|++|+++ .+
T Consensus       290 ----------------------------------~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~-~~  333 (390)
T 3o6n_A          290 ----------------------------------YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL  333 (390)
T ss_dssp             ----------------------------------SSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CC
T ss_pred             ----------------------------------ccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccc-ee
Confidence                                              0112345666666666666 56666666666666666666666 33


Q ss_pred             cccccCCCCcceEecCCccccC
Q 036815          549 PSSLGRLRNLGVFDASHNRLQG  570 (1013)
Q Consensus       549 p~~~~~l~~L~~L~ls~N~l~g  570 (1013)
                      |  +..+++|+.|++++|.+++
T Consensus       334 ~--~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          334 K--LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             C--CCTTCCCSEEECCSSCEEH
T ss_pred             C--chhhccCCEEEcCCCCccc
Confidence            3  4555555555555555553

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.4e-34  Score=345.69  Aligned_cols=241  Identities=21%  Similarity=0.236  Sum_probs=132.7

Q ss_pred             CCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEE
Q 036815          149 SSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESL  228 (1013)
Q Consensus       149 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  228 (1013)
                      .+++.|++++|.++ .+|..++..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++ ++...+.++++|++|
T Consensus        51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVL  128 (597)
T ss_dssp             CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred             CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC-CCHHHHcCCCCCCEE
Confidence            44555555555555 4555544555555555555555555555555555555555555555552 333334555555555


Q ss_pred             EcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCcc
Q 036815          229 ILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL  308 (1013)
Q Consensus       229 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l  308 (1013)
                      +|++|.+++..+..|+.+++|++|++++|.+++ +++..+..+++|+.|++++|.+++.   .++.+++|+.|++++|.+
T Consensus       129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l  204 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL  204 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB-CCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred             EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC-CChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcc
Confidence            555555553333334555555555555555542 2223334445555555555555433   134455666666666655


Q ss_pred             CCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhh
Q 036815          309 NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEF  388 (1013)
Q Consensus       309 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  388 (1013)
                      ++                             +...++|+.|++++|.+. .+|..+  .++|+.|+|++|.+++  +..+
T Consensus       205 ~~-----------------------------l~~~~~L~~L~ls~n~l~-~~~~~~--~~~L~~L~L~~n~l~~--~~~l  250 (597)
T 3oja_B          205 ST-----------------------------LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWL  250 (597)
T ss_dssp             SE-----------------------------EECCTTCSEEECCSSCCC-EEECSC--CSCCCEEECCSSCCCC--CGGG
T ss_pred             cc-----------------------------ccCCchhheeeccCCccc-cccccc--CCCCCEEECCCCCCCC--Chhh
Confidence            42                             111235667777777766 333322  2466777777777664  3566


Q ss_pred             hccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCC
Q 036815          389 SRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT  429 (1013)
Q Consensus       389 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  429 (1013)
                      ..+++|+.|+|++|.+++..|..|+++++|++|+|++|.++
T Consensus       251 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  291 (597)
T 3oja_B          251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV  291 (597)
T ss_dssp             GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC
T ss_pred             ccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC
Confidence            66677777777777776666666666666666666666655

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-35  Score=328.77  Aligned_cols=254  Identities=23%  Similarity=0.332  Sum_probs=172.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHH-HHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEME-TLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||.||+|.+. +++.||||++..... ....++..|+. +++.++||||+++++++.+++..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67899999999999999999986 688999998865432 22345566666 6777899999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++ +|.+++..... .....+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 88887753221 1123489999999999999999999995  289999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccc----cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYY----QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...   ......||+.|+|||++    .+..++.++|||||||++|||++|+.||........    .... ...+....
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~-~~~~~~~~  249 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLTQ-VVKGDPPQ  249 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CC-CCCSCCCC
T ss_pred             ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHHH-HhcCCCCC
Confidence            321   22334689999999998    466789999999999999999999999975321110    0000 00000000


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       +....   .....          ..+.+++.+||+.||++|||++|
T Consensus       250 -~~~~~---~~~~~----------~~l~~li~~~l~~dp~~Rps~~e  282 (327)
T 3aln_A          250 -LSNSE---EREFS----------PSFINFVNLCLTKDESKRPKYKE  282 (327)
T ss_dssp             -CCCCS---SCCCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCCcc---cccCC----------HHHHHHHHHHhhCChhhCcCHHH
Confidence             00000   00011          13568999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.2e-35  Score=329.01  Aligned_cols=195  Identities=28%  Similarity=0.429  Sum_probs=165.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCE------
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE------  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  804 (1013)
                      ++|.+.+.||+|+||.||+|++. +|+.||||++.....  ...+.+.+|+.++++++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57899999999999999999986 688999998865322  224568899999999999999999999987653      


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+||||++ ++|.+++..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       104 ~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence            499999998 588777631        288999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +++.....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       172 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          172 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             CTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             cccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99765321     234578999999999876 678999999999999999999999997643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.6e-36  Score=351.07  Aligned_cols=203  Identities=27%  Similarity=0.409  Sum_probs=172.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc-CccchHHHHHHHHHHhccCCcceeeeccEEEe------CCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL-SCQGDREFMAEMETLGKIKHRNLVPLLGYCKI------GEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  804 (1013)
                      .++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|++++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999985 6889999987543 22334678999999999999999999998755      667


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCc---EEEe
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEME---ARVS  881 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~  881 (1013)
                      .++||||++||+|.+++.....   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            8999999999999999975432   23488889999999999999999999   9999999999999997765   9999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |||.++......   ......||+.|+|||++.+..++.++||||+||++|||++|..||...
T Consensus       167 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~  226 (676)
T 3qa8_A          167 DLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN  226 (676)
T ss_dssp             SCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence            999998765322   223467899999999999999999999999999999999999999753

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.4e-35  Score=353.63  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=190.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcC----CCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKD----GSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      .++|++.+.||+|+||.||+|++..    +..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            4678899999999999999999753    45789998754322 23467899999999999999999999985 456899


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       468 v~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             EEECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             EEEcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            999999999999997432     2388999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.....     .+.... +..+....
T Consensus       540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~~~~~~-i~~~~~~~  612 (656)
T 2j0j_A          540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGR-IENGERLP  612 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH-HHHTCCCC
T ss_pred             ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH-HHcCCCCC
Confidence            7643221 22234456789999999998899999999999999999997 9999975331     111111 11111111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .++.       .+          ..+.+++.+||+.||++|||++|
T Consensus       613 -~~~~-------~~----------~~l~~li~~~l~~dP~~RPs~~e  641 (656)
T 2j0j_A          613 -MPPN-------CP----------PTLYSLMTKCWAYDPSRRPRFTE  641 (656)
T ss_dssp             -CCTT-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCcc-------cc----------HHHHHHHHHHcCCChhHCcCHHH
Confidence             1111       11          12568999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.5e-35  Score=334.43  Aligned_cols=246  Identities=23%  Similarity=0.337  Sum_probs=180.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .+|.+.++||+|+||+||.....+++.||||++.....   ..+.+|+++++++ +||||+++++++.+....|+||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            45888899999999997766566799999999864332   2356899999999 7999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-----CCcEEEeecccce
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-----EMEARVSDFGMAR  887 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~a~  887 (1013)
                      + |+|.+++......     .++..++.++.||+.||+|||++   +|+||||||+||+++.     ...+||+|||+|+
T Consensus       101 ~-g~L~~~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A          101 A-ATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             S-EEHHHHHHSSSCC-----CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             C-CCHHHHHHhcCCC-----ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            7 5999999754321     33445678999999999999999   9999999999999953     3358899999998


Q ss_pred             eccccCcc-eeeeeeccCCCccCccccc---CCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcC
Q 036815          888 LISALDTH-LSVSTLAGTPGYVPPEYYQ---SFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREG  962 (1013)
Q Consensus       888 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  962 (1013)
                      ........ .......||+.|+|||++.   +..++.++||||+||++|||++ |..||.....      ..........
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------~~~~~~~~~~  245 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------RQANILLGAC  245 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------HHHHHHTTCC
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------HHHHHHhccC
Confidence            76533211 2234467999999999997   4567889999999999999999 9999854321      1111111111


Q ss_pred             ccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          963 KQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       963 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ......+..               .....+.+++.+||+.||++|||++|
T Consensus       246 -~~~~~~~~~---------------~~~~~~~~li~~~L~~dP~~Rps~~e  280 (432)
T 3p23_A          246 -SLDCLHPEK---------------HEDVIARELIEKMIAMDPQKRPSAKH  280 (432)
T ss_dssp             -CCTTSCTTC---------------HHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             -CccccCccc---------------cccHHHHHHHHHHHhCCHhhCCCHHH
Confidence             111111100               01122568999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6e-35  Score=330.92  Aligned_cols=199  Identities=22%  Similarity=0.335  Sum_probs=167.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-----------CcceeeeccEEEe
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-----------HRNLVPLLGYCKI  801 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  801 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||||++.. .....+.+.+|++++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            57999999999999999999985 688999998753 2334567889999998886           8999999999876


Q ss_pred             CC----EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC----
Q 036815          802 GE----ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD----  873 (1013)
Q Consensus       802 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~----  873 (1013)
                      .+    ..++||||+ +++|.+++.....    ..+++..++.++.||+.||+|||+++  +|+||||||+||+++    
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence            54    789999999 7899999975432    23889999999999999999999942  899999999999994    


Q ss_pred             --CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          874 --HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       874 --~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                        ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence              4458999999999876432     233478999999999999999999999999999999999999998654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.7e-34  Score=323.25  Aligned_cols=198  Identities=25%  Similarity=0.356  Sum_probs=169.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CC-CEEEEEEeeccCccchHHHHHHHHHHhccCCcc------eeeeccEEEeCCE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DG-SSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN------LVPLLGYCKIGEE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  804 (1013)
                      .++|++.+.||+|+||+||+|++. ++ +.||+|++.. .....+.+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            367999999999999999999986 34 6899998753 2334567889999999997766      8999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEe------------
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLL------------  872 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill------------  872 (1013)
                      .++||||+ ++++.+++....    ...+++..++.++.||+.||+|||++   +|+||||||+||++            
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENN----FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             EEEEEecc-CCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            99999999 567777775432    13489999999999999999999999   99999999999999            


Q ss_pred             -------CCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          873 -------DHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       873 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                             +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                   56789999999999864332     23457899999999999999999999999999999999999999764

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.9e-33  Score=320.14  Aligned_cols=313  Identities=21%  Similarity=0.250  Sum_probs=240.5

Q ss_pred             CCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCC
Q 036815           72 NSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSL  151 (1013)
Q Consensus        72 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  151 (1013)
                      .+++++.|++++|.++..+....   ..+++|++|+|++|.|+++.+..|.++++|++|+|++|++++..+..|+++++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~---~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  119 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALL---DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL  119 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHH---HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             ccCCceEEEecCCchhhCChhHh---cccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCC
Confidence            35778888888888875544322   346788888888888888777788888888888888888887777788888888


Q ss_pred             CEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcc
Q 036815          152 QRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS  231 (1013)
Q Consensus       152 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~  231 (1013)
                      ++|++++|.++ .+|..++..+++|++|++++|++++..+..+..+++|++|++++|++++ ++   +..+++|++|+++
T Consensus       120 ~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~---~~~l~~L~~L~l~  194 (390)
T 3o6n_A          120 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD---LSLIPSLFHANVS  194 (390)
T ss_dssp             CEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB-CC---GGGCTTCSEEECC
T ss_pred             CEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc-cc---cccccccceeecc
Confidence            88888888888 6777766667888888888888887777778888888888888888873 33   3557788888888


Q ss_pred             cccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCC
Q 036815          232 NNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS  311 (1013)
Q Consensus       232 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  311 (1013)
                      +|.+++     +...++|+.|++++|.+... +...   .++|+.|++++|.+++.  ..+..+++|+.|++++|.++  
T Consensus       195 ~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~~---~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~--  261 (390)
T 3o6n_A          195 YNLLST-----LAIPIAVEELDASHNSINVV-RGPV---NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE--  261 (390)
T ss_dssp             SSCCSE-----EECCSSCSEEECCSSCCCEE-ECCC---CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC--
T ss_pred             cccccc-----cCCCCcceEEECCCCeeeec-cccc---cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCC--
Confidence            887763     22335677777777777633 3322   35666666666666643  35566666666666666655  


Q ss_pred             CCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhcc
Q 036815          312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRL  391 (1013)
Q Consensus       312 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l  391 (1013)
                                            +..|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+
T Consensus       262 ----------------------~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l  317 (390)
T 3o6n_A          262 ----------------------KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF  317 (390)
T ss_dssp             ----------------------EEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHH
T ss_pred             ----------------------CcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCcccccc
Confidence                                  344566778889999999999998 56777788999999999999999 788889999


Q ss_pred             CCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCC
Q 036815          392 TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDI  432 (1013)
Q Consensus       392 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  432 (1013)
                      ++|+.|+|++|+++. +|  +..+++|++|++++|++++..
T Consensus       318 ~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~  355 (390)
T 3o6n_A          318 DRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNS  355 (390)
T ss_dssp             TTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHH
T ss_pred             CcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchh
Confidence            999999999999984 44  778999999999999998753

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2e-34  Score=316.81  Aligned_cols=254  Identities=29%  Similarity=0.457  Sum_probs=227.3

Q ss_pred             CCCceEEcCCCcccc--cCCccccccCcccEEEeeC-CccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCce
Q 036815          272 SSLEELRLPDNLITG--VIPGQLSECTQLKVIDLSL-NYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD  348 (1013)
Q Consensus       272 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~ls~-N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  348 (1013)
                      .+++.|+|++|.+++  .+|..+.++++|++|++++ |.+.+.+|..++++++|+.|++++|.+++.+|..|+++++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            467778888888887  7788888888899999985 8888888888888899999999999988889999999999999


Q ss_pred             EECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccC-CCceEEccCCeeeeecCCCCcCCCCCcEEEccCCc
Q 036815          349 LILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLT-RLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNN  427 (1013)
Q Consensus       349 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~  427 (1013)
                      |+|++|.+++.+|..+..+++|++|+|++|++++.+|..+..++ .|+.|+|++|++++.+|..+..++ |++|++++|+
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~  208 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence            99999999999999999999999999999999999999999998 999999999999999999999987 9999999999


Q ss_pred             CCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCC
Q 036815          428 LTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQY  507 (1013)
Q Consensus       428 l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  507 (1013)
                      +++.+|..                                                                    +..+
T Consensus       209 l~~~~~~~--------------------------------------------------------------------~~~l  220 (313)
T 1ogq_A          209 LEGDASVL--------------------------------------------------------------------FGSD  220 (313)
T ss_dssp             EEECCGGG--------------------------------------------------------------------CCTT
T ss_pred             ccCcCCHH--------------------------------------------------------------------HhcC
Confidence            88655433                                                                    3345


Q ss_pred             CccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEEC
Q 036815          508 QTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDL  587 (1013)
Q Consensus       508 ~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l  587 (1013)
                      ++|++|+|++|++++.+|. ++.+++|++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|.. .+++.|+.+++
T Consensus       221 ~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l  298 (313)
T 1ogq_A          221 KNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAY  298 (313)
T ss_dssp             SCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGT
T ss_pred             CCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHh
Confidence            7899999999999977665 889999999999999999999999999999999999999999999987 88999999999


Q ss_pred             cCCC-CCCcC
Q 036815          588 SNNE-LTGPI  596 (1013)
Q Consensus       588 ~~n~-l~~~~  596 (1013)
                      ++|+ ++|.+
T Consensus       299 ~~N~~lc~~p  308 (313)
T 1ogq_A          299 ANNKCLCGSP  308 (313)
T ss_dssp             CSSSEEESTT
T ss_pred             cCCCCccCCC
Confidence            9998 77753

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-34  Score=348.42  Aligned_cols=229  Identities=21%  Similarity=0.329  Sum_probs=184.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc--CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCE-----E
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK--DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEE-----R  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  805 (1013)
                      ++|++.+.||+|+||+||+|++.  +++.||||++..... .....+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67999999999999999999986  588999998764322 334568899999999999999999999987554     6


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGM  885 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  885 (1013)
                      |+||||++|++|.+++..        .+++..++.++.||+.||.|||++   +||||||||+||+++.+ .+||+|||+
T Consensus       160 ~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence            999999999999987642        389999999999999999999999   99999999999999986 899999999


Q ss_pred             ceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccc
Q 036815          886 ARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQM  965 (1013)
Q Consensus       886 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  965 (1013)
                      ++.....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........                
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------  284 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------  284 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------
T ss_pred             chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------
Confidence            9876432      3456999999999987654 8899999999999999999988764211100                


Q ss_pred             cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          966 EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       966 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                         ....            ........+.+++.+||+.||++||++.
T Consensus       285 ---~~~~------------~~~~~~~~l~~li~~~l~~dP~~R~~~~  316 (681)
T 2pzi_A          285 ---PEDD------------PVLKTYDSYGRLLRRAIDPDPRQRFTTA  316 (681)
T ss_dssp             ---CTTC------------HHHHHCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred             ---cccc------------cccccCHHHHHHHhhhccCChhhCCCHH
Confidence               0000            0001112366899999999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-33  Score=308.73  Aligned_cols=227  Identities=20%  Similarity=0.252  Sum_probs=171.6

Q ss_pred             cCCCCC-CeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHH-hccCCcceeeeccEEEe----CCEEE
Q 036815          734 NGFSAE-SLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETL-GKIKHRNLVPLLGYCKI----GEERL  806 (1013)
Q Consensus       734 ~~y~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  806 (1013)
                      ++|.+. +.||+|+||.||+|.+. +++.||+|++..     ...+.+|++++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            457776 78999999999999985 688999998743     35677899888 55689999999999877    66789


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCcEEEeec
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EMEARVSDF  883 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Df  883 (1013)
                      +||||+++|+|.+++....    ...+++..++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+||
T Consensus        92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEeecCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            9999999999999997543    23489999999999999999999999   9999999999999998   788999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      |+++...                        +..++.++||||+||++|||++|+.||........          ... 
T Consensus       165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~~-  209 (299)
T 3m2w_A          165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPG-  209 (299)
T ss_dssp             TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CC-
T ss_pred             ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hHH-
Confidence            9986432                        23467899999999999999999999975432110          000 


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....+....    .....  .........+.+++.+||+.||++|||++|
T Consensus       210 ~~~~~~~~~----~~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rps~~e  253 (299)
T 3m2w_A          210 MKTRIRMGQ----YEFPN--PEWSEVSEEVKMLIRNLLKTEPTQRMTITE  253 (299)
T ss_dssp             SCCSSCTTC----CSSCH--HHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHHhhcc----ccCCc--hhcccCCHHHHHHHHHHcccChhhCCCHHH
Confidence            000000000    00000  000000123668999999999999999864

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=9.2e-33  Score=331.94  Aligned_cols=313  Identities=21%  Similarity=0.242  Sum_probs=232.6

Q ss_pred             CCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCC
Q 036815           73 SDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQ  152 (1013)
Q Consensus        73 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  152 (1013)
                      +++++.|++++|.++..+..++   ..+++|++|+|++|.|+++.+..|.++++|++|+|++|.+++..+..|+++++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~---~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  126 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALL---DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT  126 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHH---HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             CCCceEEEeeCCCCCCcCHHHH---ccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCC
Confidence            5677888888888775544322   3466788888888888877777788888888888888888877777778888888


Q ss_pred             EeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEccc
Q 036815          153 RLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN  232 (1013)
Q Consensus       153 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~  232 (1013)
                      +|+|++|.++ .+|..++..+++|++|+|++|.+++..|..|..+++|++|++++|.+++ ++   +..+++|+.|++++
T Consensus       127 ~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~---~~~l~~L~~L~l~~  201 (597)
T 3oja_B          127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD---LSLIPSLFHANVSY  201 (597)
T ss_dssp             EEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB-CC---GGGCTTCSEEECCS
T ss_pred             EEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC-cC---hhhhhhhhhhhccc
Confidence            8888888887 6666666667788888888888877777777778888888888887773 33   34567777777777


Q ss_pred             ccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCC
Q 036815          233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSI  312 (1013)
Q Consensus       233 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  312 (1013)
                      |.+++     +...++|+.|++++|.++. ++...   .++|+.|+|++|.+++.  ..+..+++|+.|++++|.++   
T Consensus       202 n~l~~-----l~~~~~L~~L~ls~n~l~~-~~~~~---~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~---  267 (597)
T 3oja_B          202 NLLST-----LAIPIAVEELDASHNSINV-VRGPV---NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE---  267 (597)
T ss_dssp             SCCSE-----EECCTTCSEEECCSSCCCE-EECSC---CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC---
T ss_pred             Ccccc-----ccCCchhheeeccCCcccc-ccccc---CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccC---
Confidence            77763     2334567777777776653 22222   24566666666666542  44555566666666665555   


Q ss_pred             CcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccC
Q 036815          313 PQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLT  392 (1013)
Q Consensus       313 p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  392 (1013)
                                           +..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..++
T Consensus       268 ---------------------~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~  324 (597)
T 3oja_B          268 ---------------------KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD  324 (597)
T ss_dssp             ---------------------EEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHT
T ss_pred             ---------------------CCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCC
Confidence                                 4556677788899999999999984 6888888999999999999999 7888999999


Q ss_pred             CCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCC
Q 036815          393 RLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       393 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  433 (1013)
                      +|+.|+|++|++++. |  +..+++|++|++++|+++|..+
T Consensus       325 ~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~  362 (597)
T 3oja_B          325 RLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSL  362 (597)
T ss_dssp             TCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHH
T ss_pred             CCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhH
Confidence            999999999999843 3  6788999999999999987643

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.2e-32  Score=306.29  Aligned_cols=307  Identities=24%  Similarity=0.321  Sum_probs=233.7

Q ss_pred             hhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCC
Q 036815           70 LSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLS  149 (1013)
Q Consensus        70 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~  149 (1013)
                      +..+++|++|++++|.+.....     ...+++|++|++++|.++++.+  +.++++|++|++++|.+++.  ..|..++
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~~~-----~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~  110 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASIQG-----IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLT  110 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCCTT-----GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred             chhcccccEEEEeCCccccchh-----hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCC
Confidence            4567889999999998875432     2457889999999999987644  88899999999999988854  4688899


Q ss_pred             CCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEE
Q 036815          150 SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLI  229 (1013)
Q Consensus       150 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  229 (1013)
                      +|++|++++|.++ .++.  +..+++|++|++++|......+ .+..+++|++|++++|.+.+ ++.  +..+++|++|+
T Consensus       111 ~L~~L~l~~n~i~-~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~-~~~--~~~l~~L~~L~  183 (347)
T 4fmz_A          111 NLRELYLNEDNIS-DISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD-VTP--IANLTDLYSLS  183 (347)
T ss_dssp             TCSEEECTTSCCC-CCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCC-CGG--GGGCTTCSEEE
T ss_pred             cCCEEECcCCccc-Cchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCC-chh--hccCCCCCEEE
Confidence            9999999999888 4444  4557888888888886553433 47888888888888888873 333  67788888888


Q ss_pred             cccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccC
Q 036815          230 LSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN  309 (1013)
Q Consensus       230 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~  309 (1013)
                      +++|.+++..+  +..+++|+.|++++|.+++..+   +..+++|+.|++++|.+++..+  +..+++|++|++++|.++
T Consensus       184 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~---~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~  256 (347)
T 4fmz_A          184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP---VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS  256 (347)
T ss_dssp             CTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ccCCccccccc--ccCCCccceeecccCCCCCCch---hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccC
Confidence            88888874322  7778888888888887774432   4566777777777777775543  677777777777777766


Q ss_pred             CCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhh
Q 036815          310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFS  389 (1013)
Q Consensus       310 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  389 (1013)
                      + +                         +.+..+++|++|++++|++++ + ..+..+++|++|++++|++++..|..+.
T Consensus       257 ~-~-------------------------~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~  308 (347)
T 4fmz_A          257 D-I-------------------------NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIG  308 (347)
T ss_dssp             C-C-------------------------GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHH
T ss_pred             C-C-------------------------hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhh
Confidence            2 1                         245667788888888888885 3 4577888899999999988888888888


Q ss_pred             ccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCC
Q 036815          390 RLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT  429 (1013)
Q Consensus       390 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  429 (1013)
                      .+++|+.|++++|++++..|  +..+++|++||+++|.++
T Consensus       309 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             TCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             ccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            88899999999998886655  788889999999988775

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1e-31  Score=300.85  Aligned_cols=307  Identities=23%  Similarity=0.319  Sum_probs=215.9

Q ss_pred             ccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCC
Q 036815           45 FSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNC  124 (1013)
Q Consensus        45 ~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l  124 (1013)
                      +..+++|++|++++|.++ .++.  +..+++|++|+|++|++++...     ...+++|++|++++|.++++  +.+.++
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~~~~-----~~~l~~L~~L~L~~n~i~~~--~~~~~l  109 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITDISP-----LSNLVKLTNLYIGTNKITDI--SALQNL  109 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG-----GTTCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred             chhcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCccccchh-----hhcCCcCCEEEccCCcccCc--hHHcCC
Confidence            345666667777766665 3333  4566667777777766664332     23556677777777766653  346777


Q ss_pred             CCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEE
Q 036815          125 TKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLD  204 (1013)
Q Consensus       125 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~  204 (1013)
                      ++|++|++++|++++..+  +..+++|++|++++|.....++.  +..+++|++|++++|.+.+..+  +..+++|++|+
T Consensus       110 ~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~--~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~  183 (347)
T 4fmz_A          110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP--LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS  183 (347)
T ss_dssp             TTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEE
T ss_pred             CcCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccccc--hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEE
Confidence            777777777777764432  66777777777777754423332  3445677777777777765443  66777777777


Q ss_pred             ccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcc
Q 036815          205 LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLI  284 (1013)
Q Consensus       205 L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l  284 (1013)
                      +++|.+. .++.  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+   +..+++|++|++++|.+
T Consensus       184 l~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l  255 (347)
T 4fmz_A          184 LNYNQIE-DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP---LANLSQLTWLEIGTNQI  255 (347)
T ss_dssp             CTTSCCC-CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCC
T ss_pred             ccCCccc-cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc---hhcCCCCCEEECCCCcc
Confidence            7777776 3333  5677778888888877774333  6777788888888887774332   56678888888888888


Q ss_pred             cccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhh
Q 036815          285 TGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAEL  364 (1013)
Q Consensus       285 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l  364 (1013)
                      ++.  ..+..+++|+.|++++|.+++.                          +.+..+++|++|++++|.+++..|..+
T Consensus       256 ~~~--~~~~~l~~L~~L~l~~n~l~~~--------------------------~~~~~l~~L~~L~L~~n~l~~~~~~~l  307 (347)
T 4fmz_A          256 SDI--NAVKDLTKLKMLNVGSNQISDI--------------------------SVLNNLSQLNSLFLNNNQLGNEDMEVI  307 (347)
T ss_dssp             CCC--GGGTTCTTCCEEECCSSCCCCC--------------------------GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred             CCC--hhHhcCCCcCEEEccCCccCCC--------------------------hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence            764  4688899999999999988731                          135567889999999999998888889


Q ss_pred             cCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeee
Q 036815          365 FSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK  405 (1013)
Q Consensus       365 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  405 (1013)
                      ..+++|++|++++|++++..|  +..+++|+.|++++|+++
T Consensus       308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            999999999999999996555  888999999999999886

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-33  Score=306.58  Aligned_cols=172  Identities=16%  Similarity=0.127  Sum_probs=150.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.......   .+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            67999999999999999999987 48899999886543322   367899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++|++|.+++...        ....++.+++.|++.||+|||++   +|+||||||+||+++.++.+||+++|     
T Consensus       111 e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred             EecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence            999999999999531        23446788999999999999999   99999999999999999999998543     


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                                       |++       .++.++|||||||++|||++|+.||....
T Consensus       175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred             -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                             333       36889999999999999999999998754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-33  Score=322.96  Aligned_cols=242  Identities=16%  Similarity=0.135  Sum_probs=176.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc---cchHHHHHHHHHHhccCC-cceeeec-----------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC---QGDREFMAEMETLGKIKH-RNLVPLL-----------  796 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~-----------  796 (1013)
                      +..|...++||+|+||+||+|++. +|+.||||++.....   ...+.+.+|+.+++.++| ++.....           
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777889999999999999976 689999998763322   224678999999999976 2211111           


Q ss_pred             ----------cEEEe-----CCEEEEEEEcccCCCHHHHhccccc-CCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 036815          797 ----------GYCKI-----GEERLLVYEFMKFGSLEEVLHGRAK-ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI  860 (1013)
Q Consensus       797 ----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  860 (1013)
                                .++..     ....+++|+++ +++|.+++..... ......+++..+..++.|+++||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                      11111     12356777765 5899998852211 12245588999999999999999999999   99


Q ss_pred             EecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccc----------cCCCCCccchhHhHHHH
Q 036815          861 IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY----------QSFRCTAKGDVYSFGVV  930 (1013)
Q Consensus       861 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~i  930 (1013)
                      |||||||+||+++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999999865432     334567 999999999          56668899999999999


Q ss_pred             HHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCC
Q 036815          931 LLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010 (1013)
Q Consensus       931 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1010 (1013)
                      +|||++|+.||.........              ...+.     .....+          ..+.+++.+||+.||++|||
T Consensus       307 l~elltg~~Pf~~~~~~~~~--------------~~~~~-----~~~~~~----------~~~~~li~~~l~~dP~~Rpt  357 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGS--------------EWIFR-----SCKNIP----------QPVRALLEGFLRYPKEDRLL  357 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCS--------------GGGGS-----SCCCCC----------HHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHCCCCCCCcchhhhH--------------HHHHh-----hcccCC----------HHHHHHHHHHccCChhhCcC
Confidence            99999999999764321110              00000     000111          12568999999999999999


Q ss_pred             CCC
Q 036815         1011 MLQ 1013 (1013)
Q Consensus      1011 ~~e 1013 (1013)
                      +.|
T Consensus       358 ~~~  360 (413)
T 3dzo_A          358 PLQ  360 (413)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=4e-34  Score=318.69  Aligned_cols=190  Identities=19%  Similarity=0.201  Sum_probs=158.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc--------cchHHHHHHHHHHhccC-----------------
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC--------QGDREFMAEMETLGKIK-----------------  788 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~-----------------  788 (1013)
                      ++|++.+.||+|+||+||+|++ +++.||||++.....        ...+.+.+|++++++++                 
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            5688999999999999999998 589999999865421        22377899999998886                 


Q ss_pred             ---------CcceeeeccEEEe-------------CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHH
Q 036815          789 ---------HRNLVPLLGYCKI-------------GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA  846 (1013)
Q Consensus       789 ---------h~niv~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~  846 (1013)
                               ||||+++++++.+             ++..|+||||+++|++.+.+..       ..+++..++.++.||+
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHH
Confidence                     4555555555543             6789999999999976666632       2379999999999999


Q ss_pred             HHHHHHH-hcCCCCeEecCCCcccEEeCCCC--------------------cEEEeecccceeccccCcceeeeeeccCC
Q 036815          847 KGLCFLH-HNCIPHIIHRDMKSSNVLLDHEM--------------------EARVSDFGMARLISALDTHLSVSTLAGTP  905 (1013)
Q Consensus       847 ~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~  905 (1013)
                      .||+||| ++   +|+||||||+||+++.++                    .+||+|||+|+....       ....||+
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~  241 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD  241 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence            9999999 88   999999999999999887                    899999999987643       1347999


Q ss_pred             CccCcccccCCCCCccchhHhHHHH-HHHHHcCCCCCC
Q 036815          906 GYVPPEYYQSFRCTAKGDVYSFGVV-LLELLTGKRPTD  942 (1013)
Q Consensus       906 ~y~aPE~~~~~~~~~~~DvwslG~i-l~elltg~~pf~  942 (1013)
                      .|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            999999998766 899999998777 778888999974

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.98  E-value=3.3e-31  Score=294.46  Aligned_cols=288  Identities=24%  Similarity=0.305  Sum_probs=170.8

Q ss_pred             CccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEe
Q 036815           75 KLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRL  154 (1013)
Q Consensus        75 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  154 (1013)
                      +++.++++++.++..+..+      .++|++|+|++|.|+++.+..|.++++|++|++++|++++..|..|+++++|++|
T Consensus        34 ~l~~l~~~~~~l~~ip~~~------~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  107 (332)
T 2ft3_A           34 HLRVVQCSDLGLKAVPKEI------SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKL  107 (332)
T ss_dssp             ETTEEECCSSCCSSCCSCC------CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEE
T ss_pred             cCCEEECCCCCccccCCCC------CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEE
Confidence            6788888888887544432      3678889999998888888889999999999999999988888889999999999


Q ss_pred             eCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCC-CCChhhhhcCCCCcEEEcccc
Q 036815          155 DLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISG-PFPDSVLENLGSLESLILSNN  233 (1013)
Q Consensus       155 ~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~~l~~L~~L~L~~n  233 (1013)
                      ++++|.++ .+|..++   ++|++|++++|+++...+..|.++++|++|++++|.++. ......+..+ +|++|++++|
T Consensus       108 ~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n  182 (332)
T 2ft3_A          108 YISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEA  182 (332)
T ss_dssp             ECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSS
T ss_pred             ECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCC
Confidence            99999888 6776654   577888888887776666667777777777777777642 1122223333 5555555555


Q ss_pred             cCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCC
Q 036815          234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP  313 (1013)
Q Consensus       234 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  313 (1013)
                      ++++ +|..+.  +                         +|++|++++|.+++..+..+..+++|+.|++++|++++..+
T Consensus       183 ~l~~-l~~~~~--~-------------------------~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  234 (332)
T 2ft3_A          183 KLTG-IPKDLP--E-------------------------TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN  234 (332)
T ss_dssp             BCSS-CCSSSC--S-------------------------SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCT
T ss_pred             CCCc-cCcccc--C-------------------------CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCCh
Confidence            5552 333222  3                         44445555555554444455555555555555555553322


Q ss_pred             cccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcC------CCCCCeEEecCCccC--CCCC
Q 036815          314 QELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS------CSNLEWISLTGNELT--GQIP  385 (1013)
Q Consensus       314 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~------l~~L~~L~L~~N~l~--~~~p  385 (1013)
                      ..+..+++|+.|++++|.++ .+|..+..+++|++|++++|++++..+..+..      ..+|+.|++++|++.  +..|
T Consensus       235 ~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~  313 (332)
T 2ft3_A          235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP  313 (332)
T ss_dssp             TGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCG
T ss_pred             hHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCc
Confidence            22222222222222222222 33344444555555555555555433333332      234555555555544  3444


Q ss_pred             hhhhccCCCceEEccCC
Q 036815          386 PEFSRLTRLAVLQLGNN  402 (1013)
Q Consensus       386 ~~~~~l~~L~~L~L~~N  402 (1013)
                      ..|..+++|+.|++++|
T Consensus       314 ~~~~~l~~L~~l~l~~n  330 (332)
T 2ft3_A          314 ATFRCVTDRLAIQFGNY  330 (332)
T ss_dssp             GGGTTBCCSTTEEC---
T ss_pred             ccccccchhhhhhcccc
Confidence            44555555555555544

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.5e-35  Score=346.26  Aligned_cols=310  Identities=21%  Similarity=0.210  Sum_probs=187.5

Q ss_pred             CcccEEECCCCCCCCCCCcc-ccCCCCCCEEecCCCcccc----cCcccccCCCCCCEeeCcCCcccCcCCccchhccC-
Q 036815          101 NSLLHLDLSQNHIMDVIPSS-LSNCTKLKILNLSFNLLAG----EIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACD-  174 (1013)
Q Consensus       101 ~~L~~L~Ls~n~i~~~~~~~-l~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~-  174 (1013)
                      ++|++|||++|++++..... +..+++|++|++++|++++    .++..+..+++|++|++++|.+++..+..++..++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            46777788777776654333 6677888888888888774    23556777788888888888887545555555555 


Q ss_pred             ---CCcEEECCCCCCCC----cCCccccCCCCCCEEEccCCCCCCCCChhhhh----cCCCCcEEEcccccCCCcC----
Q 036815          175 ---SLLELKLPHNNITG----SFPVTLSSCSWLQLLDLSNNNISGPFPDSVLE----NLGSLESLILSNNMISGSF----  239 (1013)
Q Consensus       175 ---~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~----~l~~L~~L~L~~n~l~~~~----  239 (1013)
                         +|++|+|++|+++.    .++..+..+++|++|++++|.+++..+..+..    ..++|++|++++|++++..    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               68888888888874    34777888889999999999886433333222    3457888888888887533    


Q ss_pred             CcCCCCCCCcCEEEecCCeecccCCCCCCC----CCCCCceEEcCCCccccc----CCccccccCcccEEEeeCCccCCC
Q 036815          240 PDSISSCKTLRIVDFSSNRVSGIIPPDICP----GVSSLEELRLPDNLITGV----IPGQLSECTQLKVIDLSLNYLNGS  311 (1013)
Q Consensus       240 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~  311 (1013)
                      +..+..+++|+.|++++|.+++..+..+..    ..++|+.|++++|.+++.    ++..+..+++|+.|++++|.+++.
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence            445556678888888888776433222211    133566666666666543    344455566666666666655421


Q ss_pred             CCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccccc----CchhhcCCCCCCeEEecCCccCCCCChh
Q 036815          312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE----IPAELFSCSNLEWISLTGNELTGQIPPE  387 (1013)
Q Consensus       312 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~  387 (1013)
                      ....+.                   +..+..+++|++|++++|.++..    ++..+..+++|++|+|++|.+++..+..
T Consensus       243 ~~~~l~-------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~  303 (461)
T 1z7x_W          243 GMAELC-------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL  303 (461)
T ss_dssp             HHHHHH-------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred             HHHHHH-------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHH
Confidence            100000                   11122345666666666666542    4555555666666666666665433333


Q ss_pred             hhcc-----CCCceEEccCCeeeee----cCCCCcCCCCCcEEEccCCcCC
Q 036815          388 FSRL-----TRLAVLQLGNNRFKGE----IPGELGNCSSLVWLDLNSNNLT  429 (1013)
Q Consensus       388 ~~~l-----~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~  429 (1013)
                      +...     ++|+.|+|++|.+++.    +|..+..+++|++||+++|.++
T Consensus       304 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~  354 (461)
T 1z7x_W          304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE  354 (461)
T ss_dssp             HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCH
T ss_pred             HHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccc
Confidence            3332     3555555555555433    2334444455555555555444

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=1.9e-30  Score=288.09  Aligned_cols=289  Identities=25%  Similarity=0.320  Sum_probs=169.0

Q ss_pred             CccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEe
Q 036815           75 KLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRL  154 (1013)
Q Consensus        75 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  154 (1013)
                      +++.++++++.++..+..+      .++++.|+|++|+|+++.+..|.++++|++|+|++|++++..|..|+++++|++|
T Consensus        32 ~l~~l~~~~~~l~~lp~~~------~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (330)
T 1xku_A           32 HLRVVQCSDLGLEKVPKDL------PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL  105 (330)
T ss_dssp             ETTEEECTTSCCCSCCCSC------CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred             CCeEEEecCCCccccCccC------CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEE
Confidence            6788888888887544332      3678889999998888877788899999999999999988888889999999999


Q ss_pred             eCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCC-CChhhhhcCCCCcEEEcccc
Q 036815          155 DLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP-FPDSVLENLGSLESLILSNN  233 (1013)
Q Consensus       155 ~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~~l~~L~~L~L~~n  233 (1013)
                      ++++|.++ .+|..++   ++|++|++++|++++..+..+.++++|++|++++|.++.. .....+..+++|++|++++|
T Consensus       106 ~Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n  181 (330)
T 1xku_A          106 YLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT  181 (330)
T ss_dssp             ECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred             ECCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC
Confidence            99999888 6776654   5677777777777766666677777777777777766421 22233455566666666666


Q ss_pred             cCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCC
Q 036815          234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP  313 (1013)
Q Consensus       234 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  313 (1013)
                      +++. +|..+.                           ++|+.|++++|.+++..+..+..+++|+.|++++|.+++..+
T Consensus       182 ~l~~-l~~~~~---------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  233 (330)
T 1xku_A          182 NITT-IPQGLP---------------------------PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN  233 (330)
T ss_dssp             CCCS-CCSSCC---------------------------TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECT
T ss_pred             cccc-CCcccc---------------------------ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeCh
Confidence            5552 332222                           345555555555555555555556666666666665553322


Q ss_pred             cccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcC------CCCCCeEEecCCccCC--CCC
Q 036815          314 QELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFS------CSNLEWISLTGNELTG--QIP  385 (1013)
Q Consensus       314 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~------l~~L~~L~L~~N~l~~--~~p  385 (1013)
                      ..+..+++|+.|++++|.++ .+|..+..+++|++|++++|++++..+..+..      ...|+.|++++|++..  ..|
T Consensus       234 ~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~  312 (330)
T 1xku_A          234 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP  312 (330)
T ss_dssp             TTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCG
T ss_pred             hhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCc
Confidence            22222222222222222222 33334444455555555555555333333322      1334444444444431  233


Q ss_pred             hhhhccCCCceEEccCC
Q 036815          386 PEFSRLTRLAVLQLGNN  402 (1013)
Q Consensus       386 ~~~~~l~~L~~L~L~~N  402 (1013)
                      ..|..++.++.++|++|
T Consensus       313 ~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          313 STFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             GGGTTCCCGGGEEC---
T ss_pred             cccccccceeEEEeccc
Confidence            34444444444444444

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=3.2e-35  Score=343.35  Aligned_cols=260  Identities=20%  Similarity=0.179  Sum_probs=144.1

Q ss_pred             CCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCc----CCccccCCCCCCEEEccCCCCCCCCChhhhhcCC--
Q 036815          150 SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGS----FPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLG--  223 (1013)
Q Consensus       150 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~--  223 (1013)
                      +|++|++++|.+++.....++..+++|++|+|++|++++.    ++..+..+++|++|++++|.+++..+..++..++  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            3455555555554322233344455555555555555532    2445556677777777777765433444445555  


Q ss_pred             --CCcEEEcccccCCC----cCCcCCCCCCCcCEEEecCCeecccCCCCC----CCCCCCCceEEcCCCcccccC----C
Q 036815          224 --SLESLILSNNMISG----SFPDSISSCKTLRIVDFSSNRVSGIIPPDI----CPGVSSLEELRLPDNLITGVI----P  289 (1013)
Q Consensus       224 --~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~~l~~L~~L~L~~n~l~~~~----~  289 (1013)
                        +|++|++++|+++.    .++..+..+++|++|++++|.+++..+..+    ....++|++|++++|.+++..    +
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  163 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  163 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence              57777777777763    346667777777777777777764332221    223456888888888777643    4


Q ss_pred             ccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCc-CCCCCCceEECcccccccc----Cchhh
Q 036815          290 GQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPEL-GKCKNLKDLILNNNKLSGE----IPAEL  364 (1013)
Q Consensus       290 ~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~----~p~~l  364 (1013)
                      ..+..+++|++|++++|.+++..+..+..                    .+ ..+++|++|++++|.+++.    ++..+
T Consensus       164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~--------------------~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  223 (461)
T 1z7x_W          164 SVLRAKPDFKELTVSNNDINEAGVRVLCQ--------------------GLKDSPCQLEALKLESCGVTSDNCRDLCGIV  223 (461)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHH--------------------HHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred             HHHhhCCCCCEEECcCCCcchHHHHHHHH--------------------HHhcCCCCceEEEccCCCCcHHHHHHHHHHH
Confidence            55666788888888888876433322221                    00 0123455555555555532    34445


Q ss_pred             cCCCCCCeEEecCCccCCCCC-----hhhhccCCCceEEccCCeeeee----cCCCCcCCCCCcEEEccCCcCC
Q 036815          365 FSCSNLEWISLTGNELTGQIP-----PEFSRLTRLAVLQLGNNRFKGE----IPGELGNCSSLVWLDLNSNNLT  429 (1013)
Q Consensus       365 ~~l~~L~~L~L~~N~l~~~~p-----~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~  429 (1013)
                      ..+++|++|++++|.+++...     ..+..+++|+.|++++|++++.    ++..+.++++|++|++++|.++
T Consensus       224 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~  297 (461)
T 1z7x_W          224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG  297 (461)
T ss_dssp             HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred             HhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence            555555555555555543211     1112355555555555555532    3444555555666666655554

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=2.1e-30  Score=287.86  Aligned_cols=288  Identities=25%  Similarity=0.271  Sum_probs=236.1

Q ss_pred             cceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeC
Q 036815            2 LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL   81 (1013)
Q Consensus         2 l~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~L   81 (1013)
                      ++.++++++.++.+|..   .++.+++|+|++|++.+ ++...|.++++|++|+|++|.+++..| ..+..+++|++|+|
T Consensus        33 l~~l~~~~~~l~~lp~~---~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L  107 (330)
T 1xku_A           33 LRVVQCSDLGLEKVPKD---LPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISP-GAFAPLVKLERLYL  107 (330)
T ss_dssp             TTEEECTTSCCCSCCCS---CCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEEC
T ss_pred             CeEEEecCCCccccCcc---CCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCH-HHhcCCCCCCEEEC
Confidence            67899999999999875   45789999999999976 566678999999999999999985444 45788999999999


Q ss_pred             CCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccc--cCcccccCCCCCCEeeCcCC
Q 036815           82 SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAG--EIPRTFGQLSSLQRLDLSNN  159 (1013)
Q Consensus        82 s~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~n  159 (1013)
                      ++|+++..+..+      +++|++|++++|.++++.+..|.++++|++|++++|.++.  ..+..|.++++|++|++++|
T Consensus       108 s~n~l~~l~~~~------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n  181 (330)
T 1xku_A          108 SKNQLKELPEKM------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT  181 (330)
T ss_dssp             CSSCCSBCCSSC------CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred             CCCcCCccChhh------cccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC
Confidence            999998554432      3789999999999999888889999999999999999964  67788999999999999999


Q ss_pred             cccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcC
Q 036815          160 HITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSF  239 (1013)
Q Consensus       160 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  239 (1013)
                      .++ .+|..++   ++|++|++++|++++..+..+..+++|++|++++|.+++ ++...+..+++|++|++++|+++ .+
T Consensus       182 ~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~-~l  255 (330)
T 1xku_A          182 NIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KV  255 (330)
T ss_dssp             CCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE-ECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred             ccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce-eChhhccCCCCCCEEECCCCcCc-cC
Confidence            998 6777654   789999999999998888899999999999999999984 44445788999999999999998 67


Q ss_pred             CcCCCCCCCcCEEEecCCeecccCCCCCCCC------CCCCceEEcCCCcccc--cCCccccccCcccEEEeeCCc
Q 036815          240 PDSISSCKTLRIVDFSSNRVSGIIPPDICPG------VSSLEELRLPDNLITG--VIPGQLSECTQLKVIDLSLNY  307 (1013)
Q Consensus       240 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~------l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~ls~N~  307 (1013)
                      |..+..+++|++|++++|++++. +...+..      ...++.|++.+|.+..  ..|..|..++.++.+++++|+
T Consensus       256 p~~l~~l~~L~~L~l~~N~i~~~-~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          256 PGGLADHKYIQVVYLHNNNISAI-GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CTTTTTCSSCCEEECCSSCCCCC-CTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ChhhccCCCcCEEECCCCcCCcc-ChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            88899999999999999999844 4444322      3567777777777653  445667777777777777764

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=1.6e-30  Score=289.02  Aligned_cols=287  Identities=24%  Similarity=0.265  Sum_probs=235.8

Q ss_pred             cceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeC
Q 036815            2 LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL   81 (1013)
Q Consensus         2 l~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~L   81 (1013)
                      ++.++++++.++.+|..   .++++++|+|++|++.+ ++...|.++++|++|+|++|.+++..| ..+..+++|++|+|
T Consensus        35 l~~l~~~~~~l~~ip~~---~~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           35 LRVVQCSDLGLKAVPKE---ISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHE-KAFSPLRKLQKLYI  109 (332)
T ss_dssp             TTEEECCSSCCSSCCSC---CCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECG-GGSTTCTTCCEEEC
T ss_pred             CCEEECCCCCccccCCC---CCCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCH-hHhhCcCCCCEEEC
Confidence            67899999999999876   35689999999999976 566678999999999999999984434 55788999999999


Q ss_pred             CCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccc--cCcccccCCCCCCEeeCcCC
Q 036815           82 SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAG--EIPRTFGQLSSLQRLDLSNN  159 (1013)
Q Consensus        82 s~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~n  159 (1013)
                      ++|+++..+...      .++|++|++++|.|+++.+..|.++++|++|++++|.++.  ..+..+..+ +|++|++++|
T Consensus       110 ~~n~l~~l~~~~------~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n  182 (332)
T 2ft3_A          110 SKNHLVEIPPNL------PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEA  182 (332)
T ss_dssp             CSSCCCSCCSSC------CTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSS
T ss_pred             CCCcCCccCccc------cccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCC
Confidence            999998554433      2789999999999999888889999999999999999963  677888888 9999999999


Q ss_pred             cccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcC
Q 036815          160 HITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSF  239 (1013)
Q Consensus       160 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  239 (1013)
                      .++ .+|..++   ++|++|++++|.+++..+..+..+++|++|++++|++++ ++...+..+++|++|++++|+++ .+
T Consensus       183 ~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~-~l  256 (332)
T 2ft3_A          183 KLT-GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RV  256 (332)
T ss_dssp             BCS-SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC-CCTTGGGGCTTCCEEECCSSCCC-BC
T ss_pred             CCC-ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc-CChhHhhCCCCCCEEECCCCcCe-ec
Confidence            999 5777654   689999999999998888899999999999999999984 45445788999999999999998 67


Q ss_pred             CcCCCCCCCcCEEEecCCeecccCCCCCCCC------CCCCceEEcCCCccc--ccCCccccccCcccEEEeeCCc
Q 036815          240 PDSISSCKTLRIVDFSSNRVSGIIPPDICPG------VSSLEELRLPDNLIT--GVIPGQLSECTQLKVIDLSLNY  307 (1013)
Q Consensus       240 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~------l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~ls~N~  307 (1013)
                      |..+..+++|+.|++++|++++. +...+..      ..+|+.|++.+|.+.  +..|..|..+++|+.+++++|+
T Consensus       257 p~~l~~l~~L~~L~l~~N~l~~~-~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          257 PAGLPDLKLLQVVYLHTNNITKV-GVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CTTGGGCTTCCEEECCSSCCCBC-CTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ChhhhcCccCCEEECCCCCCCcc-ChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            88899999999999999999844 4443332      356778888888776  5666777778888888887774

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=5.8e-29  Score=274.77  Aligned_cols=225  Identities=21%  Similarity=0.276  Sum_probs=171.0

Q ss_pred             CcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEe
Q 036815          296 TQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISL  375 (1013)
Q Consensus       296 ~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  375 (1013)
                      +.++.|++++|.++ .+|..++++++|+.|++++|.++ .+|..++++++|++|+|++|+++ .+|..+..+++|++|+|
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            34444455544444 44444444444444444444444 56666777777788888888877 67777778888888888


Q ss_pred             cCCccCCCCChhhhc---------cCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCC
Q 036815          376 TGNELTGQIPPEFSR---------LTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLG  446 (1013)
Q Consensus       376 ~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~  446 (1013)
                      ++|++.+.+|..+..         +++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|+.           
T Consensus       158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~-----------  224 (328)
T 4fcg_A          158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPA-----------  224 (328)
T ss_dssp             EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGG-----------
T ss_pred             CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchh-----------
Confidence            887777777776654         888888888888888 788888888888888888888874 3332           


Q ss_pred             CcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCCh
Q 036815          447 GFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPD  526 (1013)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~  526 (1013)
                                                                               +..+++|++|+|++|++.+.+|.
T Consensus       225 ---------------------------------------------------------l~~l~~L~~L~Ls~n~~~~~~p~  247 (328)
T 4fcg_A          225 ---------------------------------------------------------IHHLPKLEELDLRGCTALRNYPP  247 (328)
T ss_dssp             ---------------------------------------------------------GGGCTTCCEEECTTCTTCCBCCC
T ss_pred             ---------------------------------------------------------hccCCCCCEEECcCCcchhhhHH
Confidence                                                                     23346788899999888888998


Q ss_pred             hhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCC
Q 036815          527 EIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT  593 (1013)
Q Consensus       527 ~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~  593 (1013)
                      .++.+++|++|+|++|++.+.+|.+++++++|+.|+|++|++.|.+|+++++++.|+.++++.|.+.
T Consensus       248 ~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          248 IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             HhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            8999999999999998888889988999999999999999988999999999999999988877554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=9.3e-31  Score=315.90  Aligned_cols=83  Identities=13%  Similarity=0.063  Sum_probs=49.2

Q ss_pred             CCccCEEEccCCcccc-cCChhhhCCCCCcEEecCCCccCCC-CcccccCCCCcceEecCCccccCCCcccc-cCCCcce
Q 036815          507 YQTLEYLDLSYNQFRG-KIPDEIGDMIALQVLELAHNQLSGE-IPSSLGRLRNLGVFDASHNRLQGQIPESF-SNLSFLV  583 (1013)
Q Consensus       507 ~~~L~~L~ls~N~l~g-~iP~~i~~l~~L~~L~L~~n~l~g~-ip~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~l~  583 (1013)
                      +++|++|++++|++++ .+|..+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|++++.-...+ ..++.+.
T Consensus       462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~  541 (592)
T 3ogk_B          462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWN  541 (592)
T ss_dssp             CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEE
T ss_pred             CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcE
Confidence            3557777777777765 3444556677777777777776644 34444567777777777777665422222 3455555


Q ss_pred             EEECcC
Q 036815          584 QIDLSN  589 (1013)
Q Consensus       584 ~l~l~~  589 (1013)
                      ...+..
T Consensus       542 ~~~~~~  547 (592)
T 3ogk_B          542 IELIPS  547 (592)
T ss_dssp             EEEECC
T ss_pred             EEEecC
Confidence            444443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=2.8e-28  Score=269.33  Aligned_cols=224  Identities=19%  Similarity=0.239  Sum_probs=170.3

Q ss_pred             CCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECc
Q 036815          273 SLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILN  352 (1013)
Q Consensus       273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~  352 (1013)
                      .++.|+|++|.++ .+|..+.++++|++|++++|.++ .+|..++++++|+.|++++|.++ .+|..++++++|++|+|+
T Consensus        82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~  158 (328)
T 4fcg_A           82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR  158 (328)
T ss_dssp             TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred             ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence            3444444444444 33444444555555555555554 44555555555555555555554 556666777777777777


Q ss_pred             cccccccCchhhcC---------CCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEc
Q 036815          353 NNKLSGEIPAELFS---------CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL  423 (1013)
Q Consensus       353 ~N~l~~~~p~~l~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  423 (1013)
                      +|++.+.+|..+..         +++|++|+|++|+++ .+|..++.+++|+.|+|++|+++ .+|..+.++++|++|+|
T Consensus       159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~L  236 (328)
T 4fcg_A          159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL  236 (328)
T ss_dssp             EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEEC
T ss_pred             CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEEC
Confidence            77777777776654         899999999999998 88999999999999999999998 57778999999999999


Q ss_pred             cCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCccccc
Q 036815          424 NSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSL  503 (1013)
Q Consensus       424 ~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  503 (1013)
                      ++|++.+.+|..+                                                                   
T Consensus       237 s~n~~~~~~p~~~-------------------------------------------------------------------  249 (328)
T 4fcg_A          237 RGCTALRNYPPIF-------------------------------------------------------------------  249 (328)
T ss_dssp             TTCTTCCBCCCCT-------------------------------------------------------------------
T ss_pred             cCCcchhhhHHHh-------------------------------------------------------------------
Confidence            9999887776543                                                                   


Q ss_pred             ccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCcccc
Q 036815          504 FTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQ  569 (1013)
Q Consensus       504 ~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~  569 (1013)
                       ..+++|++|+|++|++.+.+|.+++.+++|++|+|++|++.|.+|+++++|++|+.++++.|.+.
T Consensus       250 -~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          250 -GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             -TCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             -cCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence             33567999999999999999999999999999999999999999999999999999999988775

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.95  E-value=8.5e-29  Score=277.53  Aligned_cols=206  Identities=19%  Similarity=0.258  Sum_probs=102.8

Q ss_pred             CCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCc
Q 036815          196 SCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLE  275 (1013)
Q Consensus       196 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  275 (1013)
                      .|+.....++++|.++ .+|..+   .++|++|++++|++++..+..+.++++|++|++++|++++ +++..+.++++|+
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~---~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~  103 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGL---TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLE  103 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTC---CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCC
T ss_pred             CCCCCeEeeCCCCCcc-cccccc---cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCc-cCHhhcCCCCCCC
Confidence            3444555666666666 555433   2356666666666664444455555555555555555552 2223333444444


Q ss_pred             eEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccc
Q 036815          276 ELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNK  355 (1013)
Q Consensus       276 ~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  355 (1013)
                      +|++++|++++..+..+..+++|++|++++|+++ .+|.                      ...+.++++|++|++++|+
T Consensus       104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~----------------------~~~~~~l~~L~~L~l~~n~  160 (353)
T 2z80_A          104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGE----------------------TSLFSHLTKLQILRVGNMD  160 (353)
T ss_dssp             EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCS----------------------SCSCTTCTTCCEEEEEESS
T ss_pred             EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCc----------------------hhhhccCCCCcEEECCCCc
Confidence            4444444444333333444444444444444443 1110                      0244555555555555552


Q ss_pred             -ccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCC-CcCCCCCcEEEccCCcCCc
Q 036815          356 -LSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGE-LGNCSSLVWLDLNSNNLTG  430 (1013)
Q Consensus       356 -l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~  430 (1013)
                       +.+..+..+..+++|++|++++|++++..|..+..+++|+.|++++|++. .+|.. +..+++|++|++++|++++
T Consensus       161 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~  236 (353)
T 2z80_A          161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT  236 (353)
T ss_dssp             SCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTT
T ss_pred             cccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccc
Confidence             44333445555555555555555555555555555555555555555554 22222 2335555555555555554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=2.4e-28  Score=268.15  Aligned_cols=257  Identities=19%  Similarity=0.261  Sum_probs=137.0

Q ss_pred             CcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCccccc--CCccccccCcccEEEeeCCccCCCCCcccccCcchHHH
Q 036815          248 TLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV--IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF  325 (1013)
Q Consensus       248 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L  325 (1013)
                      +|+.|++++|+++ .++...+..+++|+.|++++|.++..  .+..+..+++|++|++++|.++ .+             
T Consensus        29 ~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l-------------   93 (306)
T 2z66_A           29 SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM-------------   93 (306)
T ss_dssp             TCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EE-------------
T ss_pred             CCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cC-------------
Confidence            3444444444443 33333334444444444444444422  2344445666666666666655 22             


Q ss_pred             HhhhccccCCCCcCcCCCCCCceEECccccccccCc-hhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCee
Q 036815          326 IAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP-AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRF  404 (1013)
Q Consensus       326 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  404 (1013)
                                 |..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..|..+..+++|+.|+|++|++
T Consensus        94 -----------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  162 (306)
T 2z66_A           94 -----------SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF  162 (306)
T ss_dssp             -----------EEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred             -----------hhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence                       2334445555555555555553332 3455566666666666666655555566666666666666666


Q ss_pred             ee-ecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccc
Q 036815          405 KG-EIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQ  483 (1013)
Q Consensus       405 ~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  483 (1013)
                      ++ .+|..+.++++|++|++++|++++..|..                                                
T Consensus       163 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~------------------------------------------------  194 (306)
T 2z66_A          163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTA------------------------------------------------  194 (306)
T ss_dssp             GGGEECSCCTTCTTCCEEECTTSCCCEECTTT------------------------------------------------
T ss_pred             ccccchhHHhhCcCCCEEECCCCCcCCcCHHH------------------------------------------------
Confidence            54 45666666666666666666655433322                                                


Q ss_pred             cCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCC-CCcceEe
Q 036815          484 IPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRL-RNLGVFD  562 (1013)
Q Consensus       484 ~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l-~~L~~L~  562 (1013)
                                          +..+++|++|+|++|++++..+..++.+++|++|+|++|++++..|..+..+ ++|+.|+
T Consensus       195 --------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~  254 (306)
T 2z66_A          195 --------------------FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN  254 (306)
T ss_dssp             --------------------TTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEE
T ss_pred             --------------------hcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEE
Confidence                                1223456666666666665444456666666666666666666666666666 3666666


Q ss_pred             cCCccccCCCc--ccccCCCcceEEECcCCCCCCcCCC
Q 036815          563 ASHNRLQGQIP--ESFSNLSFLVQIDLSNNELTGPIPQ  598 (1013)
Q Consensus       563 ls~N~l~g~~p--~~~~~l~~l~~l~l~~n~l~~~~p~  598 (1013)
                      |++|.+++.-+  .....+...+.+.+..+.+.+..|.
T Consensus       255 L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          255 LTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             CTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             ccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence            66666665322  1111222333344455555555554

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=8.9e-27  Score=276.44  Aligned_cols=267  Identities=26%  Similarity=0.317  Sum_probs=159.7

Q ss_pred             CcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEec
Q 036815          176 LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS  255 (1013)
Q Consensus       176 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  255 (1013)
                      ++.|++++|.++ .+|..+.  ++|++|+|++|+++ .+|.    .+++|++|+|++|+++ .+|.   .+++|++|+++
T Consensus        42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred             CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence            444444444444 2222222  44555555555554 3333    2445555555555554 2332   34555555555


Q ss_pred             CCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCC
Q 036815          256 SNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGK  335 (1013)
Q Consensus       256 ~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~  335 (1013)
                      +|++++ +|.    .+++|+.|++++|++++ +|..   +++|++|++++|.+++ +|                      
T Consensus       110 ~N~l~~-l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~----------------------  157 (622)
T 3g06_A          110 SNPLTH-LPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LP----------------------  157 (622)
T ss_dssp             SCCCCC-CCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CC----------------------
T ss_pred             CCcCCC-CCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cC----------------------
Confidence            555542 222    24455556666665553 2322   3566777777776652 22                      


Q ss_pred             CCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCC
Q 036815          336 IPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNC  415 (1013)
Q Consensus       336 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  415 (1013)
                        .   .+.+|+.|++++|+++ .+|   ..+++|+.|++++|.+++ +|..   +++|+.|++++|.++ .+|..   +
T Consensus       158 --~---~~~~L~~L~L~~N~l~-~l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~  220 (622)
T 3g06_A          158 --A---LPSELCKLWAYNNQLT-SLP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---P  220 (622)
T ss_dssp             --C---CCTTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---C
T ss_pred             --C---ccCCCCEEECCCCCCC-CCc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---C
Confidence              1   1245667777777776 355   345677777777777773 4432   356777777777777 45543   4


Q ss_pred             CCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCcccccccccc
Q 036815          416 SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARM  495 (1013)
Q Consensus       416 ~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  495 (1013)
                      ++|++|+|++|++++ +|.                                                             
T Consensus       221 ~~L~~L~Ls~N~L~~-lp~-------------------------------------------------------------  238 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LPV-------------------------------------------------------------  238 (622)
T ss_dssp             TTCCEEECCSSCCSC-CCC-------------------------------------------------------------
T ss_pred             CCCCEEEccCCccCc-CCC-------------------------------------------------------------
Confidence            677888888877763 321                                                             


Q ss_pred             ccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCccc
Q 036815          496 YSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPES  575 (1013)
Q Consensus       496 ~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~  575 (1013)
                                .+++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .||..++++++|+.|+|++|.++|.+|..
T Consensus       239 ----------~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~  303 (622)
T 3g06_A          239 ----------LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA  303 (622)
T ss_dssp             ----------CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHH
T ss_pred             ----------CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHH
Confidence                      1245777888888887 5776   5677888888888888 77888888888888888888888877777


Q ss_pred             ccCCC
Q 036815          576 FSNLS  580 (1013)
Q Consensus       576 ~~~l~  580 (1013)
                      +..++
T Consensus       304 l~~L~  308 (622)
T 3g06_A          304 LREIT  308 (622)
T ss_dssp             HHHHH
T ss_pred             HHhcc
Confidence            66554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=1.6e-30  Score=313.82  Aligned_cols=409  Identities=15%  Similarity=0.075  Sum_probs=266.7

Q ss_pred             CCCcccEEECCCCCC-C--CCCCcccc------------CCCCCCEEecCCCcccccCcccccCC--CCCCEeeCcCCc-
Q 036815           99 SCNSLLHLDLSQNHI-M--DVIPSSLS------------NCTKLKILNLSFNLLAGEIPRTFGQL--SSLQRLDLSNNH-  160 (1013)
Q Consensus        99 ~~~~L~~L~Ls~n~i-~--~~~~~~l~------------~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~n~-  160 (1013)
                      .+++|++|+|+++.. .  +.+|..+.            .+++|++|+|++|.+++..+..+...  .+|++|++++|. 
T Consensus        71 ~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~  150 (592)
T 3ogk_B           71 RFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSG  150 (592)
T ss_dssp             HCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEE
T ss_pred             hCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCC
Confidence            466788888877532 1  12222222            57788888888887776555555553  348888887775 


Q ss_pred             ccCcCCccchhccCCCcEEECCCCCCCCcC----CccccCCCCCCEEEccCCCCCCCCC---hhhhhcCCCCcEEEcccc
Q 036815          161 ITGWIPSELGNACDSLLELKLPHNNITGSF----PVTLSSCSWLQLLDLSNNNISGPFP---DSVLENLGSLESLILSNN  233 (1013)
Q Consensus       161 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~~---~~~~~~l~~L~~L~L~~n  233 (1013)
                      ++......+...+++|++|+|++|.+++..    +..+..+++|++|++++|.+++...   ..++.++++|++|++++|
T Consensus       151 ~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~  230 (592)
T 3ogk_B          151 FTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF  230 (592)
T ss_dssp             EEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSC
T ss_pred             cCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCc
Confidence            321111223345677888888888776552    2234567778888888877752211   123456777888888877


Q ss_pred             cCCCcCCcCCCCCCCcCEEEecCCeeccc--CCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCC
Q 036815          234 MISGSFPDSISSCKTLRIVDFSSNRVSGI--IPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS  311 (1013)
Q Consensus       234 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  311 (1013)
                      .+.+ ++..+..+++|+.|+++.+.....  .....+..+++|+.|.+.++... .+|..+..+++|++|++++|.+++.
T Consensus       231 ~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~  308 (592)
T 3ogk_B          231 EILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETE  308 (592)
T ss_dssp             BGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHH
T ss_pred             cHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHH
Confidence            7764 556677777777777775322100  00112233455666665554322 3444555556666666666554321


Q ss_pred             CCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecC-----------Ccc
Q 036815          312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTG-----------NEL  380 (1013)
Q Consensus       312 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~-----------N~l  380 (1013)
                      .                       ++..+..+++|++|+++++...+.++..+..+++|++|+|++           |.+
T Consensus       309 ~-----------------------~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~  365 (592)
T 3ogk_B          309 D-----------------------HCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLV  365 (592)
T ss_dssp             H-----------------------HHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCC
T ss_pred             H-----------------------HHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCcc
Confidence            1                       112356778899999984433334555556789999999993           566


Q ss_pred             CCC-CChhhhccCCCceEEccCCeeeeecCCCCcC-CCCCcEEEcc----CCcCCcCCCchhhhccCCCCCCCcccCCce
Q 036815          381 TGQ-IPPEFSRLTRLAVLQLGNNRFKGEIPGELGN-CSSLVWLDLN----SNNLTGDIPPRLGRQLGAKPLGGFLSSNTL  454 (1013)
Q Consensus       381 ~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l~----~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~  454 (1013)
                      ++. ++..+..+++|+.|+++.|++++..+..+.. +++|+.|+++    .|.+++. |..-                  
T Consensus       366 ~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~-p~~~------------------  426 (592)
T 3ogk_B          366 SQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL-PLDN------------------  426 (592)
T ss_dssp             CHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSC-CCHH------------------
T ss_pred             CHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCc-hHHH------------------
Confidence            543 2233456899999999999998877777765 8899999996    5555532 1100                  


Q ss_pred             EEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCC--cccccCChhhhC-C
Q 036815          455 VFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYN--QFRGKIPDEIGD-M  531 (1013)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N--~l~g~iP~~i~~-l  531 (1013)
                                                                  .++..+..+++|++|+++++  .+++..+..++. +
T Consensus       427 --------------------------------------------~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~  462 (592)
T 3ogk_B          427 --------------------------------------------GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYS  462 (592)
T ss_dssp             --------------------------------------------HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSC
T ss_pred             --------------------------------------------HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhC
Confidence                                                        01122345678999999853  477777777765 8


Q ss_pred             CCCcEEecCCCccCC-CCcccccCCCCcceEecCCccccCC-CcccccCCCcceEEECcCCCCCCc
Q 036815          532 IALQVLELAHNQLSG-EIPSSLGRLRNLGVFDASHNRLQGQ-IPESFSNLSFLVQIDLSNNELTGP  595 (1013)
Q Consensus       532 ~~L~~L~L~~n~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~-~p~~~~~l~~l~~l~l~~n~l~~~  595 (1013)
                      ++|++|+|++|++++ .+|..+..+++|+.|+|++|.+++. +|..+..+++|+.|+|++|++++.
T Consensus       463 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          463 PNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             TTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             ccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            999999999999987 4677778999999999999999865 455567899999999999998864

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=2.5e-29  Score=276.30  Aligned_cols=206  Identities=23%  Similarity=0.245  Sum_probs=144.5

Q ss_pred             CcchHHHHhhhccccCCCCcCc--CCCCCCceEECccccccccCchhhcCC-----CCCCeEEecCCccCCCCChhhhcc
Q 036815          319 LEHLEQFIAWFNGLEGKIPPEL--GKCKNLKDLILNNNKLSGEIPAELFSC-----SNLEWISLTGNELTGQIPPEFSRL  391 (1013)
Q Consensus       319 l~~L~~L~l~~n~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~l  391 (1013)
                      +++|+.|++++|.+++.+|..+  +.+++|++|+|++|++++. |..+..+     ++|++|+|++|++++..|..|+.+
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            3444444444444444455544  6677777777777777755 6666665     777777777777776666777777


Q ss_pred             CCCceEEccCCeeeee--cCCCC--cCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCC
Q 036815          392 TRLAVLQLGNNRFKGE--IPGEL--GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGV  467 (1013)
Q Consensus       392 ~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (1013)
                      ++|++|+|++|++.+.  +|..+  .++++|++|+|++|++++. |..                                
T Consensus       173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~--------------------------------  219 (312)
T 1wwl_A          173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP-SGV--------------------------------  219 (312)
T ss_dssp             SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCH-HHH--------------------------------
T ss_pred             CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcch-HHH--------------------------------
Confidence            7777777777776654  23333  6777777777777776521 100                                


Q ss_pred             CcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCC-hhhhCCCCCcEEecCCCccCC
Q 036815          468 GGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIP-DEIGDMIALQVLELAHNQLSG  546 (1013)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP-~~i~~l~~L~~L~L~~n~l~g  546 (1013)
                                                      ....+..+++|++|||++|++++.+| ..+..+++|++|+|++|+++ 
T Consensus       220 --------------------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-  266 (312)
T 1wwl_A          220 --------------------------------CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-  266 (312)
T ss_dssp             --------------------------------HHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-
T ss_pred             --------------------------------HHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-
Confidence                                            00123345778899999999987775 45667888999999999998 


Q ss_pred             CCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCc
Q 036815          547 EIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGP  595 (1013)
Q Consensus       547 ~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~  595 (1013)
                      .+|..+.  ++|+.|||++|+|++. |. +..+++|+.|+|++|++++.
T Consensus       267 ~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~  311 (312)
T 1wwl_A          267 QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS  311 (312)
T ss_dssp             SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred             hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence            8888877  8899999999999865 66 88889999999999988863

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=3.9e-28  Score=266.45  Aligned_cols=253  Identities=20%  Similarity=0.224  Sum_probs=194.0

Q ss_pred             CEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCC--CChhhhhcCCCCcEEE
Q 036815          152 QRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP--FPDSVLENLGSLESLI  229 (1013)
Q Consensus       152 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~~~~~~~~l~~L~~L~  229 (1013)
                      +.++++++.++ .+|..++   ++|++|+|++|+++.+.+..|.++++|++|++++|+++..  .+.. +..+++|++|+
T Consensus        10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~~~~~~L~~L~   84 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS-DFGTTSLKYLD   84 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHH-HHSCSCCCEEE
T ss_pred             CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccc-cccccccCEEE
Confidence            46777777777 6676553   5688888888888766666678888888888888887622  1333 45678888888


Q ss_pred             cccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccC
Q 036815          230 LSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLN  309 (1013)
Q Consensus       230 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~  309 (1013)
                      +++|.++ .++..+..+++|++|++++|++++..+...+..+++|++|++++|.+.+..+..+..+++|++|++++|.++
T Consensus        85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  163 (306)
T 2z66_A           85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ  163 (306)
T ss_dssp             CCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred             CCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence            8888887 466678888888888888888885544456677888888888888888777777888888888888888776


Q ss_pred             CCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhh
Q 036815          310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFS  389 (1013)
Q Consensus       310 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  389 (1013)
                      +.                       .+|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+.
T Consensus       164 ~~-----------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  220 (306)
T 2z66_A          164 EN-----------------------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK  220 (306)
T ss_dssp             GG-----------------------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT
T ss_pred             cc-----------------------cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc
Confidence            31                       2455667777888888888888877777888888888888888888876666788


Q ss_pred             ccCCCceEEccCCeeeeecCCCCcCCC-CCcEEEccCCcCCcCCC
Q 036815          390 RLTRLAVLQLGNNRFKGEIPGELGNCS-SLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       390 ~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p  433 (1013)
                      .+++|+.|+|++|++++..|..+..++ +|++|+|++|++++..+
T Consensus       221 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~  265 (306)
T 2z66_A          221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  265 (306)
T ss_dssp             TCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred             CcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence            888888888888888888888888874 88888888888887643

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.95  E-value=2e-27  Score=266.35  Aligned_cols=280  Identities=23%  Similarity=0.224  Sum_probs=158.7

Q ss_pred             CCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcE
Q 036815           99 SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLE  178 (1013)
Q Consensus        99 ~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~  178 (1013)
                      .|+.....+++++.++.+ |..+.  ++|++|++++|++++..+..|.++++|++|++++|.++                
T Consensus        29 ~C~~~~~c~~~~~~l~~i-P~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~----------------   89 (353)
T 2z80_A           29 SCDRNGICKGSSGSLNSI-PSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN----------------   89 (353)
T ss_dssp             EECTTSEEECCSTTCSSC-CTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC----------------
T ss_pred             CCCCCeEeeCCCCCcccc-ccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC----------------
Confidence            345555567777777653 33332  36666666666666555556666666666666666665                


Q ss_pred             EECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCC-cCCCCCCCcCEEEecCC
Q 036815          179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFP-DSISSCKTLRIVDFSSN  257 (1013)
Q Consensus       179 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N  257 (1013)
                               +..+..|.++++|++|++++|+++ .++...+..+++|++|++++|+++...+ ..+..+++|++|++++|
T Consensus        90 ---------~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n  159 (353)
T 2z80_A           90 ---------TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM  159 (353)
T ss_dssp             ---------EECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEES
T ss_pred             ---------ccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCC
Confidence                     333334444444555555555544 3444444445555555555555542222 24445555555555555


Q ss_pred             e-ecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCC
Q 036815          258 R-VSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKI  336 (1013)
Q Consensus       258 ~-l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~  336 (1013)
                      . +. .++...+.++++|++|++++|.+++..|..+..+++|++|++++|.++ .+|..+                    
T Consensus       160 ~~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~--------------------  217 (353)
T 2z80_A          160 DTFT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF--------------------  217 (353)
T ss_dssp             SSCC-EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHH--------------------
T ss_pred             cccc-ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhh--------------------
Confidence            2 32 333334444555555555555555555555566666666666666554 222111                    


Q ss_pred             CcCcCCCCCCceEECccccccccCchhhc---CCCCCCeEEecCCccCC----CCChhhhccCCCceEEccCCeeeeecC
Q 036815          337 PPELGKCKNLKDLILNNNKLSGEIPAELF---SCSNLEWISLTGNELTG----QIPPEFSRLTRLAVLQLGNNRFKGEIP  409 (1013)
Q Consensus       337 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p  409 (1013)
                         +..+++|+.|++++|.+++..+..+.   ..+.++.++|++|.+++    .+|..+..+++|+.|+|++|+++ .+|
T Consensus       218 ---~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~  293 (353)
T 2z80_A          218 ---VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVP  293 (353)
T ss_dssp             ---HHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCC
T ss_pred             ---hhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccC
Confidence               11234445555555555433322222   24456666666666654    46777888888999999999988 666


Q ss_pred             CC-CcCCCCCcEEEccCCcCCcCCC
Q 036815          410 GE-LGNCSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       410 ~~-~~~l~~L~~L~l~~N~l~~~~p  433 (1013)
                      .. +.++++|++|+|++|++++..|
T Consensus       294 ~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          294 DGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             HHHHhcCCCCCEEEeeCCCccCcCC
Confidence            66 5889999999999999998876

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=2.7e-26  Score=272.36  Aligned_cols=263  Identities=25%  Similarity=0.331  Sum_probs=208.3

Q ss_pred             CCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceE
Q 036815          198 SWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL  277 (1013)
Q Consensus       198 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  277 (1013)
                      .+++.|++++|.++ .+|..+.   ++|++|++++|.++ .+|.   .+++|++|+|++|+|+ .+|.    .+++|++|
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L  106 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV----LPPGLLEL  106 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC---TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC----CCTTCCEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC---CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC----CCCCCCEE
Confidence            45888888888887 6776543   68888888888887 4454   4678888888888877 3443    46778888


Q ss_pred             EcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccc
Q 036815          278 RLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS  357 (1013)
Q Consensus       278 ~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  357 (1013)
                      ++++|.+++. |.   .+++|+.|++++|++++ +                        |..   +++|++|+|++|+++
T Consensus       107 ~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-l------------------------p~~---l~~L~~L~Ls~N~l~  154 (622)
T 3g06_A          107 SIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-L------------------------PVL---PPGLQELSVSDNQLA  154 (622)
T ss_dssp             EECSCCCCCC-CC---CCTTCCEEECCSSCCSC-C------------------------CCC---CTTCCEEECCSSCCS
T ss_pred             ECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-C------------------------CCC---CCCCCEEECcCCcCC
Confidence            8888877754 32   45677777777777762 2                        222   378999999999998


Q ss_pred             ccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhh
Q 036815          358 GEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLG  437 (1013)
Q Consensus       358 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  437 (1013)
                      + +|.   .+++|+.|++++|.++ .+|   ..+++|+.|+|++|+++ .+|..   +++|+.|++++|.++. +|.   
T Consensus       155 ~-l~~---~~~~L~~L~L~~N~l~-~l~---~~~~~L~~L~Ls~N~l~-~l~~~---~~~L~~L~L~~N~l~~-l~~---  218 (622)
T 3g06_A          155 S-LPA---LPSELCKLWAYNNQLT-SLP---MLPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPA---  218 (622)
T ss_dssp             C-CCC---CCTTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS-CCC---
T ss_pred             C-cCC---ccCCCCEEECCCCCCC-CCc---ccCCCCcEEECCCCCCC-CCCCc---cchhhEEECcCCcccc-cCC---
Confidence            4 554   3478999999999999 466   45788999999999998 46654   4789999999998862 221   


Q ss_pred             hccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccC
Q 036815          438 RQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSY  517 (1013)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~  517 (1013)
                                                                                          .+++|++|+|++
T Consensus       219 --------------------------------------------------------------------~~~~L~~L~Ls~  230 (622)
T 3g06_A          219 --------------------------------------------------------------------LPSGLKELIVSG  230 (622)
T ss_dssp             --------------------------------------------------------------------CCTTCCEEECCS
T ss_pred             --------------------------------------------------------------------CCCCCCEEEccC
Confidence                                                                                024699999999


Q ss_pred             CcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCC
Q 036815          518 NQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIP  597 (1013)
Q Consensus       518 N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p  597 (1013)
                      |+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+++|.+|
T Consensus       231 N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~  301 (622)
T 3g06_A          231 NRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL  301 (622)
T ss_dssp             SCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHH
T ss_pred             CccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCH
Confidence            99995 88   56789999999999999 7887   6789999999999999 899999999999999999999999887


Q ss_pred             C
Q 036815          598 Q  598 (1013)
Q Consensus       598 ~  598 (1013)
                      .
T Consensus       302 ~  302 (622)
T 3g06_A          302 Q  302 (622)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=2.6e-26  Score=265.42  Aligned_cols=251  Identities=19%  Similarity=0.230  Sum_probs=205.1

Q ss_pred             CCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEc
Q 036815          151 LQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLIL  230 (1013)
Q Consensus       151 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  230 (1013)
                      .+.++.+++.++ .+|..+.   ++++.|+|++|+|+.+.+..|.++++|++|+|++|+++ .++...|.++++|++|+|
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L  119 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLEL  119 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EECGGGGTTCSSCCEEEC
T ss_pred             CCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccChhhccCCccCCEEEC
Confidence            456777777777 6776654   56788888888888777778888888888888888887 455556778888888888


Q ss_pred             ccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCC-cccccCCccccccCcccEEEeeCCccC
Q 036815          231 SNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN-LITGVIPGQLSECTQLKVIDLSLNYLN  309 (1013)
Q Consensus       231 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~ls~N~l~  309 (1013)
                      ++|+++...+..+..+++|++|++++|+++ .++...+..+++|+.|++++| .+....+..|..+++|+.|++++|.++
T Consensus       120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~  198 (440)
T 3zyj_A          120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR  198 (440)
T ss_dssp             CSSCCSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred             CCCcCCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence            888888666667888888888888888887 556666777888888888884 455555567888888999999988887


Q ss_pred             CCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhh
Q 036815          310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFS  389 (1013)
Q Consensus       310 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  389 (1013)
                       .+|                         .+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..|.
T Consensus       199 -~~~-------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  252 (440)
T 3zyj_A          199 -EIP-------------------------NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD  252 (440)
T ss_dssp             -SCC-------------------------CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSST
T ss_pred             -ccc-------------------------ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhc
Confidence             222                         256778999999999999988889999999999999999999988888999


Q ss_pred             ccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCC
Q 036815          390 RLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       390 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  433 (1013)
                      .+++|+.|+|++|++++..+..+..+++|++|+|++|.+.++..
T Consensus       253 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          253 NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             CCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence            99999999999999997777788999999999999999987653

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.94  E-value=8.1e-27  Score=270.61  Aligned_cols=249  Identities=23%  Similarity=0.259  Sum_probs=179.4

Q ss_pred             CcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHh
Q 036815          248 TLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIA  327 (1013)
Q Consensus       248 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l  327 (1013)
                      ....++.+++.++ .+|..+.   ++++.|+|++|.+++..+..|.++++|+.|+|++|.+++                 
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-----------------  113 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-----------------  113 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE-----------------
T ss_pred             CCcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC-----------------
Confidence            3456777777776 4555442   467777777777777667777777777777777777663                 


Q ss_pred             hhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCC-eeee
Q 036815          328 WFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNN-RFKG  406 (1013)
Q Consensus       328 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~  406 (1013)
                             ..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..+..|..+++|+.|+|++| .+..
T Consensus       114 -------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~  186 (452)
T 3zyi_A          114 -------IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEY  186 (452)
T ss_dssp             -------ECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCE
T ss_pred             -------cChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccc
Confidence                   33455666777777777777777555556777777888888888777555567777888888888774 4443


Q ss_pred             ecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCc
Q 036815          407 EIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPT  486 (1013)
Q Consensus       407 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (1013)
                      ..+..|.++++|++|+|++|++++ +|.                                                    
T Consensus       187 i~~~~~~~l~~L~~L~L~~n~l~~-~~~----------------------------------------------------  213 (452)
T 3zyi_A          187 ISEGAFEGLFNLKYLNLGMCNIKD-MPN----------------------------------------------------  213 (452)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCSS-CCC----------------------------------------------------
T ss_pred             cChhhccCCCCCCEEECCCCcccc-ccc----------------------------------------------------
Confidence            333457788888888888887763 221                                                    


Q ss_pred             cccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCc
Q 036815          487 LKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHN  566 (1013)
Q Consensus       487 l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N  566 (1013)
                                       +..+++|++|||++|++++..|..++.+++|+.|+|++|++++..|..|..+++|+.|+|++|
T Consensus       214 -----------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  276 (452)
T 3zyi_A          214 -----------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN  276 (452)
T ss_dssp             -----------------CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             -----------------ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCC
Confidence                             123456788888888888777888888888888888888888777778888888888888888


Q ss_pred             cccCCCcccccCCCcceEEECcCCCCCC
Q 036815          567 RLQGQIPESFSNLSFLVQIDLSNNELTG  594 (1013)
Q Consensus       567 ~l~g~~p~~~~~l~~l~~l~l~~n~l~~  594 (1013)
                      +|++..+..+..+++|+.|+|++|++..
T Consensus       277 ~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          277 NLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             CCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             cCCccChHHhccccCCCEEEccCCCcCC
Confidence            8886666777888888888888887654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.94  E-value=1.3e-26  Score=251.35  Aligned_cols=254  Identities=23%  Similarity=0.255  Sum_probs=171.9

Q ss_pred             cEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeC
Q 036815           77 ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDL  156 (1013)
Q Consensus        77 ~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  156 (1013)
                      +.++++++.++.++..+      .++|++|+|++|.|+++.+..|.++++|++|++++|++++..+..|..+++|++|++
T Consensus        14 ~~~~c~~~~l~~ip~~~------~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l   87 (285)
T 1ozn_A           14 VTTSCPQQGLQAVPVGI------PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL   87 (285)
T ss_dssp             CEEECCSSCCSSCCTTC------CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             eEEEcCcCCcccCCcCC------CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeC
Confidence            45666666665433221      246677777777777666666777777777777777777666777777777777777


Q ss_pred             cCCc-ccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccC
Q 036815          157 SNNH-ITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI  235 (1013)
Q Consensus       157 s~n~-l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l  235 (1013)
                      ++|. ++ .++...+..+++|++|++++|++++..+..+.++++|++|++++|+++ .++...+..+++|++|++++|++
T Consensus        88 ~~n~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l  165 (285)
T 1ozn_A           88 SDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI  165 (285)
T ss_dssp             CSCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CCCCCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-ccCHhHhccCCCccEEECCCCcc
Confidence            7776 55 444444445677777777777777776777777788888888888777 45555567777888888888888


Q ss_pred             CCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcc
Q 036815          236 SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQE  315 (1013)
Q Consensus       236 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~  315 (1013)
                      ++..+..+..+++|+.|++++|.+++.. +..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++....+..
T Consensus       166 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~  244 (285)
T 1ozn_A          166 SSVPERAFRGLHSLDRLLLHQNRVAHVH-PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR  244 (285)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCEEC-TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred             cccCHHHhcCccccCEEECCCCcccccC-HhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH
Confidence            7655566777888888888888887443 344566788888888888888776677888888999999999887433221


Q ss_pred             cccCcchHHHHhhhccccCCCCcCc
Q 036815          316 LGKLEHLEQFIAWFNGLEGKIPPEL  340 (1013)
Q Consensus       316 l~~l~~L~~L~l~~n~l~~~~p~~~  340 (1013)
                       .-...++.+....+.+....|..+
T Consensus       245 -~~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          245 -PLWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             -HHHHHHHHCCSEECCCBEEESGGG
T ss_pred             -HHHHHHHhcccccCccccCCchHh
Confidence             112334444444444444444443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.94  E-value=3.2e-26  Score=265.56  Aligned_cols=251  Identities=21%  Similarity=0.241  Sum_probs=198.9

Q ss_pred             CCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEc
Q 036815          151 LQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLIL  230 (1013)
Q Consensus       151 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  230 (1013)
                      ...++.+++.++ .+|..+.   +++++|+|++|+|+++.+..|.++++|++|+|++|+++ .++...|.++++|++|+|
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L  130 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL  130 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEEC
T ss_pred             CcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcccCCEEEC
Confidence            456667777776 6666553   46777777777777777777777888888888888777 344445677778888888


Q ss_pred             ccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCC-cccccCCccccccCcccEEEeeCCccC
Q 036815          231 SNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN-LITGVIPGQLSECTQLKVIDLSLNYLN  309 (1013)
Q Consensus       231 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~ls~N~l~  309 (1013)
                      ++|+++...+..+..+++|++|++++|+++ .++...+..+++|+.|++++| .+....+..|..+++|+.|++++|.++
T Consensus       131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~  209 (452)
T 3zyi_A          131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK  209 (452)
T ss_dssp             CSSCCSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCCcCCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence            888877666666777788888888888777 556666677788888888774 455455556888888888888888877


Q ss_pred             CCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhh
Q 036815          310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFS  389 (1013)
Q Consensus       310 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  389 (1013)
                      + +|                         .+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..|.
T Consensus       210 ~-~~-------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  263 (452)
T 3zyi_A          210 D-MP-------------------------NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD  263 (452)
T ss_dssp             S-CC-------------------------CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred             c-cc-------------------------cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhc
Confidence            2 22                         356778999999999999988899999999999999999999988899999


Q ss_pred             ccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCC
Q 036815          390 RLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       390 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  433 (1013)
                      .+++|+.|+|++|++++..+..+..+++|++|+|++|.+.++..
T Consensus       264 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          264 GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             TCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred             CCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence            99999999999999997777788999999999999999987754

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.94  E-value=4.3e-27  Score=255.15  Aligned_cols=252  Identities=22%  Similarity=0.234  Sum_probs=160.3

Q ss_pred             CEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhh
Q 036815          250 RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWF  329 (1013)
Q Consensus       250 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~  329 (1013)
                      +.++.+++.++ .+|..+   .++|+.|++++|.+++..+..|..+++|++|++++|.+++.                  
T Consensus        14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~------------------   71 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI------------------   71 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE------------------
T ss_pred             eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCcccee------------------
Confidence            45555555555 334332   24566666666666665556666666777777776666532                  


Q ss_pred             ccccCCCCcCcCCCCCCceEECcccc-ccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeec
Q 036815          330 NGLEGKIPPELGKCKNLKDLILNNNK-LSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEI  408 (1013)
Q Consensus       330 n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  408 (1013)
                            .|..|..+++|++|++++|. +....|..+..+++|++|++++|.+++..|..|..+++|++|++++|++++..
T Consensus        72 ------~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  145 (285)
T 1ozn_A           72 ------DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP  145 (285)
T ss_dssp             ------CTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             ------CHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC
Confidence                  23445556666666666665 55444666666677777777777776666666777777777777777776555


Q ss_pred             CCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccc
Q 036815          409 PGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLK  488 (1013)
Q Consensus       409 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  488 (1013)
                      +..+.++++|++|+|++|++++..+.                                                      
T Consensus       146 ~~~~~~l~~L~~L~l~~n~l~~~~~~------------------------------------------------------  171 (285)
T 1ozn_A          146 DDTFRDLGNLTHLFLHGNRISSVPER------------------------------------------------------  171 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTT------------------------------------------------------
T ss_pred             HhHhccCCCccEEECCCCcccccCHH------------------------------------------------------
Confidence            55567777777777777766532211                                                      


Q ss_pred             cccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccc
Q 036815          489 SCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRL  568 (1013)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l  568 (1013)
                                    .|..+++|++|++++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|+|++|.+
T Consensus       172 --------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~  237 (285)
T 1ozn_A          172 --------------AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW  237 (285)
T ss_dssp             --------------TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred             --------------HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCc
Confidence                          122345677777777777777777777777777777777777765556677777777888888777


Q ss_pred             cCCCcccccCCCcceEEECcCCCCCCcCCC
Q 036815          569 QGQIPESFSNLSFLVQIDLSNNELTGPIPQ  598 (1013)
Q Consensus       569 ~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~  598 (1013)
                      ++..+.. .-...++.+..+.|.+.+..|.
T Consensus       238 ~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          238 VCDCRAR-PLWAWLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             ECSGGGH-HHHHHHHHCCSEECCCBEEESG
T ss_pred             cCCCCcH-HHHHHHHhcccccCccccCCch
Confidence            7544321 1123355556677777777775

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=5e-29  Score=274.54  Aligned_cols=266  Identities=22%  Similarity=0.238  Sum_probs=194.3

Q ss_pred             cEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeC
Q 036815          226 ESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSL  305 (1013)
Q Consensus       226 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~  305 (1013)
                      +.++++.+.+.......+..+++|+.|++++|++++ +++..+..+++|+.|++++|.+++..+  +..+++|++|++++
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCC-CCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCc-CCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            334444444443333333444556666666665553 222333445555555555555554433  55555555555555


Q ss_pred             CccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCC
Q 036815          306 NYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIP  385 (1013)
Q Consensus       306 N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  385 (1013)
                      |+++                        +     +...++|++|++++|++++..+.   .+++|++|++++|++++..|
T Consensus        90 n~l~------------------------~-----l~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~  137 (317)
T 3o53_A           90 NYVQ------------------------E-----LLVGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRD  137 (317)
T ss_dssp             SEEE------------------------E-----EEECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGG
T ss_pred             Cccc------------------------c-----ccCCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccc
Confidence            5554                        1     11237899999999999865443   36789999999999997777


Q ss_pred             hhhhccCCCceEEccCCeeeeecCCCCc-CCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCc
Q 036815          386 PEFSRLTRLAVLQLGNNRFKGEIPGELG-NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSC  464 (1013)
Q Consensus       386 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (1013)
                      ..+..+++|+.|+|++|++++..|..+. .+++|++|+|++|.+++. |.                              
T Consensus       138 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~------------------------------  186 (317)
T 3o53_A          138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG------------------------------  186 (317)
T ss_dssp             BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC------------------------------
T ss_pred             hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc------------------------------
Confidence            7899999999999999999987777774 789999999999988642 10                              


Q ss_pred             cCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCcc
Q 036815          465 KGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQL  544 (1013)
Q Consensus       465 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l  544 (1013)
                                                             ...+++|++|||++|+++ .+|..++.+++|++|+|++|++
T Consensus       187 ---------------------------------------~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l  226 (317)
T 3o53_A          187 ---------------------------------------QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL  226 (317)
T ss_dssp             ---------------------------------------CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCC
T ss_pred             ---------------------------------------ccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCcc
Confidence                                                   012467999999999999 5777799999999999999999


Q ss_pred             CCCCcccccCCCCcceEecCCcccc-CCCcccccCCCcceEEECc-CCCCCCcCCC
Q 036815          545 SGEIPSSLGRLRNLGVFDASHNRLQ-GQIPESFSNLSFLVQIDLS-NNELTGPIPQ  598 (1013)
Q Consensus       545 ~g~ip~~~~~l~~L~~L~ls~N~l~-g~~p~~~~~l~~l~~l~l~-~n~l~~~~p~  598 (1013)
                      + .+|..+..+++|+.|++++|.++ +.+|..+..++.|+.++++ .+.++|..|.
T Consensus       227 ~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             C-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             c-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            9 68999999999999999999999 8889999999999999999 4567776664

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=4.2e-28  Score=286.21  Aligned_cols=184  Identities=17%  Similarity=0.067  Sum_probs=128.6

Q ss_pred             ecccCCcEEEEEEEc-CCCEEEEEEeeccC----------ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEEE
Q 036815          742 IGCGGFGEVFKATLK-DGSSVAIKKLIRLS----------CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       742 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .+.|+.|.+..++.. .|+.||+|.+.+..          ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            455666666655432 58889999886432          11235699999999999 7999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++|++|.+++.....      ++..   +|+.||+.||+|+|++   |||||||||+|||++.+|++||+|||+|+..
T Consensus       322 Eyv~G~~L~d~i~~~~~------l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE------IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC------CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             ecCCCCcHHHHHHhCCC------CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            99999999999975432      5543   5899999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP  940 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  940 (1013)
                      ....  .......||+.|||||++.+. +..++|+||+|++.+++.++..+
T Consensus       390 ~~~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          390 PQDC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            4322  223456799999999999764 56789999999998877665444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=6.9e-28  Score=264.76  Aligned_cols=248  Identities=20%  Similarity=0.248  Sum_probs=207.4

Q ss_pred             ccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccc-cCCCCcCcC-------CCCCCceEECccccccccCchh
Q 036815          292 LSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGL-EGKIPPELG-------KCKNLKDLILNNNKLSGEIPAE  363 (1013)
Q Consensus       292 ~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~  363 (1013)
                      ++..++|+.|++++|.+  .+|..+...  |+.|++++|.+ ...+|..+.       ++++|++|+|++|++++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            45566777778888877  667666654  77788888877 345666665       7899999999999999999998


Q ss_pred             h--cCCCCCCeEEecCCccCCCCChhhhcc-----CCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCC--c
Q 036815          364 L--FSCSNLEWISLTGNELTGQIPPEFSRL-----TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIP--P  434 (1013)
Q Consensus       364 l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~  434 (1013)
                      +  ..+++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..|+++++|++|+|++|+++|.++  +
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            7  8999999999999999977 8999988     999999999999998888999999999999999999876421  1


Q ss_pred             hhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEE
Q 036815          435 RLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLD  514 (1013)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~  514 (1013)
                      .+                                                                  .+..+++|++|+
T Consensus       194 ~~------------------------------------------------------------------~~~~l~~L~~L~  207 (312)
T 1wwl_A          194 AL------------------------------------------------------------------CPLKFPTLQVLA  207 (312)
T ss_dssp             HS------------------------------------------------------------------CTTSCTTCCEEE
T ss_pred             HH------------------------------------------------------------------HhccCCCCCEEE
Confidence            10                                                                  124467899999


Q ss_pred             ccCCcccc--cCCh-hhhCCCCCcEEecCCCccCCCCc-ccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCC
Q 036815          515 LSYNQFRG--KIPD-EIGDMIALQVLELAHNQLSGEIP-SSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN  590 (1013)
Q Consensus       515 ls~N~l~g--~iP~-~i~~l~~L~~L~L~~n~l~g~ip-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n  590 (1013)
                      |++|++++  .+|. .+..+++|++|+|++|++++.+| ..+..+++|+.|+|++|+|+ .+|..+.  ++|+.|||++|
T Consensus       208 L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N  284 (312)
T 1wwl_A          208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYN  284 (312)
T ss_dssp             CTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSS
T ss_pred             CCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCC
Confidence            99999993  3333 34688999999999999998876 56678999999999999998 8999887  89999999999


Q ss_pred             CCCCcCCCCCCCCCCCcccccCCC
Q 036815          591 ELTGPIPQRGQLSTLPASQYANNP  614 (1013)
Q Consensus       591 ~l~~~~p~~~~~~~~~~~~~~~n~  614 (1013)
                      ++++. |....+.++..+.+.+|+
T Consensus       285 ~l~~~-p~~~~l~~L~~L~L~~N~  307 (312)
T 1wwl_A          285 RLDRN-PSPDELPQVGNLSLKGNP  307 (312)
T ss_dssp             CCCSC-CCTTTSCEEEEEECTTCT
T ss_pred             CCCCC-hhHhhCCCCCEEeccCCC
Confidence            99998 667778888888888886

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=1.3e-27  Score=263.12  Aligned_cols=259  Identities=23%  Similarity=0.195  Sum_probs=168.8

Q ss_pred             cceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeC
Q 036815            2 LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL   81 (1013)
Q Consensus         2 l~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~L   81 (1013)
                      ++.++++.+.+...+...+..+++|++|+|++|++.+ ++...|..+++|++|+|++|.+++..+   +..+++|++|+|
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~L   87 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDL   87 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCC-CCHHHHTTCTTCCEEECTTSCCEEEEE---ETTCTTCCEEEC
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCc-CCHHHhhCCCcCCEEECCCCcCCcchh---hhhcCCCCEEEC
Confidence            4566777777777777777777778888888888766 454567788888888888888774443   677778888888


Q ss_pred             CCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcc
Q 036815           82 SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHI  161 (1013)
Q Consensus        82 s~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  161 (1013)
                      ++|++++..        ..++|++|++++|+|+++.+.   .+++|++|++++|++++..+..+..+++|++|++++|.+
T Consensus        88 s~n~l~~l~--------~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  156 (317)
T 3o53_A           88 NNNYVQELL--------VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI  156 (317)
T ss_dssp             CSSEEEEEE--------ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCC
T ss_pred             cCCcccccc--------CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCC
Confidence            888777433        125777888888877765443   356677777777777776666777777777777777777


Q ss_pred             cCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCc
Q 036815          162 TGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPD  241 (1013)
Q Consensus       162 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  241 (1013)
                      ++..+..++..+++|++|+|++|++++..+  ...+++|++|++++|+++ .++.. +..+++|++|++++|+++ .+|.
T Consensus       157 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~-~~~l~~L~~L~L~~N~l~-~l~~  231 (317)
T 3o53_A          157 DTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLA-FMGPE-FQSAAGVTWISLRNNKLV-LIEK  231 (317)
T ss_dssp             CEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCC-EECGG-GGGGTTCSEEECTTSCCC-EECT
T ss_pred             CcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCC-cchhh-hcccCcccEEECcCCccc-chhh
Confidence            754455555556677777777777765522  223666777777777666 34443 455666666666666666 3455


Q ss_pred             CCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcC
Q 036815          242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLP  280 (1013)
Q Consensus       242 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~  280 (1013)
                      .+..+++|+.|++++|.+.....+..+..+++|+.|++.
T Consensus       232 ~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             TCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             HhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            566666666666666665522222233334444444444

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=8.6e-26  Score=261.00  Aligned_cols=248  Identities=24%  Similarity=0.252  Sum_probs=167.1

Q ss_pred             ccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEee
Q 036815           76 LELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLD  155 (1013)
Q Consensus        76 L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  155 (1013)
                      .+.+++++++++.++..++      ++++.|+|++|+|+++.+..|.++++|++|+|++|+++++.+..|.++++|++|+
T Consensus        45 ~~~v~c~~~~l~~iP~~~~------~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~  118 (440)
T 3zyj_A           45 FSKVICVRKNLREVPDGIS------TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLE  118 (440)
T ss_dssp             SCEEECCSCCCSSCCSCCC------TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEE
T ss_pred             CCEEEeCCCCcCcCCCCCC------CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEE
Confidence            4566777777765444332      5677777777777777777777777777777777777777777777777777777


Q ss_pred             CcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccC
Q 036815          156 LSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI  235 (1013)
Q Consensus       156 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l  235 (1013)
                      |++|+++ .++...+..+++|++|+|++|+++.+.+..|..+++|++|++++|+..+.++...+.++++|++|++++|++
T Consensus       119 L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l  197 (440)
T 3zyj_A          119 LFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL  197 (440)
T ss_dssp             CCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred             CCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence            7777777 566555556677777777777777666667777777777777775443356665667777777777777777


Q ss_pred             CCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcc
Q 036815          236 SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQE  315 (1013)
Q Consensus       236 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~  315 (1013)
                      + .+| .+..+++|+.|+|++|++++ +++..+.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++     
T Consensus       198 ~-~~~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-----  269 (440)
T 3zyj_A          198 R-EIP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-----  269 (440)
T ss_dssp             S-SCC-CCTTCSSCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC-----
T ss_pred             c-ccc-ccCCCcccCEEECCCCccCc-cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc-----
Confidence            6 333 35666666666666666663 333444556666666666666666666666666666666666666652     


Q ss_pred             cccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccc
Q 036815          316 LGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS  357 (1013)
Q Consensus       316 l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  357 (1013)
                                         ..+..|..+++|+.|+|++|.+.
T Consensus       270 -------------------~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          270 -------------------LPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             -------------------CCTTTTSSCTTCCEEECCSSCEE
T ss_pred             -------------------cChhHhccccCCCEEEcCCCCcc
Confidence                               23344566677788888888765

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=5.6e-27  Score=273.15  Aligned_cols=236  Identities=23%  Similarity=0.244  Sum_probs=171.6

Q ss_pred             CCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHH
Q 036815          246 CKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF  325 (1013)
Q Consensus       246 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L  325 (1013)
                      +++|+.|+|++|.+++ +++..+..+++|+.|+|++|.+++..|  +..+++|++|++++|.+++               
T Consensus        33 ~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~---------------   94 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQ-ISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE---------------   94 (487)
T ss_dssp             GGGCCEEECCSSCCCC-CCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE---------------
T ss_pred             CCCccEEEeeCCcCCC-CCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC---------------
Confidence            3466666666666653 333344556666666666666655443  5566666666666665552               


Q ss_pred             HhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeee
Q 036815          326 IAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFK  405 (1013)
Q Consensus       326 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  405 (1013)
                                +|    ..++|++|++++|.+++..+.   .+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.++
T Consensus        95 ----------l~----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  157 (487)
T 3oja_A           95 ----------LL----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID  157 (487)
T ss_dssp             ----------EE----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCC
T ss_pred             ----------CC----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCC
Confidence                      11    126788888888888865543   3578888888888888777888888888888888888888


Q ss_pred             eecCCCCc-CCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCccccccc
Q 036815          406 GEIPGELG-NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQI  484 (1013)
Q Consensus       406 ~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  484 (1013)
                      +..|..+. .+++|++|+|++|.+++..+                                                   
T Consensus       158 ~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~---------------------------------------------------  186 (487)
T 3oja_A          158 TVNFAELAASSDTLEHLNLQYNFIYDVKG---------------------------------------------------  186 (487)
T ss_dssp             EEEGGGGGGGTTTCCEEECTTSCCCEEEC---------------------------------------------------
T ss_pred             CcChHHHhhhCCcccEEecCCCccccccc---------------------------------------------------
Confidence            88887776 78888888888888774311                                                   


Q ss_pred             CccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecC
Q 036815          485 PTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDAS  564 (1013)
Q Consensus       485 ~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls  564 (1013)
                                         +..+++|++|||++|++++ +|+.++.+++|+.|+|++|+|+ .+|..++.+++|+.|+++
T Consensus       187 -------------------~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~  245 (487)
T 3oja_A          187 -------------------QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR  245 (487)
T ss_dssp             -------------------CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECT
T ss_pred             -------------------cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcC
Confidence                               0124568888888888885 5666888888888888888888 488888888888888888


Q ss_pred             Ccccc-CCCcccccCCCcceEEECc
Q 036815          565 HNRLQ-GQIPESFSNLSFLVQIDLS  588 (1013)
Q Consensus       565 ~N~l~-g~~p~~~~~l~~l~~l~l~  588 (1013)
                      +|.+. +.+|..+..++.|+.++++
T Consensus       246 ~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          246 GNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             TCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCcCcchHHHHHhCCCCcEEecc
Confidence            88887 7788888888888877775

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=7.7e-27  Score=271.99  Aligned_cols=244  Identities=22%  Similarity=0.200  Sum_probs=188.5

Q ss_pred             cCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEE
Q 036815          295 CTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWIS  374 (1013)
Q Consensus       295 l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  374 (1013)
                      +++|+.|+|++|.+++..|..|+.+++|+.|++++|.+++..|  ++.+++|++|+|++|.+++. |    ..++|++|+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~----~~~~L~~L~  105 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIETLH  105 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE-E----ECTTCCEEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC-C----CCCCcCEEE
Confidence            3355666666666655555555556666666666666554444  88899999999999999853 3    238999999


Q ss_pred             ecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCce
Q 036815          375 LTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTL  454 (1013)
Q Consensus       375 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~  454 (1013)
                      +++|.+++..+.   .+++|+.|+|++|++++..|..++++++|++|+|++|.+++.+|..+.                 
T Consensus       106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-----------------  165 (487)
T 3oja_A          106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA-----------------  165 (487)
T ss_dssp             CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG-----------------
T ss_pred             CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh-----------------
Confidence            999999966554   468899999999999998899999999999999999999876554432                 


Q ss_pred             EEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCC
Q 036815          455 VFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIAL  534 (1013)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L  534 (1013)
                                                                        ..+++|++|+|++|.|++. |. +..+++|
T Consensus       166 --------------------------------------------------~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L  193 (487)
T 3oja_A          166 --------------------------------------------------ASSDTLEHLNLQYNFIYDV-KG-QVVFAKL  193 (487)
T ss_dssp             --------------------------------------------------GGTTTCCEEECTTSCCCEE-EC-CCCCTTC
T ss_pred             --------------------------------------------------hhCCcccEEecCCCccccc-cc-cccCCCC
Confidence                                                              1346799999999999965 43 4469999


Q ss_pred             cEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCC-CcCCC-CCCCCCCCccccc-
Q 036815          535 QVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELT-GPIPQ-RGQLSTLPASQYA-  611 (1013)
Q Consensus       535 ~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~-~~~p~-~~~~~~~~~~~~~-  611 (1013)
                      ++|+|++|+++| +|..++.+++|+.|+|++|+|++ +|..+..++.|+.|++++|+++ +.+|. ...+..+...... 
T Consensus       194 ~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~  271 (487)
T 3oja_A          194 KTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT  271 (487)
T ss_dssp             CEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHH
T ss_pred             CEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccc
Confidence            999999999995 77779999999999999999995 8999999999999999999998 55553 2333333333332 


Q ss_pred             ------CCCCCCCC
Q 036815          612 ------NNPGLCGV  619 (1013)
Q Consensus       612 ------~n~~lc~~  619 (1013)
                            +|+..|..
T Consensus       272 ~~~~~~~~~~~c~~  285 (487)
T 3oja_A          272 VKKLTGQNEEECTV  285 (487)
T ss_dssp             HHHHTSSSSCCCSS
T ss_pred             cccccCCCcccccC
Confidence                  56666654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=5.3e-29  Score=300.71  Aligned_cols=406  Identities=17%  Similarity=0.169  Sum_probs=243.6

Q ss_pred             ccccccCCCCCcEEecCCCCccccc---C-----------cccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeC
Q 036815           16 STSLLQLPFGLKQLELSSAGLVGLV---P-----------DNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL   81 (1013)
Q Consensus        16 ~~~~~~~~~~l~~L~L~~~~i~~~~---~-----------~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~L   81 (1013)
                      +...+...++|++|+|++|.....+   |           ..++..+++|++|+|++|.+++..+..+...+++|++|+|
T Consensus        58 ~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L  137 (594)
T 2p1m_B           58 PATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL  137 (594)
T ss_dssp             HHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEE
T ss_pred             HHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeC
Confidence            4455556667888888877532111   1           1123457788888888887775555555446778888888


Q ss_pred             CCC-cccCccCCCCcCCCCCCcccEEECCCCCCCCCCCcccc----CCCCCCEEecCCCc--cccc-CcccccCCCCCCE
Q 036815           82 SYN-NLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLS----NCTKLKILNLSFNL--LAGE-IPRTFGQLSSLQR  153 (1013)
Q Consensus        82 s~n-~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~----~l~~L~~L~L~~n~--l~~~-~~~~~~~l~~L~~  153 (1013)
                      ++| .++..  ++......+++|++|+|++|.+++..+..+.    .+++|++|++++|.  ++.. ....+..+++|++
T Consensus       138 ~~~~~~~~~--~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~  215 (594)
T 2p1m_B          138 SSCEGFSTD--GLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKS  215 (594)
T ss_dssp             ESCEEEEHH--HHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCE
T ss_pred             CCcCCCCHH--HHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcE
Confidence            877 44421  0111113467788888888877665444443    56688888888776  2211 1112234678888


Q ss_pred             eeCcCC-cccCcCCccchhccCCCcEEECCCCC-------CCCcCCccccCCCCCCEE-EccCCCCCCCCChhhhhcCCC
Q 036815          154 LDLSNN-HITGWIPSELGNACDSLLELKLPHNN-------ITGSFPVTLSSCSWLQLL-DLSNNNISGPFPDSVLENLGS  224 (1013)
Q Consensus       154 L~Ls~n-~l~~~~~~~~~~~l~~L~~L~L~~n~-------l~~~~~~~l~~l~~L~~L-~L~~N~l~~~~~~~~~~~l~~  224 (1013)
                      |++++| .++ .++.. ...+++|++|+++.+.       +.+ .+..+.++++|+.| .+.+.... .++ .++..+++
T Consensus       216 L~L~~~~~~~-~l~~~-~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~-~~~~~~~~  290 (594)
T 2p1m_B          216 LKLNRAVPLE-KLATL-LQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLP-AVYSVCSR  290 (594)
T ss_dssp             EECCTTSCHH-HHHHH-HHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGG-GGHHHHTT
T ss_pred             EecCCCCcHH-HHHHH-HhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccchh-hHH-HHHHhhCC
Confidence            888877 444 23333 3345778888765442       222 22355666777776 33332211 122 22345667


Q ss_pred             CcEEEcccccCCCcC-CcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcC---------CCcccccCCcccc-
Q 036815          225 LESLILSNNMISGSF-PDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLP---------DNLITGVIPGQLS-  293 (1013)
Q Consensus       225 L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~---------~n~l~~~~~~~~~-  293 (1013)
                      |++|++++|.+++.. ...+..+++|+.|++++| +++.....+...+++|++|++.         .+.+++.....+. 
T Consensus       291 L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~  369 (594)
T 2p1m_B          291 LTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM  369 (594)
T ss_dssp             CCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHH
T ss_pred             CCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHH
Confidence            777777777655322 222445677777777766 4322222222345667777662         2344433222332 


Q ss_pred             ccCcccEEEeeCCccCCCCCcccc-cCcchHHHHhh--h----ccccCC-----CCcCcCCCCCCceEECccccccccCc
Q 036815          294 ECTQLKVIDLSLNYLNGSIPQELG-KLEHLEQFIAW--F----NGLEGK-----IPPELGKCKNLKDLILNNNKLSGEIP  361 (1013)
Q Consensus       294 ~l~~L~~L~ls~N~l~~~~p~~l~-~l~~L~~L~l~--~----n~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p  361 (1013)
                      .+++|+.|+++.|.+++..+..+. .+++|+.|++.  +    +.++..     ++..+..+++|+.|+|++ .+++..+
T Consensus       370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~  448 (594)
T 2p1m_B          370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF  448 (594)
T ss_dssp             HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred             hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHH
Confidence            367777777777777655444444 46677777776  2    334311     111256678899999977 6776666


Q ss_pred             hhhcC-CCCCCeEEecCCccCCCCChhh-hccCCCceEEccCCeeeeecCC-CCcCCCCCcEEEccCCcCCc
Q 036815          362 AELFS-CSNLEWISLTGNELTGQIPPEF-SRLTRLAVLQLGNNRFKGEIPG-ELGNCSSLVWLDLNSNNLTG  430 (1013)
Q Consensus       362 ~~l~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~  430 (1013)
                      ..+.. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|++|++++|+++.
T Consensus       449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~  520 (594)
T 2p1m_B          449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF  520 (594)
T ss_dssp             HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred             HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence            66665 8889999999999876555555 6789999999999998654443 34568899999999998853

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=7.6e-29  Score=299.37  Aligned_cols=85  Identities=9%  Similarity=0.047  Sum_probs=46.8

Q ss_pred             CCccCEEEccCCcccccCChhh-hCCCCCcEEecCCCccCCCCcc-cccCCCCcceEecCCccccCCCcccc-cCCCcce
Q 036815          507 YQTLEYLDLSYNQFRGKIPDEI-GDMIALQVLELAHNQLSGEIPS-SLGRLRNLGVFDASHNRLQGQIPESF-SNLSFLV  583 (1013)
Q Consensus       507 ~~~L~~L~ls~N~l~g~iP~~i-~~l~~L~~L~L~~n~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~l~  583 (1013)
                      +++|++|+|++|.+++..+..+ ..+++|++|+|++|.+++..+. .+..+++|+.|++++|+++..-...+ ..++.|.
T Consensus       455 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~  534 (594)
T 2p1m_B          455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLN  534 (594)
T ss_dssp             CTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEE
T ss_pred             chhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCE
Confidence            3456666666666655444444 4566666666666666543333 33346666666666666643333333 3445555


Q ss_pred             EEECcCCC
Q 036815          584 QIDLSNNE  591 (1013)
Q Consensus       584 ~l~l~~n~  591 (1013)
                      ...+..+.
T Consensus       535 i~~~~~~~  542 (594)
T 2p1m_B          535 VEVIDERG  542 (594)
T ss_dssp             EEEECSSS
T ss_pred             EEEecCCC
Confidence            55554443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=1.7e-24  Score=233.44  Aligned_cols=194  Identities=22%  Similarity=0.204  Sum_probs=142.4

Q ss_pred             CcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCC
Q 036815          337 PPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCS  416 (1013)
Q Consensus       337 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  416 (1013)
                      +..|.++++|++|++++|++++..+..+..+++|++|+|++|++++..+..|..+++|+.|++++|++++..+..+.+++
T Consensus        45 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  124 (276)
T 2z62_A           45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK  124 (276)
T ss_dssp             TTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCT
T ss_pred             HhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCC
Confidence            34566677777788888877766666777777888888888887766667777788888888888888766565777888


Q ss_pred             CCcEEEccCCcCCcC-CCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCcccccccccc
Q 036815          417 SLVWLDLNSNNLTGD-IPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARM  495 (1013)
Q Consensus       417 ~L~~L~l~~N~l~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  495 (1013)
                      +|++|++++|++++. +|.                                                             
T Consensus       125 ~L~~L~l~~n~l~~~~l~~-------------------------------------------------------------  143 (276)
T 2z62_A          125 TLKELNVAHNLIQSFKLPE-------------------------------------------------------------  143 (276)
T ss_dssp             TCCEEECCSSCCCCCCCCG-------------------------------------------------------------
T ss_pred             CCCEEECcCCccceecCch-------------------------------------------------------------
Confidence            888888888877641 232                                                             


Q ss_pred             ccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCc----EEecCCCccCCCCcccccCCCCcceEecCCccccCC
Q 036815          496 YSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQ----VLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQ  571 (1013)
Q Consensus       496 ~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~----~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~  571 (1013)
                             .+..+++|++|++++|++++..|..++.+.+|+    .|++++|+++ .+|.......+|+.|+|++|++++.
T Consensus       144 -------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~-~~~~~~~~~~~L~~L~L~~n~l~~~  215 (276)
T 2z62_A          144 -------YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSV  215 (276)
T ss_dssp             -------GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCC-EECTTSSCSCCEEEEECCSSCCSCC
T ss_pred             -------hhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCccc-ccCccccCCCcccEEECCCCceeec
Confidence                   233456788888888888876667777777776    7888888888 4555555555788888888888865


Q ss_pred             CcccccCCCcceEEECcCCCCCCcCCCC
Q 036815          572 IPESFSNLSFLVQIDLSNNELTGPIPQR  599 (1013)
Q Consensus       572 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~  599 (1013)
                      .+..+..+++|+.|+|++|++++..|..
T Consensus       216 ~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          216 PDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             CHhHhcccccccEEEccCCcccccCCch
Confidence            5566788888888888888888776643

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=4.3e-25  Score=259.09  Aligned_cols=186  Identities=16%  Similarity=0.188  Sum_probs=146.8

Q ss_pred             CCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCcc--------chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          737 SAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQ--------GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ...+.||+|+||.||+|.. .++.+++|+.......        ..+++.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 4789999986543221        124579999999999999999777777777888999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||++|++|.+++..              +..++.|+++||+|||++   +|+||||||+||+++.  ++||+|||+|+.
T Consensus       418 mE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             EECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             EECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEE
Confidence            999999999999863              457899999999999999   9999999999999999  999999999998


Q ss_pred             ccccCcce-----eeeeeccCCCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          889 ISALDTHL-----SVSTLAGTPGYVPPEYYQS--FRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       889 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      ........     ......||+.|||||++..  ..|+.++|+|+..+-..+-+.++.+|.
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            75432211     1235679999999999986  567888999999999988888877763

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=2.6e-24  Score=231.16  Aligned_cols=221  Identities=24%  Similarity=0.279  Sum_probs=162.2

Q ss_pred             CCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECc
Q 036815          273 SLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILN  352 (1013)
Q Consensus       273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~  352 (1013)
                      ++..+++..+.+.+.  ..+..+++|+.|++++|.++. +                         ..+..+++|++|+++
T Consensus        20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-------------------------~~l~~l~~L~~L~l~   71 (272)
T 3rfs_A           20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-------------------------QGIQYLPNVRYLALG   71 (272)
T ss_dssp             HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-------------------------TTGGGCTTCCEEECT
T ss_pred             HHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-------------------------cccccCCCCcEEECC
Confidence            344555555555543  234566777777777776651 1                         235567778888888


Q ss_pred             cccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCC
Q 036815          353 NNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDI  432 (1013)
Q Consensus       353 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  432 (1013)
                      +|.+++ + ..+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..+.++++|++|++++|++++..
T Consensus        72 ~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  149 (272)
T 3rfs_A           72 GNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLP  149 (272)
T ss_dssp             TSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccC
Confidence            888874 3 36778888888888888888766667788888888888888888666666788888888888888877433


Q ss_pred             CchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCE
Q 036815          433 PPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEY  512 (1013)
Q Consensus       433 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~  512 (1013)
                      |..                                                                    |..+++|++
T Consensus       150 ~~~--------------------------------------------------------------------~~~l~~L~~  161 (272)
T 3rfs_A          150 KGV--------------------------------------------------------------------FDKLTNLTE  161 (272)
T ss_dssp             TTT--------------------------------------------------------------------TTTCTTCCE
T ss_pred             HHH--------------------------------------------------------------------hccCccCCE
Confidence            221                                                                    233467888


Q ss_pred             EEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCC
Q 036815          513 LDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNEL  592 (1013)
Q Consensus       513 L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l  592 (1013)
                      |++++|++++..|..++.+++|++|+|++|++++..|..++.+++|+.|+|++|.+.|..|       .|+.++++.|++
T Consensus       162 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-------~l~~l~~~~n~~  234 (272)
T 3rfs_A          162 LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-------GIRYLSEWINKH  234 (272)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT-------TTHHHHHHHHHT
T ss_pred             EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc-------HHHHHHHHHHhC
Confidence            8888888886666667888888888888888887777778888888888888888876544       577788888888


Q ss_pred             CCcCCC
Q 036815          593 TGPIPQ  598 (1013)
Q Consensus       593 ~~~~p~  598 (1013)
                      +|.+|.
T Consensus       235 ~g~ip~  240 (272)
T 3rfs_A          235 SGVVRN  240 (272)
T ss_dssp             GGGBBC
T ss_pred             CCcccC
Confidence            888886

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.90  E-value=1.2e-23  Score=226.95  Aligned_cols=227  Identities=22%  Similarity=0.223  Sum_probs=159.1

Q ss_pred             EEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCC
Q 036815          178 ELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSN  257 (1013)
Q Consensus       178 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  257 (1013)
                      ..+..+..++ .+|..+.  ++|++|++++|+++ .++...+..+++|++|++++|++++..+..+..+++|++|++++|
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n   86 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN   86 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCC-EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             eEEecCCCcc-ccCCCCC--CCccEEECCCCccc-ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence            4555555555 2333332  45777777777776 334334566677777777777776555556666667777777777


Q ss_pred             eecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCC
Q 036815          258 RVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIP  337 (1013)
Q Consensus       258 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p  337 (1013)
                      .+++ ++...+.++++|++|++++|.+++..+..+..+++|++|++++|.+++.                       .+|
T Consensus        87 ~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------------~l~  142 (276)
T 2z62_A           87 PIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF-----------------------KLP  142 (276)
T ss_dssp             CCCE-ECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC-----------------------CCC
T ss_pred             ccCc-cChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee-----------------------cCc
Confidence            6663 3344445566666666666666655555566666666666666665521                       246


Q ss_pred             cCcCCCCCCceEECccccccccCchhhcCCCCCC----eEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCc
Q 036815          338 PELGKCKNLKDLILNNNKLSGEIPAELFSCSNLE----WISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELG  413 (1013)
Q Consensus       338 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  413 (1013)
                      ..++.+++|++|+|++|++++..+..+..+++|+    .|++++|++++..+..+ ...+|+.|+|++|++++..+..+.
T Consensus       143 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~  221 (276)
T 2z62_A          143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFD  221 (276)
T ss_dssp             GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTT
T ss_pred             hhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhHhc
Confidence            7788888999999999999977777777777776    89999999995544444 455899999999999966666679


Q ss_pred             CCCCCcEEEccCCcCCcCCC
Q 036815          414 NCSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       414 ~l~~L~~L~l~~N~l~~~~p  433 (1013)
                      ++++|++|+|++|++++..|
T Consensus       222 ~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          222 RLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             TCCSCCEEECCSSCBCCCTT
T ss_pred             ccccccEEEccCCcccccCC
Confidence            99999999999999999876

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.90  E-value=1.4e-22  Score=217.48  Aligned_cols=201  Identities=26%  Similarity=0.325  Sum_probs=121.2

Q ss_pred             CcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccE
Q 036815           26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH  105 (1013)
Q Consensus        26 l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~  105 (1013)
                      .+.+++++++++. +|..+.   ++|++|+|++|.++ .++...+..+++|++|+|++|+++......+   ..+++|++
T Consensus        18 ~~~l~~~~~~l~~-ip~~~~---~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~---~~l~~L~~   89 (270)
T 2o6q_A           18 KNSVDCSSKKLTA-IPSNIP---ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF---KELKNLET   89 (270)
T ss_dssp             TTEEECTTSCCSS-CCSCCC---TTCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTT---SSCTTCCE
T ss_pred             CCEEEccCCCCCc-cCCCCC---CCCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhh---cCCCCCCE
Confidence            4455555555543 444321   34555555555555 3333344555555555555555554333221   23455666


Q ss_pred             EECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCC
Q 036815          106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNN  185 (1013)
Q Consensus       106 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~  185 (1013)
                      |+|++|.++++.+..|.++++|++|++++|++++..+..|..+++|++|++++|.++ .+|...+..+++|++|+|++|+
T Consensus        90 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~  168 (270)
T 2o6q_A           90 LWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQ  168 (270)
T ss_dssp             EECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCCcccceeEecCCc
Confidence            666666666555555666666666666666666666666666666666666666666 4555545555667777777777


Q ss_pred             CCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCC
Q 036815          186 ITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS  236 (1013)
Q Consensus       186 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~  236 (1013)
                      +++..+..|..+++|++|++++|+++ .++...+..+++|+.|++++|.+.
T Consensus       169 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          169 LKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CcEeChhHhccCCCcCEEECCCCcCC-cCCHHHhccccCCCEEEecCCCee
Confidence            76666666667777777777777776 455555666777777777777765

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.89  E-value=4.7e-23  Score=221.29  Aligned_cols=210  Identities=20%  Similarity=0.259  Sum_probs=129.7

Q ss_pred             cCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCC
Q 036815          122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQ  201 (1013)
Q Consensus       122 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  201 (1013)
                      ..+++|++|++++|.++..  ..+..+++|++|++++|.+++ ++  .+..+++|++|+|++|.+++..+..+..+++|+
T Consensus        38 ~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  112 (272)
T 3rfs_A           38 NELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK  112 (272)
T ss_dssp             HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             ccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence            3444444455544444422  234444555555555555442 21  122345555555555555555555555666666


Q ss_pred             EEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCC
Q 036815          202 LLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPD  281 (1013)
Q Consensus       202 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~  281 (1013)
                      +|++++|+++ .++...+..+++|++|++++|++++..+..+..+++|+.|++++|+++ .++...+..+++|+.|++++
T Consensus       113 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~  190 (272)
T 3rfs_A          113 ELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQ  190 (272)
T ss_dssp             EEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred             EEECCCCcCC-ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC-ccCHHHhcCCccCCEEECCC
Confidence            6666666665 344444556666666666666666555555666677777777777766 34455556677777777777


Q ss_pred             CcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCC
Q 036815          282 NLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKN  345 (1013)
Q Consensus       282 n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  345 (1013)
                      |++++..+..+..+++|+.|++++|++.+.       ++.|+.+.++.|.++|.+|..++.+..
T Consensus       191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          191 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             CcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            777777777788888899999999988754       346778888888888888877776544

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.89  E-value=3.6e-22  Score=214.22  Aligned_cols=202  Identities=26%  Similarity=0.352  Sum_probs=108.5

Q ss_pred             ccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEee
Q 036815           76 LELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLD  155 (1013)
Q Consensus        76 L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  155 (1013)
                      .+.+++++++++.++..+      .+++++|+|++|+|+++.+..|.++++|++|++++|+++.+.+..|.++++|++|+
T Consensus        18 ~~~l~~~~~~l~~ip~~~------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~   91 (270)
T 2o6q_A           18 KNSVDCSSKKLTAIPSNI------PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW   91 (270)
T ss_dssp             TTEEECTTSCCSSCCSCC------CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEE
T ss_pred             CCEEEccCCCCCccCCCC------CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEE
Confidence            445555555555332221      13455666666666555555566666666666666666655445555566666666


Q ss_pred             CcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccC
Q 036815          156 LSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI  235 (1013)
Q Consensus       156 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l  235 (1013)
                      +++|.++ .++...+..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .++...+..+++|++|++++|++
T Consensus        92 l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l  169 (270)
T 2o6q_A           92 VTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL  169 (270)
T ss_dssp             CCSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CCCCcCC-cCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCCcccceeEecCCcC
Confidence            6666655 344444444455555555555555444444455555555555555554 33333344444444444444444


Q ss_pred             CCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCC
Q 036815          236 SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG  310 (1013)
Q Consensus       236 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~  310 (1013)
                      ++                         ++...+..+++|+.|++++|++++..+..+..+++|+.|++++|++..
T Consensus       170 ~~-------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          170 KR-------------------------VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             SC-------------------------CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cE-------------------------eChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            43                         333334445555555555555555555556667777777777777663

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.89  E-value=1.1e-22  Score=220.17  Aligned_cols=205  Identities=23%  Similarity=0.229  Sum_probs=133.4

Q ss_pred             cCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCc
Q 036815          340 LGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV  419 (1013)
Q Consensus       340 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  419 (1013)
                      ++++++|+++++++|.++ .+|..+.  ++++.|+|++|.+++..|..|..+++|+.|+|++|++++..+ . ..+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCC
Confidence            556667777777777776 5555543  567777777777776666677777777777777777764333 2 5677777


Q ss_pred             EEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCc
Q 036815          420 WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGP  499 (1013)
Q Consensus       420 ~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  499 (1013)
                      +|+|++|+++ .+|..                                                                
T Consensus        81 ~L~Ls~N~l~-~l~~~----------------------------------------------------------------   95 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLL----------------------------------------------------------------   95 (290)
T ss_dssp             EEECCSSCCS-SCCCC----------------------------------------------------------------
T ss_pred             EEECCCCcCC-cCchh----------------------------------------------------------------
Confidence            7777777665 23321                                                                


Q ss_pred             ccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCC
Q 036815          500 VLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL  579 (1013)
Q Consensus       500 ~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l  579 (1013)
                          +..+++|++|+|++|++++..|..++.+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+
T Consensus        96 ----~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l  171 (290)
T 1p9a_G           96 ----GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL  171 (290)
T ss_dssp             ----TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTC
T ss_pred             ----hccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCc
Confidence                2234556777777777775545667777777777777777775445556677777777777777774444455667


Q ss_pred             CcceEEECcCCCCCCcCCCCCCCCCCCcccccCCCCCCC
Q 036815          580 SFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCG  618 (1013)
Q Consensus       580 ~~l~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~lc~  618 (1013)
                      ++|+.|+|++|+++..++.......+....+.|||.-|.
T Consensus       172 ~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          172 ENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             CCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence            777777777777775444444555566666777776663

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=1.2e-23  Score=230.83  Aligned_cols=190  Identities=22%  Similarity=0.218  Sum_probs=136.2

Q ss_pred             CCCcCc--CCCCCCceEECccccccccCc----hhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeee-
Q 036815          335 KIPPEL--GKCKNLKDLILNNNKLSGEIP----AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGE-  407 (1013)
Q Consensus       335 ~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-  407 (1013)
                      ..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|++++..|..|+.+++|++|+|++|++.+. 
T Consensus       106 ~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  185 (310)
T 4glp_A          106 TMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGER  185 (310)
T ss_dssp             CCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHH
T ss_pred             chhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccch
Confidence            334444  566777777777777775444    3445677888888888888777777777888888888888877542 


Q ss_pred             -c--CCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCccccccc
Q 036815          408 -I--PGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQI  484 (1013)
Q Consensus       408 -~--p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  484 (1013)
                       +  +..+.++++|++|+|++|+++. +|...                                                
T Consensus       186 ~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~------------------------------------------------  216 (310)
T 4glp_A          186 GLMAALCPHKFPAIQNLALRNTGMET-PTGVC------------------------------------------------  216 (310)
T ss_dssp             HHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHH------------------------------------------------
T ss_pred             hhhHHHhhhcCCCCCEEECCCCCCCc-hHHHH------------------------------------------------
Confidence             2  2334677888888888887752 11100                                                


Q ss_pred             CccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCC---CCCcEEecCCCccCCCCcccccCCCCcceE
Q 036815          485 PTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDM---IALQVLELAHNQLSGEIPSSLGRLRNLGVF  561 (1013)
Q Consensus       485 ~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l---~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L  561 (1013)
                                      ...+..+++|++||||+|++++.+|+.++.+   ++|++|+|++|+++ .+|..+.  ++|+.|
T Consensus       217 ----------------~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L  277 (310)
T 4glp_A          217 ----------------AALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVL  277 (310)
T ss_dssp             ----------------HHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCE
T ss_pred             ----------------HHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEE
Confidence                            0112345678888999999988778888777   58899999999988 7888775  788999


Q ss_pred             ecCCccccCCCcccccCCCcceEEECcCCCCCC
Q 036815          562 DASHNRLQGQIPESFSNLSFLVQIDLSNNELTG  594 (1013)
Q Consensus       562 ~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~  594 (1013)
                      ||++|++++ +|. +..++.|+.|+|++|+++.
T Consensus       278 ~Ls~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          278 DLSSNRLNR-APQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             ECCSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred             ECCCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence            999999985 344 6777888889999988874

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.88  E-value=2.8e-24  Score=241.30  Aligned_cols=261  Identities=19%  Similarity=0.204  Sum_probs=175.2

Q ss_pred             EEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCC----ccccccC-cccEEEeeCCccCCCCCcccccCcchHHHH
Q 036815          252 VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIP----GQLSECT-QLKVIDLSLNYLNGSIPQELGKLEHLEQFI  326 (1013)
Q Consensus       252 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~  326 (1013)
                      ++++.|.+++.+|. +....++|++|+|++|.+++..+    ..+..++ +|++|++++|.+++..+..+..+       
T Consensus         3 ~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~-------   74 (362)
T 3goz_A            3 YKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI-------   74 (362)
T ss_dssp             EECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHH-------
T ss_pred             cccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHH-------
Confidence            45555555543332 22223346666666666555444    4455555 56666666665554333322221       


Q ss_pred             hhhccccCCCCcCcCC-CCCCceEECccccccccCchhhcC----C-CCCCeEEecCCccCCCCChhhhc-----cCCCc
Q 036815          327 AWFNGLEGKIPPELGK-CKNLKDLILNNNKLSGEIPAELFS----C-SNLEWISLTGNELTGQIPPEFSR-----LTRLA  395 (1013)
Q Consensus       327 l~~n~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~l~~----l-~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~  395 (1013)
                                   +.. .++|++|+|++|.+++..+..+..    + ++|++|+|++|++++..+..+..     .++|+
T Consensus        75 -------------l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~  141 (362)
T 3goz_A           75 -------------LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT  141 (362)
T ss_dssp             -------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCC
T ss_pred             -------------HhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCcee
Confidence                         111 278899999999998777765544    3 88999999999998776666554     25899


Q ss_pred             eEEccCCeeeee----cCCCCcCCC-CCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcc
Q 036815          396 VLQLGNNRFKGE----IPGELGNCS-SLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGL  470 (1013)
Q Consensus       396 ~L~L~~N~l~~~----~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  470 (1013)
                      +|+|++|++++.    ++..+..++ +|++|+|++|++++..+..+...                               
T Consensus       142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~-------------------------------  190 (362)
T 3goz_A          142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF-------------------------------  190 (362)
T ss_dssp             EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH-------------------------------
T ss_pred             EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHH-------------------------------
Confidence            999999998853    333445555 89999999998876555443321                               


Q ss_pred             cccccCCcccccccCccccccccccccCcccccccCC-CccCEEEccCCccccc----CChhhhCC-CCCcEEecCCCcc
Q 036815          471 LEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQY-QTLEYLDLSYNQFRGK----IPDEIGDM-IALQVLELAHNQL  544 (1013)
Q Consensus       471 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~L~~L~ls~N~l~g~----iP~~i~~l-~~L~~L~L~~n~l  544 (1013)
                                                       +... ++|++|||++|++++.    +|..+..+ ++|++|+|++|.+
T Consensus       191 ---------------------------------l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l  237 (362)
T 3goz_A          191 ---------------------------------LASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL  237 (362)
T ss_dssp             ---------------------------------HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCC
T ss_pred             ---------------------------------HHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCC
Confidence                                             2223 4789999999999853    56666664 5899999999999


Q ss_pred             CCCCc----ccccCCCCcceEecCCccccCC-------CcccccCCCcceEEECcCCCCCCcCC
Q 036815          545 SGEIP----SSLGRLRNLGVFDASHNRLQGQ-------IPESFSNLSFLVQIDLSNNELTGPIP  597 (1013)
Q Consensus       545 ~g~ip----~~~~~l~~L~~L~ls~N~l~g~-------~p~~~~~l~~l~~l~l~~n~l~~~~p  597 (1013)
                      ++..+    ..+..+++|+.|+|++|.+.+.       ++..+..++.|+.||+++|++.+..|
T Consensus       238 ~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             CCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             CcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence            97544    3456778999999999996543       34467788999999999999886633

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.88  E-value=1.1e-24  Score=244.69  Aligned_cols=85  Identities=24%  Similarity=0.207  Sum_probs=44.3

Q ss_pred             CCceEECccccccccCchhhc----CC-CCCCeEEecCCccCCC----CChhhhcc-CCCceEEccCCeeeeecC----C
Q 036815          345 NLKDLILNNNKLSGEIPAELF----SC-SNLEWISLTGNELTGQ----IPPEFSRL-TRLAVLQLGNNRFKGEIP----G  410 (1013)
Q Consensus       345 ~L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~L~~N~l~~~~p----~  410 (1013)
                      +|++|+|++|++++..+..+.    .+ ++|++|+|++|.+++.    ++..+..+ ++|+.|+|++|++++..+    .
T Consensus       168 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  247 (362)
T 3goz_A          168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKL  247 (362)
T ss_dssp             TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHH
T ss_pred             cccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHH
Confidence            566666666666554444333    22 4666666666666532    33334432 356666666666553322    2


Q ss_pred             CCcCCCCCcEEEccCCcCC
Q 036815          411 ELGNCSSLVWLDLNSNNLT  429 (1013)
Q Consensus       411 ~~~~l~~L~~L~l~~N~l~  429 (1013)
                      .+..+++|++|+|++|.++
T Consensus       248 ~~~~l~~L~~L~L~~n~l~  266 (362)
T 3goz_A          248 LKDSLKHLQTVYLDYDIVK  266 (362)
T ss_dssp             TTTTTTTCSEEEEEHHHHT
T ss_pred             HHhcCCCccEEEeccCCcc
Confidence            3345566666666666544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=5.8e-25  Score=249.61  Aligned_cols=248  Identities=20%  Similarity=0.253  Sum_probs=186.6

Q ss_pred             CCCCCceEEcCCCcccccCC----ccccccCcccEEEeeCCccC---CCCCcccccCcchHHHHhhhccccCCCCcCcCC
Q 036815          270 GVSSLEELRLPDNLITGVIP----GQLSECTQLKVIDLSLNYLN---GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGK  342 (1013)
Q Consensus       270 ~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~ls~N~l~---~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~  342 (1013)
                      .+++|+.|+|++|.+++..+    ..+..+++|++|+|++|.+.   +.+|..+..                 +...+..
T Consensus        30 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~-----------------l~~~l~~   92 (386)
T 2ca6_A           30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL-----------------LLQALLK   92 (386)
T ss_dssp             HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH-----------------HHHHHTT
T ss_pred             cCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHH-----------------HHHHHhh
Confidence            45677888888887776533    33667778888888776443   233322211                 1134567


Q ss_pred             CCCCceEECccccccc----cCchhhcCCCCCCeEEecCCccCCCCChhhh----cc---------CCCceEEccCCeee
Q 036815          343 CKNLKDLILNNNKLSG----EIPAELFSCSNLEWISLTGNELTGQIPPEFS----RL---------TRLAVLQLGNNRFK  405 (1013)
Q Consensus       343 l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~  405 (1013)
                      +++|++|+|++|.+++    .+|..+..+++|++|+|++|.+++..+..+.    .+         ++|++|+|++|+++
T Consensus        93 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~  172 (386)
T 2ca6_A           93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE  172 (386)
T ss_dssp             CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred             CCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence            8899999999999986    4777888899999999999998754444444    33         89999999999987


Q ss_pred             -eecC---CCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccc
Q 036815          406 -GEIP---GELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL  481 (1013)
Q Consensus       406 -~~~p---~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  481 (1013)
                       +.+|   ..+..+++|++|+|++|.++..   .+..                                           
T Consensus       173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~---g~~~-------------------------------------------  206 (386)
T 2ca6_A          173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPE---GIEH-------------------------------------------  206 (386)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHH---HHHH-------------------------------------------
T ss_pred             cHHHHHHHHHHHhCCCcCEEECcCCCCCHh---HHHH-------------------------------------------
Confidence             3445   4667888999999999987621   0000                                           


Q ss_pred             cccCccccccccccccCcccccccCCCccCEEEccCCccc----ccCChhhhCCCCCcEEecCCCccCCC----Ccccc-
Q 036815          482 LQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFR----GKIPDEIGDMIALQVLELAHNQLSGE----IPSSL-  552 (1013)
Q Consensus       482 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~----g~iP~~i~~l~~L~~L~L~~n~l~g~----ip~~~-  552 (1013)
                                       ..+..+..+++|++|+|++|+++    +.+|..+..+++|++|+|++|.+++.    +|..+ 
T Consensus       207 -----------------l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~  269 (386)
T 2ca6_A          207 -----------------LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS  269 (386)
T ss_dssp             -----------------HHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred             -----------------HHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHh
Confidence                             01113445678999999999996    68999999999999999999999976    67777 


Q ss_pred             -cCCCCcceEecCCccccC----CCcccc-cCCCcceEEECcCCCCCCcCC
Q 036815          553 -GRLRNLGVFDASHNRLQG----QIPESF-SNLSFLVQIDLSNNELTGPIP  597 (1013)
Q Consensus       553 -~~l~~L~~L~ls~N~l~g----~~p~~~-~~l~~l~~l~l~~n~l~~~~p  597 (1013)
                       +.+++|+.|+|++|++++    .+|..+ .++++|+.|+|++|++++..|
T Consensus       270 ~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             TCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             hccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence             449999999999999998    599888 678999999999999997664

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.88  E-value=3.3e-22  Score=216.32  Aligned_cols=207  Identities=22%  Similarity=0.235  Sum_probs=166.8

Q ss_pred             cccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCC
Q 036815          193 TLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVS  272 (1013)
Q Consensus       193 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~  272 (1013)
                      .+.++++|+++++++|.++ .+|..+   .++++.|+|++|++++..+..+..+++|+.|++++|.+++. +..  ..++
T Consensus         5 ~~~~l~~l~~l~~~~~~l~-~ip~~~---~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~--~~l~   77 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD--GTLP   77 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS-SCCSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC--SCCT
T ss_pred             cccccCCccEEECCCCCCC-cCCCCC---CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC--CCCC
Confidence            3567888999999999988 677654   36788999999998877777888888888888888888743 222  4567


Q ss_pred             CCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECc
Q 036815          273 SLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILN  352 (1013)
Q Consensus       273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~  352 (1013)
                      +|+.|++++|+++ .+|..+..+++|++|++++|++++                        ..|..|..+++|++|+|+
T Consensus        78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~------------------------l~~~~~~~l~~L~~L~L~  132 (290)
T 1p9a_G           78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS------------------------LPLGALRGLGELQELYLK  132 (290)
T ss_dssp             TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCC------------------------CCSSTTTTCTTCCEEECT
T ss_pred             cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcc------------------------cCHHHHcCCCCCCEEECC
Confidence            7777777777776 455666677777777777776663                        334567888899999999


Q ss_pred             cccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCC
Q 036815          353 NNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDI  432 (1013)
Q Consensus       353 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  432 (1013)
                      +|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++ .+|..+..+.+|+.|+|++|++.+..
T Consensus       133 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            99999776777889999999999999999666667789999999999999999 88999999999999999999998653

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=2.1e-21  Score=205.73  Aligned_cols=182  Identities=24%  Similarity=0.286  Sum_probs=143.5

Q ss_pred             CCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEcc
Q 036815          345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLN  424 (1013)
Q Consensus       345 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  424 (1013)
                      +.++++++++.++ .+|..+.  ++|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            4567888888887 6776655  578888888888887777788888888888888888887777778888888888888


Q ss_pred             CCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccc
Q 036815          425 SNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLF  504 (1013)
Q Consensus       425 ~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  504 (1013)
                      +|++++..|.                                                                    .|
T Consensus        92 ~n~l~~~~~~--------------------------------------------------------------------~~  103 (251)
T 3m19_A           92 NNQLASLPLG--------------------------------------------------------------------VF  103 (251)
T ss_dssp             TSCCCCCCTT--------------------------------------------------------------------TT
T ss_pred             CCcccccChh--------------------------------------------------------------------Hh
Confidence            8887743222                                                                    12


Q ss_pred             cCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceE
Q 036815          505 TQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQ  584 (1013)
Q Consensus       505 ~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~  584 (1013)
                      ..+++|++|+|++|++++..|..++.+.+|++|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.
T Consensus       104 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  183 (251)
T 3m19_A          104 DHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT  183 (251)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             cccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence            34567888888888888555555788888888888888888655557888888889999999888777778888888899


Q ss_pred             EECcCCCCCCcCC
Q 036815          585 IDLSNNELTGPIP  597 (1013)
Q Consensus       585 l~l~~n~l~~~~p  597 (1013)
                      |+|++|++++..+
T Consensus       184 L~l~~N~~~c~~~  196 (251)
T 3m19_A          184 ITLFGNQFDCSRC  196 (251)
T ss_dssp             EECCSCCBCTTST
T ss_pred             EEeeCCceeCCcc
Confidence            9999998887644

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.87  E-value=2.8e-22  Score=219.86  Aligned_cols=202  Identities=21%  Similarity=0.254  Sum_probs=171.4

Q ss_pred             CCCCceEECccccccccCchhh--cCCCCCCeEEecCCccCCCCC----hhhhccCCCceEEccCCeeeeecCCCCcCCC
Q 036815          343 CKNLKDLILNNNKLSGEIPAEL--FSCSNLEWISLTGNELTGQIP----PEFSRLTRLAVLQLGNNRFKGEIPGELGNCS  416 (1013)
Q Consensus       343 l~~L~~L~L~~N~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  416 (1013)
                      +++|++|++++|.+++..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|++.+..|..+.+++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            3569999999999999999988  899999999999999998666    4456799999999999999988889999999


Q ss_pred             CCcEEEccCCcCCcC--CCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccc
Q 036815          417 SLVWLDLNSNNLTGD--IPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFAR  494 (1013)
Q Consensus       417 ~L~~L~l~~N~l~~~--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  494 (1013)
                      +|++|||++|++++.  +|.                                                            
T Consensus       170 ~L~~L~Ls~N~l~~~~~~~~------------------------------------------------------------  189 (310)
T 4glp_A          170 ALTSLDLSDNPGLGERGLMA------------------------------------------------------------  189 (310)
T ss_dssp             TCCEEECCSCTTCHHHHHHT------------------------------------------------------------
T ss_pred             CCCEEECCCCCCccchhhhH------------------------------------------------------------
Confidence            999999999998643  110                                                            


Q ss_pred             cccCcccccccCCCccCEEEccCCcccccCChh----hhCCCCCcEEecCCCccCCCCcccccCC---CCcceEecCCcc
Q 036815          495 MYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDE----IGDMIALQVLELAHNQLSGEIPSSLGRL---RNLGVFDASHNR  567 (1013)
Q Consensus       495 ~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~----i~~l~~L~~L~L~~n~l~g~ip~~~~~l---~~L~~L~ls~N~  567 (1013)
                            +..+..+++|++|+|++|+++ .+|..    ++.+++|++|+|++|++++.+|+.++.+   ++|+.|+|++|+
T Consensus       190 ------~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~  262 (310)
T 4glp_A          190 ------ALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAG  262 (310)
T ss_dssp             ------TSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSC
T ss_pred             ------HHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCC
Confidence                  001234568999999999998 45542    5888999999999999998889988887   699999999999


Q ss_pred             ccCCCcccccCCCcceEEECcCCCCCCcCCCCCCCCCCCcccccCCCC
Q 036815          568 LQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPG  615 (1013)
Q Consensus       568 l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~  615 (1013)
                      |+ .+|..+.  ++|+.|+|++|++++. |....+..+..+.+.+|+-
T Consensus       263 l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l  306 (310)
T 4glp_A          263 LE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPF  306 (310)
T ss_dssp             CC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTT
T ss_pred             CC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCC
Confidence            99 8898875  8999999999999984 4356678888888888863

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.86  E-value=5.3e-22  Score=208.87  Aligned_cols=211  Identities=23%  Similarity=0.259  Sum_probs=154.3

Q ss_pred             cccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCc-cCCCCchhhhhCCCCccEEeCCC-
Q 036815            6 KLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN-LTGFLPETLLSNSDKLELLDLSY-   83 (1013)
Q Consensus         6 ~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~l~~L~~L~Ls~-   83 (1013)
                      +++.+.++.+|.    .++++++|+|++|++.+ ++...|.++++|++|++++|. ++ .++...+.++++|++|+|++ 
T Consensus        17 ~v~c~~l~~ip~----~~~~l~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~   90 (239)
T 2xwt_C           17 RVTCKDIQRIPS----LPPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNT   90 (239)
T ss_dssp             EEEECSCSSCCC----CCTTCCEEEEESCCCSE-ECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEE
T ss_pred             eeEccCccccCC----CCCcccEEEEeCCcceE-ECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCC
Confidence            333444777776    55678888888888866 566678888888888888886 76 56666678888888888887 


Q ss_pred             CcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCC---EEecCCC-cccccCcccccCCCCCC-EeeCcC
Q 036815           84 NNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLK---ILNLSFN-LLAGEIPRTFGQLSSLQ-RLDLSN  158 (1013)
Q Consensus        84 n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~Ls~  158 (1013)
                      |+++......+   ..+++|++|++++|.++++ |. |..+++|+   +|++++| +++++.+..|.++++|+ +|++++
T Consensus        91 n~l~~i~~~~f---~~l~~L~~L~l~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~  165 (239)
T 2xwt_C           91 RNLTYIDPDAL---KELPLLKFLGIFNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN  165 (239)
T ss_dssp             TTCCEECTTSE---ECCTTCCEEEEEEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCS
T ss_pred             CCeeEcCHHHh---CCCCCCCEEeCCCCCCccc-cc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCC
Confidence            88875543322   3567788888888888773 43 77777777   8888888 78777667788888888 888888


Q ss_pred             CcccCcCCccchhccCCCcEEECCCCC-CCCcCCccccCC-CCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccc
Q 036815          159 NHITGWIPSELGNACDSLLELKLPHNN-ITGSFPVTLSSC-SWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN  233 (1013)
Q Consensus       159 n~l~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n  233 (1013)
                      |+++ .+|...+.. ++|++|+|++|+ ++.+.+..|.++ ++|+.|++++|+++ .+|..   .+++|+.|+++++
T Consensus       166 n~l~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          166 NGFT-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CCCC-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT---TCTTCSEEECTTC
T ss_pred             CCCc-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh---HhccCceeeccCc
Confidence            8887 677766665 678888888884 776666777777 77777777777776 45543   4667777777655

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.86  E-value=1.8e-23  Score=237.29  Aligned_cols=252  Identities=21%  Similarity=0.264  Sum_probs=194.5

Q ss_pred             cCCcCCCCCCCcCEEEecCCeecccCCCC---CCCCCCCCceEEcCCCc---ccccCCccc-------cccCcccEEEee
Q 036815          238 SFPDSISSCKTLRIVDFSSNRVSGIIPPD---ICPGVSSLEELRLPDNL---ITGVIPGQL-------SECTQLKVIDLS  304 (1013)
Q Consensus       238 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---~~~~l~~L~~L~L~~n~---l~~~~~~~~-------~~l~~L~~L~ls  304 (1013)
                      .++..+..+++|+.|+|++|.+++..+..   .+..+++|+.|+|++|.   +++.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            45667778899999999999998654322   34568999999999964   555555554       688999999999


Q ss_pred             CCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhc----CC---------CCCC
Q 036815          305 LNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF----SC---------SNLE  371 (1013)
Q Consensus       305 ~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~----~l---------~~L~  371 (1013)
                      +|.+++....                    .+|..+..+++|++|+|++|.+++..+..+.    .+         ++|+
T Consensus       103 ~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~  162 (386)
T 2ca6_A          103 DNAFGPTAQE--------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR  162 (386)
T ss_dssp             SCCCCTTTHH--------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             CCcCCHHHHH--------------------HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCc
Confidence            9998842111                    1234556678899999999998754444444    33         8999


Q ss_pred             eEEecCCccC-CCCC---hhhhccCCCceEEccCCeee--e---ecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCC
Q 036815          372 WISLTGNELT-GQIP---PEFSRLTRLAVLQLGNNRFK--G---EIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGA  442 (1013)
Q Consensus       372 ~L~L~~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~  442 (1013)
                      +|+|++|+++ +.+|   ..+..+++|+.|+|++|+++  |   ..|..+.++++|++|+|++|.++..-          
T Consensus       163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g----------  232 (386)
T 2ca6_A          163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG----------  232 (386)
T ss_dssp             EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH----------
T ss_pred             EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH----------
Confidence            9999999997 4455   46778999999999999997  3   45668899999999999999875210          


Q ss_pred             CCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccc
Q 036815          443 KPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRG  522 (1013)
Q Consensus       443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g  522 (1013)
                                                                            .+.++..+..+++|++|+|++|++++
T Consensus       233 ------------------------------------------------------~~~l~~~l~~~~~L~~L~L~~n~i~~  258 (386)
T 2ca6_A          233 ------------------------------------------------------SSALAIALKSWPNLRELGLNDCLLSA  258 (386)
T ss_dssp             ------------------------------------------------------HHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             ------------------------------------------------------HHHHHHHHccCCCcCEEECCCCCCch
Confidence                                                                  00122334456789999999999987


Q ss_pred             c----CChhh--hCCCCCcEEecCCCccCC----CCcccc-cCCCCcceEecCCccccCCCc
Q 036815          523 K----IPDEI--GDMIALQVLELAHNQLSG----EIPSSL-GRLRNLGVFDASHNRLQGQIP  573 (1013)
Q Consensus       523 ~----iP~~i--~~l~~L~~L~L~~n~l~g----~ip~~~-~~l~~L~~L~ls~N~l~g~~p  573 (1013)
                      .    +|..+  +.+++|++|+|++|.+++    .+|..+ .++++|+.|+|++|++++..|
T Consensus       259 ~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          259 RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             hhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            6    67777  449999999999999997    499988 679999999999999998775

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=3.4e-21  Score=210.58  Aligned_cols=210  Identities=21%  Similarity=0.329  Sum_probs=142.4

Q ss_pred             eEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccc
Q 036815          276 ELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNK  355 (1013)
Q Consensus       276 ~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  355 (1013)
                      .+.+..+.+++..  .+..+++|+.|++++|.++.                         +| .+..+++|++|+|++|.
T Consensus        23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-------------------------l~-~~~~l~~L~~L~L~~n~   74 (308)
T 1h6u_A           23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------------------------IE-GVQYLNNLIGLELKDNQ   74 (308)
T ss_dssp             HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-------------------------CT-TGGGCTTCCEEECCSSC
T ss_pred             HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-------------------------ch-hhhccCCCCEEEccCCc
Confidence            3344444444332  24456677777777776652                         22 35556677777777777


Q ss_pred             ccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCch
Q 036815          356 LSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPR  435 (1013)
Q Consensus       356 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  435 (1013)
                      +++ ++. +..+++|++|+|++|++++ ++ .+..+++|+.|+|++|++++ +|. +.++++|++|++++|++++..|  
T Consensus        75 i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--  146 (308)
T 1h6u_A           75 ITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--  146 (308)
T ss_dssp             CCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--
T ss_pred             CCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--
Confidence            774 333 7777777777777777774 33 57777778888888887774 333 7777888888888877653211  


Q ss_pred             hhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEc
Q 036815          436 LGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDL  515 (1013)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~l  515 (1013)
                                                                                          +..+++|++|++
T Consensus       147 --------------------------------------------------------------------l~~l~~L~~L~l  158 (308)
T 1h6u_A          147 --------------------------------------------------------------------LAGLTNLQYLSI  158 (308)
T ss_dssp             --------------------------------------------------------------------GGGCTTCCEEEC
T ss_pred             --------------------------------------------------------------------ccCCCCccEEEc
Confidence                                                                                223456778888


Q ss_pred             cCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCc
Q 036815          516 SYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGP  595 (1013)
Q Consensus       516 s~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~  595 (1013)
                      ++|++++ +|. ++.+++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++.
T Consensus       159 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          159 GNAQVSD-LTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             CSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             cCCcCCC-Chh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            8888874 554 7788888888888888874 443 7788888888888888875443  77788888888888887763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=5.8e-22  Score=212.81  Aligned_cols=153  Identities=16%  Similarity=0.141  Sum_probs=122.8

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc------------------cchHHHHHHHHHHhcc
Q 036815          726 FSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC------------------QGDREFMAEMETLGKI  787 (1013)
Q Consensus       726 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l  787 (1013)
                      +..+......|.+.+.||+|+||.||+|++.+|+.||+|.+.....                  .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3444555667888899999999999999997789999998853221                  1235688999999999


Q ss_pred             CCcceeeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCc
Q 036815          788 KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKS  867 (1013)
Q Consensus       788 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  867 (1013)
                      +  | +++.+++.. +..|+||||++|++|.+ +..            .....++.|++.||+|||+.   +|+||||||
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp  221 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQ  221 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCH
Confidence            9  5 777776544 55699999999999988 421            12346999999999999999   999999999


Q ss_pred             ccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCccccc
Q 036815          868 SNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ  914 (1013)
Q Consensus       868 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  914 (1013)
                      +||+++ ++.+||+|||+|+.               +..|+|||++.
T Consensus       222 ~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          222 YNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             TSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             HHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            999999 99999999999963               33478999875

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.86  E-value=2.1e-21  Score=204.33  Aligned_cols=199  Identities=16%  Similarity=0.154  Sum_probs=143.2

Q ss_pred             CCceEECccccccccCchhhcCCCCCCeEEecCCc-cCCCCChhhhccCCCceEEccC-CeeeeecCCCCcCCCCCcEEE
Q 036815          345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNE-LTGQIPPEFSRLTRLAVLQLGN-NRFKGEIPGELGNCSSLVWLD  422 (1013)
Q Consensus       345 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~  422 (1013)
                      +|++|++++|++++..+..+..+++|++|++++|+ +++..+..|..+++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            78888888888886666678888888888888886 7755556788888888888887 888866667788888888888


Q ss_pred             ccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccc
Q 036815          423 LNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLS  502 (1013)
Q Consensus       423 l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  502 (1013)
                      +++|++++ +|. ++.                                                                
T Consensus       112 l~~n~l~~-lp~-~~~----------------------------------------------------------------  125 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTK----------------------------------------------------------------  125 (239)
T ss_dssp             EEEECCCS-CCC-CTT----------------------------------------------------------------
T ss_pred             CCCCCCcc-ccc-ccc----------------------------------------------------------------
Confidence            88888774 442 111                                                                


Q ss_pred             cccCCCccCEEEccCC-cccccCChhhhCCCCCc-EEecCCCccCCCCcccccCCCCcceEecCCcc-ccCCCcccccCC
Q 036815          503 LFTQYQTLEYLDLSYN-QFRGKIPDEIGDMIALQ-VLELAHNQLSGEIPSSLGRLRNLGVFDASHNR-LQGQIPESFSNL  579 (1013)
Q Consensus       503 ~~~~~~~L~~L~ls~N-~l~g~iP~~i~~l~~L~-~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l  579 (1013)
                       +..++.|++|++++| ++++..|..++.+.+|+ .|+|++|+++ .+|......++|+.|+|++|+ +++..|..|..+
T Consensus       126 -l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l  203 (239)
T 2xwt_C          126 -VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV  203 (239)
T ss_dssp             -CCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTC
T ss_pred             -ccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhcc
Confidence             001122348888888 88755555678888888 8888888888 777665555788888888884 875556677788


Q ss_pred             -CcceEEECcCCCCCCcCCCCCCCCCCCcccccCC
Q 036815          580 -SFLVQIDLSNNELTGPIPQRGQLSTLPASQYANN  613 (1013)
Q Consensus       580 -~~l~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n  613 (1013)
                       ++|+.|++++|++++..+.  .+..+..+...++
T Consensus       204 ~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          204 YSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             SBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred             ccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence             8888888888888754433  4555555555544

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.85  E-value=4e-23  Score=229.87  Aligned_cols=252  Identities=20%  Similarity=0.257  Sum_probs=176.1

Q ss_pred             CcCEEEecCCeecccCCCCCCCCC--CCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHH
Q 036815          248 TLRIVDFSSNRVSGIIPPDICPGV--SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQF  325 (1013)
Q Consensus       248 ~L~~L~L~~N~l~~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L  325 (1013)
                      .++.+++++|.+.+    ..+..+  ++++.|++++|.+.+..+. +..+++|++|++++|.+++.              
T Consensus        48 ~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~--------------  108 (336)
T 2ast_B           48 LWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS--------------  108 (336)
T ss_dssp             TSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH--------------
T ss_pred             hheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH--------------
Confidence            36677777776542    122223  5566666666666655443 34566666666666655421              


Q ss_pred             HhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCC-ccCC-CCChhhhccCCCceEEccCC-
Q 036815          326 IAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGN-ELTG-QIPPEFSRLTRLAVLQLGNN-  402 (1013)
Q Consensus       326 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~L~~N-  402 (1013)
                               .+|..+..+++|++|+|++|.+++..|..+..+++|++|+|++| .+++ .++..+..+++|+.|++++| 
T Consensus       109 ---------~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~  179 (336)
T 2ast_B          109 ---------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF  179 (336)
T ss_dssp             ---------HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT
T ss_pred             ---------HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC
Confidence                     13445667788888888888888778888888888888888888 5765 26667888888888888888 


Q ss_pred             eeeee-cCCCCcCCC-CCcEEEccCCc--CCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCc
Q 036815          403 RFKGE-IPGELGNCS-SLVWLDLNSNN--LTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRP  478 (1013)
Q Consensus       403 ~l~~~-~p~~~~~l~-~L~~L~l~~N~--l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  478 (1013)
                      .+++. ++..+.+++ +|++|++++|.  ++.                                                
T Consensus       180 ~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~------------------------------------------------  211 (336)
T 2ast_B          180 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQK------------------------------------------------  211 (336)
T ss_dssp             TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCH------------------------------------------------
T ss_pred             CcChHHHHHHHHhcccCCCEEEeCCCcccCCH------------------------------------------------
Confidence            88754 566677888 88899888883  331                                                


Q ss_pred             ccccccCccccccccccccCcccccccCCCccCEEEccCCc-ccccCChhhhCCCCCcEEecCCCc-cCCCCcccccCCC
Q 036815          479 ERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ-FRGKIPDEIGDMIALQVLELAHNQ-LSGEIPSSLGRLR  556 (1013)
Q Consensus       479 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~-l~g~iP~~i~~l~~L~~L~L~~n~-l~g~ip~~~~~l~  556 (1013)
                                         +.++..+..+++|++|++++|. +++..|..++.+++|++|+|++|. ++......+++++
T Consensus       212 -------------------~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~  272 (336)
T 2ast_B          212 -------------------SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP  272 (336)
T ss_dssp             -------------------HHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCT
T ss_pred             -------------------HHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCC
Confidence                               0112233456789999999999 777888899999999999999995 3222223688899


Q ss_pred             CcceEecCCccccCCCcccccCC-CcceEEECcCCCCCCcCCC
Q 036815          557 NLGVFDASHNRLQGQIPESFSNL-SFLVQIDLSNNELTGPIPQ  598 (1013)
Q Consensus       557 ~L~~L~ls~N~l~g~~p~~~~~l-~~l~~l~l~~n~l~~~~p~  598 (1013)
                      +|+.|++++| ++.   ..+..+ ..+..|++++|++++..|.
T Consensus       273 ~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~  311 (336)
T 2ast_B          273 TLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARP  311 (336)
T ss_dssp             TCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred             CCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCC
Confidence            9999999998 332   233333 2366677899999998875

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.85  E-value=4.5e-21  Score=213.97  Aligned_cols=239  Identities=21%  Similarity=0.144  Sum_probs=148.3

Q ss_pred             ceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccE-EeC
Q 036815            3 SVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLEL-LDL   81 (1013)
Q Consensus         3 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~-L~L   81 (1013)
                      +.++.++++++.+|..   +++++++|+|++|+|.. +|.++|.++++|++|+|++|.+.+.+|..+|.++++|++ +.+
T Consensus        12 ~~v~C~~~~Lt~iP~~---l~~~l~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVTEIPSD---LPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCCSCCTT---CCTTCSEEEEESCCCSE-ECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCCccCcC---cCCCCCEEEccCCcCCC-cCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            3567888888888875   46778888888888865 787888888888888888888876777777777777664 455


Q ss_pred             CCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCC-CcccccCcccccCCC-CCCEeeCcCC
Q 036815           82 SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSF-NLLAGEIPRTFGQLS-SLQRLDLSNN  159 (1013)
Q Consensus        82 s~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~L~Ls~n  159 (1013)
                      ++|+++.+....+   ..+++|++|++++|+|+.+.+..+....++..|++.+ +++..+.+..|..+. .++.|++++|
T Consensus        88 ~~N~l~~l~~~~f---~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N  164 (350)
T 4ay9_X           88 KANNLLYINPEAF---QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN  164 (350)
T ss_dssp             EETTCCEECTTSB---CCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred             cCCcccccCchhh---hhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence            5677765443322   3456667777777776665555555555666666643 455555555555553 4666666666


Q ss_pred             cccCcCCccchhccCCCcEEECCC-CCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccc-cCCC
Q 036815          160 HITGWIPSELGNACDSLLELKLPH-NNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN-MISG  237 (1013)
Q Consensus       160 ~l~~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~  237 (1013)
                      +|+ .++..++.. .+|++|++.+ |.++.+.+..|.++++|++|+|++|+|+ .+|...   +.+|+.|.+.++ .++ 
T Consensus       165 ~i~-~i~~~~f~~-~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~---~~~L~~L~~l~~~~l~-  237 (350)
T 4ay9_X          165 GIQ-EIHNSAFNG-TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG---LENLKKLRARSTYNLK-  237 (350)
T ss_dssp             CCC-EECTTSSTT-EEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSS---CTTCCEEECTTCTTCC-
T ss_pred             ccc-CCChhhccc-cchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhh---hccchHhhhccCCCcC-
Confidence            666 555555543 4566666653 4555554555666666666666666665 455432   334444443333 222 


Q ss_pred             cCCcCCCCCCCcCEEEecC
Q 036815          238 SFPDSISSCKTLRIVDFSS  256 (1013)
Q Consensus       238 ~~~~~~~~l~~L~~L~L~~  256 (1013)
                      .+| .+.++++|+.+++.+
T Consensus       238 ~lP-~l~~l~~L~~l~l~~  255 (350)
T 4ay9_X          238 KLP-TLEKLVALMEASLTY  255 (350)
T ss_dssp             CCC-CTTTCCSCCEEECSC
T ss_pred             cCC-CchhCcChhhCcCCC
Confidence            333 244455555555443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=4.1e-21  Score=224.90  Aligned_cols=67  Identities=25%  Similarity=0.330  Sum_probs=38.3

Q ss_pred             ccCEEEccCCcccccCChhhhCCCCC-------cEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCC
Q 036815          509 TLEYLDLSYNQFRGKIPDEIGDMIAL-------QVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLS  580 (1013)
Q Consensus       509 ~L~~L~ls~N~l~g~iP~~i~~l~~L-------~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~  580 (1013)
                      +|++|||++|+|+ .+|. +..  +|       +.|+|++|+|+ .||..++.+++|+.|+|++|.|+|.+|..+..+.
T Consensus       181 ~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          181 SLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             TCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             CCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            3555555555555 4555 433  44       66666666666 4666666666666666666666666666655543

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.85  E-value=3.3e-20  Score=196.53  Aligned_cols=178  Identities=22%  Similarity=0.294  Sum_probs=120.3

Q ss_pred             CccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEe
Q 036815           75 KLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRL  154 (1013)
Q Consensus        75 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  154 (1013)
                      ..++++++++.++..+..+.      ++++.|+|++|.|+++.+..|.++++|++|+|++|++++..+..|..+++|++|
T Consensus        15 ~~~~l~~~~~~l~~~p~~~~------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L   88 (251)
T 3m19_A           15 GKKEVDCQGKSLDSVPSGIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTL   88 (251)
T ss_dssp             GGTEEECTTCCCSSCCSCCC------TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCeEEecCCCCccccCCCCC------CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEE
Confidence            45667777777765444332      467777777777777777777777777777777777777777777777777777


Q ss_pred             eCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEccccc
Q 036815          155 DLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNM  234 (1013)
Q Consensus       155 ~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~  234 (1013)
                      ++++|.++ .++...+..+++|++|+|++|+|++..+..|..+++|++|+|++|+++ .++...+..+++|++|+|++|+
T Consensus        89 ~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~  166 (251)
T 3m19_A           89 GLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQ  166 (251)
T ss_dssp             ECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred             ECCCCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC-ccCHHHcCcCcCCCEEECCCCc
Confidence            77777777 555555555667777777777777666666666777777777777776 4444445666677777777777


Q ss_pred             CCCcCCcCCCCCCCcCEEEecCCeec
Q 036815          235 ISGSFPDSISSCKTLRIVDFSSNRVS  260 (1013)
Q Consensus       235 l~~~~~~~~~~l~~L~~L~L~~N~l~  260 (1013)
                      +++..+..+..+++|+.|++++|.+.
T Consensus       167 l~~~~~~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          167 LQSVPHGAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             CCccCHHHHhCCCCCCEEEeeCCcee
Confidence            66555556666666666666666665

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.84  E-value=4.4e-22  Score=221.47  Aligned_cols=255  Identities=20%  Similarity=0.200  Sum_probs=171.7

Q ss_pred             CCcEEeCCCCccCCCCchhhhhCC--CCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCC-CCccccCCCC
Q 036815           50 NLVYLNASYNNLTGFLPETLLSNS--DKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPSSLSNCTK  126 (1013)
Q Consensus        50 ~L~~L~L~~n~i~~~~~~~~~~~l--~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~-~~~~l~~l~~  126 (1013)
                      .++.|++++|.+.    ...+..+  ++++.|++++|.+++.....    ..+++|++|+|++|.+++. .+..+..+++
T Consensus        48 ~~~~l~l~~~~~~----~~~~~~~~~~~l~~L~l~~n~l~~~~~~~----~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~  119 (336)
T 2ast_B           48 LWQTLDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAEH----FSPFRVQHMDLSNSVIEVSTLHGILSQCSK  119 (336)
T ss_dssp             TSSEEECTTCBCC----HHHHHHHHHTTCSEEECTTCEECSCCCSC----CCCBCCCEEECTTCEECHHHHHHHHTTBCC
T ss_pred             hheeeccccccCC----HHHHHhhhhccceEEEcCCccccccchhh----ccCCCCCEEEccCCCcCHHHHHHHHhhCCC
Confidence            4788899888776    2334445  78889999998888655443    2578889999998888765 6667888889


Q ss_pred             CCEEecCCCcccccCcccccCCCCCCEeeCcCC-cccCcCCccchhccCCCcEEECCCC-CCCCc-CCccccCCC-CCCE
Q 036815          127 LKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN-HITGWIPSELGNACDSLLELKLPHN-NITGS-FPVTLSSCS-WLQL  202 (1013)
Q Consensus       127 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~l~~l~-~L~~  202 (1013)
                      |++|++++|.+++..+..++.+++|++|++++| .+++.....++..+++|++|++++| .+++. .+..+..++ +|++
T Consensus       120 L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~  199 (336)
T 2ast_B          120 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ  199 (336)
T ss_dssp             CSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCE
T ss_pred             CCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCE
Confidence            999999999888777888888889999999988 6764322333455688888888888 88754 456677788 8888


Q ss_pred             EEccCC--CCCCCCChhhhhcCCCCcEEEccccc-CCCcCCcCCCCCCCcCEEEecCCe-ecccCCCCCCCCCCCCceEE
Q 036815          203 LDLSNN--NISGPFPDSVLENLGSLESLILSNNM-ISGSFPDSISSCKTLRIVDFSSNR-VSGIIPPDICPGVSSLEELR  278 (1013)
Q Consensus       203 L~L~~N--~l~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~l~~L~~L~  278 (1013)
                      |++++|  .+++......+..+++|++|++++|. +++..+..+..+++|+.|++++|. +..... ..+..+++|+.|+
T Consensus       200 L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~-~~l~~~~~L~~L~  278 (336)
T 2ast_B          200 LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL-LELGEIPTLKTLQ  278 (336)
T ss_dssp             EECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGG-GGGGGCTTCCEEE
T ss_pred             EEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHH-HHHhcCCCCCEEe
Confidence            888888  45422112345678888888888887 666666677777888888888774 221110 1233455666666


Q ss_pred             cCCCcccccCCcccccc-CcccEEEeeCCccCCCCCcccc
Q 036815          279 LPDNLITGVIPGQLSEC-TQLKVIDLSLNYLNGSIPQELG  317 (1013)
Q Consensus       279 L~~n~l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~p~~l~  317 (1013)
                      +++| ++.   ..+..+ ..|..|++++|++++..|..++
T Consensus       279 l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          279 VFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             CTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             ccCc-cCH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence            6655 221   122222 1244444556666555554444

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.84  E-value=3.2e-20  Score=202.80  Aligned_cols=193  Identities=25%  Similarity=0.303  Sum_probs=110.9

Q ss_pred             cCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCC
Q 036815           46 SKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCT  125 (1013)
Q Consensus        46 ~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~  125 (1013)
                      ..+++|++|++++|.++ .++.  +..+++|++|+|++|++++...     ...+++|++|+|++|.++++  ..+..++
T Consensus        38 ~~l~~L~~L~l~~~~i~-~l~~--~~~l~~L~~L~L~~n~i~~~~~-----~~~l~~L~~L~L~~n~l~~~--~~~~~l~  107 (308)
T 1h6u_A           38 ADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP-----LKNLTKITELELSGNPLKNV--SAIAGLQ  107 (308)
T ss_dssp             HHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG-----GTTCCSCCEEECCSCCCSCC--GGGTTCT
T ss_pred             HHcCCcCEEEeeCCCcc-Cchh--hhccCCCCEEEccCCcCCCChh-----HccCCCCCEEEccCCcCCCc--hhhcCCC
Confidence            34555666666666665 3332  4556666666666666654332     23455666666666666553  2466666


Q ss_pred             CCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEc
Q 036815          126 KLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL  205 (1013)
Q Consensus       126 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L  205 (1013)
                      +|++|++++|++++..  .+..+++|++|++++|.++ .++.  +..+++|++|+|++|++++..+  +..+++|+.|++
T Consensus       108 ~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l  180 (308)
T 1h6u_A          108 SIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQIT-NISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA  180 (308)
T ss_dssp             TCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccC-cCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEEC
Confidence            6666666666666432  2666666666666666666 2332  3345666666666666664433  566666666666


Q ss_pred             cCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeec
Q 036815          206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVS  260 (1013)
Q Consensus       206 ~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  260 (1013)
                      ++|++++ ++.  +..+++|++|++++|++++..  .+..+++|+.|++++|+++
T Consensus       181 ~~n~l~~-~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          181 DDNKISD-ISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             CSSCCCC-CGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred             CCCccCc-Chh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence            6666653 332  455666666666666666432  2555666666666666665

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.84  E-value=1.6e-20  Score=209.54  Aligned_cols=240  Identities=17%  Similarity=0.170  Sum_probs=173.6

Q ss_pred             CEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcE-EEc
Q 036815          152 QRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLES-LIL  230 (1013)
Q Consensus       152 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~-L~L  230 (1013)
                      ++++.++++++ .+|..+.   +++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.++...|.+++++.+ +.+
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~---~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC---TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCC-ccCcCcC---CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            56778888888 7887663   578899999999987777788999999999999999876778777888888775 566


Q ss_pred             ccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCC-CcccccCCccccccC-cccEEEeeCCcc
Q 036815          231 SNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPD-NLITGVIPGQLSECT-QLKVIDLSLNYL  308 (1013)
Q Consensus       231 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~L~ls~N~l  308 (1013)
                      ++|+++...+..|..+++|++|++++|+++ .++...+....++..|++.+ +++....+..|..+. .++.|++++|+|
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i  166 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI  166 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred             cCCcccccCchhhhhccccccccccccccc-cCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence            778888777888899999999999999987 44555555566777788755 567766666676664 578888888888


Q ss_pred             CCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcc-ccccccCc-hhhcCCCCCCeEEecCCccCCCCCh
Q 036815          309 NGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNN-NKLSGEIP-AELFSCSNLEWISLTGNELTGQIPP  386 (1013)
Q Consensus       309 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~  386 (1013)
                      + .+                        |.......+|+.|++++ |.++ .+| ..|..+++|++|+|++|+|+...+.
T Consensus       167 ~-~i------------------------~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~  220 (350)
T 4ay9_X          167 Q-EI------------------------HNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSY  220 (350)
T ss_dssp             C-EE------------------------CTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSS
T ss_pred             c-CC------------------------ChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChh
Confidence            7 23                        33333445677788764 4555 455 4567788888888888888843333


Q ss_pred             hhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCC
Q 036815          387 EFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN  426 (1013)
Q Consensus       387 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  426 (1013)
                      .|.   +|+.|.+.++.--..+| .+.++++|+.++++++
T Consensus       221 ~~~---~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          221 GLE---NLKKLRARSTYNLKKLP-TLEKLVALMEASLTYP  256 (350)
T ss_dssp             SCT---TCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCH
T ss_pred             hhc---cchHhhhccCCCcCcCC-CchhCcChhhCcCCCC
Confidence            444   44444444333233667 4788889999998754

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.83  E-value=1.9e-20  Score=219.27  Aligned_cols=182  Identities=26%  Similarity=0.410  Sum_probs=152.8

Q ss_pred             cccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEec
Q 036815          297 QLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLT  376 (1013)
Q Consensus       297 ~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  376 (1013)
                      +|+.|++++|.+++ +|                        ..+.  ++|++|+|++|+++ .+|   ..+++|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp------------------------~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls  108 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LP------------------------DNLP--PQITVLEITQNALI-SLP---ELPASLEYLDAC  108 (571)
T ss_dssp             TCSEEECCSSCCSC-CC------------------------SCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECC
T ss_pred             CccEEEeCCCCCCc-cC------------------------HhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEcc
Confidence            78888888887773 33                        3332  57999999999998 677   457899999999


Q ss_pred             CCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEE
Q 036815          377 GNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVF  456 (1013)
Q Consensus       377 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~  456 (1013)
                      +|+|++ +|. +..  +|+.|+|++|++++ +|.   .+++|++|+|++|++++ +|.                      
T Consensus       109 ~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~----------------------  157 (571)
T 3cvr_A          109 DNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE----------------------  157 (571)
T ss_dssp             SSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC----------------------
T ss_pred             CCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC----------------------
Confidence            999996 777 665  89999999999996 777   68999999999999875 442                      


Q ss_pred             EeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcE
Q 036815          457 VRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQV  536 (1013)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~  536 (1013)
                                                                       .+++|++|+|++|+|++ +|. ++  ++|++
T Consensus       158 -------------------------------------------------~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~  184 (571)
T 3cvr_A          158 -------------------------------------------------LPTSLEVLSVRNNQLTF-LPE-LP--ESLEA  184 (571)
T ss_dssp             -------------------------------------------------CCTTCCEEECCSSCCSC-CCC-CC--TTCCE
T ss_pred             -------------------------------------------------cCCCcCEEECCCCCCCC-cch-hh--CCCCE
Confidence                                                             12568999999999996 888 76  99999


Q ss_pred             EecCCCccCCCCcccccCCCCc-------ceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCC
Q 036815          537 LELAHNQLSGEIPSSLGRLRNL-------GVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQ  598 (1013)
Q Consensus       537 L~L~~n~l~g~ip~~~~~l~~L-------~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~  598 (1013)
                      |+|++|+|+ .+|. +..  +|       +.|+|++|+|+ .||..+..+++|+.|+|++|+|+|.+|.
T Consensus       185 L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          185 LDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             EECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             EECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            999999999 8998 765  78       99999999998 7999999999999999999999998875

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=2.3e-20  Score=191.66  Aligned_cols=91  Identities=25%  Similarity=0.328  Sum_probs=53.7

Q ss_pred             cCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCc
Q 036815          340 LGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV  419 (1013)
Q Consensus       340 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  419 (1013)
                      |+.+++|++|++++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+.++++|+
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  127 (208)
T 2o6s_A           48 FDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLK  127 (208)
T ss_dssp             TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCC
Confidence            44555555666666655544344455566666666666666644444556666666666666666654444566666666


Q ss_pred             EEEccCCcCCc
Q 036815          420 WLDLNSNNLTG  430 (1013)
Q Consensus       420 ~L~l~~N~l~~  430 (1013)
                      +|++++|++++
T Consensus       128 ~L~l~~N~l~~  138 (208)
T 2o6s_A          128 DLRLYQNQLKS  138 (208)
T ss_dssp             EEECCSSCCSC
T ss_pred             EEECCCCccce
Confidence            66666666653

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.81  E-value=6.3e-19  Score=180.91  Aligned_cols=191  Identities=20%  Similarity=0.261  Sum_probs=140.1

Q ss_pred             CEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcc
Q 036815          152 QRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS  231 (1013)
Q Consensus       152 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~  231 (1013)
                      +.++.+++.++ .+|..+.   ++|++|++++|++++..+..|..+++|++|++++|+++ .++...+..+++|++|+++
T Consensus        10 ~~v~c~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls   84 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGIP---AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLS   84 (208)
T ss_dssp             TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             CEEEecCCCcc-CCCCCCC---CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECC
Confidence            45666666666 5555442   46777777777777666666777777888888888777 5555566777788888888


Q ss_pred             cccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCC
Q 036815          232 NNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS  311 (1013)
Q Consensus       232 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  311 (1013)
                      +|++++..+..+..+++|++|++++|+++ .++...+..+++|+.|++++|.+++..+..+..+++|+.|++++|++.+ 
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-  162 (208)
T 2o6s_A           85 TNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-  162 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-
T ss_pred             CCcCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-
Confidence            88887655566777888888888888887 4555666778888888888888887777778889999999999998774 


Q ss_pred             CCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccccc
Q 036815          312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE  359 (1013)
Q Consensus       312 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  359 (1013)
                            .++.|+.|.++.|.++|.+|..++.++.    ++..|...+.
T Consensus       163 ------~~~~l~~L~~~~n~~~g~ip~~~~~l~~----~~~~C~~~~~  200 (208)
T 2o6s_A          163 ------TCPGIRYLSEWINKHSGVVRNSAGSVAP----DSAKCSGSGK  200 (208)
T ss_dssp             ------CTTTTHHHHHHHHHCTTTBBCTTSSBCT----TCSBBTTTCC
T ss_pred             ------CCCCHHHHHHHHHhCCceeeccCccccC----CccccccCCC
Confidence                  3457888888888888888888876654    4444444433

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.79  E-value=3.9e-19  Score=192.34  Aligned_cols=192  Identities=22%  Similarity=0.291  Sum_probs=154.9

Q ss_pred             cchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEc
Q 036815          320 EHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQL  399 (1013)
Q Consensus       320 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  399 (1013)
                      ..+..+.+..+.+++.  ..+..+++|+.|++++|.+. .++ .+..+++|++|++++|++++. +. +..+++|+.|+|
T Consensus        24 ~~~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l   97 (291)
T 1h6t_A           24 AETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFL   97 (291)
T ss_dssp             HHHHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEEC
T ss_pred             HHHHHHHhcCCCcccc--cchhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEEC
Confidence            3444555666555532  23557889999999999998 444 488899999999999999954 44 899999999999


Q ss_pred             cCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcc
Q 036815          400 GNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPE  479 (1013)
Q Consensus       400 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  479 (1013)
                      ++|++++ +| .+.++++|++|++++|++++. |                                              
T Consensus        98 ~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~----------------------------------------------  128 (291)
T 1h6t_A           98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-N----------------------------------------------  128 (291)
T ss_dssp             CSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-G----------------------------------------------
T ss_pred             CCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-h----------------------------------------------
Confidence            9999985 44 489999999999999988741 1                                              


Q ss_pred             cccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcc
Q 036815          480 RLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLG  559 (1013)
Q Consensus       480 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~  559 (1013)
                                             .+..+++|++|++++|++++ + +.++.+++|+.|+|++|++++..|  ++.+++|+
T Consensus       129 -----------------------~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~  181 (291)
T 1h6t_A          129 -----------------------GLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ  181 (291)
T ss_dssp             -----------------------GGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred             -----------------------hhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEccCCccccchh--hcCCCccC
Confidence                                   12335679999999999995 4 689999999999999999996444  99999999


Q ss_pred             eEecCCccccCCCcccccCCCcceEEECcCCCCCCc
Q 036815          560 VFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGP  595 (1013)
Q Consensus       560 ~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~  595 (1013)
                      .|+|++|++++ +|. +..+++|+.|++++|+++..
T Consensus       182 ~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          182 NLYLSKNHISD-LRA-LAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             EEECCSSCCCB-CGG-GTTCTTCSEEEEEEEEEECC
T ss_pred             EEECCCCcCCC-Chh-hccCCCCCEEECcCCcccCC
Confidence            99999999985 564 89999999999999998863

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=1.4e-18  Score=179.50  Aligned_cols=89  Identities=17%  Similarity=0.207  Sum_probs=46.0

Q ss_pred             CccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEEC
Q 036815          508 QTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDL  587 (1013)
Q Consensus       508 ~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l  587 (1013)
                      ++|++|+|++|++++..|..++.+++|++|+|++|++++..|..|+.+++|+.|+|++|++++..|..|..+++|+.|+|
T Consensus        81 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  160 (220)
T 2v70_A           81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNL  160 (220)
T ss_dssp             TTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEe
Confidence            34444444444444433344555555555555555555444555555555555555555555544555555555555555


Q ss_pred             cCCCCCCcC
Q 036815          588 SNNELTGPI  596 (1013)
Q Consensus       588 ~~n~l~~~~  596 (1013)
                      ++|++++..
T Consensus       161 ~~N~l~c~c  169 (220)
T 2v70_A          161 LANPFNCNC  169 (220)
T ss_dssp             CSCCEECSG
T ss_pred             cCcCCcCCC
Confidence            555555443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.77  E-value=1.1e-18  Score=206.98  Aligned_cols=191  Identities=23%  Similarity=0.316  Sum_probs=124.4

Q ss_pred             chHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEcc
Q 036815          321 HLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG  400 (1013)
Q Consensus       321 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  400 (1013)
                      .+..+.+..+.+....  .+..+++|+.|++++|.+. .+| .+..+++|+.|+|++|++++..|  +..+++|+.|+|+
T Consensus        22 ~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD   95 (605)
T ss_dssp             HHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred             HHHHHhccCCCccccc--chhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence            3444555555554322  2456667777777777776 343 46777777777777777774433  7777777777777


Q ss_pred             CCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCccc
Q 036815          401 NNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER  480 (1013)
Q Consensus       401 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  480 (1013)
                      +|++++ +| .+..+++|++|+|++|.+++ +|                                               
T Consensus        96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-----------------------------------------------  125 (605)
T 1m9s_A           96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-----------------------------------------------  125 (605)
T ss_dssp             SSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-----------------------------------------------
T ss_pred             CCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-----------------------------------------------
Confidence            777763 33 67777777777777776653 11                                               


Q ss_pred             ccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcce
Q 036815          481 LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGV  560 (1013)
Q Consensus       481 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~  560 (1013)
                                            .+..+++|+.|+|++|++++ + ..++.+++|+.|+|++|++++..|  ++.+++|+.
T Consensus       126 ----------------------~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~  179 (605)
T 1m9s_A          126 ----------------------GLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN  179 (605)
T ss_dssp             ----------------------GGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             ----------------------cccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCE
Confidence                                  01234567777777777774 3 567777777777777777775444  777777777


Q ss_pred             EecCCccccCCCcccccCCCcceEEECcCCCCCCc
Q 036815          561 FDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGP  595 (1013)
Q Consensus       561 L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~  595 (1013)
                      |+|++|+|++ +| .+..+++|+.|+|++|++++.
T Consensus       180 L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          180 LYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             EECCSSCCCB-CG-GGTTCTTCSEEECCSEEEECC
T ss_pred             EECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcCC
Confidence            7777777764 33 467777777777777777654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.76  E-value=1.7e-18  Score=193.89  Aligned_cols=176  Identities=30%  Similarity=0.302  Sum_probs=125.8

Q ss_pred             ceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhh-ccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccC
Q 036815          347 KDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFS-RLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNS  425 (1013)
Q Consensus       347 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  425 (1013)
                      +.+++++|.++ .+|..+.  +.++.|+|++|+|++..+..|. .+++|+.|+|++|++++..|..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            56788888877 5666554  3577888888888866666666 788888888888888876667788888888888888


Q ss_pred             CcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCccccccc
Q 036815          426 NNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFT  505 (1013)
Q Consensus       426 N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  505 (1013)
                      |++++..|.                                                                    .|.
T Consensus        98 N~l~~~~~~--------------------------------------------------------------------~~~  109 (361)
T 2xot_A           98 NHLHTLDEF--------------------------------------------------------------------LFS  109 (361)
T ss_dssp             SCCCEECTT--------------------------------------------------------------------TTT
T ss_pred             CcCCcCCHH--------------------------------------------------------------------HhC
Confidence            877643221                                                                    233


Q ss_pred             CCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccc----cCCCCcceEecCCccccCCCcccccCCCc
Q 036815          506 QYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSL----GRLRNLGVFDASHNRLQGQIPESFSNLSF  581 (1013)
Q Consensus       506 ~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~----~~l~~L~~L~ls~N~l~g~~p~~~~~l~~  581 (1013)
                      .+++|++|+|++|+|++..|..++.+.+|+.|+|++|+|+ .+|..+    ..+++|+.|||++|+|++..+..+..++.
T Consensus       110 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~  188 (361)
T 2xot_A          110 DLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA  188 (361)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCH
T ss_pred             CCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccH
Confidence            4567788888888888777778888888888888888888 466554    56788888888888887555566777765


Q ss_pred             c--eEEECcCCCCCC
Q 036815          582 L--VQIDLSNNELTG  594 (1013)
Q Consensus       582 l--~~l~l~~n~l~~  594 (1013)
                      +  +.|+|++|++..
T Consensus       189 ~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          189 WVKNGLYLHNNPLEC  203 (361)
T ss_dssp             HHHTTEECCSSCEEC
T ss_pred             hhcceEEecCCCccC
Confidence            3  667777766653

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=2.1e-19  Score=218.73  Aligned_cols=188  Identities=24%  Similarity=0.312  Sum_probs=100.7

Q ss_pred             hccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeec
Q 036815          329 FNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEI  408 (1013)
Q Consensus       329 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  408 (1013)
                      .|.+. ..|..+..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+.|++|+.|+|++|+|+ .+
T Consensus       210 ~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l  285 (727)
T 4b8c_D          210 ENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL  285 (727)
T ss_dssp             -------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred             cccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence            34443 45667777777888888888777 67777777777778888877777 77777777777777777777777 67


Q ss_pred             CCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccc
Q 036815          409 PGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLK  488 (1013)
Q Consensus       409 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  488 (1013)
                      |..|++|++|++|+|++|.++ .+|..                                                     
T Consensus       286 p~~~~~l~~L~~L~L~~N~l~-~lp~~-----------------------------------------------------  311 (727)
T 4b8c_D          286 PAELGSCFQLKYFYFFDNMVT-TLPWE-----------------------------------------------------  311 (727)
T ss_dssp             CSSGGGGTTCSEEECCSSCCC-CCCSS-----------------------------------------------------
T ss_pred             ChhhcCCCCCCEEECCCCCCC-ccChh-----------------------------------------------------
Confidence            777777777777777777765 44432                                                     


Q ss_pred             cccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCC-CcEEecCCCccCCCCcccccCCCCcceEecCCc-
Q 036815          489 SCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA-LQVLELAHNQLSGEIPSSLGRLRNLGVFDASHN-  566 (1013)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~-L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N-  566 (1013)
                                     |..+++|++|+|++|.|+|.+|..++.+.. +..|+|++|.++|.+|..      |+.|++++| 
T Consensus       312 ---------------~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~  370 (727)
T 4b8c_D          312 ---------------FGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDG  370 (727)
T ss_dssp             ---------------TTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------------
T ss_pred             ---------------hhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeeccc
Confidence                           233456777777777777777777655432 234677777777777754      344556655 


Q ss_pred             -------cccCCCcccccCCCcceEEECcCCCCCCc
Q 036815          567 -------RLQGQIPESFSNLSFLVQIDLSNNELTGP  595 (1013)
Q Consensus       567 -------~l~g~~p~~~~~l~~l~~l~l~~n~l~~~  595 (1013)
                             .|.+.++..+..+..+....+++|-+.+.
T Consensus       371 ~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~  406 (727)
T 4b8c_D          371 EPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQH  406 (727)
T ss_dssp             -------------------------------CCCGG
T ss_pred             ccccccCCccccccchhhcccccceeeeeccccccc
Confidence                   34444444455555566666666665543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=1.8e-20  Score=220.95  Aligned_cols=79  Identities=22%  Similarity=0.172  Sum_probs=53.8

Q ss_pred             CCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCC-cccccCCCCcceEecCCccccCCCccc---ccCCCcc
Q 036815          507 YQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEI-PSSLGRLRNLGVFDASHNRLQGQIPES---FSNLSFL  582 (1013)
Q Consensus       507 ~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~i-p~~~~~l~~L~~L~ls~N~l~g~~p~~---~~~l~~l  582 (1013)
                      +++|++|+|++|+|++ +| .++.+++|++|+|++|+|++.+ |..++.+++|+.|+|++|+|++.+|..   +..+++|
T Consensus       485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L  562 (567)
T 1dce_A          485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV  562 (567)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred             CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence            3556777777777774 66 6777777777777777777655 777777777777777777777654422   2336677


Q ss_pred             eEEEC
Q 036815          583 VQIDL  587 (1013)
Q Consensus       583 ~~l~l  587 (1013)
                      +.||+
T Consensus       563 ~~L~l  567 (567)
T 1dce_A          563 SSILT  567 (567)
T ss_dssp             SEEEC
T ss_pred             CccCC
Confidence            77654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.76  E-value=5.5e-18  Score=175.07  Aligned_cols=80  Identities=28%  Similarity=0.316  Sum_probs=45.2

Q ss_pred             ceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCC
Q 036815          347 KDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN  426 (1013)
Q Consensus       347 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  426 (1013)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            45666666665 4554443  45566666666665444445555555566666666555555555555555555555555


Q ss_pred             cCC
Q 036815          427 NLT  429 (1013)
Q Consensus       427 ~l~  429 (1013)
                      +++
T Consensus        91 ~l~   93 (220)
T 2v9t_B           91 KIT   93 (220)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.75  E-value=7.3e-18  Score=175.44  Aligned_cols=89  Identities=26%  Similarity=0.310  Sum_probs=50.9

Q ss_pred             CccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEEC
Q 036815          508 QTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDL  587 (1013)
Q Consensus       508 ~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l  587 (1013)
                      ++|++|||++|+|++..|..++.+.+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus        88 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  166 (229)
T 3e6j_A           88 TQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL  166 (229)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEe
Confidence            44555555555555433334455566666666666665 55666666666666666666665444445566666666666


Q ss_pred             cCCCCCCcCC
Q 036815          588 SNNELTGPIP  597 (1013)
Q Consensus       588 ~~n~l~~~~p  597 (1013)
                      ++|++++..+
T Consensus       167 ~~N~~~c~c~  176 (229)
T 3e6j_A          167 FGNPWDCECR  176 (229)
T ss_dssp             TTSCBCTTBG
T ss_pred             eCCCccCCcc
Confidence            6666655443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.75  E-value=3.4e-18  Score=191.38  Aligned_cols=176  Identities=26%  Similarity=0.217  Sum_probs=121.3

Q ss_pred             cEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCcccc-CCCCCCEEecCCCcccccCcccccCCCCCCEee
Q 036815           77 ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLS-NCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLD  155 (1013)
Q Consensus        77 ~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  155 (1013)
                      +.+++++++++.++..+      .+.++.|+|++|+|+++.+..|. ++++|++|+|++|+|+++.+..|.++++|++|+
T Consensus        21 ~~l~c~~~~l~~iP~~~------~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~   94 (361)
T 2xot_A           21 NILSCSKQQLPNVPQSL------PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLD   94 (361)
T ss_dssp             TEEECCSSCCSSCCSSC------CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CEEEeCCCCcCccCccC------CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEE
Confidence            45666666666443332      23466777777777776666666 777777777777777776667777777777777


Q ss_pred             CcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhh---hcCCCCcEEEccc
Q 036815          156 LSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVL---ENLGSLESLILSN  232 (1013)
Q Consensus       156 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~---~~l~~L~~L~L~~  232 (1013)
                      |++|+|+ .++...+..+++|++|+|++|+|+.+.+..|.++++|+.|+|++|+++ .+|...+   ..+++|++|+|++
T Consensus        95 Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~  172 (361)
T 2xot_A           95 LSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSS  172 (361)
T ss_dssp             CCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCS
T ss_pred             CCCCcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCC
Confidence            7777777 555555566677777777777777777777778888888888888887 5666655   4577777777777


Q ss_pred             ccCCCcCCcCCCCCCC--cCEEEecCCeec
Q 036815          233 NMISGSFPDSISSCKT--LRIVDFSSNRVS  260 (1013)
Q Consensus       233 n~l~~~~~~~~~~l~~--L~~L~L~~N~l~  260 (1013)
                      |+|+...+..+..++.  ++.|+|++|.+.
T Consensus       173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             SCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            7777544455555655  366777777665

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.75  E-value=3.1e-18  Score=203.09  Aligned_cols=171  Identities=28%  Similarity=0.346  Sum_probs=92.4

Q ss_pred             CCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEE
Q 036815          100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL  179 (1013)
Q Consensus       100 ~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  179 (1013)
                      +++|+.|++++|.|.++  ..+..+++|+.|+|++|++++..+  +..+++|+.|+|++|.++                 
T Consensus        42 L~~L~~L~l~~n~i~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-----------------  100 (605)
T 1m9s_A           42 LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-----------------  100 (605)
T ss_dssp             HTTCCCCBCTTCCCCCC--TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC-----------------
T ss_pred             CCCCCEEECcCCCCCCC--hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCC-----------------
Confidence            34455555555555443  134555555555555555543322  444555555555555444                 


Q ss_pred             ECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCee
Q 036815          180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRV  259 (1013)
Q Consensus       180 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  259 (1013)
                              +.  ..+..+++|+.|+|++|++.+ ++.  +..+++|+.|+|++|++++.  ..+..+++|+.|+|++|.+
T Consensus       101 --------~l--~~l~~l~~L~~L~Ls~N~l~~-l~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l  165 (605)
T 1m9s_A          101 --------DL--SSLKDLKKLKSLSLEHNGISD-ING--LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI  165 (605)
T ss_dssp             --------CC--TTSTTCTTCCEEECTTSCCCC-CGG--GGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCC
T ss_pred             --------CC--hhhccCCCCCEEEecCCCCCC-Ccc--ccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcC
Confidence                    32  134555555555555555552 221  44555566666666655532  4455566666666666666


Q ss_pred             cccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCC
Q 036815          260 SGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS  311 (1013)
Q Consensus       260 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  311 (1013)
                      ++..+   +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++.+.
T Consensus       166 ~~~~~---l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          166 SDIVP---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             CCCGG---GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred             CCchh---hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence            54333   44566666666666666643  2466777777777777777643

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.75  E-value=7.6e-20  Score=215.66  Aligned_cols=180  Identities=21%  Similarity=0.227  Sum_probs=140.8

Q ss_pred             CCCCCCceEECccccccccCchhhcCCCCCCeEEecCCc-------------cCCCCChhhhccCCCceEE-ccCC----
Q 036815          341 GKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNE-------------LTGQIPPEFSRLTRLAVLQ-LGNN----  402 (1013)
Q Consensus       341 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N----  402 (1013)
                      ..+++|+.|+|++|+++ .+|..++.+++|+.|++++|.             +.+.+|..++.+++|+.|+ ++.|    
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~  424 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD  424 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence            34566666666666665 566666666666666665554             4456666667777776666 4444    


Q ss_pred             ---------eeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCccccc
Q 036815          403 ---------RFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEF  473 (1013)
Q Consensus       403 ---------~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  473 (1013)
                               .+++ +|.     ..|++|+|++|++++ +|.                                       
T Consensus       425 L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~---------------------------------------  458 (567)
T 1dce_A          425 LRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH---------------------------------------  458 (567)
T ss_dssp             HHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC---------------------------------------
T ss_pred             hhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC---------------------------------------
Confidence                     4442 221     258899999998875 442                                       


Q ss_pred             ccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCccccc
Q 036815          474 AGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLG  553 (1013)
Q Consensus       474 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~  553 (1013)
                                                    +..+++|++|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .++
T Consensus       459 ------------------------------~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~  505 (567)
T 1dce_A          459 ------------------------------LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVA  505 (567)
T ss_dssp             ------------------------------GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGT
T ss_pred             ------------------------------ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccC
Confidence                                          233567999999999999 899999999999999999999996 88 899


Q ss_pred             CCCCcceEecCCccccCCC-cccccCCCcceEEECcCCCCCCcCCCCC
Q 036815          554 RLRNLGVFDASHNRLQGQI-PESFSNLSFLVQIDLSNNELTGPIPQRG  600 (1013)
Q Consensus       554 ~l~~L~~L~ls~N~l~g~~-p~~~~~l~~l~~l~l~~n~l~~~~p~~~  600 (1013)
                      .+++|+.|+|++|+|++.+ |..++.+++|+.|+|++|++++.+|...
T Consensus       506 ~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~  553 (567)
T 1dce_A          506 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE  553 (567)
T ss_dssp             TCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred             CCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH
Confidence            9999999999999999887 9999999999999999999999888653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.75  E-value=8.6e-18  Score=173.63  Aligned_cols=153  Identities=24%  Similarity=0.279  Sum_probs=98.5

Q ss_pred             ceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCC
Q 036815            3 SVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLS   82 (1013)
Q Consensus         3 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls   82 (1013)
                      +.+++++|.++.+|..   .+..+++|+|++|++.+..+..+|..+++|++|+|++|.|+ .++...+..+++|++|+|+
T Consensus        14 ~~l~~s~n~l~~iP~~---~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls   89 (220)
T 2v70_A           14 TTVDCSNQKLNKIPEH---IPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLT   89 (220)
T ss_dssp             TEEECCSSCCSSCCSC---CCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECC
T ss_pred             CEeEeCCCCcccCccC---CCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-EECHHHhCCCCCCCEEECC
Confidence            3567777777777664   34556677777777766545556677777777777777776 3444446666777777777


Q ss_pred             CCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCccc
Q 036815           83 YNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT  162 (1013)
Q Consensus        83 ~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  162 (1013)
                      +|++++.....+   ..+++|++|+|++|+|+++.|..|.++++|++|+|++|++++..|..|..+++|++|++++|.+.
T Consensus        90 ~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A           90 SNRLENVQHKMF---KGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             SSCCCCCCGGGG---TTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             CCccCccCHhHh---cCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            777664433211   34566666666666666666666666666666666666666666666666666666666666665

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.74  E-value=1.4e-17  Score=172.10  Aligned_cols=152  Identities=26%  Similarity=0.308  Sum_probs=107.0

Q ss_pred             cEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeC
Q 036815           77 ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDL  156 (1013)
Q Consensus        77 ~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  156 (1013)
                      +.+++++++++.++..+      .++|+.|+|++|+|+++.+..|.++++|++|+|++|+++++.+..|.++++|++|+|
T Consensus        14 ~~v~c~~~~l~~iP~~l------~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L   87 (220)
T 2v9t_B           14 NIVDCRGKGLTEIPTNL------PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVL   87 (220)
T ss_dssp             TEEECTTSCCSSCCSSC------CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEEC
T ss_pred             CEEEcCCCCcCcCCCcc------CcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEEC
Confidence            46667777766544332      256777788888777777777888888888888888888777778888888888888


Q ss_pred             cCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCC
Q 036815          157 SNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS  236 (1013)
Q Consensus       157 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~  236 (1013)
                      ++|.|+ .+|...+..+++|++|+|++|+|++..+..|..+++|++|+|++|+++ .++...+..+++|++|+|++|.+.
T Consensus        88 s~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           88 YGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC-EECHHHHhCCCCCCEEEeCCCCcC
Confidence            888887 666666666677777777777777666666777777777777777766 344444555666666666666554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.74  E-value=1.8e-17  Score=172.40  Aligned_cols=157  Identities=24%  Similarity=0.284  Sum_probs=134.0

Q ss_pred             CCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEcc
Q 036815          345 NLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLN  424 (1013)
Q Consensus       345 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  424 (1013)
                      +.+.++.+++.++ .+|..+.  ++|++|+|++|.+++..|..|..+++|+.|+|++|++++..+..|.++++|++|+|+
T Consensus        20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls   96 (229)
T 3e6j_A           20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG   96 (229)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence            3567899999888 7777664  889999999999998888999999999999999999986555678999999999999


Q ss_pred             CCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccc
Q 036815          425 SNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLF  504 (1013)
Q Consensus       425 ~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  504 (1013)
                      +|++++..+.                                                                    .|
T Consensus        97 ~N~l~~l~~~--------------------------------------------------------------------~~  108 (229)
T 3e6j_A           97 TNQLTVLPSA--------------------------------------------------------------------VF  108 (229)
T ss_dssp             SSCCCCCCTT--------------------------------------------------------------------TT
T ss_pred             CCcCCccChh--------------------------------------------------------------------Hh
Confidence            9998743322                                                                    13


Q ss_pred             cCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCc
Q 036815          505 TQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIP  573 (1013)
Q Consensus       505 ~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p  573 (1013)
                      ..+++|++|+|++|+|+ .+|..++.+++|++|+|++|+|++..+..+..+++|+.|+|++|.+++..+
T Consensus       109 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          109 DRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            34578999999999999 899999999999999999999996556779999999999999999997654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=6.5e-18  Score=171.54  Aligned_cols=85  Identities=16%  Similarity=0.214  Sum_probs=44.6

Q ss_pred             CCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcE
Q 036815          341 GKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW  420 (1013)
Q Consensus       341 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  420 (1013)
                      +.+++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..|..+.++++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            45555666666666665 444 4555555555555555443  2234555555555555555555444555555555555


Q ss_pred             EEccCCcCC
Q 036815          421 LDLNSNNLT  429 (1013)
Q Consensus       421 L~l~~N~l~  429 (1013)
                      |++++|+++
T Consensus       117 L~Ls~n~i~  125 (197)
T 4ezg_A          117 LDISHSAHD  125 (197)
T ss_dssp             EECCSSBCB
T ss_pred             EEecCCccC
Confidence            555555444

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.74  E-value=5.4e-19  Score=215.18  Aligned_cols=192  Identities=24%  Similarity=0.249  Sum_probs=120.9

Q ss_pred             cCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccc
Q 036815          279 LPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG  358 (1013)
Q Consensus       279 L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  358 (1013)
                      +..|.+. ..+..+..++.|+.|+|++|.+. .                        +|..+.++++|++|+|++|.|+ 
T Consensus       208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~------------------------l~~~~~~l~~L~~L~Ls~N~l~-  260 (727)
T 4b8c_D          208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-N------------------------ISANIFKYDFLTRLYLNGNSLT-  260 (727)
T ss_dssp             ---------------CCCCCCEEECTTSCCS-C------------------------CCGGGGGCCSCSCCBCTTSCCS-
T ss_pred             cccccee-cChhhhccCCCCcEEECCCCCCC-C------------------------CChhhcCCCCCCEEEeeCCcCc-
Confidence            3344544 55677788888888888888877 3                        3444556788999999999999 


Q ss_pred             cCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhh
Q 036815          359 EIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGR  438 (1013)
Q Consensus       359 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  438 (1013)
                      .+|..++.+++|++|+|++|.|+ .+|..|+.|++|+.|+|++|.|+ .+|..|++|++|++|+|++|+|+|.+|..+..
T Consensus       261 ~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  338 (727)
T 4b8c_D          261 ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE  338 (727)
T ss_dssp             CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred             ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence            88999999999999999999999 88999999999999999999998 88999999999999999999999988876643


Q ss_pred             ccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCC
Q 036815          439 QLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYN  518 (1013)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N  518 (1013)
                      ..                                                                   ..+..|+|++|
T Consensus       339 ~~-------------------------------------------------------------------~~~~~l~l~~N  351 (727)
T 4b8c_D          339 KS-------------------------------------------------------------------VTGLIFYLRDN  351 (727)
T ss_dssp             HH-------------------------------------------------------------------HHHHHHHHHHC
T ss_pred             cc-------------------------------------------------------------------hhhhHHhhccC
Confidence            20                                                                   01123688999


Q ss_pred             cccccCChhhhCCCCCcEEecCCC--------ccCCCCcccccCCCCcceEecCCccccCCC
Q 036815          519 QFRGKIPDEIGDMIALQVLELAHN--------QLSGEIPSSLGRLRNLGVFDASHNRLQGQI  572 (1013)
Q Consensus       519 ~l~g~iP~~i~~l~~L~~L~L~~n--------~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~  572 (1013)
                      .++|.+|.++      ..|++++|        .|++.++..+.++..+....+++|-+.+..
T Consensus       352 ~l~~~~p~~l------~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~  407 (727)
T 4b8c_D          352 RPEIPLPHER------RFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHY  407 (727)
T ss_dssp             CCCCCCCCC-----------------------------------------------CCCGGG
T ss_pred             cccCcCcccc------ceeEeecccccccccCCccccccchhhcccccceeeeecccccccc
Confidence            9999998754      45566666        555555666677888888889999886433

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=4.3e-18  Score=180.51  Aligned_cols=138  Identities=20%  Similarity=0.167  Sum_probs=106.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-cCCCE--EEEEEeeccCcc------------------------chHHHHHHHHHHhc
Q 036815          734 NGFSAESLIGCGGFGEVFKATL-KDGSS--VAIKKLIRLSCQ------------------------GDREFMAEMETLGK  786 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  786 (1013)
                      .-|.+.+.||+|+||.||+|.+ .+|+.  ||||++......                        ....+.+|++++.+
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999998 67888  999976432111                        01357899999999


Q ss_pred             cCCcce--eeeccEEEeCCEEEEEEEcccC-C----CHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHH-hcCCC
Q 036815          787 IKHRNL--VPLLGYCKIGEERLLVYEFMKF-G----SLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH-HNCIP  858 (1013)
Q Consensus       787 l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~  858 (1013)
                      +.|+++  ...+++    ...++||||+++ |    +|.++...         .++..+..++.|++.|+.||| +.   
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---  190 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEA---  190 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTS---
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHC---
Confidence            988764  333332    356899999953 3    77776532         223456789999999999999 88   


Q ss_pred             CeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          859 HIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       859 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      +|+||||||+||+++.  .++|+|||+|...
T Consensus       191 givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999999998  9999999999754

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=9.9e-18  Score=170.16  Aligned_cols=156  Identities=17%  Similarity=0.242  Sum_probs=132.8

Q ss_pred             hcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCC
Q 036815          364 LFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAK  443 (1013)
Q Consensus       364 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~  443 (1013)
                      ...+++|+.|++++|.++ .+| .+..+++|+.|++++|.++  .+..+..+++|++|++++|++++..|..        
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~--------  107 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPN--------  107 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCC--------
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChh--------
Confidence            366789999999999999 677 7999999999999999775  4458899999999999999987644432        


Q ss_pred             CCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCccccc
Q 036815          444 PLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGK  523 (1013)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~  523 (1013)
                                                                                  +..+++|++|++++|++++.
T Consensus       108 ------------------------------------------------------------l~~l~~L~~L~Ls~n~i~~~  127 (197)
T 4ezg_A          108 ------------------------------------------------------------LSGLTSLTLLDISHSAHDDS  127 (197)
T ss_dssp             ------------------------------------------------------------CTTCTTCCEEECCSSBCBGG
T ss_pred             ------------------------------------------------------------hcCCCCCCEEEecCCccCcH
Confidence                                                                        33457899999999999998


Q ss_pred             CChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCC
Q 036815          524 IPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTG  594 (1013)
Q Consensus       524 iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~  594 (1013)
                      .|..++.+++|++|+|++|.+.+.+| .++.+++|+.|++++|++++ +| .+..+++|+.|++++|++.+
T Consensus       128 ~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          128 ILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             GHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             hHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            99999999999999999998444787 79999999999999999985 55 78999999999999999865

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=2.9e-18  Score=182.47  Aligned_cols=82  Identities=17%  Similarity=0.238  Sum_probs=42.0

Q ss_pred             cCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceE
Q 036815          318 KLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVL  397 (1013)
Q Consensus       318 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  397 (1013)
                      .+.++..+++..|.+++. + .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++. |. +..+++|+.|
T Consensus        17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEE
Confidence            345566666666666522 2 3555555555555555555 333 444555555555555555532 22 4445555555


Q ss_pred             EccCCeee
Q 036815          398 QLGNNRFK  405 (1013)
Q Consensus       398 ~L~~N~l~  405 (1013)
                      +|++|+++
T Consensus        91 ~L~~N~l~   98 (263)
T 1xeu_A           91 SVNRNRLK   98 (263)
T ss_dssp             ECCSSCCS
T ss_pred             ECCCCccC
Confidence            55555544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.73  E-value=1.8e-17  Score=179.31  Aligned_cols=189  Identities=25%  Similarity=0.291  Sum_probs=117.2

Q ss_pred             CCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCE
Q 036815           50 NLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKI  129 (1013)
Q Consensus        50 ~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~  129 (1013)
                      ++..+.+..+.+++..+   +..+++|+.|++++|.++... .    ...+++|++|+|++|+++++.+  +.++++|++
T Consensus        25 ~~~~~~l~~~~~~~~~~---~~~l~~L~~L~l~~~~i~~~~-~----~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~   94 (291)
T 1h6t_A           25 ETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQ-G----IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGW   94 (291)
T ss_dssp             HHHHHHTTCSCTTSEEC---HHHHHTCCEEECTTSCCCCCT-T----GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             HHHHHHhcCCCcccccc---hhhcCcccEEEccCCCcccCh-h----HhcCCCCCEEEccCCccCCCcc--cccCCCCCE
Confidence            34556677776664433   345677788888888776442 1    2346777777777777776544  777777777


Q ss_pred             EecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCC
Q 036815          130 LNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNN  209 (1013)
Q Consensus       130 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~  209 (1013)
                      |++++|++++.  ..+..+++|++|++++|.+++ ++ . +..+++|++|++++|++++.  ..+..+++|++|++++|+
T Consensus        95 L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~-~~-~-l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~  167 (291)
T 1h6t_A           95 LFLDENKVKDL--SSLKDLKKLKSLSLEHNGISD-IN-G-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQ  167 (291)
T ss_dssp             EECCSSCCCCG--GGGTTCTTCCEEECTTSCCCC-CG-G-GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred             EECCCCcCCCC--hhhccCCCCCEEECCCCcCCC-Ch-h-hcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCc
Confidence            77777777643  336777777777777777763 32 2 23356666666666666654  455666666666666666


Q ss_pred             CCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeec
Q 036815          210 ISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVS  260 (1013)
Q Consensus       210 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  260 (1013)
                      +++ ++.  +..+++|++|++++|++++ ++ .+..+++|+.|++++|+++
T Consensus       168 l~~-~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          168 ISD-IVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             CCC-CGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred             ccc-chh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence            653 222  4556666666666666653 22 3555566666666666554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=7.5e-18  Score=179.23  Aligned_cols=172  Identities=21%  Similarity=0.270  Sum_probs=146.2

Q ss_pred             CCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEE
Q 036815          342 KCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWL  421 (1013)
Q Consensus       342 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  421 (1013)
                      .+.++..+++++|.++ .++ .+..+++|++|++++|.++ .+| .+..+++|+.|+|++|++++..|  +.++++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            4567888899999998 444 6888999999999999998 566 78999999999999999995444  9999999999


Q ss_pred             EccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCccc
Q 036815          422 DLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVL  501 (1013)
Q Consensus       422 ~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  501 (1013)
                      +|++|++++ +|..                                                                  
T Consensus        91 ~L~~N~l~~-l~~~------------------------------------------------------------------  103 (263)
T 1xeu_A           91 SVNRNRLKN-LNGI------------------------------------------------------------------  103 (263)
T ss_dssp             ECCSSCCSC-CTTC------------------------------------------------------------------
T ss_pred             ECCCCccCC-cCcc------------------------------------------------------------------
Confidence            999998874 2210                                                                  


Q ss_pred             ccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCc
Q 036815          502 SLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSF  581 (1013)
Q Consensus       502 ~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~  581 (1013)
                         .. ++|++|+|++|++++ +| .++.+++|+.|+|++|++++ +| .++.+++|+.|+|++|++++.  ..+..+++
T Consensus       104 ---~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~  173 (263)
T 1xeu_A          104 ---PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKK  173 (263)
T ss_dssp             ---CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCC
T ss_pred             ---cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCC
Confidence               01 468999999999995 54 69999999999999999995 55 799999999999999999976  77899999


Q ss_pred             ceEEECcCCCCCCcC
Q 036815          582 LVQIDLSNNELTGPI  596 (1013)
Q Consensus       582 l~~l~l~~n~l~~~~  596 (1013)
                      |+.|++++|++++..
T Consensus       174 L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          174 VNWIDLTGQKCVNEP  188 (263)
T ss_dssp             CCEEEEEEEEEECCC
T ss_pred             CCEEeCCCCcccCCc
Confidence            999999999998763

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=1.2e-17  Score=168.68  Aligned_cols=88  Identities=24%  Similarity=0.345  Sum_probs=41.0

Q ss_pred             ccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECc
Q 036815          509 TLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLS  588 (1013)
Q Consensus       509 ~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~  588 (1013)
                      +|++|+|++|+|++..|..++.+.+|++|+|++|++++..|..|+.+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus        55 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  134 (192)
T 1w8a_A           55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA  134 (192)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECT
T ss_pred             CCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeC
Confidence            34444444444444444444444444444444444444334444444444444444444444444444444444444444


Q ss_pred             CCCCCCcC
Q 036815          589 NNELTGPI  596 (1013)
Q Consensus       589 ~n~l~~~~  596 (1013)
                      +|++++..
T Consensus       135 ~N~l~c~c  142 (192)
T 1w8a_A          135 SNPFNCNC  142 (192)
T ss_dssp             TCCBCCSG
T ss_pred             CCCccCcC
Confidence            44444443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.69  E-value=4.4e-16  Score=175.40  Aligned_cols=272  Identities=15%  Similarity=0.184  Sum_probs=215.9

Q ss_pred             ccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCC
Q 036815           18 SLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNE   97 (1013)
Q Consensus        18 ~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~   97 (1013)
                      .++.....++.+.+.+ .+. .|+..+|.++ +|+++++..+ ++ .++..+|.++ +|+.+.+.. .++.+....+   
T Consensus       107 ~~~~~~~~l~~i~ip~-~i~-~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF---  176 (401)
T 4fdw_A          107 VLTEILKGYNEIILPN-SVK-SIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFNS-TVQEIVFPS-TLEQLKEDIF---  176 (401)
T ss_dssp             EEEEECSSCSEEECCT-TCC-EECTTTTTTC-CCSEEECCTT-CC-EECTTTTTTC-CCCEEECCT-TCCEECSSTT---
T ss_pred             EEEEecCCccEEEECC-ccC-EehHhhcccC-CccEEEeCCC-cc-EECHHhcCCC-CceEEEeCC-CccEehHHHh---
Confidence            3445556788888875 343 3778889885 7999998876 65 6667777775 699999986 6665544433   


Q ss_pred             CCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCc
Q 036815           98 NSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLL  177 (1013)
Q Consensus        98 ~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~  177 (1013)
                      ..|++|+.++|++|+++.+...+|. +.+|+.+.|..+ ++.+...+|.++++|+.+++..| ++ .++...|.. .+|+
T Consensus       177 ~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~-~~L~  251 (401)
T 4fdw_A          177 YYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE-SGIT  251 (401)
T ss_dssp             TTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTT-CCCS
T ss_pred             hCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc-Ccccccccc-CCcc
Confidence            5788999999999999988888887 589999999854 77788889999999999999875 55 677777776 7899


Q ss_pred             EEECCCCCCCCcCCccccCCCCCCEEEccCCCCC----CCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEE
Q 036815          178 ELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNIS----GPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVD  253 (1013)
Q Consensus       178 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~----~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  253 (1013)
                      .+.+ .+.++.+...+|.+|++|+.+++.+|.+.    ..++...|.++++|+.+.+.+ .++.....+|.++++|+.+.
T Consensus       252 ~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~  329 (401)
T 4fdw_A          252 TVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLT  329 (401)
T ss_dssp             EEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEE
T ss_pred             EEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEE
Confidence            9999 45677788889999999999999888664    136677889999999999984 57767778899999999999


Q ss_pred             ecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccC-cccEEEeeCCccC
Q 036815          254 FSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECT-QLKVIDLSLNYLN  309 (1013)
Q Consensus       254 L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~ls~N~l~  309 (1013)
                      +..| ++ .+....|.++ +|+.+.+.+|.+.......|..++ .++.|.+..+.+.
T Consensus       330 lp~~-l~-~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          330 IPAN-VT-QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             ECTT-CC-EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             ECcc-cc-EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            9766 55 6677888888 999999999998877778888884 7889998887654

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.69  E-value=4.7e-17  Score=179.73  Aligned_cols=281  Identities=18%  Similarity=0.171  Sum_probs=164.9

Q ss_pred             cceecccCCcccccccccc-cCCCCCcEEecCCCCcccc-cCcccccCCCCCcEEeCCCCccCCCCchhhhhC-------
Q 036815            2 LSVLKLSSNLFTLNSTSLL-QLPFGLKQLELSSAGLVGL-VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSN-------   72 (1013)
Q Consensus         2 l~~L~l~~n~~~~~~~~~~-~~~~~l~~L~L~~~~i~~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~-------   72 (1013)
                      |+.|+++++ +....-..+ ...++|++|+|++|+|... .+.+.+   +.+..+.+..|    .+|..+|.+       
T Consensus        27 l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~----~I~~~aF~~~~~~~~~   98 (329)
T 3sb4_A           27 ITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMAN----FVPAYAFSNVVNGVTK   98 (329)
T ss_dssp             CSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTT----EECTTTTEEEETTEEE
T ss_pred             eeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccc----ccCHHHhccccccccc
Confidence            567777765 221111122 2266799999999988611 222222   22445555555    344556677       


Q ss_pred             -CCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcc----cccCcccccC
Q 036815           73 -SDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLL----AGEIPRTFGQ  147 (1013)
Q Consensus        73 -l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l----~~~~~~~~~~  147 (1013)
                       |++|+.|+|.+ +++.+....+   ..|++|+.|++++|.++.+.+.+|.++.++..+.+..+..    ......+|.+
T Consensus        99 g~~~L~~l~L~~-~i~~I~~~aF---~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~  174 (329)
T 3sb4_A           99 GKQTLEKVILSE-KIKNIEDAAF---KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE  174 (329)
T ss_dssp             ECTTCCC-CBCT-TCCEECTTTT---TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred             ccCCCcEEECCc-cccchhHHHh---hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence             78888888877 6765554433   4677788888888887777777888777777777665322    2334455666


Q ss_pred             CCCCC-EeeCcCCcccCcCCccchhc---cCCCcEEECCCCCCCCcCCccc-cCCCCCCEEEccCCCCCCCCChhhhhcC
Q 036815          148 LSSLQ-RLDLSNNHITGWIPSELGNA---CDSLLELKLPHNNITGSFPVTL-SSCSWLQLLDLSNNNISGPFPDSVLENL  222 (1013)
Q Consensus       148 l~~L~-~L~Ls~n~l~~~~~~~~~~~---l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~~~~~~~~l  222 (1013)
                      +..|+ .+.+....   .++..++..   ..++..+.+.++-.. .....+ ..+++|+.|+|++|+++ .++...|.++
T Consensus       175 ~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~  249 (329)
T 3sb4_A          175 GEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQK  249 (329)
T ss_dssp             SCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTC
T ss_pred             ccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCC
Confidence            66666 44443321   222222221   234455555443211 111111 23566666666666665 5666666666


Q ss_pred             CCCcEEEcccccCCCcCCcCCCCCCCcC-EEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEE
Q 036815          223 GSLESLILSNNMISGSFPDSISSCKTLR-IVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI  301 (1013)
Q Consensus       223 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  301 (1013)
                      .+|++|+|.+| ++.+...+|.++++|+ .+++.+ .++ .++...|.++++|+.+++.+|.++.+.+.+|.++++|+.+
T Consensus       250 ~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          250 KYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             TTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred             CCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence            66777766666 5555556666666776 777766 454 4556666677777777777777776666777777777776


Q ss_pred             E
Q 036815          302 D  302 (1013)
Q Consensus       302 ~  302 (1013)
                      +
T Consensus       327 y  327 (329)
T 3sb4_A          327 Y  327 (329)
T ss_dssp             E
T ss_pred             c
Confidence            5

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.68  E-value=1.1e-15  Score=172.04  Aligned_cols=268  Identities=13%  Similarity=0.145  Sum_probs=199.7

Q ss_pred             cccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccC
Q 036815           44 LFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSN  123 (1013)
Q Consensus        44 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~  123 (1013)
                      ++..+..++++.+.. .++ .++..+|.++ +|+.+.+..+ ++.+....+.   .+ +|+.+.+.. .++.+...+|.+
T Consensus       108 ~~~~~~~l~~i~ip~-~i~-~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~---~~-~L~~i~lp~-~l~~I~~~aF~~  178 (401)
T 4fdw_A          108 LTEILKGYNEIILPN-SVK-SIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFF---NS-TVQEIVFPS-TLEQLKEDIFYY  178 (401)
T ss_dssp             EEEECSSCSEEECCT-TCC-EECTTTTTTC-CCSEEECCTT-CCEECTTTTT---TC-CCCEEECCT-TCCEECSSTTTT
T ss_pred             EEEecCCccEEEECC-ccC-EehHhhcccC-CccEEEeCCC-ccEECHHhcC---CC-CceEEEeCC-CccEehHHHhhC
Confidence            455567788888875 355 5666677776 6888888766 6655544332   23 688888885 777778888888


Q ss_pred             CCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEE
Q 036815          124 CTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLL  203 (1013)
Q Consensus       124 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  203 (1013)
                      |++|+.+++++|+++.+...+|. +.+|+.+.+.++ ++ .++...|..|++|+.+++..| ++.+...+|.+ .+|+.+
T Consensus       179 c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i  253 (401)
T 4fdw_A          179 CYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTV  253 (401)
T ss_dssp             CTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEE
T ss_pred             cccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEE
Confidence            88999999988888877777776 588888888854 66 777888888888999988874 66677777777 788888


Q ss_pred             EccCCCCCCCCChhhhhcCCCCcEEEcccccCC-----CcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEE
Q 036815          204 DLSNNNISGPFPDSVLENLGSLESLILSNNMIS-----GSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELR  278 (1013)
Q Consensus       204 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  278 (1013)
                      .+. +.++ .++...|.++++|+.+.+.+|.+.     .....+|..+++|+.+++.. .++ .++...|.++.+|+.+.
T Consensus       254 ~lp-~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~L~~l~  329 (401)
T 4fdw_A          254 KLP-NGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRKVTQLT  329 (401)
T ss_dssp             EEE-TTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCSCCEEE
T ss_pred             EeC-CCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCCccEEE
Confidence            884 4465 566777888888999988887664     35567888888899888884 465 67777888888899888


Q ss_pred             cCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCc-chHHHHhhhcc
Q 036815          279 LPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLE-HLEQFIAWFNG  331 (1013)
Q Consensus       279 L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~-~L~~L~l~~n~  331 (1013)
                      |.+| ++.+...+|.++ +|+.+++++|.+....+..|..++ .+..+++..+.
T Consensus       330 lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~  381 (401)
T 4fdw_A          330 IPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES  381 (401)
T ss_dssp             ECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred             ECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence            8655 666777888888 899999988887755556666664 45555554443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.67  E-value=3.1e-17  Score=181.22  Aligned_cols=288  Identities=13%  Similarity=0.102  Sum_probs=211.8

Q ss_pred             CCCCcEEecCCCCcccccCcccccC-CCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCC--
Q 036815           23 PFGLKQLELSSAGLVGLVPDNLFSK-LPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENS--   99 (1013)
Q Consensus        23 ~~~l~~L~L~~~~i~~~~~~~~~~~-l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~--   99 (1013)
                      ..+++.|.++++ +.. ..-..+.. +++|++|||++|+|......  ....+.++.+.+..|.|.   ...   ...  
T Consensus        24 ~~~l~~L~l~g~-i~~-~~~~~l~~~l~~L~~LdLs~n~i~~~~~~--~~~~~~~~~~~~~~~~I~---~~a---F~~~~   93 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNA-EDFRHLRDEFPSLKVLDISNAEIKMYSGK--AGTYPNGKFYIYMANFVP---AYA---FSNVV   93 (329)
T ss_dssp             HHHCSEEEEEEE-ECH-HHHHHHHHSCTTCCEEEEEEEEECCEEES--SSSSGGGCCEEECTTEEC---TTT---TEEEE
T ss_pred             hCceeEEEEecc-ccH-HHHHHHHHhhccCeEEecCcceeEEecCc--cccccccccccccccccC---HHH---hcccc
Confidence            346899999874 211 01112333 78999999999999721111  112223566777777665   221   235  


Q ss_pred             ------CCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcc----cCcCCccc
Q 036815          100 ------CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHI----TGWIPSEL  169 (1013)
Q Consensus       100 ------~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l----~~~~~~~~  169 (1013)
                            |++|+.|+|.+ .++.+...+|.+|++|++|++++|.+..+.+.+|..+.++..+.++.+..    . .+....
T Consensus        94 ~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~-~i~~~~  171 (329)
T 3sb4_A           94 NGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKN-RWEHFA  171 (329)
T ss_dssp             TTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTST-TTTTSC
T ss_pred             cccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccc-cccccc
Confidence                  89999999999 99999999999999999999999999889999999999888888877432    2 344455


Q ss_pred             hhccCCCc-EEECCCCC-CCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCC
Q 036815          170 GNACDSLL-ELKLPHNN-ITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCK  247 (1013)
Q Consensus       170 ~~~l~~L~-~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  247 (1013)
                      +..|..|+ .+.+.... +............+++.+.+.++-.. .....+...+++|+.|+|++|+++.+...+|..++
T Consensus       172 f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~  250 (329)
T 3sb4_A          172 FIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKK  250 (329)
T ss_dssp             EEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCT
T ss_pred             cccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCC
Confidence            55667777 56555432 11111112224567888888776322 11222334589999999999999977788999999


Q ss_pred             CcCEEEecCCeecccCCCCCCCCCCCCc-eEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHH
Q 036815          248 TLRIVDFSSNRVSGIIPPDICPGVSSLE-ELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFI  326 (1013)
Q Consensus       248 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~  326 (1013)
                      +|+.+++.+| ++ .++...|.++.+|+ .+.+.+ .++.+.+.+|.+|++|+.|++++|.++...+..|.++++|+.++
T Consensus       251 ~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          251 YLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             TCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             CCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            9999999998 66 78889999999999 999999 88878889999999999999999999966777899999888653

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.67  E-value=1.2e-16  Score=161.32  Aligned_cols=81  Identities=26%  Similarity=0.332  Sum_probs=46.0

Q ss_pred             ceEECccccccccCchhhcCCCCCCeEEecCCccCCCCCh-hhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccC
Q 036815          347 KDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPP-EFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNS  425 (1013)
Q Consensus       347 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  425 (1013)
                      +.+++++|.++ .+|..+..  +|++|++++|++++..+. .|..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56666666665 55554432  566666666666544332 255566666666666666555555555555555555555


Q ss_pred             CcCCc
Q 036815          426 NNLTG  430 (1013)
Q Consensus       426 N~l~~  430 (1013)
                      |++++
T Consensus        88 N~l~~   92 (192)
T 1w8a_A           88 NKIKE   92 (192)
T ss_dssp             CCCCE
T ss_pred             CcCCc
Confidence            55543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=1.2e-15  Score=150.47  Aligned_cols=61  Identities=21%  Similarity=0.241  Sum_probs=29.6

Q ss_pred             CCCCeEEecCCccC-CCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCc
Q 036815          368 SNLEWISLTGNELT-GQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG  430 (1013)
Q Consensus       368 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  430 (1013)
                      ++|++|++++|.++ +.+|..+..+++|+.|+|++|.+++.  ..+..+++|++|++++|++++
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~   85 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFG   85 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCS
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCch
Confidence            34445555555544 34444445555555555555555432  444444555555555544443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.62  E-value=6.6e-15  Score=166.83  Aligned_cols=332  Identities=15%  Similarity=0.187  Sum_probs=174.9

Q ss_pred             cCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCc
Q 036815           40 VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPS  119 (1013)
Q Consensus        40 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~  119 (1013)
                      |+..+|.+|.+|+++.+.. .++ .++..+|.+|++|+.++|.++ ++.+....+   ..|.+|+.+.+..+ +..+...
T Consensus        62 Ig~~AF~~c~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF---~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           62 IGYAAFQGCRKVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTF---SGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             ECTTTTTTCTTEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTT---TTCTTCCCCCCCTT-CCEECTT
T ss_pred             hHHHHhhCCCCceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhh---cccccchhhcccCc-eeeecce
Confidence            5555666666666666653 244 445555666666666666543 332322222   34555555544432 3334444


Q ss_pred             cccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCC
Q 036815          120 SLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSW  199 (1013)
Q Consensus       120 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~  199 (1013)
                      +|.++..++......  +..+...+|.++++|+.+.+.++. . .++...|..|.+|+.+.+..+ ++.+...+|.++..
T Consensus       135 aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~  209 (394)
T 4fs7_A          135 AFKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-E-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECIL  209 (394)
T ss_dssp             TTTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-C-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTT
T ss_pred             eeecccccccccCcc--ccccchhhhcccCCCcEEecCCcc-c-eeccccccCCCCceEEEcCCC-ceEeCchhhccccc
Confidence            555554333222221  222334455566666666665432 2 344555555556666665544 44444555556666


Q ss_pred             CCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEc
Q 036815          200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL  279 (1013)
Q Consensus       200 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  279 (1013)
                      |+.+.+..+...  +... +....+|+.+.+..+ ++......+..+..|+.+.+..+..  .+....|.....++.+..
T Consensus       210 L~~i~~~~~~~~--i~~~-~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~--~i~~~~F~~~~~l~~~~~  283 (394)
T 4fs7_A          210 LENMEFPNSLYY--LGDF-ALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL--RIGGSLFYNCSGLKKVIY  283 (394)
T ss_dssp             CCBCCCCTTCCE--ECTT-TTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC--EECSCTTTTCTTCCEEEE
T ss_pred             cceeecCCCceE--eehh-hcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc--eeeccccccccccceecc
Confidence            665555544322  1111 122345555555433 2223344555555566665555432  233444455555555555


Q ss_pred             CCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccccc
Q 036815          280 PDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE  359 (1013)
Q Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  359 (1013)
                      ..+.+.   ..+|..+.+|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++......|.++++|+.+++..| ++..
T Consensus       284 ~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I  357 (394)
T 4fs7_A          284 GSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKI  357 (394)
T ss_dssp             CSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEE
T ss_pred             Cceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEe
Confidence            444322   234555556666665543 33233345555555655555432 44344567888888999988776 6655


Q ss_pred             CchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceE
Q 036815          360 IPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVL  397 (1013)
Q Consensus       360 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  397 (1013)
                      ....|.++++|+.+++..+ ++ .+...|.+.++|+.+
T Consensus       358 ~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          358 GANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             CTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             hHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            6678888899999998765 33 345667777777654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=1.7e-16  Score=173.70  Aligned_cols=140  Identities=13%  Similarity=0.153  Sum_probs=98.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc--------------cchHHH--------HHHHHHHhccCCc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC--------------QGDREF--------MAEMETLGKIKHR  790 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~h~  790 (1013)
                      ..-|++.+.||+|+||.||+|...+|+.||||++.....              ......        .+|...+.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            344899999999999999999999999999997642100              001112        2355555555433


Q ss_pred             ceeeeccEEEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccE
Q 036815          791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNV  870 (1013)
Q Consensus       791 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  870 (1013)
                      ++.-..-+..  ...++||||++|++|.++..          .  .....++.|++.+|.|||+.   |||||||||.||
T Consensus       174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~----------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NI  236 (397)
T 4gyi_A          174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS----------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNI  236 (397)
T ss_dssp             TCSCCCEEEE--ETTEEEEECCSCEEGGGCCC----------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             CCCCCeeeec--cCceEEEEecCCccHhhhcc----------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHE
Confidence            3221111111  12379999999988865432          1  12356789999999999999   999999999999


Q ss_pred             EeCCCC----------cEEEeecccceec
Q 036815          871 LLDHEM----------EARVSDFGMARLI  889 (1013)
Q Consensus       871 ll~~~~----------~~kl~Dfg~a~~~  889 (1013)
                      |+++++          .+.|+||+.+...
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccC
Confidence            998876          3899999988654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.61  E-value=1.9e-15  Score=149.04  Aligned_cols=135  Identities=23%  Similarity=0.230  Sum_probs=118.1

Q ss_pred             cCCCceEEccCCeee-eecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCc
Q 036815          391 LTRLAVLQLGNNRFK-GEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGG  469 (1013)
Q Consensus       391 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  469 (1013)
                      .++|+.|++++|+++ +.+|..+..+++|++|++++|.+++.  .                                   
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~-----------------------------------   65 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--S-----------------------------------   65 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--S-----------------------------------
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--h-----------------------------------
Confidence            478999999999998 78999999999999999999988742  1                                   


Q ss_pred             ccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCc
Q 036815          470 LLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIP  549 (1013)
Q Consensus       470 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip  549 (1013)
                                                       .+..+++|++|+|++|++++.+|..++.+++|++|+|++|++++ +|
T Consensus        66 ---------------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~  111 (168)
T 2ell_A           66 ---------------------------------NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-IS  111 (168)
T ss_dssp             ---------------------------------SCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SG
T ss_pred             ---------------------------------hhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-ch
Confidence                                             13345789999999999998899999999999999999999995 54


Q ss_pred             --ccccCCCCcceEecCCccccCCCc---ccccCCCcceEEECcCCCCCCcC
Q 036815          550 --SSLGRLRNLGVFDASHNRLQGQIP---ESFSNLSFLVQIDLSNNELTGPI  596 (1013)
Q Consensus       550 --~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l~~l~~l~l~~n~l~~~~  596 (1013)
                        ..++.+++|+.|++++|++++..+   ..+..+++|+.|++++|.+....
T Consensus       112 ~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  163 (168)
T 2ell_A          112 TLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP  163 (168)
T ss_dssp             GGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred             hHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence              799999999999999999996555   48999999999999999887543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.60  E-value=1.2e-15  Score=147.03  Aligned_cols=129  Identities=22%  Similarity=0.238  Sum_probs=92.5

Q ss_pred             cCCCceEEccCCeee-eecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCc
Q 036815          391 LTRLAVLQLGNNRFK-GEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGG  469 (1013)
Q Consensus       391 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  469 (1013)
                      .++|+.|++++|.++ +.+|..+..+++|++|++++|.+++.  .                                   
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~-----------------------------------   58 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--A-----------------------------------   58 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--T-----------------------------------
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--h-----------------------------------
Confidence            356777777777776 66777777777777777777766532  0                                   


Q ss_pred             ccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCC-C
Q 036815          470 LLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE-I  548 (1013)
Q Consensus       470 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~-i  548 (1013)
                                                       .+..+++|++|++++|++++.+|..++.+++|++|+|++|++++. .
T Consensus        59 ---------------------------------~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~  105 (149)
T 2je0_A           59 ---------------------------------NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLST  105 (149)
T ss_dssp             ---------------------------------TCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHH
T ss_pred             ---------------------------------hhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHH
Confidence                                             122345677788888888766777777788888888888888752 3


Q ss_pred             cccccCCCCcceEecCCccccCCCc---ccccCCCcceEEECcC
Q 036815          549 PSSLGRLRNLGVFDASHNRLQGQIP---ESFSNLSFLVQIDLSN  589 (1013)
Q Consensus       549 p~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l~~l~~l~l~~  589 (1013)
                      |..++.+++|+.|++++|++++..|   ..+..+++|+.||+++
T Consensus       106 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A          106 IEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             HGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             HHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            4778888888888888888876555   4677888888888764

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.58  E-value=1.7e-14  Score=163.49  Aligned_cols=319  Identities=16%  Similarity=0.171  Sum_probs=195.9

Q ss_pred             ccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccc
Q 036815           60 NLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAG  139 (1013)
Q Consensus        60 ~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~  139 (1013)
                      .++ .+...+|.+|.+|+.+.|.. .++.+....+   ..|.+|+.++|.++ ++.+...+|.++.+|+.+.+..+ +..
T Consensus        58 ~Vt-sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF---~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~  130 (394)
T 4fs7_A           58 DVV-SIGYAAFQGCRKVTEIKIPS-TVREIGEFAF---ENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKS  130 (394)
T ss_dssp             EEE-EECTTTTTTCTTEEEEECCT-TCCEECTTTT---TTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCE
T ss_pred             eEe-EhHHHHhhCCCCceEEEeCC-CccCcchhHh---hCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eee
Confidence            344 56667788888888888864 3654444333   46778888888754 66667777888888888777654 444


Q ss_pred             cCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhh
Q 036815          140 EIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVL  219 (1013)
Q Consensus       140 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~  219 (1013)
                      +...+|.++..++.......  . .+....|..|++|+.+.+..+. ..+...+|.++.+|+.+++..| ++ .+....|
T Consensus       131 i~~~aF~~~~~~~~~~~~~~--~-~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F  204 (394)
T 4fs7_A          131 IGVEAFKGCDFKEITIPEGV--T-VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCF  204 (394)
T ss_dssp             ECTTTTTTCCCSEEECCTTC--C-EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CC-EECTTTT
T ss_pred             ecceeeecccccccccCccc--c-ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ce-EeCchhh
Confidence            66667777654443333322  2 3445566677788888886553 3366667777888888877765 33 4555667


Q ss_pred             hcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCccc
Q 036815          220 ENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLK  299 (1013)
Q Consensus       220 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  299 (1013)
                      .++..|+.+.+..+...  +.........|+.+.+..+. + .+....+.+...++.+.+..+... .....|..+..++
T Consensus       205 ~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~-~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~  279 (394)
T 4fs7_A          205 AECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-T-ELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLK  279 (394)
T ss_dssp             TTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-C-EECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCC
T ss_pred             ccccccceeecCCCceE--eehhhcccCCCceEEECCCc-e-ecccccccccccceeEEcCCCcce-eeccccccccccc
Confidence            77777777777665433  23334445677777775442 2 344555666677777777665433 4556667777777


Q ss_pred             EEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCc
Q 036815          300 VIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNE  379 (1013)
Q Consensus       300 ~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  379 (1013)
                      .+....+.+.                           ...|..+.+|+.+.+.++ ++......|.++++|+.++|..+ 
T Consensus       280 ~~~~~~~~i~---------------------------~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-  330 (394)
T 4fs7_A          280 KVIYGSVIVP---------------------------EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-  330 (394)
T ss_dssp             EEEECSSEEC---------------------------TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-
T ss_pred             eeccCceeec---------------------------cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-
Confidence            7666554322                           123455566666666544 44344455666666666666543 


Q ss_pred             cCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCC
Q 036815          380 LTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN  426 (1013)
Q Consensus       380 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  426 (1013)
                      ++..-..+|.++++|+.+.+..| ++..-..+|.+|++|+.+++..+
T Consensus       331 v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          331 VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            44344456666666766666655 44444556666777777666543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.58  E-value=2e-15  Score=145.51  Aligned_cols=128  Identities=18%  Similarity=0.225  Sum_probs=87.9

Q ss_pred             CCCCeEEecCCccC-CCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCC
Q 036815          368 SNLEWISLTGNELT-GQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLG  446 (1013)
Q Consensus       368 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~  446 (1013)
                      ++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..+.++++|++|++++|.+++.+|..+          
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~----------   84 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLA----------   84 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHH----------
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHh----------
Confidence            45666666666666 56666666677777777777777644  567777777777777777765444322          


Q ss_pred             CcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCccccc-CC
Q 036815          447 GFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGK-IP  525 (1013)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~-iP  525 (1013)
                                                                                ..+++|++|++++|++++. .|
T Consensus        85 ----------------------------------------------------------~~l~~L~~L~ls~N~i~~~~~~  106 (149)
T 2je0_A           85 ----------------------------------------------------------EKCPNLTHLNLSGNKIKDLSTI  106 (149)
T ss_dssp             ----------------------------------------------------------HHCTTCCEEECTTSCCCSHHHH
T ss_pred             ----------------------------------------------------------hhCCCCCEEECCCCcCCChHHH
Confidence                                                                      2245677788888887752 34


Q ss_pred             hhhhCCCCCcEEecCCCccCCCCc---ccccCCCCcceEecCC
Q 036815          526 DEIGDMIALQVLELAHNQLSGEIP---SSLGRLRNLGVFDASH  565 (1013)
Q Consensus       526 ~~i~~l~~L~~L~L~~n~l~g~ip---~~~~~l~~L~~L~ls~  565 (1013)
                      ..++.+++|++|++++|.+++..+   ..++.+++|+.||+++
T Consensus       107 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A          107 EPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             GGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             HHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            677888888888888888885444   4677888888888764

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.57  E-value=1.1e-14  Score=146.74  Aligned_cols=88  Identities=25%  Similarity=0.342  Sum_probs=52.7

Q ss_pred             CCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEE
Q 036815          507 YQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQID  586 (1013)
Q Consensus       507 ~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~  586 (1013)
                      +++|++|||++|++++..|..|+.+.+|++|+|++|++++..|..|+.+++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus        53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  132 (193)
T 2wfh_A           53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA  132 (193)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred             ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence            34556666666666654445566666666666666666654555566666666666666666644444566666666666


Q ss_pred             CcCCCCCC
Q 036815          587 LSNNELTG  594 (1013)
Q Consensus       587 l~~n~l~~  594 (1013)
                      |++|++.+
T Consensus       133 L~~N~~~C  140 (193)
T 2wfh_A          133 IGANPLYC  140 (193)
T ss_dssp             CCSSCEEC
T ss_pred             eCCCCeec
Confidence            66666554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.55  E-value=2.4e-14  Score=144.14  Aligned_cols=99  Identities=27%  Similarity=0.308  Sum_probs=78.4

Q ss_pred             CCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcC
Q 036815          335 KIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGN  414 (1013)
Q Consensus       335 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  414 (1013)
                      .+|..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..
T Consensus        45 ~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~  124 (193)
T 2wfh_A           45 LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFND  124 (193)
T ss_dssp             SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTT
T ss_pred             hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhc
Confidence            34455666777888888888888766677888888888888888888777778888888888888888888555556888


Q ss_pred             CCCCcEEEccCCcCCcCCC
Q 036815          415 CSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       415 l~~L~~L~l~~N~l~~~~p  433 (1013)
                      +++|++|+|++|.+.+...
T Consensus       125 l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A          125 LSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CTTCCEEECCSSCEECSGG
T ss_pred             CccccEEEeCCCCeecCCc
Confidence            8999999999998887643

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.54  E-value=1.7e-16  Score=161.19  Aligned_cols=152  Identities=26%  Similarity=0.320  Sum_probs=103.1

Q ss_pred             CCCCCCeEEecCCccCCCCCh------hhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhc
Q 036815          366 SCSNLEWISLTGNELTGQIPP------EFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQ  439 (1013)
Q Consensus       366 ~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~  439 (1013)
                      ...+++.+++++|.++|.+|.      .+..+++|+.|+|++|++++ +| .+.++++|++|++++|.++ .+|..+   
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~---   89 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD---   89 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH---
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh---
Confidence            334444444454444444444      77777777777777777774 56 6777777777777777665 344322   


Q ss_pred             cCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCc
Q 036815          440 LGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQ  519 (1013)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~  519 (1013)
                                                                                       ..+++|++|++++|+
T Consensus        90 -----------------------------------------------------------------~~~~~L~~L~L~~N~  104 (198)
T 1ds9_A           90 -----------------------------------------------------------------AVADTLEELWISYNQ  104 (198)
T ss_dssp             -----------------------------------------------------------------HHHHHCSEEEEEEEE
T ss_pred             -----------------------------------------------------------------hcCCcCCEEECcCCc
Confidence                                                                             122457788888888


Q ss_pred             ccccCChhhhCCCCCcEEecCCCccCCCCc--ccccCCCCcceEecCCccccCCCccc----------ccCCCcceEEEC
Q 036815          520 FRGKIPDEIGDMIALQVLELAHNQLSGEIP--SSLGRLRNLGVFDASHNRLQGQIPES----------FSNLSFLVQIDL  587 (1013)
Q Consensus       520 l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip--~~~~~l~~L~~L~ls~N~l~g~~p~~----------~~~l~~l~~l~l  587 (1013)
                      +++ +| .++.+++|++|+|++|+++ .+|  ..++.+++|+.|++++|.+++.+|..          +..+++|+.|| 
T Consensus       105 l~~-l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld-  180 (198)
T 1ds9_A          105 IAS-LS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD-  180 (198)
T ss_dssp             CCC-HH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC-
T ss_pred             CCc-CC-ccccCCCCCEEECCCCcCC-chhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC-
Confidence            884 55 6788888888888888888 444  37788888888888888888776653          77788888776 


Q ss_pred             cCCCCC
Q 036815          588 SNNELT  593 (1013)
Q Consensus       588 ~~n~l~  593 (1013)
                       +|.++
T Consensus       181 -~~~i~  185 (198)
T 1ds9_A          181 -GMPVD  185 (198)
T ss_dssp             -CGGGT
T ss_pred             -CcccC
Confidence             44443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.53  E-value=2e-14  Score=142.95  Aligned_cols=133  Identities=23%  Similarity=0.241  Sum_probs=104.6

Q ss_pred             CceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcc
Q 036815          274 LEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNN  353 (1013)
Q Consensus       274 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~  353 (1013)
                      .+.+++++|.++.. |..+  .++|+.|++++|.++                        +..+..|+.+++|++|++++
T Consensus         9 ~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~------------------------~~~~~~~~~l~~L~~L~l~~   61 (177)
T 2o6r_A            9 GTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQ------------------------SLPHGVFDKLTQLTKLSLSQ   61 (177)
T ss_dssp             TTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCC------------------------CCCTTTTTTCTTCSEEECCS
T ss_pred             CCEEEecCCCCccC-CCCC--CCCCcEEEeCCCccc------------------------EeCHHHhcCcccccEEECCC
Confidence            35566666666633 3222  245666666666665                        33345577888999999999


Q ss_pred             ccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCC
Q 036815          354 NKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       354 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  433 (1013)
                      |++++..+..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..+.++++|++|+|++|++++..|
T Consensus        62 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           62 NQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            99997666678899999999999999997777778999999999999999996655567899999999999999998876

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.51  E-value=1.4e-13  Score=136.77  Aligned_cols=131  Identities=22%  Similarity=0.207  Sum_probs=78.6

Q ss_pred             ccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEee
Q 036815           76 LELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLD  155 (1013)
Q Consensus        76 L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  155 (1013)
                      .+.+++++|+++..+..      ..++|++|++++|+++++.+..|.++++|++|++++|++++..+..|..+++|++|+
T Consensus         9 ~~~l~~~~~~l~~~p~~------~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~   82 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTG------IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY   82 (177)
T ss_dssp             TTEEECCSSCCSSCCTT------CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCEEEecCCCCccCCCC------CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEE
Confidence            34555666655533322      124566666666666665555566666777777777776655555566666666666


Q ss_pred             CcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCC
Q 036815          156 LSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP  213 (1013)
Q Consensus       156 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  213 (1013)
                      +++|.++ .++...+..+++|++|+|++|++++..+..+..+++|++|++++|.+.+.
T Consensus        83 l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           83 LHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCCCcc-ccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            6666666 44444444456666666666666655555556666666666666666543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.50  E-value=3.6e-16  Score=158.73  Aligned_cols=152  Identities=24%  Similarity=0.302  Sum_probs=114.3

Q ss_pred             CCCCCceEECccccccccCch------hhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCC
Q 036815          342 KCKNLKDLILNNNKLSGEIPA------ELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNC  415 (1013)
Q Consensus       342 ~l~~L~~L~L~~N~l~~~~p~------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  415 (1013)
                      ....++.++++.|.++|.+|.      .+..+++|++|+|++|.+++ +| .+..+++|+.|++++|+++ .+|..+..+
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~   92 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA   92 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence            344566666666666666655      78888888888888888885 66 8888888888888888887 677777777


Q ss_pred             CCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCcccccccccc
Q 036815          416 SSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARM  495 (1013)
Q Consensus       416 ~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  495 (1013)
                      ++|++|++++|++++ +| .+                                                           
T Consensus        93 ~~L~~L~L~~N~l~~-l~-~~-----------------------------------------------------------  111 (198)
T 1ds9_A           93 DTLEELWISYNQIAS-LS-GI-----------------------------------------------------------  111 (198)
T ss_dssp             HHCSEEEEEEEECCC-HH-HH-----------------------------------------------------------
T ss_pred             CcCCEEECcCCcCCc-CC-cc-----------------------------------------------------------
Confidence            888888888888764 22 11                                                           


Q ss_pred             ccCcccccccCCCccCEEEccCCcccccCC--hhhhCCCCCcEEecCCCccCCCCccc----------ccCCCCcceEec
Q 036815          496 YSGPVLSLFTQYQTLEYLDLSYNQFRGKIP--DEIGDMIALQVLELAHNQLSGEIPSS----------LGRLRNLGVFDA  563 (1013)
Q Consensus       496 ~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP--~~i~~l~~L~~L~L~~n~l~g~ip~~----------~~~l~~L~~L~l  563 (1013)
                               ..+++|++|++++|++++ +|  ..++.+++|++|++++|.+++.+|..          +..+++|+.|| 
T Consensus       112 ---------~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld-  180 (198)
T 1ds9_A          112 ---------EKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD-  180 (198)
T ss_dssp             ---------HHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC-
T ss_pred             ---------ccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC-
Confidence                     223568888888888883 44  37888888888888888888766653          78888999887 


Q ss_pred             CCcccc
Q 036815          564 SHNRLQ  569 (1013)
Q Consensus       564 s~N~l~  569 (1013)
                       +|.++
T Consensus       181 -~~~i~  185 (198)
T 1ds9_A          181 -GMPVD  185 (198)
T ss_dssp             -CGGGT
T ss_pred             -CcccC
Confidence             67665

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.50  E-value=4e-14  Score=140.52  Aligned_cols=62  Identities=13%  Similarity=0.160  Sum_probs=32.0

Q ss_pred             hcCCCCCCeEEecCCccCCCCChhhhccC-CCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCC
Q 036815          364 LFSCSNLEWISLTGNELTGQIPPEFSRLT-RLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLT  429 (1013)
Q Consensus       364 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  429 (1013)
                      +.++++|++|++++|.++ .+|. +..+. +|+.|+|++|++++.  ..+.++++|++|++++|.++
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~   77 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC   77 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc
Confidence            344555555555555555 3333 33332 556666666655543  34555555555555555554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.46  E-value=1.3e-13  Score=136.72  Aligned_cols=130  Identities=22%  Similarity=0.192  Sum_probs=67.2

Q ss_pred             CcccEEECCCCCCCCCCCccccCC-CCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEE
Q 036815          101 NSLLHLDLSQNHIMDVIPSSLSNC-TKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL  179 (1013)
Q Consensus       101 ~~L~~L~Ls~n~i~~~~~~~l~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  179 (1013)
                      .+|+.|++++|+++++ +. +..+ ++|++|++++|++++.  ..|..+++|++|++++|.++ .+|..++..+++|++|
T Consensus        19 ~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L   93 (176)
T 1a9n_A           19 VRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTEL   93 (176)
T ss_dssp             TSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEE
T ss_pred             CCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEE
Confidence            3444455555544432 22 2222 2555555555555543  34555555555666555555 3444444445555555


Q ss_pred             ECCCCCCCCcCC-ccccCCCCCCEEEccCCCCCCCCChh---hhhcCCCCcEEEcccccCC
Q 036815          180 KLPHNNITGSFP-VTLSSCSWLQLLDLSNNNISGPFPDS---VLENLGSLESLILSNNMIS  236 (1013)
Q Consensus       180 ~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~---~~~~l~~L~~L~L~~n~l~  236 (1013)
                      +|++|+|+...+ ..+..+++|+.|++++|.++ .+|..   ++..+++|+.|++++|.+.
T Consensus        94 ~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           94 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             ECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            555555543221 24555666666666666665 33433   3455666666666666543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.41  E-value=1.6e-11  Score=138.83  Aligned_cols=334  Identities=15%  Similarity=0.245  Sum_probs=180.3

Q ss_pred             ccCcccccCCC-CCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCc---ccCccCCCCcCCCCCCcccEEECCCCCCC
Q 036815           39 LVPDNLFSKLP-NLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN---LTGSISGFSLNENSCNSLLHLDLSQNHIM  114 (1013)
Q Consensus        39 ~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~---l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~  114 (1013)
                      .|++.+|.++. .|+++.+-.+ ++ .+...+|.+|.+|+.+.++.|.   ++.+....+   ..|.+|+.+.+..+ ++
T Consensus        53 ~Ig~~aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF---~~c~~L~~i~~~~~-~~  126 (394)
T 4gt6_A           53 KIGDRVFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAF---MFCSELTDIPILDS-VT  126 (394)
T ss_dssp             EECTTTTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTT---TTCTTCCBCGGGTT-CS
T ss_pred             EcCHhhccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhc---hhcccceeeccCCc-cc
Confidence            46777787774 4888888644 55 5666778888888888877653   333322222   34555665555443 44


Q ss_pred             CCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccc
Q 036815          115 DVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTL  194 (1013)
Q Consensus       115 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l  194 (1013)
                      .+...+|.++.+|+.+.+..+ +..+...+|..+.+|+.+.+.++ ++ .+....|.. .+|+.+.+..+-. .+...+|
T Consensus       127 ~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF~~-~~l~~i~ip~~~~-~i~~~af  201 (394)
T 4gt6_A          127 EIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VT-AIEERAFTG-TALTQIHIPAKVT-RIGTNAF  201 (394)
T ss_dssp             EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTT-CCCSEEEECTTCC-EECTTTT
T ss_pred             eehhhhhhhhcccccccccce-eeeecccceecccccccccccce-ee-Eeccccccc-cceeEEEECCccc-ccccchh
Confidence            455566666666776666543 33355556666666666666554 33 344444442 4566666654322 2444555


Q ss_pred             cCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCC
Q 036815          195 SSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSL  274 (1013)
Q Consensus       195 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  274 (1013)
                      ..+.+|+......+... .+...++........-..           .+.....+..+.+..+ ++ .+....|.++..|
T Consensus       202 ~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~ip~~-v~-~i~~~aF~~c~~L  267 (394)
T 4gt6_A          202 SECFALSTITSDSESYP-AIDNVLYEKSANGDYALI-----------RYPSQREDPAFKIPNG-VA-RIETHAFDSCAYL  267 (394)
T ss_dssp             TTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEEE-----------ECCTTCCCSEEECCTT-EE-EECTTTTTTCSSC
T ss_pred             hhccccceecccccccc-cccceeeccccccccccc-----------ccccccccceEEcCCc-ce-Ecccceeeecccc
Confidence            66666666555544332 111111111111000000           0111223333333322 22 2334455556666


Q ss_pred             ceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccc
Q 036815          275 EELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNN  354 (1013)
Q Consensus       275 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N  354 (1013)
                      +.+.+.++... ....+|.+++.|+.+.+.. .++                        ......|.++.+|+.++|..+
T Consensus       268 ~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~------------------------~I~~~aF~~c~~L~~i~lp~~  321 (394)
T 4gt6_A          268 ASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RIT------------------------ELPESVFAGCISLKSIDIPEG  321 (394)
T ss_dssp             CEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCC------------------------EECTTTTTTCTTCCEEECCTT
T ss_pred             cEEecccccce-ecCcccccccccccccCCC-ccc------------------------ccCceeecCCCCcCEEEeCCc
Confidence            66666544332 4455666666666666642 222                        123346777778888888754


Q ss_pred             cccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcC
Q 036815          355 KLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNL  428 (1013)
Q Consensus       355 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  428 (1013)
                       ++......|.++++|+.+.|..+ ++..-..+|.++++|+.+++.++....   ..+..+++|+.+.+..|.+
T Consensus       322 -v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          322 -ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             -CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             -ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence             55455567788888888888654 554556678888888888888876542   4567778888888776643

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.38  E-value=1.4e-12  Score=128.30  Aligned_cols=109  Identities=25%  Similarity=0.277  Sum_probs=94.1

Q ss_pred             ccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecC
Q 036815          298 LKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTG  377 (1013)
Q Consensus       298 L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  377 (1013)
                      .+.+++++|.++                         .+|..+.  ++|++|+|++|++++..|..+..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-------------------------~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~   63 (170)
T 3g39_A           11 GTTVDCSGKSLA-------------------------SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDN   63 (170)
T ss_dssp             TTEEECTTSCCS-------------------------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCS
T ss_pred             CCEEEeCCCCcC-------------------------ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCC
Confidence            467788888776                         2343332  6899999999999988889999999999999999


Q ss_pred             CccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCC
Q 036815          378 NELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIP  433 (1013)
Q Consensus       378 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  433 (1013)
                      |+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+
T Consensus        64 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           64 NQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            99997777788999999999999999997666779999999999999999998764

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.38  E-value=1.3e-11  Score=139.65  Aligned_cols=324  Identities=15%  Similarity=0.218  Sum_probs=178.9

Q ss_pred             cccccccccccCC-CCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCc---cCCCCchhhhhCCCCccEEeCCCCcc
Q 036815           11 LFTLNSTSLLQLP-FGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNN---LTGFLPETLLSNSDKLELLDLSYNNL   86 (1013)
Q Consensus        11 ~~~~~~~~~~~~~-~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~~l~~L~~L~Ls~n~l   86 (1013)
                      .++.|...+|... ..|+.+.+-++ + ..|...+|.+|.+|+++.++.|.   ++ .+...+|.+|..|+.+.+..+ +
T Consensus        50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-v-t~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~-~  125 (394)
T 4gt6_A           50 PVSKIGDRVFCNYKYVLTSVQIPDT-V-TEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS-V  125 (394)
T ss_dssp             EEEEECTTTTTTCCSCCCEEEECTT-C-CEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-C
T ss_pred             eeeEcCHhhccCCCCcCEEEEECCC-e-eEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-c
Confidence            3677778888766 35889988764 4 34778889999999999988763   55 566777888888888877654 4


Q ss_pred             cCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCC
Q 036815           87 TGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIP  166 (1013)
Q Consensus        87 ~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  166 (1013)
                      +.+....+   ..|.+|+.+.+..+ +..+....|.++..|+.+.+..+ ++.+...+|.. .+|+.+.+..+-.  .+.
T Consensus       126 ~~I~~~aF---~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~--~i~  197 (394)
T 4gt6_A          126 TEIDSEAF---HHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT--RIG  197 (394)
T ss_dssp             SEECTTTT---TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC--EEC
T ss_pred             ceehhhhh---hhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCccc--ccc
Confidence            43333322   46788888888643 45566778888888888888765 44455566654 5688887766532  234


Q ss_pred             ccchhccCCCcEEECCCCCCCCcCCccc-------------cCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccc
Q 036815          167 SELGNACDSLLELKLPHNNITGSFPVTL-------------SSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN  233 (1013)
Q Consensus       167 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l-------------~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n  233 (1013)
                      ...+..|.++.......+.........+             .....+..+.+..+ ++ .+....|.++..|+.+.+.++
T Consensus       198 ~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~-v~-~i~~~aF~~c~~L~~i~lp~~  275 (394)
T 4gt6_A          198 TNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNG-VA-RIETHAFDSCAYLASVKMPDS  275 (394)
T ss_dssp             TTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTT-EE-EECTTTTTTCSSCCEEECCTT
T ss_pred             cchhhhccccceecccccccccccceeecccccccccccccccccccceEEcCCc-ce-EcccceeeecccccEEecccc
Confidence            4445556666666655443331111111             11112222222211 11 122334555555555555544


Q ss_pred             cCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCC
Q 036815          234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP  313 (1013)
Q Consensus       234 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  313 (1013)
                      ..+ ....+|.++++|+.+.+.. .++ .++...|.++.+|+.+.+.++ ++.+...+|.+|.+|+.+.+..+ ++..-.
T Consensus       276 ~~~-I~~~aF~~c~~L~~i~l~~-~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~  350 (394)
T 4gt6_A          276 VVS-IGTGAFMNCPALQDIEFSS-RIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPE  350 (394)
T ss_dssp             CCE-ECTTTTTTCTTCCEEECCT-TCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCG
T ss_pred             cce-ecCcccccccccccccCCC-ccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhH
Confidence            332 3444555555555555542 233 344555555555666655543 44344455555666666665433 332333


Q ss_pred             cccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccc
Q 036815          314 QELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKL  356 (1013)
Q Consensus       314 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  356 (1013)
                      .+|.++.+|+.+.+.++....   ..+....+|+.+.+..|.+
T Consensus       351 ~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          351 SAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             GGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             hHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            455555555555555443321   3455667777777766654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.36  E-value=1.6e-12  Score=127.87  Aligned_cols=90  Identities=27%  Similarity=0.264  Sum_probs=66.8

Q ss_pred             CccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEEC
Q 036815          508 QTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDL  587 (1013)
Q Consensus       508 ~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l  587 (1013)
                      ++|++|+|++|+|++..|..++.+.+|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            66777888888887666777777778888888888877544555677777888888888877655556777777888888


Q ss_pred             cCCCCCCcCC
Q 036815          588 SNNELTGPIP  597 (1013)
Q Consensus       588 ~~n~l~~~~p  597 (1013)
                      ++|++++..+
T Consensus       110 ~~N~~~c~c~  119 (170)
T 3g39_A          110 LNNPWDCACS  119 (170)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCCCCCch
Confidence            8887776655

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.34  E-value=2.5e-12  Score=126.82  Aligned_cols=90  Identities=26%  Similarity=0.274  Sum_probs=58.1

Q ss_pred             CccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEEC
Q 036815          508 QTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDL  587 (1013)
Q Consensus       508 ~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l  587 (1013)
                      ++|++|+|++|+|++..|..++.+++|++|+|++|+|++..|..|+++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            56667777777777655666677777777777777776433334566777777777777776444444666777777777


Q ss_pred             cCCCCCCcCC
Q 036815          588 SNNELTGPIP  597 (1013)
Q Consensus       588 ~~n~l~~~~p  597 (1013)
                      ++|++....+
T Consensus       113 ~~N~~~c~~~  122 (174)
T 2r9u_A          113 YNNPWDCECR  122 (174)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCcccccc
Confidence            7776665443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.33  E-value=3.2e-12  Score=126.12  Aligned_cols=105  Identities=26%  Similarity=0.294  Sum_probs=94.6

Q ss_pred             CEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCC
Q 036815          511 EYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNN  590 (1013)
Q Consensus       511 ~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n  590 (1013)
                      +.+|+++|+++ .+|..+.  ..|++|+|++|+|++..|..|+++++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            68999999998 8999875  89999999999999888999999999999999999999766666899999999999999


Q ss_pred             CCCCcCCC-CCCCCCCCcccccCCCCCCC
Q 036815          591 ELTGPIPQ-RGQLSTLPASQYANNPGLCG  618 (1013)
Q Consensus       591 ~l~~~~p~-~~~~~~~~~~~~~~n~~lc~  618 (1013)
                      ++++.+|. ...+..+..+.+.+|+.-|.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            99987775 67788899999999987663

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.30  E-value=4.4e-14  Score=157.51  Aligned_cols=186  Identities=20%  Similarity=0.136  Sum_probs=107.2

Q ss_pred             CCCCcEEeCCCCccCCCCchhh---h-hCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccc--
Q 036815           48 LPNLVYLNASYNNLTGFLPETL---L-SNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL--  121 (1013)
Q Consensus        48 l~~L~~L~L~~n~i~~~~~~~~---~-~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l--  121 (1013)
                      +++|++|+|++|.|++.....+   + ..+++|++|+|++|.++.....  .....+++|++|+|++|.|++.....+  
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~--~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~  148 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLR--TLLPVFLRARKLGLQLNSLGPEACKDLRD  148 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHH--HTHHHHHTEEEEECCSSCCCHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHH--HHHHHHHhccHhhcCCCCCCHHHHHHHHH
Confidence            4567777777777763222111   1 1235777777777777632111  111234567778888887776544444  


Q ss_pred             ---cCCCCCCEEecCCCccccc----CcccccCCCCCCEeeCcCCcccCcCCccc---hhccCCCcEEECCCCCCCCcC-
Q 036815          122 ---SNCTKLKILNLSFNLLAGE----IPRTFGQLSSLQRLDLSNNHITGWIPSEL---GNACDSLLELKLPHNNITGSF-  190 (1013)
Q Consensus       122 ---~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~---~~~l~~L~~L~L~~n~l~~~~-  190 (1013)
                         ...++|++|+|++|.+++.    ++..+..+++|++|+|++|.|++.....+   ...+++|++|+|++|.|++.. 
T Consensus       149 ~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~  228 (372)
T 3un9_A          149 LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA  228 (372)
T ss_dssp             HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHH
T ss_pred             HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHH
Confidence               3457788888888887643    33344667778888888888764321111   123467888888888887543 


Q ss_pred             ---CccccCCCCCCEEEccCCCCCCCCChhhhhcCCC-----CcEEE--cccccCC
Q 036815          191 ---PVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGS-----LESLI--LSNNMIS  236 (1013)
Q Consensus       191 ---~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~-----L~~L~--L~~n~l~  236 (1013)
                         +..+..+++|++|+|++|.|++..... +..+..     |+.+.  +..|.+.
T Consensus       229 ~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~-L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          229 LALARAAREHPSLELLHLYFNELSSEGRQV-LRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             HHHHHHHHHCSSCCEEECTTSSCCHHHHHH-HHHCC------CEEECCCC----CH
T ss_pred             HHHHHHHHhCCCCCEEeccCCCCCHHHHHH-HHHHhcCCCccchhhHhhhcCCccC
Confidence               334456688888888888887433222 222221     55555  5555554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=1.3e-11  Score=131.43  Aligned_cols=144  Identities=12%  Similarity=0.014  Sum_probs=113.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEEE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ..+.|++....+.|+.+.||++... ++.+++|............+.+|+++++.+. +..+.++++++.+.+..|+|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3457888888899999999999864 7899999875422223346889999999884 6778899999998999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC----------------------------------  856 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  856 (1013)
                      |++|.++.+.+..           ......++.+++++++.||+..                                  
T Consensus        91 ~i~G~~l~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           91 EADGVLCSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             CCSSEEHHHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             ecCCeehhhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999876421           1123467889999999999810                                  


Q ss_pred             ----------------------CCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          857 ----------------------IPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       857 ----------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                                            ...++|+|++|.||+++.+..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  1359999999999999876556799999775

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.27  E-value=8.4e-14  Score=155.23  Aligned_cols=189  Identities=19%  Similarity=0.124  Sum_probs=128.4

Q ss_pred             CCCCCcEEecCCCCcccccCccccc-----CCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCC-CCc
Q 036815           22 LPFGLKQLELSSAGLVGLVPDNLFS-----KLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISG-FSL   95 (1013)
Q Consensus        22 ~~~~l~~L~L~~~~i~~~~~~~~~~-----~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~   95 (1013)
                      ..+.|++|+|++|.+... ....+.     ..++|++|+|++|.|++.....+...+++|++|+|++|+++..... +..
T Consensus        70 ~~~~L~~L~Ls~n~l~~~-~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~  148 (372)
T 3un9_A           70 VLSSLRQLNLAGVRMTPV-KCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRD  148 (372)
T ss_dssp             HHTTCCEEECTTSCCCHH-HHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHH
T ss_pred             HHhhCCEEEecCCCCCHH-HHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHH
Confidence            445688999999988542 222222     3368999999999987554445555667899999999999743211 111


Q ss_pred             CC-CCCCcccEEECCCCCCCCC----CCccccCCCCCCEEecCCCcccccC----cccccCCCCCCEeeCcCCcccCcCC
Q 036815           96 NE-NSCNSLLHLDLSQNHIMDV----IPSSLSNCTKLKILNLSFNLLAGEI----PRTFGQLSSLQRLDLSNNHITGWIP  166 (1013)
Q Consensus        96 ~~-~~~~~L~~L~Ls~n~i~~~----~~~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l~~~~~  166 (1013)
                      .. ..+++|++|+|++|.|++.    ++..+..+++|++|+|++|.|++..    +..+..+++|++|+|++|.|++...
T Consensus       149 ~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~  228 (372)
T 3un9_A          149 LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA  228 (372)
T ss_dssp             HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHH
T ss_pred             HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHH
Confidence            11 2357899999999998764    3344577899999999999997543    5566778899999999999985433


Q ss_pred             ccchh---ccCCCcEEECCCCCCCCcCCccccCC---C--CCCEEE--ccCCCCC
Q 036815          167 SELGN---ACDSLLELKLPHNNITGSFPVTLSSC---S--WLQLLD--LSNNNIS  211 (1013)
Q Consensus       167 ~~~~~---~l~~L~~L~L~~n~l~~~~~~~l~~l---~--~L~~L~--L~~N~l~  211 (1013)
                      ..+..   .+++|++|+|++|.|++.....+..+   .  .|+.+.  +..|.+.
T Consensus       229 ~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          229 LALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             HHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred             HHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence            33333   34889999999999987655555433   2  166776  6666654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.17  E-value=3.6e-11  Score=133.62  Aligned_cols=98  Identities=17%  Similarity=0.158  Sum_probs=72.8

Q ss_pred             ccCcccccccCCCccCEEEccC-CcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcc
Q 036815          496 YSGPVLSLFTQYQTLEYLDLSY-NQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE  574 (1013)
Q Consensus       496 ~~~~~~~~~~~~~~L~~L~ls~-N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~  574 (1013)
                      ....+|. +..+++|++|+|++ |+|++..|..|+.|.+|+.|+|++|+|+|..|..|++|++|+.|+|++|+|++..|.
T Consensus        20 ~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~   98 (347)
T 2ifg_A           20 ALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWK   98 (347)
T ss_dssp             CCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCST
T ss_pred             CCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHH
Confidence            3445666 77777888888885 888866667788888888888888888877777778888888888888888755555


Q ss_pred             cccCCCcceEEECcCCCCCCc
Q 036815          575 SFSNLSFLVQIDLSNNELTGP  595 (1013)
Q Consensus       575 ~~~~l~~l~~l~l~~n~l~~~  595 (1013)
                      .|..++ |+.|+|++|++...
T Consensus        99 ~~~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           99 TVQGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             TTCSCC-CCEEECCSSCCCCC
T ss_pred             HcccCC-ceEEEeeCCCccCC
Confidence            555555 88888888887754

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.13  E-value=7e-11  Score=131.30  Aligned_cols=106  Identities=19%  Similarity=0.154  Sum_probs=94.4

Q ss_pred             EEEccCC-cccccCChhhhCCCCCcEEecCC-CccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcC
Q 036815          512 YLDLSYN-QFRGKIPDEIGDMIALQVLELAH-NQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSN  589 (1013)
Q Consensus       512 ~L~ls~N-~l~g~iP~~i~~l~~L~~L~L~~-n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~  589 (1013)
                      .++++++ +|+ .||. |+.+.+|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.++++|+.|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4799998 999 6999 99999999999996 999977778999999999999999999999999999999999999999


Q ss_pred             CCCCCcCCCCCCCCCCCcccccCCCCCCCC
Q 036815          590 NELTGPIPQRGQLSTLPASQYANNPGLCGV  619 (1013)
Q Consensus       590 n~l~~~~p~~~~~~~~~~~~~~~n~~lc~~  619 (1013)
                      |+|++.+|.......+..+.+.+|+.-|..
T Consensus        90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A           90 NALESLSWKTVQGLSLQELVLSGNPLHCSC  119 (347)
T ss_dssp             SCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             CccceeCHHHcccCCceEEEeeCCCccCCC
Confidence            999988776544444888889999988853

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.13  E-value=2.9e-09  Score=119.77  Aligned_cols=303  Identities=13%  Similarity=0.167  Sum_probs=200.8

Q ss_pred             cCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCC
Q 036815           21 QLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSC  100 (1013)
Q Consensus        21 ~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~  100 (1013)
                      ....+|+.+.+.. +++. |+..+|.+|.+|++++|..+ ++ .+...+|.++ +|+.+.+..+ ++.+....+   .. 
T Consensus        43 ~~~~~i~~v~ip~-~vt~-Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF---~~-  112 (379)
T 4h09_A           43 KDRDRISEVRVNS-GITS-IGEANFNSCYNMTKVTVAST-VT-SIGDGAFADT-KLQSYTGMER-VKKFGDYVF---QG-  112 (379)
T ss_dssp             GGGGGCSEEEECT-TEEE-ECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTC-CCCEEEECTT-CCEECTTTT---TT-
T ss_pred             ccccCCEEEEeCC-CccC-hHHHHhhCCCCCCEEEeCCc-ce-EechhhhcCC-CCceEECCce-eeEecccee---cc-
Confidence            3445688888874 4544 78888999999999999754 65 6677778887 6888777643 444443333   22 


Q ss_pred             CcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcC-----------Cccc
Q 036815          101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI-----------PSEL  169 (1013)
Q Consensus       101 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-----------~~~~  169 (1013)
                      .+|+.+++..+ ++.+...+|.++ +|+.+.+..+ ++.+...+|..+..++.+.+..+......           ....
T Consensus       113 ~~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (379)
T 4h09_A          113 TDLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILES  189 (379)
T ss_dssp             CCCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEE
T ss_pred             CCcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecc
Confidence            37888888765 444555666665 5676666543 44466677888888888877664322000           0011


Q ss_pred             hhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCc
Q 036815          170 GNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTL  249 (1013)
Q Consensus       170 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  249 (1013)
                      +..+..+..+.+..+. .......+..+.+|+.+.+..+ +. .+....|.++..|+.+.+..+ ++.....++..+.+|
T Consensus       190 ~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l  265 (379)
T 4h09_A          190 YPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTAL  265 (379)
T ss_dssp             CCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred             ccccccccccccccce-eEEeecccccccccceeeeccc-ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehh
Confidence            2223445555554432 2245566777888888888655 33 345556777888888888765 554566778888888


Q ss_pred             CEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhh
Q 036815          250 RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWF  329 (1013)
Q Consensus       250 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~  329 (1013)
                      +.+.+..+ +. .++...|.++.+|+.+.+.++.++.+...+|.+|.+|+.+++..+ ++..-..+|.++.+|+.+.+..
T Consensus       266 ~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~  342 (379)
T 4h09_A          266 KTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK  342 (379)
T ss_dssp             CEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred             cccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence            88888654 44 566777788888888888888888777788888888888888754 5534456788888888777654


Q ss_pred             ccccCCCCcCcCCCC
Q 036815          330 NGLEGKIPPELGKCK  344 (1013)
Q Consensus       330 n~l~~~~p~~~~~l~  344 (1013)
                      + ++......|.++.
T Consensus       343 ~-v~~I~~~aF~~c~  356 (379)
T 4h09_A          343 S-ITLIESGAFEGSS  356 (379)
T ss_dssp             T-CCEECTTTTTTSS
T ss_pred             c-cCEEchhHhhCCC
Confidence            3 4434445566553

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.10  E-value=4.3e-09  Score=118.31  Aligned_cols=304  Identities=11%  Similarity=0.090  Sum_probs=196.5

Q ss_pred             cccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccC
Q 036815           44 LFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSN  123 (1013)
Q Consensus        44 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~  123 (1013)
                      .|....+|+++.+.. .++ .++..+|.+|.+|+.++|..+ ++.+....+   ..| +|+.+.+..+ ++.+...+|.+
T Consensus        41 ~~~~~~~i~~v~ip~-~vt-~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF---~~c-~l~~i~~~~~-l~~I~~~aF~~  112 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GIT-SIGEANFNSCYNMTKVTVAST-VTSIGDGAF---ADT-KLQSYTGMER-VKKFGDYVFQG  112 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEE-EECTTTTTTCTTCCEEEECTT-CCEECTTTT---TTC-CCCEEEECTT-CCEECTTTTTT
T ss_pred             ccccccCCEEEEeCC-Ccc-ChHHHHhhCCCCCCEEEeCCc-ceEechhhh---cCC-CCceEECCce-eeEeccceecc
Confidence            356667788888864 455 566777888888888888643 554444433   234 5777776543 55566666766


Q ss_pred             CCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCC------------cCC
Q 036815          124 CTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITG------------SFP  191 (1013)
Q Consensus       124 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~------------~~~  191 (1013)
                      + +|+.+.+..+ ++.+...+|.++ +|+.+.+..+ ++ .+....+..+.+++.+.+..+....            ...
T Consensus       113 ~-~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~-~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (379)
T 4h09_A          113 T-DLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VT-TIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTIL  187 (379)
T ss_dssp             C-CCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEE
T ss_pred             C-CcccccCCCc-cccccccccccc-eeeeeeccce-ee-ccccchhcccccccccccccccceeecccceeccccccee
Confidence            5 7888888765 333555566654 5666666544 33 4555556667778777776654321            112


Q ss_pred             ccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCC
Q 036815          192 VTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGV  271 (1013)
Q Consensus       192 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l  271 (1013)
                      ..+..+..+..+.+.....  .+....+..+.+|+.+.+..+ +.......+..+..|+.+.+..+ ++ .+....|.++
T Consensus       188 ~~~~~~~~~~~~~~~~~~~--~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~  262 (379)
T 4h09_A          188 ESYPAAKTGTEFTIPSTVK--TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNC  262 (379)
T ss_dssp             EECCTTCCCSEEECCTTCC--EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTC
T ss_pred             cccccccccccccccccee--EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCcccccee
Confidence            2344555666666554422  223344566778888887655 34355667778888888888766 44 4566777778


Q ss_pred             CCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEEC
Q 036815          272 SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLIL  351 (1013)
Q Consensus       272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L  351 (1013)
                      .+|+.+.+..+ +......+|..+++|+.+.+.++.++......|.++.+|+.+.+..+ ++......|.++++|+.+.+
T Consensus       263 ~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i  340 (379)
T 4h09_A          263 TALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY  340 (379)
T ss_dssp             TTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred             ehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence            88888888654 55456677888888888888888777555667888888888877643 55455667888888888888


Q ss_pred             ccccccccCchhhcCCC
Q 036815          352 NNNKLSGEIPAELFSCS  368 (1013)
Q Consensus       352 ~~N~l~~~~p~~l~~l~  368 (1013)
                      ..+ ++..-..+|.+++
T Consensus       341 p~~-v~~I~~~aF~~c~  356 (379)
T 4h09_A          341 PKS-ITLIESGAFEGSS  356 (379)
T ss_dssp             CTT-CCEECTTTTTTSS
T ss_pred             CCc-cCEEchhHhhCCC
Confidence            654 5534445565553

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.05  E-value=2e-10  Score=122.12  Aligned_cols=137  Identities=14%  Similarity=0.061  Sum_probs=99.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcc--eeeeccEEEeCCEEEEEEEcc
Q 036815          735 GFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN--LVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      +|.+..+.+.|..+.||++...+|+.+++|.....   ....+.+|+++++.+.+.+  +.+++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34443333456679999998777888999976432   2345788999999885444  566888888777889999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC------------------------------------  856 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------  856 (1013)
                      +|.++.  ...         .+   ...++.++++.++.||+..                                    
T Consensus        98 ~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           98 PGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             SSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             CCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            998874  211         11   1256777888888888641                                    


Q ss_pred             -------------------CCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          857 -------------------IPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       857 -------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                                         ...++|+|++|.||+++.++.+.|+|||.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                               11399999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.85  E-value=4.2e-09  Score=117.38  Aligned_cols=142  Identities=13%  Similarity=0.188  Sum_probs=105.7

Q ss_pred             CCCeecccCCcEEEEEEEcCCCEEEEEEee--ccC-ccchHHHHHHHHHHhccC--CcceeeeccEEEeC---CEEEEEE
Q 036815          738 AESLIGCGGFGEVFKATLKDGSSVAIKKLI--RLS-CQGDREFMAEMETLGKIK--HRNLVPLLGYCKIG---EERLLVY  809 (1013)
Q Consensus       738 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  809 (1013)
                      ..+.++.|.++.||++... +..+++|+..  ... ......+.+|+++++.+.  +..+.+++.++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999999876 5688888654  221 122356889999999986  45688888888766   4579999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC---------------------------------  856 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------  856 (1013)
                      ||++|..+.+...        ..++...+..++.++++.|+.||+..                                 
T Consensus       121 e~v~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          121 EFVSGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             ECCCCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EecCCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            9999877643111        12567788889999999999999731                                 


Q ss_pred             ----------------------CCCeEecCCCcccEEeCCCCc--EEEeeccccee
Q 036815          857 ----------------------IPHIIHRDMKSSNVLLDHEME--ARVSDFGMARL  888 (1013)
Q Consensus       857 ----------------------~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~  888 (1013)
                                            ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  247999999999999997753  68999999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.81  E-value=1.8e-09  Score=119.08  Aligned_cols=180  Identities=14%  Similarity=0.137  Sum_probs=86.9

Q ss_pred             CCcEEecCCCCccc-cc----C--cccccCCCCCcEEeCCCCccCC--------CCchhhhhCCCCccEEeCCCCc-ccC
Q 036815           25 GLKQLELSSAGLVG-LV----P--DNLFSKLPNLVYLNASYNNLTG--------FLPETLLSNSDKLELLDLSYNN-LTG   88 (1013)
Q Consensus        25 ~l~~L~L~~~~i~~-~~----~--~~~~~~l~~L~~L~L~~n~i~~--------~~~~~~~~~l~~L~~L~Ls~n~-l~~   88 (1013)
                      .++.|.+..++..+ ..    +  ......+++|+.|.+..+...+        .....++..+++|++|+|++|. +. 
T Consensus       108 ~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-  186 (362)
T 2ra8_A          108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-  186 (362)
T ss_dssp             GCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-
T ss_pred             hcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-
Confidence            47788888665421 10    0  0113456788888776542210        0122455677788888887762 21 


Q ss_pred             ccCCCCcCCCCCCcccEEECCCCCCCCCCCcccc--CCCCCCEEecCC--Cccccc-----Ccccc--cCCCCCCEeeCc
Q 036815           89 SISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLS--NCTKLKILNLSF--NLLAGE-----IPRTF--GQLSSLQRLDLS  157 (1013)
Q Consensus        89 ~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~--~l~~L~~L~L~~--n~l~~~-----~~~~~--~~l~~L~~L~Ls  157 (1013)
                      .    .  ...+++|++|+|..|.++......+.  .+++|++|+|+.  |...+.     +...+  ..+++|++|+|+
T Consensus       187 l----~--~~~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~  260 (362)
T 2ra8_A          187 I----G--KKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIV  260 (362)
T ss_dssp             C----C--SCBCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEE
T ss_pred             e----c--cccCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCC
Confidence            1    1  01256777777777776543333332  567777777643  111100     01112  135566666666


Q ss_pred             CCcccCcCCccchh--ccCCCcEEECCCCCCCCcC----CccccCCCCCCEEEccCCCCC
Q 036815          158 NNHITGWIPSELGN--ACDSLLELKLPHNNITGSF----PVTLSSCSWLQLLDLSNNNIS  211 (1013)
Q Consensus       158 ~n~l~~~~~~~~~~--~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~N~l~  211 (1013)
                      +|.+++..+..++.  .+++|++|+|+.|.+++..    +..+..+++|+.|+|++|.++
T Consensus       261 ~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          261 DAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             SCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            66655333222221  2344555555555544321    112223444444444444443

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.79  E-value=1.3e-09  Score=120.01  Aligned_cols=186  Identities=13%  Similarity=0.208  Sum_probs=119.4

Q ss_pred             cCCCCCCceEECccccc---------cccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCC
Q 036815          340 LGKCKNLKDLILNNNKL---------SGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPG  410 (1013)
Q Consensus       340 ~~~l~~L~~L~L~~N~l---------~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  410 (1013)
                      +.++++|+.|.+..+..         .+.+...+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.+......
T Consensus       135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~  211 (362)
T 2ra8_A          135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVE  211 (362)
T ss_dssp             HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHH
T ss_pred             hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHH
Confidence            44556777777765432         1235566677889999999887311 2333 3 378899999988887644333


Q ss_pred             CCc--CCCCCcEEEccCC--cCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCc
Q 036815          411 ELG--NCSSLVWLDLNSN--NLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPT  486 (1013)
Q Consensus       411 ~~~--~l~~L~~L~l~~N--~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (1013)
                      .+.  .+++|+.|+|+.+  ...|...  +                                             ..+. 
T Consensus       212 ~l~~~~lp~L~~L~L~~~~~~~~~~~~--~---------------------------------------------~~l~-  243 (362)
T 2ra8_A          212 DILGSDLPNLEKLVLYVGVEDYGFDGD--M---------------------------------------------NVFR-  243 (362)
T ss_dssp             HHHHSBCTTCCEEEEECBCGGGTCCSC--G---------------------------------------------GGTG-
T ss_pred             HHHHccCCCCcEEEEeccccccccchh--H---------------------------------------------HHHH-
Confidence            443  6889999988632  2111100  0                                             0000 


Q ss_pred             cccccccccccCcccccccCCCccCEEEccCCcccccCChhhh---CCCCCcEEecCCCccCCC----CcccccCCCCcc
Q 036815          487 LKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIG---DMIALQVLELAHNQLSGE----IPSSLGRLRNLG  559 (1013)
Q Consensus       487 l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~---~l~~L~~L~L~~n~l~g~----ip~~~~~l~~L~  559 (1013)
                             ....      ...+++|++|+|++|.+.+..+..+.   .+++|++|+|+.|.+++.    ++..+.++++|+
T Consensus       244 -------~~l~------~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~  310 (362)
T 2ra8_A          244 -------PLFS------KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK  310 (362)
T ss_dssp             -------GGSC------TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCS
T ss_pred             -------HHHh------cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcce
Confidence                   0000      02356899999999999865555554   578999999999999863    566667789999


Q ss_pred             eEecCCccccCCCcccccC-CCcceEEECcCCC
Q 036815          560 VFDASHNRLQGQIPESFSN-LSFLVQIDLSNNE  591 (1013)
Q Consensus       560 ~L~ls~N~l~g~~p~~~~~-l~~l~~l~l~~n~  591 (1013)
                      .|+|++|.++...-..+.. +  ...+++++|+
T Consensus       311 ~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          311 FINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             EEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             EEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence            9999999887543333333 2  3568888876

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.79  E-value=2.8e-09  Score=115.75  Aligned_cols=183  Identities=18%  Similarity=0.203  Sum_probs=120.5

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccC-Ccc--eeeeccEEEeCC---EEEEEEEcc
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRN--LVPLLGYCKIGE---ERLLVYEFM  812 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  812 (1013)
                      .+.++.|....||++.    +.+++|....  ......+.+|+++++.+. +..  +.+++.....++   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4678999999999863    5688886432  233467889999998883 332  344444433332   347999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN-------------------------------------  855 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------  855 (1013)
                      +|.++.+...        ..++..++..++.++++.++.||+.                                     
T Consensus        99 ~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           99 KGVPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             CCEECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             CCeECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            9988865432        1156677778888888888888861                                     


Q ss_pred             ------------------CCCCeEecCCCcccEEeCC--CCcEEEeecccceeccccCcceeeeeeccCCCc---cCccc
Q 036815          856 ------------------CIPHIIHRDMKSSNVLLDH--EMEARVSDFGMARLISALDTHLSVSTLAGTPGY---VPPEY  912 (1013)
Q Consensus       856 ------------------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aPE~  912 (1013)
                                        ..+.++|+|++|.||+++.  ...+.++||+.+..-.... .     ......+   ..|+.
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-D-----l~~~~~~~~~~~~~~  244 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-D-----FISLMEDDEEYGMEF  244 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-H-----HHTTCCTTTSCCHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-H-----HHHHHhhccccCHHH
Confidence                              1135899999999999998  4567899999987532210 0     0001111   22322


Q ss_pred             cc----CC----------CCCccchhHhHHHHHHHHHcCCCCC
Q 036815          913 YQ----SF----------RCTAKGDVYSFGVVLLELLTGKRPT  941 (1013)
Q Consensus       913 ~~----~~----------~~~~~~DvwslG~il~elltg~~pf  941 (1013)
                      ..    ..          ......+.|++|.++|.+.+|..+|
T Consensus       245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11    00          0112368999999999999998775

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.44  E-value=1.6e-08  Score=100.39  Aligned_cols=119  Identities=13%  Similarity=0.144  Sum_probs=60.0

Q ss_pred             cccCCCCCcEEeCCCC-ccCCCCc---hhhhhCCCCccEEeCCCCcccCccC-CCCcCCCCCCcccEEECCCCCCCCC--
Q 036815           44 LFSKLPNLVYLNASYN-NLTGFLP---ETLLSNSDKLELLDLSYNNLTGSIS-GFSLNENSCNSLLHLDLSQNHIMDV--  116 (1013)
Q Consensus        44 ~~~~l~~L~~L~L~~n-~i~~~~~---~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~~~~~~~L~~L~Ls~n~i~~~--  116 (1013)
                      ++...++|++|+|++| .|++...   ...+...++|++|+|++|+++.... .+.......++|++|+|++|.|++.  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            4556677777777777 6663211   1224455667777777776653111 1111112234566666666665543  


Q ss_pred             --CCccccCCCCCCEEec--CCCcccccC----cccccCCCCCCEeeCcCCccc
Q 036815          117 --IPSSLSNCTKLKILNL--SFNLLAGEI----PRTFGQLSSLQRLDLSNNHIT  162 (1013)
Q Consensus       117 --~~~~l~~l~~L~~L~L--~~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l~  162 (1013)
                        +...+...+.|++|+|  ++|.|++..    ...+...++|++|+|++|.+.
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence              2333444555666666  555555322    222333455555555555554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.38  E-value=6.7e-08  Score=95.95  Aligned_cols=91  Identities=16%  Similarity=0.181  Sum_probs=41.1

Q ss_pred             ccCCCCCCEEecCCC-ccccc----CcccccCCCCCCEeeCcCCcccCcCCccchhc---cCCCcEEECCCCCCCCc---
Q 036815          121 LSNCTKLKILNLSFN-LLAGE----IPRTFGQLSSLQRLDLSNNHITGWIPSELGNA---CDSLLELKLPHNNITGS---  189 (1013)
Q Consensus       121 l~~l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~---l~~L~~L~L~~n~l~~~---  189 (1013)
                      +...+.|++|+|++| .+.+.    +...+...++|++|+|++|.|++.....++..   .++|++|+|++|.|++.   
T Consensus        32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~  111 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL  111 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence            344455555555555 44421    22233344555555555555543222122111   13455555555554432   


Q ss_pred             -CCccccCCCCCCEEEc--cCCCCC
Q 036815          190 -FPVTLSSCSWLQLLDL--SNNNIS  211 (1013)
Q Consensus       190 -~~~~l~~l~~L~~L~L--~~N~l~  211 (1013)
                       +...+...++|++|+|  ++|.|.
T Consensus       112 ~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A          112 ALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHhCCCceEEEecCCCCCCC
Confidence             2334444555666666  555554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.37  E-value=2.1e-07  Score=96.83  Aligned_cols=78  Identities=22%  Similarity=0.307  Sum_probs=43.7

Q ss_pred             CCccCEEEccCCcccc--cCChhhhCCCCCcEEecCCCccCCCCcccccCCC--CcceEecCCccccCCCcc-------c
Q 036815          507 YQTLEYLDLSYNQFRG--KIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLR--NLGVFDASHNRLQGQIPE-------S  575 (1013)
Q Consensus       507 ~~~L~~L~ls~N~l~g--~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~--~L~~L~ls~N~l~g~~p~-------~  575 (1013)
                      +++|++|+||+|+|++  .+|..++.+++|+.|+|++|+|++.  ..+..++  +|+.|+|++|.+++.+|.       .
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i  246 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI  246 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence            4456666666666665  4455556666666666666666642  2334444  566666666666655542       2


Q ss_pred             ccCCCcceEEE
Q 036815          576 FSNLSFLVQID  586 (1013)
Q Consensus       576 ~~~l~~l~~l~  586 (1013)
                      +..+++|+.||
T Consensus       247 l~~~P~L~~LD  257 (267)
T 3rw6_A          247 RERFPKLLRLD  257 (267)
T ss_dssp             HHHCTTCCEES
T ss_pred             HHHCcccCeEC
Confidence            44555555554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.35  E-value=8e-08  Score=100.06  Aligned_cols=89  Identities=20%  Similarity=0.282  Sum_probs=70.0

Q ss_pred             CccCE--EEccCCccc---ccCChhhhCCCCCcEEecCCCccCC--CCcccccCCCCcceEecCCccccCCCcccccCCC
Q 036815          508 QTLEY--LDLSYNQFR---GKIPDEIGDMIALQVLELAHNQLSG--EIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLS  580 (1013)
Q Consensus       508 ~~L~~--L~ls~N~l~---g~iP~~i~~l~~L~~L~L~~n~l~g--~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~  580 (1013)
                      ..|..  ++++.|+..   +.++-...++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.
T Consensus       141 p~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~  218 (267)
T 3rw6_A          141 PDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIK  218 (267)
T ss_dssp             HHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGT
T ss_pred             cchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcc
Confidence            34544  778888544   3333333678999999999999998  6778889999999999999999964  3444444


Q ss_pred             --cceEEECcCCCCCCcCCC
Q 036815          581 --FLVQIDLSNNELTGPIPQ  598 (1013)
Q Consensus       581 --~l~~l~l~~n~l~~~~p~  598 (1013)
                        .|++|+|++|++++.+|.
T Consensus       219 ~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          219 GLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             TSCCSEEECTTSTTGGGCSS
T ss_pred             cCCcceEEccCCcCccccCc
Confidence              899999999999998773

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.32  E-value=2.7e-06  Score=90.41  Aligned_cols=135  Identities=17%  Similarity=0.142  Sum_probs=97.7

Q ss_pred             eecccCCc-EEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEEEcccCCCH
Q 036815          741 LIGCGGFG-EVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       741 ~lG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      .+..|..| .||+.... ++..+++|.-..   .....+.+|+..++.+. +-.+.++++++.+++..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 69988765 456788886432   23456888999998884 44577888899999999999999999888


Q ss_pred             HHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 036815          818 EEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC-----------------------------------------  856 (1013)
Q Consensus       818 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------  856 (1013)
                      .+.....          ......+..++++.++.||+..                                         
T Consensus       108 ~~~~~~~----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          108 FQVLEEY----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             HHHHHHC----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             cccccCC----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            7765321          1122346667777777777421                                         


Q ss_pred             --------------CCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          857 --------------IPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       857 --------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                                    .+.++|+|+++.||+++.++.+-|+||+.+..
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                          12389999999999999877778999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.28  E-value=4.2e-06  Score=90.42  Aligned_cols=136  Identities=21%  Similarity=0.179  Sum_probs=92.9

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCc---ceeeeccEEE-eCCEEEEEEEcccC
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHR---NLVPLLGYCK-IGEERLLVYEFMKF  814 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  814 (1013)
                      .+.++.|....||+.    ++.+++|.-.  .......+.+|+++++.+.+.   .+.+.+.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888899988    5678888632  222346788999999999642   3556666664 34567899999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN---------------------------------------  855 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------  855 (1013)
                      .++.+....        .++......++.++++.|+.||+.                                       
T Consensus        98 ~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           98 QILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             EECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             eECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            888763211        023344444555555555555532                                       


Q ss_pred             ------------------CCCCeEecCCCcccEEeCC---CCc-EEEeeccccee
Q 036815          856 ------------------CIPHIIHRDMKSSNVLLDH---EME-ARVSDFGMARL  888 (1013)
Q Consensus       856 ------------------~~~~ivH~Dlkp~Nill~~---~~~-~kl~Dfg~a~~  888 (1013)
                                        ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                              2235799999999999987   455 48999998865

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.10  E-value=3.6e-06  Score=93.38  Aligned_cols=79  Identities=8%  Similarity=-0.020  Sum_probs=54.4

Q ss_pred             Cee-cccCCcEEEEEEEc-------CCCEEEEEEeeccC---ccchHHHHHHHHHHhccC-C--cceeeeccEEEeC---
Q 036815          740 SLI-GCGGFGEVFKATLK-------DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIK-H--RNLVPLLGYCKIG---  802 (1013)
Q Consensus       740 ~~l-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  802 (1013)
                      +.| +.|....+|+....       +++.+++|......   ......+.+|+.+++.+. +  -.+.+++.++.++   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            467 78888999998764       25678888653322   111245778999988884 2  3567788777654   


Q ss_pred             CEEEEEEEcccCCCHH
Q 036815          803 EERLLVYEFMKFGSLE  818 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~  818 (1013)
                      +..++||||++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999987654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.89  E-value=2.2e-06  Score=82.42  Aligned_cols=89  Identities=19%  Similarity=0.206  Sum_probs=44.9

Q ss_pred             cccEEECCCCCCCCCCCccccCCCCCCEEecCCCc-ccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEE
Q 036815          102 SLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNL-LAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK  180 (1013)
Q Consensus       102 ~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  180 (1013)
                      .|++||+++|.|++..-..+.++++|++|+|++|. |++..-..++.++                     ..+++|++|+
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~---------------------~~~~~L~~L~  120 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLE---------------------NLQKSMLEME  120 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCH---------------------HHHHHCCEEE
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcc---------------------cccCCCCEEE
Confidence            45555555555555444445555555555555552 4433333333321                     0123455555


Q ss_pred             CCCC-CCCCcCCccccCCCCCCEEEccCCC-CC
Q 036815          181 LPHN-NITGSFPVTLSSCSWLQLLDLSNNN-IS  211 (1013)
Q Consensus       181 L~~n-~l~~~~~~~l~~l~~L~~L~L~~N~-l~  211 (1013)
                      |++| +|++..-..+..+++|++|+++++. ++
T Consensus       121 Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~~It  153 (176)
T 3e4g_A          121 IISCGNVTDKGIIALHHFRNLKYLFLSDLPGVK  153 (176)
T ss_dssp             EESCTTCCHHHHHHGGGCTTCCEEEEESCTTCC
T ss_pred             cCCCCcCCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence            5554 2544433445667777777777763 44

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.87  E-value=6.2e-05  Score=82.83  Aligned_cols=144  Identities=18%  Similarity=0.291  Sum_probs=81.7

Q ss_pred             CeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCC--cceeeecc------EEEeCCEEEEEEEc
Q 036815          740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH--RNLVPLLG------YCKIGEERLLVYEF  811 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~  811 (1013)
                      +.|+.|..+.||++...++ .+++|+...    ....+..|+++++.+..  -.+.+++.      +...++..++||+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3456677899999987644 588887643    23445556666665531  12333332      22356778999999


Q ss_pred             ccCCCHH--------------HHhccccc-C--CC-----CccccHHH-------------------------------H
Q 036815          812 MKFGSLE--------------EVLHGRAK-A--RD-----QRILTWDA-------------------------------R  838 (1013)
Q Consensus       812 ~~~g~L~--------------~~l~~~~~-~--~~-----~~~l~~~~-------------------------------~  838 (1013)
                      ++|.++.              ..+|.... .  ..     ...-.|..                               .
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11221111 0  00     00112211                               1


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          839 KKIARGAAKGLCFLHH----------NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       839 ~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      ..+..++.+++++|++          ..+..++|||+++.||+++.++.+.++||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1122234446667763          1235899999999999998888899999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.85  E-value=4.6e-05  Score=85.77  Aligned_cols=75  Identities=16%  Similarity=0.031  Sum_probs=49.6

Q ss_pred             CCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-------cchHHHHHHHHHHhccCC--c-ceeeeccEEEeCCEEEE
Q 036815          739 ESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-------QGDREFMAEMETLGKIKH--R-NLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  807 (1013)
                      .+.+|.|.++.||+++.. +++.+++|.......       ....++..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999764 468899997643211       123456789999887742  3 34455543  4455689


Q ss_pred             EEEcccCC
Q 036815          808 VYEFMKFG  815 (1013)
Q Consensus       808 v~e~~~~g  815 (1013)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.81  E-value=3e-06  Score=81.52  Aligned_cols=87  Identities=15%  Similarity=0.125  Sum_probs=69.9

Q ss_pred             CCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCC-CCCCCCccccCC----CCCCEEecCCC-cccccCccccc
Q 036815           73 SDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNH-IMDVIPSSLSNC----TKLKILNLSFN-LLAGEIPRTFG  146 (1013)
Q Consensus        73 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~-i~~~~~~~l~~l----~~L~~L~L~~n-~l~~~~~~~~~  146 (1013)
                      -.+|++|||++|.++...  +. ....|++|++|+|++|. |++..-..++.+    ++|++|+|++| +|++..-..+.
T Consensus        60 ~~~L~~LDLs~~~Itd~G--L~-~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~  136 (176)
T 3e4g_A           60 KYKIQAIDATDSCIMSIG--FD-HMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALH  136 (176)
T ss_dssp             CCCEEEEEEESCCCCGGG--GG-GGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGG
T ss_pred             CceEeEEeCcCCCccHHH--HH-HhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHh
Confidence            357999999999987432  22 22579999999999994 888766667764    47999999998 48877777888


Q ss_pred             CCCCCCEeeCcCCc-cc
Q 036815          147 QLSSLQRLDLSNNH-IT  162 (1013)
Q Consensus       147 ~l~~L~~L~Ls~n~-l~  162 (1013)
                      ++++|++|++++|. ++
T Consensus       137 ~~~~L~~L~L~~c~~It  153 (176)
T 3e4g_A          137 HFRNLKYLFLSDLPGVK  153 (176)
T ss_dssp             GCTTCCEEEEESCTTCC
T ss_pred             cCCCCCEEECCCCCCCC
Confidence            99999999999985 55

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.72  E-value=0.00012  Score=78.18  Aligned_cols=78  Identities=21%  Similarity=0.201  Sum_probs=56.4

Q ss_pred             CCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCC---cceeeeccEEEeCCEEEEEEEcc
Q 036815          736 FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH---RNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       736 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ..-++.+|.|..+.||+.+..+|+.|++|+...........|..|++.|+.+.-   -.+.+++++  .  ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEee
Confidence            344567899999999999999999999997644444444568899999988842   234454443  2  246899999


Q ss_pred             cCCCH
Q 036815          813 KFGSL  817 (1013)
Q Consensus       813 ~~g~L  817 (1013)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.68  E-value=0.00023  Score=76.27  Aligned_cols=141  Identities=18%  Similarity=0.174  Sum_probs=91.9

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccC---CcceeeeccEEEeCCEEEEEEEcccCC
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK---HRNLVPLLGYCKIGEERLLVYEFMKFG  815 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  815 (1013)
                      .+.|+.|....+|+... +++.+++|....   .....+..|++.++.+.   ...+.+++.++...+..++||||++|.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            35789999999999986 477889987543   23566889999988883   367888888888888899999999987


Q ss_pred             CHH--------H---Hhccccc-CC-----C----------CccccHHHHH---HHH----------------HHHHHH-
Q 036815          816 SLE--------E---VLHGRAK-AR-----D----------QRILTWDARK---KIA----------------RGAAKG-  848 (1013)
Q Consensus       816 ~L~--------~---~l~~~~~-~~-----~----------~~~l~~~~~~---~i~----------------~~i~~~-  848 (1013)
                      .+.        +   .+|.... ..     +          ...-+|....   ++.                ..+++. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            642        1   2232211 00     0          0011343321   111                111111 


Q ss_pred             HHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          849 LCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       849 L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      ...|.. ...+.+||+|+.+.|++++.++ +.|+||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            123321 1246899999999999999887 8899984

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.55  E-value=1.2e-05  Score=78.95  Aligned_cols=14  Identities=36%  Similarity=0.653  Sum_probs=6.5

Q ss_pred             CCCCEEecCCCccc
Q 036815          125 TKLKILNLSFNLLA  138 (1013)
Q Consensus       125 ~~L~~L~L~~n~l~  138 (1013)
                      +.|++|+|++|.|+
T Consensus        98 ~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           98 PSLRVLNVESNFLT  111 (197)
T ss_dssp             SSCCEEECCSSBCC
T ss_pred             CccCeEecCCCcCC
Confidence            44444444444444

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.55  E-value=1.6e-05  Score=78.02  Aligned_cols=119  Identities=16%  Similarity=0.123  Sum_probs=72.1

Q ss_pred             cccCCCCCcEEeCCCC-ccCCCC---chhhhhCCCCccEEeCCCCcccCccC-CCCcCCCCCCcccEEECCCCCCCCCCC
Q 036815           44 LFSKLPNLVYLNASYN-NLTGFL---PETLLSNSDKLELLDLSYNNLTGSIS-GFSLNENSCNSLLHLDLSQNHIMDVIP  118 (1013)
Q Consensus        44 ~~~~l~~L~~L~L~~n-~i~~~~---~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~~~~~~~L~~L~Ls~n~i~~~~~  118 (1013)
                      ++.+-+.|++|+|++| .|.+..   -...+...+.|+.|+|++|+|++... .+...+...+.|++|+|++|.|++...
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            4455667888888875 776321   12334566778888888888874322 233333445678888888888876433


Q ss_pred             ----ccccCCCCCCEEecCCC---ccccc----CcccccCCCCCCEeeCcCCccc
Q 036815          119 ----SSLSNCTKLKILNLSFN---LLAGE----IPRTFGQLSSLQRLDLSNNHIT  162 (1013)
Q Consensus       119 ----~~l~~l~~L~~L~L~~n---~l~~~----~~~~~~~l~~L~~L~Ls~n~l~  162 (1013)
                          .++..-+.|++|+|++|   .+...    +..++..-++|+.|+++.|.+.
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence                34455566888888755   33322    2334445567777777766554

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.38  E-value=0.00054  Score=77.46  Aligned_cols=77  Identities=13%  Similarity=0.129  Sum_probs=48.1

Q ss_pred             CCCeEecCCCcccEEeCCCCcEEEeecccceeccccCcceeeeeecc--CCCccCcccccCC---CCCccchhHhHHHHH
Q 036815          857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAG--TPGYVPPEYYQSF---RCTAKGDVYSFGVVL  931 (1013)
Q Consensus       857 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~il  931 (1013)
                      ...++|||++|.||+++.++ ++++||+.+..-...   ........  ...|++|+.....   ......++.+....+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            34899999999999998876 999999988753211   00001111  1346666654311   112235566778888


Q ss_pred             HHHHcC
Q 036815          932 LELLTG  937 (1013)
Q Consensus       932 ~elltg  937 (1013)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            887765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.37  E-value=0.0011  Score=71.82  Aligned_cols=162  Identities=11%  Similarity=0.088  Sum_probs=89.1

Q ss_pred             cCHHHHHHHhcCCCCC-----CeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcc--eeeec
Q 036815          724 LKFSQLIEATNGFSAE-----SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN--LVPLL  796 (1013)
Q Consensus       724 ~~~~~~~~~~~~y~~~-----~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  796 (1013)
                      ++.+++.....+|.+.     +.|+.|....+|+....++ .+++|.....  .....+..|+.+++.+....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4445555555556653     3456788889999987655 6788876432  12345667888877663211  33333


Q ss_pred             c------EEEeCCEEEEEEEcccCCCHHH--------------Hhcccc-cCC-C----CccccHHHHHH----------
Q 036815          797 G------YCKIGEERLLVYEFMKFGSLEE--------------VLHGRA-KAR-D----QRILTWDARKK----------  840 (1013)
Q Consensus       797 ~------~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~-~~~-~----~~~l~~~~~~~----------  840 (1013)
                      .      +....+..+++++|++|..+..              .++... ... .    .....|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            2      1223467789999999865311              112110 000 0    01112322110          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          841 --IARGAAKGLCFLHHN----CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       841 --i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                        +...+.+.++++++.    .+.+++|+|+++.||+++.++.+.++||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011244455666532    134799999999999999876568999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.28  E-value=0.0037  Score=67.94  Aligned_cols=145  Identities=10%  Similarity=0.111  Sum_probs=83.0

Q ss_pred             CeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCc--ceeeeccE-----EEeCCEEEEEEEcc
Q 036815          740 SLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHR--NLVPLLGY-----CKIGEERLLVYEFM  812 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~  812 (1013)
                      ..++ |....||++...+|+.+++|..... ......+..|..+++.+...  .+++++..     ...++..++||+|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 8888999988777778999976432 22355677888888777421  23444432     23356778999999


Q ss_pred             cCCCHH-----HH---------hccccc---CCCCccccHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 036815          813 KFGSLE-----EV---------LHGRAK---ARDQRILTWDAR----KKI---------------ARGAAKGLCFLHHN-  855 (1013)
Q Consensus       813 ~~g~L~-----~~---------l~~~~~---~~~~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~-  855 (1013)
                      +|..+.     ..         +|....   .......++...    ..+               ...+.+.++.+.+. 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            975432     11         111110   000011222111    000               11111223333321 


Q ss_pred             ---CCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          856 ---CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       856 ---~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                         .+..++|||+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234689999999999999 4 899999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.06  E-value=0.004  Score=67.82  Aligned_cols=144  Identities=13%  Similarity=0.092  Sum_probs=73.7

Q ss_pred             CeecccCCcE-EEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCC--cceeeeccEEEeCCEEEEEEEcccCCC
Q 036815          740 SLIGCGGFGE-VFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH--RNLVPLLGYCKIGEERLLVYEFMKFGS  816 (1013)
Q Consensus       740 ~~lG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  816 (1013)
                      +.|+.|.... +|+....+++.+++|......   ...+..|+.+++.+..  -.+.+++.+..+.+  ++|||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3455554444 667765446777777543221   1234567777766632  23555665533333  68999998777


Q ss_pred             HHHHhccccc--------------------CCCCccccHHHHH--------------------HHHHHHHHHHHHHHh--
Q 036815          817 LEEVLHGRAK--------------------ARDQRILTWDARK--------------------KIARGAAKGLCFLHH--  854 (1013)
Q Consensus       817 L~~~l~~~~~--------------------~~~~~~l~~~~~~--------------------~i~~~i~~~L~~LH~--  854 (1013)
                      +.+++.....                    ......++.....                    .....+.+.++.+.+  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            7655432110                    0000001111000                    000111222233311  


Q ss_pred             -cCCCCeEecCCCcccEEeCCC----CcEEEeeccccee
Q 036815          855 -NCIPHIIHRDMKSSNVLLDHE----MEARVSDFGMARL  888 (1013)
Q Consensus       855 -~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~~  888 (1013)
                       .....++|||+++.||+++.+    +.+.++||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             123479999999999999875    6799999998865

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.01  E-value=0.0019  Score=69.26  Aligned_cols=141  Identities=13%  Similarity=0.058  Sum_probs=74.9

Q ss_pred             CCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcce-eeeccEEEeCCEEEEEEEcc-cCCC
Q 036815          739 ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNL-VPLLGYCKIGEERLLVYEFM-KFGS  816 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  816 (1013)
                      .+.|+.|....+|++     +.+++|........ .....+|+.+++.+....+ .+++++  +.+.-++|+||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678999999999998     56888865432111 1123568888777742222 455543  333346899999 6644


Q ss_pred             HHHH------------------hcccccCCCCccccHHHHHHHHH--------------HHHHHHH----HHHh-cCCCC
Q 036815          817 LEEV------------------LHGRAKARDQRILTWDARKKIAR--------------GAAKGLC----FLHH-NCIPH  859 (1013)
Q Consensus       817 L~~~------------------l~~~~~~~~~~~l~~~~~~~i~~--------------~i~~~L~----~LH~-~~~~~  859 (1013)
                      +...                  +|..........-.+.....+..              .+.+.+.    .+.. ..+..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4321                  11111000000000111111111              0111111    1111 12345


Q ss_pred             eEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          860 IIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       860 ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      ++|+|+.+.||+ ..++.+.++||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5666789999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.00  E-value=0.0018  Score=71.37  Aligned_cols=143  Identities=15%  Similarity=0.143  Sum_probs=82.9

Q ss_pred             CeecccCCcEEEEEEEc--------CCCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEEE
Q 036815          740 SLIGCGGFGEVFKATLK--------DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +.+..|-...+|++...        +++.+++|+.-. .......+.+|.++++.+. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56777888899999864        247888887422 2223456778999998884 3333566665543    28999


Q ss_pred             cccCCCHHH--------------H---hcccccCCCCccc--cHHHHHHHHHHHHH-------------------HHHHH
Q 036815          811 FMKFGSLEE--------------V---LHGRAKARDQRIL--TWDARKKIARGAAK-------------------GLCFL  852 (1013)
Q Consensus       811 ~~~~g~L~~--------------~---l~~~~~~~~~~~l--~~~~~~~i~~~i~~-------------------~L~~L  852 (1013)
                      |++|.++..              .   +|..... ..+..  -+.++.++..++..                   .+..|
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~-~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMP-FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCS-SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCC-CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            999855431              0   1111110 11111  24455555443322                   23333


Q ss_pred             Hh----c-CCCCeEecCCCcccEEeCCC----CcEEEeeccccee
Q 036815          853 HH----N-CIPHIIHRDMKSSNVLLDHE----MEARVSDFGMARL  888 (1013)
Q Consensus       853 H~----~-~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~~  888 (1013)
                      .+    . .+..++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            22    1 12469999999999999876    7899999998864

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.92  E-value=0.00094  Score=61.18  Aligned_cols=55  Identities=22%  Similarity=0.308  Sum_probs=33.6

Q ss_pred             eecccCCccc--ccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccC
Q 036815            4 VLKLSSNLFT--LNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLT   62 (1013)
Q Consensus         4 ~L~l~~n~~~--~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~   62 (1013)
                      .+|.+++.++  .+|..   ++.++++|+|++|+|+. ++.++|..+++|++|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~---lp~~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTA---FPVDTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSC---CCTTCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCC---CCcCCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCee
Confidence            4566666666  66643   55556666666666644 56666666666666666666543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.61  E-value=0.0077  Score=67.88  Aligned_cols=72  Identities=18%  Similarity=0.188  Sum_probs=48.5

Q ss_pred             CeecccCCcEEEEEEEcC--------CCEEEEEEeeccCccchHHHHHHHHHHhccCCcc-eeeeccEEEeCCEEEEEEE
Q 036815          740 SLIGCGGFGEVFKATLKD--------GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN-LVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  810 (1013)
                      +.|+.|....||++...+        ++.+++|+....  .....+..|..+++.+...+ ..++++.+.  +  .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence            567888899999998753        478888876321  12255668999988884333 356666543  2  28999


Q ss_pred             cccCCCH
Q 036815          811 FMKFGSL  817 (1013)
Q Consensus       811 ~~~~g~L  817 (1013)
                      |++|.++
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9987443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.51  E-value=0.004  Score=56.97  Aligned_cols=54  Identities=24%  Similarity=0.279  Sum_probs=28.3

Q ss_pred             EEeCCCCccc--CccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcc
Q 036815           78 LLDLSYNNLT--GSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLL  137 (1013)
Q Consensus        78 ~L~Ls~n~l~--~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l  137 (1013)
                      .++.++++++  .++..++      ++|++|+|++|+|+.+.+..|..+++|++|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp------~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP------VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC------TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC------cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            4555555554  3333222      3455555555555555555555555555555555544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.36  E-value=0.02  Score=62.29  Aligned_cols=31  Identities=26%  Similarity=0.383  Sum_probs=27.9

Q ss_pred             CCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       858 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999988765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.32  E-value=0.0097  Score=67.32  Aligned_cols=73  Identities=14%  Similarity=0.026  Sum_probs=45.8

Q ss_pred             CeecccCCcEEEEEEEcC-CCEEEEEEeeccCccchHHHHHHHHHHhccCCcce-eeeccEEEeCCEEEEEEEcccCCCH
Q 036815          740 SLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNL-VPLLGYCKIGEERLLVYEFMKFGSL  817 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  817 (1013)
                      +.|+.|-...+|++...+ ++.+++|+..... ...-...+|..+++.+...++ .++++++.  +  ..||||++|.++
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            567888889999998764 4678888653221 111112578888888854444 56666652  2  259999997544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.24  E-value=0.0042  Score=68.76  Aligned_cols=73  Identities=16%  Similarity=0.131  Sum_probs=42.5

Q ss_pred             CeecccCCcEEEEEEEcC---------CCEEEEEEeeccCccchHHHHHHHHHHhccCCcc-eeeeccEEEeCCEEEEEE
Q 036815          740 SLIGCGGFGEVFKATLKD---------GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN-LVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  809 (1013)
                      +.++.|....+|++...+         ++.+++|...... ........|.++++.+.... +.++++.+  .+  ++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            456778888999998753         2688888653321 11112357888888774333 44565443  22  6899


Q ss_pred             EcccCCCH
Q 036815          810 EFMKFGSL  817 (1013)
Q Consensus       810 e~~~~g~L  817 (1013)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99997543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.86  E-value=0.075  Score=59.20  Aligned_cols=144  Identities=13%  Similarity=0.119  Sum_probs=83.0

Q ss_pred             CCeecccCCcEEEEEEEcC--------CCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEE
Q 036815          739 ESLIGCGGFGEVFKATLKD--------GSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      .+.+..|-...+|+....+        ++.+++++..... ...-...+|..+++.+. +.-..++++.+  .+  +.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence            3467778889999998763        5788888753321 11112357888888774 32344555433  22  6899


Q ss_pred             EcccCCCHHH-----------------Hhccccc-----CC--CCccccHHHHHHHHHHH-------------------H
Q 036815          810 EFMKFGSLEE-----------------VLHGRAK-----AR--DQRILTWDARKKIARGA-------------------A  846 (1013)
Q Consensus       810 e~~~~g~L~~-----------------~l~~~~~-----~~--~~~~l~~~~~~~i~~~i-------------------~  846 (1013)
                      ||++|.++..                 .+|....     ..  ...+-.+.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999865321                 0111111     00  11111234333333222                   2


Q ss_pred             HHHHHHHh---------------------cCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          847 KGLCFLHH---------------------NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       847 ~~L~~LH~---------------------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      ..+.+|.+                     ..+..++|+|+.+.||+ +.++.+.++||..|..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     11236899999999999 7788999999999864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=91.54  E-value=0.62  Score=45.76  Aligned_cols=103  Identities=16%  Similarity=0.128  Sum_probs=67.0

Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      -+|.++|..+.     .+++++++|.++.|.+.+|.-.-.+.  .-..+=+.|..|++..+|.+...+ +.+.       
T Consensus        33 vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           33 LSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             ccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-------
Confidence            47899997654     45999999999999999987762210  111223457999999999987764 1110       


Q ss_pred             ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 036815          895 HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRP  940 (1013)
Q Consensus       895 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  940 (1013)
                             .....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus        98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                   1122466888763 3456788999999999999985444

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=90.33  E-value=0.48  Score=52.55  Aligned_cols=30  Identities=23%  Similarity=0.401  Sum_probs=25.3

Q ss_pred             CeEecCCCcccEEe------CCCCcEEEeeccccee
Q 036815          859 HIIHRDMKSSNVLL------DHEMEARVSDFGMARL  888 (1013)
Q Consensus       859 ~ivH~Dlkp~Nill------~~~~~~kl~Dfg~a~~  888 (1013)
                      .++|+|+.+.||++      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4457799999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.48  E-value=1.9  Score=42.30  Aligned_cols=115  Identities=5%  Similarity=0.091  Sum_probs=78.1

Q ss_pred             CCcceeeeccEEEeCCEEEEEEEcccC-CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 036815          788 KHRNLVPLLGYCKIGEERLLVYEFMKF-GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMK  866 (1013)
Q Consensus       788 ~h~niv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  866 (1013)
                      .||++++. .+..+++...+.++.-+. -+... +         +..+...+++++.+|+....+++.+     +|--++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~  106 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLA  106 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEe
Confidence            68888866 455666776666664431 22222 2         2378889999999999988666654     788999


Q ss_pred             cccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 036815          867 SSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTD  942 (1013)
Q Consensus       867 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~  942 (1013)
                      |+|++++.++.+++.-.|+-..+                   +|.     ..+...=.-.+=|++..+++++..|+
T Consensus       107 P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          107 PDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999999877753221                   222     11112223346788899999988875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1013
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-57
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-51
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-46
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-31
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-30
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-28
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-08
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-29
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-27
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-17
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-13
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-13
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-11
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.004
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-10
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-10
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-10
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-10
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-10
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	9e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-09
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-08
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-08
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-08
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	5e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.004
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-06
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	5e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 7e-65
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 31/281 (11%)

Query: 736  FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
             +    IG G FG V+K       +V +  +   + Q  + F  E+  L K +H N++  
Sbjct: 10   ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 796  LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
            +GY     +  +V ++ +  SL   LH       +          IAR  A+G+ +LH  
Sbjct: 70   MGYS-TAPQLAIVTQWCEGSSLYHHLHII-----ETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 856  CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
             I   IHRD+KS+N+ L  ++  ++ DFG+A + S          L+G+  ++ PE  + 
Sbjct: 124  SI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 916  FRC---TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL 972
                  + + DVY+FG+VL EL+TG+ P     + + N    +   V  G     +    
Sbjct: 181  QDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRGYLSPDLSK-- 233

Query: 973  LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                     +  + +K ++       +C+     +RP   Q
Sbjct: 234  ------VRSNCPKAMKRLMA------ECLKKKRDERPLFPQ 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 2e-59
 Identities = 65/273 (23%), Positives = 119/273 (43%), Gaps = 33/273 (12%)

Query: 741  LIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
             +G G FGEV+       + VA+K  ++        F+AE   + +++H+ LV L     
Sbjct: 20   RLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77

Query: 801  IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
              E   ++ E+M+ GSL + L   +  +    LT +    +A   A+G+ F+      + 
Sbjct: 78   TQEPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEER---NY 130

Query: 861  IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTA 920
            IHRD++++N+L+   +  +++DFG+ARLI   + + +         +  PE       T 
Sbjct: 131  IHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 921  KGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTD 980
            K DV+SFG++L E++T  R               V   +  G +M               
Sbjct: 190  KSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERGYRMVR------------P 232

Query: 981  ESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            ++  EE+ +++R       C  + P  RP    
Sbjct: 233  DNCPEELYQLMR------LCWKERPEDRPTFDY 259

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 3e-57
 Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 33/272 (12%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
            IG G FG V      +   VAIK  IR     + +F+ E E + K+ H  LV L G C  
Sbjct: 13   IGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71

Query: 802  GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
                 LV+EFM+ G L + L        + +   +    +     +G   + +     +I
Sbjct: 72   QAPICLVFEFMEHGCLSDYLR-----TQRGLFAAETLLGMCLDVCEG---MAYLEEACVI 123

Query: 862  HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAK 921
            HRD+ + N L+      +VSDFGM R +       S  T      +  PE +   R ++K
Sbjct: 124  HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSK 182

Query: 922  GDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDE 981
             DV+SFGV++ E+ +  +        +      V   +  G ++    P L         
Sbjct: 183  SDVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFRLY--KPRLA-------- 227

Query: 982  SEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
              +  V +++        C  + P  RP   +
Sbjct: 228  --STHVYQIMN------HCWKERPEDRPAFSR 251

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 6e-57
 Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 19/281 (6%)

Query: 732  ATNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKH 789
              + F   S +G G  G VFK + K  G  +A K +        R   + E++ L +   
Sbjct: 4    KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 790  RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
              +V   G      E  +  E M  GSL++VL    +      +      K++    KGL
Sbjct: 64   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGL 117

Query: 850  CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
             +L       I+HRD+K SN+L++   E ++ DFG++  +     +    +  GT  Y+ 
Sbjct: 118  TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMS 171

Query: 910  PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
            PE  Q    + + D++S G+ L+E+  G+ P         +      M   + +      
Sbjct: 172  PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP-----IPPPDAKELELMFGCQVEGDAAET 226

Query: 970  PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010
            P           S   + +  +   E+    V++ P K P+
Sbjct: 227  PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 4e-56
 Identities = 61/292 (20%), Positives = 111/292 (38%), Gaps = 29/292 (9%)

Query: 739  ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
            +  IG G FGEV++   + G  VA+K       +      AE+     ++H N++  +  
Sbjct: 8    QESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 799  C----KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
                     +  LV ++ + GSL + L+       +  +T +   K+A   A GL  LH 
Sbjct: 66   DNKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHM 118

Query: 855  NCI-----PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV--STLAGTPGY 907
              +     P I HRD+KS N+L+       ++D G+A    +    + +  +   GT  Y
Sbjct: 119  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 908  VPPEYYQS------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE 961
            + PE          F    + D+Y+ G+V  E+          +         V      
Sbjct: 179  MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 962  GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
             +  +V+  + L           E ++ M    +I  +C     + R   L+
Sbjct: 239  EEMRKVVCEQKLRPNIPNRWQSCEALRVMA---KIMRECWYANGAARLTALR 287

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-56
 Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 33/272 (12%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI 801
            +G G FG V     +    VAIK  I+     + EF+ E + +  + H  LV L G C  
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70

Query: 802  GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHII 861
                 ++ E+M  G L   L        +         ++ +   + + +L        +
Sbjct: 71   QRPIFIITEYMANGCLLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLESK---QFL 122

Query: 862  HRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAK 921
            HRD+ + N L++ +   +VSDFG++R +   +   SV +      + PPE     + ++K
Sbjct: 123  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLMYSKFSSK 181

Query: 922  GDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDE 981
             D+++FGV++ E+ +  +   +               + +G ++    P L         
Sbjct: 182  SDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQGLRLY--RPHLA-------- 226

Query: 982  SEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
              +E+V  ++        C  +   +RP    
Sbjct: 227  --SEKVYTIM------YSCWHEKADERPTFKI 250

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (490), Expect = 1e-55
 Identities = 72/306 (23%), Positives = 127/306 (41%), Gaps = 50/306 (16%)

Query: 726  FSQLIEATNGFSAE---------SLIGCGGFGEVFKATLKDGSS----VAIKKLIR-LSC 771
            F    EA   F+ E          +IG G FGEV    LK        VAIK L    + 
Sbjct: 9    FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 772  QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQR 831
            +  R+F++E   +G+  H N++ L G        +++ EFM+ GSL+  L          
Sbjct: 69   KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--- 125

Query: 832  ILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI-- 889
              T      + RG A G+ +L        +HRD+ + N+L++  +  +VSDFG++R +  
Sbjct: 126  --TVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 890  -SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFG 947
             ++  T+ S         +  PE  Q  + T+  DV+S+G+V+ E+++ G+RP     + 
Sbjct: 181  DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-----YW 235

Query: 948  DTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSK 1007
            D      +   + +  ++                     + +++      L C     + 
Sbjct: 236  DMTNQDVIN-AIEQDYRLPP------------PMDCPSALHQLM------LDCWQKDRNH 276

Query: 1008 RPNMLQ 1013
            RP   Q
Sbjct: 277  RPKFGQ 282

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-55
 Identities = 66/278 (23%), Positives = 123/278 (44%), Gaps = 39/278 (14%)

Query: 742  IGCGGFGEVFKATLK---DGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPLLG 797
            +GCG FG V +   +       VAIK L + + + D E  M E + + ++ +  +V L+G
Sbjct: 17   LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 798  YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             C+  E  +LV E    G L + L G+     +  +      ++    + G+ +L     
Sbjct: 77   VCQ-AEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEEK-- 128

Query: 858  PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV-STLAGTPGYVPPEYYQSF 916
             + +HRD+ + NVLL +   A++SDFG+++ + A D++ +  S       +  PE     
Sbjct: 129  -NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187

Query: 917  RCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV 975
            + +++ DV+S+GV + E L+ G++P  K    +      V   + +GK+ME         
Sbjct: 188  KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMEC-------- 233

Query: 976  TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                      E+  ++        C       RP+ L 
Sbjct: 234  ----PPECPPELYALMS------DCWIYKWEDRPDFLT 261

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 3e-55
 Identities = 70/278 (25%), Positives = 113/278 (40%), Gaps = 33/278 (11%)

Query: 736  FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
               E  +G G FGEV+  T    + VAIK  ++        F+ E + + K++H  LV L
Sbjct: 19   LRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 796  LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
                   E   +V E+M  GSL + L G       + L       +A   A G+ ++   
Sbjct: 78   YAVVSE-EPIYIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 856  CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                 +HRD++++N+L+   +  +V+DFG+ARLI   + + +         +  PE    
Sbjct: 133  NY---VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALY 188

Query: 916  FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV 975
             R T K DV+SFG++L EL T  R               V  +V  G +M          
Sbjct: 189  GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVERGYRMPC-------- 235

Query: 976  TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                     E + +++       QC    P +RP    
Sbjct: 236  ----PPECPESLHDLMC------QCWRKEPEERPTFEY 263

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (485), Expect = 6e-55
 Identities = 74/314 (23%), Positives = 125/314 (39%), Gaps = 51/314 (16%)

Query: 725  KFSQLIEATNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQGDR-EF 777
            K   L    N       IG G FG VF+A           + VA+K L   +    + +F
Sbjct: 4    KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 778  MAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAK----------- 826
              E   + +  + N+V LLG C +G+   L++E+M +G L E L   +            
Sbjct: 64   QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 827  -------ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEAR 879
                   +     L+   +  IAR  A G+ +L        +HRD+ + N L+   M  +
Sbjct: 124  STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVK 180

Query: 880  VSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKR 939
            ++DFG++R I + D + +    A    ++PPE     R T + DV+++GVVL E+ +   
Sbjct: 181  IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 940  PTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQ 999
                    +      V   VR+G  +               E+   E+  ++R       
Sbjct: 241  QPYYGMAHE-----EVIYYVRDGNILAC------------PENCPLELYNLMR------L 277

Query: 1000 CVDDFPSKRPNMLQ 1013
            C    P+ RP+   
Sbjct: 278  CWSKLPADRPSFCS 291

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 4e-54
 Identities = 68/303 (22%), Positives = 121/303 (39%), Gaps = 50/303 (16%)

Query: 736  FSAESLIGCGGFGEVFKATLKDGSS------VAIKKLIRLSCQGDRE-FMAEMETLGKI- 787
                 ++G G FG+V  AT    S       VA+K L   +   +RE  M+E++ + ++ 
Sbjct: 39   LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 788  KHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR-----------------AKARDQ 830
             H N+V LLG C +     L++E+  +G L   L  +                  +  D 
Sbjct: 99   SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 831  RILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
             +LT++     A   AKG+ FL        +HRD+ + NVL+ H    ++ DFG+AR I 
Sbjct: 159  NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 891  ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN 950
            +   ++          ++ PE       T K DV+S+G++L E+ +         +    
Sbjct: 216  SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----YPGIP 271

Query: 951  LVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPN 1010
            +       ++ G +M+                  EE+  +++       C      KRP+
Sbjct: 272  VDANFYKLIQNGFKMDQ------------PFYATEEIYIIMQ------SCWAFDSRKRPS 313

Query: 1011 MLQ 1013
               
Sbjct: 314  FPN 316

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 8e-54
 Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 39/279 (13%)

Query: 736  FSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPL 795
                  IG G FG+V     + G+ VA+K +   +    + F+AE   + +++H NLV L
Sbjct: 9    LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 65

Query: 796  LGYCKIGEERL-LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
            LG     +  L +V E+M  GSL + L  R +     +L  D   K +    + + +L  
Sbjct: 66   LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 855  NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
            N   + +HRD+ + NVL+  +  A+VSDFG+ +  S+        T      +  PE  +
Sbjct: 122  N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALR 173

Query: 915  SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL 974
              + + K DV+SFG++L E+ +  R      +    L   V  +V +G +M+        
Sbjct: 174  EKKFSTKSDVWSFGILLWEIYSFGRVP----YPRIPLK-DVVPRVEKGYKMDA------- 221

Query: 975  VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                  +     V E+++       C     + RP+ LQ
Sbjct: 222  -----PDGCPPAVYEVMK------NCWHLDAAMRPSFLQ 249

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 42/283 (14%)

Query: 739  ESLIGCGGFGEVFKATLKD-GSSVAIKKLI--RLSCQGDREFMAEMETLGKIKHRNLVPL 795
            +  IG G F  V+K    +    VA  +L   +L+    + F  E E L  ++H N+V  
Sbjct: 14   DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 796  LGYC----KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
                    K  +  +LV E M  G+L+  L         +++     +   R   KGL F
Sbjct: 74   YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQF 127

Query: 852  LHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            LH    P IIHRD+K  N+ +       ++ D G+A L  A         + GTP ++ P
Sbjct: 128  LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAP 182

Query: 911  EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP 970
            E Y+  +     DVY+FG+ +LE+ T + P     + +      +  +V  G +    D 
Sbjct: 183  EMYEE-KYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDK 236

Query: 971  ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
              +            EVKE++        C+     +R ++  
Sbjct: 237  VAI-----------PEVKEIIE------GCIRQNKDERYSIKD 262

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-53
 Identities = 62/278 (22%), Positives = 117/278 (42%), Gaps = 38/278 (13%)

Query: 742  IGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCK 800
            +G G FG+V+KA  K+     A K +   S +   ++M E++ L    H N+V LL    
Sbjct: 20   LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 801  IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHI 860
                  ++ EF   G+++ V+        +R LT    + + +     L +LH N    I
Sbjct: 80   YENNLWILIEFCAGGAVDAVML-----ELERPLTESQIQVVCKQTLDALNYLHDN---KI 131

Query: 861  IHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC-- 918
            IHRD+K+ N+L   + + +++DFG++   +         +  GTP ++ PE         
Sbjct: 132  IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKD 189

Query: 919  ---TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV 975
                 K DV+S G+ L+E+   + P       + N +  V +K+ + +   +  P     
Sbjct: 190  RPYDYKADVWSLGITLIEMAEIEPP-----HHELNPMR-VLLKIAKSEPPTLAQPSRW-- 241

Query: 976  TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                    +   K+ ++      +C++     R    Q
Sbjct: 242  --------SSNFKDFLK------KCLEKNVDARWTTSQ 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-53
 Identities = 71/281 (25%), Positives = 118/281 (41%), Gaps = 39/281 (13%)

Query: 741  LIGCGGFGEVFKATLKDGSS----VAIKKLIRLSCQGD-REFMAEMETLGKIKHRNLVPL 795
            +IG G FG V+  TL D        A+K L R++  G+  +F+ E   +    H N++ L
Sbjct: 34   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 796  LGYCKIGEER-LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
            LG C   E   L+V  +MK G L   +            T           AKG+     
Sbjct: 94   LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGM---KF 145

Query: 855  NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI--SALDTHLSVSTLAGTPGYVPPEY 912
                  +HRD+ + N +LD +   +V+DFG+AR +     D+  + +       ++  E 
Sbjct: 146  LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 913  YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL 972
             Q+ + T K DV+SFGV+L EL+T   P     + D N        + +G+++    PE 
Sbjct: 206  LQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITV-YLLQGRRLL--QPEY 258

Query: 973  LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                        + + E++      L+C       RP+  +
Sbjct: 259  C----------PDPLYEVM------LKCWHPKAEMRPSFSE 283

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-53
 Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 45/293 (15%)

Query: 741  LIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIK-HRNL 792
             +G G FG+V +AT           +VA+K L   +   +RE  M+E++ L  +  H N+
Sbjct: 30   TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 793  VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKA------------RDQRILTWDARKK 840
            V LLG C IG   L++ E+  +G L   L  +  +             D+  L  +    
Sbjct: 90   VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
             +   AKG+ FL      + IHRD+ + N+LL H    ++ DFG+AR I     ++    
Sbjct: 150  FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
                  ++ PE   +   T + DV+S+G+ L EL +         +    +       ++
Sbjct: 207  ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----PYPGMPVDSKFYKMIK 262

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            EG +M               E    E+ ++++       C D  P KRP   Q
Sbjct: 263  EGFRMLS------------PEHAPAEMYDIMK------TCWDADPLKRPTFKQ 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 7e-53
 Identities = 59/282 (20%), Positives = 116/282 (41%), Gaps = 41/282 (14%)

Query: 739  ESLIGCGGFGEVFKATLKDGSS---VAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLV 793
            +  +G G FG V K   +       VA+K L   +       E +AE   + ++ +  +V
Sbjct: 12   DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 794  PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
             ++G C+  E  +LV E  + G L + L         R +      ++    + G+ +L 
Sbjct: 72   RMIGICEA-ESWMLVMEMAELGPLNKYLQ------QNRHVKDKNIIELVHQVSMGMKYLE 124

Query: 854  HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGTPGYVPPEY 912
             +   + +HRD+ + NVLL  +  A++SDFG+++ + A + +    T       +  PE 
Sbjct: 125  ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 913  YQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE 971
               ++ ++K DV+SFGV++ E  + G++P       +      V   + +G++M      
Sbjct: 182  INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGC---- 231

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                          E+ +++        C       RP    
Sbjct: 232  --------PAGCPREMYDLMN------LCWTYDVENRPGFAA 259

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-52
 Identities = 63/280 (22%), Positives = 114/280 (40%), Gaps = 35/280 (12%)

Query: 741  LIGCGGFGEVFKATLK-DGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
             IG G +G   K   K DG  +  K+L    ++    +  ++E+  L ++KH N+V    
Sbjct: 11   TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 798  YCKIGEERLL--VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH-- 853
                     L  V E+ + G L  V+    K R  + L  +   ++       L   H  
Sbjct: 71   RIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMTQLTLALKECHRR 128

Query: 854  HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
             +    ++HRD+K +NV LD +   ++ DFG+AR+++   +        GTP Y+ PE  
Sbjct: 129  SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQM 186

Query: 914  QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL 973
                   K D++S G +L EL     P       +      +  K+REGK   +      
Sbjct: 187  NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKFRRI------ 234

Query: 974  LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                      ++E+ E++       + ++     RP++ +
Sbjct: 235  ------PYRYSDELNEIIT------RMLNLKDYHRPSVEE 262

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (465), Expect = 3e-52
 Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 45/285 (15%)

Query: 736  FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
            FS    IG G FG V+ A  +++   VAIKK+     Q +   ++ + E+  L K++H N
Sbjct: 17   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 792  LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
             +   G         LV E+    + + +   +      + L       +  GA +GL +
Sbjct: 77   TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAY 130

Query: 852  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
            LH +   ++IHRD+K+ N+LL      ++ DFG A +++        ++  GTP ++ PE
Sbjct: 131  LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPE 181

Query: 912  YYQSF---RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI 968
               +    +   K DV+S G+  +EL   K P       + N +  +   + + +   + 
Sbjct: 182  VILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSAL-YHIAQNESPALQ 235

Query: 969  DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                           +E  +  V        C+   P  RP    
Sbjct: 236  SGHW-----------SEYFRNFVD------SCLQKIPQDRPTSEV 263

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 6e-52
 Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 34/281 (12%)

Query: 736  FSAESLIGCGGFGEVFKATLK-DGSSVAIKKL-IRLSCQGDREFMAEMETLGKIKHRNLV 793
            +     +G G +GEV  A  +    +VA+K + ++ +         E+     + H N+V
Sbjct: 7    WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 794  PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
               G+ + G  + L  E+   G L + +           +     ++       G+ +LH
Sbjct: 67   KFYGHRREGNIQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLH 120

Query: 854  HNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYY 913
                  I HRD+K  N+LLD     ++SDFG+A +    +    ++ + GT  YV PE  
Sbjct: 121  GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 914  QSFR-CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL 972
            +         DV+S G+VL  +L G+ P D+          W + K       ++     
Sbjct: 178  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----- 232

Query: 973  LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                             ++       + + + PS R  +  
Sbjct: 233  -----------DSAPLALLH------KILVENPSARITIPD 256

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-51
 Identities = 63/274 (22%), Positives = 119/274 (43%), Gaps = 35/274 (12%)

Query: 741  LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
             IG G  G V+ A  +  G  VAI+++           + E+  + + K+ N+V  L   
Sbjct: 27   KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
             +G+E  +V E++  GSL +V+        +  +       + R   + L FLH N    
Sbjct: 87   LVGDELWVVMEYLAGGSLTDVVT-------ETCMDEGQIAAVCRECLQALEFLHSN---Q 136

Query: 860  IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCT 919
            +IHRD+KS N+LL  +   +++DFG    I+   +    ST+ GTP ++ PE        
Sbjct: 137  VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYG 194

Query: 920  AKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGT 979
             K D++S G++ +E++ G+ P     + + N +  + +    G        +L       
Sbjct: 195  PKVDIWSLGIMAIEMIEGEPP-----YLNENPLRALYLIATNGTPELQNPEKL------- 242

Query: 980  DESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                +   ++ +       +C+D    KR +  +
Sbjct: 243  ----SAIFRDFLN------RCLDMDVEKRGSAKE 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-51
 Identities = 62/285 (21%), Positives = 122/285 (42%), Gaps = 38/285 (13%)

Query: 736  FSAESLIGCGGFGEVFKATLKDGSS-----VAIKKLIRLSCQGDR-EFMAEMETLGKIKH 789
             + + +IG G FGEV+K  LK  S      VAIK L     +  R +F+ E   +G+  H
Sbjct: 9    VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 790  RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
             N++ L G     +  +++ E+M+ G+L++ L  +         +      + RG A G+
Sbjct: 69   HNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-----DGEFSVLQLVGMLRGIAAGM 123

Query: 850  CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGTPGYV 908
                +    + +HRD+ + N+L++  +  +VSDFG++R++         ++       + 
Sbjct: 124  ---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 909  PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI 968
             PE     + T+  DV+SFG+V+ E++T       +          V   + +G ++   
Sbjct: 181  APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKAINDGFRLP-- 233

Query: 969  DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                      T       + +++      +QC     ++RP    
Sbjct: 234  ----------TPMDCPSAIYQLM------MQCWQQERARRPKFAD 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 2e-51
 Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 44/295 (14%)

Query: 734  NGFSAESLIGCGGFGEVFKATLKDGSS---VAIKKLIRLSCQGD-REFMAEMETLGKI-K 788
            N    + +IG G FG+V KA +K        AIK++   + + D R+F  E+E L K+  
Sbjct: 10   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 789  HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAK----------ARDQRILTWDAR 838
            H N++ LLG C+      L  E+   G+L + L                     L+    
Sbjct: 70   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 839  KKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSV 898
               A   A+G+    +      IHRD+ + N+L+     A+++DFG++R     + ++  
Sbjct: 130  LHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183

Query: 899  STLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK 958
            +       ++  E       T   DV+S+GV+L E+++         +         + K
Sbjct: 184  TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYE-K 238

Query: 959  VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            + +G ++E               +  +EV +++R      QC  + P +RP+  Q
Sbjct: 239  LPQGYRLEK------------PLNCDDEVYDLMR------QCWREKPYERPSFAQ 275

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-51
 Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 42/282 (14%)

Query: 736  FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGD---REFMAEMETLGKIKHRN 791
            F     +G G FG V+ A  K     +A+K L +   +      +   E+E    ++H N
Sbjct: 8    FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 792  LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            ++ L GY        L+ E+   G++   L                        A  L +
Sbjct: 68   ILRLYGYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITELANALSY 121

Query: 852  LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
             H      +IHRD+K  N+LL    E +++DFG +    +        TL GT  Y+PPE
Sbjct: 122  CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPE 174

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE 971
              +      K D++S GV+  E L GK P + + + +T          +   ++E   P+
Sbjct: 175  MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---------YKRISRVEFTFPD 225

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
             +           E  ++++       + +   PS+RP + +
Sbjct: 226  FV----------TEGARDLIS------RLLKHNPSQRPMLRE 251

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (454), Expect = 6e-51
 Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 33/279 (11%)

Query: 736  FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
             + +  +G G +GEV++   K    +VA+K  ++       EF+ E   + +IKH NLV 
Sbjct: 19   ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 795  LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
            LLG C       ++ EFM +G+L + L       +++ ++      +A   +  + +L  
Sbjct: 78   LLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 855  NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
                + IHRD+ + N L+      +V+DFG++RL++  DT+ + +       +  PE   
Sbjct: 134  K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLA 189

Query: 915  SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLL 974
              + + K DV++FGV+L E+ T         +   +L   V   + +  +ME        
Sbjct: 190  YNKFSIKSDVWAFGVLLWEIATYGMSP----YPGIDL-SQVYELLEKDYRMER------- 237

Query: 975  VTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                  E   E+V E++R       C    PS RP+  +
Sbjct: 238  -----PEGCPEKVYELMR------ACWQWNPSDRPSFAE 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-49
 Identities = 67/289 (23%), Positives = 115/289 (39%), Gaps = 37/289 (12%)

Query: 736  FSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQGDR-EFMAEMETLGKIK 788
             +    +G G FG V++   K        + VAIK +   +   +R EF+ E   + +  
Sbjct: 22   ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 789  HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRI----LTWDARKKIARG 844
              ++V LLG    G+  L++ E M  G L+  L     A          +     ++A  
Sbjct: 82   CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 845  AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
             A G+ +L+ N     +HRD+ + N ++  +   ++ DFGM R I   D +         
Sbjct: 142  IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 905  PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ 964
              ++ PE  +    T   DV+SFGVVL E+ T      +    +      V   V EG  
Sbjct: 199  VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----QVLRFVMEGGL 253

Query: 965  MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            ++  D            +  + + E++R       C    P  RP+ L+
Sbjct: 254  LDKPD------------NCPDMLFELMR------MCWQYNPKMRPSFLE 284

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-48
 Identities = 58/295 (19%), Positives = 118/295 (40%), Gaps = 41/295 (13%)

Query: 726  FSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSS-----VAIKKLIRLSC-QGDREFMA 779
              ++++ T  F    ++G G FG V+K             VAIK+L   +  + ++E + 
Sbjct: 2    LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60

Query: 780  EMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARK 839
            E   +  + + ++  LLG C +     L+ + M FG L + +        +  +      
Sbjct: 61   EAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-----KDNIGSQYLL 114

Query: 840  KIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVS 899
                  AKG+ +L       ++HRD+ + NVL+      +++DFG+A+L+ A +      
Sbjct: 115  NWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171

Query: 900  TLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMK 958
                   ++  E       T + DV+S+GV + EL+T G +P D     +      +   
Sbjct: 172  GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSI 225

Query: 959  VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            + +G+++                    +V  ++      ++C       RP   +
Sbjct: 226  LEKGERLPQ------------PPICTIDVYMIM------VKCWMIDADSRPKFRE 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 4e-48
 Identities = 60/280 (21%), Positives = 107/280 (38%), Gaps = 39/280 (13%)

Query: 742  IGCGGFGEVFKATLK----DGSSVAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVP 794
            +G G FG V +           SVA+K L   +    +   +F+ E+  +  + HRNL+ 
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 795  LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
            L G       ++ V E    GSL + L      + Q         + A   A+G+ +L  
Sbjct: 76   LYGVVLTPPMKM-VTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMGYLES 129

Query: 855  NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST-LAGTPGYVPPEYY 913
                  IHRD+ + N+LL      ++ DFG+ R +   D H  +         +  PE  
Sbjct: 130  KRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 914  QSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL 973
            ++   +   D + FGV L E+ T  +      +   N    +    +EG+++        
Sbjct: 187  KTRTFSHASDTWMFGVTLWEMFTYGQEP----WIGLNGSQILHKIDKEGERLPR------ 236

Query: 974  LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                   E   +++  ++      +QC    P  RP  + 
Sbjct: 237  ------PEDCPQDIYNVM------VQCWAHKPEDRPTFVA 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  171 bits (433), Expect = 2e-47
 Identities = 64/300 (21%), Positives = 119/300 (39%), Gaps = 38/300 (12%)

Query: 717  FQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDR 775
            +  Q  ++K   ++   + +     +G G FG V + T    G++ A K ++        
Sbjct: 12   YYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 68

Query: 776  EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTW 835
                E++T+  ++H  LV L    +   E +++YEFM  G L E +           ++ 
Sbjct: 69   TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-----HNKMSE 123

Query: 836  DARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV--SDFGMARLISALD 893
            D   +  R   KGLC +H N   + +H D+K  N++   +    +   DFG+      LD
Sbjct: 124  DEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LD 177

Query: 894  THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVG 953
               SV    GT  +  PE  +        D++S GV+   LL+G  P      G+ +   
Sbjct: 178  PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG----GENDDET 233

Query: 954  WVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
               +K  +    +     +           +E+ K+ +R      + +   P+ R  + Q
Sbjct: 234  LRNVKSCDWNMDDSAFSGI-----------SEDGKDFIR------KLLLADPNTRMTIHQ 276

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-47
 Identities = 73/292 (25%), Positives = 121/292 (41%), Gaps = 44/292 (15%)

Query: 741  LIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQGD-REFMAEMETLGKIKHR-NL 792
             +G G FG+V +A            +VA+K L   +   + R  M+E++ L  I H  N+
Sbjct: 20   PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 793  VPLLGYC-KIGEERLLVYEFMKFGSLEEVLHGR----------AKARDQRILTWDARKKI 841
            V LLG C K G   +++ EF KFG+L   L  +           +   +  LT +     
Sbjct: 80   VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 842  ARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTL 901
            +   AKG+ FL        IHRD+ + N+LL  +   ++ DFG+AR I     ++     
Sbjct: 140  SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 902  AGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE 961
                 ++ PE       T + DV+SFGV+L E+ +         +    +      +++E
Sbjct: 197  RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----PYPGVKIDEEFCRRLKE 252

Query: 962  GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            G +M   D                E+ + +      L C    PS+RP   +
Sbjct: 253  GTRMRAPD------------YTTPEMYQTM------LDCWHGEPSQRPTFSE 286

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-47
 Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 13/214 (6%)

Query: 736 FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR---LSCQGDREFMAEMETLGKIKHRN 791
           F    ++G G F  V  A  L      AIK L +   +          E + + ++ H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
            V L    +  E+      + K G L + +                 +         L +
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR------KIGSFDETCTRFYTAEIVSALEY 123

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           LH   I   IHRD+K  N+LL+ +M  +++DFG A+++S        ++  GT  YV PE
Sbjct: 124 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 912 YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                      D+++ G ++ +L+ G  P    +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-46
 Identities = 72/293 (24%), Positives = 121/293 (41%), Gaps = 46/293 (15%)

Query: 741  LIGCGGFGEVFKATLK--------DGSSVAIKKLIRLSCQGD-REFMAEMETLGKI-KHR 790
             +G G FG+V  A             + VA+K L   + + D  + ++EME +  I KH+
Sbjct: 20   PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 791  NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGR----------AKARDQRILTWDARKK 840
            N++ LLG C       ++ E+   G+L E L  R               +  L+      
Sbjct: 80   NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 841  IARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVST 900
             A   A+G+ +L        IHRD+ + NVL+  +   +++DFG+AR I  +D +   + 
Sbjct: 140  CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 901  LAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR 960
                  ++ PE       T + DV+SFGV+L E+ T         +     V  +   ++
Sbjct: 197  GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVP-VEELFKLLK 251

Query: 961  EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            EG +M+               +   E+  M+R       C    PS+RP   Q
Sbjct: 252  EGHRMDK------------PSNCTNELYMMMR------DCWHAVPSQRPTFKQ 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 6e-46
 Identities = 57/278 (20%), Positives = 105/278 (37%), Gaps = 38/278 (13%)

Query: 741  LIGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHRNLVPL 795
             IG G FG+V +           +VAIK     +    RE F+ E  T+ +  H ++V L
Sbjct: 14   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 796  LGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHN 855
            +G         ++ E    G L   L  R  +     L   +    A   +  L +L   
Sbjct: 74   IGVI-TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLESK 127

Query: 856  CIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 915
                 +HRD+ + NVL+      ++ DFG++R +     + + S       ++ PE    
Sbjct: 128  ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINF 183

Query: 916  FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLV 975
             R T+  DV+ FGV + E+L       +    +      V  ++  G+++ +        
Sbjct: 184  RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLPM-------- 230

Query: 976  TKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                  +    +  ++       +C    PS+RP   +
Sbjct: 231  ----PPNCPPTLYSLMT------KCWAYDPSRRPRFTE 258

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 3e-45
 Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 32/283 (11%)

Query: 733  TNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-FMAEMETLGKIKHR 790
             + +    ++G G F EV  A   +    VAIK + + + +G       E+  L KIKH 
Sbjct: 8    RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 791  NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            N+V L    + G    L+ + +  G L + +       ++   T     ++       + 
Sbjct: 68   NIVALDDIYESGGHLYLIMQLVSGGELFDRI------VEKGFYTERDASRLIFQVLDAVK 121

Query: 851  FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
            +LH   I H   +        LD + +  +SDFG++++    D    +ST  GTPGYV P
Sbjct: 122  YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAP 178

Query: 911  EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP 970
            E       +   D +S GV+   LL G  P     F D N     +  ++   + +    
Sbjct: 179  EVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQILKAEYEFDSPYW 233

Query: 971  ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            + +          ++  K+ +R        ++  P KR    Q
Sbjct: 234  DDI----------SDSAKDFIR------HLMEKDPEKRFTCEQ 260

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  163 bits (414), Expect = 9e-45
 Identities = 51/276 (18%), Positives = 100/276 (36%), Gaps = 35/276 (12%)

Query: 741  LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
             +G G FG V +      G     K +             E+  + ++ H  L+ L    
Sbjct: 36   ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
            +   E +L+ EF+  G L + +           ++        R A +GL  +H +    
Sbjct: 96   EDKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHEH---S 147

Query: 860  IIHRDMKSSNVLLDHEMEARV--SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
            I+H D+K  N++ + +  + V   DFG+A  ++  +     +    T  +  PE      
Sbjct: 148  IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREP 204

Query: 918  CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK 977
                 D+++ GV+   LL+G  P   +D  +T       +K  + +  E     +     
Sbjct: 205  VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVKRCDWEFDEDAFSSV----- 255

Query: 978  GTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                  + E K+ ++        +   P KR  +  
Sbjct: 256  ------SPEAKDFIK------NLLQKEPRKRLTVHD 279

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  159 bits (404), Expect = 2e-44
 Identities = 67/286 (23%), Positives = 116/286 (40%), Gaps = 39/286 (13%)

Query: 733  TNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD---REFMAEMETLGKIK 788
            ++ +    ++G GG  EV  A  L+    VA+K L     +       F  E +    + 
Sbjct: 6    SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 789  HRNLVPLLGYC----KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARG 844
            H  +V +          G    +V E++   +L +++H       +  +T     ++   
Sbjct: 66   HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH------TEGPMTPKRAIEVIAD 119

Query: 845  AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR-LISALDTHLSVSTLAG 903
            A + L F H N    IIHRD+K +N+++      +V DFG+AR +  + ++    + + G
Sbjct: 120  ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176

Query: 904  TPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK 963
            T  Y+ PE  +     A+ DVYS G VL E+LTG+ P     F   + V      VRE  
Sbjct: 177  TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----FTGDSPVSVAYQHVREDP 231

Query: 964  QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009
                   E L          + ++  +V       + +   P  R 
Sbjct: 232  IPPSARHEGL----------SADLDAVVL------KALAKNPENRY 261

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 3e-43
 Identities = 52/226 (23%), Positives = 99/226 (43%), Gaps = 10/226 (4%)

Query: 728 QLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE-FMAEMETLG 785
           Q+ +    ++  S IG G +G V  A    +   VAIKK+     Q   +  + E++ L 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 786 KIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGA 845
           + +H N++ +    +      +   ++    +   L+   K    + L+ D         
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQI 118

Query: 846 AKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI-SALDTHLSVSTLAGT 904
            +GL ++H     +++HRD+K SN+LL+   + ++ DFG+AR+     D    ++    T
Sbjct: 119 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 905 PGYVPPEY-YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
             Y  PE    S   T   D++S G +L E+L+ +       + D 
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 221

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 3e-43
 Identities = 53/277 (19%), Positives = 98/277 (35%), Gaps = 34/277 (12%)

Query: 739  ESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
               +G G FG V +          + K +++          E+  L   +HRN++ L   
Sbjct: 10   AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 799  CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
             +  EE ++++EF+    + E ++  A       L             + L FLH +   
Sbjct: 70   FESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSH--- 121

Query: 859  HIIHRDMKSSNVLLDHEMEARV--SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
            +I H D++  N++      + +   +FG AR +   D       L   P Y  PE +Q  
Sbjct: 122  NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHD 178

Query: 917  RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVT 976
              +   D++S G ++  LL+G  P       +TN      +   E    E    E+    
Sbjct: 179  VVSTATDMWSLGTLVYVLLSGINPFL----AETNQQIIENIMNAEYTFDEEAFKEI---- 230

Query: 977  KGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                   + E  + V       + +      R    +
Sbjct: 231  -------SIEAMDFVD------RLLVKERKSRMTASE 254

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  155 bits (392), Expect = 9e-42
 Identities = 63/247 (25%), Positives = 100/247 (40%), Gaps = 22/247 (8%)

Query: 734 NGFSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSC---QGDREFMAE---METLGK 786
           N FS   +IG GGFGEV+     D G   A+K L +      QG+   + E   +  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 787 IKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAA 846
                +V +       ++   + + M  G L   L          + +    +  A    
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS------QHGVFSEADMRFYAAEII 117

Query: 847 KGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPG 906
            GL  +H+     +++RD+K +N+LLD     R+SD G+A   S    H SV    GT G
Sbjct: 118 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 170

Query: 907 YVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQM 965
           Y+ PE  Q      +  D +S G +L +LL G  P  +    D + +          +  
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAVELP 229

Query: 966 EVIDPEL 972
           +   PEL
Sbjct: 230 DSFSPEL 236

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-41
 Identities = 59/283 (20%), Positives = 112/283 (39%), Gaps = 15/283 (5%)

Query: 740  SLIGCGGFGEVFKATLK--DGSSVAIKKLIRLSCQGDRE-----FMAEMETLGKIKHRNL 792
            + IG G +G+VFKA      G  VA+K++   + +          +A +  L   +H N+
Sbjct: 13   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 793  VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
            V L   C +          + F  +++ L        +  +  +  K +     +GL FL
Sbjct: 73   VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 853  HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
            H +    ++HRD+K  N+L+    + +++DFG+AR+ S        +++  T  Y  PE 
Sbjct: 133  HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEV 186

Query: 913  YQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT--NLVGWVKMKVREGKQMEVIDP 970
                      D++S G +  E+   K         D    ++  + +   E    +V  P
Sbjct: 187  LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 971  ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                 +K     E           ++ L+C+   P+KR +   
Sbjct: 247  RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (382), Expect = 5e-41
 Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 18/209 (8%)

Query: 741 LIGCGGFGEVFKATLK-DGSSVAIKKL---IRLSCQGDREFMAEMETLGKIKHRNLVPLL 796
            +G G FG V     + +G   A+K L   I +  +       E   L  + H  ++ + 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 797 GYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC 856
           G  +  ++  ++ ++++ G L  +L    +  +     +         AA+    L +  
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY---------AAEVCLALEYLH 121

Query: 857 IPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF 916
              II+RD+K  N+LLD     +++DFG A+ +  +       TL GTP Y+ PE   + 
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTK 176

Query: 917 RCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                 D +SFG+++ E+L G  P    +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSN 205

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  150 bits (379), Expect = 6e-41
 Identities = 63/295 (21%), Positives = 116/295 (39%), Gaps = 50/295 (16%)

Query: 736  FSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD---------REFMAEMETLG 785
            +  + ++G G    V +          A+K +                    + E++ L 
Sbjct: 5    YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 786  KIK-HRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARG 844
            K+  H N++ L    +      LV++ MK G L + L  +        L+    +KI R 
Sbjct: 65   KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRA 118

Query: 845  AAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGT 904
              + +C LH     +I+HRD+K  N+LLD +M  +++DFG +     LD    +  + GT
Sbjct: 119  LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGT 172

Query: 905  PGYVPPEYYQSFRC------TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMK 958
            P Y+ PE  +            + D++S GV++  LL G  P     F     +  ++M 
Sbjct: 173  PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMI 227

Query: 959  VREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
            +    Q    + +            ++ VK++V       + +   P KR    +
Sbjct: 228  MSGNYQFGSPEWDDY----------SDTVKDLVS------RFLVVQPQKRYTAEE 266

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 7e-41
 Identities = 62/219 (28%), Positives = 90/219 (41%), Gaps = 16/219 (7%)

Query: 736 FSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDRE---FMAEMETLGK-IKHR 790
           F    ++G G FG+VF A  K      AIK L +     D +    M E   L    +H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 791 NLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            L  +    +  E    V E++  G L   +    K               A     GL 
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQ 117

Query: 851 FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPP 910
           FLH      I++RD+K  N+LLD +   +++DFGM +     D     +T  GTP Y+ P
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAP 172

Query: 911 EYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
           E     +     D +SFGV+L E+L G+ P    D  + 
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 2e-40
 Identities = 52/287 (18%), Positives = 95/287 (33%), Gaps = 36/287 (12%)

Query: 734  NGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNL 792
            N +     IG G FG+++  T +  G  VAIK     +     +   E +    ++    
Sbjct: 7    NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVG 64

Query: 793  VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
            +P + +C    +  ++   +   SLE++ +        R  +      +A      + ++
Sbjct: 65   IPTIRWCGAEGDYNVMVMELLGPSLEDLFN-----FCSRKFSLKTVLLLADQMISRIEYI 119

Query: 853  HHNCIPHIIHRDMKSSNVL---LDHEMEARVSDFGMARLISALDTHLSV-----STLAGT 904
            H     + IHRD+K  N L           + DFG+A+      TH  +       L GT
Sbjct: 120  HSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 905  PGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQ 964
              Y     +     + + D+ S G VL+    G  P               K +    K+
Sbjct: 177  ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK----RQKYERISEKK 232

Query: 965  MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
            M      L        +    E    + +      C       +P+ 
Sbjct: 233  MSTPIEVL-------CKGYPSEFATYLNF------CRSLRFDDKPDY 266

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 56/283 (19%), Positives = 106/283 (37%), Gaps = 26/283 (9%)

Query: 742  IGCGGFGEVFKATLKDGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
            IG G +G V+KA    G + A+KK+   +         + E+  L ++KH N+V L    
Sbjct: 10   IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 800  KIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH 859
               +  +LV+E +     + +         +  L     K        G+ + H      
Sbjct: 70   HTKKRLVLVFEHLDQDLKKLLDV------CEGGLESVTAKSFLLQLLNGIAYCHDR---R 120

Query: 860  IIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RC 918
            ++HRD+K  N+L++ E E +++DFG+AR           +    T  Y  P+      + 
Sbjct: 121  VLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 919  TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTKG 978
            +   D++S G +  E++ G         G +     +++    G       P +  + K 
Sbjct: 179  STTIDIWSVGCIFAEMVNGTPLFP----GVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 979  TDESEAEEVKEMVRYLEITLQCVDDF--------PSKRPNMLQ 1013
                   E      +L+   +   D         P++R    Q
Sbjct: 235  DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 5e-40
 Identities = 63/288 (21%), Positives = 110/288 (38%), Gaps = 31/288 (10%)

Query: 741  LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDRE-----FMAEMETLGKIKHRNLVP 794
             +G G F  V+KA  K     VAIKK+        ++      + E++ L ++ H N++ 
Sbjct: 5    FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 795  LLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
            LL          LV++FM+      +           +LT    K       +GL +LH 
Sbjct: 65   LLDAFGHKSNISLVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 855  NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQ 914
            + I   +HRD+K +N+LLD     +++DFG+A+       + + +    T  Y  PE   
Sbjct: 119  HWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLF 173

Query: 915  SFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL 973
              R      D+++ G +L ELL           GD++L    ++    G   E   P++ 
Sbjct: 174  GARMYGVGVDMWAVGCILAELLLRVPFLP----GDSDLDQLTRIFETLGTPTEEQWPDMC 229

Query: 974  LVTKGTDESEAEEVKEMVRYLEITLQCVD--------DFPSKRPNMLQ 1013
             +           +     +       +D        + P  R    Q
Sbjct: 230  SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN-PCARITATQ 276

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 2e-39
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 20/222 (9%)

Query: 736 FSAESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP 794
           ++   +IG G FG V++A L D G  VAIKK++    Q  R    E++ + K+ H N+V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 795 LLGYCKIGEER------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKG 848
           L  +     E+       LV +++         H     R ++ L     K       + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS---RAKQTLPVIYVKLYMYQLFRS 134

Query: 849 LCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVSTLAGTPGY 907
           L ++H      I HRD+K  N+LLD +    ++ DFG A+ +       +VS +      
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYR 189

Query: 908 VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
            P   + +   T+  DV+S G VL ELL G+     D   D 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  144 bits (365), Expect = 5e-39
 Identities = 55/284 (19%), Positives = 93/284 (32%), Gaps = 38/284 (13%)

Query: 739  ESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLG 797
               IG G FG +F+ T L +   VAIK   R S     +   E  T   +     +P + 
Sbjct: 10   GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 798  YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
            Y        ++   +   SLE++L         R  +       A+     +  +H    
Sbjct: 68   YFGQEGLHNVLVIDLLGPSLEDLLD-----LCGRKFSVKTVAMAAKQMLARVQSIHEK-- 120

Query: 858  PHIIHRDMKSSNVLLD-----HEMEARVSDFGMARLISALDTHLSV-----STLAGTPGY 907
              +++RD+K  N L+      +     V DFGM +      T   +       L+GT  Y
Sbjct: 121  -SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 908  VPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV 967
            +    +     + + D+ + G V +  L G  P      G        K +    K+   
Sbjct: 180  MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ----GLKAATNKQKYERIGEKKQST 235

Query: 968  IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011
               EL            EE  + + Y        +      P+ 
Sbjct: 236  PLRELC-------AGFPEEFYKYMHY------ARNLAFDATPDY 266

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-38
 Identities = 64/288 (22%), Positives = 108/288 (37%), Gaps = 22/288 (7%)

Query: 736  FSAESLIGCGGFGEVFKATLK-DGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNL 792
            F     IG G +G V+KA  K  G  VA+KK+     +       + E+  L ++ H N+
Sbjct: 4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 793  VPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFL 852
            V LL       +  LV+EF+     + +      A     +     K       +GL F 
Sbjct: 64   VKLLDVIHTENKLYLVFEFLHQDLKKFM-----DASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 853  HHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEY 912
            H + +   +HRD+K  N+L++ E   +++DFG+AR           +    T  Y  PE 
Sbjct: 119  HSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEI 173

Query: 913  YQSFR-CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT------NLVGWVKMKVREGKQM 965
                +  +   D++S G +  E++T +     D   D        L    ++       M
Sbjct: 174  LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 966  EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                P      +         + E  R L   +   D  P+KR +   
Sbjct: 234  PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD--PNKRISAKA 279

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-38
 Identities = 61/282 (21%), Positives = 120/282 (42%), Gaps = 41/282 (14%)

Query: 741  LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGY 798
            ++G G  G+V +    +     A+K L     Q   +   E+E   +  +  ++V ++  
Sbjct: 19   VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 799  CK----IGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH 854
             +      +  L+V E +  G L   +    + R  +  T     +I +   + + +LH 
Sbjct: 74   YENLYAGRKCLLIVMECLDGGELFSRI----QDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 855  NCIPHIIHRDMKSSNVLLDHEME---ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
                +I HRD+K  N+L   +      +++DFG A+  ++ ++    +T   TP YV PE
Sbjct: 130  I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPE 183

Query: 912  YYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE 971
                 +     D++S GV++  LL G  P   +      +   +K ++R G+  E  +PE
Sbjct: 184  VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH--GLAISPGMKTRIRMGQ-YEFPNPE 240

Query: 972  LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
               V+        EEVK ++R        +   P++R  + +
Sbjct: 241  WSEVS--------EEVKMLIR------NLLKTEPTQRMTITE 268

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-37
 Identities = 67/294 (22%), Positives = 118/294 (40%), Gaps = 32/294 (10%)

Query: 742  IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGY 798
            IG G FGEVFKA   K G  VA+KK++  + +       + E++ L  +KH N+V L+  
Sbjct: 18   IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 799  CKIGEER--------LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLC 850
            C+              LV++F +      + +   K       T    K++ +    GL 
Sbjct: 78   CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNGLY 131

Query: 851  FLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT--HLSVSTLAGTPGYV 908
            ++H N    I+HRDMK++NVL+  +   +++DFG+AR  S          +    T  Y 
Sbjct: 132  YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 909  PPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV 967
            PPE     R      D++  G ++ E+ T       +       +          +    
Sbjct: 189  PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 968  IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVD--------DFPSKRPNMLQ 1013
            +D   L       + +  +VK+ ++        +D        D P++R +   
Sbjct: 249  VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD-PAQRIDSDD 301

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-37
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 23/218 (10%)

Query: 739 ESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE------FMAEMETLGKIK--H 789
             L+G GGFG V+    + D   VAIK + +       E         E+  L K+    
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
             ++ LL + +  +  +L+ E  +               ++  L  +  +       + +
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAV 123

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
              H+     ++HRD+K  N+L+D    E ++ DFG   L+   DT  +     GT  Y 
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYT--DFDGTRVYS 176

Query: 909 PPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PPE+ +  R       V+S G++L +++ G  P + D+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 6e-36
 Identities = 59/284 (20%), Positives = 105/284 (36%), Gaps = 44/284 (15%)

Query: 741  LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDR------EFMAEMETLGKIKHRNLV 793
             +G G F  V K   K  G   A K + +   +  R      +   E+  L +I+H N++
Sbjct: 17   ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 794  PLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH 853
             L    +   + +L+ E +  G L + L       ++  LT +   +  +    G+ +LH
Sbjct: 77   TLHEVYENKTDVILILELVAGGELFDFLA------EKESLTEEEATEFLKQILNGVYYLH 130

Query: 854  HNCIPHIIHRDMKSSNVLLDHEMEAR----VSDFGMARLISALDTHLSVSTLAGTPGYVP 909
               I    H D+K  N++L      +    + DFG+A  I   +       + GTP +V 
Sbjct: 131  SLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVA 184

Query: 910  PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID 969
            PE         + D++S GV+   LL+G  P      GDT       +     +  +   
Sbjct: 185  PEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDEYF 240

Query: 970  PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013
                          +   K+ +R      + +   P KR  +  
Sbjct: 241  SNT-----------SALAKDFIR------RLLVKDPKKRMTIQD 267

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-35
 Identities = 51/216 (23%), Positives = 86/216 (39%), Gaps = 15/216 (6%)

Query: 734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKH 789
           N F    L+G G FG+V     K  G   A+K L +       E    + E   L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
             L  L    +  +    V E+   G L   L        +R+ T +  +         L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS------RERVFTEERARFYGAEIVSAL 118

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVP 909
               +     +++RD+K  N++LD +   +++DFG+ +   +    +   T  GTP Y+ 
Sbjct: 119 ---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLA 173

Query: 910 PEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD 945
           PE  +        D +  GVV+ E++ G+ P    D
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-35
 Identities = 60/284 (21%), Positives = 104/284 (36%), Gaps = 26/284 (9%)

Query: 742  IGCGGFGEVFKATLK-DGSSVAIKKL--IRLSCQGDREFMAEMETLGKIKHRNLVPLLGY 798
            IG G +G VFKA  +     VA+K++             + E+  L ++KH+N+V L   
Sbjct: 10   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 799  CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIP 858
                ++  LV+EF      +              L  +  K       KGL F H     
Sbjct: 70   LHSDKKLTLVFEFCDQDLKKYFDS------CNGDLDPEIVKSFLFQLLKGLGFCHSR--- 120

Query: 859  HIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC 918
            +++HRD+K  N+L++   E ++++FG+AR           S    T  Y PP+     + 
Sbjct: 121  NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKL 178

Query: 919  -TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELLLVTK 977
             +   D++S G +  EL    RP      G+       ++    G   E   P +  +  
Sbjct: 179  YSTSIDMWSAGCIFAELANAGRPLFP---GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 978  GTDESEAEEVKEMVRYLEITLQCVDDF--------PSKRPNMLQ 1013
                        +V  +        D         P +R +  +
Sbjct: 236  YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (339), Expect = 5e-35
 Identities = 49/208 (23%), Positives = 80/208 (38%), Gaps = 18/208 (8%)

Query: 742 IGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDRE---FMAEMETLGKIKHRNLVPLLG 797
           +G G FG V      + G+  A+K L +      ++    + E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
             K      +V E++  G +   L            +    +  A        +LH    
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR------RIGRFSEPHARFYAAQIVLTFEYLHSL-- 160

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             +I+RD+K  N+L+D +   +V+DFG A+            TL GTP  + PE   S  
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKG 214

Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDD 945
                D ++ GV++ E+  G  P   D 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 7e-35
 Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 20/283 (7%)

Query: 741  LIGCGGFGEVFKAT-LKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLG 797
             +G G +G V  A   + G+ VAIKKL R   S    +    E+  L  ++H N++ LL 
Sbjct: 25   PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 798  YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
                 E      +F           G+        L  D  + +     KGL ++H    
Sbjct: 85   VFTPDETLDDFTDFYLVMPFMGTDLGKL--MKHEKLGEDRIQFLVYQMLKGLRYIHAA-- 140

Query: 858  PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSF- 916
              IIHRD+K  N+ ++ + E ++ DFG+AR   +      ++    T  Y  PE   ++ 
Sbjct: 141  -GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWM 194

Query: 917  RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT-NLVGWVKMKVREGKQMEVIDPELLLV 975
            R T   D++S G ++ E++TGK      D  D    +  V           +   E    
Sbjct: 195  RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254

Query: 976  TKGTDESEAEEVKEMVRY-----LEITLQCVDDFPSKRPNMLQ 1013
             KG  E E ++   ++       + +  + +     +R    +
Sbjct: 255  MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (316), Expect = 3e-32
 Identities = 45/213 (21%), Positives = 87/213 (40%), Gaps = 24/213 (11%)

Query: 734 NGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRN 791
           + +     +G G + EVF+A  + +   V +K L        ++   E++ L  ++   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPN 91

Query: 792 LVPLLGYCKIGEERL--LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
           ++ L    K    R   LV+E +     +++          + LT    +       K L
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKAL 142

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            + H   I H   RD+K  NV++DHE  + R+ D+G+A        +   +    +  + 
Sbjct: 143 DYCHSMGIMH---RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFK 196

Query: 909 PPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRP 940
            PE    ++      D++S G +L  ++  K P
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-31
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 12/212 (5%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLG 797
            IG G  G V  A       +VAIKKL R   +    +    E+  +  + H+N++ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 798 YCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI 857
                +    + EF     + E++        Q  L  +    +      G+  LH    
Sbjct: 84  VFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG- 139

Query: 858 PHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFR 917
             IIHRD+K SN+++  +   ++ DFG+AR      T   ++    T  Y  PE      
Sbjct: 140 --IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 918 CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
                D++S G ++ E++  K      D+ D 
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 6e-31
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 20/238 (8%)

Query: 717 FQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKAT-LKDGSSVAIKKLIR--LSCQG 773
           ++++L K  +    E    +   S +G G +G V  A   K G  VA+KKL R   S   
Sbjct: 5   YRQELNKTIW----EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60

Query: 774 DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHG-RAKARDQRI 832
            +    E+  L  +KH N++ LL           + EF     +  ++          + 
Sbjct: 61  AKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQK 117

Query: 833 LTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL 892
           LT D  + +     +GL ++H      IIHRD+K SN+ ++ + E ++ DFG+AR     
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----- 169

Query: 893 DTHLSVSTLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
            T   ++    T  Y  PE   ++       D++S G ++ ELLTG+      D  D 
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  123 bits (308), Expect = 1e-30
 Identities = 85/392 (21%), Positives = 146/392 (37%), Gaps = 38/392 (9%)

Query: 46  SKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH 105
           + L   +       N+T  + +T L   D++  L      +  SI G        N+L  
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDL---DQVTTLQADRLGIK-SIDGVE----YLNNLTQ 70

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWI 165
           ++ S N + D+ P  L N TKL  + ++ N +A   P       +   L  +       +
Sbjct: 71  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128

Query: 166 PSELGNACDSLLELKLPHNNITGSFPVTLSSCSW-----------LQLLDLSNNNISGPF 214
            +        L    +   +                         L  L+  + + +   
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188

Query: 215 PDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSL 274
             SVL  L +LESLI +NN IS   P  I     L  +  + N++  I        +++L
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDI---GTLASLTNL 243

Query: 275 EELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEG 334
            +L L +N I+ + P  LS  T+L  + L  N ++   P  L  L  L       N  + 
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QL 297

Query: 335 KIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRL 394
           +    +   KNL  L L  N +S   P  + S + L+ +    N+++       + LT +
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353

Query: 395 AVLQLGNNRFKGEIPGELGNCSSLVWLDLNSN 426
             L  G+N+     P  L N + +  L LN  
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  117 bits (292), Expect = 1e-28
 Identities = 88/443 (19%), Positives = 152/443 (34%), Gaps = 80/443 (18%)

Query: 148 LSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSN 207
           L+   +  L   ++T  +        D +  L+     I  S    +   + L  ++ SN
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75

Query: 208 NNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDI 267
           N ++   P   L+NL  L  ++++NN I+   P +  +  T   +  +       +    
Sbjct: 76  NQLTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 268 CPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIA 327
                 L    +            +S  + L  +         +  + L  L  LE+   
Sbjct: 133 NLNRLELSSNTIS----------DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182

Query: 328 WFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPE 387
             N  +      L K  NL+ LI  NN++S   P      +NL+ +SL GN+L       
Sbjct: 183 SSN--KVSDISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGT 236

Query: 388 FSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGG 447
            + LT L  L L NN+     P  L   + L  L L +N ++   P              
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-------------- 280

Query: 448 FLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQY 507
                                             L   T  +           +S  +  
Sbjct: 281 ----------------------------------LAGLTALTNLELNENQLEDISPISNL 306

Query: 508 QTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNR 567
           + L YL L +N      P  +  +  LQ L  A+N++S    SSL  L N+    A HN+
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362

Query: 568 LQGQIPESFSNLSFLVQIDLSNN 590
           +    P   +NL+ + Q+ L++ 
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  113 bits (283), Expect = 2e-27
 Identities = 73/370 (19%), Positives = 134/370 (36%), Gaps = 35/370 (9%)

Query: 75  KLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSF 134
           +     L   N+T ++S     +   + +  L   +  I  +    +     L  +N S 
Sbjct: 23  EKMKTVLGKTNVTDTVS-----QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 135 NLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTL 194
           N L    P     L+ L  + ++NN I    P         L        +I     +T 
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 195 SSCSWLQLLDLSN----------NNISGPFPDSVLENLGSLESLILSNNMISGSFPDSI- 243
            +   L    +S+            +S     + L+ L +L +L   +   +     S+ 
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 244 SSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDL 303
           +    L  +  ++N++S I P  I     +L+EL L  N +     G L+  T L  +DL
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 304 SLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAE 363
           + N ++   P  L  L  L +     N +    P          +L  N  +      + 
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----DISP 302

Query: 364 LFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL 423
           + +  NL +++L  N ++   P   S LT+L  L   NN+        L N +++ WL  
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 424 NSNNLTGDIP 433
             N ++   P
Sbjct: 359 GHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  103 bits (257), Expect = 4e-24
 Identities = 79/378 (20%), Positives = 149/378 (39%), Gaps = 41/378 (10%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
           +  L+    G+  +   +    L NL  +N S N LT   P   L N  KL  + ++ N 
Sbjct: 46  VTTLQADRLGIKSI---DGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQ 99

Query: 86  L-TGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRT 144
           +   +      N        +     + + ++   +    +   I ++S       + + 
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159

Query: 145 FGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLD 204
                      L+N      +                  ++   S    L+  + L+ L 
Sbjct: 160 SFGNQVTDLKPLANLTTLERL----------------DISSNKVSDISVLAKLTNLESLI 203

Query: 205 LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP 264
            +NN IS   P  +L N   L+ L L+ N +      +++S   L  +D ++N++S + P
Sbjct: 204 ATNNQISDITPLGILTN---LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 258

Query: 265 PDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQ 324
                G++ L EL+L  N I+ + P  L+  T L  ++L+ N L    P     L++L  
Sbjct: 259 ---LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTY 311

Query: 325 FIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQI 384
              +FN +    P  +     L+ L   NNK+S    + L + +N+ W+S   N+++   
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367

Query: 385 PPEFSRLTRLAVLQLGNN 402
           P   + LTR+  L L + 
Sbjct: 368 P--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 9e-08
 Identities = 50/317 (15%), Positives = 95/317 (29%), Gaps = 41/317 (12%)

Query: 302 DLSLNYLNGSIPQ-ELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEI 360
            L    +  ++ Q +L ++  L+        ++G     +    NL  +  +NN+L+   
Sbjct: 28  VLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDIT 82

Query: 361 PAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVW 420
           P  L + + L  I +  N++    P                         +     + + 
Sbjct: 83  P--LKNLTKLVDILMNNNQIADITPLANLTNL-----TGLTLFNNQITDIDPLKNLTNLN 135

Query: 421 LDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPER 480
               S+N   DI    G     +   G   ++              +            +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 481 LLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELA 540
           L  + +L + +       P          L+ L L+ NQ +      +  +  L  L+LA
Sbjct: 196 LTNLESLIATNNQISDITP----LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 541 HNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIP--------------------ESFSNLS 580
           +NQ+S   P  L  L  L       N++    P                       SNL 
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 581 FLVQIDLSNNELTGPIP 597
            L  + L  N ++   P
Sbjct: 308 NLTYLTLYFNNISDISP 324

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 9e-30
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 21/220 (9%)

Query: 741 LIGCGGFGEVFKATL----KDGSSVAIKKL----IRLSCQGDREFMAEMETLGKIKHR-N 791
           ++G G +G+VF          G   A+K L    I    +       E + L  I+    
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 792 LVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCF 851
           LV L    +   +  L+ +++  G L   L  R +  +  +  +           + +  
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY---------VGEIVLA 141

Query: 852 LHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPE 911
           L H     II+RD+K  N+LLD      ++DFG+++   A +T  +     GT  Y+ P+
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGTIEYMAPD 200

Query: 912 YYQSFR--CTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
             +          D +S GV++ ELLTG  P   D   ++
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (293), Expect = 5e-29
 Identities = 49/221 (22%), Positives = 84/221 (38%), Gaps = 15/221 (6%)

Query: 741 LIGCGGFGEVFKAT-LKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYC 799
            +G G F  V+ A  + + + VA+K  +R           E++ L ++   +        
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 800 KIGEERLL----------VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
                +LL          V+  M F  L E L    K  + R +     K+I++    GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSDFGMARLISALDTHLSVSTLAGTPGYV 908
            ++H  C   IIH D+K  NVL++       +    +A L +A       +    T  Y 
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 909 PPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDT 949
            PE           D++S   ++ EL+TG    + D+    
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  112 bits (279), Expect = 1e-27
 Identities = 72/329 (21%), Positives = 114/329 (34%), Gaps = 46/329 (13%)

Query: 79  LDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
           +  S   L        + ++       LDL  N I ++      N   L  L L  N ++
Sbjct: 15  VQCSDLGLE------KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68

Query: 139 GEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCS 198
              P  F  L  L+RL LS N +   +P ++      L       N IT       +  +
Sbjct: 69  KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVH---ENEITKVRKSVFNGLN 124

Query: 199 WLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNR 258
            + +++L  N                           SG    +    K L  +  +   
Sbjct: 125 QMIVVELGTN-----------------------PLKSSGIENGAFQGMKKLSYIRIADTN 161

Query: 259 VSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGK 318
           ++  IP  + P   SL EL L  N IT V    L     L  + LS N ++      L  
Sbjct: 162 IT-TIPQGLPP---SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217

Query: 319 LEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG------EIPAELFSCSNLEW 372
             HL +     N L  K+P  L   K ++ + L+NN +S         P      ++   
Sbjct: 218 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 276

Query: 373 ISLTGNELT-GQIPPE-FSRLTRLAVLQL 399
           +SL  N +   +I P  F  +   A +QL
Sbjct: 277 VSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 96.6 bits (239), Expect = 3e-22
 Identities = 60/285 (21%), Positives = 103/285 (36%), Gaps = 19/285 (6%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
            ++L L +N  T       +    L  L L +  +  + P   F+ L  L  L  S N L
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA-FAPLVKLERLYLSKNQL 91

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSL 121
              LPE +     +L      + N    +     N  +   ++ L  +      +   + 
Sbjct: 92  KE-LPEKMPKTLQELR----VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146

Query: 122 SNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL 181
               KL  + ++   +   IP+  G   SL  L L  N IT    + L    ++L +L L
Sbjct: 147 QGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKG-LNNLAKLGL 202

Query: 182 PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG---- 237
             N+I+     +L++   L+ L L+NN +          +   ++ + L NN IS     
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL--ADHKYIQVVYLHNNNISAIGSN 260

Query: 238 --SFPDSISSCKTLRIVDFSSNRVSGI-IPPDICPGVSSLEELRL 279
               P   +   +   V   SN V    I P     V     ++L
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.9 bits (198), Expect = 5e-17
 Identities = 45/260 (17%), Positives = 90/260 (34%), Gaps = 27/260 (10%)

Query: 335 KIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRL 394
           K+P +L    +   L L NNK++     +  +  NL  + L  N+++   P  F+ L +L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 395 AVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTL 454
             L L  N+ K            L   +     +   +                L+   +
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF-------------NGLNQMIV 128

Query: 455 VFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLD 514
           V +        G+    E    +  + L    +   +   +  G          +L  L 
Sbjct: 129 VELGTNPLKSSGI----ENGAFQGMKKLSYIRIADTNITTIPQG-------LPPSLTELH 177

Query: 515 LSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE 574
           L  N+        +  +  L  L L+ N +S     SL    +L     ++N+L  ++P 
Sbjct: 178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 236

Query: 575 SFSNLSFLVQIDLSNNELTG 594
             ++  ++  + L NN ++ 
Sbjct: 237 GLADHKYIQVVYLHNNNISA 256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.8 bits (120), Expect = 4e-07
 Identities = 17/113 (15%), Positives = 33/113 (29%)

Query: 508 QTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNR 567
                LDL  N+       +  ++  L  L L +N++S   P +   L  L     S N+
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 568 LQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVP 620
           L+    +    L  L   +    ++   +        +               
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 2e-21
 Identities = 27/161 (16%), Positives = 51/161 (31%), Gaps = 23/161 (14%)

Query: 740 SLIGCGGFGEVFKATLKDGSSVAIK----------KLIRLSCQGDREFMAEMETLGKIKH 789
            L+G G    VF    +      +K          K+      GD  F        + + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 790 RNLVPLLGYCKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGL 849
           R L  L G           Y +     L E++      ++   +  +   ++     + +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDA----KELYRVRVENPDEVLDMILEEV 116

Query: 850 CFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS 890
              +H     I+H D+   NVL+  E    + DF  +  + 
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 92.9 bits (229), Expect = 5e-21
 Identities = 66/290 (22%), Positives = 103/290 (35%), Gaps = 38/290 (13%)

Query: 345 NLKDLILNNNKLSG--EIPAELFSCSNLEWISLTGNE-LTGQIPPEFSRLTRLAVLQLGN 401
            + +L L+   L     IP+ L +   L ++ + G   L G IPP  ++LT+L  L + +
Sbjct: 51  RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 402 NRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRL-------GRQLGAKPLGGFLSSNTL 454
               G IP  L    +LV LD + N L+G +PP +       G       + G +  +  
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 455 VFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLD 514
            F +   +       L          L       S +     +                 
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV----LFGSDKNTQKI 226

Query: 515 LSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE 574
                       ++G    L  L+L +N++ G +P  L +L+ L   + S N L G+IP+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 575 SFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPEC 624
                                    G L     S YANN  LCG PLP C
Sbjct: 287 G------------------------GNLQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 85.6 bits (210), Expect = 1e-18
 Identities = 71/274 (25%), Positives = 110/274 (40%), Gaps = 10/274 (3%)

Query: 146 GQLSSLQRLDLSNNHITGW--IPSELGNACDSLLELKLPHN-NITGSFPVTLSSCSWLQL 202
            Q   +  LDLS  ++     IPS L N    L  L +    N+ G  P  ++  + L  
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105

Query: 203 LDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGI 262
           L +++ N+SG  PD +   + +L +L  S N +SG+ P SISS   L  + F  NR+SG 
Sbjct: 106 LYITHTNVSGAIPDFL-SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164

Query: 263 IPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHL 322
           IP            + +  N +T       +              +       L   +  
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLT--GKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222

Query: 323 EQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTG 382
            Q I            ++G  KNL  L L NN++ G +P  L     L  ++++ N L G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282

Query: 383 QIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCS 416
           +I P+   L R  V    NN+     P  L  C+
Sbjct: 283 EI-PQGGNLQRFDVSAYANNKCLCGSP--LPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 84.4 bits (207), Expect = 3e-18
 Identities = 56/272 (20%), Positives = 94/272 (34%), Gaps = 6/272 (2%)

Query: 116 VIPSSLSNCTKLKILNLSFNLLAG--EIPRTFGQLSSLQRLDLSNNHITGWIPSELGNAC 173
           V+  + +   ++  L+LS   L     IP +   L  L  L +   +             
Sbjct: 41  VLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100

Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNN 233
             L  L + H N++G+ P  LS    L  LD S N +SG  P   + +L +L  +    N
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGN 159

Query: 234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLS 293
            ISG+ PDS  S   L      S   + +         +           +       L 
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISR--NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLF 217

Query: 294 ECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNN 353
              +                 ++G  ++L       N + G +P  L + K L  L ++ 
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277

Query: 354 NKLSGEIPAELFSCSNLEWISLTGNELTGQIP 385
           N L GEIP +  +    +  +   N+     P
Sbjct: 278 NNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 67.5 bits (163), Expect = 1e-12
 Identities = 58/270 (21%), Positives = 98/270 (36%), Gaps = 10/270 (3%)

Query: 46  SKLPNLVYLNASYNNLTGFLP-ETLLSNSDKLELLDLSYN-NLTGSISGFSLNENSCNSL 103
           ++   +  L+ S  NL    P  + L+N   L  L +    NL G I            L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA---IAKLTQL 103

Query: 104 LHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITG 163
            +L ++  ++   IP  LS    L  L+ S+N L+G +P +   L +L  +    N I+G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 164 WIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLG 223
            IP   G+       + +  N +TG  P T ++ +   +    N            +   
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDK-- 221

Query: 224 SLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNL 283
                I             +   K L  +D  +NR+ G +P  +   +  L  L +  N 
Sbjct: 222 -NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNN 279

Query: 284 ITGVIPGQLSECTQLKVIDLSLNYLNGSIP 313
           + G IP Q     +  V   + N      P
Sbjct: 280 LCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 64.4 bits (155), Expect = 1e-11
 Identities = 63/267 (23%), Positives = 94/267 (35%), Gaps = 52/267 (19%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNN 85
           +  L+LS   L    P  + S L NL YLN  Y      L   +     KL  L   Y  
Sbjct: 52  VNNLDLSGLNLPKPYP--IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109

Query: 86  LTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTF 145
            T          +   +L+ LD S N +   +P S+S+   L  +    N ++G IP ++
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169

Query: 146 GQLSSLQR-LDLSNNHITGWIPSELGNACD------------------------------ 174
           G  S L   + +S N +TG IP    N                                 
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229

Query: 175 ---------------SLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVL 219
                          +L  L L +N I G+ P  L+   +L  L++S NN+ G  P    
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--G 287

Query: 220 ENLGSLESLILSNNMISGSFPDSISSC 246
            NL   +    +NN      P  + +C
Sbjct: 288 GNLQRFDVSAYANNKCLCGSP--LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.7 bits (148), Expect = 1e-10
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 4/76 (5%)

Query: 123 NCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLP 182
               L  L+L  N + G +P+   QL  L  L++S N++ G IP   G            
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYA 299

Query: 183 HNNITGSFPVTLSSCS 198
           +N      P  L +C+
Sbjct: 300 NNKCLCGSP--LPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 47.1 bits (110), Expect = 6e-06
 Identities = 21/77 (27%), Positives = 31/77 (40%), Gaps = 7/77 (9%)

Query: 49  PNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDL 108
            NL  L+   N + G LP+ L +    L  L++S+NNL G I        +         
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGL-TQLKFLHSLNVSFNNLCGEIPQGG----NLQRFDVSAY 298

Query: 109 SQNHIMDVIPSSLSNCT 125
           + N  +   P  L  CT
Sbjct: 299 ANNKCLCGSP--LPACT 313

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.6 bits (210), Expect = 8e-19
 Identities = 47/234 (20%), Positives = 74/234 (31%), Gaps = 6/234 (2%)

Query: 203 LDLSNNNISGPFPDSVLENLG-SLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSG 261
                  +      +V   +  + + + L  N IS     S  +C+ L I+   SN ++ 
Sbjct: 16  TSCPQQGLQ-----AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70

Query: 262 IIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEH 321
           I            +     +  +  V P       +L  + L    L    P     L  
Sbjct: 71  IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130

Query: 322 LEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELT 381
           L+      N L+           NL  L L+ N++S           +L+ + L  N + 
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190

Query: 382 GQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPR 435
              P  F  L RL  L L  N         L    +L +L LN N    D   R
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.3 bits (204), Expect = 5e-18
 Identities = 51/271 (18%), Positives = 94/271 (34%), Gaps = 13/271 (4%)

Query: 40  VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENS 99
           VP  +         +    N ++  +P         L +L L  N L    +        
Sbjct: 26  VPVGIP---AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81

Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
                        +  V P++     +L  L+L    L    P  F  L++LQ L L +N
Sbjct: 82  LEQ--LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139

Query: 160 HITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVL 219
            +         +   +L  L L  N I+            L  L L  N ++   P +  
Sbjct: 140 ALQALPDDTFRD-LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA-F 197

Query: 220 ENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL 279
            +LG L +L L  N +S    ++++  + L+ +  + N           P  + L++ R 
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC--DCRARPLWAWLQKFRG 255

Query: 280 PDNLITGVIPGQLSECTQLKVIDLSLNYLNG 310
             + +   +P +L+      +  L+ N L G
Sbjct: 256 SSSEVPCSLPQRLA---GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.9 bits (195), Expect = 7e-17
 Identities = 64/280 (22%), Positives = 102/280 (36%), Gaps = 12/280 (4%)

Query: 79  LDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
                  L       ++      +   + L  N I  V  +S   C  L IL L  N+LA
Sbjct: 16  TSCPQQGLQ------AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69

Query: 139 GEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCS 198
                 F  L+ L++LDLS+N     +     +    L  L L    +    P      +
Sbjct: 70  RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129

Query: 199 WLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNR 258
            LQ L L +N +    PD    +LG+L  L L  N IS     +     +L  +    NR
Sbjct: 130 ALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188

Query: 259 VSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGK 318
           V+ + P      +  L  L L  N ++ +    L+    L+ + L+ N            
Sbjct: 189 VAHVHPHAFRD-LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPL 246

Query: 319 LEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSG 358
              L++F    + +   +P  L   ++LK   L  N L G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRL-AGRDLKR--LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.5 bits (163), Expect = 1e-12
 Identities = 50/308 (16%), Positives = 83/308 (26%), Gaps = 51/308 (16%)

Query: 288 IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLK 347
           +P  +   +Q   I L  N ++           +L       N L             L+
Sbjct: 26  VPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 348 DLILNNNKLSGEIPAELFS-CSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKG 406
            L L++N     +    F     L  + L    L    P  F  L  L  L L +N  + 
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 407 EIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKG 466
                  +  +L  L L+ N ++                  F   ++L  +    N    
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPE------------RAFRGLHSLDRLLLHQNRVAH 191

Query: 467 VGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPD 526
           V                                    F     L  L L  N       +
Sbjct: 192 VHP--------------------------------HAFRDLGRLMTLYLFANNLSALPTE 219

Query: 527 EIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQID 586
            +  + ALQ L L  N    +  +       L  F  S + +   +P+  +         
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLK---R 275

Query: 587 LSNNELTG 594
           L+ N+L G
Sbjct: 276 LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (144), Expect = 3e-10
 Identities = 48/271 (17%), Positives = 87/271 (32%), Gaps = 26/271 (9%)

Query: 352 NNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGE 411
               L   +P  + +    + I L GN ++      F     L +L L +N         
Sbjct: 19  PQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 412 LGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTL--VFVRNVGNSCKGVGG 469
               + L  LDL+ N     + P     LG       L +  L    ++ +G        
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVDPATFHGLG------RLHTLHLDRCGLQELGPGLFRGLA 129

Query: 470 LLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIG 529
            L++  ++   L  +P                  F     L +L L  N+          
Sbjct: 130 ALQYLYLQDNALQALPD---------------DTFRDLGNLTHLFLHGNRISSVPERAFR 174

Query: 530 DMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSN 589
            + +L  L L  N+++   P +   L  L       N L     E+ + L  L  + L++
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234

Query: 590 NELTGPIPQRGQLSTLPASQYANNPGLCGVP 620
           N        R   + L   + +++   C +P
Sbjct: 235 NPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.1 bits (141), Expect = 8e-10
 Identities = 50/260 (19%), Positives = 78/260 (30%), Gaps = 27/260 (10%)

Query: 366 SCSNLEW--ISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL 423
            C N      S     L   +P      ++   + L  NR           C +L  L L
Sbjct: 7   VCYNEPKVTTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWL 63

Query: 424 NSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQ 483
           +SN L                           F          +    +   + P     
Sbjct: 64  HSNVLARIDAAA--------------------FTGLALLEQLDLSDNAQLRSVDPATFHG 103

Query: 484 IPTLKSCDFARMYSGPVL-SLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHN 542
           +  L +    R     +   LF     L+YL L  N  +    D   D+  L  L L  N
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163

Query: 543 QLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTG-PIPQRGQ 601
           ++S     +   L +L       NR+    P +F +L  L+ + L  N L+  P      
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223

Query: 602 LSTLPASQYANNPGLCGVPL 621
           L  L   +  +NP +C    
Sbjct: 224 LRALQYLRLNDNPWVCDCRA 243

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.9 bits (198), Expect = 3e-17
 Identities = 42/276 (15%), Positives = 86/276 (31%), Gaps = 15/276 (5%)

Query: 152 QRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNIS 211
           Q LDL+  ++   +   L +    ++  + P + +        S    +Q +DLSN+ I 
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE 59

Query: 212 GPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS--SNRVSGIIPPDICP 269
                 +L     L++L L    +S    ++++    L  ++ S  S      +   +  
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 270 GVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWF 329
                E         T              +  L+L+    ++ +               
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 330 N------GLEGKIPPELGKCKNLKDLILNN-NKLSGEIPAELFSCSNLEWISLTGNELTG 382
                   L+     E  +   L+ L L+    +  E   EL     L+ + + G    G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 383 QIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSL 418
            +      L     LQ+  + F       +GN  + 
Sbjct: 240 TLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQ 272

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.7 bits (169), Expect = 2e-13
 Identities = 39/275 (14%), Positives = 89/275 (32%), Gaps = 13/275 (4%)

Query: 105 HLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGW 164
            LDL+  ++   +   L +   +       + +   +   F     +Q +DLSN+ I   
Sbjct: 4   TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVS 61

Query: 165 IPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSV------ 218
               + + C  L  L L    ++     TL+  S L  L+LS  +    F          
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 219 -LENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL 277
            L+ L        +   +  +      +   L +  +  N     +   +    + +   
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181

Query: 278 RLPDNLITGVIPGQLSECTQLKVIDLS-LNYLNGSIPQELGKLEHLEQFIAWFNGLEGKI 336
                ++      +  +   L+ + LS    +      ELG++  L+    +    +G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241

Query: 337 PPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLE 371
                   +L+   +N +  +      + +  N E
Sbjct: 242 QLLKEALPHLQ---INCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.4 bits (168), Expect = 3e-13
 Identities = 48/277 (17%), Positives = 98/277 (35%), Gaps = 18/277 (6%)

Query: 79  LDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
           LDL+  NL   ++G  L++     ++     ++ +   +    S   +++ ++LS +++ 
Sbjct: 5   LDLTGKNLHPDVTGRLLSQG----VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIE 59

Query: 139 GE-IPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSC 197
              +     Q S LQ L L    ++  I + L     +L+ L L   +    F +     
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK-NSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 198 SWLQLLDLSNNNISGPFPDSVLENLGSLESLI-------LSNNMISGSFPDSISSCKTLR 250
           S  +L +L+ +         V   +  +   I          N+        +  C  L 
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 251 IVDFSSNRVSGIIPPDICPGVSSLEELRLPD-NLITGVIPGQLSECTQLKVIDLSLNYLN 309
            +D S + +           ++ L+ L L     I      +L E   LK + +     +
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238

Query: 310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNL 346
           G++      L HL+      +       P +G  KN 
Sbjct: 239 GTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQ 272

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.4 bits (150), Expect = 5e-11
 Identities = 41/256 (16%), Positives = 88/256 (34%), Gaps = 12/256 (4%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           +   +   +            PF ++ ++LS++ +       + S+   L  L+     L
Sbjct: 25  VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTGSI----SGFSLNENSCNSLLHLDLSQNHIMDVI 117
           +  +  TL  NS+ + L     +  +              +  N     D ++ H+   +
Sbjct: 84  SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143

Query: 118 PSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLL 177
                  T+L +     NL   ++     +  +L  LDLS++ +      +     + L 
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203

Query: 178 ELKLPH-NNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL-GSLESLILSNNMI 235
            L L    +I     + L     L+ L +         PD  L+ L  +L  L ++ +  
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-----VPDGTLQLLKEALPHLQINCSHF 258

Query: 236 SGSFPDSISSCKTLRI 251
           +     +I + K   I
Sbjct: 259 TTIARPTIGNKKNQEI 274

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.004
 Identities = 16/71 (22%), Positives = 32/71 (45%), Gaps = 2/71 (2%)

Query: 497 SGPVLSLFTQYQTLEYLDLSYNQFRGK-IPDEIGDMIALQVLELAHNQLSGEIPSSLGRL 555
             P+   F+ ++ ++++DLS +      +   +     LQ L L   +LS  I ++L + 
Sbjct: 36  DQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKN 94

Query: 556 RNLGVFDASHN 566
            NL   + S  
Sbjct: 95  SNLVRLNLSGC 105

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.0 bits (162), Expect = 1e-12
 Identities = 48/206 (23%), Positives = 72/206 (34%), Gaps = 9/206 (4%)

Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
             S LE+     N+T + P  L       +L LS N +   F  + L     L  L L  
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYT-FSLATLMPYTRLTQLNLDR 64

Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQL 292
             ++    D          +  +  +      P +   + +L  L +  N +T +  G L
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQ----SLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 293 SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILN 352
               +L+ + L  N L    P  L     LE+     N L       L   +NL  L+L 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 353 NNKLSGEIPAELFSCSNLEWISLTGN 378
            N L   IP   F    L +  L GN
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.7 bits (161), Expect = 2e-12
 Identities = 42/213 (19%), Positives = 77/213 (36%), Gaps = 10/213 (4%)

Query: 144 TFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLL 203
              +++S   ++    ++T  +P +L         L L  N +      TL   + L  L
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 204 DLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGII 263
           +L    ++    D  L  LG+L+        +        +        +  ++     +
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-----L 115

Query: 264 PPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLE 323
           P     G+  L+EL L  N +  + PG L+   +L+ + L+ N L       L  LE+L+
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 324 QFIAWFNGLEGKIPPELGKCKNLKDLILNNNKL 356
             +   N L   IP        L    L+ N  
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.7 bits (156), Expect = 6e-12
 Identities = 43/211 (20%), Positives = 65/211 (30%), Gaps = 26/211 (12%)

Query: 242 SISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
            +S   +   V+     ++ + PPD+         L L +NL+       L   T+L  +
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 302 DLS-LNYLNGSIPQELGKLEHLEQFIAWF--------------------NGLEGKIPPEL 340
           +L         +   L  L  L+                          N L       L
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 341 GKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLG 400
                L++L L  N+L    P  L     LE +SL  N LT       + L  L  L L 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 401 NNRFKGEIPGELGNCSSLVWLDLNSNNLTGD 431
            N     IP        L +  L+ N    +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.0 bits (149), Expect = 6e-11
 Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 10/212 (4%)

Query: 98  NSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLS 157
           +   S L ++  + ++   +P  L       IL+LS NLL      T    + L +L+L 
Sbjct: 7   SKVASHLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 158 NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDS 217
              +T        +    +L      +N   S P+   +   L +LD+S N ++   P  
Sbjct: 64  RAELTKLQV----DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-LPLG 118

Query: 218 VLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL 277
            L  LG L+ L L  N +    P  ++    L  +  ++N ++  +P  +  G+ +L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTL 177

Query: 278 RLPDNLITGVIPGQLSECTQLKVIDLSLNYLN 309
            L +N +   IP        L    L  N   
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.3 bits (147), Expect = 1e-10
 Identities = 39/208 (18%), Positives = 62/208 (29%), Gaps = 30/208 (14%)

Query: 71  SNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKIL 130
           S       ++    NLT      +L  +       L LS+N +     ++L   T+L  L
Sbjct: 7   SKVASHLEVNCDKRNLT------ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 131 NLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGN------------------- 171
           NL          +  G L  L  LDLS+N +                             
Sbjct: 61  NLDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 172 --ACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLI 229
                  L+      N   + P  L + +         NN     P  +L  L +L++L+
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 230 LSNNMISGSFPDSISSCKTLRIVDFSSN 257
           L  N +  + P        L       N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.5 bits (145), Expect = 2e-10
 Identities = 41/213 (19%), Positives = 73/213 (34%), Gaps = 11/213 (5%)

Query: 193 TLSSCSWLQLLDLSNNNISGPFPDSVLENLG-SLESLILSNNMISGSFPDSISSCKTLRI 251
            +S  +    ++    N++     ++  +L      L LS N++      ++     L  
Sbjct: 5   EVSKVASHLEVNCDKRNLT-----ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 252 VDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS 311
           ++     ++ +      P + +        +     +P        L V+D+S N L   
Sbjct: 60  LNLDRAELTKLQVDGTLPVLGT----LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115

Query: 312 IPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLE 371
               L  L  L++     N L+   P  L     L+ L L NN L+      L    NL+
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 372 WISLTGNELTGQIPPEFSRLTRLAVLQLGNNRF 404
            + L  N L   IP  F     L    L  N +
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 3e-10
 Identities = 46/209 (22%), Positives = 71/209 (33%), Gaps = 14/209 (6%)

Query: 25  GLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYN 84
              ++      L   +P +L     +   L+ S N L  F   T L    +L  L+L   
Sbjct: 11  SHLEVNCDKRNLTA-LPPDLP---KDTTILHLSENLLYTFSLAT-LMPYTRLTQLNLDRA 65

Query: 85  NLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRT 144
            LT      +L       +L      ++ +  +P        L +L++SFN L       
Sbjct: 66  ELTKLQVDGTL------PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 145 FGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLD 204
              L  LQ L L  N +   +P  L      L +L L +NN+T      L+    L  L 
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 205 LSNNNISGPFPDSVLENLGSLESLILSNN 233
           L  N++              L    L  N
Sbjct: 179 LQENSLYTIPKG--FFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.6 bits (135), Expect = 3e-09
 Identities = 30/207 (14%), Positives = 50/207 (24%), Gaps = 5/207 (2%)

Query: 339 ELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQ 398
           E+ K  +  ++  +   L+  +P +L    +   + L+ N L           TRL  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 399 LGNNRFK-GEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFV 457
           L        ++ G L    +L        +L           +         S       
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 458 RNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSY 517
                    + G                  K        +     L    + L+ L L  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 518 NQFRGKIPDEIGDMIALQVLELAHNQL 544
           N     IP        L    L  N  
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 3e-08
 Identities = 46/255 (18%), Positives = 71/255 (27%), Gaps = 53/255 (20%)

Query: 366 SCSNLEW---ISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLD 422
             S +     ++     LT  +PP+  + T   +L L  N         L   + L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 423 LNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLL 482
           L+   LT                                                     
Sbjct: 62  LDRAELTKLQVDG----------------------------------------------- 74

Query: 483 QIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHN 542
            +P L + D +      +  L      L  LD+S+N+        +  +  LQ L L  N
Sbjct: 75  TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134

Query: 543 QLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQL 602
           +L    P  L     L     ++N L        + L  L  + L  N L          
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGS 194

Query: 603 STLPASQYANNPGLC 617
             LP +    NP LC
Sbjct: 195 HLLPFAFLHGNPWLC 209

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 57.4 bits (138), Expect = 1e-10
 Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 8/111 (7%)

Query: 128 KILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNIT 187
           ++L+L+   L   +     QL  +  LDLS+N +    P+       +L  L++   +  
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-----LAALRCLEVLQASDN 53

Query: 188 GSFPV-TLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG 237
               V  +++   LQ L L NN +        L +   L  L L  N +  
Sbjct: 54  ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 55.1 bits (132), Expect = 1e-09
 Identities = 24/130 (18%), Positives = 41/130 (31%), Gaps = 12/130 (9%)

Query: 53  YLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNH 112
            L+ ++ +LT       L     +  LDLS+N L       +             L  + 
Sbjct: 2   VLHLAHKDLTVLCH---LEQLLLVTHLDLSHNRLRALPPALAALRCLE------VLQASD 52

Query: 113 IMDVIPSSLSNCTKLKILNLSFNLLAG-EIPRTFGQLSSLQRLDLSNNHITG--WIPSEL 169
                   ++N  +L+ L L  N L      +       L  L+L  N +     I   L
Sbjct: 53  NALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 112

Query: 170 GNACDSLLEL 179
                S+  +
Sbjct: 113 AEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 53.2 bits (127), Expect = 6e-09
 Identities = 25/123 (20%), Positives = 54/123 (43%), Gaps = 9/123 (7%)

Query: 201 QLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVS 260
           ++L L++ +++       LE L  +  L LS+N +    P ++++ + L ++  S N + 
Sbjct: 1   RVLHLAHKDLTVL---CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE 56

Query: 261 GIIPPDICPGVSSLEELRLPDNLITGV-IPGQLSECTQLKVIDLSLNYLNGSIPQELGKL 319
            +      P +   +EL L +N +        L  C +L +++L  N L         +L
Sbjct: 57  NVDGVANLPRL---QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERL 112

Query: 320 EHL 322
             +
Sbjct: 113 AEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 1e-07
 Identities = 30/108 (27%), Positives = 45/108 (41%), Gaps = 6/108 (5%)

Query: 336 IPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLA 395
           +   L +   +  L L++N+L    P  L +   LE +  + N    +     + L RL 
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALENVDGVANLPRLQ 68

Query: 396 VLQLGNNRFKG-EIPGELGNCSSLVWLDLNSNNLTG--DIPPRLGRQL 440
            L L NNR +       L +C  LV L+L  N+L     I  RL   L
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 4e-07
 Identities = 22/110 (20%), Positives = 38/110 (34%), Gaps = 8/110 (7%)

Query: 179 LKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGS 238
           L L H ++T      L     +  LDLS+N +    P      L +L  L +     +  
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDNAL 55

Query: 239 F-PDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV 287
              D +++   L+ +   +NR+              L  L L  N +   
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 5e-07
 Identities = 22/117 (18%), Positives = 42/117 (35%), Gaps = 26/117 (22%)

Query: 512 YLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNL------------- 558
            L L++      +   +  ++ +  L+L+HN+L    P+ L  LR L             
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58

Query: 559 ---------GVFDASHNRLQG-QIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTL 605
                          +NRLQ     +   +   LV ++L  N L      + +L+ +
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 23/87 (26%), Positives = 34/87 (39%), Gaps = 4/87 (4%)

Query: 2   LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNL 61
           ++ L LS N       +L      L+ LE+  A    L   +  + LP L  L    N L
Sbjct: 22  VTHLDLSHNRLRALPPAL----AALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRL 77

Query: 62  TGFLPETLLSNSDKLELLDLSYNNLTG 88
                   L +  +L LL+L  N+L  
Sbjct: 78  QQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 59.7 bits (143), Expect = 2e-10
 Identities = 41/227 (18%), Positives = 75/227 (33%), Gaps = 20/227 (8%)

Query: 175 SLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNM 234
           + +++    +N+T    VT +    +  L      ++       ++ L +L  L L +N 
Sbjct: 20  NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELKDNQ 74

Query: 235 ISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSE 294
           I       ++  K L  +       + +       G+ S++ L L    IT V P     
Sbjct: 75  I-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129

Query: 295 CTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNN 354
             Q       L      I                    +      L     L  L  ++N
Sbjct: 130 NLQ------VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 355 KLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGN 401
           K+S   P  L S  NL  + L  N+++   P   +  + L ++ L N
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.2 bits (134), Expect = 3e-09
 Identities = 30/239 (12%), Positives = 66/239 (27%), Gaps = 22/239 (9%)

Query: 186 ITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISS 245
           I   FP    + +    +    +N++         +L  + +L      ++    + +  
Sbjct: 9   INVIFP--DPALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTI--EGVQY 61

Query: 246 CKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSL 305
              L  ++   N+++ + P              L       +    L   + +  +    
Sbjct: 62  LNNLIGLELKDNQITDLAPLK-----------NLTKITELELSGNPLKNVSAIAGLQSIK 110

Query: 306 NYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELF 365
                S              +        +I              L+           L 
Sbjct: 111 TLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLA 170

Query: 366 SCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLN 424
           + S L  +    N+++   P   + L  L  + L NN+     P  L N S+L  + L 
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 55.8 bits (133), Expect = 4e-09
 Identities = 47/230 (20%), Positives = 77/230 (33%), Gaps = 29/230 (12%)

Query: 39  LVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNEN 98
           + PD     L N + + A  +N+T  + +  L     +  L      +T +I G      
Sbjct: 12  IFPD---PALANAIKIAAGKSNVTDTVTQADLDG---ITTLSAFGTGVT-TIEGVQ---- 60

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSN 158
             N+L+ L+L  N I D+ P           L+ +       I       +         
Sbjct: 61  YLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120

Query: 159 NHITGWIPSELGNACDSLLELKLP-------------HNNITGSFPVTLSSCSWLQLLDL 205
           +       S L      L ++                  N   S    L++ S L  L  
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180

Query: 206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS 255
            +N IS   P   L +L +L  + L NN IS   P  +++   L IV  +
Sbjct: 181 DDNKISDISP---LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.6 bits (122), Expect = 1e-07
 Identities = 37/230 (16%), Positives = 68/230 (29%), Gaps = 17/230 (7%)

Query: 363 ELFSCSNLEW---ISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV 419
            +F    L     I+   + +T  +    + L  +  L          I G +   ++L+
Sbjct: 11  VIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLI 66

Query: 420 WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPE 479
            L+L  N +T   P +   ++    L G    N              +            
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 480 RLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLEL 539
            L  +  L                           LS    +      + ++  L  L+ 
Sbjct: 127 GLSNLQVLYLDLNQITNI------SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180

Query: 540 AHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSN 589
             N++S   P  L  L NL      +N++    P   +N S L  + L+N
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 4e-07
 Identities = 30/222 (13%), Positives = 57/222 (25%), Gaps = 14/222 (6%)

Query: 344 KNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNR 403
            N   +    + ++  +         +  +S  G  +T         L  L  L+L +N+
Sbjct: 19  ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74

Query: 404 FKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNS 463
                          +            +                L+S  +  V  +   
Sbjct: 75  ITDL------APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128

Query: 464 CKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGK 523
                  L+   I     L   T              L+       L  L    N+    
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188

Query: 524 IPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASH 565
            P  +  +  L  + L +NQ+S   P  L    NL +   ++
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 20/99 (20%), Positives = 34/99 (34%), Gaps = 29/99 (29%)

Query: 109 SQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSE 168
           S  +      + L+N +KL  L    N ++   P     L +L  + L NN I+   P  
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212

Query: 169 LGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSN 207
                                    L++ S L ++ L+N
Sbjct: 213 -------------------------LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 0.001
 Identities = 14/63 (22%), Positives = 28/63 (44%), Gaps = 6/63 (9%)

Query: 20  LQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELL 79
           L     L  L+     +  + P    + LPNL+ ++   N ++   P   L+N+  L ++
Sbjct: 169 LANLSKLTTLKADDNKISDISP---LASLPNLIEVHLKNNQISDVSP---LANTSNLFIV 222

Query: 80  DLS 82
            L+
Sbjct: 223 TLT 225

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 61.4 bits (147), Expect = 2e-10
 Identities = 50/339 (14%), Positives = 98/339 (28%), Gaps = 25/339 (7%)

Query: 95  LNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRL 154
           L +        L+L+   +   +P    +   L+ L  S N L  E+P     L SL   
Sbjct: 32  LRDCLDRQAHELELNNLGLSS-LPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVD 86

Query: 155 DLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPF 214
           + +   ++   P        +    KLP    +    +     + L+ L     ++    
Sbjct: 87  NNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIA 146

Query: 215 PDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSL 274
             +           +     I                ++      + +        +  L
Sbjct: 147 AGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206

Query: 275 EELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAW------ 328
             +   +NL+  +     S        +   +            +               
Sbjct: 207 TTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL 266

Query: 329 --FNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPP 386
              N    +I        +L++L ++NNKL  E+PA       LE +  + N L  ++P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE 321

Query: 387 EFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNS 425
               L     L +  N  + E P       S+  L +NS
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDIP---ESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.2 bits (131), Expect = 2e-08
 Identities = 18/79 (22%), Positives = 35/79 (44%), Gaps = 9/79 (11%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDA 563
                +LE L++S N+   ++P        L+ L  + N L+ E+P     L+ L     
Sbjct: 280 CDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQL---HV 331

Query: 564 SHNRLQGQIPESFSNLSFL 582
            +N L+ + P+   ++  L
Sbjct: 332 EYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.2 bits (131), Expect = 2e-08
 Identities = 23/91 (25%), Positives = 36/91 (39%), Gaps = 8/91 (8%)

Query: 515 LSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPE 574
              N    +I        +L+ L +++N+L  E+P+   RL  L    AS N L  ++PE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPE 321

Query: 575 SFSNLSFLVQIDLSNNELTGPIPQRGQLSTL 605
              NL  L    +  N L         +  L
Sbjct: 322 LPQNLKQL---HVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.8 bits (130), Expect = 2e-08
 Identities = 53/325 (16%), Positives = 90/325 (27%), Gaps = 25/325 (7%)

Query: 124 CTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELG---------NACD 174
             +   L L+   L+  +P        L+ L  S N +T  +P             N   
Sbjct: 37  DRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91

Query: 175 SLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNM 234
           +L +L      +  S               L   ++       + +   SLE +   NN 
Sbjct: 92  ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151

Query: 235 ISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSE 294
           +            T    D +S +    +P  +   V+    L     L           
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL-TTIY 210

Query: 295 CTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNN 354
                +  L     +                +                   L   +   N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270

Query: 355 KLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGN 414
             S EI +      +LE ++++ N+L  ++P    RL R   L    N    E+P    N
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQN 325

Query: 415 CSSLVWLDLNSNNLTG--DIPPRLG 437
              L  L +  N L    DIP  + 
Sbjct: 326 ---LKQLHVEYNPLREFPDIPESVE 347

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.1 bits (123), Expect = 2e-07
 Identities = 63/341 (18%), Positives = 112/341 (32%), Gaps = 32/341 (9%)

Query: 22  LPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL 81
           L     +LEL++ GL  L P+      P+L  L AS N+LT  LPE   S    L+ L +
Sbjct: 36  LDRQAHELELNNLGLSSL-PELP----PHLESLVASCNSLTE-LPELPQS----LKSLLV 85

Query: 82  SYNNLTGSISGFSLNENSCNSLLH---------LDLSQNHIMDVIPSSLSNCTKLKILNL 132
             NNL        L E    S                +   +D             +  +
Sbjct: 86  DNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFI 145

Query: 133 SFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPV 192
           +      E       L  L  +   NN +       L           L       + P 
Sbjct: 146 AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLP- 204

Query: 193 TLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIV 252
            L++      L  +  ++        + +    +   L  ++      ++I S  +    
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264

Query: 253 DFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSI 312
           +      S      +C    SLEEL + +N +   +P       +L+ +  S N+L   +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLA-EV 319

Query: 313 PQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNN 353
           P+    L+ L      +N L  + P      ++L+   +N+
Sbjct: 320 PELPQNLKQLH---VEYNPLR-EFPDIPESVEDLR---MNS 353

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.3 bits (137), Expect = 4e-10
 Identities = 29/151 (19%), Positives = 49/151 (32%), Gaps = 9/151 (5%)

Query: 108 LSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPS 167
           L+   I     +  +N  + + L+L    +   I      L     +D S+N I      
Sbjct: 3   LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 59

Query: 168 ELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLES 227
                   L  L + +N I         +   L  L L+NN++        L +L SL  
Sbjct: 60  P---LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 116

Query: 228 LILSN---NMISGSFPDSISSCKTLRIVDFS 255
           L +               I     +R++DF 
Sbjct: 117 LCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 9e-05
 Identities = 21/122 (17%), Positives = 40/122 (32%), Gaps = 4/122 (3%)

Query: 504 FTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDA 563
           +T       LDL   +    I +    +     ++ + N++          LR L     
Sbjct: 14  YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLV 70

Query: 564 SHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPE 623
           ++NR+          L  L ++ L+NN L   +     L++L +  Y             
Sbjct: 71  NNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKH 129

Query: 624 CR 625
            R
Sbjct: 130 YR 131

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (94), Expect = 2e-04
 Identities = 24/132 (18%), Positives = 46/132 (34%), Gaps = 7/132 (5%)

Query: 176 LLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMI 235
             EL L    I        ++      +D S+N I           L  L++L+++NN I
Sbjct: 20  DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP---LLRRLKTLLVNNNRI 75

Query: 236 SGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRL---PDNLITGVIPGQL 292
                    +   L  +  ++N +  +   D    + SL  L +   P           +
Sbjct: 76  CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVI 135

Query: 293 SECTQLKVIDLS 304
            +  Q++V+D  
Sbjct: 136 YKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 22/152 (14%), Positives = 49/152 (32%), Gaps = 6/152 (3%)

Query: 6   KLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFL 65
           KL++ L  +   +        ++L+L    +  +  +NL + L     ++ S N +    
Sbjct: 2   KLTAEL--IEQAAQYTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIRKLD 57

Query: 66  PETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCT 125
              LL     L + +     +   +       +    +L  +           +SL + T
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQA--LPDLTELILTNNSLVELGDLDPLASLKSLT 115

Query: 126 KLKILNLSFNLLAGEIPRTFGQLSSLQRLDLS 157
            L IL                ++  ++ LD  
Sbjct: 116 YLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 0.001
 Identities = 26/130 (20%), Positives = 41/130 (31%), Gaps = 7/130 (5%)

Query: 272 SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNG 331
               EL L    I  VI    +   Q   ID S N +          L  L+  +   N 
Sbjct: 18  VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNNR 74

Query: 332 LEGKIPPELGKCKNLKDLILNNNKLSG-EIPAELFSCSNLEWISLTG---NELTGQIPPE 387
           +            +L +LIL NN L        L S  +L ++ +               
Sbjct: 75  ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134

Query: 388 FSRLTRLAVL 397
             ++ ++ VL
Sbjct: 135 IYKVPQVRVL 144

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.8 bits (145), Expect = 5e-10
 Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 9/102 (8%)

Query: 88  GSISGFSLNENSCNSLLHLDLSQNHIMDV----IPSSLSNCTKLKILNLSFNLLAGEIPR 143
           G            + L  L L+   + D     + ++L     L+ L+LS N L      
Sbjct: 356 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415

Query: 144 TFGQ-----LSSLQRLDLSNNHITGWIPSELGNACDSLLELK 180
              +        L++L L + + +  +   L         L+
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.6 bits (142), Expect = 1e-09
 Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 8/93 (8%)

Query: 150 SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITG----SFPVTLSSCSWLQLLDL 205
            +Q LD+    ++    +EL         ++L    +T          L     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 206 SNNNISGPFPDSVLENLGS----LESLILSNNM 234
            +N +       VL+ L +    ++ L L N  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.8 bits (140), Expect = 2e-09
 Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 6/90 (6%)

Query: 50  NLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTG-SISGFSLNENSCNSLLHLDL 108
           ++  L+     L+      LL    + +++ L    LT       S       +L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 109 SQNHIMDVIPSSL-----SNCTKLKILNLS 133
             N + DV    +     +   K++ L+L 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.1 bits (138), Expect = 4e-09
 Identities = 21/99 (21%), Positives = 35/99 (35%), Gaps = 12/99 (12%)

Query: 70  LSNSDKLELLDLSYNNLTG-SISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLS-----N 123
                 L +L L+  +++  S S  +    + +SL  LDLS N + D     L       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 124 CTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT 162
              L+ L L     + E+         LQ L+     + 
Sbjct: 425 GCLLEQLVLYDIYWSEEMED------RLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.9 bits (135), Expect = 7e-09
 Identities = 21/104 (20%), Positives = 34/104 (32%), Gaps = 11/104 (10%)

Query: 73  SDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHI----MDVIPSSLSNCTKLK 128
           S  ++ LD+    L+ +   ++           + L    +       I S+L     L 
Sbjct: 1   SLDIQSLDIQCEELSDA--RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58

Query: 129 ILNLSFNLLAGEIPRTFGQL-----SSLQRLDLSNNHITGWIPS 167
            LNL  N L         Q        +Q+L L N  +TG    
Sbjct: 59  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.9 bits (135), Expect = 8e-09
 Identities = 13/88 (14%), Positives = 34/88 (38%), Gaps = 8/88 (9%)

Query: 200 LQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISG----SFPDSISSCKTLRIVDFS 255
           +Q LD+    +S      +L  L   + + L +  ++         ++     L  ++  
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 256 SNRVSGIIPPDICPGVSS----LEELRL 279
           SN +  +    +  G+ +    +++L L
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (133), Expect = 1e-08
 Identities = 22/119 (18%), Positives = 39/119 (32%), Gaps = 25/119 (21%)

Query: 118 PSSLSNCTKLKILNLSFNLL----AGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNAC 173
                  + L++L L+   +       +  T     SL+ LDLSNN +      +L  + 
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES- 420

Query: 174 DSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESL-ILS 231
                ++ P                 L+ L L +   S    D +        SL ++S
Sbjct: 421 -----VRQPGCL--------------LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 2e-08
 Identities = 14/93 (15%), Positives = 30/93 (32%), Gaps = 9/93 (9%)

Query: 102 SLLHLDLSQNHIMDV-IPSSLSNCTKLKILNLSFNLL----AGEIPRTFGQLSSLQRLDL 156
            +  LD+    + D      L    + +++ L    L      +I        +L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 157 SNNHITG----WIPSELGNACDSLLELKLPHNN 185
            +N +       +   L      + +L L +  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.6 bits (129), Expect = 4e-08
 Identities = 24/112 (21%), Positives = 40/112 (35%), Gaps = 29/112 (25%)

Query: 149 SSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNN 208
           S L+ L L++  ++    S L                        L +   L+ LDLSNN
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAAT---------------------LLANHSLRELDLSNN 407

Query: 209 NISGP----FPDSVLENLGSLESLILSNNMISGSFPDSIS----SCKTLRIV 252
            +         +SV +    LE L+L +   S    D +        +LR++
Sbjct: 408 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 3e-07
 Identities = 17/93 (18%), Positives = 28/93 (30%), Gaps = 10/93 (10%)

Query: 345 NLKDLILNNNKLSGEIPAELFSC-SNLEWISLTGNELTGQ----IPPEFSRLTRLAVLQL 399
           +++ L +   +LS    AEL       + + L    LT      I         LA L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 400 GNNRFKGEIPGELG-----NCSSLVWLDLNSNN 427
            +N         +          +  L L +  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 4e-07
 Identities = 15/94 (15%), Positives = 27/94 (28%), Gaps = 5/94 (5%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETL---LSNSDKLELLDLS 82
           ++ L++    L       L   L     +      LT    + +   L  +  L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 83  YNNLT--GSISGFSLNENSCNSLLHLDLSQNHIM 114
            N L   G        +     +  L L    + 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 5e-07
 Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 4/75 (5%)

Query: 249 LRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV----IPGQLSECTQLKVIDLS 304
           ++ +D     +S     ++ P +   + +RL D  +T      I   L     L  ++L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 305 LNYLNGSIPQELGKL 319
            N L       + + 
Sbjct: 64  SNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 2e-06
 Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 11/96 (11%)

Query: 45  FSKLPNLVYLNASYNNLTGFLPETL---LSNSDKLELLDLSYNNLTGSIS---GFSLNEN 98
                 L  L  +  +++     +L   L  +  L  LDLS N L  +       S+ + 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLS----NCTKLKIL 130
            C  L  L L   +  + +   L     +   L+++
Sbjct: 425 GCL-LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 5/77 (6%)

Query: 369 NLEWISLTGNELTGQIPPE-FSRLTRLAVLQLGNNRFKGE----IPGELGNCSSLVWLDL 423
           +++ + +   EL+     E    L +  V++L +          I   L    +L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 424 NSNNLTGDIPPRLGRQL 440
            SN L       + + L
Sbjct: 63  RSNELGDVGVHCVLQGL 79

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 10/91 (10%)

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIA-LQVLELAHNQLSGE----IPSSLGRLRNLGVFDAS 564
           ++ LD+   +       E+  ++   QV+ L    L+      I S+L     L   +  
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 565 HNRLQGQIPESF-----SNLSFLVQIDLSNN 590
            N L             +    + ++ L N 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 4e-06
 Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 5/88 (5%)

Query: 474 AGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI- 532
              +P  +L++  L  CD +      + +      +L  LDLS N        ++ + + 
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 533 ----ALQVLELAHNQLSGEIPSSLGRLR 556
                L+ L L     S E+   L  L 
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 7e-06
 Identities = 16/93 (17%), Positives = 25/93 (26%), Gaps = 9/93 (9%)

Query: 361 PAELFSCSNLEWISLTGNELTGQ----IPPEFSRLTRLAVLQLGNNRFKGEIPGELG--- 413
                  S L  + L   +++      +         L  L L NN        +L    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 414 --NCSSLVWLDLNSNNLTGDIPPRLGRQLGAKP 444
                 L  L L     + ++  RL      KP
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKP 454

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 8e-06
 Identities = 17/112 (15%), Positives = 34/112 (30%), Gaps = 24/112 (21%)

Query: 213 PFPDSVLENLGSLESLILSNNMISG----SFPDSISSCKTLRIVDFSSNRVSGIIPPDIC 268
                + +    L  L L++  +S     S   ++ +  +LR +D S+N +       + 
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418

Query: 269 PGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLE 320
             V                          L+ + L   Y +  +   L  LE
Sbjct: 419 ESVRQP--------------------GCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 9e-06
 Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 5/70 (7%)

Query: 534 LQVLELAHNQLSGE-IPSSLGRLRNLGVFDASHNRLQGQ----IPESFSNLSFLVQIDLS 588
           +Q L++   +LS       L  L+   V       L       I  +      L +++L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 589 NNELTGPIPQ 598
           +NEL      
Sbjct: 64  SNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 16/75 (21%), Positives = 27/75 (36%), Gaps = 9/75 (12%)

Query: 534 LQVLELAHNQLSGE----IPSSLGRLRNLGVFDASHNRLQGQIPESFS-----NLSFLVQ 584
           L+VL LA   +S      + ++L    +L   D S+N L                  L Q
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 585 IDLSNNELTGPIPQR 599
           + L +   +  +  R
Sbjct: 431 LVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 18/108 (16%), Positives = 33/108 (30%), Gaps = 25/108 (23%)

Query: 289 PGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD 348
            G     + L+V+ L+   ++ S    L                       L    +L++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAAT--------------------LLANHSLRE 401

Query: 349 LILNNNKLSGEIPAELFS-----CSNLEWISLTGNELTGQIPPEFSRL 391
           L L+NN L      +L          LE + L     + ++      L
Sbjct: 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 7e-05
 Identities = 14/106 (13%), Positives = 33/106 (31%), Gaps = 27/106 (25%)

Query: 298 LKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS 357
           ++ +D+    L+ +   EL                       L   +  + + L++  L+
Sbjct: 4   IQSLDIQCEELSDARWAEL-----------------------LPLLQQCQVVRLDDCGLT 40

Query: 358 GE----IPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQL 399
                 I + L     L  ++L  NEL         +  +    ++
Sbjct: 41  EARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 21/101 (20%), Positives = 34/101 (33%), Gaps = 23/101 (22%)

Query: 268 CPGVSSLEELRLPDNLITGV----IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLE 323
               S L  L L D  ++      +   L     L+ +DLS N L  +   +L  +E + 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL--VESVR 422

Query: 324 QFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAEL 364
           Q                     L+ L+L +   S E+   L
Sbjct: 423 Q-----------------PGCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 3e-04
 Identities = 15/72 (20%), Positives = 25/72 (34%), Gaps = 7/72 (9%)

Query: 26  LKQLELSSAGLVGLVPDNL---FSKLPNLVYLNASYNNLTGF----LPETLLSNSDKLEL 78
           L+ L L+   +      +L        +L  L+ S N L       L E++      LE 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 79  LDLSYNNLTGSI 90
           L L     +  +
Sbjct: 431 LVLYDIYWSEEM 442

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 9/61 (14%), Positives = 16/61 (26%), Gaps = 4/61 (6%)

Query: 499 PVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIA----LQVLELAHNQLSGEIPSSLGR 554
               L    Q  + + L           +I   +     L  L L  N+L       + +
Sbjct: 18  RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ 77

Query: 555 L 555
            
Sbjct: 78  G 78

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.7 bits (136), Expect = 6e-10
 Identities = 29/141 (20%), Positives = 48/141 (34%), Gaps = 12/141 (8%)

Query: 95  LNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRL 154
           +++    S   LDL            L       +LN   ++ A  +      +  L  L
Sbjct: 16  MSKRYDGSQQALDLKGLRS----DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSL 70

Query: 155 DLSNNHITGWIP-SELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP 213
           +LSNN +      S +     +L  L L  N +     +       L+ L L  N++S  
Sbjct: 71  NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130

Query: 214 FPD------SVLENLGSLESL 228
           F D      ++ E    L  L
Sbjct: 131 FRDQSTYISAIRERFPKLLRL 151

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (102), Expect = 2e-05
 Identities = 26/111 (23%), Positives = 46/111 (41%), Gaps = 6/111 (5%)

Query: 60  NLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV--I 117
           +L G   +  L   +   +L+   +++  ++     N      LL L+LS N +  +  +
Sbjct: 28  DLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRIIEEN---IPELLSLNLSNNRLYRLDDM 83

Query: 118 PSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSE 168
            S +     LKILNLS N L  E      +   L+ L L  N ++     +
Sbjct: 84  SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 3e-05
 Identities = 32/146 (21%), Positives = 46/146 (31%), Gaps = 13/146 (8%)

Query: 17  TSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKL 76
             ++   +   Q  L    L GL  D         V LN   +         +  N  +L
Sbjct: 13  KLIMSKRYDGSQQALD---LKGLRSDPDLVAQNIDVVLNRRSSMAA--TLRIIEENIPEL 67

Query: 77  ELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNL 136
             L+LS N L   +   S       +L  L+LS N +            KL+ L L  N 
Sbjct: 68  LSLNLSNNRLYR-LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126

Query: 137 LAGEIPRTFG-------QLSSLQRLD 155
           L+               +   L RLD
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (97), Expect = 9e-05
 Identities = 32/159 (20%), Positives = 58/159 (36%), Gaps = 11/159 (6%)

Query: 155 DLSNNHITGWIPSELGNACD-SLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP 213
           +L    +   +   +    D S   L L            L + +   +L+  ++  +  
Sbjct: 3   ELKPEQVEQ-LKLIMSKRYDGSQQALDLKGLR----SDPDLVAQNIDVVLNRRSSMAA-- 55

Query: 214 FPDSVLENLGSLESLILSNNMISG--SFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGV 271
               + EN+  L SL LSNN +         +     L+I++ S N +      D   G 
Sbjct: 56  TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKG- 114

Query: 272 SSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNG 310
             LEEL L  N ++     Q +  + ++     L  L+G
Sbjct: 115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 6e-04
 Identities = 22/125 (17%), Positives = 41/125 (32%), Gaps = 5/125 (4%)

Query: 311 SIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNL 370
            +   + K     Q      GL  +  P+L        L   ++  +  +     +   L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67

Query: 371 EWISLTGNELTGQ--IPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNL 428
             ++L+ N L     +     +   L +L L  N  K E   +      L  L L+ N+L
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 429 TGDIP 433
           +    
Sbjct: 128 SDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 0.001
 Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 6/116 (5%)

Query: 485 PTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQL 544
            + ++ D   + S P L        L       +     +     ++  L  L L++N+L
Sbjct: 22  GSQQALDLKGLRSDPDLVAQNIDVVLNRR----SSMAATLRIIEENIPELLSLNLSNNRL 77

Query: 545 SG--EIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQ 598
               ++ S + +  NL + + S N L+ +          L ++ L  N L+     
Sbjct: 78  YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 56.8 bits (135), Expect = 5e-09
 Identities = 52/332 (15%), Positives = 92/332 (27%), Gaps = 34/332 (10%)

Query: 93  FSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLL----AGEIPRTFGQL 148
           FS+   S    L LD         + + L     +K + LS N +    A  +       
Sbjct: 3   FSIEGKS----LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 58

Query: 149 SSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNN 208
             L+  + S+      +  E+  A   LL+  L    +        +     Q   +   
Sbjct: 59  KDLEIAEFSDIFTG-RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 117

Query: 209 NISGPFPDSVLENLGSLESLIL--SNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPD 266
           +   P     L N G         +  +   +      +   LR +    NR+      +
Sbjct: 118 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 177

Query: 267 ICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFI 326
                 S   L                        +   + L   +           Q  
Sbjct: 178 WAKTFQSHRLLHTVKM------------VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN 225

Query: 327 AWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSC------SNLEWISLTGNEL 380
            + +     +   L    NL++L LN+  LS    A +           L+ + L  NE+
Sbjct: 226 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 285

Query: 381 TGQIPPE-----FSRLTRLAVLQLGNNRFKGE 407
                         ++  L  L+L  NRF  E
Sbjct: 286 ELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 52.6 bits (124), Expect = 1e-07
 Identities = 36/315 (11%), Positives = 77/315 (24%), Gaps = 15/315 (4%)

Query: 126 KLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNA---CDSLLELKLP 182
            LK+  ++       +     +  S++ + LS N I       L         L   +  
Sbjct: 9   SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 183 HNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDS 242
                        +   L    L    +             + E LI   +  +      
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 243 ISSCKTL-RIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVI 301
           + +     +     +  +  +           L  +    N +      + ++  Q   +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187

Query: 302 DLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIP 361
             ++  +   I  E  +   LE            +            L +          
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247

Query: 362 AELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGEL-----GNCS 416
             L  C     +S  G                L  L+L  N  + +    L         
Sbjct: 248 LGLNDCL----LSARGAAAVVD-AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302

Query: 417 SLVWLDLNSNNLTGD 431
            L++L+LN N  + +
Sbjct: 303 DLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 51.8 bits (122), Expect = 2e-07
 Identities = 43/332 (12%), Positives = 86/332 (25%), Gaps = 67/332 (20%)

Query: 76  LELLDLSYNNLTG-SISGFSLNENSCNSLLHLDLSQNHIMD----VIPSSLSNCTKLKIL 130
           +E   L  + +T              +S+  + LS N I       +  ++++   L+I 
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 131 NLSFN---LLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKL------ 181
             S      +  EIP     L          + +     +    A + L++         
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124

Query: 182 -----------------PHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGS 224
                                   +      +   L+ +    N +         +   S
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184

Query: 225 LESLILSNNMISGSFPDSISSCKTL-----------RIVDFSSNRVSGIIPPDICPGVSS 273
              L     + +G  P+ I                  + D +   +             +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244

Query: 274 LEELRLPDNLITGVIPGQLSEC------TQLKVIDLSLNYLNGSIPQELGKLEHLEQFIA 327
           L EL L D L++      + +         L+ + L  N +     + L  +        
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI------- 297

Query: 328 WFNGLEGKIPPELGKCKNLKDLILNNNKLSGE 359
                         K  +L  L LN N+ S E
Sbjct: 298 ------------DEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.5 bits (116), Expect = 1e-06
 Identities = 46/326 (14%), Positives = 97/326 (29%), Gaps = 20/326 (6%)

Query: 247 KTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITG----VIPGQLSECTQLKVID 302
           K+L++   ++     +          S++E+ L  N I       +   ++    L++ +
Sbjct: 8   KSLKLDAITTEDEKSVFAV--LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAE 65

Query: 303 LSLNY---LNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE 359
            S  +   +   IP+ L  L          + +           +      L+ +     
Sbjct: 66  FSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125

Query: 360 IPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV 419
           +              +        +  +      L  +  G NR +     E        
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185

Query: 420 WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPE 479
            L      +   I P     +    L G      L  +    N+   +G       ++  
Sbjct: 186 RLLHTVKMVQNGIRPE---GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242

Query: 480 RLLQIPTLKSCDFARMYSGPVLSLFTQYQ--TLEYLDLSYNQFRGKIPDEIGDMIA---- 533
             L+   L  C  +   +  V+  F++ +   L+ L L YN+        +  +I     
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302

Query: 534 -LQVLELAHNQLSGEIPSSLGRLRNL 558
            L  LEL  N+ S E    +  +R +
Sbjct: 303 DLLFLELNGNRFSEE-DDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.3 bits (105), Expect = 3e-05
 Identities = 33/305 (10%), Positives = 85/305 (27%), Gaps = 35/305 (11%)

Query: 336 IPPELGKCKNLKDLILNNNKLSGE----IPAELFSCSNLEWISLTGN---ELTGQIPPEF 388
           +   L +  ++K+++L+ N +  E    +   + S  +LE    +      +  +IP   
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 389 SRL-------TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLG 441
             L        +L  ++L +N F       L +  S      +       + P+ G ++ 
Sbjct: 83  RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142

Query: 442 AKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVL 501
                  ++             C              +       L +    +    P  
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202

Query: 502 SLFTQYQTLE----------YLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSS 551
                 + L             +   +     +   +     L+ L L    LS    ++
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262

Query: 552 LGR------LRNLGVFDASHNRLQGQIPES-----FSNLSFLVQIDLSNNELTGPIPQRG 600
           +           L      +N ++     +        +  L+ ++L+ N  +       
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVD 322

Query: 601 QLSTL 605
           ++  +
Sbjct: 323 EIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.5 bits (103), Expect = 5e-05
 Identities = 13/79 (16%), Positives = 24/79 (30%), Gaps = 9/79 (11%)

Query: 81  LSYNNLTGSIS---GFSLNENSCNSLLHLDLSQNHIMDVIPSSL-----SNCTKLKILNL 132
           L+   L+   +     + ++     L  L L  N I      +L          L  L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 133 SFNLLAGEIPRTFGQLSSL 151
           + N    E      ++  +
Sbjct: 310 NGNRF-SEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.4 bits (95), Expect = 4e-04
 Identities = 40/297 (13%), Positives = 76/297 (25%), Gaps = 28/297 (9%)

Query: 175 SLLELKLPHNNITG----SFPVTLSSCSWLQLLDLSNNNISGPFPD---SVLENLGSLES 227
           S+    L  + IT     S    L     ++ + LS N I           + +   LE 
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 228 LILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV 287
              S+        +   + + L        ++  +   D   G ++ E L    +  T +
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 288 IPGQL--SECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKN 345
               L  +         ++      ++ ++      L   I   N LE     E  K   
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 346 LKDLILNNNKLSGEIPAELFS-------------CSNLEWISLTGNELTGQIPPEFSRLT 392
              L+     +   I  E                       +   +  +  +        
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243

Query: 393 RLAVLQLGNNRFKGEIPGELGNC------SSLVWLDLNSNNLTGDIPPRLGRQLGAK 443
            L  L L +          + +         L  L L  N +  D    L   +  K
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 7e-04
 Identities = 15/88 (17%), Positives = 26/88 (29%), Gaps = 4/88 (4%)

Query: 26  LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTG----FLPETLLSNSDKLELLDL 81
           L    LS+ G   +V      +   L  L   YN +       L   +      L  L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 82  SYNNLTGSISGFSLNENSCNSLLHLDLS 109
           + N  +             ++    +L 
Sbjct: 310 NGNRFSEEDDVVDEIREVFSTRGRGELD 337

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 0.001
 Identities = 39/321 (12%), Positives = 84/321 (26%), Gaps = 28/321 (8%)

Query: 25  GLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETL---LSNSDKLELLDL 81
            LK   +++     +       +  ++  +  S N +       L   +++   LE+ + 
Sbjct: 9   SLKLDAITTEDEKSVFAV--LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 82  SYNNLT-------GSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSF 134
           S             ++         C  L  + LS N         L +           
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 135 NLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSEL----GNACDSLLELKLPHNNITGSF 190
            L    +    G   +    +L+ N      P       G        +K          
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 191 PVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLR 250
            +         +      ++         E            ++ S +   ++ S   LR
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 251 IVDFSSNRVSGIIPPDICPGVS-----SLEELRLPDNLITGVIPGQLSE-----CTQLKV 300
            +  +   +S      +    S      L+ LRL  N I       L          L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 301 IDLSLNYLN--GSIPQELGKL 319
           ++L+ N  +    +  E+ ++
Sbjct: 307 LELNGNRFSEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 17/89 (19%), Positives = 34/89 (38%), Gaps = 12/89 (13%)

Query: 156 LSNNHITGWIPSELGNACD-----SLLELKLPHNNITGSFPVTLSS-----CSWLQLLDL 205
           L++  ++    + + +A        L  L+L +N I      TL +        L  L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 206 SNNNISGPFPDSVLENLGSLESLILSNNM 234
           + N  S    D V++ +  + S      +
Sbjct: 310 NGNRFSE--EDDVVDEIREVFSTRGRGEL 336

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.8 bits (127), Expect = 2e-08
 Identities = 33/226 (14%), Positives = 68/226 (30%), Gaps = 8/226 (3%)

Query: 40  VPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENS 99
           +P +L     N + L      L   + +   S    LE +++S N++   I     +   
Sbjct: 23  IPSDLP---RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 78

Query: 100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNN 159
               + ++ + N +     +  +      +L  +  +           L  +      N 
Sbjct: 79  KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 138

Query: 160 HITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVL 219
           +I     +         + L L  N I        +     +L    NNN+    P+ V 
Sbjct: 139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL-EELPNDVF 197

Query: 220 ENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPP 265
                   L +S   I       + + K LR     + +    +P 
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKK---LPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.0 bits (125), Expect = 4e-08
 Identities = 32/227 (14%), Positives = 63/227 (27%), Gaps = 7/227 (3%)

Query: 79  LDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA 138
                + +T       +  +   + + L      +  +   + S    L+ + +S N + 
Sbjct: 13  FLCQESKVT------EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66

Query: 139 GEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCS 198
             I                         +         L+  L  N      P      S
Sbjct: 67  EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126

Query: 199 WLQLLDLSNNNISGPFPDSVLENLGSLESLILS-NNMISGSFPDSISSCKTLRIVDFSSN 257
             ++L    +NI+    +       S ES+IL  N        +   +   L  ++ S N
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186

Query: 258 RVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLS 304
                +P D+  G S    L +    I  +    L    +L+     
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.4 bits (121), Expect = 1e-07
 Identities = 35/242 (14%), Positives = 63/242 (26%), Gaps = 11/242 (4%)

Query: 196 SCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS 255
            CS  ++     + ++   P  +  N      L      +      + S    L  ++ S
Sbjct: 7   HCSN-RVFLCQESKVTE-IPSDLPRNA---IELRFVLTKLRVIQKGAFSGFGDLEKIEIS 61

Query: 256 SNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQE 315
            N V  +I  D+   +  L E+R+        I  +  +        L  N     +P  
Sbjct: 62  QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 121

Query: 316 LGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD---LILNNNKLSGEIPAELFSCSNLEW 372
                  +  +   + +               +   L LN N +              E 
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181

Query: 373 ISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDI 432
                N L       F   +   +L +   R        L N   L        NL   +
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KL 238

Query: 433 PP 434
           P 
Sbjct: 239 PT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 2e-07
 Identities = 30/234 (12%), Positives = 65/234 (27%), Gaps = 12/234 (5%)

Query: 366 SCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNS 425
            CSN        +++T +IP +         L+    + +    G       L  ++++ 
Sbjct: 7   HCSNRV-FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62

Query: 426 NNLTGDIPPRLGR--------QLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIR 477
           N++   I   +          ++       +++      + N+        G+     + 
Sbjct: 63  NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 122

Query: 478 PERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVL 537
               LQ   L   D   +++    S          L L+ N  +             ++ 
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182

Query: 538 ELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNE 591
              +N L               + D S  R+         NL  L      N +
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (104), Expect = 2e-05
 Identities = 29/239 (12%), Positives = 74/239 (30%), Gaps = 9/239 (3%)

Query: 150 SLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNN 209
           S +      + +T  IPS+L     + +EL+     +        S    L+ +++S N+
Sbjct: 9   SNRVFLCQESKVTE-IPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64

Query: 210 ISGP--FPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDI 267
           +                   +  +NN++  +     +      ++  ++          I
Sbjct: 65  VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 124

Query: 268 CPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIA 327
                 L +++   N+ T      +    +  ++ L+ N +           +  E  ++
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184

Query: 328 WFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPP 386
             N LE               L ++  ++       L +   L   S    +   ++P 
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (102), Expect = 3e-05
 Identities = 41/241 (17%), Positives = 80/241 (33%), Gaps = 8/241 (3%)

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSN 158
            C S       ++ +   IPS L        L      L       F     L+++++S 
Sbjct: 7   HC-SNRVFLCQESKV-TEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62

Query: 159 NHITGWIPSELGNACDSLLELKLPH-NNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDS 217
           N +   I +++ +    L E+++   NN+    P    +   LQ L +SN  I       
Sbjct: 63  NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 122

Query: 218 VLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL 277
            + +L  +   I  N  I     +S        ++ + +      I      G    E  
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182

Query: 278 RLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIP 337
              +N +  +        +   ++D+S   ++      L  L+ L         L+ K+P
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--STYNLK-KLP 239

Query: 338 P 338
            
Sbjct: 240 T 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (98), Expect = 1e-04
 Identities = 13/50 (26%), Positives = 19/50 (38%), Gaps = 3/50 (6%)

Query: 38  GLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLT 87
             +P+++F      V L+ S   +   LP   L N  KL        NL 
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARST--YNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 2e-04
 Identities = 11/58 (18%), Positives = 20/58 (34%), Gaps = 13/58 (22%)

Query: 98  NSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLD 155
           +  +  + LD+S+  I  +    L N  KL+  +                L  L  L+
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY-------------NLKKLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 5e-04
 Identities = 31/229 (13%), Positives = 58/229 (25%), Gaps = 34/229 (14%)

Query: 240 PDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLK 299
              I  C + R+     ++V+ I P D+     +  ELR     +  +  G  S    L+
Sbjct: 2   HHRICHC-SNRVFLCQESKVTEI-PSDLPR---NAIELRFVLTKLRVIQKGAFSGFGDLE 56

Query: 300 VIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS-- 357
            I++S N +   I  ++         I                        L  +     
Sbjct: 57  KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116

Query: 358 --------------------------GEIPAELFSCSNLEWISLTGNELTGQIPPEFSRL 391
                                      E  + +        + L  N +       F+  
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176

Query: 392 TRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQL 440
               +    NN  +          S  V LD++   +   +P      L
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS-LPSYGLENL 224

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 3e-08
 Identities = 34/194 (17%), Positives = 64/194 (32%), Gaps = 24/194 (12%)

Query: 48  LPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLD 107
           L   +       N+T  + +T L     +  L      +  SI G        N+L  ++
Sbjct: 17  LAEKMKTVLGKTNVTDTVSQTDLDQ---VTTLQADRLGIK-SIDGVE----YLNNLTQIN 68

Query: 108 LSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPS 167
            S N + D+ P          ++N +       +             +   +       +
Sbjct: 69  FSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128

Query: 168 ELGNACDSLLELK-------------LPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPF 214
            L     S   +              L  ++   +    L++ + L+ LD+S+N +S   
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDI- 187

Query: 215 PDSVLENLGSLESL 228
             SVL  L +LESL
Sbjct: 188 --SVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.7 bits (104), Expect = 1e-05
 Identities = 28/187 (14%), Positives = 55/187 (29%), Gaps = 20/187 (10%)

Query: 198 SWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSN 257
           +      L   N++         +L  + +L      I     D +     L  ++FS+N
Sbjct: 18  AEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72

Query: 258 RVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVID-------------LS 304
           +++ I P      +  +         IT +          L                   
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132

Query: 305 LNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAEL 364
           L   + +I                F+  +      L     L+ L +++NK+S    + L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190

Query: 365 FSCSNLE 371
              +NLE
Sbjct: 191 AKLTNLE 197

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 5e-04
 Identities = 38/191 (19%), Positives = 73/191 (38%), Gaps = 25/191 (13%)

Query: 102 SLLHLDLSQNHIMDVIPSS-LSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNH 160
             +   L + ++ D +  + L   T L+   L    + G        L++L +++ SNN 
Sbjct: 19  EKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQ 73

Query: 161 ITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLE 220
           +T   P  L N    +  L   +     +    L++ + L L +    +I      + L 
Sbjct: 74  LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 221 NLGSLESLILSNNMISG--------------SFPDSISSCKTLRIVDFSSNRVSGIIPPD 266
            L    + I   + +SG              +    +++  TL  +D SSN+VS I    
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVL- 190

Query: 267 ICPGVSSLEEL 277
               +++LE L
Sbjct: 191 --AKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 32/192 (16%), Positives = 58/192 (30%), Gaps = 28/192 (14%)

Query: 175 SLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNM 234
             ++  L   N+T    V+ +    +  L      I        +E L +L  +  SNN 
Sbjct: 19  EKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI---DGVEYLNNLTQINFSNNQ 73

Query: 235 ISGSFPDSISSCK-----------------TLRIVDFSSNRVSGIIPPDICPGVSSLEEL 277
           ++   P    +                    L  +   +   + I   D    +++L  L
Sbjct: 74  LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 133

Query: 278 RLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIP 337
            L  N I+ +         Q        +    +  + L  L  LE+     N +     
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNF----SSNQVTDLKPLANLTTLERLDISSNKVSD--I 187

Query: 338 PELGKCKNLKDL 349
             L K  NL+ L
Sbjct: 188 SVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 27/191 (14%), Positives = 64/191 (33%), Gaps = 12/191 (6%)

Query: 368 SNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNN 427
           +      L    +T  +    + L ++  LQ      K  I G +   ++L  ++ ++N 
Sbjct: 18  AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQ 73

Query: 428 LTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTL 487
           LT          L        +  N          +       L     +   +  +  L
Sbjct: 74  LTDI------TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 127

Query: 488 KSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGE 547
            + +   + S  +  +           L+++  +      + ++  L+ L+++ N++S  
Sbjct: 128 TNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD- 186

Query: 548 IPSSLGRLRNL 558
             S L +L NL
Sbjct: 187 -ISVLAKLTNL 196

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 35/206 (16%), Positives = 61/206 (29%), Gaps = 18/206 (8%)

Query: 229 ILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVI 288
           I  +  I+  F D+  +             V+  +       +  +  L+     I   I
Sbjct: 2   ITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIKS-I 55

Query: 289 PGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD 348
            G +     L  I+ S N L             L+      + L                
Sbjct: 56  DG-VEYLNNLTQINFSNNQLTDIT--------PLKNLTKLVDILMNNNQIADITPLANLT 106

Query: 349 LILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEI 408
            +      + +I       +      L  +  T       S LT L  L   +N+     
Sbjct: 107 NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLK 166

Query: 409 PGELGNCSSLVWLDLNSNNLTGDIPP 434
           P  L N ++L  LD++SN ++ DI  
Sbjct: 167 P--LANLTTLERLDISSNKVS-DISV 189

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 2e-06
 Identities = 30/202 (14%), Positives = 64/202 (31%), Gaps = 19/202 (9%)

Query: 103 LLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHIT 162
            +  +L +  + D +  + +    +  +  + + +          L ++ +L L+ N +T
Sbjct: 26  TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81

Query: 163 GWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENL 222
              P              L +          +   S L+ L    +        S +  L
Sbjct: 82  DIKPLA-----------NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130

Query: 223 GSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDN 282
             L  L       +     ++ S  T        +     I P    G++ L+ L L  N
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188

Query: 283 LITGVIPGQLSECTQLKVIDLS 304
            I+ +    L+    L V++L 
Sbjct: 189 HISDLRA--LAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.5 bits (109), Expect = 5e-06
 Identities = 32/200 (16%), Positives = 66/200 (33%), Gaps = 24/200 (12%)

Query: 46  SKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH 105
                 +  N    ++T  + +  L   + ++ +  + +++  S+ G         ++  
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQNEL---NSIDQIIANNSDIK-SVQGIQ----YLPNVTK 72

Query: 106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQ------------LSSLQR 153
           L L+ N + D+ P +         L+ +       +                  ++ L  
Sbjct: 73  LFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132

Query: 154 LDLSNNHITGWIPSELGNACDSLLELKLP-HNNITGSFPVTLSSCSWLQLLDLSNNNISG 212
           L    +   G            L +L      +   S  V L+  + LQ L LS N+IS 
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 192

Query: 213 PFPDSVLENLGSLESLILSN 232
                 L  L +L+ L L +
Sbjct: 193 L---RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.8 bits (102), Expect = 3e-05
 Identities = 32/207 (15%), Positives = 63/207 (30%), Gaps = 19/207 (9%)

Query: 147 QLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLS 206
             +   + +L    +T  +        +S+ ++   +++I       +     +  L L+
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQNE---LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76

Query: 207 NNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPD 266
            N ++   P + L+N             +               +    S  +      D
Sbjct: 77  GNKLTDIKPLANLKN----------LGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD 126

Query: 267 ICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFI 326
           I   V   +   L            LS  T+L  + L  N ++  +P  L  L  L+   
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184

Query: 327 AWFNGLEGKIPPELGKCKNLKDLILNN 353
              N +       L   KNL  L L +
Sbjct: 185 LSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 31/243 (12%), Positives = 68/243 (27%), Gaps = 40/243 (16%)

Query: 351 LNNNKLSGEIP-AELFSCSNLE---WISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKG 406
           L +  ++   P  ++FS          +L    +T  +    + L  +  +   N+  K 
Sbjct: 3   LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS 60

Query: 407 EIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKG 466
                +    ++  L LN N LT        + L      G+L  +              
Sbjct: 61  VQG--IQYLPNVTKLFLNGNKLTDI------KPLANLKNLGWLFLDENKVKDLSSLKDLK 112

Query: 467 VGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPD 526
               L         +  +  L   +   + +  +  +    +  +   LS    +     
Sbjct: 113 KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV 172

Query: 527 EIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQID 586
            +  +  LQ L L+ N +S                             + + L  L  ++
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--------------------------LRALAGLKNLDVLE 206

Query: 587 LSN 589
           L +
Sbjct: 207 LFS 209

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 3e-06
 Identities = 15/97 (15%), Positives = 28/97 (28%), Gaps = 1/97 (1%)

Query: 173 CDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSN 232
                 L+   +         L     L  L + N           L  LG L +L +  
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 233 NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICP 269
           + +    PD+      L  ++ S N +  +    +  
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG 102

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 2e-05
 Identities = 20/154 (12%), Positives = 36/154 (23%), Gaps = 9/154 (5%)

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPR-TFGQLSSLQRLDLS 157
             +    L  +++  +D     L     L  L +        +       L  L+ L + 
Sbjct: 6   CPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 158 NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDS 217
            + +    P                  N   S          LQ L LS N +       
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNL--SFNALESLSWKTVQGLSLQELVLSGNPLHCSCALR 122

Query: 218 VLENLGSLESLILSNNMISGSFPDS-----ISSC 246
            L+         +    +             +SC
Sbjct: 123 WLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASC 156

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (91), Expect = 5e-04
 Identities = 21/133 (15%), Positives = 40/133 (30%), Gaps = 2/133 (1%)

Query: 510 LEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPS-SLGRLRNLGVFDASHNRL 568
              L  + +         +     L  L + + Q    +    L  L  L       + L
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 569 QGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYANNPGLCGVPLPECRNGN 628
           +   P++F     L +++LS N L     +  Q  +L     + NP  C   L   +   
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128

Query: 629 NQPALNPSVDAAR 641
            +          +
Sbjct: 129 EEGLGGVPEQKLQ 141

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.2 bits (92), Expect = 4e-04
 Identities = 34/187 (18%), Positives = 58/187 (31%), Gaps = 10/187 (5%)

Query: 99  SCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSN 158
            C     +D +   + + IP  +        L L+ N L                     
Sbjct: 7   HC-EGTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELK 62

Query: 159 NHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSV 218
            +    I          + EL+L  N I             L+ L+L +N IS   P S 
Sbjct: 63  RNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS- 121

Query: 219 LENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELR 278
            E+L SL SL L++N  + +   +  +    +    +        P      V  ++   
Sbjct: 122 FEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKK-SLNGGAARCGAPSK----VRDVQIKD 176

Query: 279 LPDNLIT 285
           LP +   
Sbjct: 177 LPHSEFK 183

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1013
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.9
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.87
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.86
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.73
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.73
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.72
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.72
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.68
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.67
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.66
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.64
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.57
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.54
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.48
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.45
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.45
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.43
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.39
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.32
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.27
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.16
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.12
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.5
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.37
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.26
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.78
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.78
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.75
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.38
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.22
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.19
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.93
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.19
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.03

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=418.23  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=200.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||+||+|+++ +++.||||++..... ...+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999986 689999999865432 2345689999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      ++||+|.+++...      ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++++||+|||+|+....
T Consensus        85 ~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          85 CSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             CTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cCCCcHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            9999999998643      2489999999999999999999999   999999999999999999999999999998765


Q ss_pred             cCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...........||+.|||||++.+..+ +.++||||+||++|||++|+.||............+    ........ ..+
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~----~~~~~~~~-~~~  230 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKTYLN-PWK  230 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH----HTTCTTST-TGG
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCC-ccc
Confidence            444444456789999999999988776 578999999999999999999997654332222111    11111100 000


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       .+          ..+.+++.+||+.||++||||+|
T Consensus       231 ~-------~s----------~~~~~li~~~L~~dP~~R~t~~e  256 (271)
T d1nvra_         231 K-------ID----------SAPLALLHKILVENPSARITIPD  256 (271)
T ss_dssp             G-------SC----------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             c-------CC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            0       01          12458999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-48  Score=415.33  Aligned_cols=246  Identities=25%  Similarity=0.390  Sum_probs=203.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999975 68999999987665556678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      +||+|.+++...       .+++.+++.++.||+.||+|||++   +||||||||+||+++.++++||+|||+|+.+...
T Consensus       100 ~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1         100 AGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             TTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            999999987542       389999999999999999999999   9999999999999999999999999999876542


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+...     .................++.+
T Consensus       170 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~  242 (293)
T d1yhwa1         170 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTPELQNPEKL  242 (293)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSCCCSSGGGS
T ss_pred             c--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCCCCCCCCcccC
Confidence            2  223456799999999999999999999999999999999999999975331     111222222211111111111


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                             +          ..+.+++.+||+.||++||||+|
T Consensus       243 -------s----------~~~~~li~~~L~~dP~~R~s~~e  266 (293)
T d1yhwa1         243 -------S----------AIFRDFLNRCLDMDVEKRGSAKE  266 (293)
T ss_dssp             -------C----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             -------C----------HHHHHHHHHHccCChhHCcCHHH
Confidence                   1          12568999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=406.52  Aligned_cols=242  Identities=25%  Similarity=0.390  Sum_probs=199.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++.+.   .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999986 6889999988643   2234567899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|+|.+++....      .+++..++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||+|+..
T Consensus        86 Ey~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             ECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             eecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeec
Confidence            9999999999997543      389999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ...    ......||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+.... +......  ++
T Consensus       157 ~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~-i~~~~~~--~p  224 (263)
T d2j4za1         157 PSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKR-ISRVEFT--FP  224 (263)
T ss_dssp             CCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHH-HHTTCCC--CC
T ss_pred             CCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHH-HHcCCCC--CC
Confidence            432    2235679999999999999999999999999999999999999997532     1111111 1111110  11


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +       ..+          ..+.+++.+||+.||++|||++|
T Consensus       225 ~-------~~s----------~~~~~li~~~L~~dp~~R~t~~e  251 (263)
T d2j4za1         225 D-------FVT----------EGARDLISRLLKHNPSQRPMLRE  251 (263)
T ss_dssp             T-------TSC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             c-------cCC----------HHHHHHHHHHccCCHhHCcCHHH
Confidence            1       011          12558999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-48  Score=411.13  Aligned_cols=246  Identities=20%  Similarity=0.274  Sum_probs=198.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||+||+|+++ +++.||||++.+..   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46999999999999999999986 68999999886422   233467899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||+|.+++....      .+++..++.++.|++.||+|||++   +||||||||+||++++++.+||+|||+|+.+
T Consensus        88 Ey~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             CCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceec
Confidence            9999999999987543      389999999999999999999999   9999999999999999999999999999987


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      .............||+.|+|||++.+..++.++||||+||++|||++|+.||....     ....... +.....  .++
T Consensus       159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~-i~~~~~--~~p  230 (288)
T d1uu3a_         159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLIFQK-IIKLEY--DFP  230 (288)
T ss_dssp             C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH-HHTTCC--CCC
T ss_pred             ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----HHHHHHH-HHcCCC--CCC
Confidence            65444434455679999999999999999999999999999999999999997532     1111111 111111  011


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..       .+          ..+.+++.+||+.||++|||++|
T Consensus       231 ~~-------~s----------~~~~~li~~~L~~dP~~R~t~~e  257 (288)
T d1uu3a_         231 EK-------FF----------PKARDLVEKLLVLDATKRLGCEE  257 (288)
T ss_dssp             TT-------CC----------HHHHHHHHTTSCSSGGGSTTSGG
T ss_pred             cc-------CC----------HHHHHHHHHHccCCHhHCcCHHH
Confidence            11       11          12468999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=410.69  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=200.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      +.|++.+.||+|+||+||+|++. +++.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999986 68899999987666566678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++....     ..+++..+..++.||+.||+|||++   +||||||||+||+++.++++||+|||+|+.....
T Consensus        92 ~~g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          92 AGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             TTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             CCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999986432     2389999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CcceeeeeeccCCCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQ-----SFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      .  .......||+.|+|||++.     +..++.++||||+||++|||+||+.||.+....+  .   ...... ......
T Consensus       164 ~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~---~~~i~~-~~~~~~  235 (288)
T d2jfla1         164 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--V---LLKIAK-SEPPTL  235 (288)
T ss_dssp             H--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--H---HHHHHH-SCCCCC
T ss_pred             c--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--H---HHHHHc-CCCCCC
Confidence            1  1233567999999999984     4568899999999999999999999997643211  1   111111 111110


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+.      ..+          ..+.+++.+||+.||++|||++|
T Consensus       236 ~~~~------~~s----------~~~~~li~~~L~~dp~~R~t~~e  265 (288)
T d2jfla1         236 AQPS------RWS----------SNFKDFLKKCLEKNVDARWTTSQ  265 (288)
T ss_dssp             SSGG------GSC----------HHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             Cccc------cCC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            0000      001          12568999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=405.07  Aligned_cols=251  Identities=29%  Similarity=0.443  Sum_probs=191.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeecc--CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRL--SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||+||+|+.+  ..||||++...  .....+.|.+|++++++++|||||++++++. ++..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            357999999999999999999864  46999988543  2334567999999999999999999999875 456899999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+++|+|.+++....     ..+++..+..++.||++||+|||++   +||||||||+||+++.++.+||+|||+|+...
T Consensus        84 y~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             CCCEEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             cCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            999999999996432     2389999999999999999999999   99999999999999999999999999998776


Q ss_pred             ccCcceeeeeeccCCCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQS---FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      ............||+.|||||++.+   ..++.++|||||||++|||+||+.||.......     .+......+...  
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-----~~~~~~~~~~~~--  228 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-----QIIFMVGRGYLS--  228 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHHHHHTSCC--
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-----HHHHHHhcCCCC--
Confidence            5444444456789999999999864   357899999999999999999999997543211     111112211111  


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                        +.........+          ..+.+++.+||+.||++||||+|
T Consensus       229 --p~~~~~~~~~~----------~~l~~li~~cl~~dp~~RPt~~~  262 (276)
T d1uwha_         229 --PDLSKVRSNCP----------KAMKRLMAECLKKKRDERPLFPQ  262 (276)
T ss_dssp             --CCGGGSCTTCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --Ccchhccccch----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence              11111111111          12568999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=404.16  Aligned_cols=252  Identities=25%  Similarity=0.343  Sum_probs=188.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEe--CCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKI--GEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  808 (1013)
                      ++|++.+.||+|+||+||+|+++ +|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+  ++..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999986 689999999865432  223568899999999999999999999865  4567999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCC--CCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCI--PHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~--~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      |||+++|+|.+++.....  ....+++..++.++.|++.||+|||++..  .+||||||||+||+++.++.+||+|||+|
T Consensus        84 mEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          84 MEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EecCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            999999999999865432  22348999999999999999999999710  13999999999999999999999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +.+....  .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.     .+ +...+..+....
T Consensus       162 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~-~~~~i~~~~~~~  233 (269)
T d2java1         162 RILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KE-LAGKIREGKFRR  233 (269)
T ss_dssp             HHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH-HHHHHHHTCCCC
T ss_pred             eecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HH-HHHHHHcCCCCC
Confidence            8765322  223456799999999999999999999999999999999999999975321     11 112222222211


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ++..       .+          ..+.+++.+||+.||++|||++|
T Consensus       234 -~~~~-------~s----------~~l~~li~~~L~~dp~~Rps~~e  262 (269)
T d2java1         234 -IPYR-------YS----------DELNEIITRMLNLKDYHRPSVEE  262 (269)
T ss_dssp             -CCTT-------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCcc-------cC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence             1111       11          12568999999999999999864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-47  Score=402.37  Aligned_cols=246  Identities=27%  Similarity=0.461  Sum_probs=189.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||+||+|++.+++.||||++.. .....++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            46888899999999999999998888999998865 34456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|+|.+++....     ..+++..+..++.|+|+||+|||++   +|+||||||+||+++.++.+||+|||+|+......
T Consensus        84 ~g~L~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          84 HGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             TCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             CCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            999999986432     3488999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcC-CCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG-KRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      . .......||+.|+|||++.+..++.++|||||||++|||+|+ ++||....     ..+.... +..+...  ..|..
T Consensus       156 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----~~~~~~~-i~~~~~~--~~p~~  226 (263)
T d1sm2a_         156 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVED-ISTGFRL--YKPRL  226 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----HHHHHHH-HHHTCCC--CCCTT
T ss_pred             c-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----HHHHHHH-HHhcCCC--CCccc
Confidence            2 222345789999999999999999999999999999999995 44443321     1222221 2211111  11111


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            .+          ..+.+++.+||+.||++||||+|
T Consensus       227 ------~~----------~~l~~li~~cl~~~p~~Rps~~~  251 (263)
T d1sm2a_         227 ------AS----------THVYQIMNHCWKERPEDRPAFSR  251 (263)
T ss_dssp             ------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------cC----------HHHHHHHHHHccCCHhHCcCHHH
Confidence                  01          13568999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-47  Score=414.99  Aligned_cols=200  Identities=28%  Similarity=0.423  Sum_probs=177.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+.+.+|+.++++++|||||+++++|.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999986 68899999886543 2334678999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      |++||+|.+++....      .+++..++.++.|++.||+|||+ +   +|+||||||+|||++.++++||+|||+|+..
T Consensus        85 y~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             CCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             cCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999997543      38999999999999999999997 5   8999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      ....    .....||+.|+|||++.+..|+.++||||+||++|||++|+.||...+
T Consensus       156 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         156 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             CCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            4321    234689999999999999999999999999999999999999998654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=398.54  Aligned_cols=241  Identities=27%  Similarity=0.394  Sum_probs=190.7

Q ss_pred             CCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEe----CCEEEEEE
Q 036815          737 SAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKI----GEERLLVY  809 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  809 (1013)
                      +..+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    +...|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999986 67899999886543  2234568999999999999999999999865    34679999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCcccEEeC-CCCcEEEeecccc
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPH--IIHRDMKSSNVLLD-HEMEARVSDFGMA  886 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~a  886 (1013)
                      ||+++|+|.+++....      .+++..++.++.||++||+|||++   +  |+||||||+||+++ .++.+||+|||+|
T Consensus        92 E~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             ECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             eCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            9999999999997543      389999999999999999999998   7  99999999999996 4789999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +.....    ......||+.|||||++.+ .++.++||||+||++|||++|+.||.....    ... +...+..+....
T Consensus       163 ~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~-~~~~i~~~~~~~  232 (270)
T d1t4ha_         163 TLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQ-IYRRVTSGVKPA  232 (270)
T ss_dssp             GGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHH-HHHHHTTTCCCG
T ss_pred             eeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHH-HHHHHHcCCCCc
Confidence            864322    2235679999999999876 589999999999999999999999975321    111 112222222111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .++..       ..          ..+.+++.+||++||++||||+|
T Consensus       233 ~~~~~-------~~----------~~~~~li~~~l~~dp~~R~s~~e  262 (270)
T d1t4ha_         233 SFDKV-------AI----------PEVKEIIEGCIRQNKDERYSIKD  262 (270)
T ss_dssp             GGGGC-------CC----------HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccCcc-------CC----------HHHHHHHHHHccCCHhHCcCHHH
Confidence            11111       11          12558999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-47  Score=401.65  Aligned_cols=247  Identities=25%  Similarity=0.386  Sum_probs=196.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||+||+|++++++.||||++... ....+.|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            468888999999999999999988889999988643 3456789999999999999999999998754 56789999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|+|.+++.....    ..+++..+..|+.||++||+|||++   +|+||||||+||++++++.+||+|||+|+......
T Consensus        91 ~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          91 NGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             TCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999998864432    3489999999999999999999999   99999999999999999999999999999875422


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                       ........||+.|+|||++.+..++.++|||||||++|||+||..|+.....    ..+.. ..+..+..... ++   
T Consensus       164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~-~~i~~~~~~~~-p~---  233 (272)
T d1qpca_         164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVI-QNLERGYRMVR-PD---  233 (272)
T ss_dssp             -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHH-HHHHTTCCCCC-CT---
T ss_pred             -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHH-HHHHhcCCCCC-cc---
Confidence             2233446789999999999999999999999999999999996666543221    11111 11222211110 00   


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                          ..+          ..+.+++.+||+.||++||||+|
T Consensus       234 ----~~~----------~~l~~li~~cl~~~P~~Rpt~~e  259 (272)
T d1qpca_         234 ----NCP----------EELYQLMRLCWKERPEDRPTFDY  259 (272)
T ss_dssp             ----TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----cCh----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence                011          12568999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-46  Score=389.86  Aligned_cols=246  Identities=22%  Similarity=0.396  Sum_probs=203.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||+||+|++++++.||||++... ....++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            579999999999999999999988889999988654 3456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|++.+++....     ..+++..+++++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+|+......
T Consensus        83 ~g~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          83 NGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             TEEHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             CCcHHHhhhccc-----cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            999999976443     2388999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      . .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....     .+ +...+..+....  .|..
T Consensus       155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----~~-~~~~i~~~~~~~--~p~~  225 (258)
T d1k2pa_         155 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SE-TAEHIAQGLRLY--RPHL  225 (258)
T ss_dssp             C-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HH-HHHHHHTTCCCC--CCTT
T ss_pred             c-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----HH-HHHHHHhCCCCC--Cccc
Confidence            2 22334678999999999999999999999999999999998 8999976431     11 122222221111  1111


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            ..          ..+.+++.+||+.||++|||++|
T Consensus       226 ------~~----------~~l~~li~~cl~~dP~~RPt~~e  250 (258)
T d1k2pa_         226 ------AS----------EKVYTIMYSCWHEKADERPTFKI  250 (258)
T ss_dssp             ------CC----------HHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             ------cc----------HHHHHHHHHHccCCHhHCcCHHH
Confidence                  11          13569999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-47  Score=408.52  Aligned_cols=247  Identities=24%  Similarity=0.325  Sum_probs=184.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .+.|++.+.||+|+||+||+|+++ +++.||||++.+... .....+.+|++++++++||||+++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            357999999999999999999986 689999999865432 234568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC---CCCcEEEeecccce
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD---HEMEARVSDFGMAR  887 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~  887 (1013)
                      |++||+|.+++....      .+++..+..++.||+.||+|||++   +||||||||+||++.   .++.+||+|||+|+
T Consensus        88 ~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          88 LVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             CCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             ccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence            999999999996432      389999999999999999999999   999999999999995   57899999999998


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc-ccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK-QME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  966 (1013)
                      ......   ......||+.|||||++.+..++.++||||+||++|||++|+.||.+...     .+.......... ...
T Consensus       159 ~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~  230 (307)
T d1a06a_         159 MEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AKLFEQILKAEYEFDS  230 (307)
T ss_dssp             -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHTTCCCCCT
T ss_pred             EccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHhccCCCCCC
Confidence            764322   23456799999999999999999999999999999999999999975321     111111111111 110


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ...+.       .+          ..+.+++.+||+.||++|||++|
T Consensus       231 ~~~~~-------~s----------~~~~~li~~~L~~dP~~R~s~~e  260 (307)
T d1a06a_         231 PYWDD-------IS----------DSAKDFIRHLMEKDPEKRFTCEQ  260 (307)
T ss_dssp             TTTTT-------SC----------HHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccccC-------CC----------HHHHHHHHHHccCCHhHCcCHHH
Confidence            00011       11          12568999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-46  Score=411.76  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=202.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999986 68899999987666556678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC--CCcEEEeecccceecc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH--EMEARVSDFGMARLIS  890 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~~  890 (1013)
                      +||+|.+++....     ..+++..++.++.||+.||+|||++   +||||||||+||+++.  ++.+||+|||+|+.+.
T Consensus       106 ~gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         106 SGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             CSCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999985432     2389999999999999999999999   9999999999999964  5789999999998765


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-CccccccC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEVID  969 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~d  969 (1013)
                      ...   ......||+.|||||++.+..++.++||||+||++|||++|+.||.+..     ..+........ ........
T Consensus       178 ~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~  249 (350)
T d1koaa2         178 PKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----DDETLRNVKSCDWNMDDSAF  249 (350)
T ss_dssp             TTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCCSCCGGG
T ss_pred             ccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCCCCcccc
Confidence            432   2345689999999999999999999999999999999999999997542     11222221111 11111110


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.+       +          ..+.+++.+||+.||++|||++|
T Consensus       250 ~~~-------s----------~~~~~li~~~L~~dP~~R~t~~e  276 (350)
T d1koaa2         250 SGI-------S----------EDGKDFIRKLLLADPNTRMTIHQ  276 (350)
T ss_dssp             GGC-------C----------HHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cCC-------C----------HHHHHHHHHHccCChhHCcCHHH
Confidence            111       1          12568999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-46  Score=402.42  Aligned_cols=248  Identities=26%  Similarity=0.382  Sum_probs=199.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||+||+|+++ +++.||||++... ....+++.+|++++++++|||||+++++|.+++..++||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            46888899999999999999987 5788999987543 345678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++.....    ..+++..+..++.||++||+|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus        96 ~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          96 TYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             TTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             cCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999999965432    3489999999999999999999999   9999999999999999999999999999876542


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                       .........|++.|+|||++.+..++.++|||||||++|||++|..||.....    ..... ..+..+..... ++  
T Consensus       169 -~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~~-~~i~~~~~~~~-~~--  239 (287)
T d1opja_         169 -TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVY-ELLEKDYRMER-PE--  239 (287)
T ss_dssp             -SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHH-HHHHTTCCCCC-CT--
T ss_pred             -CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHHH-HHHhcCCCCCC-Cc--
Confidence             22333445689999999999999999999999999999999997777653221    11111 11222111110 00  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..+          ..+.+++.+||+.||++||||+|
T Consensus       240 -----~~~----------~~l~~li~~cl~~dP~~Rps~~e  265 (287)
T d1opja_         240 -----GCP----------EKVYELMRACWQWNPSDRPSFAE  265 (287)
T ss_dssp             -----TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -----cch----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence                 111          12568999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-46  Score=404.70  Aligned_cols=248  Identities=27%  Similarity=0.426  Sum_probs=185.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CC---EEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GS---SVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.++||+|+||+||+|+++. ++   .||||++..... ...++|.+|++++++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            457788999999999999999863 32   588888754332 3346799999999999999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|+|.+++....     ..+++.++..++.||++||+|||++   +||||||||+|||++.++.+||+|||+|+.
T Consensus       106 ~Ey~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             EECCTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEecCCCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence            99999999999886432     2389999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCccee---eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          889 ISALDTHLS---VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       889 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      .........   .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....     .+.... +..+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~~~~~~-i~~~~~  251 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDVINA-IEQDYR  251 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH-HHTTCC
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----HHHHHH-HHcCCC
Confidence            654322211   223457899999999999999999999999999999998 8999875331     111211 222111


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ... +..       .+          ..+.+++.+||+.||++||||+|
T Consensus       252 ~~~-~~~-------~~----------~~l~~li~~cl~~~P~~RPs~~e  282 (299)
T d1jpaa_         252 LPP-PMD-------CP----------SALHQLMLDCWQKDRNHRPKFGQ  282 (299)
T ss_dssp             CCC-CTT-------CC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCC-Ccc-------ch----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence            110 000       11          12568999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4e-46  Score=410.08  Aligned_cols=247  Identities=20%  Similarity=0.265  Sum_probs=202.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999986 68999999987655555677899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC--CCCcEEEeecccceecc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD--HEMEARVSDFGMARLIS  890 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~a~~~~  890 (1013)
                      +||+|.+++....     ..+++.+++.++.||+.||+|||++   |||||||||+|||++  .++.+||+|||+|+.+.
T Consensus       109 ~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         109 SGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             CCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             CCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence            9999999875432     3489999999999999999999999   999999999999998  57899999999999875


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-cCccccccC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-EGKQMEVID  969 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~d  969 (1013)
                      ...   ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+...     .+....... .........
T Consensus       181 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~~  252 (352)
T d1koba_         181 PDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNVKRCDWEFDEDAF  252 (352)
T ss_dssp             TTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHCCCCCCSSTT
T ss_pred             CCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCcccc
Confidence            432   23456799999999999999999999999999999999999999975331     111111111 111111111


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +.       .+          ..+.+++.+||+.||++|||++|
T Consensus       253 ~~-------~s----------~~~~~li~~~L~~dp~~R~s~~e  279 (352)
T d1koba_         253 SS-------VS----------PEAKDFIKNLLQKEPRKRLTVHD  279 (352)
T ss_dssp             TT-------SC----------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             cC-------CC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            11       11          12568999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-46  Score=402.40  Aligned_cols=242  Identities=25%  Similarity=0.365  Sum_probs=195.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc---hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG---DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      +.|+..+.||+|+||+||+|++. +++.||||++.......   .+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35888999999999999999986 67889999986543332   356889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+++|++..++...      ..+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+..
T Consensus        95 E~~~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             ECCSEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EecCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccccc
Confidence            999999998776543      2389999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCcceeeeeeccCCCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQS---FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ..      .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.....     .+....... .....
T Consensus       166 ~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~~~~i~~-~~~~~  233 (309)
T d1u5ra_         166 AP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQ-NESPA  233 (309)
T ss_dssp             SS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH-SCCCC
T ss_pred             CC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHh-CCCCC
Confidence            43      234579999999999864   4689999999999999999999999975321     111111111 11111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..       .+          ..+.+++.+||+.||++||||+|
T Consensus       234 ~~~~~-------~s----------~~~~~li~~~L~~dP~~Rpt~~e  263 (309)
T d1u5ra_         234 LQSGH-------WS----------EYFRNFVDSCLQKIPQDRPTSEV  263 (309)
T ss_dssp             CSCTT-------SC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCC-------CC----------HHHHHHHHHHCcCChhHCcCHHH
Confidence            11111       11          12568999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-46  Score=406.06  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=200.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-C-----CEEEEEEeecc-CccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-G-----SSVAIKKLIRL-SCQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  805 (1013)
                      ++|++.+.||+|+||+||+|++.. +     ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            568899999999999999999753 2     26899987543 233446789999999998 899999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccC-----------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcc
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKA-----------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSS  868 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  868 (1013)
                      |+||||+++|+|.+++......                 .....+++..++.++.||++||+|||++   +||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            9999999999999999754321                 1223589999999999999999999999   9999999999


Q ss_pred             cEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCC
Q 036815          869 NVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFG  947 (1013)
Q Consensus       869 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~  947 (1013)
                      ||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999998766555445556778999999999999999999999999999999998 89999764322


Q ss_pred             CccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          948 DTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       948 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       ..+...    +..+...+. ++       ..+          ..+.+++.+||+.||++||||+|
T Consensus       274 -~~~~~~----~~~~~~~~~-p~-------~~~----------~~l~~li~~cl~~dP~~RPt~~e  316 (325)
T d1rjba_         274 -ANFYKL----IQNGFKMDQ-PF-------YAT----------EEIYIIMQSCWAFDSRKRPSFPN  316 (325)
T ss_dssp             -HHHHHH----HHTTCCCCC-CT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -HHHHHH----HhcCCCCCC-CC-------cCC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence             112222    222111110 00       011          12568999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=394.50  Aligned_cols=247  Identities=26%  Similarity=0.454  Sum_probs=195.4

Q ss_pred             cCCCCCCe-ecccCCcEEEEEEEc---CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESL-IGCGGFGEVFKATLK---DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~-lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||++..... ...++|.+|++++++++|||||+++|++.+ +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            34566664 999999999999875   345799999865433 334679999999999999999999999865 567899


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|+|.+++....     ..+++..+..++.||++||+|||++   +||||||||+||+++.++.+||+|||+|+.
T Consensus        87 mE~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEeCCCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence            99999999999985432     2489999999999999999999999   999999999999999999999999999998


Q ss_pred             ccccCcce-eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          889 ISALDTHL-SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       889 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      +....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....  .....    .+..+...+
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~----~i~~~~~~~  232 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMA----FIEQGKRME  232 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHH----HHHTTCCCC
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHH----HHHcCCCCC
Confidence            76543322 2234568899999999999999999999999999999998 9999976432  22222    222222221


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ++.       .+          ..+.+++.+||+.||++|||+.|
T Consensus       233 ~-p~~-------~~----------~~l~~li~~cl~~~p~~RPs~~~  261 (285)
T d1u59a_         233 C-PPE-------CP----------PELYALMSDCWIYKWEDRPDFLT  261 (285)
T ss_dssp             C-CTT-------CC----------HHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             C-CCc-------CC----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence            1 111       11          12568999999999999999853

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-45  Score=394.66  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=200.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc------cchHHHHHHHHHHhccCCcceeeeccEEEeCCEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC------QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  805 (1013)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++.+...      ...+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999986 689999999864322      2346799999999999999999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC----cEEEe
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM----EARVS  881 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~  881 (1013)
                      |+||||++||+|.+++....      .+++..++.++.|++.||+|||++   +||||||||+||+++.++    .+|++
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEec
Confidence            99999999999999997543      389999999999999999999999   999999999999998876    49999


Q ss_pred             ecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          882 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       882 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      |||+|+......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+...     .+.... +..
T Consensus       160 DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~-i~~  230 (293)
T d1jksa_         160 DFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLAN-VSA  230 (293)
T ss_dssp             CCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHT
T ss_pred             chhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----HHHHHH-HHh
Confidence            999998765432   23355789999999999999999999999999999999999999976431     111111 111


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....  ..+...   ...+          ..+.+++.+||+.||++|||++|
T Consensus       231 ~~~~--~~~~~~---~~~s----------~~~~~li~~~L~~dP~~R~s~~e  267 (293)
T d1jksa_         231 VNYE--FEDEYF---SNTS----------ALAKDFIRRLLVKDPKKRMTIQD  267 (293)
T ss_dssp             TCCC--CCHHHH---TTSC----------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             cCCC--CCchhc---CCCC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            1110  000000   0011          12568999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-45  Score=396.20  Aligned_cols=241  Identities=23%  Similarity=0.323  Sum_probs=199.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++.+.   .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            46999999999999999999986 7899999998653   2233567889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||+|.+++....      .+++..++.++.|++.||+|||++   +||||||||+||+++.+|.+||+|||+|+..
T Consensus        85 ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          85 EYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             ECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence            9999999999997543      388999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHh-cCcccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVR-EGKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  968 (1013)
                      ....  .......||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+.     .+..+.... .......+
T Consensus       156 ~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~i~~~~~~~p~~~  228 (337)
T d1o6la_         156 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEEIRFPRTL  228 (337)
T ss_dssp             CCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCTTS
T ss_pred             ccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHHHHhcCCCCCCccC
Confidence            4322  223456799999999999999999999999999999999999999986432     111221111 11111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .+                     .+.+++.+||++||++||+.
T Consensus       229 s~---------------------~~~dli~~~L~~dP~~R~~~  250 (337)
T d1o6la_         229 SP---------------------EAKSLLAGLLKKDPKQRLGG  250 (337)
T ss_dssp             CH---------------------HHHHHHHHHTCSSTTTSTTC
T ss_pred             CH---------------------HHHHHHHhhccCCchhhccc
Confidence            11                     24589999999999999973

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=388.10  Aligned_cols=240  Identities=24%  Similarity=0.411  Sum_probs=188.7

Q ss_pred             CeecccCCcEEEEEEEcC---CCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcccC
Q 036815          740 SLIGCGGFGEVFKATLKD---GSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMKF  814 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  814 (1013)
                      +.||+|+||+||+|.+++   ++.||||++....  ....+++.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998753   4679999885432  2234679999999999999999999999864 557899999999


Q ss_pred             CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccCc
Q 036815          815 GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALDT  894 (1013)
Q Consensus       815 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  894 (1013)
                      |+|.+++....      .+++..+..++.||+.||+|||++   +||||||||+||+++.++.+|++|||+|+.+.....
T Consensus        92 g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          92 GPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            99999997543      389999999999999999999999   999999999999999999999999999987754333


Q ss_pred             ce-eeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChhh
Q 036815          895 HL-SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPEL  972 (1013)
Q Consensus       895 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  972 (1013)
                      .. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+...  ..    +...+..+..... ++  
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~----~~~~i~~~~~~~~-p~--  233 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SE----VTAMLEKGERMGC-PA--  233 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH----HHHHHHTTCCCCC-CT--
T ss_pred             ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HH----HHHHHHcCCCCCC-Cc--
Confidence            22 2334678999999999999999999999999999999998 8999976431  11    1122222221111 11  


Q ss_pred             hcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          973 LLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       973 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..+          ..+.+++.+||+.||++|||++|
T Consensus       234 -----~~~----------~~~~~li~~cl~~dp~~RPs~~~  259 (277)
T d1xbba_         234 -----GCP----------REMYDLMNLCWTYDVENRPGFAA  259 (277)
T ss_dssp             -----TCC----------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             -----ccC----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence                 111          12568999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-44  Score=391.21  Aligned_cols=236  Identities=22%  Similarity=0.355  Sum_probs=196.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeecc---CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRL---SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+.   .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46999999999999999999986 6899999998642   2233567899999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||++||++..++.....      +++..++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||+|+..
T Consensus        84 E~~~gg~l~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~  154 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV  154 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             eecCCcccccccccccc------ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEe
Confidence            99999999999875443      78888999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Ccccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  968 (1013)
                      ...     .....||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+........ ......+
T Consensus       155 ~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~~~~p~~~  224 (316)
T d1fota_         155 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAELRFPPFF  224 (316)
T ss_dssp             SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCCCCCCTTS
T ss_pred             ccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----HHHHHHHHHcCCCCCCCCC
Confidence            532     234679999999999999999999999999999999999999997533     11222221111 1111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1009 (1013)
                      ++                     .+.+++.+||+.||++||
T Consensus       225 s~---------------------~~~~li~~~L~~dp~~R~  244 (316)
T d1fota_         225 NE---------------------DVKDLLSRLITRDLSQRL  244 (316)
T ss_dssp             CH---------------------HHHHHHHHHTCSCTTTCT
T ss_pred             CH---------------------HHHHHHHHHhhhCHHhcc
Confidence            11                     245899999999999997

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=392.27  Aligned_cols=247  Identities=29%  Similarity=0.424  Sum_probs=192.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEccc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMK  813 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  813 (1013)
                      ++|++.+.||+|+||.||+|++++++.||||++.. .....+.|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECc-ccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            46889999999999999999999888999998754 34456789999999999999999999999854 56789999999


Q ss_pred             CCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccccC
Q 036815          814 FGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISALD  893 (1013)
Q Consensus       814 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  893 (1013)
                      +|++..++.....    ..++|.++..++.||++||+|||++   +|+||||||+||+++.++++||+|||+|+......
T Consensus        95 ~g~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          95 KGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             TCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             CCchhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999999875432    2389999999999999999999999   99999999999999999999999999998764322


Q ss_pred             cceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChhhh
Q 036815          894 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPELL  973 (1013)
Q Consensus       894 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  973 (1013)
                       ........||+.|+|||++.+..++.++|||||||++|||++|..||.....    ..+.... +..+.... .++.. 
T Consensus       168 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~~~~~-i~~~~~~~-~~~~~-  239 (285)
T d1fmka3         168 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQ-VERGYRMP-CPPEC-  239 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHH-HHTTCCCC-CCTTS-
T ss_pred             -ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HHHHHHH-HHhcCCCC-CCccc-
Confidence             2233446789999999999999999999999999999999997766554321    1222221 11111111 11111 


Q ss_pred             cccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          974 LVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       974 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                            +          .++.+++.+||+.||++||||+|
T Consensus       240 ------~----------~~l~~li~~cl~~dP~~Rps~~~  263 (285)
T d1fmka3         240 ------P----------ESLHDLMCQCWRKEPEERPTFEY  263 (285)
T ss_dssp             ------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------C----------HHHHHHHHHHcccCHhHCcCHHH
Confidence                  1          12568999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-45  Score=390.00  Aligned_cols=249  Identities=24%  Similarity=0.413  Sum_probs=188.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCC-----CEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDG-----SSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      +.|+..++||+|+||.||+|.++.+     ..||||++...... ...+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999997642     36999988643322 34568999999999999999999999999999999


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ||||+.++++.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        87 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEecccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence            999999999999886433     2389999999999999999999999   99999999999999999999999999998


Q ss_pred             eccccCc-ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDT-HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ....... ........||+.|+|||++.+..++.++|||||||++|||++|..||..... .   .+... .+..+....
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~---~~~~~-~i~~~~~~~  233 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-N---HEVMK-AINDGFRLP  233 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-H---HHHHH-HHHTTCCCC
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-H---HHHHH-HHhccCCCC
Confidence            7654322 2223345689999999999999999999999999999999997666543221 1   11111 122221111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . +...                 ...+.+++.+||+.||++||||+|
T Consensus       234 ~-~~~~-----------------~~~l~~li~~cl~~~p~~RPt~~e  262 (283)
T d1mqba_         234 T-PMDC-----------------PSAIYQLMMQCWQQERARRPKFAD  262 (283)
T ss_dssp             C-CTTC-----------------BHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             C-chhh-----------------HHHHHHHHHHHCcCCHhHCcCHHH
Confidence            0 0000                 013568999999999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=389.93  Aligned_cols=243  Identities=27%  Similarity=0.385  Sum_probs=197.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHh-ccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLG-KIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||+||+|+++ +++.||||++.+..   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999986 68899999986432   223455667777665 68999999999999999999999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|+|.+++.....      +++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+|+.
T Consensus        82 mEy~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EeecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhh
Confidence            999999999999975443      78999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCcccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVI  968 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  968 (1013)
                      .....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  ..  +.............+
T Consensus       153 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~--~~~i~~~~~~~p~~~  226 (320)
T d1xjda_         153 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--EL--FHSIRMDNPFYPRWL  226 (320)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH--HHHHHHCCCCCCTTS
T ss_pred             ccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HH--HHHHHcCCCCCCccC
Confidence            54322  2234567999999999999999999999999999999999999999764311  11  111111111111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ++                     .+.+++.+||+.||++|||+.
T Consensus       227 s~---------------------~~~dli~~~L~~dP~~R~s~~  249 (320)
T d1xjda_         227 EK---------------------EAKDLLVKLFVREPEKRLGVR  249 (320)
T ss_dssp             CH---------------------HHHHHHHHHSCSSGGGSBTTB
T ss_pred             CH---------------------HHHHHHHHhcccCCCCCcCHH
Confidence            11                     256899999999999999985

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-44  Score=392.96  Aligned_cols=236  Identities=23%  Similarity=0.262  Sum_probs=196.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  809 (1013)
                      ++|++.+.||+|+||.||+|+++ +|+.||||++.+..   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46999999999999999999986 68999999885422   233467889999999999999999999999999999999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceec
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLI  889 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  889 (1013)
                      ||+.+|+|.+++....      .+++..++.++.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+..
T Consensus       121 e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             ECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            9999999999997543      389999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Ccccccc
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQMEVI  968 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  968 (1013)
                      ...     .....||+.|||||++.+..++.++||||+||++|||+||+.||.+..     ........... ......+
T Consensus       192 ~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~~~~p~~~  261 (350)
T d1rdqe_         192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSGKVRFPSHF  261 (350)
T ss_dssp             SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCTTC
T ss_pred             ccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHHHhcCCCCCCccC
Confidence            532     234579999999999999999999999999999999999999997532     11122211111 1111111


Q ss_pred             ChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCC
Q 036815          969 DPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP 1009 (1013)
Q Consensus       969 d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1009 (1013)
                      ++                     .+.+++.+||+.||++|+
T Consensus       262 s~---------------------~~~~li~~~L~~dP~kR~  281 (350)
T d1rdqe_         262 SS---------------------DLKDLLRNLLQVDLTKRF  281 (350)
T ss_dssp             CH---------------------HHHHHHHHHSCSCTTTCT
T ss_pred             CH---------------------HHHHHHHHHhhhCHHhcc
Confidence            11                     255899999999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-44  Score=383.64  Aligned_cols=247  Identities=24%  Similarity=0.366  Sum_probs=197.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---------chHHHHHHHHHHhccC-CcceeeeccEEEeC
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---------GDREFMAEMETLGKIK-HRNLVPLLGYCKIG  802 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  802 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||||++.+....         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57999999999999999999985 6889999998653221         1235789999999997 99999999999999


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      +..|+||||+++|+|.+++....      .+++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~D  153 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD  153 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEcc
Confidence            99999999999999999997543      389999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccC------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQS------FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVK  956 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~  956 (1013)
                      ||+|+.+....   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.....     .. ..
T Consensus       154 FG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-----~~-~~  224 (277)
T d1phka_         154 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----ML-ML  224 (277)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH-HH
T ss_pred             chheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----HH-HH
Confidence            99999875422   2345679999999999853      3568899999999999999999999986431     11 11


Q ss_pred             HHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          957 MKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       957 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..+... ...+..    ...+          ..+.+++.+||++||++|||++|
T Consensus       225 ~~i~~~~~~-~~~~~~----~~~s----------~~~~~li~~~L~~~p~~R~s~~e  266 (277)
T d1phka_         225 RMIMSGNYQ-FGSPEW----DDYS----------DTVKDLVSRFLVVQPQKRYTAEE  266 (277)
T ss_dssp             HHHHHTCCC-CCTTTG----GGSC----------HHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HHHHhCCCC-CCCccc----ccCC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            111111111 000000    0011          12568999999999999999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-44  Score=388.06  Aligned_cols=249  Identities=26%  Similarity=0.360  Sum_probs=191.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc---chHHHHHHHHHHhccCCcceeeeccEEEeCC----E
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ---GDREFMAEMETLGKIKHRNLVPLLGYCKIGE----E  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  804 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||||++......   ..+.+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999985 6889999998654332   2356899999999999999999999987643    4


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+||||++|++|.+++....      .+++.+++.++.||+.||+|||++   +||||||||+||+++.++..+++|||
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred             EEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence            789999999999999886543      389999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCc-ceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          885 MARLISALDT-HLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       885 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      .++....... ........||+.|+|||++.+..+++++||||+||++|||+||+.||....     ..+..........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~~~~~~~  231 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQHVREDP  231 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCC
T ss_pred             hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-----HHHHHHHHHhcCC
Confidence            9876543222 223345679999999999999999999999999999999999999997532     1222222222222


Q ss_pred             cc-cccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCC-CCC
Q 036815          964 QM-EVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRP-NML 1012 (1013)
Q Consensus       964 ~~-~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ 1012 (1013)
                      .. ....+.       .+          ..+.+++.+||++||++|| ||+
T Consensus       232 ~~~~~~~~~-------~s----------~~l~~li~~~L~~dp~~R~~sa~  265 (277)
T d1o6ya_         232 IPPSARHEG-------LS----------ADLDAVVLKALAKNPENRYQTAA  265 (277)
T ss_dssp             CCGGGTSSS-------CC----------HHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             CCCchhccC-------CC----------HHHHHHHHHHccCCHhHCHhHHH
Confidence            11 111111       11          1256899999999999999 543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-44  Score=391.69  Aligned_cols=255  Identities=27%  Similarity=0.448  Sum_probs=201.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCE
Q 036815          732 ATNGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       732 ~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  804 (1013)
                      ..++|++.+.||+|+||+||+|+++      +++.||||++...... ..++|.+|++++++++||||++++++|.+.+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            4578999999999999999999974      3468999988654333 34679999999999999999999999999999


Q ss_pred             EEEEEEcccCCCHHHHhccccc------------------CCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAK------------------ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMK  866 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~------------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  866 (1013)
                      .++||||+++|+|.+++.....                  ......+++..+..++.|++.||+|||++   +|||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence            9999999999999999964322                  11223489999999999999999999999   99999999


Q ss_pred             cccEEeCCCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCC-CCCCCCC
Q 036815          867 SSNVLLDHEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK-RPTDKDD  945 (1013)
Q Consensus       867 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~  945 (1013)
                      |+||+++.++.+||+|||+|+...............+++.|+|||++.+..++.++|||||||++|||++|. +||....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999998765544444445667899999999999999999999999999999999986 5665432


Q ss_pred             CCCccHHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          946 FGDTNLVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       946 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           ..+.. ..+..+..... ++.+       +          ..+.+++.+||+.||++||||.|
T Consensus       248 -----~~e~~-~~v~~~~~~~~-p~~~-------~----------~~~~~li~~cl~~~P~~RPt~~e  291 (301)
T d1lufa_         248 -----HEEVI-YYVRDGNILAC-PENC-------P----------LELYNLMRLCWSKLPADRPSFCS  291 (301)
T ss_dssp             -----HHHHH-HHHHTTCCCCC-CTTC-------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -----HHHHH-HHHHcCCCCCC-Cccc-------h----------HHHHHHHHHHcCCChhHCcCHHH
Confidence                 11211 22333322211 1111       1          12568999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=392.20  Aligned_cols=248  Identities=20%  Similarity=0.252  Sum_probs=199.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      .++|++.+.||+|+||+||+|+++ +++.||||++... ......+.+|++++++++||||+++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999987 6788999988543 33456688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC--CcEEEeecccceec
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE--MEARVSDFGMARLI  889 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~a~~~  889 (1013)
                      ++||+|.+++....     ..+++.+++.++.||+.||+|||++   +|+||||||+||+++.+  ..+||+|||+++..
T Consensus        83 ~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          83 ISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999996432     2389999999999999999999999   99999999999999854  57999999999876


Q ss_pred             cccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccC
Q 036815          890 SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVID  969 (1013)
Q Consensus       890 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d  969 (1013)
                      ....   ......+|+.|+|||...+..++.++||||+||++|+|++|+.||.....     .+...........   ++
T Consensus       155 ~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----~~~~~~i~~~~~~---~~  223 (321)
T d1tkia_         155 KPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIENIMNAEYT---FD  223 (321)
T ss_dssp             CTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCC---CC
T ss_pred             ccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC---CC
Confidence            4322   23456789999999999999999999999999999999999999976431     1111211111100   01


Q ss_pred             hhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          970 PELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       970 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ....   ...+          ..+.+++.+||+.||++|||++|
T Consensus       224 ~~~~---~~~s----------~~~~~li~~~L~~dp~~R~s~~e  254 (321)
T d1tkia_         224 EEAF---KEIS----------IEAMDFVDRLLVKERKSRMTASE  254 (321)
T ss_dssp             HHHH---TTSC----------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             hhhc---cCCC----------HHHHHHHHHHccCChhHCcCHHH
Confidence            1000   0011          12568999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.5e-43  Score=391.84  Aligned_cols=242  Identities=24%  Similarity=0.336  Sum_probs=193.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC---ccchHHHHH---HHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS---CQGDREFMA---EMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|++. +|+.||||++.+..   ......+.+   |+++++.++|||||++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999986 68999999885422   122233444   466777788999999999999999999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||++||+|.+++....      .+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|
T Consensus        84 ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeecee
Confidence            9999999999999997543      278999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-Ccc
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-GKQ  964 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~  964 (1013)
                      +.+....    .....||+.|+|||++.+ ..++.++||||+||++|||+||+.||......+  .....+..... ...
T Consensus       155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~  228 (364)
T d1omwa3         155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVEL  228 (364)
T ss_dssp             EECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSSSCCCCC
T ss_pred             eecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcccCCCCC
Confidence            8765422    234579999999999864 568999999999999999999999998654332  11111111110 001


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      ...+++                     .+.+++.+||+.||++|||+
T Consensus       229 ~~~~s~---------------------~~~~li~~~L~~dP~~R~t~  254 (364)
T d1omwa3         229 PDSFSP---------------------ELRSLLEGLLQRDVNRRLGC  254 (364)
T ss_dssp             CSSSCH---------------------HHHHHHHHHTCSSTTTSTTT
T ss_pred             CCCCCH---------------------HHHHHHHHHcccCHHHhCCC
Confidence            111111                     25689999999999999995

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-44  Score=390.27  Aligned_cols=247  Identities=24%  Similarity=0.423  Sum_probs=191.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCC----EEEEEEeecc-CccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGS----SVAIKKLIRL-SCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  807 (1013)
                      ++|++.++||+|+||+||+|++. +|+    +||+|++... .....+++.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35999999999999999999975 344    5888887543 334467899999999999999999999999765 5678


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                      ++||+.+|+|.+++....     ..+++..++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||+|+
T Consensus        88 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             EEEeccCCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence            899999999999886532     3489999999999999999999999   99999999999999999999999999999


Q ss_pred             eccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcccc
Q 036815          888 LISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQME  966 (1013)
Q Consensus       888 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  966 (1013)
                      ...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.....  ......+    ..+....
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i----~~~~~~~  233 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSIL----EKGERLP  233 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHH----HHTCCCC
T ss_pred             ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCCCCC
Confidence            8765444444445678999999999999999999999999999999999 7888875432  1222222    2121111


Q ss_pred             ccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          967 VIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       967 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . ++..       +          ..+.+++.+||+.||++|||++|
T Consensus       234 ~-p~~~-------~----------~~~~~li~~cl~~dP~~RPs~~e  262 (317)
T d1xkka_         234 Q-PPIC-------T----------IDVYMIMVKCWMIDADSRPKFRE  262 (317)
T ss_dssp             C-CTTB-------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C-Cccc-------C----------HHHHHHHHHhCCCChhhCcCHHH
Confidence            0 1110       0          12568999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-44  Score=391.41  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=192.1

Q ss_pred             cCCCCCC-eecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhcc-CCcceeeeccEEEe----CCEEE
Q 036815          734 NGFSAES-LIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKI-KHRNLVPLLGYCKI----GEERL  806 (1013)
Q Consensus       734 ~~y~~~~-~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~  806 (1013)
                      ++|.+.+ +||+|+||+||+|++. +++.||||++.+     ...+.+|++++.++ +||||++++++|.+    +...|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5788764 6999999999999985 689999998743     35678899987655 89999999999875    45689


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCcEEEeec
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EMEARVSDF  883 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Df  883 (1013)
                      +|||||+||+|.+++....    ...+++.+++.++.||+.||+|||++   +|+||||||+||+++.   .+.+||+||
T Consensus        86 ivmEy~~gg~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEECCCCCcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            9999999999999997532    23499999999999999999999999   9999999999999986   467999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCc
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGK  963 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  963 (1013)
                      |+|+......   ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.+......  ..........+.
T Consensus       159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~~  233 (335)
T d2ozaa1         159 GFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMGQ  233 (335)
T ss_dssp             TTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCS
T ss_pred             ceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHhcCC
Confidence            9998765432   23456799999999999999999999999999999999999999976442211  111111111111


Q ss_pred             cccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          964 QMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       964 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      . .. +           ......+  ...+.+++.+||+.||++|||++|
T Consensus       234 ~-~~-~-----------~~~~~~~--s~~~~~li~~~L~~dP~~R~s~~e  268 (335)
T d2ozaa1         234 Y-EF-P-----------NPEWSEV--SEEVKMLIRNLLKTEPTQRMTITE  268 (335)
T ss_dssp             S-SC-C-----------TTHHHHS--CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             C-CC-C-----------CcccccC--CHHHHHHHHHHccCChhHCcCHHH
Confidence            0 00 0           0000011  123568999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=379.51  Aligned_cols=241  Identities=29%  Similarity=0.454  Sum_probs=186.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEe-CCEEEEEEEcc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKI-GEERLLVYEFM  812 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  812 (1013)
                      ++|++.+.||+|+||.||+|+++ |+.||||++..  ....+.+.+|++++++++||||++++|+|.+ .+..|+||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            35778899999999999999986 78999998854  2345779999999999999999999999865 45689999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++.....    ..+++..+++++.||+.||+|||+.   +|+||||||+||+++.++.+|++|||+++.....
T Consensus        84 ~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          84 AKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             TTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             CCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999975432    2489999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                           .....+++.|+|||++.+..+++++|||||||++|||+| |++||.....  .....++    ..+...+. ++.
T Consensus       157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i----~~~~~~~~-~~~  224 (262)
T d1byga_         157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRV----EKGYKMDA-PDG  224 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHH----TTTCCCCC-CTT
T ss_pred             -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCCCCCC-Ccc
Confidence                 234467899999999999999999999999999999998 6777765322  2222222    22222111 111


Q ss_pred             hhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 LLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .       +          .++.+++.+||+.||++||||+|
T Consensus       225 ~-------~----------~~~~~li~~cl~~dP~~Rps~~~  249 (262)
T d1byga_         225 C-------P----------PAVYEVMKNCWHLDAAMRPSFLQ  249 (262)
T ss_dssp             C-------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C-------C----------HHHHHHHHHHcccCHhHCcCHHH
Confidence            1       1          13568999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=382.35  Aligned_cols=248  Identities=24%  Similarity=0.375  Sum_probs=187.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC--C--CEEEEEEeeccC---ccchHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD--G--SSVAIKKLIRLS---CQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||.||+|++..  +  ..||||++.+..   ....++|.+|++++++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            468899999999999999998642  2  368999875432   2334679999999999999999999999965 4678


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      +||||+++|++.+++....     ..+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        87 lv~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eeeeeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhh
Confidence            9999999999999886543     2389999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCccee-eeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCcc
Q 036815          887 RLISALDTHLS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQ  964 (1013)
Q Consensus       887 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  964 (1013)
                      +.......... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||.+..     ..+........+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-----~~~~~~~i~~~~~~  233 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQILHKIDKEGER  233 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTSCCC
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-----HHHHHHHHHhCCCC
Confidence            98755433322 234567889999999999999999999999999999998 899997532     12222222222221


Q ss_pred             ccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          965 MEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       965 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+. .+       ..+          ..+.+++.+||+.||++||||+|
T Consensus       234 ~~~-~~-------~~~----------~~l~~li~~cl~~dp~~RPt~~e  264 (273)
T d1u46a_         234 LPR-PE-------DCP----------QDIYNVMVQCWAHKPEDRPTFVA  264 (273)
T ss_dssp             CCC-CT-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCC-cc-------ccc----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            111 11       111          12568999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=378.80  Aligned_cols=246  Identities=24%  Similarity=0.403  Sum_probs=184.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC----CCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD----GSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.+.||+|+||.||+|++..    +..||||++...... ..+.+.+|++++++++||||++++|++. ++..|+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            568899999999999999998753    346888887543332 3466999999999999999999999985 4678999


Q ss_pred             EEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          809 YEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      |||+++|++.+++....     ..+++..++.++.||++||+|||++   +||||||||+||+++.++.+||+|||+|+.
T Consensus        86 ~E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEeccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence            99999999999876432     2389999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHHHhcCccccc
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLVGWVKMKVREGKQMEV  967 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  967 (1013)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.....  ......    +..+.... 
T Consensus       158 ~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~----i~~~~~~~-  229 (273)
T d1mp8a_         158 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGR----IENGERLP-  229 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHH----HHTTCCCC-
T ss_pred             ccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHH----HHcCCCCC-
Confidence            654222 22345668999999999999999999999999999999998 8999876432  222221    22222111 


Q ss_pred             cChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          968 IDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       968 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +++.       .+          ..+.+++.+||+.||++||||+|
T Consensus       230 ~~~~-------~~----------~~~~~li~~cl~~dp~~Rps~~e  258 (273)
T d1mp8a_         230 MPPN-------CP----------PTLYSLMTKCWAYDPSRRPRFTE  258 (273)
T ss_dssp             CCTT-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCC-------CC----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence            1111       11          12568999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=383.03  Aligned_cols=262  Identities=23%  Similarity=0.234  Sum_probs=189.6

Q ss_pred             CCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccc-----hHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEcc
Q 036815          739 ESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQG-----DREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFM  812 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  812 (1013)
                      .++||+|+||+||+|+++ +|+.||||++.......     .+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999986 68999999885432221     246889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      .++++..+....      ..+++..++.+++||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+.....
T Consensus        83 ~~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          83 ETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             SEEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             cchHHhhhhhcc------cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCC
Confidence            988777665432      3378889999999999999999999   9999999999999999999999999999876432


Q ss_pred             CcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccChh
Q 036815          893 DTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDPE  971 (1013)
Q Consensus       893 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  971 (1013)
                      .  .......||+.|+|||++.+ ..++.++||||+||++|||++|++||......  .....+.............+..
T Consensus       154 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         154 N--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             C--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTT
T ss_pred             c--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHHhcCCCChhhccchh
Confidence            2  22334579999999999865 46799999999999999999999999764311  1111111111111111000000


Q ss_pred             ---hhcccCCCChhhHHHH--HHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          972 ---LLLVTKGTDESEAEEV--KEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       972 ---~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                         .....+..........  .....+.+++.+||+.||++||||+|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e  276 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ  276 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence               0000000000000000  00123678999999999999999865

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-43  Score=381.00  Aligned_cols=201  Identities=27%  Similarity=0.402  Sum_probs=169.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||||++.....  ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999985 689999999854322  235678999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      |+.++ +.+++....    ...+++..++.++.|++.||+|||++   +||||||||+||+++.++.+||+|||.|+...
T Consensus        82 ~~~~~-~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          82 FLHQD-LKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             CCSEE-HHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             ecCCc-hhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceecc
Confidence            99865 444443221    23389999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ...  .......||+.|+|||++.... ++.++||||+||++|+|++|+.||...
T Consensus       154 ~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         154 VPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             CCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence            322  2234557999999999877655 578999999999999999999999754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=382.89  Aligned_cols=254  Identities=28%  Similarity=0.408  Sum_probs=189.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeC-CE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIG-EE  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  804 (1013)
                      ++|++.+.||+|+||.||+|++.      +++.||||++..... ...+.+.+|..++.++ +|+||+++++++.+. ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            56889999999999999999874      246899998864332 3345678888888777 689999999988664 46


Q ss_pred             EEEEEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH  874 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  874 (1013)
                      .++||||+++|+|.+++......          .....+++..+..++.||++||+|||++   +||||||||+||+++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            89999999999999999754321          1123489999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCC-CCCCCCCCCCccHHH
Q 036815          875 EMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK-RPTDKDDFGDTNLVG  953 (1013)
Q Consensus       875 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~  953 (1013)
                      ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||...... .    
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~----  244 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-E----  244 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-H----
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-H----
Confidence            9999999999998765544444445567999999999999999999999999999999999964 567643321 1    


Q ss_pred             HHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          954 WVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       954 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+...+..+......+ .       .+          ..+.+++.+||+.||++||||+|
T Consensus       245 ~~~~~~~~~~~~~~~~-~-------~~----------~~l~~li~~cl~~dP~~Rpt~~e  286 (299)
T d1ywna1         245 EFCRRLKEGTRMRAPD-Y-------TT----------PEMYQTMLDCWHGEPSQRPTFSE  286 (299)
T ss_dssp             HHHHHHHHTCCCCCCT-T-------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHhcCCCCCCCc-c-------CC----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            1222222222221111 0       11          12568999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=382.38  Aligned_cols=254  Identities=29%  Similarity=0.440  Sum_probs=201.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCcc-chHHHHHHHHHHhcc-CCcceeeeccEEEeCCEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKI-KHRNLVPLLGYCKIGEER  805 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  805 (1013)
                      ++|++.++||+|+||.||+|++.      +++.||||++...... ...++.+|+.+++++ +|||||++++++.+++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            56888999999999999999863      3568999998654333 345688999999999 699999999999999999


Q ss_pred             EEEEEcccCCCHHHHhcccccC------------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          806 LLVYEFMKFGSLEEVLHGRAKA------------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       806 ~lv~e~~~~g~L~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ++||||+++|+|.++++.....            .....+++..+..++.||++||+|||++   +||||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence            9999999999999999754321            1233589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcC-CCCCCCCCCCCccHH
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTG-KRPTDKDDFGDTNLV  952 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~  952 (1013)
                      .++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+ .+||.... ....+.
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~-~~~~~~  258 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-VDSKFY  258 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-SSHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC-HHHHHH
Confidence            9999999999999987665555555567899999999999999999999999999999999995 55444322 222222


Q ss_pred             HHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          953 GWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       953 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..+..    +.... .+...       +          ..+.+++.+||+.||++||||+|
T Consensus       259 ~~i~~----~~~~~-~~~~~-------~----------~~l~~Li~~cl~~dP~~RPs~~~  297 (311)
T d1t46a_         259 KMIKE----GFRML-SPEHA-------P----------AEMYDIMKTCWDADPLKRPTFKQ  297 (311)
T ss_dssp             HHHHH----TCCCC-CCTTS-------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHhc----CCCCC-Ccccc-------c----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            22222    11111 00000       0          12568999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-43  Score=375.14  Aligned_cols=236  Identities=24%  Similarity=0.420  Sum_probs=190.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCcc------chHHHHHHHHHHhccC--CcceeeeccEEEeCCE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQ------GDREFMAEMETLGKIK--HRNLVPLLGYCKIGEE  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  804 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||||++.+....      ...++.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999986 6899999998643211      1234678999999986  8999999999999999


Q ss_pred             EEEEEEcccC-CCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCC-CcEEEee
Q 036815          805 RLLVYEFMKF-GSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHE-MEARVSD  882 (1013)
Q Consensus       805 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~D  882 (1013)
                      .|+||||+.+ +++.+++....      .+++..++.++.|+++||+|||++   +|+||||||+||+++.+ +.+||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             EEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECc
Confidence            9999999976 67888876433      389999999999999999999999   99999999999999854 7999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRC-TAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      ||+|+.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....       .    ... 
T Consensus       155 FG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~----i~~-  218 (273)
T d1xwsa_         155 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E----IIR-  218 (273)
T ss_dssp             CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----HHH-
T ss_pred             cccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------H----Hhh-
Confidence            9999875432    2335679999999999987665 567999999999999999999997421       1    011 


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +..  .+++       ..+          ..+.+++.+||+.||++|||++|
T Consensus       219 ~~~--~~~~-------~~s----------~~~~~li~~~L~~dp~~R~s~~e  251 (273)
T d1xwsa_         219 GQV--FFRQ-------RVS----------SECQHLIRWCLALRPSDRPTFEE  251 (273)
T ss_dssp             CCC--CCSS-------CCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccc--CCCC-------CCC----------HHHHHHHHHHccCCHhHCcCHHH
Confidence            100  0111       111          12568999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-43  Score=377.74  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=197.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC--------CCEEEEEEeeccCc-cchHHHHHHHHHHhcc-CCcceeeeccEEEeCC
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD--------GSSVAIKKLIRLSC-QGDREFMAEMETLGKI-KHRNLVPLLGYCKIGE  803 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  803 (1013)
                      ++|++.+.||+|+||.||+|+...        +..||||++..... ....++.+|...+.++ +||||++++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            468889999999999999998642        23799998865443 2346788899999888 8999999999999999


Q ss_pred             EEEEEEEcccCCCHHHHhcccccC----------CCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeC
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKA----------RDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLD  873 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  873 (1013)
                      ..++||||+++|+|.+++......          .....+++.+++.++.||+.||+|||++   +||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence            999999999999999999755321          1234589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 036815          874 HEMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLT-GKRPTDKDDFGDTNLV  952 (1013)
Q Consensus       874 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~  952 (1013)
                      .++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |.+||.....  .   
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~---  244 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--E---  244 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H---
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--H---
Confidence            999999999999998765544444455678999999999999999999999999999999998 6888764331  1   


Q ss_pred             HHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          953 GWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       953 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                       .+...+..+..... ++       ..+          ..+.+++.+||+.||++||||+|
T Consensus       245 -~~~~~i~~~~~~~~-p~-------~~~----------~~l~~li~~cl~~dP~~Rps~~e  286 (299)
T d1fgka_         245 -ELFKLLKEGHRMDK-PS-------NCT----------NELYMMMRDCWHAVPSQRPTFKQ  286 (299)
T ss_dssp             -HHHHHHHTTCCCCC-CS-------SCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -HHHHHHHcCCCCCC-Cc-------cch----------HHHHHHHHHHccCCHhHCcCHHH
Confidence             12222222222211 11       111          12568999999999999999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=375.94  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=188.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHH--HHHHHhccCCcceeeeccEEEeCC----EEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMA--EMETLGKIKHRNLVPLLGYCKIGE----ERLL  807 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l  807 (1013)
                      ++|.+.+.||+|+||.||+|++. |+.||||++...   ..+.+.+  |+..+.+++||||+++++++.+.+    ..|+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            45777889999999999999974 889999987532   2334444  445556789999999999997643    6799


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCcccEEeCCCCcEEEee
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC-----IPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      ||||+++|+|.++++..       .++|..+.+++.|+|.||+|+|+..     ..+||||||||+||+++.++.+||+|
T Consensus        79 v~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            99999999999999743       2899999999999999999999731     23999999999999999999999999


Q ss_pred             cccceeccccCcce--eeeeeccCCCccCcccccCC------CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCcc----
Q 036815          883 FGMARLISALDTHL--SVSTLAGTPGYVPPEYYQSF------RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTN----  950 (1013)
Q Consensus       883 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~----  950 (1013)
                      ||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||+||..||.........    
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            99999875433322  23456799999999998754      3677999999999999999999887643322111    


Q ss_pred             -----HHHHHHHHHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          951 -----LVGWVKMKVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       951 -----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                           .................++..            .........+.+++.+||+.||++||||.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~p~~~~~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  287 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCEQKLRPNIPNR------------WQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGG------------GGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             ccccchHHHHHHHHhccccCCCCCcc------------cCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence                 111122222111111111110            011122334678999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-42  Score=373.92  Aligned_cols=244  Identities=28%  Similarity=0.448  Sum_probs=190.1

Q ss_pred             CCeecccCCcEEEEEEEcCC----CEEEEEEeeccC-ccchHHHHHHHHHHhccCCcceeeeccEEEe-CCEEEEEEEcc
Q 036815          739 ESLIGCGGFGEVFKATLKDG----SSVAIKKLIRLS-CQGDREFMAEMETLGKIKHRNLVPLLGYCKI-GEERLLVYEFM  812 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  812 (1013)
                      .++||+|+||+||+|++.++    ..||||++.... ....++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999998642    258999886433 3334679999999999999999999999876 46889999999


Q ss_pred             cCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecccc
Q 036815          813 KFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISAL  892 (1013)
Q Consensus       813 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  892 (1013)
                      ++|+|.+++....     ...++..+.+++.|+++||.|+|+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       112 ~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         112 KHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             TTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             ecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999987543     2377888999999999999999999   9999999999999999999999999999876543


Q ss_pred             Ccc--eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhcCccccccCh
Q 036815          893 DTH--LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVREGKQMEVIDP  970 (1013)
Q Consensus       893 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  970 (1013)
                      ...  .......||+.|+|||.+.+..++.++||||||+++|||+||..||....... ....++    ..+....  .|
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i----~~g~~~~--~p  256 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYL----LQGRRLL--QP  256 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH----HTTCCCC--CC
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHH----HcCCCCC--Cc
Confidence            221  12234568999999999999999999999999999999999888876533221 122222    2222111  11


Q ss_pred             hhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          971 ELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       971 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      ..      ..          ..+.+++.+||+.||++||||+|
T Consensus       257 ~~------~~----------~~l~~li~~cl~~dP~~RPs~~e  283 (311)
T d1r0pa_         257 EY------CP----------DPLYEVMLKCWHPKAEMRPSFSE  283 (311)
T ss_dssp             TT------CC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cc------Cc----------HHHHHHHHHHcCCCHhHCcCHHH
Confidence            10      01          12568999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=376.56  Aligned_cols=250  Identities=27%  Similarity=0.427  Sum_probs=192.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcC-CC--EEEEEEeeccC-ccchHHHHHHHHHHhcc-CCcceeeeccEEEeCCEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKD-GS--SVAIKKLIRLS-CQGDREFMAEMETLGKI-KHRNLVPLLGYCKIGEERLLV  808 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  808 (1013)
                      ++|++.++||+|+||+||+|++++ +.  .||||++.... ....+.+.+|+++++++ +||||++++|++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            468889999999999999999864 33  47788775433 23445799999999998 799999999999999999999


Q ss_pred             EEcccCCCHHHHhccccc----------CCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          809 YEFMKFGSLEEVLHGRAK----------ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       809 ~e~~~~g~L~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      |||+++|+|.++++....          ......+++..+..++.||++||.|+|++   +||||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            999999999999975421          12234589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCC-CCCCCCCCCccHHHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKR-PTDKDDFGDTNLVGWVKM  957 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-pf~~~~~~~~~~~~~~~~  957 (1013)
                      ||+|||+|+......   ......||..|+|||.+.+..++.++|||||||++|||++|.. ||....     ..+... 
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~~~~~-  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYE-  237 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHH-
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HHHHHH-
Confidence            999999998654322   2234568999999999999999999999999999999999765 554322     122222 


Q ss_pred             HHhcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          958 KVREGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       958 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .+..+..... +..+       +          ..+.+++.+||+.||++||||+|
T Consensus       238 ~i~~~~~~~~-~~~~-------~----------~~~~~li~~cl~~dP~~RPs~~e  275 (309)
T d1fvra_         238 KLPQGYRLEK-PLNC-------D----------DEVYDLMRQCWREKPYERPSFAQ  275 (309)
T ss_dssp             HGGGTCCCCC-CTTB-------C----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHhcCCCCC-CccC-------C----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            2222211111 0000       0          12568999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-42  Score=372.79  Aligned_cols=200  Identities=23%  Similarity=0.320  Sum_probs=171.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEEc
Q 036815          734 NGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEF  811 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  811 (1013)
                      ++|++.+.||+|+||+||+|++++|+.||||++.....  ...+.+.+|+.++++++||||+++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57999999999999999999999999999999855332  2347899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceeccc
Q 036815          812 MKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLISA  891 (1013)
Q Consensus       812 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  891 (1013)
                      +.++.+..+....      ..+++..++.++.||+.||+|||++   +||||||||+||+++.++.+|++|||.|.....
T Consensus        82 ~~~~~~~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          82 LDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             CSEEHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             ehhhhHHHHHhhc------CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            9987777776433      3389999999999999999999999   999999999999999999999999999987643


Q ss_pred             cCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          892 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       892 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      ..  .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus       153 ~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         153 PV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             Cc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            22  22334568999999999875 45689999999999999999999999754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=375.89  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=200.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc------CCCEEEEEEeeccCcc-chHHHHHHHHHHhccCCcceeeeccEEEeCCEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK------DGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  806 (1013)
                      ++|++.+.||+|+||+||+|.+.      +++.||||++...... ....+.+|++++++++||||+++++++..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            46788899999999999999874      2578999998654332 3356899999999999999999999999999999


Q ss_pred             EEEEcccCCCHHHHhccccc----CCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          807 LVYEFMKFGSLEEVLHGRAK----ARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      +||||+++|+|.+++.....    ......+++..+.+++.|+++||.|||++   +|+||||||+|||+++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence            99999999999999864321    11223478999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCC-CCCCCCCCCCccHHHHHHHHHhc
Q 036815          883 FGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGK-RPTDKDDFGDTNLVGWVKMKVRE  961 (1013)
Q Consensus       883 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~  961 (1013)
                      ||+|+...............+|+.|+|||.+.+..++.++|||||||++|||+||. .||...     ...++... +..
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~~-i~~  250 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRF-VME  250 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHH-HHT
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHHHH-HHh
Confidence            99998776544444444557899999999999999999999999999999999985 666432     22223222 222


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      +...... +       ..+          ..+.+++.+||+.||++||||+|
T Consensus       251 ~~~~~~p-~-------~~~----------~~l~~li~~cl~~~P~~RPs~~~  284 (308)
T d1p4oa_         251 GGLLDKP-D-------NCP----------DMLFELMRMCWQYNPKMRPSFLE  284 (308)
T ss_dssp             TCCCCCC-T-------TCC----------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCc-c-------cch----------HHHHHHHHHHcCCChhHCcCHHH
Confidence            2221111 1       111          13668999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=375.69  Aligned_cols=201  Identities=24%  Similarity=0.380  Sum_probs=167.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-C-CCEEEEEEeeccCc--cchHHHHHHHHHHhcc---CCcceeeeccEEEe----
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-D-GSSVAIKKLIRLSC--QGDREFMAEMETLGKI---KHRNLVPLLGYCKI----  801 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  801 (1013)
                      .++|++.+.||+|+||+||+|++. + ++.||||++.....  .....+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999984 4 56789998854322  2234566788877666   79999999999853    


Q ss_pred             -CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEE
Q 036815          802 -GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARV  880 (1013)
Q Consensus       802 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  880 (1013)
                       ....+++|||++++.+.......     ...+++..++.++.|++.||+|||++   +||||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCceEEEEEEeccCCchhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence             34679999999987766554322     23388999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          881 SDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       881 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +|||.++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       158 ~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         158 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence            999999865432   2234568999999999999999999999999999999999999999764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-41  Score=364.43  Aligned_cols=246  Identities=23%  Similarity=0.306  Sum_probs=195.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc----CCCEEEEEEeeccC----ccchHHHHHHHHHHhccCC-cceeeeccEEEeCCE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK----DGSSVAIKKLIRLS----CQGDREFMAEMETLGKIKH-RNLVPLLGYCKIGEE  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  804 (1013)
                      ++|++.+.||+|+||+||+|+..    +|+.||||++.+..    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999863    47899999885432    2234568899999999976 899999999999999


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .++||||+.+|+|.+++.....      +++..+..++.|++.|++|+|++   +||||||||+||+++.++.+||+|||
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eeeeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeecc
Confidence            9999999999999999975543      67888999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCC--CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHHhc-
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSF--RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKVRE-  961 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-  961 (1013)
                      +|+.+...... ......|++.|+|||.+.+.  .++.++||||+||++|||++|+.||......+.. .......... 
T Consensus       175 ~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~~~~~~~~  252 (322)
T d1vzoa_         175 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKSE  252 (322)
T ss_dssp             EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHHHCC
T ss_pred             chhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcccCC
Confidence            99876543222 23356799999999998754  4678999999999999999999999876544332 2222221111 


Q ss_pred             CccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCC
Q 036815          962 GKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNM 1011 (1013)
Q Consensus       962 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1011 (1013)
                      .......++                     .+.+++.+||++||++|||+
T Consensus       253 ~~~~~~~s~---------------------~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         253 PPYPQEMSA---------------------LAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             CCCCTTSCH---------------------HHHHHHHHHTCSSGGGSTTS
T ss_pred             CCCcccCCH---------------------HHHHHHHHHcccCHHHcCCC
Confidence            111111111                     25689999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=363.89  Aligned_cols=269  Identities=24%  Similarity=0.331  Sum_probs=192.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccC--ccchHHHHHHHHHHhccCCcceeeeccEEEe--------C
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLS--CQGDREFMAEMETLGKIKHRNLVPLLGYCKI--------G  802 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  802 (1013)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  .....++.+|++++++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67999999999999999999985 78999999875432  2334678999999999999999999998855        3


Q ss_pred             CEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEee
Q 036815          803 EERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSD  882 (1013)
Q Consensus       803 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  882 (1013)
                      +..|+||||++++.+..+....      ..+++..++.+++|++.||.|||++   +||||||||+||+++.++.+|++|
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             ceEEEEEeccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence            4579999999987766554332      2388899999999999999999999   999999999999999999999999


Q ss_pred             cccceeccccCcc--eeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHHH
Q 036815          883 FGMARLISALDTH--LSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLVGWVKMKV  959 (1013)
Q Consensus       883 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  959 (1013)
                      ||+|+.+......  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..  +......+....
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~~~~~i~~~~  238 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLC  238 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHH
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHHHHHHHHHhc
Confidence            9999876532221  122345699999999998765 68999999999999999999999997532  111111111111


Q ss_pred             hcCcc--ccccC-hhh---hcccCCCChhhHHHH---HHHHHHHHHHHhcccCCCCCCCCCCC
Q 036815          960 REGKQ--MEVID-PEL---LLVTKGTDESEAEEV---KEMVRYLEITLQCVDDFPSKRPNMLQ 1013 (1013)
Q Consensus       960 ~~~~~--~~~~d-~~~---~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~e 1013 (1013)
                      .....  ....+ ...   ...............   .....+.+++.+||++||++||||+|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e  301 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD  301 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence            11100  00000 000   000011111111111   11224678999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=367.50  Aligned_cols=203  Identities=24%  Similarity=0.353  Sum_probs=167.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc-cchHHHHHHHHHHhccCCcceeeeccEEEeCC----EEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC-QGDREFMAEMETLGKIKHRNLVPLLGYCKIGE----ERL  806 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  806 (1013)
                      +.+|++.+.||+|+||+||+|++. +|+.||||++.+... ...+.+.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            467999999999999999999975 799999999865432 23457889999999999999999999986643    234


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccc
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMA  886 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  886 (1013)
                      ++++|+.+|+|.+++...       .+++..++.++.|++.||+|||++   +||||||||+||+++.++.+||+|||+|
T Consensus        87 ~l~~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            555667789999999642       389999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccccCcc-eeeeeeccCCCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          887 RLISALDTH-LSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       887 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +........ .......||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            876443221 1234567899999999985 4567899999999999999999999997643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=359.50  Aligned_cols=199  Identities=26%  Similarity=0.338  Sum_probs=173.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCCEEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      ++|++.+.||+|+||+||+|++. +++.||||++.....  ....++.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999986 688999999854332  234678999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecccceecc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARLIS  890 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  890 (1013)
                      ++.++++..++....      .+++..++.++.|++.||+|||++   +||||||||+||+++.++.+|++|||.|+...
T Consensus        82 ~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          82 FCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             CCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhccc
Confidence            999999988876433      378999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccCcceeeeeeccCCCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCC
Q 036815          891 ALDTHLSVSTLAGTPGYVPPEYYQSFR-CTAKGDVYSFGVVLLELLTGKRPTDK  943 (1013)
Q Consensus       891 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~  943 (1013)
                      ....  ......+++.|+|||++.+.. ++.++||||+||++|||++|+.||..
T Consensus       153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         153 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             SCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             CCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            4322  223445778999999987654 68999999999999999999999764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-40  Score=356.11  Aligned_cols=250  Identities=22%  Similarity=0.279  Sum_probs=187.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceee-eccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVP-LLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||||.+....  ...++.+|++++++++|++++. +.+++.+++..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            357999999999999999999985 68899999875432  2345789999999998776554 4555677889999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC---CCcEEEeecccce
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH---EMEARVSDFGMAR  887 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a~  887 (1013)
                      |++ +++.+.+....     ..+++..+..++.|++.||+|||++   +||||||||+||+++.   +..+|++|||+|+
T Consensus        84 ~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          84 LLG-PSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             CCC-CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EcC-Cchhhhhhhcc-----CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            995 56666664322     3489999999999999999999999   9999999999999864   4579999999999


Q ss_pred             eccccCcc-----eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccH--HHHHHHHHh
Q 036815          888 LISALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNL--VGWVKMKVR  960 (1013)
Q Consensus       888 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~~  960 (1013)
                      .+......     .......||+.|+|||++.+..++.++|||||||++|||+||+.||..........  ..+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            87543321     12345679999999999999999999999999999999999999998654332211  111111111


Q ss_pred             cCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          961 EGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       961 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ..  .....       ...+          ..+.+++.+|++.||++||+++
T Consensus       235 ~~--~~~~~-------~~~p----------~~~~~li~~cl~~~p~~RP~~~  267 (299)
T d1ckia_         235 TP--IEVLC-------KGYP----------SEFATYLNFCRSLRFDDKPDYS  267 (299)
T ss_dssp             SC--HHHHT-------TTSC----------HHHHHHHHHHHHSCTTCCCCHH
T ss_pred             CC--hhHhc-------cCCC----------HHHHHHHHHHccCChhHCcCHH
Confidence            10  00000       0111          1256899999999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.7e-40  Score=352.85  Aligned_cols=251  Identities=20%  Similarity=0.233  Sum_probs=195.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCC-cceeeeccEEEeCCEEEEEEE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH-RNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      .++|++.+.||+|+||+||+|++. +++.||||.+....  ....+.+|+++++.+.| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            368999999999999999999986 68899999774432  23457789999999965 899999999999999999999


Q ss_pred             cccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCC-----CCcEEEeeccc
Q 036815          811 FMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDH-----EMEARVSDFGM  885 (1013)
Q Consensus       811 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~  885 (1013)
                      |+ +++|.+++....     ..+++.++..++.|++.||+|||++   +||||||||+||+++.     ++.+||+|||+
T Consensus        82 ~~-~~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          82 LL-GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             CC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ec-CCCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            99 589999886433     2389999999999999999999999   9999999999999974     57899999999


Q ss_pred             ceeccccCcc-----eeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCccHH-HHHHHHH
Q 036815          886 ARLISALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDDFGDTNLV-GWVKMKV  959 (1013)
Q Consensus       886 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~  959 (1013)
                      |+.+......     .......||+.|||||++.+..++.++|||||||++|||+||+.||........... ..+....
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            9986543221     123356799999999999999999999999999999999999999986544332111 1111111


Q ss_pred             hcCccccccChhhhcccCCCChhhHHHHHHHHHHHHHHHhcccCCCCCCCCCC
Q 036815          960 REGKQMEVIDPELLLVTKGTDESEAEEVKEMVRYLEITLQCVDDFPSKRPNML 1012 (1013)
Q Consensus       960 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1012 (1013)
                      ..... .    ++   ....+          ..+.+++..|++.+|++||+++
T Consensus       233 ~~~~~-~----~l---~~~~p----------~~l~~ii~~~~~~~~~~rP~y~  267 (293)
T d1csna_         233 QSTPL-R----EL---CAGFP----------EEFYKYMHYARNLAFDATPDYD  267 (293)
T ss_dssp             HHSCH-H----HH---TTTSC----------HHHHHHHHHHHHCCTTCCCCHH
T ss_pred             CCCCh-H----Hh---cCCCC----------HHHHHHHHHHhcCCcccCcCHH
Confidence            10000 0    00   01111          1256888999999999999753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-40  Score=363.69  Aligned_cols=198  Identities=28%  Similarity=0.352  Sum_probs=163.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccCCcceeeeccEEEeC------CEEEE
Q 036815          735 GFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIG------EERLL  807 (1013)
Q Consensus       735 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  807 (1013)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    ...+|++++++++||||++++++|...      .+.|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4778899999999999999986 689999999865432    234799999999999999999998643      35789


Q ss_pred             EEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-cEEEeecccc
Q 036815          808 VYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMA  886 (1013)
Q Consensus       808 v~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a  886 (1013)
                      ||||++++.+..... ...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|
T Consensus        97 v~Ey~~~~~~~~l~~-~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          97 VLDYVPETVYRVARH-YSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEECCSEEHHHHHHH-HHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEeccCCccHHHHHh-hhh--ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            999998664443332 111  223489999999999999999999999   999999999999999875 8999999999


Q ss_pred             eeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          887 RLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       887 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      +.......   .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus       171 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~  227 (350)
T d1q5ka_         171 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  227 (350)
T ss_dssp             EECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             hhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence            87654332   234579999999998765 578999999999999999999999997643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-40  Score=361.90  Aligned_cols=196  Identities=29%  Similarity=0.417  Sum_probs=163.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeCC------
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIGE------  803 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  803 (1013)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....  ...+.+.+|++++++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            367999999999999999999986 689999999864322  22456889999999999999999999997654      


Q ss_pred             EEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeec
Q 036815          804 ERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDF  883 (1013)
Q Consensus       804 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  883 (1013)
                      +.|+||||+ +.++..+....       .+++..++.++.|++.||+|||++   +||||||||+||+++.++.+|++||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecc-cccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence            569999999 46788777532       289999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccccCcceeeeeeccCCCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          884 GMARLISALDTHLSVSTLAGTPGYVPPEYYQS-FRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       884 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      |.|+.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       166 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         166 GLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             TTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence            999876432     234678999999999876 45689999999999999999999999764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-40  Score=362.24  Aligned_cols=196  Identities=25%  Similarity=0.322  Sum_probs=159.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEe------CCE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKI------GEE  804 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  804 (1013)
                      ++|++.++||+|+||+||+|++. +|+.||||++.....  ....++.+|+.++++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999987 689999999865432  223568899999999999999999999964      368


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .|+||||+.++.+ +.+.        ..+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+|++|||
T Consensus        97 ~~iv~Ey~~~~l~-~~~~--------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccchHHH-Hhhh--------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            8999999986544 4442        1278999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      +++....   ........+|+.|+|||++.+..+++++||||+||++|||++|+.||.+.
T Consensus       165 ~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         165 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence            9886543   22334567899999999999999999999999999999999999999764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.2e-40  Score=359.61  Aligned_cols=194  Identities=23%  Similarity=0.347  Sum_probs=167.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEeC--CEEEEEE
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIG--EERLLVY  809 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  809 (1013)
                      ++|++.++||+|+||+||+|++. +++.||||++..   ...+++.+|++++++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999985 688999998753   23567889999999995 99999999998753  5689999


Q ss_pred             EcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCC-cEEEeeccccee
Q 036815          810 EFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEM-EARVSDFGMARL  888 (1013)
Q Consensus       810 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~  888 (1013)
                      ||+++++|..+..         .+++..++.++.||+.||+|||++   +||||||||+|||++.++ .+|++|||+|+.
T Consensus       112 e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         112 EHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             ECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             eecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence            9999999876542         389999999999999999999999   999999999999998765 689999999987


Q ss_pred             ccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          889 ISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       889 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                      .....   ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus       180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         180 YHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             CCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             ccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            65432   23456789999999998765 47999999999999999999999997643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=354.21  Aligned_cols=197  Identities=27%  Similarity=0.400  Sum_probs=164.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCc--cchHHHHHHHHHHhccCCcceeeeccEEEeC-----CE
Q 036815          733 TNGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSC--QGDREFMAEMETLGKIKHRNLVPLLGYCKIG-----EE  804 (1013)
Q Consensus       733 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  804 (1013)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+...  ...+++.+|++++++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467999999999999999999986 689999999864332  2335688999999999999999999998642     34


Q ss_pred             EEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcEEEeecc
Q 036815          805 RLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEARVSDFG  884 (1013)
Q Consensus       805 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  884 (1013)
                      .+++++|+.+|+|.+++...       .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+|++|||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence            46677888899999998532       389999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccccCcceeeeeeccCCCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 036815          885 MARLISALDTHLSVSTLAGTPGYVPPEYYQSF-RCTAKGDVYSFGVVLLELLTGKRPTDKD  944 (1013)
Q Consensus       885 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~  944 (1013)
                      .|......     .....|++.|+|||+..+. .++.++||||+||++|+|++|+.||.+.
T Consensus       167 ~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         167 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             ---CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            99765321     2345688999999987665 4688999999999999999999999764

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=3.6e-35  Score=320.90  Aligned_cols=259  Identities=35%  Similarity=0.577  Sum_probs=224.6

Q ss_pred             cccEEEeeCCccCC--CCCcccccCcchHHHHhhh-ccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeE
Q 036815          297 QLKVIDLSLNYLNG--SIPQELGKLEHLEQFIAWF-NGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWI  373 (1013)
Q Consensus       297 ~L~~L~ls~N~l~~--~~p~~l~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  373 (1013)
                      +++.|+|++|.++|  .+|..++++++|+.|++++ |.++|.+|..|++|++|++|+|++|++.+..+..+..+..|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            45556666666655  3555666666666666654 56666778888888999999999999998888889999999999


Q ss_pred             EecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCC-cEEEccCCcCCcCCCchhhhccCCCCCCCcccCC
Q 036815          374 SLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSL-VWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSN  452 (1013)
Q Consensus       374 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~  452 (1013)
                      ++++|.+.+.+|..+.+++.|+.+++++|++.|.+|..+..+.++ +.+++++|+++|..|..++.              
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~--------------  196 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN--------------  196 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG--------------
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccc--------------
Confidence            999999999999999999999999999999999999999888876 88999999998877755432              


Q ss_pred             ceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCC
Q 036815          453 TLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMI  532 (1013)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~  532 (1013)
                                                                            + .+.++++++|.+.|.+|..++.+.
T Consensus       197 ------------------------------------------------------l-~~~~l~l~~~~~~~~~~~~~~~~~  221 (313)
T d1ogqa_         197 ------------------------------------------------------L-NLAFVDLSRNMLEGDASVLFGSDK  221 (313)
T ss_dssp             ------------------------------------------------------C-CCSEEECCSSEEEECCGGGCCTTS
T ss_pred             ------------------------------------------------------c-cccccccccccccccccccccccc
Confidence                                                                  1 245799999999999999999999


Q ss_pred             CCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECcCCCCCCcCCCCCCCCCCCcccccC
Q 036815          533 ALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPASQYAN  612 (1013)
Q Consensus       533 ~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~  612 (1013)
                      +|+.|++++|.++|.+| .++.+++|+.|+|++|+|+|.+|++|+++++|+.|||++|+|+|.+|+.+.+++++.+.+.|
T Consensus       222 ~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~  300 (313)
T d1ogqa_         222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN  300 (313)
T ss_dssp             CCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCS
T ss_pred             ccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCC
Confidence            99999999999998765 68999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCC
Q 036815          613 NPGLCGVPLPECR  625 (1013)
Q Consensus       613 n~~lc~~~~~~~~  625 (1013)
                      |+.+||.|+|.|.
T Consensus       301 N~~l~g~plp~c~  313 (313)
T d1ogqa_         301 NKCLCGSPLPACT  313 (313)
T ss_dssp             SSEEESTTSSCCC
T ss_pred             CccccCCCCCCCC
Confidence            9999999999994

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.7e-34  Score=320.80  Aligned_cols=200  Identities=22%  Similarity=0.281  Sum_probs=158.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEc-CCCEEEEEEeeccCccchHHHHHHHHHHhccC-----------CcceeeeccEEEe
Q 036815          734 NGFSAESLIGCGGFGEVFKATLK-DGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-----------HRNLVPLLGYCKI  801 (1013)
Q Consensus       734 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  801 (1013)
                      ++|+++++||+|+||+||+|++. +|+.||||++.+.. ...+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999985 68999999886432 23456788999888775           5789999998864


Q ss_pred             --CCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCC--
Q 036815          802 --GEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEM--  876 (1013)
Q Consensus       802 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~--  876 (1013)
                        ....+++++++..+.........   .....+++..++.++.||+.||+|||+ .   +|+||||||+||+++.++  
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred             ccccceeeeeeeccccccccccccc---ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence              35666777766554433322211   122348889999999999999999998 6   999999999999998765  


Q ss_pred             ----cEEEeecccceeccccCcceeeeeeccCCCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 036815          877 ----EARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVLLELLTGKRPTDKDD  945 (1013)
Q Consensus       877 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~  945 (1013)
                          .++++|||.|+.....     .....||+.|+|||++.+..++.++||||+||+++||++|+.||....
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence                3999999999865432     234579999999999999999999999999999999999999998654

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=5.6e-32  Score=295.34  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=224.5

Q ss_pred             CCceEEcCCCcccc--cCCccccccCcccEEEeeC-CccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceE
Q 036815          273 SLEELRLPDNLITG--VIPGQLSECTQLKVIDLSL-NYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDL  349 (1013)
Q Consensus       273 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~ls~-N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  349 (1013)
                      .++.|+|++|.+++  .+|..++++++|++|+|++ |.++|.+|..++++++|+.|++++|.+.+..+..+..+..|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            46677777777766  4678899999999999986 88888899999999999999999999998888899999999999


Q ss_pred             ECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCC-ceEEccCCeeeeecCCCCcCCCCCcEEEccCCcC
Q 036815          350 ILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRL-AVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNL  428 (1013)
Q Consensus       350 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  428 (1013)
                      ++++|.+.+.+|..+.+++.|+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+.++..+ ++++++|..
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            999999999999999999999999999999999999999998886 889999999999999999887655 799999988


Q ss_pred             CcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccccccCCC
Q 036815          429 TGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLSLFTQYQ  508 (1013)
Q Consensus       429 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  508 (1013)
                      .|.+|..+                                                                    ..++
T Consensus       210 ~~~~~~~~--------------------------------------------------------------------~~~~  221 (313)
T d1ogqa_         210 EGDASVLF--------------------------------------------------------------------GSDK  221 (313)
T ss_dssp             EECCGGGC--------------------------------------------------------------------CTTS
T ss_pred             cccccccc--------------------------------------------------------------------cccc
Confidence            87766433                                                                    2346


Q ss_pred             ccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCCCcceEEECc
Q 036815          509 TLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNLSFLVQIDLS  588 (1013)
Q Consensus       509 ~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~l~l~  588 (1013)
                      +|+.+++++|.++|.+| +++.+++|++|+|++|+|+|.+|++|++|++|++|||++|+|+|.||+ +++++.|+.++++
T Consensus       222 ~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~  299 (313)
T d1ogqa_         222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYA  299 (313)
T ss_dssp             CCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTC
T ss_pred             ccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhC
Confidence            78999999999997655 799999999999999999999999999999999999999999999995 6889999999999


Q ss_pred             CCC-CCCc-CCC
Q 036815          589 NNE-LTGP-IPQ  598 (1013)
Q Consensus       589 ~n~-l~~~-~p~  598 (1013)
                      +|+ ++|. +|.
T Consensus       300 ~N~~l~g~plp~  311 (313)
T d1ogqa_         300 NNKCLCGSPLPA  311 (313)
T ss_dssp             SSSEEESTTSSC
T ss_pred             CCccccCCCCCC
Confidence            997 7775 453

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.2e-27  Score=269.24  Aligned_cols=341  Identities=28%  Similarity=0.361  Sum_probs=205.1

Q ss_pred             CCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEE
Q 036815          100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL  179 (1013)
Q Consensus       100 ~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  179 (1013)
                      +.+|++|++++|+|+++  +.+..+++|++|+|++|+|+++.  .|+++++|++|++++|.+.                 
T Consensus        43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~-----------------  101 (384)
T d2omza2          43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA-----------------  101 (384)
T ss_dssp             HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-----------------
T ss_pred             hCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc-----------------
Confidence            34555666666655543  23555555555555555555432  2555555555555555554                 


Q ss_pred             ECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCee
Q 036815          180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRV  259 (1013)
Q Consensus       180 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  259 (1013)
                              +..  .++.+++|+.|++++|.+++. +.  ......+..+....|.+....+..................+
T Consensus       102 --------~i~--~l~~l~~L~~L~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  168 (384)
T d2omza2         102 --------DIT--PLANLTNLTGLTLFNNQITDI-DP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL  168 (384)
T ss_dssp             --------CCG--GGTTCTTCCEEECCSSCCCCC-GG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC
T ss_pred             --------ccc--ccccccccccccccccccccc-cc--ccccccccccccccccccccccccccccccccccccccchh
Confidence                    222  244555566666666655532 11  23344555555555555432222222222222222222111


Q ss_pred             cccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcC
Q 036815          260 SGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPE  339 (1013)
Q Consensus       260 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~  339 (1013)
                      .      .+.............|...  ....+..+++++.+++++|.+++..|                          
T Consensus       169 ~------~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--------------------------  214 (384)
T d2omza2         169 K------PLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--------------------------  214 (384)
T ss_dssp             G------GGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--------------------------
T ss_pred             h------hhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--------------------------
Confidence            1      1112223333344444332  23345566677777777776653211                          


Q ss_pred             cCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCc
Q 036815          340 LGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV  419 (1013)
Q Consensus       340 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  419 (1013)
                      +..+++|+.|++++|.++. + ..+..+++|+.|++++|.+++..  .+..+++|+.|++++|++++..  .+..++.++
T Consensus       215 ~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~  288 (384)
T d2omza2         215 LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALT  288 (384)
T ss_dssp             GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCS
T ss_pred             ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--ccccccccc
Confidence            2334667777888887763 3 35677778888888888877433  3667778888888888877432  366777888


Q ss_pred             EEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCc
Q 036815          420 WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGP  499 (1013)
Q Consensus       420 ~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  499 (1013)
                      .+++++|.+++. +                                                                  
T Consensus       289 ~l~~~~n~l~~~-~------------------------------------------------------------------  301 (384)
T d2omza2         289 NLELNENQLEDI-S------------------------------------------------------------------  301 (384)
T ss_dssp             EEECCSSCCSCC-G------------------------------------------------------------------
T ss_pred             cccccccccccc-c------------------------------------------------------------------
Confidence            888887776531 1                                                                  


Q ss_pred             ccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCC
Q 036815          500 VLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL  579 (1013)
Q Consensus       500 ~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l  579 (1013)
                         .+..+++++.|++++|++++ ++ .+..+++|++|+|++|+++ .+| .++++++|++|++++|++++.+|  +.++
T Consensus       302 ---~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l  372 (384)
T d2omza2         302 ---PISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANL  372 (384)
T ss_dssp             ---GGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTC
T ss_pred             ---ccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccC
Confidence               12234678889999999985 44 3888999999999999998 466 68999999999999999997655  8889


Q ss_pred             CcceEEECcCC
Q 036815          580 SFLVQIDLSNN  590 (1013)
Q Consensus       580 ~~l~~l~l~~n  590 (1013)
                      ++|+.|+|++|
T Consensus       373 ~~L~~L~L~~N  383 (384)
T d2omza2         373 TRITQLGLNDQ  383 (384)
T ss_dssp             TTCSEEECCCE
T ss_pred             CCCCEeeCCCC
Confidence            99999999987

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.95  E-value=5.1e-27  Score=264.13  Aligned_cols=342  Identities=27%  Similarity=0.353  Sum_probs=193.5

Q ss_pred             CCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCC
Q 036815           48 LPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKL  127 (1013)
Q Consensus        48 l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L  127 (1013)
                      +.+|++|++++|+|++ +..  +..+++|++|+|++|+|++..+     ...+++|++|++++|.|.++.  .++++++|
T Consensus        43 l~~l~~L~l~~~~I~~-l~g--l~~L~nL~~L~Ls~N~l~~l~~-----l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L  112 (384)
T d2omza2          43 LDQVTTLQADRLGIKS-IDG--VEYLNNLTQINFSNNQLTDITP-----LKNLTKLVDILMNNNQIADIT--PLANLTNL  112 (384)
T ss_dssp             HTTCCEEECCSSCCCC-CTT--GGGCTTCCEEECCSSCCCCCGG-----GTTCTTCCEEECCSSCCCCCG--GGTTCTTC
T ss_pred             hCCCCEEECCCCCCCC-ccc--cccCCCCCEEeCcCCcCCCCcc-----ccCCccccccccccccccccc--cccccccc
Confidence            4455566666665552 221  3455556666666665554321     234555666666666655542  25556666


Q ss_pred             CEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccC
Q 036815          128 KILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSN  207 (1013)
Q Consensus       128 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~  207 (1013)
                      +.|++++|.+++..+  ......+..+....|.+. .+....................     ...+...+.........
T Consensus       113 ~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  184 (384)
T d2omza2         113 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISS  184 (384)
T ss_dssp             CEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEEC-CCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCS
T ss_pred             ccccccccccccccc--cccccccccccccccccc-ccccccccccccccccccccch-----hhhhccccccccccccc
Confidence            666666665553322  233444555555555444 1111111111111111111111     11223333344444444


Q ss_pred             CCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCccccc
Q 036815          208 NNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGV  287 (1013)
Q Consensus       208 N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~  287 (1013)
                      |....   ...+..+++++.+++++|.+++..+  +...++|+.|++++|++++. +  .+..+++|+.|++++|.+++.
T Consensus       185 ~~~~~---~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~-~--~l~~l~~L~~L~l~~n~l~~~  256 (384)
T d2omza2         185 NKVSD---ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-G--TLASLTNLTDLDLANNQISNL  256 (384)
T ss_dssp             SCCCC---CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-G--GGGGCTTCSEEECCSSCCCCC
T ss_pred             ccccc---ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc-c--hhhcccccchhccccCccCCC
Confidence            43331   1123445555555555555553322  33445555566666555421 1  233455566666666665543


Q ss_pred             CCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCC
Q 036815          288 IPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSC  367 (1013)
Q Consensus       288 ~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  367 (1013)
                      .+  +..+++|+.|++++|++++..  .+..+..++.+.+..|.+++  +..+..+++++.|++++|++++. + .+..+
T Consensus       257 ~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l  328 (384)
T d2omza2         257 AP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI-S-PVSSL  328 (384)
T ss_dssp             GG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCC-G-GGGGC
T ss_pred             Cc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCC-c-ccccC
Confidence            22  555566666666666665322  25555556666666666553  34577788999999999999864 3 38889


Q ss_pred             CCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCc
Q 036815          368 SNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNN  427 (1013)
Q Consensus       368 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~  427 (1013)
                      ++|++|++++|+++ .++ .+.++++|++|++++|++++..|  +.++++|+.|+|++|.
T Consensus       329 ~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         329 TKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             TTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             CCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            99999999999998 454 68999999999999999996554  8899999999999983

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=4.4e-25  Score=239.27  Aligned_cols=248  Identities=27%  Similarity=0.303  Sum_probs=213.6

Q ss_pred             cceecccCCcccccccccccCCCCCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeC
Q 036815            2 LSVLKLSSNLFTLNSTSLLQLPFGLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDL   81 (1013)
Q Consensus         2 l~~L~l~~n~~~~~~~~~~~~~~~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~L   81 (1013)
                      ++.+|.+++.++.+|+.   +++++++|+|++|+|+. +|...|.++++|++|++++|.+. .+++..|.++++|+.|++
T Consensus        12 ~~~~~C~~~~L~~lP~~---l~~~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~l~~n~~~-~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          12 LRVVQCSDLGLEKVPKD---LPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             TTEEECTTSCCCSCCCS---CCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEEC
T ss_pred             CCEEEecCCCCCccCCC---CCCCCCEEECcCCcCCC-cChhHhhcccccccccccccccc-ccchhhhhCCCccCEecc
Confidence            46789999999999986   57889999999999966 78778999999999999999998 565566899999999999


Q ss_pred             CCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCccc--ccCcccccCCCCCCEeeCcCC
Q 036815           82 SYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLA--GEIPRTFGQLSSLQRLDLSNN  159 (1013)
Q Consensus        82 s~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~Ls~n  159 (1013)
                      ++|+++.++..      ....++.|++++|.+.++.+..+.....++.++...|...  ...+..+..+++|+.+++++|
T Consensus        87 ~~n~l~~l~~~------~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n  160 (305)
T d1xkua_          87 SKNQLKELPEK------MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT  160 (305)
T ss_dssp             CSSCCSBCCSS------CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred             cCCccCcCccc------hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccC
Confidence            99999865443      3468999999999999988888888999999999988654  345667889999999999999


Q ss_pred             cccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcC
Q 036815          160 HITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSF  239 (1013)
Q Consensus       160 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  239 (1013)
                      .++ .+|..+   +++|++|++++|.++...+..|.+++.+++|++++|.++ .++...+.++++|++|+|++|+|+ .+
T Consensus       161 ~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~-~~~~~~~~~l~~L~~L~L~~N~L~-~l  234 (305)
T d1xkua_         161 NIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KV  234 (305)
T ss_dssp             CCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC-EECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred             Ccc-ccCccc---CCccCEEECCCCcCCCCChhHhhcccccccccccccccc-ccccccccccccceeeeccccccc-cc
Confidence            998 677654   478999999999999888999999999999999999998 555566789999999999999998 56


Q ss_pred             CcCCCCCCCcCEEEecCCeecccCCCCC
Q 036815          240 PDSISSCKTLRIVDFSSNRVSGIIPPDI  267 (1013)
Q Consensus       240 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~  267 (1013)
                      |..+..+++|+.|+|++|+|+ .++...
T Consensus       235 p~~l~~l~~L~~L~Ls~N~i~-~i~~~~  261 (305)
T d1xkua_         235 PGGLADHKYIQVVYLHNNNIS-AIGSND  261 (305)
T ss_dssp             CTTTTTCSSCCEEECCSSCCC-CCCTTS
T ss_pred             ccccccccCCCEEECCCCccC-ccChhh
Confidence            888999999999999999998 444433

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=2.7e-24  Score=233.02  Aligned_cols=220  Identities=22%  Similarity=0.351  Sum_probs=123.1

Q ss_pred             CccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEe
Q 036815           75 KLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRL  154 (1013)
Q Consensus        75 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  154 (1013)
                      .++.++.++++++.++..++      +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.+.+|.++++|++|
T Consensus        11 ~~~~~~C~~~~L~~lP~~l~------~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L   84 (305)
T d1xkua_          11 HLRVVQCSDLGLEKVPKDLP------PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL   84 (305)
T ss_dssp             ETTEEECTTSCCCSCCCSCC------TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred             cCCEEEecCCCCCccCCCCC------CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEe
Confidence            45667777777765544332      467778888888777666678888888888888888887777778888888888


Q ss_pred             eCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCC-CChhhhhcCCCCcEEEcccc
Q 036815          155 DLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGP-FPDSVLENLGSLESLILSNN  233 (1013)
Q Consensus       155 ~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~~l~~L~~L~L~~n  233 (1013)
                      ++++|+++ .+|...+   ..+..|++.+|.+....+..+.....+..++...|..... .....+..+++|+.+++++|
T Consensus        85 ~l~~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n  160 (305)
T d1xkua_          85 YLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT  160 (305)
T ss_dssp             ECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred             cccCCccC-cCccchh---hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccC
Confidence            88888877 5665433   4566777777777665555555666666666666543211 11223444555555555555


Q ss_pred             cCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCcc
Q 036815          234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYL  308 (1013)
Q Consensus       234 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l  308 (1013)
                      .++ .++..+  .++|+.|++++|.++.. +...+.+++.++.|++++|.+++..+..+..+++|++|+|++|+|
T Consensus       161 ~l~-~l~~~~--~~~L~~L~l~~n~~~~~-~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L  231 (305)
T d1xkua_         161 NIT-TIPQGL--PPSLTELHLDGNKITKV-DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL  231 (305)
T ss_dssp             CCC-SCCSSC--CTTCSEEECTTSCCCEE-CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred             Ccc-ccCccc--CCccCEEECCCCcCCCC-ChhHhhccccccccccccccccccccccccccccceeeecccccc
Confidence            544 222221  23444444444443322 112223333333333333333333333333334444444444333

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=4.2e-24  Score=228.65  Aligned_cols=266  Identities=18%  Similarity=0.233  Sum_probs=145.7

Q ss_pred             eCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcc-cc
Q 036815          155 DLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS-NN  233 (1013)
Q Consensus       155 ~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~-~n  233 (1013)
                      +.++++++ .+|..++   +.+++|+|++|+|+.+.+..|.++++|++|++++|++. .++...+..+..++.+... .|
T Consensus        17 ~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~-~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          17 SCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             ECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSCT
T ss_pred             EcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccc-cccccccccccccccccccccc
Confidence            44444444 4444432   23455555555555444445555555555555555554 3333344445555555433 33


Q ss_pred             cCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCC
Q 036815          234 MISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIP  313 (1013)
Q Consensus       234 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  313 (1013)
                      .++...+..+.++++|++|++++|.+. .++...+....+|+.+++++|.++++.+..|..+++|+.|++++|.+++..+
T Consensus        92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_          92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             ccccccchhhcccccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence            444444455555555555555555554 3333344445555555555555555555555556666666666666654444


Q ss_pred             cccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCC
Q 036815          314 QELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTR  393 (1013)
Q Consensus       314 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  393 (1013)
                      ..|.++++|+.+++.+|++++..|..|.++++|++|++++|++.+..+..+..+++|++|+|++|++...-+. -.-...
T Consensus       171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~  249 (284)
T d1ozna_         171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW  249 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHH
T ss_pred             hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHH
Confidence            4444444444444444444445566677777777777777777776667777777777777777777643221 111223


Q ss_pred             CceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCc
Q 036815          394 LAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTG  430 (1013)
Q Consensus       394 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  430 (1013)
                      ++.+....+++....|..+.+   +...+++.+.|+|
T Consensus       250 l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g  283 (284)
T d1ozna_         250 LQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG  283 (284)
T ss_dssp             HHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred             HHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence            455555666666666766543   3444455555554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.8e-23  Score=223.65  Aligned_cols=225  Identities=24%  Similarity=0.272  Sum_probs=163.9

Q ss_pred             EEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCc
Q 036815           78 LLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLS  157 (1013)
Q Consensus        78 ~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  157 (1013)
                      .+++++++++.++..+      .+++++|+|++|+|+.+.+.+|.++++|++|++++|++..+.+..+..+..++.+...
T Consensus        15 ~v~c~~~~L~~iP~~i------p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~   88 (284)
T d1ozna_          15 TTSCPQQGLQAVPVGI------PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS   88 (284)
T ss_dssp             EEECCSSCCSSCCTTC------CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             EEEcCCCCCCccCCCC------CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc
Confidence            3455555555333322      2456777777777776666677777777777777777777777777777777777654


Q ss_pred             -CCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCC
Q 036815          158 -NNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS  236 (1013)
Q Consensus       158 -~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~  236 (1013)
                       .|.++ .++...+..+++|++|++++|.+....+..+...++|+.+++++|+++ .++...|..+++|++|++++|+++
T Consensus        89 ~~~~~~-~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~  166 (284)
T d1ozna_          89 DNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS  166 (284)
T ss_dssp             SCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cccccc-cccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCccc
Confidence             34455 555555566677777777777777666667777778888888888887 566666777788888888888887


Q ss_pred             CcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeCCccCCC
Q 036815          237 GSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGS  311 (1013)
Q Consensus       237 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  311 (1013)
                      ...+..|..+++|+.+++++|++++ +++..+.++++|++|++++|.+.+..+..|+.+++|+.|++++|++...
T Consensus       167 ~l~~~~f~~l~~L~~l~l~~N~l~~-i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         167 SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             ccchhhhccccccchhhhhhccccc-cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence            7667778888888888888888874 4445567788888888888888888788888899999999999988753

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.9e-21  Score=205.18  Aligned_cols=197  Identities=25%  Similarity=0.247  Sum_probs=138.4

Q ss_pred             CcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccE
Q 036815           26 LKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLH  105 (1013)
Q Consensus        26 l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~  105 (1013)
                      +.+++.++++++. +|+++.   +++++|+|++|.|+ .+|...|.++++|++|+|++|+|+.....     ..+++|++
T Consensus        12 ~~~v~C~~~~L~~-iP~~lp---~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~l~~~-----~~l~~L~~   81 (266)
T d1p9ag_          12 HLEVNCDKRNLTA-LPPDLP---KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKLQVD-----GTLPVLGT   81 (266)
T ss_dssp             CCEEECTTSCCSS-CCSCCC---TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCEEECC-----SCCTTCCE
T ss_pred             CeEEEccCCCCCe-eCcCcC---cCCCEEECcCCcCC-CcCHHHhhccccccccccccccccccccc-----cccccccc
Confidence            4455666666654 455432   35666666666665 45555566666666666666666643221     23566777


Q ss_pred             EECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCC
Q 036815          106 LDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNN  185 (1013)
Q Consensus       106 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~  185 (1013)
                      |+|++|+++. .+..+.++++|++|++++|.+....+..+..+.++++|++++|.++ .++...+..+++|+.|++++|+
T Consensus        82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_          82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSC
T ss_pred             cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccc-eeccccccccccchhccccccc
Confidence            7777777765 3556777778888888888877777777777788888888888887 6666666667788888888888


Q ss_pred             CCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCC
Q 036815          186 ITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMIS  236 (1013)
Q Consensus       186 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~  236 (1013)
                      +++..+..|..+++|++|+|++|+|+ .+|..++ .+++|+.|+|++|.+.
T Consensus       160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~-~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF-GSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT-TTCCCSEEECCSCCBC
T ss_pred             ccccCccccccccccceeecccCCCc-ccChhHC-CCCCCCEEEecCCCCC
Confidence            88777777888888888888888887 7777654 5778888888888775

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.8e-21  Score=205.42  Aligned_cols=205  Identities=21%  Similarity=0.222  Sum_probs=163.8

Q ss_pred             cCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCC
Q 036815          195 SSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSL  274 (1013)
Q Consensus       195 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  274 (1013)
                      .....+.+.+.++++++ .+|..+   .+++++|+|++|+|++..+..|.++++|++|+|++|+|+ .++.  +..+++|
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~l---p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--~~~l~~L   79 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--DGTLPVL   79 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC--CSCCTTC
T ss_pred             cccCCCeEEEccCCCCC-eeCcCc---CcCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc--ccccccc
Confidence            45566777888888888 677653   256888899988888666677888888888888888887 3332  2456777


Q ss_pred             ceEEcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECccc
Q 036815          275 EELRLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNN  354 (1013)
Q Consensus       275 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N  354 (1013)
                      +.|+|++|+++. .+..+..+++|+.|++++|.+.+                        ..+..+..+.++++|++++|
T Consensus        80 ~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~------------------------~~~~~~~~l~~l~~L~l~~n  134 (266)
T d1p9ag_          80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS------------------------LPLGALRGLGELQELYLKGN  134 (266)
T ss_dssp             CEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCC------------------------CCSSTTTTCTTCCEEECTTS
T ss_pred             cccccccccccc-cccccccccccccccccccccce------------------------eecccccccccccccccccc
Confidence            777777777764 35566777777777777776653                        34456677888999999999


Q ss_pred             cccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCC
Q 036815          355 KLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDI  432 (1013)
Q Consensus       355 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  432 (1013)
                      .+++..+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|+.+..+++|++|+|++|++.++.
T Consensus       135 ~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             ccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            999776777788999999999999999888888999999999999999999 89999999999999999999998753

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=1.8e-22  Score=201.31  Aligned_cols=163  Identities=17%  Similarity=0.158  Sum_probs=119.2

Q ss_pred             CCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCc------------------cchHHHHHHHHHHhccCCcceeeeccE
Q 036815          737 SAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSC------------------QGDREFMAEMETLGKIKHRNLVPLLGY  798 (1013)
Q Consensus       737 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  798 (1013)
                      .+.++||+|+||+||+|++.+|+.||||++.....                  ........|...+.++.|+++++.+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            46789999999999999999999999997642110                  001234568889999999999988765


Q ss_pred             EEeCCEEEEEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCcccEEeCCCCcE
Q 036815          799 CKIGEERLLVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMEA  878 (1013)
Q Consensus       799 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  878 (1013)
                      .  .  .++||||+++..+.+             ++......++.|+++|++|||++   +|+||||||+||+++++ .+
T Consensus        83 ~--~--~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~  141 (191)
T d1zara2          83 E--G--NAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GI  141 (191)
T ss_dssp             E--T--TEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EE
T ss_pred             c--C--CEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CE
Confidence            3  2  369999999754432             33344567899999999999999   99999999999999965 58


Q ss_pred             EEeecccceeccccCcceeeeeeccCCCccC------cccccCCCCCccchhHhHHHHH
Q 036815          879 RVSDFGMARLISALDTHLSVSTLAGTPGYVP------PEYYQSFRCTAKGDVYSFGVVL  931 (1013)
Q Consensus       879 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwslG~il  931 (1013)
                      +++|||.|+........          .|..      .|. ....|+.++|+||..--+
T Consensus       142 ~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         142 WIIDFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EECCCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EEEECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99999999765422111          0111      111 135678899999976443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=5e-19  Score=195.40  Aligned_cols=159  Identities=26%  Similarity=0.337  Sum_probs=74.7

Q ss_pred             CCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEc
Q 036815          126 KLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDL  205 (1013)
Q Consensus       126 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L  205 (1013)
                      .|++|++++|.+... | .++.+++|++|++++|.+. ..+..    ...+..+.+..+....  ...+..++.++.|++
T Consensus        99 ~L~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~-~~~~~----~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l  169 (353)
T d1jl5a_          99 LLEYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYA  169 (353)
T ss_dssp             TCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSS--CCCCTTCTTCCEEEC
T ss_pred             ccccccccccccccc-c-chhhhccceeecccccccc-ccccc----cccccchhhccccccc--cccccccccceeccc
Confidence            355555555555422 2 2344555555555555554 22221    1344555554444332  233455566666666


Q ss_pred             cCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCccc
Q 036815          206 SNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLIT  285 (1013)
Q Consensus       206 ~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~  285 (1013)
                      ++|.+. .++.    .....+.+...++.+. .. ..+..++.|+.+++++|.... .+    ....++..+.+.++.+.
T Consensus       170 ~~n~~~-~~~~----~~~~~~~l~~~~~~~~-~~-~~~~~l~~L~~l~l~~n~~~~-~~----~~~~~l~~~~~~~~~~~  237 (353)
T d1jl5a_         170 DNNSLK-KLPD----LPLSLESIVAGNNILE-EL-PELQNLPFLTTIYADNNLLKT-LP----DLPPSLEALNVRDNYLT  237 (353)
T ss_dssp             CSSCCS-SCCC----CCTTCCEEECCSSCCS-SC-CCCTTCTTCCEEECCSSCCSS-CC----SCCTTCCEEECCSSCCS
T ss_pred             cccccc-cccc----cccccccccccccccc-cc-ccccccccccccccccccccc-cc----ccccccccccccccccc
Confidence            666554 2221    1223445555555444 22 234556666666666665542 11    12345556666666555


Q ss_pred             ccCCccccccCcccEEEeeCCccC
Q 036815          286 GVIPGQLSECTQLKVIDLSLNYLN  309 (1013)
Q Consensus       286 ~~~~~~~~~l~~L~~L~ls~N~l~  309 (1013)
                      .. +   .....+...++..+.+.
T Consensus       238 ~~-~---~~~~~l~~~~~~~~~~~  257 (353)
T d1jl5a_         238 DL-P---ELPQSLTFLDVSENIFS  257 (353)
T ss_dssp             CC-C---CCCTTCCEEECCSSCCS
T ss_pred             cc-c---ccccccccccccccccc
Confidence            22 1   12334555555555443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=1.3e-18  Score=192.14  Aligned_cols=313  Identities=28%  Similarity=0.347  Sum_probs=197.2

Q ss_pred             CCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCccc
Q 036815           25 GLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLL  104 (1013)
Q Consensus        25 ~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~  104 (1013)
                      ++++|+|++|+++. +|+    ..++|++|+|++|+|+ .+|.    ...+|++|++++|+++....       ..+.|+
T Consensus        39 ~l~~LdLs~~~L~~-lp~----~~~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~~l~~-------lp~~L~  101 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPE----LPPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKALSD-------LPPLLE  101 (353)
T ss_dssp             TCSEEECTTSCCSC-CCS----CCTTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSCCCS-------CCTTCC
T ss_pred             CCCEEEeCCCCCCC-CCC----CCCCCCEEECCCCCCc-cccc----chhhhhhhhhhhcccchhhh-------hccccc
Confidence            57788888888755 564    2467888888888887 5664    24578888888887773321       124688


Q ss_pred             EEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCC
Q 036815          105 HLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHN  184 (1013)
Q Consensus       105 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n  184 (1013)
                      +|++++|.|..+ | .+..+++|++|++++|.+... +   .....+..+.+..+.....  .. ...++.++.+.+++|
T Consensus       102 ~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~-~---~~~~~l~~l~~~~~~~~~~--~~-l~~l~~l~~L~l~~n  172 (353)
T d1jl5a_         102 YLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKL-P---DLPPSLEFIAAGNNQLEEL--PE-LQNLPFLTAIYADNN  172 (353)
T ss_dssp             EEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSSC--CC-CTTCTTCCEEECCSS
T ss_pred             cccccccccccc-c-chhhhccceeecccccccccc-c---cccccccchhhcccccccc--cc-ccccccceecccccc
Confidence            888888888764 3 356788888888888877633 2   2345566777766655421  11 233567888888888


Q ss_pred             CCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCC
Q 036815          185 NITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIP  264 (1013)
Q Consensus       185 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  264 (1013)
                      .+.....    .....+.+..+++.+. .++.  +..++.|+.+++++|.... .+.   ...++..+.+..+.+... +
T Consensus       173 ~~~~~~~----~~~~~~~l~~~~~~~~-~~~~--~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~  240 (353)
T d1jl5a_         173 SLKKLPD----LPLSLESIVAGNNILE-ELPE--LQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-P  240 (353)
T ss_dssp             CCSSCCC----CCTTCCEEECCSSCCS-SCCC--CTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-C
T ss_pred             ccccccc----cccccccccccccccc-cccc--ccccccccccccccccccc-ccc---cccccccccccccccccc-c
Confidence            7764322    1233456666666665 4443  3567788888888887652 332   345677777887776522 1


Q ss_pred             CCCCCCCCCCceEEcCCCcccccCCcccccc-CcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCC
Q 036815          265 PDICPGVSSLEELRLPDNLITGVIPGQLSEC-TQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKC  343 (1013)
Q Consensus       265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l  343 (1013)
                          .....+....+..+.+.+.     ..+ ......++..|.+.+ +                           ...+
T Consensus       241 ----~~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~-~---------------------------~~~~  283 (353)
T d1jl5a_         241 ----ELPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRS-L---------------------------CDLP  283 (353)
T ss_dssp             ----CCCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSE-E---------------------------CCCC
T ss_pred             ----ccccccccccccccccccc-----ccccchhcccccccCcccc-c---------------------------cccC
Confidence                1234566666666655432     111 234555666665541 1                           1124


Q ss_pred             CCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEEc
Q 036815          344 KNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLDL  423 (1013)
Q Consensus       344 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  423 (1013)
                      ++|++|+|++|+++ .+|..   +++|+.|+|++|+|+ .+|..   +++|++|++++|+++ .+|...   .+|+.|.+
T Consensus       284 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~  351 (353)
T d1jl5a_         284 PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRM  351 (353)
T ss_dssp             TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEEC
T ss_pred             CCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeEC
Confidence            57888888888887 56643   567888888888887 56643   457888888888887 667542   45666655


Q ss_pred             c
Q 036815          424 N  424 (1013)
Q Consensus       424 ~  424 (1013)
                      .
T Consensus       352 ~  352 (353)
T d1jl5a_         352 N  352 (353)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=5.8e-22  Score=227.94  Aligned_cols=390  Identities=19%  Similarity=0.146  Sum_probs=244.2

Q ss_pred             CCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCc---hhhhhCCCCccEEeCCCCcccCccC-CCCc-CCCC
Q 036815           25 GLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLP---ETLLSNSDKLELLDLSYNNLTGSIS-GFSL-NENS   99 (1013)
Q Consensus        25 ~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~---~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~-~~~~   99 (1013)
                      +|++|+|+++++++..-...+..+++++.|+|++|+|++...   ..++..+++|++|||++|+|+.... .+.. ....
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            589999999999664334567778999999999999884321   2346788999999999999873211 1110 1123


Q ss_pred             CCcccEEECCCCCCCCC----CCccccCCCCCCEEecCCCcccccCccccc-----CCCCCCEeeCcCCcccCcCCc---
Q 036815          100 CNSLLHLDLSQNHIMDV----IPSSLSNCTKLKILNLSFNLLAGEIPRTFG-----QLSSLQRLDLSNNHITGWIPS---  167 (1013)
Q Consensus       100 ~~~L~~L~Ls~n~i~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~Ls~n~l~~~~~~---  167 (1013)
                      ..+|++|+|++|+|++.    ++..+..+++|++|++++|.+++.....+.     .......+......+......   
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  162 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence            45799999999999864    345677889999999999988753322221     223344455544433311111   


Q ss_pred             cchhccCCCcEEECCCCCCCCcCC----ccc-cCCCCCCEEEccCCCCCCCCCh---hhhhcCCCCcEEEcccccCCC--
Q 036815          168 ELGNACDSLLELKLPHNNITGSFP----VTL-SSCSWLQLLDLSNNNISGPFPD---SVLENLGSLESLILSNNMISG--  237 (1013)
Q Consensus       168 ~~~~~l~~L~~L~L~~n~l~~~~~----~~l-~~l~~L~~L~L~~N~l~~~~~~---~~~~~l~~L~~L~L~~n~l~~--  237 (1013)
                      ........++.++++++.+.....    ..+ ..-.....+++..+.+......   ..+...+.++.+++++|.+..  
T Consensus       163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~  242 (460)
T d1z7xw1         163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  242 (460)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence            111233568888888876653211    111 1224566788887766522111   224456788888888887642  


Q ss_pred             ---cCCcCCCCCCCcCEEEecCCeecccCCCCC---CCCCCCCceEEcCCCcccccCCccc-----cccCcccEEEeeCC
Q 036815          238 ---SFPDSISSCKTLRIVDFSSNRVSGIIPPDI---CPGVSSLEELRLPDNLITGVIPGQL-----SECTQLKVIDLSLN  306 (1013)
Q Consensus       238 ---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~ls~N  306 (1013)
                         ...........++.+++++|.+........   +...+.++.+++++|.+++.....+     .....|+.+++++|
T Consensus       243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~  322 (460)
T d1z7xw1         243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC  322 (460)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence               122334456678888888887653321111   1235667778888887764322222     23356778888877


Q ss_pred             ccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccccc----Cchhhc-CCCCCCeEEecCCccC
Q 036815          307 YLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGE----IPAELF-SCSNLEWISLTGNELT  381 (1013)
Q Consensus       307 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~-~l~~L~~L~L~~N~l~  381 (1013)
                      .++......++                    ..+...++|++|+|++|+++..    ++..+. ..+.|++|+|++|.|+
T Consensus       323 ~l~~~~~~~l~--------------------~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~  382 (460)
T d1z7xw1         323 SFTAACCSHFS--------------------SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS  382 (460)
T ss_dssp             CCBGGGHHHHH--------------------HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             chhhhhhhhcc--------------------cccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence            76632211111                    1223446799999999998753    334443 4567999999999997


Q ss_pred             CC----CChhhhccCCCceEEccCCeeeeecCCCC----c-CCCCCcEEEccCCcCCcCCCc
Q 036815          382 GQ----IPPEFSRLTRLAVLQLGNNRFKGEIPGEL----G-NCSSLVWLDLNSNNLTGDIPP  434 (1013)
Q Consensus       382 ~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~-~l~~L~~L~l~~N~l~~~~p~  434 (1013)
                      ..    ++..+..+++|++|+|++|+++......+    . +.+.|++|++++|.+....+.
T Consensus       383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~  444 (460)
T d1z7xw1         383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED  444 (460)
T ss_dssp             HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred             hHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHH
Confidence            42    44556778999999999999975433222    2 445799999999988754443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=5.5e-21  Score=219.68  Aligned_cols=190  Identities=23%  Similarity=0.183  Sum_probs=121.5

Q ss_pred             CCCCCceEECccccccc-----cCchhhcCCCCCCeEEecCCccCCC----CChhhhccCCCceEEccCCeeeeecCCCC
Q 036815          342 KCKNLKDLILNNNKLSG-----EIPAELFSCSNLEWISLTGNELTGQ----IPPEFSRLTRLAVLQLGNNRFKGEIPGEL  412 (1013)
Q Consensus       342 ~l~~L~~L~L~~N~l~~-----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  412 (1013)
                      ..+.++.+++++|.+..     ..+........|+.+++++|.+...    ....+...+.++.+++++|.++......+
T Consensus       224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l  303 (460)
T d1z7xw1         224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL  303 (460)
T ss_dssp             HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred             ccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence            44667778887777642     1223334456778888888877532    22334566777788888887753222111


Q ss_pred             -----cCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCcc
Q 036815          413 -----GNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTL  487 (1013)
Q Consensus       413 -----~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  487 (1013)
                           ...+.|+.+++++|.++......+                                                   
T Consensus       304 ~~~l~~~~~~L~~l~l~~~~l~~~~~~~l---------------------------------------------------  332 (460)
T d1z7xw1         304 CETLLEPGCQLESLWVKSCSFTAACCSHF---------------------------------------------------  332 (460)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCBGGGHHHH---------------------------------------------------
T ss_pred             hccccccccccccccccccchhhhhhhhc---------------------------------------------------
Confidence                 234567788887776653211111                                                   


Q ss_pred             ccccccccccCcccccccCCCccCEEEccCCccccc----CChhhh-CCCCCcEEecCCCccCC----CCcccccCCCCc
Q 036815          488 KSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGK----IPDEIG-DMIALQVLELAHNQLSG----EIPSSLGRLRNL  558 (1013)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~----iP~~i~-~l~~L~~L~L~~n~l~g----~ip~~~~~l~~L  558 (1013)
                                   ...+....+|++||||+|++++.    +++.+. ....|++|+|++|+++.    .+++.+...++|
T Consensus       333 -------------~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L  399 (460)
T d1z7xw1         333 -------------SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL  399 (460)
T ss_dssp             -------------HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred             -------------ccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCC
Confidence                         11223345789999999998743    444454 35679999999999974    256667778999


Q ss_pred             ceEecCCccccCCCcccc----c-CCCcceEEECcCCCCCCc
Q 036815          559 GVFDASHNRLQGQIPESF----S-NLSFLVQIDLSNNELTGP  595 (1013)
Q Consensus       559 ~~L~ls~N~l~g~~p~~~----~-~l~~l~~l~l~~n~l~~~  595 (1013)
                      ++|||++|+++......+    . +...|+.|++++|.+...
T Consensus       400 ~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             CEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             CEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence            999999999875433333    2 344689999999888753

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=1.3e-17  Score=171.09  Aligned_cols=168  Identities=24%  Similarity=0.370  Sum_probs=106.5

Q ss_pred             cCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCc
Q 036815          340 LGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLV  419 (1013)
Q Consensus       340 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  419 (1013)
                      +.++++|++|++++|++++..|  +..+++|+++++++|.++ .++ .+..+++|+.+.+++|...+.  ..+...+.+.
T Consensus        59 l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~  132 (227)
T d1h6ua2          59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQ  132 (227)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCC
T ss_pred             HhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccccccccccc--chhccccchh
Confidence            4455556666666666553222  555566666666666555 232 355556666666666655432  2234455555


Q ss_pred             EEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCc
Q 036815          420 WLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGP  499 (1013)
Q Consensus       420 ~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  499 (1013)
                      .++++.+.+...                                                                    
T Consensus       133 ~l~~~~~~~~~~--------------------------------------------------------------------  144 (227)
T d1h6ua2         133 VLYLDLNQITNI--------------------------------------------------------------------  144 (227)
T ss_dssp             EEECCSSCCCCC--------------------------------------------------------------------
T ss_pred             hhhchhhhhchh--------------------------------------------------------------------
Confidence            565555544311                                                                    


Q ss_pred             ccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceEecCCccccCCCcccccCC
Q 036815          500 VLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVFDASHNRLQGQIPESFSNL  579 (1013)
Q Consensus       500 ~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l  579 (1013)
                        ..+...++|++|++++|++++ ++ .++++++|++|+|++|+++ .+|. ++++++|+.|+|++|++++ +|. ++++
T Consensus       145 --~~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~-i~~-l~~l  216 (227)
T d1h6ua2         145 --SPLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD-VSP-LANT  216 (227)
T ss_dssp             --GGGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCB-CGG-GTTC
T ss_pred             --hhhcccccccccccccccccc-ch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCCC-Ccc-cccC
Confidence              112334678888888888873 33 3788888999999988888 4554 7888889999999998884 543 7888


Q ss_pred             CcceEEECcC
Q 036815          580 SFLVQIDLSN  589 (1013)
Q Consensus       580 ~~l~~l~l~~  589 (1013)
                      ++|+.|++++
T Consensus       217 ~~L~~L~lsn  226 (227)
T d1h6ua2         217 SNLFIVTLTN  226 (227)
T ss_dssp             TTCCEEEEEE
T ss_pred             CCCCEEEeeC
Confidence            8888888874

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=5.5e-18  Score=175.96  Aligned_cols=221  Identities=14%  Similarity=0.120  Sum_probs=149.7

Q ss_pred             CEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcc
Q 036815          152 QRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILS  231 (1013)
Q Consensus       152 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~  231 (1013)
                      +.++.+++.++ .+|..++   +++++|+|++|+|+.+.+.+|.++++|++|++++|.+.+.++...|.++++++++.+.
T Consensus        11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            56777777777 6776654   4678888888888876677788888888888888887755666667788888888765


Q ss_pred             c-ccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCcccccCCccccccC-cccEEEeeCCccC
Q 036815          232 N-NMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECT-QLKVIDLSLNYLN  309 (1013)
Q Consensus       232 ~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~ls~N~l~  309 (1013)
                      . |.+....+..+.++++|+.+++++|.+....+...+..+..+..+...++.+....+..+..++ .++.|++++|+++
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence            4 5676666777888888888888888887443444444556666667777777766666666654 6788888888887


Q ss_pred             CCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCce-EECccccccccCchhhcCCCCCCeEEecCCccCCCCChhh
Q 036815          310 GSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKD-LILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEF  388 (1013)
Q Consensus       310 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  388 (1013)
                      . ++.                        ......+++. +++++|+++...+..|.++++|++|+|++|+++...+..|
T Consensus       167 ~-i~~------------------------~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~  221 (242)
T d1xwdc1         167 E-IHN------------------------CAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL  221 (242)
T ss_dssp             E-ECT------------------------TTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSC
T ss_pred             c-ccc------------------------ccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHH
Confidence            2 322                        1222233333 3456666663333446667777777777777774444456


Q ss_pred             hccCCCceEEccC
Q 036815          389 SRLTRLAVLQLGN  401 (1013)
Q Consensus       389 ~~l~~L~~L~L~~  401 (1013)
                      .++++|+.|++.+
T Consensus       222 ~~l~~L~~l~~~~  234 (242)
T d1xwdc1         222 ENLKKLRARSTYN  234 (242)
T ss_dssp             TTCCEEESSSEES
T ss_pred             cCCcccccCcCCC
Confidence            6666666665543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=5.2e-17  Score=166.46  Aligned_cols=202  Identities=24%  Similarity=0.287  Sum_probs=111.6

Q ss_pred             EecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEEC
Q 036815           29 LELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDL  108 (1013)
Q Consensus        29 L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~L  108 (1013)
                      ++++.+++++.++   +..+.+|++|++++|+|+ .++.  +..+++|++|++++|++++..+     ...+++++++++
T Consensus        24 ~~l~~~~~~d~~~---~~~l~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~ls~n~i~~~~~-----l~~l~~l~~l~~   92 (227)
T d1h6ua2          24 IAAGKSNVTDTVT---QADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP-----LKNLTKITELEL   92 (227)
T ss_dssp             HHTTCSSTTSEEC---HHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG-----GTTCCSCCEEEC
T ss_pred             HHhCCCCcCCcCC---HHHcCCcCEEECCCCCCC-cchh--HhcCCCCcEeecCCceeecccc-----cccccccccccc
Confidence            4455555544322   334555666666666665 2332  4556666666666666653321     234556666666


Q ss_pred             CCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCC
Q 036815          109 SQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITG  188 (1013)
Q Consensus       109 s~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  188 (1013)
                      ++|.++++  ..+.++++|+.+++++|...+.  ..+...+.++.+.++.+.+....+   +..+++|++|++++|.+++
T Consensus        93 ~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~L~~L~l~~n~~~~  165 (227)
T d1h6ua2          93 SGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP---LAGLTNLQYLSIGNAQVSD  165 (227)
T ss_dssp             CSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCC
T ss_pred             cccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchhhh---hcccccccccccccccccc
Confidence            66666543  2456666666666666665533  234555666666666666552211   2234566666666666653


Q ss_pred             cCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEec
Q 036815          189 SFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFS  255 (1013)
Q Consensus       189 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  255 (1013)
                      ..  .+.++++|++|+|++|++++ ++.  +.++++|++|+|++|++++. + .+.++++|+.|+++
T Consensus       166 ~~--~l~~l~~L~~L~Ls~n~l~~-l~~--l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         166 LT--PLANLSKLTTLKADDNKISD-ISP--LASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT  225 (227)
T ss_dssp             CG--GGTTCTTCCEEECCSSCCCC-CGG--GGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred             ch--hhcccccceecccCCCccCC-Chh--hcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence            32  25566666666666666652 332  45666666666666666632 2 25566666666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=1.6e-17  Score=167.59  Aligned_cols=184  Identities=23%  Similarity=0.309  Sum_probs=145.4

Q ss_pred             hHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccC
Q 036815          322 LEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGN  401 (1013)
Q Consensus       322 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  401 (1013)
                      .....+..+.+++.++.  ..+.+|++|++++|.++. ++ .+..+++|++|+|++|++++ ++ .++.+++|+.|++++
T Consensus        26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~   99 (210)
T d1h6ta2          26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDE   99 (210)
T ss_dssp             HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCS
T ss_pred             HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccc
Confidence            33445555655544332  356789999999999984 33 47889999999999999985 44 468899999999999


Q ss_pred             CeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccc
Q 036815          402 NRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERL  481 (1013)
Q Consensus       402 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  481 (1013)
                      |+++ .+| .+.++++|+.|++++|.++. ++                                                
T Consensus       100 n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~~------------------------------------------------  128 (210)
T d1h6ta2         100 NKVK-DLS-SLKDLKKLKSLSLEHNGISD-IN------------------------------------------------  128 (210)
T ss_dssp             SCCC-CGG-GGTTCTTCCEEECTTSCCCC-CG------------------------------------------------
T ss_pred             cccc-ccc-cccccccccccccccccccc-cc------------------------------------------------
Confidence            9998 455 58889999999999987642 11                                                


Q ss_pred             cccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCcceE
Q 036815          482 LQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNLGVF  561 (1013)
Q Consensus       482 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L~~L  561 (1013)
                                           .+..++.|+++++++|.+++  +..++.+++|+++++++|++++ ++. ++++++|+.|
T Consensus       129 ---------------------~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L  183 (210)
T d1h6ta2         129 ---------------------GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNL  183 (210)
T ss_dssp             ---------------------GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEE
T ss_pred             ---------------------cccccccccccccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEE
Confidence                                 12335678999999999984  4568889999999999999994 553 8999999999


Q ss_pred             ecCCccccCCCcccccCCCcceEEECcC
Q 036815          562 DASHNRLQGQIPESFSNLSFLVQIDLSN  589 (1013)
Q Consensus       562 ~ls~N~l~g~~p~~~~~l~~l~~l~l~~  589 (1013)
                      +|++|+++ .+| .++.+++|+.|+|++
T Consensus       184 ~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         184 YLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             ECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             ECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence            99999998 576 589999999999974

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=1.5e-17  Score=172.73  Aligned_cols=200  Identities=17%  Similarity=0.115  Sum_probs=110.3

Q ss_pred             CCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCC-CCCCCcCCccccCCCCCCEEE
Q 036815          126 KLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPH-NNITGSFPVTLSSCSWLQLLD  204 (1013)
Q Consensus       126 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~  204 (1013)
                      ++++|++++|+|+.+.+.+|.++++|++|++++|.+...++...+..+++++++.+.+ |++....+..|.++++|+.|+
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            4555555555555444445555555555555555554344444444455555555433 455555555666666666666


Q ss_pred             ccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCC-CcCEEEecCCeecccCCCCCCCCCCCCceEEcCCCc
Q 036815          205 LSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCK-TLRIVDFSSNRVSGIIPPDICPGVSSLEELRLPDNL  283 (1013)
Q Consensus       205 L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~  283 (1013)
                      +++|.+....+...+..+..+..+...++.+....+..+..++ .++.|++++|+++ .++...+....-++.+.+.+|+
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~  188 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNN  188 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTT
T ss_pred             cchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-ccccccccchhhhccccccccc
Confidence            6666665322222333445555555566666644445555543 6667777777776 4444444332223333456667


Q ss_pred             ccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHH
Q 036815          284 ITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFI  326 (1013)
Q Consensus       284 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~  326 (1013)
                      ++...+..|.++++|++|++++|+++...+..|.++++|+.++
T Consensus       189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~  231 (242)
T d1xwdc1         189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS  231 (242)
T ss_dssp             CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred             cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCc
Confidence            7755556677777777777777777733333455555554443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=3.6e-17  Score=163.57  Aligned_cols=183  Identities=23%  Similarity=0.331  Sum_probs=133.8

Q ss_pred             CcchHHHHhhhccccCCCCcCcCCCCCCceEECccccccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEE
Q 036815          319 LEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQ  398 (1013)
Q Consensus       319 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  398 (1013)
                      +.+.....+..+.+++.+  ....+.++++|++++|.++ .+ +.+..+++|++|++++|++++. ++ ++++++|+.|+
T Consensus        17 l~~~i~~~l~~~~~~~~~--~~~~l~~l~~L~l~~~~i~-~l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~   90 (199)
T d2omxa2          17 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDIL   90 (199)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEE
T ss_pred             HHHHHHHHhCCCCCCCcc--CHHHhcCCCEEECCCCCCC-Cc-cccccCCCcCcCccccccccCc-cc-ccCCccccccc
Confidence            334445556666665433  2345678889999999887 34 3577888899999999988853 33 88888899999


Q ss_pred             ccCCeeeeecCCCCcCCCCCcEEEccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCc
Q 036815          399 LGNNRFKGEIPGELGNCSSLVWLDLNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRP  478 (1013)
Q Consensus       399 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  478 (1013)
                      +++|.+. .++ .+.++++|+.|++++|......                                              
T Consensus        91 l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~----------------------------------------------  122 (199)
T d2omxa2          91 MNNNQIA-DIT-PLANLTNLTGLTLFNNQITDID----------------------------------------------  122 (199)
T ss_dssp             CCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG----------------------------------------------
T ss_pred             ccccccc-ccc-cccccccccccccccccccccc----------------------------------------------
Confidence            9988887 444 4788888999988888665210                                              


Q ss_pred             ccccccCccccccccccccCcccccccCCCccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCcccccCCCCc
Q 036815          479 ERLLQIPTLKSCDFARMYSGPVLSLFTQYQTLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIPSSLGRLRNL  558 (1013)
Q Consensus       479 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip~~~~~l~~L  558 (1013)
                                              .+..+++|+.|++++|++. .+| .+..+.+|+.|++++|++++ +| .++++++|
T Consensus       123 ------------------------~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L  174 (199)
T d2omxa2         123 ------------------------PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTL  174 (199)
T ss_dssp             ------------------------GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTC
T ss_pred             ------------------------ccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC-Cc-cccCCCCC
Confidence                                    1233567888899998887 454 58888889999999998884 54 48888889


Q ss_pred             ceEecCCccccCCCcccccCCCcceEE
Q 036815          559 GVFDASHNRLQGQIPESFSNLSFLVQI  585 (1013)
Q Consensus       559 ~~L~ls~N~l~g~~p~~~~~l~~l~~l  585 (1013)
                      +.|++++|+++. +| .++.+++|+.|
T Consensus       175 ~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         175 ERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             CEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             CEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            999999988874 54 47777777765

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.68  E-value=2.5e-17  Score=163.76  Aligned_cols=173  Identities=22%  Similarity=0.256  Sum_probs=109.7

Q ss_pred             cEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEE
Q 036815           27 KQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHL  106 (1013)
Q Consensus        27 ~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L  106 (1013)
                      ++++.++++++. +|++++   +++++|+|++|.|+..++...|.++++|++|+|++|++.......+   ..+++|++|
T Consensus        11 ~~v~Cs~~~L~~-iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~---~~~~~L~~L   83 (192)
T d1w8aa_          11 TTVDCTGRGLKE-IPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF---EGASHIQEL   83 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT---TTCTTCCEE
T ss_pred             CEEEEeCCCcCc-cCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc---cccccccee
Confidence            345555555543 454432   3455566666655544444455555666666666666554433322   244566677


Q ss_pred             ECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCC
Q 036815          107 DLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNI  186 (1013)
Q Consensus       107 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l  186 (1013)
                      +|++|+|+.+.+.+|.++++|++|+|++|+|+.+.+++|..+++|++|+|++|.+........+  ...++.+.+..+.+
T Consensus        84 ~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~--~~~l~~~~l~~~~~  161 (192)
T d1w8aa_          84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAA  161 (192)
T ss_dssp             ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH--HHHHHHHCCSGGGC
T ss_pred             eeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH--hhhhhhhcccCCCe
Confidence            7777777777777788888888888888888888888888888888888888887632222221  23466666777777


Q ss_pred             CCcCCccccCCCCCCEEEccCCCCC
Q 036815          187 TGSFPVTLSSCSWLQLLDLSNNNIS  211 (1013)
Q Consensus       187 ~~~~~~~l~~l~~L~~L~L~~N~l~  211 (1013)
                      +...|..   +..++.++|+.|.++
T Consensus       162 ~c~~p~~---l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         162 RCGAPSK---VRDVQIKDLPHSEFK  183 (192)
T ss_dssp             BBCSSTT---TTTSBGGGSCTTTCC
T ss_pred             EeCCChh---hcCCEeeecCHhhCc
Confidence            6555544   455667788888876

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.67  E-value=1.3e-16  Score=158.55  Aligned_cols=155  Identities=20%  Similarity=0.255  Sum_probs=96.4

Q ss_pred             CCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCeecccCCCCCCCCCCCCceE
Q 036815          198 SWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRVSGIIPPDICPGVSSLEEL  277 (1013)
Q Consensus       198 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  277 (1013)
                      +++++|+|++|+|+..++...|.++++|++|+|++|.+....+..+..+++|++|+|++|+|+ .+++..|.++++|++|
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~-~l~~~~F~~l~~L~~L  107 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTL  107 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC-EECSSSSTTCTTCCEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccccc-ccCHHHHhCCCccccc
Confidence            345555555555554444455566666666666666666666666666666777777777666 5566666777777777


Q ss_pred             EcCCCcccccCCccccccCcccEEEeeCCccCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEECcccccc
Q 036815          278 RLPDNLITGVIPGQLSECTQLKVIDLSLNYLNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLILNNNKLS  357 (1013)
Q Consensus       278 ~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  357 (1013)
                      +|++|+|++..+++|..+++|++|+|++|++..... ...-...++.+.+..+.+....|..   +..++.++|+.|.+.
T Consensus       108 ~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         108 NLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK  183 (192)
T ss_dssp             ECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred             ccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCc
Confidence            777777777777788888888888888888874322 1111223455555555555444433   334455556665554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.66  E-value=9e-16  Score=153.23  Aligned_cols=178  Identities=28%  Similarity=0.362  Sum_probs=89.2

Q ss_pred             EEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCCCCCCEEec
Q 036815           53 YLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNL  132 (1013)
Q Consensus        53 ~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L  132 (1013)
                      .+.++.+.+++.++.   ..++++++|++++|+++.. .+    ...+++|++|++++|+|+++.+  +.++++|++|++
T Consensus        22 ~~~l~~~~~~~~~~~---~~l~~l~~L~l~~~~i~~l-~~----l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l   91 (199)
T d2omxa2          22 KTVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSI-DG----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM   91 (199)
T ss_dssp             HHHTTCSSTTSEECH---HHHTTCCEEECTTSCCCCC-TT----GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHhCCCCCCCccCH---HHhcCCCEEECCCCCCCCc-cc----cccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence            334444444433221   2334455555555555422 11    1234555555555555554322  555555566666


Q ss_pred             CCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCCC
Q 036815          133 SFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNISG  212 (1013)
Q Consensus       133 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~  212 (1013)
                      ++|.+... + .+.++++|+.|++++|.+.. ++.  ...+++|+.|++++|++...  ..+..+++|+.|++++|++++
T Consensus        92 ~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~-~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2          92 NNNQIADI-T-PLANLTNLTGLTLFNNQITD-IDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             CSSCCCCC-G-GGTTCTTCSEEECCSSCCCC-CGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred             cccccccc-c-cccccccccccccccccccc-ccc--cchhhhhHHhhhhhhhhccc--ccccccccccccccccccccC
Confidence            55555432 1 35555556666665555542 211  22345566666666655432  235556666666666666652


Q ss_pred             CCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEE
Q 036815          213 PFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIV  252 (1013)
Q Consensus       213 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  252 (1013)
                       ++.  +.++++|++|++++|++++ + ..++++++|+.|
T Consensus       165 -l~~--l~~l~~L~~L~ls~N~i~~-i-~~l~~L~~L~~L  199 (199)
T d2omxa2         165 -LKP--LANLTTLERLDISSNKVSD-I-SVLAKLTNLESL  199 (199)
T ss_dssp             -CGG--GTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred             -Ccc--ccCCCCCCEEECCCCCCCC-C-ccccCCCCCCcC
Confidence             322  4556666666666666653 2 235555665554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.64  E-value=8e-16  Score=155.00  Aligned_cols=165  Identities=28%  Similarity=0.325  Sum_probs=86.1

Q ss_pred             CCcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEE
Q 036815          100 CNSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLEL  179 (1013)
Q Consensus       100 ~~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  179 (1013)
                      +.+|++|++++|.|+++.  .+..+++|++|++++|++++..  .++.+++|++|++++|+++ .++.  +..+++|+.|
T Consensus        45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L  117 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLSS--LKDLKKLKSL  117 (210)
T ss_dssp             HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGGG--GTTCTTCCEE
T ss_pred             hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc-cccc--cccccccccc
Confidence            446667777777766542  3566666777777777666432  3556666666666666665 3331  2224555555


Q ss_pred             ECCCCCCCCcCCccccCCCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCCee
Q 036815          180 KLPHNNITGSFPVTLSSCSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSNRV  259 (1013)
Q Consensus       180 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  259 (1013)
                      ++++|.+...  ..+..+++|+.+++++|.+++ .+  .+..+++|+++++++|++++. + .+.               
T Consensus       118 ~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~-~~--~~~~l~~L~~l~l~~n~l~~i-~-~l~---------------  175 (210)
T d1h6ta2         118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITD-IT--VLSRLTKLDTLSLEDNQISDI-V-PLA---------------  175 (210)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCC-G-GGT---------------
T ss_pred             cccccccccc--ccccccccccccccccccccc-cc--ccccccccccccccccccccc-c-ccc---------------
Confidence            5555554422  234444555555555555442 11  123444444444444444421 1 133               


Q ss_pred             cccCCCCCCCCCCCCceEEcCCCcccccCCccccccCcccEEEeeC
Q 036815          260 SGIIPPDICPGVSSLEELRLPDNLITGVIPGQLSECTQLKVIDLSL  305 (1013)
Q Consensus       260 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~  305 (1013)
                                ++++|++|++++|++++. + .+..+++|++|+|++
T Consensus       176 ----------~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         176 ----------GLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             ----------TCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred             ----------CCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence                      445555555555555432 2 356666666666653

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=4.6e-16  Score=164.73  Aligned_cols=224  Identities=22%  Similarity=0.222  Sum_probs=134.0

Q ss_pred             cEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCC-CCccccCCCCCCEE
Q 036815           52 VYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDV-IPSSLSNCTKLKIL  130 (1013)
Q Consensus        52 ~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L  130 (1013)
                      ++|||+++.+.......++..  .+..+.++...+......    .....+|++|||++|.+++. ....+.++++|++|
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~~--~~~~lrl~~~~~~~~~~~----~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L   76 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAE----HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL   76 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHHT--TCSEEECTTCEECSCCCS----CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             CEEECCCCCCCchHHHHHHhc--cceEeeccccccccchhh----hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccc
Confidence            356777665542222233322  345566665554422111    12334678888887777643 23446778888888


Q ss_pred             ecCCCcccccCcccccCCCCCCEeeCcCC-cccCcCCccchhccCCCcEEECCCC-CCCCcC-Ccccc-CCCCCCEEEcc
Q 036815          131 NLSFNLLAGEIPRTFGQLSSLQRLDLSNN-HITGWIPSELGNACDSLLELKLPHN-NITGSF-PVTLS-SCSWLQLLDLS  206 (1013)
Q Consensus       131 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~-~~~l~-~l~~L~~L~L~  206 (1013)
                      ++++|.+++..+..++.+++|++|++++| .+++..-..++..+++|++|++++| .+++.. ...+. ..++|+.|+++
T Consensus        77 ~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~  156 (284)
T d2astb2          77 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS  156 (284)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred             cccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhc
Confidence            88888887767777778888888888885 5653333344556778888888875 444321 12222 34678888887


Q ss_pred             CC--CCCCCCChhhhhcCCCCcEEEcccc-cCCCcCCcCCCCCCCcCEEEecCC-eecccCCCCCCCCCCCCceEEcCCC
Q 036815          207 NN--NISGPFPDSVLENLGSLESLILSNN-MISGSFPDSISSCKTLRIVDFSSN-RVSGIIPPDICPGVSSLEELRLPDN  282 (1013)
Q Consensus       207 ~N--~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~l~~L~~L~L~~n  282 (1013)
                      ++  .+++.....++.++++|++|++++| .+++.....+.++++|++|++++| .+++..... +..+++|+.|++.++
T Consensus       157 ~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~-L~~~~~L~~L~l~~~  235 (284)
T d2astb2         157 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE-LGEIPTLKTLQVFGI  235 (284)
T ss_dssp             SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGG-GGGCTTCCEEECTTS
T ss_pred             ccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHH-HhcCCCCCEEeeeCC
Confidence            64  3443323345567788888888875 466666667777777777777775 454332222 233455555555554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=2.3e-16  Score=167.15  Aligned_cols=215  Identities=21%  Similarity=0.252  Sum_probs=109.5

Q ss_pred             CCCCCEEEccCCCCCCCCChhhhhcCCCCcEEEcccccCCCcCCcCCCCCCCcCEEEecCC-eecccCCCCCCCCCCCCc
Q 036815          197 CSWLQLLDLSNNNISGPFPDSVLENLGSLESLILSNNMISGSFPDSISSCKTLRIVDFSSN-RVSGIIPPDICPGVSSLE  275 (1013)
Q Consensus       197 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~l~~L~  275 (1013)
                      ..+|++||+++|.+++.....++..+++|++|++++|.+++..+..++++++|+.|++++| .+++..-..++.++++|+
T Consensus        45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~  124 (284)
T d2astb2          45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD  124 (284)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred             CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence            3456666666665543333344555666666666666665555555566666666666664 343222122233456666


Q ss_pred             eEEcCCC-ccccc-CCccccc-cCcccEEEeeCCc--cCCCCCcccccCcchHHHHhhhccccCCCCcCcCCCCCCceEE
Q 036815          276 ELRLPDN-LITGV-IPGQLSE-CTQLKVIDLSLNY--LNGSIPQELGKLEHLEQFIAWFNGLEGKIPPELGKCKNLKDLI  350 (1013)
Q Consensus       276 ~L~L~~n-~l~~~-~~~~~~~-l~~L~~L~ls~N~--l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  350 (1013)
                      +|++++| .+++. +...+.. ++.|+.|+++++.  ++..   .      +              ...+.++++|++|+
T Consensus       125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~---~------l--------------~~l~~~~~~L~~L~  181 (284)
T d2astb2         125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS---D------L--------------STLVRRCPNLVHLD  181 (284)
T ss_dssp             EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHH---H------H--------------HHHHHHCTTCSEEE
T ss_pred             ccccccccccccccchhhhcccccccchhhhcccccccccc---c------c--------------cccccccccccccc
Confidence            6666665 33321 1122222 3567777776542  2210   0      0              00112345666666


Q ss_pred             Cccc-cccccCchhhcCCCCCCeEEecCC-ccCCCCChhhhccCCCceEEccCCeee-eecCCCCcCCCCCcEEEccCCc
Q 036815          351 LNNN-KLSGEIPAELFSCSNLEWISLTGN-ELTGQIPPEFSRLTRLAVLQLGNNRFK-GEIPGELGNCSSLVWLDLNSNN  427 (1013)
Q Consensus       351 L~~N-~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~  427 (1013)
                      +++| .+++..+..+.++++|++|+|++| .+++.....++++++|+.|+++++ ++ +.++.....+++|+   +..++
T Consensus       182 L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~---i~~~~  257 (284)
T d2astb2         182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQ---INCSH  257 (284)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSE---ESCCC
T ss_pred             cccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcccc---ccCcc
Confidence            6664 355555556666666666666664 455545555666666666666665 22 11111112344433   45566


Q ss_pred             CCcCCCchhhh
Q 036815          428 LTGDIPPRLGR  438 (1013)
Q Consensus       428 l~~~~p~~~~~  438 (1013)
                      ++...++.++.
T Consensus       258 ls~~~~~~~~~  268 (284)
T d2astb2         258 FTTIARPTIGN  268 (284)
T ss_dssp             SCCTTCSSCSS
T ss_pred             CCCCCCCccCc
Confidence            66555555443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=5.1e-14  Score=134.35  Aligned_cols=124  Identities=23%  Similarity=0.169  Sum_probs=78.3

Q ss_pred             CcccEEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEE
Q 036815          101 NSLLHLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELK  180 (1013)
Q Consensus       101 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  180 (1013)
                      .++++|||++|+|+.+ +..+..+++|+.|+|++|+|+..  +.|..+++|++|++++|+++ .++..++..+++|++|+
T Consensus        18 ~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~   93 (162)
T d1a9na_          18 VRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI   93 (162)
T ss_dssp             TSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred             CcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhccccccc-CCCccccccccccccce
Confidence            3456666666666654 34445666677777777777643  34666777777777777776 56655555566777777


Q ss_pred             CCCCCCCCcCC-ccccCCCCCCEEEccCCCCCCCCCh---hhhhcCCCCcEEE
Q 036815          181 LPHNNITGSFP-VTLSSCSWLQLLDLSNNNISGPFPD---SVLENLGSLESLI  229 (1013)
Q Consensus       181 L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~---~~~~~l~~L~~L~  229 (1013)
                      +++|+|+.... ..+..+++|++|++++|.++ ..+.   .++..+|+|+.||
T Consensus        94 L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          94 LTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             eccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            77777664322 35667777777777777775 3332   3456677777765

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.45  E-value=2.1e-13  Score=123.47  Aligned_cols=118  Identities=27%  Similarity=0.334  Sum_probs=67.3

Q ss_pred             EEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCC
Q 036815          105 HLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHN  184 (1013)
Q Consensus       105 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n  184 (1013)
                      .|||++|+|+.+ + .+.++++|++|++++|+|+ .+|..|+.+++|++|++++|.|+ .+|.  +..+++|++|++++|
T Consensus         2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSS
T ss_pred             EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc--cccccccCeEECCCC
Confidence            456666666543 2 3556666666666666665 33445666666666666666665 3432  233456666666666


Q ss_pred             CCCCcC-CccccCCCCCCEEEccCCCCCC--CCChhhhhcCCCCcEE
Q 036815          185 NITGSF-PVTLSSCSWLQLLDLSNNNISG--PFPDSVLENLGSLESL  228 (1013)
Q Consensus       185 ~l~~~~-~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~~l~~L~~L  228 (1013)
                      +|++.. ...+..+++|++|++++|++++  ..+..+...+|+|+.|
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            665443 2345666667777777766642  2344555666777665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.45  E-value=1.4e-15  Score=166.62  Aligned_cols=253  Identities=18%  Similarity=0.106  Sum_probs=122.8

Q ss_pred             ccCCCCCcEEeCCCCccCCCCchh---hhhCCCCccEEeCCCCcccCccCC-------CCcCCCCCCcccEEECCCCCCC
Q 036815           45 FSKLPNLVYLNASYNNLTGFLPET---LLSNSDKLELLDLSYNNLTGSISG-------FSLNENSCNSLLHLDLSQNHIM  114 (1013)
Q Consensus        45 ~~~l~~L~~L~L~~n~i~~~~~~~---~~~~l~~L~~L~Ls~n~l~~~~~~-------~~~~~~~~~~L~~L~Ls~n~i~  114 (1013)
                      +.....|++|+|++|.|++.....   .+...++|+.|+++++........       +......+++|+.|+|++|.++
T Consensus        27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  106 (344)
T d2ca6a1          27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG  106 (344)
T ss_dssp             HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred             HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence            556677888888888776332222   244567777777777655421110       1111223455556666665555


Q ss_pred             CCCCc----cccCCCCCCEEecCCCcccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCCCCCCCcC
Q 036815          115 DVIPS----SLSNCTKLKILNLSFNLLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPHNNITGSF  190 (1013)
Q Consensus       115 ~~~~~----~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  190 (1013)
                      +....    .+..+++|++|++++|.++......++..  |..          ..........+.|+.+.+++|+++...
T Consensus       107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~--l~~----------~~~~~~~~~~~~L~~l~l~~n~i~~~~  174 (344)
T d2ca6a1         107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQE----------LAVNKKAKNAPPLRSIICGRNRLENGS  174 (344)
T ss_dssp             TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHH----------HHHHHHHHTCCCCCEEECCSSCCTGGG
T ss_pred             cccccchhhhhcccccchheeccccccccccccccccc--ccc----------cccccccccCcccceeecccccccccc
Confidence            43221    22344555555555555432111111000  000          000000011234455555555444221


Q ss_pred             ----CccccCCCCCCEEEccCCCCCCCCC----hhhhhcCCCCcEEEcccccCCCc----CCcCCCCCCCcCEEEecCCe
Q 036815          191 ----PVTLSSCSWLQLLDLSNNNISGPFP----DSVLENLGSLESLILSNNMISGS----FPDSISSCKTLRIVDFSSNR  258 (1013)
Q Consensus       191 ----~~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~  258 (1013)
                          ...+..++.|++|+|++|.+.+...    ...+..+++|++|+|++|.++..    +...+..+++|++|++++|.
T Consensus       175 ~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~  254 (344)
T d2ca6a1         175 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL  254 (344)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCC
T ss_pred             cccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCc
Confidence                1223344555666666555542110    11233455566666666655421    22344555666666666666


Q ss_pred             ecccCCCCCCC-----CCCCCceEEcCCCcccccC----Ccccc-ccCcccEEEeeCCccC
Q 036815          259 VSGIIPPDICP-----GVSSLEELRLPDNLITGVI----PGQLS-ECTQLKVIDLSLNYLN  309 (1013)
Q Consensus       259 l~~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~----~~~~~-~l~~L~~L~ls~N~l~  309 (1013)
                      |++.....++.     ....|++|++++|.|+...    ...+. ++++|+.|++++|++.
T Consensus       255 i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         255 LSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             CCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             cCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            65432222211     1245777888888776432    23332 5788999999999997

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=1.1e-13  Score=131.97  Aligned_cols=111  Identities=20%  Similarity=0.150  Sum_probs=61.8

Q ss_pred             ccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCcccEEECCCCCCCCCCCccccCC
Q 036815           45 FSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLLHLDLSQNHIMDVIPSSLSNC  124 (1013)
Q Consensus        45 ~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l~~l  124 (1013)
                      |.++.++++|+|++|+|+ .++ ..+..+++|+.|+|++|+|+.. ++    ...+++|++|++++|+|+++.+..+..+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~-~~~~~l~~L~~L~Ls~N~i~~l-~~----~~~l~~L~~L~ls~N~i~~l~~~~~~~l   86 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIRKL-DG----FPLLRRLKTLLVNNNRICRIGEGLDQAL   86 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCC-CGGGGTTCCSEEECCSSCCCEE-CC----CCCCSSCCEEECCSSCCCEECSCHHHHC
T ss_pred             ccCcCcCcEEECCCCCCC-ccC-ccccccccCCEEECCCCCCCcc-CC----cccCcchhhhhcccccccCCCccccccc
Confidence            455556666666666665 343 2345566666666666666533 11    1245556666666666655544445556


Q ss_pred             CCCCEEecCCCcccccCc-ccccCCCCCCEeeCcCCccc
Q 036815          125 TKLKILNLSFNLLAGEIP-RTFGQLSSLQRLDLSNNHIT  162 (1013)
Q Consensus       125 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~  162 (1013)
                      ++|++|++++|++++... ..+..+++|++|++++|.++
T Consensus        87 ~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          87 PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             TTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cccccceeccccccccccccccccccccchhhcCCCccc
Confidence            666666666666653211 34555566666666666555

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.43  E-value=5.1e-15  Score=161.98  Aligned_cols=240  Identities=21%  Similarity=0.151  Sum_probs=144.5

Q ss_pred             cCCCCCcEEecCCCCcccccC---cccccCCCCCcEEeCCCCccC---CCCch------hhhhCCCCccEEeCCCCcccC
Q 036815           21 QLPFGLKQLELSSAGLVGLVP---DNLFSKLPNLVYLNASYNNLT---GFLPE------TLLSNSDKLELLDLSYNNLTG   88 (1013)
Q Consensus        21 ~~~~~l~~L~L~~~~i~~~~~---~~~~~~l~~L~~L~L~~n~i~---~~~~~------~~~~~l~~L~~L~Ls~n~l~~   88 (1013)
                      +-...|++|+|++|.|.....   ...+...++|+.|+++++.+.   +..+.      ..+..+++|++|+|++|.++.
T Consensus        28 ~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  107 (344)
T d2ca6a1          28 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP  107 (344)
T ss_dssp             HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred             hhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccc
Confidence            445679999999998833211   123567899999999988554   12221      225578999999999999974


Q ss_pred             ccC-CCCcCCCCCCcccEEECCCCCCCCCCCccc-------------cCCCCCCEEecCCCcccccC----cccccCCCC
Q 036815           89 SIS-GFSLNENSCNSLLHLDLSQNHIMDVIPSSL-------------SNCTKLKILNLSFNLLAGEI----PRTFGQLSS  150 (1013)
Q Consensus        89 ~~~-~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~l-------------~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~  150 (1013)
                      ... .+......+++|++|++++|.++......+             ...+.|+.|++++|+++...    ...+..+++
T Consensus       108 ~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~  187 (344)
T d2ca6a1         108 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL  187 (344)
T ss_dssp             TTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT
T ss_pred             ccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhh
Confidence            311 122222356899999999998854221111             34677888888888876432    233456678


Q ss_pred             CCEeeCcCCcccCcC----CccchhccCCCcEEECCCCCCCCc----CCccccCCCCCCEEEccCCCCCCCCChhhhh--
Q 036815          151 LQRLDLSNNHITGWI----PSELGNACDSLLELKLPHNNITGS----FPVTLSSCSWLQLLDLSNNNISGPFPDSVLE--  220 (1013)
Q Consensus       151 L~~L~Ls~n~l~~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~--  220 (1013)
                      |++|++++|.++...    .......+++|++|+|++|.++..    +...+..+++|++|+|++|.|++.....+..  
T Consensus       188 L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l  267 (344)
T d2ca6a1         188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF  267 (344)
T ss_dssp             CCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHH
T ss_pred             hcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHh
Confidence            888888888876321    111223446677777777776533    2344556677777777777766332222211  


Q ss_pred             -c--CCCCcEEEcccccCCCcC----CcCCC-CCCCcCEEEecCCeec
Q 036815          221 -N--LGSLESLILSNNMISGSF----PDSIS-SCKTLRIVDFSSNRVS  260 (1013)
Q Consensus       221 -~--l~~L~~L~L~~n~l~~~~----~~~~~-~l~~L~~L~L~~N~l~  260 (1013)
                       .  .+.|++|++++|+|+...    ...+. ++++|+.|++++|++.
T Consensus       268 ~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             hhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence             1  234666666666655321    11221 3445555555555543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.39  E-value=9.1e-13  Score=119.12  Aligned_cols=42  Identities=24%  Similarity=0.241  Sum_probs=17.2

Q ss_pred             ccCCCCCCEEecCCCcccccC-cccccCCCCCCEeeCcCCccc
Q 036815          121 LSNCTKLKILNLSFNLLAGEI-PRTFGQLSSLQRLDLSNNHIT  162 (1013)
Q Consensus       121 l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~  162 (1013)
                      +.++++|++|++++|++++.. ...+..+++|++|++++|.++
T Consensus        61 ~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            334444444444444443221 123344444444444444443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.32  E-value=3.5e-14  Score=140.63  Aligned_cols=75  Identities=29%  Similarity=0.395  Sum_probs=52.3

Q ss_pred             ccCEEEccCCcccccCChhhhCCCCCcEEecCCCccCCCCc--ccccCCCCcceEecCCccccCCCccc----------c
Q 036815          509 TLEYLDLSYNQFRGKIPDEIGDMIALQVLELAHNQLSGEIP--SSLGRLRNLGVFDASHNRLQGQIPES----------F  576 (1013)
Q Consensus       509 ~L~~L~ls~N~l~g~iP~~i~~l~~L~~L~L~~n~l~g~ip--~~~~~l~~L~~L~ls~N~l~g~~p~~----------~  576 (1013)
                      +|++|++++|+++ .++ .+..+++|+.|+|++|+++ .++  ..+..+++|+.|+|++|.++...+..          +
T Consensus        94 ~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi  170 (198)
T d1m9la_          94 TLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV  170 (198)
T ss_dssp             HCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHH
T ss_pred             ccccccccccccc-ccc-cccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHH
Confidence            4777777777777 343 4777788888888888887 455  46778888888888888876544332          4


Q ss_pred             cCCCcceEEE
Q 036815          577 SNLSFLVQID  586 (1013)
Q Consensus       577 ~~l~~l~~l~  586 (1013)
                      ..+++|+.||
T Consensus       171 ~~lp~L~~LD  180 (198)
T d1m9la_         171 KRLPNLKKLD  180 (198)
T ss_dssp             HHCSSCCEES
T ss_pred             HHCCCcCEeC
Confidence            5566777665

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.27  E-value=1.1e-13  Score=136.97  Aligned_cols=143  Identities=23%  Similarity=0.304  Sum_probs=106.6

Q ss_pred             CCceEECccc--cccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCcCCCCCcEEE
Q 036815          345 NLKDLILNNN--KLSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELGNCSSLVWLD  422 (1013)
Q Consensus       345 ~L~~L~L~~N--~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  422 (1013)
                      .++.+++.++  .+. .+|..+..+++|++|+|++|+|+ .++ .+..+++|+.|+|++|+++ .+|..+..+++|++|+
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~   99 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW   99 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence            3455666654  344 56778888999999999999988 454 5888999999999999987 6676566667899999


Q ss_pred             ccCCcCCcCCCchhhhccCCCCCCCcccCCceEEEeccCCCccCCCcccccccCCcccccccCccccccccccccCcccc
Q 036815          423 LNSNNLTGDIPPRLGRQLGAKPLGGFLSSNTLVFVRNVGNSCKGVGGLLEFAGIRPERLLQIPTLKSCDFARMYSGPVLS  502 (1013)
Q Consensus       423 l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  502 (1013)
                      +++|+++. ++                                                                     
T Consensus       100 l~~N~i~~-l~---------------------------------------------------------------------  109 (198)
T d1m9la_         100 ISYNQIAS-LS---------------------------------------------------------------------  109 (198)
T ss_dssp             CSEEECCC-HH---------------------------------------------------------------------
T ss_pred             cccccccc-cc---------------------------------------------------------------------
Confidence            99988762 11                                                                     


Q ss_pred             cccCCCccCEEEccCCcccccCC--hhhhCCCCCcEEecCCCccCCCCccc----------ccCCCCcceEe
Q 036815          503 LFTQYQTLEYLDLSYNQFRGKIP--DEIGDMIALQVLELAHNQLSGEIPSS----------LGRLRNLGVFD  562 (1013)
Q Consensus       503 ~~~~~~~L~~L~ls~N~l~g~iP--~~i~~l~~L~~L~L~~n~l~g~ip~~----------~~~l~~L~~L~  562 (1013)
                      .+..+++|++||+++|+++ .++  ..++.+++|+.|+|++|.++...+..          +..+++|+.||
T Consensus       110 ~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         110 GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             cccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            0223457889999999998 455  46788999999999999887433322          67789999987

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=6.4e-11  Score=111.63  Aligned_cols=103  Identities=20%  Similarity=0.192  Sum_probs=46.4

Q ss_pred             EEECCCCCCCCCCCccccCCCCCCEEecCCC-cccccCcccccCCCCCCEeeCcCCcccCcCCccchhccCCCcEEECCC
Q 036815          105 HLDLSQNHIMDVIPSSLSNCTKLKILNLSFN-LLAGEIPRTFGQLSSLQRLDLSNNHITGWIPSELGNACDSLLELKLPH  183 (1013)
Q Consensus       105 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~  183 (1013)
                      .++.+++.+.+ .|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+ .++...+..+++|++|+|++
T Consensus        12 ~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          12 GLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             CEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCCEEECCS
T ss_pred             eEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-CcccccccccccccceeccC
Confidence            34444444433 2333444444555555433 244444444445555555555555544 34333344444444444444


Q ss_pred             CCCCCcCCccccCCCCCCEEEccCCCC
Q 036815          184 NNITGSFPVTLSSCSWLQLLDLSNNNI  210 (1013)
Q Consensus       184 n~l~~~~~~~l~~l~~L~~L~L~~N~l  210 (1013)
                      |+|+.+.+..|... +|+.|+|++|.+
T Consensus        90 N~l~~l~~~~~~~~-~l~~L~L~~Np~  115 (156)
T d2ifga3          90 NALESLSWKTVQGL-SLQELVLSGNPL  115 (156)
T ss_dssp             SCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred             CCCcccChhhhccc-cccccccCCCcc
Confidence            44443333333222 355555555555

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.12  E-value=1.3e-10  Score=109.58  Aligned_cols=96  Identities=23%  Similarity=0.202  Sum_probs=81.1

Q ss_pred             CCCcCcCCCCCCceEECcccc-ccccCchhhcCCCCCCeEEecCCccCCCCChhhhccCCCceEEccCCeeeeecCCCCc
Q 036815          335 KIPPELGKCKNLKDLILNNNK-LSGEIPAELFSCSNLEWISLTGNELTGQIPPEFSRLTRLAVLQLGNNRFKGEIPGELG  413 (1013)
Q Consensus       335 ~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  413 (1013)
                      ..|..+..+++|++|++++|+ ++...+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|++|+++ .+|....
T Consensus        22 ~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~  100 (156)
T d2ifga3          22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTV  100 (156)
T ss_dssp             TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTT
T ss_pred             cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhh
Confidence            445667778899999998764 88666678999999999999999999777888999999999999999999 6666655


Q ss_pred             CCCCCcEEEccCCcCCcC
Q 036815          414 NCSSLVWLDLNSNNLTGD  431 (1013)
Q Consensus       414 ~l~~L~~L~l~~N~l~~~  431 (1013)
                      ...+|+.|+|++|.+.+.
T Consensus       101 ~~~~l~~L~L~~Np~~C~  118 (156)
T d2ifga3         101 QGLSLQELVLSGNPLHCS  118 (156)
T ss_dssp             CSCCCCEEECCSSCCCCC
T ss_pred             ccccccccccCCCcccCC
Confidence            556899999999999754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.50  E-value=2.3e-07  Score=95.57  Aligned_cols=149  Identities=12%  Similarity=0.034  Sum_probs=103.0

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEE
Q 036815          728 QLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERL  806 (1013)
Q Consensus       728 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  806 (1013)
                      ++...-..|+.++..+.++.+.||+... +++.+++|+...........+.+|..+++.+. +--+.+++.+..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            3444456677666555555678998864 46778888775544444456778888887773 444677888888889999


Q ss_pred             EEEEcccCCCHHHHhcccccCCCCccccHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 036815          807 LVYEFMKFGSLEEVLHGRAKARDQRILTWDARKKIARGAAKGLCFLHHNC------------------------------  856 (1013)
Q Consensus       807 lv~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------  856 (1013)
                      +||++++|.++.+.....           .....++.++++.++.||+..                              
T Consensus        87 lv~~~l~G~~~~~~~~~~-----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC-----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             EEEEeccccccccccccc-----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            999999998887654211           112234555666666666321                              


Q ss_pred             --------------------------CCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          857 --------------------------IPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       857 --------------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                                                ...++|+|+.|.||++++++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                      12389999999999999876677999998753

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.37  E-value=8.8e-09  Score=97.41  Aligned_cols=123  Identities=24%  Similarity=0.108  Sum_probs=64.9

Q ss_pred             CCcEEecCCCCcccccCcccccCCCCCcEEeCCCCccCCCCchhhhhCCCCccEEeCCCCcccCccCCCCcCCCCCCccc
Q 036815           25 GLKQLELSSAGLVGLVPDNLFSKLPNLVYLNASYNNLTGFLPETLLSNSDKLELLDLSYNNLTGSISGFSLNENSCNSLL  104 (1013)
Q Consensus        25 ~l~~L~L~~~~i~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~  104 (1013)
                      ..+.|++++++....     +..+..+..++...+.++ .+ ..++..+++|++|+|++|+|+.... +......+++|+
T Consensus        23 ~~~~Ldls~l~~~~~-----l~~~~~~~~l~~~~~~~~-~l-~~~~~~~~~L~~L~Ls~N~i~~l~~-~~~~~~~l~~L~   94 (162)
T d1koha1          23 SQQALDLKGLRSDPD-----LVAQNIDVVLNRRSSMAA-TL-RIIEENIPELLSLNLSNNRLYRLDD-MSSIVQKAPNLK   94 (162)
T ss_dssp             SSCCBCCCCCSSCTT-----TTTTTCCCCTTSHHHHHH-HH-HHHHHHCTTCCCCCCCSSCCCCCSG-GGTHHHHSTTCC
T ss_pred             hhCeeecccCCCCch-----hhhccchhhcchhhhHhh-hh-HHHHHhCCCCCEeeCCCccccCCch-hHHHHhhCCccc
Confidence            466677776654211     333444445555544333 22 3345667888888888888874321 111123456666


Q ss_pred             EEECCCCCCCCCCCccccCCCCCCEEecCCCcccccCc-------ccccCCCCCCEee
Q 036815          105 HLDLSQNHIMDVIPSSLSNCTKLKILNLSFNLLAGEIP-------RTFGQLSSLQRLD  155 (1013)
Q Consensus       105 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-------~~~~~l~~L~~L~  155 (1013)
                      .|||++|.|+++.+-.+....+|++|++++|.+.....       ..+..+++|+.||
T Consensus        95 ~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             ccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            66666666666433233334456666666666653322       1134455555554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.26  E-value=4.7e-08  Score=92.24  Aligned_cols=66  Identities=24%  Similarity=0.228  Sum_probs=32.0

Q ss_pred             ccCCCCCCEeeCcCCcccCcCC--ccchhccCCCcEEECCCCCCCCcCCccccCCCCCCEEEccCCCCC
Q 036815          145 FGQLSSLQRLDLSNNHITGWIP--SELGNACDSLLELKLPHNNITGSFPVTLSSCSWLQLLDLSNNNIS  211 (1013)
Q Consensus       145 ~~~l~~L~~L~Ls~n~l~~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~  211 (1013)
                      +..+++|++|+|++|+|+ .++  ...+..+++|+.|+|++|.|+...+..+....+|+.|++++|.+.
T Consensus        61 ~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          61 EENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             HHhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            344555666666666655 222  122333455555555555555433322223344555555555554

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.78  E-value=2.8e-06  Score=80.16  Aligned_cols=15  Identities=0%  Similarity=-0.192  Sum_probs=7.1

Q ss_pred             cCCCCCCEEecCCCc
Q 036815          122 SNCTKLKILNLSFNL  136 (1013)
Q Consensus       122 ~~l~~L~~L~L~~n~  136 (1013)
                      ...+.|++|++++|.
T Consensus        97 ~~n~sL~~L~l~~n~  111 (167)
T d1pgva_          97 LVTQSIVEFKADNQR  111 (167)
T ss_dssp             TTTCCCSEEECCCCS
T ss_pred             HhCCcCCEEECCCCc
Confidence            344445555554443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.78  E-value=2.7e-05  Score=79.03  Aligned_cols=129  Identities=15%  Similarity=0.064  Sum_probs=83.8

Q ss_pred             ecccCC-cEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccC--CcceeeeccEEEeCCEEEEEEEcccCCCHH
Q 036815          742 IGCGGF-GEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIK--HRNLVPLLGYCKIGEERLLVYEFMKFGSLE  818 (1013)
Q Consensus       742 lG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  818 (1013)
                      +..|.. +.||+....++..+++|.....   ....+..|+..++.+.  .-.+.+++.+..+++..++||+|++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444543 6799998877878888864332   2334677888887773  334667788878888899999999986543


Q ss_pred             HHhcccccCCCCccccHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 036815          819 EVLHGRAKARDQRILTWDARKKIARGAAKGLCFLH---------------------------------------------  853 (1013)
Q Consensus       819 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH---------------------------------------------  853 (1013)
                      +..           ...   ...+.++++.|+-||                                             
T Consensus        95 ~~~-----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (255)
T d1nd4a_          95 SSH-----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  160 (255)
T ss_dssp             TSC-----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             ccc-----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence            210           000   011222333333333                                             


Q ss_pred             ------hcC----CCCeEecCCCcccEEeCCCCcEEEeecccce
Q 036815          854 ------HNC----IPHIIHRDMKSSNVLLDHEMEARVSDFGMAR  887 (1013)
Q Consensus       854 ------~~~----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  887 (1013)
                            ...    ...++|+|+.|.||+++.+..+.|+||+.+.
T Consensus       161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                  211    1248999999999999987667899999775

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.75  E-value=4e-06  Score=79.02  Aligned_cols=14  Identities=7%  Similarity=0.238  Sum_probs=8.1

Q ss_pred             hhCCCCccEEeCCC
Q 036815           70 LSNSDKLELLDLSY   83 (1013)
Q Consensus        70 ~~~l~~L~~L~Ls~   83 (1013)
                      ..+.++|++|+|++
T Consensus        11 ~~n~~~L~~L~L~~   24 (167)
T d1pgva_          11 REDDTDLKEVNINN   24 (167)
T ss_dssp             HTTCSSCCEEECTT
T ss_pred             HhCCCCCcEEEeCC
Confidence            34456666666665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.38  E-value=0.00027  Score=76.24  Aligned_cols=76  Identities=17%  Similarity=0.071  Sum_probs=49.1

Q ss_pred             CCeecccCCcEEEEEEEcC-CCEEEEEEeeccC-------ccchHHHHHHHHHHhccC-C--cceeeeccEEEeCCEEEE
Q 036815          739 ESLIGCGGFGEVFKATLKD-GSSVAIKKLIRLS-------CQGDREFMAEMETLGKIK-H--RNLVPLLGYCKIGEERLL  807 (1013)
Q Consensus       739 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  807 (1013)
                      .+.||.|....||++...+ ++.|+||.-....       .....+...|++.++.+. +  ..+.+++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999998764 6789999653210       112234567888887662 2  345566544  4556679


Q ss_pred             EEEcccCCC
Q 036815          808 VYEFMKFGS  816 (1013)
Q Consensus       808 v~e~~~~g~  816 (1013)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.22  E-value=1.8e-05  Score=74.44  Aligned_cols=14  Identities=7%  Similarity=0.124  Sum_probs=7.0

Q ss_pred             cCCCCCCEeeCcCC
Q 036815          146 GQLSSLQRLDLSNN  159 (1013)
Q Consensus       146 ~~l~~L~~L~Ls~n  159 (1013)
                      ...++|+.|+++.+
T Consensus       129 ~~n~~L~~L~l~~~  142 (166)
T d1io0a_         129 EKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHCSSCCEEECCCS
T ss_pred             HhCCCcCEEeCcCC
Confidence            34455555555444

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.19  E-value=1.8e-05  Score=74.35  Aligned_cols=123  Identities=14%  Similarity=0.108  Sum_probs=83.9

Q ss_pred             ccccccCCCCCcEEecCC-CCccccc---CcccccCCCCCcEEeCCCCccCCCCch---hhhhCCCCccEEeCCCCcccC
Q 036815           16 STSLLQLPFGLKQLELSS-AGLVGLV---PDNLFSKLPNLVYLNASYNNLTGFLPE---TLLSNSDKLELLDLSYNNLTG   88 (1013)
Q Consensus        16 ~~~~~~~~~~l~~L~L~~-~~i~~~~---~~~~~~~l~~L~~L~L~~n~i~~~~~~---~~~~~l~~L~~L~Ls~n~l~~   88 (1013)
                      -..+....+.|++|+|++ +.+....   -..++..+++|++|+|++|.+++....   ..+...+.++.+++++|.++.
T Consensus         9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~   88 (166)
T d1io0a_           9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG   88 (166)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence            334445567899999998 4563221   112356789999999999999743222   346678999999999999974


Q ss_pred             cc-CCCCcCCCCCCcccEEEC--CCCCCCCC----CCccccCCCCCCEEecCCCccc
Q 036815           89 SI-SGFSLNENSCNSLLHLDL--SQNHIMDV----IPSSLSNCTKLKILNLSFNLLA  138 (1013)
Q Consensus        89 ~~-~~~~~~~~~~~~L~~L~L--s~n~i~~~----~~~~l~~l~~L~~L~L~~n~l~  138 (1013)
                      .. ..+.......++|+.++|  ++|.+.+.    +...+...+.|++|+++.+...
T Consensus        89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_          89 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             hhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence            22 222333445678887665  56778653    4445667899999999887653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.93  E-value=0.0025  Score=66.43  Aligned_cols=139  Identities=11%  Similarity=0.077  Sum_probs=79.3

Q ss_pred             CcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCCcc-----eeeec--cEEEeCCEEEEEEEcccCCCHH-
Q 036815          747 FGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRN-----LVPLL--GYCKIGEERLLVYEFMKFGSLE-  818 (1013)
Q Consensus       747 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~l~--~~~~~~~~~~lv~e~~~~g~L~-  818 (1013)
                      .-.||+++..+|+.|++|.... .....+++..|...+..+....     .+..-  ..+..++..+.++++++|..+. 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            4689999999999999996543 3445677888998887774221     11211  1334567788999999863321 


Q ss_pred             ----HH---------hccc---ccCCCCccccH-------------------HHHHHHHHHHHHHHHHHHh----cCCCC
Q 036815          819 ----EV---------LHGR---AKARDQRILTW-------------------DARKKIARGAAKGLCFLHH----NCIPH  859 (1013)
Q Consensus       819 ----~~---------l~~~---~~~~~~~~l~~-------------------~~~~~i~~~i~~~L~~LH~----~~~~~  859 (1013)
                          .+         ++..   .........++                   .....+...+.+.++.+..    ..+.+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                11         1110   00001111111                   1111122222223333322    22357


Q ss_pred             eEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          860 IIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       860 ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      +||+|+.+.||+++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            9999999999999754  45899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.19  E-value=0.021  Score=58.85  Aligned_cols=162  Identities=12%  Similarity=0.067  Sum_probs=85.1

Q ss_pred             cCHHHHHHHhcCCCCCCeec-----ccCCcEEEEEEEcCCCEEEEEEeeccCccchHHHHHHHHHHhccCC-----ccee
Q 036815          724 LKFSQLIEATNGFSAESLIG-----CGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKH-----RNLV  793 (1013)
Q Consensus       724 ~~~~~~~~~~~~y~~~~~lG-----~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv  793 (1013)
                      ++.+++.....+|.+++...     .|---+.|+.+..+| .+++|+....  ...+++..|++++..+..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence            55677777778888866554     455578899987755 4888876432  223455667777766632     2222


Q ss_pred             eecc---EEEeCCEEEEEEEcccCCCHHH--------------Hhcc----cccCCCCccc-----------------cH
Q 036815          794 PLLG---YCKIGEERLLVYEFMKFGSLEE--------------VLHG----RAKARDQRIL-----------------TW  835 (1013)
Q Consensus       794 ~l~~---~~~~~~~~~lv~e~~~~g~L~~--------------~l~~----~~~~~~~~~l-----------------~~  835 (1013)
                      ...+   +....+..+.++.++.+.....              .++.    ..........                 ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            2111   2233556677777776532211              0000    0000000000                 00


Q ss_pred             HHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcccEEeCCCCcEEEeeccccee
Q 036815          836 DARKKIARGAAKGLCFLHH-NCIPHIIHRDMKSSNVLLDHEMEARVSDFGMARL  888 (1013)
Q Consensus       836 ~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  888 (1013)
                      ......+......+...+. ..+.++||+|+.++||+++.+...-|+||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            1111112222222222221 1234799999999999999987778999998853

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.03  E-value=0.0048  Score=66.23  Aligned_cols=72  Identities=17%  Similarity=0.125  Sum_probs=48.2

Q ss_pred             CeecccCCcEEEEEEEcCC--------CEEEEEEeeccCccchHHHHHHHHHHhccC-CcceeeeccEEEeCCEEEEEEE
Q 036815          740 SLIGCGGFGEVFKATLKDG--------SSVAIKKLIRLSCQGDREFMAEMETLGKIK-HRNLVPLLGYCKIGEERLLVYE  810 (1013)
Q Consensus       740 ~~lG~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  810 (1013)
                      +.|+.|-.-.+|++..+++        +.|+++..-  .........+|..+++.+. +.-..++++++..    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g--~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF--NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC--SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC--CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            5688888899999987542        456666543  2233445668999988884 4334577776642    58999


Q ss_pred             cccCCCH
Q 036815          811 FMKFGSL  817 (1013)
Q Consensus       811 ~~~~g~L  817 (1013)
                      |++|.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987543